PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Minohara, M; Tachikawa, T; Nakanishi, Y; Hikita, Y; Kourkoutis, LF; Lee, JS; Kao, CC; Yoshita, M; Akiyama, H; Bell, C; Hwang, HY				Minohara, Makoto; Tachikawa, Takashi; Nakanishi, Yasuo; Hikita, Yasuyuki; Kourkoutis, Lena F.; Lee, Jun-Sik; Kao, Chi-Chang; Yoshita, Masahiro; Akiyama, Hidefumi; Bell, Christopher; Hwang, Harold Y.			Atomically Engineered Metal Insulator Transition at the TiO2/LaAlO3 Heterointerface	NANO LETTERS			English	Article						anatase TiO2; heterointerfaces; termination layer switching metal-insulator transition	ANATASE TIO2; OXIDE INTERFACES; SINGLE-CRYSTALS; THIN-FILMS	We demonstrate that the atomic boundary conditions of simple binary oxides can be used to impart dramatic changes of state. By changing the substrate surface termination of LaAlO3 (001) from AlO2 to LaO, the room-temperature sheet conductance of anatase TiO2 films are increased by over 3 orders of magnitude, transforming the intrinsic insulating state to a high mobility metallic state, while maintaining excellent optical transparency.	[Minohara, Makoto; Tachikawa, Takashi; Hikita, Yasuyuki; Bell, Christopher; Hwang, Harold Y.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Tachikawa, Takashi; Nakanishi, Yasuo] Univ Tokyo, Dept Adv Mat Sci, Kashiwa, Chiba 2778561, Japan; [Kourkoutis, Lena F.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Kourkoutis, Lena F.] Kavil Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA; [Lee, Jun-Sik; Kao, Chi-Chang] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Yoshita, Masahiro; Akiyama, Hidefumi] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Hwang, Harold Y.] Stanford Univ, Dept Appl Phys, Geballe Lab Adv Mat, Stanford, CA 94305 USA	Minohara, M (reprint author), High Energy Accelerator Org KEK, IMSS, Photon Factory, Tsukuba, Ibaraki 3050801, Japan.	minohara@post.kek.jp	Bell, Christopher/B-8785-2009; Minohara, Makoto/A-8841-2012; Hikita, Yasuyuki/F-5600-2011	Bell, Christopher/0000-0003-4732-0354; 	Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering Division [DE-AC02-76SF00515]; ONR-MURI [N00014-12-1-0976]	We thank H. Hosono and K. S. Takahashi for discussions and H. Takagi and M. Lippmaa for experimental support. This work was primarily supported by the Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering Division, under contract DE-AC02-76SF00515 (M.M., T.T., Y.H, C.B., J.L, and H.Y.H.). M.M. acknowledges partial support from the ONR-MURI number N00014-12-1-0976. X-ray absorption spectroscopy studies were carried out at the SSRL, a Directorate of SLAC and an Office of Science User Facility operated for the US DOE Office of Science by Stanford University.	Liao ZL, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3159471; Murakami M, 2001, APPL PHYS LETT, V78, P2664, DOI 10.1063/1.1365412; Wang ZC, 2010, J APPL PHYS, V108, DOI 10.1063/1.3516496; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; Furubayashi Y, 2007, J APPL PHYS, V101, DOI 10.1063/1.2721748; Nishimura J, 2004, JPN J APPL PHYS 2, V43, pL1032, DOI 10.1143/JJAP.43.L1032; Herranz G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.216803; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Furubayashi Y, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1949728; Mannhart J, 2010, SCIENCE, V327, P1607, DOI 10.1126/science.1181862; Willmott PR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.155502; Hwang HY, 2012, NAT MATER, V11, P103, DOI [10.1038/nmat3223, 10.1038/NMAT3223]; Hitosugi T, 2005, JPN J APPL PHYS 2, V44, pL1063, DOI 10.1143/JJAP.44.L1063; [Anonymous], 1972, NATURE; TANG H, 1993, SOLID STATE COMMUN, V87, P847, DOI 10.1016/0038-1098(93)90427-O; FORRO L, 1994, J APPL PHYS, V75, P633, DOI 10.1063/1.355801; Siemons W, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.196802; Alves H, 2008, NAT MATER, V7, P574, DOI 10.1038/nmat2205; DIEBOLD U, 1995, SURF SCI, V331, P845, DOI 10.1016/0039-6028(95)00124-7; Hikita Y, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.073101; Kalabukhov A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121404; Lanier CH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.086102; MACCHESNEY JB, 1962, J AM CERAM SOC, V45, P416, DOI 10.1111/j.1151-2916.1962.tb11185.x; Minami T., 2005, SEMICOND SCI TECH, V20, pS35, DOI DOI 10.1088/0268-1242/20/4/004; Nagao Y, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3507898; Oregan B., 1991, NATURE, V353, P6346; Sclafani A, 1996, J PHYS CHEM-US, V100, P13655, DOI 10.1021/jp9533584; Tachikawa T, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4733724; TANG H, 1994, J APPL PHYS, V75, P2042, DOI 10.1063/1.356306; Weissmann M, 2009, J PHYS CONF SER, V167, DOI 10.1088/1742-6596/167/1/012060; Zheng SJ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766338	31	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	NOV	2014	14	11					6743	6746		10.1021/nl5039192		4	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AU6PE	WOS:000345723800113		
J	Alvira, S; Cuellar, J; Rohl, A; Yamamoto, S; Itoh, H; Alfonso, C; Rivas, G; Buchner, J; Valpuesta, JM				Alvira, Sara; Cuellar, Jorge; Roehl, Alina; Yamamoto, Soh; Itoh, Hideaki; Alfonso, Carlos; Rivas, German; Buchner, Johannes; Valpuesta, Jose M.			Structural characterization of the substrate transfer mechanism in Hsp70/Hsp90 folding machinery mediated by Hop	NATURE COMMUNICATIONS			English	Article							HEAT-SHOCK-PROTEIN; SIZE-DISTRIBUTION ANALYSIS; HSP90 CHAPERONE MACHINERY; LIGAND-BINDING DOMAIN; MOLECULAR CHAPERONE; GLUCOCORTICOID-RECEPTOR; IN-VIVO; TETRATRICOPEPTIDE REPEAT; ELECTRON CRYOMICROSCOPY; CONFORMATIONAL-CHANGES	In eukarya, chaperones Hsp70 and Hsp90 act coordinately in the folding and maturation of a range of key proteins with the help of several co-chaperones, especially Hop. Although biochemical data define the Hop-mediated Hsp70-Hsp90 substrate transfer mechanism, the intrinsic flexibility of these proteins and the dynamic nature of their complexes have limited the structural studies of this mechanism. Here we generate several complexes in the Hsp70/Hsp90 folding pathway (Hsp90: Hop, Hsp90: Hop: Hsp70 and Hsp90: Hop: Hsp70 with a fragment of the client protein glucocorticoid receptor (GR-LBD)), and determine their 3D structure using electron microscopy techniques. Our results show that one Hop molecule binds to one side of the Hsp90 dimer in both extended and compact conformations, through Hop domain rearrangement that take place when Hsp70 or Hsp70: GR-LBD bind to Hsp90: Hop. The compact conformation of the Hsp90: Hop: Hsp70: GR-LBD complex shows that GR-LBD binds to the side of the Hsp90 dimer opposite the Hop attachment site.	[Alvira, Sara; Cuellar, Jorge; Valpuesta, Jose M.] CSIC, Ctr Nacl Biotecnol, Madrid 28049, Spain; [Roehl, Alina; Buchner, Johannes] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci CIPSM, D-85747 Garching, Germany; [Yamamoto, Soh; Itoh, Hideaki] Akita Univ, Fac & Grad Sch Engn & Resource Sci, Dept Life Sci, Akita 0108502, Japan; [Yamamoto, Soh] Sapporo Med Univ, Sch Med, Dept Microbiol, Sapporo, Hokkaido 0608556, Japan; [Alfonso, Carlos; Rivas, German] CSIC, Ctr Invest Biol, Madrid 28040, Spain	Valpuesta, JM (reprint author), CSIC, Ctr Nacl Biotecnol, Darwin 3, Madrid 28049, Spain.	jmv@cnb.csic.es	Alfonso, Carlos/K-1316-2014; Partearroyo, CIB-Biblioteca/L-3262-2014	Alfonso, Carlos/0000-0001-7165-4800; Partearroyo, CIB-Biblioteca/0000-0002-1692-4481	Spanish Ministry of Science and Innovation [BFU2013-44202, BES-2008-009031]; Deutsche Forschungsgemeinscaft [SFB1035]; CompInt programme of the Elitenetzwerk Bayern	We thank Dr Jesus Avila (CBM-CSIC, Madrid) for the gift of human Hsp90 alpha cDNA, Juan Roman Luque and Jorge Martinez (CIB Analytical Ultracentrifugation Facility) for technical assistance and Catherine Mark for editorial assistance. This work was supported by a grants from the Spanish Ministry of Science and Innovation (BFU2013-44202 to J.M.V.) and from the Deutsche Forschungsgemeinscaft (SFB1035) to J.B. S.A. was supported by fellowship from the Spanish Ministry of Science and Innovation (BES-2008-009031). A.R. was supported by the CompInt programme of the Elitenetzwerk Bayern.	Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Street TO, 2010, PROTEIN SCI, V19, P57, DOI 10.1002/pro.282; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Hartson SD, 1999, BIOCHEMISTRY-US, V38, P3837, DOI 10.1021/bi983027s; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pascual-Montano A, 2001, J STRUCT BIOL, V133, P233, DOI 10.1006/jsbi.2001.4369; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Yamamoto S, 2014, J BIOL CHEM, V289, P9880, DOI 10.1074/jbc.M114.553255; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Wegele H, 2003, J BIOL CHEM, V278, P25970, DOI 10.1074/jbc.M301548200; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Dittmar KD, 1998, J BIOL CHEM, V273, P7358, DOI 10.1074/jbc.273.13.7358; Nollen EAA, 2002, J CELL SCI, V115, P2809; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007; Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Flom G, 2007, BIOCHEM J, V404, P159, DOI 10.1042/BJ20070084; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Schuck P, 2002, BIOPHYS J, V82, P1096; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Qian XG, 2002, BIOCHEM J, V361, P27, DOI 10.1042/0264-6021:3610027; Schuck P, 2000, BIOPHYS J, V78, P1606; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Golas MM, 2009, EMBO J, V28, P766, DOI 10.1038/emboj.2009.19; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lee CT, 2012, EMBO J, V31, P1518, DOI 10.1038/emboj.2012.37; Carrigan PE, 2004, J BIOL CHEM, V279, P16185, DOI 10.1074/jbc.M314130200; Carrigan PE, 2006, PROTEIN SCI, V15, P522, DOI 10.1110/ps.051810106; Liebscher M, 2009, J BACTERIOL, V191, P1456, DOI 10.1128/JB.01131-08; Aprile FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067961; Benaroudj N, 1997, J BIOL CHEM, V272, P8744; Benaroudj N, 1996, J BIOL CHEM, V271, P18471; Bledsoe RK, 2004, VITAM HORM, V68, P49; Buchner J, 1998, METHOD ENZYMOL, V290, P409, DOI 10.1016/S0076-6879(98)90034-9; Chang HCJ, 1997, MOL CELL BIOL, V17, P318; Ebong IO, 2011, P NATL ACAD SCI USA, V108, P17939, DOI 10.1073/pnas.1106261108; Garcia de la Torre J., 2001, EUR BIOPHYS J, V30, P457, DOI DOI 10.1007/S002490100176; Gigant B, 1997, P NATL ACAD SCI USA, V94, P7857, DOI 10.1073/pnas.94.15.7857; Grad Iwona, 2007, Mol Cell Endocrinol, V275, P2, DOI 10.1016/j.mce.2007.05.018; HUTCHISON KA, 1995, J BIOL CHEM, V270, P18841; Jackson S. E., 2012, TOP CURR CHEM, V328, P155; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Morishima Y, 2001, BIOCHEMISTRY-US, V40, P1109, DOI 10.1021/bi002399+; Ratzke C., 2011, P NATL ACAD SCI USA, V109, P161; Richter K, 2011, STRUCTURE, V19, P445, DOI 10.1016/j.str.2011.03.007; Scheres SHW, 2010, METHOD ENZYMOL, V482, P295, DOI 10.1016/S0076-6879(10)82012-9; Simunovic M, 2012, BIOPHYS J, V103, P284, DOI 10.1016/j.bpj.2012.06.018; Suzuki H., 2008, BIOCHEMISTRY-US, V49, P8577; Yi F, 2010, PROTEIN SCI, V19, P19, DOI 10.1002/pro.278	70	8	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5484	10.1038/ncomms6484		13	Multidisciplinary Sciences	Science & Technology - Other Topics	AU9KF	WOS:000345910500012		
J	Chakravarty, D; Sboner, A; Nair, SS; Giannopoulou, E; Li, RH; Hennig, S; Mosquera, JM; Pauwels, J; Park, K; Kossai, M; MacDonald, TY; Fontugne, J; Erho, N; Vergara, IA; Ghadessi, M; Davicioni, E; Jenkins, RB; Palanisamy, N; Chen, ZM; Nakagawa, S; Hirose, T; Bander, NH; Beltran, H; Fox, AH; Elemento, O; Rubin, MA				Chakravarty, Dimple; Sboner, Andrea; Nair, Sujit S.; Giannopoulou, Eugenia; Li, Ruohan; Hennig, Sven; Mosquera, Juan Miguel; Pauwels, Jonathan; Park, Kyung; Kossai, Myriam; MacDonald, Theresa Y.; Fontugne, Jacqueline; Erho, Nicholas; Vergara, Ismael A.; Ghadessi, Mercedeh; Davicioni, Elai; Jenkins, Robert B.; Palanisamy, Nallasivam; Chen, Zhengming; Nakagawa, Shinichi; Hirose, Tetsuro; Bander, Neil H.; Beltran, Himisha; Fox, Archa H.; Elemento, Olivier; Rubin, Mark A.			The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer	NATURE COMMUNICATIONS			English	Article							LONG NONCODING RNA; GENE-EXPRESSION PROFILES; ANDROGEN RECEPTOR; MEMBRANE ANTIGEN; RADICAL PROSTATECTOMY; INCREASED SURVIVAL; NUCLEAR-BODIES; PROGRESSION; CHROMATIN; REVEALS	The androgen receptor (AR) plays a central role in establishing an oncogenic cascade that drives prostate cancer progression. Some prostate cancers escape androgen dependence and are often associated with an aggressive phenotype. The oestrogen receptor alpha (ER alpha) is expressed in prostate cancers, independent of AR status. However, the role of ER alpha remains elusive. Using a combination of chromatin immunoprecipitation (ChIP) and RNA-sequencing data, we identified an ER alpha-specific non-coding transcriptome signature. Among putatively ER alpha-regulated intergenic long non-coding RNAs (lncRNAs), we identified nuclear enriched abundant transcript 1 (NEAT1) as the most significantly overexpressed lncRNA in prostate cancer. Analysis of two large clinical cohorts also revealed that NEAT1 expression is associated with prostate cancer progression. Prostate cancer cells expressing high levels of NEAT1 were recalcitrant to androgen or AR antagonists. Finally, we provide evidence that NEAT1 drives oncogenic growth by altering the epigenetic landscape of target gene promoters to favour transcription.	[Chakravarty, Dimple; Sboner, Andrea; Mosquera, Juan Miguel; Kossai, Myriam; Fontugne, Jacqueline; Beltran, Himisha; Elemento, Olivier; Rubin, Mark A.] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Chakravarty, Dimple; Sboner, Andrea; Mosquera, Juan Miguel; Kossai, Myriam; Fontugne, Jacqueline; Beltran, Himisha; Elemento, Olivier; Rubin, Mark A.] Cornell Univ, Weill Med Coll, Inst Precis Med, New York, NY 10021 USA; [Chakravarty, Dimple; Sboner, Andrea; Mosquera, Juan Miguel; Kossai, Myriam; Fontugne, Jacqueline; Beltran, Himisha; Elemento, Olivier; Rubin, Mark A.] New York Presbyterian Hosp, New York, NY 10021 USA; [Sboner, Andrea; Elemento, Olivier] Cornell Univ, Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Nair, Sujit S.] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20037 USA; [Giannopoulou, Eugenia] CUNY, New York City Coll Technol, Dept Biol Sci, Brooklyn, NY 11201 USA; [Giannopoulou, Eugenia] Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Giannopoulou, Eugenia] Hosp Special Surg, David Z Rosensweig Genom Res Ctr, New York, NY 10021 USA; [Li, Ruohan; Fox, Archa H.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, WA 6009, Australia; [Hennig, Sven] Chem Genom Ctr, D-44227 Dortmund, Germany; [Erho, Nicholas; Vergara, Ismael A.; Ghadessi, Mercedeh; Davicioni, Elai] GenomeDx Biosci, Res & Dev, Vancouver, BC V6B 1B8, Canada; [Jenkins, Robert B.] Mayo Clin, Dept Pathol & Lab Med, Rochester, MN 55905 USA; [Palanisamy, Nallasivam] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48105 USA; [Palanisamy, Nallasivam] Henry Ford Hlth Syst, Med Grp Urol Prostate Canc Res, Detroit, MI 48202 USA; [Chen, Zhengming] Weill Cornell Med Coll, Dept Publ Hlth, Div Biostat & Epidemiol, New York, NY 10021 USA; [Nakagawa, Shinichi] RIKEN, Adv Res Inst, RNA Biol Lab, Wako, Saitama 3510198, Japan; [Hirose, Tetsuro] Hokkaido Univ, Inst Med Genet, Kita Ku, Sapporo, Hokkaido 0600815, Japan; [Bander, Neil H.] Cornell Univ, Weill Cornell Med Coll, Dept Urol, New York, NY 10021 USA	Rubin, MA (reprint author), Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, 413 East 69th St,Room 1402, New York, NY 10021 USA.	rubinma@med.cornell.edu	Li, Ruohan/O-8690-2014; Fox, Archa/H-9219-2014; Nakagawa, Shinichi/I-4192-2014	Fox, Archa/0000-0003-1962-270X; 	NCI [R01 CA152057]; Early Detection Research Network NCI [U01 CA111275]; Prostate Cancer Foundation Young Investigator award; Clinical and Translation Science Center at Weill Cornell Medical College [UL1TR000457]	This work was supported by NCI R01 CA152057 (A.S. and M.A.R.), the Early Detection Research Network NCI U01 CA111275 (M.A.R.) and the Prostate Cancer Foundation Young Investigator award (D.C. and M.B.). We thank Francesca Demichelis for identification of somatic copy number variations, Wasay Hussain for the RNA sequencing analysis, Anastas Popratiloff from George Washington University for advice on imaging. We also thank John S. Mattick and Marcel Dinger for their help in accessing and using data from www.lncrnadb.org. This investigation received editorial support from grant UL1TR000457 of the Clinical and Translation Science Center at Weill Cornell Medical College.	Luo J, 2001, CANCER RES, V61, P4683; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Gumulec J, 2012, NEOPLASMA, V59, P191, DOI 10.4149/neo_2012_025; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Magee JA, 2001, CANCER RES, V61, P5692; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Setlur SR, 2008, J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Burger MJ, 2002, INT J CANCER, V100, P228, DOI 10.1002/ijc.10468; Tamura K, 2007, CANCER RES, V67, P5117, DOI 10.1158/0008-5472.CAN-06-4040; Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Ricke WA, 2008, FASEB J, V22, P1512, DOI 10.1096/fj.07-9526com; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Welsh JB, 2001, CANCER RES, V61, P5974; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Bonkhoff H, 1999, AM J PATHOL, V155, P641, DOI 10.1016/S0002-9440(10)65160-7; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Barwick BG, 2010, BRIT J CANCER, V102, P570, DOI 10.1038/sj.bjc.6605519; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Karnes RJ, 2013, J UROLOGY, V190, P2047, DOI 10.1016/j.juro.2013.06.017; Singh PB, 2008, EUR J CANCER, V44, P928, DOI 10.1016/j.ejca.2008.02.051; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; LaTulippe E, 2002, CANCER RES, V62, P4499; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Rickman DS, 2010, NEOPLASIA, V12, P1031, DOI 10.1593/neo.10866; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Ross JS, 2003, CLIN CANCER RES, V9, P6357; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Rhodes DR, 2004, NEOPLASIA, V6, P1; Blute ML, 2001, J UROLOGY, V165, P119, DOI 10.1097/00005392-200101000-00030; Chu C., 2012, J VIS EXP, V61; Erho N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066855; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Gibb EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025915; Jiang N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074386; Nicolaiew N, 2009, EUR J ENDOCRINOL, V160, P101, DOI 10.1530/EJE-08-0321; Romano A, 2010, MOL CELL ENDOCRINOL, V314, P90, DOI 10.1016/j.mce.2009.08.008; Xiao Z, 2001, CANCER RES, V61, P6029	58	18	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5383	10.1038/ncomms6383		16	Multidisciplinary Sciences	Science & Technology - Other Topics	AU5CN	WOS:000345624800004		
J	Fukuda, A; Tomikawa, J; Miura, T; Hata, K; Nakabayashi, K; Eggan, K; Akutsu, H; Umezawa, A				Fukuda, Atsushi; Tomikawa, Junko; Miura, Takumi; Hata, Kenichiro; Nakabayashi, Kazuhiko; Eggan, Kevin; Akutsu, Hidenori; Umezawa, Akihiro			The role of maternal-specific H3K9me3 modification in establishing imprinted X-chromosome inactivation and embryogenesis in mice	NATURE COMMUNICATIONS			English	Article							EMBRYONIC STEM-CELLS; MOUSE EMBRYOS; DNA METHYLATION; HISTONE METHYLATION; OOCYTE GROWTH; GENE; CHROMATIN; HETEROCHROMATIN; DEGRADATION; EXPRESSION	Maintaining a single active X-chromosome by repressing Xist is crucial for embryonic development in mice. Although the Xist activator RNF12/RLIM is present as a maternal factor, maternal Xist (Xm-Xist) is repressed during preimplantation phases to establish imprinted X-chromosome inactivation (XCI). Here we show, using a highly reproducible chromatin immunoprecipitation method that facilitates chromatin analysis of preimplantation embryos, that H3K9me3 is enriched at the Xist promoter region, preventing Xm-Xist activation by RNF12. The high levels of H3K9me3 at the Xist promoter region are lost in embryonic stem (ES) cells, and ES-cloned embryos show RNF12-dependent Xist expression. Moreover, lack of Xm-XCI in the trophectoderm, rather than loss of paternally expressed imprinted genes, is the primary cause of embryonic lethality in 70-80% of parthenogenotes immediately after implantation. This study reveals that H3K9me3 is involved in the imprinting that silences Xm-Xist. Our findings highlight the role of maternal-specific H3K9me3 modification in embryo development.	[Fukuda, Atsushi; Miura, Takumi; Akutsu, Hidenori; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Setagaya Ku, Tokyo 1578535, Japan; [Tomikawa, Junko; Hata, Kenichiro; Nakabayashi, Kazuhiko] Natl Res Inst Child Hlth & Dev, Dept Maternal Foetal Biol, Setagaya Ku, Tokyo 1578535, Japan; [Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Akutsu, H (reprint author), Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	akutsu-h@ncchd.go.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Ministry of Health, Labour and Welfare (MHLW); JST-CREST; JSPS KAKENHI [24890300];  [21390456]	We are grateful to T. Sado for critical reading of this manuscript and discussions. We thank T. Sugawara and H. Kobayashi for helpful comments; A. Bradley for providing the PiggyBac vector; K. Kusakabe, T. Kikuchi, Y. Harada, S. Kanai and Y. Takahashi for technical assistance with some experiments and analysis; and T. Kawasaki for preparation of figures. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; a grant from the Ministry of Health, Labour and Welfare (MHLW) to H.A. and A.U.; a Grant-in-aid for Scientific Research (21390456); a grant from JST-CREST to H.A.; and a JSPS KAKENHI Grant-in-Aid for Research Activity Start-up to A.F. (24890300).	Tada T, 2000, DEVELOPMENT, V127, P3101; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Kawahara M, 2007, NAT BIOTECHNOL, V25, P1045, DOI 10.1038/nbt1331; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Liu N, 2010, J MOL CELL BIOL, V2, P333, DOI 10.1093/jmcb/mjq029; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Zhang L, 2012, MOL CELL, V46, P650, DOI 10.1016/j.molcel.2012.04.003; Okamoto I, 2000, DEVELOPMENT, V127, P4137; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Gontan C, 2012, NATURE, V485, P386, DOI 10.1038/nature11070; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Duszczyk MM, 2011, RNA, V17, P1973, DOI 10.1261/rna.2747411; Shin J, 2014, NATURE, V511, P86, DOI 10.1038/nature13286; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Hoki Y, 2009, DEVELOPMENT, V136, P139, DOI 10.1242/dev.026427; Chiba H, 2008, GENESIS, V46, P768, DOI 10.1002/dvg.20438; Nesterova TB, 2001, DEV BIOL, V235, P343, DOI 10.1006/dbio.2001.0295; Barakat TS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002001; Dindot SV, 2009, GENOME RES, V19, P1374, DOI 10.1101/gr.089185.108; Fukuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011274; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Ono Y, 2006, BIOL REPROD, V75, P210, DOI 10.1095/biolreprod.105.049171; Sugimoto M, 2007, PLOS GENET, V3, P1309, DOI 10.1371/journal.pgen.0030116; Turner B., 2001, MAPPING PROTEIN DNA	40	9	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5464	10.1038/ncomms6464		14	Multidisciplinary Sciences	Science & Technology - Other Topics	AU9KC	WOS:000345910100001		
J	Hira, R; Ohkubo, F; Masamizu, Y; Ohkura, M; Nakai, J; Okada, T; Matsuzaki, M				Hira, Riichiro; Ohkubo, Fuki; Masamizu, Yoshito; Ohkura, Masamichi; Nakai, Junichi; Okada, Takashi; Matsuzaki, Masanori			Reward-timing-dependent bidirectional modulation of cortical microcircuits during optical single-neuron operant conditioning	NATURE COMMUNICATIONS			English	Article							MOTOR CORTEX; SYNAPTIC PLASTICITY; IN-VIVO; VOLITIONAL CONTROL; PREFRONTAL CORTEX; BEHAVING MICE; UNIT-ACTIVITY; DOPAMINE; TASK; STRIATUM	Animals rapidly adapt to environmental change. To reveal how cortical microcircuits are rapidly reorganized when an animal recognizes novel reward contingency, we conduct two photon calcium imaging of layer 2/3 motor cortex neurons in mice and simultaneously reinforce the activity of a single cortical neuron with water delivery. Here we show that when the target neuron is not relevant to a pre-trained forelimb movement, the mouse increases the target neuron activity and the number of rewards delivered during 15-min operant conditioning without changing forelimb movement behaviour. The reinforcement bidirectionally modulates the activity of subsets of non-target neurons, independent of distance from the target neuron. The bidirectional modulation depends on the relative timing between the reward delivery and the neuronal activity, and is recreated by pairing reward delivery and photoactivation of a subset of neurons. Reward-timing-dependent bidirectional modulation may be one of the fundamental processes in microcircuit reorganization for rapid adaptation.	[Hira, Riichiro; Ohkubo, Fuki; Masamizu, Yoshito; Matsuzaki, Masanori] Natl Inst Basic Biol, Div Brain Circuits, Okazaki, Aichi 444, Japan; [Hira, Riichiro; Ohkubo, Fuki; Masamizu, Yoshito; Matsuzaki, Masanori] Grad Univ Adv Studies Sokendai, Okazaki, Aichi, Japan; [Hira, Riichiro; Ohkubo, Fuki; Masamizu, Yoshito; Matsuzaki, Masanori] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Ohkura, Masamichi; Nakai, Junichi] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan; [Okada, Takashi] Nippon Med Sch, Dept Biochem & Mol Biol, Tokyo 1138602, Japan	Matsuzaki, M (reprint author), Natl Inst Basic Biol, Div Brain Circuits, Okazaki, Aichi 444, Japan.	mzakim@nibb.ac.jp	Ohkura, Masamichi/J-6976-2012		Scientific Research on Innovative Areas 'Mesoscopic Neurocircuitry' [22115005]; Strategic Research Program for Brain Sciences 'Construction of System for Spread of Primate Model Animals'; Ministry of Education, Culture, Sports, Science and Technology [25893287]; Mitsubishi Foundation; Takeda Foundation; Toyoaki Foundation;  [23300148];  [26830020];  [26830021]	We thank Ms J. Saito and M. Himeno for technical assistance, Dr T. Chiyo for assistance with AAV purification and Dr Y.R. Tanaka for helpful discussion. We are grateful to the Functional Genomics and the Spectrography and Bioimaging Facility at NIBB for allowing us to use the equipment. We thank Dr L.L. Looger at HHMI for providing the GCaMP6f vector, Dr K. Deisseroth at Stanford University for providing pAAV and Dr J.M. Wilson at the University of Pennsylvania for providing helper plasmids pAAV2-1 and pAAV2-9. This work was supported by Scientific Research on Innovative Areas 'Mesoscopic Neurocircuitry' (No. 22115005 to M.M.), a Scientific Research grant (No. 23300148 to M.M.), Grants-in-Aid for Young Scientists (No. 26830020 to Y.M. and No. 26830021 to R.H.), the Strategic Research Program for Brain Sciences 'Construction of System for Spread of Primate Model Animals' (to M.M.), a Research Activity Start-up fund (No. 25893287 to R.H.) from the Ministry of Education, Culture, Sports, Science and Technology, and Mitsubishi Foundation, Takeda Foundation and Toyoaki Foundation grants to M.M.	GARRIS PA, 1994, J NEUROSCI, V14, P442; Hira R, 2013, J NEUROSCI, V33, P1377, DOI 10.1523/JNEUROSCI.2550-12.2013; Schafer RJ, 2011, SCIENCE, V332, P1568, DOI 10.1126/science.1199892; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Green AM, 2011, TRENDS NEUROSCI, V34, P61, DOI 10.1016/j.tins.2010.11.003; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Masamizu Y, 2014, NAT NEUROSCI, V17, P987, DOI 10.1038/nn.3739; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Isomura Y, 2013, J NEUROSCI, V33, P10209, DOI 10.1523/JNEUROSCI.0381-13.2013; Hira R, 2009, J NEUROSCI METH, V179, P258, DOI 10.1016/j.jneumeth.2009.02.001; Bao SW, 2003, P NATL ACAD SCI USA, V100, P1405, DOI 10.1073/pnas.0337527100; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Arduin PJ, 2013, J NEUROSCI, V33, P8308, DOI 10.1523/JNEUROSCI.2744-12.2013; Masamizu Y, 2011, NEUROSCIENCE, V193, P249, DOI 10.1016/j.neuroscience.2011.06.080; FETZ EE, 1973, J NEUROPHYSIOL, V36, P179; Legenstein R, 2010, J NEUROSCI, V30, P8400, DOI 10.1523/JNEUROSCI.4284-09.2010; Xiao WD, 1999, J VIROL, V73, P3994; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Koralek AC, 2012, NATURE, V483, P331, DOI 10.1038/nature10845; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Clancy K. B., 2014, NAT NEUROSCI, V17, P807; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; Gage Gregory J, 2005, J Neural Eng, V2, P52, DOI 10.1088/1741-2560/2/2/006; Hira R, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00055; Hwang EJ, 2013, CURR BIOL, V23, P353, DOI 10.1016/j.cub.2013.01.027; Legenstein R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000180; Lutcke H, 2013, TRENDS NEUROSCI, V36, P375, DOI 10.1016/j.tins.2013.03.008; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; O'Connor D. H., 2010, NEURON, V67, P1048; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051286; Okada T, 2005, HUM GENE THER, V16, P1212, DOI 10.1089/hum.2005.16.1212; Okada T, 2009, HUM GENE THER, V20, P1013, DOI 10.1089/hum.2009.006; Tennant K. A., 2011, CEREB CORTEX, V21, P865	41	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5551	10.1038/ncomms6551		12	Multidisciplinary Sciences	Science & Technology - Other Topics	AU9LG	WOS:000345913600015		
J	Ishikawa, K; Yamaguchi, K; Sakamoto, K; Yoshimura, S; Inoue, K; Tsuge, S; Kojima, C; Kawasaki, T				Ishikawa, Kazuya; Yamaguchi, Koji; Sakamoto, Kazuaki; Yoshimura, Satomi; Inoue, Kento; Tsuge, Seiji; Kojima, Chojiro; Kawasaki, Tsutomu			Bacterial effector modulation of host E3 ligase activity suppresses PAMP-triggered immunity in rice	NATURE COMMUNICATIONS			English	Article							RECEPTOR-LIKE KINASE; ORYZAE PV. ORYZAE; UBIQUITIN LIGASE; XANTHOMONAS-ORYZAE; INNATE IMMUNITY; CELL-DEATH; PLANT IMMUNITY; ARABIDOPSIS; PROTEIN; RESISTANCE	Pathogen effector proteins are delivered to host cells to suppress plant immunity. However, the mechanisms by which effector proteins function are largely unknown. Here we show that expression of XopP(Xoo), an effector of rice pathogen Xanthomonas oryzae pv. oryzae, in rice strongly suppresses peptidoglycan (PGN)- and chitin-triggered immunity and resistance to X. oryzae. XopP(Xoo) targets OsPUB44, a rice ubiquitin E3 ligase with a unique U-box domain. We find that XopP(Xoo) directly interacts with the OsPUB44 U-box domain and inhibits ligase activity. Two amino-acid residues specific for the OsPUB44 U-box domain are identified, which are responsible for the interaction with XopP(Xoo). Silencing of OsPUB44 suppresses PGN- and chitin-triggered immunity and X. oryzae resistance, indicating that OsPUB44 positively regulates immune responses. Thus, it is likely that Xop(PXoo) suppresses immune responses by directly interacting with and inhibiting a positive regulator of plant immunity.	[Ishikawa, Kazuya; Yamaguchi, Koji; Sakamoto, Kazuaki; Yoshimura, Satomi; Inoue, Kento; Kawasaki, Tsutomu] Kinki Univ, Grad Sch Agr, Dept Adv Biosci, Nara 6318505, Japan; [Tsuge, Seiji] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan; [Kojima, Chojiro] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Kawasaki, T (reprint author), Kinki Univ, Grad Sch Agr, Dept Adv Biosci, 3327-204 Nakamachi, Nara 6318505, Japan.	t-kawasaki@nara.kindai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23380028, 24113519, 25114517, S1101035]; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology; JSPS Fellows	We thank Dr Ayako Furutani (Ibaraki University) for technical advice, Dr Seiji Takayama (NAIST) for his kind gift of the BiFC vectors and members of the Kawasaki Lab for technical assistance and participation in discussions. This research was supported by Grants-in-Aid for Scientific Research (B)(23380028), for Scientific Research on Innovative Areas (24113519 and 25114517), and by a Strategic Project to Support the Formation of Research Bases at Private Universities: Matching Fund Subsidy from the Ministry of Education, Culture, Sports, Science and Technology, 2011-2015 (S1101035) to T.K., by a Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology to C.K. and a Grant-in-Aid for JSPS Fellows to K. Ishikawa.	Azevedo C, 2001, TRENDS PLANT SCI, V6, P354, DOI 10.1016/S1360-1385(01)01960-4; Yamaguchi K, 2012, PLANT J, V70, P389, DOI 10.1111/j.1365-313X.2011.04874.x; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Midoh N, 1996, PLANT CELL PHYSIOL, V37, P9; Trujillo M, 2010, CURR OPIN PLANT BIOL, V13, P402, DOI 10.1016/j.pbi.2010.04.002; Zhu Q, 1995, PLANT MOL BIOL, V29, P535, DOI 10.1007/BF00020983; Kawano Y, 2010, CELL HOST MICROBE, V7, P362, DOI 10.1016/j.chom.2010.04.010; Sinha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075867; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; Yang CW, 2006, PLANT CELL, V18, P1084, DOI 10.1105/tpc.105.039198; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Lieberherr D, 2005, PLANT PHYSIOL, V138, P1644, DOI 10.1104/pp.104.057414; Durrant WE, 2000, PLANT CELL, V12, P963, DOI 10.1105/tpc.12.6.963; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Kim JG, 2013, CELL HOST MICROBE, V13, P143, DOI 10.1016/j.chom.2013.01.006; Zeng LR, 2008, MOL PLANT, V1, P800, DOI 10.1093/mp/ssn044; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Gonzalez-Lamothe R, 2006, PLANT CELL, V18, P1067, DOI 10.1105/tpc.106.040998; Akimoto-Tomiyama C, 2012, MOL PLANT MICROBE IN, V25, P505, DOI 10.1094/MPMI-06-11-0167; Stegmann M, 2012, PLANT CELL, V24, P4703, DOI 10.1105/tpc.112.104463; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Sadanandom A, 2012, NEW PHYTOL, V196, P13, DOI 10.1111/j.1469-8137.2012.04266.x; Canonne J, 2011, PLANT CELL, V23, P3498, DOI 10.1105/tpc.111.088815; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Trujillo M, 2008, CURR BIOL, V18, P1396, DOI 10.1016/j.cub.2008.07.085; Cho SK, 2008, PLANT CELL, V20, P1899, DOI 10.1105/tpc.108.060699; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Block A, 2011, CURR OPIN MICROBIOL, V14, P39, DOI 10.1016/j.mib.2010.12.011; Yamaguchi K, 2013, CELL HOST MICROBE, V13, P347, DOI 10.1016/j.chom.2013.02.007; Cheong H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073346; Furutani A, 2009, MOL PLANT MICROBE IN, V22, P96, DOI 10.1094/MPMI-22-1-0096; Ustun S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003427; Willmann R, 2011, P NATL ACAD SCI USA, V108, P19824, DOI 10.1073/pnas.1112862108; Yamaguchi K., 2013, Plant Signaling and Behavior, V8, pe25662, DOI 10.4161/psb.25662; Yamaguchi K, 2013, BIOSCI BIOTECH BIOCH, V77, P796, DOI 10.1271/bbb.120929	45	2	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5430	10.1038/ncomms6430		11	Multidisciplinary Sciences	Science & Technology - Other Topics	AU5CO	WOS:000345625000010		
J	Lee, H; Lee, JK; Park, MH; Hong, YR; Marti, HH; Kim, H; Okada, Y; Otsu, M; Seo, EJ; Park, JH; Bae, JH; Okino, N; He, XX; Schuchman, EH; Bae, JS; Jin, HK				Lee, Hyun; Lee, Jong Kil; Park, Min Hee; Hong, Yu Ri; Marti, Hugo H.; Kim, Hyongbum; Okada, Yohei; Otsu, Makoto; Seo, Eul-Ju; Park, Jae-Hyung; Bae, Jae-Hoon; Okino, Nozomu; He, Xingxuan; Schuchman, Edward H.; Bae, Jae-sung; Jin, Hee Kyung			Pathological roles of the VEGF/SphK pathway in Niemann-Pick type C neurons	NATURE COMMUNICATIONS			English	Article							ENDOTHELIAL GROWTH-FACTOR; DISEASE TYPE-C; PLURIPOTENT STEM-CELLS; PURKINJE NEURONS; CHOLESTEROL ACCUMULATION; STEM/PROGENITOR CELLS; AUTOPHAGY; SPHINGOSINE-1-PHOSPHATE; KINASES; MODEL	Sphingosine is a major storage compound in Niemann-Pick type C disease (NP-C), although the pathological role(s) of this accumulation have not been fully characterized. Here we found that sphingosine kinase (SphK) activity is reduced in NP-C patient fibroblasts and NP-C mouse Purkinje neurons (PNs) due to defective vascular endothelial growth factor (VEGF) levels. Sphingosine accumulation due to inactivation of VEGF/SphK pathway led to PNs loss via inhibition of autophagosome-lysosome fusion in NP-C mice. VEGF activates SphK by binding to VEGFR2, resulting in decreased sphingosine storage as well as improved PNs survival and clinical outcomes in NP-C cells and mice. We also show that induced pluripotent stem cell (iPSC)-derived human NP-C neurons are generated and the abnormalities caused by VEGF/SphK inactivity in these cells are corrected by replenishment of VEGF. Overall, these results reveal a pathogenic mechanism in NP-C neurons where defective SphK activity is due to impaired VEGF levels.	[Lee, Hyun; Lee, Jong Kil; Park, Min Hee; Hong, Yu Ri; Bae, Jae-sung; Jin, Hee Kyung] Kyungpook Natl Univ, Stem Cell Neuroplast Res Grp, Taegu 702701, South Korea; [Lee, Hyun; Hong, Yu Ri; Jin, Hee Kyung] Kyungpook Natl Univ, Coll Vet Med, Cell & Matrix Res Inst, Dept Lab Anim Med, Taegu 702701, South Korea; [Lee, Jong Kil; Park, Min Hee; Bae, Jae-sung] Kyungpook Natl Univ, Sch Med, Dept Physiol, Cell & Matrix Res Inst, Taegu 702701, South Korea; [Lee, Jong Kil; Park, Min Hee; Bae, Jae-sung] Kyungpook Natl Univ, Plus KNU Biomed Convergence Program BK21, Dept Biomed Sci, Taegu 700842, South Korea; [Marti, Hugo H.] Heidelberg Univ, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany; [Kim, Hyongbum] Hanyang Univ, Grad Sch Biomed Sci & Engn, Coll Med, Seoul 133791, South Korea; [Okada, Yohei] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Otsu, Makoto] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med, Tokyo 1088639, Japan; [Seo, Eul-Ju] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul 138736, South Korea; [Park, Jae-Hyung; Bae, Jae-Hoon] Keimyung Univ, Sch Med, Dept Physiol, Taegu 704701, South Korea; [Okino, Nozomu] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fukuoka 8128581, Japan; [He, Xingxuan; Schuchman, Edward H.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	Bae, JS (reprint author), Kyungpook Natl Univ, Stem Cell Neuroplast Res Grp, Taegu 702701, South Korea.	jsbae@knu.ac.kr; hkjin@knu.ac.kr			Bio & Medical Technology Development Program of the National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning, Republic of Korea [2011-0019356, 2012M3A9C6050107, 2012M3A9C6049913]; Korea Healthcare Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [A120367]	We thank Victor A. DeAngelis for help with UPLC analysis. We are grateful to Hyun Ok Kim and Tomoyuki Yamaguchi for kindly providing reagents. This work was supported by the Bio & Medical Technology Development Program (2011-0019356, 2012M3A9C6050107, 2012M3A9C6049913) of the National Research Foundation (NRF) of Korea funded by the Ministry of Science, ICT & Future Planning, Republic of Korea. This study was also supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (A120367).	Aebischer P, 2001, TRENDS NEUROSCI, V24, P533, DOI 10.1016/S0166-2236(00)01899-3; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Xia P, 1998, P NATL ACAD SCI USA, V95, P14196, DOI 10.1073/pnas.95.24.14196; Kim TK, 2002, J PHARM PHARMACOL, V54, P897, DOI 10.1211/002235702760089009; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Cvetanovic M, 2011, NAT MED, V17, P1445, DOI 10.1038/nm.2494; Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325; de Almodovar CR, 2010, J NEUROSCI, V30, P15052, DOI 10.1523/JNEUROSCI.0477-10.2010; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Maetzel D, 2014, STEM CELL REP, V2, P866, DOI 10.1016/j.stemcr.2014.03.014; Foraker JE, 2011, J NEUROCHEM, V119, P1052, DOI 10.1111/j.1471-4159.2011.07511.x; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Miyoshi H, 1998, J VIROL, V72, P8150; Vanier MT, 1999, NEUROCHEM RES, V24, P481, DOI 10.1023/A:1022575511354; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Lee H, 2010, STEM CELLS, V28, P821, DOI 10.1002/stem.401; Bilmen JG, 2001, EUR J BIOCHEM, V268, P6318, DOI 10.1046/j.0014-2956.2001.02589.x; Wood JM, 2000, CANCER RES, V60, P2178; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Bae JS, 2005, HUM GENE THER, V16, P1006, DOI 10.1089/hum.2005.16.1006; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585; Blom T, 2012, TRAFFIC, V13, P1234, DOI 10.1111/j.1600-0854.2012.01379.x; Edsall LC, 1997, J NEUROSCI, V17, P6952; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561; Billich A, 2004, ANAL BIOCHEM, V326, P114, DOI 10.1016/j.ab.2003.11.018; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Le Stunff H, 2002, BBA-MOL CELL BIOL L, V1582, P8, DOI 10.1016/S1388-1981(02)00132-4; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Meske V, 2014, NEUROBIOL DIS, V64, P88, DOI [10.1016/j.nbd.2013.12.018, 10.1016/j.nbd2013.12.018]; Okabe M, 2009, BLOOD, V114, P1764, DOI 10.1182/blood-2009-02-203695; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Sentilhes L, 2010, J NEUROPATH EXP NEUR, V69, P111, DOI 10.1097/NEN.0b013e3181ccc9a9; Trilck M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-144; Yu DZ, 2014, J BIOMOL SCREEN, V19, P1164, DOI 10.1177/1087057114537378	45	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5514	10.1038/ncomms6514		17	Multidisciplinary Sciences	Science & Technology - Other Topics	AU9LA	WOS:000345913000019		
J	Morisaki, H; Koretsune, T; Hotta, C; Takeya, J; Kimura, T; Wakabayashi, Y				Morisaki, Hazuki; Koretsune, Takashi; Hotta, Chisa; Takeya, Jun; Kimura, Tsuyoshi; Wakabayashi, Yusuke			Large surface relaxation in the organic semiconductor tetracene	NATURE COMMUNICATIONS			English	Article							MOLECULAR STRUCTURE; SINGLE-CRYSTALS; PENTACENE; TRANSPORT; PREDICTIONS; MOBILITY; ENERGY; FILMS	Organic crystals are likely to have a large degree of structural relaxation near their surfaces because of the weak inter-molecular interactions. The design of organic field-effect transistors requires a detailed knowledge of the surface relaxation as the carriers usually transfer within the first few molecular layers at the semiconductor surfaces, and their transport properties reflect the structural changes through the transfer integral. Here, we report the direct observation of the surface relaxation of an organic semiconductor, a tetracene single crystal, by means of X-ray crystal truncation rod scattering measurements. A significant degree of surface relaxation is observed, taking place only in the first monolayer at the semiconductor surface. First principles calculations show that the resultant transfer integrals are completely different between the bulk and surface of the semiconductor.	[Morisaki, Hazuki; Kimura, Tsuyoshi; Wakabayashi, Yusuke] Osaka Univ, Grad Sch Engn Sci, Div Mat Phys, Toyonaka, Osaka 5608531, Japan; [Koretsune, Takashi] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Hotta, Chisa] Univ Tokyo, Grad Sch Arts & Sci, Meguro 1538902, Japan; [Takeya, Jun] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan	Wakabayashi, Y (reprint author), Osaka Univ, Grad Sch Engn Sci, Div Mat Phys, Toyonaka, Osaka 5608531, Japan.	wakabayashi@mp.es.osaka-u.ac.jp	Wakabayashi, Yusuke/F-1621-2010	Wakabayashi, Yusuke/0000-0003-3107-0338	JSPS KAKENHI [23684026, 25800204, 26287080, 26105008]; Toray Science Foundation; TEPCO Memorial Foundation.	We thank Professor K. Ueno, Professor T. Takahashi and Dr T. Shirasawa for their valuable discussions. The single crystals were grown with the help of Dr Y. Okada. This work was supported by Grants-In-Aid for Scientific Research (JSPS KAKENHI, Grant Nos 23684026, 25800204, 26287080, 26105008), the Toray Science Foundation and the TEPCO Memorial Foundation.	CAMPBELL RB, 1961, ACTA CRYSTALLOGR, V14, P705, DOI 10.1107/S0365110X61002163; Minemawari H, 2011, NATURE, V475, P364, DOI 10.1038/nature10313; Ortmann F, 2011, PHYS STATUS SOLIDI B, V248, P511, DOI 10.1002/pssb.201046278; Reese C, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2388151; de Boer RWI, 2003, APPL PHYS LETT, V83, P4345, DOI 10.1063/1.1629144; Dediu VA, 2009, NAT MATER, V8, P707, DOI [10.1038/nmat2510, 10.1038/NMAT2510]; da Silva DA, 2005, ADV MATER, V17, P1072, DOI 10.1002/adma.200401866; Hummer K, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205205; Yacoby Y, 2002, NAT MATER, V1, P99, DOI 10.1038/nmat735; ROBERTSON J, 1961, ACTA CRYSTALLOGR, V14, P697, DOI 10.1107/S0365110X61002151; Schiefer S, 2007, J AM CHEM SOC, V129, P10316, DOI 10.1021/ja0730516; Butko VY, 2003, SOLID STATE COMMUN, V128, P431, DOI [10.1016/j.ssc.2003.08.041, 10.1016/j.ssc.2003.08.014]; Koch N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.156803; OVERNEY RM, 1991, J CHEM PHYS, V94, P8441, DOI 10.1063/1.460077; Willmott PR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.155502; Kakuta H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.247601; Takeya J, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2711393; Ohtomo M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3232205; Hasegawa S, 1999, PROG SURF SCI, V60, P89, DOI 10.1016/S0079-6816(99)00008-8; Mannsfeld SCB, 2009, ADV MATER, V21, P2294, DOI 10.1002/adma.200803328; Deng WQ, 2004, J PHYS CHEM B, V108, P8614, DOI 10.1021/jp0495848; Kowarik S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.125504; Li Y, 2012, J PHYS CHEM LETT, V3, P3325, DOI 10.1021/jz301575u; Machida S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.156401; Yanagisawa S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.115438; Vollmer A, 2012, J ELECTRON SPECTROSC, V185, P55, DOI 10.1016/j.elspec.2012.01.003; Ambrosch-Draxl C, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/125010; Alves H, 2008, NAT MATER, V7, P574, DOI 10.1038/nmat2205; de Wijs GA, 2003, SYNTHETIC MET, V139, P109, DOI 10.1016/S0379-6779(03)00020-1; ROBINSON IK, 1986, PHYS REV B, V33, P3830, DOI 10.1103/PhysRevB.33.3830; Rossi M, 2009, J PHYS CHEM C, V113, P6821, DOI 10.1021/jp8086978; Wakabayashi Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.066103; Wakabayashi Y, 2011, J APPL PHYS, V110, DOI 10.1063/1.3661523	33	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5400	10.1038/ncomms6400		6	Multidisciplinary Sciences	Science & Technology - Other Topics	AU5CN	WOS:000345624800021		
J	Murakami, M; Goncharov, AF; Hirao, N; Masuda, R; Mitsui, T; Thomas, SM; Bina, CR				Murakami, Motohiko; Goncharov, Alexander F.; Hirao, Naohisa; Masuda, Ryo; Mitsui, Takaya; Thomas, Sylvia-Monique; Bina, Craig R.			High-pressure radiative conductivity of dense silicate glasses with potential implications for dark magmas	NATURE COMMUNICATIONS			English	Article							EARTHS LOWER MANTLE; LATTICE THERMAL-CONDUCTIVITY; REFRACTIVE-INDEX; DEEP MANTLE; MELT; MOSSBAUER; STATE; CORE; BASE; DIFFERENTIATION	The possible presence of dense magmas at Earth's core-mantle boundary is expected to substantially affect the dynamics and thermal evolution of Earth's interior. However, the thermal transport properties of silicate melts under relevant high-pressure conditions are poorly understood. Here we report in situ high-pressure optical absorption and synchrotron Mossbauer spectroscopic measurements of iron-enriched dense silicate glasses, as laboratory analogues for dense magmas, up to pressures of 85 GPa. Our results reveal a significant increase in absorption coefficients, by almost one order of magnitude with increasing pressure to similar to 50 GPa, most likely owing to gradual changes in electronic structure. This suggests that the radiative thermal conductivity of dense silicate melts may decrease with pressure and so may be significantly smaller than previously expected under core-mantle boundary conditions. Such dark magmas heterogeneously distributed in the lower mantle would result in significant lateral heterogeneity of heat flux through the core-mantle boundary.	[Murakami, Motohiko] Tohoku Univ, Grad Sch Sci, Dept Earth & Planetary Mat Sci, Sendai, Miyagi 9808578, Japan; [Goncharov, Alexander F.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Hirao, Naohisa] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Masuda, Ryo; Mitsui, Takaya] Japan Atom Energy Agcy, Sayo, Hyogo 6795148, Japan; [Thomas, Sylvia-Monique] Univ Nevada, Dept Geosci, Las Vegas, NV 89154 USA; [Bina, Craig R.] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA	Murakami, M (reprint author), Tohoku Univ, Grad Sch Sci, Dept Earth & Planetary Mat Sci, Sendai, Miyagi 9808578, Japan.	motohiko@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)/The Japan Society for the Promotion of Science (JSPS) Kakenhi [22684028, 24654170, 25247087]; Frontier Research Institute for Interdisciplinary Sciences, Tohoku University; National Science Foundation (NSF) [EAR-1015239, EAR/IF-1128867]; Army Research Office; SPring-8 [2011A3501]	We thank Maddury Somayazulu, Takashi Yoshino, Reinhard Boehler and Amol Karandikar for their experimental assistance. Suggestions from Takashi Nakagawa improved the manuscript. Jay Bass and Satoshi Okumura are gratefully acknowledged for their valuable comments. This work was supported by Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)/The Japan Society for the Promotion of Science (JSPS) Kakenhi grant numbers 22684028, 24654170 and 25247087, and a Grant for Program Research from Frontier Research Institute for Interdisciplinary Sciences, Tohoku University (to M.M.), and by the National Science Foundation (NSF) EAR-1015239, NSF EAR/IF-1128867 and Army Research Office (to A.F.G.). Mossbauer experiments were performed under the approval of SPring-8 (2011A3501).	ABRAS A, 1972, PHYS REV A, V6, P2343, DOI 10.1103/PhysRevA.6.2343; AGEE CB, 1988, EARTH PLANET SC LETT, V90, P144, DOI 10.1016/0012-821X(88)90097-0; ANDERSON OL, 1965, J GEOPHYS RES, V70, P1463, DOI 10.1029/JZ070i006p01463; WILLIAMS Q, 1988, SCIENCE, V239, P902, DOI 10.1126/science.239.4842.902; Benmore CJ, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054105; Manthilake GM, 2011, P NATL ACAD SCI USA, V108, P17901, DOI 10.1073/pnas.1110594108; Lee CTA, 2010, NATURE, V463, P930, DOI 10.1038/nature08824; Ohtani E, 2001, EARTH PLANET SC LETT, V193, P69, DOI 10.1016/S0012-821X(01)00505-2; Keppler H, 2008, SCIENCE, V322, P1529, DOI [10.1126/science.1164609, 10.1126/science.114609]; Klima RL, 2007, METEORIT PLANET SCI, V42, P235; Ohta K, 2012, EARTH PLANET SC LETT, V349, P109, DOI 10.1016/j.epsl.2012.06.043; HANADA T, 1988, J NON-CRYST SOLIDS, V105, P39, DOI 10.1016/0022-3093(88)90335-3; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; Lay T, 2008, NAT GEOSCI, V1, P25, DOI 10.1038/ngeo.2007.44; Williams Q, 1996, SCIENCE, V273, P1528, DOI 10.1126/science.273.5281.1528; Lee SK, 2008, P NATL ACAD SCI USA, V105, P7925, DOI 10.1073/pnas.0802667105; Sanloup C, 2013, NATURE, V503, P104, DOI 10.1038/nature12668; Lee SK, 2004, GEOCHIM COSMOCHIM AC, V68, P4189, DOI 10.1016/j.gca.2004.04.002; Mitsui T, 2009, J SYNCHROTRON RADIAT, V16, P723, DOI 10.1107/S0909049509033615; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; Goncharov AF, 2008, NATURE, V456, P231, DOI 10.1038/nature07412; Lee SK, 2011, P NATL ACAD SCI USA, V108, P6847, DOI 10.1073/pnas.1019634108; Garnero EJ, 2008, SCIENCE, V320, P626, DOI 10.1126/science.1148028; Nomura R, 2011, NATURE, V473, P199, DOI 10.1038/nature09940; Thomas SM, 2012, EARTH PLANET SC LETT, V357, P130, DOI 10.1016/j.epsl.2012.09.035; Allwardt JR, 2007, AM MINERAL, V92, P1093, DOI 10.2138/am.2007.2530; Goncharov AF, 2006, SCIENCE, V312, P1205, DOI 10.1126/science.1125622; Burns R.G., 1993, MINERALOGICAL APPL C; CAMERON AGW, 1991, ICARUS, V92, P204, DOI 10.1016/0019-1035(91)90046-V; CLARK MG, 1967, J CHEM PHYS, V47, P4250, DOI 10.1063/1.1701608; Garnero E., 1998, CHILD PSYCHIAT HUMAN, V28, P273; Hayashi N., 2010, J PHYS SOC JPN, V79; Kono Y, 2008, J MINER PETROL SCI, V103, P126, DOI 10.2465/jmps.071022c; Kuryaeva RG, 1997, PHYS CHEM MINER, V25, P48, DOI 10.1007/s002690050085; LITTERST FJ, 1977, J NON-CRYST SOLIDS, V24, P19, DOI 10.1016/0022-3093(77)90058-8; Maddock A. G., 1997, MOSSBAUER SPECTROSCO; MILLER GH, 1991, J GEOPHYS RES-SOLID, V96, P11849, DOI 10.1029/91JB01203; Prescher C, 2014, EARTH PLANET SC LETT, V385, P130, DOI 10.1016/j.epsl.2013.10.040; Sanchez-Valle C, 2010, EARTH PLANET SC LETT, V295, P523, DOI 10.1016/j.epsl.2010.04.034; Sato T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184102; Sato T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.255502; Shen GY, 2007, P NATL ACAD SCI USA, V104, P14576, DOI 10.1073/pnas.0703098104; STOLPER E, 1981, J GEOPHYS RES, V86, P6261, DOI 10.1029/JB086iB07p06261; Stevenson D.J., 1990, ORIGIN EARTH, P231	44	2	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5428	10.1038/ncomms6428		6	Multidisciplinary Sciences	Science & Technology - Other Topics	AU5CO	WOS:000345625000008		
J	Nakade, S; Tsubota, T; Sakane, Y; Kume, S; Sakamoto, N; Obara, M; Daimon, T; Sezutsu, H; Yamamoto, T; Sakuma, T; Suzuki, KT				Nakade, Shota; Tsubota, Takuya; Sakane, Yuto; Kume, Satoshi; Sakamoto, Naoaki; Obara, Masanobu; Daimon, Takaaki; Sezutsu, Hideki; Yamamoto, Takashi; Sakuma, Tetsushi; Suzuki, Ken-ichi T.			Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9	NATURE COMMUNICATIONS			English	Article							ZINC-FINGER NUCLEASES; TARGETED INTEGRATION; REPAIR; GENES; CLEAVAGE; SYSTEM	Genome engineering using programmable nucleases enables homologous recombination (HR)-mediated gene knock-in. However, the labour used to construct targeting vectors containing homology arms and difficulties in inducing HR in some cell type and organisms represent technical hurdles for the application of HR-mediated knock-in technology. Here, we introduce an alternative strategy for gene knock-in using transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (Cas9) mediated by microhomology-mediated end-joining, termed the PITCh (Precise Integration into Target Chromosome) system. TALEN-mediated PITCh, termed TAL-PITCh, enables efficient integration of exogenous donor DNA in human cells and animals, including silkworms and frogs. We further demonstrate that CRISPR/Cas9-mediated PITCh, termed CRIS-PITCh, can be applied in human cells without carrying the plasmid backbone sequence. Thus, our PITCh-ing strategies will be useful for a variety of applications, not only in cultured cells, but also in various organisms, including invertebrates and vertebrates.	[Nakade, Shota; Sakane, Yuto; Kume, Satoshi; Sakamoto, Naoaki; Yamamoto, Takashi; Sakuma, Tetsushi; Suzuki, Ken-ichi T.] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima, Hiroshima 7398526, Japan; [Tsubota, Takuya; Sezutsu, Hideki] Natl Inst Agrobiol Sci, Transgen Silkworm Res Unit, Tsukuba, Ibaraki 3058634, Japan; [Obara, Masanobu] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Higashihiroshima, Hiroshima 7398526, Japan; [Daimon, Takaaki] Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Tsukuba, Ibaraki 3058634, Japan	Sakuma, T (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 7398526, Japan.	tetsushi-sakuma@hiroshima-u.ac.jp; suzuk107@hiroshima-u.ac.jp		Daimon, Takaaki/0000-0002-8382-1132	Japan Society for the Promotion of Science [25890014, 25124708]; Ministry of Agriculture, Forestry and Fisheries; NIAS Strategic Research Fund	We thank Dr Hiroshi Ochiai (Hiroshima University, Hiroshima, Japan) for sharing the synthesized mNeonGreen cDNA, Dr Keiro Uchino (National Institute of the Agrobiological Sciences, Ibaraki, Japan) for injecting the silkworm, Dr Yoko Takasu (National Institute of the Agrobiological Sciences, Ibaraki, Japan) for instructing the TALEN mRNA synthesis, Mr Kaoru Nakamura and Mr Toshihiko Misawa (National Institute of the Agrobiological Sciences, Ibaraki, Japan) for rearing the silkworms and Ms Satoko Kawamoto (National Institute of the Agrobiological Sciences, Ibaraki, Japan) for technical assistance. This work was supported by the Japan Society for the Promotion of Science (25890014 to T. S. and 25124708 to K. T. S.), the Ministry of Agriculture, Forestry and Fisheries, and the NIAS Strategic Research Fund.	Ochiai H, 2014, P NATL ACAD SCI USA, V111, P1461, DOI 10.1073/pnas.1317008111; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Taleei R, 2013, MUTAT RES-GEN TOX EN, V756, P206, DOI 10.1016/j.mrgentox.2013.06.004; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/nmeth.2413, 10.1038/NMETH.2413]; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Sakane Y, 2014, DEV GROWTH DIFFER, V56, P108, DOI 10.1111/dgd.12105; Doyon Y, 2011, NAT METHODS, V8, P74, DOI [10.1038/nmeth.1539, 10.1038/NMETH.1539]; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; DAIMON T, 2014, BOMBYX MORI DEV GROW, V56, P14; Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326; Motoi N, 2011, CELL TISSUE RES, V344, P445, DOI 10.1007/s00441-011-1163-0; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Suzuki KIT, 2010, DEV DYNAM, V239, P3172, DOI 10.1002/dvdy.22451; Suzuki KT, 2013, BIOL OPEN, V2, P448, DOI 10.1242/bio.20133855; Takasu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073458; Tsubota T., 2014, BOMBYX MORI G3, V4, P1347	34	19	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5560	10.1038/ncomms6560		8	Multidisciplinary Sciences	Science & Technology - Other Topics	AU9LH	WOS:000345913700005		
J	Piochon, C; Kloth, AD; Grasselli, G; Titley, HK; Nakayama, H; Hashimoto, K; Wan, V; Simmons, DH; Eissa, T; Nakatani, J; Cherskov, A; Miyazaki, T; Watanabe, M; Takumi, T; Kano, M; Wang, SSH; Hansel, C				Piochon, Claire; Kloth, Alexander D.; Grasselli, Giorgio; Titley, Heather K.; Nakayama, Hisako; Hashimoto, Kouichi; Wan, Vivian; Simmons, Dana H.; Eissa, Tahra; Nakatani, Jin; Cherskov, Adriana; Miyazaki, Taisuke; Watanabe, Masahiko; Takumi, Toru; Kano, Masanobu; Wang, Samuel S. -H.; Hansel, Christian			Cerebellar plasticity and motor learning deficits in a copy-number variation mouse model of autism	NATURE COMMUNICATIONS			English	Article							CLIMBING FIBER INNERVATION; TERM SYNAPTIC DEPRESSION; X MENTAL-RETARDATION; GAMMA MUTANT MICE; PURKINJE-CELLS; VESTIBULOOCULAR REFLEX; SPECTRUM DISORDERS; ANGELMAN SYNDROME; PROXIMAL 15Q; CHILDREN	A common feature of autism spectrum disorder (ASD) is the impairment of motor control and learning, occurring in a majority of children with autism, consistent with perturbation in cerebellar function. Here we report alterations in motor behaviour and cerebellar synaptic plasticity in a mouse model (patDp/+) for the human 15q11-13 duplication, one of the most frequently observed genetic aberrations in autism. These mice show ASD-resembling social behaviour deficits. We find that in patDp/+ mice delay eyeblink conditioning-a form of cerebellum-dependent motor learning-is impaired, and observe deregulation of a putative cellular mechanism for motor learning, long-term depression (LTD) at parallel fibre-Purkinje cell synapses. Moreover, developmental elimination of surplus climbing fibres-a model for activity-dependent synaptic pruning-is impaired. These findings point to deficits in synaptic plasticity and pruning as potential causes for motor problems and abnormal circuit development in autism.	[Piochon, Claire; Grasselli, Giorgio; Titley, Heather K.; Wan, Vivian; Simmons, Dana H.; Eissa, Tahra; Hansel, Christian] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Kloth, Alexander D.; Cherskov, Adriana; Wang, Samuel S. -H.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kloth, Alexander D.; Cherskov, Adriana; Wang, Samuel S. -H.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Nakayama, Hisako; Hashimoto, Kouichi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurophysiol, Hiroshima 7348551, Japan; [Nakatani, Jin] Shiga Univ Med Sci, Otsu, Shiga 5202192, Japan; [Miyazaki, Taisuke; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Takumi, Toru] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Tokyo 1130033, Japan	Hansel, C (reprint author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	chansel@bsd.uchicago.edu		Titley, Heather/0000-0002-2058-108X	Ministry of Education, Culture, Sports, Science and Technology in Japan [25242077, 23111005, 25123716, 25117006, 2420007, 25000015]; Ministry's Strategic Research Program for Brain Sciences; CREST from the Japanese Science and Technology Agency; MEXT, Japan; Global COE Program; Nancy Lurie Marks Family Foundation; National Institutes of Health [NS045193, F31 MH098651]; Simons Foundation [SFARI 221582, SFARI 203507, SFARI 311232]; Brain Research Foundation [BRF SG 2011-07]	We would like to thank E.H. Cook and P.Mason for helpful suggestions and for critically reading the manuscript. This work was supported by Ministry of Education, Culture, Sports, Science and Technology in Japan Grants-in-Aid for Scientific Research (25242077 and 23111005 to T.T.; 25123716 and 25117006 to K.H.; 2420007 to M.W.; 25000015 to M.K.), and the Ministry's Strategic Research Program for Brain Sciences (M.K.), CREST from the Japanese Science and Technology Agency (T.T.), MEXT, Japan (M.K.), the Global COE Program (M.K.), a grant from the Nancy Lurie Marks Family Foundation (S.S.-H.W.), National Institutes of Health grants NS045193 (S.S.-H.W.) and F31 MH098651 (A.K.), Simons Foundation grants SFARI 221582 (S.S.- H.W.), SFARI 203507 and SFARI 311232 (C.H.), and a grant from the Brain Research Foundation BRF SG 2011-07 (C.H.).	Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Piochon C, 2007, J NEUROSCI, V27, P10797, DOI 10.1523/JNEUROSCI.2422-07.2007; Fournier KA, 2010, J AUTISM DEV DISORD, V40, P1227, DOI 10.1007/s10803-010-0981-3; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Leitges M, 2004, NEURON, V44, P585, DOI 10.1016/j.neuron.2004.10.024; AIBA A, 1994, CELL, V79, P377; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Green D, 2009, DEV MED CHILD NEUROL, V51, P311, DOI 10.1111/j.1469-8749.2008.03242.x; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Fatemi SH, 2012, CEREBELLUM, V11, P777, DOI 10.1007/s12311-012-0355-9; Wang SSH, 2014, NEURON, V83, P518, DOI 10.1016/j.neuron.2014.07.016; Johnson BP, 2013, NEUROSCIENCE, V243, P76, DOI 10.1016/j.neuroscience.2013.03.051; Courchesne E, 1997, CURR OPIN NEUROBIOL, V7, P269, DOI 10.1016/S0959-4388(97)80016-5; Palmen SJMC, 2004, BRAIN, V127, P2572, DOI 10.1093/brain/awh287; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Williams DL, 2006, NEUROPSYCHOLOGY, V20, P21, DOI 10.1037/0894-4105.20.1.21; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Carper RA, 2000, BRAIN, V123, P836, DOI 10.1093/brain/123.4.836; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bolton PF, 2001, AM J MED GENET, V105, P675, DOI 10.1002/ajmg.1551; SEARS LL, 1994, J AUTISM DEV DISORD, V24, P737, DOI 10.1007/BF02172283; Bostan AC, 2013, TRENDS COGN SCI, V17, P241, DOI 10.1016/j.tics.2013.03.003; Kaufmann WE, 2003, J CHILD NEUROL, V18, P463, DOI 10.1177/08830738030180070501; Mostofsky SH, 2009, BRAIN, V132, P2413, DOI 10.1093/brain/awp088; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Oristaglio J, 2013, NEUROSCIENCE, V248, P708, DOI 10.1016/j.neuroscience.2013.06.007; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Schonewille M, 2011, NEURON, V70, P43, DOI 10.1016/j.neuron.2011.02.044; Cook EH, 1997, AM J HUM GENET, V60, P928; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178; Pugh JR, 2008, J NEUROSCI, V28, P10549, DOI 10.1523/JNEUROSCI.2061-08.2008; Gao ZY, 2012, NAT REV NEUROSCI, V13, P619, DOI 10.1038/nrn3312; CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609; Grant SGN, 2012, CURR OPIN NEUROBIOL, V22, P522, DOI 10.1016/j.conb.2012.02.002; Urraca N, 2013, AUTISM RES, V6, P268, DOI 10.1002/aur.1284; Kimpo RR, 2007, J NEUROSCI, V27, P5672, DOI 10.1523/JNEUROSCI.0801-07.2007; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Ohyama T, 2006, J NEUROSCI, V26, P12656, DOI 10.1523/JNEUROSCI.4023-06.2006; Wegiel J, 2013, BRAIN RES, V1512, P106, DOI 10.1016/j.brainres.2013.03.037; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Heck DH, 2008, HUM MOL GENET, V17, P2181, DOI 10.1093/hmg/ddn117; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; Miyata M, 2001, EUR J NEUROSCI, V13, P1945, DOI 10.1046/j.0953-816x.2001.01570.x; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Grasselli G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020791; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Hansel C, 2008, LEARNING MEMORY COMP, V4, P327; Ito M, 2014, PROG BRAIN RES, V210, P1, DOI 10.1016/B978-0-444-63356-9.00001-7; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Kaneko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020108; Markram Henry, 2007, Front Neurosci, V1, P77, DOI 10.3389/neuro.01.1.1.006.2007; Marquez-Ruiz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036184; Mosconi MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063709; Piochon Claire, 2010, J Neurosci, V30, P15330, DOI 10.1523/JNEUROSCI.4344-10.2010; Rinaldo L, 2010, FUNCT NEUROL, V25, P135; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Tamada K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015126; Titley HK, 2010, J NEUROPHYSIOL, V104, P3657, DOI 10.1152/jn.00664.2010; Zoghbi H.Y., 2012, COLD SPRING HARB PER, V4, P4, DOI DOI 10.1101/CSHPERSPECT.A009886	70	8	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5586	10.1038/ncomms6586		12	Multidisciplinary Sciences	Science & Technology - Other Topics	AW1XK	WOS:000346081800001		
J	Shi, XM; Zhang, ZL; Zhan, XM; Cao, M; Satoh, T; Akira, S; Shpargel, K; Magnuson, T; Li, QT; Wang, RF; Wang, CC; Ge, K; Wu, J				Shi, Xuanming; Zhang, Zilai; Zhan, Xiaoming; Cao, Mou; Satoh, Takashi; Akira, Shizuo; Shpargel, Karl; Magnuson, Terry; Li, Qingtian; Wang, Rongfu; Wang, Chaochen; Ge, Kai; Wu, Jiang			An epigenetic switch induced by Shh signalling regulates gene activation during development and medulloblastoma growth	NATURE COMMUNICATIONS			English	Article							EMBRYONIC STEM-CELLS; SONIC HEDGEHOG; DEMETHYLASE JMJD3; CEREBELLUM DEVELOPMENT; NEURAL DEVELOPMENT; SPINAL-CORD; POLYCOMB; GENOME; DIFFERENTIATION; EXPRESSION	The Sonic hedgehog (Shh) signalling pathway plays important roles during development and in cancer. Here we report a Shh-induced epigenetic switch that cooperates with Gli to control transcription outcomes. Before induction, poised Shh target genes are marked by a bivalent chromatin domain containing a repressive histone H3K27me3 mark and an active H3K4me3 mark. Shh activation induces a local switch of epigenetic cofactors from the H3K27 methyltransferase polycomb repressive complex 2 (PRC2) to an H3K27me3 demethylase Jmjd3/Kdm6b-centred coactivator complex. We also find that non-enzymatic activities of Jmjd3 are important and that Jmjd3 recruits the Set1/MLL H3K4 methyltransferase complexes in a Shh-dependent manner to resolve the bivalent domain. In vivo, changes of the bivalent domain accompanied Shh-activated cerebellar progenitor proliferation. Overall, our results reveal a regulatory mechanism that underlies the activation of Shh target genes and provides insight into the causes of various diseases and cancers exhibiting altered Shh signalling.	[Shi, Xuanming; Zhang, Zilai; Zhan, Xiaoming; Cao, Mou; Wu, Jiang] Univ Texas SW Med Ctr Dallas, Dept Physiol & Dev Biol, Dallas, TX 75390 USA; [Satoh, Takashi; Akira, Shizuo] Osaka Univ, RIMD, World Premier Inst, Lab Host Def,Immunol Frontier Res Ctr, Osaka, Japan; [Satoh, Takashi; Akira, Shizuo] Osaka Univ, Dept Host Def, RIMD, Osaka, Japan; [Shpargel, Karl; Magnuson, Terry] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; [Li, Qingtian; Wang, Rongfu] Methodist Hosp, Res Inst, Ctr Inflammat & Epigenet, Houston, TX 77030 USA; [Wang, Chaochen; Ge, Kai] NIDDK, NIH, Bethesda, MD 20892 USA	Wu, J (reprint author), Univ Texas SW Med Ctr Dallas, Dept Physiol & Dev Biol, Dallas, TX 75390 USA.	jiang9.wu@utsouthwestern.edu	Shi, Xuanming/I-8559-2014; Akira, Shizuo/C-3134-2009; 	Ge, Kai/0000-0002-7442-5138	March of Dimes Foundation; American Cancer Society; NIH [R21MH102820]; Department of Defense Visionary postdoc fellowship	We thank Qiu Wang and Yu Chen for technical support, Dr Chao Xing for RNA-seq analyses and Dr Jin Jiang for reagents and critical discussion. This work was supported by grants from March of Dimes Foundation (J.W.), American Cancer Society (J.W.), NIH (R21MH102820, J.W.) and Department of Defense Visionary postdoc fellowship (X.S.).	Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Malatesta M, 2013, CANCER RES, V73, P6323, DOI 10.1158/0008-5472.CAN-12-4660; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Estaras C, 2012, DEVELOPMENT, V139, P2681, DOI 10.1242/dev.078345; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Peterson KA, 2012, GENE DEV, V26, P2802, DOI 10.1101/gad.207142.112; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Oosterveen T, 2012, DEV CELL, V23, P1006, DOI 10.1016/j.devcel.2012.09.015; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Lei QB, 2004, DEVELOPMENT, V131, P3593, DOI 10.1242/dev.01230; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Taipale J, 2000, NATURE, V406, P1005; Di Meglio T, 2013, SCIENCE, V339, P204, DOI 10.1126/science.1229326; Burgold T, 2012, CELL REP, V2, P1244, DOI 10.1016/j.celrep.2012.09.013; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Ding Q, 1998, DEVELOPMENT, V125, P2533; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Chen SZ, 2012, GENE DEV, V26, P1364, DOI 10.1101/gad.186056.111; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Rallu M, 2002, DEVELOPMENT, V129, P4963; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Zhao W, 2013, CELL, V152, P1037, DOI 10.1016/j.cell.2013.02.006; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Zhan XM, 2011, P NATL ACAD SCI USA, V108, P12758, DOI 10.1073/pnas.1018510108; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kallin EM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000506; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; van der Vlag J, 1999, NAT GENET, V23, P474	70	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5425	10.1038/ncomms6425		12	Multidisciplinary Sciences	Science & Technology - Other Topics	AU5CO	WOS:000345625000005		
J	Takahashi, Y; Kumatani, A; Munakata, H; Inomata, H; Ito, K; Ino, K; Shiku, H; Unwin, PR; Korchev, YE; Kanamura, K; Matsue, T				Takahashi, Yasufumi; Kumatani, Akichika; Munakata, Hirokazu; Inomata, Hirotaka; Ito, Komachi; Ino, Kosuke; Shiku, Hitoshi; Unwin, Patrick R.; Korchev, Yuri E.; Kanamura, Kiyoshi; Matsue, Tomokazu			Nanoscale visualization of redox activity at lithium-ion battery cathodes	NATURE COMMUNICATIONS			English	Article							SCANNING ELECTROCHEMICAL MICROSCOPY; HETEROGENEOUS ELECTRON-TRANSFER; CONDUCTANCE MICROSCOPY; LIFEPO4; RESOLUTION; LI; DIFFUSION; TRANSPORT; INTERCALATION; BEHAVIOR	Intercalation and deintercalation of lithium ions at electrode surfaces are central to the operation of lithium-ion batteries. Yet, on the most important composite cathode surfaces, this is a rather complex process involving spatially heterogeneous reactions that have proved difficult to resolve with existing techniques. Here we report a scanning electrochemical cell microscope based approach to define a mobile electrochemical cell that is used to quantitatively visualize electrochemical phenomena at the battery cathode material LiFePO4, with resolution of similar to 100 nm. The technique measures electrode topography and different electrochemical properties simultaneously, and the information can be combined with complementary microscopic techniques to reveal new perspectives on structure and activity. These electrodes exhibit highly spatially heterogeneous electrochemistry at the nanoscale, both within secondary particles and at individual primary nanoparticles, which is highly dependent on the local structure and composition.	[Takahashi, Yasufumi; Kumatani, Akichika; Matsue, Tomokazu] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Takahashi, Yasufumi; Inomata, Hirotaka; Ito, Komachi; Ino, Kosuke; Shiku, Hitoshi; Matsue, Tomokazu] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808579, Japan; [Munakata, Hirokazu; Kanamura, Kiyoshi] Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Tokyo 1920397, Japan; [Unwin, Patrick R.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Korchev, Yuri E.] Univ London Imperial Coll Sci Technol & Med, Div Med, London W12 0NN, England	Takahashi, Y (reprint author), Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan.	takahashi@bioinfo.che.tohoku.ac.jp	Takahashi, Yasufumi/G-5777-2011; Matsue, Tomokazu/F-9688-2010		Japan Science and Technology Agency; Japan Society for the Promotion of Science [25248032, 24710140, 24750005]; Cabinet Office, Government of Japan, through its 'Funding Program for Next Generation World-Leading Researchers'; Asahi Glass Foundation; Murata Science Foundation; European Research Council Advanced Investigator Grant [ERC-2009-AdG247143]; Engineering and Physical Sciences Research Council	This work was supported by a Grant-in-Aid for Development of Systems and Technology for Advanced Measurement and Analysis, and Advanced Low Carbon Technology Research and Development Program from the Japan Science and Technology Agency, Grants-in-Aid for Scientific Research (A) (no. 25248032) and for Young Scientists (B) (nos. 24710140 and 24750005) from the Japan Society for the Promotion of Science. This work was partly supported by the Cabinet Office, Government of Japan, through its 'Funding Program for Next Generation World-Leading Researchers'. Y.T. was supported by Asahi Glass Foundation and the Murata Science Foundation. P.R.U. acknowledges support from a European Research Council Advanced Investigator Grant (ERC-2009-AdG247143 QUANTIF). Y.E.K. was supported by the Engineering and Physical Sciences Research Council.	Takahashi Y, 2010, J AM CHEM SOC, V132, P10118, DOI 10.1021/ja1029478; Aaronson BDB, 2013, J AM CHEM SOC, V135, P3873, DOI 10.1021/ja310632k; Arruda TM, 2011, NANO LETT, V11, P4161, DOI 10.1021/nl202039v; Laforge FO, 2009, ANAL CHEM, V81, P3143, DOI 10.1021/ac900335c; Williams CG, 2009, ANAL CHEM, V81, P2486, DOI 10.1021/ac802114r; Lai SCS, 2011, J AM CHEM SOC, V133, P10744, DOI 10.1021/ja203955b; Nishimura S, 2008, NAT MATER, V7, P707, DOI 10.1038/nmat2251; Munakata H, 2012, J POWER SOURCES, V217, P444, DOI 10.1016/j.jpowsour.2012.06.037; Jebaraj AJJ, 2013, ACCOUNTS CHEM RES, V46, P1192, DOI 10.1021/ar300210q; Guell AG, 2012, J AM CHEM SOC, V134, P7258, DOI 10.1021/ja3014902; Balke N, 2012, NANO LETT, V12, P3399, DOI 10.1021/nl300219g; Huang R, 2012, CURR OPIN SOLID ST M, V16, P31, DOI 10.1016/j.cossms.2011.08.002; Fisher CAJ, 2008, J MATER CHEM, V18, P1209, DOI 10.1039/b715935h; Shen M, 2012, J AM CHEM SOC, V134, P9856, DOI 10.1021/ja3023785; Lipson AL, 2011, ADV MATER, V23, P5613, DOI 10.1002/adma.201103094; Takahashi Y, 2011, ANGEW CHEM INT EDIT, V50, P9638, DOI 10.1002/anie.201102796; Beaulieu LY, 2003, J ELECTROCHEM SOC, V150, pA1457, DOI 10.1149/1.1613668; Balke N, 2010, NAT NANOTECHNOL, V5, P749, DOI 10.1038/nnano.2010.174; Gaberscek M, 2007, ELECTROCHEM COMMUN, V9, P2778, DOI 10.1016/j.elecom.2007.09.020; Baddour-Hadjean R, 2010, CHEM REV, V110, P1278, DOI 10.1021/cr800344k; Guell AG, 2012, P NATL ACAD SCI USA, V109, P11487, DOI 10.1073/pnas.1203671109; Takahashi Y, 2012, P NATL ACAD SCI USA, V109, P11540, DOI 10.1073/pnas.1203570109; Nakano H, 2008, J ELECTROCHEM SOC, V155, pA909, DOI 10.1149/1.2988048; Inaba M, 1999, ELECTROCHIM ACTA, V45, P99, DOI 10.1016/S0013-4686(99)00196-6; Zampardi G, 2013, CHEM COMMUN, V49, P9347, DOI 10.1039/c3cc44576c; Gu L, 2011, J AM CHEM SOC, V133, P4661, DOI 10.1021/ja109412x; Balke N, 2010, NANO LETT, V10, P3420, DOI 10.1021/nl101439x; Chueh WC, 2013, NANO LETT, V13, P866, DOI 10.1021/nl3031899; Mi CH, 2007, J ELECTROANAL CHEM, V602, P245, DOI 10.1016/j.jelechem.2007.01.007; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Dokko K, 2009, J POWER SOURCES, V189, P783, DOI 10.1016/j.jpowsour.2008.07.081; Liu XH, 2009, J POWER SOURCES, V189, P706, DOI 10.1016/j.jpowsour.2008.08.050; Novak P, 2009, NAT METHODS, V6, P279, DOI [10.1038/nmeth.1306, 10.1038/NMETH.1306]; Ebejer N, 2010, ANAL CHEM, V82, P9141, DOI 10.1021/ac102191u; Patten HV, 2012, ANGEW CHEM INT EDIT, V51, P7002, DOI 10.1002/anie.201203057; Cogswell DA, 2013, NANO LETT, V13, P3036, DOI 10.1021/nl400497t; Bard A. J., 2000, ELECTROCHEMICAL METH; Clark JM, 2012, ANGEW CHEM INT EDIT, V51, P13149, DOI 10.1002/anie.201205997; Come J, 2011, J ELECTROCHEM SOC, V158, pA1090, DOI 10.1149/1.3619791; Lai SCS, 2012, ANGEW CHEM INT EDIT, V51, P5405, DOI 10.1002/anie.201200564; Manickam M, 2006, J POWER SOURCES, V158, P646, DOI 10.1016/j.jpowsour.2005.08.059; Yu DYW, 2007, J ELECTROCHEM SOC, V154, pA253, DOI 10.1149/1.2434687	42	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5450	10.1038/ncomms6450		7	Multidisciplinary Sciences	Science & Technology - Other Topics	AU9JT	WOS:000345909200003		
J	Takeda, H; Hattori, M; Nishizawa, T; Yamashita, K; Shah, STA; Caffrey, M; Maturana, AD; Ishitani, R; Nureki, O				Takeda, Hironori; Hattori, Motoyuki; Nishizawa, Tomohiro; Yamashita, Keitaro; Shah, Syed T. A.; Caffrey, Martin; Maturana, Andres D.; Ishitani, Ryuichiro; Nureki, Osamu			Structural basis for ion selectivity revealed by high-resolution crystal structure of Mg2+ channel MgtE	NATURE COMMUNICATIONS			English	Article							POTASSIUM CHANNEL; STREPTOMYCES-LIVIDANS; LIPIDIC MESOPHASES; K+ SELECTIVITY; CALCIUM-ION; METAL-IONS; MAGNESIUM; TRANSPORTER; HYDRATION; CORA	Magnesium is the most abundant divalent cation in living cells and is crucial to several biological processes. MgtE is a Mg2+ channel distributed in all domains of life that contributes to the maintenance of cellular Mg2+ homeostasis. Here we report the highresolution crystal structures of the transmembrane domain of MgtE, bound to Mg2+, Mn2+ and Ca2+. The high-resolution Mg2+ bound crystal structure clearly visualized the hydrated Mg2+ ion within its selectivity filter. Based on those structures and biochemical analyses, we propose a cation selectivity mechanism for MgtE in which the geometry of the hydration shell of the fully hydrated Mg2+ ion is recognized by the side-chain carboxylate groups in the selectivity filter. This is in contrast to the K+-selective filter of KcsA, which recognizes a dehydrated K+ ion. Our results further revealed a cation-binding site on the periplasmic side, which regulate channel opening and prevents conduction of near-cognate cations.	[Takeda, Hironori; Hattori, Motoyuki; Nishizawa, Tomohiro; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Takeda, Hironori; Hattori, Motoyuki; Nishizawa, Tomohiro; Ishitani, Ryuichiro; Nureki, Osamu] RIKEN, Global Res Cluster, Wako, Saitama 3510198, Japan; [Hattori, Motoyuki] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Hattori, Motoyuki] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Yamashita, Keitaro] RIKEN SPring 8 Ctr, SR Life Sci Instrumentat Unit, Sayo, Hyogo 6795148, Japan; [Shah, Syed T. A.; Caffrey, Martin] Univ Dublin Trinity Coll, Sch Med, Membrane Struct & Funct Biol Grp, Dublin 2, Ireland; [Shah, Syed T. A.; Caffrey, Martin] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; [Maturana, Andres D.] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nureki, O (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	nureki@bs.s.u-tokyo.ac.jp			Platform for Drug Discovery; Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI [22117007, 24227004, 25291011, 26711003]; FIRST programme; PRESTO; JST; HPCI STRATEGIC PROGRAM Computational Life Science and Application in Drug Discovery; MEXT; Private University Strategic Research Foundation Support Program (MEXT)	We thank H. Nishimasu (University of Tokyo) for helpful discussions, A. Kurabayashi for technical support, the RIKEN Integrated Cluster of Clusters (RICC) for providing computational resources and the beamline staff members at BL32XU of SPring-8 (Hyogo, Japan) for technical assistance during data collection. The synchrotron radiation experiments were performed at BL32XU of SPring-8, Japan, with approval from RIKEN (Proposal Nos. 2012B1146, 2012B1162, 2013A1128, 2013A1168 and 2013A1128), and at I03 of the Diamond Light Source, UK. This work was supported by the Platform for Drug Discovery, Informatics and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), by JSPS KAKENHI (grant numbers 22117007, 24227004, 25291011 and 26711003), by the FIRST programme, by PRESTO, JST, by a Grant-in-Aid for JSPS Fellows, by a grant for the HPCI STRATEGIC PROGRAM Computational Life Science and Application in Drug Discovery and Medical Development from MEXT, and by grants from the Private University Strategic Research Foundation Support Program (MEXT).	Aakesson R., 1994, J AM CHEM SOC, V116, P8691, DOI 10.1021/ja00098a032; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; Meuser D, 1999, FEBS LETT, V462, P447, DOI 10.1016/S0014-5793(99)01579-3; Pfoh R, 2012, P NATL ACAD SCI USA, V109, P18809, DOI 10.1073/pnas.1209018109; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Bajgar R, 2001, J BIOL CHEM, V276, P33369, DOI 10.1074/jbc.M103320200; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; SCHREMPF H, 1995, EMBO J, V14, P5170; Cowan JA, 2002, BIOMETALS, V15, P225, DOI 10.1023/A:1016022730880; Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4; Pavlov M, 1998, J PHYS CHEM A, V102, P219, DOI 10.1021/jp972072r; KLEINBERG ME, 1984, J MEMBRANE BIOL, V80, P257, DOI 10.1007/BF01868444; Garlid KD, 1996, J BIOL CHEM, V271, P8796; Ishijima S, 2012, BBA-BIOMEMBRANES, V1818, P2202, DOI 10.1016/j.bbamem.2012.04.015; Persson I, 2010, PURE APPL CHEM, V82, P1901, DOI 10.1351/PAC-CON-09-10-22; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Alam A, 2009, NAT STRUCT MOL BIOL, V16, P35, DOI 10.1038/nsmb.1537; Guskov A, 2012, P NATL ACAD SCI USA, V109, P18459, DOI 10.1073/pnas.1210076109; Alexander RT, 2008, J AM SOC NEPHROL, V19, P1451, DOI 10.1681/ASN.2008010098; Sahni J, 2013, MOL ASPECTS MED, V34, P620, DOI 10.1016/j.mam.2012.05.012; Hattori M, 2009, EMBO J, V28, P3602, DOI 10.1038/emboj.2009.288; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Marino T, 2006, J PHYS CHEM B, V110, P24666, DOI 10.1021/jp0645972; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Suzuki Y, 2002, ANAL CHEM, V74, P1423, DOI 10.1021/ac010914j; Jalilehvand F, 2001, J AM CHEM SOC, V123, P431, DOI 10.1021/ja001533a; Cherezov V, 2011, CURR OPIN STRUC BIOL, V21, P559, DOI 10.1016/j.sbi.2011.06.007; Kolisek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071096; Misquitta LV, 2004, STRUCTURE, V12, P2113, DOI 10.1016/j.str.2004.09.020; Moomaw A. S., 2009, PHYSIOLOGY BETHESDA, P275; Solt I, 2007, J PHYS CHEM B, V111, P6272, DOI 10.1021/jp0668192; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; YATSIMIRSKY KB, 1994, TEOR EKSP KHIM, V30, P1, DOI 10.1007/BF00535915	41	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5374	10.1038/ncomms6374		10	Multidisciplinary Sciences	Science & Technology - Other Topics	AU6US	WOS:000345740200005		
J	Wu, W; Cheng, JG; Matsubayashi, K; Kong, PP; Lin, FK; Jin, CQ; Wang, NL; Uwatoko, Y; Luo, JL				Wu, Wei; Cheng, Jinguang; Matsubayashi, Kazuyuki; Kong, Panpan; Lin, Fukun; Jin, Changqing; Wang, Nanlin; Uwatoko, Yoshiya; Luo, Jianlin			Superconductivity in the vicinity of antiferromagnetic order in CrAs	NATURE COMMUNICATIONS			English	Article							QUANTUM PHASE-TRANSITION; ELECTRONIC-STRUCTURE; MAGNETIC-PROPERTIES; PRESSURE; CHROMIUM; METAL	One of the common features of unconventional superconducting systems such as the heavy-fermion, high transition-temperature cuprate and iron-pnictide superconductors is that the superconductivity emerges in the vicinity of long-range antiferromagnetically ordered state. In addition to doping charge carriers, the application of external pressure is an effective and clean approach to induce unconventional superconductivity near a magnetic quantum critical point. Here we report on the discovery of superconductivity on the verge of antiferromagnetic order in CrAs via the application of external pressure. Bulk superconductivity with T-c approximate to 2 K emerges at the critical pressure P-c approximate to 8 kbar, where the first-order antiferromagnetic transition at T-N approximate to 265 K under ambient pressure is completely suppressed. The close proximity of superconductivity to an antiferromagnetic order suggests an unconventional pairing mechanism for CrAs. The present finding opens a new avenue for searching novel superconductors in the Cr and other transition metal-based systems.	[Wu, Wei; Cheng, Jinguang; Kong, Panpan; Lin, Fukun; Jin, Changqing; Wang, Nanlin; Luo, Jianlin] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Wu, Wei; Cheng, Jinguang; Kong, Panpan; Lin, Fukun; Jin, Changqing; Wang, Nanlin; Luo, Jianlin] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Cheng, Jinguang; Matsubayashi, Kazuyuki; Uwatoko, Yoshiya] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Jin, Changqing; Wang, Nanlin; Luo, Jianlin] Collaborat Innovat Ctr Quantum Matter, Beijing, Peoples R China; [Wang, Nanlin] Peking Univ, Sch Phys, Int Ctr Quantum Mat, Beijing 100871, Peoples R China	Cheng, JG (reprint author), Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China.	jgcheng@iphy.ac.cn; uwatoko@issp.u-tokyo.ac.jp; jlluo@iphy.ac.cn	Cheng, Jinguang/A-8342-2012; Matsubayashi, Kazuyuki/F-7696-2013		National Science Foundation of China [11025422, 11304371, 11220101003]; National Basic Research Program of China [2014CB921500, 2011CB921700]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB01020300, XDB07000000]; KAKENHI [23340101, 252460135]; Ministry of Education, Culture, Sports, Science and Technology [24740220]; JSPS [12F02023]	We thank Y.P. Wang, Z. Fang, J.Q. Yan, J. S. Zhou, J. B. Goodenough, N.Mori, T. Kato, T. Kanomata, M. Matsuda, F. Steglich, Q. Si, P. J. Sun, G. M. Zhang and L. Yu for fruitful discussions. Work at IOP/CAS was supported by the National Science Foundation of China (Grant Nos. 11025422, 11304371, 11220101003), the National Basic Research Program of China (Grant Nos. 2014CB921500, 2011CB921700) and the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant Nos. XDB01020300, XDB07000000). Work at ISSP/UT was partially supported by Grant-in-Aid for Scientific Research, KAKENHI (Grant Nos. 23340101, 252460135), the Grant-in-Aid for Young Scientist B (No. 24740220) from the Ministry of Education, Culture, Sports, Science and Technology and the JSPS fellowship for foreign researchers (Grant No. 12F02023).	FAWCETT E, 1988, REV MOD PHYS, V60, P209, DOI 10.1103/RevModPhys.60.209; WATANABE H, 1969, J APPL PHYS, V40, P1128, DOI 10.1063/1.1657559; Jaramillo R, 2010, P NATL ACAD SCI USA, V107, P13631, DOI [10.1073/pnas.1005036107, 10.1073/pnas.100S036107]; Mathur ND, 1998, NATURE, V394, P39; SELTE K, 1971, ACTA CHEM SCAND, V25, P1703, DOI 10.3891/acta.chem.scand.25-1703; BOLLER H, 1971, SOLID STATE COMMUN, V9, P1699, DOI 10.1016/0038-1098(71)90344-9; von Lohneysen H, 2007, REV MOD PHYS, V79, P1015, DOI 10.1103/RevModPhys.79.1015; Jaramillo R, 2009, NATURE, V459, P405, DOI 10.1038/nature08008; Jin K, 2011, NATURE, V476, P73, DOI 10.1038/nature10308; Paglione J, 2010, NAT PHYS, V6, P645, DOI 10.1038/NPHYS1759; Yeh A, 2002, NATURE, V419, P459, DOI 10.1038/nature01044; Ito T, 2007, J MAGN MAGN MATER, V310, pE558, DOI 10.1016/j.jmmm.2006.10.470; KAZAMA N, 1971, J PHYS SOC JPN, V30, P1319, DOI 10.1143/JPSJ.30.1319; MATTHIAS BT, 1962, PHYS REV, V128, P588, DOI 10.1103/PhysRev.128.588; MORIYA T, 1995, J PHYS SOC JPN, V64, P960, DOI 10.1143/JPSJ.64.960; Moriya T., 1985, SPIN FLUCTUATIONS IT; Motizuki K, 2009, SPRINGER SER MATER S, V131, P1; THOMPSON JD, 1984, REV SCI INSTRUM, V55, P231, DOI 10.1063/1.1137730; Uwatoko Y., 2002, REV HIGH PRESS SCI T, V12, P306; Wei W., 2010, SCI CHINA, V53, P1207; Zavadskii EA, 1980, SOV PHYS JETP, V51, P542	21	14	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5508	10.1038/ncomms6508		5	Multidisciplinary Sciences	Science & Technology - Other Topics	AU9LA	WOS:000345913000013		
J	Yasuhara, T; Suzuki, T; Katsura, M; Miyagawa, K				Yasuhara, Takaaki; Suzuki, Takahiko; Katsura, Mari; Miyagawa, Kiyoshi			Rad54B serves as a scaffold in the DNA damage response that limits checkpoint strength	NATURE COMMUNICATIONS			English	Article							HOMOLOGOUS RECOMBINATION; HUMAN-CELLS; WILD-TYPE; P53; ADAPTATION; REPAIR; UBIQUITINATION; REGULATOR; DEPENDS; DOMAINS	The strength of the DNA damage checkpoint critically influences cell fate, yet the mechanisms behind the fine tuning of checkpoint strength during the DNA damage response (DDR) are poorly understood. Here we show that Rad54B-a SNF2 helicase-like DNA-repair protein-limits the strength of both the G1/S and G2/M checkpoints. We find that Rad54B functions as a scaffold for p53 degradation via its direct interaction with the MDM2-MDMX ubiquitin-ligase complex. During the early phases of the DDR, Rad54B is upregulated, thereby maintaining low checkpoint strength and facilitating cell cycle progression. Once the p53-mediated checkpoint is established, Rad54B is downregulated, and high checkpoint strength is maintained. Constitutive upregulation of Rad54B activity, which is frequently observed in tumours, promotes genomic instability because of checkpoint override. Thus, the scaffolding function of Rad54B dynamically regulates the maintenance of genome integrity by limiting checkpoint strength.	[Yasuhara, Takaaki; Miyagawa, Kiyoshi] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med,Lab Mol Radiol, Bunkyo Ku, Tokyo 1130033, Japan; [Suzuki, Takahiko] Teikyo Univ, Fac Med Technol, Dept Radiol Technol, Itabashi Ku, Tokyo 1738605, Japan; [Katsura, Mari] Univ Tokyo, Isotope Sci Ctr, Bunkyo Ku, Tokyo 1130032, Japan	Miyagawa, K (reprint author), Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med,Lab Mol Radiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyag-tky@umin.ac.jp		Yasuhara, Takaaki/0000-0002-6719-5709	JSPS; Ministry of Health, Labour and Welfare of Japan	This work is dedicated to the memory of my (T.Y.) mother, Fumiko Yasuhara, who died of breast cancer while it was in progress. T.Y. is a Research Fellow of the Japan Society for the Promotion of Science (JSPS). This work was supported by a Grants-in-Aid for Scientific Research from JSPS to T.Y. and by a Grants-in-Aid for the 3rd-term Comprehensive 10-Year Strategy for Cancer Control and for Cancer Research from the Ministry of Health, Labour and Welfare of Japan.	Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Ceballos SJ, 2011, BBA-GENE REGUL MECH, V1809, P509, DOI 10.1016/j.bbagrm.2011.06.006; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9; Syljuasen RG, 2006, CANCER RES, V66, P10253, DOI 10.1158/0008-5472.CAN-06-2144; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Ohouo PY, 2013, NATURE, V493, P120, DOI 10.1038/nature11658; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Hiramoto T, 1999, ONCOGENE, V18, P3422, DOI 10.1038/sj.onc.1202691; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Miyagawa K, 2002, EMBO J, V21, P175, DOI 10.1093/emboj/21.1.175; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Wesoly J, 2006, MOL CELL BIOL, V26, P976, DOI 10.1128/MCB.26.3.976-989.2006; Gerloff DL, 2012, FEBS LETT, V586, P2711, DOI 10.1016/j.febslet.2012.05.005; Kirshner M, 2009, DNA REPAIR, V8, P253, DOI 10.1016/j.dnarep.2008.11.005; Mahabir AG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-24; Mahabir AG, 2008, TOXICOL LETT, V183, P112, DOI 10.1016/j.toxlet.2008.10.005; Tanaka K, 2002, NUCLEIC ACIDS RES, V30, P1346, DOI 10.1093/nar/30.6.1346; Tanaka K, 2000, J BIOL CHEM, V275, P26316, DOI 10.1074/jbc.M910306199; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175	25	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5426	10.1038/ncomms6426		11	Multidisciplinary Sciences	Science & Technology - Other Topics	AU5CO	WOS:000345625000006		
J	Yotsumoto, Y; Chang, LH; Ni, R; Pierce, R; Andersen, GJ; Watanabe, T; Sasaki, Y				Yotsumoto, Yuko; Chang, Li-Hung; Ni, Rui; Pierce, Russell; Andersen, George J.; Watanabe, Takeo; Sasaki, Yuka			White matter in the older brain is more plastic than in the younger brain	NATURE COMMUNICATIONS			English	Article							SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; PRIMARY VISUAL-CORTEX; AGE-RELATED-CHANGES; TIME-COURSE; DIFFERENTIAL VULNERABILITY; TEXTURE-DISCRIMINATION; GRAY-MATTER; LIFE-SPAN; IN-VIVO	Visual perceptual learning (VPL) with younger subjects is associated with changes in functional activation of the early visual cortex. Although overall brain properties decline with age, it is unclear whether these declines are associated with visual perceptual learning. Here we use diffusion tensor imaging to test whether changes in white matter are involved in VPL for older adults. After training on a texture discrimination task for three daily sessions, both older and younger subjects show performance improvements. While the older subjects show significant changes in fractional anisotropy (FA) in the white matter beneath the early visual cortex after training, no significant change in FA is observed for younger subjects. These results suggest that the mechanism for VPL in older individuals is considerably different from that in younger individuals and that VPL of older individuals involves reorganization of white matter.	[Yotsumoto, Yuko] Univ Tokyo, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Chang, Li-Hung; Watanabe, Takeo; Sasaki, Yuka] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Chang, Li-Hung] Natl Yang Ming Univ, Sch Humanities & Social Sci, Educ Ctr Humanities & Social Sci, Taipei 112, Taiwan; [Ni, Rui; Pierce, Russell; Andersen, George J.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	Sasaki, Y (reprint author), Brown Univ, Dept Cognit Linguist & Psychol Sci, 190 Thayer St, Providence, RI 02912 USA.	yuka_sasaki@brown.edu			NIH [R01AG031941, R01MH091801, R01EY015980, R01EY019466, R01EY018334]; NSF [BCS-1261765]; JSPS KAKENHI [23680028, 25119003]; JSPS SCOPE [112103017]	This research was carried out in part at the Athinoula A. Martinos Center for Biomedical Imaging at the Massachusetts General Hospital, using resources provided by the Center for Functional Neuroimaging Technologies, P41RR14075, a P41 Regional Resource supported by the Biomedical Technology Program of the National Center for Research Resources, National Institutes of Health (NIH). This work was also supported by NIH grants R01AG031941, R01MH091801, R01EY015980, R01EY019466, R01EY018334, NSF BCS-1261765, JSPS KAKENHI-23680028, JSPS KAKENHI-25119003 and SCOPE-112103017.	Andersen GJ, 2010, J VISION, V10, DOI 10.1167/10.13.4; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Courchesne E, 2000, RADIOLOGY, V216, P672; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Yotsumoto Y, 2009, CURR BIOL, V19, P1278, DOI 10.1016/j.cub.2009.06.011; Fjell AM, 2008, NEUROIMAGE, V42, P1654, DOI 10.1016/j.neuroimage.2008.06.005; Adini Y, 2004, J VISION, V4, P993, DOI 10.1167/4.12.2; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Imfeld A, 2009, NEUROIMAGE, V46, P600, DOI 10.1016/j.neuroimage.2009.02.025; de Villers-Sidani E, 2010, P NATL ACAD SCI USA, V107, P13900, DOI 10.1073/pnas.1007885107; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Andersen GJ, 2006, PSYCHOL AGING, V21, P74, DOI 10.1037/0882-7974.21.1.74; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Suzuki Y, 2003, NMR BIOMED, V16, P257, DOI 10.1002/nbm.848; Partridge SC, 2004, NEUROIMAGE, V22, P1302, DOI 10.1016/j.neuroimaging.2004.02.038; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Kochunov P, 2011, NEUROIMAGE, V58, P41, DOI 10.1016/j.neuroimage.2011.05.050; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Walker MP, 2005, CEREB CORTEX, V15, P1666, DOI 10.1093/cercor/bhi043; Salat DH, 2005, ANN NY ACAD SCI, V1064, P37, DOI 10.1196/annals.1340.009; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Buckner RL, 2000, J COGNITIVE NEUROSCI, V12, P24, DOI 10.1162/089892900564046; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fize D, 2003, J NEUROSCI, V23, P7395; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; van der Kouwe AJW, 2005, NEUROIMAGE, V27, P222, DOI 10.1016/j.neuroimage.2005.03.03; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; Dinse HR, 2006, PROG BRAIN RES, V157, P57, DOI 10.1016/S0079-6123(06)57005-0; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Bloss EB, 2011, J NEUROSCI, V31, P7831, DOI 10.1523/JNEUROSCI.0839-11.2011; Barr DJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00328; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1006/jmrb.1996.0086; Brehmer Y, 2008, PSYCHOL AGING, V23, P227, DOI 10.1037/0882-7974.23.2.227; Brubaker CJ, 2009, NEUROTOXICOLOGY, V30, P867, DOI 10.1016/j.neuro.2009.07.007; Chang LH, 2015, NEUROBIOL AGING, V36, P315, DOI 10.1016/j.neurobiolaging.2014.08.025; Fahle M, 2002, PERCEPTUAL LEARNING; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Hua TM, 2006, NEUROBIOL AGING, V27, P155, DOI 10.1016/j.neurobiolaging.2004.12.012; Kannurpatti SS, 2010, MAGN RESON IMAGING, V28, P466, DOI 10.1016/j.mri.2009.12.007; Lemaitre H., 2012, NEUROBIOL AGING, V33; Mednick SC, 2005, P NATL ACAD SCI USA, V102, P3881, DOI 10.1073/pnas.0407866102; Nir TM, 2013, NEUROIMAGE-CLIN, V3, P180, DOI 10.1016/j.nicl.2013.07.006; Piech V, 2013, P NATL ACAD SCI USA, V110, pE4108, DOI 10.1073/pnas.1317019110; Steele CJ, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00289	70	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								6504	10.1038/ncomms6504		8	Multidisciplinary Sciences	Science & Technology - Other Topics	AU9LA	WOS:000345913000009		
J	Kitada, R; Sasaki, AT; Okamoto, Y; Kochiyama, T; Sadato, N				Kitada, Ryo; Sasaki, Akihiro T.; Okamoto, Yuko; Kochiyama, Takanori; Sadato, Norihiro			Role of the precuneus in the detection of incongruency between tactile and visual texture information: A functional MRI study	NEUROPSYCHOLOGIA			English	Article						fMRI; Material; Multisensory; Orientation; Touch; Vision	LONG-TERM-MEMORY; ASSOCIATIVE MEMORY; HUMAN BRAIN; PARAHIPPOCAMPAL CORTICES; EFFECTIVE CONNECTIVITY; SOMATOSENSORY CORTEX; ALZHEIMERS-DISEASE; FRONTAL-CORTEX; PARIETAL LOBE; IMAGING DATA	Visual clues as to the physical substance of manufactured objects can be misleading. For example, a plastic ring can appear to be made of gold. However, we can avoid misidentifying an object's substance by comparing visual and tactile information. As compared to the spatial properties of an object (e.g., orientation), however, little information regarding physical object properties (material properties) is shared between vision and touch. How can such different kinds of information be compared in the brain? One possibility is that the visuo-tactile comparison of material information is mediated by associations that are previously learned between the two modalities. Previous studies suggest that a cortical network involving the medial temporal lobe and precuneus plays a critical role in the retrieval of information from long-term memory. Here, we used functional magnetic resonance imaging (fMRI) to test whether these brain regions are involved in the visuo-tactile comparison of material properties. The stimuli consisted of surfaces in which an oriented plastic bar was placed on a background texture. Twenty-two healthy participants determined whether the orientations of visually- and tactually-presented bar stimuli were congruent in the orientation conditions, and whether visually- and tactually-presented background textures were congruent in the texture conditions. The texture conditions revealed greater activation of the fusiform gyrus, medial temporal lobe and lateral prefrontal cortex compared with the orientation conditions. In the texture conditions, the precuneus showed greater response to incongruent stimuli than to congruent stimuli. This incongruency effect was greater for the texture conditions than for the orientation conditions. These results suggest that the precuneus is involved in detecting incongruency between tactile and visual texture information in concert with the medial temporal lobe, which is tightly linked with long-term memory. (C) 2014 Elsevier Ltd. All rights reserved.	[Kitada, Ryo; Sadato, Norihiro] Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 4448585, Japan; [Kitada, Ryo; Sadato, Norihiro] Grad Univ Adv Studies Sokendai, Dept Physiol Sci, Miura, Kanagawa, Japan; [Sasaki, Akihiro T.] Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 5458585, Japan; [Sasaki, Akihiro T.] RIKEN Ctr Life Sci Technol, Pathophysiol & Hlth Sci Team, Kobe, Hyogo 6500047, Japan; [Okamoto, Yuko] Univ Fukui, Res Ctr Child Mental Dev, Eiheiji 9101193, Japan; [Kochiyama, Takanori] ATR Brain Act Imaging Ctr, Seika 6190288, Japan	Kitada, R (reprint author), Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 4448585, Japan.	kitada@nips.ac.jp			Japan Society for the Promotion of Science [23700326]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25135734]; MEXT of Japan [21220005]	This work was supported by a Grant-in-aid for Young Scientists (B) (#23700326) from the Japan Society for the Promotion of Science and by a Grant-in-Aid for Scientific Research on Innovative Areas, "Brain and Information Science on SHITSUKAN" (#25135734) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to RK; and by a Grant-in-Aid for Scientific Research (#21220005) and "Development of biomarker candidates for social behavior" carried out under the Strategic Research Program for Brain Sciences from the MEXT of Japan to NS. We thank Dr. Tomonori Kito of Juntendo University, and Ms. Mamiko Arata and Mr. Yoshikuni Ito of the National Institute for Physiological Sciences for their technical advice and assistance.	SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Ranganath C, 2004, J NEUROSCI, V24, P3917, DOI 10.1523/JNEUROSCI.5053-03.2004; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Cavina-Pratesi C, 2010, CEREB CORTEX, V20, P433, DOI 10.1093/cercor/bhp111; Fleming RW, 2014, VISION RES, V94, P62, DOI 10.1016/j.visres.2013.11.004; Francis ST, 2000, NEUROIMAGE, V11, P188, DOI 10.1006/nimg.2000.0541; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Krause BJ, 1999, BRAIN, V122, P255, DOI 10.1093/brain/122.2.255; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Albright TD, 2012, NEURON, V74, P227, DOI 10.1016/j.neuron.2012.04.001; Hadjikhani N, 1998, J NEUROSCI, V18, P1072; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Roland PE, 1998, P NATL ACAD SCI USA, V95, P3295, DOI 10.1073/pnas.95.6.3295; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Saito DN, 2003, COGNITIVE BRAIN RES, V17, P14, DOI 10.1016/S0926-6410(03)00076-4; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Weniger G, 2004, HIPPOCAMPUS, V14, P785, DOI 10.1002/hipo.10216; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Lederman SJ, 1997, J EXP PSYCHOL HUMAN, V23, P1680, DOI 10.1037//0096-1523.23.6.1680; Kim S, 2010, HUM BRAIN MAPP, V31, P678, DOI 10.1002/hbm.20897; Tal N, 2009, EXP BRAIN RES, V198, P165, DOI 10.1007/s00221-009-1949-4; Matsuda H, 2007, J NUCL MED, V48, P1289, DOI 10.2967/jnumed.106.037218; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Sathian K, 2011, NEUROIMAGE, V57, P462, DOI 10.1016/j.neuroimage.2011.05.001; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Zhang MM, 2004, COGN AFFECT BEHAV NE, V4, P251, DOI 10.3758/CABN.4.2.251; Hiramatsu C, 2011, NEUROIMAGE, V57, P482, DOI 10.1016/j.neuroimage.2011.04.056; Whitaker TA, 2008, BRAIN RES, V1242, P59, DOI 10.1016/j.brainres.2008.05.037; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Holdstock JS, 2009, CEREB CORTEX, V19, P2993, DOI 10.1093/cercor/bhp073; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Kitada R, 2005, NEUROIMAGE, V25, P90, DOI 10.1016/j.neuroimage.2004.11.026; Lacey S, 2010, EUR J NEUROSCI, V31, P1882, DOI 10.1111/j.1460-9568.2010.07204.x; FRIEDMAN DP, 1986, J COMP NEUROL, V252, P323, DOI 10.1002/cne.902520304; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Cant JS, 2007, CEREB CORTEX, V17, P713, DOI 10.1093/cercor/bhk022; Fitzgerald PJ, 2006, J NEUROSCI, V26, P6473, DOI 10.1523/JNEUROSCI.5057-05.2006; Cavina-Pratesi C, 2010, CEREB CORTEX, V20, P2319, DOI 10.1093/cercor/bhp298; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Peltier S, 2007, NEUROPSYCHOLOGIA, V45, P476, DOI 10.1016/j.neuropsychologia.2006.03.003; Eck J, 2013, NEUROIMAGE, V75, P123, DOI 10.1016/j.neuroimage.2013.02.075; Stoesz MR, 2003, INT J PSYCHOPHYSIOL, V50, P41, DOI 10.1016/S0167-8760(03)00123-5; Cant JS, 2011, J NEUROSCI, V31, P8248, DOI 10.1523/JNEUROSCI.6113-10.2011; Kassuba T, 2013, NEUROIMAGE, V65, P59, DOI 10.1016/j.neuroimage.2012.09.054; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; Stilla R, 2008, HUM BRAIN MAPP, V29, P1123, DOI 10.1002/hbm.20456; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Libby LA, 2012, J NEUROSCI, V32, P6550, DOI 10.1523/JNEUROSCI.3711-11.2012; Grefkes C, 2002, NEURON, V35, P173, DOI 10.1016/S0896-6273(02)00741-9; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Ashburner J., 2007, NEUROIMAGE, V38, P5; Burton H, 1997, CEREB CORTEX, V7, P3, DOI 10.1093/cercor/7.1.3; Deshpande G, 2008, NEUROIMAGE, V40, P1807, DOI 10.1016/j.neuroimage.2008.01.044; Deshpande G, 2010, NEUROIMAGE, V49, P1991, DOI 10.1016/j.neuroimage.2009.08.052; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Friston KJ, 1994, HUMAN BRAIN MAPPING, V10, P153, DOI 10.1002/hbm.460010207; Gonzalo D, 2000, NEUROIMAGE, V11, P243, DOI 10.1006/nimg.2000.0540; Harada T, 2004, J NEUROSCI, V24, P7524, DOI 10.1523/JNEUROSCI.1395-04.2004; Harrington GS, 2001, BRAIN RES, V897, P188, DOI 10.1016/S0006-8993(01)02139-4; Hasegawa I, 1998, SCIENCE, V281, P814, DOI 10.1126/science.281.5378.814; Holmes A, 1998, NEUROIMAGE, V7, pS754; Jones L. A., 2006, HUMAN HAND FUNCTION; Kitada R, 2006, J NEUROSCI, V26, P7491, DOI 10.1523/JNEUROSCI.0822-06.2006; Lacey S, 2011, EXP BRAIN RES, V213, P267, DOI 10.1007/s00221-011-2623-1; Nakashita S, 2008, BRAIN RES BULL, V75, P513, DOI 10.1016/j.brainresbull.2007.09.004; Nicholson KG, 2004, PERCEPTION, V33, P339, DOI 10.1068/p5136; SAKAI K, 1994, TRENDS NEUROSCI, V17, P287, DOI 10.1016/0166-2236(94)90058-2; Servos P, 2001, Brain Res Cogn Brain Res, V12, P307; Tanabe HC, 2005, J NEUROSCI, V25, P6409, DOI 10.1523/JNEUROSCI.0636-05.2005; Tanabe HC, 2009, NEUROSCIENCE, V160, P688, DOI 10.1016/j.neuroscience.2009.02.078; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	83	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	NOV	2014	64						252	262		10.1016/j.neuropsychologia.2014.09.028		11	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	AU6TL	WOS:000345734500025		
J	Tamakoshi, G; Hamori, S				Tamakoshi, Go; Hamori, Shigeyuki			The conditional dependence structure of insurance sector credit default swap indices	NORTH AMERICAN JOURNAL OF ECONOMICS AND FINANCE			English	Article						Insurance sector CDS; Copulas; Financial crises; Systemic risk	MARKETS; CDS	This study assesses the dependence structure of insurance sector credit default swap indices, using a copula-GARCH approach. We use daily data of the US, EU, and UK insurance sectors, covering the period from January 2004 to June 2013. We find substantial increases in dependence during the financial crisis periods. Prior to the crises, various copulas are found to best fit each pair; specifically, asymmetric tail dependence is found for the UK-US pair, suggesting the possibility of large simultaneous losses. However, during the crisis periods, the Frank copula fits best, with no significant tail dependence detected, implying low systemic risks. (C) 2014 Elsevier Inc. All rights reserved.	[Tamakoshi, Go] Kobe Univ, Dept Econ, Nada Ku, Kobe, Hyogo 6578501, Japan; [Hamori, Shigeyuki] Kobe Univ, Fac Econ, Nada Ku, Kobe, Hyogo 6578501, Japan	Tamakoshi, G (reprint author), Kobe Univ, Dept Econ, Nada Ku, 2-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	tamakosh@gj9.so-net.ne.jp					Acharya V., 2009, WORKING PAPER; Aloui R, 2013, J INT MONEY FINANC, V32, P719, DOI 10.1016/j.jimonfin.2012.06.006; Harrington SE, 2009, J RISK INSUR, V76, P785, DOI 10.1111/j.1539-6975.2009.01330.x; Genest C, 2009, INSUR MATH ECON, V44, P199, DOI 10.1016/j.insmatheco.2007.10.005; Zolotko M, 2014, ENERG ECON, V43, P284, DOI 10.1016/j.eneco.2014.02.019; Poon SH, 2004, REV FINANC STUD, V17, P581, DOI 10.1093/rfs/hhg058; GENEST C, 1995, BIOMETRIKA, V82, P543, DOI 10.1093/biomet/82.3.543; Hammoudeh S, 2011, N AM J ECON FINANC, V22, P257, DOI 10.1016/j.najef.2011.04.001; Lee TH, 2009, J ECONOMETRICS, V150, P207, DOI 10.1016/j.jeconom.2008.12.008; Yang L, 2014, J INT FINANC MARK I, V29, P109, DOI 10.1016/j.intfin.2013.12.003; Chen Hua, 2013, J RISK INSURANCE; Chen L. H., 2011, Q REV EC FINANCE, V51, P408; GLOSTEN LR, 1993, J FINANC, V48, P1779, DOI 10.2307/2329067; Hammoudeh S, 2013, APPL ECON, V45, P213, DOI 10.1080/00036846.2011.597727; Hammoudeh S., 2013, FINANCIAL REV, V48, P151; Kojadinovic I, 2011, STAT COMPUT, V21, P17, DOI 10.1007/s11222-009-9142-y; NELSON DB, 1991, ECONOMETRICA, V59, P347, DOI 10.2307/2938260; Sklar A., 1959, FONCTIONS REPARTITIO, V8; Zakoian J. M., 1991, THRESHOLD HETE UNPUB	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1062-9408	1879-0860		N AM J ECON FINANC	N. Am. Econ. Financ.	NOV	2014	30						122	132		10.1016/j.najef.2014.09.002		11	Business, Finance; Economics	Business & Economics	AU7ZJ	WOS:000345816400007		
J	Koba, K; Yanagita, T				Koba, Kazunori; Yanagita, Teruyoshi			Health benefits of conjugated linoleic acid (CLA)	OBESITY RESEARCH & CLINICAL PRACTICE			English	Review						Conjugated linoleic acid (CLA); Anticarcinogenic; Antiobesity; Antidiabetic; Antihypertensive	MAMMARY-CANCER PREVENTION; PROLIFERATOR-ACTIVATED RECEPTOR; REDUCES BODY-FAT; HUMAN BREAST-CANCER; GENE-EXPRESSION; INSULIN SENSITIVITY; SKELETAL-MUSCLE; PPAR-GAMMA; OLETF RATS; SELECTIVE ESTERIFICATION	Conjugated linoleic acid (CLA) is a group of positional and geometric (cis or trans) isomers of linoleic acid with a conjugated double bond. The most representative CLA isomers are 9c, 11t-18:2 and 10t, 12c-18:2. CLA has been shown to exert various potent physiological functions such as anticarcinogenic, antiobese, antidiabetic and antihypertensive properties. This means CLA can be effective to prevent lifestyle diseases or metabolic syndromes. Also, reports suggest that physiological effects of CLA are different between the isomers, for example the 10t, 12c isomer is anticarcinogenic, antiobese and antidiabetic, whereas the 9c, 11t isomer is mainly anticarcinogenic. We describe here the physiological properties of CLA including the possible mechanism and the possibility to benefit human health. (C) 2013 Asian Oceanian Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.	[Koba, Kazunori] Nagasaki Univ, Dept Nutr Sci, Siebold Nagasaki 8512195, Japan; [Yanagita, Teruyoshi] Nishikyushu Univ, Dept Hlth & Nutr Sci, Saga 8400806, Japan	Koba, K (reprint author), Nagasaki Univ, 1-1-1 Manabino, Nagasaki 8512195, Japan.	koba@sun.ac.jp					Akahoshi A, 2004, LIPIDS, V39, P25, DOI 10.1007/s11745-004-1197-3; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Riserus U, 2002, DIABETES CARE, V25, P1516, DOI 10.2337/diacare.25.9.1516; Nagao K, 2005, J BIOSCI BIOENG, V100, P152, DOI 10.1263/jbb.100.152; KEPLER CR, 1966, J BIOL CHEM, V241, P1350; IP C, 1995, NUTR CANCER, V24, P241; Riserus U, 2004, DIABETOLOGIA, V47, P1016, DOI 10.1007/s00125-004-1421-8; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Pariza MW, 2000, P SOC EXP BIOL MED, V223, P8, DOI 10.1046/j.1525-1373.2000.22302.x; Lee KN, 1998, BIOCHEM BIOPH RES CO, V248, P817, DOI 10.1006/bbrc.1998.8994; Ip C, 1996, CARCINOGENESIS, V17, P1045, DOI 10.1093/carcin/17.5.1045; Gaullier JM, 2004, AM J CLIN NUTR, V79, P1118; Houseknecht KL, 1998, BIOCHEM BIOPH RES CO, V244, P678, DOI 10.1006/bbrc.1998.8303; Inoue N, 2004, BIOCHEM BIOPH RES CO, V323, P679, DOI 10.1016/j.bbrc.2004.08.139; Park Y, 1999, LIPIDS, V34, P235, DOI 10.1007/s11745-999-0358-8; IP C, 1991, CANCER RES, V51, P6118; SHULTZ TD, 1992, CANCER LETT, V63, P125, DOI 10.1016/0304-3835(92)90062-Z; Larsen TM, 2003, J LIPID RES, V44, P2234, DOI 10.1194/jlr.R300011-JLR200; Ip C, 1999, J NUTR, V129, P2135; Takahashi Y, 2003, BBA-MOL CELL BIOL L, V1631, P265, DOI 10.1016/S1388-1981(03)00038-6; Nagao K, 2003, BIOCHEM BIOPH RES CO, V310, P562, DOI 10.1016/j.bbrc.2003.09.044; Khan SA, 2003, J NUTR BIOCHEM, V14, P554, DOI 10.1016/S0955-2863(03)00098-6; Park Y, 1997, LIPIDS, V32, P853, DOI 10.1007/s11745-997-0109-x; Roche HM, 2002, DIABETES, V51, P2037, DOI 10.2337/diabetes.51.7.2037; Blankson H, 2000, J NUTR, V130, P2943; PARIZA MW, 1985, CARCINOGENESIS, V6, P591, DOI 10.1093/carcin/6.4.591; Pariza MW, 2001, PROG LIPID RES, V40, P283, DOI 10.1016/S0163-7827(01)00008-X; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Smedman A, 2001, LIPIDS, V36, P773, DOI 10.1007/s11745-001-0784-7; Belury MA, 2003, J NUTR, V133, p257S; Chajes V, 2003, NUTR CANCER, V45, P17, DOI 10.1207/S15327914NC4501_2; Chin S. F., 1992, Journal of Food Composition and Analysis, V5, P185, DOI 10.1016/0889-1575(92)90037-K; Choi YJ, 2000, J NUTR, V130, P1920; Chujo H, 2003, CANCER LETT, V202, P81, DOI 10.1016/S0304-3835(03)00478-6; Dhiman R.R., 1999, J DAIRY SCI, V82, P2146; HA YL, 1987, CARCINOGENESIS, V8, P1881, DOI 10.1093/carcin/8.12.1881; Inoue N, 2006, J AGR FOOD CHEM, V54, P7935, DOI 10.1021/jf061284v; Ip C, 2002, NUTR CANCER, V43, P52, DOI 10.1207/S15327914NC431_6; IP C, 1994, CANCER, V74, P1050; Kubota T, 1998, CANCER RES, V58, P3344; Li GM, 2006, EUR J PHARMACOL, V545, P93, DOI 10.1016/j.ejphar.2006.06.059; McNeill GP, 1999, J AM OIL CHEM SOC, V76, P1265, DOI 10.1007/s11746-999-0137-9; Moloney F, 2004, AM J CLIN NUTR, V80, P887; Moya-Camarena SY, 1999, J LIPID RES, V40, P1426; Moya-Camarena SY, 1999, BBA-MOL CELL BIOL L, V1436, P331, DOI 10.1016/S0005-2760(98)00121-0; Nagao K, 2003, BIOCHEM BIOPH RES CO, V306, P134, DOI 10.1016/S0006-291X(03)00929-X; Nagao K, 2003, NUTRITION, V19, P652, DOI 10.1016/S0899-9007(03)00060-1; Nagao T, 2003, BIOSCI BIOTECH BIOCH, V67, P1429, DOI 10.1271/bbb.67.1429; Nagao T, 2002, J AM OIL CHEM SOC, V79, P303, DOI 10.1007/s11746-002-0478-6; Ohtsu H, 2005, NUTR RES, V25, P655, DOI 10.1016/j.nutres.2005.05.008; Peters JM, 2001, BBA-MOL CELL BIOL L, V1533, P233, DOI 10.1016/S1388-1981(01)00155-X; Proctor SD, 2007, DIABETES OBES METAB, V9, P87, DOI 10.1111/j.1463-1326.2006.00578.x; Rahman SM, 2001, NUTRITION, V17, P385, DOI 10.1016/S0899-9007(00)00584-0; Reaney MJT, 1999, ADV CONJUGATED LINOL, V1, P39; Ryder JW, 2001, DIABETES, V50, P1149, DOI 10.2337/diabetes.50.5.1149; Sakono M, 2002, J NUTR SCI VITAMINOL, V48, P405; SCHONBERG S, 1995, ANTICANCER RES, V15, P1241; Sugano M, 2001, BIOSCI BIOTECH BIOCH, V65, P2535, DOI 10.1271/bbb.65.2535; Takahashi N, 1999, FEBS LETT, V455, P135, DOI 10.1016/S0014-5793(99)00871-6; Thom E, 2001, J INT MED RES, V29, P392; Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534; Wang YM, 2006, BIOSCI BIOTECH BIOCH, V70, P355, DOI 10.1271/bbb.70.355; Whigham LD, 2004, FOOD CHEM TOXICOL, V42, P1701, DOI 10.1016/j.fct.2004.06.008; Yamasaki M, 2002, CANCER LETT, V188, P171, DOI 10.1016/S0304-3835(02)00459-7; Zhao WS, 2009, AM J HYPERTENS, V22, P680, DOI 10.1038/ajh.2009.56	66	5	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1871-403X	1878-0318		OBES RES CLIN PRACT	Obes. Res. Clin. Pract.	NOV-DEC	2014	8	6					E525	E532		10.1016/j.orcp.2013.10.001		8	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	AU5EI	WOS:000345629600002		
J	Sakamoto, T; Takahashi, N; Goto, T; Kawada, T				Sakamoto, Tomoya; Takahashi, Nobuyuki; Goto, Tsuyoshi; Kawada, Teruo			Dietary factors evoke thermogenesis in adipose tissues	OBESITY RESEARCH & CLINICAL PRACTICE			English	Review						Thermogenesis; Brown adipose tissue; Food factors	UNCOUPLING PROTEIN-1 CONTENT; VIRGIN OLIVE OIL; FATTY-ACID; ENERGY-EXPENDITURE; ENHANCES NORADRENALINE; ADRENALINE SECRETIONS; INSULIN-RESISTANCE; PUNGENT PRINCIPLE; CAPSICUM FRUITS; RATS	In dietary factors, energetic food constituents and the "non-energetic food constituents'' such as smell and taste through sensory nerve stimulation have been found to be linked intrinsically with the accelerated expression of diet-induced thermogenesis that accompanies the burning of fat within brown adipose tissues (BAT). The compounds are responsible for BAT and uncoupling protein-1 (UCP1) activation or induction caused by food components. Many of these activate and strengthen BAT activation through the following pathway: sensory stimulations induce sympathetic nerve activation through central phase. In the fight against obesity, the development of food compounds and pharmaceuticals that activate or induce BAT and UCP1 is expected. In this review, we discuss that how dietary compounds effect thermogenesis through BAT and UCP1. (C) 2014 Asian Oceanian Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.	[Sakamoto, Tomoya; Takahashi, Nobuyuki; Goto, Tsuyoshi; Kawada, Teruo] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji, Kyoto, Japan; [Takahashi, Nobuyuki; Goto, Tsuyoshi; Kawada, Teruo] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Res Unit Physiol Chem, Kyoto, Japan	Kawada, T (reprint author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji, Kyoto, Japan.	fat@kais.kyoto-u.ac.jp					Aita S, 2011, HIMAN KENKYU, V17, P41; Power ML, 2008, APPETITE, V50, P194, DOI 10.1016/j.appet.2007.10.006; Kawada T, 1998, J AGR FOOD CHEM, V46, P1225, DOI 10.1021/jf9711000; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shen J, 2005, NEUROSCI LETT, V380, P289, DOI 10.1016/j.neulet.2005.01.058; KAWADA T, 1986, P SOC EXP BIOL MED, V183, P250; Masuda Y, 2003, J APPL PHYSIOL, V95, P2408, DOI 10.1152/japplphysiol.00828.2002; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; SCLAFANI A, 1976, PHYSIOL BEHAV, V17, P461, DOI 10.1016/0031-9384(76)90109-8; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; KAWADA T, 1991, J AGR FOOD CHEM, V39, P651, DOI 10.1021/jf00004a004; SADURSKIS A, 1995, AM J PHYSIOL-ENDOC M, V269, pE351; Wendel AA, 2009, LIPIDS, V44, P975, DOI 10.1007/s11745-009-3348-9; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105; Mattes RD, 2009, ANNU REV NUTR, V29, P305, DOI 10.1146/annurev-nutr-080508-141108; COUSIN B, 1992, J CELL SCI, V103, P931; KAWADA T, 1986, J NUTR, V116, P1272; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; Sakamoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC729, DOI 10.1152/ajpcell.00312.2012; Iwasaki Y, 2011, BIOSCI BIOTECH BIOCH, V75, P904, DOI 10.1271/bbb.100850; Oi-Kano Y, 2008, J NUTR SCI VITAMINOL, V54, P363, DOI 10.3177/jnsv.54.363; Mattes RD, 1997, J AM DIET ASSOC, V97, P406, DOI 10.1016/S0002-8223(97)00101-6; LEBLANC J, 1985, AM J PHYSIOL, V248, pE333; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Maeda H, 2005, BIOCHEM BIOPH RES CO, V332, P392, DOI 10.1016/j.bbrc.2005.05.002; Hirai S, 2010, MEDIAT INFLAMM, DOI 10.1155/2010/367838; JEZEK P, 1994, FEBS LETT, V343, P22, DOI 10.1016/0014-5793(94)80599-7; KAUFMAN LN, 1986, J CLIN INVEST, V77, P551, DOI 10.1172/JCI112336; Kawada T, 2011, BROWN AD TISS 2011 U, P38; Kogure A, 2002, CLIN EXP PHARMACOL P, V29, P391, DOI 10.1046/j.1440-1681.2002.03675.x; LANDSBERG L, 1984, CLIN ENDOCRINOL META, V13, P475; Li T, 2008, VEGETABLES FRUITS NU, P202; MACDONALD I, 1984, ANN NUTR METAB, V28, P226, DOI 10.1159/000176808; Matsumoto T, 2011, JAP SOC BIOSC BIOT A, P66; Mizushige T, 2007, J NUTR SCI VITAMINOL, V53, P1, DOI 10.3177/jnsv.53.1; Muto T., 1976, DIGESTION ABSORPTION, P222; Nagai K, 2011, BROWN AD TISS 2011 U, P36; NIIJIMA A, 1986, AM J PHYSIOL, V251, pR240; Oi-Kano Y, 2007, J NUTR BIOCHEM, V18, P685, DOI 10.1016/j.jnutbio.2006.11.009; SAITO M, 1989, AM J PHYSIOL, V257, pE374; Sugita J, 2013, BR J NUTR, V11, P1; Tanaka T, 1978, PROTEIN NUTR, P126; Tanaka T, 1978, EIYO TO SHOKURYO, V31, P1; Tomas P, 2004, BBA-BIOENERGETICS, V1658, P157, DOI 10.1016/j.bbabio.2004.05.010; WATANABE T, 1988, AM J PHYSIOL, V255, pE23; Wlodek D, 2003, J THEOR BIOL, V225, P33, DOI 10.1016/S0022-5193(03)00218-2	53	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1871-403X	1878-0318		OBES RES CLIN PRACT	Obes. Res. Clin. Pract.	NOV-DEC	2014	8	6					E533	E539		10.1016/j.orcp.2013.12.002		7	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	AU5EI	WOS:000345629600003		
J	Yonezawa, K; Haruna, M; Shiraishi, M; Matsuzaki, M; Sanada, H				Yonezawa, Kaori; Haruna, Megumi; Shiraishi, Mie; Matsuzaki, Masayo; Sanada, Hiromi			Relationship Between Skin Barrier Function in Early Neonates and Diaper Dermatitis During the First Month of Life: A Prospective Observational Study	PEDIATRIC DERMATOLOGY			English	Article							DIFFERENT BODY AREAS; INFANT; RASH	Diaper dermatitis, a common skin problem in newborn infants, is characterized by poor functioning of the skin barrier. This study aimed to elucidate the relationship between skin barrier function in 4-day-old infants and the occurrence of diaper dermatitis during the first month of life. We recruited healthy Japanese infants born at 35 weeks of gestation or more. We measured indicators of skin barrier function, namely skin pH and transepidermal water loss, in 4-day-old infants on four places on the body. Individual characteristics were recorded from the infants' medical charts. The presence of diaper dermatitis was judged using the diaper rash and erythema scoring scale, which was based on daily recording of the infants' skin condition by their parents. The parents also filled out a questionnaire 1 month after birth regarding stool frequency and certain external factors. The association between diaper dermatitis and skin barrier function was assessed using multiple logistic regression analysis. The analysis included 88 infants. The incidence of diaper dermatitis was 25.0%. After adjusting for stool frequency for 1 month we noted that high pH on the inner arm skin in 4-day-old infants increased the risk of diaper dermatitis during the first month of life (adjusted odds ratio 3.35 [95% confidence interval = 1.12, 10.04]). Early neonatal skin pH may predict the risk of diaper dermatitis during the first month of life. Our results may be useful in devising strategies to prevent diaper dermatitis.	[Yonezawa, Kaori; Haruna, Megumi; Shiraishi, Mie; Matsuzaki, Masayo] Univ Tokyo, Grad Sch Med, Div Hlth Sci & Nursing, Dept Midwifery & Womens Hlth, Tokyo, Japan; [Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Div Hlth Sci & Nursing, Dept Gerontol Nursing & Wound Care Management, Tokyo, Japan	Haruna, M (reprint author), Univ Tokyo, Grad Sch Med, Div Hlth Sci & Nursing, Dept Midwifery & Womens Hlth, Tokyo, Japan.	mharuna-tky@umin.ac.jp					Visscher MO, 2000, PEDIATR DERMATOL, V17, P52, DOI 10.1046/j.1525-1470.2000.01710.x; Philipp R, 1997, BRIT J GEN PRACT, V47, P493; Bartels NG, 2010, PEDIATR DERMATOL, V27, P1, DOI 10.1111/j.1525-1470.2009.01068.x; Yosipovitch G, 2000, PEDIATRICS, V106, P105, DOI 10.1542/peds.106.1.105; Hoeger PH, 2002, PEDIATR DERMATOL, V19, P256, DOI 10.1046/j.1525-1470.2002.00082.x; Adalat S, 2007, PEDIATR DERMATOL, V24, P483, DOI 10.1111/j.1525-1470.2007.00499.x; Visscher MO, 2000, PEDIATR DERMATOL, V17, P45, DOI 10.1046/j.1525-1470.2000.01711.x; Chiou YB, 2004, SKIN PHARMACOL PHYSI, V17, P57, DOI 10.1159/000076015; BERG RW, 1994, PEDIATR DERMATOL, V11, P18, DOI 10.1111/j.1525-1470.1994.tb00066.x; Blume-Peytavi U, 2012, PEDIATR DERMATOL, V29, P1, DOI 10.1111/j.1525-1470.2011.01594.x; HAYAKAWA R, 1987, Pediatrician, V14, P18; Humphrey S, 2006, Skin Therapy Lett, V11, P1; Kawajiri Y, 1993, J PEDIAT DERMATOL, V12, P77; Odio MR, 2000, DERMATOLOGY, V200, P238, DOI 10.1159/000018366; Rippke Frank, 2002, Am J Clin Dermatol, V3, P261, DOI 10.2165/00128071-200203040-00004; Shirasaka M, 2007, JPN J DERMATOL, V117, P1147; Stamatas GN, 2011, PEDIATR DERMATOL, V28, P99, DOI 10.1111/j.1525-1470.2011.01308.x	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-8046	1525-1470		PEDIATR DERMATOL	Pediatr. Dermatol.	NOV-DEC	2014	31	6					692	697		10.1111/pde.12394		6	Dermatology; Pediatrics	Dermatology; Pediatrics	AU6DW	WOS:000345694100024		
J	Bierwage, A; Shinohara, K				Bierwage, Andreas; Shinohara, Kouji			Orbit-based analysis of resonant excitations of Alfven waves in tokamaks	PHYSICS OF PLASMAS			English	Article							NEUTRAL BEAM INJECTION; TOROIDAL PLASMAS; JT-60U; EIGENMODES; SIMULATIONS; DRIVEN	The exponential growth phase of fast-ion-driven Alfvenic instabilities is simulated and the resonant wave-particle interactions are analyzed numerically. The simulations are carried out in realistic magnetic geometry and with a realistic particle distribution for a JT-60U plasma driven by negative-ion-based neutral beams. In order to deal with the large magnetic drifts of the fast ions, two new mapping methods are developed and applied. The first mapping yields the radii and pitch angles at the points, where the unperturbed orbit of a particle intersects the mid-plane. These canonical coordinates allow to express analysis results (e.g., drive profiles and resonance widths) in a form that is easy to understand and directly comparable to the radial mode structure. The second mapping yields the structure of the wave field along the particle trajectory. This allows us to unify resonance conditions for trapped and passing particles, determine which harmonics are driven, and which orders of the resonance are involved. This orbit-based resonance analysis (ORA) method is applied to fast-ion-driven instabilities with toroidal mode numbers n = 1-3. After determining the order and width of each resonance, the kinetic compression of resonant particles and the effect of linear resonance overlap are examined. On the basis of the ORA results, implications for the fully nonlinear regime, for the long-time evolution of the system in the presence of a fast ion source, and for the interpretation of experimental observations are discussed. (C) 2014 AIP Publishing LLC.	[Bierwage, Andreas] Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan; [Shinohara, Kouji] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan	Bierwage, A (reprint author), Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan.	bierwage.andreas@jaea.go.jp			Japan Society for the Promotion of Science (JSPS) [25820443]	Useful discussion with Sergio Briguglio (ENEA, Frascati, Italy) and Yasushi Todo (NIFS, Toki, Japan) were thankfully acknowledged. This work was partly supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), Grant No. 25820443. The simulations were carried out using the supercomputer systems Fujitsu BX-900 at JAEA, Ibaraki, Japan, and HELIOS at IFERC, Aomori, Japan, under the Broader Approach collaboration between Euratom and Japan, implemented by Fusion for Energy and JAEA.	Todo Y, 1998, PHYS PLASMAS, V5, P1321, DOI 10.1063/1.872791; TANI K, 1981, J PHYS SOC JPN, V50, P1726, DOI 10.1143/JPSJ.50.1726; Todo Y, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2234296; Shinohara K, 2001, NUCL FUSION, V41, P603, DOI 10.1088/0029-5515/41/5/313; Kusama Y, 1999, NUCL FUSION, V39, P1837, DOI 10.1088/0029-5515/39/11Y/324; CHEN L, 1994, PHYS PLASMAS, V1, P1519, DOI 10.1063/1.870702; Bierwage A, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073007; Azumi M., 1980, P 4 INT S COMP METH, P335; Berk HL, 1995, NUCL FUSION, V35, P1661, DOI 10.1088/0029-5515/35/12/I30; Bierwage A, 2012, COMPUT PHYS COMMUN, V183, P1107, DOI 10.1016/j.cpc.2012.01.013; Bierwage Andreas, 2011, Plasma and Fusion Research, V6, DOI 10.1585/pfr.6.2403109; Bierwage A, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/1/015005; Bierwage A, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/10/104001; Bierwage A, 2012, PLASMA FUSION RES, V7; Briguglio S, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4901028; Briguglio S, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2710208; CHENG CZ, 1986, PHYS FLUIDS, V29, P3695, DOI 10.1063/1.865801; Deng W, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/4/043006; FU GY, 1995, PHYS PLASMAS, V2, P1029, DOI 10.1063/1.871382; FU GY, 1995, PHYS REV LETT, V75, P2336, DOI 10.1103/PhysRevLett.75.2336; Ishikawa M, 2005, NUCL FUSION, V45, P1474, DOI 10.1088/0029-5515/45/12/002; PARK W, 1992, PHYS FLUIDS B-PLASMA, V4, P2033, DOI 10.1063/1.860011; Schneller M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/12/123003; Shinohara K, 2004, PLASMA PHYS CONTR F, V46, pS31, DOI 10.1088/0741-3335/46/7/S03; Todo Y, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1828084; White R. B., 2001, THEORY TOROIDALLY CO, p80f	26	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	1070-664X	1089-7674		PHYS PLASMAS	Phys. Plasmas	NOV	2014	21	11							112116	10.1063/1.4902519		21	Physics, Fluids & Plasmas	Physics	AU5JZ	WOS:000345644200019		
J	Greenwald, M; Bader, A; Baek, S; Bakhtiari, M; Barnard, H; Beck, W; Bergerson, W; Bespamyatnov, I; Bonoli, P; Brower, D; Brunner, D; Burke, W; Candy, J; Churchill, M; Cziegler, I; Diallo, A; Dominguez, A; Duval, B; Edlund, E; Ennever, P; Ernst, D; Faust, I; Fiore, C; Fredian, T; Garcia, O; Gao, C; Goetz, J; Golfinopoulos, T; Granetz, R; Grulke, O; Hartwig, Z; Horne, S; Howard, N; Hubbard, A; Hughes, J; Hutchinson, I; Irby, J; Izzo, V; Kessel, C; LaBombard, B; Lau, C; Li, C; Lin, Y; Lipschultz, B; Loarte, A; Marmar, E; Mazurenko, A; McCracken, G; McDermott, R; Meneghini, O; Mikkelsen, D; Mossessian, D; Mumgaard, R; Myra, J; Nelson-Melby, E; Ochoukov, R; Olynyk, G; Parker, R; Pitcher, S; Podpaly, Y; Porkolab, M; Reinke, M; Rice, J; Rowan, W; Schmidt, A; Scott, S; Shiraiwa, S; Sierchio, J; Smick, N; Snipes, JA; Snyder, P; Sorbom, B; Stillerman, J; Sung, C; Takase, Y; Tang, V; Terry, J; Terry, D; Theiler, C; Tronchin-James, A; Tsujii, N; Vieira, R; Walk, J; Wallace, G; White, A; Whyte, D; Wilson, J; Wolfe, S; Wright, G; Wright, J; Wukitch, S; Zweben, S				Greenwald, M.; Bader, A.; Baek, S.; Bakhtiari, M.; Barnard, H.; Beck, W.; Bergerson, W.; Bespamyatnov, I.; Bonoli, P.; Brower, D.; Brunner, D.; Burke, W.; Candy, J.; Churchill, M.; Cziegler, I.; Diallo, A.; Dominguez, A.; Duval, B.; Edlund, E.; Ennever, P.; Ernst, D.; Faust, I.; Fiore, C.; Fredian, T.; Garcia, O.; Gao, C.; Goetz, J.; Golfinopoulos, T.; Granetz, R.; Grulke, O.; Hartwig, Z.; Horne, S.; Howard, N.; Hubbard, A.; Hughes, J.; Hutchinson, I.; Irby, J.; Izzo, V.; Kessel, C.; LaBombard, B.; Lau, C.; Li, C.; Lin, Y.; Lipschultz, B.; Loarte, A.; Marmar, E.; Mazurenko, A.; McCracken, G.; McDermott, R.; Meneghini, O.; Mikkelsen, D.; Mossessian, D.; Mumgaard, R.; Myra, J.; Nelson-Melby, E.; Ochoukov, R.; Olynyk, G.; Parker, R.; Pitcher, S.; Podpaly, Y.; Porkolab, M.; Reinke, M.; Rice, J.; Rowan, W.; Schmidt, A.; Scott, S.; Shiraiwa, S.; Sierchio, J.; Smick, N.; Snipes, J. A.; Snyder, P.; Sorbom, B.; Stillerman, J.; Sung, C.; Takase, Y.; Tang, V.; Terry, J.; Terry, D.; Theiler, C.; Tronchin-James, A.; Tsujii, N.; Vieira, R.; Walk, J.; Wallace, G.; White, A.; Whyte, D.; Wilson, J.; Wolfe, S.; Wright, G.; Wright, J.; Wukitch, S.; Zweben, S.			20 years of research on the Alcator C-Mod tokamak	PHYSICS OF PLASMAS			English	Review							SCRAPE-OFF-LAYER; INTERNAL TRANSPORT BARRIERS; ION-CYCLOTRON RANGE; PLASMA-FACING COMPONENTS; L-H TRANSITION; IMPURITY TOROIDAL ROTATION; X-RAY OBSERVATIONS; LOWER-HYBRID WAVES; NO MOMENTUM INPUT; PRESSURE GAS INJECTION	The object of this review is to summarize the achievements of research on the Alcator C-Mod tokamak [Hutchinson et al., Phys. Plasmas 1, 1511 (1994) and Marmar, Fusion Sci. Technol. 51, 261 (2007)] and to place that research in the context of the quest for practical fusion energy. C-Mod is a compact, high-field tokamak, whose unique design and operating parameters have produced a wealth of new and important results since it began operation in 1993, contributing data that extends tests of critical physical models into new parameter ranges and into new regimes. Using only high-power radio frequency (RF) waves for heating and current drive with innovative launching structures, C-Mod operates routinely at reactor level power densities and achieves plasma pressures higher than any other toroidal confinement device. C-Mod spearheaded the development of the vertical-target divertor and has always operated with high-Z metal plasma facing components-approaches subsequently adopted for ITER. C-Mod has made ground-breaking discoveries in divertor physics and plasma-material interactions at reactor-like power and particle fluxes and elucidated the critical role of cross-field transport in divertor operation, edge flows and the tokamak density limit. C-Mod developed the I-mode and the Enhanced D alpha H-mode regimes, which have high performance without large edge localized modes and with pedestal transport self-regulated by short-wavelength electromagnetic waves. C-Mod has carried out pioneering studies of intrinsic rotation and demonstrated that self-generated flow shear can be strong enough in some cases to significantly modify transport. C-Mod made the first quantitative link between the pedestal temperature and the H-mode's performance, showing that the observed self-similar temperature profiles were consistent with critical-gradient-length theories and followed up with quantitative tests of nonlinear gyrokinetic models. RF research highlights include direct experimental observation of ion cyclotron range of frequency (ICRF) mode-conversion, ICRF flow drive, demonstration of lower-hybrid current drive at ITER-like densities and fields and, using a set of novel diagnostics, extensive validation of advanced RF codes. Disruption studies on C-Mod provided the first observation of non-axisymmetric halo currents and non-axisymmetric radiation in mitigated disruptions. A summary of important achievements and discoveries are included. (C) 2014 AIP Publishing LLC.	[Greenwald, M.; Baek, S.; Barnard, H.; Beck, W.; Bonoli, P.; Brunner, D.; Burke, W.; Ennever, P.; Ernst, D.; Faust, I.; Fiore, C.; Fredian, T.; Gao, C.; Golfinopoulos, T.; Granetz, R.; Hartwig, Z.; Hubbard, A.; Hughes, J.; Hutchinson, I.; Irby, J.; LaBombard, B.; Li, C.; Lin, Y.; Marmar, E.; Mumgaard, R.; Parker, R.; Porkolab, M.; Rice, J.; Shiraiwa, S.; Sierchio, J.; Sorbom, B.; Stillerman, J.; Sung, C.; Terry, J.; Terry, D.; Vieira, R.; Walk, J.; Wallace, G.; White, A.; Whyte, D.; Wolfe, S.; Wright, G.; Wright, J.; Wukitch, S.] MIT Plasma Sci & Fusion Ctr, Cambridge, MA 02139 USA; [Bader, A.; Bakhtiari, M.; Goetz, J.] Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; [Bergerson, W.; Brower, D.] Univ Calif Los Angeles, Inst Plasma & Fusion Res, Los Angeles, CA 90095 USA; [Bespamyatnov, I.; Rowan, W.] Univ Texas Austin, Fus Res Ctr, Austin, TX 78712 USA; [Candy, J.; Meneghini, O.; Snyder, P.] Gen Atom Co, San Diego, CA 92186 USA; [Churchill, M.; Diallo, A.; Dominguez, A.; Edlund, E.; Kessel, C.; Mikkelsen, D.; Scott, S.; Wilson, J.; Zweben, S.] Princeton Plasma Phys Lab, Princeton, NJ 08540 USA; [Cziegler, I.; Izzo, V.] Univ Calif San Diego, Ctr Momentum Transport & Flow Org, La Jolla, CA 92093 USA; [Duval, B.; Theiler, C.] Ecole Polytech Fed Lausanne, Ctr Rech Phys Plasmas, CH-1015 Lausanne, Switzerland; [Garcia, O.] Univ Tromso, Dept Phys & Technol, N-9037 Tromso, Norway; [Grulke, O.] EURATOM, MPI Plasma Phys, D-17491 Greifswald, Germany; [Grulke, O.] Ernst Moritz Arndt Univ Greifswald, D-17489 Greifswald, Germany; [Horne, S.] Energetiq Technol, Woburn, MA 01801 USA; [Howard, N.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN 37830 USA; [Lau, C.] ORNL, Oak Ridge, TN 37831 USA; [Lipschultz, B.; Reinke, M.] Univ York, York YO10 5DD, N Yorkshire, England; [Loarte, A.; Pitcher, S.; Snipes, J. A.] ITER Org, F-13067 St Paul Les Durance, France; [Mazurenko, A.] Block Engn, Marlborough, MA 01752 USA; [McCracken, G.] UKAEA, Culham Ctr Fus Energy, Abingdon OX14 3DB, Oxon, England; [McDermott, R.; Ochoukov, R.] Max Planck Inst Plasma Phys, EURATOM Assoc, D-85748 Garching, Germany; [Mossessian, D.] AllianceBernstein, New York, NY 10105 USA; [Myra, J.] Lodestar Res Corp, Boulder, CO 80301 USA; [Nelson-Melby, E.] Raytheon Co, Tucson, AZ 85756 USA; [Olynyk, G.] McKinsey & Co Inc, Toronto, ON M5S 1K9, Canada; [Podpaly, Y.] Natl Inst Sci & Technol, Gaithersburg, MD 20899 USA; [Schmidt, A.; Tang, V.] LLNL, Livermore, CA 94550 USA; [Smick, N.] GT Adv Technol, Merrimack, NH 03054 USA; [Takase, Y.; Tsujii, N.] Univ Tokyo, Tokyo 113033, Japan; [Tronchin-James, A.] Facebook LLC, Menlo Pk, CA 94205 USA	Greenwald, M (reprint author), MIT Plasma Sci & Fusion Ctr, Cambridge, MA 02139 USA.		Garcia, Odd Erik/A-4417-2013; Lipschultz, Bruce/J-7726-2012; 	Garcia, Odd Erik/0000-0002-2377-8718; Lipschultz, Bruce/0000-0001-5968-3684; Greenwald, Martin/0000-0002-4438-729X	DOE [DE-FC02-99ER54512, DE-FG03-94ER-54241, DE-AC02-78ET-51013, DE-AC02-09CH11466, DE-FG02-95ER54309, DE-AC02-05CH11231, DE-AC52-07NA27344, DE-FG02-97ER54392, DE-SC00-02060]; NSF [DMR-08-19762]; Swiss National Science Foundation; Alexander-von-Humboldt Foundation	The authors wish to thank the extraordinarily able Alcator staff, students, and collaborators who have worked on this program since its inception. A full list of those contributors, which is as complete as we can make it given the imperfection of our records and our memories, is included in the Appendix. The work described here only touches on a selection of the research highlights produced by this team; much must be left out due to limits on space and time. The authors also wish to thank DOE, our principal funding agency under who have supported this work mainly under cooperative agreement C-Mod: DE-FC02-99ER54512 but also under DE-FG03-94ER-54241, DE-AC02-78ET-51013, DE-AC02-09CH11466, DE-FG02-95ER54309, DE-AC02-05CH11231, DE-AC52-07NA27344, DE-FG02-97ER54392, and DE-SC00-02060. International Contributors have been funded through NSF DMR-08-19762, the Swiss National Science Foundation and the Alexander-von-Humboldt Foundation among others.	Howard NT, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/12/123011; Shiraiwa S, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3609835; LaBombard B, 1997, J NUCL MATER, V241, P149, DOI 10.1016/S0022-3115(97)80037-2; Reinke ML, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/4/045004; Granetz RS, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4886802; White AE, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4803089; Wright GM, 2013, J NUCL MATER, V438, pS84, DOI 10.1016/j.jnucmat.2013.01.013; Howard NT, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4869078; Yoshida M, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/12/123005; TAKASE Y, 1985, PHYS FLUIDS, V28, P983, DOI 10.1063/1.865070; Izzo VA, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063032; Federici G, 2001, NUCL FUSION, V41, P1967, DOI 10.1088/0029-5515/41/12/218; Theiler C, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/8/083017; Baek SG, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4861127; Stillerman JA, 2006, FUSION ENG DES, V81, P1905, DOI 10.1016/j.fusengdes.2006.04.054; Baek SG, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4884355; PARKER RR, 1985, NUCL FUSION, V25, P1127, DOI 10.1088/0029-5515/25/9/023; Rice JE, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/3/033004; Pitcher CS, 2000, PHYS PLASMAS, V7, P1894, DOI 10.1063/1.874013; LaBombard B, 2004, NUCL FUSION, V44, P1047, DOI 10.1088/0029-5515/44/10/001; Diamond PH, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/4/045002; Terry PW, 2000, REV MOD PHYS, V72, P109, DOI 10.1103/RevModPhys.72.109; LaBombard B, 2008, Physics of Plasmas, V15, DOI 10.1063/1.2838246; Granetz R, 2006, NUCL FUSION, V46, P1001, DOI 10.1088/0029-5515/46/12/003; Neu RL, 2014, IEEE T PLASMA SCI, V42, P552, DOI 10.1109/TPS.2014.2298253; Rice JE, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.215001; Bonoli PT, 2007, FUSION SCI TECHNOL, V51, P401; Terry JL, 2009, J NUCL MATER, V390-91, P339, DOI 10.1016/j.jnucmat.2009.01.152; Glasser AH, 1999, PLASMA PHYS CONTR F, V41, pA747, DOI 10.1088/0741-3335/41/3A/067; Evans TE, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/2/024002; Smick N, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/2/023001; Zweben SJ, 2002, PHYS PLASMAS, V9, P1981, DOI 10.1063/1.1445179; Krasheninnikov SI, 2001, PHYS LETT A, V283, P368, DOI 10.1016/S0375-9601(01)00252-3; Mazurenko A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.225004; Snyder PB, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3699623; Wilson HR, 2002, PHYS PLASMAS, V9, P1277, DOI 10.1063/1.1459058; LaBombard B, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3566059; Izzo VA, 2006, NUCL FUSION, V46, P541, DOI 10.1088/0029-5515/46/5/006; Rice JE, 2002, NUCL FUSION, V42, P510, DOI 10.1088/0029-5515/42/5/303; Lau C, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/2/025008; Najmabadi F, 2006, FUSION ENG DES, V80, P3, DOI 10.1016/j.fusengdes.2005.11.003; WESSON JA, 1989, NUCL FUSION, V29, P641, DOI 10.1088/0029-5515/29/4/009; McDermott RM, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3080721; Rice JE, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.125003; Lin Y, 2008, FUSION ENG DES, V83, P241, DOI 10.1016/j.fusengdes.2007.12.015; Rice JE, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093015; Wallace GM, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4729734; Shiraiwa S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113028; Sung C, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/8/083010; Rice JE, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/8/083005; Granetz RS, 1996, NUCL FUSION, V36, P545, DOI 10.1088/0029-5515/36/5/I02; LaBombard B, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1876294; Stangeby PC, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063001; Hubbard AE, 1998, PLASMA PHYS CONTR F, V40, P689, DOI 10.1088/0741-3335/40/5/024; Greenwald M, 1997, NUCL FUSION, V37, P793, DOI 10.1088/0029-5515/37/6/I07; LaBombard B, 2001, PHYS PLASMAS, V8, P2107, DOI 10.1063/1.1352596; Wukitch SJ, 2004, PLASMA PHYS CONTR F, V46, P1479, DOI 10.1088/0741-3335/46/9/010; Eich T, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093031; Bertelli N, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/7/074003; Garcia OE, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.265001; Wright JC, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3166137; CONNOR JW, 1975, NUCL FUSION, V15, P415, DOI 10.1088/0029-5515/15/3/007; Walk JR, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4872220; Lau C, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/9/095003; YUSHMANOV PN, 1990, NUCL FUSION, V30, P1999, DOI 10.1088/0029-5515/30/10/001; Federici G, 2003, PLASMA PHYS CONTR F, V45, P1523, DOI 10.1088/0741-3335/45/9/301; Lipschultz B, 2007, J NUCL MATER, V363, P1110, DOI 10.1016/j.jnucmat.2007.01.227; Greenwald M, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3298884; Hartwig ZS, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4832420; Fujisawa A, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/1/013001; Loarte A, 2003, PLASMA PHYS CONTR F, V45, P1549, DOI 10.1088/0741-3335/45/9/302; Greenwald M, 1999, PHYS PLASMAS, V6, P1943, DOI 10.1063/1.873451; Barnard HS, 2011, J NUCL MATER, V415, pS301, DOI 10.1016/j.jnucmat.2010.12.317; Lipschultz B, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/4/045009; Rice JE, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/7/075701; Rhodes TL, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063022; Mirnov S, 1999, NUCL FUSION, V39, P2577, DOI 10.1088/0029-5515/39/12/308; Connor JW, 2004, NUCL FUSION, V44, pR1, DOI 10.1088/0029-5515/44/4/R01; Greenwald M, 2007, FUSION SCI TECHNOL, V51, P266; Groebner RJ, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093024; Marmar ES, 2007, FUSION SCI TECHNOL, V51, P261; Mikkelsen DR, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.135003; Rice JE, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/2/025004; Golfinopoulos T, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4873595; Ernst DR, 2004, PHYS PLASMAS, V11, P2637, DOI 10.1063/1.1705653; Garcia OE, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4802942; Rice JE, 1998, NUCL FUSION, V38, P75, DOI 10.1088/0029-5515/38/1/306; Churchill RM, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/12/122002; Hubbard AE, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3582135; Bortolon A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.235003; KEILHACKER M, 1987, PLASMA PHYS CONTR F, V29, P1401, DOI 10.1088/0741-3335/29/10A/320; Woller KB, 2013, J NUCL MATER, V438, pS913, DOI 10.1016/j.jnucmat.2013.01.198; White AE, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/11/113005; Lin Y, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063002; White AE, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/8/083019; Smick N, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3069290; Fundamenski W, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/6/062003; LaBombard B, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4873918; Diallo A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.115001; Whyte DG, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.055001; Dimits AM, 2000, PHYS PLASMAS, V7, P969, DOI 10.1063/1.873896; Rice JE, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.265001; Wolf RC, 2003, PLASMA PHYS CONTR F, V45, pR1, DOI 10.1088/0741-3335/45/1/201; Loarte A, 1999, J NUCL MATER, V266, P587, DOI 10.1016/S0022-3115(98)00590-X; Terry JL, 2005, NUCL FUSION, V45, P1321, DOI 10.1088/0029-5515/45/11/013; Angioni C, 2007, NUCL FUSION, V47, P1326, DOI 10.1088/0029-5515/47/9/033; Shiraiwa S, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3396371; Whyte DG, 2012, FUSION ENG DES, V87, P234, DOI 10.1016/j.fusengdes.2011.12.011; ADAM J, 1987, PLASMA PHYS CONTR F, V29, P443, DOI 10.1088/0741-3335/29/4/001; Connor JW, 1998, PHYS PLASMAS, V5, P2687, DOI 10.1063/1.872956; Ochoukov R, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/1/015004; HUTCHINSON IH, 1994, PHYS PLASMAS, V1, P1511, DOI 10.1063/1.870701; GREENWALD M, 1988, NUCL FUSION, V28, P2199, DOI 10.1088/0029-5515/28/12/009; STRAIT EJ, 1995, PHYS REV LETT, V74, P2483, DOI 10.1103/PhysRevLett.74.2483; Greenwald M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104004; Meneghini O, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3216548; Olynyk GM, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/092001; Bakhtiari M, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063007; Izzo V A, 2008, Physics of Plasmas, V15, DOI 10.1063/1.2841526; Wallace GM, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3465662; Tsujii N, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4745613; LaBombard B, 2011, J NUCL MATER, V415, pS349, DOI 10.1016/j.jnucmat.2010.07.021; Whyte DG, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/10/105005; Baek SG, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/5/052001; Holland C, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3085792; LABOMBARD B, 1995, PHYS PLASMAS, V2, P2242, DOI 10.1063/1.871248; Conway GD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.065001; CODA S, 1992, REV SCI INSTRUM, V63, P4974, DOI 10.1063/1.1143516; Rice JE, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/12/124042; Churchill RM, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4821084; Lipschultz B, 2001, NUCL FUSION, V41, P585, DOI 10.1088/0029-5515/41/5/311; Batchelor DA, 2007, PLASMA SCI TECHNOL, V9, P312, DOI 10.1088/1009-0630/9/3/13; Wakatani M, 1999, NUCL FUSION, V39, P2175, DOI 10.1088/0029-5515/39/12/302; Federici G, 2003, J NUCL MATER, V313, P11, DOI 10.1016/S0022-3115(02)01327-2; Gurcan OD, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3503624; Wallace GM, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073012; Terry JL, 2007, J NUCL MATER, V363, P994, DOI 10.1016/j.jnucmat.2007.01.266; Bonoli P T, 2008, Physics of Plasmas, V15, DOI 10.1063/1.2904569; Maggi CF, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/2/023007; Barnes M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.055005; Terry JL, 2007, FUSION SCI TECHNOL, V51, P342; PERKINS FW, 1989, NUCL FUSION, V29, P583, DOI 10.1088/0029-5515/29/4/004; Rice JE, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3695213; Lisgo S, 2005, J NUCL MATER, V337, P139, DOI 10.1016/j.jnucmat.2004.09.073; Angioni C, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/12/124017; Brambilla M, 1999, PLASMA PHYS CONTR F, V41, P1, DOI 10.1088/0741-3335/41/1/002; Xu XQ, 2000, PHYS PLASMAS, V7, P1951, DOI 10.1063/1.874044; Rogers BN, 1998, PHYS REV LETT, V81, P4396, DOI 10.1103/PhysRevLett.81.4396; Gao C, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/8/083025; TROYON F, 1984, PLASMA PHYS CONTR F, V26, P209, DOI 10.1088/0741-3335/26/1A/319; Garrett ML, 2012, FUSION ENG DES, V87, P1570, DOI 10.1016/j.fusengdes.2012.04.011; Dorland W, 2000, PHYS REV LETT, V85, P5579, DOI 10.1103/PhysRevLett.85.5579; Wukitch SJ, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4803882; LaBombard B, 2000, NUCL FUSION, V40, P2041, DOI 10.1088/0029-5515/40/12/308; Cziegler I, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/7/075013; Howard NT, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4795301; Rice JE, 2005, NUCL FUSION, V45, P251, DOI 10.1088/0029-5515/45/4/005; Shiraiwa S, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/103024; ASDEX Team, 1989, NUCL FUSION, V29; Bader A, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/9/094019; Bader A., 2011, P 19 TOP C RAD FREQ, V1406; Barnard H., 2014, THESIS; Basse NP, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1899161; Basse NP, 2007, FUSION SCI TECHNOL, V51, P476; Bateman G, 1998, PHYS PLASMAS, V5, P2355, DOI 10.1063/1.872909; Baylor LR, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4818772; Bergerson WF, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4731757; Berry LA, 1999, PHYS REV LETT, V82, P1871, DOI 10.1103/PhysRevLett.82.1871; BIGLARI H, 1990, PHYS FLUIDS B-PLASMA, V2, P1, DOI 10.1063/1.859529; Bonoli PT, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4884360; Bonoli PT, 2000, PHYS PLASMAS, V7, P1886, DOI 10.1063/1.874012; BORRASS K, 1991, NUCL FUSION, V31, P1035, DOI 10.1088/0029-5515/31/6/003; Bosco J., 1991, P 14 IEEE NPSS S FUS, V2, P782; Bromberg L, 2011, FUSION SCI TECHNOL, V60, P635; Brunner D., 2013, THESIS; Brunner D, 2011, J NUCL MATER, V415, pS375, DOI 10.1016/j.jnucmat.2010.10.026; Brunner D, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/9/095010; Brunner D, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3689770; Brunner D, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4793785; Burckhart A, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/10/105010; Candy J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.045001; Choi M, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3314336; CONNOR JW, 1977, NUCL FUSION, V17, P1047, DOI 10.1088/0029-5515/17/5/015; Cziegler I, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3421577; Cziegler I, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4803914; D'Ippolito D. A., 2013, PLASMA PHYS CONTROLL, V55; Dominguez A., 2012, THESIS; Dux R., 2000, STRAHL USER MANUAL; Ernst D., 2012, B AM PHYS SOC, V57, P73; Ernst D. R., 2006, P 21 INT AT EN AG FU; Ernst D. R., 1998, P 17 IAEA FUS EN C; Ernst D. R., 2004, P 20 INT AT EN AG FU; Fiore CL, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/6/064008; Fiore CL, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694668; Fiore CL, 2004, PHYS PLASMAS, V11, P2480, DOI 10.1063/1.1652785; Fiore CL, 2007, FUSION SCI TECHNOL, V51, P303; Fiore CL, 2004, PLASMA PHYS CONTR F, V46, pB281, DOI 10.1088/0741-3335/46/12B/024; Fiore CL, 2001, PHYS PLASMAS, V8, P2023, DOI 10.1063/1.1345883; Fredian TW, 2002, FUSION ENG DES, V60, P229, DOI 10.1016/S0920-3796(02)00013-3; Garcia OE, 2013, J NUCL MATER, V438, pS180, DOI 10.1016/j.jnucmat.2013.01.054; Garnier D. T., 1996, P 16 IAEA FUS EN C, V1, P907; Goetz JA, 1999, PHYS PLASMAS, V6, P1899, DOI 10.1063/1.873447; Goetz JA, 1999, J NUCL MATER, V266, P354, DOI 10.1016/S0022-3115(98)00582-0; Goetz JA, 2001, NUCL FUSION, V41, P1751, DOI 10.1088/0029-5515/41/12/101; GOLDSTON RJ, 1992, FUSION TECHNOL, V21, P1050; Golfinopoulos T, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4871550; Golovato SN, 1996, AIP CONF PROC, P23; GORMEZANO C, 1986, PLASMA PHYS CONTR F, V28, P1365, DOI 10.1088/0741-3335/28/9A/014; Granetz R. S., 1996, P 16 IAEA C MONTR 19, V1, P757; Greenwald M, 2000, PLASMA PHYS CONTR F, V42, pA263, DOI 10.1088/0741-3335/42/5A/331; Greenwald M, 2002, PLASMA PHYS CONTR F, V44, pR27, DOI 10.1088/0741-3335/44/8/201; Greenwald M, 2007, NUCL FUSION, V47, pL26, DOI 10.1088/0029-5515/47/9/L03; GREENWALD M, 1984, PHYS REV LETT, V53, P352, DOI 10.1103/PhysRevLett.53.352; Greenwald M, 2004, COMPUT PHYS COMMUN, V164, P1, DOI 10.1016/j.cpc.2004.06.001; Greenwald M., 1986, P 11 INT C PLASM PHY, V1, P139; GROEBNER RJ, 1990, PHYS REV LETT, V64, P3015, DOI 10.1103/PhysRevLett.64.3015; Groebner RJ, 1998, PLASMA PHYS CONTR F, V40, P673, DOI 10.1088/0741-3335/40/5/021; Groebner RJ, 2004, NUCL FUSION, V44, P204, DOI 10.1088/0029-5515/44/1/022; Mirnov S, 1999, NUCL FUSION, V39, P2251, DOI 10.1088/0029-5515/39/12/303; Guzdar PN, 1996, PHYS PLASMAS, V3, P3701, DOI 10.1063/1.871520; Hammett G. W., 1986, THESIS; Hartwig Z., 2014, THESIS; Hartwig Z., J NUCL MAT UNPUB; Hartwig ZS, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3478634; Harvey R., 2012, P 24 FUS EN C, P374; Harvey R. W., 1992, P IAEA TECHN COMM M, P489; Hender TC, 1996, FUSION TECHNOL, V30, P1605; HINNOV E, 1978, NUCL FUSION, V18, P1305, DOI 10.1088/0029-5515/18/9/010; Horne SF, 1997, FUSION TECHNOL, V32, P152; Howard NT, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3565448; Howard NT, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694113; Howard NT, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/6/063002; Howard N. T., PHYS PLASM IN PRESS; Howard NT, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/12/124004; Hubbard A., 1996, P 16 IAEA C FUS EN M, V1, P875; Hubbard A. E., 2004, P 31 EUR C CONTR FUS, V28B; Hubbard A. E., 2012, P 24 IAEA FUS EN C; Hubbard AE, 2002, PLASMA PHYS CONTR F, V44, pA359, DOI 10.1088/0741-3335/44/5A/338; Hubbard AE, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2714297; Hubbard AE, 2006, PLASMA PHYS CONTR F, V48, pA121, DOI 10.1088/0741-3335/48/5A/S11; Hubbard AE, 2004, PLASMA PHYS CONTR F, V46, pA95, DOI 10.1088/0741-3335/46/5A/010; Hughes JW, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/8/083007; Hughes JW, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2180748; Hughes JW, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/4/043016; Hughes JW, 2001, REV SCI INSTRUM, V72, P1107, DOI 10.1063/1.1319367; Hughes JW, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/6/064001; Hughes JW, 2002, PHYS PLASMAS, V9, P3019, DOI 10.1063/1.1486224; Hughes JW, 2007, NUCL FUSION, V47, P1057, DOI 10.1088/0029-5515/47/8/041; Hughes JW, 2007, FUSION SCI TECHNOL, V51, P317; Hulse R. A., 1993, MODELING IMPURITY CO; Hutchinson IH, 2000, PHYS REV LETT, V84, P3330, DOI 10.1103/PhysRevLett.84.3330; Ince-Cushman A, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2968707; Ince-Cushman A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.035002; Irby J, 2007, FUSION SCI TECHNOL, V51, P460; Isoz P. F., 1990, P 16 S FUS TECHN LON, V2, P1264; Perkins FW, 1999, NUCL FUSION, V39, P2137, DOI 10.1088/0029-5515/39/12/301; Jaeger EF, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2173629; Jaeger EF, 2003, AIP CONF PROC, V694, P475; JANEV RK, 1993, ATOMIC PLASMA MAT IN; Kadomtsev B. B., 1975, SOV J PLASMA PHYS, V1, P295; Kasten CP, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4728090; Kirnev G, 2007, PLASMA PHYS CONTR F, V49, P689, DOI 10.1088/0741-3335/49/6/001; Ko JS, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2953681; Kohno H, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3677262; Kotschenreuther M., 1996, P 16 IAEA FUS EN C, V2, P371; Kukushkin AS, 2005, NUCL FUSION, V45, P608, DOI 10.1088/0029-5515/45/7/008; LaBombard B, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2754392; LaBombard B., 1991, P 14 IEEE NPSS S FUS, V1, P31; LaBombard B, 2005, NUCL FUSION, V45, P1658, DOI 10.1088/0029-5515/45/12/022; LABOMBARD B, 1995, J NUCL MATER, V220, P976, DOI 10.1016/0022-3115(94)00457-9; LaBombard B., 2002, P 19 IAEA FUS EN C; LeBlanc BP, 1999, PHYS REV LETT, V82, P331, DOI 10.1103/PhysRevLett.82.331; Lee WD, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.205003; Lin L, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/6/065006; Lin Y, 2003, PLASMA PHYS CONTR F, V45, P1013, DOI 10.1088/0741-3335/45/6/313; Lin Y, 1999, REV SCI INSTRUM, V70, P1078, DOI 10.1063/1.1149370; Lin Y, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.235002; Lin Y, 2003, AIP CONF PROC, V694, P50; Lin Y, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3082936; Lin Y, 2005, PLASMA PHYS CONTR F, V47, P1207, DOI 10.1088/0741-3335/47/8/005; Lin Y, 2007, AIP CONF PROC, V933, P187; LIPSCHULTZ B, 1984, J NUCL MATER, V121, P441, DOI 10.1016/0022-3115(84)90158-2; Lipschultz B, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2180767; Lipschultz B, 1997, J NUCL MATER, V241, P771, DOI 10.1016/S0022-3115(97)80138-9; Lipschultz B, 2007, FUSION SCI TECHNOL, V51, P369; Lipschultz B, 2007, FUSION SCI TECHNOL, V51, P390; Lipschultz B., 1996, P 16 INT AT EN AG C, V1, P425; Lisgo S, 2003, J NUCL MATER, V313, P1089, DOI 10.1016/S0022-3115(02)01543-X; Loarte A, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3567547; Luce TC, 2002, NUCL FUSION, V42, P1193, DOI 10.1088/0029-5515/42/10/303; Luke T., 1995, THESIS; Ma Y, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/2/023010; Ma Y, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/8/082002; Manz P, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4748143; Martin Y. R., 2008, P 11 IAEA TECHN M H, V123; McKee G, 2000, PHYS REV LETT, V84, P1922, DOI 10.1103/PhysRevLett.84.1922; Meade DM, 2001, FUSION TECHNOL, V39, P336; Meneghini O, 2011, FUSION SCI TECHNOL, V60, P40; Mikkelsen D., 2007, B AM PHYS SOC, V52, P154; Mikkelsen D., 2002, P 19 IAEA FUS EN C; MILORA SL, 1986, REV SCI INSTRUM, V57, P2356, DOI 10.1063/1.1138677; Mossessian DA, 2003, PHYS PLASMAS, V10, P689, DOI 10.1063/1.1538252; Mossessian DA, 2003, PHYS PLASMAS, V10, P1720, DOI 10.1063/1.1561618; Mumgaard RT, 2014, AIP CONF PROC, V1580, P394, DOI 10.1063/1.4864571; Myra JR, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.195004; Nachtrieb RT, 1999, J NUCL MATER, V266, P896, DOI 10.1016/S0022-3115(98)00617-5; Nelson-Melby E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.155004; Niemczewski A, 1997, NUCL FUSION, V37, P151, DOI 10.1088/0029-5515/37/2/I04; Ochoukov R, 2013, J NUCL MATER, V438, pS875, DOI 10.1016/j.jnucmat.2013.01.189; OShea P. J., 1997, P 12 TOPL C RAD FREQ, V403, P89; Parker R, 2009, AIP CONF PROC, V1187, P319, DOI 10.1063/1.3273757; Pedersen TS, 2000, NUCL FUSION, V40, P1795, DOI 10.1088/0029-5515/40/10/310; Pedersen TS, 1999, REV SCI INSTRUM, V70, P586, DOI 10.1063/1.1149487; PERKINS FW, 1977, NUCL FUSION, V17, P1197, DOI 10.1088/0029-5515/17/6/008; Pick M. A., 1991, P 14 IEEE S FUS ENG, V1, P187; Pitcher CS, 2001, REV SCI INSTRUM, V72, P103, DOI 10.1063/1.1329897; Porkolab M, 1999, AIP CONF PROC, V485, P79; Porkolab M, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/12/124029; Reinke ML, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/1/012001; Reinke ML, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3494380; Reinke ML, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/4/043006; Reinke ML, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/12/125004; Rice JE, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/16/165702; Rice JE, 1997, NUCL FUSION, V37, P241, DOI 10.1088/0029-5515/37/2/I09; Rice JE, 2004, NUCL FUSION, V44, P379, DOI 10.1088/0029-5515/44/3/001; Rice JE, 1997, PHYS PLASMAS, V4, P1605, DOI 10.1063/1.872291; Rice JE, 1997, NUCL FUSION, V37, P421, DOI 10.1088/0029-5515/37/3/I11; Rice JE, 2000, PHYS PLASMAS, V7, P1825, DOI 10.1063/1.874004; Rice JE, 1999, NUCL FUSION, V39, P1175, DOI 10.1088/0029-5515/39/9/310; Rice JE, 2007, FUSION SCI TECHNOL, V51, P357; Rice JE, 2003, NUCL FUSION, V43, P781, DOI 10.1088/0029-5515/43/8/320; Rice JE, 2001, NUCL FUSION, V41, P277, DOI 10.1088/0029-5515/41/3/304; Rice JE, 2007, FUSION SCI TECHNOL, V51, P288; Rice JE, 2007, FUSION SCI TECHNOL, V51, P451; Rice JE, 2000, J PHYS B-AT MOL OPT, V33, P5435, DOI 10.1088/0953-4075/33/23/315; Ryter F, 1998, PLASMA PHYS CONTR F, V40, P725, DOI 10.1088/0741-3335/40/5/032; Schmidt A, 2011, LIBR J, V136, P18; Schmidt AE, 2009, AIP CONF PROC, V1187, P339, DOI 10.1063/1.3273762; Schuller FC, 1995, PLASMA PHYS CONTR F, V37, pA135, DOI 10.1088/0741-3335/37/11A/009; Scott B, 1997, PLASMA PHYS CONTR F, V39, P1635, DOI 10.1088/0741-3335/39/10/010; Shafranov D., 1970, SOV PHYS TECH PHYS U, V15, P175; Shimada M., 2008, NUCL FUSION, V48, P1; Sips ACC, 2002, PLASMA PHYS CONTR F, V44, pA391, DOI 10.1088/0741-3335/44/5A/342; Smirnov A. P., 1995, B AM PHYS SOC, V40, P1837; Snipes J., 2008, P 35 EUR PHYS SOC C, V32D; Snipes JA, 2001, PLASMA PHYS CONTR F, V43, pL23, DOI 10.1088/0741-3335/43/4/101; Snipes JA, 1996, PLASMA PHYS CONTR F, V38, P1127, DOI 10.1088/0741-3335/38/8/005; SNIPES JA, 1994, NUCL FUSION, V34, P1039, DOI 10.1088/0029-5515/34/7/I08; Snipes JA, 2002, PLASMA PHYS CONTR F, V44, P381, DOI 10.1088/0741-3335/44/3/308; SORBOM B. N., FUSION ENG DES UNPUB; Stek P., 1997, THESIS; Stillerman J, 1999, FUSION ENG DES, V43, P301, DOI 10.1016/S0920-3796(98)00398-6; STIX TH, 1990, PHYS FLUIDS B-PLASMA, V2, P1729, DOI 10.1063/1.859444; Stix T.H., 1992, WAVES PLASMAS; Takase Y, 1997, PHYS PLASMAS, V4, P1647, DOI 10.1063/1.872269; TAKASE Y, 1992, AIP CONF PROC, V244, P189; Takase Y., 1997, P 12 TOP C RAD FREQ, V403, P33; Takase Y, 1996, PLASMA PHYS CONTR F, V38, P2215, DOI 10.1088/0741-3335/38/12/013; Tang V, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2238519; Tang V, 2007, PLASMA PHYS CONTR F, V49, P873, DOI 10.1088/0741-3335/49/6/013; Terry J., 2012, P 24 IAEA FUS EN C; Terry JL, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3478669; Terry JL, 2013, J NUCL MATER, V438, pS212, DOI 10.1016/j.jnucmat.2013.01.029; Terry JL, 2001, J NUCL MATER, V290, P757, DOI 10.1016/S0022-3115(00)00453-0; Terry JL, 1998, PHYS PLASMAS, V5, P1759, DOI 10.1063/1.872845; Terry JL, 1998, AIP CONF PROC, V443, P43, DOI 10.1063/1.56565; Terry JL, 2005, J NUCL MATER, V337, P322, DOI 10.1016/j.jnucmat.2004.10.092; Terry PW, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2928909; Thomsen K., 1998, P 17 INT C PLASM PHY, V3, P987; Titus P. H., 1999, P 18 IEEE S FUS ENG, V1, P427; WAELBROECK F, 1989, PLASMA PHYS CONTR F, V31, P185, DOI 10.1088/0741-3335/31/2/004; Walk JR, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/6/063011; Wampler W. R., 1999, P 18 IEEE S FUS ENG, V1, P267; White AE, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/11/115003; Whyte DG, 1997, J NUCL MATER, V241, P660, DOI 10.1016/S0022-3115(97)80118-3; Whyte DG, 2009, J NUCL MATER, V390-91, P911, DOI 10.1016/j.jnucmat.2009.01.234; Whyte DG, 2007, J NUCL MATER, V363, P1160, DOI 10.1016/j.jnucmat.2007.01.149; Wilson JR, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/11/115015; Wilson JR, 2009, AIP CONF PROC, V1187, P327, DOI 10.1063/1.3273759; WILSON KL, 1991, NUCL FUSION, V1, P31; WOLFE SM, 1986, NUCL FUSION, V26, P329, DOI 10.1088/0029-5515/26/3/006; Wright GM, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/4/042003; Wright JC, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/4/045007; Wright JC, 2004, COMPUT PHYS COMMUN, V164, P330, DOI 10.1016/j.cpc.2004.06.044; Wright JC, 2004, PHYS PLASMAS, V11, P2473, DOI 10.1063/1.1652731; Wukitch S., 2010, P 23 IAEA FUS EN C; Wukitch S., 2012, P 24 IAEA FUS EN C, P406; Wukitch S. J., 2013, P 24 IAEA FUS EN C S, P406; Wukitch S. J., 1998, P 2 EUR TOP C RAD FR; Wukitch SJ, 2009, J NUCL MATER, V390-91, P951, DOI 10.1016/j.jnucmat.2009.01.245; Wukitch SJ, 2007, AIP CONF PROC, V933, P75; Wukitch SJ, 2001, AIP CONF PROC, V595, P43; Wukitch SJ, 2003, AIP CONF PROC, V694, P178; Wukitch SJ, 2007, J NUCL MATER, V363, P491, DOI 10.1016/j.jnucmat.2007.01.273; Wukitch SJ, 2002, PHYS PLASMAS, V9, P2149, DOI 10.1063/1.1467347; Wukitch SJ, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1866142; Xu XQ, 2003, PHYS PLASMAS, V10, P1773, DOI 10.1063/1.1566032; Zhurovich K, 2007, NUCL FUSION, V47, P1220, DOI 10.1088/0029-5515/47/9/019; Zweben S. J., 2011, P 38 EPS C PLASM PHY, V35, P1608; ZWEBEN SJ, 1989, PHYS FLUIDS B-PLASMA, V1, P2058, DOI 10.1063/1.859070	400	4	4	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	1070-664X	1089-7674		PHYS PLASMAS	Phys. Plasmas	NOV	2014	21	11							110501	10.1063/1.4901920		50	Physics, Fluids & Plasmas	Physics	AU5JZ	WOS:000345644200001		
J	Iwawaki, T; Habara, H; Baton, S; Morita, K; Fuchs, J; Chen, S; Nakatsutsumi, M; Rousseaux, C; Filippi, F; Nazarov, W; Tanaka, KA				Iwawaki, T.; Habara, H.; Baton, S.; Morita, K.; Fuchs, J.; Chen, S.; Nakatsutsumi, M.; Rousseaux, C.; Filippi, F.; Nazarov, W.; Tanaka, K. A.			Collimated fast electron beam generation in critical density plasma	PHYSICS OF PLASMAS			English	Article							LASER; IGNITION; LIGHT	Significantly collimated fast electron beam with a divergence angle 10 degrees (FWHM) is observed when an ultra-intense laser pulse (I = 10(14) W/cm(2), 300 fs) irradiates a uniform critical density plasma. The uniform plasma is created through the ionization of an ultra-low density (5mg/c.c.) plastic foam by X-ray burst from the interaction of intense laser (I = 10(14) W/cm(2), 600 ps) with a thin Cu foil. 2D Particle-In-Cell (PIC) simulation well reproduces the collimated electron beam with a strong magnetic field in the region of the laser pulse propagation. To understand the physical mechanism of the collimation, we calculate energetic electron motion in the magnetic field obtained from the 2D PIC simulation. As the results, the strong magnetic field (300 MG) collimates electrons with energy over a few MeV. This collimation mechanism may attract attention in many applications such as electron acceleration, electron microscope and fast ignition of laser fusion. (C) 2014 AIP Publishing LLC.	[Iwawaki, T.; Habara, H.; Morita, K.; Tanaka, K. A.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Baton, S.; Fuchs, J.; Chen, S.; Nakatsutsumi, M.] Univ Paris 06, CEA, Ecole Polytech, LULI,CNRS, F-91128 Palaiseau, France; [Nakatsutsumi, M.] European Xray Free Electron Laser Facil XFEL GmbH, Hamburg, Germany; [Rousseaux, C.] CEA, DAM, DIF, F-91297 Arpajon, France; [Filippi, F.] Univ Roma La Sapienza, Dip SBAI, I-00161 Rome, Italy; [Nazarov, W.] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland	Iwawaki, T (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	iwawaki-t@eie.eng.osaka-u.ac.jp			JSPS [25 . 858]; Cooperation toward Leadership in Innovative Creation (CLIC) Internship Program; X-ray free electron laser priority strategy program of MEXT (Osaka University) [12005014];  [22246122];  [23360412]	The authors gratefully acknowledge the support of the staff of the ELFIE in the execution of this work (11-TW-F4). Moreover, we thank Professor H. Sakagami at National Institute for Fusion Science for his permission of use of 2D-PIC FISCOF code and Dr. P. Nicolai at Universite Bordeaux for conducting 1D CHIC hydro-radiative simulation. A part of this work was supported by Grants-in-Aid for Scientific Research, type A (Grant No. 22246122) and type B (Grant No. 23360412) and JSPS Research Fellowship for young scientists (25 . 858), Cooperation toward Leadership in Innovative Creation (CLIC) Internship Program and X-ray free electron laser priority strategy program of MEXT (12005014 Osaka University).	Scott RHH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.015001; KRUER WL, 1985, PHYS FLUIDS, V28, P430, DOI 10.1063/1.865171; Debayle A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036405; HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013; Habara H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.095004; TAJIMA T, 1979, PHYS REV LETT, V43, P267, DOI 10.1103/PhysRevLett.43.267; Kodama R, 2004, NATURE, V432, P1005, DOI 10.1038/nature03133; Pukhov A, 1999, PHYS PLASMAS, V6, P2847, DOI 10.1063/1.873242; Bonnet T, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4775719; Kar S, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/5/055001; Maire PH, 2007, SIAM J SCI COMPUT, V29, P1781, DOI 10.1137/050633019; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; Tanaka KA, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1824371; Green JS, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.015003; Lei AL, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066403; Pukhov A, 1996, PHYS REV LETT, V76, P3975, DOI 10.1103/PhysRevLett.76.3975; Willingale L, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.105002; Chen S., PHYS PLASMAS UNPUB; Chung H. K., 2005, HIGH ENERGY DENSITY, V1, P3, DOI DOI 10.1016/J.HEDP.2005.07.001; Habara H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.055001; Inoue S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.185001; Ivancic S., 2013, P 55 ANN M APS DIV P; Kodama R, 2001, PHYS PLASMAS, V8, P2268, DOI 10.1063/1.1352598; Li YT, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036405; Mason RJ, 1998, PHYS PLASMAS, V5, P211, DOI 10.1063/1.872690; Matsuoka T, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/10/105011; Nakanii N, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2971235; Naseri N, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3339910; Ovchinnikov VM, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.065007; Pukhov A, 1998, PHYS PLASMAS, V5, P1880, DOI 10.1063/1.872821; Sakagami H., 2002, P 2 INT C IN FUS SCI, P380; Tanaka KA, 2004, PLASMA PHYS CONTR F, V46, pB41, DOI 10.1088/0741-3335/46/12B/004; Tanimoto T, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/2/022095; Uematsu Y, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4890575; Yabuuchi T, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2722303; Ziegler J. F., TRANSPORT IONS MATTE	36	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	1070-664X	1089-7674		PHYS PLASMAS	Phys. Plasmas	NOV	2014	21	11							113103	10.1063/1.4900868		8	Physics, Fluids & Plasmas	Physics	AU5JZ	WOS:000345644200052		
J	Kasuya, N; Sugita, S; Inagaki, S; Itoh, K; Yagi, M; Itoh, SI				Kasuya, N.; Sugita, S.; Inagaki, S.; Itoh, K.; Yagi, M.; Itoh, S. -I.			On violation of local closure of transport relation in high-temperature magnetized plasmas	PHYSICS OF PLASMAS			English	Article							TURBULENCE	Rapid propagation of heat modulation and a hysteresis in the gradient-flux relation are found in a global nonlinear simulation of drift-interchange mode turbulence in toroidal helical plasmas. A global mode is excited nonlinearly and induces the turbulence flux in a limited radial region. The nonlinear couplings take a finite temporal duration for redistributing the energy. The mode also has a seesaw effect: increase of the amplitude of the global mode, at the other radii, works to absorb the energy form microscopic modes to suppress the turbulence. Successive excitations of microscopic modes cause the accelerated propagation of change of the heat flux like turbulence spreading after the onset of modulation. Owing to these processes, the hysteresis appears in the gradient-flux relation, which is compared with experiments. (C) 2014 AIP Publishing LLC.	[Kasuya, N.; Inagaki, S.; Itoh, S. -I.] Kyushu Univ, Appl Mech Res Inst, Fukuoka 8168580, Japan; [Kasuya, N.; Inagaki, S.; Itoh, K.; Yagi, M.; Itoh, S. -I.] Kyushu Univ, Res Ctr Plasma Turbulence, Fukuoka 8168580, Japan; [Sugita, S.] Chubu Univ, Int Digital Earth Appl Sci Res Ctr, Kasugai, Aichi 4878501, Japan; [Itoh, K.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Yagi, M.] Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan	Kasuya, N (reprint author), Kyushu Univ, Appl Mech Res Inst, Fukuoka 8168580, Japan.	kasuya@riam.kyushu-u.ac.jp	Kasuya, Naohiro/D-3871-2015; Kyushu, RIAM/F-4018-2015	Kasuya, Naohiro/0000-0001-8210-5700; 	JSPS [24760703, 23244113, 21224014]; NIFS [NIFS13KNST050, NIFS13KOCT001]; RIAM of Kyushu University; Asada Science foundation;  [10J04534]	Authors acknowledge discussions with Professor A. Fujisawa, Professor K. Ida, Dr. M. Sasaki, and Dr. Y. Nagashima. This work was supported by the Grant-in-Aid for Young Scientists (24760703), for Scientific Research (23244113, 21224014) of JSPS and for JSPS Fellows (10J04534), by the collaboration program of NIFS (NIFS13KNST050, NIFS13KOCT001) and of RIAM of Kyushu University, and Asada Science foundation.	Naulin V, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1905603; Hahm TS, 2004, PLASMA PHYS CONTR F, V46, pA323, DOI 10.1088/0741-3335/46/5A/036; Naulin V, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2141396; Diamond PH, 2005, PLASMA PHYS CONTR F, V47, pR35, DOI 10.1088/0741-3335/47/5/R01; YUSHMANOV PN, 1990, NUCL FUSION, V30, P1999, DOI 10.1088/0029-5515/30/10/001; Fujisawa A, 2007, NUCL FUSION, V47, pS718, DOI 10.1088/0029-5515/47/10/S19; Gurcan OD, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1853385; Del-Castillo-Negrete D, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/7/075009; Dif-Pradalier G, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.025401; Garbet X, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2824375; Gentle KW, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2163251; GENTLE KW, 1995, PHYS REV LETT, V74, P3620, DOI 10.1103/PhysRevLett.74.3620; Ida K, 2012, P 24 FUS EN C SAN DI; Inagaki S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.115001; Inagaki S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113006; Itoh K, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/9/095016; Itoh K., 2009, J PLASMA FUSION RES, V8, P119; Itoh SI, 2012, SCI REP-UK, V2, DOI 10.1038/srep00860; Itoh SI, 2001, PLASMA PHYS CONTR F, V43, P1055, DOI 10.1088/0741-3335/43/8/304; Itoh SI, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073035; Kasuya N., 2011, PLASMA FUSION RES, V6; Kasuya N, 2013, PLASMA FUSION RES, V8; Kim S S, 2010, P 23 FUS EN C DAEJ K; Stroth U, 1996, PLASMA PHYS CONTR F, V38, P611, DOI 10.1088/0741-3335/38/4/010; Tamura N, 2007, NUCL FUSION, V47, P449, DOI 10.1088/0029-5515/47/5/009; Wakatani M., 1998, STELLARATOR HELIOTRO	26	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	1070-664X	1089-7674		PHYS PLASMAS	Phys. Plasmas	NOV	2014	21	11							110701	10.1063/1.4902102		4	Physics, Fluids & Plasmas	Physics	AU5JZ	WOS:000345644200002		
J	Lesur, M; Diamond, PH; Kosuga, Y				Lesur, M.; Diamond, P. H.; Kosuga, Y.			Phase-space jets drive transport and anomalous resistivity	PHYSICS OF PLASMAS			English	Article							ION-ELECTRON INSTABILITY; CLUMP PAIR CREATION; SOLITARY WAVES; DENSITY HOLES; PLASMA; SIMULATION; TURBULENCE; EVOLUTION; VORTICES; DYNAMICS	In the presence of wave dissipation, phase-space structures spontaneously emerge in nonlinear Vlasov dynamics. These structures include not only well-known self-trapped vortices (holes) but also elongated filaments, resembling jets, as reported in this work. These jets are formed by straining due to interacting holes. Jets are highly anisotropic, and connect low and high velocity regions over a range larger than the electron thermal velocity. Jets survive long enough for particles to scatter between low and high phase-space density regions. Jets are found to contribute significantly to electron redistribution, velocity-space transport, and anomalous resistivity. (C) 2014 AIP Publishing LLC.	[Lesur, M.; Kosuga, Y.] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan; [Lesur, M.] Kyushu Univ, Res Ctr Plasma Turbulence, Kasuga, Fukuoka 8168580, Japan; [Diamond, P. H.] NFRI, WCI Ctr Fus Theory, Taejon 305333, South Korea; [Diamond, P. H.] Univ Calif San Diego, CMTFO, La Jolla, CA 92093 USA; [Diamond, P. H.] Univ Calif San Diego, CASS, La Jolla, CA 92093 USA; [Kosuga, Y.] Kyushu Univ, Inst Adv Study, Fukuoka 8168580, Japan; [Kosuga, Y.] Kyushu Univ, Appl Mech Res Inst, Fukuoka 8168580, Japan	Lesur, M (reprint author), Kyushu Univ, Appl Mech Res Inst, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	maxime.lesur@polytechnique.org	Kyushu, RIAM/F-4018-2015		JSPS, Japan [21224014, 23244113, 25887041]; RIAM of Kyushu University; Asada Science Foundation; WCI Program of the NRF of Korea - Ministry of Education, Science and Technology of Korea [WCI 2009-001]; CMTFO via U.S. DoE [DE-FG0204ER54738]	The authors are grateful for stimulating discussions with K. Itoh, S.-I. Itoh, C. Nguyen, Y. Idomura, X. Garbet, and the participants in the 2009, 2011, and 2013 Festival de Theorie. This work was supported by three grants-in-aid for scientific research of JSPS, Japan (21224014, 23244113, and 25887041), by the collaboration program of the RIAM of Kyushu University and Asada Science Foundation, by the WCI Program of the NRF of Korea funded by the Ministry of Education, Science and Technology of Korea [WCI 2009-001], and by CMTFO via U.S. DoE Grant No. DE-FG0204ER54738. Computations were performed on the Plasma Simulator at NIFS.	DUPREE TH, 1982, PHYS FLUIDS, V25, P277, DOI 10.1063/1.863734; DUPREE TH, 1983, PHYS FLUIDS, V26, P2460, DOI 10.1063/1.864430; BERK HL, 1970, PHYS FLUIDS, V13, P980, DOI 10.1063/1.1693039; DUPREE TH, 1972, PHYS FLUIDS, V15, P334, DOI 10.1063/1.1693911; Lilley MK, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3486535; Omura Y, 1996, J GEOPHYS RES, V101, P2685, DOI 10.1029/95JA03145; Schamel H, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3682047; Berk HL, 1999, PHYS PLASMAS, V6, P3102, DOI 10.1063/1.873550; ROBERTS KV, 1967, PHYS REV LETT, V19, P297, DOI 10.1103/PhysRevLett.19.297; BERMAN RH, 1985, PHYS FLUIDS, V28, P155, DOI 10.1063/1.865176; Oohara W, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.205005; SCHAMEL H, 1986, PHYS REP, V140, P161, DOI 10.1016/0370-1573(86)90043-8; Lesur M, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3234249; GREAVES RG, 1995, PHYS REV LETT, V75, P3846, DOI 10.1103/PhysRevLett.75.3846; Berk HL, 1997, PHYS LETT A, V234, P213, DOI 10.1016/S0375-9601(97)00523-9; Drake JF, 2003, SCIENCE, V299, P873, DOI 10.1126/science.1080333; MCWILLIAMS JC, 1984, J FLUID MECH, V146, P21, DOI 10.1017/S0022112084001750; Eliasson B, 2006, PHYS REP, V422, P225, DOI 10.1016/j.physrep.2005.10.003; BERMAN RH, 1982, PHYS REV LETT, V48, P1249, DOI 10.1103/PhysRevLett.48.1249; BIGLARI H, 1988, PHYS FLUIDS, V31, P2644, DOI 10.1063/1.866542; BOUTROSGHALI T, 1982, PHYS FLUIDS, V25, P874, DOI 10.1063/1.863817; Diamond P. H., 2010, MODERN PLASMA PHYS, V1; DUPREE TH, 1970, PHYS REV LETT, V25, P789, DOI 10.1103/PhysRevLett.25.789; HSU CT, 1994, PHYS REV LETT, V72, P2503, DOI 10.1103/PhysRevLett.72.2503; Kosuga Y, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3662428; Kosuga Y., 2014, PLASMA FUSION RES, V9; Lesur M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.031101; Lesur M, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/7/075005; Lesur M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4804644; MYNICK HE, 1994, NUCL FUSION, V34, P1277, DOI 10.1088/0029-5515/34/9/I09; Nyqvist RM, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/9/094020; Oppenheim MM, 2001, GEOPHYS RES LETT, V28, P1891, DOI 10.1029/2000GL012383; Petkaki P, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA010092; SAEKI K, 1979, PHYS REV LETT, V42, P501, DOI 10.1103/PhysRevLett.42.501; SAKANAKA PH, 1972, PHYS FLUIDS, V15, P304, DOI 10.1063/1.1693908; Schamel H, 1996, PHYS SCRIPTA, VT63, P63, DOI 10.1088/0031-8949/1996/T63/009; SCHAMEL H, 1979, PHYS SCRIPTA, V20, P336, DOI 10.1088/0031-8949/20/3-4/006; Watt CEJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013451	38	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	1070-664X	1089-7674		PHYS PLASMAS	Phys. Plasmas	NOV	2014	21	11							112307	10.1063/1.4902525		9	Physics, Fluids & Plasmas	Physics	AU5JZ	WOS:000345644200027		
J	Mikkelsen, DR; Nunami, M; Watanabe, TH; Sugama, H; Tanaka, K				Mikkelsen, D. R.; Nunami, M.; Watanabe, T. -H.; Sugama, H.; Tanaka, K.			Verification of gyrokinetic microstability codes with an LHD configuration	PHYSICS OF PLASMAS			English	Article							TEMPERATURE-GRADIENT TURBULENCE; SIMULATIONS	We extend previous benchmarks of the GS2 and GKV-X codes to verify their algorithms for solving the gyrokinetic Vlasov-Poisson equations for plasma microturbulence. Code benchmarks are the most complete way of verifying the correctness of implementations for the solution of mathematical models for complex physical processes such as those studied here. The linear stability calculations reported here are based on the plasma conditions of an ion-ITB plasma in the LHD configuration. The plasma parameters and the magnetic geometry differ from previous benchmarks involving these codes. We find excellent agreement between the independently written pre-processors that calculate the geometrical coefficients used in the gyrokinetic equations. Grid convergence tests are used to establish the resolution and domain size needed to obtain converged linear stability results. The agreement of the frequencies, growth rates, and eigenfunctions in the benchmarks reported here provides additional verification that the algorithms used by the GS2 and GKV-X codes are correctly finding the linear eigenvalues and eigenfunctions of the gyrokinetic Vlasov-Poisson equations. (C) 2014 AIP Publishing LLC.	[Mikkelsen, D. R.] Princeton Plasma Phys Lab, Princeton, NJ 08543 USA; [Nunami, M.; Sugama, H.; Tanaka, K.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Watanabe, T. -H.] Nagoya Univ Furo cho, Dept Phys, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Mikkelsen, DR (reprint author), Princeton Plasma Phys Lab, POB 451, Princeton, NJ 08543 USA.	dmikkelsen@pppl.gov			Japanese Ministry of Education, Culture, Sports, Science and Technology [22760660, 26820398]; Japan/U.S. Cooperation in Fusion Research and Development; U.S. Department of Energy [DE-AC02-76CH03073]	We thank J. A. Baumgaertel, G. W. Hammett, and P. Xanthopoulos for helpful discussions. This work has been done under the collaboration research of the National Institute for Fusion Science. It is a pleasure to acknowledge cooperation and discussions with Professor K. Komori, Professor O. Kaneko, and Professor H. Yamada of the National Institute for Fusion Science. One of the authors (M.N.) was supported in part by the Japanese Ministry of Education, Culture, Sports, Science and Technology, Grant (Nos. 22760660 and 26820398), and by Japan/U.S. Cooperation in Fusion Research and Development. This work was supported by U.S. Department of Energy Contract No. DE-AC02-76CH03073. Use of parallel computer clusters at PPPL is gratefully acknowledged.	Candy J, 2003, J COMPUT PHYS, V186, P545, DOI 10.1016/S0021-9991(03)00079-2; Jenko F, 2000, PHYS PLASMAS, V7, P1904, DOI 10.1063/1.874014; Gorler T, 2011, J COMPUT PHYS, V230, P7053, DOI 10.1016/j.jcp.2011.05.034; Ida K, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3111097; KOTSCHENREUTHER M, 1995, COMPUT PHYS COMMUN, V88, P128, DOI 10.1016/0010-4655(95)00035-E; Xanthopoulos P, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2338818; Candy J, 2004, PHYS PLASMAS, V11, pL25, DOI 10.1063/1.1695358; Chen Y, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4821982; Watanabe TH, 2007, NUCL FUSION, V47, P1383, DOI 10.1088/0029-5515/47/9/041; Dorland W, 2000, PHYS REV LETT, V85, P5579, DOI 10.1103/PhysRevLett.85.5579; Miller RL, 1998, PHYS PLASMAS, V5, P973, DOI 10.1063/1.872666; Baumgaertel J. A., 2012, THESIS PRINCETON U; Baumgaertel JA, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3662064; BEER MA, 1995, PHYS PLASMAS, V2, P2687, DOI 10.1063/1.871232; Bravenec RV, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4826511; Bravenec RV, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3671907; COOPER WA, 1992, PLASMA PHYS CONTR F, V34, P1011; Dimits AM, 2007, NUCL FUSION, V47, P817, DOI 10.1088/0029-5515/47/8/012; Highcock E., 2012, THESIS U OXFORD; HIRSHMAN SP, 1991, J COMPUT PHYS, V96, P99, DOI 10.1016/0021-9991(91)90267-O; Nevins WM, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2402510; Nevins WM, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2759890; Nunami M, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4704568; Nunami Masanori, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.016; Nunami M., 2011, PLASMA FUSION RES, V6, DOI DOI 10.1585/PFR.6.1403001; Rewoldt G, 1999, PHYS PLASMAS, V6, P4705, DOI 10.1063/1.873757; Rewoldt G, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2089247; Tanaka K, 2010, PLASMA FUSION RES, V5, pS2053, DOI DOI 10.1585/PFR.5.S2053; Watanabe TH, 2006, NUCL FUSION, V46, P24, DOI 10.1088/0029-5515/46/1/003; Xanthopoulos P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.245002; Xanthopoulos P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.035002; Xanthopoulos P, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3187907; Xanthopoulos P, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3010708	33	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	1070-664X	1089-7674		PHYS PLASMAS	Phys. Plasmas	NOV	2014	21	11							112305	10.1063/1.4902124		8	Physics, Fluids & Plasmas	Physics	AU5JZ	WOS:000345644200025		
J	van Berkel, M; Zwart, HJ; Tamura, N; Hogeweij, GMD; Inagaki, S; de Baar, MR; Ida, K				van Berkel, M.; Zwart, H. J.; Tamura, N.; Hogeweij, G. M. D.; Inagaki, S.; de Baar, M. R.; Ida, K.			Explicit approximations to estimate the perturbative diffusivity in the presence of convectivity and damping. I. Semi-infinite slab approximations	PHYSICS OF PLASMAS			English	Article							HEAT-PULSE-PROPAGATION; TOKAMAK PLASMAS; ZONAL FLOW; TRANSPORT; JET	In this paper, a number of new approximations are introduced to estimate the perturbative diffusivity (chi), convectivity (V), and damping (tau) in cylindrical geometry. For this purpose, the harmonic components of heat waves induced by localized deposition of modulated power are used. The approximations are based on semi-infinite slab approximations of the heat equation. The main result is the approximation of chi under the influence of V and tau based on the phase of two harmonics making the estimate less sensitive to calibration errors. To understand why the slab approximations can estimate chi well in cylindrical geometry, the relationships between heat transport models in slab and cylindrical geometry are studied. In addition, the relationship between amplitude and phase with respect to their derivatives, used to estimate chi, is discussed. The results are presented in terms of the relative error for the different derived approximations for different values of frequency, transport coefficients, and dimensionless radius. The approximations show a significant region in which chi, V, and tau can be estimated well, but also regions in which the error is large. Also, it is shown that some compensation is necessary to estimate V and tau in a cylindrical geometry. On the other hand, errors resulting from the simplified assumptions are also discussed showing that estimating realistic values for V and tau based on infinite domains will be difficult in practice. This paper is the first part (Part I) of a series of three papers. In Part II and Part III, cylindrical approximations based directly on semi-infinite cylindrical domain (outward propagating heat pulses) and inward propagating heat pulses in a cylindrical domain, respectively, will be treated.	[van Berkel, M.; Tamura, N.; Ida, K.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [van Berkel, M.] Japan Soc Promot Sci, Tokyo, Japan; [van Berkel, M.; Hogeweij, G. M. D.; de Baar, M. R.] EURATOM, Dutch Inst Fundamental Energy Res, FOM Inst DIFFER, Trilateral Euregio Cluster, NL-3430 BE Nieuwegein, Netherlands; [van Berkel, M.; de Baar, M. R.] Eindhoven Univ Technol, Dept Mech Engn, Control Syst Technol Grp, NL-5600 MB Eindhoven, Netherlands; [Zwart, H. J.] Eindhoven Univ Technol, Dept Mech Engn, Dynam & Control Grp, NL-5600 MB Eindhoven, Netherlands; [Zwart, H. J.] Univ Twente, Dept Appl Math, NL-7500 AE Enschede, Netherlands; [Inagaki, S.] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan	van Berkel, M (reprint author), Natl Inst Fus Sci, 322 Oroshi Cho, Toki, Gifu 5095292, Japan.		Kyushu, RIAM/F-4018-2015		NWO-RFBR Centre-of-Excellence on Fusion Physics and Technology [047.018.002]	The first author is an international research fellow of the Japan Society for the Promotion of Science and hence wishes to express his gratitude to the JSPS for making this research possible. This work is also supported by NWO-RFBR Centre-of-Excellence on Fusion Physics and Technology (Grant No. 047.018.002).	DeBoo JC, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4750061; Diamond PH, 2005, PLASMA PHYS CONTR F, V47, pR35, DOI 10.1088/0741-3335/47/5/R01; Fujisawa A, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/1/013001; JACCHIA A, 1991, PHYS FLUIDS B-PLASMA, V3, P3033, DOI 10.1063/1.859781; Curtain R, 2009, AUTOMATICA, V45, P1101, DOI 10.1016/j.automatica.2009.01.008; Mantica P, 2006, CR PHYS, V7, P634, DOI 10.1016/j.crhy.2006.06.004; Chen L, 2000, PHYS PLASMAS, V7, P3129, DOI 10.1063/1.874222; Bateman H., 1953, HIGHER TRANSCENDENTA; BISHOP CM, 1990, PLASMA PHYS CONTR F, V32, P203, DOI 10.1088/0741-3335/32/3/005; CALLEN JD, 1977, PHYS REV LETT, V38, P491, DOI 10.1103/PhysRevLett.38.491; CARDOZO NJL, 1988, NUCL FUSION, V28, P1173, DOI 10.1088/0029-5515/28/7/002; Curtain R. F., 1995, INTRO INFINITE DIMEN, V21; Cuyt A., 2008, HDB CONTINUED FRACTI; DEHAAS JCM, 1991, NUCL FUSION, V31, P1261, DOI 10.1088/0029-5515/31/7/003; Diamond PH, 2000, PHYS REV LETT, V84, P4842, DOI 10.1103/PhysRevLett.84.4842; Dudok de Wit T., 1991, Nuclear Fusion, V31, DOI 10.1088/0029-5515/31/2/011; Erdelyi A., 1956, ASYMPTOTIC EXPANSION; Eury SP, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2084887; FREDRICKSON ED, 1986, NUCL FUSION, V26, P849, DOI 10.1088/0029-5515/26/7/002; Freidberg J., 2007, PLASMA PHYS FUSION E; GENTLE KW, 1988, PHYS FLUIDS, V31, P1105, DOI 10.1063/1.866790; GOEDHEER WJ, 1986, NUCL FUSION, V26, P1043, DOI 10.1088/0029-5515/26/8/004; HOGEWEIJ GMD, 1991, PLASMA PHYS CONTR F, V33, P189, DOI 10.1088/0741-3335/33/3/003; Inagaki S, 2006, NUCL FUSION, V46, P133, DOI 10.1088/0029-5515/46/1/015; JAHNS GL, 1978, NUCL FUSION, V18, P609, DOI 10.1088/0029-5515/18/5/002; Jones W. B., 1980, CONTINUED FRACTIONS, V11; Ljung L, 1999, SYSTEM IDENTIFICATIO; Lopes Cardozo N. J., 1995, Plasma Physics and Controlled Fusion, V37, DOI 10.1088/0741-3335/37/8/001; LUCE TC, 1992, PHYS REV LETT, V68, P52, DOI 10.1103/PhysRevLett.68.52; Mantica P, 2006, PLASMA PHYS CONTR F, V48, P385, DOI 10.1088/0741-3335/48/3/004; MORET JM, 1993, NUCL FUSION, V33, P1185, DOI 10.1088/0029-5515/33/8/I07; Pintelon R., 2012, SYSTEM IDENTIFICATIO; Polyanin A. D., 2003, HDB EXACT SOLUTIONS, V2; Ryter F, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/12/124043; Slater L.J., 1960, CONFLUENT HYPERGEOME; SOLER M, 1979, NUCL FUSION, V19, P703, DOI 10.1088/0029-5515/19/6/002; van Berkel M, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/10/105004; van Berkel M, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4901311; van Berkel M, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4901310; Wesson J, 2011, TOKAMAKS, V149; Witvoet G, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/073024	41	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	1070-664X	1089-7674		PHYS PLASMAS	Phys. Plasmas	NOV	2014	21	11							112507	10.1063/1.4901309		13	Physics, Fluids & Plasmas	Physics	AU5JZ	WOS:000345644200034		
J	van Berkel, M; Tamura, N; Hogeweij, GMD; Zwart, HJ; Inagaki, S; de Baar, MR; Ida, K				van Berkel, M.; Tamura, N.; Hogeweij, G. M. D.; Zwart, H. J.; Inagaki, S.; de Baar, M. R.; Ida, K.			Explicit approximations to estimate the perturbative diffusivity in the presence of convectivity and damping. III. Cylindrical approximations for heat waves traveling inwards	PHYSICS OF PLASMAS			English	Article							TRANSPORT; PLASMAS	In this paper, a number of new explicit approximations are introduced to estimate the perturbative diffusivity (chi), convectivity (V), and damping (tau) in cylindrical geometry. For this purpose, the harmonic components of heat waves induced by localized deposition of modulated power are used. The approximations are based on the heat equation in cylindrical geometry using the symmetry (Neumann) boundary condition at the plasma center. This means that the approximations derived here should be used only to estimate transport coefficients between the plasma center and the off-axis perturbative source. If the effect of cylindrical geometry is small, it is also possible to use semi-infinite domain approximations presented in Part I and Part II of this series. A number of new approximations are derived in this part, Part III, based upon continued fractions of the modified Bessel function of the first kind and the confluent hypergeometric function of the first kind. These approximations together with the approximations based on semi-infinite domains are compared for heat waves traveling towards the center. The relative error for the different derived approximations is presented for different values of the frequency, transport coefficients, and dimensionless radius. Moreover, it is shown how combinations of different explicit formulas can be used to estimate the transport coefficients over a large parameter range for cases without convection and damping, cases with damping only, and cases with convection and damping. The relative error between the approximation and its underlying model is below 2% for the case, where only diffusivity and damping are considered. If also convectivity is considered, the diffusivity can be estimated well in a large region, but there is also a large region in which no suitable approximation is found. This paper is the third part (Part III) of a series of three papers. In Part I, the semi-infinite slab approximations have been treated. In Part II, cylindrical approximations are treated for heat waves traveling towards the plasma edge assuming a semi-infinite domain.	[van Berkel, M.; Tamura, N.; Ida, K.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [van Berkel, M.] Japan Soc Promot Sci, Tokyo, Japan; [van Berkel, M.; Hogeweij, G. M. D.; de Baar, M. R.] EURATOM, Dutch Inst Fundamental Energy Res, FOM Inst DIFFER, Trilateral Euregio Cluster, NL-3430 BE Nieuwegein, Netherlands; [van Berkel, M.; de Baar, M. R.] Eindhoven Univ Technol, Dept Mech Engn, Control Syst Technol Grp, NL-5600 MB Eindhoven, Netherlands; [Zwart, H. J.] Eindhoven Univ Technol, Dept Mech Engn, Dynam & Control Grp, NL-5600 MB Eindhoven, Netherlands; [Zwart, H. J.] Univ Twente, Dept Appl Math, NL-7500 AE Enschede, Netherlands; [Inagaki, S.] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan	van Berkel, M (reprint author), Natl Inst Fus Sci, 322 Oroshi Cho, Toki, Gifu 5095292, Japan.		Kyushu, RIAM/F-4018-2015		NWO-RFBR Centre-of-Excellence on Fusion Physics and Technology [047.018.002]	The first author was currently an International Research Fellow of the Japan Society for the Promotion of Science and hence wishes to express his gratitude to the JSPS for making this research possible. This work was also supported by NWO-RFBR Centre-of-Excellence on Fusion Physics and Technology (Grant No. 047.018.002).	Abramowitz M., 1976, HDB MATH FUNCTIONS F; JACCHIA A, 1991, PHYS FLUIDS B-PLASMA, V3, P3033, DOI 10.1063/1.859781; Bateman H., 1953, HIGHER TRANSCENDENTA; Carslaw H. S., 1959, CONDUCTION HEAT SOLI, V1; Cuyt A., 2008, HDB CONTINUED FRACTI, p[324, 362, 363]; Eury SP, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2084887; Jones W. B., 1980, CONTINUED FRACTIONS, V11; CARDOZO NJL, 1995, PLASMA PHYS CONTR F, V37, P799, DOI 10.1088/0741-3335/37/8/001; Luke Y L, 1969, SPECIAL FUNCTIONS TH, V1; Polyanin A. D., 2003, HDB EXACT SOLUTIONS, V2; Slater L.J., 1960, CONFLUENT HYPERGEOME; van Berkel M, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4901309; van Berkel M, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4901310	13	2	2	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	1070-664X	1089-7674		PHYS PLASMAS	Phys. Plasmas	NOV	2014	21	11							112509	10.1063/1.4901311		11	Physics, Fluids & Plasmas	Physics	AU5JZ	WOS:000345644200036		
J	van Berkel, M; Hogeweij, GMD; Tamura, N; Zwart, HJ; Inagaki, S; de Baar, MR; Ida, K				van Berkel, M.; Hogeweij, G. M. D.; Tamura, N.; Zwart, H. J.; Inagaki, S.; de Baar, M. R.; Ida, K.			Explicit approximations to estimate the perturbative diffusivity in the presence of convectivity and damping. II. Semi-infinite cylindrical approximations	PHYSICS OF PLASMAS			English	Article							HEAT PULSE-PROPAGATION; TRANSPORT; PLASMAS	In this paper, a number of new explicit approximations are introduced to estimate the perturbative diffusivity (chi), convectivity (V), and damping (tau) in a cylindrical geometry. For this purpose, the harmonic components of heat waves induced by localized deposition of modulated power are used. The approximations are based upon the heat equation in a semi-infinite cylindrical domain. The approximations are based upon continued fractions, asymptotic expansions, and multiple harmonics. The relative error for the different derived approximations is presented for different values of frequency, transport coefficients, and dimensionless radius. Moreover, it is shown how combinations of different explicit formulas can yield good approximations over a wide parameter space for different cases, such as no convection and damping, only damping, and both convection and damping. This paper is the second part (Part II) of a series of three papers. In Part I, the semi-infinite slab approximations have been treated. In Part III, cylindrical approximations are treated for heat waves traveling towards the center of the plasma.	[van Berkel, M.; Tamura, N.; Ida, K.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [van Berkel, M.] Japan Soc Promot Sci, Tokyo, Japan; [van Berkel, M.; Hogeweij, G. M. D.; de Baar, M. R.] EURATOM, Dutch Inst Fundamental Energy Res, FOM Inst DIFFER, Trilateral Euregio Cluster, NL-3430 BE Nieuwegein, Netherlands; [van Berkel, M.; de Baar, M. R.] Eindhoven Univ Technol, Dept Mech Engn, Control Syst Technol, NL-5600 MB Eindhoven, Netherlands; [Zwart, H. J.] Eindhoven Univ Technol, Dept Mech Engn, Dynam & Control Grp, NL-5600 MB Eindhoven, Netherlands; [Zwart, H. J.] Univ Twente, Dept Appl Math, NL-7500 AE Enschede, Netherlands; [Inagaki, S.] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan	van Berkel, M (reprint author), Natl Inst Fus Sci, 322 Oroshi Cho, Toki, Gifu 5095292, Japan.		Kyushu, RIAM/F-4018-2015		NWO-RFBR Centre-of-Excellence on Fusion Physics and Technology [047.018.002]	The first author is currently an international research fellow of the Japan Society for the Promotion of Science and hence wishes to express his gratitude to the JSPS for making this research possible. This work is also supported by NWO-RFBR Centre-of-Excellence on Fusion Physics and Technology (Grant No. 047.018.002).	Abramowitz M., 1976, HDB MATH FUNCTIONS F; JACCHIA A, 1991, PHYS FLUIDS B-PLASMA, V3, P3033, DOI 10.1063/1.859781; Curtain R, 2009, AUTOMATICA, V45, P1101, DOI 10.1016/j.automatica.2009.01.008; Bateman H., 1953, HIGHER TRANSCENDENTA; CARDOZO NJL, 1988, NUCL FUSION, V28, P1173, DOI 10.1088/0029-5515/28/7/002; Carslaw H. S., 1959, CONDUCTION HEAT SOLI, V1; Cuyt A., 2008, HDB CONTINUED FRACTI; Erdelyi A., 1956, ASYMPTOTIC EXPANSION; Eury SP, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2084887; FREDRICKSON ED, 1986, NUCL FUSION, V26, P849, DOI 10.1088/0029-5515/26/7/002; Jones W. B., 1980, CONTINUED FRACTIONS, V11; Ljung L, 1999, SYSTEM IDENTIFICATIO; CARDOZO NJL, 1995, PLASMA PHYS CONTR F, V37, P799, DOI 10.1088/0741-3335/37/8/001; Luke Y L, 1969, SPECIAL FUNCTIONS TH, V1; Pintelon R., 2012, SYSTEM IDENTIFICATIO; Polyanin A. D., 2003, HDB EXACT SOLUTIONS, V2; Slater L.J., 1960, CONFLUENT HYPERGEOME; SOLER M, 1979, NUCL FUSION, V19, P703, DOI 10.1088/0029-5515/19/6/002; van Berkel M, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/10/105004; van Berkel M, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4901311; van Berkel M., 2014, PHYS PLASMAS, V21; von Kamke E., 1959, DIFFERENTIALGLEICHUN	22	2	2	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	1070-664X	1089-7674		PHYS PLASMAS	Phys. Plasmas	NOV	2014	21	11							112508	10.1063/1.4901310		12	Physics, Fluids & Plasmas	Physics	AU5JZ	WOS:000345644200035		
J	Yambe, K; Hirano, Y; Sakakita, H; Koguchi, H				Yambe, Kiyoyuki; Hirano, Yoichi; Sakakita, Hajime; Koguchi, Haruhisa			Improved confinement region without large magnetohydrodynamic activity in TPE-RX reversed-field pinch plasma	PHYSICS OF PLASMAS			English	Article							TRANSPORT; FLUCTUATIONS; SINGLE; EDGE; TURBULENCE; SYSTEM; MODES; PARTICLE; STATES; SHEAR	We found that spontaneous improved confinement was brought about depending on the operating region in the Toroidal Pinch Experiment-Reversed eXperiment (TPE-RX) reversed-field pinch plasma [Y. Yagi et al., Fusion Eng. Des. 45, 421 (1999)]. Gradual decay of the toroidal magnetic field at plasma surface B-tw reversal makes it possible to realize a prolonged discharge, and the poloidal beta value and energy confinement time increase in the latter half of the discharge, where reversal and pinch parameters become shallow and low, respectively. In the latter half of the discharge, the plasma current and volume-averaged toroidal magnetic field < B-t > increase again, the electron density slowly decays, the electron temperature and soft X-ray radiation intensity increase, and the magnetic fluctuations are markedly reduced. In this period of improved confinement, the value of < B-t >-B-tw)/B-pw, where B-pw is the poloidal magnetic field at the plasma surface, stays almost constant, which indicates that the dynamo action occurs without large magnetohydrodynamic activities. (C) 2014 AIP Publishing LLC.	[Yambe, Kiyoyuki; Hirano, Yoichi; Sakakita, Hajime; Koguchi, Haruhisa] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058568, Japan	Yambe, K (reprint author), Niigata Univ, Niigata 9502181, Japan.				Budget for Nuclear Research of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science Core-to-Core Program [22001]	This study was financially supported by the Budget for Nuclear Research of the Ministry of Education, Culture, Sports, Science and Technology of Japan, based on the screening and counseling by the Atomic Energy Commission, and also in part by the Japan Society for the Promotion of Science Core-to-Core Program 22001.	Marrelli L, 2002, PHYS PLASMAS, V9, P2868, DOI 10.1063/1.1482766; Martin P, 2000, PHYS PLASMAS, V7, P1984, DOI 10.1063/1.874054; SARFF JS, 1994, PHYS REV LETT, V72, P3670, DOI 10.1103/PhysRevLett.72.3670; Antoni V, 1998, PHYS REV LETT, V80, P4185, DOI 10.1103/PhysRevLett.80.4185; BODIN HAB, 1980, NUCL FUSION, V20, P1255, DOI 10.1088/0029-5515/20/10/006; BRUNSELL PR, 1994, PHYS PLASMAS, V1, P2297, DOI 10.1063/1.870627; BRUNSELL PR, 1993, PHYS FLUIDS B-PLASMA, V5, P885, DOI 10.1063/1.860939; Carraro L, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073048; Chapman BE, 1998, PHYS REV LETT, V80, P2137, DOI 10.1103/PhysRevLett.80.2137; FIKSEL G, 1994, PHYS REV LETT, V72, P1028, DOI 10.1103/PhysRevLett.72.1028; FINN JM, 1992, PHYS FLUIDS B-PLASMA, V4, P1262, DOI 10.1063/1.860082; Frassinetti L, 2007, PLASMA PHYS CONTR F, V49, P199, DOI 10.1088/0741-3335/49/3/001; Hirano Y., 2001, J PLASMA FUSION RES, V77, P793; Hirano Y, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2118728; Hirano Y, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2405343; Hirano Y, 1996, NUCL FUSION, V36, P721, DOI 10.1088/0029-5515/36/6/I04; INGRAHAM JC, 1990, PHYS FLUIDS B-PLASMA, V2, P143, DOI 10.1063/1.859526; JI H, 1991, PHYS REV LETT, V67, P62, DOI 10.1103/PhysRevLett.67.62; Koguchi H., 2007, PLASMA FUSION RES, V2, DOI 10.1585/pfr.2.050; Koguchi H, 2004, REV SCI INSTRUM, V75, P4004, DOI 10.1063/1.1789606; Martini S, 1999, PLASMA PHYS CONTR F, V41, pA315, DOI 10.1088/0741-3335/41/3A/025; NORDLUND P, 1994, PHYS PLASMAS, V1, P4032, DOI 10.1063/1.870873; REMPEL TD, 1991, PHYS REV LETT, V67, P1438, DOI 10.1103/PhysRevLett.67.1438; Shinozaki K., 2006, J PLASMA FUSION RES, V7, P81; Yagi Y, 1999, FUSION ENG DES, V46, P47, DOI 10.1016/S0920-3796(99)00065-4; Yagi Y, 1999, FUSION ENG DES, V45, P421, DOI 10.1016/S0920-3796(99)00056-3; Yambe K, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3596540; Yambe K, 2004, J PHYS SOC JPN, V73, P907, DOI 10.1143/JPSJ.73.907	28	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	1070-664X	1089-7674		PHYS PLASMAS	Phys. Plasmas	NOV	2014	21	11							114502	10.1063/1.4901350		4	Physics, Fluids & Plasmas	Physics	AU5JZ	WOS:000345644200079		
J	Yu, Q; Gu, YJ; Li, XF; Huang, S; Zhang, F; Kong, Q; Ma, YY; Kawata, S				Yu, Q.; Gu, Y. J.; Li, X. F.; Huang, S.; Zhang, F.; Kong, Q.; Ma, Y. Y.; Kawata, S.			Controllable high-quality electron beam generation by phase slippage effect in layered targets	PHYSICS OF PLASMAS			English	Article							LASER-PULSES; ACCELERATOR; PLASMAS	The bubble structure generated by laser-plasma interactions changes in size depending on the local plasma density. The self-injection electrons' position with respect to wakefield can be controlled by tailoring the longitudinal plasma density. A regime to enhance the energy of the wakefield accelerated electrons and to improve the beam quality is proposed and achieved using layered plasmas with increasing densities. Both the wakefield size and the electron bunch duration are significantly contracted in this regime. The electrons remain in the strong acceleration phase of the wakefield, while their energy spread decreases because of their tight spatial distribution. An electron beam of 0.5 GeV with less than 1% energy spread is obtained through 2.5D particle-in-cell simulations. (C) 2014 AIP Publishing LLC.	[Yu, Q.; Gu, Y. J.; Li, X. F.; Huang, S.; Zhang, F.; Kong, Q.] Fudan Univ, Inst Modern Phys, Appl Ion Beam Phys Lab, Key Lab,Minist Educ, Shanghai 200433, Peoples R China; [Gu, Y. J.] ASCR, Inst Phys, ELI Beamlines Project, Prague 18221, Czech Republic; [Ma, Y. Y.] Natl Univ Def Technol, Coll Sci, Changsha 410073, Hunan, Peoples R China; [Kawata, S.] Utsunomiya Univ, Dept Adv Interdisciplinary Sci, Utsunomiya, Tochigi 3218585, Japan	Kong, Q (reprint author), Fudan Univ, Inst Modern Phys, Appl Ion Beam Phys Lab, Key Lab,Minist Educ, Shanghai 200433, Peoples R China.	qkong@fudan.edu.cn	Gu, Yanjun/G-5767-2014	Gu, Yanjun/0000-0002-6234-8489	NSFC [11175048]; SNSF [11ZR1402700]; Shanghai Scientific Research Innovation Key Projects [12ZZ011]; Shanghai Leading Academic Discipline Project [B107]; JSPS-CAS CUP Program; CORE of Utsunomiya University; Czech Science Foundation [CZ.1.07/2.3.00/20.0279]; ELI [CZ.1.05/1.1.00/02.0061]	This work was partly supported by NSFC (No. 11175048), the SNSF (No. 11ZR1402700), and Shanghai Scientific Research Innovation Key Projects No. 12ZZ011. Support from Shanghai Leading Academic Discipline Project B107, the JSPS-CAS CUP Program, and the CORE of Utsunomiya University is also acknowledged. The project benefited from the support of the Czech Science Foundation (Project No. CZ.1.07/2.3.00/20.0279) and from ELI (Project No. CZ.1.05/1.1.00/02.0061).	Mangles SPD, 2004, NATURE, V431, P535, DOI 10.1038/nature02939; SPRANGLE P, 1988, APPL PHYS LETT, V53, P2146, DOI 10.1063/1.100300; Esarey E, 1997, IEEE J QUANTUM ELECT, V33, P1879, DOI 10.1109/3.641305; Lu W, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.165002; Sprangle P, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.056405; BORISOV AB, 1992, PHYS REV A, V45, P5830, DOI 10.1103/PhysRevA.45.5830; TAJIMA T, 1979, PHYS REV LETT, V43, P267, DOI 10.1103/PhysRevLett.43.267; Wang WM, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4765056; Chien TY, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.115003; SUN GZ, 1987, PHYS FLUIDS, V30, P526, DOI 10.1063/1.866349; Vieira J, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.225001; Faure J, 2006, NATURE, V444, P737, DOI 10.1038/nature05393; Rittershofer W, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3430638; Esarey E, 2000, PHYS REV LETT, V84, P3081, DOI 10.1103/PhysRevLett.84.3081; Gorbunov L. M., 1987, Soviet Physics - JETP, V66; Kaganovich D, 1999, APPL PHYS LETT, V75, P772, DOI 10.1063/1.124508; KATSOULEAS T, 1986, PHYS REV A, V33, P2056, DOI 10.1103/PhysRevA.33.2056; Langdon A. B., 1976, METHODS COMPUTATIONA, V16, P327; Lehe R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.085005; Li FY, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.135002; Lu W, 2007, PHYS REV SPEC TOP-AC, V10, DOI 10.1103/PhysRevSTAB.10.061301; Pukhov A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.025401; Wen M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/045010; Yu LL, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.125001; Zhua X., 2010, REV SCI INSTRUM, V81	25	2	2	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	1070-664X	1089-7674		PHYS PLASMAS	Phys. Plasmas	NOV	2014	21	11							113106	10.1063/1.4901600		6	Physics, Fluids & Plasmas	Physics	AU5JZ	WOS:000345644200055		
J	Kamimura, Y; Usami, H				Kamimura, Yutaka; Usami, Hiroyuki			Determination of a nonlinearity from blow-up time	PROCEEDINGS OF THE JAPAN ACADEMY SERIES A-MATHEMATICAL SCIENCES			English	Article						Inverse problem; blow-up time; multiplicative Wiener-Hopf		We study an inverse problem to determine a nonlinearity of an autonomous equation from a blow-up time of solutions of the equation. A local well-posedness of the inverse problem near a nonlinearity of the type u(1+sigma), sigma > 0, is established. The paper also suggests that the inverse problem has a good, mathematical structure from a viewpoint of the Wiener-Hopf theory in integral equations.	[Kamimura, Yutaka] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Minato Ku, Tokyo 1088477, Japan; [Usami, Hiroyuki] Gifu Univ, Fac Engn, Appl Phys Course, Gifu 5011193, Japan	Kamimura, Y (reprint author), Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan.				JSPS KAKENHI [23540196, 26400159]	This research was supported by JSPS KAKENHI Grant Numbers 23540196, 26400159.	Iwasaki K., 1999, J INTEGRAL EQU APPL, V11, P461, DOI 10.1216/jiea/1181074295; Iwasaki K, 2001, J MATH BIOL, V43, P101, DOI 10.1007/s002850100096; KELLER JB, 1957, COMMUN PUR APPL MATH, V10, P503, DOI 10.1002/cpa.3160100402; Schwartz J.T., 1969, NONLINEAR FUNCTIONAL; Usami H., 1987, HIROSHIMA MATH J, V17, P175; USAMI H, 1992, J MATH ANAL APPL, V164, P59, DOI 10.1016/0022-247X(92)90145-4	6	0	0	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2194			P JPN ACAD A-MATH	Proc. Jpn. Acad. Ser. A-Math. Sci.	NOV	2014	90	9					127	132		10.3792/pjaa.90.127		6	Mathematics	Mathematics	AU9YE	WOS:000345946700001		
J	Tanaka, H				Tanaka, Hidekazu			Transcendence of special values of log double sine function	PROCEEDINGS OF THE JAPAN ACADEMY SERIES A-MATHEMATICAL SCIENCES			English	Article						Double sine function; transcendency; Catalan constant		In 2009 [4,5], S. Gun, M. R. Murty, P. Rath studied transcendental values of the logarithm of the gamma function. They showed that for any rational number x with 0 < x < 1/2 the number log Gamma(x) + log Gamma(1 - x) is transcendental with at most one possible exception. In this paper, we study transcendental values of log double sine function using their method.	Tokyo Inst Technol, Dept Math, Tokyo 1528551, Japan	Tanaka, H (reprint author), Tokyo Inst Technol, Dept Math, 2-12-1 Ookayama, Tokyo 1528551, Japan.						DENINGER C, 1992, INVENT MATH, V107, P135, DOI 10.1007/BF01231885; Baker A., 1975, TRANSCENDENTAL NUMBE; Barnes E.W., 1904, T CAMBRIDGE PHILOS S, V19, P374; Gun S, 2009, J NUMBER THEORY, V129, P2154, DOI 10.1016/j.jnt.2009.01.008; Koyama S, 2007, J NUMBER THEORY, V123, P204, DOI 10.1016/j.jnt.2006.07.010; Kurokawa N., 2004, KYUSHU J MATH, V58, P141, DOI 10.2206/kyushujm.58.141; Kurokawa N, 2003, FORUM MATH, V15, P839, DOI 10.1515/form.2003.042; Lerch M., 1894, ROZPRAVY CESKE AKAD, V3, P1	8	0	0	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2194			P JPN ACAD A-MATH	Proc. Jpn. Acad. Ser. A-Math. Sci.	NOV	2014	90	9					133	134		10.3792/pjaa.90.133		2	Mathematics	Mathematics	AU9YE	WOS:000345946700002		
J	Liang, X; Matano, H				Liang, Xing; Matano, Hiroshi			Maximizing the spreading speed of KPP fronts in two-dimensional stratified media	PROCEEDINGS OF THE LONDON MATHEMATICAL SOCIETY			English	Article							BIOLOGICAL INVASIONS; TRAVELING-WAVES; PROPAGATION; ENVIRONMENTS; DIFFUSION; MODELS	We consider the equation u(t) = u(xx) + u(yy) + b(x) f(u) + g(u), (x, y) is an element of R-2 with monostable nonlinearity, where b(x) is a nonnegative measure on R that is periodic in x, which, in the present context, is regarded as a measure on R2 that is homogeneous in y. In the case where b(x) is a smooth periodic function, it is known that, for each theta is an element of [0, 2 pi), there exists a value c*(theta; b) > 0 such that a 'planar' travelling wave propagating in direction. with average speed c exists if and only if c >= c*(theta; b). This value c*(theta; b) is called the 'minimal speed' in direction.. We first extend this result to the case where b is any nonnegative measure on R that is periodic with period, say, L > 0. We also verify that the known formula for the 'spreading speed' remains valid when b is a measure. Furthermore, we show that c*(theta; b) depends on. monotonically in a certain sense. We then study the question of maximizing c*(theta; b) by varying the measure b under the constraint integral([0,L)) b(x) dx = alpha L, where a is an arbitrarily given positive constant. We prove that the maximum is attained when b is equal to the measure h(x) := alpha L Sigma(k is an element of Z) delta(x + kL), where delta denotes Dirac's delta function on R. Note that this result holds regardless of the choice of theta is an element of[0, 2 pi). Next we focus on the case b = h and study the asymptotic shape of spreading fronts for large L and small L. Finally, we show that if we allow b to depend also on y, that is, if b(x, y) is a general two-dimensional measure that is periodic in x, y, then c*(theta; b) is no longer bounded from above as b varies under similar constraints. In fact, the equation u(t) = u(xx) + u(yy) + b(x, y) f(u) + g(u), (x, y) is an element of R-2 is not well-posed for some choices of b.	[Liang, Xing] Univ Sci & Technol China, Wu Wen Tsun Key Lab Math, Hefei 230026, Anhui, Peoples R China; [Liang, Xing] Univ Sci & Technol China, Sch Math Sci, Hefei 230026, Anhui, Peoples R China; [Matano, Hiroshi] Univ Tokyo, Grad Sch Math Sci, Tokyo 1538914, Japan	Liang, X (reprint author), Univ Sci & Technol China, Wu Wen Tsun Key Lab Math, Hefei 230026, Anhui, Peoples R China.	xliang@ustc.edu.cn; matano@ms.u-tokyo.ac.jp			NSFC [11171319]	The first author was supported by NSFC 11171319.	Alfaro M, 2008, J DIFFER EQUATIONS, V245, P505, DOI 10.1016/j.jde.2008.01.014; Kinezaki N, 2003, THEOR POPUL BIOL, V64, P291, DOI 10.1016/S0040-5809(03)00091-1; Berestycki H, 2005, J MATH PURE APPL, V84, P1101, DOI 10.1016/j.matpur.2004.10.006; ARONSON DG, 1978, ADV MATH, V30, P33, DOI 10.1016/0001-8708(78)90130-5; Hamel F, 2008, J MATH PURE APPL, V89, P355, DOI 10.1016/j.matpur.2007.12.005; Weinberger HF, 2002, J MATH BIOL, V45, P511, DOI 10.1007/s00285-002-0169-3; SHIGESADA N, 1986, THEOR POPUL BIOL, V30, P143, DOI 10.1016/0040-5809(86)90029-8; Xin J, 2000, SIAM REV, V42, P161, DOI 10.1137/S0036144599364296; Berestycki H, 2010, J AM MATH SOC, V23, P1; Berestycki H, 2002, COMMUN PUR APPL MATH, V55, P949, DOI 10.1002/cpa.3022; WEINBERGER HF, 1982, SIAM J MATH ANAL, V13, P353, DOI 10.1137/0513028; Berestycki H, 2005, J EUR MATH SOC, V7, P173; Aronson D G, 1975, LECT NOTES MATH, V446, P5; BREZIS H., 2010, FUNCTIONAL ANAL SOBO; Liang X, 2010, T AM MATH SOC, V362, P5605; Nadin G, 2010, SIAM J MATH ANAL, V41, P2388, DOI 10.1137/080743597; Shigesada N, 1997, BIOL INVASIONS THEOR; Volpert A.I., 1994, TRANSLATIONS MATH MO, V140; Yan P., 2012, ABSTR APPL ANAL, V2012, P1; Zhao X.-Q., 2003, DYNAMICAL SYSTEMS PO	20	0	0	LONDON MATH SOC	LONDON	MORGAN HOUSE, 57-58 RUSSELL SQ, LONDON WC1B 4HS, ENGLAND	0024-6115	1460-244X		P LOND MATH SOC	Proc. London Math. Soc.	NOV	2014	109		5				1137	1174		10.1112/plms/pdu031		38	Mathematics	Mathematics	AU8HE	WOS:000345836400002		
J	Wada, H; Matsumoto, T; Yamashita, Y				Wada, Hideo; Matsumoto, Takeshi; Yamashita, Yoshiki			Natural History of Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						TTP; TMA; aHUS; STEC-HUS; ADAMTS-13	VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; UPSHAW-SCHULMAN-SYNDROME; ESCHERICHIA-COLI; PLASMA-EXCHANGE; CLINICAL PRESENTATION; ADAMTS-13 DEFICIENCY; VONWILLEBRAND-FACTOR; FACTOR MULTIMERS; STEC-HUS	The differential diagnosis of thrombotic microangiopathy (TMA) has become clearer following the establishment of the relationships between (1) diarrhea-associated hemolytic uremic syndrome (HUS) and Shiga toxin-producing Escherichia coli-HUS (STEC-HUS), (2) a markedly reduced ADAMTS-13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) level and typical thrombotic thrombocytopenic purpura (TTP), and (3) abnormalities in the complement regulatory system and atypical HUS (aHUS). These TMAs include typical TTP, other forms of TMA, STEC-HUS, and aHUS. The pathological mechanisms of TMA still overlap among several forms of TMA. With respect to the management of TMA, the use of plasma exchange (PE) for typical TTP, additional steroid therapy for TMA and rituximab for typical TTP with a high titer of the inhibitor of ADAMTS-13, as well as eculizumab for aHUS, have also been established. Although several issues remain in the pathophysiology and management of TMA, new findings will hopefully resolve these problems in the near future.	[Wada, Hideo] Mie Univ, Grad Sch Med, Dept Mol & Lab Med, Tsu, Mie 5148507, Japan; [Matsumoto, Takeshi] Mie Univ, Grad Sch Med, Dept Blood Transfus, Tsu, Mie 5148507, Japan; [Yamashita, Yoshiki] Mie Univ, Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie 5148507, Japan	Wada, H (reprint author), Mie Univ, Grad Sch Med, Dept Mol & Lab Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	wadahide@clin.medic.mie-u.ac.jp			Japanese Ministry of Health, Labor and Welfare; Japanese Ministry of Education, Science, Sports and Culture	Our work is supported in part by research grants from the Japanese Ministry of Health, Labor and Welfare, and the Japanese Ministry of Education, Science, Sports and Culture.	ANAGNOU NP, 1991, HAEMATOLOGIA, V24, P101; Michael M, 2009, AM J KIDNEY DIS, V53, P259, DOI 10.1053/j.ajkd.2008.07.038; Arya M, 2002, BLOOD, V99, P3971, DOI 10.1182/blood-2001-11-0060; KARMALI MA, 1983, LANCET, V1, P619; Furlan M, 2001, BEST PRACT RES CL HA, V14, P437, DOI 10.1053/beha.2001.0142; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Cataland SR, 2012, AM J HEMATOL, V87, P430, DOI 10.1002/ajh.23106; Nishio K, 2004, P NATL ACAD SCI USA, V101, P10578, DOI 10.1073/pnas.0402041101; Fujimura Y, 2009, BRIT J HAEMATOL, V144, P742, DOI 10.1111/j.1365-2141.2008.07515.x; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Ray PE, 2001, PEDIATR NEPHROL, V16, P823; Fujimura Y, 2011, J THROMB HAEMOST, V9, P283, DOI 10.1111/j.1538-7836.2011.04341.x; Caprioli J, 2006, BLOOD, V108, P1267, DOI 10.1182/blood-2005-10-007252; Turner N, 2014, SEMIN THROMB HEMOST, V40, P544, DOI 10.1055/s-0034-1383547; Tsai HM, 2010, INT J HEMATOL, V91, P1, DOI 10.1007/s12185-009-0476-1; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Noris M, 2012, NAT REV NEPHROL, V8, P622, DOI 10.1038/nrneph.2012.195; Trachtman H, 2012, NAT REV NEPHROL, V8, P658, DOI 10.1038/nrneph.2012.196; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Noris M, 2010, CLIN J AM SOC NEPHRO, V5, P1844, DOI 10.2215/CJN.02210310; Fremeaux-Bacchi V, 2008, BLOOD, V112, P4948, DOI 10.1182/blood-2008-01-133702; Beutin L, 2012, J FOOD PROTECT, V75, P408, DOI 10.4315/0362-028X.JFP-11-452; Besbas N, 2006, KIDNEY INT, V70, P423, DOI 10.1038/sj.ki.5001581; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Ono T, 2006, BLOOD, V107, P528, DOI 10.1182/blood-2005-03-1087; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200; Gerritsen HE, 2001, BLOOD, V98, P1654, DOI 10.1182/blood.V98.6.1654; Hofer J, 2014, SEMIN THROMB HEMOST, V40, P431, DOI 10.1055/s-0034-1375297; Terrell DR, 2005, J THROMB HAEMOST, V3, P1432, DOI 10.1111/j.1538-7836.2005.01436.x; Francis KK, 2007, ONCOLOGIST, V12, P11, DOI 10.1634/theoncologist.12-1-11; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Noris M, 2003, LANCET, V362, P1542, DOI 10.1016/S0140-6736(03)14742-3; Fujikawa K, 2001, BLOOD, V98, P1662, DOI 10.1182/blood.V98.6.1662; Spinale JM, 2013, PEDIATR NEPHROL, V28, P2097, DOI 10.1007/s00467-012-2383-6; Jacob S, 2012, SEMIN THROMB HEMOST, V38, P845, DOI 10.1055/s-0032-1328894; Levy GG, 2005, BLOOD, V106, P11, DOI 10.1182/blood-2004-10-4097; Veyradier A, 2004, J THROMB HAEMOST, V2, P424, DOI 10.1111/j.1538-7933.2004.00623.x; Zheng XL, 2004, BLOOD, V103, P4043, DOI 10.1182/blood-2003-11-4035; Fujimura Y, 2010, INTERNAL MED, V49, P7, DOI 10.2169/internalmedicine.49.2706; Ferrari S, 2007, BLOOD, V109, P2815, DOI 10.1182/blood-2006-02-006064; Feys HB, 2006, J THROMB HAEMOST, V4, P955, DOI 10.1111/j.1538-7836.2006.01833.x; Furlan M, 1996, BLOOD, V87, P4223; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Habe K, 2012, THROMB RES, V129, P598, DOI 10.1016/j.thromres.2011.10.011; Mele C, 2014, SEMIN IMMUNOPATHOL, V36, P399, DOI 10.1007/s00281-014-0416-x; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; Caprioli J, 2003, HUM MOL GENET, V12, P3385, DOI 10.1093/hmg/ddg363; Kielstein JT, 2012, NEPHROL DIAL TRANSPL, V27, P3807, DOI 10.1093/ndt/gfs394; TOROK TJ, 1995, AM J HEMATOL, V50, P84, DOI 10.1002/ajh.2830500203; Tsai HM, 1996, BLOOD, V87, P4235; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Froissart A, 2012, CRIT CARE MED, V40, P104, DOI 10.1097/CCM.0b013e31822e9d66; Kaplan BS, 1998, J AM SOC NEPHROL, V9, P1126; Soejima K, 2001, J BIOCHEM-TOKYO, V130, P475; Riedl M, 2014, SEMIN THROMB HEMOST, V40, P413, DOI 10.1055/s-0034-1376521; BELL WR, 1991, NEW ENGL J MED, V325, P398, DOI 10.1056/NEJM199108083250605; BURNS ER, 1982, BLOOD, V60, P1030; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; Egan JA, 2004, J CLIN APHERESIS, V19, P125, DOI 10.1002/jca.20016; George JN, 2004, SEMIN HEMATOL, V41, P60, DOI 10.1053/j.seminhematol.2003.10.001; George JN, 2006, J CLIN APHERESIS, V21, P49, DOI 10.1002/jca.20091; George JN, 2008, J CLIN APHERESIS, V23, P129, DOI 10.1002/jca.20169; Heinen Stefan, 2006, Hum Mutat, V27, P292, DOI 10.1002/humu.9408; Ito-Habe N, 2010, INT J HEMATOL, V92, P68, DOI 10.1007/s12185-010-0599-4; Johnson K K, 2006, BLOOD, V108, P31; Kavanagh D, 2008, MOL IMMUNOL, V45, P95, DOI 10.1016/j.molimm.2007.05.004; Matsumoto M, 2004, BLOOD, V103, P1305, DOI 10.1182/blood-2003-06-1796; Matsumoto M, 2004, SEMIN HEMATOL, V41, P68, DOI 10.1053/j.seminhematol.2003.10.009; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; Mody RK, 2012, ARCH PEDIAT ADOL MED, V166, P902, DOI 10.1001/archpediatrics.2012.471; Mori Y, 2002, TRANSFUSION, V42, P572, DOI 10.1046/j.1537-2995.2002.00100.x; NEAME PB, 1980, SEMIN THROMB HEMOST, V6, P416, DOI 10.1055/s-2007-1005113; Nguyen TC, 2007, HAEMATOL-HEMATOL J, V92, P121, DOI 10.3324/haematol.10262; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; Rock GA, 2000, BRIT J HAEMATOL, V109, P496, DOI 10.1046/j.1365-2141.2000.01941.x; Scully M, 2012, BRIT J HAEMATOL, V158, P323, DOI 10.1111/j.1365-2141.2012.09167.x; SHUMAK KH, 1995, ANN INTERN MED, V122, P569; SIDDIQUI FA, 1985, J CLIN INVEST, V76, P1330, DOI 10.1172/JCI112107; Sun Ling, 2014, Zhonghua Xue Ye Xue Za Zhi, V35, P147, DOI 10.3760/cma.j.issn.0253-2727.2014.02.019; Takahashi N, 2013, THROMB RES, V131, P225, DOI 10.1016/j.thromres.2012.12.002; Tsai H M, 2001, Clin Lab, V47, P387; Tsai HM, 2006, KIDNEY INT, V70, P16, DOI 10.1038/sj.ki.5001535; Tsai HM, 2002, J MOL MED-JMM, V80, P639, DOI 10.1007/s00109-002-0369-8; Uemura M, 2008, THROMB HAEMOSTASIS, V99, P1019, DOI 10.1160/TH08-01-0006; UPSHAW JD, 1978, NEW ENGL J MED, V298, P1350, DOI 10.1056/NEJM197806152982407; Veyradier A, 2003, J PEDIATR-US, V142, P310, DOI 10.1067/mpd.2003.79; Wada H, 2013, J THROMB HAEMOST, V11, P761, DOI DOI 10.1111/JTH.12155; WAGNER DD, 1993, THROMB HAEMOSTASIS, V70, P105; Walport MJ, 2001, NEW ENGL J MED, V344, P1058; WEHINGER H, 1968, KLIN WOCHENSCHR, V46, P874, DOI 10.1007/BF01746247; WU KK, 1985, J CLIN INVEST, V75, P168, DOI 10.1172/JCI111670; Wurzner R, 2014, SEMIN THROMB HEMOST, V40, P508, DOI 10.1055/s-0034-1375298	94	1	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.	NOV	2014	40	8					866	873		10.1055/s-0034-1395154		8	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	AU6DM	WOS:000345693000009		
J	Fuchiwaki, Y; Nagai, H				Fuchiwaki, Yusuke; Nagai, Hidenori			Study of a Liquid Plug-Flow Thermal Cycling Technique Using a Temperature Gradient-Based Actuator	SENSORS			English	Article						thermal cycling; DNA amplification; PCR; microfluidics	DNA AMPLIFICATION; ANALYSIS SYSTEM	Easy-to-use thermal cycling for performing rapid and small-volume DNA amplification on a single chip has attracted great interest in the area of rapid field detection of biological agents. For this purpose, as a more practical alternative to conventional continuous flow thermal cycling, liquid plug-flow thermal cycling utilizes a thermal gradient generated in a serpentine rectangular flow microchannel as an actuator. The transit time and flow speed of the plug flow varied drastically in each temperature zone due to the difference in the tension at the interface between temperature gradients. According to thermal distribution analyses in microfluidics, the plug flow allowed for a slow heating process, but a fast cooling process. The thermal cycle of the microfluid was consistent with the recommended temperature gradient for PCR. Indeed, amplification efficiency of the plug flow was superior to continuous flow PCR, and provided an impressive improvement over previously-reported flow microchannel thermal cycling techniques.	[Fuchiwaki, Yusuke] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa 7610395, Japan; [Fuchiwaki, Yusuke] CEA LETI, F-38054 Grenoble 9, France; [Nagai, Hidenori] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Ikeda, Osaka 5638577, Japan	Fuchiwaki, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, 2217-14 Hayashi Cho, Takamatsu, Kagawa 7610395, Japan.	yu-fuchiwaki@aist.go.jp; hide.nagai@aist.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24710146]	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24710146).	Lagally ET, 2000, SENSOR ACTUAT B-CHEM, V63, P138, DOI 10.1016/S0925-4005(00)00350-6; Fukuba T, 2004, CHEM ENG J, V101, P151, DOI 10.1016/j.cej.2003.11.016; Obeid PJ, 2003, ANAL CHIM ACTA, V494, P1, DOI 10.1016/S0003-2670(03)00898-5; Zhang CS, 2007, NUCLEIC ACIDS RES, V35, P4223, DOI 10.1093/nar/gkm389; Belgrader P, 2003, ANAL CHEM, V75, P3446, DOI 10.1021/ac034062u; Ferrance JP, 2003, ANAL CHIM ACTA, V500, P223, DOI 10.1016/j.aca.2003.08.067; Martin U. K., 1998, SCIENCE, V280, P1046; Nakayama T, 2010, ANAL BIOANAL CHEM, V396, P457, DOI 10.1007/s00216-009-3160-7; Schneegass I, 2001, REV MOL BIOTECHNOL, V82, P101, DOI 10.1016/S1389-0352(01)00033-2	9	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	NOV	2014	14	11					20235	20244		10.3390/s141120235		10	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	AU4ES	WOS:000345562800016		
J	Liu, YL; Goda, R; Samata, K; Kanda, A; Hu, N; Zhang, JY; Ning, HM; Wu, LK				Liu, Yaolu; Goda, Riu; Samata, Kiyoshi; Kanda, Atsushi; Hu, Ning; Zhang, Jianyu; Ning, Huiming; Wu, Liangke			An Efficient Algorithm Embedded in an Ultrasonic Visualization Technique for Damage Inspection Using the AE Sensor Excitation Method	SENSORS			English	Article						visualization technique; Lamb waves; kinetic energy; diagnostic image	LAMB WAVES; IDENTIFICATION	To improve the reliability of a Lamb wave visualization technique and to obtain more information about structural damages (e.g., size and shape), we put forward a new signal processing algorithm to identify damage more clearly in an inspection region. Since the kinetic energy of material particles in a damaged area would suddenly change when ultrasonic waves encounter the damage, the new algorithm embedded in the wave visualization technique is aimed at monitoring the kinetic energy variations of all points in an inspection region to construct a damage diagnostic image. To validate the new algorithm, three kinds of surface damages on the center of aluminum plates, including two non-penetrative slits with different depths and a circular dent, were experimentally inspected. From the experimental results, it can be found that the new algorithm can remarkably enhance the quality of the diagnostic image, especially for some minor defects.	[Liu, Yaolu; Kanda, Atsushi; Hu, Ning; Zhang, Jianyu; Ning, Huiming; Wu, Liangke] Chongqing Univ, Coll Aerosp Engn, Chongqing 400044, Peoples R China; [Goda, Riu; Hu, Ning] Chiba Univ, Dept Mech Engn, Chiba 2638522, Japan; [Samata, Kiyoshi] JAL Engn Co Ltd, Tokyo 1440041, Japan; [Kanda, Atsushi] Japan Aerosp Explorat Agcy, Tokyo 1810015, Japan	Hu, N (reprint author), Chongqing Univ, Coll Aerosp Engn, Chongqing 400044, Peoples R China.	liuyl28@163.com; r.goda@chiba-u.jp; kiyoshi.samata@jal.com; kanda@chofu.jaxa.jp; ninghu@cqu.edu.cn; jyzhang@vip.126.com; ninghuiming@gmail.com; zdliangke@163.com			JAXA (Japan Aerospace Exploration Agency, Japan) [JX-PSPC-386770]	This work is partially supported by the Research Fund from JAXA (Japan Aerospace Exploration Agency, Japan) (JX-PSPC-386770).	Morii M, 2011, CMC-COMPUT MATER CON, V26, P37; Horan P, 2013, NDT&E INT, V55, P21, DOI 10.1016/j.ndteint.2013.01.004; Drinkwater BW, 2006, NDT&E INT, V39, P525, DOI 10.1016/j.ndteint.2006.03.006; Mian A, 2004, COMPOS SCI TECHNOL, V64, P657, DOI 10.1016/j.compscitech.2003.07.005; Yashiro S, 2007, COMPOS SCI TECHNOL, V67, P3202, DOI 10.1016/j.compscitech.2007.04.006; Dattoma V, 2001, NDT&E INT, V34, P515, DOI 10.1016/S0963-8695(00)00082-7; Honda T., 2007, RELIAB ENG ASS JPN, V29, P350; Hu N, 2008, COMPOS SCI TECHNOL, V68, P1548, DOI 10.1016/j.compscitech.2007.10.015; Jeong HJ, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/6/064301; Li DS, 2012, SENSORS-BASEL, V12, P9502, DOI 10.3390/s120709502; Li FC, 2006, SMART MATER STRUCT, V15, P1585, DOI 10.1088/0964-1726/15/6/010; Liu YL, 2014, SENSORS-BASEL, V14, P1902, DOI 10.3390/s140201902; Miao XT, 2011, J INTEL MAT SYST STR, V22, P1983, DOI 10.1177/1045389X11421821; Takatsubo J., 2006, T JPN SOC MECH ENG A, V72, P945; Yashiro S., 2008, J JPN SOC COMPOS MAT, V34, P60; Zhang HY, 2010, CHINESE PHYS LETT, V27, DOI 10.1088/0256-307X/27/10/104301; Zhou C, 2011, MECH SYST SIGNAL PR, V25, P2135, DOI 10.1016/j.ymssp.2011.02.001	17	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	NOV	2014	14	11					20439	20450		10.3390/s141120439		12	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	AU4ES	WOS:000345562800029		
J	Fuchiwaki, Y; Tanaka, M; Makita, Y; Ooie, T				Fuchiwaki, Yusuke; Tanaka, Masato; Makita, Yoji; Ooie, Toshihiko			New Approach to a Practical Quartz Crystal Microbalance Sensor Utilizing an Inkjet Printing System	SENSORS			English	Article						QCM; inkjet print; inexpensive	IMMUNOSENSOR; FLOW; QCM; LIQUID	The present work demonstrates a valuable approach to developing quartz crystal microbalance (QCM) sensor units inexpensively for reliable determination of analytes. This QCM sensor unit is constructed by inkjet printing equipment utilizing background noise removal techniques. Inkjet printing equipment was chosen as an alternative to an injection pump in conventional flow-mode systems to facilitate the commercial applicability of these practical devices. The results demonstrate minimization of fluctuations from external influences, determination of antigen-antibody interactions in an inkjet deposition, and quantification of C-reactive protein in the range of 50-1000 ng.mL(-1). We thus demonstrate a marketable application of an inexpensive and easily available QCM sensor system.	[Fuchiwaki, Yusuke; Tanaka, Masato; Makita, Yoji; Ooie, Toshihiko] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa 7610395, Japan; [Fuchiwaki, Yusuke] MINATEC, CEA LETI, F-38054 Grenoble 9, France	Fuchiwaki, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, 2217-14 Hayashi Cho, Takamatsu, Kagawa 7610395, Japan.	yu-fuchiwaki@aist.go.jp; mst-tanaka@aist.go.jp; y-makita@aist.go.jp; toshihiko-ooie@aist.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24710146]; Amada Foundation for Laser Processing	This work was supported by the Amada Foundation for Laser Processing and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 24710146).	Abe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053620; Lucklum R, 2006, ANAL BIOANAL CHEM, V384, P667, DOI 10.1007/s00216-005-0236-x; Desai S, 2010, MATER SCI ENG B-ADV, V168, P127, DOI 10.1016/j.mseb.2009.11.006; Ferreira NS, 2014, BIOSENS BIOELECTRON, V53, P193, DOI 10.1016/j.bios.2013.09.056; Michalzik M, 2005, SENSOR ACTUAT B-CHEM, V111, P410, DOI 10.1016/j.snb.2005.03.048; Kim JD, 2010, POLYMER, V51, P2147, DOI 10.1016/j.polymer.2010.03.038; Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011; Zheng QA, 2011, ANAL BIOCHEM, V410, P171, DOI 10.1016/j.ab.2010.10.024; Setti L, 2005, BIOSENS BIOELECTRON, V20, P2019, DOI 10.1016/j.bios.2004.09.022; Abe K, 2008, ANAL CHEM, V80, P6928, DOI 10.1021/ac800604v; Bianco M, 2013, BIOSENS BIOELECTRON, V42, P646, DOI 10.1016/j.bios.2012.10.012; Fuchiwaki Y, 2014, SENSOR ACTUAT A-PHYS, V219, P1, DOI 10.1016/j.sna.2014.08.010; Fuchiwaki Y, 2012, ANAL LETT, V45, P262, DOI 10.1080/00032719.2011.633180; Lee YG, 2005, TALANTA, V65, P1335, DOI 10.1016/j.talanta.2004.09.011; Liao H., 2014, LIPIDS HLTH DIS, V13, P1; Lieberzeit PA, 2009, SENSORS-BASEL, V9, P9805, DOI 10.3390/s91209805; Nicolini C, 2012, SENSORS-BASEL, V12, P17112, DOI 10.3390/s121217112; Seidler K, 2009, SENSORS-BASEL, V9, P8146, DOI 10.3390/s91008146; Umezu S, 2011, SENSOR ACTUAT A-PHYS, V166, P251, DOI 10.1016/j.sna.2009.12.004; Wessels A, 2013, SENSORS-BASEL, V13, P12012, DOI 10.3390/s130912012; Yatsushiro S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018807	21	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	NOV	2014	14	11					20468	20479		10.3390/s141120468		12	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	AU4ES	WOS:000345562800031		
J	Harun, NH; Misron, N; Sidek, RM; Aris, I; Wakiwaka, H; Tashiro, K				Harun, Noor Hasmiza; Misron, Norhisam; Sidek, Roslina Mohd; Aris, Ishak; Wakiwaka, Hiroyuki; Tashiro, Kunihisa			Dual Resonant Frequencies Effects on an Induction-Based Oil Palm Fruit Sensor	SENSORS			English	Article						induction; resonant frequency; air coil; oil palm; frequency characteristics; maturity classification; inductive concepts	COLOR-VISION SYSTEM; RIPENESS CLASSIFICATION; BUNCHES	As the main exporter in the oil palm industry, the need to improve the quality of palm oil has become the main interest among all the palm oil millers in Malaysia. To produce good quality palm oil, it is important for the miller to harvest a good oil palm Fresh Fruit Bunch (FFB). Conventionally, the main reference used by Malaysian harvesters is the manual grading standard published by the Malaysian Palm Oil Board (MPOB). A good oil palm FFB consists of all matured fruitlets, aged between 18 to 21 weeks of antheses (WAA). To expedite the harvesting process, it is crucial to implement an automated detection system for determining the maturity of the oil palm FFB. Various automated detection methods have been proposed by researchers in the field to replace the conventional method. In our preliminary study, a novel oil palm fruit sensor to detect the maturity of oil palm fruit bunch was proposed. The design of the proposed air coil sensor based on the inductive sensor was further investigated mainly in the context of the effect of coil diameter to improve its sensitivity. In this paper, the sensitivity of the inductive sensor was further examined with a dual flat-type shape of air coil. The dual air coils were tested on fifteen samples of fruitlet from two categories, namely ripe and unripe. Samples were tested within 20 Hz to 10 MHz while evaluations on both peaks were done separately before the gap between peaks was analyzed. A comparative analysis was conducted to investigate the improvement in sensitivity of the induction-based oil palm fruit sensor as compared to previous works. Results from the comparative study proved that the inductive sensor using a dual flat-type shape air coil has improved by up to 167%. This provides an indication in the improvement in the coil sensitivity of the palm oil fruit sensor based on the induction concept.	[Harun, Noor Hasmiza; Misron, Norhisam; Sidek, Roslina Mohd; Aris, Ishak] Univ Putra Malaysia, Fac Engn, Serdang 43400, Selangor, Malaysia; [Misron, Norhisam] Univ Putra Malaysia, Inst Adv Technol ITMA, Serdang 43400, Selangor, Malaysia; [Harun, Noor Hasmiza] Univ Kuala Lumpur, British Malaysian Inst, Gombak 53100, Selangor, Malaysia; [Wakiwaka, Hiroyuki; Tashiro, Kunihisa] Shinshu Univ, Fac Engn, Nagano 3808553, Japan	Misron, N (reprint author), Univ Putra Malaysia, Fac Engn, Serdang 43400, Selangor, Malaysia.	noorhasmiza@unikl.edu.my; norhisam@upm.edu.my; roslinams@upm.edu.my; ishak_ar@upm.edu.my; wakiwak@shinshu-u.ac.jp; tashiro@shinshu-u.ac.jp			University Putra Malaysia	The authors would like to thank Norhisam Misron, from University Putra Malaysia, for his technical support during the induction-based oil palm fruit sensor fabrication, data analysis and correction and improvement of the manuscript. The authors would also like to acknowledge the University Putra Malaysia, for its financial support, and the Institute of Advanced Technology, the University Putra Malaysia and the Shinshu University, Nagano Japan for their collaboration.	Abbas Z, 2005, IEEE SENS J, V5, P1281, DOI 10.1109/JSEN.2005.859249; Abdullah MZ, 2001, FOOD BIOPROD PROCESS, V79, P223, DOI 10.1205/096030801753252298; Abdullah MZ, 2002, J FOOD PROCESS PRES, V26, P213, DOI 10.1111/j.1745-4549.2002.tb00481.x; Alfatni Meftah Salem M, 2008, Journal of Applied Sciences, V8, DOI 10.3923/jas.2008.1444.1452; Alfatni M.S.M., 2007, P 7 SAUD ENG C KING, P299; Jamil N, 2009, 2009 INTERNATIONAL CONFERENCE OF SOFT COMPUTING AND PATTERN RECOGNITION, P245, DOI 10.1109/SoCPaR.2009.57; Fadilah N, 2012, SENSORS-BASEL, V12, P14179, DOI 10.3390/s121014179; Asif I.Z., 2013, J FOOD ENG, V116, P515; Balasundram S. K., 2006, Journal of Plant Sciences, V1, P217; Bonnie T.Y.P., 2011, J OIL PALM RES, V23, P1055; Choong T.S.Y., 2006, INT J FOOD ENG, V2, P838; Harun NH, 2013, SENSORS-BASEL, V13, P2254, DOI 10.3390/s130202254; Hazir MHM, 2012, J FOOD ENG, V113, P534, DOI 10.1016/j.jfoodeng.2012.07.008; Ismail W. I. W., 2000, J OIL PALM RES, V12, P38; Ismail W.I.W., 2012, P WORLD MULT SYST CY, P168; Ismail W.I.W., 2009, ENG E T, V4, P56; Jaffar A., 2009, INT J MECH MECHATRON, V9, P18; Junkwon P., 2009, Agricultural Information Research, V18, P72, DOI 10.3173/air.18.72; Junkwon P., 2009, Agricultural Information Research, V18, P130, DOI 10.3173/air.18.130; Kalyana Sundram, 2003, Asia Pacific Journal of Clinical Nutrition, V12, P355; Khalid K., 2006, P INT RF MICR C RFM, P10; Khalid K.B., 1998, MEAS SCI TECHNOL, V9, P1191, DOI 10.1088/0957-0233/9/8/008; Khalid K.B., 2004, SUBSURF SENS TECHNOL, V5, P63; Malaysian Palm Oil Board, 2003, OIL PALM FRUIT GRAD; Misron N, 2014, SENSORS-BASEL, V14, P2431, DOI 10.3390/s140202431; Mohamad Saufi M.K., 2012, J FOOD AGRIC ENVIRON, V10, P620; Norhisam M, 2008, SENSOR ACTUAT A-PHYS, V147, P470, DOI 10.1016/j.sna.2008.05.033; Osama M.B.S., 2012, COMPUT ELECTRON AGR, V82, P55; Razali MH, 2011, J FOOD AGRIC ENVIRON, V9, P570; Shariff R., CORRELATION OIL CONT; Sharifudin M.S., 2010, INT J AGRIC BIOL, V12, P101; Siregar I.M., 1976, P MAL INT AGR OIL PA, P711; Tan C.H., 2009, FOOD CHEM, V113, P654; Tan YA, 2010, EUR J LIPID SCI TECH, V112, P838, DOI 10.1002/ejlt.201000020; Yeow YK, 2010, MEAS SCI REV, V10, P7, DOI 10.2478/v10048-010-0002.x; Zakaria Z., 1998, THESIS U PUTRA MALAY	36	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1424-8220			SENSORS-BASEL	Sensors	NOV	2014	14	11					21923	21940		10.3390/s141121923		18	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Chemistry; Electrochemistry; Instruments & Instrumentation	AU4ES	WOS:000345562800106		
J	Dadkhah, S; Abd Manaf, A; Hori, Y; Hassanien, AE; Sadeghi, S				Dadkhah, Sajjad; Abd Manaf, Azizah; Hori, Yoshiaki; Hassanien, Aboul Ella; Sadeghi, Somayeh			An effective SVD-based image tampering detection and self-recovery using active watermarking	SIGNAL PROCESSING-IMAGE COMMUNICATION			English	Article						SVD; Tamper localization; Self-recovery; Image security; Active watermarking	FRAGILE WATERMARKING; AUTHENTICATION; SCHEME; CODE	In this paper, an effective tamper detection and self-recovery algorithm based on singular value decomposition (SVD) is proposed. This method generates two distinct tamper detection keys based on the singular value decomposition of the image blocks. Each generated tamper detection and self-recovery key is distinct for each image block and is encrypted using a secret key. A random block-mapping sequence and three unique optimizations are employed to improve the efficiency of the proposed tamper detection and the robustness against various security attacks, such as collage attack and constant-average attack. To improve the proposed tamper localization, a mixed block-partitioning technique for 4 x 4 and 2 x 2 blocks is utilized. The performance of the proposed scheme and its robustness against various tampering attacks is analyzed. The experimental results demonstrate that the proposed tamper detection is superior in terms of tamper detection efficiency with a tamper detection rate higher than 99%, security robustness and self-recovery image quality for tamper ratio up to 55%. (C) 2014 Elsevier B.V. All rights reserved.	[Dadkhah, Sajjad] Univ Teknol Malaysia, Fac Comp, Kuala Lumpur 54100, Malaysia; [Abd Manaf, Azizah] Univ Teknol Malaysia, Adv Informat Sch, Kuala Lumpur 54100, Malaysia; [Hori, Yoshiaki] Saga Univ, Org Gen Educ, Saga 8408502, Japan; [Hassanien, Aboul Ella] Cairo Univ, Dept Informat Technol, Giza, Egypt; [Sadeghi, Somayeh] Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia	Dadkhah, S (reprint author), Univ Teknol Malaysia, Fac Comp, Kuala Lumpur 54100, Malaysia.	dsajjad2@live.utm.my; azizah07@ic.utm.my; horiyo@cc.saga-u.ac.jp; aboitcairo@fci-cu.edu.eg; ssomayeh@siswa.um.edu.my	Abdul Manaf, Azizah /M-5776-2015		Universiti Teknologi Malaysia; ERGS - Universiti Teknologi Malaysia (UTM) [4L043, R.K130000.7838.4L043]; Ministry of Higher Education (MOHE)	The authors would like to thank Universiti Teknologi Malaysia for their educational and financial support. This work is funded by the ERGS Grant under vote no. 4L043 which is supported by Universiti Teknologi Malaysia (UTM) (Grant no. R.K130000.7838.4L043) and the Ministry of Higher Education (MOHE).	Liu SH, 2007, APPL MATH COMPUT, V185, P869, DOI 10.1016/j.amc.2006.07.036; Rosales-Roldan L, 2013, SIGNAL PROCESS-IMAGE, V28, P69, DOI 10.1016/j.image.2012.11.006; Lin PL, 2005, PATTERN RECOGN, V38, P2519, DOI 10.1016/j.patcog.2005.02.007; Fridrich J, 2002, J ELECTRON IMAGING, V11, P262, DOI 10.1117/1.1459449; Chamlawi R, 2010, COMPUT ELECTR ENG, V36, P578, DOI 10.1016/j.compeleceng.2009.12.003; Holliman M, 2000, IEEE T IMAGE PROCESS, V9, P432, DOI 10.1109/83.826780; Zhang XP, 2011, IEEE T INF FOREN SEC, V6, P1223, DOI 10.1109/TIFS.2011.2159208; Lee TY, 2008, PATTERN RECOGN, V41, P3497, DOI 10.1016/j.patcog.2008.05.003; Chang CC, 2008, PATTERN RECOGN, V41, P654, DOI 10.1016/j.patcog.2007.06.003; Chang J.-D., 2013, 2013 IEEE INT S NEXT, P173; Chang CC, 2011, J SYST SOFTWARE, V84, P1462, DOI 10.1016/j.jss.2011.02.029; Dadkhah S., 2012, INT J COMPUT SCI ISS, V9; Dadkhah S., 2014, BIOINSPIRING CYBER S, P115; Hao L., IEICE T INF SYST, V91; Ho A. T., 2005, GEOSC REM SENS S 200, V2, P4; Huang SC, 2012, J MAR SCI TECH-TAIW, V20, P49; Lin ET, 2000, P SOC PHOTO-OPT INS, V3971, P152, DOI 10.1117/12.384969; Lin PL, 2001, J SYST SOFTWARE, V55, P261, DOI 10.1016/S0164-1212(00)00075-3; Patra B., IEEE INT S INT SIGN, P430; Qian Z., 2012, INT J COMPUT SCI ISS, V9; Shengbing C., 2010, J MULTIMED, V5; Tong XJ, 2013, SIGNAL PROCESS-IMAGE, V28, P301, DOI 10.1016/j.image.2012.12.003; Wang L.-J., 2013, INT J COMMUN, V2; Yang CW, 2010, SIGNAL PROCESS, V90, P331, DOI 10.1016/j.sigpro.2009.07.007; Zhao X, 2011, STUD COMPUT INTELL, V346, P139; Zhu SM, 2010, CHIN OPT LETT, V8, P661, DOI 10.3788/COL20100807.0661	26	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0923-5965	1879-2677		SIGNAL PROCESS-IMAGE	Signal Process.-Image Commun.	NOV	2014	29	10					1197	1210		10.1016/j.image.2014.09.001		14	Engineering, Electrical & Electronic	Engineering	AU9YW	WOS:000345948800013		
J	Tan, X; Sun, CM; Sirault, X; Furbank, R; Pham, TD				Tan, Xiao; Sun, Changming; Sirault, Xavier; Furbank, Robert; Pham, Than D.			Stereo matching using cost volume watershed and region merging	SIGNAL PROCESSING-IMAGE COMMUNICATION			English	Article						3D/stereo scene analysis; Stereo matching; Watershed segmentation; Region merging; Graph cuts	BELIEF PROPAGATION; LAYERED STEREO; GRAPH CUTS; ALGORITHM; SEGMENTATION; SURFACES	Segment based disparity estimation methods have been proposed in many different ways. Most of these studies are built upon the hypothesis that no large disparity jump exists within a segment. When this hypothesis does not hold, it is difficult for these methods to estimate disparities correctly. Therefore, these methods work well only when the images are initially over segmented but do not work well for under segmented cases. To solve this problem, we present a new segment based stereo matching method which consists of two algorithms: a cost volume watershed algorithm (CVW) and a region merging (RM) algorithm. For incorrectly under segmented regions where pixels on different objects are grouped into one segment, the CVW algorithm regroups the pixels on different objects into different segments and provides disparity estimation to the pixels in different segments accordingly. For unreliable and occluded regions, we merge them into neighboring reliable segments for robust disparity estimation. The comparison between our method and the current state-of-the-art methods shows that our method is very competitive and is robust particularly when the images are initially under segmented. Crown Copyright (C) 2014 Published by Elsevier B.V. All rights reserved.	[Tan, Xiao] Univ New S Wales, Canberra, ACT 2600, Australia; [Tan, Xiao; Sun, Changming] CSIRO Computat Informat, N Ryde, NSW 1670, Australia; [Sirault, Xavier; Furbank, Robert] CSIRO Plant Ind, Canberra, ACT 2601, Australia; [Pham, Than D.] Univ Aizu, Aizu Res Cluster Med Engn & Informat, Fukushima 9658580, Japan	Tan, X (reprint author), Univ New S Wales, Canberra, ACT 2600, Australia.		Sun, Changming/A-3276-2008; Sirault, Xavier/B-3014-2008; Furbank, Robert/A-1884-2010	Sun, Changming/0000-0001-5943-1989; Sirault, Xavier/0000-0002-4873-1844; 	China Scholarship Council; CSIRO's Transformational Biology Capability Platform	We thank Chao Zhang and Ran Su of the University of New South Wales (Australia) for their comments. Tan is partially supported by the China Scholarship Council. Sun is partially supported by the CSIRO's Transformational Biology Capability Platform. A preliminary conference version of this paper appeared in [32].	Zitnick CL, 2004, ACM T GRAPHIC, V23, P600, DOI 10.1145/1015706.1015766; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Hirschmuller H, 2008, IEEE T PATTERN ANAL, V30, P328, DOI 10.1109/TPAMl.2007.1166; MARR D, 1976, SCIENCE, V194, P283, DOI 10.1126/science.968482; Zitnick CL, 2007, INT J COMPUT VISION, V75, P49, DOI 10.1007/s11263-006-0018-8; KANADE T, 1994, IEEE T PATTERN ANAL, V16, P920, DOI 10.1109/34.310690; Bobick AF, 1999, INT J COMPUT VISION, V33, P181, DOI 10.1023/A:1008150329890; Geiger A, 2011, LECT NOTES COMPUT SC, V6492, P25, DOI 10.1007/978-3-642-19315-6_3; Klaus A, 2006, INT C PATT RECOG, P15; Lin MH, 2004, IEEE T PATTERN ANAL, V26, P1073, DOI 10.1109/TPAMI.2004.54; Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; Belhumeur PN, 1996, INT J COMPUT VISION, V19, P237, DOI 10.1007/BF00055146; De-Maeztu L, 2012, IEEE T PATTERN ANAL, V34, P410, DOI 10.1109/TPAMI.2011.192; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Hong L, 2004, PROC CVPR IEEE, P74; Zhang K, 2009, IEEE T CIRC SYST VID, V19, P1073, DOI 10.1109/TCSVT.2009.2020478; Fusiello A, 1997, PROC CVPR IEEE, P858, DOI 10.1109/CVPR.1997.609428; Woodford O, 2009, IEEE T PATTERN ANAL, V31, P2115, DOI [10.1109/TPAMI.2009.131, 10.1109/TPAMI.2009.91]; Sun J, 2005, PROC CVPR IEEE, P399; Sun J, 2003, IEEE T PATTERN ANAL, V25, P787; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; Bleyer M, 2010, PROC CVPR IEEE, P1570, DOI 10.1109/CVPR.2010.5539783; Yoon KJ, 2006, IEEE T PATTERN ANAL, V28, P650; Kim JC, 2005, PROC CVPR IEEE, P1075; Felzenszwalb PF, 2006, INT J COMPUT VISION, V70, P41, DOI 10.1007/s11263-006-7899-4; Baker S, 1998, PROC CVPR IEEE, P434, DOI 10.1109/CVPR.1998.698642; Beucher S., 1992, OPTICAL ENG, V12, P433; Bleyer M, 2004, IEEE IMAGE PROC, P2997; Cigla C, 2013, SIGNAL PROCESS-IMAGE, V28, P1072, DOI 10.1016/j.image.2013.04.001; COX IJ, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P733; Hirschmuller H., 2007, CVPR IEEE COMP SOC C, V1, P1; Ishikawa H., 1998, LNCS, V1406, P232; Okutomi M, 2002, INT J COMPUT VISION, V47, P261, DOI 10.1023/A:1014510328154; Tan X., 2012, IMAGE VISION COMPUT, P340; Tao H., 2001, INT C COMP VIS, V1, p532 ; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Wang L., 2011, IEEE C COMP VIS PATT, P3033; Wang Z., 2008, IEEE C COMP VIS PATT, P1; Yang Q, 2008, IEEE T PATTERN ANAL, V31, P492; Yang Q., 2008, BRIT MACH VIS C, P1	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0923-5965	1879-2677		SIGNAL PROCESS-IMAGE	Signal Process.-Image Commun.	NOV	2014	29	10					1232	1244		10.1016/j.image.2014.06.002		13	Engineering, Electrical & Electronic	Engineering	AU9YW	WOS:000345948800016		
J	Nakamura, R; Tanaka, Y; Ogata, A; Masakazu, N				Nakamura, Rikiya; Tanaka, Yoko; Ogata, Atsuhiko; Masakazu, Naruse			Scientific evidence by fluorescence spectrometry for safflower red on ancient Japanese textiles stored in the Shosoin Treasure House repository	STUDIES IN CONSERVATION			English	Article						Dye analysis; Safflower red; Excitation-emission matrix fluorescence spectrometry; Shosoin textile; Noninvasive analysis; Reflectance spectrometry	EMISSION; PIGMENTS; IDENTIFICATION; SPECTROSCOPY; CARTHAMIN; DYESTUFF; SPECTRUM; MEDIA; LIGHT; CLOTH	Shosoin textiles, handed down from the eighth century in Nara, Japan, have entranced many people with their beautiful colors made from natural dyes. Dye analysis of the Shosoin textiles, including the red carpet laid inside the workshop hall at the Todaiji Temple in Nara, used for the inauguration of the statue of the Great Buddha in the temple in 752 AD; a red undergarment and a gown with a tie-dyed design worn by craftsmen in the Todaiji Temple; and embroidered shoes belonging to Empress Komyo (701-760 AD), were conducted by excitation emission matrix fluorescence spectrometry equipped with a fiber optics probe. Comparison of the spectra to references identified safflower red (Carthamus tinctorius L.) in the red or orange areas on these original textiles. The spectrometry of the gown and the shoes offered the identification not only of safflower red but also of amur cork tree. This study finds these examples to be the oldest scientifically confirmed presence of safflower red on historic textiles at present.	[Nakamura, Rikiya; Tanaka, Yoko; Ogata, Atsuhiko; Masakazu, Naruse] Off Shosoin Treasure House, Nara, Japan	Nakamura, R (reprint author), Imperial Household Agcy, Off Shosoin Treasure House, Nara, Japan.	rikiya.nakamura@kunaicho.go.jp					Clementi C, 2008, APPL PHYS A-MATER, V92, P25, DOI 10.1007/s00339-008-4474-6; Clementi C, 2009, APPL SPECTROSC, V63, P1323, DOI 10.1366/000370209790109058; Romani A, 2010, ACCOUNTS CHEM RES, V43, P837, DOI 10.1021/ar900291y; Verri G, 2008, APPL SPECTROSC, V62, P1295, DOI 10.1366/000370208786822296; Nakamura R, 2009, ANAL CHEM, V81, P5691, DOI 10.1021/ac900428a; Degano I, 2009, APPL SPECTROSC REV, V44, P363, DOI 10.1080/05704920902937876; Nevin A, 2008, APPL PHYS A-MATER, V92, P69, DOI 10.1007/s00339-008-4460-z; Claro A, 2010, J CULT HERIT, V11, P27, DOI 10.1016/j.culher.2009.03.006; Cardon D., 2007, NATURAL DYES SOURCES; Cho MH, 2000, J AGR FOOD CHEM, V48, P3917, DOI 10.1021/jf99110138; Clementi C, 2007, ANAL CHIM ACTA, V596, P46, DOI 10.1016/j.aca.2007.05.036; de la Rie E.R., 1982, STUDIES CONSERVATION, V27, P1, DOI 10.2307/1505977; Degano I, 2011, J CULT HERIT, V12, P295, DOI 10.1016/j.culher.2011.02.003; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55; Hioki K, 2008, STUD CONSERV, V53, P131; Hofenk de Graaf J. H., 2004, COLORFUL ORIGINS CHE; Kojima M., 2003, J JAPAN SOC CONSERVA, V47, P21; Koren Z. C., 2001, DYES HIST ARCHAEOL, V16/17, P158; Lech K., 2009, ORG MASS SPECTROM, P365, DOI DOI 10.1002/9780470741917.CH13; Matsuda Y., 1997, J JAPAN SOC CONSERVA, V41, P54; Melo MJ, 2010, ACCOUNTS CHEM RES, V43, P857, DOI 10.1021/ar9001894; Mills J. S., 1994, ORGANIC CHEM MUSEUM; Mussak B., 2010, HDB NATURAL COLORANT; Naruse M., 2001, B OFFICE SHOSOIN TRE, V23, P61; Nevin A, 2006, ANAL CHIM ACTA, V573, P341, DOI 10.1016/j.aca.2006.01.027; OBARA H, 1979, CHEM LETT, P201, DOI 10.1246/cl.1979.201; Powe AM, 2010, ANAL CHEM, V82, P4865, DOI 10.1021/ac101131p; Sasaki Y, 2008, J JAPAN SOC CONSERVA, V53, P35; Schweppe H., 1986, ADV CHEM, V212, P153; SHIMOYAMA S, 1992, BUNSEKI KAGAKU, V41, P243; Shimoyama S, 1997, BUNSEKI KAGAKU, V46, P791; Takagi Y, 1970, B STUDY JAPANESE CUL, V21, P48; Taylor G., 1989, DYES HIST ARCHAEOLOG, V8, P70; Uemura R., 1959, B STUDY JAPANESE CUL, V11, P72; Wallert A., 1986, STUD CONSERV, V31, P145, DOI 10.2307/1506245; Wouters J., 1985, STUDIES CONSERVATION, V30, P119, DOI 10.2307/1505927; Wouters J, 2010, STUD CONSERV, V55, P186	37	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0039-3630	2047-0584		STUD CONSERV	Stud. Conserv.	NOV	2014	59	6					367	376		10.1179/2047058413Y.0000000082		10	Archaeology; Art; Chemistry, Applied; Chemistry, Analytical; Spectroscopy	Archaeology; Art; Chemistry; Spectroscopy	AU6SY	WOS:000345733200002		
J	Iida, S; Miyayama, T; Fisher, GL; Hammond, JS; Bryan, SR; Sanada, N				Iida, Shin-ichi; Miyayama, Takuya; Fisher, Gregory L.; Hammond, John S.; Bryan, Scott R.; Sanada, Noriaki			A new approach for determining accurate chemical distributions using in-situ GCIB cross-section imaging	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		organic depth profiling; accurate chemical distributions; in-situ GCIB cross-section imaging	CLUSTER ION-BEAMS	Time-of-flight secondary ion mass spectrometry (TOF-SIMS) has become widely used to characterize various kinds of materials, especially organic materials. It has recently become possible to investigate the molecular distributions underneath the surface using Ar-GCIB (gas cluster ion beam) depth profiling. It is an important new capability for practical use of TOF-SIMS because the subsurface and interface chemistry plays an important role in the performance of many products. However, it is difficult to obtain accurate chemical depth distributions using sputter depth profiling when the sample has a significant surface roughness and/or inhomogeneous structure. In order to resolve this problem, we proposed an approach to determine the accurate chemical distributions using GCIB cross-section imaging method. In this study, this approach was demonstrated for practical organic samples, and accurate chemical depth distributions were determined. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Iida, Shin-ichi; Sanada, Noriaki] ULVAC PHI Inc, Chigasaki, Kanagawa 2538522, Japan; [Miyayama, Takuya; Fisher, Gregory L.; Hammond, John S.; Bryan, Scott R.] Phys Elect Inc, Chanhassen, MN 55317 USA	Iida, S (reprint author), ULVAC PHI Inc, 370 Enzo, Chigasaki, Kanagawa 2538522, Japan.	shinichi_iida@ulvac.com					Miyayama T, 2010, SURF INTERFACE ANAL, V42, P1453, DOI 10.1002/sia.3675; Robinson MA, 2012, ANAL CHEM, V84, P4880, DOI 10.1021/ac300480g; Ninomiya S, 2009, RAPID COMMUN MASS SP, V23, P1601, DOI 10.1002/rcm.4046; Shard AG, 2012, ANAL CHEM, V84, P7865, DOI 10.1021/ac301567t; IIDA S, 2012, J SURF ANAL, V18, pA61; Muramoto S, 2011, SURF INTERFACE ANAL, V43, P58, DOI 10.1002/sia.3479; SCHUELER BW, 2013, TOF SIMS MAT ANAL MA, P247; WUCHER A, 2013, CLUSTER SECONDARY IO, P207; YAMADA I, 2011, MRS P, V1354, DOI DOI 10.1557/OPL.2011.1081	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		83	86		10.1002/sia.5595		4	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200022		
J	Kawashima, T; Kurosawa, T; Aoyagi, S; Sheraz, S; Fletcher, JS; Futigami, M; Lockyer, NP; Vickerman, JC				Kawashima, Tomoko; Kurosawa, Takako; Aoyagi, Satoka; Sheraz (nee Rabbani), Sadia; Fletcher, John S.; Futigami, Masayo; Lockyer, Nicholas P.; Vickerman, John C.			Examination of fragment ions of polystyrene in TOF-SIMS spectra using MS/MS	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		TOF-SIMS; MS/MS; collision induced dissociation; polystyrene; qualitative analysis		In this study, tendencies of ionization and cleavage processes of time-of-flight (TOF)-SIMS were examined using MS/MS, which enables an easy qualitative analysis of organic matters, to clarify the fragment ions showing structures of the organic materials. In this paper, a result of reviewing fragment ions in TOF-SIMS spectra for polystyrene (PS) as the representative material is shown. Samples were measured with collision induced dissociation (CID)-MS/MS of 1200L (Varian Inc., USA) and TOF-SIMS J105 (Ionoptika Ltd, UK) for the examination of fragment ions of the PS in TOF-SIMS spectra. The use of CID MS/MS with a wide range of energy distribution is effective for the study of the ionization and cleavage process of TOF-SIMS. As a result, the fragment ions representing the PS structure were clarified, which is useful for the material definition. The qualitative analysis was also applied to the fragment ions particularly obtained in this examination. It is suggested that the examination of the fragmentation process using MS/MS is useful for the mass spectra analysis of organic materials in TOF-SIMS. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Kawashima, Tomoko; Kurosawa, Takako; Futigami, Masayo] Panasonic Corp, Moriguchi, Osaka, Japan; [Aoyagi, Satoka] Seikei Univ, Dept Mat & Life Sci, Musashino, Tokyo, Japan; [Sheraz (nee Rabbani), Sadia; Lockyer, Nicholas P.; Vickerman, John C.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Fletcher, John S.] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	Kawashima, T (reprint author), Panasonic Corp, 3-4 Hikaridai, Seika, Kyoto 6190237, Japan.	hosokawa.tomoko@jp.panasonic.com		fletcher, john/0000-0002-9418-8571			Fletcher JS, 2008, ANAL CHEM, V80, P9058, DOI 10.1021/ac8015278; Hill R, 2011, SURF INTERFACE ANAL, V43, P506, DOI 10.1002/sia.3562; COOKS RG, 1995, J MASS SPECTROM, V30, P1215, DOI 10.1002/jms.1190300902; Fletcher JS, 2013, METABOLOMICS, V9, P535, DOI 10.1007/s11306-012-0487-4; LEGGETT GJ, 1992, SURF INTERFACE ANAL, V18, P210, DOI 10.1002/sia.740180306; Moritani K, 2011, SURF INTERFACE ANAL, V43, P241, DOI 10.1002/sia.3551	6	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		92	95		10.1002/sia.5548		4	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200024		
J	Nishinomiya, S; Toshin, K; Hayashi, S; Iuchi, K; Se, N; Moritani, K; Mochiji, K				Nishinomiya, S.; Toshin, K.; Hayashi, S.; Iuchi, K.; Se, N.; Moritani, K.; Mochiji, K.			TOF-SIMS study of polyester/melamine resin with Ar gas cluster ion beam	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		SIMS; Ar-GCIB; paint film; melamine self-condensation	PROJECTILES; SURFACE; FILMS	A pre-coated steel sheet for household electrical appliances needs to be highly formable and stain resistant. In recent years, secondary ion mass spectrometry (SIMS) with a time-of-flight (TOF) mass analyzer with an Ar gas cluster ion beam (Ar-GCIB) has been widely used as a structure analysis technology of organic molecules. In this paper, we looked into the effectiveness of Ar-GCIB-TOF-SIMS as a structure analysis technique of paint film. As a result, we could detect the trimer fragment ions of hexamethoxymethylmelamine in the range of m/z=400-800 for the first time for the spin-coating of HMMM on a Si wafer. By evaluation of characteristic monomer fragment ions, we could find out the different surface distributions of melamine-formaldehyde resin with the different formulations of paint films. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Nishinomiya, S.; Toshin, K.; Hayashi, S.] Nippon Steel & Sumitomo Met Corp, Futtsu, Chiba 2938511, Japan; [Iuchi, K.; Se, N.; Moritani, K.; Mochiji, K.] Univ Hyogo, Grad Sch Engn, Dept Mech & Syst Engn, Himeji, Hyogo 6712201, Japan	Nishinomiya, S (reprint author), Nippon Steel & Sumitomo Met Corp, 20-1 Shintomi, Futtsu, Chiba 2938511, Japan.	nishinomiya.6p8.suguru@jp.nssmc.com					Miyayama T, 2010, SURF INTERFACE ANAL, V42, P1453, DOI 10.1002/sia.3675; Ninomiya S, 2007, NUCL INSTRUM METH B, V256, P493, DOI 10.1016/j.nimb.2006.12.047; Moritani K, 2013, NUCL INSTRUM METH B, V315, P300, DOI 10.1016/j.nimb.2013.05.064; Gebhardt CR, 2009, ANGEW CHEM INT EDIT, V48, P4162, DOI 10.1002/anie.200804431; Matsuo J, 1997, NUCL INSTRUM METH B, V121, P459, DOI 10.1016/S0168-583X(96)00541-1; Good R. J., 1979, SURFACE COLLOID SCI, VII; Hiraoka K, 2011, SURF INTERFACE ANAL, V43, P236, DOI 10.1002/sia.3486; Kanai H., 1994, NIPPON STEEL TECHNIC, V63, P27; Kanai H, 1997, TETSU TO HAGANE, V83, P791; Leadley SR, 1998, SURF INTERFACE ANAL, V26, P444, DOI 10.1002/(SICI)1096-9918(19980515)26:6<444::AID-SIA387>3.0.CO;2-5; Moritani K, 2008, APPL SURF SCI, V255, P948, DOI 10.1016/j.apsusc.2008.05.010; Tanaka M, 2010, RAPID COMMUN MASS SP, V24, P1405, DOI 10.1002/rcm.4529; Terada T., 1992, PROG ORG COAT, V20, P81	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		100	104		10.1002/sia.5613		5	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200026		
J	Aoyagi, S; Kodani, N; Yano, A; Asao, T; Iwai, H; Kudo, M				Aoyagi, Satoka; Kodani, Noriko; Yano, Akira; Asao, Toshiki; Iwai, Hideo; Kudo, Masahiro			ToF-SIMS data analysis for complex plant tissue samples using multivariate analysis and G-SIMS	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		ToF-SIMS; G-SIMS; multivariate curve resolution; sinigrin; plant tissue	ION MASS-SPECTROMETRY; PROTEIN	Recently, controlled production of plants to enhance specific ingredients, such as sinigrin in Wasabi effective for antibacterial and anticancer, in the plants has become more important in order to use the ingredients efficiently. It is, however, difficult to develop a plant production method for controlling the sinigrin amount, because the sinigrin production mechanism is not clear. Therefore, it is crucial to evaluate distribution and metabolic pathways of sinigrin and related molecules in the wasabi tissue. Because time-of-flight (ToF)-SIMS provides molecular distributions of insulation samples including plant tissues on a submicron scale, it is useful for such a purpose. On the other hand, interpretation of intricate ToF-SIMS spectra of complex samples is often difficult. Recently, multivariate analysis techniques, such as principal component analysis and multivariate curve resolution, successfully applied into a variety of scientific fields have been also introduced into ToF-SIMS data. Moreover, gentle secondary ion mass spectrometry (G-SIMS), developed for analyzing static-SIMS spectra in terms of the degree of fragmentation, has recently been applied to various samples. In this study, sections of Wasabi petioles were evaluated with ToF-SIMS and the data analysis techniques to clarify the distribution of sinigrin molecule in the wasabi tissue. A combination of multivariate analysis and G-SIMS worked effectively to interpret the complex ToF-SIMS data of the plant tissue. As a result, the detailed distribution of sinigrin in the plant tissue was indicated by ToF-SIMS and the data analysis techniques. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Aoyagi, Satoka; Kodani, Noriko; Yano, Akira; Asao, Toshiki] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan; [Iwai, Hideo] Natl Inst Mat Sci, Mat Anal Stn, Tsukuba, Ibaraki 3050047, Japan; [Kudo, Masahiro] Seikei Univ, Fac Sci & Technol, Musashino, Tokyo 1808633, Japan	Aoyagi, S (reprint author), Seikei Univ, Fac Sci & Technol, 3-3-1 Kitamachi, Musashino, Tokyo 1808633, Japan.	aoyagi@st.seikei.ac.jp					Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t; Lara-Lledo M, 2012, INT J FOOD MICROBIOL, V156, P25, DOI 10.1016/j.ijfoodmicro.2012.02.018; Aoyagi S, 2013, SURF INTERFACE ANAL, V45, P264, DOI 10.1002/sia.4893; Aoyagi S, 2012, RAPID COMMUN MASS SP, V26, P2815, DOI 10.1002/rcm.6409; Aoyagi S, 2012, SURF INTERFACE ANAL, V44, P772, DOI 10.1002/sia.4822; Gilmore IS, 2000, APPL SURF SCI, V161, P465, DOI 10.1016/S0169-4332(00)00317-2; Grubb C. D., TRENDS PLANT SCI, V11, P89; Lee JLS, 2009, SURF INTERFACE ANAL, V41, P653, DOI 10.1002/sia.3070; Mihara I, 2013, SURF INTERFACE ANAL, V45, P453, DOI 10.1002/sia.5002	9	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		131	135		10.1002/sia.5588		5	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200033		
J	Tang, SS; Guillermier, C; Wang, M; Poczatek, JC; Suzuki, N; Loscalzo, J; Lechene, C				Tang, S. S.; Guillermier, C.; Wang, M.; Poczatek, J. C.; Suzuki, N.; Loscalzo, J.; Lechene, C.			Quantitative imaging of selenoprotein with multi-isotope imaging mass spectrometry (MIMS)	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		multi-isotope imaging mass spectrometry; MIMS; NanoSIMS; whole cell; section; selenoprotein turnover; [Se-82]-selenite; [Se-82]-selenite		Multi-isotope imaging mass spectrometry (MIMS) allows high-resolution quantitative imaging of protein and nucleic acid synthesis at the level of a single cell using stable isotope labels. We employed MIMS to determine the compartmental localization of selenoproteins tagged with stable isotope selenium compounds in human aortic endothelial cells (HAEC), and to compare the efficiency of labeling (to determine the ideal selenium source) from these compounds: [Se-82]-selenite, [Se-77]-seleno-methionine, and [Se-76]-methyl-selenocysteine. We found that all three selenium isotopes appear to be localized in the nucleus as well as in the cytoplasm. For MIMS detection, we compared freeze-drying to thin layer versus thin sectioning for sample preparation. MIMS provides a unique and novel way to dissect selenoprotein synthesis in cells. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Tang, S. S.; Loscalzo, J.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA; [Guillermier, C.; Wang, M.; Poczatek, J. C.; Lechene, C.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Guillermier, C.; Wang, M.; Poczatek, J. C.; Lechene, C.] NRIMS, Cambridge, MA USA; [Suzuki, N.] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba 2608675, Japan	Lechene, C (reprint author), Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA.	cpl@harvard.edu					ABRAHAM EH, 1985, AM J PHYSIOL, V248, pC154; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Ottaviano FG, 2009, MOL CELL BIOCHEM, V327, P111, DOI 10.1007/s11010-009-0049-x; LECHENE C, 1985, BIOL CELL, V55, P177; Peterson B. H., 1997, CANCER EPIDEM BIOMAR, V6, P63; Suzuki KT, 2006, J HEALTH SCI, V52, P590, DOI 10.1248/jhs.52.590; Suzuki KT, 2008, TOXICOL APPL PHARM, V227, P76, DOI 10.1016/j.taap.2007.10.001	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		154	157		10.1002/sia.5625		4	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200039		
J	Ide, Y; Waki, M; Ishizaki, I; Nagata, Y; Yamazaki, F; Hayasaka, T; Masaki, N; Ikegami, K; Kondo, T; Shibata, K; Ogura, H; Sanada, N; Setou, M				Ide, Yoshimi; Waki, Michihiko; Ishizaki, Itsuko; Nagata, Yasuyuki; Yamazaki, Fumiyoshi; Hayasaka, Takahiro; Masaki, Noritaka; Ikegami, Koji; Kondo, Takeshi; Shibata, Kiyoshi; Ogura, Hiroyuki; Sanada, Noriaki; Setou, Mitsutoshi			Single cell lipidomics of SKBR-3 breast cancer cells by using time-of-flight secondary-ion mass spectrometry	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		time-of-flight secondary-ion mass spectrometry (TOF-SIMS); single cell analysis; breast cancer; phospholipids; fatty acids	VISUALIZATION; LIPIDS; PHOSPHATIDYLCHOLINE; METABOLISM; DEPENDENCE; DIVISION; NEURONS; SIMS	Breast cancer is the most common cancer among women worldwide. The molecular characterization of breast tumor cells by using single-cell lipidomics remains relatively unexplored. Here, we introduce a time-of-flight secondary-ion mass spectrometry (TOF-SIMS) approach to visualize the lipids in individual breast cancer cells. The SKBR-3 breast cancer cell line was cultured and dispersed into individual cells. After attachment to a substrate, the cells were rinsed with ammonium acetate and were analyzed using TOF-SIMS. The instrument was operated with Bi-3(2+) as the primary ion. The distributions of ions, including positively charged phosphocholine, and negatively charged phosphates and fatty acids, were simultaneously visualized. These ions were distributed predominantly at the cell attachment sites. The signal intensities of fatty acid ions were determined from the mass spectra at the regions-of-interest. The results of fatty acid analyses on breast cancer cells were consistent with those of our previous study in which prominent expression of stearoyl-CoA desaturase 1 in breast cancer cells was demonstrated. Static TOF-SIMS was shown to be an effective method for determining the lipid molecular signature of the plasma membrane of individual breast cancer cells. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ide, Yoshimi; Waki, Michihiko; Nagata, Yasuyuki; Yamazaki, Fumiyoshi; Hayasaka, Takahiro; Masaki, Noritaka; Ikegami, Koji; Kondo, Takeshi; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Ide, Yoshimi; Ogura, Hiroyuki] Hamamatsu Univ Sch Med, Dept Surg 1, Hamamatsu, Shizuoka 4313192, Japan; [Ishizaki, Itsuko; Sanada, Noriaki] ULVAC PHI Inc, Chigasaki, Kanagawa, Japan; [Nagata, Yasuyuki] Hamamatsu Univ Sch Med, Ctr Oncol, Hamamatsu, Shizuoka 4313192, Japan; [Shibata, Kiyoshi] Hamamatsu Univ Sch Med, Equipment Ctr, Hamamatsu, Shizuoka 4313192, Japan	Setou, M (reprint author), Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	setou@hama-med.ac.jp		Waki, Michihiko/0000-0002-3754-9780			Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Yang HJ, 2012, J BIOL CHEM, V287, P5290, DOI 10.1074/jbc.M111.316877; Kurabe N, 2013, CANCER SCI, V104, P1295, DOI 10.1111/cas.12221; Roongta UV, 2011, MOL CANCER RES, V9, P1551, DOI 10.1158/1541-7786.MCR-11-0126; Yang HJ, 2010, SURF INTERFACE ANAL, V42, P1606, DOI 10.1002/sia.3581; Cillero-Pastor B, 2012, ANAL CHEM, V84, P8909, DOI 10.1021/ac301853q; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Rivenbark AG, 2013, AM J PATHOL, V183, P1113, DOI 10.1016/j.ajpath.2013.08.002; Sugiura Y, 2012, ANAL BIOANAL CHEM, V403, P1851, DOI 10.1007/s00216-012-5988-5; Passarelli MK, 2013, ANAL CHEM, V85, P2231, DOI 10.1021/ac303038j; Yoshimura Y, 2012, ANAL BIOANAL CHEM, V403, P1885, DOI 10.1007/s00216-012-5876-z; Enomoto H, 2011, ANAL BIOANAL CHEM, V400, P1913, DOI 10.1007/s00216-011-4924-4; Amantonico A, 2010, ANAL BIOANAL CHEM, V398, P2493, DOI 10.1007/s00216-010-3850-1; Bich C, 2013, ANAL CHEM, V85, P7745, DOI 10.1021/ac4009513; Boggio KJ, 2011, EXPERT REV PROTEOMIC, V8, P591, DOI [10.1586/epr.11.53, 10.1586/EPR.11.53]; Belu AM, 2003, BIOMATERIALS, V24, P3635, DOI 10.1016/S0142-9612(03)00159-5; Piwowar AM, 2013, SURF INTERFACE ANAL, V45, P302, DOI 10.1002/sia.4882; Lee ES, 2013, ATHEROSCLEROSIS, V226, P378, DOI 10.1016/j.atherosclerosis.2012.11.003; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Baritaki S, 2007, ADV CANCER RES, V98, P149, DOI 10.1016/S0065-230X(06)98005-1; Bandyopadhyay A, 2013, CHARACTERIZATION OF BIOMATERIALS, P1; Goto K, 2012, CHEMBIOCHEM, V13, P1103, DOI 10.1002/cbic.201200146; Goto-Inoue N, 2012, ANAL BIOANAL CHEM, V403, P1863, DOI 10.1007/s00216-012-5809-x; Hirano H., 2013, ANAL BIOANAL CHEM, V406, P1573; Ide Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061204; Ishikawa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048873; Ostrowski SG, 2005, ANAL CHEM, V77, P6190, DOI 10.1021/ac0508189; Rabbani S., 2013, ANAL CHEM, V85, P5654; SCHUELER BW, 1992, MICROSC MICROANAL M, V3, P119, DOI 10.1051/mmm:0199200302-3011900; Uchiyama Y., 2013, ANAL BIOANAL CHEM, V406, P1307; Waki ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026721	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		181	184		10.1002/sia.5523		4	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200046		
J	Nagata, Y; Ishizaki, I; Waki, M; Ide, Y; Hossen, MA; Ohnishi, K; Sanada, N; Setou, M				Nagata, Yasuyuki; Ishizaki, Itsuko; Waki, Michihiko; Ide, Yoshimi; Hossen, Md Amir; Ohnishi, Kazunori; Sanada, Noriaki; Setou, Mitsutoshi			Glutaraldehyde fixation method for single-cell lipid analysis by time-of-flight secondary ion-mass spectrometry	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		time-of-flight secondary ion-mass spectrometry (TOF-SIMS); single-cell analysis; multiple myeloma; glutaraldehyde fixation; phospholipids; fatty acids	PHOSPHATIDYLCHOLINE 16/0/16/1; CHEMICAL-COMPOSITION; MULTIPLE-MYELOMA; ANIMAL-CELLS; TOF-SIMS; VISUALIZATION; PROGRESSION; METABOLISM; SURVIVAL; NEURONS	Lipid metabolism has attracted much attention in tumor biology studies. Recently, time-of-flight secondary ion-mass spectrometry (TOF-SIMS) imaging has enabled in situ lipid analysis of biological specimens with a submicrometer spatial resolution for analyses of tumor cells. In clinical settings, sample preservation is important, and specimens are often obtained from patients at different times; these samples must be preserved prior to measurement, and preservation techniques commonly involve chemical fixation with aldehydes. However, the influence of sample preservation on TOF-SIMS analysis of fatty acids has not been reported. Thus, we examined the influence of glutaraldehyde fixation on TOF-SIMS analyses by using the multiple myeloma cell line U266. We prepared two indium-tin-oxide-coated glass slides on which cells were attached. One slide was fixed with 0.25% glutaraldehyde and rinsed in ammonium acetate buffer, whereas the other was left untreated. The specimens were subjected to TOF-SIMS analyses in negative-ion mode, and signals in the mass range of m/z 0-1850 were monitored. Both fixed and unfixed cells exhibited intense ion peaks corresponding to phosphoric acids and five types of fatty acids, putatively derived from membrane phospholipids. These ions were localized at the cell attachment site. We statistically compared the mean intensity of fatty acids between fixed and unfixed cells and found that both showed equivalent signals. Glutaraldehyde fixation was thus shown to be an effective method for preparing samples for single-cell lipid analysis by TOF-SIMS. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Nagata, Yasuyuki; Waki, Michihiko; Ide, Yoshimi; Hossen, Md Amir; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Nagata, Yasuyuki; Ohnishi, Kazunori] Hamamatsu Univ Sch Med, Ctr Oncol, Hamamatsu, Shizuoka 4313192, Japan; [Ishizaki, Itsuko; Sanada, Noriaki] ULVAC PHI Inc, Chigasaki, Kanagawa, Japan; [Ide, Yoshimi] Hamamatsu Univ Sch Med, Dept Surg 1, Hamamatsu, Shizuoka 4313192, Japan	Setou, M (reprint author), Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	setou@hama-med.ac.jp		Waki, Michihiko/0000-0002-3754-9780			Kumar SK, 2012, LEUKEMIA, V26, P149, DOI 10.1038/leu.2011.196; Yang HJ, 2012, J BIOL CHEM, V287, P5290, DOI 10.1074/jbc.M111.316877; Kurabe N, 2013, CANCER SCI, V104, P1295, DOI 10.1111/cas.12221; Yang HJ, 2010, SURF INTERFACE ANAL, V42, P1606, DOI 10.1002/sia.3581; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Yang HJ, 2010, MED MOL MORPHOL, V43, P158, DOI 10.1007/s00795-009-0487-2; Breitenstein D, 2007, ANGEW CHEM INT EDIT, V46, P5332, DOI 10.1002/anie.200604468; Sugiura Y, 2012, ANAL BIOANAL CHEM, V403, P1851, DOI 10.1007/s00216-012-5988-5; Passarelli MK, 2013, ANAL CHEM, V85, P2231, DOI 10.1021/ac303038j; Bich C, 2013, ANAL CHEM, V85, P7745, DOI 10.1021/ac4009513; Malm J, 2009, ANAL CHEM, V81, P7197, DOI 10.1021/ac900636v; Uchiyama Y, 2014, ANAL BIOANAL CHEM, V406, P1307, DOI 10.1007/s00216-013-7062-3; Lee ES, 2013, ATHEROSCLEROSIS, V226, P378, DOI 10.1016/j.atherosclerosis.2012.11.003; Morita Y, 2013, J HEPATOL, V59, P292, DOI 10.1016/j.jhep.2013.02.030; Breitenstein D, 2008, APPL SURF SCI, V255, P1249, DOI 10.1016/j.apsusc.2008.05.289; Cillero-Pastor B, 2013, ARTHRITIS RHEUM-US, V65, P710, DOI 10.1002/art.37799; Goto K, 2012, CHEMBIOCHEM, V13, P1103, DOI 10.1002/cbic.201200146; Goto-Inoue N, 2012, ANAL BIOANAL CHEM, V403, P1863, DOI 10.1007/s00216-012-5809-x; Hirano H., 2013, ANAL BIOANAL CHEM; Ide Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061204; Ishikawa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048873; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kyoung Y. K., 2012, SURF INTERFACE ANAL, V45, P150; Passarelli MK, 2013, SURF INTERFACE ANAL, V45, P298, DOI 10.1002/sia.5036; Rabbani S., 2013, ANAL CHEM, V85, P5654; Robinson M., 2013, BIOINTERPHASES, V8, P1; SKEHAN P, 1975, J MEMBRANE BIOL, V24, P87, DOI 10.1007/BF01868617; Waki ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026721; Wehrl HF, 2013, CANCER RES, V73, P1470, DOI 10.1158/0008-5472.CAN-12-2532; WITTEKIND DH, 1985, HISTOCHEM J, V17, P263, DOI 10.1007/BF01004591	30	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		185	188		10.1002/sia.5522		4	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200047		
J	Kajiwara, Y; Iwai, H; Nakagawa, K; Kodani, N; Aoyagi, S				Kajiwara, Yasuko; Iwai, Hideo; Nakagawa, Keizo; Kodani, Noriko; Aoyagi, Satoka			Evaluation of hydroxyapatite nanoparticles synthesized with phosphate surfactant by means of G-SIMS and g-ogram	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		Time-of-Flight Secondary Ion Mass Spectroscopy (ToF-SIMS); Gentle-SIMS (G-SIMS); g-ogram; Hydroxyapatite (HAp) Nanoparticles	ION MASS-SPECTROMETRY; DODECYLPHOSPHATE; IDENTIFICATION; SEPARATION; TEMPLATE; PROTEIN	Inorganic and organic composite materials have been utilized as high-functional materials over a wide variety of industrial fields. Understanding interactions between inorganic and organic components is important for their further improvements. In this study, hydroxyapatite (HAp) nanoparticles synthesized with sodium dodecylphosphate (SDP) were evaluated using gentle-SIMS (G-SIMS) and g-ogram, which are spectrum analysis methods for time-of-flight SIMS. As a result, G-SIMS and g-ogram indicates that SDP molecules are adsorbed onto the surface of HAp nanoparticles and partly used to form HAp nanostructures. The more intact fragment ions indicated by G-SIMS and g-ogram imply that lamellar structures are formed in HAp sample synthesized with the high SDP concentration. Therefore, it is suggested that G-SIMS and g-ogram provide useful information for understanding chemistry of fine structures within inorganic and organic composite materials. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Kajiwara, Yasuko; Aoyagi, Satoka] Tottori Univ, United Grad Sch Agr Sci, Tottori 6808553, Japan; [Kajiwara, Yasuko] Mitsubishi Gas Chem Co Inc, MGC Anal Ctr, Tokyo 1258601, Japan; [Iwai, Hideo] Natl Inst Mat Sci, Mat Anal Stn, Tsukuba, Ibaraki 3050047, Japan; [Nakagawa, Keizo] Univ Tokushima, Inst Sci & Technol, Dept Adv Mat, Minamijosanjima, Tokushima 7708506, Japan; [Kodani, Noriko; Aoyagi, Satoka] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan	Aoyagi, S (reprint author), Shimane Univ, Fac Life & Environm Sci, Matsue Shi 1060, Matsue, Shimane 6908504, Japan.	aoyagi@life.shimane-u.ac.jp					Seah MP, 2010, J PHYS CHEM C, V114, P5351, DOI 10.1021/jp905037k; Liu C, 2007, APPL SURF SCI, V253, P6840, DOI 10.1016/j.apsusc.2007.01.119; Aoyagi S, 2012, RAPID COMMUN MASS SP, V26, P2815, DOI 10.1002/rcm.6409; Arai Y., 2012, 25 INT S CHEM ENG, pOE; Gilmore IS, 2000, APPL SURF SCI, V161, P465, DOI 10.1016/S0169-4332(00)00317-2; Green FM, 2008, RAPID COMMUN MASS SP, V22, P2602, DOI 10.1002/rcm.3648; Green FM, 2008, INT J MASS SPECTROM, V272, P38, DOI 10.1016/j.ijms.2007.12.016; Mihara I, 2013, SURF INTERFACE ANAL, V45, P453, DOI 10.1002/sia.5002; Nakagawa K, 2011, CHEM LETT, V40, P387, DOI 10.1246/cl.2011.387; Ogaki R, 2011, ANAL CHEM, V83, P3627, DOI 10.1021/ac200347a; Ozin GA, 1997, J MATER CHEM, V7, P1601, DOI 10.1039/a702416i	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		209	212		10.1002/sia.5398		4	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200052		
J	Kobayashi, D; Otomo, S; Aoyagi, S; Itoh, H				Kobayashi, Daisuke; Otomo, Shinya; Aoyagi, Satoka; Itoh, Hiroto			Mass-scale calibration of TOF-SIMS spectra using quaternary ammonium ions	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		TOF-SIMS; mass-scale calibration; quaternary ammonium ion; internal additive; relative mass accuracy	ENERGY-DISTRIBUTIONS; MOLECULES; ACCURACY	A novel method with quaternary ammonium salts as internal additives has been applied to the mass-scale calibration of time-of-flight secondary ion mass spectrometry (TOF-SIMS). Five kinds of quaternary ammonium salts, octyltrimethylammonium bromide (C8TMA), tetradecyltrimethylammonium chloride (C14TMA), octadecyltrimethylammonium chloride (C18TMA), cetylpyridinium chloride (CPC) and benzyldimethyltetradecylammonium chloride (Bzl) were diluted with NH3 aqueous solution and were mixed in equal quantities. The mixed solution was covered on a Si wafer and was measured by TOF-SIMS. When molecular ions of C8TMA, C14TMA, and C18TMA were used for the mass-scale calibration, the relative mass accuracy of low-mass CXHY fragment ions indicated negative values and depended on the carbon chain length and the degree of unsaturation. This result means that the conventional mass-scale calibration with frequently employed low-mass CXHY fragment ions leads to degradation of the mass accuracy of high-mass molecular ions. To improve the mass accuracy of molecular ions of CPC and Bzl, ions should be selected for the mass-scale calibration in the following two ways: One way is for ions to consist only of molecular ions of C8TMA, C14TMA, and C18TMA, and the other way is for ions to include one of the molecular ions: C8TMA, C14TMA, and C18TMA, along with the CXHY fragment ions. This novel mass-scale calibration method is promising for realizing the correct identification of unknown high-mass molecular ions. Those quaternary ammonium salts are powerful candidates of internal additives. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Kobayashi, Daisuke] Asahi Glass Co Ltd, Res Ctr, Yokohama, Kanagawa 2218755, Japan; [Otomo, Shinya] Furukawa Elect Corp Ltd, Yokohama R&D Labs, Yokohama, Kanagawa, Japan; [Aoyagi, Satoka] Seikei Univ, Dept Mat & Life Sci, Musashino, Japan; [Itoh, Hiroto] Konica Minolta Inc, Mat Anal Technol Div, Tokyo, Japan	Kobayashi, D (reprint author), Asahi Glass Co Ltd, Res Ctr, Kanagawa Ku, 1150 Hazawa Cho, Yokohama, Kanagawa 2218755, Japan.	daisuke-kobayashi@agc.com					Abe Y., 2010, J SURF ANAL, V17, P186; SCHWIETERS J, 1991, J VAC SCI TECHNOL A, V9, P2864, DOI 10.1116/1.577145; Green FM, 2010, SURF INTERFACE ANAL, V42, P129, DOI 10.1002/sia.3181; Bertrand P., 1996, MIKROCHIM ACTA S, V13, P167; Delcorte A, 2006, APPL SURF SCI, V252, P6542, DOI 10.1016/j.apsusc.2006.02.260; Gilmore IS, 2007, SURF INTERFACE ANAL, V39, P817, DOI [10.1002/sia.2596, 10.1002/sia]; Green FM, 2006, J AM SOC MASS SPECTR, V17, P514, DOI 10.1016/j.jasms.2005.12.005; HARING RA, 1987, NUCL INSTRUM METH B, V28, P205, DOI 10.1016/0168-583X(87)90106-6; HOOGERBRUGGE R, 1987, NUCL INSTRUM METH B, V18, P600; Kobayashi D., 2013, SCI INT S SIMS REL T, P37; Kobayashi D., 2014, J SURF ANAL, V20, P187; Nakanaga T, 2012, INT J MASS SPECTROM, V311, P24, DOI 10.1016/j.ijms.2011.11.014; NIEHUIS E, 1989, SURF INTERFACE ANAL, V14, P135, DOI 10.1002/sia.740140307; Otomo S., 2011, 18 INT C 2 ION MASS, P280; REICHLMAIER S, 1994, SURF INTERFACE ANAL, V21, P739, DOI 10.1002/sia.740211102; URBASSEK HM, 1987, NUCL INSTRUM METH B, V18, P587	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		229	232		10.1002/sia.5605		4	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200057		
J	Takano, A; Nonaka, H; Homma, Y; Tomita, M; Murase, A; Hayashi, S; Barozzi, M; Kim, KJ; Sykes, D; Simons, D; Bennett, J; Magee, CW				Takano, Akio; Nonaka, Hidehiko; Homma, Yoshikazu; Tomita, Mitsuhiro; Murase, Atsushi; Hayashi, Syunichi; Barozzi, Mario; Kim, Kyung Joon; Sykes, David; Simons, David; Bennett, Joe; Magee, Charles W.			VAMAS round-robin study to evaluate a correction method for saturation effects in D-SIMS	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		SIMS; detector; saturation; approximation intermediate extended dead time; VAMAS; round-robin test		Recently, dynamic SIMS (D-SIMS) is being used to analyze ions simultaneously over a wide range of concentrations, from matrix level to extremely low (ngg(-1)). However, D-SIMS detectors, which are mostly used in pulse counting systems, have problems with detector saturation. Thus, the ion intensities of SIMS must be corrected in their high-intensity region. It has been reported that the approximation intermediate extended dead-time model (a-IED model) can be used to correct saturated intensity in the higher region better than can the conventional model. In this study, we evaluated the usefulness of the a-IED model to correct partially saturated and saturated intensities for magnetic-sector-type D-SIMS and quadrupole-type D-SIMS for the effects of dead time. Nine organizations from five countries participated in this project. Analyzed specimens were an arsenic-implanted silicon wafer and a diffused BN onto Si wafer. The instruments used to analyze arsenic-implanted samples were five quadrupole-type SIMS and four magnetic-sector-type SIMS. The instruments used to analyze the BN-diffused samples were three quadrupole-type SIMS, four magnetic-sector-type SIMS, and one time-of-flight-type SIMS. We validated the usefulness of the a-IED model to correct saturated intensities for all SIMS in this round-robin test. The optimum extension parameter tends to be affected by the ratio of the maximum reliable intensity to the maximum intensity. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Takano, Akio] NTT Adv Technol Corp NTT AT, Mat & Anal Ctr, Atsugi, Kanagawa 2430124, Japan; [Nonaka, Hidehiko] Natl Inst Adv Ind Sci & Technol, Measurement Solut Res Ctr, Tosu, Saga, Japan; [Homma, Yoshikazu] Tokyo Univ Sci, Dept Phys, Shinjuku Ku, Tokyo 162, Japan; [Tomita, Mitsuhiro] Toshiba Co Ltd, Ctr Res & Dev, Yokohama, Kanagawa, Japan; [Murase, Atsushi] Toyota Cent Res & Dev Labs Inc, Mat Anal & Evaluat Div, Nagakute, Aichi 48011, Japan; [Hayashi, Syunichi] Nippon Steel & Sumikin Technol Co Ltd NSST, Futtsu, Japan; [Barozzi, Mario] Fdn Bruno Kessler, MinaLab, Trento, Italy; [Kim, Kyung Joon] KRISS, Adv Technol Div, Taejon, South Korea; [Sykes, David] Loughborough Surface Anal Ltd LSA, Loughborough, Leics, England; [Simons, David] NIST, Surface & Microanal Sci Div, Gaithersburg, MD 20899 USA; [Bennett, Joe] Novati Technol Inc, Austin, TX 78741 USA; [Magee, Charles W.] EAG, East Windsor, CT 06088 USA	Takano, A (reprint author), NTT Adv Technol Corp NTT AT, Ctr Mat Anal, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430124, Japan.	akio.takano@ntt-at.co.jp					Ida T, 2005, J APPL CRYSTALLOGR, V38, P426, DOI 10.1107/S0021889805005637; Lee JLS, 2012, SURF INTERFACE ANAL, V44, P1, DOI 10.1002/sia.3761; STEPHAN T, 1994, J VAC SCI TECHNOL A, V12, P405, DOI 10.1116/1.579255; Takano A, 2012, SURF INTERFACE ANAL, V44, P1287, DOI 10.1002/sia.5004	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		244	248		10.1002/sia.5537		5	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200061		
J	Miyasaka, T; Yamauchi, T; Nagatomi, T; Kono, T				Miyasaka, Toyomitsu; Yamauchi, Takeshi; Nagatomi, Takaharu; Kono, Teiichiro			Ar cluster ion beam sputtering of InSb investigated by ToF-SIMS	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		Ar cluster ion beam; InSb; ToF-SIMS; depth profiling; depth resolution; surface topography		Ar gas cluster ion beam (GCIB) sputtering of InSb was investigated, and the sputtering rate and depth resolution of time-of-flight secondary ion mass spectrometry sputter depth profiling were examined. The practical sputtering rate for InSb using 20keV Ar-2500(+) irradiation was confirmed at the incident angles of 0 degrees, 40 degrees, and 60 degrees, and the sputtering rate was too low to perform sputtering at 80 degrees. The preferential sputtering and surface roughness observed under GCIB irradiation was lower than that observed under 3keV Ar+ irradiation. Characteristic ripple formation was confirmed under 20keV Ar-2500(+) irradiation and had a strong influence on the depth resolution. The highest depth resolution was obtained at the incident angle of 0 degrees because no ripple formation occurred and the level of surface roughness was low among the irradiation of GCIB at incident angles of 0 degrees, 40 degrees, and 60 degrees. The present results revealed that GCIB sputtering is an effective method for sputter depth profiling of InSb. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Miyasaka, Toyomitsu; Yamauchi, Takeshi; Nagatomi, Takaharu; Kono, Teiichiro] Asahi Kasei Corp, Anal & Simulat Ctr, Fuji, Shizuoka 4168501, Japan	Miyasaka, T (reprint author), Asahi Kasei Corp, Anal & Simulat Ctr, 2-1 Samejima, Fuji, Shizuoka 4168501, Japan.	miyasaka.tc@om.asahi-kasei.co.jp					Kakuta S, 2007, SURF COAT TECH, V201, P8632, DOI 10.1016/j.surfcoat.2006.03.064; Kuze N., 1997, 3 5S REV, V10, P28; Saeed SR, 2009, NUCL INSTRUM METH B, V267, P2752, DOI 10.1016/j.nimb.2009.05.023; Ueno K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.092202	4	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		261	263		10.1002/sia.5648		3	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200065		
J	Nakata, Y; Fujiyama, N; Sameshima, J; Yoshikawa, M				Nakata, Yoshihiko; Fujiyama, Noriyuki; Sameshima, Junichiro; Yoshikawa, Masanobu			Use of ionic liquids in SIMS depth profiling	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		dynamic SIMS; ionic liquid; depth profiling; charge neutralization; insulator; pulp	FAST-ATOM-BOMBARDMENT; SCANNING-ELECTRON-MICROSCOPE; MASS-SPECTROMETRY; MATRIX	A room temperature ionic liquid (IL) is a molten salt with melting point below 100 degrees C and has extremely low vapor pressure, allowing use in a high vacuum chamber. In scanning electron microscopy, the ILs have been found to behave as electrically conductive materials and successfully applied for conductive coating of insulating specimens. It is well known that dynamic SIMS analysis of an insulator causes charge buildup and requires a conductive film coating and electron gun, which can distort depth profiling of metal elements. In this study, 1-ethyl-3-methylimidazolium tetrafluoroborate was employed to test the applicability for charge neutralization in depth profiling of insulators. Mass spectra were successfully obtained from the IL droplets deposited onto a Si substrate without charge buildup. Deposition of the IL onto fiber pulp samples enabled us to acquire continuous secondary ions from the pulp samples. It implies the potential use of the IL as a conductive film for depth profiling of metal elements in insulators such as SiO2 and SiN. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Nakata, Yoshihiko; Fujiyama, Noriyuki; Sameshima, Junichiro; Yoshikawa, Masanobu] Toray Res Ctr Ltd, Otsu, Shiga 5208567, Japan	Nakata, Y (reprint author), Toray Res Ctr Ltd, 3-7,Sonoyama 3 Chome, Otsu, Shiga 5208567, Japan.	Yoshihiko_Nakata@trc.toray.co.jp					ABERTH W, 1982, ANAL CHEM, V54, P2029, DOI 10.1021/ac00249a028; Wilkes JS, 2004, J MOL CATAL A-CHEM, V214, P11, DOI 10.1016/j.molcata.2003.11.029; Arimoto S, 2008, ELECTROCHIM ACTA, V53, P6228, DOI 10.1016/j.electacta.2008.01.001; Armstrong DW, 2001, ANAL CHEM, V73, P3679, DOI 10.1021/ac010259f; BARBER M, 1981, BIOCHEM J, V197, P401; Fitzgerald JJD, 2010, ANAL CHEM, V82, P4413, DOI 10.1021/ac100133c; Kuwabata S, 2006, CHEM LETT, V35, P600, DOI 10.1246/cl.2006.600; BARBER M, 1981, NATURE, V293, P270, DOI 10.1038/293270a0; McKinley JM, 2000, J VAC SCI TECHNOL A, V18, P273, DOI 10.1116/1.582146; WILKES JS, 1992, J CHEM SOC CHEM COMM, P965, DOI 10.1039/c39920000965; WONG SS, 1985, BIOMED MASS SPECTROM, V12, P43, DOI 10.1002/bms.1200120109	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		264	266		10.1002/sia.5655		3	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200066		
J	Karen, A; Ito, K; Kubo, Y				Karen, Akiya; Ito, Kimihiko; Kubo, Yoshimi			TOF-SIMS analysis of lithium air battery discharge products utilizing gas cluster ion beam sputtering for surface stabilization	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		TOF-SIMS; gas cluster ion beam (GCIB); lithium battery		TOF-SIMS investigation on various lithium reference materials has been carried out for the characterization of reaction products on electrodes of lithium air batteries (LAB). In conjunction with argon gas cluster ion beam (GCIB) sputtering which can stabilize the surface of lithium compounds effectively, characteristic secondary ion species have been found for identification and differentiation among them. On the surface of real discharged carbon cathodes of LAB, lithium peroxide and related products were recognized under coexistence of electrolyte components and confirmed by the experiment using O-18(2) as reaction gas in the discharging process. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Karen, Akiya; Ito, Kimihiko; Kubo, Yoshimi] Natl Inst Mat Sci, Global Res Ctr Environm & Energy Based Nanomat Sc, Tsukuba, Ibaraki 3050044, Japan	Karen, A (reprint author), Natl Inst Mat Sci, Global Res Ctr Environm & Energy Based Nanomat Sc, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	KAREN.Akiya@nims.go.jp					Scrosati B, 2011, ENERG ENVIRON SCI, V4, P3287, DOI 10.1039/c1ee01388b; Lu P, 2011, ELECTROCHEM COMMUN, V13, P1035, DOI 10.1016/j.elecom.2011.06.026; Verma P, 2010, ELECTROCHIM ACTA, V55, P6332, DOI 10.1016/j.electacta.2010.05.072; Etacheri V, 2011, ENERG ENVIRON SCI, V4, P3243, DOI 10.1039/c1ee01598b; Younesi R, 2012, J PHYS CHEM C, V116, P20673, DOI 10.1021/jp302168h; Jung HG, 2012, NAT CHEM, V4, P579, DOI [10.1038/nchem.1376, 10.1038/NCHEM.1376]; Bruce P. G., 2011, NAT MATER, V11, P9	7	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		344	347		10.1002/sia.5508		4	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200086		
J	Fujiwara, Y; Saito, N				Fujiwara, Yukio; Saito, Naoaki			Time-of-flight secondary ion mass spectrometry (TOF-SIMS) using an ionic-liquid primary ion beam source	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		electrospray; vacuum electrospray; ionic liquid; charged droplet; ion source; ion beam; SIMS; TOF; sputtering; deposition	LARGE BIOMOLECULES; CLUSTER-IMPACT; ELECTROSPRAY; DESORPTION; MATRICES	An orthogonal acceleration time-of-flight secondary ion mass spectrometry (TOF-SIMS) system has been developed using a prototype vacuum-electrospay primary beam source that is capable of producing continuous ion beam of an ionic liquid. As a primary ion beam, an imidazolium ionic liquid, 1-ethyl-3-methylimidazolium bis(trifluoromethanesulfonyl) amide (EMI-TFSA), was electrosprayed at pressures around 2x10(-4)Pa and a flow rate of 50nL/min. Using the TOF-SIMS system, three samples were analyzed: (i) EMI-TFSA, (ii) an ammonium ionic liquid, N,N-diethyl-N-methyl-N-(2-methoxyethyl)ammonium bis(trifluoromethanesulfonyl) amide (DEME-TFSA), and (iii) a polyethylene glycol (PEG300). Preliminary data showed that the vacuum electrospray of the ionic liquid was applicable to a primary ion beam source for SIMS. Nevertheless, irradiation of the ionic-liquid beam caused deposition as well as sputtering. The deposition would result from larger m/z components of ionic-liquid charged droplets. This is because projectile energy per nucleon of the larger m/z components seems too low to sputter materials. Because m/z values of charged droplets decrease with decreasing flow rate, it is required to reduce the flow rate of the ionic liquid so as to suppress the deposition of the ionic-liquid beam. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Fujiwara, Yukio; Saito, Naoaki] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Fujiwara, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	yukio-fujiwara@aist.go.jp					Fujiwara Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.036701; Weibel D, 2003, ANAL CHEM, V75, P1754, DOI 10.1021/ac026338o; Ninomiya S, 2007, NUCL INSTRUM METH B, V256, P493, DOI 10.1016/j.nimb.2006.12.047; Fujiwara Y, 2012, J APPL PHYS, V111, DOI 10.1063/1.3693558; Hiraoka K, 2006, J MASS SPECTROM, V41, P894, DOI 10.1002/jms.1048; Armstrong DW, 2001, ANAL CHEM, V73, P3679, DOI 10.1021/ac010259f; MAHONEY JF, 1992, J AM SOC MASS SPECTR, V3, P311, DOI 10.1016/1044-0305(92)87058-7; Gamero-Castano M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.145701; Moritani K, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.046001; Castner DG, 2003, NATURE, V422, P129, DOI 10.1038/422129a; Dertinger JJ, 2013, J AM SOC MASS SPECTR, V24, P348, DOI 10.1007/s13361-012-0568-7; CORNETT DS, 1994, RAPID COMMUN MASS SP, V8, P996; Davies N, 2003, APPL SURF SCI, V203, P223, DOI 10.1016/S0169-4332(02)00631-1; GOMEZ A, 1994, PHYS FLUIDS, V6, P404, DOI 10.1063/1.868037; Saito N, 2007, RAPID COMMUN MASS SP, V21, P2654, DOI 10.1002/rcm.3139; Asakawa D, 2011, RAPID COMMUN MASS SP, V25, P655, DOI 10.1002/rcm.4909; Vandervorst W, 2008, APPL SURF SCI, V255, P805, DOI 10.1016/j.apsusc.2008.05.090; Iltgen K, 1997, J VAC SCI TECHNOL A, V15, P460, DOI 10.1116/1.580874; Fitzgerald JJD, 2010, ANAL CHEM, V82, P4413, DOI 10.1021/ac100133c; Gamero-Castano M, 2009, J APPL PHYS, V106, DOI 10.1063/1.3211304; Fujiwara Y, 2010, NUCL INSTRUM METH B, V268, P1938, DOI 10.1016/j.nimb.2010.02.097; MAHONEY JF, 1991, RAPID COMMUN MASS SP, V5, P441, DOI 10.1002/rcm.1290051004; Aksyonov SA, 2001, RAPID COMMUN MASS SP, V15, P2001, DOI 10.1002/rcm.470; Fujiwara Y, 2011, CHEM PHYS LETT, V501, P335, DOI 10.1016/j.cplett.2010.11.067; Jaworek A, 2008, J ELECTROSTAT, V66, P197, DOI 10.1016/j.elstat.2007.10.001; Hiraoka K, 2006, EUR PHYS J D, V38, P225, DOI 10.1140/epjd/e2005-00282-6; Lee JLS, 2010, ANAL CHEM, V82, P98, DOI 10.1021/ac901045q; Asakawa D, 2007, RAPID COMMUN MASS SP, V21, P1579, DOI 10.1002/rcm.3004; BERGMANN T, 1990, REV SCI INSTRUM, V61, P2585, DOI 10.1063/1.1141842; Delcorte A., 2009, ANAL CHEM, V82, P6676; Enderes F., 2006, PHYS CHEM CHEM PHYS, V8, P2101; Fujiwara Y, 2013, SURF INTERFACE ANAL, V45, P517, DOI 10.1002/sia.5071; Fujiwara Y., 2009, P 7 INT S AT LEV CHA, P471; Fujiwara Y, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.126005; Fujiwara Y., 2010, VACUUM, V84, P544; Gamero-Castano M, 2009, APPL SURF SCI, V255, P8556, DOI 10.1016/j.apsusc.2009.06.018; Gillen G, 1999, J VAC SCI TECHNOL A, V17, P845, DOI 10.1116/1.581657; Mahoney CM, 2010, MASS SPECTROM REV, V29, P247, DOI 10.1002/mas.20233; MUTOH M, 1979, J APPL PHYS, V50, P3174, DOI 10.1063/1.326352; Sanada N, 2004, SURF INTERFACE ANAL, V36, P280, DOI 10.1002/sia.1680; Tomita M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2266995; Winograd N, 2005, ANAL CHEM, V77, p142A, DOI 10.1021/ac053355f	42	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		348	352		10.1002/sia.5662		5	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200087		
J	Fujii, M; Kusakari, M; Matsuda, K; Man, N; Seki, T; Aoki, T; Matsuo, J				Fujii, Makiko; Kusakari, Masakazu; Matsuda, Kazuhiro; Man, Naoki; Seki, Toshio; Aoki, Takaaki; Matsuo, Jiro			Lipid compounds analysis with MeV-SIMS apparatus for biological applications	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		SIMS; MeV-energy; lipid; detection limit; quantitative; biological	MASS-SPECTROMETRY	Secondary ion mass spectrometry (SIMS) is one of the powerful methods that can be applied to high sensitivity mass analysis and high-spatial resolution mass imaging. For the analysis of minor components of the complex biological samples, however, superior sensitivity with low background is required. We have developed an MeV-SIMS apparatus with distinctively high secondary ion yield for large organic molecules. In this study, the detection limit of our original MeV-SIMS apparatus was investigated using compounds of two lipids. In the acquired mass spectra, the molecular ions of both lipids were clearly observed with high quantitativity. In addition, the results were compared with conventional time-of-flight-SIMS results. As a result, the detection limit of MeV-SIMS apparatus was found to be below 0.1% and was much lower than that of the conventional Bi cluster SIMS. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Fujii, Makiko; Matsuo, Jiro] Kyoto Univ, Quantum Sci & Engn Ctr, Uji, Kyoto 6110011, Japan; [Kusakari, Masakazu; Seki, Toshio] Kyoto Univ, Dept Nucl Engn, Uji, Kyoto 6110011, Japan; [Matsuda, Kazuhiro; Man, Naoki] Toray Res Ctr Ltd, Surface Anal Labs, Otsu, Shiga 5208567, Japan; [Aoki, Takaaki] Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto 6158510, Japan	Fujii, M (reprint author), Kyoto Univ, Quantum Sci & Engn Ctr, Uji, Kyoto 6110011, Japan.	fujii.makiko.68x@st.kyoto-u.ac.jp					Khatib-Shahidi S, 2006, ANAL CHEM, V78, P6448, DOI 10.1021/ac060788p; Fletcher JS, 2011, MASS SPECTROM REV, V30, P142, DOI 10.1002/mas.20275; Guilhaus M, 2000, MASS SPECTROM REV, V19, P65, DOI 10.1002/(SICI)1098-2787(2000)19:2<65::AID-MAS1>3.0.CO;2-E; Wucher A, 2006, APPL SURF SCI, V252, P6482, DOI 10.1016/j.apsusc.2006.02.070; Chernushevich IV, 2001, J MASS SPECTROM, V36, P849, DOI 10.1002/jms.207; Atkinson SJ, 2007, RAPID COMMUN MASS SP, V21, P1271, DOI 10.1002/rcm.2952; Dawson J. H. J., 1989, RAPID COMMUN MASS SP, V3, P155, DOI DOI 10.1002/RCM.1290030511; Mahoney CM, 2010, MASS SPECTROM REV, V29, P247, DOI 10.1002/mas.20233; Matsuo J, 2010, SURF INTERFACE ANAL, V42, P1612, DOI 10.1002/sia.3585; Nakata Y, 2009, J MASS SPECTROM, V44, P128, DOI 10.1002/jms.1482; Tamvakopoulos CS, 2000, RAPID COMMUN MASS SP, V14, P1729, DOI 10.1002/1097-0231(20001015)14:19<1729::AID-RCM85>3.0.CO;2-5; Vickerman J. C., 2001, TOF SIMS SURFACE ANA; Wakamatsu Y, 2011, NUCL INSTRUM METH B, V269, P2251, DOI 10.1016/j.nimb.2011.02.069; Winograd N, 2005, ANAL CHEM, V77, p142A, DOI 10.1021/ac053355f; Yamada H, 2011, SURF INTERFACE ANAL, V43, P363, DOI 10.1002/sia.3408	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		353	356		10.1002/sia.5524		4	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200088		
J	Ninomiya, S; Chen, LC; Sakai, Y; Hiraoka, K				Ninomiya, Satoshi; Chen, Lee Chuin; Sakai, Yuji; Hiraoka, Kenzo			Evaluation of a diode laser-assisted vacuum-type charged droplet beam source	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		electrospray; vacuum; charged droplet; laser	ION MASS-SPECTROMETRY; DEPTH ANALYSIS; ELECTROSPRAY; IMPACT; WATER; BOMBARDMENT; TIME	The electrospray droplet impact (EDI) method based on ambient electrospray technique was developed as a novel massive cluster beam gun, but in its current status, the EDI method lacks adequate beam focusing and brightness. To improve the performance of the current EDI method, we developed a technique for producing electrospray of aqueous solutions under vacuum. In a previous study, the tip of the electrospray emitter was irradiated with an infrared (IR) CO2 laser (wavelength: 10.6 mu m) to prevent freezing of the aqueous solutions. In this paper, a near-IR diode laser (wavelength: 808nm) was adopted for heating the tip of the electrospray emitter as an alternative to the IR laser. A stable vacuum electrospray of aqueous solutions was obtained, whereas the 808nm light was poorly absorbed by water compared with the 10.6-mu m IR laser. The characteristics of the vacuum electrospray assisted by a near-IR laser are presented. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ninomiya, Satoshi; Chen, Lee Chuin] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008511, Japan; [Sakai, Yuji; Hiraoka, Kenzo] Univ Yamanashi, Clean Energy Res Ctr, Kofu, Yamanashi 4008511, Japan	Ninomiya, S (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, 4-3-11 Takeda, Kofu, Yamanashi 4008511, Japan.	sninomiya@yamanashi.ac.jp; hiraoka@yamanashi.ac.jp					HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; Weibel D, 2003, ANAL CHEM, V75, P1754, DOI 10.1021/ac026338o; Hiraoka K, 2006, J MASS SPECTROM, V41, P894, DOI 10.1002/jms.1048; Kollmer F, 2004, APPL SURF SCI, V231, P153, DOI 10.1016/j.apsusc.2004.03.101; Ninomiya S, 2009, RAPID COMMUN MASS SP, V23, P1601, DOI 10.1002/rcm.4046; Touboul D, 2004, ANAL CHEM, V76, P1550, DOI 10.1021/ac035243z; Sheraz S, 2013, ANAL CHEM, V85, P5654, DOI 10.1021/ac4013732; Yamada I, 2001, MAT SCI ENG R, V34, P231, DOI 10.1016/S0927-796X(01)00034-1; Ninomiya S, 2012, RAPID COMMUN MASS SP, V26, P863, DOI 10.1002/rcm.6181; Hiraoka K, 2006, EUR PHYS J D, V38, P225, DOI 10.1140/epjd/e2005-00282-6; Hiraoka K, 2010, J VAC SCI TECHNOL A, V28, P510, DOI 10.1116/1.3420465; LeviSetti R, 1997, MICROSC RES TECHNIQ, V36, P301, DOI 10.1002/(SICI)1097-0029(19970215)36:4<301::AID-JEMT8>3.0.CO;2-O; Sakai Y, 2011, SURF INTERFACE ANAL, V43, P1605, DOI 10.1002/sia.3754; Sakai Y, 2010, SURF INTERFACE ANAL, V42, P658, DOI 10.1002/sia.3254; Sakai Y, 2012, SURF INTERFACE ANAL, V44, P938, DOI 10.1002/sia.4843; Winograd N, 2005, ANAL CHEM, V77, p142A, DOI 10.1021/ac053355f	16	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		364	367		10.1002/sia.5532		4	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200091		
J	Nojima, M; Suzuki, M; Fujii, M; Seki, T; Matsuo, J				Nojima, Masashi; Suzuki, Masato; Fujii, Makiko; Seki, Toshio; Matsuo, Jiro			Development of organic SIMS system with Ar-GCIB and IMS-4f	SURFACE AND INTERFACE ANALYSIS			English	Article; Proceedings Paper	19th International Conference on Secondary Ion Mass Spectrometry (SIMS)	SEP 29-OCT 04, 2013	Jeju, SOUTH KOREA	ULVAC PHI Inc, CAMECA, ION TOF GmbH		Ar-GCIB; dynamic; IMS-4f	GAS CLUSTER IONS; MASS-SPECTROMETRY; BOMBARDMENT	We have developed Ar-gas cluster ion beam (GCIB) dynamic secondary ion mass spectrometry system by introducing Ar-GCIB column to IMS-4f. Mass spectrums of arginine and polystyrene (PS) are obtained with typical fragment ions. Depth profiles of PS are obtained within 10nm depth resolutions. Secondary ion images of fine-patterned PS are observed within 10 mu m image resolutions. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Nojima, Masashi] Tokyo Univ Sci, RIST, Noda, Chiba 2788510, Japan; [Nojima, Masashi; Suzuki, Masato] Tokyo Univ Sci, Fac Sci & Technol, Noda, Chiba 2788510, Japan; [Fujii, Makiko; Matsuo, Jiro] Kyoto Univ, Quantum Sci & Engn Ctr, Kyoto 6110011, Japan; [Seki, Toshio] Kyoto Univ, Dept Nucl Engn, Kyoto 6110011, Japan	Seki, T (reprint author), Kyoto Univ, Dept Nucl Engn, Kyoto 6110011, Japan.	seki@sakura.nucleng.kyoto-u.ac.jp					Ninomiya S, 2007, NUCL INSTRUM METH B, V256, P493, DOI 10.1016/j.nimb.2006.12.047; Gillen G, 2006, APPL SURF SCI, V252, P6521, DOI 10.1016/j.apsusc.2006.02.234; Moritani K, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.046001; Gnaser H, 2013, RAPID COMMUN MASS SP, V27, P1490, DOI 10.1002/rcm.6599; Ichiki K, 2013, SURF INTERFACE ANAL, V45, P522, DOI 10.1002/sia.5092; Matsuo J., 2007, APPL SURF SCI, V255, P1235; Matsuo J, 2012, SURF INTERFACE ANAL, V44, P729, DOI 10.1002/sia.4856; Moritani K, 2008, APPL SURF SCI, V255, P948, DOI 10.1016/j.apsusc.2008.05.010; Shumasher M., 1988, SIMS 6, P177; Zhang N, 2012, ANALYST, V137, P5051, DOI 10.1039/c2an35770d	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	NOV	2014	46			1	SI		368	371		10.1002/sia.5671		4	Chemistry, Physical	Chemistry	AU6EN	WOS:000345696200092		
J	Yamada, T; Okuda, Y; Kushida, M; Sumida, K; Takeuchi, H; Nagahori, H; Fukuda, T; Lake, BG; Cohen, SM; Kawamura, S				Yamada, Tomoya; Okuda, Yu; Kushida, Masahiko; Sumida, Kayo; Takeuchi, Hayato; Nagahori, Hirohisa; Fukuda, Takako; Lake, Brian G.; Cohen, Samuel M.; Kawamura, Satoshi			Human Hepatocytes Support the Hypertrophic but not the Hyperplastic Response to the Murine Nongenotoxic Hepatocarcinogen Sodium Phenobarbital in an In Vivo Study Using a Chimeric Mouse with Humanized Liver	TOXICOLOGICAL SCIENCES			English	Article						liver tumors; sodium phenobarbital; humanized mice; mode of action; cytochrome P450; cell proliferation; human risk assessment	CONSTITUTIVE ANDROSTANE RECEPTOR; SYNTHETIC PYRETHROID METOFLUTHRIN; HUMAN RELEVANCE ANALYSIS; NUCLEAR RECEPTOR; TUMOR PROMOTION; DNA-SYNTHESIS; MICE; CAR; INDUCTION; MODE	High doses of sodium phenobarbital (NaPB), a constitutive androstane receptor (CAR) activator, have been shown to produce hepatocellular tumors in rodents by a mitogenic mode of action (MOA) involving CAR activation. The effect of 1-week dietary treatment with NaPB on liver weight and histopathology, hepatic CYP2B enzyme activity and CYP2B/3A mRNA expression, replicative DNA synthesis and selected genes related to cell proliferation, and functional transcriptomic and metabolomic analyses was studied in male CD-1 mice, Wistar Hannover (WH) rats, and chimeric mice with human hepatocytes. The treatment of chimeric mice with 1000-1500-ppm NaPB resulted in plasma levels around 3-5-fold higher than those observed in human subjects given therapeutic doses of NaPB. NaPB produced dose-dependent increases in hepatic CYP2B activity and CYP2B/3A mRNA levels in all animal models. Integrated functional metabolomic and transcriptomic analyses demonstrated that the responses to NaPB in the human liver were clearly different from those in rodents. Although NaPB produced a dose-dependent increase in hepatocyte replicative DNA synthesis in CD-1 mice and WH rats, no increase in replicative DNA synthesis was observed in human hepatocyte-originated areas of chimeric mice. In addition, treatment with NaPB had no effect on Ki-67, PCNA, GADD45 beta, and MDM2 mRNA expression in chimeric mice, whereas significant increases were observed in CD-1 mice and/or WH rats. However, increases in hepatocyte replicative DNA synthesis were observed in chimeric mice both in vivo and in vitro after treatment epidermal growth factor. Thus, although NaPB could activate CAR in both rodent and human hepatocytes, NaPB did not increase replicative DNA synthesis in human hepatocytes of chimeric mice, whereas it was mitogenic to rat and mouse hepatocytes. As human hepatocytes are refractory to the mitogenic effects of NaPB, the MOA for NaPB-induced rodent liver tumor formation is thus not relevant for humans.	[Yamada, Tomoya; Okuda, Yu; Kushida, Masahiko; Sumida, Kayo; Takeuchi, Hayato; Nagahori, Hirohisa; Fukuda, Takako; Kawamura, Satoshi] Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana Ku, Osaka 5548558, Japan; [Lake, Brian G.] Univ Surrey, Fac Hlth & Med Sci, Ctr Toxicol, Guildford GU2 7XH, Surrey, England; [Cohen, Samuel M.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Cohen, Samuel M.] Univ Nebraska Med Ctr, Nebraska Med Ctr 983135, Omaha, NE 68198 USA	Yamada, T (reprint author), Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5548558, Japan.	yamadat8@sc.sumitomo-chem.co.jp			Sumitomo Chemical Co., Ltd	Sumitomo Chemical Co., Ltd.	Braeuning A, 2014, TOXICOL SCI, V140, P259, DOI 10.1093/toxsci/kfu099; Foster JR, 2014, XENOBIOTICA, V44, P109, DOI 10.3109/00498254.2013.867553; Iatropoulos MJ, 1996, EXP TOXICOL PATHOL, V48, P175; Tian JM, 2011, J CLIN INVEST, V121, P4491, DOI 10.1172/JCI38760; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Tateno C, 2013, LAB INVEST, V93, P54, DOI 10.1038/labinvest.2012.158; Holsapple MP, 2006, TOXICOL SCI, V89, P51, DOI 10.1093/toxsci/kfj001; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sonich-Mullin C, 2001, REGUL TOXICOL PHARM, V34, P146, DOI 10.1006/rtph.2001.1493; Cohen SM, 2011, TOXICOL SCI, V120, pS76, DOI 10.1093/toxsci/kfq365; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; Boobis AR, 2006, CRIT REV TOXICOL, V36, P781, DOI 10.1080/10408440600977677; Columbano A, 2005, HEPATOLOGY, V42, P1118, DOI 10.1002/hep.20883; Tateno C, 2011, ENDOCRINOLOGY, V152, P1479, DOI 10.1210/en.2010-0953; Deguchi Y, 2009, TOXICOL SCI, V108, P69, DOI 10.1093/toxsci/kfp006; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Tolson AH, 2010, ADV DRUG DELIVER REV, V62, P1238, DOI 10.1016/j.addr.2010.08.006; Papa S, 2008, J CLIN INVEST, V118, P1911, DOI 10.1172/JCI33913; Cohen SM, 2004, TOXICOL SCI, V78, P181, DOI 10.1093/toxsci/kfh073; Ross J, 2010, TOXICOL SCI, V116, P452, DOI 10.1093/toxsci/kfq118; Meek ME, 2003, CRIT REV TOXICOL, V33, P591, DOI 10.1080/10408440390250136; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Whysner J, 1996, PHARMACOL THERAPEUT, V71, P153, DOI 10.1016/0163-7258(96)00067-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Wei P, 2000, NATURE, V407, P920; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Cohen SM, 2010, TOXICOL PATHOL, V38, P487, DOI 10.1177/0192623310363813; Elcombe CR, 2014, CRIT REV TOXICOL, V44, P64, DOI 10.3109/10408444.2013.835786; Friedman GD, 2009, INT J CANCER, V125, P2173, DOI 10.1002/ijc.24545; Hirose Y, 2009, TOXICOLOGY, V258, P64, DOI 10.1016/j.tox.2009.01.007; IARC, 2001, IARC MON EV CARC RIS, V79, P161; Jones HB, 2009, FOOD CHEM TOXICOL, V47, P1333, DOI 10.1016/j.fct.2009.03.014; Kitamura S, 2014, XENOBIOTICA, V44, P123, DOI 10.3109/00498254.2013.868062; Lake B. G., 1987, BIOCH TOXICOLOGY PRA, P183; Lake BG, 2009, XENOBIOTICA, V39, P582, DOI 10.1080/00498250903098184; La Vecchia C, 2014, EUR J CANCER PREV, V23, P1, DOI 10.1097/CEJ.0b013e32836014c8; Luisier R., 2014, TOXICOL SCI, V138, P501; Masumoto N, 2007, J ENDOCRINOL, V194, P529, DOI 10.1677/JOE-07-0126; Molnar Ferdinand, 2013, Drug Metabolism and Drug Interactions, V28, P79, DOI 10.1515/dmdi-2013-0009; MONRO A, 1993, REGUL TOXICOL PHARM, V18, P115, DOI 10.1006/rtph.1993.1048; Moore JT, 2003, BBA-GEN SUBJECTS, V1619, P235, DOI 10.1016/S0304-4165(02)00481-6; Papa S, 2007, J BIOL CHEM, V282, P19029, DOI 10.1074/jbc.M703112200; PARZEFALL W, 1991, CANCER RES, V51, P1143; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; SOUZA SC, 1995, P NATL ACAD SCI USA, V92, P959, DOI 10.1073/pnas.92.4.959; Yamamoto Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010121	47	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	NOV	2014	142	1					137	157		10.1093/toxsci/kfu173		21	Toxicology	Toxicology	AU8IT	WOS:000345840600014		
J	Torii, Y; Goto, Y; Nakahira, S; Ginnaga, A				Torii, Yasushi; Goto, Yoshitaka; Nakahira, Shinji; Ginnaga, Akihiro			Establishment of alternative potency test for botulinum toxin type A using compound muscle action potential (CMAP) in rats	TOXICON			English	Article						Botulinum toxin; CMAP; Mouse ip LD50; Quantitative analysis; ICH	CLOSTRIDIUM-BOTULINUM; NEUROTOXINS; ASSAY; STANDARDS; BIOASSAY; MICE	The biological activity of botulinum toxin type A has been evaluated using the mouse intraperitoneal (ip) LD50 test. This method requires a large number of mice to precisely determine toxin activity, and, as such, poses problems with regard to animal welfare. We previously developed a compound muscle action potential (CMAP) assay using rats as an alternative method to the mouse ip LD50 test. In this study, to evaluate this quantitative method of measuring toxin activity using CMAP, we assessed the parameters necessary for quantitative tests according to ICH Q2 (R1). This assay could be used to evaluate the activity of the toxin, even when inactive toxin was mixed with the sample. To reduce the number of animals needed, this assay was set to measure two samples per animal. Linearity was detected over a range of 0.1-12.8 U/mL, and the measurement range was set at 0.4-6.4 U/mL. The results for accuracy and precision showed low variability. The body weight was selected as a variable factor, but it showed no effect on the CMAP amplitude. In this study, potency tests using the rat CMAP assay of botulinum toxin type A demonstrated that it met the criteria for a quantitative analysis method. (C) 2014 Elsevier Ltd. All rights reserved.	[Torii, Yasushi; Goto, Yoshitaka; Nakahira, Shinji; Ginnaga, Akihiro] Chemo Sero Therapeut Res Inst KAKETSUKEN, Kita Ku, Kumamoto 8608568, Japan; [Torii, Yasushi] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan	Torii, Y (reprint author), Osaka Univ, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	torii@bact.med.osaka-u.ac.jp					Alder S., 2010, ALTERN LAB ANIM, V38, P315; Hallis B, 1996, J CLIN MICROBIOL, V34, P1934; Aoki KR, 2001, TOXICON, V39, P1815, DOI 10.1016/S0041-0101(01)00101-5; PEARCE LB, 1994, TOXICOL APPL PHARM, V128, P69, DOI 10.1006/taap.1994.1181; Torii Y, 2010, TOXICON, V55, P407, DOI 10.1016/j.toxicon.2009.09.005; Montecucco C, 1996, ARCH TOX S, V18, P342; Sesardic D, 2003, BIOLOGICALS, V31, P265, DOI 10.1016/j.biologicals.2003.001; Bigalke H, 2001, EXP NEUROL, V168, P162, DOI 10.1006/exnr.2000.7583; Schiavo G, 2000, PHYSIOL REV, V80, P717; Wictome M, 1999, APPL ENVIRON MICROB, V65, P3787; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; [Anonymous], 2005, VAL AN PROC TEXT MET, VQ2; Sesardic D, 1996, PHARMACOL TOXICOL, V78, P283; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; JAHN R, 1994, ANN NY ACAD SCI, V733, P245, DOI 10.1111/j.1749-6632.1994.tb17274.x; Jones RGA, 2006, BIOLOGICALS, V34, P223, DOI 10.1016/j.biologicals.2005.11.009; Kim SH, 2012, TOXICON, V60, P341, DOI 10.1016/j.toxicon.2012.05.003; Rasetti-Escargueil C, 2011, TOXICON, V57, P1008, DOI 10.1016/j.toxicon.2011.04.003; Sakaguchi G, 1983, PHARMACOL THERAPEUT, V19, P165; Sakaguchi G, 1981, BIOMEDICAL ASPECTS B, P21; Sakamoto T, 2009, TOXICON, V54, P857, DOI 10.1016/j.toxicon.2009.06.020; Straughan DW, 2006, ATLA-ALTERN LAB ANIM, V34, P305; SUGII S, 1975, INFECT IMMUN, V12, P1262; TAKAHASHI M, 1990, INT J FOOD MICROBIOL, V11, P271, DOI 10.1016/0168-1605(90)90020-6; Yoneda S, 2005, EUR J PHARMACOL, V508, P223, DOI 10.1016/j.ejphar.2004.12.007	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0041-0101			TOXICON	Toxicon	NOV	2014	90						97	105		10.1016/j.toxicon.2014.07.013		9	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	AU7ZR	WOS:000345817200010		
J	Satoh, N; Kon, T; Yamagishi, N; Takahashi, T; Natsuaki, T; Yoshikawa, N				Satoh, Nozomi; Kon, Tatsuya; Yamagishi, Noriko; Takahashi, Tsubasa; Natsuaki, Tomohide; Yoshikawa, Nobuyuki			Apple Latent Spherical Virus Vector as Vaccine for the Prevention and Treatment of Mosaic Diseases in Pea, Broad Bean, and Eustoma Plants by Bean Yellow Mosaic Virus	VIRUSES-BASEL			English	Article						ALSV vaccine; pea; broad bean; eustoma; BYMV; preventive and curative effects	CROSS-PROTECTION; ARABIDOPSIS-THALIANA; IMMUNE-SYSTEM; RNA; POTYVIRUS; PROTEINS; INFECTIONS; SEQUENCE; DEFENSE; TOBACCO	We investigated the protective effects of a viral vector based on an Apple latent spherical virus (ALSV) harboring a segment of the Bean yellow mosaic virus (BYMV) genome against mosaic diseases in pea, broad bean, and eustoma plants caused by BYMV infection. In pea plants pre-inoculated with the ALSV vaccine and challenge inoculated with BYMV expressing green fluorescence protein, BYMV multiplication occurred in inoculated leaves, but was markedly inhibited in the upper leaves. No mosaic symptoms due to BYMV infection were observed in the challenged plants pre-inoculated with the ALSV vaccine. Simultaneous inoculation with the ALSV vaccine and BYMV also prevented mosaic symptoms in broad bean and eustoma plants, and BYMV accumulation was strongly inhibited in the upper leaves of plants treated with the ALSV vaccine. Pea and eustoma plants were pre-inoculated with BYMV followed by inoculation with the ALSV vaccine to investigate the curative effects of the ALSV vaccine. In both plant species, recovery from mosaic symptoms was observed in upper leaves and BYMV accumulation was inhibited in leaves developing post-ALSV vaccination. These results show that ALSV vaccination not only prevents mosaic diseases in pea, broad bean, and eustoma, but that it is also effective in curing these diseases.	[Satoh, Nozomi; Kon, Tatsuya; Yamagishi, Noriko; Takahashi, Tsubasa; Yoshikawa, Nobuyuki] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Natsuaki, Tomohide] Utsunomiya Univ, Fac Agr, Utsunomiya, Tochigi 3218505, Japan	Yoshikawa, N (reprint author), Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan.	a2514010@iwate-u.ac.jp; tkon@iwate-u.ac.jp; nyama@iwate-u.ac.jp; tsubasa-t@imic.co.jp; natsuaki@cc.utsunomiya-u.ac.jp; yoshikawa@iwate-u.ac.jp			Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Ministry of Agriculture, Forestry and Fisheries, Japan	This work was supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry and Grants-in-Aid for Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fisheries from the Ministry of Agriculture, Forestry and Fisheries, Japan.	Adams MJ, 2012, VIRUS TAXONOMY, P1069; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Yaegashi H, 2007, ARCH VIROL, V152, P1839, DOI 10.1007/s00705-007-1011-4; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Nicaise V, 2007, FEBS LETT, V581, P1041, DOI 10.1016/j.febslet.2007.02.007; Igarashi A, 2009, VIROLOGY, V386, P407, DOI 10.1016/j.virol.2009.01.039; Yamagishi N, 2009, PLANT MOL BIOL, V71, P15, DOI 10.1007/s11103-009-9505-y; Maejima K, 2011, PHYTOPATHOLOGY, V101, P567, DOI 10.1094/PHYTO-10-10-0280; Ratcliff FG, 1999, PLANT CELL, V11, P1207; Culver JN, 1996, VIROLOGY, V226, P228, DOI 10.1006/viro.1996.0650; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Takahashi T, 2007, PHYTOPATHOLOGY, V97, P1200, DOI 10.1094/PHYTO-97-10-1200; SHUKLA DD, 1988, J GEN VIROL, V69, P2703, DOI 10.1099/0022-1317-69-11-2703; Li CJ, 2000, J GEN VIROL, V81, P541; Li C, 2004, ARCH VIROL, V149, P1541, DOI 10.1007/s00705-004-0310-2; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Kishi K., 1998, PLANT DIS JAPAN; Koganezawa H., 2011, VIRUS VIRUS LIKE DIS, P23; Lecellier CH, 2004, IMMUNOL REV, V198, P285, DOI 10.1111/j.0105-2896.2004.00128.x; Maejima K, 2010, J GEN PLANT PATHOL, V76, P229, DOI 10.1007/s10327-010-0233-6; ORELLANA RG, 1978, APPL ENVIRON MICROB, V36, P814; Rohani B, 2008, Commun Agric Appl Biol Sci, V73, P303; Sasaki S, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-15; Sasaya Takahide, 1998, Annals of the Phytopathological Society of Japan, V64, P24; Taki A, 2013, VIRUS RES, V176, P251, DOI 10.1016/j.virusres.2013.06.015; Tamura A, 2013, VIROLOGY, V446, P314, DOI 10.1016/j.virol.2013.08.019; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; WALKEY DGA, 1992, PLANT PATHOL, V41, P762, DOI 10.1111/j.1365-3059.1992.tb02560.x; Wang XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050627; WEN F, 1991, J GEN VIROL, V72, P791, DOI 10.1099/0022-1317-72-4-791; Wylie SJ, 2008, PLANT DIS, V92, P1596, DOI 10.1094/PDIS-92-12-1596; Yamagishi N., 2010, JULIUS KUHN ARCH, V427, P226	36	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	NOV	2014	6	11					4242	4257		10.3390/v6114242		16	Virology	Virology	AU4FL	WOS:000345565200007		
J	Kitamura, A; Nakagami, G; Yoshida, M; Noguchi, H; Nishijima, Y; Minematsu, T; Naito, A; Sugawara, J; Shibayama, H; Takahashi, K; Hakuta, A; Umemoto, J; Terada, N; Segawa, R; Mori, T; Sanada, H				Kitamura, Aya; Nakagami, Gojiro; Yoshida, Mikako; Noguchi, Hiroshi; Nishijima, Yoshimi; Minematsu, Takeo; Naito, Ayumi; Sugawara, Jun; Shibayama, Hiroki; Takahashi, Kazuo; Hakuta, Amiko; Umemoto, Junichi; Terada, Nao; Segawa, Ryo; Mori, Taketoshi; Sanada, Hiromi			Visualization of Tumor Necrosis Factor-alpha Distributions Within Pressure Ulcer Tissue Using the Wound Blotting Method: A Case Report and Discussion	WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE			English	Article						assessment; exudate; pressure ulcer; protein distribution; wound blotting	TOOL	Wound blotting can be used to visualize the protein distribution on a wound bed through protein collection by attaching a nitrocellulose membrane to the wound surface. This study checked for consistency between the protein distributions determined by wound blotting and those determined by removal of the tissue. A patient who was planning to undergo surgical debridement of an ulcer in the sacral region that was caused by lying down for a long period after a cerebral hemorrhage was recruited in Fujisawa City Hospital, Kanagawa, Japan. Wound blotting was performed just prior to surgical debridement and the debrided tissue embedded in paraffin. The ulcer, which had a 2.9 cm major axis, was divided into 2.0 areas approximately 0.35 cm(2) each, and the consistency of tumor necrosis factor-a positivity between the wound blotting samples and tissue sections was examined in each area. The sensitivity and specificity of wound blotting were 89% and 82%, respectively. This wound blotting method noninvasively revealed the protein distributions within the wound tissue.	[Kitamura, Aya; Nakagami, Gojiro; Yoshida, Mikako; Noguchi, Hiroshi; Nishijima, Yoshimi; Minematsu, Takeo; Mori, Taketoshi; Sanada, Hiromi] Univ Tokyo, Tokyo 1130033, Japan; [Naito, Ayumi; Sugawara, Jun; Takahashi, Kazuo; Umemoto, Junichi; Terada, Nao; Segawa, Ryo] Fujisawa City Hosp, Fujisawa, Kanagawa, Japan; [Shibayama, Hiroki; Takahashi, Kazuo] Saitama Med Ctr, Saitama, Japan; [Hakuta, Amiko] Yokohama City Univ Med, Yokohama, Kanagawa, Japan	Sanada, H (reprint author), Univ Tokyo, Dept Gerontol Nursing Wound Care Management, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hsanada-tky@umin.ac.jp			Japan Society for the Promotion of Science	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Ai S, 2004, GERIATR GERONTOL INT, V4, P141, DOI 10.1111/j.1447-0594.2004.00243.x; Matsui Y, 2011, WOUND REPAIR REGEN, V19, P309, DOI 10.1111/j.1524-475X.2011.00674.x; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Eming SA, 2010, J PROTEOME RES, V9, P4758, DOI 10.1021/pr100456d; Hasmann A, 2011, EXP DERMATOL, V20, P508, DOI 10.1111/j.1600-0625.2011.01256.x; Ashcroft GS, 2012, WOUND REPAIR REGEN, V20, P38, DOI 10.1111/j.1524-475X.2011.00748.x; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Weinstein DA, 2010, J AM ACAD DERMATOL, V63, P146, DOI 10.1016/j.jaad.2009.08.004; Minematsu T, 2013, WOUND REPAIR REGEN, V21, P329, DOI 10.1111/wrr.12017; Bates-Jensen B M, 1992, Decubitus, V5, P20; Stremitzer Stefan, 2007, Int Wound J, V4, P156, DOI 10.1111/j.1742-481X.2007.00334.x; Trostrup H, 2011, BRIT J DERMATOL, V165, P292, DOI 10.1111/j.1365-2133.2011.10384.x	12	0	0	H M P COMMUNICATIONS	MALVERN	83 GENERAL WARREN BLVD, STE 100, MALVERN, PA 19355 USA	1044-7946	1943-2704		WOUNDS	Wounds-Compend. Clin. Res. Pract.	NOV	2014	26	11					323	329				7	Dermatology; Surgery	Dermatology; Surgery	AU6UE	WOS:000345736300004		
J	Altmann, CF; Uesaki, M; Ono, K; Matsuhashi, M; Mima, T; Fukuyama, H				Altmann, Christian F.; Uesaki, Maiko; Ono, Kentaro; Matsuhashi, Masao; Mima, Tatsuya; Fukuyama, Hidenao			Categorical speech perception during active discrimination of consonants and vowels	NEUROPSYCHOLOGIA			English	Article						Auditory information processing; Auditory perception; Categorical perception; Human subjects; Magnetoencephalography; Phonological processing	HUMAN AUDITORY-CORTEX; VOICE ONSET TIME; ELECTROPHYSIOLOGICAL EVIDENCE; BRAIN MECHANISMS; LEXICAL TONES; SOUNDS; CATEGORIZATION; ADAPTATION; IDENTIFICATION; RESPONSES	Categorical perception of phonemes describes the phenomenon that, when phonemes are classified they are often perceived to fall into distinct categories even though physically they follow a continuum along a feature dimension. While consonants such as plosives have been proposed to be perceived categorically, the representation of vowels has been described to be more continuous. We aimed at testing this difference in representation at a behavioral and neurophysiological level using human magnetoencephalography (MEG). To this end, we designed stimuli based on natural speech by morphing along a phonological continuum entailing changes of the voiced stop-consonant or the steady-state vowel of a consonant vowel (CV) syllable. Then, while recording MEG, we presented participants with consecutive pairs of either same or different CV syllables. The differences were such that either both CV syllables were from within the same category or belonged to different categories. During the MEG experiment, the participants actively discriminated the stimulus pairs. Behaviorally, we found that discrimination was easier for the between-compared to the within-category contrast for both consonants and vowels. However, this categorical effect was significantly stronger for the consonants compared to vowels, in line with a more continuous representation of vowels. At the neural level, we observed significant repetition suppression of MEG evoked fields, i.e. lower amplitudes for physically same compared to different stimulus pairs, at around 430 to 500 ms after the onset of the second stimulus. Source reconstruction revealed generating sources of this repetition suppression effect within left superior temporal sulcus and gyms, posterior to Heschl's gyms. A region-of-interest analysis within this region showed a clear categorical effect for consonants, but not for vowels, providing further evidence for the important role of left superior temporal areas in categorical representation during active phoneme discrimination. (C) 2014 Elsevier Ltd. All rights reserved.	[Altmann, Christian F.; Ono, Kentaro; Matsuhashi, Masao; Mima, Tatsuya; Fukuyama, Hidenao] Kyoto Univ, Human Brain Res Ctr, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan; [Altmann, Christian F.; Uesaki, Maiko; Ono, Kentaro] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Kyoto 6068501, Japan; [Uesaki, Maiko] Kyoto Univ, Grad Sch Letters, Dept Psychol, Kyoto 6068501, Japan	Altmann, CF (reprint author), Kyoto Univ, Human Brain Res Ctr, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawaracho, Kyoto 6068507, Japan.	christian.altmann.6z@kyoto-u.ac.jp			Special Coordination Fund for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Society for the Promotion of Science [23730701, 25870333, 24300192, 2450226]	This work was supported by the Special Coordination Fund for Promoting Science and Technology to CFA from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Grants-in-Aid for Young Scientists (B) 23730701 and 25870333 to CFA, and Grants-in-Aid for Scientific Research (B) 24300192 and for Exploratory Research (2450226) to TM from the Japan Society for the Promotion of Science. We would like to thank Hideki Kawahara and Toshio Irino for helpful discussion on the STRAIGHT software and experimental design. We would also like to thank Marc Chevillet for helpful advice on experimental design and Kimihiro Nakamura for valuable comments on a first draft of this manuscript.	Ackermann H, 1999, COGNITIVE BRAIN RES, V7, P511, DOI 10.1016/S0926-6410(98)00054-8; Altmann CF, 2008, CEREB CORTEX, V18, P1350, DOI 10.1093/cercor/bhm166; Altmann CF, 2012, CLIN NEUROPHYSIOL, V123, P2273, DOI 10.1016/j.clinph.2012.04.004; WERKER JF, 1984, J ACOUST SOC AM, V75, P1866, DOI 10.1121/1.390988; Diehl RL, 2004, ANNU REV PSYCHOL, V55, P149, DOI 10.1146/annurev.psych.55.090902.142028; Iverson P, 2000, PERCEPT PSYCHOPHYS, V62, P874, DOI 10.3758/BF03206929; KLUENDER KR, 1987, SCIENCE, V237, P1195, DOI 10.1126/science.3629235; Myers EB, 2009, PSYCHOL SCI, V20, P895, DOI 10.1111/j.1467-9280.2009.02380.x; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; Xi J, 2010, NEUROSCIENCE, V170, P223, DOI 10.1016/j.neuroscience.2010.06.077; MAY B, 1989, J ACOUST SOC AM, V85, P837, DOI 10.1121/1.397555; Chevillet MA, 2013, J NEUROSCI, V33, P5208, DOI 10.1523/JNEUROSCI.1870-12.2013; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Kuhl PK, 2010, NEURON, V67, P713, DOI 10.1016/j.neuron.2010.08.038; Schweinberger SR, 2008, CURR BIOL, V18, P684, DOI 10.1016/j.cub.2008.04.015; Maris E, 2004, PSYCHOPHYSIOLOGY, V41, P142, DOI 10.1111/j.1469-8986.2003.00139.x; Frye RE, 2007, J COGNITIVE NEUROSCI, V19, P1476, DOI 10.1162/jocn.2007.19.9.1476; Zhang LJ, 2012, NEUROREPORT, V23, P35, DOI 10.1097/WNR.0b013e32834e4842; Buracas GT, 2002, NEUROIMAGE, V16, P801, DOI 10.1006/nimg.2002.1116; Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Raizada RDS, 2007, NEURON, V56, P726, DOI 10.1016/j.neuron.2007.11.001; FRY DB, 1962, LANG SPEECH, V5, P171; Toscano JC, 2010, PSYCHOL SCI, V21, P1532, DOI 10.1177/0956797610384142; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Bidelman GM, 2013, NEUROIMAGE, V79, P201, DOI 10.1016/j.neuroimage.2013.04.093; Obleser J, 2003, NEUROIMAGE, V20, P1839, DOI 10.1016/j.neuroimage.2003.07.019; Holt LL, 2010, ATTEN PERCEPT PSYCHO, V72, P1218, DOI 10.3758/APP.72.5.1218; Lee YS, 2012, J NEUROSCI, V32, P3942, DOI 10.1523/JNEUROSCI.3814-11.2012; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; MICELI G, 1980, BRAIN LANG, V11, P159, DOI 10.1016/0093-934X(80)90117-0; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Joanisse MF, 2007, CEREB CORTEX, V17, P2084, DOI 10.1093/cercor/bhl124; Dehaene-Lambertz G, 2005, NEUROIMAGE, V24, P21, DOI 10.1016/j.neuroimage.2004.09.039; DehaeneLambertz G, 1997, NEUROREPORT, V8, P919, DOI 10.1097/00001756-199703030-00021; HOLM S, 1979, SCAND J STAT, V6, P65; Mirman D, 2004, J ACOUST SOC AM, V116, P1198, DOI 10.1121/1.1766020; PISONI DB, 1975, MEM COGNITION, V3, P7, DOI 10.3758/BF03198202; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Altmann CF, 2007, CEREB CORTEX, V17, P2601, DOI 10.1093/cercor/bhl167; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; PISONI DB, 1973, PERCEPT PSYCHOPHYS, V13, P253, DOI 10.3758/BF03214136; Blumstein Sheila E., 1995, P915; Turkeltaub PE, 2010, BRAIN LANG, V114, P1, DOI 10.1016/j.bandl.2010.03.008; KUHL PK, 1978, J ACOUST SOC AM, V63, P905, DOI 10.1121/1.381770; MAISTE AC, 1995, EAR HEARING, V16, P68, DOI 10.1097/00003446-199502000-00006; Chakladar S, 2008, J NEUROSCI METH, V170, P45, DOI 10.1016/j.jneumeth.2007.12.023; EIMAS PD, 1963, LANG SPEECH, V6, P206; Friston K. J., 1994, HUMAN BRAIN MAPPING, V1, P214; Henson RN, 2007, NEUROIMAGE, V38, P422, DOI 10.1016/j.neuroimage.2007.07.026; Hoshiyama M, 2007, EUR J NEUROSCI, V25, P854, DOI 10.1111/j.1460-9568.2007.05315.x; Jaaskelainen L. P., 2004, P NATL ACAD SCI USA, V101, P6809; Kawahara H, 2003, P IEEE INT C AC SPEE, VI, P256; KUHL PK, 1991, PERCEPT PSYCHOPHYS, V50, P93, DOI 10.3758/BF03212211; KUHL PK, 1983, J ACOUST SOC AM, V73, P1003, DOI 10.1121/1.389148; Kuriki S, 2006, J NEUROSCI, V26, P4046, DOI 10.1523/JNEUROSCI.3907-05.2006; Kuriki S, 2007, CEREB CORTEX, V17, P2725, DOI 10.1093/cercor/bhl182; Macmillan N. A., 2005, DETECTION THEORY USE; Mattout J., 2007, COMPUT INTEL NEUROSC, P67613, DOI DOI 10.1155/2007/67613; Minagawa-Kawai Y, 2005, J COGNITIVE NEUROSCI, V17, P1376, DOI 10.1162/0898929054985482; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Schweinberger SR, 2001, NEUROPSYCHOLOGIA, V39, P921, DOI 10.1016/S0028-3932(01)00023-9; Simos PG, 1998, COGNITIVE BRAIN RES, V7, P215, DOI 10.1016/S0926-6410(98)00037-8; Spreckelmeyer K. N., 2008, BRAIN COGNITION, V69, P121, DOI DOI 10.1016/J.BANDC.2008.06.003; Zaske R, 2009, EUR J NEUROSCI, V30, P527, DOI 10.1111/j.1460-9568.2009.06839.x; Zhang LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016305	69	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	NOV	2014	64						13	23		10.1016/j.neuropsychologia.2014.09.006		11	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	AU6TL	WOS:000345734500002		
J	Shinohara, K				Shinohara, Katsutoshi			On the minimality of semigroup actions on the interval which are C-1-close to the identity	PROCEEDINGS OF THE LONDON MATHEMATICAL SOCIETY			English	Article							PHASE-TRANSITIONS; PHYSICAL MEASURES	We consider semigroup actions on the interval generated by two attracting maps. It is known that if the generators are sufficiently C-2-close to the identity, then the minimal set coincides with the whole interval. In this article, we give a counterexample to this result in the C-1-topology.	Tokyo Metropolitan Univ, Dept Math & Informat Sci, Hachioji, Tokyo, Japan	Shinohara, K (reprint author), Tokyo Metropolitan Univ, Dept Math & Informat Sci, 1-1 Minami Osawa, Hachioji, Tokyo, Japan.	herrsinon@07.alumni.u-tokyo.ac.jp			London Mathematical Society; Aihara Project; FIRST program from JSPS; CSTP	This research is partially supported by the London Mathematical Society Grant and the Aihara Project, the FIRST program from JSPS, initiated by CSTP.	Moreira CGTD, 1996, ANN I H POINCARE-AN, V13, P741; Diaz LJ, 2011, NONLINEARITY, V24, P3391, DOI 10.1088/0951-7715/24/12/005; Avila A, 2010, COMMENT MATH HELV, V85, P813, DOI 10.4171/CMH/212; Diaz LJ, 2012, FUND MATH, V216, P55, DOI 10.4064/fm216-1-2; BARRIENTOS P, 2012, PREPRINT; BARRIENTOS P, PREPRINT; Deroin B, 2007, ACTA MATH-DJURSHOLM, V199, P199, DOI 10.1007/s11511-007-0020-1; Duminy G., 1977, UNPUB; Hardy G.H., 2008, INTRO THEORY NUMBERS; Herman M., 1979, PUBL MATH IHES, V49, P5, DOI 10.1007/BF02684798; Ilyashenko Y, 2010, NONLINEARITY, V23, P1199, DOI 10.1088/0951-7715/23/5/010; Kleptsyn V, 2014, MOSC MATH J, V14, P339; Moreira CG, 2011, ACTA MATH-DJURSHOLM, V206, P311, DOI 10.1007/s11511-011-0064-0; Navas A., 2004, ENSEIGN MATH, V50, P29; NAVAS A, 2012, PREPRINT; NAVAS A, 2011, CHICAGO LECT MATH, V99; Palis J., 1993, CAMBRIDGE STUDIES AD, V35; RAIBEKAS A, THESIS; SHINOHARA K, PREPRINT; TSUBOI T, 1995, J MATH SOC JPN, V47, P1, DOI 10.2969/jmsj/04710001; Tsujii M, 2005, ACTA MATH-DJURSHOLM, V194, P37, DOI 10.1007/BF02392516; Ures R, 1995, ANN SCI ECOLE NORM S, V28, P747; Viana M, 2013, ANN I H POINCARE-AN, V30, P845, DOI 10.1016/j.anihpc.2012.11.002	23	0	0	LONDON MATH SOC	LONDON	MORGAN HOUSE, 57-58 RUSSELL SQ, LONDON WC1B 4HS, ENGLAND	0024-6115	1460-244X		P LOND MATH SOC	Proc. London Math. Soc.	NOV	2014	109		5				1175	1202		10.1112/plms/pdu032		28	Mathematics	Mathematics	AU8HE	WOS:000345836400003		
J	Ishii, S; Inoue, SI; Ueda, R; Otomo, A				Ishii, Satoshi; Inoue, Shin-ichiro; Ueda, Rieko; Otomo, Akira			Optical Detection in a Waveguide Geometry with a Single Metallic Contact	ACS PHOTONICS			English	Article						Hot carrier; metal thin film; optical waveguide; internal photoemission	SCHOTTKY DETECTOR; PHOTODETECTORS; PERFORMANCE; COLLECTION; EXTRACTION; DEPENDENCE; JUNCTIONS; CURRENTS; SIGE; BAND	A single metallic contact attached to an optical waveguide is used to electrically detect near-infrared guided light through an optical waveguide. The device has a metal-insulator-metal structure, where the difference in the number of excited hot carriers in the top and bottom metallic layers can generate a photocurrent. The simple, compact structure of the device allows it to be integrated with any type of optical waveguide to monitor the guided light.	[Ishii, Satoshi; Inoue, Shin-ichiro; Ueda, Rieko; Otomo, Akira] Natl Inst Informat & Commun Technol, Adv ICT Res Inst, Kobe, Hyogo 6512492, Japan; [Inoue, Shin-ichiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Ishii, S (reprint author), NIMS, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan.	sishii@nims.go.jp	ISHII, Satoshi/O-4547-2014		Ministry of Internal Affairs and Communications under the Strategic Information and Communications R&D Promotion Programme (SCOPE)	This work was partially supported by the Ministry of Internal Affairs and Communications under the Strategic Information and Communications R&D Promotion Programme (SCOPE).	Smit M, 2012, LASER PHOTONICS REV, V6, P1, DOI 10.1002/lpor.201100001; Young IA, 2010, IEEE J SOLID-ST CIRC, V45, P235, DOI 10.1109/JSSC.2009.2034444; Goykhman I, 2012, OPT EXPRESS, V20, P28594, DOI 10.1364/OE.20.028594; Knight MW, 2013, NANO LETT, V13, P1687, DOI 10.1021/nl400196z; Ahn D, 2007, OPT EXPRESS, V15, P3916, DOI 10.1364/OE.15.003916; Wang FM, 2011, NANO LETT, V11, P5426, DOI 10.1021/nl203196z; Akbari A, 2010, OPT EXPRESS, V18, P8505, DOI 10.1364/OE.18.008505; GOODMAN AM, 1971, J APPL PHYS, V42, P2823, DOI 10.1063/1.1660633; POWELL RJ, 1970, J APPL PHYS, V41, P2424, DOI 10.1063/1.1659238; Chalabi H, 2014, NANO LETT, V14, P1374, DOI 10.1021/nl4044373; Neutens P, 2009, NAT PHOTONICS, V3, P283, DOI 10.1038/NPHOTON.2009.47; Knight MW, 2011, SCIENCE, V332, P702, DOI 10.1126/science.1203056; Stella K, 2011, J ELECTROCHEM SOC, V158, pP65, DOI 10.1149/1.3566194; Thissen P, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113014; Goykhman I, 2011, NANO LETT, V11, P2219, DOI 10.1021/nl200187v; Pradhan AK, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3684833; Diesing D, 2004, APPL PHYS B-LASERS O, V78, P443, DOI 10.1007/s00340-003-1391-4; Dufaux T, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3503534; MICHAELSON HB, 1977, J APPL PHYS, V48, P4729, DOI 10.1063/1.323539; Bersch E, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085114; BRAUNSTE.A, 1965, PHYS REV LETT, V14, P219, DOI 10.1103/PhysRevLett.14.219; BURSHTEIN Z, 1975, PHYS REV B, V12, P3453, DOI 10.1103/PhysRevB.12.3453; DEIMEL PP, 1990, IEEE PHOTONIC TECH L, V2, P499, DOI 10.1109/68.56637; ELCHINGER GM, 1976, J APPL PHYS, V47, P591, DOI 10.1063/1.322674; GOODMAN AM, 1966, J APPL PHYS, V37, P3580, DOI 10.1063/1.1708906; GUNDLACH KH, 1975, THIN SOLID FILMS, V28, P107, DOI 10.1016/0040-6090(75)90279-5; Kato K, 1999, IEEE T MICROW THEORY, V47, P1265, DOI 10.1109/22.775466; Kovacs D A, 2007, PHYS REV B, V76; Scales C, 2011, J LIGHTWAVE TECHNOL, V29, P1852, DOI 10.1109/JLT.2011.2147279; Shiraishi T., 2011, COST EFFECTIVE ON BO; Slayman C., 1978, Picosecond phenomena; Sobhani A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2642; SPLETT A, 1994, IEEE PHOTONIC TECH L, V6, P59, DOI 10.1109/68.265889; Thylen L., 2006, J ZHEJIANG UNIV-SC A, V7, P1961; Vivien L, 2009, OPT EXPRESS, V17, P6252, DOI 10.1364/OE.17.006252; Wang FM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2728	36	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2330-4022			ACS PHOTONICS	ACS Photonics	NOV	2014	1	11					1089	1092		10.1021/ph500131v		4	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Optics; Physics, Applied; Physics, Condensed Matter	Science & Technology - Other Topics; Materials Science; Optics; Physics	AU3WW	WOS:000345542400001		
J	Yoshida, H; Yamamoto, T; Mori, Y; Masuda, H; Okazaki, K; Sugasawa, H				Yoshida, Hideto; Yamamoto, Tetsuya; Mori, Yasushige; Masuda, Hiroaki; Okazaki, Kenji; Sugasawa, Hirosuke			Particle size measurement of reference particle candidates and uncertainty region of count and mass based cumulative distribution	ADVANCED POWDER TECHNOLOGY			English	Article						Particle size; Reference particle; Uncertainty region; Log-normal distribution; Size measurement	SAMPLE-SIZE	In order to confirm reliable particle size measurement technique and to prepare standard reference particles for calibrating particle size measurement devices, uncertainty region of count and mass based size distribution have been theoretically examined. The uncertainty region of count base cumulative size distribution is smaller than that of the mass base cumulative distribution. The uncertainty region of count base cumulative size distribution is nearly constant over wide range of particle diameter and the region is nearly constant for sample size greater than about 20,000. On the other hand, the uncertainty region of mass base cumulative distribution increases with the increase of particle diameter. The reliability of theoretical uncertainty region is confirmed by the experimental data of particle size measurement. (C) 2014 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.	[Yoshida, Hideto; Yamamoto, Tetsuya; Okazaki, Kenji] Hiroshima Univ, Dept Chem Engn, Hiroshima 7398527, Japan; [Mori, Yasushige] Doshisha Univ, Dept Chem Engn & Mat Sci, Kyoto 6300321, Japan; [Masuda, Hiroaki] Kyoto Univ, Kobe, Hyogo 6508586, Japan; [Masuda, Hiroaki] Kobe Gakuin Univ, Cooperat Res Ctr Life Sci, Chuou Ku, Kobe, Hyogo 6508586, Japan; [Sugasawa, Hirosuke] Horiba Co Ltd, Minami Ku, Kyoto 6018510, Japan	Yoshida, H (reprint author), Hiroshima Univ, Dept Chem Engn, 1-4-1 Kagamiyama, Hiroshima 7398527, Japan.	r736619@hiroshima-u.ac.jp	Yamamoto, Tetsuya/C-9065-2011				Yoshida H, 2012, ADV POWDER TECHNOL, V23, P185, DOI 10.1016/j.apt.2011.01.011; [Anonymous], 2009, 13320 ISO; Masuda H, 1999, ADV POWDER TECHNOL, V10, P159, DOI 10.1016/S0921-8831(08)60447-1; Masuda H., 1971, J CHEM ENG JAPAN, V4, P60, DOI 10.1252/jcej.4.60; Mori Y, 2007, PART PART SYST CHAR, V24, P91, DOI 10.1002/ppsc.200601048; Witt W, 2012, CHEM-ING-TECH, V84, P211, DOI 10.1002/cite.201100172; Yoshida H, 2001, ADV POWDER TECHNOL, V12, P79, DOI 10.1163/156855201744976; Yoshida H, 2003, ADV POWDER TECHNOL, V14, P17, DOI 10.1163/156855203762469876; Yoshida H, 2011, ADV POWDER TECHNOL, V22, P43, DOI 10.1016/j.apt.2010.03.004	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8831	1568-5527		ADV POWDER TECHNOL	Adv. Powder Technol.	NOV	2014	25	6					1748	1753		10.1016/j.apt.2014.07.001		6	Engineering, Chemical	Engineering	AT9EE	WOS:000345230000013		
J	Kobayakawa, M; Yasuda, M; Matsusaka, S				Kobayakawa, Murino; Yasuda, Masatoshi; Matsusaka, Shuji			Microscopic analysis of saltation of particles on an obliquely oscillating plate	ADVANCED POWDER TECHNOLOGY			English	Article						Oblique oscillation; Fine particle; Saltation; Restitution coefficient; Fluid resistance	GRANULAR-MATERIALS; SIZE SEPARATION; CAPILLARY-TUBE; VIBRATION; POWDER; CONVECTION; FLUIDIZATION; IMPACT; BEADS; MEDIA	This paper presents a microscopic analysis of the saltation of particles on an obliquely oscillating plate driven by sine waves with an amplitude on the order of tens of micrometers and a frequency on the order of hundreds of hertz. To examine the effect of the diameter of a particle on its motion, the trajectories and velocities of different-sized particles, from 0.5 to 500 mu m in mass median diameter, are analyzed using images captured by a high-speed microscope camera. The results show that larger particles bounce higher, whereas smaller particles easily agglomerate and bounce only slightly, owing to the low restitution caused by their loosely packed structure. In addition, larger particles bounce forward and backward repeatedly, while the agglomerated particles always bounce forward, and consequently have the highest transport velocity among these particles. The particle motion and the transport velocity can be explained by a theoretical probability model. (C) 2014 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.	[Kobayakawa, Murino; Yasuda, Masatoshi; Matsusaka, Shuji] Kyoto Univ, Dept Chem Engn, Kyoto 6158510, Japan	Matsusaka, S (reprint author), Kyoto Univ, Dept Chem Engn, Kyoto 6158510, Japan.	matsu@cheme.kyoto-u.ac.jp			JSPS KAKENHI Grant [25-1710]	This work was supported by JSPS KAKENHI Grant Number 25-1710. The authors acknowledge the financial support. In addition, the authors are thankful to Taimei Chemicals Co., Ltd. and Fujimi Incorporated for providing particles.	Grochowski R, 2004, APPL PHYS LETT, V84, P1019, DOI 10.1063/1.1646219; WARR S, 1995, PHYS REV E, V52, P5596, DOI 10.1103/PhysRevE.52.5596; PAK HK, 1994, NATURE, V371, P231, DOI 10.1038/371231a0; Kharaz AH, 2001, POWDER TECHNOL, V120, P281, DOI 10.1016/S0032-5910(01)00283-2; Matsusaka S, 1995, ADV POWDER TECHNOL, V6, P283, DOI 10.1016/S0921-8831(08)60518-X; Ishii K, 2011, ADV POWDER TECHNOL, V22, P522, DOI 10.1016/j.apt.2010.07.008; Jiang YB, 2009, POWDER TECHNOL, V188, P242, DOI 10.1016/j.powtec.2008.05.003; Kudrolli A, 2004, REP PROG PHYS, V67, P209, DOI 10.1088/0034-4885/67/3/R01; Zainuddin IM, 2012, PART PART SYST CHAR, V29, P8, DOI 10.1002/ppsc.201100052; CLEMENT E, 1993, INT J MOD PHYS B, V7, P1807, DOI 10.1142/S0217979293002602; WOOD LA, 1981, J SOUND VIB, V78, P329, DOI 10.1016/S0022-460X(81)80143-5; LUDING S, 1994, PHYS REV E, V49, P1634, DOI 10.1103/PhysRevE.49.1634; Gorham DA, 2000, POWDER TECHNOL, V112, P193, DOI 10.1016/S0032-5910(00)00293-X; LAROCHE C, 1989, J PHYS-PARIS, V50, P699, DOI 10.1051/jphys:01989005007069900; Matsusaka S, 1996, ADV POWDER TECHNOL, V7, P141, DOI 10.1016/S0921-8831(08)60509-9; Sloot EM, 1996, POWDER TECHNOL, V87, P203, DOI 10.1016/0032-5910(96)03091-4; Nam CH, 2004, AICHE J, V50, P1776, DOI 10.1002/aic.10237; KNIGHT JB, 1993, PHYS REV LETT, V70, P3728, DOI 10.1103/PhysRevLett.70.3728; FENG CC, 1972, J ACOUST SOC AM, V52, P254, DOI 10.1121/1.1913087; Barroso JJ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026206; Cooke W, 1996, PHYS REV E, V53, P2812, DOI 10.1103/PhysRevE.53.2812; GALLAS JAC, 1992, PHYS REV LETT, V69, P1371, DOI 10.1103/PhysRevLett.69.1371; Germinard J.-C., 2003, PHYS REV E, V68; Iijima M, 2009, J AM CHEM SOC, V131, P16342, DOI 10.1021/ja906655r; Matsusaka S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01190; LUCK JM, 1993, PHYS REV E, V48, P3988, DOI 10.1103/PhysRevE.48.3988; TAGUCHI YH, 1992, PHYS REV LETT, V69, P1367, DOI 10.1103/PhysRevLett.69.1367; Wank JR, 2001, POWDER TECHNOL, V121, P195, DOI 10.1016/S0032-5910(01)00337-0; Zamankhan P, 2011, PHYSICA A, V390, P1402, DOI 10.1016/j.physa.2010.11.039; Zamankhan P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021306	30	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8831	1568-5527		ADV POWDER TECHNOL	Adv. Powder Technol.	NOV	2014	25	6					1845	1853		10.1016/j.apt.2014.07.016		9	Engineering, Chemical	Engineering	AT9EE	WOS:000345230000027		
J	Kobayakawa, M; Fujimoto, A; Sakata, M; Yasuda, M; Matsusaka, S				Kobayakawa, Murino; Fujimoto, Ayumi; Sakata, Mitsuhiro; Yasuda, Masatoshi; Matsusaka, Shuji			Numerical and theoretical study of particle saltation on an obliquely oscillating plate	ADVANCED POWDER TECHNOLOGY			English	Article						Oblique oscillation; Particle saltation; Restitution coefficient; Fluid resistance; Impulse	GRANULAR-MATERIALS; VIBRATORY CONVEYORS; SIZE SEPARATION; CAPILLARY-TUBE; POWDER; CONVECTION; BEADS; FLUIDIZATION; VIBRATIONS; TRANSPORT	Particle saltation on an obliquely oscillating plate is simulated using a mass-point model that considers gravity, fluid resistance, restitution, and friction. The calculated results are in good agreement with results obtained experimentally for particles with different diameters and restitutions. A large particle with high restitution bounces forward and backward repeatedly, whereas a particle with low restitution only bounces forward and consequently has a high transport velocity. The mechanism for the difference in the motion of the particles can be explained by taking into account the phase angle of the oscillating plate and the impulse during particle collision. (C) 2014 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.	[Kobayakawa, Murino; Fujimoto, Ayumi; Sakata, Mitsuhiro; Yasuda, Masatoshi; Matsusaka, Shuji] Kyoto Univ, Dept Chem Engn, Kyoto 6158510, Japan	Matsusaka, S (reprint author), Kyoto Univ, Dept Chem Engn, Kyoto 6158510, Japan.	matsu@cheme.kyoto-u.ac.jp			JSPS KAKENHI Grant [25-1710]	This work was supported by JSPS KAKENHI Grant Number 25-1710. The authors acknowledge the financial support.	Grochowski R, 2004, APPL PHYS LETT, V84, P1019, DOI 10.1063/1.1646219; WARR S, 1995, PHYS REV E, V52, P5596, DOI 10.1103/PhysRevE.52.5596; PAK HK, 1994, NATURE, V371, P231, DOI 10.1038/371231a0; Kobayakawa M, 2014, ADV POWDER TECHNOL, V25, P1845, DOI 10.1016/j.apt.2014.07.016; Matsusaka S, 1995, ADV POWDER TECHNOL, V6, P283, DOI 10.1016/S0921-8831(08)60518-X; Simsek E, 2008, PARTICUL SCI TECHNOL, V26, P177, DOI 10.1080/02726350801903772; Ishii K, 2011, ADV POWDER TECHNOL, V22, P522, DOI 10.1016/j.apt.2010.07.008; Falcon E, 1998, EUR PHYS J B, V5, P111, DOI 10.1007/s100510050424; Jiang YB, 2009, POWDER TECHNOL, V188, P242, DOI 10.1016/j.powtec.2008.05.003; Kudrolli A, 2004, REP PROG PHYS, V67, P209, DOI 10.1088/0034-4885/67/3/R01; RADEMACHER FJC, 1994, FORSCH INGENIEURWES, V60, P261, DOI 10.1007/BF02601316; GALLAS JAC, 1992, J PHYS II, V2, P1389; Zainuddin IM, 2012, PART PART SYST CHAR, V29, P8, DOI 10.1002/ppsc.201100052; CLEMENT E, 1993, INT J MOD PHYS B, V7, P1807, DOI 10.1142/S0217979293002602; WOOD LA, 1981, J SOUND VIB, V78, P329, DOI 10.1016/S0022-460X(81)80143-5; LUDING S, 1994, PHYS REV E, V49, P1634, DOI 10.1103/PhysRevE.49.1634; LAROCHE C, 1989, J PHYS-PARIS, V50, P699, DOI 10.1051/jphys:01989005007069900; Matsusaka S, 1996, ADV POWDER TECHNOL, V7, P141, DOI 10.1016/S0921-8831(08)60509-9; Sloot EM, 1996, POWDER TECHNOL, V87, P203, DOI 10.1016/0032-5910(96)03091-4; Nam CH, 2004, AICHE J, V50, P1776, DOI 10.1002/aic.10237; KNIGHT JB, 1993, PHYS REV LETT, V70, P3728, DOI 10.1103/PhysRevLett.70.3728; FENG CC, 1972, J ACOUST SOC AM, V52, P254, DOI 10.1121/1.1913087; Barroso JJ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026206; Cooke W, 1996, PHYS REV E, V53, P2812, DOI 10.1103/PhysRevE.53.2812; GALLAS JAC, 1992, PHYS REV LETT, V69, P1371, DOI 10.1103/PhysRevLett.69.1371; Germinard J.-C., 2003, PHYS REV E, V68; Lumay G, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13016-1; Matsusaka S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01190; LUCK JM, 1993, PHYS REV E, V48, P3988, DOI 10.1103/PhysRevE.48.3988; TAGUCHI YH, 1992, PHYS REV LETT, V69, P1367, DOI 10.1103/PhysRevLett.69.1367; Wank JR, 2001, POWDER TECHNOL, V121, P195, DOI 10.1016/S0032-5910(01)00337-0; Zamankhan P, 2011, PHYSICA A, V390, P1402, DOI 10.1016/j.physa.2010.11.039; Zamankhan P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021306	33	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8831	1568-5527		ADV POWDER TECHNOL	Adv. Powder Technol.	NOV	2014	25	6					1854	1859		10.1016/j.apt.2014.07.017		6	Engineering, Chemical	Engineering	AT9EE	WOS:000345230000028		
J	Zaidi, AA; Tsuji, T; Tanaka, T				Zaidi, Ali Abbas; Tsuji, Takuya; Tanaka, Toshitsugu			A new relation of drag force for high Stokes number monodisperse spheres by direct numerical simulation	ADVANCED POWDER TECHNOLOGY			English	Article						Drag force law; Gas-solid flows; Multiphase flows; Immersed Boundary Method; Direct numerical simulation	DISCRETE PARTICLE SIMULATION; GAS-SOLID SUSPENSIONS; COMPUTATIONAL FLUID-DYNAMICS; RANDOM ARRAYS; POROUS-MEDIA; PARTICULATE SUSPENSIONS; BOLTZMANN-EQUATION; INDUCED TURBULENCE; BIDISPERSE ARRAYS; KINETIC-THEORY	Immersed Boundary Method simulations are used to propose a drag correlation for randomly arranged monodisperse spheres. The solid volume fraction is varied from 0.05 to 0.5 and Reynolds number is varied from 0.01 to 1000. The particles have constant relative velocity to fluid and thus the present results are applicable to high Stokes number gas-solid flows. Average drag force acting on particles in both regular and random arrangements is compared with literature and good agreement is observed. At the end a new drag relation for monodisperse spheres is proposed and the physics behind its development is explained. (C) 2014 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.	[Zaidi, Ali Abbas; Tsuji, Takuya; Tanaka, Toshitsugu] Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan	Tanaka, T (reprint author), Osaka Univ, Dept Mech Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tanaka@mech.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	The authors would like to acknowledge Ministry of Education, Culture, Sports, Science and Technology, Japan for providing financial assistance. We are also grateful to Cybermedia Center, Osaka University and Center for Computing and Media Studies, Kyoto University for providing computational resources.	TANAKA M, 1993, PHYS FLUIDS A-FLUID, V5, P2079, DOI 10.1063/1.858546; Kajishima T, 2004, INT J HEAT FLUID FL, V25, P721, DOI 10.1016/j.ijheatfluidflow.2004.05.007; Bokkers GA, 2004, POWDER TECHNOL, V140, P176, DOI 10.1016/j.powtec.2004.01.018; Koch DL, 1999, J FLUID MECH, V400, P229, DOI 10.1017/S0022112099006485; Holloway W, 2010, AICHE J, V56, P1995, DOI 10.1002/aic.12127; ANDERSON TB, 1967, IND ENG CHEM FUND, V6, P527, DOI 10.1021/i160024a007; Heynderickx GJ, 2004, IND ENG CHEM RES, V43, P4635, DOI 10.1021/ie034122m; Xu BH, 1997, CHEM ENG SCI, V52, P2785, DOI 10.1016/S0009-2509(97)00081-X; DING J, 1990, AICHE J, V36, P523, DOI 10.1002/aic.690360404; ZICK AA, 1982, J FLUID MECH, V115, P13, DOI 10.1017/S0022112082000627; Xu M, 2012, CHEM ENG J, V207, P746, DOI 10.1016/j.cej.2012.07.049; Hoomans BPB, 1996, CHEM ENG SCI, V51, P99, DOI 10.1016/0009-2509(95)00271-5; HASIMOTO H, 1959, J FLUID MECH, V5, P317, DOI 10.1017/S0022112059000222; Goldstein S, 1930, P CAMB PHILOS SOC, V26, P1; Yin XL, 2009, AICHE J, V55, P1352, DOI 10.1002/aic.11800; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47; Koch DL, 1997, J FLUID MECH, V349, P31, DOI 10.1017/S002211209700671X; Beetstra R, 2007, AICHE J, V53, P489, DOI 10.1002/aic.11065; Hill RJ, 2001, J FLUID MECH, V448, P213, DOI 10.1017/S0022112001005948; Tenneti S, 2011, INT J MULTIPHAS FLOW, V37, P1072, DOI 10.1016/j.ijmultiphaseflow.2011.05.010; Andrade JS, 1997, PHYS REV LETT, V79, P3901, DOI 10.1103/PhysRevLett.79.3901; Mittal R, 2005, ANNU REV FLUID MECH, V37, P239, DOI 10.1146/annurev.fluid.37.061903.175743; Hill RJ, 2001, J FLUID MECH, V448, P243, DOI 10.1017/S0022112001005936; Tsuji T, 2003, INT J MULTIPHAS FLOW, V29, P1431, DOI 10.1016/S0301-9322(03)00137-X; ERGUN S, 1952, CHEM ENG PROG, V48, P89; Kajishima T, 2002, INT J HEAT FLUID FL, V23, P639, DOI 10.1016/S0142-727X(02)00159-5; Van der Hoef MA, 2005, J FLUID MECH, V528, P233, DOI 10.1017/S0022112004003295; Wang SA, 2011, POWDER TECHNOL, V208, P98, DOI 10.1016/j.powtec.2010.12.007; LADD AJC, 1994, J FLUID MECH, V271, P311, DOI 10.1017/S0022112094001783; Du W, 2006, CHEM ENG SCI, V61, P1401, DOI 10.1016/j.ces.2005.08.013; TSUJI Y, 1993, POWDER TECHNOL, V77, P79, DOI 10.1016/0032-5910(93)85010-7; LADD AJC, 1990, J CHEM PHYS, V93, P3484, DOI 10.1063/1.458830; Yin XL, 2009, IND ENG CHEM RES, V48, P227, DOI 10.1021/ie800171p; [Anonymous], MPICH2 VERS 1 3 2; Kajishima T, 2001, JSME INT J B-FLUID T, V44, P526, DOI 10.1299/jsmeb.44.526; Benyahia S, 2010, IND ENG CHEM RES, V49, P5122, DOI 10.1021/ie900658k; Berrouk AS, 2010, CHEM ENG J, V160, P810, DOI 10.1016/j.cej.2010.04.001; DIFELICE R, 1994, INT J MULTIPHAS FLOW, V20, P153, DOI 10.1016/0301-9322(94)90011-6; Gidaspow D., 1986, APPL MECH REV, V39, P1; Gomez LC, 2004, BRAZ J CHEM ENG, V21, P569, DOI 10.1590/S0104-66322004000400006; Hirsch C., 1988, NUMERICAL COMPUTATIO, V1, P283; KIM S, 1985, J FLUID MECH, V154, P269, DOI 10.1017/S0022112085001525; LADD AJC, 1994, J FLUID MECH, V271, P285, DOI 10.1017/S0022112094001771; Leboreiro J, 2008, POWDER TECHNOL, V184, P275, DOI 10.1016/j.powtec.2007.08.015; Richardson J. F., 1954, T I CHEM ENG-LOND, V32, P35; Rojas S, 1998, PHYS REV E, V58, P4776, DOI 10.1103/PhysRevE.58.4776; SANGANI AS, 1982, INT J MULTIPHAS FLOW, V8, P343, DOI 10.1016/0301-9322(82)90047-7; Schiller L., 1935, VDI ZEITUNG; Syamlal M., 1987, GEN DRAG CORRELATION; Yin X. L., 2007, PHYS FLUIDS, V19; Yu Y. H., 1966, CHEM ENG PROGR S SER, V62, P100	51	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8831	1568-5527		ADV POWDER TECHNOL	Adv. Powder Technol.	NOV	2014	25	6					1860	1871		10.1016/j.apt.2014.07.019		12	Engineering, Chemical	Engineering	AT9EE	WOS:000345230000029		
J	Shinto, H; Fukasawa, T; Yoshisue, K; Tezuka, M; Orita, M				Shinto, Hiroyuki; Fukasawa, Tomonori; Yoshisue, Kosuke; Tezuka, Mikihito; Orita, Mayumi			Cell membrane disruption induced by amorphous silica nanoparticles in erythrocytes, lymphocytes, malignant melanocytes, and macrophages	ADVANCED POWDER TECHNOLOGY			English	Article						Silica nanoparticles; Mammalian cells; Hemolysis; Cytotoxicity; Membrane disruption	SUPPORTED LIPID-BILAYERS; ATOMIC-FORCE MICROSCOPY; HUMAN ENDOTHELIAL-CELLS; IN-VITRO; HEMOLYTIC-ACTIVITY; MESOPOROUS SILICA; OXIDATIVE STRESS; PHOSPHOLIPID-BILAYERS; UNILAMELLAR VESICLES; INDUCED CYTOTOXICITY	It is of critical importance to examine carefully the potential adverse effects of engineered nanoparticles (NPs) on human health and environments. In the present study, we have investigated the disruption of cell membranes induced by amorphous silica NPs in erythrocytes, lymphocytes (Jurkat), malignant melanocytes (B16F10), and macrophages (J774.1); these four types of mammalian cells have distinctive characteristics in terms of nucleated/non-nucleated cells, adherent/non-adherent cells, endocytosis, and phagocytosis. The silica-induced membranolysis was examined by exposing these different cells to serum-free culture media containing the amorphous silica NPs of different diameters (28, 50, 55, 156, and 461 nm) under similar conditions. We investigated how the silica-induced membranolysis of the cells of different origins is influenced by the size and dose of the silica NPs. Additionally, the interaction forces of a silica microsphere with a living cell or a giant unilamellar vesicle composed of zwitterionic phosphatidylcholine lipids were measured by colloid-probe atomic force microcopy, whereby the affinities of silica surface for plasma membranes and protein-free phospholipid membranes were estimated. Possible mechanism of the silica-induced membranolysis was discussed. (C) 2014 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.	[Shinto, Hiroyuki; Fukasawa, Tomonori; Yoshisue, Kosuke; Tezuka, Mikihito; Orita, Mayumi] Kyoto Univ, Dept Chem Engn, Nishikyo Ku, Kyoto 6158510, Japan	Shinto, H (reprint author), Fukuoka Univ, Dept Chem Engn, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	hshinto@fukuoka-u.ac.jp	Fukasawa, Tomonori/J-3396-2015	Fukasawa, Tomonori/0000-0003-0183-2231	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) in Japan [22686072, 23656489, 25289276, S0901039, S1201010]; Iketani Science and Technology Foundation; Hosokawa Powder Technology Foundation; Information Center of Particle Technology, Japan	The authors thank for financial support by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) in Japan (Grants-in-Aid for Scientific Research, Nos. 22686072, 23656489, and 25289276; Strategic Development of Research Infrastructure for Private Universities, Nos. S0901039 and S1201010), Iketani Science and Technology Foundation, Hosokawa Powder Technology Foundation, and the Information Center of Particle Technology, Japan.	Yu KO, 2009, J NANOPART RES, V11, P15, DOI 10.1007/s11051-008-9417-9; Murashov V, 2006, J OCCUP ENVIRON HYG, V3, P718, DOI 10.1080/15459620601015950; NASH T, 1966, NATURE, V210, P259, DOI 10.1038/210259a0; HARLEY JD, 1961, NATURE, V189, P1010, DOI 10.1038/1891010a0; Horie M, 2009, CHEM RES TOXICOL, V22, P543, DOI 10.1021/tx800289z; Corbalan JJ, 2011, INT J NANOMED, V6, P2821, DOI 10.2147/IJN.S25071; Ghiazza M, 2010, CHEM RES TOXICOL, V23, P620, DOI 10.1021/tx900369x; Iyer S, 2009, NAT NANOTECHNOL, V4, P389, DOI [10.1038/nnano.2009.77, 10.1038/NNANO.2009.77]; Lin WS, 2006, TOXICOL APPL PHARM, V217, P252, DOI 10.1016/j.taap.2006.10.004; Ye YY, 2010, TOXICOL IN VITRO, V24, P751, DOI 10.1016/j.tiv.2010.01.001; Park EJ, 2009, TOXICOL LETT, V184, P18, DOI 10.1016/j.toxlet.2008.10.012; ESUMI K, 1993, LANGMUIR, V9, P622, DOI 10.1021/la00026a044; Eom HJ, 2009, TOXICOL IN VITRO, V23, P1326, DOI 10.1016/j.tiv.2009.07.010; Seantier B, 2005, J PHYS CHEM B, V109, P21755, DOI 10.1021/jp053482f; Lam J, 2009, BIOPHYS J, V96, P248, DOI 10.1529/biophysj.108.139154; Xu J, 2009, J PHYS CHEM C, V113, P2187, DOI 10.1021/jp807680d; Ye YY, 2010, ENVIRON TOXICOL PHAR, V29, P131, DOI 10.1016/j.etap.2009.12.002; Lin YS, 2009, CHEM MATER, V21, P3979, DOI 10.1021/cm901259n; Oleson TA, 2008, LANGMUIR, V24, P4865, DOI 10.1021/la703599g; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]; Wang B, 2008, P NATL ACAD SCI USA, V105, P18171, DOI 10.1073/pnas.0807296105; Mornet S, 2005, NANO LETT, V5, P281, DOI 10.1021/nl048153y; Tao ZM, 2009, CHEM RES TOXICOL, V22, P1869, DOI 10.1021/tx900276u; Lin YS, 2010, J AM CHEM SOC, V132, P4834, DOI 10.1021/ja910846q; Rapuano R, 1997, J COLLOID INTERF SCI, V193, P104, DOI 10.1006/jcis.1997.5060; Slowing II, 2009, SMALL, V5, P57, DOI 10.1002/smll.200800926; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; Wallace WE, 2007, J NANOPART RES, V9, P23, DOI 10.1007/s11051-006-9159-5; de Planque MRR, 2011, ACS NANO, V5, P3599, DOI 10.1021/nn103320j; Shinto H, 2012, COLLOID SURFACE B, V91, P114, DOI 10.1016/j.colsurfb.2011.10.060; Savarala S, 2011, LANGMUIR, V27, P5850, DOI 10.1021/la200636k; Fede C, 2012, ANAL BIOANAL CHEM, V404, P1789, DOI 10.1007/s00216-012-6246-6; Moura SP, 2005, LANGMUIR, V21, P10160, DOI 10.1021/la0504614; Wang F, 2009, TOXICOL IN VITRO, V23, P808, DOI 10.1016/j.tiv.2009.04.009; Seantier B, 2009, LANGMUIR, V25, P5767, DOI 10.1021/la804172f; Zhao YN, 2011, ACS NANO, V5, P1366, DOI 10.1021/nn103077k; Moscho A, 1996, P NATL ACAD SCI USA, V93, P11443, DOI 10.1073/pnas.93.21.11443; Chen M, 2005, EXP CELL RES, V305, P51, DOI 10.1016/j.yexcr.2004.12.021; Chang JS, 2007, ENVIRON SCI TECHNOL, V41, P2064, DOI 10.1021/es062347t; Yu T, 2011, ACS NANO, V5, P5717, DOI 10.1021/nn2013904; Richter RP, 2003, LANGMUIR, V19, P1632, DOI 10.1021/la026427w; Reimhult E, 2002, J CHEM PHYS, V117, P7401, DOI [10.1063/1.1515320, 10.1063/1.1513230]; Waters KM, 2009, TOXICOL SCI, V107, P553, DOI 10.1093/toxsci/kfn250; Napierska D, 2009, SMALL, V5, P846, DOI 10.1002/smll.200800461; Bauer AT, 2011, BIOMATERIALS, V32, P8385, DOI 10.1016/j.biomaterials.2011.07.078; Brown SC, 2007, ADV POWDER TECHNOL, V18, P69, DOI 10.1163/156855207779768214; Castranova V., 1995, SILICA SILICA INDUCE; Chunbo Y., 1995, J COLLOID INTERF SCI, V172, P536, DOI 10.1006/jcis.1995.1285; Diociaiuti M, 1999, ENVIRON RES, V80, P197, DOI 10.1006/enrs.1998.3892; Dobrovolskaia M.A., 2013, HDB IMMUNOLOGICAL PR; Fubini B, 1998, SURFACE PROPERTIES OF SILICAS, P415; Geys J, 2010, TOXICOL IN VITRO, V24, P620, DOI 10.1016/j.tiv.2009.10.007; Iler R. K., 1979, CHEM SILICA, P622; Jabbour A.J., 1995, SILICA SILICA INDUCE, P137; Kim HW, 2009, J NANOPART RES, V11, P55, DOI 10.1007/s11051-008-9447-3; KOZIN F, 1982, J COLLOID INTERF SCI, V88, P326, DOI 10.1016/0021-9797(82)90262-4; NOLAN RP, 1981, ENVIRON RES, V26, P503, DOI 10.1016/0013-9351(81)90226-7; Oleson TA, 2010, J COLLOID INTERF SCI, V352, P327, DOI 10.1016/j.jcis.2010.08.057; Petushkov A, 2010, ADV MOLEC TOXICOL, V4, P223, DOI 10.1016/S1872-0854(10)04007-5; SCHLIPKOTER H, 1961, KLIN WOCHENSCHR, V39, P1182, DOI 10.1007/BF01532453; Shinto H, 2013, COLLOID SURFACE B, V108, P8, DOI 10.1016/j.colsurfb.2013.02.021; Shinto H, 2012, ADV POWDER TECHNOL, V23, P693, DOI 10.1016/j.apt.2012.05.004; SINGH SV, 1983, ENVIRON HEALTH PERSP, V51, P55, DOI 10.2307/3429728; Stalder K., 1970, BEITR SILIKOSE-FORSC, V5, P237; STALDER K., 1965, NATURE, V207, P874, DOI 10.1038/207874a0; SUMMERTON J, 1977, EXP MOL PATHOL, V26, P113, DOI 10.1016/0014-4800(77)90071-5; Thomassen L. C. J., 2009, LANGMUIR, V26, P328; Vakurov A., 2011, LANGMUIR, V28, P1246; Wang HR, 2012, RSC ADV, V2, P11336, DOI 10.1039/c2ra22127f; WEISSMAN.G, 1972, NATURE-NEW BIOL, V240, P167; Wildt B., 2013, HDB IMMUNOLOGICAL PR; Yang H, 2010, J NANOSCI NANOTECHNO, V10, P561, DOI 10.1166/jnn.2010.1735; Zhang CG, 1998, P NATL ACAD SCI USA, V95, P6290, DOI 10.1073/pnas.95.11.6290	73	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8831	1568-5527		ADV POWDER TECHNOL	Adv. Powder Technol.	NOV	2014	25	6					1872	1881		10.1016/j.apt.2014.09.002		10	Engineering, Chemical	Engineering	AT9EE	WOS:000345230000030		
J	Yamaguchi, M; Nishijima, T; Shimazaki, J; Takamura, E; Yokoi, N; Watanabe, H; Ohashi, Y				Yamaguchi, Masahiko; Nishijima, Takeshi; Shimazaki, Jun; Takamura, Etsuko; Yokoi, Norihiko; Watanabe, Hitoshi; Ohashi, Yuichi			Clinical Usefulness of Diquafosol for Real-World Dry Eye Patients: A Prospective, Open-Label, Non-Interventional, Observational Study	ADVANCES IN THERAPY			English	Article						Corneal and conjunctival fluorescein staining score; Diquafosol; Dry eye; Observational post-marketing study; Ophthalmology; Patient-reported outcome; Subjective symptom	MEIBOMIAN GLAND DYSFUNCTION; QUALITY-OF-LIFE; OPHTHALMIC SOLUTION; RABBIT CONJUNCTIVA; FLUID SECRETION; WORKSHOP 2007; IN-VIVO; HYALURONAN; DISEASE; SUBCOMMITTEE	This study was designed to evaluate the efficacy and safety of 3% diquafosol ophthalmic solution in dry eye patients in clinical practice. Subjects were dry eye patients who had never used diquafosol, and observation was conducted prospectively over 2 months. The corneal and conjunctival fluorescein staining score, tear film break-up time, 12 dry eye-related subjective symptoms, patient-reported outcomes, and adverse events were investigated. Data were collected from 465 medical institutions for 3,196 patients. Diquafosol led to significant improvement in all subjective symptoms and objective findings (P < 0.001, paired t test). Diquafosol was effective regardless of the degree of severity according to the corneal and conjunctival fluorescein staining score or therapeutic pattern. Overall, 76.0% patients responded that their condition had improved. Adverse reactions were observed in 6.3% of patients. The major adverse reactions were eye discharge, eye irritation, and eye pain. Diquafosol was effective for various dry eye patients in clinical practice, and no significant safety-related problems occurred.	[Yamaguchi, Masahiko; Ohashi, Yuichi] Ehime Univ, Sch Med, Matsuyama, Ehime 790, Japan; [Nishijima, Takeshi] Santen Pharmaceut Co Ltd, Osaka, Japan; [Shimazaki, Jun] Tokyo Dent Coll Ichikawa Gen Hosp, Chiba, Japan; [Takamura, Etsuko] Tokyo Womens Med Univ, Sch Med, Tokyo, Japan; [Yokoi, Norihiko] Kyoto Prefectural Univ Med, Kyoto, Japan; [Watanabe, Hitoshi] Kansai Rosai Hosp, Kobe, Hyogo, Japan	Nishijima, T (reprint author), Santen Pharmaceut Co Ltd, Osaka, Japan.	takeshi.nishijima@santen.co.jp			Santen Pharmaceutical Co., Ltd. Osaka, Japan	Sponsorship and article processing charges for this study were funded by Santen Pharmaceutical Co., Ltd. Osaka, Japan. All named authors meet the ICMJE criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published. All authors had full access to all of the data in this study and Takeshi Nishijima takes complete responsibility for the integrity of the data and accuracy of the data analysis.	Arita R, 2013, BRIT J OPHTHALMOL, V97, P725, DOI 10.1136/bjophthalmol-2012-302668; Albietz JM, 2000, OPTOMETRY VISION SCI, V77, P357, DOI 10.1097/00006324-200007000-00010; MATHERS WD, 1993, OPHTHALMOLOGY, V100, P347; Koh S, 2003, AM J OPHTHALMOL, V136, P513, DOI 10.1016/S0002-9394(03)00317-9; Sakane Y, 2013, JAMA OPHTHALMOL, V131, P1331, DOI 10.1001/jamaophthalmol.2013.4503; Hosoya KI, 1999, J PHARMACOL EXP THER, V291, P53; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Li YS, 2001, AM J PHYSIOL-CELL PH, V281, pC595; [Anonymous], 2007, OCUL SURF, V5, P163; Jumblatt JE, 1998, EXP EYE RES, V67, P341, DOI 10.1006/exer.1998.0520; Murakami T, 2003, J OCUL PHARMACOL TH, V19, P345, DOI 10.1089/108076803322279390; [Anonymous], 2007, OCUL SURF, V5, P75; Shimazaki-Den S, 2013, CORNEA, V32, P1120, DOI 10.1097/ICO.0b013e3182930b1d; Cowlen MS, 2003, EXP EYE RES, V77, P77, DOI 10.1016/S0014-4835(03)00068-X; Yokoi N, 2014, AM J OPHTHALMOL, V157, P85, DOI 10.1016/j.ajo.2013.09.009; Murakami T, 2004, OPHTHAL RES, V36, P89, DOI 10.1159/000076887; NAKAMURA M, 1993, CORNEA, V12, P433, DOI 10.1097/00003226-199309000-00010; Takamura E, 2012, BRIT J OPHTHALMOL, V96, P1310, DOI 10.1136/bjophthalmol-2011-301448; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; Matsumoto Y, 2012, OPHTHALMOLOGY, V119, P1954, DOI 10.1016/j.ophtha.2012.04.010; NAKAMURA M, 1994, CURR EYE RES, V13, P385, DOI 10.3109/02713689409167303; NAKAMURA M, 1994, J CELL PHYSIOL, V159, P415, DOI 10.1002/jcp.1041590305; Paranjpe Deval Reshma, 2003, Ophthalmol Clin North Am, V16, P37, DOI 10.1016/S0896-1549(02)00106-2; Shimazaki J., 2007, ATARASHII GANKA, V24, P181; Yamaguchi M, 2012, ATARASHII GANKA, V29, P527	25	6	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0741-238X	1865-8652		ADV THER	Adv. Ther.	NOV	2014	31	11					1169	1181		10.1007/s12325-014-0162-4		13	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	AU4MC	WOS:000345584200004		
J	Hafez, HA; Al-Naib, I; Oguri, K; Sekine, Y; Dignam, MM; Ibrahim, A; Cooke, DG; Tanaka, S; Komori, F; Hibino, H; Ozaki, T				Hafez, H. A.; Al-Naib, I.; Oguri, K.; Sekine, Y.; Dignam, M. M.; Ibrahim, A.; Cooke, D. G.; Tanaka, S.; Komori, F.; Hibino, H.; Ozaki, T.			Nonlinear transmission of an intense terahertz field through monolayer graphene	AIP ADVANCES			English	Article							EPITAXIAL GRAPHENE; EFFECT TRANSISTORS; CONDUCTIVITY; SPECTROSCOPY; GENERATION; CARBON	We report nonlinear terahertz (THz) effects in monolayer graphene, giving rise to transmission enhancement of a single-cycle THz pulse when the incident THz peak electric field is increased. This transmission enhancement is attributed to reduced photoconductivity, due to saturation effects in the field-induced current and increased intraband scattering rates arising from transient heating of electrons. We have developed a tight-binding model of the response using the length gauge interaction Hamiltonian that provides good qualitative agreement. The model fully accounts for the nonlinear response arising from the linear dispersion energy spectrum in graphene. The results reveal a strong dependence of the scattering time on the THz field, which is at the heart of the observed nonlinear response. (C) 2014 Author(s).	[Hafez, H. A.; Ibrahim, A.; Ozaki, T.] INRS, Adv Laser Light Source, INRS EMT, Varennes, PQ J3X 1S2, Canada; [Al-Naib, I.; Dignam, M. M.] Queens Univ, Dept Phys Engn Phys & Astron, Kingston, ON K7L 3N6, Canada; [Oguri, K.; Sekine, Y.; Hibino, H.] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; [Cooke, D. G.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Tanaka, S.] Kyushu Univ, Dept Appl Quantum Phys & Nucl Engn, Fukuoka 8190395, Japan; [Komori, F.] Univ Tokyo, Inst Solid State Phys, Chiba 2778581, Japan	Ozaki, T (reprint author), INRS, Adv Laser Light Source, INRS EMT, Varennes, PQ J3X 1S2, Canada.	ozaki@emt.inrs.ca	Hibino, Hiroki/D-2072-2014; Cooke, David/A-7360-2008; Al-Naib, Ibraheem/A-2344-2009; 	Hibino, Hiroki/0000-0002-8604-8640; Ozaki, Tsuneyuki/0000-0001-8857-3900	Natural Sciences and Engineering Research Council of Canada (NSERC); Ministere de l'Enseignement superieur, de la Recherche, de la Science et de la Technologie of Quebec; Fonds de recherche du Quebec Nature et technologies; Research Foundation for Opto-Science and Technology (Japan)	The authors would like to acknowledge the Natural Sciences and Engineering Research Council of Canada (NSERC), the Ministere de l'Enseignement superieur, de la Recherche, de la Science et de la Technologie of Quebec, the Fonds de recherche du Quebec Nature et technologies and the Research Foundation for Opto-Science and Technology (Japan) for their financial support, and thank J. E. Sipe for many useful discussions related to the theoretical model.	Al-Naib I., 2014, ARXIV14071273; Ang YS, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3549201; Vicarelli L, 2012, NAT MATER, V11, P865, DOI [10.1038/nmat3417, 10.1038/NMAT3417]; Bonaccorso F, 2012, MATER TODAY, V15, P564, DOI 10.1016/S1369-7021(13)70014-2; Blanchard F, 2011, IEEE J SEL TOP QUANT, V17, P5, DOI 10.1109/JSTQE.2010.2047715; Karasawa H, 2011, J INFRARED MILLIM TE, V32, P655, DOI 10.1007/s10762-010-9677-1; AVERSA C, 1995, PHYS REV B, V52, P14636, DOI 10.1103/PhysRevB.52.14636; Nair RR, 2008, SCIENCE, V320, P1308, DOI 10.1126/science.1156965; Hwang HY, 2013, J PHYS CHEM B, V117, P15819, DOI 10.1021/jp407548a; Docherty CJ, 2012, J INFRARED MILLIM TE, V33, P797, DOI 10.1007/s10762-012-9913-y; Shareef S, 2012, J OPT SOC AM B, V29, P274; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Tielrooij KJ, 2013, NAT PHYS, V9, P248, DOI [10.1038/nphys2564, 10.1038/NPHYS2564]; Rana F, 2008, IEEE T NANOTECHNOL, V7, P91, DOI 10.1109/TNANO.2007.910334; Buron JD, 2012, NANO LETT, V12, P5074, DOI 10.1021/nl301551a; Lee DS, 2008, NANO LETT, V8, P4320, DOI 10.1021/nl802156w; Abergel DSL, 2010, ADV PHYS, V59, P261, DOI 10.1080/00018732.2010.487978; Choi H, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3122348; Zhou SY, 2007, NAT MATER, V6, P770, DOI 10.1038/nmat2003; Paul MJ, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/085019; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Tassin P, 2013, SCIENCE, V341, P620, DOI 10.1126/science.1242253; Dawlaty JM, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2990753; Allen MJ, 2010, CHEM REV, V110, P132, DOI 10.1021/cr900070d; Ishikawa KL, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.201402; Maeng I, 2012, NANO LETT, V12, P551, DOI 10.1021/nl202442b; Ren L, 2012, NANO LETT, V12, P3711, DOI 10.1021/nl301496r; Mak KF, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.196405; Tani S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.166603; Bowlan P, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.041408; Jnawali G, 2013, NANO LETT, V13, P524, DOI 10.1021/nl303988q; Hebling J, 1996, OPT QUANT ELECTRON, V28, P1759, DOI 10.1007/BF00698541; Hibino H, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/37/374005; Hrong J., 2011, PHYS REV B, V83; Mikhailov S. A., 2008, J PHYS-CONDENS MAT, V20, P38204; Novoselov K. S., 2005, NATURE, V438, P179; Winnerl S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.237401; Winzer T, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4768780	38	5	5	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	NOV	2014	4	11							117118	10.1063/1.4902096		8	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	AU4KE	WOS:000345578800018		
J	Kitora, S; Abe, M; Toki, H				Kitora, Shuji; Abe, Masayuki; Toki, Hiroshi			Electromagnetic noise in electric circuits: Ringing and resonance phenomena in the common mode	AIP ADVANCES			English	Article							RADIATION	It is generally believed that electromagnetic noise originates from the coupling of electric signals in a circuit with electric signals in surrounding materials in the environment. However, the noise phenomenon had not been quantified until now. In order to study the phenomenon of noise, we considered a standard circuit (two transmission lines), to which an additional transmission line was introduced in order to explicitly take into account the effect of conductors in the environment. We performed calculations using a newly developed multiconductor transmission-line theory for the resulting three-line circuit in order to determine the magnitude of the coupling between the circuit and the conductors in the environment under various conditions. We observed ringing and resonance phenomena in the common mode, which influenced the performance of the normal mode as electromagnetic noise. Our findings were confirmed by recent experiments in which conductor lines were arranged in various ways using a printed circuit board (PCB). The ordinary usage of electricity in the standard electric circuit was found to be worst in exciting the common mode noise. (C) 2014 Author(s).	[Kitora, Shuji] Osaka Univ, Sch Engn, Suita, Osaka 5650871, Japan; [Abe, Masayuki] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Toki, Hiroshi] Osaka Univ, Sci & Technol Entrepreneurship Lab, Suita, Osaka 5650871, Japan	Kitora, S (reprint author), Osaka Univ, Sch Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	toki@rcnp.osaka-u.ac.jp			JSPS [21540267, 26600099, 24360016, 25106002]	The authors would like to thank Prof. Y. Kanematsu and Prof. Y. Sugimoto for their support throughout the course of the present research. This work was supported by JSPS Research Grants (Nos. 21540267, 26600099, 24360016, and 25106002).	Matsushima T, 2009, IEICE T COMMUN, VE92B, P1929, DOI 10.1587/transcom.E92.B.1929; Kobayashi H., 2009, P PART ACC C; Matsushima T., 2012, IEEE, V978, P409; Paul C. R., 2008, ANAL MULTICONDUCTOR; Takeyama S., 1982, ELECTROMAGNETISM PHE, P1; Toki H, 2014, P JPN ACAD B-PHYS, V90, P29, DOI 10.2183/pjab.90.29; Toki H, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.014201; Toki H, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.094201; Watanabe T, 2010, IEICE T COMMUN, VE93B, P1746, DOI 10.1587/transcom.E93.B.1746	9	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	NOV	2014	4	11							117119	10.1063/1.4902098		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	AU4KE	WOS:000345578800019		
J	Kobayashi, T; Suzuki, Y; Makimoto, N; Funakubo, H; Maeda, R				Kobayashi, Takeshi; Suzuki, Yasuhiro; Makimoto, Natsumi; Funakubo, Hiroshi; Maeda, Ryutaro			Influence of pulse poling on the piezoelectric property of Pb(Zr-0.52, Ti-0.48)O-3 thin films	AIP ADVANCES			English	Article							MEMS; ORIENTATION; CAPACITORS; DEPOSITION; OPERATION; EQUATIONS; GROWTH	We have investigated the influence of pulse poling on the piezoelectric property of Pb(Zr-0.52, Ti-0.48)O-3 (PZT) thin films. 1.9-mu m-thick PZT thin films were deposited by sol-gel method and fabricated into microelectromechanical systems (MEMS) based piezoelectric microcantilevers. 1 kHz of unipolar or bipolar triangle pulse wave between 30-100 V was applied to the PZT thin films. The effective piezoelectric constant d(31), under small signal actuation at 1-3 Vpp, was estimated from the tip displacement of the piezoelectric microcantilevers. The highest piezoelectric constant vertical bar d31 vertical bar as high as 105 pm/V has been obtained by downward unipolar pulse poling at 100 V. (C) 2014 Author(s).	[Kobayashi, Takeshi; Suzuki, Yasuhiro; Makimoto, Natsumi; Maeda, Ryutaro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058564, Japan; [Funakubo, Hiroshi] Tokyo Inst Technol, Yokohama, Kanagawa 2268502, Japan	Kobayashi, T (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058564, Japan.				Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; Council for Science and Technology Policy (CSTP); JSPS KAKENHI [25820339]	This research is granted by the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)", initiated by the Council for Science and Technology Policy (CSTP). This research is also granted by JSPS KAKENHI Grant No. 25820339.	Kobayashi T, 2005, THIN SOLID FILMS, V489, P74, DOI 10.1016/j.tsf.2005.05.004; Fujii E, 2007, IEEE T ULTRASON FERR, V54, P2431, DOI 10.1109/TUFFC.2007.556; Ogawa T, 1998, JPN J APPL PHYS 1, V37, P5241, DOI 10.1143/JJAP.37.5241; Kobayashi T, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2736296; Liu HC, 2011, J MICROELECTROMECH S, V20, P1131, DOI 10.1109/JMEMS.2011.2162488; Kohli M, 1998, APPL PHYS LETT, V72, P3217, DOI 10.1063/1.121554; Kobayashi T, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/10/105030; Xu F, 2001, J APPL PHYS, V89, P1336, DOI 10.1063/1.1325005; Ledermann N, 2003, SENSOR ACTUAT A-PHYS, V105, P162, DOI 10.1016/S0924-4247(03)00090-6; Liu HC, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4723846; Hajati A, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4772469; Dekkers M, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/2/025008; Kobayashi T, 2013, SENSOR ACTUAT A-PHYS, V198, P87, DOI 10.1016/j.sna.2013.04.016; Gao R., 2013, NATURE COMMUNICATION, V4, P2791; Hong S, 1999, J APPL PHYS, V86, P607, DOI 10.1063/1.370774; Hong SB, 2002, APPL PHYS LETT, V81, P3437, DOI 10.1063/1.1517396; Kobayashi T, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/11/115007; Kobayashi T, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/6/065008; Kobayashi T, 2008, THIN SOLID FILMS, V516, P5272, DOI 10.1016/j.tsf.2007.07.067; Kobayashi T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KA01; Nogami H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LD11; Nogami H, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/9/095001; SMITS JG, 1991, IEEE T ULTRASON FERR, V38, P256, DOI 10.1109/58.79611; Tomimatsu Y, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/12/125023; Weinberg MS, 1999, J MICROELECTROMECH S, V8, P529, DOI 10.1109/84.809069	25	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	NOV	2014	4	11							117116	10.1063/1.4901912		7	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	AU4KE	WOS:000345578800016		
J	Omichi, M; Choi, W; Sakamaki, D; Tsukuda, S; Sugimoto, M; Seki, S				Omichi, Masaaki; Choi, Wookjin; Sakamaki, Daisuke; Tsukuda, Satoshi; Sugimoto, Masaki; Seki, Shu			A simple and rapid method for high-resolution visualization of single-ion tracks	AIP ADVANCES			English	Article							GAMMA-IRRADIATION; CROSS-LINKING; ACRYLIC-ACID; HEAVY-IONS; BEAM; NANOSTRUCTURES; SENSITIVITY; FABRICATION; RADIATION; POLYMER	Prompt determination of spatial points of single-ion tracks plays a key role in high-energy particle induced-cancer therapy and gene/plant mutations. In this study, a simple method for the high-resolution visualization of single-ion tracks without etching was developed through the use of polyacrylic acid (PAA)-N, N'-methylene bisacrylamide (MBAAm) blend films. One of the steps of the proposed method includes exposure of the irradiated films to water vapor for several minutes. Water vapor was found to promote the cross-linking reaction of PAA and MBAAm to form a bulky cross-linked structure; the ion-track scars were detectable at a nanometer scale by atomic force microscopy. This study demonstrated that each scar is easily distinguishable, and the amount of generated radicals of the ion tracks can be estimated by measuring the height of the scars, even in highly dense ion tracks. This method is suitable for the visualization of the penumbra region in a single-ion track with a high spatial resolution of 50 nm, which is sufficiently small to confirm that a single ion hits a cell nucleus with a size ranging between 5 and 20 mu m. (C) 2014 Author(s).	[Omichi, Masaaki; Choi, Wookjin; Sakamaki, Daisuke; Seki, Shu] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Omichi, Masaaki] Anan Natl Coll Technol, Ctr Collaborat Res, Anan, Tokushima 7740017, Japan; [Tsukuda, Satoshi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Sugimoto, Masaki] Japan Atom Energy Agcy, Takasaki Adv Radiat Res Inst, Takasaki, Gunma 3701292, Japan	Seki, S (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	seki@chem.eng.osaka-u.ac.jp	Seki, Shu/E-5346-2010	Seki, Shu/0000-0001-7851-4405	JSPS; MEXT Japan [22226017, 26249145]; Sekisui Chemical Grant Program for Research;  [25810129]	This work was supported by the JSPS Funding Program for Next-Generation World-Leading Research (NEXT Program), a Grant-in-Aid for Scientific Research (S) and (A) from MEXT Japan (No. 22226017, No. 26249145), Grant-in-Aid for Young Scientists (B) (No. 25810129), and a Sekisui Chemical Grant Program for Research. This work was performed under the Shared Use Program of JAEA Facilities.	ADLER G, 1960, J POLYM SCI, V48, P195, DOI 10.1002/pol.1960.1204815021; LaVerne JA, 2000, RADIAT RES, V153, P487, DOI 10.1667/0033-7587(2000)153[0487:TEOHII]2.0.CO;2; Seki S, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.144203; Ansari K, 2004, APPL PHYS LETT, V85, P476, DOI 10.1063/1.1773933; Seki S, 2001, ADV MATER, V13, P1663, DOI 10.1002/1521-4095(200111)13:22<1663::AID-ADMA1663>3.0.CO;2-8; Kumar A, 2007, J APPL PHYS, V101, DOI 10.1063/1.2404794; Toulemonde M, 2004, NUCL INSTRUM METH B, V216, P1, DOI 10.1016/j.nimb.2003.11.013; YOUNG DA, 1958, NATURE, V182, P375, DOI 10.1038/182375a0; Omichi M, 2012, ACS APPL MATER INTER, V4, P5492, DOI 10.1021/am3014086; LaVerne JA, 2012, RADIAT PHYS CHEM, V81, P1287, DOI 10.1016/j.radphyschem.2011.11.014; Chen JH, 2006, J MEMBRANE SCI, V277, P249, DOI 10.1016/j.memsci.2005.10.036; WILSON RR, 1946, RADIOLOGY, V47, P487; Hussain AMP, 2006, J PHYS D APPL PHYS, V39, P750, DOI 10.1088/0022-3727/39/4/023; Jabbari E, 1999, IRAN POLYM J, V8, P263; van Kan JA, 2003, APPL PHYS LETT, V83, P1629, DOI 10.1063/1.1604468; CARTWRIGHT BG, 1978, NUCL INSTRUM METHODS, V153, P457, DOI 10.1016/0029-554X(78)90989-8; CHATTERJEE A, 1976, RADIAT ENVIRON BIOPH, V13, P215, DOI 10.1007/BF01330766; Bajwa N, 2003, J APPL PHYS, V94, P326, DOI 10.1063/1.1581381; Aumayr F., 2011, J PHYS CONDENSED MAT, V23; FLEISCHE.RL, 1965, SCIENCE, V149, P383, DOI 10.1126/science.149.3682.383; FLEISCHE.RL, 1967, PHYS REV, V156, P353, DOI 10.1103/PhysRev.156.353; FLEISCHE.RL, 1967, SCIENCE, V155, P187, DOI 10.1126/science.155.3759.187; HILL DJT, 1990, POLYMER, V31, P538, DOI 10.1016/0032-3861(90)90399-J; HIRONO Y, 1970, RADIAT RES, V44, P204, DOI 10.2307/3573183; Johnson CE, 2009, RADIAT MEAS, V44, P742, DOI 10.1016/j.radmeas.2009.10.080; LaVerne J.A., 2004, CHARGED PARTICLE PHO, P403; LAWLER JP, 1975, EUR POLYM J, V11, P755, DOI 10.1016/0014-3057(75)90112-3; Maeyoshi Y., 2012, SCI REPORTS, V2; MEI M, 1994, ADV SPACE RES, V14, P363, DOI 10.1016/0273-1177(94)90489-8; Omichi M., 2014, NATURE COMMUNICATION, V5; PRICE PB, 1962, NATURE, V196, P732, DOI 10.1038/196732a0; Rosenberg M. J., 2014, REV SCI INSTRUMENTS, V85; van Kan JA, 2006, NANO LETT, V6, P579, DOI 10.1021/nl052478c; Wambersie A., 2004, CHARGED PARTICLE PHO, P743; Yamamoto M, 1997, RADIAT MEAS, V28, P227, DOI 10.1016/S1350-4487(97)00073-5	35	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	NOV	2014	4	11							117128	10.1063/1.4902164		8	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	AU4KE	WOS:000345578800028		
J	Su, DX; Zheng, RC; Nakano, K; Cartmell, MP				Su, Dongxu; Zheng, Rencheng; Nakano, Kimihiko; Cartmell, Matthew P.			On square-wave-driven stochastic resonance for energy harvesting in a bistable system	AIP ADVANCES			English	Article								Stochastic resonance is a physical phenomenon through which the throughput of energy within an oscillator excited by a stochastic source can be boosted by adding a small modulating excitation. This study investigates the feasibility of implementing square-wave-driven stochastic resonance to enhance energy harvesting. The motivating hypothesis was that such stochastic resonance can be efficiently realized in a bistable mechanism. However, the condition for the occurrence of stochastic resonance is conventionally defined by the Kramers rate. This definition is inadequate because of the necessity and difficulty in estimating white noise density. A bistable mechanism has been designed using an explicit analytical model which implies a new approach for achieving stochastic resonance in the paper. Experimental tests confirm that the addition of a small-scale force to the bistable system excited by a random signal apparently leads to a corresponding amplification of the response that we now term square-wave-driven stochastic resonance. The study therefore indicates that this approach may be a promising way to improve the performance of an energy harvester under certain forms of random excitation. (C) 2014 Author(s).	[Su, Dongxu] Univ Tokyo, Grad Sch Engn, Tokyo 1538505, Japan; [Zheng, Rencheng; Nakano, Kimihiko] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Cartmell, Matthew P.] Univ Sheffield, Dept Mech Engn, Sheffield S1 3JD, S Yorkshire, England	Su, DX (reprint author), Univ Tokyo, Grad Sch Engn, Tokyo 1538505, Japan.	sudx@iis.u-tokyo.ac.jp			China Scholarship Council (CSC) [201206050004]	The study was supported by special funding made available to the Institute of Industrial Science at The University of Tokyo, Japan. DXS expresses his gratitude to the China Scholarship Council (CSC) for the financial support (Grant No: 201206050004).	Challa VR, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/01/015035; Zheng RC, 2014, J SOUND VIB, V333, P2568, DOI 10.1016/j.jsv.2014.01.020; Xu CD, 2013, J APPL PHYS, V114, DOI 10.1063/1.4821644; Harmer GP, 2002, IEEE T INSTRUM MEAS, V51, P299, DOI 10.1109/19.997828; Stanton SC, 2010, PHYSICA D, V239, P640, DOI 10.1016/j.physd.2010.01.019; Mann BP, 2010, J SOUND VIB, V329, P1215, DOI 10.1016/j.jsv.2009.11.034; Mann BP, 2009, J SOUND VIB, V319, P515, DOI 10.1016/j.jsv.2008.06.011; Halim MA, 2013, J APPL PHYS, V114, DOI 10.1063/1.4816249; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Daqaq MF, 2010, J SOUND VIB, V329, P3621, DOI 10.1016/j.jsv.2010.04.002; Barton DAW, 2010, J VIB ACOUST, V132, DOI 10.1115/1.4000809; Leland ES, 2006, SMART MATER STRUCT, V15, P1413, DOI 10.1088/0964-1726/15/5/030; Chapeau-Blondeau F., 2000, PHYS REV E, V6, P1940; Daqaq M. F., 2011, J SOUND VIBRATION, V330, P2254; Halim MA, 2014, J APPL PHYS, V115, DOI 10.1063/1.4867216; Hu HG, 2012, J PHYS CONF SER, V382, DOI 10.1088/1742-6596/382/1/012024; McInnes CR, 2008, J SOUND VIB, V318, P655, DOI 10.1016/j.jsv.2008.07.017; Meimukhin D, 2013, J INTEL MAT SYST STR, V24, P1736, DOI 10.1177/1045389X13484102; Stanton S. C., 2009, APPL PHYS LETT, V95, P1; Su D., 2013, ASME 2013 DYN SYST C; Tang L., 2010, J INTEL MAT SYST STR, V21, P1869; Xu TB, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/6/065015	22	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	NOV	2014	4	11							117140	10.1063/1.4903167		10	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	AU4KE	WOS:000345578800040		
J	Suzuki, S; Kuno, T; Urushibata, K; Kobayashi, K; Sakuma, N; Washio, K; Kishimoto, H; Kato, A; Manabe, A				Suzuki, S.; Kuno, T.; Urushibata, K.; Kobayashi, K.; Sakuma, N.; Washio, K.; Kishimoto, H.; Kato, A.; Manabe, A.			A (Nd, Zr)(Fe, Co)(11.5)Ti0.5Nx compound as a permanent magnet material	AIP ADVANCES			English	Article							FE; ND	We studied NdFe11TiNx compounds as permanent magnet materials. The (Nd-0.7, Zr-0.3)(Fe0.75Co0.25)(11.5)Ti0.5N0.52 powder that contained a limited amount of the alpha-(Fe, Co) phase shows fairly good magnetic properties, such as a saturation polarization (J(s)) of 1.68 T and an anisotropic field (H-a) of 2.88 (Law of approach to saturation) -4.0 MA/m (Intersection of magnetization curves). Both properties are comparable to those of the Nd2Fe14B phase. (C) 2014 Author(s).	[Suzuki, S.; Kuno, T.; Urushibata, K.; Kobayashi, K.] SIST, Shizuoka 4378555, Japan; [Sakuma, N.; Washio, K.; Kishimoto, H.; Kato, A.; Manabe, A.] Toyota Motor Co Ltd, Toyota, Aichi 4718572, Japan	Kobayashi, K (reprint author), SIST, 2200-2 Toyosawa, Shizuoka 4378555, Japan.	koba@ms.sist.ac.jp					SAGAWA M, 1984, J APPL PHYS, V55, P2083, DOI 10.1063/1.333572; YANG YC, 1991, SOLID STATE COMMUN, V78, P317, DOI 10.1016/0038-1098(91)90205-A; SUZUKI S, 1992, IEEE T MAGN, V28, P2005, DOI 10.1109/20.179659; Bernardi J, 1998, J APPL PHYS, V83, P6396, DOI 10.1063/1.367557; OHASHI K, 1988, J APPL PHYS, V64, P5714, DOI 10.1063/1.342235; Buschow K. H. J., 1995, HDB MAGNETIC MAT, V9, P357; Chikazumi S, 1997, PHYS FERROMAGNETISM, P503; Coey J.M.D., 1999, PERMANT MAGNETISM, P159; Czerlinsky E., 1932, ANN PHYS, V405, P80, DOI 10.1002/andp.19324050107; Goll D., 2014, PHYS STATUS SOLIDI-R; Hirayama Y., 2014, SCRIPTA METERIALIA; Hirosawa S, 2004, IEEE T MAGN, V40, P2883, DOI 10.1109/TMAG.2004.834216; KATTER M, 1991, J APPL PHYS, V70, P3188, DOI 10.1063/1.349302; Kobayashi K, 2002, J MAGN MAGN MATER, V247, P42, DOI 10.1016/S0304-8853(02)00144-0; Kronmuller H., 2013, MICROMAGNETISM MICRO, P176; Sakurada S, 1996, J APPL PHYS, V79, P4611, DOI 10.1063/1.361679	16	2	2	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	NOV	2014	4	11							117131	10.1063/1.4902176		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	AU4KE	WOS:000345578800031		
J	Zhang, JQ; Wong, H; Yu, DQ; Kakushima, K; Iwai, H				Zhang, Jieqiong; Wong, Hei; Yu, Danqun; Kakushima, Kuniyuki; Iwai, Hiroshi			X-ray photoelectron spectroscopy study of high-k CeO2/La2O3 stacked dielectrics	AIP ADVANCES			English	Article							MOS-TRANSISTORS; XPS; FILMS; CEO2; CMOS	This work presents a detailed study on the chemical composition and bond structures of CeO2/La2O3 stacked gate dielectrics based on x-ray photoelectron spectroscopy (XPS) measurements at different depths. The chemical bonding structures in the interfacial layers were revealed by Gaussian decompositions of Ce 3d, La 3d, Si 2s, and O 1s photoemission spectra at different depths. We found that La atoms can diffuse into the CeO2 layer and a cerium-lanthanum complex oxide was formed in between the CeO2 and La2O3 films. Ce3+ and Ce4+ states always coexist in the as-deposited CeO2 film. Quantitative analyses were also conducted. The amount of CeO2 phase decreases by about 8% as approaching the CeO2/La2O3 interface. In addition, as compared with the single layer La2O3 sample, the CeO2/La2O3 stack exhibits a larger extent of silicon oxidation at the La2O3/Si interface. For the CeO2/La2O3 gate stack, the out-diffused lanthanum atoms can promote the reduction of CeO2 which produce more atomic oxygen. This result confirms the significant improvement of electrical properties of CeO2/La2O3 gated devices as the excess oxygen would help to reduce the oxygen vacancies in the film and would suppress the formation of interfacial La-silicide also. (C) 2014 Author(s).	[Zhang, Jieqiong; Wong, Hei] City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China; [Wong, Hei; Yu, Danqun] Zhejiang Univ, Dept Informat Sci & Elect Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Kakushima, Kuniyuki; Iwai, Hiroshi] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268502, Japan	Zhang, JQ (reprint author), City Univ Hong Kong, Dept Elect Engn, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.	heiwong@ieee.org			GRF of Research Grants Council of Hong Kong, Hong Kong [121212]	This work is supported by the GRF Project #121212 of Research Grants Council of Hong Kong, Hong Kong.	Wang AQ, 2003, J VAC SCI TECHNOL B, V21, P1169, DOI 10.1116/1.1577569; Garvie LAJ, 1999, J PHYS CHEM SOLIDS, V60, P1943, DOI 10.1016/S0022-3697(99)00218-8; Zoellner MH, 2012, J CRYST GROWTH, V355, P159, DOI 10.1016/j.jcrysgro.2012.06.050; Holgado JP, 2000, APPL SURF SCI, V161, P301, DOI 10.1016/S0169-4332(99)00577-2; Holgado JP, 2000, APPL SURF SCI, V158, P164, DOI 10.1016/S0169-4332(99)00597-8; Wong H, 2006, MICROELECTRON ENG, V83, P1867, DOI 10.1016/j.mee.2006.01.271; Fan J, 2007, CATAL TODAY, V126, P303, DOI 10.1016/j.cattod.2007.06.005; Inamoto S, 2010, J APPL PHYS, V107, DOI 10.1063/1.3445874; Iwai H, 2012, ECS TRANSACTIONS, V50, P13, DOI 10.1149/05005.0013ecst; Kakushima K, 2010, MICROELECTRON RELIAB, V50, P790, DOI 10.1016/j.microrel.2010.02.001; Luo XJ, 2009, CATAL LETT, V133, P382, DOI 10.1007/s10562-009-0177-7; Nohira H, 2011, ECS TRANSACTIONS, V41, P137, DOI 10.1149/1.3633293; Wong H, 2010, J ELECTROCHEM SOC, V157, pG49, DOI 10.1149/1.3268128; Wong H., 2012, NANOCMOS GATE DIELEC, P113; Wong H, 2012, VACUUM, V86, P929, DOI 10.1016/j.vacuum.2011.06.023; Wong H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4768943; Wong H., 2013, VACUUM, V86, P990; Yang BL, 2012, MICROELECTRON RELIAB, V52, P1613, DOI 10.1016/j.microrel.2011.10.009; Zhang ZY, 2009, J ALLOY COMPD, V476, P318, DOI 10.1016/j.jallcom.2008.08.050	19	2	2	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	NOV	2014	4	11							117117	10.1063/1.4902017		9	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	AU4KE	WOS:000345578800017		
J	Arai, Y; Harada, M; Okadat, T				Arai, Yuta; Harada, Makoto; Okada, Tetsuo			Single Micro-channel Formation in a Gap between Probe Electrodes by Freezing an Aqueous Electrolyte	ANALYTICAL SCIENCES			English	Article						Temperature-controllable micro channel; ice grain boundary; frozen electrolyte; resistance measurements; channel blocking	NANOFLUIDIC DEVICES; PHASE COEXISTENT; ICE; SENSORS; MECHANISM; KINETICS	A size-tunable micro-channel is fabricated in a gap between two probe electrodes by freezing aqueous KCl. The channel has been characterized by resistance measurements and channel blocking by resistive particles. The channel size can be varied by the temperature even after the preparation of the channel. The channel is potentially useful not only for size-selective particle counting but also for the size-selective separation or filtration of particles and macromolecules.	[Arai, Yuta; Harada, Makoto; Okada, Tetsuo] Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan	Okadat, T (reprint author), Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan.	tokada@chem.titech.ac.jp	Okada, Tetsuo/D-4746-2015	Okada, Tetsuo/0000-0002-1976-7936	Japan Society for the Promotion of Science	This work has been supported by a Grant-in-Aid from the Japan Society for the Promotion of Science.	Anzo K, 2013, J PHYS CHEM A, V117, P10619, DOI 10.1021/jp409126p; Kasianowicz JJ, 2008, ANNU REV ANAL CHEM, V1, P737, DOI 10.1146/annurev.anchem.1.031207.112818; Rozmanov D, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4748377; Harms ZD, 2011, ANAL CHEM, V83, P9573, DOI 10.1021/ac202358t; Li J, 2003, NANO LETT, V3, P929, DOI 10.1021/nl034220x; Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/nnano.2011.129, 10.1038/NNANO.2011.129]; Shamoto T, 2010, J AM CHEM SOC, V132, P13135, DOI 10.1021/ja1055214; Oukhaled A, 2012, ACS CHEM BIOL, V7, P1935, DOI 10.1021/cb300449t; Tasaki Y, 2011, ANAL CHEM, V83, P9593, DOI 10.1021/ac202378m; Han CP, 2011, J AM CHEM SOC, V133, P7644, DOI 10.1021/ja2004939; Ito K, 2013, ANAL METHODS-UK, V5, P5912, DOI 10.1039/c3ay41307a; Zhou KM, 2011, ANNU REV ANAL CHEM, V4, P321, DOI 10.1146/annurev-anchem-061010-113938; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Hashimoto T, 2011, ANAL CHEM, V83, P3950, DOI 10.1021/ac200785n; Tasaki Y, 2012, J AM CHEM SOC, V134, P6128, DOI 10.1021/ja301989d; Cohen-Adad R., 1991, SOLUBILITY DATA SER, V47, P2255; JACCARD C, 1965, ANN NY ACAD SCI, V125, P390, DOI 10.1111/j.1749-6632.1965.tb45405.x; Li G, 1999, SENSOR ACTUAT B-CHEM, V59, P1, DOI 10.1016/S0925-4005(99)00007-6; Nagashima K, 1997, J CRYST GROWTH, V171, P577, DOI 10.1016/S0022-0248(96)00664-1; Peng S., 2003, NANO LETT, V3, P347, DOI DOI 10.1021/NL034010K; Spannuth M, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3665927	21	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	NOV	2014	30	11					1035	1037				3	Chemistry, Analytical	Chemistry	AU3YW	WOS:000345547400001		
J	Kobayashi, H; Katano, K; Hashimoto, T; Hayashita, T				Kobayashi, Hiroyuki; Katano, Kohei; Hashimoto, Takeshi; Hayashita, Takashi			Solvent Effect on the Fluorescence Response of Hydroxycoumarin Bearing a Dipicolylamine Binding Site to Metal Ions	ANALYTICAL SCIENCES			English	Article						Ion recognition; dipicolylamine; solvent effect; fluorescence response; chemosensor	LIVING CELLS; PROBES; MG2+; CHEMOSENSOR; RECOGNITION; MAGNESIUM; RECEPTOR	The fluorescence behavior of a probe dpa-HC, which has a coumarin derivative that acts as a fluorophore and a dipicolylamine (DPA) unit that functions as a metal ion-recognition site, was investigated with various metal ions in aqueous and several non-aqueous solvents. In aqueous solution, the fluorescence of dpa-HC was enhanced by Zn2+ and Cd2+, but was quenched by other metal ions. On the other hand, in an acetonitrile solution, only Mg2+ enhanced the fluorescence, and the addition of a small amount of water quenched this fluorescence. This dramatic selectivity change is explained by stabilization of a metal-dpa-HC complex due to acetonitrile coordination and ON-OFF switching of the intramolecular photoinduced electron transfer (PET) from the nitrogen lone pair of DPA to the coumarin derivative.	[Kobayashi, Hiroyuki; Katano, Kohei; Hashimoto, Takeshi; Hayashita, Takashi] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, Tokyo 1028554, Japan	Hayashita, T (reprint author), Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028554, Japan.	ta-hayas@sophia.ac.jp			Japan Society for the Promotion of Science [22350039, 24655069]	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (22350039 and 24655069).	Hu ZQ, 2010, CHEM COMMUN, V46, P3765, DOI 10.1039/c001587c; Hao EH, 2011, J PHYS CHEM A, V115, P8234, DOI 10.1021/jp202700s; Trapani V, 2010, ANALYST, V135, P1855, DOI 10.1039/c0an00087f; Mizukami S, 2009, INORG CHEM, V48, P7630, DOI 10.1021/ic900247r; de Silva AP, 2009, ANALYST, V134, P2385, DOI 10.1039/b912527m; PEARSON RG, 1968, J CHEM EDUC, V45, P643; Kwon JY, 2005, J AM CHEM SOC, V127, P10107, DOI 10.1021/ja051075b; Chen XQ, 2011, CHEM SOC REV, V40, P4783, DOI 10.1039/c1cs15037e; Ngo HT, 2012, CHEM SOC REV, V41, P4928, DOI 10.1039/c2cs35087d; Ishida M, 2010, ANGEW CHEM INT EDIT, V49, P91, DOI 10.1002/anie.200904859; Kim JS, 2007, CHEM REV, V107, P3780, DOI 10.1021/cr068046j; Komatsu H, 2004, J AM CHEM SOC, V126, P16353, DOI 10.1021/ja049624l; Farruggia G, 2006, J AM CHEM SOC, V128, P344, DOI 10.1021/ja056523u; Guo T, 2013, CHEM COMMUN, V49, P1862, DOI 10.1039/c3cc38471c; Hatai J, 2014, CHEM COMMUN, V50, P64, DOI 10.1039/c3cc46285d; Kim M. J., 2009, CHEM COMMUN, V45, P7215; Kumai M, 2012, ANAL SCI, V28, P121; Kurishita Y, 2012, J AM CHEM SOC, V134, P18779, DOI 10.1021/ja308754g; Ma YY, 2012, ANALYST, V137, P2313, DOI 10.1039/c2an35200a; Ooyama Y, 2011, CHEM COMMUN, V47, P4448, DOI 10.1039/c1cc10470e; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Song KC, 2007, TETRAHEDRON LETT, V48, P5397, DOI 10.1016/j.tetlet.2007.06.010	22	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	NOV	2014	30	11					1045	1050				6	Chemistry, Analytical	Chemistry	AU3YW	WOS:000345547400003		
J	Baj, S; Krawczyk, T; Pradel, N; Azam, MG; Shibata, T; Dragusha, S; Skutil, K; Pawlyta, M; Kai, M				Baj, Stefan; Krawczyk, Tomasz; Pradel, Natalia; Azam, Md Golam; Shibata, Takayuki; Dragusha, Shpend; Skutil, Krzysztof; Pawlyta, Miroslawa; Kai, Masaaki			Carbon Nanofiber-based Luminol-biotin Probe for Sensitive Chemiluminescence Detection of Protein	ANALYTICAL SCIENCES			English	Article						Chemiluminescence; carbon nanofiber; luminol; proteins; streptavidin	SOLID-PHASE MEMBRANE; SIGNAL AMPLIFICATION; IMMUNOASSAY; IMMUNOSENSOR; NANOTUBES	A carbon nanofiber-based luminol-biotin probe was synthesized for the sensitive chemiluminescence (CL) detection of a target protein by grafting luminol and biotin onto an oxidized carbon nanofiber. This carbon nanofiber was prepared by chemical vapor-deposition with methane in the presence of the Ni-Cu-MgO catalyst, which was followed by oxidization with HNO3-H2SO4 to produce a carboxyl group on the surface of the nanofiber. The material was grafted with luminol and biotin by means of a standard carbodiimide activation of COOH groups to produce corresponding amides. The substance was water-soluble and thus could be utilized as a sensitive CL probe for a protein assay. The probe showed highly specific affinity towards the biotin-labeled antibody via a streptavidin-biotin interaction. The detection limit for this model assay was approximately 0.2 pmol of the biotinized IgG spotted on a polyvinylidene fluoride (PVDF) membrane. Nonspecific binding to other proteins was not observed. Therefore, the synthesized carbon nanofiber-based CL probe may be useful for a sensitive and specific analysis of the target protein.	[Baj, Stefan; Krawczyk, Tomasz; Pradel, Natalia; Skutil, Krzysztof] Silesian Tech Univ, Dept Chem Organ Technol & Petrochem, Fac Chem, PL-44100 Gliwice, Poland; [Azam, Md Golam; Shibata, Takayuki; Dragusha, Shpend; Kai, Masaaki] Nagasaki Univ, Grad Sch Biomed Sci, Fac Pharmaceut Sci, Nagasaki 8528521, Japan; [Pawlyta, Miroslawa] Silesian Tech Univ, Inst Engn Mat & Biomat, PL-44100 Gliwice, Poland	Krawczyk, T (reprint author), Silesian Tech Univ, Dept Chem Organ Technol & Petrochem, Fac Chem, Ul Krzywoustego 4, PL-44100 Gliwice, Poland.	tomasz.krawczyk@polsl.pl	Krawczyk, Tomasz/F-4746-2010	Krawczyk, Tomasz/0000-0002-4862-0079			Amir RJ, 2007, CHEM-EUR J, V13, P812, DOI 10.1002/chem.200601263; Huang JS, 2010, ANAL METHODS-UK, V2, P202, DOI 10.1039/b9ay00312f; Bi S, 2009, BIOSENS BIOELECTRON, V24, P2961, DOI 10.1016/j.bios.2009.03.002; Soto CM, 2006, J AM CHEM SOC, V128, P5184, DOI 10.1021/ja058574x; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; Lai GS, 2009, ANAL CHEM, V81, P9730, DOI 10.1021/ac901996a; Wang J, 2008, TRAC-TREND ANAL CHEM, V27, P619, DOI 10.1016/j.trac.2008.05.009; Cooper CL, 2005, CURR OPIN COLLOID IN, V10, P52, DOI 10.1016/j.cocis.2005.05.007; Scrimin P, 2011, CHEM SOC REV, V40, P4488, DOI 10.1039/c1cs15024c; Song YJ, 2011, ADV MATER, V23, P4215, DOI 10.1002/adma.201101853; Wu LN, 2007, J IMMUNOL METHODS, V322, P12, DOI 10.1016/j.jim.2007.01.026; Lei JP, 2012, CHEM SOC REV, V41, P2122, DOI 10.1039/c1cs15274b; Chen SY, 2010, BIOCONJUGATE CHEM, V21, P979, DOI 10.1021/bc9005656; Sia SK, 2004, ANGEW CHEM INT EDIT, V43, P498, DOI 10.1002/anie.200353016; Chan CPY, 2004, ANAL CHEM, V76, P3638, DOI 10.1021/ac0353740; Azam Golam, 2011, Anal Sci, V27, P715; Azam MG, 2011, ANAL BIOANAL CHEM, V401, P1211, DOI 10.1007/s00216-011-5196-8; Ding L, 2009, ELECTROCHEM COMMUN, V11, P760, DOI 10.1016/j.elecom.2009.01.032; Genc R, 2011, ANAL CHEM, V83, P563, DOI 10.1021/ac1023765; GREEN N. M., 1970, Methods in Enzymology, V18A, P418; KARATANI H, 1987, B CHEM SOC JPN, V60, P2023, DOI 10.1246/bcsj.60.2023; Krawczyk T, 2010, ANALYST, V135, P2894, DOI 10.1039/c0an00282h; Marquette CA, 2006, SENSOR ACTUAT B-CHEM, V113, P664, DOI 10.1016/j.snb.2005.07.015; Roda Aldo, 2003, Anal Chem, V75, p463A; Wang HY, 2004, J PHYS CHEM B, V108, P20273, DOI 10.1021/jp040496x; Zhang H, 2009, TALANTA, V79, P700, DOI 10.1016/j.talanta.2009.04.056; Zhang H, 2007, ANGEW CHEM INT EDIT, V46, P8226, DOI 10.1002/anie.200702290; Zhang Q, 2007, BIOCONJUGATE CHEM, V18, P1668, DOI 10.1021/bc060289v; Zhou M, 2003, ANAL CHEM, V75, P6708, DOI 10.1021/ac034664d	29	1	1	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	NOV	2014	30	11					1051	1056				6	Chemistry, Analytical	Chemistry	AU3YW	WOS:000345547400004		
J	Bessho, K; Kanaya, N; Shimada, S; Katsuta, S; Monjushiro, H				Bessho, Kotaro; Kanaya, Naoki; Shimada, Saki; Katsuta, Shoichi; Monjushiro, Hideaki			Adsorption Behavior of Beryllium(II) on Copper-oxide Nanoparticles Dispersed in Water: A Model for Be-7 Colloid Formation in the Cooling Water for Electromagnets at High-energy Accelerator Facilities	ANALYTICAL SCIENCES			English	Article						Colloid; copper oxide; beryllium(II); complexation; accelerator; cooling water	RADIONUCLIDES; IONS	The adsorption behavior of Be(II) on CuO nanoparticles dispersed in water was studied as a model for colloid formation of radioactive Be-7 nuclides in the cooling water used for electromagnets at high-energy proton accelerator facilities. An aqueous Be(II) solution and commercially available CuO nanoparticles were mixed, and the adsorption of Be(II) on CuO was quantitatively examined. From a detailed analysis of the adsorption data measured as a function of the pH, it was confirmed that Be(II) is adsorbed on the CuO nanoparticles by complex formation with the hydroxyl groups on the CuO surface (>S-OH) according to the following equation: n > S-OH + Be2+ (sic) (> S-O)(n) Be(2-n)+ + nH(+) (n = 2,3) S : solid surface. The surface-complexation constants corresponding to the above equilibrium, beta((s,2)) and beta((s,3)), were determined for four types of CuO nanoparticles. The beta((s,2)) value was almost independent of the type of nanoparticle, whereas the beta((s,3)) values varied with the particle size. These complexation constants successfully explain Be-7 colloid formation in the cooling water used for electromagnets at the 12-GeV proton accelerator facility.	[Bessho, Kotaro; Monjushiro, Hideaki] High Energy Accelerator Res Org KEK, Radiat Sci Ctr, Tsukuba, Ibaraki 3050801, Japan; [Bessho, Kotaro] J PARC Ctr, Safety Div, Naka, Ibaraki 3191195, Japan; [Kanaya, Naoki; Shimada, Saki; Katsuta, Shoichi] Chiba Univ, Grad Sch Sci, Inage Ku, Chiba 2638522, Japan	Bessho, K (reprint author), High Energy Accelerator Res Org KEK, Radiat Sci Ctr, 1-1 Oho, Tsukuba, Ibaraki 3050801, Japan.	kotaro.bessho@kek.jp	Katsuta, Shoichi/A-3931-2015				Rahnemaie R, 2006, J COLLOID INTERF SCI, V297, P379, DOI 10.1016/j.jcis.2005.11.003; [Anonymous], SPALL NEUTR SOURC SN; [Anonymous], 1990, REV MINERAL; Baker RW, 2004, MEMBRANE TECHNOLOGY, P72; BALISTRIERI L, 1981, DEEP-SEA RES, V28, P101, DOI 10.1016/0198-0149(81)90085-6; Bessho K., 2010, P 11 WORKSH ENV RAD, P19; Bessho K., 2013, P 11 M TASK FORC SHI, P61; Chinea E, 1997, MAIN GROUP MET CHEM, V20, P11; DEGUELDRE C, 1995, NUCL SCI ENG, V120, P65; Everest DA, 1964, CHEM BERYLLIUM; Firestone R.B., 1996, TABLE ISOTOPES; Ikeda Y., 2009, NUCL INSTRUM METH A, V600, P1; Itoh S., 1998, P 14 M INT COLL ADV, P823; Kanaya N., 2014, 94 ANN M CHEM SOC JA; Kondo K., 1981, KEK INTERNAL, P80; Matsumura H, 2009, NUCL TECHNOL, V168, P979; Matsumura H, 2014, PROG NUCL SCI TECHNO, V4, P372; SCHWARZE.G, 1969, HELV CHIM ACTA, V52, P644, DOI 10.1002/hlca.19690520313; Stumn W., 1987, AQUATIC SURFACE CHEM; Sverjensky DA, 2006, GEOCHIM COSMOCHIM AC, V70, P2427, DOI 10.1016/j.gca.2006.01.006	20	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	NOV	2014	30	11					1069	1074				6	Chemistry, Analytical	Chemistry	AU3YW	WOS:000345547400007		
J	Ishizaka, S; Yamauchi, K; Kitamura, N				Ishizaka, Shoji; Yamauchi, Kunihiro; Kitamura, Noboru			Reversible Control of the Equilibrium Size of a Single Aerosol Droplet by Change in Relative Humidity	ANALYTICAL SCIENCES			English	Article						Laser trapping; Raman spectroscopy; aerosol; relative humidity	CIRRUS CLOUD FORMATION; FORCE OPTICAL TRAP; AMMONIUM-SULFATE; RAMAN-SPECTROSCOPY; WATER DROPLETS; NUCLEATION; PARTICLES; CLIMATE; GROWTH	Noncontact levitation of single micrometer-sized water droplets in air can be achieved by a laser trapping technique. The equilibrium size of a water droplet is quite sensitive to relative humidity in the surrounding gas phase. In order to investigate the physical and chemical properties of single water droplets in air as a function of the droplet size or solute concentration, laser trapping experiments were conducted under controlled humidity conditions. In this study, we developed a trapping chamber equipped with a relative humidity controller and demonstrated the reversible control of the equilibrium size of a single droplet levitated in air through a change in relative humidity. Furthermore, relative humidity was successfully evaluated by means of cavity enhanced Raman spectroscopy of a trapped water droplet.	[Ishizaka, Shoji] Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima 7398526, Japan; [Yamauchi, Kunihiro; Kitamura, Noboru] Hokkaido Univ, Grad Sch Chem Sci & Engn, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan; [Yamauchi, Kunihiro; Kitamura, Noboru] Hokkaido Univ, Grad Sch Chem Sci & Engn, Dept Chem Sci & Engn, Sapporo, Hokkaido 0600810, Japan	Ishizaka, S (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima 7398526, Japan.	ishizaka@hiroshima-u.ac.jp			JST, PRESTO; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [25410144]	This research was supported by JST, PRESTO and Grand-in-Aid for Scientific Research (C) (No. 25410144) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Mitchem L, 2006, J PHYS CHEM A, V110, P8116, DOI 10.1021/jp061135f; Baker MB, 1997, SCIENCE, V276, P1072, DOI 10.1126/science.276.5315.1072; Hargreaves G, 2010, J PHYS CHEM A, V114, P1806, DOI 10.1021/jp9095985; Magome N, 2003, J PHYS CHEM B, V107, P3988, DOI 10.1021/jp034336h; Baker MB, 2008, NATURE, V451, P299, DOI 10.1038/nature06594; ASHKIN A, 1975, SCIENCE, V187, P1073, DOI 10.1126/science.187.4181.1073; Mitchem L, 2008, CHEM SOC REV, V37, P756, DOI 10.1039/b609713h; Kohler H, 1936, T FARADAY SOC, V32, P1152, DOI 10.1039/tf9363201152; Hopkins RJ, 2004, PHYS CHEM CHEM PHYS, V6, P4924, DOI 10.1039/b414459g; Abbatt JPD, 2006, SCIENCE, V313, P1770, DOI 10.1126/science.1129726; Chelf JH, 2001, J GEOPHYS RES-ATMOS, V106, P1215, DOI 10.1029/2000JD900477; Hill S.C., 1990, LIGHT SCATTERING PAR; Ishizaka S, 2010, PHYS CHEM CHEM PHYS, V12, P9852, DOI 10.1039/c003887c; Ishizaka S, 2013, BUNSEKI KAGAKU, V62, P361; Ishizaka S, 2011, CHEM PHYS LETT, V506, P117, DOI 10.1016/j.cplett.2011.02.058; Ishizaka S, 2013, ANAL SCI, V29, P1223; Lewis ER, 2006, J AEROSOL SCI, V37, P1605, DOI 10.1016/j.jaerosci.2006.04.001; LOW RDH, 1969, J ATMOS SCI, V26, P608, DOI 10.1175/1520-0469(1969)026<0608:AGEFTS>2.0.CO;2; Martin ST, 1998, GEOPHYS RES LETT, V25, P1657, DOI 10.1029/98GL00634; NOVOTNY OSP, 1985, DENSITY OF AQUEOUS S; Symes R, 2004, PHYS CHEM CHEM PHYS, V6, P474, DOI 10.1039/b313370b; Tabazadeh A, 1998, GEOPHYS RES LETT, V25, P1379, DOI 10.1029/97GL03585; 1923, LANDOLT BORNSTEIN PH, V5	23	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	NOV	2014	30	11					1075	1079				5	Chemistry, Analytical	Chemistry	AU3YW	WOS:000345547400008		
J	Shirasu, N; Kuroki, M				Shirasu, Naoto; Kuroki, Masahide			Simultaneous Genotyping of Single-nucleotide Polymorphisms in Alcoholism-related Genes Using Duplex and Triplex Allele-specific PCR with Two-step Thermal Cycles	ANALYTICAL SCIENCES			English	Article						Alcohol dehydrogenase; aldehyde dehydrogenase; allele-specific PCR; genotyping; mu-opioid receptor; single nucleotide polymorphism; two-step PCR	JAPANESE; ASSOCIATION; DEPENDENCE; A118G; BLOOD	We developed a time- and cost-effective multiplex allele-specific polymerase chain reaction (AS-PCR) method based on the two-step PCR thermal cycles for genotyping single-nucleotide polymorphisms in three alcoholism-related genes: alcohol dehydrogenase 1B, aldehyde dehydrogenase 2 and mu-opioid receptor. Applying MightyAmp (R) DNA polymerase with optimized AS-primers and PCR conditions enabled us to achieve effective and selective amplification of the target alleles from alkaline lysates of a human hair root, and simultaneously to determine the genotypes within less than 1.5 h using minimal lab equipment.	[Shirasu, Naoto; Kuroki, Masahide] Fukuoka Univ, Dept Biochem, Fac Med, Fukuoka 8140180, Japan	Shirasu, N (reprint author), Fukuoka Univ, Dept Biochem, Fac Med, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	shirasu@fukuoka-u.ac.jp					Iannone MA, 2000, CYTOMETRY, V39, P131, DOI 10.1002/(SICI)1097-0320(20000201)39:2<131::AID-CYTO6>3.0.CO;2-U; Chen DY, 2012, DRUG ALCOHOL DEPEN, V123, P1, DOI 10.1016/j.drugalcdep.2011.10.012; Hayashida M, 2009, ANAL SCI, V25, P1487; De La Vega FA, 2005, MUTAT RES-FUND MOL M, V573, P111, DOI 10.1016/j.mrfmmm.2005.01.008; Birley AJ, 2009, HUM MOL GENET, V18, P1533, DOI 10.1093/hmg/ddp060; Hayashida M, 2010, ANAL SCI, V26, P503; Higuchi S, 1996, ALCOHOL CLIN EXP RES, V20, P493, DOI 10.1111/j.1530-0277.1996.tb01080.x; Howell WM, 1999, NAT BIOTECHNOL, V17, P87, DOI 10.1038/5270; Little S, 2001, CURR PROTOC HUM GENE, DOI [DOI 10.1002/0471142905.HG0908S07, 10.1002/0471142905.hg0908s07]; Lu YQ, 2009, MUTAGENESIS, V24, P303, DOI 10.1093/mutage/gep008; Nishizawa D, 2006, NEUROPSYCHOBIOLOGY, V53, P137, DOI 10.1159/000093099	11	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	NOV	2014	30	11					1093	1096				4	Chemistry, Analytical	Chemistry	AU3YW	WOS:000345547400011		
J	Yamauchi, M; Imabayashi, E; Matsuda, H; Nakagawara, J; Takahashi, M; Shimosegawa, E; Hatazawa, J; Suzuki, M; Iwanaga, H; Fukuda, K; Iihara, K; Iida, H				Yamauchi, Miho; Imabayashi, Etsuko; Matsuda, Hiroshi; Nakagawara, Jyoji; Takahashi, Masaaki; Shimosegawa, Eku; Hatazawa, Jun; Suzuki, Michiyasu; Iwanaga, Hideyuki; Fukuda, Kenji; Iihara, Koji; Iida, Hidehiro			Quantitative assessment of rest and acetazolamide CBF using quantitative SPECT reconstruction and sequential administration of I-123-iodoamphetamine: comparison among data acquired at three institutions	ANNALS OF NUCLEAR MEDICINE			English	Article						Single-photon emission computed tomography; Cerebral blood flow; Cerebral vascular disease; Kinetic modeling; Ischemia	CEREBRAL-BLOOD-FLOW; EMISSION COMPUTED-TOMOGRAPHY; SPLIT-DOSE I-123-IODOAMPHETAMINE; SCATTER CORRECTION METHODS; CEREBROVASCULAR REACTIVITY; ALZHEIMERS-DISEASE; ARTERY OCCLUSION; NOISE PROPERTIES; METABOLIC-RATE; MONTE-CARLO	Purpose A recently developed technique which reconstructs quantitative images from original projection data acquired using existing single-photon emission computed tomography (SPECT) devices enabled quantitative assessment of cerebral blood flow (CBF) at rest and after acetazolamide challenge. This study was intended to generate a normal database and to investigate its inter-institutional consistency. Methods The three institutions carried out a series of SPECT scanning on 32 healthy volunteers, following a recently proposed method that involved dual administration of 123 I-iodoamphetamine during a single SPECT scan. Intra-institute and inter-institutional variations of regional CBF values were evaluated both at rest and after acetazolamide challenge. Functional images were pooled for both rest and acetazolamide CBF, and inter-institutional difference was evaluated among these images using two independent software programs. Results Quantitative assessment of CBF images at rest and after acetazolamide was successfully achieved with the given protocol in all institutions. Intra-institutional variation of CBF values at rest and after acetazolamide was consistent with previously reported values. Quantitative CBF values showed no significant difference among institutions in all regions, except for a posterior cerebral artery region after acetazolamide challenge in one institution which employed SPECT device with lowest spatial resolution. Pooled CBF images at rest and after acetazolamide generated using two software programs showed no institutional differences after equalization of the spatial resolution. Conclusions SPECT can provide reproducible images from projection data acquired using different SPECT devices. A common database acquired at different institutions may be shared among institutions, if images are reconstructed using a quantitative reconstruction program, and acquired by following a standardized protocol.	[Yamauchi, Miho; Iida, Hidehiro] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Investigat Radiol, Suita, Osaka 5658565, Japan; [Imabayashi, Etsuko; Matsuda, Hiroshi] Saitama Med Univ, Dept Nucl Med, Saitama 3501298, Japan; [Nakagawara, Jyoji; Takahashi, Masaaki] Nakamura Mem Hosp, Minami Ku, Sapporo, Hokkaido 0050802, Japan; [Shimosegawa, Eku; Hatazawa, Jun] Osaka Univ, Sch Med, Dept Nucl Med, Suita, Osaka 5650871, Japan; [Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan; [Iwanaga, Hideyuki] Yamaguchi Univ, Dept Radiol Technol, Ube, Yamaguchi 7558505, Japan; [Fukuda, Kenji; Iihara, Koji] Natl Cerebral & Cardiovasc Ctr Hosp, Dept Neurosurg, Suita, Osaka 5658565, Japan	Iida, H (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Investigat Radiol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	iida@ri.ncvc.go.jp					Iida H, 1998, J NUCL CARDIOL, V5, P313, DOI 10.1016/S1071-3581(98)90133-7; Zaidi H, 2004, EUR J NUCL MED MOL I, V31, P761, DOI 10.1007/s00259-004-1495-z; Matsuda H, 2007, AM J NEURORADIOL, V28, P731; MEIKLE SR, 1994, J NUCL MED, V35, P360; YAMAGUCHI T, 1986, STROKE, V17, P1220; Mizumura S, 2003, ANN NUCL MED, V17, P289, DOI 10.1007/BF02988523; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Kim KM, 2003, J NUCL MED, V44, P512; Tossici-Bolt L, 2011, EUR J NUCL MED MOL I, V38, P1529, DOI 10.1007/s00259-011-1801-5; Mizumura S, 2004, ANN NUCL MED, V18, P13, DOI 10.1007/BF02985609; MINOSHIMA S, 1995, J NUCL MED, V36, P1238; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Ogasawara K, 2003, J NUCL MED, V44, P520; Ito H, 2004, EUR J NUCL MED MOL I, V31, P635, DOI 10.1007/s00259-003-1430-8; IIDA H, 1994, J NUCL MED, V35, P2019; Joshi A, 2009, NEUROIMAGE, V46, P154, DOI 10.1016/j.neuroimage.2009.01.057; Ogasawara K, 2002, STROKE, V33, P1857, DOI 10.1161/33; Iida H, 2010, J NUCL MED, V51, P1624, DOI 10.2967/jnumed.110.078352; Eberl S, 1996, J NUCL MED, V37, P137; Friston KJ, 1997, HUMAN BRAIN FUNCTION, P25; GRAHAM LS, 1995, MED PHYS, V22, P401, DOI 10.1118/1.597605; Hapdey S, 2004, IEEE NUCL SCI CONF R, P3170; Hatazawa J, 1997, J NUCL MED, V38, P1102; Hayashida K, 1996, NUCL MED COMMUN, V17, P1047, DOI 10.1097/00006231-199612000-00008; Hori Y, 2012, J NUCL MED, P141; Iida Hidehiro, 1996, Kaku Igaku, V33, P143; Iida H, 1998, J NUCL MED, V39, P1789; Iida H, 1998, J NUCL MED, V39, P18181; IIDA H, 1991, CIBA F SYMP, V163, P23; Iida Hidehiro, 1995, Kaku Igaku, V32, P263; Iida H, 1996, J CEREBR BLOOD F MET, V16, P781; Iida H, 1994, Eur J Nucl Med, V21, P1072; Iida H, 2013, ANN NUCL MED, V27, P25, DOI 10.1007/s12149-012-0655-7; Iida Hidehiro, 1995, Kaku Igaku, V32, P155; Iida H, 1999, IEEE T NUCL SCI, V46, P720, DOI 10.1109/23.775605; Ishii K, 2006, EUR J NUCL MED MOL I, V33, P575, DOI 10.1007/s00259-005-0015-0; Ito H, 2000, J CEREBR BLOOD F MET, V20, P1264; Kim KM, 2001, IEEE T NUCL SCI, V48, P689; Kim KM, 2006, NEUROIMAGE, V46, P689; Kurisu Rei, 2002, Kaku Igaku, V39, P13; Nakagawara J, 1999, No To Shinkei, V51, P502; Nakagawara J, 2000, No To Shinkei, V52, P873; Narita Yuichiro, 1999, Kaku Igaku, V36, P83; Narita Y, 1997, IEEE T NUCL SCI, V44, P2465, DOI 10.1109/23.656453; Narita Y, 1996, PHYS MED BIOL, V41, P2481, DOI 10.1088/0031-9155/41/11/017; Ogasawara Kuniaki, 2006, Nihon Rinsho, V64 Suppl 7, P524; Ogasawara K, 2002, J CEREBR BLOOD F MET, V22, P1142; Ogura T, 1999, Kaku Igaku, V36, P879; Ogura T, 2009, ANN NUCL MED, V23, P33, DOI 10.1007/s12149-008-0203-7; Yoneda H, 2012, J CEREBR BLOOD F MET, V32, P1757, DOI 10.1038/jcbfm.2012.67	50	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	NOV	2014	28	9					836	850		10.1007/s12149-014-0879-9		15	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU1SI	WOS:000345400100002		
J	Koshino, K; Fukushima, K; Fukumoto, M; Hori, Y; Moriguchi, T; Zeniya, T; Nishimura, Y; Kiso, K; Iida, H				Koshino, Kazuhiro; Fukushima, Kazuhito; Fukumoto, Masaji; Hori, Yuki; Moriguchi, Tetsuaki; Zeniya, Tsutomu; Nishimura, Yoshihiro; Kiso, Keisuke; Iida, Hidehiro			Quantification of myocardial blood flow using Tl-201 SPECT and population-based input function	ANNALS OF NUCLEAR MEDICINE			English	Article						Myocardial blood flow; SPECT; Thallium-201; Input function	PERFUSION SPECT; PET; MISREGISTRATION; IODINE-123-IMP; TOMOGRAPHY; VALIDATION; CT; REREGISTRATION; QUANTITATION; O-15-WATER	Objectives Thallium-201 (Tl-201) single photon emission computed tomography (SPECT) is an important tool in the diagnosis of ischemic heart disease. Absolute quantification of myocardial blood flow (MBF) has the potential to provide more useful information on myocardial perfusion than semi-quantitative assessments. This study aimed to validate the quantification of MBF using Tl-201 cardiac SPECT based on a population-averaged input function (STD-IF) and one-point blood sample technique. Methods Tl-201 emission and computed tomography (CT)-based attenuation scans were performed on 11 healthy volunteers at rest using a SPECT/CT scanner. Individual input functions (IND-IFs) during the emission scans were based on arterial blood samples. The STD-IF technique was validated as follows: (1) optimal time to calibrate a STD-IF was determined to minimize differences between the calibrated STD-IF and the IND-IFs. (2) Tissue time-activity curves (TTACs) were generated based on a single-tissue compartment model for MBFtrue = 0.5, 1.0, 1.5, and 2.0 mL/min/g, a constant distribution volume of 45 mL/mL, and IND-IFs. The pseudo STD-IF for each subject was generated using the leave-one-out technique. Using the optimal calibration time and the pseudo STD-IFs, MBF values were estimated on the TTACs with an autoradiography method. Optimal mid-scan time (MST) with a fixed duration of 20 min was determined to minimize intersubject variation in estimated MBF errors, and (3) Global and regional MBF values estimated with pseudo STD-IFs were compared to those with IND-IFs using the optimal calibration time and MST. Results The optimal calibration time and MST were both 20 min after Tl-201 injection. Global MBF determined using both IND-IFs and pseudo STD-IF showed significant correlations with rate-pressure products, R-2 = 0.645; p < 0.01 and (true) = 0.303; p < 0.05, respectively. The mean percent error in regional MBF using pseudo STD-IFs was 0.69 +/- 7.80 % (-12.80 to 14.25 %). No significant difference was observed between regional MBF values using IND-IFs and pseudo STD-IFs. Conclusion This study demonstrated that the proposed technique based on a STD-IF and one-point blood sample provided hemodynamically reasonable global MBF values and the regional MBF values comparable to those with IND-IFs.	[Koshino, Kazuhiro; Hori, Yuki; Moriguchi, Tetsuaki; Zeniya, Tsutomu; Iida, Hidehiro] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Investigat Radiol, Suita, Osaka 5658565, Japan; [Fukushima, Kazuhito; Nishimura, Yoshihiro; Kiso, Keisuke] Natl Cerebral & Cardiovasc Ctr Hosp, Dept Radiol, Suita, Osaka, Japan; [Fukumoto, Masaji] Natl Hosp Org Osaka Natl Hosp, Dept Radiol, Chuo Ku, Osaka, Japan	Koshino, K (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Investigat Radiol, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	koshino@ncvc.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [13308422]	This research was partially supported by a 2013 Grant-in-Aid for Young Scientists (B), no 13308422, from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Iida H, 2008, EUR J NUCL MED MOL I, V35, P896, DOI 10.1007/s00259-007-0654-4; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Kovalski G, 2007, J NUCL MED, V48, P630, DOI 10.2967/jnumed.106.037390; Iida H, 1998, J NUCL CARDIOL, V5, P313, DOI 10.1016/S1071-3581(98)90133-7; Goetze S, 2007, J NUCL CARDIOL, V14, P200, DOI 10.1016/j.nuclcard.2006.12.325; Hermansen F, 1998, EUR J NUCL MED, V25, P751, DOI 10.1007/s002590050279; WEINBERG IN, 1988, J NUCL MED, V29, P241; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Goetze S, 2007, J NUCL MED, V48, P1090, DOI 10.2967/jnumed.107.040535; Di Carli MF, 2007, J NUCL MED, V48, P783, DOI 10.2967/jnumed.106.032789; IIDA H, 1994, J NUCL MED, V35, P2019; Kajander S, 2010, CIRCULATION, V122, P603, DOI 10.1161/CIRCULATIONAHA.109.915009; Fricke H, 2004, J NUCL MED, V45, P1619; Garcia EV, 2012, J NUCL CARDIOL, V19, pS19, DOI 10.1007/s12350-011-9488-3; Hatazawa J, 1997, J NUCL MED, V38, P1102; IIDA H, 1992, J NUCL MED, V33, P1669; Iida H, 1996, J CEREBR BLOOD F MET, V16, P781; Iida H, 1994, Eur J Nucl Med, V21, P1072; IIDA H, 1991, J NUCL MED, V32, P2169; ITO H, 1995, J NUCL MED, V36, P2339; Jia L, 1995, NUCL SCI IEEE T, V42, P1207; Katoh C, 2004, J NUCL MED, V45, P1908; Kennedy JA, 2009, J NUCL MED, V50, P1471, DOI 10.2967/jnumed.109.062141; Knuuti J, 2009, J NUCL CARDIOL, V16, P497, DOI 10.1007/s12350-009-9101-1; Koshino K, 2012, J NUCL CARDIOL, V19, P524, DOI 10.1007/s12350-012-9522-0; Koshino K, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-33; Narita Y, 1997, IEEE T NUCL SCI, V44, P2465, DOI 10.1109/23.656453; WEICH HF, 1977, CIRCULATION, V56, P188	28	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	NOV	2014	28	9					917	925		10.1007/s12149-014-0888-8		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU1SI	WOS:000345400100011		
J	Xu, R; Kido, S; Suga, K; Hirano, Y; Tachibana, R; Muramatsu, K; Chagawa, K; Tanaka, S				Xu, Rui; Kido, Shoji; Suga, Kazuyoshi; Hirano, Yasushi; Tachibana, Rie; Muramatsu, Keiichiro; Chagawa, Kazuki; Tanaka, Satoshi			Texture analysis on F-18-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions	ANNALS OF NUCLEAR MEDICINE			English	Article						Texture analysis; Bone and soft-tissue lesions; F-18-FDG PET/CT; Computer-aided diagnosis (CAD)	CELL LUNG-CANCER; HETEROGENEITY; FEATURES; SARCOMAS; VOLUME; CT	Objective The purpose is to develop and evaluate the ability of the computer-aided diagnosis (CAD) methods that apply texture analysis and pattern classification to differentiate malignant and benign bone and soft-tissue lesions on F-18-fluorodeoxy-glucose positron emission tomography/computed tomography (F-18-FDG PET/CT) images. Methods Subjects were 103 patients with 59 malignant and 44 benign bone and soft tissue lesions larger than 25 mm in diameter. Variable texture parameters of standardized uptake values (SUV) and CT Hounsfield unit values were three-dimensionally calculated in lesional volumes-of-interest segmented on PET/CT images. After selection of a subset of the most optimal texture parameters, a support vector machine classifier was used to automatically differentiate malignant and benign lesions. We developed three kinds of CAD method. Two of them utilized only texture parameters calculated on either CT or PET images, and the other one adopted the combined PET and CT texture parameters. Their abilities of differential diagnosis were compared with the SUV method with an optimal cut-off value of the maximum SUV. Results The CAD methods utilizing only optimal PET (or CT) texture parameters showed sensitivity of 83.05 % (81.35 %), specificity of 63.63 % (61.36 %), and accuracy of 74.76 % (72.82 %). Although the ability of differential diagnosis by PET or CT texture analysis alone was not significantly different from the SUV method whose sensitivity, specificity, and accuracy were 64.41, 61.36, and 63.11 % (the optimal cut-off SUVmax was 5.4 +/- 0.9 in the 10-fold cross-validation test), the CAD method with the combined PET and CT optimal texture parameters (PET: entropy and coarseness, CT: entropy and correlation) exhibited significantly better performance compared with the SUV method (p = 0.0008), showing a sensitivity of 86.44 %, specificity of 77.27 %, and accuracy of 82.52 %. Conclusions The present CAD method using texture analysis to analyze the distribution/heterogeneity of SUV and CT values for malignant and benign bone and soft-tissue lesions improved the differential diagnosis on F-18-FDG PET/CT images.	[Xu, Rui] Ritsumeikan Univ, Ritsumeikan Global Innovat Res Org, Kusatsu, Shiga 5258577, Japan; [Kido, Shoji; Hirano, Yasushi] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Suga, Kazuyoshi] St Hill Hosp, Dept Radiol, Ube, Yamaguchi, Japan; [Tachibana, Rie] Oshima Natl Coll Maritime Technol, Informat Sci & Technol Dept, Yamaguchi, Japan; [Muramatsu, Keiichiro; Chagawa, Kazuki] Yamaguchi Univ, Sch Med, Dept Orthoped, Ube, Yamaguchi 755, Japan; [Tanaka, Satoshi] Ritsumeikan Univ, Coll Informat Sci & Engn, Kusatsu, Shiga, Japan	Xu, R (reprint author), Ritsumeikan Univ, Ritsumeikan Global Innovat Res Org, 1-1 Nojihigashi 1 Chome, Kusatsu, Shiga 5258577, Japan.	qdruixu@gmail.com			MEXT KAKENHI [21103008]; MEXT; R-GIRO research fund from Ritsumeikan University	This research was supported in part by MEXT KAKENHI Grant Number 21103008, the MEXT-supported program for the strategic research foundation at private universities (2013-2017) and the R-GIRO research fund from Ritsumeikan University.	Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; Brooks FJ, 2014, J NUCL MED, V55, P37, DOI 10.2967/jnumed.112.116715; Tylski P, 2010, J NUCL MED, V51, P268, DOI 10.2967/jnumed.109.066241; Meyer D, 2003, NEUROCOMPUTING, V55, P169, DOI 10.1016/S0925-2312(03)00431-4; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Nestle U, 2005, J NUCL MED, V46, P1342; AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Schwarzbach MHM, 2000, ANN SURG, V231, P380, DOI 10.1097/00000658-200003000-00011; Chen W, 2007, MAGN RESON MED, V58, P562, DOI 10.1002/mrm.21347; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Tixier F, 2012, J NUCL MED, V53, P693, DOI 10.2967/jnumed.111.099127; Kido S, 2002, J COMPUT ASSIST TOMO, V26, P573, DOI 10.1097/01.RCT.0000029045.35986.9F; Shin DS, 2008, ANN NUCL MED, V22, P603, DOI 10.1007/s12149-008-0151-2; Charest M, 2009, EUR J NUCL MED MOL I, V36, P1944, DOI 10.1007/s00259-009-1203-0; SHANNON CE, 1948, AT&T TECH J, V27, P623; Chicklore S, 2013, EUR J NUCL MED MOL I, V40, P133, DOI 10.1007/s00259-012-2247-0; Aoki Jun, 2003, J Orthop Sci, V8, P435, DOI 10.1007/s10776-001-0539-6; Bischoff M, 2010, ARCH ORTHOP TRAUM SU, V130, P819, DOI 10.1007/s00402-009-0937-2; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Davnall Fergus, 2012, Insights Imaging, V3, P573, DOI 10.1007/s13244-012-0196-6; Dimitrakopoulou-Strauss A, 2002, J NUCL MED, V43, P510; Japkowicz N, 2011, EVALUATION LEARNING; Kurani AS, 2004, P 7 IASTED INT C COM; Piperkova E, 2009, CLIN NUCL MED, V34, P146, DOI 10.1097/RLU.0b013e3181966f9d; Suga K, 2011, JPN J CLIN RADIOL, V56, P855; Vapnik V, 1999, NATURE STAT LEARNING	27	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	NOV	2014	28	9					926	935		10.1007/s12149-014-0895-9		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU1SI	WOS:000345400100012		
J	Takayanagi, K				Takayanagi, Kazuo			Effective interaction in the Rayleigh-Schrodinger perturbation theory	ANNALS OF PHYSICS			English	Article						Effective interaction; Folded diagram; Bracketing representation; Rayleigh-Schrodinger perturbation theory	NUCLEI; EXPANSION; OPERATORS; MODEL	We present a unified description of the effective interaction v in the Rayleigh-Schrodinger perturbation theory. First, we generalize the well-known bracketing expression for the energy shift Delta E in a one-dimensional model space to express the effective interaction upsilon in a multi-dimensional model space. Second, we show that the generalized bracketing representation has a natural graphic expression in terms of folded diagrams. The present work thus gives a unified understanding of the effective interaction (i) in one- and multi-dimensional model spaces and (ii) in algebraic (bracketing) and graphic (folded diagram) representations. (C) 2014 Elsevier Inc. All rights reserved.	Sophia Univ, Dept Phys, Chiyoda Ku, Tokyo 1028554, Japan	Takayanagi, K (reprint author), Sophia Univ, Dept Phys, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028554, Japan.	k-takaya@sophia.ac.jp					Andreozzi F, 1996, PHYS REV C, V54, P684, DOI 10.1103/PhysRevC.54.684; BRANDOW BH, 1967, REV MOD PHYS, V39, P771, DOI 10.1103/RevModPhys.39.771; SUZUKI K, 1980, PROG THEOR PHYS, V64, P2091, DOI 10.1143/PTP.64.2091; SCHUCAN TH, 1972, ANN PHYS-NEW YORK, V73, P108, DOI 10.1016/0003-4916(72)90315-6; Dean DJ, 2004, PROG PART NUCL PHYS, V53, P419, DOI 10.1016/j.ppnp.2004.05.001; SCHUCAN TH, 1973, ANN PHYS-NEW YORK, V76, P483, DOI 10.1016/0003-4916(73)90044-4; BLOCH C, 1958, NUCL PHYS, V6, P329, DOI 10.1016/0029-5582(58)90116-0; LINDGREN I, 1974, J PHYS B-AT MOL OPT, V7, P2441, DOI 10.1088/0022-3700/7/18/010; BLOCH C, 1958, NUCL PHYS, V8, P91, DOI 10.1016/0029-5582(58)90136-6; Brandow B.H., 1977, ADV QUANTUM CHEM, V10, P187, DOI 10.1016/S0065-3276(08)60581-X; ELLIS PJ, 1977, REV MOD PHYS, V49, P777, DOI 10.1103/RevModPhys.49.777; Hjorth-Jensen M., 1995, Physics Reports, V261, DOI 10.1016/0370-1573(95)00012-6; KRENCIGL.EM, 1974, NUCL PHYS A, VA235, P171, DOI 10.1016/0375-9474(74)90184-5; Kuo T.T.S., 1990, SPRINGER LECT NOTES, V364; Lindgren I., 1986, ATOMIC MANY BODY THE; Shavitt I., 2009, MANY BODY THEORY CHE; Suzuki K, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.024304; Takayanagi K, 2011, NUCL PHYS A, V864, P91, DOI 10.1016/j.nuclphysa.2011.06.025; Takayanagi K, 2013, NUCL PHYS A, V899, P107, DOI 10.1016/j.nuclphysa.2013.01.006; Takayanagi K, 2011, NUCL PHYS A, V852, P61, DOI 10.1016/j.nuclphysa.2011.01.003; Tsunoda N, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.024313	21	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-4916	1096-035X		ANN PHYS-NEW YORK	Ann. Phys.	NOV	2014	350						501	532		10.1016/j.aop.2014.08.002		32	Physics, Multidisciplinary	Physics	AT8OU	WOS:000345193100026		
J	Iwasaki, K; Yamamoto, H				Iwasaki, Keiji; Yamamoto, Hanako			Recruitment and population structure of the non-indigenous brackish-water mytilid Xenostrobus securis (Lamark, 1819) in the Kino River, Japan	AQUATIC INVASIONS			English	Article						axe-head mussel; brackish water; Japan; non-indigenous mussel; population structure; recruitment	WESTERN AUSTRALIAN ESTUARY; EDULIS-L; MUSCULISTA-SENHOUSIA; LAKE HAMANA; MOLLUSCA; CALIFORNIANUS; SETTLEMENT; BIVALVIA; REPRODUCTION; ATTACHMENT	The recruitment and population structure of the non-indigenous brackish water mytilid Xenostrobus securis (Lamark, 1819), native to Australasia, were studied in the lower reaches of the Kino River, central Japan. Post-larvae >2 mm in shell length were found exclusively among barnacle stands of Fistulobalanus kondakovi (Tarasov and Zevina, 1957) and algal fronds of Gloiopeltis tenax (Turner) Decaisone, 1842 from January to May and from July to October. Density of the post-larvae was much greater in the latter period than in the former. Small mussels with shell lengths of 2-4 mm settled to the conspecific mussel beds in April and September. Primary and secondary settlements onto different substrates were observed in the early stages of the life cycle. Two or three cohorts were identified in conspecific mussel beds, and they grew at a rate of ca. 1 mm per month. Density in the beds fluctuated monthly and was greater in the lower than in the middle intertidal zone, suggesting greater spatial heterogeneity in density due to predation in the former.	[Iwasaki, Keiji] Nara Univ, Inst Nat Sci, Nara 6318502, Japan; [Yamamoto, Hanako] Nara Univ, Fac Literature, Nara 6318502, Japan	Iwasaki, K (reprint author), Nara Univ, Inst Nat Sci, 1500 Misasagicho, Nara 6318502, Japan.	iwasaki@daibutsu.nara-u.ac.jp			JSPS KAKENHI Grant [18510208]	We are grateful to T. Kimura (Mie University) and M. Otani (Marine Ecological Institute) for providing information on X. securis and other non-indigenous marine organisms in Japan, and to two anonymous reviewers for their valuable comments. This work was supported by JSPS KAKENHI Grant Number 18510208.	Abdel-Razek Fatma A., 1993, Suisan Zoshoku, V41, P97; Abdel-Razek Fatma A., 1993, Suisan Zoshoku, V41, P89; Adarraga I, 2012, AQUAT INVASIONS, V7, P171, DOI 10.3391/ai.2012.7.2.003; Strayer DL, 2006, FRESHWATER BIOL, V51, P117, DOI 10.1111/j.1365-2427.2005.01482.x; WILSON BR, 1968, J NAT HIST, V2, P307, DOI 10.1080/00222936800770341; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Garci ME, 2007, AQUACULT INT, V15, P19, DOI 10.1007/s10499-006-9062-1; EYSTER LS, 1987, J EXP MAR BIOL ECOL, V114, P99; Darrigran G, 2007, AMBIO, V36, P575, DOI 10.1579/0044-7447(2007)36[575:AEPFAP]2.0.CO;2; SEED R, 1969, OECOLOGIA, V3, P277, DOI 10.1007/BF00390380; Gofas S, 2003, OCEANOGR MAR BIOL, V41, P237; Pascual S, 2010, BIOL INVASIONS, V12, P2091, DOI 10.1007/s10530-009-9611-4; GRIFFITHS CL, 1987, S AFR J MARINE SCI, V5, P547; BAYNE BL, 1964, J ANIM ECOL, V33, P513, DOI 10.2307/2569; Barbieri Michele, 2011, Marine Biodiversity Records, V4; Colgan DJ, 2013, MOLLUSCAN RES, V33, P272, DOI 10.1080/13235818.2013.826574; Crooks Jeffrey A., 2009, V204, P287; Crooks JA, 1996, ESTUARIES, V19, P225; Gayanilo F., 2005, FAO ICLARM STOCK ASS; Iwasaki Keiji, 2004, Bulletin of Plankton Society of Japan, V51, P132; Iwasaki K, 2006, ASSESSMENT CONTROL B, P104; Iwasaki Keiji, 2004, Japanese Journal of Benthology, V59, P22; Kimura Taeko, 2012, Venus (Tokyo), V70, P11; Kimura T., 1995, B SOC SEA WATER SCI, V49, P148; Kimura Taeko, 2009, Marine Biodiversity Records, V2, pe89, DOI 10.1017/S175526720900102X; Kimura Taeko, 1999, Venus the Japanese Journal of Malacology, V58, P101; Kimura Taeko, 1996, Venus the Japanese Journal of Malacology, V55, P215; Kohama T, 2001, NIPPON SUISAN GAKK, V67, P664; LANE DJW, 1985, MAR BIOL, V84, P301, DOI 10.1007/BF00392500; Lazzari G., 1994, Bollettino Malacologico, V30, P195; Minchin D, 1998, INVASIVE AQUATIC SPE, P135; Morton B, 1996, ZEBRA MUSSELS OTHER, P1; MORTON B, 1975, Malacological Review, V8, P91; Nalepa TF, 1993, ZEBRA MUSSELS BIOL I; PETERSEN JH, 1984, J EXP MAR BIOL ECOL, V82, P147, DOI 10.1016/0022-0981(84)90100-X; PETERSEN JH, 1984, VELIGER, V27, P7; Seed R, 1992, MUSSEL MYTILUS ECOLO, P87; Shirafuji J, 2003, BENTHIC COMMUNITIES, P20; SIGURDSSON JB, 1976, NATURE, V262, P386, DOI 10.1038/262386a0; WILSON BR, 1969, J NAT HIST, V3, P93, DOI 10.1080/00222936900770111; YAMADA SB, 1989, AQUACULTURE, V81, P275	41	0	0	REGIONAL EURO-ASIAN BIOLOGICAL INVASIONS CENTRE-REABIC	HELSINKI	PL 3, HELSINKI, 00981, FINLAND	1798-6540	1818-5487		AQUAT INVASIONS	Aquat. Invasions	NOV	2014	9	4					479	487		10.3391/ai.2014.9.4.06		9	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	AU4QT	WOS:000345597500006		
J	Kawabata, KS; Akitaya, H; Yamanaka, M; Itoh, R; Maeda, K; Moritani, Y; Ui, T; Kawabata, M; Mori, K; Nogami, D; Nomoto, K; Suzuki, N; Takaki, K; Tanaka, M; Ueno, I; Chiyonobu, S; Harao, T; Matsui, R; Miyamoto, H; Nagae, O; Nakashima, A; Nakaya, H; Ohashi, Y; Ohsugi, T; Komatsu, T; Sakimoto, K; Sasada, M; Sato, H; Tanaka, H; Urano, T; Yamashita, T; Yoshida, M; Arai, A; Ebisuda, N; Fukazawa, Y; Fukui, A; Hashimoto, O; Honda, S; Izumiura, H; Kanda, Y; Kawaguchi, K; Kawai, N; Kuroda, D; Masumoto, K; Nakaoka, T; Takata, K; Uemura, M; Yanagisawa, K				Kawabata, K. S.; Akitaya, H.; Yamanaka, M.; Itoh, R.; Maeda, K.; Moritani, Y.; Ui, T.; Kawabata, M.; Mori, K.; Nogami, D.; Nomoto, K.; Suzuki, N.; Takaki, K.; Tanaka, M.; Ueno, I.; Chiyonobu, S.; Harao, T.; Matsui, R.; Miyamoto, H.; Nagae, O.; Nakashima, A.; Nakaya, H.; Ohashi, Y.; Ohsugi, T.; Komatsu, T.; Sakimoto, K.; Sasada, M.; Sato, H.; Tanaka, H.; Urano, T.; Yamashita, T.; Yoshida, M.; Arai, A.; Ebisuda, N.; Fukazawa, Y.; Fukui, A.; Hashimoto, O.; Honda, S.; Izumiura, H.; Kanda, Y.; Kawaguchi, K.; Kawai, N.; Kuroda, D.; Masumoto, K.; Nakaoka, T.; Takata, K.; Uemura, M.; Yanagisawa, K.			OPTICAL AND NEAR-INFRARED POLARIMETRY OF HIGHLY REDDENED Type Ia SUPERNOVA 2014J: PECULIAR PROPERTIES OF DUST IN M82	ASTROPHYSICAL JOURNAL LETTERS			English	Article						circumstellar matter; dust, extinction; galaxies: individual (Messier 82); polarization; supernovae: individual (SN 2014J)	HUBBLE-SPACE-TELESCOPE; INTERSTELLAR LINEAR-POLARIZATION; SN 2014J; WAVELENGTH DEPENDENCE; PROGENITOR SYSTEM; GALAXY M82; SPECTROPOLARIMETRY; EXTINCTION; STARS; CONSTRAINTS	We present optical and near-infrared multi-band linear polarimetry of the highly reddened Type Ia supernova (SN) 2014J that appeared in M82. SN 2014J exhibits large polarization at shorter wavelengths, e.g., 4.8% in the B band, which decreases rapidly at longer wavelengths, while the position angle of the polarization remains at approximately 40. over the observed wavelength range. These polarimetric properties suggest that the observed polarization is likely predominantly caused by the interstellar dust within M82. Further analysis shows that the polarization peaks at a wavelengths much shorter than those obtained for the Galactic dust. The wavelength dependence of the polarization can be better described by an inverse power law rather than by the Serkowski law for Galactic interstellar polarization. These points suggest that the nature of the dust in M82 may be different from that in our Galaxy, with polarizing dust grains having a mean radius of <0.1 mu m.	[Kawabata, K. S.; Akitaya, H.; Itoh, R.; Ohsugi, T.; Yoshida, M.; Fukazawa, Y.; Uemura, M.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Kawabata, K. S.; Itoh, R.; Ui, T.; Kawabata, M.; Mori, K.; Takaki, K.; Ueno, I.; Chiyonobu, S.; Harao, T.; Matsui, R.; Miyamoto, H.; Nagae, O.; Ohashi, Y.; Komatsu, T.; Sakimoto, K.; Sato, H.; Tanaka, H.; Urano, T.; Yoshida, M.; Ebisuda, N.; Fukazawa, Y.; Kanda, Y.; Kawaguchi, K.; Nakaoka, T.; Takata, K.; Uemura, M.] Hiroshima Univ, Dept Phys Sci, Higashihiroshima 7398526, Japan; [Yamanaka, M.] Konan Univ, Dept Phys, Fac Sci & Engn, Kobe, Hyogo 6588501, Japan; [Yamanaka, M.; Maeda, K.] Kyoto Univ, Grad Sch Sci, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Maeda, K.; Nomoto, K.; Suzuki, N.] Univ Tokyo, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan; [Tanaka, M.; Nakaya, H.; Yamashita, T.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Nakashima, A.] Nagoya City Sci Museum, Naka Ku, Nagoya, Aichi 4600008, Japan; [Arai, A.; Honda, S.] Univ Hyogo, Ctr Astron, Nishi Harima Astron Observ, Sayo, Hyogo 6795313, Japan; [Fukui, A.; Izumiura, H.; Kuroda, D.; Yanagisawa, K.] NAOJ, Okayama Astrophys Observ, Kamogatacho Asauchi, Okayama 7190232, Japan; [Hashimoto, O.; Honda, S.] Gunma Astron Observ, Gunma 3770702, Japan; [Kawai, N.] Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan; [Masumoto, K.] Osaka Kyoiku Univ, Inst Astron, Osaka 5828582, Japan	Kawabata, KS (reprint author), Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan.	kawabtkj@hiroshima-u.ac.jp			JSPS [23340048, 23740141, 26287031, 26800100]; Optical and NIR Astronomy Inter-University Cooperation Program; OISTER; WPI Initiative; Ministry of Education, Culture, Sports, Science, and Technology in Japan	This work was supported by JSPS Research Fellowships for Young Scientists (K.T.), by the Grant-in-Aid for Scientific Research from JSPS (23340048,23740141,26287031,26800100), and by the Optical and NIR Astronomy Inter-University Cooperation Program, OISTER, and by the WPI Initiative, from the Ministry of Education, Culture, Sports, Science, and Technology in Japan.	Akitaya H, 2014, PROC SPIE, V9147, DOI 10.1117/12.2054577; Amanullah R, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/2/L21; Phillips MM, 1999, ASTRON J, V118, P1766, DOI 10.1086/301032; TURNSHEK DA, 1990, ASTRON J, V99, P1243, DOI 10.1086/115413; Foley RJ, 2014, MON NOT R ASTRON SOC, V443, P2887, DOI 10.1093/mnras/stu1378; Hillebrandt W, 2000, ANNU REV ASTRON ASTR, V38, P191, DOI 10.1146/annurev.astro.38.1.191; SERKOWSKI K, 1975, ASTROPHYS J, V196, P261, DOI 10.1086/153410; MARTIN PG, 1992, ASTROPHYS J, V392, P691, DOI 10.1086/171470; Heiles C, 2000, ASTRON J, V119, P923, DOI 10.1086/301236; Wang X, 2009, ASTROPHYS J LETT, V699, pL139, DOI 10.1088/0004-637X/699/2/L139; Patat F, 2009, ASTRON ASTROPHYS, V508, P229, DOI 10.1051/0004-6361/200810651; Ohyama Y, 2002, PUBL ASTRON SOC JPN, V54, P891; Leonard DC, 2005, ASTROPHYS J, V632, P450, DOI 10.1086/432866; Hutton S, 2014, MON NOT R ASTRON SOC, V440, P150, DOI 10.1093/mnras/stu185; WHITTET DCB, 1992, ASTROPHYS J, V386, P562, DOI 10.1086/171039; WILKING BA, 1980, ASTROPHYS J, V235, P905, DOI 10.1086/157694; Wang LF, 2008, ANNU REV ASTRON ASTR, V46, P433, DOI 10.1146/annurev.astro.40.060407.145139; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Wang LF, 2003, ASTROPHYS J, V591, P1110, DOI 10.1086/375444; Chornock R, 2008, ASTRON J, V136, P2227, DOI 10.1088/0004-6256/136/6/2227; Fossey J., 2014, CBET, V3792, P1; Goobar A, 2014, ASTROPHYS J LETT, V784, DOI 10.1088/2041-8205/784/1/L12; Hough J. H., 1987, MNRAS, V227, P1; Kawabata K. S., 2008, P SOC PHOTO-OPT INS, V7014, P70144; Kelly PL, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/3; Kotani T, 2005, NUOVO CIMENTO C, V28, P755, DOI 10.1393/ncc/i2005-10190-5; LANDOLT AU, 1992, ASTRON J, V104, P340, DOI 10.1086/116242; Margutti R, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/52; Marion G. H., 2014, APJ UNPUB; Maund JR, 2013, MON NOT R ASTRON SOC, V433, pL20, DOI 10.1093/mnrasl/slt050; Patat F., 2014, A A UNPUB; Pereira R, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201221008; Perez-Torres MA, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/38; Cox NLJ, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201219143; Phillips MM, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/38; Richmond Michael W., 2012, Journal of the American Association of Variable Star Observers, V40; Sakai S, 1999, ASTROPHYS J, V526, P599, DOI 10.1086/308032; Schlafly EF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/103; Wang L., 1997, APJ, V476, P27; Wang LF, 2006, ASTROPHYS J, V653, P490, DOI 10.1086/508250; Wang LF, 1996, ASTROPHYS J, V467, P435, DOI 10.1086/177617; Welty DE, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/2/106; Whittet D. C. B., 2003, DUST GALACTIC ENV; Yanagisawa K, 2008, P SOC PHOTO-OPT INS, V7014, P1437, DOI 10.1117/12.788905; Zheng WK, 2014, ASTROPHYS J LETT, V783, DOI 10.1088/2041-8205/783/1/L24	45	6	6	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	NOV 1	2014	795	1							L4	10.1088/2041-8205/795/1/L4		5	Astronomy & Astrophysics	Astronomy & Astrophysics	AU2NO	WOS:000345455500004		
J	Kwon, J; Tamura, M; Hough, JH; Kusakabe, N; Nagata, T; Nakajima, Y; Lucas, PW; Nagayama, T; Kandori, R				Kwon, Jungmi; Tamura, Motohide; Hough, James H.; Kusakabe, Nobuhiko; Nagata, Tetsuya; Nakajima, Yasushi; Lucas, Phil W.; Nagayama, Takahiro; Kandori, Ryo			NEAR-INFRARED CIRCULAR POLARIZATION SURVEY IN STAR-FORMING REGIONS: CORRELATIONS AND TRENDS	ASTROPHYSICAL JOURNAL LETTERS			English	Article						dust, extinction; infrared: ISM; ISM: magnetic fields; polarization; stars: formation; surveys	YOUNG STELLAR OBJECTS; R-CORONAE-AUSTRALIS; MAGNETIC-FIELDS; IMAGING POLARIMETRY; ZEEMAN OBSERVATIONS; MOLECULAR CLOUD; GSS 30; ORION; NGC-6334; COMPLEX	We have conducted a systematic near-infrared circular polarization (CP) survey in star-forming regions, covering high-mass, intermediate-mass, and low-mass young stellar objects. All the observations were made using the SIRPOL imaging polarimeter on the Infrared Survey Facility 1.4 m telescope at the South African Astronomical Observatory. We present the polarization properties of 10 sub-regions in 6 star-forming regions. The polarization patterns, extents, and maximum degrees of linear and circular polarizations are used to determine the prevalence and origin of CP in the star-forming regions. Our results show that the CP pattern is quadrupolar in general, the CP regions are extensive, up to 0.65 pc, the CP degrees are high, up to 20%, and the CP degrees decrease systematically from high- to low-mass young stellar objects. The results are consistent with dichroic extinction mechanisms generating the high degrees of CP in star-forming regions.	[Kwon, Jungmi; Tamura, Motohide] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Kwon, Jungmi; Tamura, Motohide; Kusakabe, Nobuhiko; Kandori, Ryo] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Hough, James H.; Lucas, Phil W.] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Nagata, Tetsuya] Kyoto Univ, Dept Astron, Kyoto 6068502, Japan; [Nakajima, Yasushi] Hitotsubashi Univ, Ctr Informat & Commun Technol, Kunitachi, Tokyo 1868601, Japan; [Nagayama, Takahiro] Kagoshima Univ, Dept Astrophys, Kagoshima 8900065, Japan	Kwon, J (reprint author), Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	jungmi.kwon@astron.s.u-tokyo.ac.jp			MEXT KAKENHI [19204018, 22000005]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [10147207, 10147214]; National Research Foundation (NRF) of South Africa;  [24 x 110];  [26 x 04023]	J.K. was supported by Grants-in-Aid for JSPS Fellows (24 x 110 and 26 x 04023). M.T. was supported by MEXT KAKENHI grant Nos. 19204018 and 22000005. The IRSF project is a collaboration between Nagoya University and the South African Astronomical Observatory (SAAO) supported by the Grants-in-Aid for Scientific Research on Priority Areas (A) (Nos. 10147207 and 10147214) and Optical & Near-Infrared Astronomy Inter-University Cooperation Program, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and the National Research Foundation (NRF) of South Africa.	Adams JD, 2012, ASTROPHYS J LETT, V749, DOI 10.1088/2041-8205/749/2/L24; Ageorges N, 1996, ASTROPHYS J, V463, pL101, DOI 10.1086/310058; Ainsworth RE, 2012, MON NOT R ASTRON SOC, V423, P1089, DOI 10.1111/j.1365-2966.2012.20935.x; Bailey J, 1998, SCIENCE, V281, P672, DOI 10.1126/science.281.5377.672; Crutcher RM, 2010, ASTROPHYS J, V725, P466, DOI 10.1088/0004-637X/725/1/466; Fukue T, 2009, ASTROPHYS J LETT, V692, pL88, DOI 10.1088/0004-637X/692/2/L88; Whittet DCB, 1997, ASTRON ASTROPHYS, V327, P1194; LOUGHRAN L, 1986, ASTROPHYS J, V303, P629, DOI 10.1086/164112; GENZEL R, 1989, ANNU REV ASTRON ASTR, V27, P41, DOI 10.1146/annurev.aa.27.090189.000353; Lada CJ, 2004, ASTRON J, V128, P1254, DOI 10.1086/423294; Chrysostomou A, 2007, NATURE, V450, P71, DOI 10.1038/nature06220; Kandori R, 2006, PROC SPIE, V6269, DOI 10.1117/12.670967; Lazarian A, 2007, MON NOT R ASTRON SOC, V378, P910, DOI 10.1111/j.1365-2966.2007.11817.x; Crutcher RM, 1999, ASTROPHYS J, V514, pL121, DOI 10.1086/311952; MCBREEN B, 1979, ASTROPHYS J, V232, pL183, DOI 10.1086/183061; Bastien P., 2011, ASTROPHYSICS SPACE S, V373, P201; Buschermohle M, 2005, ASTROPHYS J, V624, P821, DOI 10.1086/429244; Chrysostomou A, 1997, MON NOT R ASTRON SOC, V285, P750; Clark S, 2000, MON NOT R ASTRON SOC, V319, P337, DOI 10.1046/j.1365-8711.2000.03520.x; Clayton GC, 2005, ASTR SOC P, V343, P122; Gezari DY, 1998, ASTROPHYS J, V509, P283, DOI 10.1086/306462; Gledhill TM, 1996, MON NOT R ASTRON SOC, V282, P1418; HARVEY PM, 1983, ASTROPHYS J, V269, P613, DOI 10.1086/161068; Kwon J, 2013, ASTROPHYS J LETT, V765, DOI 10.1088/2041-8205/765/1/L6; Kwon J, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/1/35; LONSDALE CJ, 1980, ASTROPHYS J, V238, pL31, DOI 10.1086/183251; Lucas PW, 2005, ORIGINS LIFE EVOL B, V35, P29, DOI 10.1007/s11084-005-7770-6; Lucas PW, 2004, MON NOT R ASTRON SOC, V352, P1347, DOI 10.1111/j.1365-2966.2004.08026.x; MARTIN PG, 1972, MON NOT R ASTRON SOC, V159, P179; Matsumura M, 2009, ASTROPHYS J, V697, P807, DOI 10.1088/0004-637X/697/1/807; Nagayama T, 2003, P SOC PHOTO-OPT INS, V4841, P459, DOI 10.1117/12.460770; OGURA K, 1992, ASTROPHYS J, V400, P248, DOI 10.1086/171991; Reipurth B., 1999, GEN CATALOGUE HERBIG; Sarma AP, 2000, ASTROPHYS J, V533, P271, DOI 10.1086/308667; Whittet D. C. B., 1992, DUST GALACTIC ENV; WILKING BA, 1986, ASTRON J, V92, P103, DOI 10.1086/114140; Zhang QZ, 1997, ASTROPHYS J, V475, P713, DOI 10.1086/303577	37	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	NOV 1	2014	795	1							L16	10.1088/2041-8205/795/1/L16		7	Astronomy & Astrophysics	Astronomy & Astrophysics	AU2NO	WOS:000345455500016		
J	Lee, KG; Hennawi, JF; Stark, C; Prochaska, JX; White, M; Schlegel, DJ; Eilers, AC; Arinyo-i-Prats, A; Suzuki, N; Croft, RAC; Caputi, KI; Cassata, P; Ilbert, O; Garilli, B; Koekemoer, AM; Le Brun, V; Le Fevre, O; Maccagni, D; Nugent, P; Taniguchi, Y; Tasca, LAM; Tresse, L; Zamorani, G; Zucca, E				Lee, Khee-Gan; Hennawi, Joseph F.; Stark, Casey; Prochaska, J. Xavier; White, Martin; Schlegel, David J.; Eilers, Anna-Christina; Arinyo-i-Prats, Andreu; Suzuki, Nao; Croft, Rupert A. C.; Caputi, Karina I.; Cassata, Paolo; Ilbert, Olivier; Garilli, Bianca; Koekemoer, Anton M.; Le Brun, Vincent; Le Fevre, Olivier; Maccagni, Dario; Nugent, Peter; Taniguchi, Yoshiaki; Tasca, Lidia A. M.; Tresse, Laurence; Zamorani, Gianni; Zucca, Elena			LY alpha FOREST TOMOGRAPHY FROM BACKGROUND GALAXIES: THE FIRST MEGAPARSEC-RESOLUTION LARGE-SCALE STRUCTURE MAP AT Z > 2	ASTROPHYSICAL JOURNAL LETTERS			English	Article						cosmology: observations; galaxies: high-redshift; intergalactic medium; quasars: absorption lines; surveys; techniques: spectroscopic	REST-FRAME ULTRAVIOLET; BARYON ACOUSTIC-OSCILLATIONS; HUBBLE-SPACE-TELESCOPE; DIGITAL SKY SURVEY; INTERGALACTIC MEDIUM; POWER SPECTRUM; SPECTROSCOPIC SURVEY; STAR-FORMATION; COSMOS; REDSHIFT	We present the first observations of foreground Ly alpha forest absorption fromhigh-redshift galaxies, targeting 24 star-forming galaxies (SFGs) with z similar to 2.3-2.8 within a 5' x 14' region of the COSMOS field. The transverse sightline separation is similar to 2h(-1) Mpc comoving, allowing us to create a tomographic reconstruction of the three-dimensional (3D) Lya forest absorption field over the redshift range 2.20 <= z <= 2.45. The resulting map covers 6h(-1) Mpc x 14h(-1) Mpc in the transverse plane and 230h(-1) Mpc along the line of sight with a spatial resolution of approximate to 3.5h(-1) Mpc, and is the firsthigh-fidelity map of a large-scale structure on similar to Mpc scales at z > 2. Our map reveals significant structures with greater than or similar to 10h(-1) Mpc extent, including several spanning the entire transverse breadth, providing qualitative evidence for the filamentary structures predicted to exist in thehigh-redshift cosmic web. Simulated reconstructions with the same sightline sampling, spectral resolution, and signal-to-noise ratio recover the salient structures present in the underlying 3D absorption fields. Using data from other surveys, we identified 18 galaxies with known redshifts coeval with our map volume, enabling a direct comparison with our tomographic map. This shows that galaxies preferentially occupyhigh-density regions, in qualitative agreement with the same comparison applied to simulations. Our results establish the feasibility of the CLAMATO survey, which aims to obtain Ly alpha forest spectra for similar to 1000 SFGs over similar to 1deg(2) of the COSMOS field, in order to map out the intergalactic medium large-scale structure at < z > similar to 2.3 over a large volume (100h(-1) Mpc)(3).	[Lee, Khee-Gan; Hennawi, Joseph F.; Eilers, Anna-Christina] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Stark, Casey; White, Martin; Nugent, Peter] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Stark, Casey; White, Martin; Nugent, Peter] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Prochaska, J. Xavier] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Prochaska, J. Xavier; Schlegel, David J.] Univ Calif Santa Cruz, Lick Observ, Santa Cruz, CA 95064 USA; [Arinyo-i-Prats, Andreu] Univ Barcelona IEEC UB, Inst Ciencies Cosmos, E-08028 Barcelona, Spain; [Suzuki, Nao] Univ Tokyo, Kavli Inst Phys & Math Universe IPMU, Kashiwa, Chiba, Japan; [Croft, Rupert A. C.] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Caputi, Karina I.] Univ Groningen, Kapteyn Astron Inst, NL-9700 AV Groningen, Netherlands; [Cassata, Paolo] Univ Valparaiso, Fac Ciencias, Inst Fis & Astron, Valparaiso, Chile; [Cassata, Paolo; Ilbert, Olivier; Le Brun, Vincent; Le Fevre, Olivier; Tasca, Lidia A. M.; Tresse, Laurence] Aix Marseille Univ, CNRS, Lab Astrophys Marseille, UMR 7326, F-13388 Marseille, France; [Garilli, Bianca] INAF IASF, I-20133 Milan, Italy; [Koekemoer, Anton M.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Maccagni, Dario; Zamorani, Gianni; Zucca, Elena] INAF, Osservatorio Astron Bologna, I-40127 Bologna, Italy; [Taniguchi, Yoshiaki] Ehime Univ, Res Ctr Space & Cosm Evolut, Matsuyama, Ehime 7908577, Japan	Lee, KG (reprint author), Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany.	lee@mpia.de	White, Martin/I-3880-2015; Zucca, Elena/O-9396-2015; Koekemoer, Anton/F-8400-2014; 	White, Martin/0000-0001-9912-5070; Zucca, Elena/0000-0002-5845-8132; Koekemoer, Anton/0000-0002-6610-2048; Garilli, Bianca/0000-0001-7455-8750; Zamorani, Giovanni/0000-0002-2318-301X	NERSC Center, Office of Science of the U.S. D.O.E. [DE-AC02-05CH11231]	K.G.L. and A.C.E. are grateful to the National Geographic Society for travel support through the Waitt Grants program. This research used resources of the NERSC Center, which is supported by the Office of Science of the U.S. D.O.E. under Contract No. DE-AC02-05CH11231. We would like to thank those of Hawaiian ancestry, on whose sacred mountain we were privileged to be guests.	ZAROUBI S, 1995, ASTROPHYS J, V449, P446, DOI 10.1086/176070; Leitherer C, 2010, ASTROPHYS J SUPPL S, V189, P309, DOI 10.1088/0067-0049/189/2/309; Pichon C, 2001, MON NOT R ASTRON SOC, V326, P597, DOI 10.1046/j.1365-8711.2001.04595.x; Steidel CC, 2004, ASTROPHYS J, V604, P534, DOI 10.1086/381960; Capak P, 2007, ASTROPHYS J SUPPL S, V172, P99, DOI 10.1086/519081; Becker GD, 2013, MON NOT R ASTRON SOC, V430, P2067, DOI 10.1093/mnras/stt031; Caucci S, 2008, MON NOT R ASTRON SOC, V386, P211, DOI 10.1111/j.1365-2966.2008.13016.x; Leitherer C, 1999, ASTROPHYS J SUPPL S, V123, P3, DOI 10.1086/313233; Ilbert O, 2009, ASTROPHYS J, V690, P1236, DOI 10.1088/0004-637X/690/2/1236; White M, 2010, ASTROPHYS J, V713, P383, DOI 10.1088/0004-637X/713/1/383; Croft RAC, 1998, ASTROPHYS J, V495, P44, DOI 10.1086/305289; CEN RY, 1994, ASTROPHYS J, V437, pL9, DOI 10.1086/187670; Shapley AE, 2003, ASTROPHYS J, V588, P65, DOI 10.1086/373922; Koekemoer AM, 2007, ASTROPHYS J SUPPL S, V172, P196, DOI 10.1086/520086; Cisewski J, 2014, MON NOT R ASTRON SOC, V440, P2599, DOI 10.1093/mnras/stu475; Croft RAC, 2002, ASTROPHYS J, V581, P20, DOI 10.1086/344099; Scoville N, 2007, ASTROPHYS J SUPPL S, V172, P1, DOI 10.1086/516585; Hill GJ, 2004, AIP CONF PROC, V743, P224; OKE JB, 1995, PUBL ASTRON SOC PAC, V107, P375, DOI 10.1086/133562; Lilly SJ, 2007, ASTROPHYS J SUPPL S, V172, P70, DOI 10.1086/516589; Reddy NA, 2008, ASTROPHYS J SUPPL S, V175, P48, DOI 10.1086/521105; Berry M, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/4; BI HG, 1995, ASTROPHYS J, V452, P90, DOI 10.1086/176282; Brammer GB, 2012, ASTROPHYS J SUPPL S, V200, DOI 10.1088/0067-0049/200/2/13; Busca NG, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220724; Chiang YK, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/127; Dawson KS, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/1/10; Delubac T., 2014, ARXIV14041801; Diener C, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/109; Hui L, 1997, ASTROPHYS J, V486, P599, DOI 10.1086/304539; Le Fevre O., 2014, A A UNPUB; Lee KG, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/2/51; Lee K.-G., 2014, ARXIV14051072; Lee KG, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/49; Lee KG, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/3/69; Levi M., 2013, ARXIV13080847; McDonald P, 2006, ASTROPHYS J SUPPL S, V163, P80, DOI 10.1086/444361; Palanque-Delabrouille N, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201322130; Pieri MM, 2014, MON NOT R ASTRON SOC, V441, P1718, DOI 10.1093/mnras/stu577; Press WH, 1992, NUMERICAL RECIPES FO; Salvato M, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/61; Savaglio S, 2002, ASTROPHYS J, V567, P702, DOI 10.1086/338666; Slosar A, 2011, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2011/09/001; Wiener N., 1942, INTERPOLATION EXTRAP	44	5	5	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	NOV 1	2014	795	1							UNSP L12	10.1088/2041-8205/795/1/L12		7	Astronomy & Astrophysics	Astronomy & Astrophysics	AU2NO	WOS:000345455500012		
J	Tsujimoto, T; Shigeyama, T				Tsujimoto, Takuji; Shigeyama, Toshikazu			THE ORIGINS OF LIGHT AND HEAVY R-PROCESS ELEMENTS IDENTIFIED BY CHEMICAL TAGGING OF METAL-POOR STARS	ASTROPHYSICAL JOURNAL LETTERS			English	Article						Galaxy: evolution; Galaxy: halo; ISM: abundances; stars: abundances; stars: neutron	NEUTRON-CAPTURE ELEMENTS; GLOBULAR-CLUSTER M15; COMPACT OBJECT MERGERS; EARLY GALAXY; 1ST STARS; ABUNDANCES; DISPERSION; NUCLEOSYNTHESIS; ENRICHMENT; EJECTA	Growing interests in neutron star (NS) mergers as the origin of r-process elements have sprouted since the discovery of evidence for the ejection of these elements from a short-duration gamma-ray burst. The hypothesis of a NS merger origin is reinforced by a theoretical update of nucleosynthesis in NS mergers successful in yielding r-process nuclides with A > 130. On the other hand, whether the origin of light r-process elements are associated with nucleosynthesis in NS merger events remains unclear. We find a signature of nucleosynthesis in NS mergers from peculiar chemical abundances of stars belonging to the Galactic globular cluster M15. This finding combined with the recent nucleosynthesis results implies a potential diversity of nucleosynthesis in NS mergers. Based on these considerations, we are successful in the interpretation of an observed correlation between [light r-process/Eu] and [Eu/Fe] among Galactic halo stars and accordingly narrow down the role of supernova nucleosynthesis in the r-process production site. We conclude that the tight correlation by a large fraction of halo stars is attributable to the fact that core-collapse supernovae produce light r-process elements while heavy r-process elements such as Eu and Ba are produced by NS mergers. On the other hand, stars in the outlier, composed of r-enhanced stars ([Eu/Fe] greater than or similar to + 1) such as CS22892-052, were exclusively enriched by matter ejected by a subclass of NS mergers that is inclined to be massive and consist of both light and heavy r-process nuclides.	[Tsujimoto, Takuji] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Shigeyama, Toshikazu] Univ Tokyo, Sch Sci, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan	Tsujimoto, T (reprint author), Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan.	taku.tsujimoto@nao.ac.jp			JSPS [23224004]; Institute for Nuclear Theory, University of Washington [INT-PUB-14-043]	The authors wish to thank the anonymous referees for their valuable comments which have considerably improved the paper. This paper is based upon work supported in part by the JSPS Grants-in-Aid for Scientific Research (23224004) and under the hospitality of the Institute for Nuclear Theory, University of Washington (Report No.: INT-PUB-14-043).	Sneden C, 1997, ASTRON J, V114, P1964, DOI 10.1086/118618; D'Ercole A, 2008, MON NOT R ASTRON SOC, V391, P825, DOI 10.1111/j.1365-2966.2008.13915.x; Honda S, 2006, ASTROPHYS J, V643, P1180, DOI 10.1086/503195; Sneden C, 2008, ANNU REV ASTRON ASTR, V46, P241, DOI 10.1146/annurev.astro.46.060407.145207; BONDI H, 1952, MON NOT R ASTRON SOC, V112, P195; Shigeyama T, 1998, ASTROPHYS J, V507, pL135, DOI 10.1086/311699; Metzger BD, 2010, MON NOT R ASTRON SOC, V406, P2650, DOI 10.1111/j.1365-2966.2010.16864.x; Korobkin O, 2012, MON NOT R ASTRON SOC, V426, P1940, DOI 10.1111/j.1365-2966.2012.21859.x; Montes F, 2007, ASTROPHYS J, V671, P1685, DOI 10.1086/523084; Belczynski K, 2006, ASTROPHYS J, V648, P1110, DOI 10.1086/505169; Aoki W, 2005, ASTROPHYS J, V632, P611, DOI 10.1086/432862; Sneden C, 2003, ASTROPHYS J, V591, P936, DOI 10.1086/375491; Sneden C, 2000, ASTROPHYS J, V536, pL85, DOI 10.1086/312742; MATHEWS GJ, 1990, NATURE, V345, P491, DOI 10.1038/345491a0; Suda T, 2008, PUBL ASTRON SOC JPN, V60, P1159; Tanvir NR, 2013, NATURE, V500, P547, DOI 10.1038/nature12505; Barnes J, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/18; Bauswein A, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/78; Berger E., 2013, APJ, V773, P78; Cohen JG, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/2/L38; Francois P, 2007, ASTRON ASTROPHYS, V476, P935, DOI 10.1051/0004-6361:20077706; Hotokezaka K, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/1/L16; Just O., 2014, MNRAS UNPUB; Metzger BD, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/48; Otsuki K, 2006, ASTROPHYS J, V641, pL117, DOI 10.1086/504106; Qian Y.-Z., 2007, PHYS REP, V444, P237; Roederer IU, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/1/22; Shigeyama T, 2003, ASTROPHYS J, V586, pL57, DOI 10.1086/374635; Sobeck JS, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/6/175; Tsujimoto T, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/113; Tsujimoto T, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201423751; Wanajo S, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/2/L39; Worley CC, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201321097	33	5	5	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	NOV 1	2014	795	1							L18	10.1088/2041-8205/795/1/L18		4	Astronomy & Astrophysics	Astronomy & Astrophysics	AU2NO	WOS:000345455500018		
J	Yamada, N; Tsujimura, N; Kumazaki, M; Shinohara, H; Taniguchi, K; Nakagawa, Y; Naoe, T; Akao, Y				Yamada, Nami; Tsujimura, Nonoka; Kumazaki, Minami; Shinohara, Haruka; Taniguchi, Kohei; Nakagawa, Yoshihito; Naoe, Tomoki; Akao, Yuldhiro			Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Article						Angiogenesis; Colorectal cancer; Microvesicles; miR-1246; Smad signaling	ACUTE PROMYELOCYTIC LEUKEMIA; EXPRESSION; ALPHA; TRANSLOCATION; PROTEIN; BIOMARKERS; SERUM; CARCINOMA; T(15-17); GROWTH	Emerging studies on circulating microRNAs (miRNAs) or microvesicles (MVs) have shown the potential of them to be novel biomarkers and therapeutic targets for cancer. However, the biological roles of these miRNAs and MVs have not been validated yet. To determine the biological significance of MVs, we used human colorectal cancer cells as the MV donor and endothelial cells (HUVECs) as the MV recipient and demonstrated the transfer of colorectal cancer cell-derived MVs (CRC-MVs) to HUVECs and evaluated the roles of these MVs and their cargo in tumor angiogenesis. Consequently, the incubation of HUVECs with CRC-MVs promoted the proliferation, migration, and tube formation activities of these cells. Among the cargoes shuttled by the MVs, miR-1246 and TGF-beta were considered to be responsible for the pro-angiogenic function of MVs by activating Smad 1/5/8 signaling in the HUVECs. These results suggest that colorectal cancer cells secreted MVs to contribute to tumor angiogenesis. (C) 2014 Elsevier B.V. All rights reserved.	[Yamada, Nami; Tsujimura, Nonoka; Kumazaki, Minami; Shinohara, Haruka; Taniguchi, Kohei; Akao, Yuldhiro] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011193, Japan; [Nakagawa, Yoshihito] Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi 4701192, Japan; [Naoe, Tomoki] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, Nagoya, Aichi 4668550, Japan	Yamada, N (reprint author), Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, 1-1 Yanagido, Gifu 5011193, Japan.	namiyamada80@gmail.com			Ministry of Education, Science, Sports, and Culture of Japan [24659157]; Japan Society for the Promotion of Science	The work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan (grant number 24659157). N. Yamada is a research fellow of the Japan Society for the Promotion of Science, 2013-2015.	Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Yamada N, 2013, TRANSL ONCOL, V6, P482, DOI 10.1593/tlo.13280; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Seo SR, 2006, MOL CELL, V23, P547, DOI 10.1016/j.molcel.2006.06.018; Chen JY, 2013, INT J MOL MED, V32, P557, DOI 10.3892/ijmm.2013.1424; Yamada N, 2014, BBA-MOL CELL RES, V1843, P590, DOI 10.1016/j.bbamcr.2013.11.022; Cheng XW, 2012, J BIOL CHEM, V287, P23356, DOI 10.1074/jbc.M112.340505; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; ROWLEY JD, 1977, LANCET, V1, P549; Wang ZG, 1998, SCIENCE, V279, P1547; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Takeshita N, 2013, BRIT J CANCER, V108, P644, DOI 10.1038/bjc.2013.8; Jones CI, 2012, BRIT J CANCER, V107, P1987, DOI 10.1038/bjc.2012.525; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Yamada N, 2013, CANCER LETT, V335, P332, DOI 10.1016/j.canlet.2013.02.060; Bertolino P, 2005, CHEST, V128, p585S, DOI 10.1378/chest.128.6_suppl.585S; Carracedo A, 2011, CURR OPIN CELL BIOL, V23, P360, DOI 10.1016/j.ceb.2011.03.011; Grignani F, 2000, BLOOD, V96, P1531; Nguyen LA, 2005, BLOOD, V105, P292, DOI 10.1182/blood-2004-03-1185; Noguchi S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.11; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; References P, 2005, NATURE, V438, P932; Strudwick S, 2002, LEUKEMIA, V16, P1906, DOI 10.1038/sj.leu.2402724; Tang MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059477; WANG JG, 2014, PLOS ONE, V19, P9; Yang Y, 2013, BIOMED REP, V1, P495; Yoshida H, 2007, MOL CELL BIOL, V27, P5819, DOI 10.1128/MCB.02422-06	32	10	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	NOV	2014	1839	11					1256	1272		10.1016/j.bbagrm.2014.09.002		17	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AU3CM	WOS:000345490400021		
J	Barnett, CA; Bateson, M; Rowe, C				Barnett, Craig A.; Bateson, Melissa; Rowe, Candy			Better the devil you know: avian predators find variation in prey toxicity aversive	BIOLOGY LETTERS			English	Article						aposematism; European starling; Sturnus vulgaris; mimicry; chemical defence; variability	DEFENDED PREY; STRATEGIC DECISIONS; EDUCATED PREDATORS; APOSEMATIC PREY; DEFENSES; EVOLUTIONARY; AUTOMIMICRY; MIMICRY; COSTS	Toxic prey that signal their defences to predators using conspicuous warning signals are called 'aposematic'. Predators learn about the toxic content of aposematic prey and reduce their attacks on them. However, through regulating their toxin intake, predators will include aposematic prey in their diets when the benefits of gaining the nutrients they contain outweigh the costs of ingesting the prey's toxins. Predators face a problem when managing their toxin intake: prey sharing the samewarning signal often vary in their toxicities. Given that predators should avoid uncertainty when managing their toxin intake, we tested whether European starlings (Sturnus vulgaris) preferred to eat fixed-defence prey (where all prey contained a 2% quinine solution) to mixed-defence prey (where half the prey contained a 4% quinine solution and the other half contained onlywater). Our results support the idea that predators should be more ` risk-averse' when foraging on variably defended prey and suggest that variation in toxicity levels could be a form of defence.	[Barnett, Craig A.; Bateson, Melissa; Rowe, Candy] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Barnett, CA (reprint author), Rikkyo Univ, Dept Life Sci, Toshima Ku, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	optimalforager@hotmail.com	Bateson, Melissa/B-1874-2008	Bateson, Melissa/0000-0002-0861-0191	ORSAS Award; BBSRC [BB/D003245/1, BB/J016446/1]; Royal Society University Research Fellowship; Royal Society Dorothy Hodgkin Fellowship	C. A. B. was supported by a departmental studentship and an ORSAS Award, M. B. held a Royal Society University Research Fellowship and C. R. held a Royal Society Dorothy Hodgkin Fellowship during this study. The work was supported by BBSRC grants BB/D003245/1 and BB/J016446/1.	Skelhorn J, 2009, ANIM BEHAV, V78, P761, DOI 10.1016/j.anbehav.2009.07.006; Higginson AD, 2011, J ANIM ECOL, V80, P384, DOI 10.1111/j.1365-2656.2010.01786.x; Rowe C, 2013, BEHAV ECOL SOCIOBIOL, V67, P1425, DOI 10.1007/s00265-013-1515-8; ROWELLRAHIER M, 1986, J CHEM ECOL, V12, P1189, DOI 10.1007/BF01639004; MALCOLM SB, 1989, EXPERIENTIA, V45, P284, DOI 10.1007/BF01951814; Speed MP, 2012, BIOL REV, V87, P874, DOI 10.1111/j.1469-185X.2012.00228.x; Gamberale-Stille G, 2004, P ROY SOC B-BIOL SCI, V271, P2621, DOI 10.1098/rspb.2004.2893; PASTEELS JM, 1983, ANNU REV ENTOMOL, V28, P263, DOI 10.1146/annurev.en.28.010183.001403; Zalucki MP, 2001, AUSTRAL ECOL, V26, P547, DOI 10.1046/j.1442-9993.2001.01132.x; BROWER LP, 1968, SCIENCE, V161, P1349, DOI 10.1126/science.161.3848.1349; Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Rowland HM, 2007, NATURE, V448, P64, DOI 10.1038/nature05899; Barnett CA, 2007, BEHAV ECOL, V18, P645, DOI 10.1093/beheco/arm027; Barnett CA, 2012, BEHAV ECOL, V23, P418, DOI 10.1093/beheco/arr206; Bateson Melissa, 1998, P297; Foley WJ, 2005, CURR OPIN PLANT BIOL, V8, P430, DOI 10.1016/j.pbi.2005.05.009; GUILFORD T, 1994, J THEOR BIOL, V170, P311, DOI 10.1006/jtbi.1994.1192; Halpin CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044895; Holloway G.J., 1991, Chemoecology, V2, P7, DOI 10.1007/BF01240660; Ihalainen E, 2007, J EVOLUTION BIOL, V20, P780, DOI 10.1111/j.1420-9101.2006.01234.x; Poulton EB, 1890, COLOURS ANIMALS THEI; Rowland HM, 2010, ECOL LETT, V13, P1494, DOI 10.1111/j.1461-0248.2010.01539.x; Sherratt TN, 2003, OIKOS, V103, P93, DOI 10.1034/j.1600-0706.2003.12576.x; Skelhorn J, 2006, ANIM BEHAV, V72, P827, DOI 10.1016/j.anbehav.2005.12.010; Skelhorn J, 2005, BIOL LETT-UK, V1, P500, DOI 10.1098/rsbl.2005.0359; Skelhorn J, 2007, CURR BIOL, V17, P1479, DOI 10.1016/j.cub.2007.07.064; Tullberg BS, 1996, BIOL J LINN SOC, V57, P253, DOI 10.1111/j.1095-8312.1996.tb00312.x	27	2	2	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	1744-9561	1744-957X		BIOL LETTERS	Biol. Lett.	NOV 1	2014	10	11							20140533	10.1098/rsbl.2014.0533		4	Biology; Ecology; Evolutionary Biology	Life Sciences & Biomedicine - Other Topics; Environmental Sciences & Ecology; Evolutionary Biology	AU2RR	WOS:000345465900004		
J	Mori, S; Inaniwa, T; Miki, K; Shirai, T; Noda, K				Mori, S.; Inaniwa, T.; Miki, K.; Shirai, T.; Noda, K.			Implementation of a target volume design function for intrafractional range variation in a particle beam treatment planning system	BRITISH JOURNAL OF RADIOLOGY			English	Article							HEAVY-ION RADIOTHERAPY; DEFORMABLE REGISTRATION; RETROSPECTIVE ANALYSIS; LUNG-TUMORS; THERAPY; MOTION; OPTIMIZATION; IRRADIATION; ACCURACY	Objective: Treatment planning for charged particle therapy in the thoracic and abdominal regions should take account of range uncertainty due to intrafractional motion. Here, we developed a design tool (4Dtool) for the target volume [field-specific target volume (FTV)], which accounts for this uncertainty using four-dimensional CT (4DCT). Methods: Target and normal tissue contours were input manually into a treatment planning system (TPS). These data were transferred to the 4Dtool via the picture archiving and communication system (PACS). Contours at the reference phase were propagated to other phases by deformable image registration. FTV was calculated using 4DCT on the 4Dtool. The TPS displays FTV contours using digital imaging and communications in medicine files imported from the PACS. These treatment parameters on the CT image at the reference phase were then used for dose calculation on the TPS. The tool was tested in single clinical case randomly selected from patients treated at our centre for lung cancer. Results: In this clinical case, calculation of dose distribution with the 4Dtool resulted in the successful delivery of carbon-ion beam at the reference phase of 95% of the prescribed dose to the clinical target volume (CTV). Application to the other phases also provided sufficient dose to the CTV. Conclusion: The 4Dtool software allows the design of the target volume with consideration to intrafractional range variation and is now in routine clinical use at our institution. Advances in knowledge: Our alternative technique represents a practical approach to four-dimensional treatment planning within the current state of charged particle therapy.	[Mori, S.; Inaniwa, T.; Miki, K.; Shirai, T.; Noda, K.] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 260, Japan	Mori, S (reprint author), Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 260, Japan.	shinshin@nirs.go.jp					Tsujii H, 2012, JPN J CLIN ONCOL, V42, P670, DOI 10.1093/jjco/hys104; Sharp GC, 2007, PHYS MED BIOL, V52, P5771, DOI 10.1088/0031-9155/52/19/003; Zhang Y, 2012, PHYS MED BIOL, V57, P1779, DOI 10.1088/0031-9155/57/7/1779; Mori S, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130163; Kang YX, 2007, INT J RADIAT ONCOL, V67, P906, DOI 10.1016/j.ijrobp.2006.10.045; Mori S, 2009, RADIOTHER ONCOL, V92, P231, DOI 10.1016/j.radonc.2008.12.015; Mori S, 2012, J RADIAT RES, V53, P760, DOI 10.1093/jrr/rrs017; Richter D, 2013, MED PHYS, V40, DOI 10.1118/1.4800802; Yamamoto T, 2008, INT J RADIAT ONCOL, V72, P1250, DOI 10.1016/j.ijrobp.2008.06.1937; Kramer M, 2001, J RADIAT RES, V42, P39, DOI 10.1269/jrr.42.39; Bert C, 2011, PHYS MED BIOL, V56, pR113, DOI 10.1088/0031-9155/56/16/R01; Brock KK, 2010, INT J RADIAT ONCOL, V76, P583, DOI 10.1016/j.ijrobp.2009.06.031; DELUCA PM, 2007, PRESCRIBING RECORDIN; Engelsman M, 2006, INT J RADIAT ONCOL, V64, P1589, DOI 10.1016/j.ijrobp.2005.12.026; Furukawa T, 2010, MED PHYS, V37, P4874, DOI 10.1118/1.3481512; Furukawa T, 2010, MED PHYS, V37, P5672, DOI 10.1118/1.3501313; Graeff C, 2012, MED PHYS, V39, P6004, DOI 10.1118/1.4749964; *ICRU, 1999, ICRU 62; Inaniwa T, 2009, MED PHYS, V36, P2889, DOI 10.1118/1.3140586; Inaniwa T, 2007, MED PHYS, V34, P3302, DOI 10.1118/1.2754058; Mori S, 2008, INT J RADIAT ONCOL, V72, P268, DOI 10.1016/j.ijrobp.2008.05.011; Mori Shinichiro, 2013, Radiol Phys Technol, V6, P249, DOI 10.1007/s12194-013-0199-0; Mori Shinichiro, 2008, Radiol Phys Technol, V1, P83, DOI 10.1007/s12194-007-0012-z; Mori Shinichiro, 2010, Radiol Phys Technol, V3, P23, DOI 10.1007/s12194-009-0072-3; Mori S, 2013, MED PHYS, V40, DOI 10.1118/1.4792295; Rietzel E, 2006, INT J RADIAT ONCOL, V66, P287, DOI 10.1016/j.ijrobp.2006.05.024; Rietzel E, 2010, MED PHYS, V37, P449, DOI 10.1118/1.3250856	27	0	0	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0007-1285	1748-880X		BRIT J RADIOL	Br. J. Radiol.	NOV	2014	87	1043							UNSP 20140233	10.1259/bjr.20140233		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU2CI	WOS:000345423200005		
J	Niidome, Y; Tsuru, Y; Hamasaki, Y; Nakashima, N				Niidome, Yasuro; Tsuru, Yukiko; Hamasaki, Yuki; Nakashima, Naotoshi			Spectroscopic Properties and SEM Observations of Au-Ag Core-shell Nanorods Deposited on ITO Plates	BUNSEKI KAGAKU			Japanese	Article						gold nanorod; core-shell nanorod; dark-field image; surface plasmon band; anisotropic metal nanoparticle	WET CHEMICAL SYNTHESIS; GOLD NANORODS; ASPECT-RATIO; OPTICAL-PROPERTIES; SILVER NANOSTRUCTURES; NANOPRISMS; ABSORPTION; RESONANCES; NANOWIRES; SPECTRA	Gold-silver (Au-Ag) core-shell nanorods were deposited on ITO plates. The deposition was optimized to suppress the formation of aggregates and to control the densities of the nanorods on the ITO plates. Light-scattering spectra of single nanoparticles were obtained by using a dark-field illumination apparatus and a multichannel spectrophotometer. The spectra indicated that the light scattering originated from surface plasmon of the deposited core-shell nanorods. Dark-field images and SEM images were compared to investigate the relationship between the color of the scattered light and the orientation/aggregation of the core-shell nanorods on the plates. There were four kinds of nanorods on the plates: dimers of nanorods, isolated nanorods "lying" on the plate, isolated nanorods "standing" on the plate, and aggregates containing three or more nanorods. The colors of the four kinds of nanorods were red, green, blue, and white, respectively. The fraction of the "lying" nanorods on the plate was about 50 %. The "standing" nanorods were about 25 %. The dimers and the aggregates were about 12 %, respectively. It was found that the orientation of the nanorods on the plates as well as the aggregation should be taken into account when discussing the spectroscopic properties of the nanorod-deposited plates.	[Niidome, Yasuro; Tsuru, Yukiko; Hamasaki, Yuki; Nakashima, Naotoshi] Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan; [Niidome, Yasuro; Hamasaki, Yuki; Nakashima, Naotoshi] WPI, I2CNER, Nishi Ku, Fukuoka 8190395, Japan; [Nakashima, Naotoshi] JST, CREST, Kawaguchi, Saitama 3320012, Japan	Niidome, Y (reprint author), Kagoshima Univ, Grad Sch Engn, Dept Chem & Biosci, 1-21-35 Korimoto, Kagoshima 8908580, Japan.	yniidome@sci.kagoshima-u.ac.jp	Nakashima, Naotoshi/C-8791-2009				Xia YN, 2011, ACCOUNTS CHEM RES, V44, P914, DOI 10.1021/ar200061q; Lee KS, 2005, J PHYS CHEM B, V109, P20331, DOI 10.1021/jp054385p; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Xiang YU, 2008, LANGMUIR, V24, P3465, DOI 10.1021/la702999c; Chen SH, 2003, J AM CHEM SOC, V125, P16186, DOI 10.1021/ja038927x; Pastoriza-Santos I, 2002, NANO LETT, V2, P903, DOI 10.1021/nl025638i; Song JH, 2005, CHEM-EUR J, V11, P910, DOI 10.1002/chem.200400805; Nikoobakht B, 2003, CHEM MATER, V15, P1957, DOI 10.1021/cm0207321; Sun YG, 2002, NANO LETT, V2, P165, DOI 10.1021/nl010093y; Wiley BJ, 2007, NANO LETT, V7, P1032, DOI 10.1021/nl070214f; Niidome Y, 2003, CHEM COMMUN, P2376, DOI 10.1039/b307836a; Ah CS, 2001, J PHYS CHEM B, V105, P7871, DOI 10.1021/jp0113578; Jana NR, 2001, CHEM COMMUN, P617, DOI 10.1039/b100521i; Damm C, 2011, SMALL, V7, P147, DOI 10.1002/smll.201001600; Sherry LJ, 2006, NANO LETT, V6, P2060, DOI 10.1021/nl061286u; Wiley B, 2007, ACCOUNTS CHEM RES, V40, P1067, DOI 10.1021/ar7000974; Okuno Y, 2010, NANOSCALE, V2, P1489, DOI 10.1039/c0nr00130a; Chen CC, 2006, J AM CHEM SOC, V128, P3709, DOI 10.1021/ja0570180; Cortie MB, 2012, LANGMUIR, V28, P9103, DOI 10.1021/la300407u; Yu YY, 1997, J PHYS CHEM B, V101, P6661; Link S, 2005, J PHYS CHEM B, V109, P10531, DOI 10.1021/jp058091f; Jana NR, 2001, J PHYS CHEM B, V105, P4065, DOI 10.1021/jp0107964; Link S, 1999, J PHYS CHEM B, V103, P3073, DOI 10.1021/jp990183f; Link S, 1999, J PHYS CHEM B, V103, P8410, DOI 10.1021/jp9917648; Pietrobon B, 2009, ACS NANO, V3, P21, DOI 10.1021/nn800591y; Jin RC, 2001, SCIENCE, V294, P1901, DOI 10.1126/science.1066541; Gluodenis M, 2002, J PHYS CHEM B, V106, P9484, DOI 10.1021/jp014245p; Hamasaki Y, 2013, J PHYS CHEM C, V117, P2521, DOI 10.1021/jp306469s; Hamasaki Y, 2012, CHEM LETT, V41, P962, DOI 10.1246/cl.2012.962; Hayat M A, 1989, COLLOIDAL GOLD PRINC; Jiang RB, 2012, ADV MATER, V24, pOP200, DOI 10.1002/adma.201201896; Okuno Y, 2009, CHEM LETT, V38, P60, DOI 10.1246/cl.2009.60; Takahashi H, 2005, CHEM COMMUN, P2247, DOI 10.1039/b500337g; Tsuru Y, 2012, OPT COMMUN, V285, P3419, DOI 10.1016/j.optcom.2012.02.103; Wang L, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3533235	35	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	NOV	2014	63	11					857	865				9	Chemistry, Analytical	Chemistry	AU3YX	WOS:000345547500001		
J	Kushita, KN; Atarashi-Andoh, M; Amano, H				Kushita, Kouhei N.; Atarashi-Andoh, Mariko; Amano, Hikaru			Evaluation of Neutron Dose Released in the Environment by Activation of Gold	BUNSEKI KAGAKU			Japanese	Article						gold; Au-198; neutron dose; JCO criticality accident; radiation exposure	JCO CRITICALITY ACCIDENT; TOKAI-MURA	Gold is useful not only for traditional, ordinary human applications as ornaments, coins or electric devices, but also for nuclear and radiation applications. Here we report a study of activated gold for estimating the neutron dose in the environment in the case of the JCO criticality accident that occurred in Tokai, Japan, in 1999. We collected and analyzed 16 gold samples, such as rings, coins or necklaces stored at residents' houses located in the range of 168 to 568 m from the accident site of the JCO. They indicated activities of gold from 91.9 to 0.322 Bq g(-1) standardized values at 06: 15 on October 1, 1999, when the criticality reaction had ceased after 20 hours of continuation. The induced radioactivity of gold samples showed a good correlation as a power function of distance. The induced radioactivity of gold is discussed with the reference data in order to estimate dose equivalent in the environment around the JCO. This paper gives an example showing the usefulness of gold in the field of nuclear and radiation studies and applications.	[Kushita, Kouhei N.] Japan Atom Energy Agcy, Naka Fus Inst, Naka, Ibaraki 3110193, Japan; [Atarashi-Andoh, Mariko] Japan Atom Energy Agcy, Nucl Sci & Engn Ctr, Tokai, Ibaraki 3191195, Japan; [Amano, Hikaru] Japan Chem Anal Ctr, Tokai, Ibaraki 3191106, Japan	Kushita, KN (reprint author), Japan Atom Energy Agcy, Naka Fus Inst, 801-1 Mukoyama, Naka, Ibaraki 3110193, Japan.	h-amano@jcac.or.jp					Endo A, 2010, RADIAT MEAS, V45, P1484, DOI 10.1016/j.radmeas.2010.05.015; Endo S, 2000, J ENVIRON RADIOACTIV, V50, P83, DOI 10.1016/S0265-931X(00)00065-5; Gasparro J, 2004, J ENVIRON RADIOACTIV, V73, P307, DOI 10.1016/j.jenvrad.2003.10.005; Hanashima S, 2000, J ENVIRON RADIOACTIV, V50, P37, DOI 10.1016/S0265-931X(00)00058-8; Hult M, 2002, J ENVIRON RADIOACTIV, V60, P307, DOI 10.1016/S0265-931X(01)00091-1; Imanaka T, 2005, HEALTH PHYS, V88, P382, DOI 10.1097/01.HP.0000149882.84543.ad; Imanaka T, 2000, J ENVIRON RADIOACTIV, V50, P15, DOI 10.1016/S0265-931X(00)00055-2; International Commission on Radiological PRotection, 2007, ANN ICRP, V37, P66; Kofuji H, 2000, J ENVIRON RADIOACTIV, V50, P49, DOI 10.1016/S0265-931X(00)00060-6; Kohno M, 2000, NATURE, V406, P693, DOI 10.1038/35021138; Koide H, 2000, J ENVIRON RADIOACTIV, V50, P123, DOI 10.1016/S0265-931X(00)00072-2; Komura K, 2000, J ENVIRON RADIOACTIV, V50, P77, DOI 10.1016/S0265-931X(00)00064-3; Komura K, 2000, J ENVIRON RADIOACTIV, V50, P3, DOI 10.1016/S0265-931X(00)00054-0; Tanaka S I, 2001, J Radiat Res, V42 Suppl, pS1	14	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	NOV	2014	63	11					867	871				5	Chemistry, Analytical	Chemistry	AU3YX	WOS:000345547500002		
J	Toda, K				Toda, Kei			Development of Micro Gas Analysis System and Its Applications to Environmental Analysis	BUNSEKI KAGAKU			Japanese	Article						micro gas analysis system (mu GAS); on-site analysis; flow control; micro detector; breath; odor analysis; air pollution monitorin	ATMOSPHERIC HYDROGEN-SULFIDE; ON-SITE MEASUREMENT; SULFUR-DIOXIDE; CHEMILUMINESCENCE DETECTION; FLUORESCENCE DETECTION; FIELD INSTRUMENT; NITRIC-OXIDE; MICROCHANNEL COLLECTION; LIQUID-CHROMATOGRAPHY; DIMETHYL SULFIDE	Micro gas analysis system (mu GAS) was developed to monitor atmospheric chemical compounds and gases anthropogenically emitted from industries. While there is still no simple and highly sensitive instrument for most of the water-soluble gases, in these works portable and continuous monitoring systems were developed for these gases. A key device was a microchannel scrubber, which has a 20000-times higher collection/preconcentration efficiency compared to a conventional impinger. This allows us to achieve both high sensitivity and high time resolution. Other important techniques were also developed, such as novel liquid handling, miniature reactors, miniature detectors, and gas generator for on-site calibration. The mu GAS enables us to measure SO2, H2S, CH3SH, COS, NO, NO2, HONO, HCHO, NH3 and so on at ppbv levels. Urban environment, forest air, volcanic gases, and gases emitted from soils were analyzed using mu GAS, and interesting data were presented, such as localized polluted gases. Also, mu GAS was useful for investigations of atmospheric chemistries. The most difficult analytical target among the above-mentioned gases was nitric oxide, NO, because NO is not water soluble, but monitoring of NO in breath air was successful with mu GAS. A spreadsheet was developed to simulate the collection efficiency, and was utilized to design channel scrubbers. Thus, the developed channel device was applied to separate gaseous and particulate HCHO, and HCHO was found in particulate matter. The partitioning of HCHO between the gas phase and particulate matter was first investigated.	Kumamoto Univ, Dept Chem, Chuo Ku, Kumamoto 8608555, Japan	Toda, K (reprint author), Kumamoto Univ, Dept Chem, Chuo Ku, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	todakei@sci.kumamoto-u.ac.jp					Al-Horr R, 2003, ENVIRON SCI TECHNOL, V37, P5711, DOI 10.1021/es034464j; Toda K, 2006, ANAL CHEM, V78, P7284, DOI 10.1021/ac060965m; Toda K, 2011, ENVIRON SCI TECHNOL, V45, P5622, DOI 10.1021/es2006226; Dittrich PS, 2006, ANAL CHEM, V78, P3887, DOI 10.1021/ac0605602; Pandey SK, 2009, ENVIRON SCI TECHNOL, V43, P3020, DOI 10.1021/es803272f; Ohira SI, 2006, ANAL SCI, V22, P61, DOI 10.2116/analsci.22.61; Toda K, 2001, ANAL CHEM, V73, P5716, DOI 10.1021/ac010602g; Hansen MJ, 2012, J ANAL METHODS CHEM, DOI 10.1155/2012/489239; Ohira SI, 2013, TALANTA, V116, P527, DOI 10.1016/j.talanta.2013.07.037; Kawanishi H, 2006, J CHROMATOGR A, V1132, P148, DOI 10.1016/j.chroma.2006.07.086; Toda K, 2003, ANAL CHEM, V75, P4050, DOI 10.1021/ac0341719; Teshima N, 2005, ANAL CHIM ACTA, V535, P189, DOI 10.1016/j.aca.2004.12.018; Toda K, 2009, ANAL CHEM, V81, P7031, DOI 10.1021/ac901131d; Toda K, 2008, CHEM ENG COMMUN, V195, P82, DOI 10.1080/00986440701569150; Ohira SI, 2008, ANAL CHIM ACTA, V619, P143, DOI 10.1016/j.aca.2008.05.010; Toda K, 2004, ENVIRON SCI TECHNOL, V38, P1529, DOI 10.1021/es034450d; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Hashem MA, 2011, ANAL SCI, V27, P733; Nagahata T, 2013, ANAL CHEM, V85, P4461, DOI 10.1021/ac303803w; Toda K, 2014, ANAL CHIM ACTA, V841, P1, DOI 10.1016/j.aca.2014.06.019; Toda K, 2014, ENVIRON SCI TECHNOL, V48, P6636, DOI 10.1021/es500590e; Ras MR, 2009, TRAC-TREND ANAL CHEM, V28, P347, DOI 10.1016/j.trac.2008.10.009; Toda K, 2005, ANAL CHIM ACTA, V531, P41, DOI 10.1016/j.aca.2004.08.070; Kovarik ML, 2012, ANAL CHEM, V84, P516, DOI 10.1021/ac202611x; Choi W, 2010, ATMOS CHEM PHYS, V10, P8761, DOI 10.5194/acp-10-8761-2010; Sumner AL, 2001, J GEOPHYS RES-ATMOS, V106, P24387, DOI 10.1029/2000JD900761; Ohira SI, 2005, LAB CHIP, V5, P1374, DOI 10.1039/b511281h; Culbertson CT, 2014, ANAL CHEM, V86, P95, DOI 10.1021/ac403688g; Azad MAK, 2005, ATMOS ENVIRON, V39, P6077, DOI 10.1016/j.atmosenv.2005.06.042; Azad MAK, 2006, ANAL CHEM, V78, P6252, DOI 10.1021/ac060928v; Berg JM, 2010, ANAL CHIM ACTA, V664, P56, DOI 10.1016/j.aca.2010.02.006; Boring B. C., 2002, ANAL CHEM, V74, P1256; Ohira SI, 2007, ANAL CHEM, V79, P2641, DOI 10.1021/ac062334y; Ohira SI, 2002, ANAL CHEM, V74, P5890, DOI 10.1021/ac025940b; Toda K, 2005, CHEM LETT, V34, P176, DOI 10.1246/cl.2005.176; Toda K, 2007, ANAL CHIM ACTA, V603, P60, DOI 10.1016/j.aca.2007.09.052; Toda K, 2010, TALANTA, V82, P1870, DOI 10.1016/j.talanta.2010.08.001; Toda K, 2004, ANAL SCI, V20, P19, DOI 10.2116/analsci.20.19; Toda K, 2012, J ENVIRON MONITOR, V14, P1462, DOI 10.1039/c2em10935b; Toda K, 2012, ANAL CHIM ACTA, V741, P38, DOI 10.1016/j.aca.2012.06.036; Toda K, 2007, TALANTA, V71, P1652, DOI 10.1016/j.talanta.2006.07.054; Toda K, 2005, ANAL CHEM, V77, P4765, DOI 10.1021/ac050193e; Toda K, 2004, ANAL CHIM ACTA, V511, P3, DOI 10.1016/j.aca.2004.01.040; Toyo'oka T, 2001, BIOMED CHROMATOGR, V15, P240, DOI 10.1002/bmc.51; Uchiyama S, 2001, BIOMED CHROMATOGR, V15, P295, DOI 10.1002/bmc.75.abs	45	1	1	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	NOV	2014	63	11					873	883				11	Chemistry, Analytical	Chemistry	AU3YX	WOS:000345547500003		
J	Izu, R; Uchiyama, S; Bekki, K; Inaba, Y; Nakagome, H; Kunugita, N				Izu, Rina; Uchiyama, Shigehisa; Bekki, Kanae; Inaba, Yohei; Nakagome, Hideki; Kunugita, Naoki			Simultaneous Collection of Volatile Organic Compounds and Carbonyls in Mainstream Cigarette Smoke from Japanese Cigarettes Using a Sorbent Cartridge Followed by GC/MS and HPLC	BUNSEKI KAGAKU			Japanese	Article						mainstream cigarette smoke; carboxen 572; volatile organic compounds; carbonyl compounds; Neo Cedar	INDUCED LEUKEMIA; TOBACCO-SMOKE; BENZENE	Volatile organic compounds (VOCs) and carbonyl compounds in mainstream cigarette smoke from Japanese cigarettes were measured using solid-sorbent collection, followed by GC/MS and HPLC. As a result, it was shown that the major carbonyl compounds in mainstream cigarette smoke were acetaldehyde (48-56 %) and acetone (20-24 %); the major VOCs in mainstream cigarette smoke were isoprene (40-57 %) and toluene (9-12 %), respectively. A tobacco-like product, such as Neo Cedar, is the second kind pharmaceutical product; however, it generated many kinds of carcinogen, such as benzene and furans. Moreover, the total carbonyl compounds generated from Neo Cedar was 1.1-2.0-fold higher than those from commercially available cigarettes. During the collection of mainstream cigarette smoke, generation of VOCs and carbonyl compounds was varied by the condition of the smoking machine. On every puff collection, the collected amount by the 1st puff was different from that of the 2nd puff; therefore, it was suggested that the filter structure of the cigarette influenced the chemical compounds in the mainstream cigarette smoke.	[Izu, Rina; Uchiyama, Shigehisa; Bekki, Kanae; Inaba, Yohei; Kunugita, Naoki] Natl Inst Publ Hlth, Dept Environm Hlth, Wako, Saitama 3510197, Japan; [Nakagome, Hideki] Chiba Univ, Grad Sch Engn, Inage Ku, Chiba 2638522, Japan	Izu, R (reprint author), Natl Inst Publ Hlth, Dept Environm Hlth, 2-3-6 Minami, Wako, Saitama 3510197, Japan.	uchiyama@niph.go.jp		Kunugita, Naoki/0000-0002-6516-8379			Borgerding M, 2005, EXP TOXICOL PATHOL, V57, P43, DOI 10.1016/j.etp.2005.05.010; Thielen A, 2008, EXP TOXICOL PATHOL, V60, P141, DOI 10.1016/j.etp.2008.01.014; EVANS MD, 1994, AM J PHYSIOL, V266, pL593; Hecht SS, 1999, J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; [Anonymous], 2000, 3308 ISO; Uchiyama S, 2013, J CHROMATOGR A, V1314, P31, DOI 10.1016/j.chroma.2013.09.019; CORESTA, 2013, 70 CORESTA COOP CTR; CORESTA, 2013, 74 CORESTA COOP CTR; Crump KS, 1996, ENVIRON HEALTH PERSP, V104, P1437, DOI 10.2307/3433200; EFSA (European Food Safety Authority), 2004, EFSA J, V137, P1, DOI DOI 10.2903/J.EFSA.2004.137; Health Canada, 1999, T104 HLTH CAN; Health Canada, 1999, T115 HLTH CAN; Health Canada, 1999, T116 HLTH CAN; IARC, 2008, IARC MONOGRAPHS EVAL, V97, P45; IARC, 1987, IARC MON EV CARC S7, P120; IARC (International Agency for Research on Cancer), 1995, IARC MON EV CARC RIS, V63, P393; Korte JE, 2000, ENVIRON HEALTH PERSP, V108, P333, DOI 10.2307/3454352	17	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	NOV	2014	63	11					885	893				9	Chemistry, Analytical	Chemistry	AU3YX	WOS:000345547500004		
J	Suzuki, Y; Kikuta, Y; Yamada, K; Kitade, K; Maruta, T; Ichida, J; Kawakubo, S				Suzuki, Yasutada; Kikuta, Yoshihiro; Yamada, Kazuhiro; Kitade, Kazuhisa; Maruta, Toshihisa; Ichida, Junichi; Kawakubo, Susumu			Development of Ultra-violet Light-emitting Diode Based Portable Fluorometer and Its Application to Estimations of COD	BUNSEKI KAGAKU			Japanese	Article						COD; ultraviolet light-emitting diode; fluorometer; seawater; wastewater		A portable fluorometer using an ultraviolet LED (UV-LED) and a photomultiplier tube module as a light source and a detector, respectively, has been developed to estimate the chemical oxygen demand (COD) value of river-water, seawater and industrial wastewater samples. The fluorescence intensities of samples (excitation wavelength, 340 nm; emission wavelength, 450 nm) were measured by this fluorometer. Their correlation to the COD values obtained by the official titration method using permanganate as an oxidant (CODMn) was studied. The equations for the correlation at different sampling points were not identical; therefore, it should be built for every sampling point. When the sample was taken from a specific point, the time course of its fluorescence intensity versus the CODMn value showed a good correlation. In the case of multi-point sampling from Ise Bay, their correlation was good, if the sampling point was not nearby an estuary. For industrial waste-water, the CODMn of the sample from a factory whose operational condition did not change drastically, can be estimated. This flurometer has additional functions to measure the color unit and turbidity of the sample by an absorbance measurement.	[Suzuki, Yasutada; Kawakubo, Susumu] Univ Yamanashi, Dept Res, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008510, Japan; [Kikuta, Yoshihiro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Educ, Kofu, Yamanashi 4008510, Japan; [Yamada, Kazuhiro] Univ Yamanashi, Fac Engn, Kofu, Yamanashi 4008511, Japan; [Kitade, Kazuhisa; Maruta, Toshihisa; Ichida, Junichi] Tokai Techno Co Ltd, Yokaichi, Mie 5100023, Japan	Suzuki, Y (reprint author), Univ Yamanashi, Dept Res, Interdisciplinary Grad Sch Med & Engn, 4-4-37 Takeda, Kofu, Yamanashi 4008510, Japan.	yamatori@yamanashi.ac.jp					[Anonymous], 2013, K0102 JIS; Lee KH, 1999, ANAL CHIM ACTA, V398, P161, DOI 10.1016/S0003-2670(99)00417-1; van den Broeke J., 2006, SPECTROSCOPY ASIA, V2, P19; Yoshinaga T., 1982, MEM KYUSHU I TECHNOL, V12, P63	4	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	NOV	2014	63	11					895	902				8	Chemistry, Analytical	Chemistry	AU3YX	WOS:000345547500005		
J	Kishikawa, N; Tsuge, H; Kawase, S; Ono, S				Kishikawa, Nobuyuki; Tsuge, Hiroyasu; Kawase, Satoru; Ono, Satomi			Photocatalytic Performance of Prussian Blue-loaded Tungsten Oxide for Photodegradation of Acetaldehyde	BUNSEKI KAGAKU			Japanese	Article						photcatalyst; visible light; tungsten oxide; prussian blue; air purification	ORGANIC-SUBSTANCES; WO3 PHOTOCATALYSTS; TIO2; IONS	We prepared a new visible light-responsive photocatalyst, tungsten oxide, supported with Prussian blue (PB-WO3) by a kneading method. The photocatalytic performance of PB-WO3 was improved to photodegrade acetaldehyde completely under visible light. We investigated the formation rate constant of carbon dioxide (CO2) generated by the photodegradation of acetaldehyde, in order to compare the photocatalytic performance of P13-WO3 to that of tungsten oxide supported with copper oxide (CuO-WO3), which was reported previously. As a result, the formation rate constant of CO2 in PB-WO3 indicated 2.1 X 10(-2) min(-1), which was nearly twice as much as that in CuO-WO3. When we investigated the PI3-WO3 after completion of the photodegradation of acetaldehyde to find a factor for the improvement of the photocatalytic performance of PB-WO3, decoloration was observed. It was caused by the reduction of PB by exited electron. It was suggested that the oxidation reaction proceeded effectively on a positive hole, because the reduced PB supported on WO3 prevented recombination of the excited electron. Also, the photocatalytic durability of PB-WO3 was better than that of CuO-WO3, which was evaluated based on the decrease of the formation rate constants of CO2 by repeating the photodegradation of acetaldehyde.	[Kishikawa, Nobuyuki; Tsuge, Hiroyasu; Kawase, Satoru; Ono, Satomi] Nagoya Municipal Ind Res Inst, Atsuta Ku, Nagoya, Aichi 4560058, Japan	Kishikawa, N (reprint author), Nagoya Municipal Ind Res Inst, Atsuta Ku, 3-4-41 Rokuban, Nagoya, Aichi 4560058, Japan.	kishikawa.nobuyuki@nmiri.city.nagoya.jp					Irie H, 2008, CHEM PHYS LETT, V457, P202, DOI 10.1016/j.cplett.2008.04.006; Bamwenda GR, 2001, APPL CATAL A-GEN, V210, P181, DOI 10.1016/S0926-860X(00)00796-1; Arai T, 2008, CATAL COMMUN, V9, P1254, DOI 10.1016/j.catcom.2007.11.012; Karyakin AA, 2001, ELECTROANAL, V13, P813, DOI 10.1002/1521-4109(200106)13:10<813::AID-ELAN813>3.0.CO;2-Z; Maeda K, 2014, J CATAL, V310, P67, DOI 10.1016/j.jcat.2012.12.003; Abe R, 2008, J AM CHEM SOC, V130, P7780, DOI 10.1021/ja800835q; Arai T, 2008, APPL CATAL B-ENVIRON, V84, P42, DOI 10.1016/j.apcatb.2008.03.002; Nosaka Y, 2011, J PHYS CHEM C, V115, P21283, DOI 10.1021/jp2070634; Arai T, 2008, CHEM COMMUN, P5565, DOI 10.1039/b811657a; Asahi R., 2001, SCIENCE, V293, P296; Cotton F. A., 1998, BASIC INORGANIC CHEM; Niishiro R, 2014, APPL CATAL B-ENVIRON, V150, P187, DOI 10.1016/j.apcatb.2013.12.015	12	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	NOV	2014	63	11					903	908				6	Chemistry, Analytical	Chemistry	AU3YX	WOS:000345547500006		
J	Saito, N; Saito, T; Yamazaki, T; Kato, H; Ihara, T				Saito, Naoki; Saito, Takeshi; Yamazaki, Taichi; Kato, Hisashi; Ihara, Toshihide			SI-traceable Purity Evaluation of Non-protein Amino Acid as Reference Materials by Using H NMR Spectroscopy	BUNSEKI KAGAKU			Japanese	Article						non-protein amino acids; H-1 NMR; SI-traceability; purity evaluation		In recent years, it was become increasingly important to conduct quantitative analyses of several kinds of protein and non-protein amino acids in the human blood. By doing so, it is possible to detect cancer focus positivity at an early stage by monitoring profile of their concentrations. In clinical tests that strongly require high reliability of analytical values, it is essential to use amino acid reference materials that are traceable to the International System of Units (SI). However, SI-traceable reference materials of non-protein amino acids are not generally supplied worldwide. Although it is generally used in the titration method for purity evaluations of amino acid reference materials, purity evaluations using this method require much time and a large amount of sample. On the other hand, Nuclear Magnetic Resonance (NMR) spectroscopy is a rapid quantitative method that is not only SI-traceable, but also requires a small amount of the sample. In this study, we demonstrated purity evaluations of 20 kinds of non-protein amino acids by using NMR. To verify the analytical value, a titration method was used. From our results, the accuracy of the analytical value was evaluated to be approximately 1 % by optimizing the experimental conditions for each amino acid, such as the kinds of solvent. Furthermore, the difference in the analytical values between 'H NMR and titration was 0.5 % or less. Therefore, it was confirmed to able to perform rapid and accurate evaluations of the purity of non-protein amino acid reference materials by using 'H NMR spectroscopy.	[Saito, Naoki; Saito, Takeshi; Yamazaki, Taichi; Kato, Hisashi; Ihara, Toshihide] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan	Saito, N (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, 1-1-1 Umezono, Tsukuba, Ibaraki 3058563, Japan.	nao-saitou@aist.go.jp					Saito T, 2011, ACCREDIT QUAL ASSUR, V16, P421, DOI 10.1007/s00769-011-0798-6; Miyagi M, 2008, ANAL CHEM, V80, P6481, DOI 10.1021/ac8009643; Arii K, 1999, EUR J PHARM SCI, V9, P75, DOI 10.1016/S0928-0987(99)00047-0; FRIEDRICH JO, 1986, CAN J CHEM, V64, P2132, DOI 10.1139/v86-351; FUJIWARA T, 1993, J MAGN RESON SER A, V104, P103, DOI 10.1006/jmra.1993.1195; Miyagi Y., 2011, PLOS ONE, V6, P1; Yamazaki T, 2014, ACCREDIT QUAL ASSUR, V19, P275, DOI 10.1007/s00769-014-1067-2	7	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	NOV	2014	63	11					909	913				5	Chemistry, Analytical	Chemistry	AU3YX	WOS:000345547500007		
J	Yamakoshi, A; Arata, Y; Hasegawa, Y; Takashima, M; Tsukatani, T; Yonezawa, S				Yamakoshi, Akiko; Arata, Yoshiaki; Hasegawa, Yasuo; Takashima, Masayuki; Tsukatani, Toshihide; Yonezawa, Susumu			Validation of Plate-type Cell for Micro-Raman Analysis of Liquid Sample	BUNSEKI KAGAKU			Japanese	Article						Micro-Raman spectroscopy; liquid cell		Recently, the use of the Micro-Raman spectrometer for the analysis of chemical materials is attracting attention in applied chemistry and advanced technologies due to the easiness of measurement. However, in the case of a liquid sample, there is some difficulty to analyze it, especially in focusing the laser beam on a transparent liquid sample accurately by using conventional vessels, such as the NMR tube and capillaries. We report here on the validation of a newly-designed cell for Micro-Raman spectroscopy that could more easily analyze a liquid sample than using conventional vessels. This cell is a small rectangular block (30 X 30 X 15 mm) made of aluminum alloy having a cylindrical hole (Phi 10 X 5 mm) at center of the surface. First, the hole is filled with an aqueous solution or organic solvent, and then covered with a thin glass plate. By focusing the laser beam anywhere on the bottom surface of the hole, a high signal with sufficient intensity is easily detected. Similarly, a measurement using a cell made of another material, such as stainless steel, glass or polypropylene (PP) is tested. Finally, we conclude that aluminum alloy is the most suitable to be used for the cell material, due to its overall signal intensity, workability of material, low cost, resistance to chemicals and no interference to the Raman signal.	[Yamakoshi, Akiko; Tsukatani, Toshihide] NICCA Chem CO LTD, Corp Res & Innovat Ctr, Fukui 9108670, Japan; [Arata, Yoshiaki; Hasegawa, Yasuo; Takashima, Masayuki; Yonezawa, Susumu] Univ Fukui, Headquarters Innovat Soc, Acad Cooperat, Fukui 9108507, Japan	Yamakoshi, A (reprint author), NICCA Chem CO LTD, Corp Res & Innovat Ctr, 4-23-1 Bunkyo, Fukui 9108670, Japan.	a-yamakoshi@niccachemical.com					Stancovski V, 2014, J APPL ELECTROCHEM, V44, P23, DOI 10.1007/s10800-013-0628-0; Belin T., 2005, MAT SCI ENG B, V119, P10; Ferrari C., 2006, PHYS REV LETT, V97; Ryder AG, 2010, J RAMAN SPECTROSC, V41, P1266, DOI 10.1002/jrs.2586; Wolf I.D., 1996, SEMICOND SCI TECH, V11, P139, DOI DOI 10.1088/0268-1242/11/2/001	5	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	NOV	2014	63	11					915	920				6	Chemistry, Analytical	Chemistry	AU3YX	WOS:000345547500008		
J	Tokunaga, E; Hisamatsu, Y; Tanaka, K; Yamashita, N; Saeki, H; Oki, E; Kitao, H; Maehara, Y				Tokunaga, Eriko; Hisamatsu, Yuichi; Tanaka, Kimihiro; Yamashita, Nami; Saeki, Hiroshi; Oki, Eiji; Kitao, Hiroyuki; Maehara, Yoshihiko			Molecular mechanisms regulating the hormone sensitivity of breast cancer	CANCER SCIENCE			English	Review						Breast cancer; endocrine therapy; estrogen receptor; FOXA1; PI3K; Akt; mTOR pathway	ESTROGEN-RECEPTOR BINDING; EPIDERMAL-GROWTH-FACTOR; ENDOCRINE RESISTANCE; FOXA1 EXPRESSION; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTION FACTOR; TUMOR PROGRESSION; TREATED PATIENTS; AKT ACTIVITY; PATHWAY	Breast cancer is a heterogeneous disease. Approximately 70% of breast cancers are estrogen receptor (ER) positive. Endocrine therapy has dramatically improved the prognosis of ER-positive breast cancer; however, many tumors exhibit de novo or acquired resistance to endocrine therapy. A thorough understanding of the molecular mechanisms regulating hormone sensitivity or resistance is important to improve the efficacy of and overcome the resistance to endocrine therapy. The growth factor receptor signaling pathways, particularly the phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway can mediate resistance to all forms of endocrine therapy. In contrast, FOXA1 transcription factor is a key determinant of ER function and endocrine response. Intriguingly, a link between hormone resistance induced by the PI3K/Akt/mTOR pathway and the function of FOXA1 has been suggested. In this review, we focus on the PI3K/Akt/mTOR pathway and functions of FOXA1 in terms of the molecular mechanisms regulating the hormone sensitivity of breast cancer.	[Tokunaga, Eriko; Hisamatsu, Yuichi; Tanaka, Kimihiro; Yamashita, Nami; Saeki, Hiroshi; Oki, Eiji; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Tokunaga, Eriko] Kyushu Univ, Grad Sch Med Sci, Dept Comprehens Clin Oncol, Fukuoka 8128582, Japan; [Kitao, Hiroyuki] Kyushu Univ, Grad Sch Med Sci, Dept Mol Oncol, Fukuoka 8128582, Japan	Tokunaga, E (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	eriko@surg2.med.kyuhsu-u.ac.jp			Ministry of Education, Culture, Sports Science, and Technology of Japan	Ministry of Education, Culture, Sports Science, and Technology of Japan	Ananthanarayanan B, 2005, P NATL ACAD SCI USA, V102, P15081, DOI 10.1073/pnas.0502889102; Miller TW, 2011, J CLIN ONCOL, V29, P4452, DOI 10.1200/JCO.2010.34.4879; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Ali S, 2000, J MAMMARY GLAND BIOL, V5, P271, DOI 10.1023/A:1009594727358; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112; Lupien M, 2010, GENE DEV, V24, P2219, DOI 10.1101/gad.1944810; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj/bjc/6600126; Bhat-Nakshatri P, 2008, MOL CELL BIOL, V28, P7487, DOI 10.1128/MCB.00799-08; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Cui XJ, 2005, J CLIN ONCOL, V23, P7721, DOI 10.1200/JCO.2005.09.004; Bachelot T, 2012, J CLIN ONCOL, V30, P2718, DOI 10.1200/JCO.2011.39.0708; Arpino G, 2005, J NATL CANCER I, V97, P1254, DOI 10.1093/jnci/dji249; Johnston S, 2009, J CLIN ONCOL, V27, P5538, DOI 10.1200/JCO.2009.23.3734; Hisamatsu Y, 2012, ANN SURG ONCOL, V19, P1145, DOI 10.1245/s10434-011-2094-4; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Jozwik KM, 2012, NAT REV CANCER, V12, P381, DOI 10.1038/nrc3263; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Morrison MM, 2013, J CLIN INVEST, V123, P4329, DOI 10.1172/JCI66764; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Wolff AC, 2013, J CLIN ONCOL, V31, P195, DOI 10.1200/JCO.2011.38.3331; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Miller TW, 2011, CANCER DISCOV, V1, P338, DOI 10.1158/2159-8290.CD-11-0101; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Arpino G, 2004, CLIN CANCER RES, V10, P5670, DOI 10.1158/1078-0432.CCR-04-0110; Mehta RJ, 2012, BREAST CANCER RES TR, V131, P881, DOI 10.1007/s10549-011-1482-6; Habashy HO, 2008, EUR J CANCER, V44, P1541, DOI 10.1016/j.ejca.2008.04.020; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Baselga J, 2011, ONCOLOGIST, V16, P12, DOI 10.1634/theoncologist.2011-S1-12; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Bernardo GM, 2012, BIOSCIENCE REP, V32, P113, DOI 10.1042/BSR20110046; Tokunaga E, 2007, BREAST CANCER RES TR, V101, P249, DOI 10.1007/s10549-006-9295-8; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Badve S, 2009, J CLIN PATHOL, V62, P6, DOI 10.1136/jcp.2008.059899; Tokunaga E, 2006, INT J CANCER, V118, P284, DOI 10.1002/ijc.21358; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Renoir JM, 2013, BIOCHEM PHARMACOL, V85, P449, DOI 10.1016/j.bcp.2012.10.018; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Kaufman B, 2009, J CLIN ONCOL, V27, P5529, DOI 10.1200/JCO.2008.20.6847; Stal O, 2003, BREAST CANCER RES, V5, pR37, DOI 10.1186/bcr569; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Argiris A, 2004, CLIN CANCER RES, V10, P1409, DOI 10.1158/1078-0432.CCR-1060-02; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; De Laurentiis M, 2005, CLIN CANCER RES, V11, P4741, DOI 10.1158/1078-0432.CCR-04-2569; desGraffenried LA, 2004, CLIN CANCER RES, V10, P8059; Ellis MJ, 2006, J CLIN ONCOL, V24, P3019, DOI 10.1200/JCO.2005.04.3034; Hisamatsu Y, 2014, BREAST CANC IN PRESS; Liang Jiyong, 2003, Cell Cycle, V2, P339; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; Osborne CK, 2005, CLIN CANCER RES, V11, p865s; Robinson Jessica L L, 2012, Front Endocrinol (Lausanne), V3, P68, DOI 10.3389/fendo.2012.00068; Robinson Jessica L L, 2013, Front Oncol, V3, P20, DOI 10.3389/fonc.2013.00020; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Tokunaga E, 2006, EUR J CANCER, V42, P629, DOI 10.1016/j.ejca.2005.11.025	71	4	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	NOV	2014	105	11					1377	1383		10.1111/cas.12521		7	Oncology	Oncology	AU1HL	WOS:000345371600001		
J	Fujikuni, N; Yamamoto, H; Tanabe, K; Naito, Y; Sakamoto, N; Tanaka, Y; Yanagihara, K; Oue, N; Yasui, W; Ohdan, H				Fujikuni, Nobuaki; Yamamoto, Hideki; Tanabe, Kazuaki; Naito, Yutaka; Sakamoto, Naoya; Tanaka, Yuka; Yanagihara, Kazuyoshi; Oue, Naohide; Yasui, Wataru; Ohdan, Hideki			Hypoxia-mediated CD24 expression is correlated with gastric cancer aggressiveness by promoting cell migration and invasion	CANCER SCIENCE			English	Article						CD24; gastric cancer; hypoxia; hypoxia inducible factor; invasion	STEM-CELLS; PROGNOSTIC MARKER; INDUCIBLE FACTORS; GENE-EXPRESSION; STOMACH-CANCER; BREAST-CANCER; METASTASIS; CARCINOMA; SURVIVAL; ADENOCARCINOMA	CD24 is a heavily glycosylated cell surface protein that is expressed in putative stem cells and is overexpressed in various human malignancies, yet the significant roles of CD24 in gastric cancer development are still elusive. We investigated the involvement of CD24 in gastric cancer aggressiveness, which is attributed to its heterogeneity. Cultured gastric cancer cells showed diverse expression patterns in CD24, whereas other defined cell surface markers, such as CD44 and CD133, were homogenous. Purely sorted CD24-negative gastric cancer cells showed strong alteration into the CD24-positive cell type in an autochthonous manner, and reached to steady expression levels. Our clinicopathological study revealed that CD24 positivity was an independent prognostic factor in both intestinal and diffuse types of gastric cancer. CD24 expression was correlated with the advanced stages, invasiveness, and lymph node metastasis of gastric cancer. Silencing of CD24 in cultured cells significantly decreased cell migration and invasion. Hypoxic treatment upregulated CD24 expression, and simultaneously induced cell motility and invasion of gastric cancer cells. Hypoxic treatment-induced CD24 expression was significantly attenuated by knockdown of hypoxia-inducible transcription factors. These data suggest that CD24-negative cells are capable of gaining cell motility and invasiveness through the induction of CD24, which is mediated by hypoxia. CD24 would be an attractive marker to define not only the heterogeneity but also the aggressiveness of gastric cancer cells. The mechanisms by which hypoxia induces CD24 expression would also be a potential therapeutic target for gastric cancer.	[Fujikuni, Nobuaki; Yamamoto, Hideki; Tanabe, Kazuaki; Tanaka, Yuka; Ohdan, Hideki] Hiroshima Univ, Dept Gastroenterol & Transplant Surg, Hiroshima 7348551, Japan; [Naito, Yutaka; Sakamoto, Naoya; Oue, Naohide; Yasui, Wataru] Hiroshima Univ, Dept Mol Pathol, Hiroshima 7348551, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr, Exploratory Oncol & Clin Trial Ctr, Div Translat Res, Kashiwa, Chiba, Japan	Yamamoto, H (reprint author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England.	hy276@cam.ac.uk; ktanabe2@hiroshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [22591453, 22800047, 25462023]	Japan Society for the Promotion of Science (JSPS) KAKENHI (22591453, 22800047, 25462023)	Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Duckworth CA, 2012, AM J PHYSIOL-GASTR L, V303, pG915, DOI 10.1152/ajpgi.00068.2012; PIRRUCCELLO SJ, 1986, J IMMUNOL, V136, P3779; Chou YY, 2007, ANN SURG ONCOL, V14, P2748, DOI 10.1245/s10434-007-9501-x; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Sagiv E, 2006, BIOMED PHARMACOTHER, V60, P280, DOI 10.1016/j.biopha.2006.06.006; Figueiredo J, 2013, EUR J HUM GENET, V21, P301, DOI 10.1038/ejhg.2012.159; Weichert W, 2005, CLIN CANCER RES, V11, P6574, DOI 10.1158/1078-0432.CCR-05-0606; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Overdevest JB, 2011, CANCER RES, V71, P3802, DOI 10.1158/0008-5472.CAN-11-0519; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Chun N, 2012, CANCER J, V18, P355, DOI 10.1097/PPO.0b013e31826246dc; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; FISCHER GF, 1990, J IMMUNOL, V144, P638; Kristiansen G, 2003, BRIT J CANCER, V88, P231, DOI 10.1038/sj.bjc.6600702; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Kim B, 2003, CANCER RES, V63, P8248; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Guggenheim DE, 2013, J SURG ONCOL, V107, P230, DOI 10.1002/jso.23262; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x; Scheurer SB, 2004, PROTEOMICS, V4, P1737, DOI 10.1002/pmic.200300689; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Thomas S, 2012, CANCER RES, V72, P5600, DOI 10.1158/0008-5472.CAN-11-3666; Aigner S, 1997, BLOOD, V89, P3385; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Darwish Nevine S, 2004, Cancer Res Treat, V36, P298, DOI 10.4143/crt.2004.36.5.298; desAretxabala X, 1989, CANCER, V63, P791; GOSEKI N, 1992, GUT, V33, P606, DOI 10.1136/gut.33.5.606; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; OCHIAI A, 1985, JPN J CANCER RES, V76, P1064; PARK JG, 1990, CANCER RES, V50, P2773; Sobin LH, 2009, TNM CLASSIFICATION M; TSUCHIYA Y, 1993, CANCER RES, V53, P1397	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	NOV	2014	105	11					1411	1420		10.1111/cas.12522		10	Oncology	Oncology	AU1HL	WOS:000345371600005		
J	Sugihara, T; Yasunaga, H; Horiguchi, H; Matsui, H; Fujimura, T; Nishimatsu, H; Fukuhara, H; Kume, H; Yu, CH; Kattan, MW; Fushimi, K; Homma, Y				Sugihara, Toru; Yasunaga, Hideo; Horiguchi, Hiromasa; Matsui, Hiroki; Fujimura, Tetsuya; Nishimatsu, Hiroaki; Fukuhara, Hiroshi; Kume, Haruki; Yu Changhong; Kattan, Michael W.; Fushimi, Kiyohide; Homma, Yukio			Robot-assisted versus other types of radical prostatectomy: Population-based safety and cost comparison in Japan, 2012-2013	CANCER SCIENCE			English	Article						Laparoscopy; minimally invasive; prostatic neoplasm; robot technology; surgical procedures	PROPENSITY SCORE; EAU GUIDELINES; METAANALYSIS; SURGERY; CANCER; DIAGNOSIS; OUTCOMES; UROLOGY	In 2012, Japanese national insurance started covering robot-assisted surgery. We carried out a population-based comparison between robot-assisted and three other types of radical prostatectomy to evaluate the safety of robot-assisted prostatectomy during its initial year. We abstracted data for 7202 open, 2483 laparoscopic, 1181 minimal incision endoscopic, and 2126 robot-assisted radical prostatectomies for oncological stage T3 or less from the Diagnosis Procedure Combination database (April 2012-March 2013). Complication rate, transfusion rate, anesthesia time, postoperative length of stay, and cost were evaluated by pairwise one-to-one propensity-score matching and multivariable analyses with covariants of age, comorbidity, oncological stage, hospital volume, and hospital academic status. The proportion of robot-assisted radical prostatectomies dramatically increased from 8.6% to 24.1% during the first year. Compared with open, laparoscopic, and minimal incision endoscopic surgery, robot-assisted surgery was generally associated with a significantly lower complication rate (odds ratios, 0.25, 0.20, 0.33, respectively), autologous transfusion rate (0.04, 0.31, 0.10), homologous transfusion rate (0.16, 0.48, 0.14), lower cost excluding operation (differences, -5.1%, -1.8% [not significant], -10.8%) and shorter postoperative length of stay (-9.1%, +0.9% [not significant], -18.5%, respectively). However, robot-assisted surgery also resulted in a+42.6% increase in anesthesia time and +52.4% increase in total cost compared with open surgery (all P<0.05). Introduction of robotic surgery led to a dynamic change in prostate cancer surgery. Even in its initial year, robot-assisted radical prostatectomy was carried out with several favorable safety aspects compared to the conventional surgeries despite its having the longest anesthesia time and the highest cost.	[Sugihara, Toru; Yu Changhong; Kattan, Michael W.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Sugihara, Toru; Fujimura, Tetsuya; Nishimatsu, Hiroaki; Fukuhara, Hiroshi; Kume, Haruki; Homma, Yukio] Univ Tokyo, Dept Urol, Tokyo, Japan; [Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Dept Clin Data Management & Res, Clin Res Ctr, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Care Informat, Tokyo, Japan	Sugihara, T (reprint author), Dept Quantitat Hlth Sci, Cleveland Clin Main Campus,JJN3-01, Cleveland, OH 44195 USA.	ezy04707@nifty.com		Yasunaga, Hideo/0000-0002-6017-469X	Saga Prefecture, Japan; Ministry of Health, Labor, and Welfare, Japan; Council for Science and Technology Policy, Japan	Saga Prefecture, Japan; Ministry of Health, Labor, and Welfare, Japan; Council for Science and Technology Policy, Japan.	Porpiglia F, 2013, EUR UROL, V63, P606, DOI 10.1016/j.eururo.2012.07.007; Sugihara T, 2012, INT J UROL, V19, P86, DOI 10.1111/j.1442-2042.2011.02883.x; Moran PS, 2013, INT J UROL, V20, P312, DOI 10.1111/iju.12070; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Bolenz C, 2010, EUR UROL, V57, P453, DOI 10.1016/j.eururo.2009.11.008; Robertson C, 2013, BJU INT, V112, P798, DOI 10.1111/bju.12247; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Griswold ME, 2010, ANN INTERN MED, V152, P393, DOI 10.7326/0003-4819-152-6-201003160-00010; Novara G, 2012, EUR UROL, V62, P431, DOI 10.1016/j.eururo.2012.05.044; Panageas KS, 2003, ANN INTERN MED, V139, P658; Imai K, 2008, J COMPUT GRAPH STAT, V17, P892, DOI 10.1198/106186008X384898; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Asimakopoulos AD, 2011, J SEX MED, V8, P1503, DOI 10.1111/j.1743-6109.2011.02215.x; Doumerc N, 2010, BJU INT, V106, P378, DOI 10.1111/j.1464-410X.2009.09158.x; Merseburger AS, 2013, EUR UROL, V64, P277, DOI 10.1016/j.eururo.2013.05.034; Tewari A, 2012, EUR UROL, V62, P1, DOI 10.1016/j.eururo.2012.02.029; Sugihara T, 2014, INT J UROL, V21, P566, DOI 10.1111/iju.12368; Bolenz C, 2014, EUR UROL, V65, P316, DOI 10.1016/j.eururo.2012.08.059; Buuren S., 2011, J STAT SOFTW, V45, P1; Harrell Jr FE, 2013, RMS REGRESSION MODEL; Ho Daniel E., 2011, J STAT SOFTW, V42, P1; Imai K, 2009, ZELIG EVERYONES STAT; Intuitive Surgical Inc, 2013, INV PRES Q4 2013; Kihara K, 2009, INT J UROL, V16, P791, DOI 10.1111/j.1442-2042.2009.02366.x; Kuwahara K., 2012, SHINIRYO, V39, P162; Lim SK, 2013, INT J UROL, V20, P271, DOI 10.1111/j.1442-2042.2012.03193.x; OECD, 2013, OECD HLTH DAT 2013; R Core Team, 2013, R LANG ENV STAT COMP; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Sobin LH, 2002, TNM CLASSIFICATION M; Sugihara T, 2014, INT J UROL, V21, P1145, DOI 10.1111/iju.12548	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	NOV	2014	105	11					1421	1426		10.1111/cas.12523		6	Oncology	Oncology	AU1HL	WOS:000345371600006		
J	Yamaguchi, M; Takata, K; Yoshino, T; Ishizuka, N; Oguchi, M; Kobayashi, Y; Isobe, Y; Ishizawa, K; Kubota, N; Itoh, K; Usui, N; Miyazaki, K; Wasada, I; Nakamura, S; Matsuno, Y; Oshimi, K; Kinoshita, T; Tsukasaki, K; Tobinai, K				Yamaguchi, Motoko; Takata, Katsuyoshi; Yoshino, Tadashi; Ishizuka, Naoki; Oguchi, Masahiko; Kobayashi, Yukio; Isobe, Yasushi; Ishizawa, Kenichi; Kubota, Nobuko; Itoh, Kuniaki; Usui, Noriko; Miyazaki, Kana; Wasada, Izumi; Nakamura, Shigeo; Matsuno, Yoshihiro; Oshimi, Kazuo; Kinoshita, Tomohiro; Tsukasaki, Kunihiro; Tobinai, Kensei			Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy	CANCER SCIENCE			English	Article						Clinical trial; Epstein-Barr virus; extranodal NK; T-cell lymphoma; latent membrane protein 1; radiotherapy	NON-HODGKINS-LYMPHOMAS; PERIPHERAL T-CELL; NASAL-TYPE; GAMMA-DELTA; EXPRESSION; NK; RELEVANCE; ANTIGEN; MODEL; LMP1	Concurrent chemoradiotherapy has become one of the standard management approaches for newly diagnosed localized nasal natural killer (NK)/T-cell lymphoma (NKTCL). Few data are available on the prognostic biomarkers of NKTCL among patients treated with concurrent chemoradiotherapy. To evaluate the prognostic significance of immunophenotypic biomarkers for patients treated with concurrent chemoradiotherapy, latent membrane protein 1 (LMP1), cutaneous lymphocyte antigen (CLA) and cell origin were examined in samples from 32 patients who were enrolled in the Japan Clinical Oncology Group 0211 trial and treated with concurrent chemoradiotherapy. LMP1 and CLA were positive in 66% (19/29) and 29% (9/31) of the cases examined, respectively. The median follow-up duration was 68months (range, 61-94). The patients with LMP1-positive tumors showed a better overall survival (OS) than the patients with LMP1-negative tumors (hazard ratio, 0.240; 95% confidence interval [CI], 0.057-1.013; 80% CI, 0.093-0.615; P=0.035). All five patients with LMP1-negative tumors who experienced disease progression died of lymphoma, and both patients with local failure had LMP1-negative tumors. There was no significant difference in OS according to CLA expression. A total of 27 (84%) cases were of NK-cell origin, two were of T-cell origin and three were of T-cell origin. In contrast to those with tumors of NK-cell origin, all five patients with NKTCL of T-cell origin were alive without relapse at the last follow up. Our results indicate that LMP1 expression is a favorable prognostic marker and suggest that a T-cell origin of the tumor may be a favorable prognostic marker for patients with localized NKTCL treated with concurrent chemoradiotherapy.	[Yamaguchi, Motoko; Miyazaki, Kana] Mie Univ Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie 5148507, Japan; [Takata, Katsuyoshi; Yoshino, Tadashi] Okayama Univ Grad Sch Med, Dept Pathol, Okayama, Japan; [Ishizuka, Naoki] Japanese Fdn Canc Res, Canc Inst Hosp, Clin Trial Dept, Tokyo, Japan; [Oguchi, Masahiko] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Radiat Oncol, Tokyo, Japan; [Kobayashi, Yukio; Tobinai, Kensei] Natl Canc Ctr, Dept Hematol, Tokyo, Japan; [Isobe, Yasushi] Juntendo Univ Sch Med, Dept Hematol, Tokyo, Japan; [Ishizawa, Kenichi] Tohoku Univ Hosp, Dept Hematol & Rheumatol, Sendai, Miyagi, Japan; [Kubota, Nobuko] Saitama Canc Ctr, Dept Hematol, Ina, Saitama, Japan; [Itoh, Kuniaki; Tsukasaki, Kunihiro] Natl Canc Ctr Hosp East, Div Hematol & Oncol, Kashiwa, Chiba, Japan; [Usui, Noriko] Jikei Univ Sch Med, Div Hematol & Oncol, Tokyo, Japan; [Wasada, Izumi] Tokai Univ, Dept Hematol, Isehara, Kanagawa, Japan; [Nakamura, Shigeo] Nagoya Univ Hosp, Dept Pathol & Lab Med, Nagoya, Aichi, Japan; [Matsuno, Yoshihiro] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido 060, Japan; [Oshimi, Kazuo] Kushiro Chuo Hosp, Dept Internal Med, Kushiro, Japan; [Kinoshita, Tomohiro] Aichi Canc Ctr Hosp, Dept Hematol & Cell Therapy, Nagoya, Aichi 464, Japan	Yamaguchi, M (reprint author), Mie Univ Grad Sch Med, Dept Hematol & Oncol, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	waniwani@clin.medic.mie-u.ac.jp	Nakamura, Shigeo/I-1571-2012; Kobayahi, Yukio/F-2901-2015	Kobayahi, Yukio/0000-0003-2378-7865	National Cancer Center Research and Development Funds in Japan [21-6-3, 23-A-17, 26-A-4]	This work was supported in part by the National Cancer Center Research and Development Funds (21-6-3, 23-A-17, 26-A-4) in Japan.	Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; YAMAGUCHI M, 1995, CANCER, V76, P2351, DOI 10.1002/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1; Cao WF, 2008, MOL MED REP, V1, P363; Egashira M, 1999, BLOOD, V93, P599; Ryder J, 2007, INT J HEMATOL, V85, P18, DOI 10.1532/IJH97.A10612; Kanemitsu N, 2012, CLIN CANCER RES, V18, P2164, DOI 10.1158/1078-0432.CCR-11-2395; Tse E, 2013, BLOOD, V121, P4997, DOI 10.1182/blood-2013-01-453233; Kim WS, 2001, ANN ONCOL, V12, P349, DOI 10.1023/A:1011144911781; Cheung MMC, 1998, J CLIN ONCOL, V16, P70; Ito Y, 2012, CLIN CANCER RES, V18, P4183, DOI 10.1158/1078-0432.CCR-12-1064; Yamaguchi M, 2009, J CLIN ONCOL, V27, P5594, DOI 10.1200/JCO.2009.23.8295; [Anonymous], 1993, N ENGL J MED, V329, P987; Lee J, 2006, J CLIN ONCOL, V24, P612, DOI 10.1200/JCO.2005.04.1384; Zelenetz AD, 2014, J NATL COMPR CANC NE, V12, P916; Yamaguchi M, 2012, J CLIN ONCOL, V30, P4044, DOI 10.1200/JCO.2012.45.6541; Pongpruttipan T, 2012, AM J SURG PATHOL, V36, P481, DOI 10.1097/PAS.0b013e31824433d8; Suzuki R, 2014, SEMIN HEMATOL, V51, P42, DOI 10.1053/j.seminhematol.2013.11.007; Hayashi E, 2013, HUM PATHOL, V44, P1927, DOI 10.1016/j.humpath.2013.03.002; Ebert LM, 2006, J IMMUNOL, V176, P4331; Chiang AKS, 1996, INT J CANCER, V68, P285, DOI 10.1002/(SICI)1097-0215(19961104)68:3<285::AID-IJC3>3.0.CO;2-Y; Kim SJ, 2009, J CLIN ONCOL, V27, P6027, DOI 10.1200/JCO.2009.23.8592; Drenou B, 1997, BLOOD, V89, P2966; Chan J. K. C., 2001, WHO CLASSIFICATION T, P204; Chan JKC, 2008, WHO CLASSIFICATION T, P285; Chang ST, 2010, PATHOL RES PRACT, V206, P463, DOI 10.1016/j.prp.2009.07.001; Fox Christopher P, 2011, Herpesviridae, V2, P8, DOI 10.1186/2042-4280-2-8; GAULARD P, 1988, CANCER, V62, P705, DOI 10.1002/1097-0142(19880815)62:4<705::AID-CNCR2820620410>3.0.CO;2-Z; Kim GE, 2004, HEAD NECK-J SCI SPEC, V26, P584, DOI 10.1002/hed.20015; Komabayashi Y, 2014, AM J HEMATOL, V89, P25, DOI 10.1002/ajh.23570; Kwong YL, 2013, LEUKEMIA, V28, P865; Lee J, 2007, CLIN CANCER RES, V13, P3250, DOI 10.1158/1078-0432.CCR-06-2373; Li YX, 2011, LEUKEMIA LYMPHOMA, V52, P417; Mao Y, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-178; Pals ST, 2007, BLOOD, V110, P3102, DOI 10.1182/blood-2007-05-075176; Yamaguchi M, 2001, J CLIN EXP HEMATOPAT, V41, P93; Yoshino T, 2002, BRIT J HAEMATOL, V118, P482, DOI 10.1046/j.1365-2141.2002.03607.x	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	NOV	2014	105	11					1435	1441		10.1111/cas.12526		7	Oncology	Oncology	AU1HL	WOS:000345371600008		
J	Fujisawa, M; Seike, K; Fukumoto, K; Suehara, Y; Fukaya, M; Sugihara, H; Takeuchi, M; Matsue, K				Fujisawa, Manabu; Seike, Keisuke; Fukumoto, Kouta; Suehara, Yasuhito; Fukaya, Masafumi; Sugihara, Hiroki; Takeuchi, Masami; Matsue, Kosei			Oligoclonal bands in patients with multiple myeloma: Its emergence per se could not be translated to improved survival	CANCER SCIENCE			English	Article						Free light chain; minimal residual disease; Multiple myeloma; Oligoclonal band; stem cell transplantation	STEM-CELL TRANSPLANTATION; COMPLETE REMISSION; PROTEIN BANDS; CRITERIA	The emergence of oligoclonal bands (OB) has been reported in patients with multiple myeloma (MM) after stem cell transplantation (SCT) or successful chemotherapy. However, their clinical relevance remains unclear. We reviewed the clinical records of MM patients from January 2006 to May 2014. Treatment response was evaluated by International Working Group (IMWG) criteria. Serum immunofixation tests were performed at least every 3months if the patient achieved more than very good partial response (VGPR). Free light chain (FLC) and minimal residual disease measurement by multicolor flow cytometry (MFC) were performed to evaluate the response to treatment. Among the 163patients included in the study, 40 developed OB. Detection rates of OB in patients with complete response (CR), VGPR and partial response (PR) or less were 51.8, 36.3 and 0%, respectively. Patients with OB showed better progression-free survival (PFS) and overall survival (OS) rates than those without OB (P=0.028 and P<0.001, respectively). However, if the patients were limited to VGPR or CR, development of OB did not affect PFS (P=0.621 and P=0.646, respectively) or OS (P=0.189 and P=0.766, respectively). OB was observed in 60% of patients after SCT, and in 36.6% of patients with more than VGPR without SCT (P<0.001). Patients with OB tended to have less minimal residual disease than those without OB (P=0.054) and its presence may affect the stringent CR criteria. In conclusion, the emergence of OB was seen exclusively in patients with favorable responses, but its emergence per se could not be translated to improved survival.	[Fujisawa, Manabu; Seike, Keisuke; Fukumoto, Kouta; Suehara, Yasuhito; Fukaya, Masafumi; Sugihara, Hiroki; Takeuchi, Masami; Matsue, Kosei] Kameda Med Ctr, Div Hematol Oncol, Dept Med, Kamogawa, Chiba 2968602, Japan	Matsue, K (reprint author), Kameda Med Ctr, Div Hematol Oncol, Dept Med, 929 Higashi Chou, Kamogawa, Chiba 2968602, Japan.	koseimatsue@gmail.com					Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Hovenga S, 2000, BONE MARROW TRANSPL, V25, P723, DOI 10.1038/sj.bmt.1702194; Zent CS, 1998, BLOOD, V91, P3518; Byrne E, 2011, HAEMATOL-HEMATOL J, V96, pE29, DOI 10.3324/haematol.2011.041509; Caillon H, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.51; desTute RM, 2007, LEUKEMIA, V21, P2046; de Larrea CF, 2011, HAEMATOL-HEMATOL J, V96, P171, DOI 10.3324/haematol.2010.030882; Guikema JEJ, 1999, BRIT J HAEMATOL, V104, P748, DOI 10.1046/j.1365-2141.1999.01233.x; Hall Sara L, 2009, Clin Biochem Rev, V30, P113; Liu AJ, 2012, ASIAN PAC J CANCER P, V13, P1483, DOI 10.7314/APJCP.2012.13.4.1483; Rahlff J, 2012, CANCER IMMUNOL IMMUN, V61, P1639, DOI 10.1007/s00262-012-1220-x; Rawstron AC, 2008, HAEMATOL-HEMATOL J, V93, P431, DOI 10.3324/haematol.11080; Tovar N, 2013, HAEMATOLOGICA, V98, P1142, DOI 10.3324/haematol.2013.084350; Zou DH, 2014, BIOL BLOOD MARROW TR, V20, P319, DOI 10.1016/j.bbmt.2013.11.022	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	NOV	2014	105	11					1442	1446		10.1111/cas.12527		5	Oncology	Oncology	AU1HL	WOS:000345371600009		
J	Hijioka, M; Ito, T; Igarashi, H; Fujimori, N; Lee, L; Nakamura, T; Jensen, RT; Takayanagi, R				Hijioka, Masayuki; Ito, Tetsuhide; Igarashi, Hisato; Fujimori, Nao; Lee, Lingaku; Nakamura, Taichi; Jensen, Robert T.; Takayanagi, Ryoichi			Serum chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumors	CANCER SCIENCE			English	Article						Chromogranin A; Japan; pancreatic cancer; pancreatic neuroendocrine tumors; proton pump inhibitors	NEURON-SPECIFIC ENOLASE; ENDOCRINE NEOPLASIA TYPE-1; ETHNIC-DIFFERENCES; PLASMA; CARCINOMA; DIAGNOSIS; DISEASE; UTILITY; CANCER; DISCONTINUATION	Although chromogranin A (CGA) is a useful marker for pancreatic neuroendocrine tumors (pNET) in the West, its usefulness in Japanese populations is unclear. To assess this, we evaluated the serum CGA levels in 189 patients with various pancreatic diseases, including proven pNET (n=69), pancreatic cancer (PC) (n=50), chronic pancreatitis (CP) (n=50) and autoimmune pancreatitis (AIP) (n=20), and 112 normal controls (controls) using an ELISA kit. The mean CGA level of patients with pNET was significantly higher than any of the other groups (407.8 +/- 984.6ng/mL [pNET] vs 91.8 +/- 101.8ng/mL [PC], 93.6 +/- 57.5ng/mL [CP], 69.9 +/- 52.4ng/mL [AIP] and 62.5 +/- 48.3ng/mL [controls]). Limiting the analysis to patients not using proton pump inhibitors (PPI), the CGA level of patients with PC or CP was not significantly different compared with the controls. Discriminant analysis revealed that the best cut-off value of CGA to distinguish patients with pNET from the controls was 78.7ng/mL, with a sensitivity and specificity of 53.6% and 78.6%, respectively. In patients with pNET, significant factors associating with elevated CGA levels were tumor classification, tumor size, and the presence of liver metastases in univariate analysis as well as PPI use and the presence of liver metastases in multivariate analysis. We show that CGA is a useful marker for diagnosing pNET in Japanese populations and for distinguishing patients with pNET from patients with other pancreatic diseases. The increased use of CGA in Japan will likely be a helpful tool in managing these patients, as found in the West.	[Hijioka, Masayuki; Ito, Tetsuhide; Igarashi, Hisato; Fujimori, Nao; Lee, Lingaku; Nakamura, Taichi; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioreguratory Sci, Fukuoka 8128582, Japan; [Nakamura, Taichi; Jensen, Robert T.] NIDDK, Digest Dis Branch, NIH, Bethesda, MD USA	Ito, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioreguratory Sci, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	itopapa@intmed3.med.kyushu-u.ac.jp					Malaguarnera M, 2009, ARCH GERONTOL GERIAT, V48, P213, DOI 10.1016/j.archger.2008.01.014; Nehar D, 2004, CLIN ENDOCRINOL, V60, P644, DOI 10.1111/j.1365-2265.2004.02030.x; Campana D, 2007, J CLIN ONCOL, V25, P1967, DOI 10.1200/JCO.2006.10.1535; Ito T, 2012, BEST PRACT RES CL GA, V26, P737, DOI 10.1016/j.bpg.2012.12.003; Niina Y, 2012, GUT LIVER, V6, P287, DOI 10.5009/gnl.2012.6.3.287; Ito T, 2010, J GASTROENTEROL, V45, P234, DOI 10.1007/s00535-009-0194-8; Shimosegawa T, 2010, J GASTROENTEROL, V45, P584, DOI 10.1007/s00535-010-0242-4; Modlin IM, 2010, ANN SURG ONCOL, V17, P2427, DOI 10.1245/s10434-010-1006-3; Modlin IM, 2008, LANCET ONCOL, V9, P61, DOI 10.1016/S1470-2045(07)70410-2; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Nobels FRE, 1998, EUR J CLIN INVEST, V28, P431; Cimitan M, 2003, ANN ONCOL, V14, P1135, DOI 10.1093/annonc/mdg279; Ito T, 2015, J GASTROENTEROL, V50, P58, DOI 10.1007/s00535-014-0934-2; Ito T, 2012, J GASTROENTEROL, V47, P941, DOI 10.1007/s00535-012-0642-8; Paik WH, 2013, J KOREAN MED SCI, V28, P750, DOI 10.3346/jkms.2013.28.5.750; Panzuto F, 2004, J ENDOCRINOL INVEST, V27, P6; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Korse CM, 2012, EUR J CANCER, V48, P662, DOI 10.1016/j.ejca.2011.08.012; Tomassetti P, 2001, EUR J GASTROEN HEPAT, V13, P55, DOI 10.1097/00042737-200101000-00010; Welin S, 2009, NEUROENDOCRINOLOGY, V89, P302, DOI 10.1159/000179900; Nobels FRE, 1997, J CLIN ENDOCR METAB, V82, P2622, DOI 10.1210/jc.82.8.2622; Ito T, 2013, CURR OPIN GASTROEN, V29, P650, DOI 10.1097/MOG.0b013e328365efb1; Korse CM, 2011, BRIT J CANCER, V105, P1173, DOI 10.1038/bjc.2011.380; Zatelli MC, 2007, ENDOCR-RELAT CANCER, V14, P473, DOI 10.1677/ERC-07-0001; Oberg K, 2005, BEST PRACT RES CL GA, V19, P753, DOI 10.1016/j.bpg.2005.06.002; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Baudin E, 1998, BRIT J CANCER, V78, P1102, DOI 10.1038/bjc.1998.635; Bech PR, 2012, CLIN CHEM, V58, P941, DOI 10.1373/clinchem.2011.176099; Belli Susana Haydée, 2009, Acta Gastroenterol Latinoam, V39, P184; Bosman FT, 2010, WHO CLASSIFICATION T, V3; Chou WC, 2012, NEUROENDOCRINOLOGY, V95, P344, DOI 10.1159/000333853; Ganeshan D, 2013, AM J ROENTGENOL, V201, pW867, DOI 10.2214/AJR.12.10370; Glinicki P, 2010, ENDOKRYNOL POL, V61, P346; Glinicki Piotr, 2011, Endokrynol Pol, V62 Suppl 1, P25; Ito T, 2012, PANCREAS, V41, P505, DOI 10.1097/MPA.0b013e318249a92a; Ito T, 2013, INVEST NEW DRUG, V31, P1265, DOI 10.1007/s10637-012-9910-y; Ito T, 2012, JPN J CLIN ONCOL, V42, P903, DOI 10.1093/jjco/hys123; Kimura N, 2002, ENDOCR PATHOL, V13, P117, DOI 10.1385/EP:13:2:117; Kimura T, 2012, CHIN J CANCER, V31, P421, DOI 10.5732/cjc.011.10324; KONECKI DS, 1987, J BIOL CHEM, V262, P17026; Lambe M, 2003, EPIDEMIOLOGY, V14, P85, DOI 10.1097/00001648-200301000-00020; Louthan O, 2011, FOLIA BIOL-PRAGUE, V57, P173; Molina R, 2011, TUMOR BIOL, V32, P13, DOI 10.1007/s13277-010-0085-x; Mosli HH, 2012, J CLIN ENDOCR METAB, V97, pE1731, DOI 10.1210/jc.2012-1548; Nobili Elisabetta, 2008, Case Rep Gastroenterol, V2, P11, DOI 10.1159/000113218; Peracchi M, 2003, EUR J ENDOCRINOL, V148, P39, DOI 10.1530/eje.0.1480039; Sanduleanu S, 2001, EUR J CLIN INVEST, V31, P802, DOI 10.1046/j.1365-2362.2001.00890.x; Shimosegawa T, 2009, J GASTROENTEROL, V44, P503, DOI 10.1007/s00535-009-0054-6; Singh S, 2012, EXPERT REV GASTROENT, V6, P313, DOI [10.1586/egh.12.15, 10.1586/EGH.12.15]; Spadaro A, 2005, WORLD J GASTROENTERO, V11, P1987; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Zissimopoulos A, 2014, SCAND J GASTROENTERO, V49, P942, DOI 10.3109/00365521.2014.920910	52	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	NOV	2014	105	11					1464	1471		10.1111/cas.12533		8	Oncology	Oncology	AU1HL	WOS:000345371600012		
J	Iwamoto, T; Hirai, H; Yamaguchi, N; Kobayashi, N; Sugimoto, H; Tabata, T; Okuda, M				Iwamoto, Takuya; Hirai, Hiroyuki; Yamaguchi, Nozomi; Kobayashi, Natsuki; Sugimoto, Hiroko; Tabata, Tsutomu; Okuda, Masahiro			Carboplatin-induced severe hypersensitivity reaction: Role of IgE-dependent basophil activation and Fc epsilon RI	CANCER SCIENCE			English	Article						Basophil; biological markers; carboplatin; hypersensitivity reaction; immunoglobulin E	ALLERGY; RECEPTOR; CD203C; EXPRESSION; OMALIZUMAB; PURIFICATION; PROTOCOL; ANTIBODY; MARKERS; DOMAIN	Basophil activation was observed in patients with a history of carboplatin-induced severe hypersensitivity reaction (HR). However, the precise mechanism by which carboplatin induces basophil activation and the associated surrogate markers remains to be elucidated. To investigate whether IgE-dependent mechanisms, including the overexpression of Fc epsilon RI, participate in carboplatin-induced basophil activation, 13 ovarian cancer patients were enrolled: 5 with a history of carboplatin-induced severe hypersensitivity reaction within the past 2years, and 8 with no such history. The expression levels of Fc epsilon RI, IgE, and CD203c on basophils were measured using a flow cytometer. Immunoglobulin E-dependent basophil activation was evaluated by testing for IgE passive sensitization using lactic acid, and by testing for phosphatidylinositol 3-kinase inhibition, using wortmannin. In three patients positive for carboplatin hypersensitivity, pretreatment with wortmannin almost completely inhibited carboplatin-induced basophil activation (P<0.05). In a healthy control subject, whose own IgE showed no response to carboplatin, acquired reactivity to carboplatin when exposed to plasma from patients positive for carboplatin hypersensitivity. This did not occur when the same experiment was carried out using plasma from the patients negative for carboplatin hypersensitivity. Moreover, pretreatment with omalizumab, a monoclonal anti-IgE antibody, almost completely blocked carboplatin-induced basophil activation in the plasma of patients positive for carboplatin hypersensitivity. On further investigation, the HR-positive group had significantly higher levels of Fc epsilon RI compared with the negative group (P<0.05). In conclusion, an IgE-dependent mechanism incorporating Fc epsilon RI overexpression participates in carboplatin-induced severe HR. These results establish the relevance of monitoring the pharmacodynamic changes of basophils to prevent carboplatin-induced severe HR.	[Iwamoto, Takuya; Sugimoto, Hiroko; Okuda, Masahiro] Mie Univ Grad Sch Med, Dept Pharm, Tsu, Mie, Japan; [Iwamoto, Takuya; Kobayashi, Natsuki; Okuda, Masahiro] Mie Univ Grad Sch Med, Dept Clin Pharm & Biopharmaceut, Tsu, Mie, Japan; [Hirai, Hiroyuki; Yamaguchi, Nozomi] BML, R&D Ctr, Kawagoe, Saitama, Japan; [Tabata, Tsutomu] Mie Univ Grad Sch Med, Dept Obstet & Gynecol, Tsu, Mie, Japan	Iwamoto, T (reprint author), Mie Univ Hosp, Dept Pharm, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	taku-iwa@clin.medic.mie-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590188]; Research Foundation for Pharmaceutical Sciences	Ministry of Education, Culture, Sports, Science, and Technology of Japan (24590188). Research Foundation for Pharmaceutical Sciences	Hennersdorf F, 2005, CELL RES, V15, P325, DOI 10.1038/sj.cr.7290301; Sampson HA, 2003, PEDIATRICS, V111, P1601; Tanaka A, 2006, EXP DERMATOL, V15, P283, DOI 10.1111/j.0906-6705.2006.00404.x; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; Hartman ML, 2008, MOL IMMUNOL, V45, P2307, DOI 10.1016/j.molimm.2007.11.017; Caiado J, 2013, J ALLER CL IMM-PRACT, V1, P494, DOI 10.1016/j.jaip.2013.06.002; Cassard L, 2012, J IMMUNOL, V189, P2995, DOI 10.4049/jimmunol.1200968; Li XL, 2012, J IMMUNOL, V189, P4284, DOI 10.4049/jimmunol.1200704; Abuaf N, 2008, CLIN EXP ALLERGY, V38, P921, DOI 10.1111/j.1365-2222.2008.02960.x; Kumar S, 2012, INT IMMUNOPHARMACOL, V13, P432, DOI 10.1016/j.intimp.2012.05.018; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457; Dombrowicz D, 1998, IMMUNITY, V8, P517, DOI 10.1016/S1074-7613(00)80556-7; Aranda A, 2011, ALLERGY, V66, P247, DOI 10.1111/j.1398-9995.2010.02460.x; Markman M, 1999, J CLIN ONCOL, V17, P1141; MacGlashan D, 2010, CLIN EXP ALLERGY, V40, P1365, DOI 10.1111/j.1365-2222.2010.03572.x; Iwamoto T, 2012, BIOL PHARM BULL, V35, P1487; Gastaminza G, 2011, J INVEST ALLERG CLIN, V21, P108; Patil SU, 2012, J ALLERGY CLIN IMMUN, V129, P443, DOI 10.1016/j.jaci.2011.10.010; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Jonsson F, 2012, BLOOD, V119, P2533, DOI 10.1182/blood-2011-07-367334; Boumiza Radhia, 2005, Clin Mol Allergy, V3, P9, DOI 10.1186/1476-7961-3-9; Hino M, 2014, LEUKEMIA LYMPHOMA, V55, P92, DOI 10.3109/10428194.2013.794944; Lin H, 2004, J ALLERGY CLIN IMMUN, V113, P297, DOI 10.1016/j.jaci.2003.11.044; MacGlashan DW, 2012, J ALLERGY CLIN IMMUN, V130, P1130, DOI 10.1016/j.jaci.2012.05.038; MacGlashan DW, 2012, TRENDS PHARMACOL SCI, V33, P502, DOI 10.1016/j.tips.2012.06.002; Makrilia N., 2010, METAL BASED DRUGS, V1, P1; Pagani M, 2012, JPN J CLIN ONCOL, V42, P347, DOI 10.1093/jjco/hys006; Sugimoto H, 2011, CANCER CHEMOTH PHARM, V67, P415, DOI 10.1007/s00280-010-1338-5; Suzuki Hidenori, 2008, Allergol Int, V57, P347, DOI 10.2332/allergolint.O-07-506; Takai T, 2001, BIOSCI BIOTECH BIOCH, V65, P1082, DOI 10.1271/bbb.65.1082; Viardot-Helmer A, 2008, HAUTARZT, V59, P883, DOI 10.1007/s00105-008-1653-5; Vyas N, 2013, J ONCOL PHARM PRACT, V20, P278	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	NOV	2014	105	11					1472	1479		10.1111/cas.12538		8	Oncology	Oncology	AU1HL	WOS:000345371600013		
J	Ito, Y; Miyashiro, I; Ito, H; Hosono, S; Chihara, D; Nakata-Yamada, K; Nakayama, M; Matsuzaka, M; Hattori, M; Sugiyama, H; Oze, I; Tanaka, R; Nomura, E; Nishino, Y; Matsuda, T; Ioka, A; Tsukuma, H; Nakayama, T				Ito, Yuri; Miyashiro, Isao; Ito, Hidemi; Hosono, Satoyo; Chihara, Dai; Nakata-Yamada, Kayo; Nakayama, Masashi; Matsuzaka, Masashi; Hattori, Masakazu; Sugiyama, Hiromi; Oze, Isao; Tanaka, Rina; Nomura, Etsuko; Nishino, Yoshikazu; Matsuda, Tomohiro; Ioka, Akiko; Tsukuma, Hideaki; Nakayama, Tomio		J-CANSIS Res Grp	Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data	CANCER SCIENCE			English	Article						Cancer; cancer registry; conditional survival; period analysis; survival	PERIOD ANALYSIS; EMPIRICAL-EVALUATION; CHILDHOOD; PREDICTIONS; SWEDEN	Although we usually report 5-year cancer survival using population-based cancer registry data, nowadays many cancer patients survive longer and need to be followed-up for more than 5years. Long-term cancer survival figures are scarce in Japan. Here we report 10-year cancer survival and conditional survival using an established statistical approach. We received data on 1387489 cancer cases from six prefectural population-based cancer registries in Japan, diagnosed between 1993 and 2009 and followed-up for at least 5years. We estimated the 10-year relative survival of patients who were followed-up between 2002 and 2006 using period analysis. Using this 10-year survival, we also calculated the conditional 5-year survival for cancer survivors who lived for some years after diagnosis. We reported 10-year survival and conditional survival of 23 types of cancer for 15-99-year-old patients and four types of cancer for children (0-14years old) and adolescent and young adults (15-29years old) patients by sex. Variation in 10-year cancer survival by site was wide, from 5% for pancreatic cancer to 95% for female thyroid cancer. Approximately 70-80% of children and adolescent and young adult cancer patients survived for more than 10years. Conditional 5-year survival for most cancer sites increased according to years, whereas those for liver cancer and multiple myeloma did not increase. We reported 10-year cancer survival and conditional survival using population-based cancer registries in Japan. It is important for patients and clinicians to report these relevant figures using population-based data.	[Ito, Yuri; Miyashiro, Isao; Nakata-Yamada, Kayo; Nomura, Etsuko; Ioka, Akiko; Tsukuma, Hideaki; Nakayama, Tomio] Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Osaka 5378511, Japan; [Ito, Hidemi; Hosono, Satoyo; Chihara, Dai; Oze, Isao] Aichi Canc Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Nakayama, Masashi] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Urol, Osaka 5378511, Japan; [Matsuzaka, Masashi; Tanaka, Rina] Hirosaki Univ Grad Sch Med, Dept Canc Epidemiol & Community Hlth, Hirosaki, Aomori, Japan; [Hattori, Masakazu] Fukui Prefectural Hosp, Dept Canc Therapy Ctr, Fukui, Japan; [Sugiyama, Hiromi] Radiat Effects Res Fdn, Dept Epidemiol, Hiroshima, Japan; [Nishino, Yoshikazu] Miyagi Canc Ctr, Res Inst, Div Epidemiol, Natori, Miyagi 9811293, Japan; [Matsuda, Tomohiro] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Surveillance Div, Tokyo 104, Japan	Ito, Y (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Canc Epidemiol & Prevent, Ctr Canc Control & Stat, Higashinari Ku, 3-3 Nakamichi 1 Chome, Osaka 5378511, Japan.	itou-yu2@mc.pref.osaka.jp			Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labour and Welfare of Japan	Brenner H, 2002, J CLIN ONCOL, V20, P826, DOI 10.1200/JCO.20.3.826; Allemani C, 2013, INT J CANCER, V132, P2404, DOI 10.1002/ijc.27895; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Brenner H, 2004, EUR J CANCER, V40, P326, DOI 10.1016/j.ejca.2003.10.013; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Arndt V, 2007, ANN ONCOL, V18, P1734, DOI 10.1093/annonc/mdm188; Brenner H, 1997, J CLIN EPIDEMIOL, V50, P211, DOI 10.1016/S0895-4356(97)00280-1; Warren GW, 2013, INT J CANCER, V132, P401, DOI 10.1002/ijc.27617; ESTEVE J, 1990, STAT MED, V9, P529, DOI 10.1002/sim.4780090506; Brenner H, 2002, INT J EPIDEMIOL, V31, P456, DOI 10.1093/ije/31.2.456; Cancer Research UK Cancer Survival Group, 2009, STREL COMP PROGR VER; Ellison Larry F, 2011, Health Rep, V22, P21; Ito Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-304; Lee JY, 2010, ASIAN PAC J CANCER P, V11, P1459; London School of Hygiene and Tropical Medicine, CONCORD PROGR GROB S; Merrill RM, 2010, ONCOLOGIST, V15, P873, DOI 10.1634/theoncologist.2009-0211; Ministry of Health Labour and Welfare, 2011, ABR LIF TABL JAP 196; StataCorp, 2013, STAT STAT SOFTW REL; Talback M, 2012, ACTA ONCOL, V51, P17, DOI 10.3109/0284186X.2011.626444; Yu XQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-460; Zuccolo L, 2006, EUR J CANCER, V42, P1135, DOI 10.1016/j.ejca.2005.08.046	21	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	NOV	2014	105	11					1480	1486		10.1111/cas.12525		7	Oncology	Oncology	AU1HL	WOS:000345371600014		
J	Satoh, K; Nimura, S; Aoki, M; Hamasaki, M; Koga, K; Iwasaki, H; Yamashita, Y; Kataoka, H; Nabeshima, K				Satoh, Keisuke; Nimura, Satoshi; Aoki, Mikiko; Hamasaki, Makoto; Koga, Kaori; Iwasaki, Hiroshi; Yamashita, Yuichi; Kataoka, Hiroaki; Nabeshima, Kazuki			Tumor budding in colorectal carcinoma assessed by cytokeratin immunostaining and budding areas: Possible involvement of c-Met	CANCER SCIENCE			English	Article						tumor budding; sprouting; c-Met; tumor invasion	LYMPH-NODE METASTASIS; PROGNOSTIC-SIGNIFICANCE; COLON-CANCER; EXPRESSION; INVASION; RECEPTOR; GROWTH; INDEX; ADENOCARCINOMA; AMPLIFICATION	Tumor budding/sprouting has been shown to be an independent adverse prognostic factor in T1 and T3N0 colorectal carcinomas, however, its assessment could be improved by more accurate identification of budding carcinoma cells and consideration of budding areas. Moreover, tumor budding mechanisms are yet to be defined. In this study, we evaluated the identification of budding tumor cells by either H&E staining alone or H&E with immunohistochemistry and developed a scoring system based on budding grades and areas. We examined whether the budding score correlated with clinicopathologic features and prognosis and the association between tumor budding/sprouting and c-Met protein expression and phosphorylation and MET gene copy numbers because c-Met is known to play an important role in colorectal carcinoma tumorigenesis. Cytokeratin immunohistochemistry could identify tumors with shorter disease-free survival (DFS) from the low-grade budding group assessed with H&E alone. High budding scores based on budding grade and area were more significantly correlated with DFS than scores obtained using the budding grade alone. In tumors with a high budding score, c-Met expression and phosphorylation levels and MET gene copy numbers were significantly increased at the invasive front compared with those in superficial tumor portions. This study showed for the first time that high levels of phospho-c-Met at the invasive front were significantly associated with a high budding score and shorter DFS. In conclusion, a budding score assessed by budding grades and budding-positive areas correlates highly with clinicopathologic aggressive features of colorectal carcinoma.	[Satoh, Keisuke; Nimura, Satoshi; Aoki, Mikiko; Hamasaki, Makoto; Koga, Kaori; Iwasaki, Hiroshi; Nabeshima, Kazuki] Fukuoka Univ Sch Med & Hosp, Dept Pathol, Fukuoka 8140180, Japan; [Satoh, Keisuke; Yamashita, Yuichi] Fukuoka Univ Sch Med & Hosp, Dept Surg Gastroenterol, Fukuoka 8140180, Japan; [Kataoka, Hiroaki] Miyazaki Univ, Fac Med, Dept Pathol, Sect Oncopathol & Regenerat Biol, Miyazaki, Japan	Nabeshima, K (reprint author), Fukuoka Univ Sch Med & Hosp, Dept Pathol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	kaznabes@fukuoka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Research Center for Advanced Molecular Medicine, Fukuoka University, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Research Center for Advanced Molecular Medicine, Fukuoka University, Japan	Abou-Bakr A A, 2013, Gulf J Oncolog, V1, P28; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Tachibana K, 2012, LUNG CANCER, V75, P181, DOI 10.1016/j.lungcan.2011.07.008; Prall F, 2005, HISTOPATHOLOGY, V47, P17, DOI 10.1111/j.1365-2559.2005.02161.x; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; Losi L, 2006, PATHOL RES PRACT, V202, P663, DOI 10.1016/j.prp.2006.05.003; Suzuki H, 2008, ANTICANCER RES, V28, P1821; Shinto E, 2006, DIS COLON RECTUM, V49, P1422, DOI 10.1007/s10350-006-0595-1; Nakamura T, 2008, DIS COLON RECTUM, V51, P568, DOI 10.1007/s10350-008-9192-9; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Cappuzzo F, 2008, BRIT J CANCER, V99, P83, DOI 10.1038/sj.bjc.6604439; Suzuki A, 2009, AM J SURG PATHOL, V33, P1601, DOI 10.1097/PAS.0b013e3181ae29d6; Moschetta M, 2013, CLIN CANCER RES, V19, P4371, DOI 10.1158/1078-0432.CCR-13-0039; Zlobec I, 2010, ONCOTARGET, V1, P651; Janjigian YY, 2011, CANCER EPIDEM BIOMAR, V20, P1021, DOI 10.1158/1055-9965.EPI-10-1080; Otte JM, 2000, DIGESTION, V61, P237, DOI 10.1159/000007764; Kazama S, 2006, BRIT J CANCER, V94, P293, DOI 10.1038/sj.bjc.6602927; Koga K, 2013, LUNG CANCER, V82, P413, DOI 10.1016/j.lungcan.2013.09.005; Horcic M, 2013, HUM PATHOL, V44, P697, DOI 10.1016/j.humpath.2012.07.026; Ueno H, 2002, HISTOPATHOLOGY, V40, P127, DOI 10.1046/j.1365-2559.2002.01324.x; Takeuchi H, 2003, CLIN CANCER RES, V9, P1480; Puppa G, 2012, HISTOPATHOLOGY, V61, P562, DOI 10.1111/j.1365-2559.2012.04270.x; Ohtsuki K, 2008, ANTICANCER RES, V28, P1831; Matsumoto S, 2013, CANCER CYTOPATHOL, V121, P415, DOI 10.1002/cncy.21269; Zeng ZS, 2008, CANCER LETT, V265, P258, DOI 10.1016/j.canlet.2008.02.049; MORODOMI T, 1989, CANCER, V63, P539, DOI 10.1002/1097-0142(19890201)63:3<539::AID-CNCR2820630323>3.0.CO;2-S; Jedeszko C, 2009, CANCER RES, V69, P9148, DOI 10.1158/0008-5472.CAN-09-1043; Mitrovic B, 2012, MODERN PATHOL, V25, P1315, DOI 10.1038/modpathol.2012.94; DesOliveira AT, 2009, ANTICANCER RES, V29, P4807; Park KJ, 2005, DIS COLON RECTUM, V48, P1597, DOI 10.1007/s10350-005-0060-6; Rectum JSfCotCa, 2013, JAPANESE CLASSIFICAT; Shinto E, 2005, HISTOPATHOLOGY, V47, P25, DOI 10.1111/j.1365-2559.2005.02162.x; Wielenga VJM, 2000, AM J PATHOL, V157, P1563, DOI 10.1016/S0002-9440(10)64793-1	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	NOV	2014	105	11					1487	1495		10.1111/cas.12530		9	Oncology	Oncology	AU1HL	WOS:000345371600015		
J	Isoda, A; Kaira, K; Iwashina, M; Oriuchi, N; Tominaga, H; Nagamori, S; Kanai, Y; Oyama, T; Asao, T; Matsumoto, M; Sawamura, M				Isoda, Atsushi; Kaira, Kyoichi; Iwashina, Masanori; Oriuchi, Noboru; Tominaga, Hideyuki; Nagamori, Shushi; Kanai, Yoshikatsu; Oyama, Tetsunari; Asao, Takayuki; Matsumoto, Morio; Sawamura, Morio			Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma	CANCER SCIENCE			English	Article						CD98; L-type amino-acid transporter 1; melphalan; multiple myeloma; prognosis	PLASMA-CELL MYELOMA; UNDETERMINED SIGNIFICANCE; MONOCLONAL GAMMOPATHY; EMISSION-TOMOGRAPHY; COMPLETE RESPONSE; GENE-EXPRESSION; STAGING SYSTEM; LUNG-CANCER; MELPHALAN; SURVIVAL	L-type amino-acid transporter 1 (LAT1) plays a key role in cell growth and survival. To determine the prognostic significance of LAT1 in multiple myeloma (MM), we investigated the expression of LAT1 and its functional subunit, 4Fc heavy chain (CD98), on myeloma cells by immunohistochemistry in 100 newly diagnosed MM patients. High expression (moderate or strong staining intensity) of LAT1 and CD98 was detected in 56% and 45% of patients, respectively. The LAT1 expression score was positively correlated with Ki-67 index (r=0.631, P<0.001), and there was a statistically significant difference in Durie-Salmon stage between patients with high and low LAT1 expression (P=0.03). In 43 patients treated with melphalan and prednisolone, the overall response rate was significantly higher in the high LAT1 expression group (60.0%) than in the low LAT1 expression group (17.6%) (P=0.03). Multivariate analysis confirmed that high expression of LAT1 was a significant prognostic factor for predicting poor overall survival independently from the International Staging System (both P=0.01). Here, we show that the overexpression of LAT1 is significantly associated with high proliferation and poor prognosis in newly diagnosed MM patients. Thus, LAT1 may be a promising pathological marker for identifying high-risk MM.	[Isoda, Atsushi; Matsumoto, Morio; Sawamura, Morio] Natl Hosp Org Nishigunma Hosp, Dept Hematol, Gunma 3778511, Japan; [Kaira, Kyoichi; Asao, Takayuki] Gunma Univ Grad Sch Med, Dept Oncol Clin Dev, Gunma 3718511, Japan; [Iwashina, Masanori] Natl Hosp Org Nishigunma Hosp, Dept Clin Lab, Gunma 3778511, Japan; [Oriuchi, Noboru] Gunma Univ Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Gunma 3718511, Japan; [Tominaga, Hideyuki] Fukushima Med Univ, Adv Clin Res Ctr, Fukushima, Japan; [Nagamori, Shushi; Kanai, Yoshikatsu] Osaka Univ Grad Sch Med, Div Biosyst Pharmacol, Osaka, Japan; [Oyama, Tetsunari] Gunma Univ Grad Sch Med, Dept Diagnost Pathol, Gunma 3718511, Japan	Isoda, A (reprint author), Natl Hosp Org Nishigunma Hosp, Dept Hematol, 2854 Kanai, Gunma 3778511, Japan.	aisoda@netnngh.hosp.go.jp; kkaira1970@yahoo.co.jp			National Institute of Biomedical Innovation, Japan	National Institute of Biomedical Innovation, Japan	ALEXANIA.R, 1968, BLOOD, V31, P1; Wiriyasermkul P, 2012, J NUCL MED, V53, P1253, DOI 10.2967/jnumed.112.103069; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Kapoor P, 2011, LEUKEMIA, V25, P689, DOI 10.1038/leu.2010.313; Kapoor P, 2009, BLOOD, V114, P518, DOI 10.1182/blood-2009-01-202010; GREIPP PR, 1988, BLOOD, V72, P219; Ghobrial IM, 2011, LANCET ONCOL, V12, P263, DOI 10.1016/S1470-2045(11)70028-6; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Ichinoe M, 2011, PATHOL INT, V61, P281, DOI 10.1111/j.1440-1827.2011.02650.x; Bahlis NJ, 2012, BLOOD, V120, P927, DOI 10.1182/blood-2012-06-430645; Nobusawa A, 2013, EUR J NUCL MED MOL I, V40, P1692, DOI 10.1007/s00259-013-2477-9; BERGSAGEL DE, 1979, NEW ENGL J MED, V301, P743, DOI 10.1056/NEJM197910043011402; Hose D, 2011, HAEMATOL-HEMATOL J, V96, P87, DOI 10.3324/haematol.2010.030296; Gastinne T, 2007, EUR J HAEMATOL, V79, P297, DOI 10.1111/j.1600-0609.2007.00915.x; MCGIVAN JD, 1994, BIOCHEM J, V299, P321; Li RL, 2003, ANTICANCER RES, V23, P3413; Kaira K, 2008, CANCER SCI, V99, P2380, DOI 10.1111/j.1349-7006.2008.00969.x; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Shaughnessy J, 2003, BLOOD, V101, P3849, DOI 10.1182/blood-2002-09-2873; Lin J, 2004, NEOPLASIA, V6, P74; Sakata T, 2009, PATHOL INT, V59, P7, DOI 10.1111/j.1440-1827.2008.02319.x; Witte D, 2002, ANTICANCER RES, V22, P2555; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43; Zamagni E, 2011, BLOOD, V118, P5989, DOI 10.1182/blood-2011-06-361386; Alexandrakis MG, 2004, AM J CLIN ONCOL-CANC, V27, P8, DOI 10.1097/01.coc.0000045810.91816.41; Usmani SZ, 2013, BLOOD, V121, P1819, DOI 10.1182/blood-2012-08-451690; Haessler J, 2007, CLIN CANCER RES, V13, P7073, DOI 10.1158/1078-0432.CCR-07-0527; Kaira K, 2012, BRIT J CANCER, V107, P632, DOI 10.1038/bjc.2012.310; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; BLOSMANIS R, 1987, CANCER RES, V47, P1273; BOCCADORO M, 1984, BRIT J HAEMATOL, V58, P689, DOI 10.1111/j.1365-2141.1984.tb06116.x; CUZICK J, 1987, BRIT J CANCER, V55, P523, DOI 10.1038/bjc.1987.107; Goldschmidt H, 1997, BRIT J HAEMATOL, V98, P736, DOI 10.1046/j.1365-2141.1997.2783095.x; Harada N, 2000, ACTA HAEMATOL-BASEL, V103, P144, DOI 10.1159/000041037; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Isoda A, 2012, ANN NUCL MED, V26, P811, DOI 10.1007/s12149-012-0645-9; Kaira K, 2007, CLIN CANCER RES, V13, P6369, DOI 10.1158/1078-0432.CCR-07-1294; Kanai Yoshikatsu, 2003, J Toxicol Sci, V28, P1, DOI 10.2131/jts.28.1; LOKHORST HM, 1986, BRIT J HAEMATOL, V64, P271, DOI 10.1111/j.1365-2141.1986.tb04119.x; Okubo S, 2010, J NEURO-ONCOL, V99, P217, DOI 10.1007/s11060-010-0117-9; Pineda-Roman M, 2007, BRIT J HAEMATOL, V136, P393, DOI 10.1111/j.1365-2141.2006.06441.x; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; Xu JL, 2002, J CLIN PATHOL, V55, P530	47	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	NOV	2014	105	11					1496	1502		10.1111/cas.12529		7	Oncology	Oncology	AU1HL	WOS:000345371600016		
J	Yoda, T; McNamara, KM; Miki, Y; Takagi, M; Rai, Y; Ohi, Y; Sagara, Y; Tamaki, K; Hirakawa, H; Ishida, T; Suzuki, T; Ohuchi, N; Sasano, H				Yoda, Tomomi; McNamara, Keely May; Miki, Yasuhiro; Takagi, Mayu; Rai, Yoshiaki; Ohi, Yasuyo; Sagara, Yasuaki; Tamaki, Kentaro; Hirakawa, Hisashi; Ishida, Takanori; Suzuki, Takashi; Ohuchi, Noriaki; Sasano, Hironobu			Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast	CANCER SCIENCE			English	Article						Androgen; aromatase; breast cancer; estrogen; invasive lobular carcinoma	STEROID-PRODUCING ENZYMES; CELL-PROLIFERATION; IN-SITU; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-1; TUMOR CHARACTERISTICS; RECEPTOR EXPRESSION; MICROARRAY ANALYSIS; CANCER; AROMATASE; INHIBITOR	Invasive lobular carcinoma (ILC) accounts for approximately 10% of all breast carcinomas and is characterized by higher levels of androgen receptor (AR) compared to invasive ductal carcinoma (IDC). Despite this potentially androgen-responsive environment, the combined importance of AR and androgen metabolism in non-neoplastic lobules and lobular carcinoma remains unknown. Therefore, in this study, we evaluated the status of pivotal androgen-producing enzymes 17-hydroxysteroid dehydrogenase type 5 (17HSD5) and 5-reductase type 1 (5Red1) in 178 cases of ILC and surrounding histologically non-neoplastic lobular tissue using immunohistochemistry. Androgen receptor prevalence was higher but androgenic enzymes lower in ILC than non-neoplastic lobules. In ILC cases the status of 5Red1 and 17HSD5 was inversely correlated with tumor size (P=0.0053) and nuclear grade (P=0.0290), and significantly associated with better overall survival of the patients (P=0.0059). Based on these findings, we hypothesized that androgen signaling could act as a tumor suppressor. As previous studies suggested that androgens might partially act by increasing levels of the estrogen inactivating enzyme 17-hydroxysteroid dehydrogenase type 2 (17HSD2) in IDC tissues, this was reasonably considered a potential mechanism of androgen actions. Significantly positive correlation was detected between the status of androgenic enzymes and 17HSD2 (P<0.0001) and intratumoral 17HSD2 was inversely correlated with tumor size in ILC (P=0.0075). These correlations suggest one protective mode of androgen action could be through modulation of estrogen metabolism. Results of our present study indicated that androgen-producing enzymes could play pivotal protective roles in AR-enriched ILC cases.	[Yoda, Tomomi; McNamara, Keely May; Miki, Yasuhiro; Takagi, Mayu; Tamaki, Kentaro; Suzuki, Takashi; Sasano, Hironobu] Tohoku Univ Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808575, Japan; [Takagi, Mayu; Tamaki, Kentaro; Ishida, Takanori; Ohuchi, Noriaki] Tohoku Univ Grad Sch Med, Dept Surg, Sendai, Miyagi 9808575, Japan; [Rai, Yoshiaki; Ohi, Yasuyo; Sagara, Yasuaki] Social Med Corp Hakuaikai, Sagara Hosp, Kagoshima, Japan; [Tamaki, Kentaro] Nahanishi Clin, Naha, Japan; [Hirakawa, Hisashi] Tohoku Kosai Hosp, Sendai, Miyagi, Japan	McNamara, KM (reprint author), Tohoku Univ Grad Sch Med, Dept Pathol, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kmcnamara@patholo2.med.tohoku.ac.jp			Japan Society for the Promotion of Science-Australian Academy of Science postdoctoral fellowship	Keely McNamara was supported in part by a Japan Society for the Promotion of Science-Australian Academy of Science postdoctoral fellowship. We would also like to acknowledge the support and assistance of the members of the Department of Pathology, Tohoku University School of Medicine.	And S, 2002, MOL CELL ENDOCRINOL, V193, P121; Gunnarsson C, 2001, CANCER RES, V61, P8448; Suzuki T, 2005, ENDOCR-RELAT CANCER, V12, P701, DOI 10.1677/erc.1.00834; Hickey TE, 2012, MOL ENDOCRINOL, V26, P1252, DOI 10.1210/me.2012-1107; Lanzino M, 2005, J BIOL CHEM, V280, P20421, DOI 10.1074/jbc.M413576200; SILVERSTEIN MJ, 1994, CANCER, V73, P1673, DOI 10.1002/1097-0142(19940315)73:6<1673::AID-CNCR2820730620>3.0.CO;2-B; Shibuya R, 2008, ENDOCR-RELAT CANCER, V15, P113, DOI 10.1677/ERC-07-0092; Ogawa Y, 2008, INT J CLIN ONCOL, V13, P431, DOI 10.1007/s10147-008-0770-6; Wasif N, 2010, ANN SURG ONCOL, V17, P1862, DOI 10.1245/s10434-010-0953-z; Korkola JE, 2003, CANCER RES, V63, P7167; Moinfar F, 2003, CANCER, V98, P703, DOI 10.1002/cncr.11532; McNamara KM, 2013, J STEROID BIOCHEM, V133, P66, DOI 10.1016/j.jsbmb.2012.08.007; Cheng GJ, 2005, J CLIN ENDOCR METAB, V90, P435, DOI 10.1210/jc.2004-0861; Arpino G, 2004, BREAST CANCER RES, V6, pR149, DOI 10.1186/bcr767; McNamara KM, 2013, CANCER SCI, V104, P639, DOI 10.1111/cas.12121; Peters AA, 2009, CANCER RES, V69, P6131, DOI 10.1158/0008-5472.CAN-09-0452; Shibahara Y, 2013, HUM PATHOL, V44, P2338, DOI 10.1016/j.humpath.2013.04.021; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Li CI, 2000, CANCER, V88, P2561, DOI 10.1002/1097-0142(20000601)88:11<2561::AID-CNCR19>3.0.CO;2-X; Labrie F, 2003, ENDOCR REV, V24, P152, DOI 10.1210/er.2001-0031; Rakha EA, 2008, EUR J CANCER, V44, P73, DOI 10.1016/j.ejca.2007.10.009; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786; van de Water W, 2013, EUR J CANCER, V49, P297, DOI 10.1016/j.ejca.2012.07.026; Takagi K, 2013, BRIT J CANCER, V109, P100, DOI 10.1038/bjc.2013.284; POULIN R, 1988, BREAST CANCER RES TR, V12, P213, DOI 10.1007/BF01805942; Riva C, 2005, VIRCHOWS ARCH, V447, P695, DOI 10.1007/s00428-005-0003-6; Bharat A, 2009, AM J SURG, V198, P516, DOI 10.1016/j.amjsurg.2009.06.005; Biglia N, 2007, ENDOCR-RELAT CANCER, V14, P549, DOI 10.1677/ERC-06-0060; BRYAN RM, 1984, CANCER, V54, P2436, DOI 10.1002/1097-0142(19841201)54:11<2436::AID-CNCR2820541121>3.0.CO;2-H; Chanplakorn Niramol, 2011, Hormones & Cancer, V2, P73, DOI 10.1007/s12672-010-0062-2; Lapointe J, 2001, ENDOCRINOLOGY, V142, P4331, DOI 10.1210/en.142.10.4331; Metzger O, 2012, J CANC RES, V72, pS1; Montemurro F, 2013, EUR J CANCER, V49, P3376, DOI 10.1016/j.ejca.2013.06.028; RECCHIONE C, 1995, J STEROID BIOCHEM, V52, P541, DOI 10.1016/0960-0760(95)00017-T; Sasano H, 1996, J CLIN ENDOCR METAB, V81, P4042, DOI 10.1210/jc.81.11.4042; Suzuki T, 2007, INT J CANCER, V120, P285, DOI 10.1002/ijc.22317; Suzuki T, 2010, MED MOL MORPHOL, V43, P75, DOI 10.1007/s00795-010-0494-3; Takagi K, 2010, ENDOCR-RELAT CANCER, V17, P415, DOI 10.1677/ERC-09-0257; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Verma MK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-167	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	NOV	2014	105	11					1503	1509		10.1111/cas.12535		7	Oncology	Oncology	AU1HL	WOS:000345371600017		
J	Kushida, Y; Ishida, J; Fujii, M; Touma, M; Hosono, M				Kushida, Yoshihiro; Ishida, Jun-ya; Fujii, Masato; Touma, Maki; Hosono, Masamichi			Population doublings of murine CD4(+) memory T cells during continuous antigen stimulation in vivo	CELLULAR IMMUNOLOGY			English	Article						Population doublings; Memory CD4(+) T cells; In vivo culture; Serial transfer; Autoimmune gastritis	EXPERIMENTAL AUTOIMMUNE GASTRITIS; REPLICATIVE LIFE-SPAN; NEONATAL THYMECTOMY; PROGENITOR CELLS; THYMIC FUNCTION; HAYFLICK LIMIT; DONOR AGE; VITRO; MICE; TELOMERASE	We investigated the expansion rate of CD4(+) memory T cells using a newly developed in vivo system. Neonatal thymectomy abrogates the subsequent production of T cells and induces autoimmune gastritis (AIG) by the activation of CD4(+) T cells; this disease was transferred into athymic nude mice through the inoculation of splenic CD4(+) memory T cells. The transferred CD4(+) T cells increased logarithmically in number during the first 2 months in the spleen of the recipients. The serial transfer of these splenocytes at two-month intervals revealed that the numbers of the AIG-transferable generations were inversely correlated with the age of the first AIG donors. The duration of the AIG-promoting capacity of CD4(+) T cells under continuous antigenic stimulation in vivo was approximately equivalent-one and a half years. These results indicate that there exists an intrinsic population doubling limit in memory CD4(+) T cells similar to that of self-renewing naive ones. (C) 2014 Elsevier Inc. All rights reserved.	[Kushida, Yoshihiro; Ishida, Jun-ya; Fujii, Masato; Hosono, Masamichi] Niigata Univ, Grad Sch Sci & Technol, Dept Life Sci, Immunobiol Lab, Niigata 9502181, Japan; [Touma, Maki] Niigata Univ, Fac Sci, Dept Biol, Niigata 9502181, Japan	Touma, M (reprint author), Niigata Univ, Fac Sci, Dept Biol, Nishi Ku, 8050 Ikarashi 2 No Cho, Niigata 9502181, Japan.	tomaki@gs.niigata-u.ac.jp; hosono@gs.niigata-u.ac.jp			Promotion of Niigata University Education and Research Project; JSPS KAKENHI Grant [26460570]	We thank Dr. K. Hirokawa (Emeritus Prof of Tokyo Medical and Dental University) for his critical and fruitful comments and T. Saito for his artworks in our figures. This work was supported by a grant from the Promotion of Niigata University Education and Research Project, and partly by JSPS KAKENHI Grant Number 26460570 to M.T.	ADIBZADEH M, 1995, MECH AGEING DEV, V83, P171, DOI 10.1016/0047-6374(95)01625-A; Alderuccio F, 2000, INT IMMUNOL, V12, P343, DOI 10.1093/intimm/12.3.343; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; McKinstry KK, 2010, IMMUNOLOGY, V130, P1, DOI 10.1111/j.1365-2567.2010.03259.x; Douek DC, 1998, NATURE, V396, P690; MARTIN GM, 1970, LAB INVEST, V23, P86; Effros RB, 1997, IMMUNOL TODAY, V18, P450, DOI 10.1016/S0167-5699(97)01079-7; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Kaji K, 2009, HUM CELL, V22, P38, DOI 10.1111/j.1749-0774.2009.00066.x; ROHME D, 1981, P NATL ACAD SCI-BIOL, V78, P5009, DOI 10.1073/pnas.78.8.5009; Weng NP, 1998, IMMUNITY, V9, P151, DOI 10.1016/S1074-7613(00)80597-X; MITSUI Y, 1976, MECH AGEING DEV, V5, P45, DOI 10.1016/0047-6374(76)90007-5; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; Pawelec G, 1996, EXP GERONTOL, V31, P655, DOI 10.1016/S0531-5565(96)00097-6; Fujii M, 2007, J GASTROENTEROL, V42, P433, DOI 10.1007/s00535-007-2021-4; Effros RB, 2007, EXP GERONTOL, V42, P416, DOI 10.1016/j.exger.2006.11.005; De Silva HD, 1998, IMMUNOLOGY, V93, P405; Fujii M, 2014, EXP ANIM TOKYO, V63, P155; GRUBECKLOEBENSTEIN B, 1994, INT ARCH ALLERGY IMM, V104, P232; Harely C.B., 1990, NATURE, V345, P458; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Hormer R.J., 1993, INT IMMUNOL, V5, P1495; HOSONO M, 1995, MECH AGEING DEV, V78, P197, DOI 10.1016/0047-6374(94)01537-V; Hosono M., 1993, IMMUNOLOGY, V79, P392; JUCKETT DA, 1987, MECH AGEING DEV, V38, P49, DOI 10.1016/0047-6374(87)90110-2; Kushida Y, 2012, J PHYSIOL SCI, V62, P173, DOI 10.1007/s12576-012-0194-y; LY IA, 1974, J IMMUNOL METHODS, V5, P239, DOI 10.1016/0022-1759(74)90108-2; McHugh RS, 2001, EUR J IMMUNOL, V31, P2094, DOI 10.1002/1521-4141(200107)31:7<2094::AID-IMMU2094>3.0.CO;2-S; MORI Y, 1991, CLIN EXP IMMUNOL, V84, P145; NISHIO A, 1994, GASTROENTEROLOGY, V107, P1408; Pawelec G, 2002, EXP GERONTOL, V37, P265, DOI 10.1016/S0531-5565(01)00192-9; Pawelec G, 2000, BIOGERONTOLOGY, V1, P247, DOI 10.1023/A:1010086229931; PERILLO NL, 1993, EXP CELL RES, V207, P131, DOI 10.1006/excr.1993.1171; Poulin JF, 1999, J EXP MED, V190, P479, DOI 10.1084/jem.190.4.479; ROCHA B, 1983, J IMMUNOL, V131, P2158; SIMONS JWIM, 1970, GERONTOLOGY, V16, P340; Toh BH, 2000, IMMUNOL TODAY, V21, P348, DOI 10.1016/S0167-5699(00)01653-4; Valenzuela HF, 2002, CLIN IMMUNOL, V105, P117, DOI 10.1006/clim.2002.5271; Yoshida M, 2007, MICROBIOL IMMUNOL, V51, P243	39	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0008-8749	1090-2163		CELL IMMUNOL	Cell. Immunol.	NOV-DEC	2014	292	1-2					45	52		10.1016/j.cellimm.2014.09.001		8	Cell Biology; Immunology	Cell Biology; Immunology	AU3RF	WOS:000345530600008		
J	Ikegami, S; Takano, K; Kondo, K; Saeki, N; Kansaku, K				Ikegami, Shiro; Takano, Kouji; Kondo, Kiyohiko; Saeki, Naokatsu; Kansaku, Kenji			A region-based two-step P300-based brain-computer interface for patients with amyotrophic lateral sclerosis	CLINICAL NEUROPHYSIOLOGY			English	Article						BCI; BMI; P300; Visual stimuli; Amyotrophic lateral sclerosis	P300 SPELLER PARADIGM; AGE-RELATED-CHANGES; PARALYZED PATIENTS; MENTAL PROSTHESIS; STIMULUS INTERVAL; BCI; COMMUNICATION; PERFORMANCE; POTENTIALS; MOVEMENT	Objective: The P300-based brain-computer interface (BCI) is designed to help patients with motor disabilities to control their environment, and it has been used successfully in patients with amyotrophic lateral sclerosis (ALS). However, some ALS patients were unable to use the visual P300-BCI with the conventional row/column presentation. In this study, we evaluated the effect of a newly developed region-based two-step P300 speller, which has a larger flashing area than the conventional visual array. Methods: Seven ALS patients and seven age- and sex-matched able-bodied control subjects were required to input hiragana characters using our P300 BCI system. We prepared two types of input procedures, the conventional row/column (RC) speller and the two-step speller, and evaluated their online performance. Results: The mean online accuracy of the ALS patients was 24% for the RC condition and 55% for the two-step condition. The accuracy of the control subjects was 71% and 83% for the RC and two-step condition, respectively. Accuracy in ALS patients was significantly lower than that in the control subjects, and the new visual stimuli significantly increased accuracy of ALS patients. Using the new speller, two ALS patients showed an initial accuracy sufficient for practical use (>70%). The other two ALS patients, who performed better in the first trial using the new speller, continued to experience the BCI system, and their mean accuracy increased to 92%. Conclusions: The two-step procedure for the visual P300 BCI system provided significantly increased accuracy for ALS patients compared with a conventional RC speller. Significance: The new region-based two-step P300 speller was effective in ALS patients, and the system may be beneficial to expand their range of activities. (C) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Ikegami, Shiro; Takano, Kouji; Kansaku, Kenji] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Brain Funct, Syst Neurosci Sect, Tokorozawa, Saitama 3598555, Japan; [Ikegami, Shiro; Saeki, Naokatsu] Chiba Univ, Grad Sch Med, Dept Neurol Surg, Chiba 2608670, Japan; [Kondo, Kiyohiko] Yoka Hosp, Dept Neurol, Yabu, Hyogo 6678555, Japan; [Saeki, Naokatsu] Chiba Univ, Ctr Frontier Med Engn, Chiba 2630022, Japan; [Kansaku, Kenji] Univ Electrocommun, Brain Sci Inspired Life Support Res Ctr, Tokyo 1828585, Japan	Kansaku, K (reprint author), Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Brain Funct, Syst Neurosci Sect, 4-1 Namiki, Tokorozawa, Saitama 3598555, Japan.	kansaku-kenji@rehab.go.jp			Ministry of Health, Labor and Welfare of Japan	This study was partially supported by a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan to K. K. We thank Drs. T. Komatsu, N. Nagao, M. Yoneda, and T. Togaki for their help and Dr. Y. Nakajima for his continuous encouragement.	Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Fjell AM, 2001, BRAIN TOPOGR, V14, P25, DOI 10.1023/A:1012563605837; Piccione F, 2006, CLIN NEUROPHYSIOL, V117, P531, DOI 10.1016/j.clinph.2005.07.024; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Kaufmann T, 2013, CLIN NEUROPHYSIOL, V124, P893, DOI 10.1016/j.clinph.2012.11.006; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Ikegami S, 2011, CLIN NEUROPHYSIOL, V122, P991, DOI 10.1016/j.clinph.2010.08.021; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Friedman D, 1997, EVOKED POTENTIAL, V104, P498, DOI 10.1016/S0168-5597(97)00036-1; Kaper M, 2004, IEEE T BIO-MED ENG, V51, P1073, DOI 10.1109/TBME.2004.826698; Allison BZ, 2008, CLIN NEUROPHYSIOL, V119, P399, DOI 10.1016/j.clinph.2007.09.121; Sellers EW, 2006, BIOL PSYCHOL, V73, P242, DOI 10.1016/j.biopsycho.2006.04.007; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Yanagisawa T, 2012, ANN NEUROL, V71, P353, DOI 10.1002/ana.22613; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; Zickler C, 2011, CLIN EEG NEUROSCI, V42, P236; Fazel-Rezai R, 2007, P ANN INT IEEE EMBS, P2516, DOI 10.1109/IEMBS.2007.4352840; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Kubler A, 1999, EXP BRAIN RES, V124, P223, DOI 10.1007/s002210050617; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Takano K, 2009, NEUROSCI RES, V65, pS182, DOI 10.1016/j.neures.2009.09.971; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; PICTON TW, 1984, PSYCHOPHYSIOLOGY, V21, P312, DOI 10.1111/j.1469-8986.1984.tb02941.x; Takano K, 2009, CLIN NEUROPHYSIOL, V120, P1562, DOI 10.1016/j.clinph.2009.06.002; Brunner P, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00005; Cedarbaum JM, 1997, J NEUROL SCI, V152, pS1, DOI 10.1016/S0022-510X(97)00237-2; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Fazel-Rezai R, 2008, IEEE ENG MED BIO, P1147, DOI 10.1109/IEMBS.2008.4649364; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Ikegami Shiro, 2012, Front Neurol, V3, P113, DOI 10.3389/fneur.2012.00113; Jarmolowska J, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00039; Krusienski DJ, 2011, NEUROREHAB NEURAL RE, V25, P323, DOI 10.1177/1545968310382425; Leuthardt Eric C, 2004, J Neural Eng, V1, P63, DOI 10.1088/1741-2560/1/2/001; Martens SMM, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/026003; McCane L, 2009, NEUR M PLANN 2009; Müller-Putz Gernot R, 2005, J Neural Eng, V2, P123, DOI 10.1088/1741-2560/2/4/008; POLICH J, 1987, ELECTROEN CLIN NEURO, V68, P311, DOI 10.1016/0168-5597(87)90052-9; Sellers E, 2003, 43 ANN M SOC PSYCH R; Silvoni Stefano, 2009, Front Neurosci, V3, P60, DOI 10.3389/neuro.20.001.2009; Suzuki Taka-Aki, 2006, Journal of Physiological Anthropology and Applied Human Science, V25, P179, DOI 10.2114/jpa2.25.179; Toyama Shigeru, 2012, Front Neurol, V3, P114, DOI 10.3389/fneur.2012.00114; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28	53	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	NOV	2014	125	11					2305	2312		10.1016/j.clinph.2014.03.013		8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AU3NE	WOS:000345519600018		
J	Kadokura, T; Zhang, WH; Krauwinkel, W; Leeflang, S; Keirns, J; Taniuchi, Y; Nakajo, I; Smulders, R				Kadokura, Takeshi; Zhang, Wenhui; Krauwinkel, Walter; Leeflang, Stefanie; Keirns, James; Taniuchi, Yuta; Nakajo, Ikumi; Smulders, Ronald			Clinical Pharmacokinetics and Pharmacodynamics of the Novel SGLT2 Inhibitor Ipragliflozin	CLINICAL PHARMACOKINETICS			English	Review							GLUCOSE COTRANSPORTER 2; TYPE-2 DIABETES-MELLITUS; DOUBLE-BLIND; SELECTIVE INHIBITOR; JAPANESE PATIENTS; HEALTHY-SUBJECTS; ASP1941; PROFILE; MANAGEMENT; METFORMIN	Ipragliflozin (Suglat (R)) is a potent and selective inhibitor of sodium-glucose cotransporter-2 that was recently launched in Japan. Its mechanism of action involves the suppression of glucose re-absorption in the kidney proximal tubules, causing excretion of glucose in the urine. The aim of this review is to provide a comprehensive overview of currently available pharmacokinetic and pharmacodynamic data on ipragliflozin, including studies in healthy subjects, patients with type 2 diabetes mellitus and special populations. In single-and multiple-dose studies, the maximum plasma concentration and area under the plasma concentration-time curve (AUC) for ipragliflozin increased in a dose-dependent manner. Although urinary excretion of ipragliflozin is low (approximately 1 %), tubular concentration of free ipragliflozin is adequate to provide pharmacological activities. No clinically relevant effects of age, gender or food on the exposure of ipragliflozin were observed. The AUC for ipragliflozin was 20-30 % greater in patients with moderate renal or hepatic impairment than in patients with normal renal or hepatic function. In drug-drug interaction studies, the pharmacokinetics of ipragliflozin and other oral antidiabetic drugs (metformin, sitagliptin, pioglitazone, glimepiride, miglitol and mitiglinide) were not significantly affected by their co-administration. Urinary glucose excretion (UGE) also increased in a dose-dependent manner, approaching a maximum effect at 50-100 mg dosages in Japanese healthy volunteers and patients with type 2 diabetes. The change in UGE from baseline (Delta UGE) tended to be lower in older subjects and female subjects, compared with younger subjects and male subjects, respectively. Delta UGE tended to decrease with decreasing renal function, especially in patients with type 2 diabetes with moderate or severe renal impairment.	[Kadokura, Takeshi; Taniuchi, Yuta; Nakajo, Ikumi] Astellas Pharma Inc, Global Dev, Clin Pharmacol, Tokyo, Japan; [Zhang, Wenhui; Keirns, James] Astellas Pharma Global Dev, Global Clin Pharmacol & Exploratory Dev, Northbrook, IL USA; [Krauwinkel, Walter; Leeflang, Stefanie; Smulders, Ronald] Astellas Pharma Global Dev, Global Clin Pharmacol & Exploratory Dev, Leiden, Netherlands	Kadokura, T (reprint author), Astellas Pharma Inc, Global Dev, Clin Pharmacol, Tokyo, Japan.	takeshi.kadokura@astellas.com			Astellas	Ipragliflozin is under development by Astellas Pharma Inc. and Kotobuki Pharmaceutical Co., Ltd. This study was sponsored by Astellas. Medical writing and editorial support was funded by Astellas and provided by Dr. Nicholas D. Smith, Helen Roberton and ELMCOM (TM).	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; [Anonymous], 2005, ICH TOP E14 CLIN EV; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; MOGENSEN CE, 1971, SCAND J CLIN LAB INV, V28, P101, DOI 10.3109/00365517109090668; Abdul-Ghani MA, 2013, DIABETES, V62, P3324, DOI 10.2337/db13-0604; Bakris GL, 2009, KIDNEY INT, V75, P1272, DOI 10.1038/ki.2009.87; Scheen AJ, 2014, CLIN PHARMACOKINET, V53, P295, DOI 10.1007/s40262-013-0128-8; Nair S, 2010, J CLIN ENDOCR METAB, V95, P34, DOI 10.1210/jc.2009-0473; Ferrannini E, 2013, DIABETES CARE, V36, P1260, DOI 10.2337/dc12-1503; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Wilding JPH, 2013, DIABETES OBES METAB, V15, P403, DOI 10.1111/dom.12038; FARBER SJ, 1951, J CLIN INVEST, V30, P125, DOI 10.1172/JCI102424; Schwartz SL, 2011, DIABETES TECHNOL THE, V13, P1219, DOI 10.1089/dia.2011.0012; Tahara A, 2012, N-S ARCH PHARMACOL, V385, P423, DOI 10.1007/s00210-011-0713-z; Kasichayanula S, 2014, CLIN PHARMACOKINET, V53, P17, DOI 10.1007/s40262-013-0104-3; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Imamura M, 2012, BIOORGAN MED CHEM, V20, P3263, DOI 10.1016/j.bmc.2012.03.051; Levey AS, 1999, ANN INTERN MED, V130, P461; Smulders RA, 2012, DIABETES OBES METAB, V14, P937, DOI 10.1111/j.1463-1326.2012.01624.x; Scheen AJ, 2014, CLIN PHARMACOKINET, V53, P213, DOI 10.1007/s40262-013-0126-x; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10; Veltkamp SA, 2011, CLIN DRUG INVEST, V31, P839, DOI 10.2165/11594330-000000000-00000; Fujita E, 2011, 25 2011 AAPS ANN M E; International Diabetes Federation, GLOB GUID TYP 2 DIAB; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI [10.2337/dc12-0413, 10.2337/dc12-041.3]; Kadokura T, 2014, DIABETES RES CLIN PR, V106, P50, DOI 10.1016/j.diabres.2014.07.020; Kadokura T, 2011, DIABETOL INT, V2, P172, DOI DOI 10.1007/S13340-011-0037-8; Kashiwagi A, 2015, DIABETOL INT, V6, P104, DOI 10.1007/s13340-014-0182-y; Kashiwagi A, 2014, J DIABETES INVEST, V5, P382, DOI 10.1111/jdi.12156; Kashiwagi A, 2015, DIABETOL INT, V6, P125, DOI 10.1007/s13340-014-0184-9; Kashiwagi A, 2015, DIABETES OBES METAB, V17, P304, DOI 10.1111/dom.12331; Kashiwagi A, 2015, DIABETOL INT, V6, P8, DOI 10.1007/s13340-014-0164-0; Kawano H, 2012, 72 SCI SESS AM DIAB; Kitasato L, 2012, CARDIOVASC DIABETOL, V29, P11; Kuboyama Noboru, 2006, Folia Pharmacologica Japonica, V127, P223, DOI 10.1254/fpj.127.223; Nakajo I, 2012, ANN M AM SOC CLIN PH; Smulders R, 2011, 47 ANN M EUR ASS STU; Takahashi H, 2014, 57 ANN M JAP DIAB SO; Toyoshima J, 2014, 57 ANN M JAP DIAB SO; Ushigome F, 2011, 25 2011 AAPS ANN M E; Veltkamp SA, 2011, 71 SCI SESS AM DIAB; Veltkamp SA, 2012, CLIN THER, V34, P1761, DOI 10.1016/j.clinthera.2012.06.027; Zhang WH, 2013, CLIN DRUG INVEST, V33, P489, DOI 10.1007/s40261-013-0089-6; Zhang WH, 2013, CLIN THER, V35, P1150, DOI 10.1016/j.clinthera.2013.06.009	44	7	7	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0312-5963	1179-1926		CLIN PHARMACOKINET	Clin. Pharmacokinet.	NOV	2014	53	11					975	988		10.1007/s40262-014-0180-z		14	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU1OJ	WOS:000345389700002		
J	Zhang, LQ; Zeng, Z; Xie, HQ; Tao, XT; Zhang, YX; Lu, YY; Yoshikawa, A; Kawazoe, Y				Zhang, Liangqi; Zeng, Zhong; Xie, Haiqiong; Tao, Xutang; Zhang, Yongxiang; Lu, Yiyu; Yoshikawa, Akira; Kawazoe, Yoshiyuki			An alternative lattice Boltzmann model for three-dimensional incompressible flow	COMPUTERS & MATHEMATICS WITH APPLICATIONS			English	Article						Lattice Boltzmann model; Incompressible flow; Hermite tensorial polynomials; Deviatoric stress	NAVIER-STOKES EQUATION; BACKWARD-FACING STEP; BOUNDARY-CONDITIONS; CAVITY FLOW; SIMULATIONS	In this work, an alternative lattice Boltzmann (LB) model for three-dimensional (3D) incompressible flow is proposed. The equilibrium distribution function CEDE) of the present model is directly derived in accordance with the incompressibility conditions by applying the Hermite expansion. Moreover, an alternative formula for pressure computation is designed from the second order moment of the distribution function. The present 3D LB model inherits the advantageous features of Guo's LB model: the density is a constant, the fluid pressure is independent of density and the Navier-Stokes (N-S) equations for incompressible flow can be derived. Two benchmark tests, flow over a backward-facing step and the lid-driven cavity flow, are applied to validate the present model. Accurate results for these tests are obtained with the present model, and further comparisons with the previous LB models (the standard LB model, the He-Luo model and Guo's LB model) demonstrate that the present model provides better accuracy in the region of high deviatoric stress and such advantage is further enhanced by using the D3Q27 lattice. (C) 2014 Elsevier Ltd. All rights reserved.	[Zhang, Liangqi; Zeng, Zhong; Xie, Haiqiong; Zhang, Yongxiang] Chongqing Univ, Dept Engn Mech, Coll Aerosp Engn, Chongqing 400044, Peoples R China; [Zhang, Liangqi; Zeng, Zhong; Xie, Haiqiong; Lu, Yiyu] Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing 400044, Peoples R China; [Tao, Xutang] Shandong Univ, State Key Lab Crystal Mat, Jinan 250100, Peoples R China; [Yoshikawa, Akira] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Kawazoe, Yoshiyuki] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9808579, Japan	Zeng, Z (reprint author), Chongqing Univ, Dept Engn Mech, Coll Aerosp Engn, Chongqing 400044, Peoples R China.	zzeng@cqu.edu.cn	Yoshikawa, Akira/B-9986-2011		Program for Changjiang Scholars and Innovative Research Team in University [IRT13043]; Fundamental Research Funds for the Central Universities [CDJXS12240003, CDJXS10241103]; Sichuan Provincial Key Lab of Process Equipment and Control, China [GK201208]	This work is financially supported by Program for Changjiang Scholars and Innovative Research Team in University (No. IRT13043), and the Fundamental Research Funds for the Central Universities (No. CDJXS12240003 and No. CDJXS10241103), and the author Yongxiang Zhang is grateful for the support from Sichuan Provincial Key Lab of Process Equipment and Control, China (No. GK201208).	GRAD H, 1949, COMMUN PUR APPL MATH, V2, P331, DOI 10.1002/cpa.3160020403; Wu J, 2010, J COMPUT PHYS, V229, P5022, DOI 10.1016/j.jcp.2010.03.024; Erturk E, 2008, COMPUT FLUIDS, V37, P633, DOI 10.1016/j.compfluid.2007.09.003; Abe T, 1997, J COMPUT PHYS, V131, P241, DOI 10.1006/jcph.1996.5595; Yu DZ, 2002, INT J NUMER METH FL, V39, P99, DOI 10.1002/fld.280; Guo ZL, 2002, CHINESE PHYS, V11, P366, DOI 10.1088/1009-1963/11/4/310; GRAD H, 1949, COMMUN PUR APPL MATH, V2, P325, DOI 10.1002/cpa.3160020402; He XY, 1997, J STAT PHYS, V88, P927, DOI 10.1023/B:JOSS.0000015179.12689.e4; Lallemand P, 2000, PHYS REV E, V61, P6546, DOI 10.1103/PhysRevE.61.6546; Chen SY, 1996, PHYS FLUIDS, V8, P2527, DOI 10.1063/1.869035; SHAN XW, 1993, PHYS REV E, V47, P1815, DOI 10.1103/PhysRevE.47.1815; Dellar PJ, 2003, J COMPUT PHYS, V190, P351, DOI 10.1016/S0021-9991(03)00279-1; Lallemand P, 2003, J COMPUT PHYS, V184, P406, DOI 10.1016/S0021-9991(02)00022-0; Verschaeve JCG, 2010, J COMPUT PHYS, V229, P6781, DOI 10.1016/j.jcp.2010.05.022; Ding H, 2006, COMPUT METHOD APPL M, V195, P516, DOI 10.1016/j.cma.2005.02.006; HOU SL, 1995, J COMPUT PHYS, V118, P329, DOI 10.1006/jcph.1995.1103; BHATNAGAR PL, 1954, PHYS REV, V94, P511, DOI 10.1103/PhysRev.94.511; Luo LS, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056710; Yu DZ, 2003, PROG AEROSP SCI, V39, P329, DOI 10.1016/S0376-0421(03)00003-4; Lee T, 2010, J COMPUT PHYS, V229, P8045, DOI 10.1016/j.jcp.2010.07.007; Junk M, 2001, NUMER METH PART D E, V17, P383, DOI 10.1002/num.1018; He XY, 1997, PHYS REV E, V56, P6811, DOI 10.1103/PhysRevE.56.6811; QIAN YH, 1992, EUROPHYS LETT, V17, P479, DOI 10.1209/0295-5075/17/6/001; Guo ZL, 2000, J COMPUT PHYS, V165, P288, DOI 10.1006/jcph.2000.6616; Albensoeder S, 2005, J COMPUT PHYS, V206, P536, DOI 10.1016/j.jcp.2004.12.024; Mei R, 2000, J COMPUT PHYS, V161, P680, DOI 10.1006/jcph.2000.6522; Wu J, 2011, J COMPUT PHYS, V230, P2246, DOI 10.1016/j.jcp.2010.12.013; SHAN XW, 1994, PHYS REV E, V49, P2941, DOI 10.1103/PhysRevE.49.2941; Neumann P, 2013, COMPUT MECH, V51, P237, DOI 10.1007/s00466-012-0721-y; Chapman S., 1970, MATH THEORY NONUNIFO; Chen Y, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.026707; Fadel H., 2009, INT J NUMER METHODS, P1; GARTLING DK, 1990, INT J NUMER METH FL, V11, P953, DOI 10.1002/fld.1650110704; Junk M, 2000, SIAM J SCI COMPUT, V22, P1, DOI 10.1137/S1064827599357188; LADD AJC, 1994, J FLUID MECH, V271, P285, DOI 10.1017/S0022112094001771; Lin ZF, 1996, PHYS REV E, V54, P6323, DOI 10.1103/PhysRevE.54.6323; Yong WA, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.065701; Peng C., 2011, THESIS EPFL; Rahmati A R, 2009, Journal of Applied Fluid Mechanics, V2; ZOU QS, 1995, J STAT PHYS, V81, P35, DOI 10.1007/BF02179966	40	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0898-1221	1873-7668		COMPUT MATH APPL	Comput. Math. Appl.	NOV	2014	68	10					1107	1122		10.1016/j.camwa.2014.08.009		16	Mathematics, Applied	Mathematics	AU2WO	WOS:000345475600003		
J	Zhang, LQ; Zeng, Z; Xie, HQ; Zhang, YX; Lu, YY; Yoshikawa, A; Mizuseki, H; Kawazoe, Y				Zhang, Liangqi; Zeng, Zhong; Xie, Haiqiong; Zhang, Yongxiang; Lu, Yiyu; Yoshikawa, Akira; Mizuseki, Hiroshi; Kawazoe, Yoshiyuki			A comparative study of lattice Boltzmann models for incompressible flow	COMPUTERS & MATHEMATICS WITH APPLICATIONS			English	Article						Lattice Boltzmann model; Incompressible flow; Deviatoric stress; Finite difference stencils	NAVIER-STOKES EQUATION; EXTRAPOLATION METHOD; BOUNDARY-CONDITIONS; VELOCITY	For incompressible flow, a comparative study on the four lattice Boltzmann (LB) models, the standard model, the He-Luo model, Guo's model, and the present model, is performed. Theoretically, the macroscopic equations derived from the involved LB models are compared by the Chapman-Enskog analysis. Then, the analytical framework proposed in M. Junk's work is applied to investigate the finite difference stencils and the equivalent moment systems pertaining to the concerned LB models. Conclusions are drawn from the theoretical derivations that the truncated error terms, which differ among the concerned LB models, have effects on the accuracy of the modeled deviatoric stress. Moreover, the cavity flow in two dimensions is adopted as a benchmark test to confirm the theoretical demonstrations. The resulting velocity fields from the present model are more in line with the reference solutions in the region of high deviatoric stress than other three LB models, which is consistent with the theoretical expectations and is further confirmed by the comparisons of the truncation error terms. In addition, we also conclude from the numerical tests that the present model has the advantage of better convergence efficiency but suffers from the worse stability. (C) 2014 Elsevier Ltd. All rights reserved.	[Zhang, Liangqi; Zeng, Zhong; Xie, Haiqiong; Zhang, Yongxiang] Chongqing Univ, Coll Aerosp Engn, Dept Engn Mech, Chongqing 400044, Peoples R China; [Zhang, Liangqi; Lu, Yiyu] Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing 400044, Peoples R China; [Zeng, Zhong] Shandong Univ, State Key Lab Crystal Mat, Jinan 250100, Peoples R China; [Yoshikawa, Akira; Mizuseki, Hiroshi] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Kawazoe, Yoshiyuki] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9808579, Japan	Zeng, Z (reprint author), Chongqing Univ, Coll Aerosp Engn, Dept Engn Mech, Chongqing 400044, Peoples R China.	zzeng@cqu.edu.cn	Mizuseki, Hiroshi/A-8891-2011; Yoshikawa, Akira/B-9986-2011	Mizuseki, Hiroshi/0000-0003-0973-7693; 	Program for Changjiang Scholars and Innovative Research Team in University [IRT13043]; Fundamental Research Funds for the Central Universities [CDJZR13248801]; Sichuan Provincial Key Lab of Process Equipment and Control [GK201208]; Russian Megagrant Project [14.B25.31.0030]	This work is supported financially by Program for Changjiang Scholars and Innovative Research Team in University (No. IRT13043) and the Fundamental Research Funds for the Central Universities (No. CDJZR13248801). Yongxiang Zhang is grateful for the support from Sichuan Provincial Key Lab of Process Equipment and Control (No. GK201208) and Y. Kawazoe thanks the Russian Megagrant Project (No. 14.B25.31.0030) "New energy technologies and energy carriers" for supporting the present research. We also wish to thank the anonymous reviewers for their constructive comments and helpful suggestions.	GRAD H, 1949, COMMUN PUR APPL MATH, V2, P331, DOI 10.1002/cpa.3160020403; Wu J, 2010, J COMPUT PHYS, V229, P5022, DOI 10.1016/j.jcp.2010.03.024; Du R, 2006, PHYS LETT A, V359, P564, DOI 10.1016/j.physleta.2006.07.074; Yu DZ, 2002, INT J NUMER METH FL, V39, P99, DOI 10.1002/fld.280; Guo ZL, 2002, CHINESE PHYS, V11, P366, DOI 10.1088/1009-1963/11/4/310; Dellar PJ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036309; GRAD H, 1949, COMMUN PUR APPL MATH, V2, P325, DOI 10.1002/cpa.3160020402; BENZI R, 1992, PHYS REP, V222, P145, DOI 10.1016/0370-1573(92)90090-M; He XY, 1997, J STAT PHYS, V88, P927, DOI 10.1023/B:JOSS.0000015179.12689.e4; Lallemand P, 2000, PHYS REV E, V61, P6546, DOI 10.1103/PhysRevE.61.6546; Dellar PJ, 2001, PHYS REV E, V64, part. no., DOI 10.1103/PhysRevE.64.031203; Dellar PJ, 2003, J COMPUT PHYS, V190, P351, DOI 10.1016/S0021-9991(03)00279-1; HIGUERA FJ, 1989, EUROPHYS LETT, V9, P663, DOI 10.1209/0295-5075/9/7/009; HOU SL, 1995, J COMPUT PHYS, V118, P329, DOI 10.1006/jcph.1995.1103; Junk M, 2005, J COMPUT PHYS, V210, P676, DOI 10.1016/j.jcp.2005.05.003; Shan XW, 2006, J FLUID MECH, V550, P413, DOI 10.1017/S0022112005008153; Luo LS, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056710; MCNAMARA GR, 1988, PHYS REV LETT, V61, P2332, DOI 10.1103/PhysRevLett.61.2332; Yu DZ, 2003, PROG AEROSP SCI, V39, P329, DOI 10.1016/S0376-0421(03)00003-4; Ginzbourg I, 1996, J STAT PHYS, V84, P927, DOI 10.1007/BF02174124; Junk M, 2001, NUMER METH PART D E, V17, P383, DOI 10.1002/num.1018; He XY, 1997, PHYS REV E, V56, P6811, DOI 10.1103/PhysRevE.56.6811; QIAN YH, 1992, EUROPHYS LETT, V17, P479, DOI 10.1209/0295-5075/17/6/001; Guo ZL, 2000, J COMPUT PHYS, V165, P288, DOI 10.1006/jcph.2000.6616; Montessori A, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.053317; HIGUERA FJ, 1989, EUROPHYS LETT, V8, P517, DOI 10.1209/0295-5075/8/6/005; Shan XW, 1998, PHYS REV LETT, V80, P65, DOI 10.1103/PhysRevLett.80.65; Wu J, 2011, J COMPUT PHYS, V230, P2246, DOI 10.1016/j.jcp.2010.12.013; HIGUERA FJ, 1989, EUROPHYS LETT, V9, P345, DOI 10.1209/0295-5075/9/4/008; Caiazzo A, 2009, COMPUT MATH APPL, V58, P883, DOI 10.1016/j.camwa.2009.02.011; Chapman S., 1970, MATH THEORY NONUNIFO; Chen Y, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.026707; d'Humieres D, 1992, PROGR ASTRONAUTICS A, V159, P450; Frisch U., 1987, Complex Systems, V1; GHIA U, 1982, J COMPUT PHYS, V48, P387, DOI 10.1016/0021-9991(82)90058-4; Guo Z. L., 2009, THEORY APPL LATTICE; Guo ZL, 2002, PHYS FLUIDS, V14, P2007, DOI 10.1063/1.1471914; He YL, 2009, LATTICE BOLTZMANN ME; Junk M, 2000, SIAM J SCI COMPUT, V22, P1, DOI 10.1137/S1064827599357188; Latt J., 2007, THESIS; Lin ZF, 1996, PHYS REV E, V54, P6323, DOI 10.1103/PhysRevE.54.6323; Montessori A, 2014, INT J MOD PHYS C, V25, DOI 10.1142/S0129183114410034; Peng C., 2011, THESIS EPFL; Succi S., 2001, LATTICE BOLTZMANN EQ; ZOU QS, 1995, J STAT PHYS, V81, P35, DOI 10.1007/BF02179966	45	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0898-1221	1873-7668		COMPUT MATH APPL	Comput. Math. Appl.	NOV	2014	68	10					1446	1466		10.1016/j.camwa.2014.09.010		21	Mathematics, Applied	Mathematics	AU2WO	WOS:000345475600026		
J	Sato, W; Kochiyama, T; Uono, S; Matsuda, K; Usui, K; Inoue, Y; Toichi, M				Sato, Wataru; Kochiyama, Takanori; Uono, Shota; Matsuda, Kazumi; Usui, Keiko; Inoue, Yushi; Toichi, Motomi			Rapid, high-frequency, and theta-coupled gamma oscillations in the inferior occipital gyrus during face processing	CORTEX			English	Article						Face; Gamma oscillation; Inferior occipital gyrus; Intracranial field potential recording; Phase-amplitude cross-frequency coupling	HUMAN EXTRASTRIATE CORTEX; UPSIDE-DOWN FACES; HUMAN BRAIN; FUSIFORM GYRUS; OCCIPITOTEMPORAL CORTEX; PERCEPTION; RECOGNITION; PROSOPAGNOSIA; RESPONSES; STIMULI	Neuroimaging studies have found greater activation in the inferior occipital gyrus (IOG), or occipital face area, in response to faces relative to non-facial stimuli. However, the temporal, frequency, and functional profiles of IOG activity during face processing remain unclear. Here, this issue was investigated by recording intracranial field potentials in the JOG during the presentation of faces, mosaics, and houses in upright and inverted orientations. Time frequency statistical parametric mapping analyses revealed greater gamma-band activation in the TOG beginning at 110 msec and covering 40-300 Hz in response to upright faces relative to upright houses and mosaics. Phase amplitude cross-frequency coupling analyses revealed more evident theta gamma couplings at 115-256 msec during the processing of upright faces as compared with that of upright houses and mosaics. Comparable gamma-band activity was observed during the processing of inverted and upright faces at about 100-200 msec, but weaker activity and different coupling with theta-band activity after 200 msec. These patterns of activity were more evident in the right than in the left IOG. These results, together with other evidence on neural communication, suggest that broadband gamma oscillations in the right IOG conduct rapid and multistage (i.e., both featural and configural) face processing in collaboration with theta oscillations transmitted from other brain regions. (C) 2014 Elsevier Ltd. All rights reserved.	[Sato, Wataru; Kochiyama, Takanori] Kyoto Univ, Primate Res Inst, Hakubi Project, Inuyama, Aichi 4848506, Japan; [Uono, Shota; Toichi, Motomi] Kyoto Univ, Fac Human Hlth Sci, Inuyama, Aichi 4848506, Japan; [Matsuda, Kazumi; Usui, Keiko; Inoue, Yushi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka, Japan	Sato, W (reprint author), Kyoto Univ, Primate Res Inst, Hakubi Project, Inuyama, Aichi 4848506, Japan.	sato.wataru.4v@kyoto-u.ac.jp			Benesse Corporation; Organization for Promoting Research in Developmental Disorders; JSPS [LZ008]	This study was supported by funds from the Benesse Corporation, the Organization for Promoting Research in Developmental Disorders, and JSPS Funding Program for Next Generation World-Leading Researchers (No. LZ008).	Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459; Barton JJS, 2003, NEUROLOGY, V61, P220; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Davies-Thompson J, 2012, J NEUROPHYSIOL, V108, P3087, DOI 10.1152/jn.01171.2011; Voytek B, 2013, NEUROIMAGE, V64, P416, DOI 10.1016/j.neuroimage.2012.09.023; Sato W, 2011, NEUROPSYCHOLOGIA, V49, P612, DOI 10.1016/j.neuropsychologia.2010.12.025; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Klopp J, 1999, CLIN NEUROPHYSIOL, V110, P676, DOI 10.1016/S1388-2457(98)00039-X; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Liao SC, 2013, IEEE T PATTERN ANAL, V35, P1193, DOI 10.1109/TPAMI.2012.191; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1&lt;58::AID-HBM4&gt;3.0.CO;2-O; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; Kingstone A, 2000, PSYCHOL SCI, V11, P159, DOI 10.1111/1467-9280.00232; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Pitcher D, 2011, EXP BRAIN RES, V209, P481, DOI 10.1007/s00221-011-2579-1; LANGDELL T, 1978, J CHILD PSYCHOL PSYC, V19, P255, DOI 10.1111/j.1469-7610.1978.tb00468.x; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Liebe S, 2012, NAT NEUROSCI, V15, P456, DOI 10.1038/nn.3038; Kilner JM, 2005, NEUROSCI LETT, V374, P174, DOI 10.1016/j.neutlet.2004.10.052; Shin YW, 2008, SCHIZOPHRENIA BULL, V34, P538, DOI 10.1093/schbul/sbm118; Jonas J, 2012, NEUROSCIENCE, V222, P281, DOI 10.1016/j.neuroscience.2012.07.021; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Berens P, 2009, J STAT SOFTW, V31, P1; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037//0096-1523.21.3.628; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Rossion B, 2008, NEUROIMAGE, V40, P423, DOI 10.1016/j.neuroimage.2007.10.047; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Bouvier SE, 2006, CEREB CORTEX, V16, P183, DOI 10.1093/cercor/bhi096; Oswal A, 2012, J NEUROSCI, V32, P9909, DOI 10.1523/JNEUROSCI.0275-12.2012; Joseph JE, 2006, COGN AFFECT BEHAV NE, V6, P223, DOI 10.3758/CABN.6.3.223; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Tort ABL, 2013, PROG NEUROBIOL, V100, P1, DOI 10.1016/j.pneurobio.2012.09.002; Herrmann CS, 2010, NEUROSCI BIOBEHAV R, V34, P981, DOI 10.1016/j.neubiorev.2009.09.001; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; Rutishauser U, 2013, NEURON, V80, P887, DOI 10.1016/j.neuron.2013.08.029; Friston KJ, 2002, NEUROIMAGE, V16, P465, DOI 10.1006/nimg.2002.1090; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Edwards E, 2009, J NEUROPHYSIOL, V102, P377, DOI 10.1152/jn.90954.2008; Kirihara K, 2012, BIOL PSYCHIAT, V71, P873, DOI 10.1016/j.biopsych.2012.01.016; Edwards E, 2005, J NEUROPHYSIOL, V94, P4269, DOI 10.1152/jn.00324.2005; Litvak V, 2011, COMPUT INTEL NEUROSC, DOI 10.1155/2011/852961; Lachaux JP, 2003, J PHYSIOLOGY-PARIS, V97, P613, DOI 10.1016/j.jphysparis.2004.01.018; Mukamel R, 2012, ANNU REV PSYCHOL, V63, P511, DOI 10.1146/annurev-psych-120709-145401; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Sato W, 2012, J COGNITIVE NEUROSCI, V24, P1420, DOI 10.1162/jocn_a_00142; Gao ZF, 2013, HUM BRAIN MAPP, V34, P1783, DOI 10.1002/hbm.22028; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Kilner JM, 2010, ANN APPL STAT, V4, P1272, DOI 10.1214/10-AOAS337; Liu J, 2010, J COGNITIVE NEUROSCI, V22, P203, DOI 10.1162/jocn.2009.21203; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Bartlett J., 2003, PERCEPTION FACES OBJ, P21; Barton J. J., 2002, NEUROLOGY, V58, P220; Chrobak JJ, 2000, HIPPOCAMPUS, V10, P457, DOI 10.1002/1098-1063(2000)10:4<457::AID-HIPO12>3.0.CO;2-Z; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; Engell AD, 2010, J NEUROSCI, V30, P8780, DOI 10.1523/JNEUROSCI.1575-10.2010; Foucher JR, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-22; Hotting K, 2010, J INT NEUROPSYCH SOC, V16, P574, DOI 10.1017/S1355617710000275; Krizaj J, 2010, LECT NOTES COMPUT SC, V6111, P394, DOI 10.1007/978-3-642-13772-3_40; MCKELVIE SJ, 1995, BRIT J SOC PSYCHOL, V34, P325; Mihara T., 2001, EPILEPSY SURG, P613; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037//0022-3514.64.5.723; PURCELL DG, 1986, B PSYCHONOMIC SOC, V24, P118; Rosburg T, 2010, PSYCHOPHYSIOLOGY, V47, P147, DOI 10.1111/j.1469-8986.2009.00881.x; Rossion B, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00225; Scheffer-Teixeira R, 2012, CEREB CORTEX, V22, P2404, DOI 10.1093/cercor/bhr319; Strother L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018705; Tottenham N, 2006, DEVELOPMENTAL SCI, V9, P288, DOI 10.1111/j.1467-7687.2006.00491.x; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	83	2	2	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	0010-9452	1973-8102		CORTEX	Cortex	NOV	2014	60				SI		52	68		10.1016/j.cortex.2014.02.024		17	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	AU2XL	WOS:000345477800005		
J	Lipsman, N; Nakao, T; Kanayama, N; Krauss, JK; Anderson, A; Giacobbe, P; Hamani, C; Hutchison, WD; Dostrovsky, JO; Womelsdorf, T; Lozano, AM; Northoff, G				Lipsman, Nir; Nakao, Takashi; Kanayama, Noriaki; Krauss, Joachim K.; Anderson, Adam; Giacobbe, Peter; Hamani, Clement; Hutchison, William D.; Dostrovsky, Jonathan O.; Womelsdorf, Thilo; Lozano, Andres M.; Northoff, Georg			Neural overlap between resting state and self-relevant activity in human subcallosal cingulate cortex - Single unit recording in an intracranial study	CORTEX			English	Article						Resting state; Self-relevance; Default-mode network; Subcallosal cingulate cortex; Deep brain stimulation; Single-unit recording	CORTICAL MIDLINE STRUCTURES; TREATMENT-RESISTANT DEPRESSION; MEDIAL PREFRONTAL CORTEX; DEEP BRAIN-STIMULATION; DEFAULT-MODE; METAANALYSIS; AWARENESS; NETWORKS; DISEASE; REGIONS	High activity of the default mode network (DMN) has been proposed to be central in processing self-relevant events. Thus far, this hypothesis of DMN function has not been tested directly using neurophysiological techniques. To test for the link between frontal midline DMN activity and self-relevant processing we measured neuronal activity (single-neurons' firing rates) in human subcallosal cingulate cortex (SCC) in the course of Deep Brain Stimulation surgery. We find that firing rates in SCC did not change during the presentation of specifically self-relevant stimuli when compared to the preceding pre-stimulus resting state level. In contrast, we observed significant changes in firing rates during other names in SCC. Such rest-self overlap seems to be specific for SCC since increase in firing rates in response to self-relevant stimuli were observed in another region, the subthalamic nucleus, in a group of Parkinson patients receiving deep brain stimulation surgery. These results suggest specific relationship between resting state and self-related activity, rest-self overlap, in specifically SCC as core region of the default-mode network. (C) 2014 Elsevier Ltd. All rights reserved.	[Lipsman, Nir; Hamani, Clement; Lozano, Andres M.] Univ Toronto, Toronto Western Hosp, Div Neurosurg, Toronto, ON M5S 1A1, Canada; [Nakao, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima 730, Japan; [Kanayama, Noriaki] Univ Tokyo, Dept Gen Syst Studies, Grad Sch Arts & Sci, Tokyo 1138654, Japan; [Krauss, Joachim K.] Hannover Med Sch, Dept Neurosurg, D-30623 Hannover, Germany; [Anderson, Adam] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Giacobbe, Peter] Univ Toronto, Toronto Gen Hosp, Div Psychiat, Toronto, ON M5S 1A1, Canada; [Hutchison, William D.; Dostrovsky, Jonathan O.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A1, Canada; [Womelsdorf, Thilo] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [Northoff, Georg] Univ Ottawa, Mental Hlth Res Inst, Dept Psychiat, Ottawa, ON K1Z 7K4, Canada; [Northoff, Georg] Taipei Med Univ, Grad Inst Humanities Med, Taipei, Taiwan; [Northoff, Georg] Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, New Taipei City, Taiwan; [Northoff, Georg] Normal Univ Hangzhou, Ctr Cognit & Brain Disorders CBBD, Hangzhou, Zhejiang, Peoples R China	Northoff, G (reprint author), Univ Ottawa, Mental Hlth Res Inst, 1145 Carling Ave,Room 6435, Ottawa, ON K1Z 7K4, Canada.	Georg.northoff@theroyal.ca	Womelsdorf, Thilo/C-3096-2015	Womelsdorf, Thilo/0000-0001-6921-4187			Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Lemogne C, 2010, J AFFECT DISORDERS, V124, P196, DOI 10.1016/j.jad.2009.11.003; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; Grimm S, 2009, HUM BRAIN MAPP, V30, P2617, DOI 10.1002/hbm.20693; Lozano AM, 2008, BIOL PSYCHIAT, V64, P461, DOI 10.1016/j.biopsych.2008.05.034; Mantini D, 2011, J NEUROSCI, V31, P12954, DOI 10.1523/JNEUROSCI.2318-11.2011; Kuhn AA, 2005, NEUROLOGY, V65, P707, DOI 10.1212/01.wnl.0000174438.78399.bc; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Qin PM, 2011, NEUROIMAGE, V57, P1221, DOI 10.1016/j.neuroimage.2011.05.028; Raichle ME, 2009, TRENDS NEUROSCI, V32, P118, DOI 10.1016/j.tins.2008.11.001; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488; Wichmann T, 2011, NEUROSCIENCE, V198, P232, DOI 10.1016/j.neuroscience.2011.06.048; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Farb NAS, 2007, SOC COGN AFFECT NEUR, V2, P313, DOI 10.1093/scan/nsm030; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; Northoff G, 2011, NEUROSCI BIOBEHAV R, V35, P1929, DOI 10.1016/j.neubiorev.2010.12.007; Alcaro A, 2010, NEUROSCI BIOBEHAV R, V34, P592, DOI 10.1016/j.neubiorev.2009.11.023; Wiebking C, 2014, HUM BRAIN MAPP, V35, P173, DOI 10.1002/hbm.22166; Kuhn S, 2013, SCHIZOPHRENIA BULL, V39, P358, DOI 10.1093/schbul/sbr151; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Hutchison RM, 2012, CEREB CORTEX, V22, P1294, DOI 10.1093/cercor/bhr181; Lemogne C, 2012, J AFFECT DISORDERS, V136, pE1, DOI 10.1016/j.jad.2010.11.034; Lou HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022286; Northoff G, 2014, UNLOCKING BRAIN, VII; Northoff G, 2014, UNLOCKING BRAIN, V1; Northoff G, 2010, TRENDS NEUROSCI, V33, P277, DOI 10.1016/j.tins.2010.02.006; Northoff G, 2009, HUM BRAIN MAPP, V30, P369, DOI 10.1002/hbm.20510; Raichle Marcus E, 2010, Handb Clin Neurol, V95, P257, DOI 10.1016/S0072-9752(08)02118-0; Rilling JK, 2007, P NATL ACAD SCI USA, V104, P17146, DOI 10.1073/pnas.0705132104; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048	35	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	0010-9452	1973-8102		CORTEX	Cortex	NOV	2014	60				SI		139	144		10.1016/j.cortex.2014.09.008		6	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	AU2XL	WOS:000345477800011		
J	Colley, KJ; Kitajima, K; Sato, C				Colley, Karen J.; Kitajima, Ken; Sato, Chihiro			Polysialic acid: Biosynthesis, novel functions and applications	CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Review						Meningitis; neural cell adhesion molecule; neurobiology; polysialic acid; polysialyltransferase	NEURAL-CELL-ADHESION; CENTRAL-NERVOUS-SYSTEM; FIBROBLAST-GROWTH-FACTOR; LONG-TERM POTENTIATION; SEA-URCHIN SPERM; ENDO-N-ACETYLNEURAMINIDASE; MESSENGER-RNA EXPRESSION; CHINESE-HAMSTER OVARY; ST8SIA II STX; DEVELOPMENTALLY-REGULATED MEMBER	As an anti-adhesive, a reservoir for key biological molecules, and a modulator of signaling, polysialic acid (polySia) is critical for nervous system development and maintenance, promotes cancer metastasis, tissue regeneration and repair, and is implicated in psychiatric diseases. In this review, we focus on the biosynthesis and functions of mammalian polySia, and the use of polySia in therapeutic applications. PolySia modifies a small subset of mammalian glycoproteins, with the neural cell adhesion molecule, NCAM, serving as its major carrier. Studies show that mammalian polysialyltransferases employ a unique recognition mechanism to limit the addition of polySia to a select group of proteins. PolySia has long been considered an anti-adhesive molecule, and its impact on cell adhesion and signaling attributed directly to this property. However, recent studies have shown that polySia specifically binds neurotrophins, growth factors, and neurotransmitters and that this binding depends on chain length. This work highlights the importance of considering polySia quality and quantity, and not simply its presence or absence, as its various roles are explored. The capsular polySia of neuroinvasive bacteria allows these organisms to evade the host immune response. While this "stealth" characteristic has made meningitis vaccine development difficult, it has also made polySia a worthy replacement for polyetheylene glycol in the generation of therapeutic proteins with low immunogenicity and improved circulating half-lives. Bacterial polysialyltransferases are more promiscuous than the protein-specific mammalian enzymes, and new studies suggest that these enzymes have tremendous therapeutic potential, especially for strategies aimed at neural regeneration and tissue repair.	[Colley, Karen J.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan	Colley, KJ (reprint author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu	SATO, Chihiro/B-7396-2014		NIH [R01GM101949]; Japanese Ministry of Education, Science, Sports and Culture [23110002, 26110708];  [25292216]	The authors have no declarations of interest to report. Karen Colley is supported by NIH R01GM101949. Ken Kitajima is supported by Grants-in-Aid for Scientific Research (B) (25292216), and Chihiro Sato is supported by Scientific Research on Innovative Areas (No. 23110002, Deciphering sugar chain-based signals regulating integrative neural functions) (26110708) from the Japanese Ministry of Education, Science, Sports and Culture.	Ahrens J, 2011, PHARMACOLOGY, V87, P311, DOI 10.1159/000327389; Al-Saraireh YMJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073366; Albrecht A, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00043; Amoureux MC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-91; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Spinosa MR, 2007, INFECT IMMUN, V75, P3594, DOI 10.1128/IAI.01945-06; Bukalo O, 2004, J NEUROSCI, V24, P1565, DOI 10.1523/JNEUROSCI.3298-03.2004; Krocher T, 2014, DEVELOPMENT, V141, P3022, DOI 10.1242/dev.111773; Papastefanaki F, 2007, BRAIN, V130, P2159, DOI 10.1093/brain/awm155; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; ROTH J, 1988, P NATL ACAD SCI USA, V85, P2999, DOI 10.1073/pnas.85.9.2999; Sarantis H, 2012, CELL HOST MICROBE, V12, P419, DOI 10.1016/j.chom.2012.09.001; Kim KJ, 2003, CELL MICROBIOL, V5, P245, DOI 10.1046/j.1462-5822.2003.t01-1-00271.x; Manzella SM, 1996, J BIOL CHEM, V271, P12117; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; Kanato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P2735, DOI 10.1271/bbb.90637; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Fernandes AI, 2001, INT J PHARMACEUT, V217, P215, DOI 10.1016/S0378-5173(01)00603-2; Vutskits L, 2003, EUR J NEUROSCI, V17, P2119, DOI 10.1046/j.1460-9568.2003.02660.x; Zhiling Y, 2008, BIOCHEM BIOPH RES CO, V377, P926, DOI 10.1016/j.bbrc.2008.10.107; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Coutinho MF, 2012, MOL GENET METAB, V105, P542, DOI 10.1016/j.ymgme.2011.12.012; Mudo G, 2009, J NEURAL TRANSM, V116, P995, DOI 10.1007/s00702-009-0207-z; Hane M, 2012, PURE APPL CHEM, V84, P1895, DOI 10.1351/PAC-CON-11-12-10; Gravvanis AI, 2007, ACTA NEUROCHIR SUPPL, V100, P51; Petridis AK, 2011, J CLIN NEUROSCI, V18, P265, DOI 10.1016/j.jocn.2010.06.021; Willis LM, 2013, CARBOHYD RES, V378, P35, DOI 10.1016/j.carres.2013.05.007; Camand E, 2004, EUR J NEUROSCI, V20, P1161, DOI 10.1111/j.1460-9568.2004.03558.x; Hansch M, 2014, GLYCOBIOLOGY, V24, P488, DOI 10.1093/glycob/cwu023; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; Chazal G, 2000, J NEUROSCI, V20, P1446; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; Rollenhagen M, 2013, J BIOL CHEM, V288, P22880, DOI 10.1074/jbc.M113.463927; Carter NJ, 2013, BIODRUGS, V27, P263, DOI 10.1007/s40259-013-0029-2; Krug LM, 2004, CLIN CANCER RES, V10, P916, DOI 10.1158/1078-0432.CCR-03-0101; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; Muhlenhoff M, 2001, J BIOL CHEM, V276, P34066, DOI 10.1074/jbc.M101022200; Zapater JL, 2012, J BIOL CHEM, V287, P6441, DOI 10.1074/jbc.M111.322024; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005-08.016; Ghosh M, 2012, GLIA, V60, P979, DOI 10.1002/glia.22330; Ulm C, 2013, CELL MOL LIFE SCI, V70, P3695, DOI 10.1007/s00018-013-1342-0; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; Keys TG, 2014, NAT CHEM BIOL, V10, P437, DOI 10.1038/nchembio.1501; Fewou SN, 2007, J BIOL CHEM, V282, P16700, DOI 10.1074/jbc.M610797200; BONFANTI L, 1994, NEUROSCIENCE, V62, P291, DOI 10.1016/0306-4522(94)90333-6; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Turner CA, 2009, PHARMACOL BIOCHEM BE, V92, P100, DOI 10.1016/j.pbb.2008.10.018; Liu TM, 2000, J BIOL CHEM, V275, P32832, DOI 10.1074/jbc.C000573200; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Mehanna A, 2010, MOL THER, V18, P34, DOI 10.1038/mt.2009.235; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; Simon P, 2013, J BIOL CHEM, V288, P18825, DOI 10.1074/jbc.M113.451112; Hildebrandt H, 2010, ADV EXP MED BIOL, V663, P95, DOI 10.1007/978-1-4419-1170-4_6; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Galuska SP, 2010, ANAL CHEM, V82, P2059, DOI 10.1021/ac902809q; Lindhout T, 2011, P NATL ACAD SCI USA, V108, P7397, DOI 10.1073/pnas.1019266108; Calandreau L, 2010, GENES BRAIN BEHAV, V9, P958, DOI 10.1111/j.1601-183X.2010.00635.x; LANIER LL, 1989, J EXP MED, V169, P2233, DOI 10.1084/jem.169.6.2233; Foley DA, 2010, J BIOL CHEM, V285, P35056, DOI 10.1074/jbc.M110.170209; Lavdas AA, 2006, GLIA, V53, P868, DOI 10.1002/glia.20340; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Falconer RA, 2012, CURR CANCER DRUG TAR, V12, P925; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; Sato C, 1998, ANAL BIOCHEM, V261, P191, DOI 10.1006/abio.1998.2718; Gregoriadis G, 2005, INT J PHARM, V300, P125, DOI 10.1016/j.ijpharm.2005.06.007; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Gilabert-Juan J, 2013, PSYCHIAT RES, V210, P1293, DOI 10.1016/j.psychres.2013.09.001; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Miyata S, 2006, GLYCOBIOLOGY, V16, P1229, DOI 10.1093/glycob/cwl036; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; Hammond MSL, 2006, J BIOL CHEM, V281, P34859, DOI 10.1074/jbc.M602568200; Sato C, 2010, METHOD ENZYMOL, V478, P219, DOI 10.1016/S0076-6879(10)78010-1; Willis LM, 2008, GLYCOBIOLOGY, V18, P177, DOI 10.1093/glycob/cwm126; Fukuda M, 1996, CANCER RES, V56, P2237; Angata K, 2001, J BIOL CHEM, V276, P15369, DOI 10.1074/jbc.M100576200; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Ono S, 2012, J BIOL CHEM, V287, P3710, DOI 10.1074/jbc.M111.276618; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Jennings H J, 1988, Adv Exp Med Biol, V228, P495; Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106; YANG PF, 1992, J CELL BIOL, V116, P1487, DOI 10.1083/jcb.116.6.1487; Yoshimi K, 2005, ANN NEUROL, V58, P31, DOI 10.1002/ana.20506; Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; SARFF LD, 1975, LANCET, V1, P1099; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; Mehanna A, 2009, BRAIN, V132, P1449, DOI 10.1093/brain/awp128; Perez JA, 2009, J NEUROSCI, V29, P6379, DOI 10.1523/JNEUROSCI.4829-08.2009; Turetsky BI, 2003, ARCH GEN PSYCHIAT, V60, P1193, DOI 10.1001/archpsyc.60.12.1193; Seki T, 1998, J NEUROSCI, V18, P3757; Nakata D, 2006, GLYCOCONJUGATE J, V23, P423, DOI 10.1007/s10719-006-6356-5; Atz ME, 2007, PSYCHIAT GENET, V17, P55, DOI 10.1097/YPG.0b013e328012d850; Willis LM, 2013, P NATL ACAD SCI USA, V110, P7868, DOI 10.1073/pnas.1222317110; YANG PF, 1994, J BIOL CHEM, V269, P23039; Kamien B, 2014, AM J MED GENET A, V164, P782, DOI 10.1002/ajmg.a.36345; Turner CA, 2008, BRAIN RES, V1224, P63, DOI 10.1016/j.brainres.2008.05.088; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Li J, 2011, GLYCOBIOLOGY, V21, P1010, DOI 10.1093/glycob/cwr020; Saxena K, 2010, J BIOL CHEM, V285, P26628, DOI 10.1074/jbc.M109.095109; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; Rutishauser U, 1996, CURR OPIN CELL BIOL, V8, P679, DOI 10.1016/S0955-0674(96)80109-8; BARRY GT, 1957, NATURE, V179, P206, DOI 10.1038/179206a0; Thompson MG, 2013, J BIOL CHEM, V288, P7282, DOI 10.1074/jbc.M112.438374; Gregoriadis G, 1999, BIOTECHNOL GENET ENG, V16, P203; JAMES WM, 1987, BIOCHEM BIOPH RES CO, V148, P817, DOI 10.1016/0006-291X(87)90949-1; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Fumagalli F, 2005, NEUROBIOL DIS, V20, P731, DOI 10.1016/j.nbd.2005.05.005; Muhlenhoff M, 2013, NEUROCHEM RES, V38, P1134, DOI 10.1007/s11064-013-0979-2; Lantuejoul S, 1998, AM J SURG PATHOL, V22, P1267, DOI 10.1097/00000478-199810000-00012; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Tan LKK, 2010, NEW ENGL J MED, V362, P1511, DOI 10.1056/NEJMra0906357; Theis T, 2013, J BIOL CHEM, V288, P6726, DOI 10.1074/jbc.M112.444034; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Weber M, 2006, NEUROSCIENCE, V138, P1215, DOI 10.1016/j.neuroscience.2005.11.059; Graham BM, 2010, NEUROPSYCHOPHARMACOL, V35, P1348, DOI 10.1038/npp.2010.3; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Kurosawa N, 1997, J NEUROCHEM, V69, P494; Takeuchi H, 2012, J BIOL CHEM, V287, P33934, DOI 10.1074/jbc.M112.401315; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Angata K, 2002, J BIOL CHEM, V277, P36808, DOI 10.1074/jbc.M204632200; Angata K, 1997, J BIOL CHEM, V272, P7182; Gaughran F, 2006, BRAIN RES BULL, V70, P221, DOI 10.1016/j.brainresbull.2006.04.008; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; Prud'homme GJ, 2012, ONCOTARGET, V3, P921; Itoh N, 2007, BIOL PHARM BULL, V30, P1819, DOI 10.1248/bpb.30.1819; Mahal LK, 2001, SCIENCE, V294, P380, DOI 10.1126/science.1062192; Cress BF, 2014, FEMS MICROBIOL REV, V38, P660, DOI [10.1111/1574-6976.12056, 10.1111/1574-69]; Vutskits L, 2001, EUR J NEUROSCI, V13, P1391, DOI 10.1046/j.0953-816x.2001.01516.x; YIN XH, 1995, DEVELOPMENT, V121, P3439; Fernandes AI, 1997, BBA-PROTEIN STRUCT M, V1341, P26, DOI 10.1016/S0167-4838(97)00056-3; ZUBER C, 1992, J BIOL CHEM, V267, P9965; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Webster R, 2007, DRUG METAB DISPOS, V35, P9, DOI 10.1124/dmd.106.012419; BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088; Rey-Gallardo A, 2011, GLYCOBIOLOGY, V21, P655, DOI 10.1093/glycob/cwq216; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; Willis LM, 2013, P NATL ACAD SCI USA, V110, P20753, DOI 10.1073/pnas.1312637110; Mikkonen M, 1999, EUR J NEUROSCI, V11, P1754, DOI 10.1046/j.1460-9568.1999.00593.x; Kulahin N, 2011, STRUCTURE, V19, P203, DOI 10.1016/j.str.2010.12.014; Galuska SP, 2007, ANAL CHEM, V79, P7161, DOI 10.1021/ac0712446; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; Drake PM, 2008, J IMMUNOL, V181, P6850; Alenius M, 1997, J BIOL CHEM, V272, P26083, DOI 10.1074/jbc.272.42.26083; Maziade M, 2005, MOL PSYCHIATR, V10, P486, DOI 10.1038/sj.mp.4001594; RUTISHAUSER U, 1982, P NATL ACAD SCI-BIOL, V79, P685, DOI 10.1073/pnas.79.2.685; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Zanghi JA, 1998, BIOTECHNOL PROGR, V14, P834, DOI 10.1021/bp9800945; Horstkorte R, 2004, EXP CELL RES, V298, P268, DOI 10.1016/j.yexcr.2004.04.014; SADOUL R, 1983, NATURE, V304, P347, DOI 10.1038/304347a0; Kemp A, 2007, TRENDS NEUROSCI, V30, P111, DOI 10.1016/j.tins.2007.01.002; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Nagae M, 2013, J BIOL CHEM, V288, P33784, DOI 10.1074/jbc.M113.496224; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Benraiss A, 2001, J NEUROSCI, V21, P6718; HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0; AOYAGI A, 1994, BRAIN RES, V661, P117, DOI 10.1016/0006-8993(94)91188-6; Sato C, 1999, ANAL BIOCHEM, V266, P102, DOI 10.1006/abio.1998.2921; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; Francavilla C, 2009, J CELL BIOL, V187, P1101, DOI 10.1083/jcb.200903030; Wuhrer M, 2003, BIOCHIMIE, V85, P207, DOI 10.1016/S0300-9084(03)00043-9; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; HAYRINEN J, 1995, J INFECT DIS, V171, P1481; Eckhardt M, 2000, J NEUROSCI, V20, P5234; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; Aubert I, 1998, J COMP NEUROL, V399, P1; Bader Rebecca A, 2014, Ther Deliv, V5, P235, DOI 10.4155/tde.13.153; BAENZIGER JU, 1994, FASEB J, V8, P1019; Barral-Moran MJ, 2003, J NEUROSCI RES, V72, P679, DOI 10.1002/jnr.10627; Batchelor PE, 2003, J CLIN NEUROSCI, V10, P523, DOI 10.1016/S0967-5868(03)00004-3; Bax M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006987; Beecken WD, 2005, INT IMMUNOPHARMACOL, V5, P757, DOI 10.1016/j.intimp.2004.12.009; Biederer T, 2006, GENOMICS, V87, P139, DOI 10.1016/j.ygeno.2005.08.017; Blanke M. L., 2009, BIOL NMDA RECEPTOR; Bruge J, 2004, VACCINE, V22, P1087, DOI 10.1016/j.vaccine.2003.10.005; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Bunge MB, 2003, J REHABIL RES DEV, V40, P55; Carafoli F, 2008, J MOL BIOL, V377, P524, DOI 10.1016/j.jmb.2008.01.030; Castillo-Gomez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029516; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; Cheung IY, 2006, INT J CANCER, V119, P152, DOI 10.1002/ijc.21789; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; Close BE, 2000, J BIOL CHEM, V275, P4484, DOI 10.1074/jbc.275.6.4484; Close BE, 2001, GLYCOBIOLOGY, V11, P997, DOI 10.1093/glycob/11.11.997; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Colley KJ, 2010, ADV EXP MED BIOL, V663, P111, DOI 10.1007/978-1-4419-1170-4_7; Colley KJ, 2014, NAT CHEM BIOL, V10, P410, DOI 10.1038/nchembio.1506; CUNNINGHAM BA, 1983, P NATL ACAD SCI-BIOL, V80, P3116, DOI 10.1073/pnas.80.10.3116; Daston MM, 1996, J NEUROSCI, V16, P5488; DOYLE E, 1992, J NEUROSCI RES, V31, P513, DOI 10.1002/jnr.490310315; Dusart I, 1999, J COMP NEUROL, V408, P399; Ednie AR, 2012, COMPR PHYSIOL, V2, P1269, DOI 10.1002/cphy.c110044; Eggers K, 2011, J CELL SCI, V124, P3279, DOI 10.1242/jcs.084863; El Maarouf A, 2012, J BIOL CHEM, V287, P32770, DOI 10.1074/jbc.M112.377614; El Maarouf A, 2010, ADV EXP MED BIOL, V663, P137, DOI 10.1007/978-1-4419-1170-4_9; El Maarouf A, 2003, J COMP NEUROL, V460, P203, DOI 10.1002/cne.10635; El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103; FIGARELLABRANGER DF, 1990, CANCER RES, V50, P6364; FINNE J, 1982, J BIOL CHEM, V257, P1966; FINNE J, 1985, J BIOL CHEM, V260, P1265; FINNE J, 1983, LANCET, V2, P355; Foley DA, 2009, J BIOL CHEM, V284, P15505, DOI 10.1074/jbc.M809696200; Foley DA, 2010, J BIOL CHEM, V285, P27360, DOI 10.1074/jbc.M110.140038; FOX GB, 1995, J NEUROCHEM, V65, P2796; Francavilla C, 2007, J CELL SCI, V120, P4388, DOI 10.1242/jcs.010744; Franceschini I, 2004, MOL CELL NEUROSCI, V27, P151, DOI 10.1016/j.mcn.2004.05.006; Franz CK, 2005, J NEUROSCI, V25, P2081, DOI 10.1523/JNEUROSCI.4880-04.2005; FREDETTE B, 1993, J CELL BIOL, V123, P1867, DOI 10.1083/jcb.123.6.1867; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Fujita KA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000810; Galuska SP, 2006, J BIOL CHEM, V281, P31605, DOI 10.1074/jbc.M606516200; Galuska SP, 2008, J BIOL CHEM, V283, P17, DOI 10.1074/jbc.M707024200; Gerety M, 1997, ANAT REC, V247, P71; Glass JD, 2000, NEUROSCI LETT, V280, P207, DOI 10.1016/S0304-3940(00)00786-2; Glass JD, 2003, NEUROSCIENCE, V117, P203, DOI 10.1016/S0306-4522(02)00817-5; Gluer S, 1998, PEDIATR RES, V43, P145; Gluer S, 1998, BRIT J CANCER, V78, P106, DOI 10.1038/bjc.1998.450; Graham BM, 2011, NEUROSCIENCE, V189, P156, DOI 10.1016/j.neuroscience.2011.05.041; Gregoriadis G, 2000, CELL MOL LIFE SCI, V57, P1964, DOI 10.1007/PL00000676; HALL AK, 1987, J CELL BIOL, V104, P1579, DOI 10.1083/jcb.104.6.1579; HAYRINEN J, 1989, MOL IMMUNOL, V26, P523, DOI 10.1016/0161-5890(89)90003-5; Hirohashi N, 2002, J BIOL CHEM, V277, P8041, DOI 10.1074/jbc.M110661200; HOFFMAN S, 1982, J BIOL CHEM, V257, P7720; Hromatka BS, 2013, GLYCOBIOLOGY, V23, P593, DOI 10.1093/glycob/cws162; HUSMANN M, 1989, EUR J IMMUNOL, V19, P1761, DOI 10.1002/eji.1830190935; INOUE S, 1978, BIOCHEM BIOPH RES CO, V83, P1018, DOI 10.1016/0006-291X(78)91497-3; Jakobsson E, 2012, TOP CURR CHEM, DOI [10.1007/128_2012_349, DOI 10.1007/128_2012_349]; Janas T, 2011, BBA-BIOMEMBRANES, V1808, P2322, DOI 10.1016/j.bbamem.2011.05.008; Janas T, 2001, ACTA BIOCHIM POL, V48, P163; Janas T, 2010, CHEM PHYS LIPIDS, V163, P286, DOI 10.1016/j.chemphyslip.2009.12.003; JENNINGS HJ, 1985, J IMMUNOL, V134, P2651; Jennings H J, 1989, Contrib Microbiol Immunol, V10, P151; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Jokilammi A, 2004, J IMMUNOL METHODS, V295, P149, DOI 10.1016/j.jim.2004.10.006; JORGENSE.OS, 1974, J NEUROCHEM, V23, P879, DOI 10.1111/j.1471-4159.1974.tb04419.x; Kambara Y, 2011, CELL STRUCT FUNCT, V36, P69, DOI 10.1247/csf.10020; Kameda K, 1999, CANCER LETT, V137, P201, DOI 10.1016/S0304-3835(98)00359-0; Kanazawa T, 2014, GLYCOSCIENCE BIOL ME, DOI [10.1007/978-4-431-54836-2_167-1, DOI 10.1007/978-4-431-54836-2_167-1]; KERN WF, 1993, LEUKEMIA LYMPHOMA, V12, P1, DOI 10.3109/10428199309059565; Kiss JZ, 1997, CURR OPIN NEUROBIOL, V7, P640, DOI 10.1016/S0959-4388(97)80083-9; KITAJIMA K, 1988, DEV BIOL, V129, P270, DOI 10.1016/0012-1606(88)90181-9; KITAZUME S, 1994, J BIOL CHEM, V269, P22712; KOJIMA N, 1995, FEBS LETT, V360, P1, DOI 10.1016/0014-5793(95)00059-I; Kojima N, 1996, J BIOL CHEM, V271, P19457; KOMMINOTH P, 1994, AM J SURG PATHOL, V18, P399, DOI 10.1097/00000478-199404000-00008; KOMMINOTH P, 1991, AM J PATHOL, V139, P297; Krug LM, 2012, CANCER IMMUNOL IMMUN, V61, P9, DOI 10.1007/s00262-011-1083-6; KWIATKOWSKI B, 1982, J VIROL, V43, P697; LACKIE PM, 1991, DIFFERENTIATION, V47, P85, DOI 10.1111/j.1432-0436.1991.tb00226.x; LACKIE PM, 1994, DIFFERENTIATION, V57, P119, DOI 10.1046/j.1432-0436.1994.5720119.x; LACKIE PM, 1990, DEVELOPMENT, V110, P933; LAHR G, 1993, ENDOCRINOLOGY, V132, P1207, DOI 10.1210/en.132.3.1207; LETAIEF SE, 1993, BIOL CELL, V77, P269, DOI 10.1016/S0248-4900(05)80198-4; Lindhout T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069888; LIVINGSTON BD, 1993, J BIOL CHEM, V268, P11504; LIVINGSTON BD, 1988, J BIOL CHEM, V263, P9443; Livingston PO, 2005, CANCER IMMUNOL IMMUN, V54, P1018, DOI 10.1007/s00262-005-0663-8; Loudes C, 1997, EUR J NEUROSCI, V9, P2323, DOI 10.1111/j.1460-9568.1997.tb01649.x; MacNeil J, 2014, MANUAL SURVEILLANCE; Markram K, 2007, NEUROSCIENCE, V144, P788, DOI 10.1016/j.neuroscience.2006.10.024; Martersteck CM, 1996, GLYCOBIOLOGY, V6, P289, DOI 10.1093/glycob/6.3.289; MATSUDA S, 1990, BRAIN RES, V520, P310, DOI 10.1016/0006-8993(90)91720-2; McAuley EZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038172; McCarthy PC, 2013, GLYCOCONJUGATE J, V30, P857, DOI 10.1007/s10719-013-9490-x; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; METZMAN RA, 1991, MODERN PATHOL, V4, P491; Minana R, 2000, J NEUROCHEM, V75, P954, DOI 10.1046/j.1471-4159.2000.0750954.x; MIRAGALL F, 1988, DEV BIOL, V129, P516, DOI 10.1016/0012-1606(88)90397-1; Missler M, 2012, SYNAPTIC CELL ADHESI; Miyahara R, 2001, J SURG ONCOL, V77, P49, DOI 10.1002/jso.1065; Miyake K, 1997, J FERMENT BIOENG, V84, P90, DOI 10.1016/S0922-338X(97)82793-6; Miyata S, 2011, GLYCOBIOLOGY, V21, P1596, DOI 10.1093/glycob/cwr081; Miyata S, 2004, GLYCOBIOLOGY, V14, P827, DOI 10.1093/glycob/cwh100; Miyazaki T, 2008, GLYCOBIOLOGY, V18, P187, DOI 10.1093/glycob/cwm132; Moebius JM, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-13; MOOLENAAR CECK, 1990, CANCER RES, V50, P1102; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8; Muhlenhoff M, 1996, EMBO J, V15, P6943; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Murakami S, 2000, J COMP NEUROL, V420, P171; NADANO D, 1986, J BIOL CHEM, V261, P1550; Nakayama J, 1998, PATHOL INT, V48, P665, DOI 10.1111/j.1440-1827.1998.tb03967.x; NEDELEC J, 1990, J NEUROIMMUNOL, V29, P49, DOI 10.1016/0165-5728(90)90146-E; Neiiendam JL, 2004, J NEUROCHEM, V91, P920, DOI 10.1111/j.1471-4159.2004.02779.x; NELSON RW, 1995, J BIOL CHEM, V270, P17171; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Nikulin J, 2006, INT J MED MICROBIOL, V296, P553, DOI 10.1016/j.ijmm.2006.06.006; PELKONEN S, 1989, J VIROL, V63, P4409; Peterson DC, 2011, J BACTERIOL, V193, P1576, DOI 10.1128/JB.00924-10; Petridis AK, 2004, DEV DYNAM, V230, P675, DOI 10.1002/dvdy.20094; Petridis AK, 1999, ACTA NEUROCHIR, V151, P601; Phillips GR, 1997, DEV BRAIN RES, V102, P143, DOI 10.1016/S0165-3806(97)00069-2; Pon RA, 2007, GLYCOBIOLOGY, V17, P249, DOI 10.1093/glycob/cwl075; PROBSTMEIER R, 1994, J NEUROSCI RES, V37, P324, DOI 10.1002/jnr.490370305; Ram S, 2011, J BIOL CHEM, V286, P8297, DOI 10.1074/jbc.M110.184838; Ranheim TS, 1996, P NATL ACAD SCI USA, V93, P4071, DOI 10.1073/pnas.93.9.4071; Rey-Gallardo A, 2010, GLYCOBIOLOGY, V20, P1139, DOI 10.1093/glycob/cwq078; Rini J., 2009, ESSENTIALS GLYCOBIOL, P63; ROBERTS I, 1986, J BACTERIOL, V168, P1228; Rockle I, 2008, DEV NEUROBIOL, V68, P1170, DOI 10.1002/dneu.20649; Rollenhagen M, 2012, J BIOL CHEM, V287, P35170, DOI 10.1074/jbc.M112.375642; ROTH J, 1988, AM J PATHOL, V133, P227; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; SATO C, 1995, J BIOL CHEM, V270, P18923; SATO C, 1993, J BIOL CHEM, V268, P23675; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685; Schiff M, 2009, J NEUROCHEM, V110, P1661, DOI 10.1111/j.1471-4159.2009.06267.x; SEGALL GK, 1979, DEV BIOL, V71, P33, DOI 10.1016/0012-1606(79)90080-0; Seidenfaden R, 2006, NEUROCHEM INT, V49, P1, DOI 10.1016/j.neuint.2005.12.011; SEKI T, 1991, NEUROSCI RES, V12, P503; Shaw AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092556; SHIMODA Y, 1994, BIOCHEMISTRY-US, V33, P1202, DOI 10.1021/bi00171a020; SHULTS CW, 1992, DEV BRAIN RES, V65, P161, DOI 10.1016/0165-3806(92)90175-V; Stamatos NM, 2014, GLYCOBIOLOGY, V24, P864, DOI 10.1093/glycob/cwu050; Szele FG, 1996, J COMP NEUROL, V368, P439, DOI 10.1002/(SICI)1096-9861(19960506)368:3<439::AID-CNE9>3.0.CO;2-6; Tanaka F, 2000, CANCER RES, V60, P3072; Tanaka F, 2001, CANCER RES, V61, P1666; THEODOSIS DT, 1991, P NATL ACAD SCI USA, V88, P5494, DOI 10.1073/pnas.88.13.5494; Thompson MG, 2011, J BIOL CHEM, V286, P4525, DOI 10.1074/jbc.M110.200386; TOMLINSON S, 1985, J VIROL, V55, P374; Trouillas J, 2003, J NEUROSURG, V98, P1084, DOI 10.3171/jns.2003.98.5.1084; Troy FA, 1990, GLYCOCONJUGATE J, V7, P383; Tsuchiya A, 2014, HEPATOLOGY, V60, P1727, DOI 10.1002/hep.27099; Vaithianathan T, 2004, J BIOL CHEM, V279, P47975, DOI 10.1074/jbc>M407138200; Valderrama-Rincon JD, 2012, NAT CHEM BIOL, V8, P434, DOI [10.1038/nchembio.921, 10.1038/NCHEMBIO.921]; VANDIJK WC, 1979, INFECT IMMUN, V25, P603; VICARIOABEJON C, 1995, NEURON, V15, P105, DOI 10.1016/0896-6273(95)90068-3; VIMR ER, 1984, P NATL ACAD SCI-BIOL, V81, P1971, DOI 10.1073/pnas.81.7.1971; von der Ohe M, 2002, GLYCOBIOLOGY, V12, P47, DOI 10.1093/glycob/12.1.47; WALICKE PA, 1988, J NEUROSCI, V8, P2618; WATANABE M, 1992, DEV DYNAM, V194, P128; Watson K, 1999, J BIOL CHEM, V274, P21707, DOI 10.1074/jbc.274.31.21707; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Zanghi JA, 1998, J CELL PHYSIOL, V177, P248, DOI 10.1002/(SICI)1097-4652(199811)177:2<248::AID-JCP7>3.0.CO;2-N; Zhang Y, 2007, MOL CELL NEUROSCI, V35, P109, DOI 10.1016/j.mcn.2007.02.011; Zhang Y, 2007, EUR J NEUROSCI, V25, P351, DOI 10.1111/j.1460-9568.05311.x; Zhang Y, 2007, MOL THER, V15, P1796, DOI 10.1038/sj.mt.6300220; Zigova T, 1998, CELL TRANSPLANT, V7, P137, DOI 10.1016/S0963-6897(98)00009-8	377	3	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1040-9238	1549-7798		CRIT REV BIOCHEM MOL	Crit. Rev. Biochem. Mol. Biol.	NOV-DEC	2014	49	6					498	532		10.3109/10409238.2014.976606		35	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AU3FM	WOS:000345497900004		
J	Izawa, K				Izawa, Kunihiko			SOME NEW AND KNOWN SPECIES OF THE LERNANTHROPIDAE (COPEPODA, SIPHONOSTOMATOIDA) PARASITIC ON THE BRANCHIAL LAMELLAE OF JAPANESE ACTINOPTERYGIAN FISHES, WITH REVISION OF TWO KNOWN SPECIES OF THE FAMILY AND DISCUSSION ON THE INSEMINATION MODE IN THE SIPHONOSTOMATOIDA)	CRUSTACEANA			English	Article							MARINE FISHES; GENUS LERNANTHROPUS; NOV GEN.; REDESCRIPTION; ELASMOBRANCHS; PANDARIDAE; TAIWAN; BLAINVILLE; BLEEKER; WILSON	Ten species of Lernanthropidae parasitic on the branchial lamellae of Japanese marine actinopterygian fishes are (re-)described herein. These are: Lernanthropinus carangoides sp. nov., recovered from Carangoides equula (Carangidae), Lernanthropinus labracoglossae sp. nov. from Labracoglossa argentiventris (Kyphosidae), Lernanthropsis mugilii (Shishido, 1898) from Mugil cephalus (Mugilidae), Lernanthropus atrox Heller, 1865 from Pagrus major (Sparidae), Lernanthropus erythrocles sp. nov. from Erythrocles schlegelii (Emmelichthyidae), Lemanthropus incilis Ho, Liu & Lin, 2011 from Evoxymetopon poeyi (Trichiuridae), Lernanthropus seriolae Shishido, 1898 from Seriola lalandi (Carangidae), Lernanthropus talipes Wilson, 1935 from Girella punctata and Kyphosus vaigiensis (Kyphosidae), Sagum paracaesionis sp. nov. from Paracaesio xanthurus (Lutjanidae), and a Lernanthropidae sp. (male) from Parapristopoma trilineatum (Haemulidae). Lernanthropus senegalensis Diebakate & Raibaut, 1996 is transferred to the genus Lemanthropinus. Lemanthropus pristipomoides Kirtisinghe, 1937 is relegated to a junior synonym of L. talipes. The possession of the naked first antennular segment is verified for all lernanthropids herein dealt with, in both sexes. The parabasal flagellum characteristic for the family is regarded as homologous with the postantennal process that is very common among siphonostomatoids parasitic on fishes. Two different modes of insemination exist in the Siphonostomatoida. The Lernanthropidae and Eudactylinidae differ from the Caligidae and Pandalidae in their mode of insemination.	Izawa Marine Biol Lab, Tsu, Mie 5140062, Japan	Izawa, K (reprint author), Izawa Marine Biol Lab, 795-16 Kannonji, Tsu, Mie 5140062, Japan.	izawakun@sea.plala.or.jp					Izawa K, 2010, CRUSTACEANA, V83, P971, DOI 10.1163/001121610X510633; Izawa K, 2000, CRUSTACEANA, V73, P995, DOI 10.1163/156854000505047; BASSETT-SMITH P. W., 1898, ANN MAG NAT HIST, V2, P357; BASSETT-SMITH P. W., 1898, ANN MAG NAT HIST SER, V2, P77; BEN HASSINE M. O. K., 1983, THESIS U SCI TECHNOL, pi; Boxshall G.A., 2004, INTRO COPEPOD DIVERS, V166, P1; BRIAN A., 1898, B MUS ZOOL ANAT COMP, V61, P1; CKESSEY R., 1979, SMITH CONTR ZOOL, V296, P1; DEETS R. B., 1988, CAN J ZOOL, V66, P866; Delamare Deboutteville C., 1952, Vie et Milieu, V3, P292; Diebakate C, 1996, SYST PARASITOL, V34, P89, DOI 10.1007/BF00009684; FROESE R., 2013, FISHBASE; GUSSEV A. V., 1951, PARAZIT SB B, V1, P394; HO J. -S., 1985, REP SADO MAR BIOL ST, V15, P31; Ho Ju-shey, 2008, Journal of the Fisheries Society of Taiwan, V35, P251; Ho JS, 2011, ZOOL STUD, V50, P611; Humes A. G., 1964, Crustaceana, V6, P238, DOI 10.1163/156854064X00650; HUYS R., 1991, COPEPOD EVOLUTION, P1; Izawa K, 2012, CRUSTACEANA, V85, P81, DOI 10.1163/156854012X623674; Izawa K, 2011, CRUSTACEANA, V84, P1605, DOI 10.1163/156854011X605792; Izawa K, 2009, CRUSTACEANA, V82, P349, DOI 10.1163/156854008X367197; Izawa K, 2013, CRUSTACEANA, V86, P739, DOI 10.1163/15685403-00003199; Izawa K, 2008, CRUSTACEANA, V81, P695, DOI 10.1163/156854008784513465; Izawa K, 2011, CRUSTACEANA, V84, P1269, DOI 10.1163/001121611X590102; Izawa K, 2010, CRUSTACEANA, V83, P313, DOI 10.1163/001121609X12591347509329; Izawa K, 2012, CRUSTACEANA, V85, P1589, DOI 10.1163/15685403-00003129; Izawa K, 1996, J CRUSTACEAN BIOL, V16, P406, DOI 10.2307/1548896; Izawa K, 2008, CRUSTACEANA, V81, P1331, DOI 10.1163/156854008X369519; KABATA Z., 1979, PARASITIC COPEPODA B, P1; KABATA Z, 1979, CRUSTACEANA, V37, P198, DOI 10.1163/156854079X01031; Kirtsinghe P., 1964, Bulletin of the Fisheries Research Station Ceylon, V17, P45; Kirtisinghe P., 1937, Parasitology Cambridge, V29, P435; Liu Wei-Cheng, 2009, Journal of the Fisheries Society of Taiwan, V36, P119; Maran BAV, 2014, ACTA PARASITOL, V59, P139, DOI 10.2478/s11686-014-0220-8; MARKEVICH A. P., 1956, PARASITIC COPEPODS F, P1; Olivier P. A. S., 1995, Koedoe, V38, P99; Pillai N.K., 1985, pi; PILLAI N. KRISHNA, 1964, J MAR BIOL ASS INDIA, V6, P61; RADUJKOVIC B M, 1989, Acta Adriatica, V30, P237; Raibaut A, 1971, Bull Inst natn Scient Tech Oceanogr Peche Salammbo, V2, P169; RAIBAUT A., 1977, B MUS NATL HIST NAT, V329, P833; ROUBAL F. R., 1981, AUST J ZOOL S, V84, P1; Shiino S. M., 1955, Report of the Faculty of Fisheries Prefectural University of Mie, V2, P50; SHISHIDO I., 1898, DOBUTSU GAKU ZASHI, V10, P120; SHISHIDO I., 1898, DOBUTSU GAKU ZASHI, V10, P254; SHISHIDO I., 1898, DOBUTSU GAKU ZASHI, V10, P148; SHISHIDO I., 1898, SOBUTSUGAKU ZASSHI T, V10, P82; SHISHIDO I., 1898, DOBUTSU GAKU ZASHI, V10, P337; SHISHIDO I., 1898, DOBUTSU GAKU ZASHI, V10, P215; WALTER T. C., 2014, WORLDS COPEPODS; Wilson C. B., 1922, Proceedings of the United States National Museum, V60, P1; WILSON C. B., 1935, PAP TORTUGAS LAB, V29, P329; Yamaguti S., 1963, pi; Yamaguti S., 1936, PARASITIC COPEPODS 3	54	2	2	BRILL ACADEMIC PUBLISHERS	LEIDEN	PLANTIJNSTRAAT 2, P O BOX 9000, 2300 PA LEIDEN, NETHERLANDS	0011-216X	1568-5403		CRUSTACEANA	Crustaceana	NOV	2014	87	13					1521	1558		10.1163/15685403-00003373		38	Marine & Freshwater Biology	Marine & Freshwater Biology	AU3EC	WOS:000345494400004		
J	Ahamed, F; Ohtomi, J				Ahamed, F.; Ohtomi, J.			RELATIVE GROWTH AND SEXUAL MATURITY OF THE PANDALID SHRIMP PLESIONIKA IZUMIAE (DECAPODA, CARIDEA) IN KAGOSHIMA BAY, SOUTHERN JAPAN	CRUSTACEANA			English	Article						Maturation; Pandalidae; Plesionika izumiae; relative growth; secondary sexual characters	ALLOMETRIC GROWTH; CHINA SEA; CRUSTACEA; SIZE; REPRODUCTION; POPULATIONS; PORTUNIDAE; MATURATION; FECUNDITY; BRACHYURA	The pandalid shrimp Plesionika izumiae Omori, 1971 is widely distributed in the west Pacific region. This is a relatively common shrimp in the coastal waters of Japan, except off northern Honshu and Hokkaido, and it is commercially important for small-scale bottom seine fishery. The relative growth of secondary sexual characters (appendix masculina for the male and abdomen width for the female) of P. izumiae was studied in Kagoshima Bay, southern Japan, from December 2009 to November 2011. The length of the appendix masculina was measured for males, while abdomen width near the second pleopod was measured for females. The relationships between carapace length and the observed secondary sexual characters were studied using the least squares method. The appendix masculina showed positive allometric growth in relation to carapace length (CL), showing discontinuities at 7.3 mm CL. The width of the female abdomen showed positive allometric growth with CL, while indicating a discontinuity at 8.6 mm carapace length. The observed discontinuities in the growth rate of secondary sexual characters of P. izumiae might be attributed to sexual maturation.	[Ahamed, F.] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 8900065, Japan; [Ohtomi, J.] Kagoshima Univ, Fac Fisheries, Kagoshima 8900056, Japan	Ohtomi, J (reprint author), Kagoshima Univ, Fac Fisheries, 4-50-20 Shimoarata, Kagoshima 8900056, Japan.	ohtomi@fish.kagoshima-u.ac.jp					ABELLO P, 1988, MAR BIOL, V98, P39, DOI 10.1007/BF00392657; Ahamed F, 2011, J CRUSTACEAN BIOL, V31, P441, DOI 10.1651/10-3429.1; Ahamed F, 2012, J CRUSTACEAN BIOL, V32, P733, DOI 10.1163/193724012X645853; KURIS AM, 1987, J CRUSTACEAN BIOL, V7, P219, DOI 10.2307/1548603; WENNER AM, 1974, CAN J ZOOL, V52, P1095, DOI 10.1139/z74-147; LOVETT DL, 1989, J CRUSTACEAN BIOL, V9, P529, DOI 10.2307/1548585; Nates SF, 1999, FISH B-NOAA, V97, P526; ALVAREZ RZ, 1968, INVEST PESQ, V32, P1; CARTES JE, 1993, MAR ECOL PROG SER, V94, P27, DOI 10.3354/meps094027; Mantel SK, 2005, J CRUSTACEAN BIOL, V25, P450, DOI 10.1651/C-2541; AOTO T., 1952, ZOOLOGY, V11, P1; Berkeley AA, 1929, AM NAT, V63, P571, DOI 10.1086/280293; Biagi R, 2006, HYDROBIOLOGIA, V559, P247, DOI 10.1007/s10750-005-9115-x; BLACKSTONE NW, 1987, SYST ZOOL, V36, P76, DOI 10.2307/2413310; Botello A, 2006, CARIBB J SCI, V42, P171; BUTLER TH, 1964, J FISH RES BOARD CAN, V21, P1403; Cha H.K., 2001, SHRIMPS KOREAN WATER; CHACE JR F.A., 1985, SMITHS CONTR ZOOL, V411, P1; FELDER DL, 1989, J CRUSTACEAN BIOL, V9, P540, DOI 10.2307/1548586; GONZALEZGURRIARAN E, 1994, ICES J MAR SCI, V51, P133, DOI 10.1006/jmsc.1994.1015; Hartnoll R.G., 1982, P111; Hayashi K.-I., 1976, Proceedings of the Japanese Society for Systematic Zoology, VNo. 12, P46; HOLTHUIS L.B., 1980, FAO FISH SYNOP, V125, P1; Huxley J., 1932, PROBLEMS RELATIVE GR; JIANG J. X., 1985, TAIWAN STRAIT, V4, P89; KASHIWAGI M., 1974, NIPPON SUISAN GAKK, V40, P985; KING MG, 1984, J CRUSTACEAN BIOL, V4, P567, DOI 10.2307/1548071; Li XZ, 2007, CRUSTACEANA, V80, P699, DOI 10.1163/156854007781360702; Li XZ, 2006, RAFFLES B ZOOL, V54, P361; Li XZ, 2003, RAFFLES B ZOOL, V51, P257; Li Xinzheng, 2006, Memoirs of the Queensland Museum, V52, P151; Liu R., 1994, MARINE SPECIES THEIR, P545; Lizarraga-Cubedo HA, 2003, FISH RES, V65, P137, DOI 10.1016/j.fishres.2003.09.012; Manjon-Cabeza ME, 1999, CRUSTACEANA, V72, P507, DOI 10.1163/156854099503555; MANTELATTO F. L., 2005, ACTA LIMNOL BRAS, V17, P245; Mantelatto F.L.M., 1996, Nauplius, V4, P29; Miranda Ivana, 2010, Nauplius, V18, P87; Muino R, 1999, J MAR BIOL ASSOC UK, V79, P295, DOI 10.1017/S0025315498000320; OHTOMI J., 2006, CRUSTACEANA, V78, P1325; OHTOMI J., 2008, P 5 WORLD FISH C 200; Ohtomi Jun, 2004, Bulletin of the Japanese Society of Fisheries Oceanography, V68, P158; Okumura T, 2005, MAR BIOL, V148, P347, DOI 10.1007/s00227-005-0073-7; OMORI M, 1971, Crustaceana (Leiden), V20, P241, DOI 10.1163/156854071X00030; Petriella Ana M., 1997, Investigaciones Marinas Universidad Catolica de Valparaiso, V25, P135; Sokal R., 1981, BIOMETRY; TEISSIER G., 1960, PHYSL CRUSTACEA, V1, P537; THESSALOULEGAKI M, 1989, J CRUSTACEAN BIOL, V9, P595, DOI 10.2307/1548591; Tuck ID, 2000, ICES J MAR SCI, V57, P1227, DOI 10.1006/jmsc.2000.0809; Wang Yihao, 1987, Oceanologia et Limnologia Sinica, V18, P48; Wieland K, 2004, FISH RES, V69, P49, DOI 10.1016/j.fishres.2004.04.003; Williams A. B., 1984, SHRIMPS LOBSTERS CRA; Zar JH, 1984, BIOSTATISTICAL ANAL	52	0	0	BRILL ACADEMIC PUBLISHERS	LEIDEN	PLANTIJNSTRAAT 2, P O BOX 9000, 2300 PA LEIDEN, NETHERLANDS	0011-216X	1568-5403		CRUSTACEANA	Crustaceana	NOV	2014	87	13					1567	1577		10.1163/15685403-00003366		11	Marine & Freshwater Biology	Marine & Freshwater Biology	AU3EC	WOS:000345494400006		
J	Islama, MS; Hiraishi, N; Nassar, M; Yiu, C; Otsuki, M; Tagami, J				Islama, Md. Sofiqul; Hiraishi, Noriko; Nassar, Mohannad; Yiu, Cynthia; Otsuki, Masayuki; Tagami, Junji			Effect of hesperidin incorporation into a self-etching primer on durability of dentin bond	DENTAL MATERIALS			English	Article						Micro-tensile bond strength; Hybrid layer; Hesperidin; Hardness; Elastic modulus; Collagen; Cross-linker	COLLAGEN CROSS-LINKING; STRENGTH; RESIN; INTERFACE; ADHESIVE; RATS; CARCINOGENESIS; DEGRADATION; STABILITY; MATRIX	Objective. Collagen degradation at the resin-dentin interface deteriorates dentin bond durability. The use of natural cross-linkers might offer a positive approach to stabilize the resin-dentin interface. This study evaluated the effects of incorporation of natural cross linkers into a self-etch adhesive primer on the immediate and long-term micro-tensile bond strengths (mu TBS) to dentin. Methods. Experimental primers were prepared by incorporating either 0.5%, 1%, 2%, 5% of hesperidin (HPN) or 0.5% of proanthocyanidins (PA) into Clearfil SE primer. Extracted human molar teeth were restored using the experimental primers or the pure SE primer(control). The mechanical properties of the bonded interfaces were measured using the nano-indentation tests. Beam-shaped bonded specimens were sub-divided for one-day and one-year mu TBS test. Interfacial collagen morphology was observed using transmission electron microscopy. Result. The immediate mu TBS significantly increased in 0.5%, 1% and 2% HPN-incorporated groups when compared with the control. The mechanical properties of bonded interface were improved with 1% and 2% HPN-incorporated primers. For the long-term mu TBS, the 2% and 5% HPN-incorporated group were significantly higher than the control. The morphology of the collagen fibrils were preserved by 5% HPN-incorporation after one-year storage. The PA group, however, failed to improve the mu TBS and the mechanical properties of the bonded interfaces. Significance. The incorporation of 2% HPN into the self-etching primer had a positive effect on the immediate mu TBS and mechanical properties of the resin-dentin interfaces. The 5% HPN group preserved the morphology of the collagen in the hybrid layer after one-year storage in artificial saliva. (C) 2014 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.	[Islama, Md. Sofiqul; Hiraishi, Noriko; Nassar, Mohannad; Otsuki, Masayuki; Tagami, Junji] Tokyo Med & Dent Univ, Grad Sch, Dept Oral Hlth Sci, Cariol & Opert Dent, Tokyo 1138549, Japan; [Islama, Md. Sofiqul; Nassar, Mohannad; Tagami, Junji] Tokyo Med & Dent Univ, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Bunkyo Ku, Tokyo, Japan; [Yiu, Cynthia] Univ Hong Kong, Fac Dent, Paediat Dent & Orthodont, Hong Kong, Hong Kong, Peoples R China	Hiraishi, N (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Oral Hlth Sci, Cariol & Opert Dent, 1-5-45 Yushima, Tokyo 1138549, Japan.	hiraope@tmd.ac.jp	Hiraishi, Noriko/H-8751-2015		Japanese Ministry of Education, Global Center of Excellence (GCOE) program, International Research Center for molecular Science in Tooth and Bone Diseases	This work was supported by the grant from the Japanese Ministry of Education, Global Center of Excellence (GCOE) program, International Research Center for molecular Science in Tooth and Bone Diseases.	Van Meerbeek B, 2003, OPER DENT, V28, P215; Zhou P, 2012, CURR MED CHEM, V19, P226; Miller EG, 2008, NUTR CANCER, V60, P69, DOI 10.1080/01635580701616163; Pashley DH, 2004, J DENT RES, V83, P216; Hirata A, 2005, ANTICANCER RES, V25, P3367; Miguez PA, 2004, J DENT RES, V83, P807; Bedran-Russo AKB, 2009, J DENT RES, V88, P807, DOI 10.1177/0022034509342556; Epasinghe DJ, 2012, J DENT, V40, P173, DOI 10.1016/j.jdent.2011.11.013; Al-Ammar A, 2009, J BIOMED MATER RES B, V91B, P419, DOI 10.1002/jbm.b.31417; De Munck J, 2005, J DENT RES, V84, P118; Hiraishi N, 2011, J DENT, V39, P391, DOI 10.1016/j.jdent.2011.03.002; Castellan CS, 2010, DENT MATER, V26, P968, DOI 10.1016/j.dental.2010.06.001; Carrilho MRD, 2005, DENT MATER, V21, P232, DOI 10.1016/j.dental.2004.06.001; Van Meerbeek B, 2011, DENT MATER, V27, P17, DOI 10.1016/j.dental.2010.10.023; Breschi L, 2010, DENT MATER, V26, P571, DOI 10.1016/j.dental.2010.02.007; Wang Y, 2003, J DENT RES, V82, P141; Horcajada MN, 2008, J APPL PHYSIOL, V104, P648, DOI 10.1152/japplphysiol.00441.2007; Wang Y, 2005, J DENT RES, V84, P350; Van Landuyt KL, 2008, DENT MATER, V24, P1412, DOI 10.1016/j.dental.2008.02.018; Kamaraj S, 2010, EUR J PHARMACOL, V649, P320, DOI 10.1016/j.ejphar.2010.09.017; EMIM JAD, 1994, J PHARM PHARMACOL, V46, P118; Green B, 2010, J DENT, V38, P908, DOI 10.1016/j.jdent.2010.08.004; Nishitani Y, 2006, J DENT RES, V85, P1016; Breschi L, 2008, DENT MATER, V24, P90, DOI 10.1016/j.dental.2007.02.009; Liu Y, 2011, J DENT RES, V90, P953, DOI 10.1177/0022034510391799; Carvalho RM, 2004, J DENT, V32, P55, DOI 10.1016/j.dent.2003.08.003; Ding F, 2012, J PHOTOCH PHOTOBIO B, V106, P53, DOI 10.1016/j.jphotobiol.2011.10.004; Ding F, 2012, J AGR FOOD CHEM, V60, P7218, DOI 10.1021/jf300424w; Galati E M, 1994, Farmaco, V40, P709; Hashimoto M, 2002, J Dent, V30, P99, DOI 10.1016/S0300-5712(02)00004-0; Islam S, 2012, J DENT, V40, P1052, DOI 10.1016/j.jdent.2012.08.015; Islam Sofiqul Md, 2012, Dent Mater J, V31, P362; Kawaguchi K, 2004, BIOL PHARM BULL, V27, P679, DOI 10.1248/bpb.27.679; Martinez AL, 2011, PHARMACOL BIOCHEM BE, V97, P683, DOI 10.1016/j.pbb.2010.11.010; van Strijp AJP, 2003, CARIES RES, V37, P58, DOI 10.1159/000068223; Yiu CK, 2004, BIOMATERIALS, V25, P5789	36	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0109-5641	1879-0097		DENT MATER	Dent. Mater.	NOV	2014	30	11					1205	1212		10.1016/j.dental.2014.08.371		8	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	AU3PH	WOS:000345525400003		
J	Hoshika, T; Nishitani, Y; Yoshiyama, M; Key, WO; Brantley, W; Agee, KA; Breschi, L; Cadenaro, M; Tay, FR; Rueggeberg, F; Pashley, DH				Hoshika, Tomohiro; Nishitani, Yoshihiro; Yoshiyama, Masahiro; Key, William O., III; Brantley, William; Agee, Kelli A.; Breschi, Lorenzo; Cadenaro, Milena; Tay, Franklin R.; Rueggeberg, Frederick; Pashley, David H.			Effects of quaternary ammonium-methacrylates on the mechanical properties of unfilled resins	DENTAL MATERIALS			English	Article						Percent-conversion; TPO; Dry-testing; Fracture toughness; Quaternary ammonium; methacrylates; Ultimate tensile strength; Young's modulus; Wet-testing	SELF-ETCH ADHESIVES; LIGHT CURING UNITS; DENTAL ADHESIVE; WATER SORPTION; FRACTURE-TOUGHNESS; RESTORATIVE RESINS; CURED COMPOSITES; PHOTOPOLYMERIZATION; PHOTOINITIATORS; POLYMERIZATION	Objective. Adding antimicrobial/anti-MMP quaternary ammonium methacrylates (QAMs) to comonomer blends should not weaken the mechanical properties of dental resins. This work evaluated the degree conversion and mechanical properties of BisGMA/TEGDMA/HEMA(60: 30: 10) containing 0-15 mass% QAMs A-E (A: 2-acryloxyethyltrimethyl ammonium chloride; B: [3-(methacryloylamino) propyl] trimethylammonium chloride; C: [2(methacryloxy) ethyl] trimethyl ammonium chloride; D: diallyldimethyl ammonium chloride; E: 2-(methacryloyloxy) ethyltrimethyl ammonium methyl sulfate. Methods. Unfilled resins with and without QAM were placed on ATR-FTIR and light-polymerized for 20 s in a thin film at 30 degrees C. Unfilled resin beams were casted from square hollow glass tubings. Half of the beams were tested after 3 days of drying (control); the other half were tested wet after 3 days of water storage. Results. Addition of QAMs in control resins significantly increased conversion 600 s after light termination, with the exception of 5% MAPTAC (p < 0.05). Increase of QAM content within a formulation significantly increased conversion. Control beams gave dry Young's moduli of similar to 700 MPa. Addition of 5, 10 or 15 mass% QAMs produced significant reductions in dry Young's moduli except for 5% B or C. 15 mass% A, B and C lowered the wet Young's moduli of the resin beams by more than 30%. The ultimate tensile stress (UTS) of control dry resin was 89 +/- 11 MPa. Addition of 5-10 mass% QAMs had no adverse effect on the dry UTS. After water storage, the UTS of all resin blends fell significantly (p < 0.05), especially when 15 wt% QAMs was added. Control dry beams gave fracture toughness (K-IC) values of 0.88 +/- 0.1 MPa m(1/2). Wet values were significantly higher at 1.02 +/- 0.06 (p < 0.05). K-IC of dry beams varied from 0.85 +/- 0.08 at 5% QAMs to 0.49 +/- 0.05 at 15% QAMs. Wet beams gave K-IC values of 1.02 +/- 0.06 MPa m(1/2) that fell to 0.23 +/- 0.01 at 15% QAMs. Significance. Addition of 10% QAMs increased the degree of conversion of unfilled resins, but lowered wet toughness and UTS; addition of 15% QAMs lowered the mechanical properties of wet resins below acceptable levels. (C) 2014 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.	[Hoshika, Tomohiro; Nishitani, Yoshihiro; Yoshiyama, Masahiro] Okayama Univ, Grad Sch Med, Dept Operat Dent, Dent & Pharmaceut Sci, Okayama, Japan; [Key, William O., III; Brantley, William; Agee, Kelli A.; Rueggeberg, Frederick; Pashley, David H.] Georgia Regents Univ, Coll Dent Med, Dept Oral Biol, Augusta, GA USA; [Breschi, Lorenzo] Univ Trieste, Dept Biomed, Bologna, Italy; [Breschi, Lorenzo] IGM CNR, Univ Bologna, Bologna, Italy; [Cadenaro, Milena] Univ Trieste, Unit Dent Sci & Biomat, Dept Biomed, Trieste, Italy; [Tay, Franklin R.] Georgia Regents Univ, Coll Dent Med, Dept Endodont, Augusta, GA USA	Pashley, DH (reprint author), Georgia Hlth Sci Univ, Coll Dent Med, Dept Oral Biol, Augusta, GA 30912 USA.	dpashley@gru.edu		Breschi, Lorenzo/0000-0001-7621-226X	USPHS NIH/NIDCR [R01 DE015306]	The authors thank Professor Jack Ferracane for the loan of the single-edge notched-beam mold used in this study and ESSTEC for supplying the HEMA and dimethacrylates used in this work. We also thank Professor Jeff Standsbury for hydrogenating some of our QAM/dimethacrylate blends. This work was supported, in part, by USPHS NIH/NIDCR R01 DE015306(P.I. DP). Professor Pashley serves as a Highly-Cited Scholar to the Faculty of Dentistry, King Abdulazziz University, Jeddah, Saudi Arabia. The authors are grateful to Mrs. Michelle Barnes for her secretarial support.	Sideridou I, 2004, BIOMATERIALS, V25, P367, DOI 10.1016/S0142-9612(03)00529-5; Sanares AME, 2001, DENT MATER, V17, P542, DOI 10.1016/S0109-5641(01)00016-1; Ye Q, 2008, J DENT RES, V87, P829; Li F, 2013, J DENT RES, V92, P932, DOI 10.1177/0022034513502053; Leprince JG, 2011, DENT MATER, V27, P157, DOI 10.1016/j.dental.2010.09.011; Paul SJ, 1999, J DENT, V27, P209, DOI 10.1016/S0300-5712(98)00042-6; Neumann MG, 2005, J DENT, V33, P525, DOI 10.1016/j.jdent.2004.11.013; Malacarne J, 2006, DENT MATER, V22, P973, DOI 10.1016/j.dental.2005.11.020; Moszner N, 2005, DENT MATER, V21, P895, DOI 10.1016/j.dental.2005.05.001; Imazato S, 2007, DENT MATER, V23, P170, DOI 10.1016/j.dental.2006.01.005; FERRACANE JL, 1986, J BIOMED MATER RES, V20, P121, DOI 10.1002/jbm.820200111; Munksgaard EC, 2000, EUR J ORAL SCI, V108, P341, DOI 10.1034/j.1600-0722.2000.108004341.x; [Anonymous], 1995, ANN BOOK ASTM STANDA, V03, P431; Neumann MG, 2006, DENT MATER, V22, P576, DOI 10.1016/j.dental.2005.06.006; Balkenhol M, 2009, DENT MATER, V25, P917, DOI 10.1016/j.dental.2009.01.099; Cheong C, 2003, OPER DENT, V28, P747; Imazato S, 1997, J DENT RES, V76, P768; Imazato S, 2009, DENT MATER J, V28, P11; Beyth N, 2006, BIOMATERIALS, V27, P3995, DOI 10.1016/j.biomaterials.2006.03.003; Donnelly A, 2007, J ENDODONT, V33, P990, DOI 10.1016/j.joen.2006.03.021; Cadenaro M, 2010, DENT MATER, V26, P288, DOI 10.1016/j.dental.2009.11.078; Yiu CKY, 2005, BIOMATERIALS, V26, P6863, DOI 10.1016/j.biomaterials.2005.05.011; Hosaka K, 2010, DENT MATER, V26, P360, DOI 10.1016/j.dental.2009.12.007; Li F, 2009, J DENT RES, V88, P372, DOI 10.1177/0022034509334499; Jakubiak J, 2003, POLYMER, V44, P5219, DOI 10.1016/S0032-3861(03)00568-8; Palin WM, 2005, DENT MATER, V21, P852, DOI 10.1016/j.dental.2005.01.004; Guo X, 2008, DENT MATER, V24, P824, DOI 10.1016/j.denta1.2007.10.003; Song J, 2011, COLLOID SURFACE B, V82, P651, DOI 10.1016/j.colsurfb.2010.10.027; Eick JD, 2005, DENT MATER, V21, P384, DOI 10.1016/j.dental.2004.07.001; Tezvergil-Mutluay A, 2011, J DENT RES, V90, P535, DOI 10.1177/0022034510389472; Ferracane JL, 1994, J ORAL REHABIL, V21, P41; Higgs WAJ, 2001, J MATER SCI-MATER M, V12, P453, DOI 10.1023/A:1011261322881; HILL RG, 1983, BIOMATERIALS, V4, P112; Hosaka K, 2007, EUR J ORAL SCI, V115, P1; Ilie N, 2008, DENT MATER J, V27, P221; Nava D, 1996, SPECTROCHIM ACTA A, V52, P1201, DOI 10.1016/0584-8539(96)01676-5; Pashley David H, 2011, Compend Contin Educ Dent, V32, P60; Puri C, 2008, J PROSTHET DENT, V100, P302; ROBERTS JC, 1977, J DENT RES, V56, P748, DOI 10.1177/00220345770560070801; Faltermeier A, 2007, AM J ORTHOD DENTOFAC, V131, DOI 10.1016/j.ajodo.2006.07.019; Tezvergil-Mutluay A, 2011, J DENT, V39, P57, DOI 10.1016/j.jdent.2010.10.003; Ye G, 2009, DENT MATER, V25, P452	42	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0109-5641	1879-0097		DENT MATER	Dent. Mater.	NOV	2014	30	11					1213	1223		10.1016/j.dental.2014.08.365		11	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	AU3PH	WOS:000345525400004		
J	Baum, SD; Handoh, IC				Baum, Seth D.; Handoh, Itsuki C.			Integrating the planetary boundaries and global catastrophic risk paradigms	ECOLOGICAL ECONOMICS			English	Article						Global catastrophic risk; Planetary boundaries; Biogeochemical phosphorus cycle; Resilience; Risk	SAFE OPERATING SPACE; CLIMATE-CHANGE; PHOSPHORUS; AGRICULTURE; ENVIRONMENT; HUMANITY; COLLAPSE; HOLOCENE; CYCLES; SYSTEM	Planetary boundaries (PBs) and global catastrophic risk (GCR) have emerged in recent years as important paradigms for understanding and addressing global threats to humanity and the environment. This article compares the PBs and GCR paradigms and integrates them into a unified PBs-GCR conceptual framework, which we call Boundary Risk for Humanity and Nature (BRIHN). PBs emphasizes global environmental threats, whereas GCR emphasizes threats to human civilization. Both paradigms rate their global threats as top priorities for humanity but lack precision on key aspects of the impacts of the threats. Our integrated BRIHN framework combines elements from both paradigms' treatments of uncertainty and impacts. The BRIHN framework offers PBs a means of handling human impacts and offers GCR a theoretically precise definition of global catastrophe. The BRIHN framework also offers a concise stage for telling a stylized version of the story of humanity and nature co-evolving from the distant past to the present to multiple possible futures. The BRIHN framework is illustrated using the case of disruptions to the global phosphorus biogeochemical cycle. (C) 2014 Elsevier B.V. All rights reserved.	[Baum, Seth D.] Global Catastroph Risk Inst, Oakland, CA 94612 USA; [Handoh, Itsuki C.] Res Inst Humanity & Nat, Kita Ku, Kyoto 6038047, Japan	Baum, SD (reprint author), Global Catastroph Risk Inst, POB 72303, Oakland, CA 94612 USA.	seth@gcrinstitute.org; itsuki@chikyu.ac.jp			Global Catastrophic Risk Institute; Futurability Initiatives, Research Institute for Humanity and Nature; Japan Society for the Promotion of Science [22710044, 24710037]	This work was financially supported by the Global Catastrophic Risk Institute and by the Futurability Initiatives, Research Institute for Humanity and Nature. ICH was funded by the Japan Society for the Promotion of Science Grants-in-Aid for Young Scientists (B) Nos. 22710044 and 24710037. We thank Tony Barrett, Robert de Neufville, Dave Denkenberger, Jacob Haqq-Misra, Lee Kump, Diana Liverman, Tim Maher, Joshua Pearce, Kate Raworth, Carl Shulman, Will Steffen, Grant Wilson, and two anonymous reviewers for their helpful comments on earlier drafts. Any remaining errors are our own.	Tonn BE, 2002, FUTURES, V34, P117, DOI 10.1016/S0016-3287(01)00050-7; Handoh IC, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002039; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Baum Seth D., 2013, Environment Systems & Decisions, V33, P168, DOI 10.1007/s10669-012-9429-y; Gupta AK, 2004, CURR SCI INDIA, V87, P54; Wagreich M, 2011, SEDIMENT GEOL, V235, P1, DOI 10.1016/j.sedgeo.2010.10.012; Handoh IC, 2010, FUTURES, V42, P743, DOI 10.1016/j.futures.2010.04.023; Cordell D, 2014, GLOBAL ENVIRON CHANG, V24, P108, DOI 10.1016/j.gloenvcha.2013.11.005; Tonn BE, 1999, FUTURES, V31, P351; van der Leeuw S, 2011, ECOL SOC, V16, DOI 10.5751/ES-04341-160402; NG YK, 1991, SOC CHOICE WELFARE, V8, P79; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Smil V, 2000, ANNU REV ENERG ENV, V25, P53, DOI 10.1146/annurev.energy.25.1.53; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Running SW, 2012, SCIENCE, V337, P1458, DOI 10.1126/science.1227620; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Liu Y, 2008, J IND ECOL, V12, P229, DOI 10.1111/j.1530-9290.2008.00025.x; Baum SD, 2009, SPACE POLICY, V25, P75, DOI 10.1016/j.spacepol.2009.02.008; Petschel- Held G, 1999, CLIMATIC CHANGE, V41, P303, DOI 10.1023/A:1005487123751; Weitzman ML, 2009, REV ECON STAT, V91, P1, DOI 10.1162/rest.91.1.1; Costanza R, 2007, AMBIO, V36, P522, DOI 10.1579/0044-7447(2007)36[522:SOCWCW]2.0.CO;2; Matheny JG, 2007, RISK ANAL, V27, P1335, DOI 10.1111/j.1539-6924.2007.00960.x; Richerson PJ, 2001, AM ANTIQUITY, V66, P387, DOI 10.2307/2694241; Carpenter SR, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014009; Tacon AGJ, 2013, REV FISH SCI, V21, P22, DOI 10.1080/10641262.2012.753405; Scholz RW, 2013, SCI TOTAL ENVIRON, V461, P799, DOI 10.1016/j.scitotenv.2013.05.043; Bouwman L, 2013, P NATL ACAD SCI USA, V110, P20882, DOI 10.1073/pnas.1012878108; Raudsepp-Hearne C, 2010, BIOSCIENCE, V60, P576, DOI 10.1525/bio.2010.60.8.4; Maher TM, 2013, SUSTAINABILITY-BASEL, V5, P1461, DOI 10.3390/su5041461; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Bradshaw GA, 2000, CONSERV ECOL, V4; Tonn BE, 2009, FUTURES, V41, P427, DOI 10.1016/j.futures.2009.01.009; Atkinson A., 1999, IMPACT EARTH ASTEROI; Baroni IR, 2014, BIOGEOSCIENCES, V11, P977, DOI 10.5194/bg-11-977-2014; Baum S. D., 2010, SUSTAINABILITY, V2, P591; Bostrom N., 2002, J EVOL TECHNOL, P9; Bostrom N., 2003, UTILITAS, V15, P308, DOI DOI 10.1017/S0953820800004076; Bostrom N, 2013, GLOB POLICY, V4, P15, DOI 10.1111/1758-5899.12002; Bostrom Nick, 2008, GLOBAL CATASTROPHIC; Cordell D, 2011, SUSTAINABILITY-BASEL, V3, P2027, DOI 10.3390/su3102027; Cornell S, 2012, ECOL SOC, V17, DOI 10.5751/ES-04731-1701r02; Hempsell CM, 2004, JBIS-J BRIT INTERPLA, V57, P14; Henrich K, 2002, ENVIRON VALUE, V11, P489, DOI 10.3197/096327102129341190; Holling C.S., 1973, ANNU REV ECOL SYST, V4, P1; Jarvis I, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002081; Jenkyns H.C., 2011, GEOCHEM GEOPHY GEOSY, V11; Leslie John, 1996, END WORLD SCI ETHICS; Lewis SL, 2012, NATURE, V485, P417, DOI 10.1038/485417a; Meadows D., 1972, LIMITS GROWTH; Nordhaus T, 2012, PLANETARY BOUNDARIES; POSNER RICHARD A., 2004, CATASTROPHE RISK RES; Rees M., 2003, OUR FINAL CENTURY WI; Rockstrom J, 2009, ECOL SOC, V14; Steffen W., 2004, GLOBAL CHANGE EARTH; Tonn B, 2013, RISK ANAL, V33, P1772, DOI 10.1111/risa.12039; Van Vuuren DP, 2010, GLOBAL ENVIRON CHANG, V20, P428, DOI 10.1016/j.gloenvcha.2010.04.004; Wackernagel M., 1996, OUR ECOLOGICAL FOOTP; Weisman A, 2007, WORLD US	58	2	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8009	1873-6106		ECOL ECON	Ecol. Econ.	NOV	2014	107						13	21		10.1016/j.ecolecon.2014.07.024		9	Ecology; Economics; Environmental Sciences; Environmental Studies	Environmental Sciences & Ecology; Business & Economics	AU2WG	WOS:000345474800002		
J	Romao, J; Neuts, B; Nijkamp, P; Shikida, A				Romao, Joao; Neuts, Bart; Nijkamp, Peter; Shikida, Asami			Determinants of trip choice, satisfaction and loyalty in an eco-tourism destination: a modelling study on the Shiretoko Peninsula, Japan	ECOLOGICAL ECONOMICS			English	Article						Eco-tourism; Sustainability; Marketing; Motivations; Tourist satisfaction; Tourist loyalty; Structural equation modelling	STRUCTURAL MODEL; FUTURE BEHAVIOR; HERITAGE CITIES; IMAGE; MOTIVATIONS	Eco-tourism has recently gained an important position in the choice mechanism of tourists. Sustainable tourism development implies a combination of ecological protection, economic prosperity and social benefits for local communities. This requires an effective marketing policy to identify and attract visitors interested in - and motivated by - the particular local attractions of the place. This study addresses the development of tourism services on the Shiretoko Peninsula, a World Heritage Site since 2005, located in the northeast part of the Japanese island of Hokkaido. The novelty of our study is found in a systemic approach, combining tourists' characteristics and expectations/motivations regarding a certain destination with the resulting dissatisfaction and loyalty behaviour regarding the tourist site concerned. A multinomial logistic regression is applied to the tourists' characteristics and motivations, while next a structural path analysis is applied to the elements determining their satisfaction with the visit concerned. This structural model allows us to depict the relations between trip choice (in this case, the specific kind of boat tour) and the effects of this choice on tourists' satisfaction and loyalty. The implications of this analysis for the marketing and management of the site (e.g. in terms of loyalty behaviour) are also presented. (C) 2014 Elsevier B.V. All rights reserved.	[Romao, Joao; Nijkamp, Peter] Vrije Univ Amsterdam, Spatial Econ Dept, Amsterdam, Netherlands; [Romao, Joao] Univ Algarve, Res Ctr Spatial & Org Dynam, Faro, Portugal; [Neuts, Bart] Katholieke Univ Leuven, Dept Earth & Environm Sci, Leuven, Belgium; [Shikida, Asami] Hokkaido Univ, Ctr Adv Tourism Studies, Sapporo, Hokkaido 060, Japan; [Nijkamp, Peter] Adam Mickiewicz Univ, Poznan, Poland	Nijkamp, P (reprint author), Vrije Univ Amsterdam, Spatial Econ Dept, Amsterdam, Netherlands.	p.nijkamp@vu.nl	Romao, Joao/M-4317-2013	Romao, Joao/0000-0001-6024-2624	Fundacao para a Ciencia e Tecnologia Portugal	The production of this article has been partially supported by Fundacao para a Ciencia e Tecnologia Portugal.	Bansal H, 2004, TOURISM MANAGE, V25, P387, DOI 10.1016/S0261-5177(03)00135-3; Lee TH, 2009, LEISURE SCI, V31, P215, DOI 10.1080/01490400902837787; Russo AP, 2002, ANN TOURISM RES, V29, P165, DOI 10.1016/S0160-7383(01)00029-9; Chen CF, 2007, TOURISM MANAGE, V28, P1115, DOI 10.1016/j.tourman.2006.07.007; Kozak M, 2002, TOURISM MANAGE, V23, P221, DOI 10.1016/S0261-5177(01)00090-5; Williams PW, 2009, FUTURES, V41, P396, DOI 10.1016/j.futures.2008.11.019; Weaver DB, 2011, J TRAVEL RES, V50, P335, DOI 10.1177/0047287510362920; Yoon Y, 2005, TOURISM MANAGE, V26, P45, DOI 10.1016/j.tourman.2003.08.016; Ritchie JRB, 2000, TOURISM MANAGE, V21, P1; Chen CF, 2010, TOURISM MANAGE, V31, P29, DOI 10.1016/j.tourman.2009.02.008; Bandarin F., 2005, POLITICS WORLD HERIT, pv; Castro CB, 2007, TOURISM MANAGE, V28, P175, DOI 10.1016/j.tourman.2005.11.013; Choong-Ki L., 1997, TOURISM MANAGE, V188, P587; Crompton J. L., 1979, Annals of Tourism Research, V6, P408, DOI 10.1016/0160-7383(79)90004-5; Dann G. M. S., 1981, Annals of Tourism Research, V8, P187, DOI 10.1016/0160-7383(81)90082-7; Doxey G., 1976, HERITAGE CANADA, V2, P26; Field A., 2009, DISCOVERING STAT USI; Gokita, 2012, TOUR CULT, V35, P28; Hasegawa H, 2010, TOURISM MANAGE, V31, P86, DOI 10.1016/j.tourman.2009.01.008; Hosmer D. W., 1989, APPL LOGISTIC REGRES; Kozak M., 2000, Journal of Travel Research, V38, P260; Miller G, 2005, MONITORING FOR A SUSTAINABLE TOURISM TRANSITION: THE CHALLENGE OF DEVELOPING AND USING INDICATORS, P1, DOI 10.1079/9780851990514.0000; Neuts B., 2013, TOUR EC IN PRESS; Oppermann M., 2000, Journal of Travel Research, V39, P78; Ritchie J. R. B., 2003, COMPETITIVE DESTINAT; Rivera M., 2010, J ECOTOURISM, V9, P2; Romao J., 2014, TOUR EC IN PRESS; Sharpley R., 2009, TOURISM DEV ENV SUST; UNESCO, 1972, CONV PROT WORLD CULT; UNWTO, 2006, SEM TOUR SUST LOC AG; UNWTO, 2007, PRACT GUID TOUR DEST; vanderBorg J, 1996, ANN TOURISM RES, V23, P306, DOI 10.1016/0160-7383(95)00065-8; Wall G., 2006, TOURISM CHANGE IMPAC; Weaver D., 2006, SUSTAINABLE TOURISM	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8009	1873-6106		ECOL ECON	Ecol. Econ.	NOV	2014	107						195	205		10.1016/j.ecolecon.2014.07.019		11	Ecology; Economics; Environmental Sciences; Environmental Studies	Environmental Sciences & Ecology; Business & Economics	AU2WG	WOS:000345474800020		
J	Hiraguchi, R				Hiraguchi, Ryoji			On the neoclassical growth model with non-constant discounting	ECONOMICS LETTERS			English	Article						Neoclassical growth; Non-constant discounting; Time-consistency		We study the neoclassical growth model with non-constant discounting. We do not assume specific functional forms for discounting and demonstrate that the competitive economy always performs better than the planning economy. (C) 2014 Elsevier B.V. All rights reserved.	Chiba Univ, Fac Law & Econ, Inage Ku, Chiba, Japan	Hiraguchi, R (reprint author), Chiba Univ, Fac Law & Econ, Inage Ku, 1-33 Yayoi Cho, Chiba, Japan.	ryojih@gmail.com					Karp L, 2007, J ECON THEORY, V132, P557, DOI 10.1016/j.jet.2005.07.006; Krusell P, 2002, J ECON THEORY, V105, P42, DOI 10.1006/jeth.2001.2888; Abdellaoui M, 2010, ECON J, V120, P845, DOI 10.1111/j.1468-0297.2009.02308.x; Barro RJ, 1999, Q J ECON, V114, P1125, DOI 10.1162/003355399556232; Harvey M., 1986, MANAGE SCI, V32, P1123; Iverson T., 2013, OPTIMAL CARBON TAXES; Laibson D., 2001, 5635 NAT BUR EC RES; POLLAK RA, 1968, REV ECON STUD, V35, P201, DOI 10.2307/2296548; STROTZ RH, 1956, REV ECON STUD, V23, P165	9	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	NOV	2014	125	2					175	178		10.1016/j.econlet.2014.08.029		4	Economics	Business & Economics	AU3WS	WOS:000345542100008		
J	Ui, T				Ui, Takashi			The social value of public information with convex costs of information acquisition	ECONOMICS LETTERS			English	Article						Public information; Private information; Crowding-out effect; Linear quadratic Gaussian game	TRANSPARENCY; COORDINATION; DISSEMINATION; POLICY	In a beauty contest framework, welfare can decrease with public information if the precision of private information is exogenous, whereas welfare necessarily increases with public information if the precision is endogenous with linear costs of information acquisition. The purpose of this paper is to reconcile these results by considering nonlinear costs of information acquisition. The main result of this paper is a necessary and sufficient condition for welfare to increase with public information. Using it, we show that costs of information acquisition are linear if and only if welfare necessarily increases with public information. Thus, welfare can decrease with public information for any strictly convex costs. This is because convex costs mitigate the so-called crowding-out effect of public information on private information, thereby making the social value of public information with endogenous precision closer to that with exogenous precision. (C) 2014 Elsevier B.V. All rights reserved.	Hitotsubashi Univ, Dept Econ, Tokyo 1868601, Japan	Ui, T (reprint author), Hitotsubashi Univ, Dept Econ, 2-1 Naka, Tokyo 1868601, Japan.	oui@econ.hit-u.ac.jp					LI L, 1987, J ECON THEORY, V42, P140, DOI 10.1016/0022-0531(87)90107-4; Angeletos GM, 2007, ECONOMETRICA, V75, P1103, DOI 10.1111/j.1468-0262.2007.00783.x; Morris S, 2002, AM ECON REV, V92, P1521, DOI 10.1257/000282802762024610; Hellwig C, 2009, REV ECON STUD, V76, P223, DOI 10.1111/j.1467-937X.2008.00515.x; Cornand C, 2008, ECON J, V118, P718, DOI 10.1111/j.1468-0297.2008.02139.x; Myatt DP, 2012, REV ECON STUD, V79, P340, DOI 10.1093/restud/rdr018; James JG, 2011, AM ECON REV, V101, P1561, DOI 10.1257/aer.101.4.1561; Angeletos GM, 2004, AM ECON REV, V94, P91, DOI 10.1257/0002828041301641; Colombo L, 2008, ECON LETT, V100, P196, DOI 10.1016/j.econlet.2008.01.009; Colombo L., 2014, REV EC STUD IN PRESS; Hellwig C., 2005, WORKING PAPER; Svensson LEO, 2006, AM ECON REV, V96, P448, DOI 10.1257/000282806776157650; VIVES X, 1988, ECONOMETRICA, V56, P851, DOI 10.2307/1912702; Wong J, 2008, CAN J ECON, V41, P46	14	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	NOV	2014	125	2					249	252		10.1016/j.econlet.2014.09.015		4	Economics	Business & Economics	AU3WS	WOS:000345542100027		
J	Yang, W; Shimanouchi, T; Wu, SJ; Kimura, Y				Yang, Wei; Shimanouchi, Toshinori; Wu, Shengji; Kimura, Yukitaka			Investigation of the Degradation Kinetic Parameters and Structure Changes of Microcrystalline Cellulose in Subcritical Water	ENERGY & FUELS			English	Article							SUPERCRITICAL WATER; THERMOGRAVIMETRIC ANALYSIS; ACID-HYDROLYSIS; RICE BRAN; BIOMASS; LIQUEFACTION; CONVERSION; NMR; CRYSTALLINITY; TEMPERATURES	Cellulose is the most abundant nature polymer and the main component in all biomass. In this study, the degradation kinetic parameters and structure changes of microcrystalline cellulose (MCC), which served as fundamental studies for degradation of biomass in subcritical water, were investigated at the temperature range from 100 to 300 degrees C. The yield of the MCC residue began to decrease at 205 degrees C and reached the lowest value at 275 degrees C. However, it howed an increase at the temperature higher than 275 degrees C. The degradation area of MCC (205275 degrees C) was separated into zones 1 and 2 with 245 degrees C as a boundary. The activation energy (E), pre-exponential factor (A), and reaction order (n) of MCC in each zone were 226.5 kJ mol(-1), 2.3 x 10(23) s(-1), and 0.6 (zone 1) and 423.1 kJ mol(-1), 9.0 x 10(40) s(-1), and 0.5 (zone 2), respectively. There showed a breaking point of 245 degrees C for the Arrhenius plot in the reaction area. The surface morphology of the MCC residue had no significant change below 260 degrees C, as indicated by scanning electron microscopy (SEM) images. However, it was completely destroyed at the temperature above 275 degrees C, and MCC residues with strong pore structures were obtained at higher temperatures. The structures of the crystalline region of the MCC residue below 275 degrees C had no significant change, although 89.2% MCC was degraded at 275 degrees C. However, they nearly disappeared at higher temperatures with the steeply reducing crystallinity index of MCC at the same time. As for the degradation mechanism of MCC, it was proposed that only the surface of MCC was degraded at 205-245 degrees C and the hydrogen and glycosidic bonds on the interior of MCC fibrils were destroyed at the temperature range from 245 to 275 degrees C. Finally, the remaining MCC as well as generated oligomer and monomer were further degraded at higher temperatures.	[Yang, Wei; Shimanouchi, Toshinori; Kimura, Yukitaka] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan; [Wu, Shengji] Hangzhou Dianzi Univ, Coll Mat & Environm Engn, Hangzhou 310018, Zhejiang, Peoples R China	Kimura, Y (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	yktkkimu@cc.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	The authors gratefully acknowledge support by a special project from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) for the environmental and life scientific studies on the integration of a low-carbon society and ensuring food safety and security. Professor Michihiro Miyake from the Graduate School of Environmental and Life Science, Okayama University, is acknowledged for his technical assistance in the XRD analysis.	Abdullah R, 2014, J WOOD SCI, V60, P278, DOI 10.1007/s10086-014-1401-7; Agrawal K. R., 1988, CAN J CHEM ENG, V66, P403; Liu ZG, 2013, FUEL, V103, P943, DOI 10.1016/j.fuel.2012.07.069; Zhao HB, 2007, CARBOHYD POLYM, V68, P235, DOI 10.1016/j.carbpol.2006.12.013; Sasaki M, 2000, IND ENG CHEM RES, V39, P2883, DOI 10.1021/ie990690j; Lu X, 2010, BIOMASS BIOENERG, V34, P1089, DOI 10.1016/j.biombioe.2010.02.015; Xu CB, 2008, ENERG FUEL, V22, P635, DOI 10.1021/ef700424k; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rogalinski T, 2005, J SUPERCRIT FLUID, V36, P49, DOI 10.1016/j.supflu.2005.03.001; BOON JJ, 1994, BIOMASS BIOENERG, V7, P25, DOI 10.1016/0961-9534(94)00044-T; Fang Z, 2004, IND ENG CHEM RES, V43, P2454, DOI 10.1021/ie034146t; Xiang Q, 2003, APPL BIOCHEM BIOTECH, V105, P505; Parthasarathy P, 2014, ENVIRON PROG SUSTAIN, V33, P256, DOI 10.1002/ep.11763; Tolonen LK, 2011, BIOMACROMOLECULES, V12, P2544, DOI 10.1021/bm200351y; BOBLETER O, 1994, PROG POLYM SCI, V19, P797, DOI 10.1016/0079-6700(94)90033-7; SCHWALD W, 1989, J CARBOHYD CHEM, V8, P565, DOI 10.1080/07328308908048017; Rostrup-Nielsen JR, 2005, SCIENCE, V308, P1421, DOI 10.1126/science.1113354; Kumar S, 2010, BIORESOURCE TECHNOL, V101, P1337, DOI 10.1016/j.biortech.2009.09.035; Schacht C, 2008, J SUPERCRIT FLUID, V46, P299, DOI 10.1016/j.supflu.2008.01.018; Daorattanachai P, 2012, J IND ENG CHEM, V18, P1893, DOI 10.1016/j.jiec.2012.04.019; Sasaki M, 2004, AICHE J, V50, P192, DOI 10.1002/aic.10018; Asghari FS, 2010, CARBOHYD RES, V345, P124, DOI 10.1016/j.carres.2009.10.006; MOK WSL, 1992, IND ENG CHEM RES, V31, P94, DOI 10.1021/ie00001a014; Mansaray KG, 1999, BIOMASS BIOENERG, V17, P19, DOI 10.1016/S0961-9534(99)00022-7; Moller M, 2013, RSC ADV, V3, P11035, DOI 10.1039/c3ra41582a; Sasaki M, 1998, J SUPERCRIT FLUID, V13, P261, DOI 10.1016/S0896-8446(98)00060-6; Jiang F, 2011, J MOL CATAL A-CHEM, V334, P8, DOI 10.1016/j.molcata.2010.10.006; Clifford T., 1998, FUNDAMENTALS SUPERCR, P22; Duvvuri M. S., 1975, J FIRE FLAMMABILITY, V6, P468; Gaikwad A, 2014, CHEM ENG J, V240, P109, DOI 10.1016/j.cej.2013.11.060; Goldfrab J., 1968, TECHNICAL REPORT ARM; Hata S, 2008, BIOCHEM ENG J, V40, P44, DOI 10.1016/j.bej.2007.11.016; Khajavi SH, 2005, J FOOD ENG, V68, P309, DOI 10.1016/j.jfoodeng.2004.06.004; Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10; Segal L., 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003]; Shafizadeh F, 1975, APPL POLYM S, V28, P153; Shimanouchi Toshinori, 2014, Environmental Engineering Research, V19, P41, DOI 10.4491/eer.2014.19.1.041; Wiboonsirikul J, 2008, BIOSCI BIOTECH BIOCH, V72, P384, DOI 10.1271/bbb.70464; Yang W, 2015, DESALIN WATER TREAT, V53, P2831, DOI 10.1080/19443994.2014.931537	39	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	NOV	2014	28	11					6974	6980		10.1021/ef501702q		7	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	AU2TB	WOS:000345469300032		
J	Murata, K; Liu, YY; Watanabe, MM; Inaba, M; Takahara, I				Murata, Kazuhisa; Liu, Yanyong; Watanabe, Makoto M.; Inaba, Megumu; Takahara, Isao			Hydrocracking of Algae Oil into Aviation Fuel-Range Hydrocarbons Using a Pt-Re Catalyst	ENERGY & FUELS			English	Article							BOTRYOCOCCUS-BRAUNII; MICROALGAE; CONVERSION; BIODIESEL; GLYCEROL; DIESEL	Renewable green aviation and diesel-type alkanes can be produced by hydrocracking of Botryococcus braunii oil (Bot-oil) and squalane oils with PtRe/SiO2Al2O3 (SA) catalysts, which are active at 310-340 degrees C and the weight ratio of the oil/catalyst of 10. For purified Bot-oil on Pt3 wt % Re/SA at 330 degrees C, the highest aviation fuel-range hydrocarbon (C10C15) yield of 50.2% was achieved, with diesel-range hydrocarbons (C16C20) of 16.7% yield. The re-modified Pt/SA catalysts are also active for hydrocracking of squalane as the model compound of algae oil, and the C10C20 hydrocarbon yield of 68.8% was obtained. The PtRe catalyst was found to be stable for the second regeneration cycle, even with the use of crude Bot-oil. Investigation of catalyst natures indicates that metallic Pt and Re are independently present on the surface, but synergism of these two metals could play an important role in the hydrocracking reaction. The reaction pathway involves the CC bond scission reaction via a carbenium ion formed from one of the double-bond carbons over the SA catalyst, followed by hydrogenation of the C=C and C-C bonds by the PtRe catalyst and partial aromatization over the SA catalyst.	[Murata, Kazuhisa; Liu, Yanyong; Inaba, Megumu; Takahara, Isao] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058565, Japan; [Watanabe, Makoto M.] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Murata, K (reprint author), Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, AIST Tsukuba Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	kazu-murata@aist.go.jp			Agriculture, Forestry and Fisheries Research Council (AFFRC) grant of the Ministry of Agriculture, Forestry and Fisheries of Japan (MAFF)	The authors are grateful to the Agriculture, Forestry and Fisheries Research Council (AFFRC) grant of the Ministry of Agriculture, Forestry and Fisheries of Japan (MAFF).	Garciano LO, 2012, ENERG FUEL, V26, P3874, DOI 10.1021/ef300451s; Simonetti DA, 2007, J CATAL, V247, P298, DOI 10.1016/j.jcat.2007.01.022; Tran NH, 2010, FUEL, V89, P265, DOI 10.1016/j.fuel.2009.08.015; Murata K, 2010, ENERG FUEL, V24, P2404, DOI 10.1021/ef901607t; Murata K, 2008, REACT KINET CATAL L, V93, P59, DOI 10.1007/s11144-008-5190-0; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; Ross AB, 2008, BIORESOURCE TECHNOL, V99, P6494, DOI 10.1016/j.biortech.2007.11.036; HILLEN LW, 1982, BIOTECHNOL BIOENG, V24, P193, DOI 10.1002/bit.260240116; Eroglu E, 2011, J APPL PHYCOL, V23, P763, DOI 10.1007/s10811-010-9577-8; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; Garciano LO, 2014, CHEM ENG SCI, V107, P302, DOI 10.1016/j.ces.2013.12.024; Gates B. C., 1979, CHEM CATALYTIC PROCE; Kitazato H, 1989, SEKIYU GAKKAISHI, V32, P28; MILNE TA, 1990, BIOMASS, V21, P219, DOI 10.1016/0144-4565(90)90066-S; Nagano S, 2012, PROCEDIA ENVIRON SCI, V15, P73, DOI 10.1016/j.proenv.2012.05.012; Tracy NI, 2011, BIOMASS BIOENERG, V35, P1060, DOI 10.1016/j.biombioe.2010.11.027; Watanabe M. M., 2012, HDB ALGAE THEIR DIVE, P490; Yamamoto S, 2014, J APPL PHYCOL, V26, P55, DOI 10.1007/s10811-013-0065-9; Zhang Y., 2010, HYDROTHERMAL LIQUEFA, P201	21	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	NOV	2014	28	11					6999	7006		10.1021/ef5018994		8	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	AU2TB	WOS:000345469300036		
J	Bai, L; Karnowo; Kudo, S; Norinaga, K; Wang, YG; Hayashi, J				Bai, Lei; Karnowo; Kudo, Shinji; Norinaga, Koyo; Wang, Yong-gang; Hayashi, Jun-ichiro			Kinetics and Mechanism of Steam Gasification of Char from Hydrothermally Treated Woody Biomass	ENERGY & FUELS			English	Article							VICTORIAN BROWN-COAL; EARTH CATALYZED GASIFICATION; LIGNOCELLULOSIC BIOMASS; CHEMICAL ACTIVATION; HIGH-TEMPERATURE; RAPID PYROLYSIS; MODEL COMPOUNDS; SOLID REACTIONS; PORE STRUCTURE; CORN STOVER	Hydrothermal treatment (HTT) is a promising way of upgrading biomass as a solid fuel and precursor of carbon materials by eliminating or transforming carbohydrates and also leaching alkali and alkaline earth metallic (AAEM) species. This study investigated steam gasification of a woody biomass that had been upgraded by HTT at 250 degrees C. HTT removed 8797% of AAEM species from the biomass. The char from the pyrolysis of the treated biomass underwent gasification, obeying first-order kinetics with respect to the mass of char over the entire range of conversion. This kinetics arose from non-catalytic gasification. AAEM species remaining in the char had no catalytic activity. The specific surface area of char increased monotonically with its conversion from 500 to well above 2000 m(2)/g. The non-catalytic nature of the gasification was responsible for such a significant surface area development. The surface area was, however, not a factor influencing the rate of gasification. The presence of the inherent AAEM catalyst and that of the extraneous potassium catalyst altered the kinetics of gasification to zeroth order while suppressing the surface-area development not only creating but also consuming micropores. The surface area was not a kinetic factor for the catalytic gasification.	[Bai, Lei; Karnowo; Kudo, Shinji; Norinaga, Koyo; Hayashi, Jun-ichiro] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8618580, Japan; [Bai, Lei; Wang, Yong-gang] China Univ Min & Technol Beijing CUMTB, Sch Chem & Environm Engn, Dept Chem Engn & Technol, Beijing 100083, Peoples R China	Hayashi, J (reprint author), Kyushu Univ, Inst Mat Chem & Engn, 6-1 Kasuga Koen, Kasuga, Fukuoka 8618580, Japan.	junichiro_hayashi@cm.kyushu-u.ac.jp	Norinaga, Koyo/A-2597-2010		Japan Society for The Promotion of Science (JSPS) [26249120]	Lei Bai expresses personal gratitude to Kyushu University for the Friendship Scholarship provided during his participation in this research work. This work was supported by Japan Society for The Promotion of Science (JSPS) for Grant-in-Aid for Scientific Research A (Grant Number 26249120).	ADSCHIRI T, 1991, AICHE J, V37, P897, DOI 10.1002/aic.690370612; ADSCHIRI T, 1986, FUEL, V65, P927, DOI 10.1016/0016-2361(86)90200-0; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P1986, DOI 10.1016/j.biortech.2005.01.013; Chen SG, 1997, ENERG FUEL, V11, P421, DOI 10.1021/ef960099o; Keown DM, 2005, BIORESOURCE TECHNOL, V96, P1570, DOI 10.1016/j.biortech.2004.12.014; Kruse A, 2003, IND ENG CHEM RES, V42, P267, DOI 10.1021/ie0202773; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Hosokai S, 2011, ENERG FUEL, V25, P5387, DOI 10.1021/ef2003766; Yip K, 2011, P COMBUST INST, V33, P1755, DOI 10.1016/j.proci.2010.07.073; Kajitani S, 2002, FUEL, V81, P539, DOI 10.1016/S0016-2361(01)00149-1; Feng B, 2003, CARBON, V41, P507, DOI 10.1016/S0008-6223(02)00357-3; Karagoz S, 2005, FUEL, V84, P875, DOI 10.1016/j.fuel.2005.01.004; Seo DK, 2010, BIOMASS BIOENERG, V34, P1946, DOI 10.1016/j.biombioe.2010.08.008; BHATIA SK, 1980, AICHE J, V26, P379, DOI 10.1002/aic.690260308; SUZUKI T, 1992, ENERG FUEL, V6, P343, DOI 10.1021/ef00034a003; Zolin A, 2001, ENERG FUEL, V15, P1110, DOI 10.1021/ef000288d; Cetin E, 2005, FUEL, V84, P1328, DOI 10.1016/j.fuel.2004.07.016; Olsson JG, 1997, ENERG FUEL, V11, P779, DOI 10.1021/ef960096b; Kabyemela BM, 1997, IND ENG CHEM RES, V36, P1552, DOI 10.1021/ie960250h; Dayton DC, 1999, ENERG FUEL, V13, P860, DOI 10.1021/ef980256e; Hayashi J, 2000, CARBON, V38, P1873, DOI 10.1016/S0008-6223(00)00027-0; Srokol Z, 2004, CARBOHYD RES, V339, P1717, DOI 10.1016/j.carres.2004.04.018; Hayashi J, 2002, CARBON, V40, P2381, DOI 10.1016/S0008-6223(02)00118-5; Yu Y, 2008, ENERG FUEL, V22, P46, DOI 10.1021/ef700292p; Liu A, 2006, ENERG FUEL, V20, P446, DOI 10.1021/ef050192p; DAYTON DC, 1995, ENERG FUEL, V9, P855, DOI 10.1021/ef00053a018; Knudsen JN, 2004, ENERG FUEL, V18, P1385, DOI 10.1021/ef049944q; Ohman M, 2005, ENERG FUEL, V19, P1742, DOI 10.1021/ef040093w; Iryani DA, 2014, INT J GREEN ENERGY, V11, P577, DOI 10.1080/15435075.2013.777909; Asghari FS, 2006, IND ENG CHEM RES, V45, P2163, DOI 10.1021/ie051088y; Liu CG, 2005, BIORESOURCE TECHNOL, V96, P1978, DOI 10.1016/j.biortech.2005.01.012; Raveendran K, 1998, FUEL, V77, P769, DOI 10.1016/S0016-2361(97)00246-9; CHEN SG, 1992, J CATAL, V138, P12, DOI 10.1016/0021-9517(92)90003-Z; ANTAL MJ, 1990, CARBOHYD RES, V199, P91, DOI 10.1016/0008-6215(90)84096-D; Kitsuka T, 2007, ENERG FUEL, V21, P387, DOI 10.1021/ef0603986; Wu HW, 2004, FUEL, V83, P23, DOI 10.1016/S0016-2361(03)00238-2; Mursito AT, 2010, FUEL, V89, P635, DOI 10.1016/j.fuel.2009.07.004; Fu P, 2012, BIORESOURCE TECHNOL, V114, P691, DOI 10.1016/j.biortech.2012.03.072; Kruse A, 2007, IND ENG CHEM RES, V46, P87, DOI 10.1021/ie061047h; Bayarsaikhan B, 2005, FUEL, V84, P1612, DOI 10.1016/j.fuel.2005.02.008; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; Kajitani S, 2006, FUEL, V85, P163, DOI 10.1016/j.fuel.2005.07.024; Jensen PA, 2000, ENERG FUEL, V14, P1280, DOI 10.1021/ef000104v; SOHN HY, 1972, CHEM ENG SCI, V27, P763, DOI 10.1016/0009-2509(72)85011-5; Li CZ, 2000, FUEL, V79, P427, DOI 10.1016/S0016-2361(99)00178-7; Iryani D.A., 2013, PROCEDIA EARTH PLANE, V6, P441; JENKINS RG, 1973, FUEL, V52, P288, DOI 10.1016/0016-2361(73)90059-8; Kajita M, 2010, ENERG FUEL, V24, P108, DOI 10.1021/ef900513a; Keown DM, 2008, FUEL PROCESS TECHNOL, V89, P1429, DOI 10.1016/j.fuproc.2008.07.002; Kudo S., 2014, ISIJ INT IN PRESS; Kudo S, 2014, ENERG FUEL, V28, P5902, DOI 10.1021/ef501517n; LIN SY, 1993, KAGAKU KOGAKU RONBUN, V19, P325; MOJTAHEDI W, 1989, J I ENERGY, V62, P189; Mori A, 2013, ENERG FUEL, V27, P6607, DOI 10.1021/ef4016558; Sueyasu T, 2012, ENERG FUEL, V26, P199, DOI 10.1021/ef201166a; Yip K., 2009, ENERG FUEL, V24, P173	56	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	NOV	2014	28	11					7133	7139		10.1021/ef5014898h		7	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	AU2TB	WOS:000345469300051		
J	Huang, Y; Sakamoto, H; Kudo, S; Norinaga, K; Hayashi, J				Huang, Yong; Sakamoto, Hajime; Kudo, Shinji; Norinaga, Koyo; Hayashi, Jun-ichiro			Pyrolysis of Lignite with Internal Recycling and Conversion of Oil	ENERGY & FUELS			English	Article							SIZE-EXCLUSION CHROMATOGRAPHY; LOW-RANK COALS; SPONTANEOUS COMBUSTION; BROWN-COAL; LIQUID-CHROMATOGRAPHY; BIOMASS PYROLYSIS; RADICAL TRANSFER; FLASH PYROLYSIS; TAR; SOLVENT	The present authors studied pyrolysis of lignite with internal recycling of a heavier portion of the liquid product (oil), employing a reactor that experimentally simulated continuous pyrolysis in a gassolid countercurrent moving-bed reactor. The lignite particles traveled through the isothermal section at the temperature (T-iso) of 140 or 180 degrees C and then the non-isothermal section from T-iso to the peak pyrolysis temperature (T-p) of 600 degrees C. Among the volatile products, a lighter portion of the oil (LO) with a normal boiling point of <360 degrees C was allowed to escape from the reactor together with steam and non-condensable gas, while the heavier portion of the oil was sorbed by the moving particles in both sections, recycled to the pyrolysis and then converted into char, water, and non-condensable gases inside the reactor. The oil recycling increased the char yield by up to 6 wt % dry lignite. LO consisted mainly of alkanes/alkenes (3749 wt %), lower oxygenates (acids, ketones, esters, and ethers; 17 wt %), phenols (626 wt %), and monoaromatic hydrocarbons (1221 wt %), but it contained no triaromatics. LO was evaporated completely upon heating to 200 degrees C, leaving no residue. T-iso influenced the composition of LO. The heaviest compounds varied from C-17 to C-21 paraffins for T-iso of 140180 degrees C, respectively.	[Huang, Yong; Kudo, Shinji; Norinaga, Koyo; Hayashi, Jun-ichiro] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan; [Sakamoto, Hajime; Norinaga, Koyo; Hayashi, Jun-ichiro] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Hayashi, Jun-ichiro] Kyushu Univ, Res & Educ Ctr Carbon Resources, Kasuga, Fukuoka 8168580, Japan	Hayashi, J (reprint author), Kyushu Univ, Inst Mat Chem & Engn, 6-10 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	junichiro_hayashi@cm.kyushu-u.ac.jp	Norinaga, Koyo/A-2597-2010		Ministry of Environment (MOE), Japan	A part of this work was carried out in a research and development program that was financially supported by the Ministry of Environment (MOE), Japan. The authors are also grateful to the Funding Program for the Next Generation World-Leading Researchers (NEXT Program) established by the Japan Society for the Promotion of Science (JSPS).	BORWITZKY H, 1979, J CHROMATOGR, V170, P99, DOI 10.1016/S0021-9673(00)84242-9; Sonoyama N, 2013, FUEL, V114, P206, DOI 10.1016/j.fuel.2012.04.023; Sonoyama N, 2011, FUEL PROCESS TECHNOL, V92, P771, DOI 10.1016/j.fuproc.2010.09.036; Li CZ, 2013, FUEL, V112, P609, DOI 10.1016/j.fuel.2013.01.031; Hayashi J, 2000, ENERG FUEL, V14, P400, DOI 10.1021/ef9901490; MIURA K, 1991, ENERG FUEL, V5, P340, DOI 10.1021/ef00026a020; Schobert HH, 2002, FUEL, V81, P15, DOI 10.1016/S0016-2361(00)00203-9; Thielemann T, 2007, INT J COAL GEOL, V72, P1, DOI 10.1016/j.coal.2007.04.003; Yang H, 2013, ENERG FUEL, V27, P3209, DOI 10.1021/ef4001192; OGUNSOLA OI, 1992, FUEL, V71, P3, DOI 10.1016/0016-2361(92)90185-Q; MIURA K, 1991, ENERG FUEL, V5, P803, DOI 10.1021/ef00030a006; Hayashi J, 2014, ENERG FUEL, V28, P4, DOI 10.1021/ef401617k; Fei Y, 2009, FUEL, V88, P1650, DOI 10.1016/j.fuel.2009.03.017; Thami GP, 2002, CLIN EXP DERMATOL, V27, P99, DOI 10.1046/j.1365-2230.2002.00995.x; ANTAL MJ, 1995, IND ENG CHEM RES, V34, P703, DOI 10.1021/ie00042a001; Zhang C, 2014, ENERG FUEL, V28, P236, DOI 10.1021/ef401546n; Li CZ, 2007, FUEL, V86, P1664, DOI 10.1016/j.fuel.2007.01.008; Umar DF, 2006, FUEL PROCESS TECHNOL, V87, P1007, DOI 10.1016/j.fuproc.2006.07.010; Bazardorj B., 2006, FUEL, V85, P340; Guln J. A., 1986, IND ENG CHEM PROC DD, V25, P543; HAYASHI J, 1993, ENERG FUEL, V7, P1112, DOI 10.1021/ef00042a059; HAYASHI J, 1993, ENERG FUEL, V7, P57, DOI 10.1021/ef00037a011; HAYASHI J, 1995, ENERG FUEL, V9, P1035, DOI 10.1021/ef00054a015; Huang Y, 2013, ENERG FUEL, V27, P247, DOI 10.1021/ef301366x; Huang Y, 2012, ENERG FUEL, V26, P256, DOI 10.1021/ef2011673; Li C.-Z., 2004, ADV SCI VICTORIAN BR; Milne T.A., 1998, NRELTP57025357; Monazam ER, 1998, ENERG FUEL, V12, P1305, DOI 10.1021/ef980094m; Morgan TJ, 2008, ENERG FUEL, V22, P3275, DOI 10.1021/ef800333v; NORDON P, 1979, FUEL, V58, P443, DOI 10.1016/0016-2361(79)90086-3; Panth D., 2012, P AICHE 2012 SPRING; Panth D., 2012, P INT S CHEM REACT E; RICE RL, 1970, IND ENG CHEM PROD RD, V9, P30, DOI 10.1021/i360033a005; Safarova M, 2010, J ANAL APPL PYROL, V89, P265, DOI 10.1016/j.jaap.2010.09.002; Tomita H, 1995, COAL SCI TECHNOL, V24, P1511, DOI 10.1016/S0167-9449(06)80094-7; WALLCAVE L, 1971, TOXICOL APPL PHARM, V18, P41, DOI 10.1016/0041-008X(71)90313-9; WEN WY, 1984, IND ENG CHEM PROC DD, V23, P627, DOI 10.1021/i200027a001; You CF, 2013, ENERG FUEL, V27, P177, DOI 10.1021/ef301680w; Zhang CM, 2007, J CHROMATOGR A, V1167, P171, DOI 10.1016/j.chroma.2007.08.048	39	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	NOV	2014	28	11					7285	7293		10.1021/ef501785e		9	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	AU2TB	WOS:000345469300066		
J	Shadrina, E				Shadrina, Elena			Russia's natural gas policy toward Northeast Asia: Rationales, objectives and institutions	ENERGY POLICY			English	Article						Institutions; Gas policy; Russia; Eastern Siberia and Far East (ESFE); Northeast Asia (NEA)		The article examines the institutional dimensions of Russia's gas policy toward Northeast Asia (NEA(1) During the liberal economic reforms of the 1990s, development of natural gas deposits in the Russian Far East was made possible under the scheme of production sharing agreements (PSA). However, new PSAs were banned in Russia even before the advent of state capitalism in the early 2000s. This was, to a large extent, the result of strong anti-PSA lobbying led by the domestic energy business elite. Consequently, Russia's gas policy in the east began evolving from being project-specific toward being region-specific. Contemporary Russian gas policy toward NEA relies upon domestic (national and regional) and external institutions. In 2009, following the completion of a liquefied natural gas (LNG) plant in Sakhalin, Russia entered NEA gas markets. Transformations in the international gas markets facilitated the establishment of a two-pattern gas export policy in Russia in 2013. Under this policy, Russia's EU-oriented pipeline gas export remains monopolised by Gazprom, while Asia-oriented LNG export is partially liberalised. Russia has not been experiencing institutional discrepancy in NEA gas markets. However, as the markets evolve toward greater coordination, a rational option for Russia is to genuinely liberalise its gas policy. (C) 2014 Elsevier Ltd. All rights reserved.	Meiji Univ, Grad Sch Governance Studies, Chiyoda Ku, Tokyo 1010064, Japan	Shadrina, E (reprint author), Meiji Univ, Grad Sch Governance Studies, Chiyoda Ku, TA Jimbocho Bldg,604D,1-4-12 Sarugakucho, Tokyo 1010064, Japan.	elena_shadrina@yahoo.com					Aguilera RF, 2014, ENERG POLICY, V65, P1, DOI 10.1016/j.enpol.2013.10.014; Kuzemko C, 2014, J EUR PUBLIC POLICY, V21, P58, DOI 10.1080/13501763.2013.835062; Shadrina E, 2013, POST-SOV AFF, V29, P461, DOI 10.1080/1060586X.2013.837635; Blagov S., 2010, EURASIA DAILY MONIT, V7, P130; BP, 2014, BP 2014 BP ENERGY OU; Dusseault D., 2010, THESIS FACULTY SOCIA; EGP, 2007, 340 EGP; Fedorov PP, 2013, VSE KRUPNEISHIE KOMP; Gustafson T., 2012, WEEL FORTUNE BATTLE; Harris S., 2008, 20086 AUSTR NAT U DE; HENDERSON J, 2014, POTENTIAL IMPACT ASI; Kanter James, 2013, NY TIMES; Karaganov S., 2014, GREAT OC 2 RUSS BREA; Kushkina K., 2013, GOLDEN AGE GAS CHINA; Kuzjmin V., 2013, ROSSIISKAYA GAZ 3110; Milov V., 2014, GLAVNAYA PROBLENA EN; Mitrova T., 2014, GEN TEK GOTOVYATSYA; Mukhin A., 2014, LUKAVYE TSIFRY ROSNE; North DC, 2005, PRINC ECON HIST W WO, P1; North D.C., 1990, I I CHANGE EC PERFOR; OECD, 2012, CHIN CHALL IEA EXP; Opdahl I., 2013, P 13 ANN AL C HELS R; Samuels Richard J., 1987, BUSINESS JAPANESE ST; Shadrina E., 2010, PEI ELECT PUBLICATIO, V18/2010; Shadrina E., 2013, PEI ELECT PUBLICATIO, V1/2013; Shadrina E., 2010, RUSSIAS FOREIGN ENER; Shadrina E., 2014, J GOV STUD, V10, P139; Shadrina E., 2013, NEAR E U J SOC SCI, V6, P65; Shadrina E., 2014, NE ASIAN EC IN PRESS, P21; Zudin A., 2013, OBSHCHESTVENNYE NAUK, V2, P15	30	4	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-4215	1873-6777		ENERG POLICY	Energy Policy	NOV	2014	74						54	67		10.1016/j.enpol.2014.06.025		14	Energy & Fuels; Environmental Sciences; Environmental Studies	Energy & Fuels; Environmental Sciences & Ecology	AU2TL	WOS:000345470300007		
J	Motomura, M				Motomura, Masumi			Japan's need for Russian oil and gas: A shift in energy flows to the Far East	ENERGY POLICY			English	Article						Energy; East Asia; ESPO; LNG; Fukushima		This article examines the choices of Japan's governmental institutions vis-a-vis Russian supplies of oil and gas. First, there is a perceived need to diversify the sources of crude oil in order to avoid too much reliance on the Middle East. Following the inauguration of the Sakhalin oil projects and completion of the ESPO pipeline, Russian crude oil is nearing a 10% share in the Japanese market. It is suggested that Russian crude oil supplies have been chosen due to their proximity, safety and flexibility, and their positive effect on Japan's bargaining power in relation to crude suppliers in the Middle East. Second, Japan's shift from nuclear to LNG in power generation after the Fukushima accident in March 2011 increased LNG imports by 25% in just two years. While Qatar expanded its market share the most, Russia also gained, even though it only had one operational LNG project in Sakhalin-2. Russian companies are now working on several LNG projects in Northeast Asia and the Arctic region. However, the resumption of nuclear power in Japan might have a negative impact on new Russian LNG projects. (C) 2014 Elsevier Ltd. All rights reserved.	Japan Oil Gas & Met Natl Corp JOGMEC, Res & Anal Dept, Minato Ku, Tokyo 1050001, Japan	Motomura, M (reprint author), Japan Oil Gas & Met Natl Corp JOGMEC, Res & Anal Dept, Minato Ku, 10-1,Toranomon 2 Chome, Tokyo 1050001, Japan.	motomura-masumi@jogmec.go.jp					[Anonymous], 2002, NEFTE TRANSPORT; [Anonymous], 2011, NEFTE TRANSPORT; [Anonymous], 2007, MONTHL OIL STAT; ANRE, 2013, EN 2013, P56; BP, 2011, BP STAT REV WORLD EN; BP, 2012, BP STAT REV WORLD EN; British Petroleum (BP), 2014, BP STAT REV WORLD EN; JPA, 2011, SEK; JPA, 2009, SEK; JPA, 2007, SEK; JPA, 2013, SEK; JPA, 2012, SEK; Motomura M., 2013, ARCTIC GOVERNANCE JA, P13; Motomura M., 2008, ACTA SLAVICA IAPONIC, V25, P67; PAIK K, 2012, SINO RUSSIAN OIL GAS; Putin, 2004, COMMUNICATION; Sakhalin Energy, 2014, SUSTAINABLE DEV; Tabata S, 2012, RUSSIA'S ENERGY POLICIES: NATIONAL, INTERREGIONAL AND GLOBAL LEVELS, P156	18	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-4215	1873-6777		ENERG POLICY	Energy Policy	NOV	2014	74						68	79		10.1016/j.enpol.2014.08.024		12	Energy & Fuels; Environmental Sciences; Environmental Studies	Energy & Fuels; Environmental Sciences & Ecology	AU2TL	WOS:000345470300008		
J	Lee, J; Choi, SW				Lee, Jin; Choi, Sei-Woong			Different seasonal feeding activity of diverse herbivores in two temperate forests	ENTOMOLOGICAL RESEARCH			English	Article						elevation; herbivores; leaf damage; lepidopteran larvae; season	RAIN-FOREST; HABITAT FRAGMENTATION; LANDSCAPE STRUCTURE; LEAF DEVELOPMENT; TROPICAL FOREST; COMMUNITY; INSECTS; PHENOLOGY; ABUNDANCE; SELECTION	The aim of the present study was to understand the effects of abiotic conditions on seasonal feeding activity of diverse herbivores on the same oak tree species in two different forests. We tracked changes in herbivore feeding activities on an oak tree species (Quercus serrata) in two localities: a low elevation small hillock forest patch (Muan, MN) and a middle elevation mountain forest patch (Mt. Jirisan, JR). A total of five sites were selected in each of two forest localities. Data for leaf expansion, leaf chemical qualities, leaf damage ratio, and numbers of lepidopteran caterpillars were collected during spring (May) and summer (July to August), 2012. Leaf expansion rate was higher at the low hillock forest than the mid-mountain forest from spring to summer. Nitrogen and carbon content decreased seasonally at both localities. Lepidopteran larval diversity was high in the mid-mountain forest, and two-way ANOVA showed that species richness of lepidopteran larvae was significantly affected by the interaction between season and locality. Leaf damage by all herbivores was higher in the low hillock forest than the mid-mountain forest in spring, but was higher in the mid-mountain forest in summer. Relative proportion of general herbivores increased from spring to summer in the mid-mountain forest, but not in the low hillock forest. Canonical Correspondence Analysis (CCA) ordination showed that altitude- and season-related variables were significant species and environment interaction factors. Our data indicate that locality and temperature disproportionally affected the feeding activities of diverse herbivores in two different temperate forests.	[Lee, Jin] Hokkaido Univ, Tomakomai Expt Forest, Tomakomai, Hokkaido, Japan; [Choi, Sei-Woong] Mokpo Natl Univ, Dept Environm Educ, Muan, South Korea	Choi, SW (reprint author), Mokpo Natl Univ, Dept Environm Educ, 1666 Yeongsan Ro, Muan Gun 534729, Jeollanam Do, South Korea.	choisw@mokpo.ac.kr		Choi, Sei-Woong/0000-0001-6326-399X	Korea Research Foundation [KRF-2012R1A2A2A01003910]	We thank Jeong-Seop An, In-Whan Lee and Sang-Hyun Na for collecting and rearing caterpillars. This study was supported by the Korea Research Foundation (KRF-2012R1A2A2A01003910).	FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; Suzuki S, 1998, OECOLOGIA, V117, P169, DOI 10.1007/s004420050645; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Brehm G, 2007, GLOBAL ECOL BIOGEOGR, V16, P205, DOI 10.1111/j.1466-822x.2006.00281.x; [Anonymous], 2011, FUNCT ECOL, DOI DOI 10.1111/J.1365-2435.2010.01803.X; DeVries PJ, 1997, BIOL J LINN SOC, V62, P343, DOI 10.1006/bijl.1997.0155; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Garibaldi LA, 2011, GLOBAL ECOL BIOGEOGR, V20, P609, DOI 10.1111/j.1466-8238.2010.00623.x; KATO M, 1995, RES POPUL ECOL, V37, P59, DOI 10.1007/BF02515762; MILTON K, 1979, AM NAT, V114, P362, DOI 10.1086/283485; LOWMAN MD, 1983, AUST J ECOL, V8, P17, DOI 10.1111/j.1442-9993.1983.tb01515.x; Kruess A, 2003, ECOGRAPHY, V26, P283, DOI 10.1034/j.1600-0587.2003.03402.x; Matsuki S, 2006, ANN BOT-LONDON, V97, P813, DOI 10.1093/aob/mc1041; AIDE TM, 1993, ECOLOGY, V74, P455, DOI 10.2307/1939307; WOLDA H, 1988, ANNU REV ECOL SYST, V19, P1; Intachat J, 2001, J TROP ECOL, V17, P411; Hunter MD, 2002, AGR FOREST ENTOMOL, V4, P159, DOI 10.1046/j.1461-9563.2002.00152.x; Arnold AE, 2002, BIODIVERS CONSERV, V11, P1663, DOI 10.1023/A:1016888000369; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Moles AT, 2000, OIKOS, V90, P517, DOI 10.1034/j.1600-0706.2000.900310.x; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; Thies C, 2003, OIKOS, V101, P18, DOI 10.1034/j.1600-0706.2003.12567.x; Faveri SB, 2008, J TROP ECOL, V24, P57, DOI 10.1017/S0266467407004592; BOGACHEVA IA, 1994, OIKOS, V69, P119, DOI 10.2307/3545291; Brown Keith S. Jr., 1997, P91; Cappuccino N, 1997, OECOLOGIA, V110, P69, DOI 10.1007/s004420050134; Choi SW, 2008, ECOL RES, V23, P503, DOI 10.1007/s11284-007-0406-8; Choi Sei-Woong, 2009, Journal of Ecology and Field Biology, V32, P183; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Coley Phyllis D., 1996, P305; Colwell RK, 2006, ESTIMATE S STAT ESTI; Ehrlich PR, 1967, SCI AM, V206, P104; Faeth SH, 1986, ECOLOGY, V67, P476; Karolewski P, 2007, POL J ECOL, V55, P595; Kudo G, 1996, ECOL RES, V11, P283, DOI 10.1007/BF02347785; McCune B., 2011, PC ORD MULTIVARIATE; McCune B., 2002, ANAL ECOLOGICAL COMM, P300; Misumachi E, 2004, POPULATION ECOLOGY, V46, P203; Murakami M, 2005, ECOLOGICAL ENTOMOLOG, V305, P21; Savilaakso S, 2009, DIVERS DISTRIB, V15, P356, DOI 10.1111/j.1472-4642.2008.00542.x; Schmidt K., 2003, OEPP EPPO B, V33, P517; Skippari S, 2009, AFR J ECOL, V47, P537, DOI 10.1111/j.1365-2028.2008.00986.x; SPSS Inc, 2012, SPSS FOR WIND VER 20; Strong DR, 1984, INSECTS PLANTS COMMU, P313; Summerville KS, 2013, HARDWOOD ECOSYSTEM E, P108; vansAsch M., 2007, ANNU REV ENTOMOL, V52, P37; Wait DA, 1998, OIKOS, V82, P502, DOI 10.2307/3546371	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1738-2297	1748-5967		ENTOMOL RES	Entomol. Res.	NOV	2014	44	6					302	314		10.1111/1748-5967.12079		13	Entomology	Entomology	AU2PH	WOS:000345459900008		
J	Faraj, FL; Khaledi, H; Morimoto, Y; Itoh, S; Olmstead, MM; Ali, HM				Faraj, Fadhil Lafta; Khaledi, Hamid; Morimoto, Yuma; Itoh, Shinobu; Olmstead, Marilyn M.; Ali, Hapipah Mohd			A Tetradentate beta-Diiminato Ligand Containing Phenolate Substituents: Flexivalent Coordination to Mn-III, Co-III, Ni-II, and Cu-II	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Article						Coordination modes; N,O ligands; beta-Dialdiminates; Tautomerism; Non-innocent ligands	COUPLED ELECTRON-TRANSFER; DIKETIMINATE LIGANDS; ETHYLENE POLYMERIZATION; LACTIDE POLYMERIZATION; COMPLEXES; CHEMISTRY; ZIRCONIUM; OXIDATION; CATALYSTS; COBALT	A functionalized beta-dialdimine was prepared, bearing a 3,3-dimethylindoleninyl group at the meso-position and two N-phenolic groups. The structure contains three labile protons, which can be lost or migrate through tautomerism to provide an N2O2 coordination core. A number of divalent and trivalent metal ions (Cu-II, Ni-II, Co-II/III, and Mn-III) were accommodated inside the core, forming a series of intensely colored products consisting of a tricyclic MN2O2 chelate. In the resulting divalent metal complexes, the dialdimine ligand is deprotonated only at the two phenolic oxygen atoms and is thus dianionic, whereas in the trivalent metal complexes, the dialdiminato ligand is triply deprotonated. The copper and nickel complexes adopt square-planar geometries, whereas in the trivalent cobalt and manganese complexes, two neutral ancillary ligands complete an octahedral geometry around the metal center. In each case, the denticity of the diimino-diiminato ligand is four. The electrochemical oxidation of the copper and nickel complexes was studied by cyclic voltammetry.	[Faraj, Fadhil Lafta; Khaledi, Hamid; Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Kuala Lumpur 50603, Malaysia; [Faraj, Fadhil Lafta] Univ Diyala, Dept Chem, Fac Sci, Diyala, Iraq; [Morimoto, Yuma; Itoh, Shinobu] Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka 5650871, Japan; [Olmstead, Marilyn M.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	Khaledi, H (reprint author), Univ Malaya, Dept Chem, Kuala Lumpur 50603, Malaysia.	hamid.khaledi@gmail.com	Khaledi, Hamid/F-5754-2011; Morimoto, Yuma/B-6940-2011		Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy [DE-AC02-05CH11231]; University of Malaya [F(000)009-H21001, PG068-2012B]; Center for Natural Products and Drug Research, CENAR [FL011-2012]; UPSI [CG033-2013]; MEXT of Japan for Scientific Research on Innovative Areas [22105007]	We would like to thank Kamran B. Ghiassi (UC - Davis) for his assistance with the crystallography of the Cu complex. We thank the Advanced Light Source, supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy under Contract No. DE-AC02-05CH11231, for beam time. Support from the University of Malaya [HIR grant No. F(000)009-H21001 and PPP grant No. PG068-2012B], the Center for Natural Products and Drug Research, CENAR (FL011-2012), Dr. Yusnita Juahir from UPSI (Non-Ru grant No. CG033-2013) and MEXT of Japan for Scientific Research on Innovative Areas (SI grant No. 22105007) is highly appreciated.	Weinberg DR, 2012, CHEM REV, V112, P4016, DOI 10.1021/cr200177j; Salavati-Niasari M, 2003, J MOL CATAL A-CHEM, V201, P43, DOI 10.1016/S1381-1169(03)00128-6; Marlier EE, 2012, INORG CHEM, V51, P2079, DOI 10.1021/ic201780c; Huang YB, 2009, DALTON T, P767, DOI 10.1039/b820798b; Shaviv E, 2003, J ORGANOMET CHEM, V683, P165, DOI 10.1016/S0022-328X(03)00592-8; Dulong F, 2013, ORGANOMETALLICS, V32, P1328, DOI 10.1021/om3010355; Warren JJ, 2010, CHEM REV, V110, P6961, DOI 10.1021/cr100085k; Shimokawa C, 2006, J INORG BIOCHEM, V100, P1118, DOI 10.1016/j.jinorgbio.2006.02.005; Chisholm MH, 2004, INORG CHEM, V43, P6717, DOI 10.1021/ic0490730; Feng YH, 2009, INORG CHIM ACTA, V362, P3563, DOI 10.1016/j.ica.2009.03.048; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; Marshak MP, 2012, INORG CHEM, V51, P11190, DOI 10.1021/ic301970w; Marlier EE, 2011, INORG CHIM ACTA, V369, P173, DOI 10.1016/j.ica.2010.12.021; Takaichi J, 2014, INORG CHEM, V53, P6159, DOI 10.1021/ic5006693; Li L, 2013, ORGANOMETALLICS, V32, P3203, DOI 10.1021/om400105t; Hammes-Schiffer S, 2010, CHEM REV, V110, P6939, DOI 10.1021/cr1001436; Chisholm MH, 2005, INORG CHEM, V44, P8004, DOI 10.1021/ic048363d; Costentin C, 2010, CHEM REV, V110, pPR1, DOI 10.1021/cr100038y; Khusniyarov MM, 2011, ANGEW CHEM INT EDIT, V50, P1652, DOI 10.1002/anie.201005953; Dulong F, 2012, DALTON T, V41, P11980, DOI 10.1039/c2dt31220d; Bourget-Merle L, 2002, CHEM REV, V102, P3031, DOI 10.1021/cr010424r; BEDIOUI F, 1991, J ELECTROANAL CHEM, V301, P267, DOI 10.1016/0022-0728(91)85477-7; Rausaria S, 2011, J AM CHEM SOC, V133, P4200, DOI 10.1021/ja110427e; Baradarani MM, 2006, J HETEROCYCLIC CHEM, V43, P1591; Barbour L. J., 2001, J SUPRAMOL CHEM, V1, P189, DOI DOI 10.1016/S1472-7862(02)00030-8; Bruker AXS Inc, 2007, BRUK AP SAINT SADABS; Cheng YX, 2009, INORG CHIM ACTA, V362, P4678, DOI 10.1016/j.ica.2009.06.025; Doyle DJ, 2009, J ORGANOMET CHEM, V694, P2611, DOI 10.1016/j.jorganchem.2009.03.044; Dudek L, 2011, TETRAHEDRON LETT, V52, P3597, DOI 10.1016/j.tetlet.2011.05.008; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gong SG, 2008, J ORGANOMET CHEM, V693, P3509, DOI 10.1016/j.jorganchem.2008.08.024; Khaledi H, 2009, ACTA CRYSTALLOGR E, V65, pO2585, DOI 10.1107/S1600536809038495; Khaledi H, 2013, INORG CHEM, V52, P1926, DOI 10.1021/ic302150j; Pasini A, 1996, POLYHEDRON, V15, P4461, DOI 10.1016/0277-5387(96)00195-7; Pilz MF, 2007, ORGANOMETALLICS, V26, P3668, DOI 10.1021/om070221e; Schley M, 2009, J ORGANOMET CHEM, V694, P2480, DOI 10.1016/j.jorganchem.2009.04.017; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Spek A.L., 2010, PLATON; Takaichi J, 2013, DALTON T, V42, P2438, DOI 10.1039/c2dt32413j; Wei XH, 2008, DALTON T, P5235, DOI 10.1039/b806451b; Yuan SF, 2010, MACROMOL RES, V18, P690, DOI 10.1007/s13233-010-0704-9	41	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	NOV	2014		33					5752	5759		10.1002/ejic.201402745		8	Chemistry, Inorganic & Nuclear	Chemistry	AU1GU	WOS:000345369800014		
J	Tananuvat, N; Charoenkwan, P; Ohazama, A; Cairns, JRK; Kaewgahya, M; Kantaputra, PN				Tananuvat, Napaporn; Charoenkwan, Pimlak; Ohazama, Atsushi; Cairns, James R. Ketuda; Kaewgahya, Massupa; Kantaputra, Piranit Nik			Root dentin anomaly and a PLG mutation	EUROPEAN JOURNAL OF MEDICAL GENETICS			English	Article						Plasminogen; Tooth development; Root development; Dentin formation; Dentinogenesis; Dental morphology	LIGNEOUS CONJUNCTIVITIS; PLASMINOGEN DEFICIENCY; MATRIX DEGRADATION; DISULFIDE BONDS; DISEASE; SYSTEM; ACTIVATION; PROTEINS; SERIES; RISK	We report a Thai girl affected with plasminogen deficiency, Type I. Ligneous conjunctivitis was first observed when she was one-month-old. The newly recognized findings include tapered incisor roots as a result of thin root dentin, generalized short tooth roots, and mandibular prognathism. Mutation analysis of PLG demonstrated homozygous c.1193G>A missense mutation. The parents were heterozygous for c.1193G>A mutation. The c.1193G>A mutation is novel and predicted to cause amino acid substitution p.Cys398Tyr. Thin root dentin in the patient who was affected with PLG mutation and immunolocalization of Plg during early root development in mice imply the role of plasminogen in root dentin formation. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Tananuvat, Napaporn] Chiang Mai Univ, Fac Med, Dept Ophthalmol, Chiang Mai 50200, Thailand; [Charoenkwan, Pimlak] Chiang Mai Univ, Fac Med, Dept Pediat, Chiang Mai 50200, Thailand; [Ohazama, Atsushi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Biol Sci, Div Oral Anat, Niigata, Japan; [Cairns, James R. Ketuda] Suranaree Univ Technol, Inst Sci, Sch Biochem, Nakhon Ratchasima, Thailand; [Cairns, James R. Ketuda] Suranaree Univ Technol, Ctr Biomol Struct Funct & Applicat, Nakhon Ratchasima, Thailand; [Cairns, James R. Ketuda] Chulabhorn Res Inst, Biochem Lab, Bangkok, Thailand; [Kaewgahya, Massupa; Kantaputra, Piranit Nik] Chiang Mai Univ, Ctr Excellence Med Genet Res, Chiang Mai 50200, Thailand; [Kaewgahya, Massupa; Kantaputra, Piranit Nik] Chiang Mai Univ, Fac Dent, Dept Orthodont & Pediat Dent, Div Pediat Dent,Craniofacial Genet Lab, Chiang Mai 50200, Thailand; [Kantaputra, Piranit Nik] Dentaland Clin, Chiang Mai, Thailand	Kantaputra, PN (reprint author), Chiang Mai Univ, Fac Dent, Dept Orthodont & Pediat Dent, Ctr Excellence Med Genet Res,Div Pediat Dent, Chiang Mai 50200, Thailand.	dentaland17@gmail.com		Ketudat Cairns, James/0000-0003-3042-1626	Center of Excellence in Medical Genetics Research, Chiang Mai University; Thailand Research Fund (TRF) [BRG5580019]; Dental Association of Thailand; Suranaree University of Technology	We are grateful to the patient and her family for their kind cooperation and allowing us to use their medical and dental information for publication. This research was supported by Center of Excellence in Medical Genetics Research, Chiang Mai University, The Thailand Research Fund (TRF; Grant number BRG5580019), the Dental Association of Thailand, and Suranaree University of Technology (J.R.K.C.). The authors thank Dr. Neelaya Sukhamwang for providing the histopathology figures.	PATTHY L, 1984, FEBS LETT, V171, P131, DOI 10.1016/0014-5793(84)80473-1; Tefs K, 2006, BLOOD, V108, P3021, DOI 10.1182/blood-2006-04-017350; Tabbara KF, 2004, AM J OPHTHALMOL, V138, P299, DOI 10.1016/j.ajo.2004.02.067; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; PETERSEN TE, 1990, J BIOL CHEM, V265, P6104; BETZ SF, 1993, PROTEIN SCI, V2, P1551; Drew AF, 1998, BLOOD, V91, P1616; Sivolella S, 2012, J PERIODONTOL, V83, P465, DOI 10.1902/jop.2011.110261; Schuster V, 2003, SURV OPHTHALMOL, V48, P369, DOI 10.1016/S0039-6257(03)00056-0; Daci E, 1999, J BONE MINER RES, V14, P946, DOI 10.1359/jbmr.1999.14.6.946; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Okamoto A, 2003, J THROMB HAEMOST, V1, P2397, DOI 10.1046/j.1538-7836.2003.00419.x; Biasiutti FD, 1998, THROMB HAEMOSTASIS, V80, P167; Ciechanover A, 2002, HEPATOLOGY, V35, P3, DOI 10.1053/jhep.2002.30316; Daci E, 2003, J BONE MINER RES, V18, P1167, DOI 10.1359/jbmr.2003.18.7.1167; DEBART ACW, 1995, J BONE MINER RES, V10, P1374; Dotti CG, 2004, NEURODEGENER DIS, V1, P205, DOI 10.1159/000080987; Everts V, 2008, BONE, V43, P915, DOI 10.1016/j.bone.2008.07.004; Gürlü Vuslat Pelitli, 2008, Cornea, V27, P501, DOI 10.1097/ICO.0b013e318162a8e0; Hwa J, 1999, P NATL ACAD SCI USA, V96, P1932, DOI 10.1073/pnas.96.5.1932; Klammt J, 2011, THROMB HAEMOSTASIS, V105, P454, DOI 10.1160/TH10-04-0216; MIGNATTI P, 1993, PHYSIOL REV, V73, P161; Moriguchi Mitsuko, 2004, Anatomical Science International, V79, P145, DOI 10.1111/j.1447-073x.2004.00078.x; ROBINSON RM, 1984, CALCIFIED TISSUE INT, V36, P31, DOI 10.1007/BF02405291; Ronday HK, 1997, BRIT J RHEUMATOL, V36, P9; Rono B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059942; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Shigekiyo T, 2000, INT J HEMATOL, V72, P247; TAKAGI Y, 1988, CALCIFIED TISSUE INT, V42, P97, DOI 10.1007/BF02556341	29	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1769-7212	1878-0849		EUR J MED GENET	Eur. J. Med. Genet.	NOV-DEC	2014	57	11-12					630	635		10.1016/j.ejmg.2014.09.006		6	Genetics & Heredity	Genetics & Heredity	AU3JH	WOS:000345508300007		
J	Shima, T; Miyamoto, T; Kikushige, Y; Yuda, J; Tochigi, T; Yoshimoto, G; Kato, K; Takenaka, K; Iwasaki, H; Mizuno, S; Goto, N; Akashi, K				Shima, Takahiro; Miyamoto, Toshihiro; Kikushige, Yoshikane; Yuda, Junichiro; Tochigi, Taro; Yoshimoto, Goichi; Kato, Koji; Takenaka, Katsuto; Iwasaki, Hiromi; Mizuno, Shinichi; Goto, Noriko; Akashi, Koichi			The ordered acquisition of Class II and Class I mutations directs formation of human t(8;21) acute myelogenous leukemia stem cell	EXPERIMENTAL HEMATOLOGY			English	Article							ACUTE MYELOID-LEUKEMIA; RECEPTOR TYROSINE KINASE; AML1-ETO FUSION GENE; BCR-ABL; C-KIT; EMBRYONIC LETHALITY; NORMAL INDIVIDUALS; EXPRESSION; HEMATOPOIESIS; MICE	The cellular properties of leukemia stem cells (LSCs) are achieved at least through Class I and Class II mutations that generate signals for enhanced proliferation and impaired differentiation, respectively. Here we show that in t(8;21) acute myelogenous leukemia (AML), hematopoietic stem cells (HSCs) transform into LSCs via definitively-ordered acquisition of Class II (AML1/ETO) and then Class I (c-KIT mutant) abnormalities. Six t(8;21) AML patients with c-KIT mutants maintaining > 3 years of complete remission were analyzed. At diagnosis, all single LSCs had both AML1/ETO and c-KIT mutations. However, in remission, 16 out of 1,728 CD34(+)CD38(-) HSCs and 89 out of 7,187 single HSC-derived myeloerythroid colonies from these patients had AML1/ETO, whose breakpoints were identical to those found in LSCs. These cells had wild-type c-KIT, which expressed AML1/ETO at a low level, and could differentiate into mature blood cells, suggesting that they may be the persistent preleukemic stem cells. Microarray analysis suggested that mutated c-KIT signaling provides LSCs with enhanced survival and proliferation. Thus, in t(8;21) AML, the acquisition of AML1/ETO is not sufficient, and the subsequent upregulation of AML1/ETO and the additional c-KIT mutant signaling are critical steps for transformation into LSCs. (C) 2014 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.	[Shima, Takahiro; Miyamoto, Toshihiro; Kikushige, Yoshikane; Yoshimoto, Goichi; Kato, Koji; Takenaka, Katsuto; Mizuno, Shinichi; Akashi, Koichi] Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Grad Sch Med Sci, Fukuoka 8120054, Japan; [Shima, Takahiro; Yuda, Junichiro; Tochigi, Taro; Iwasaki, Hiromi; Akashi, Koichi] Kyushu Univ, Grad Sch Med, Ctr Cellular & Mol Med, Grad Sch Med Sci, Fukuoka 8120054, Japan; [Goto, Noriko] Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa 9201192, Japan	Akashi, K (reprint author), Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8120054, Japan.	akashi@med.kyushu-u.ac.jp	GOTOH, Noriko/D-8430-2015		Ministry of Education, Culture, Sports, Science, and Technology, Japan	Dr. Miyamoto and Prof. Akashi received a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Shen Y, 2011, BLOOD, V118, P5593, DOI 10.1182/blood-2011-03-343988; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Grisolano JL, 2003, P NATL ACAD SCI USA, V100, P9506, DOI 10.1073/pnas.1531730100; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; BIERNAUX C, 1995, BLOOD, V86, P3118; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Schessl C, 2005, J CLIN INVEST, V115, P2159, DOI 10.1172/JCI24225; Kikushige Y, 2010, CELL STEM CELL, V7, P708, DOI 10.1016/j.stem.2010.11.014; Yoshimoto G, 2009, BLOOD, V114, P5034, DOI 10.1182/blood-2008-12-196055; Wang YY, 2011, P NATL ACAD SCI USA, V108, P2450, DOI 10.1073/pnas.1019625108; Spiekermann K, 2003, CLIN CANCER RES, V9, P2140; Kikushige Y, 2011, CANCER CELL, V20, P246, DOI 10.1016/j.ccr.2011.06.029; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; Yergeau DA, 1997, NAT GENET, V15, P303, DOI 10.1038/ng0397-303; Shima T, 2013, BLOOD, V121, P840, DOI 10.1182/blood-2012-02-409607; Bose S, 1998, BLOOD, V92, P3362; Xiang ZF, 2007, MOL CELL BIOL, V27, P267, DOI 10.1128/MCB.01153-06; Yuan YZ, 2001, P NATL ACAD SCI USA, V98, P10398, DOI 10.1073/pnas.171321298; Peterson LF, 2004, ONCOGENE, V23, P4255, DOI 10.1038/sj.onc.1207727; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Cheng M, 2010, CIRC RES, V107, P1083, DOI 10.1161/CIRCRESAHA.110.220970; Wiemels JL, 2002, BLOOD, V99, P3801, DOI 10.1182/blood.V99.10.3801; Orfao A, 2007, BRIT J HAEMATOL, V138, P12, DOI 10.1111/j.1365-2141.2007.06619.x; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Kikushige Y, 2008, J IMMUNOL, V180, P7358; Mayerhofer M, 2008, J IMMUNOL, V180, P5466; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Miyamoto T, 1996, BLOOD, V87, P4789; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Masson K, 2009, CELL SIGNAL, V21, P1717, DOI 10.1016/j.cellsig.2009.06.002; Chu SHH, 2012, CELL STEM CELL, V11, P346, DOI 10.1016/j.stem.2012.05.027; Rowley JD, 2000, LEUKEMIA, V14, P513, DOI 10.1038/sj.leu.2401600; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Luck SC, 2010, BRIT J HAEMATOL, V148, P925, DOI 10.1111/j.1365-2141.2009.08035.x; Baer MR, 1997, BLOOD, V90, P1643; Brassesco MS, 2008, GENET MOL RES, V7, P782; Hart SM, 2002, HAEMATOLOGICA, V87, P1307; Jones D, 2010, GENE CHROMOSOME CANC, V49, P182, DOI 10.1002/gcc.20732; Klampfer L, 1996, P NATL ACAD SCI USA, V93, P14059, DOI 10.1073/pnas.93.24.14059; Murati A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-304; Nanri T, 2005, LEUKEMIA, V19, P1361, DOI 10.1038/sj.leu.2403803; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Reilly JT, 2005, BRIT J HAEMATOL, V128, P18, DOI 10.1111/j.1365-2141.2004.05236.x; Sekine Y, 2012, ONCOGENE, V31, P4384, DOI 10.1038/onc.2011.604; Xiao Z, 2001, LEUKEMIA, V15, P1906	46	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	NOV	2014	42	11					955	965		10.1016/j.exphem.2014.07.267		11	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	AU3YA	WOS:000345545300005		
J	Takahashi, M; Yoshida, M; Inoue, K; Morikawa, T; Nishikawa, A; Ogawa, K				Takahashi, Miwa; Yoshida, Midori; Inoue, Kaoru; Morikawa, Tomomi; Nishikawa, Akiyoshi; Ogawa, Kumiko			Chronic toxicity and carcinogenicity of semicarbazide hydrochloride in Wistar Hannover GALAS rats	FOOD AND CHEMICAL TOXICOLOGY			English	Article						Semicarbazide hydrochloride; Food contaminant; Chronic toxicity; Carcinogenicity; GALAS rats	SENSITIVE AMINE OXIDASE; FOOD; AZODICARBONAMIDE; INHIBITION	We performed a combined study to determine the chronic toxicity and carcinogenicity of semicarbazide hydrochloride (SEM-HCl). Male and female Wistar Hannover GALAS rats were fed a diet containing SEM-HCI at 0, 10, 50, and 250 ppm for 52 weeks (10 rats/sex/group) or for 104 weeks (50 rats/sex/group). Enlargement of the knee joints was apparent in both sexes at 250 ppm. Reduced body weight was observed at 250 ppm from week 76 only in males. SEM-HC1 exerted no toxic effects on hematology, serum biochemistry, or organ weights. Histopathologically, disarrangement of chondrocytes accompanied by increased connective tissues, and degeneration of articular cartilage were found in males at 50 ppm and above and in females at 250 ppm. Mild changes in the elastic laminae were observed at 250 ppm for both sexes in the chronic toxicity study. There were no significant intergroup differences in the incidences or types of any tumors. Taken together, toxicological effects of chronic exposure to SEM-HCI mainly occurred in the bone, cartilage, and aorta. Based on histopathological findings, the noobserved-adverse-effect-level was 10 ppm in males and 50 ppm in females (equal to 0.6 mg/kg/day in males and 3.9 mg/kg/day in females). SEM-HCI was not carcinogenic in rats. (C) 2014 Elsevier Ltd. All rights reserved.	[Takahashi, Miwa; Yoshida, Midori; Inoue, Kaoru; Morikawa, Tomomi; Ogawa, Kumiko] Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, Tokyo 1588501, Japan; [Nishikawa, Akiyoshi] Natl Inst Hlth Sci, Biol Safety Res Ctr, Setagaya Ku, Tokyo 1588501, Japan	Takahashi, M (reprint author), Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	mtakahashi@nihs.go.jp			Health and Labour Sciences Research Grants (Research on Food Safety) from the Ministry of Health, Labour, and Welfare of Japan	We thank Ms. Ayako Saikawa and Yoshimi Komatsu for technical assistance in conducting the animal study. This work was supported by Health and Labour Sciences Research Grants (Research on Food Safety) from the Ministry of Health, Labour, and Welfare of Japan.	Abramsson-Zetterberg L, 2005, TOXICOL LETT, V155, P211, DOI 10.1016/j.toxlet.2004.09.019; Stadler RH, 2004, ANALYST, V129, P276, DOI 10.1039/b314206j; de la Calle MB, 2005, ANAL BIOANAL CHEM, V382, P968, DOI 10.1007/s00216-005-3243-z; PARODI S, 1981, CANCER RES, V41, P1469; Saari L, 2004, FOOD ADDIT CONTAM, V21, P825, DOI [10.1080/02652030400002329, 10.1080/0265-2030400002329]; Hoenicke K, 2004, FOOD ADDIT CONTAM, V21, P526, DOI 10.1080/02652030410001712484; Nestmann ER, 2005, FOOD ADDIT CONTAM, V22, P875, DOI 10.1080/02652030500195312; Dawson DA, 2002, TOXICOLOGY, V177, P267, DOI 10.1016/S0300-483X(02)00233-0; Effkemann S, 2004, ANAL BIOANAL CHEM, V378, P842, DOI 10.1007/s00216-003-2270-x; EFSA, 2003, PROC AIDS MAT CONT F; EFSA, 2005, EFSA J, V219, P1; Langford SD, 1999, TOXICOL APPL PHARM, V155, P237, DOI 10.1006/taap.1998.8602; Macedo CE, 2007, BEHAV BRAIN RES, V177, P100, DOI 10.1016/j.bbr.2006.10.031; Magyar K, 2001, PURE APPL CHEM, V73, P1393, DOI 10.1351/pac200173091393; Mercier N, 2007, HYPERTENSION, V50, P234, DOI 10.1161/HYPERTENSIONAHA.107.089292; Ramamurti P., 1959, J BONE JOINT SURG BR, P590; Takahashi M, 2010, TOXICOL PATHOL, V38, P598, DOI 10.1177/0192623310368979; Takahashi M, 2009, FOOD CHEM TOXICOL, V47, P2490, DOI 10.1016/j.fct.2009.07.008; TOTH B, 1975, EUR J CANCER, V11, P17, DOI 10.1016/0014-2964(75)90032-8; WEISBURGER EK, 1981, J NATL CANCER I, V67, P75; Yoshida M, 2011, J TOXICOL SCI, V36, P297	21	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-6915	1873-6351		FOOD CHEM TOXICOL	Food Chem. Toxicol.	NOV	2014	73						84	94		10.1016/j.fct.2014.08.006		11	Food Science & Technology; Toxicology	Food Science & Technology; Toxicology	AU3CY	WOS:000345491500010		
J	Esatbeyoglu, T; Wagner, AE; Motafakkerazad, R; Nakajima, Y; Matsugo, S; Rimbach, G				Esatbeyoglu, Tuba; Wagner, Anika E.; Motafakkerazad, Rouhollah; Nakajima, Yu; Matsugo, Seiichi; Rimbach, Gerald			Free radical scavenging and antioxidant activity of betanin: Electron spin resonance spectroscopy studies and studies in cultured cells	FOOD AND CHEMICAL TOXICOLOGY			English	Article						Betanin; Beetroot; ESR; Nrf2; Heme oxygenase 1; Paraoxonase 1	PERFORMANCE LIQUID-CHROMATOGRAPHY; IONIZATION MASS-SPECTROMETRY; OXIDATIVE STRESS; DNA-DAMAGE; VULGARIS L.; BEETROOT COMPONENT; RED BEETROOT; COMET ASSAY; BETALAINS; NRF2	Betanin is a red pigment present in red beetroot. Recently, potential health benefits of betanin-rich beetroot have been suggested. However, little is known regarding the free radical scavenging and antioxidant activity of betanin. Electron spin resonance spectroscopy (ESR) and spin trapping techniques were applied to evaluate the ability of betanin to scavenge hydroxyl, superoxide, 2,2 diphenyl-1-picrylhydrazyl (DPPH), and galvinoxyl free radicals. In addition, we tested in cultured cells the ability of betanin to prevent DNA damage and to induce the transcription factor Nrf2 (nuclear factor (erythroid-derived 2)-like 2) as well as its down-stream target heme oxygenase 1 (HO-1), paraoxonase 1 (PON1) and glutathione (GSH). Betanin dose-dependently scavenged DPPH-, galvinoxyl-, superoxide-, and hydroxyl-radicals in the ESR and spin trapping studies and prevented hydrogen peroxide induced DNA damage as determined by the Comet assay.Furthermore, betanin treatment induced the transcription factor Nrf2 and resulted in an increase of HO-1 protein levels, PON1-transactivation and cellular GSH. Present data suggest that betanin is both a free radical scavenger and an inducer of antioxidant defense mechanism in cultured cells. (C) 2014 Elsevier Ltd. All rights reserved.	[Esatbeyoglu, Tuba; Wagner, Anika E.; Rimbach, Gerald] Univ Kiel, Inst Human Nutr & Food Sci, D-24118 Kiel, Germany; [Motafakkerazad, Rouhollah] Univ Tabriz, Fac Nat Sci, Dept Plant Sci, Tabriz, Iran; [Nakajima, Yu; Matsugo, Seiichi] Kanazawa Univ, Inst Sci & Engn, Fac Nat Syst, Bioengn Course, Kanazawa, Ishikawa, Japan	Rimbach, G (reprint author), Univ Kiel, Inst Human Nutr & Food Sci, Hermann Rodewald Str 6, D-24118 Kiel, Germany.	rimbach@foodsci.uni-kiel.de					VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Lorenzo Y, 2013, MUTAGENESIS, V28, P427, DOI 10.1093/mutage/get018; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Forman HJ, 2014, FREE RADICAL BIO MED, V66, P24, DOI 10.1016/j.freeradbiomed.2013.05.045; Delgado-Vargas F, 2000, CRIT REV FOOD SCI, V40, P173, DOI 10.1080/10408690091189257; Stintzing FC, 2002, J AGR FOOD CHEM, V50, P2302, DOI 10.1021/jf011305f; Kujala TS, 2002, EUR FOOD RES TECHNOL, V214, P505, DOI 10.1007/s00217-001-0478-6; Gandia-Herrero F, 2013, TRENDS PLANT SCI, V18, P334, DOI 10.1016/j.tplants.2013.01.003; Azeredo HMC, 2009, INT J FOOD SCI TECH, V44, P2365, DOI 10.1111/j.1365-2621.2007.01668.x; Kugler F, 2004, J AGR FOOD CHEM, V52, P2975, DOI 10.1021/jf035491w; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Cardozo LFMF, 2013, BIOCHIMIE, V95, P1525, DOI 10.1016/j.biochi.2013.04.012; Strack D, 2003, PHYTOCHEMISTRY, V62, P247, DOI 10.1016/S0031-9422(02)00564-2; Rimbach G, 1999, ARCH ANIM NUTR, V52, P203; Tesoriere L, 2004, AM J CLIN NUTR, V80, P941; Sakihama Y, 2012, FREE RADICAL RES, V46, P93, DOI 10.3109/10715762.2011.641157; Ernst IMA, 2011, PHARMACOL RES, V63, P233, DOI 10.1016/j.phrs.2010.11.005; Cai YZ, 1998, J AGR FOOD CHEM, V46, P2063, DOI 10.1021/jf9709966; Kujawska M, 2009, J AGR FOOD CHEM, V57, P2570, DOI 10.1021/jf803315d; Eggler AL, 2008, MOL NUTR FOOD RES, V52, pS84, DOI 10.1002/mnfr.200700249; Kapadia GJ, 2011, ANTI-CANCER AGENT ME, V11, P280; Shimizu T, 2010, J CLIN BIOCHEM NUTR, V47, P181, DOI 10.3164/jcbn.09-112; Reddy MK, 2005, J AGR FOOD CHEM, V53, P9268, DOI 10.1021/jf051399j; Esatbeyoglu T, 2012, ANGEW CHEM INT EDIT, V51, P5308, DOI 10.1002/anie.201107724; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Cheng AS, 2012, J AGR FOOD CHEM, V60, P9180, DOI 10.1021/jf302831d; Turpaev KT, 2013, BIOCHEMISTRY-MOSCOW+, V78, P111, DOI 10.1134/S0006297913020016; Castellanos-Santiago E, 2008, J AGR FOOD CHEM, V56, P5758, DOI 10.1021/jf800362t; Georgiev VG, 2010, PLANT FOOD HUM NUTR, V65, P105, DOI 10.1007/s11130-010-0156-6; Kapadia GJ, 2003, PHARMACOL RES, V47, P141, DOI 10.1016/S1043-6618(02)00285-2; Krajka-Kuzniak V, 2013, BRIT J NUTR, V110, P2138, DOI 10.1017/S0007114513001645; Mackness M, 2013, EXPERT OPIN THER TAR, V17, P829, DOI 10.1517/14728222.2013.790367; Rimbach G, 2004, BBA-GEN SUBJECTS, V1670, P229, DOI 10.1016/j.bbagen.2003.12.008; Schrader C, 2011, CURR MED CHEM, V18, P5624; Strasky Z, 2013, FOOD FUNCT, V4, P1586, DOI 10.1039/c3fo60230c; Svenson J, 2008, J AGR FOOD CHEM, V56, P7730, DOI 10.1021/jf8012053; Wagner AE, 2010, EXP DERMATOL, V19, P137, DOI 10.1111/j.1600-0625.2009.00928.x; Wagner Anika E, 2011, BMC Complement Altern Med, V11, P1, DOI 10.1186/1472-6882-11-1; Wagner AE, 2013, OXID MED CELL LONGEV, DOI 10.1155/2013/964539; Wybraniec S, 2001, PHYTOCHEMISTRY, V58, P1209, DOI 10.1016/S0031-9422(01)00336-3; Yang JH, 2014, TOXICOL APPL PHARM, V274, P293, DOI 10.1016/j.taap.2013.10.026; Zhang Q, 2013, MOL CARCINOGEN, V52, P686, DOI 10.1002/mc.21907; Zhao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075927; Zielinska-Przyjemska M, 2012, PHYTOTHER RES, V26, P845, DOI 10.1002/ptr.3649; ZZulV, 1998, VER ZUL ZUS LEB TECH	47	5	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-6915	1873-6351		FOOD CHEM TOXICOL	Food Chem. Toxicol.	NOV	2014	73						119	126		10.1016/j.fct.2014.08.007		8	Food Science & Technology; Toxicology	Food Science & Technology; Toxicology	AU3CY	WOS:000345491500014		
J	Kurashima, T; Matsuura, T; Miyamoto, A; Sano, M; Tith, B; Chann, S				Kurashima, Takayuki; Matsuura, Toshiya; Miyamoto, Asako; Sano, Makoto; Tith, Bora; Chann, Sophal			Changes in Income Structure in Frontier Villages and Implications for REDD plus Benefit Sharing	FORESTS			English	Article						REDD; benefit sharing; incentive; frontier community; household income; production system; land use; Cambodia		A methodological characteristic of the REDD+ scheme is that it attempts to reduce deforestation by rewarding communities that change problematic land use practices. This has led to discussions on benefit sharing. This article focuses on incentives for alternative land use practices among village members living in frontier areas, especially in relation to support for sustainable land use and people's livelihoods, and clarifies the issues that REDD+ projects are likely to face in this context. Although some documents regarding REDD+ projects have mentioned support to encourage such incentives, insufficient consideration has been given to the realities of the changes in frontier communities. REDD+ projects are unlikely to motivate members to embrace alternative land use practices if support or benefit sharing does not match members' expectations. Here, we examine the changes in household (HH) income and structure, as well as in livelihood activities, experienced by Cambodian frontier villagers living at the site of a planned REDD+ project. During the nine years compared in this study, the frontier villages experienced broad and imbalanced changes in HH income owing to the rapid expansion of the cultivation of cash crops. Our results indicate that benefit sharing or support inevitably becomes more difficult and challenging in frontier areas than in areas where subsistence production systems still predominate, although such frontiers could, in theory, yield maximum returns with regard to forest carbon balance if the REDD+ projects addressed benefit sharing and support and came to fruition.	[Kurashima, Takayuki; Matsuura, Toshiya; Miyamoto, Asako; Sano, Makoto] Forestry & Forest Prod Res Inst, Dept Forest Management, Tsukuba, Ibaragi 3058687, Japan; [Tith, Bora; Chann, Sophal] Forestry Adm, Inst Forest & Wildlife Res & Dev, Khan Sen Sok, Phnom Penh, Cambodia	Kurashima, T (reprint author), Forestry & Forest Prod Res Inst, Dept Forest Management, 1 Matsunosato, Tsukuba, Ibaragi 3058687, Japan.	kurakura@affrc.go.jp; matsuu50@affrc.go.jp; asakom@affrc.go.jp; masakoto@affrc.go.jp; tithbora@yahoo.com; sophal.chann@yahoo.com					Angelsen A, 2013, REV ENV ECON POLICY, V7, P91, DOI 10.1093/reep/res022; Angelsen A., 2009, REALISING REDD NATL, P125; Miyamoto M, 2006, FOREST POLICY ECON, V9, P1, DOI 10.1016/j.forpol.2005.01.003; Pacheco P, 2011, FORESTS, V2, P1, DOI 10.3390/f2010001; Blackburn T., 2011, ODDAR MEANCHEY REDD, P101; Chomitz K., 2007, LOGGERHEADS AGR EXPA, P284; Costenbader J., 2011, REDD BENEFIT SHARING, P58; Dao C, BUSINESS PROCESS ANA, P79; Enright A., 2012, APPROACH DESIGNING P, P25; Geist H. J., 2001, WHAT DRIVES TROPICAL, V4, P116; Gregersen H., 2010, DOES OPPORTUNITY COS, P23; Gregorio D.M., 2012, ANAL REDD CHALLENGES, P69; GTZ, 2012, SOC BAS REDD PROJ SI, P134; Hing V., 2009, AGR TRADE GREATER ME, P59; Kaimowitz D., 1998, EC MODELS TROPICAL D, P139; Leisz S., 2009, SE ASIAN STUDIES, V47, P237; Lindhjem H., 2011, EXPERIENCE BENEFIT S, P116; Matsuura T., 2012, P 8 INT WORKSH FOR W, P41; McKenny B., 2004, FOCUSING CAMBODIAS H, P120; Michinaka T., 2013, Journal of Sustainable Development, V6, P12; Miyamoto M., 2010, Journal of the Japanese Forest Society, V92, P226; Movik S., 2012, SOCIOECONOMIC CONDIT, P38; Muller F, 2012, COMMUNE BASED LAND A, P23; National Institute of Statistics, 2014, CENS AGR CAMB 2013 P, P33; Peskett L., 2008, MAKING REDD WORK POO, P78; Peskett L., 2011, BENEFIT SHARING REDD, P40; Pham T.T., 2013, 108 CIFOR, P69; Prpich L., 2012, MAI NDOMBE REDD JOIN, P145; PwC (PricewaterhouseCoopers), 2012, ASS OPT EFF MECH SHA, P160; R Core Team, 2014, R LANG ENV STAT COMP; Scheyvens H., 2013, REDD PROJECTS REV SE, P133; Scheyvens H., 2014, REDD PROJECTS SNAPSH, P108; Luttrell C, 2013, ECOL SOC, V18, DOI 10.5751/ES-05834-180452; World Bank, 2009, RETH FOR PARTN BEN S, P78; Wunder S, 2004, LAND USE NATURE CONS, P3	35	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1999-4907			FORESTS	Forests	NOV	2014	5	11					2865	2881		10.3390/f5112865		17	Forestry	Forestry	AU3RJ	WOS:000345531000015		
J	Sawamura, K; Maehara, K; Keira, Y; Ishikawa, HO; Sasamura, T; Yamakawa, T; Matsuno, K				Sawamura, Kyoichi; Maehara, Kazunori; Keira, Yoko; Ishikawa, Hiroyuki O.; Sasamura, Takeshi; Yamakawa, Tomoko; Matsuno, Kenji			A Test of Double Interspecific Introgression of Nucleoporin Genes in Drosophila	G3-GENES GENOMES GENETICS			English	Article						Drosophila; hybrid inviability; hybrid sterility; nucleoporin; reproductive isolation; speciation	NUCLEAR-PORE-COMPLEX; HYBRID INVIABILITY GENE; MELANOGASTER GENOME; ADAPTIVE EVOLUTION; PHI-C31; INCOMPATIBILITIES; CONSTRUCTION; DISSECTION; INTEGRASE; STERILITY	In interspecific hybrids between Drosophila melanogaster and Drosophila simulans, the D. simulans nucleoporin-encoding Nup96(sim) and Nup160(sim) can cause recessive lethality if the hybrid does not also inherit the D. simulans X chromosome. In addition, Nup160(sim) leads to recessive female sterility in the D. melanogaster genetic background. Here, we conducted carefully controlled crosses to better understand the relationship between Nup96(sim) and Nup160(sim). Nup96(sim) did not lead to female sterility in the D. melanogaster genetic background, and double introgression of Nup96(sim) and Nup160(sim) did not generally lead to lethality when one was heterozygous and the other homozygous (hemizygous). It appears that introgression of additional autosomal D. simulans genes is necessary to cause lethality and that the effect of the introgression is dominant to D. melanogaster alleles. Interestingly, the genetic background affected dominance of Nup96(sim), and double introgression carrying homozygous Nup96(sim) and hemizygous Nup160(sim) resulted in lethality. Thus, Nup96(sim) and Nup160(sim) seem to be two components of the same incompatibility.	[Sawamura, Kyoichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Maehara, Kazunori] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Keira, Yoko; Ishikawa, Hiroyuki O.] Chiba Univ, Dept Biol, Chiba 2638522, Japan; [Sasamura, Takeshi; Yamakawa, Tomoko; Matsuno, Kenji] Osaka Univ, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan	Sawamura, K (reprint author), Univ Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	sawamura@biol.tsukuba.ac.jp			Japan Society for the Promotion of Science [24570001]	We are grateful to the Bloomington Drosophila Stock Center at Indiana University and the Drosophila Genetic Resource Center at the Kyoto Institute of Technology for providing fly strains and the BAC clone. This work was supported by a Grant-in-Aid for Scientific Research (24570001) from the Japan Society for the Promotion of Science to K.S.	Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Johnson NA, 2010, TRENDS GENET, V26, P317, DOI 10.1016/j.tig.2010.04.005; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Adams RL, 2013, CELL, V152, P1218, DOI 10.1016/j.cell.2013.02.042; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bapteste E, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r85; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Tang SW, 2009, SCIENCE, V323, P779, DOI 10.1126/science.1169123; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Nolte V, 2013, GENOME RES, V23, P99, DOI 10.1101/gr.139873.112; Bilokapic S, 2012, P NATL ACAD SCI USA, V109, P15241, DOI 10.1073/pnas.1205151109; Mensch J, 2013, GENOME BIOL EVOL, V5, P2231, DOI 10.1093/gbe/evt156; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Presgraves DC, 2007, MOL BIOL EVOL, V24, P306, DOI 10.1093/molbev/msl157; Maheshwari S, 2011, ANNU REV GENET, V45, P331, DOI 10.1146/annurev-genet-110410-132514; Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]; Maehara K, 2012, GENES GENET SYST, V87, P99, DOI 10.1266/ggs.87.99; Clark NL, 2010, MOL BIOL EVOL, V27, P1152, DOI 10.1093/molbev/msp324; Ferree PM, 2012, GENET RES INT, V2012; Leducq JB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003161; Matute DR, 2014, J EVOLUTION BIOL, V27, P1691, DOI 10.1111/jeb.12422; Murakami K, 2008, GENES GENET SYST, V83, P245, DOI 10.1266/ggs.83.245; Sawamura K, 2010, GENETICS, V186, P669, DOI 10.1534/genetics.110.119867; Sawamura K, 2004, GENETICA, V120, P253, DOI 10.1023/B:GENE.0000017646.11191.b0; SAWAMURA K, 2012, INT J EVOL BIOL, DOI DOI 10.1155/2012/301894; Sawamura K, 2000, P NATL ACAD SCI USA, V97, P2652, DOI 10.1073/pnas.050558597; Shirata M, 2014, GENETICA, V142, P43, DOI 10.1007/s10709-013-9752-3; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928	33	1	1	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	NOV 1	2014	4	11					2101	2106		10.1534/g3.114.014027		6	Genetics & Heredity	Genetics & Heredity	AU0BR	WOS:000345288700005		
J	Hatakeyama, M; Nakagami, T; Yasui-Furukori, N				Hatakeyama, Makiko; Nakagami, Taku; Yasui-Furukori, Norio			Adrenal Cushing's syndrome may resemble eating disorders	GENERAL HOSPITAL PSYCHIATRY			English	Article						Adrenal Cushing's syndrome; Eating disorder; Depression; Weight loss	ANOREXIA-NERVOSA; HISTORY	We encountered a patient who presented extreme weight loss and received an eating disorder diagnosis that was later identified as adrenal Cushing's syndrome. A 32-year-old woman with a 2-year history of an eating disorder was admitted to our psychiatric ward due to dehydration, malnutrition and low weight. Her height and body weight were 152.1 cm and 29.8 kg, respectively (body mass index: 12.8). Her other symptoms included a depressed mood, decreased interest, retardation and suicidal ideation. Standard medical cares were prescribed to treat the depressive symptoms and eating disorder, but the depressive episode and low body weight of the patient persisted. Computed tomography of the abdomen revealed an unexpected left adrenal gland tumor. Cushing's syndrome was diagnosed based on several endocrinological examinations. After an enucleation of the left adrenal gland tumor, the patient began eating, and her body weight increased gradually. Her body weight increased to 42.0-47.0 kg (body mass index: 18.2-20.3). Her mental and physical conditions had stabilized. This case suggests that adrenal Cushing's syndrome may resemble eating disorders. (C) 2014 The Authors. Published by Elsevier Inc.	[Hatakeyama, Makiko; Nakagami, Taku] Ohdate City Hosp, Dept Neuropsychiat, Ohdate, Japan; [Yasui-Furukori, Norio] Hirosaki Univ, Dept Neuropsychiat, Grad Sch Med, Hirosaki, Aomori 0368562, Japan	Yasui-Furukori, N (reprint author), Hirosaki Univ, Dept Neuropsychiat, Grad Sch Med, Hirosaki, Aomori 0368562, Japan.	yasufuru@cc.hirosaki-u.ac.jp					[Anonymous], 1994, DIAGN STAT MAN MENT; Pereira AM, 2010, NEUROENDOCRINOLOGY, V92, P65, DOI 10.1159/000314317; Pollice C, 1997, INT J EAT DISORDER, V21, P367, DOI 10.1002/(SICI)1098-108X(1997)21:4<367::AID-EAT10>3.0.CO;2-W; Heaner MK, 2013, APPETITE, V65, P185, DOI 10.1016/j.appet.2013.01.005; HUDSON JI, 1987, AM J PSYCHIAT, V144, P951; Sawicka N, 2013, NEUROPSYCH DIS TREAT, V9, P431, DOI 10.2147/NDT.S40398	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	NOV-DEC	2014	36	6							UNSP 760.e9	10.1016/j.genhosppsych.2014.06.006		2	Psychiatry	Psychiatry	AU2GK	WOS:000345434400041		
J	Yasui-Furukori, N; Hashimoto, K; Tsuruga, K; Nakamura, K				Yasui-Furukori, Norio; Hashimoto, Kojiro; Tsuruga, Koji; Nakamura, Kazuhiko			Comorbidity of Stevens-Johnson syndrome and neutropenia associated with lamotrigine: a case report	GENERAL HOSPITAL PSYCHIATRY			English	Article						Stevens-Johnson syndrome; Neutropenia; Lamotrigine; Comorbidity; Bipolar disorder	TOXIC EPIDERMAL NECROLYSIS; ANTICONVULSANT HYPERSENSITIVITY SYNDROME; CARE	A 19-year-old woman with a medical history of depressive mood arrived and was treated with lamotrigine at 25 mg/day. On day 10, a high fever of 39.3 degrees C and a diffuse, erythematous, pruritic full-body rash involving the palms of her hands and the soles of her feet developed, and she was diagnosed with Stevens-Johnson syndrome (SJS). On day 17, white blood cell count (WBC) result was 1,240/mu l with 54.1% neutrophils (670/mu l), and the WBC decreased to 840/mu l with 60.7% neutrophils (510/mu l) on day 18. The trend toward improvement included skin symptoms after steroid pulse therapy using 1000 mg/day. Based on the clinical course, we concluded that the SJS and leukopenia and/or neutropenia are associated with lamotrigine. Monitoring of WBC should be kept in mind when administering lamotrigine. (C) 2014 The Authors. Published by Elsevier Inc.	[Yasui-Furukori, Norio; Hashimoto, Kojiro; Tsuruga, Koji; Nakamura, Kazuhiko] Hirosaki Univ, Dept Neuropsychiat, Grad Sch Med, Hirosaki, Aomori 0368562, Japan	Yasui-Furukori, N (reprint author), Hirosaki Univ, Dept Neuropsychiat, Grad Sch Med, Hirosaki, Aomori 0368562, Japan.	yasufuru@cc.hirosaki-u.ac.jp					Schlienger RG, 1998, EPILEPSIA, V39, pS22, DOI 10.1111/j.1528-1157.1998.tb01681.x; Mansur AT, 2008, INT J DERMATOL, V47, P1184, DOI 10.1111/j.1365-4632.2008.03827.x; Ang CC, 2011, INT J DERMATOL, V50, P1570, DOI 10.1111/j.1365-4632.2011.05007.x; Goldsmith DR, 2003, DRUGS, V63, P2029, DOI 10.2165/00003495-200363190-00009; Hirsch LJ, 2008, NEUROLOGY, V71, P1527, DOI 10.1212/01.wnl.0000334295.50403.4c; Bohan KH, 2007, PHARMACOTHERAPY, V27, P1425, DOI 10.1592/phco.27.10.1425; Page RL, 1998, PHARMACOTHERAPY, V18, P392; Rzany B, 1999, LANCET, V353, P2190, DOI 10.1016/S0140-6736(98)05418-X; Bang D, 2012, PHARMACOEPIDEM DR S, V21, P384, DOI 10.1002/pds.3212; Chaffin JJ, 1997, ANN PHARMACOTHER, V31, P720; Letko E, 2005, ANN ALLERG ASTHMA IM, V94, P419; Warnock JK, 2003, AM J CLIN DERMATOL, V4, P21, DOI 10.2165/00128071-200304010-00003; Yalcin B, 2000, J AM ACAD DERMATOL, V43, P898, DOI 10.1067/mjd.2000.100544	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	NOV-DEC	2014	36	6							UNSP 761.e9	10.1016/j.genhosppsych.2014.07.010		3	Psychiatry	Psychiatry	AU2GK	WOS:000345434400045		
J	Yamaguchi, T; Tsukioka, E; Kishi, Y				Yamaguchi, Takako; Tsukioka, Etsuko; Kishi, Yasuhiro			Outcomes after delirium in a Japanese intensive care unit	GENERAL HOSPITAL PSYCHIATRY			English	Article						Delirium; Intensive care unit; Length of stay; Social worker; Risk factors	POSTOPERATIVE DELIRIUM; ELDERLY-PATIENTS; HIP FRACTURE; ICU; CONSULTATION; MORTALITY; NEEDS; STAY; RISK	Objective: Deliriumin the intensive care unit (ICU) is recognized as a major public health problem. Few Japanese outcome studies have been reported. The purpose of the study was to investigate the hospital outcomes of ICU delirium in a Japanese general hospital. Methods: Patients were drawn from consecutive admissions to an ICU at a tertiary care university hospital. Delirium assessments were conducted using the Intensive Care Delirium Screening Checklist (ICDSC). The following information was recorded: age, sex, the reason for ICU admission, the ICDSC scores, the COmplexity PRediction Instrument (COMPRI) scores, the length of stay (LOS) in the ICU, the total hospital LOS, hospital outcomes and social worker's consultation. Results: Of the 126 patients who were evaluated, 35 (27.8%) developed delirium during the ICU stay. Older age and biopsychosocial vulnerability assessed by the COMPRI were risk factors of ICU delirium. ICU delirium was a predictor of increased mortality and associated with prolonged ICU and hospital LOS. ICU delirium was an independent risk factor for having social worker's consultation after ICU discharge. Conclusions: ICU delirium is associated with worse outcomes including mortality and LOS in Japan. ICU delirium is independently associated with further social worker's consultations, suggesting that early proactive social worker's intervention may be beneficial for the patients with ICU delirium. (C) 2014 Elsevier Inc. All rights reserved.	[Yamaguchi, Takako; Tsukioka, Etsuko] Musashikosugi Hosp, Nippon Med Sch, Dept Nursing, Kawasaki, Kanagawa 2118055, Japan; [Kishi, Yasuhiro] Musashikosugi Hosp, Nippon Med Sch, Dept Psychiat, Kawasaki, Kanagawa 2118055, Japan	Kishi, Y (reprint author), Musashikosugi Hosp, Nippon Med Sch, Dept Psychiat, Nakahara Ku, 1-396 Kosugi Cho, Kawasaki, Kanagawa 2118055, Japan.	takakoy8989@yahoo.co.jp; jeepnotyetet@yahoo.co.jp; yk1228@gmail.com					Abelha FJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13084; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8; Bergeron N, 2001, INTENS CARE MED, V27, P859; Marcantonio ER, 2000, J AM GERIATR SOC, V48, P618; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; Pandharipande PP, 2009, INTENS CARE MED, V35, P1886, DOI 10.1007/s00134-009-1573-6; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Ely EW, 2001, INTENS CARE MED, V27, P1892; Kishi Y, 2007, GEN HOSP PSYCHIAT, V29, P442, DOI 10.1016/j.genhosppsych.2007.05.006; Shehabi Y, 2010, CRIT CARE MED, V38, P2311, DOI 10.1097/CCM.0b013e3181f85759; Huyse FJ, 2001, PSYCHOSOMATICS, V42, P222, DOI 10.1176/appi.psy.42.3.222; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Olofsson B, 2005, SCAND J CARING SCI, V19, P119, DOI 10.1111/j.1471-6712.2005.00324.x; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Huyse FJ, 1997, J PSYCHOSOM RES, V43, P233, DOI 10.1016/S0022-3999(97)00011-1; Kishi Y, J PSYCHOSOM IN PRESS; Luce JM, 2013, CHEST, V144, P1381, DOI 10.1378/chest.13-0395; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; Organization for Economic Cooperation and Development, 2013, OECD HLTH DAT 2012; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Schuurmans MJ, 2003, APPL NURS RES, V16, P75, DOI 10.1016/S0897-1897(03)00012-0; Statistics Bureau Ministry of Internal Affairs and Communication, 2013, STAT JAP; Swigart SE, 2008, PSYCHOSOMATICS, V49, P104, DOI 10.1176/appi.psy.49.2.104; Tiessen James, 2013, Health Serv Manage Res, V26, P86, DOI 10.1177/0951484813512287	27	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	NOV-DEC	2014	36	6					634	636		10.1016/j.genhosppsych.2014.09.006		3	Psychiatry	Psychiatry	AU2GK	WOS:000345434400015		
J	Ishida, T; Suzuki, T; Watanabe, K; Sakurai, H; Uchida, H; Mimura, M				Ishida, Takuto; Suzuki, Takefumi; Watanabe, Koichiro; Sakurai, Hitoshi; Uchida, Hiroyuki; Mimura, Masaru			Prophylactic use of heparin for deep vein thrombosis in restrained psychiatric patients: a chart review	GENERAL HOSPITAL PSYCHIATRY			English	Article						Deep vein thrombosis; Heparin; Pulmonary embolism; Restraint; Sedation	VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; PREVENTION; DIAGNOSIS; RISK	Objective: Physical restraint sometimes causes deep vein thrombosis (DVT) and pulmonary embolism. Although unfractionated heparin (UFH) is used for the prophylaxis of DVT, its effectiveness remained unknown for restrained patients. Method: We conducted a chart review of restrained inpatients at Sakuragaoka Memorial Hospital in Japan. Restrained patients received subcutaneous injection of UFH 5000 IU bid from December 2008 to September 2010 [heparin (+) period] while UFH was not used from December 2010 to September 2012 [heparin (-) period]. A Doppler ultrasound scanning was performed to examine the presence of DVT. The incidence of DVT was compared between the two periods by chi-square test. A multiple logistic regression model was used to examine effects of demographic and clinical characteristics on the incidence of DVT. Results: No significant difference was found in the incidence of DVT between the heparin (+) and (-) periods [11.8% (11/93) vs. 11.1% (13/117)]. Sedation [odds ratio (OR)=3.78], physical comorbidities (OR=6.29) and a longer duration of restraint (OR=1.22) were associated with the incidence of DVT. Conclusion: The use of UFH was not associated with any reduction in the incidence of DVT in restrained psychiatric patients. (C) 2014 Elsevier Inc. All rights reserved.	[Ishida, Takuto] Sakuragaoka Mem Hosp, Dept Psychiat, Tama, Tokyo 2060021, Japan; [Ishida, Takuto; Suzuki, Takefumi; Watanabe, Koichiro; Sakurai, Hitoshi; Uchida, Hiroyuki; Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Suzuki, Takefumi; Sakurai, Hitoshi] Inokashira Hosp, Dept Psychiat, Tokyo, Japan; [Watanabe, Koichiro] Kyorin Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Uchida, Hiroyuki] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada	Ishida, T (reprint author), Sakuragaoka Mem Hosp, Dept Psychiat, 1-1-1 Renkouji, Tama, Tokyo 2060021, Japan.	t_ishi_2750@yahoo.co.jp	Uchida, Hiroyuki/I-4867-2015	Uchida, Hiroyuki/0000-0002-0628-7036	Astellas; Dainippon Sumitomo; Eli Lilly; Elsevier Japan; Meiji Seika; Novartis; Otsuka; Weily Japan; Pfizer; Astellas Pharmaceutical; Eisai; Otsuka Pharmaceutical; Pharmaceutical; GlaxoSmithKline; Shionogi; Dainippon-Sumitomo Pharma; Mochida Pharmaceutical; Meiji-Seika Pharma; Janssen Pharmaceutical; Yoshitomi Yakuhin; Astellas Pharma; Meiji	Dr. Suzuki has received manuscript or speaker's fees from Astellas, Dainippon Sumitomo, Eli Lilly, Elsevier Japan, Meiji Seika, Novartis, Otsuka and Weily Japan within the past 3 years.; Dr. Uchida has received grants from Pfizer, Astellas Pharmaceutical, Eisai, Otsuka Pharmaceutical, Pharmaceutical, GlaxoSmithKline, Shionogi, and Dainippon-Sumitomo Pharma, Eli Lilly, Mochida Pharmaceutical, Meiji-Seika Pharma, Janssen Pharmaceutical, and Yoshitomi Yakuhin and speaker's honoraria from Otsuka Pharmaceutical, Novartis Pharma, Eli Lilly, Shionogi, GlaxoSmithKline, Yoshitomi Yakuhin, Dainippon-Sumitomo Pharma, Meiji-Seika Pharma and Janssen Pharmaceutical within the past 3 years.; Dr. Mimura has received grants or consultant fees from Eisai, Astellas Pharma, GlaxoSmithKline and Meiji and received speaker's honoraria from Astellas Pharma, Dainippon Sumitomo Pharma, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceutical, Meiji, Otsuka Pharmaceutical, Pfizer and Yoshitomiyakuhin within the past 3 years.	Dentali F, 2007, ANN INTERN MED, V146, P278; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Mohr WK, 2003, CAN J PSYCHIAT, V48, P330; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Arana GW, 2000, J CLIN PSYCHIAT, V61, P5; Dziewas R, 2007, DYSPHAGIA, V22, P63, DOI 10.1007/s00455-006-9032-9; Heit JA, 2002, ARCH INTERN MED, V162, P1245, DOI 10.1001/archinte.162.11.1245; Steinert T, 2010, SOC PSYCH PSYCH EPID, V45, P889, DOI 10.1007/s00127-009-0132-3; Inagaki A, 1999, DOSE EQUIVALENTS PSY; Ishida T, 2014, PSYCHOSOMATICS, V55, P69, DOI 10.1016/j.psym.2013.04.001; Japanese Society of General Hospital Psychiatry, 2006, GUID PREV DEEP VEN T; Ando M, 2011, CIRC J, V75, P1258, DOI 10.1253/circj.CJ-88-0010; Kahn SR, 2012, CHEST S, V141, pe195S; Kearon C, 2012, CHEST, V141, p419s; Kearon C., 2003, CIRCULATION, V107; Maly R, 2008, PSYCHIAT CLIN NEUROS, V62, P3, DOI 10.1111/j.1440-1819.2007.01773.x; Själander A, 2008, J Intern Med, V263, P52; Tapson VF, 2008, NEW ENGL J MED, V358, P1037, DOI 10.1056/NEJMra072753; Sandercock P, 1997, LANCET, V349, P1569	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	NOV-DEC	2014	36	6					690	693		10.1016/j.genhosppsych.2014.06.007		4	Psychiatry	Psychiatry	AU2GK	WOS:000345434400025		
J	Takara, K; Kondo, T				Takara, Kiyoharu; Kondo, Tsuyoshi			Autism spectrum disorder among first-visit depressed adult patients: diagnostic clues from backgrounds and past history	GENERAL HOSPITAL PSYCHIATRY			English	Article						Autism spectrum disorder; Interpersonal friction; Bullied experience; Psychotic-like experiences; Age under 32 years	PERVASIVE DEVELOPMENTAL DISORDERS; ASPERGERS SYNDROME; FOLLOW-UP; PSYCHIATRIC COMORBIDITY; FUNCTIONING AUTISM; CLINICAL-FEATURES; SCHOOL REFUSAL; RISK-FACTORS; CHILDREN; EPIDEMIOLOGY	Objective: The present study aimed to extract discriminating indicators for diagnosis of autism spectrum disorder (ASD) from personal backgrounds and past history among depressed adult outpatients. Methods: Subjects were 430 depressed adults, consisting of patients with ASD (n=70) and those without ASD (n=360). Group comparison and discriminant analysis was conducted with regard to backgrounds (age, gender, education, marriage, living alone, physical diseases and family history of mood disorders) and past history (school non-attendance, bullied experience, psychotic-like experiences, conduct problems, suicide-related behaviors and interpersonal friction). Results: Six discriminating indicators (interpersonal friction, bullied experience, psychotic-like experiences, age under 32 years, school non-attendance and university educational level) were identified by stepwise discriminant analysis (P<.001). Absence of the first 4 indicators almost excluded ASD diagnosis with the highest negative predictive value (98%) and the least negative likelihood ratio (0.11) whereas one or more out of these 4 indicators showed low positive predictive value (32%) despite high sensitivity (93%). Conclusions: The abovementioned 4 indicators may be useful clues to cover possible ASD subjects among depressed adults although further detailed ASD focused diagnostic procedure is absolutely necessary to specify true ASD subjects. Meanwhile, absence of these 4 indicators is probably helpful to rule out ASD diagnosis. (C) 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).	[Takara, Kiyoharu; Kondo, Tsuyoshi] Univ Ryukyus, Dept Neuropsychiat, Grad Sch Med, Nishihara, Okinawa 9030215, Japan	Takara, K (reprint author), Univ Ryukyus, Dept Neuropsychiat, Grad Sch Med, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	takarakiyo1018@gmail.com					American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Vickerstaff S, 2007, J AUTISM DEV DISORD, V37, P1647, DOI 10.1007/s10803-006-0292-x; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Roy M, 2009, DTSCH ARZTEBL INT, V106, P59, DOI 10.3238/arztebl.2009.0059; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Kurita H, 2005, PSYCHIAT CLIN NEUROS, V59, P490, DOI 10.1111/j.1440-1819.2005.01403.x; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Rapoport J, 2009, J AM ACAD CHILD PSY, V48, P10, DOI 10.1097/CHI.0b013e31818b1c63; Sterling L, 2008, J AUTISM DEV DISORD, V38, P1011, DOI 10.1007/s10803-007-0477-y; Valkanova V, 2013, BIOL PSYCHIAT, V73, P406, DOI 10.1016/j.biopsych.2012.10.028; Quek LH, 2012, J CLIN PSYCHOL, V68, P1142, DOI 10.1002/jclp.21888; Woodbury-Smith MR, 2005, J AUTISM DEV DISORD, V35, P331, DOI 10.1007/s10803-005-3300-7; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Mandy W, 2011, AUTISM RES, V4, P121, DOI 10.1002/aur.178; Holwerda A, 2012, J OCCUP REHABIL, V22, P333, DOI 10.1007/s10926-011-9347-8; Kato K, 2013, GEN HOSP PSYCHIAT, V35, P50, DOI 10.1016/j.genhosppsych.2012.09.006; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Perkins NJ, 2005, BIOMETRICAL J, V47, P428, DOI 10.1002/bimj.200410133; Hofvander B, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-35; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Mazurek MO, 2014, AUTISM, V18, P223, DOI 10.1177/1362361312474121; GHAZIUDDIN M, 1991, J AUTISM DEV DISORD, V21, P349, DOI 10.1007/BF02207331; Lugnegard T, 2011, RES DEV DISABIL, V32, P1910, DOI 10.1016/j.ridd.2011.03.025; Billstedt E, 2005, J AUTISM DEV DISORD, V35, P351, DOI 10.1007/s10803-005-3302-5; de Bruin EI, 2007, J AUTISM DEV DISORD, V37, P877, DOI 10.1007/s10803-006-0215-x; Howlin P, 2005, AUTISM, V9, P533, DOI 10.1177/1362361305057871; Stewart ME, 2006, AUTISM, V10, P103, DOI 10.1177/1362361306062013; Samson AC, 2012, EMOTION, V12, P659, DOI 10.1037/a0027975; WOLFF S, 1995, J CHILD PSYCHOL PSYC, V36, P793, DOI 10.1111/j.1469-7610.1995.tb01330.x; Vannucchi G, 2014, CNS SPECTRUMS, V19, P157, DOI 10.1017/S1092852913000941; Egger HL, 2003, J AM ACAD CHILD PSY, V42, P797, DOI 10.1097/01.CHI.0000046865.56865.79; Mouridsen SE, 2008, J NEURAL TRANSM, V115, P135, DOI 10.1007/s00702-007-0798-1; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Strang JF, 2012, RES AUTISM SPECT DIS, V6, P406, DOI 10.1016/j.rasd.2011.06.015; Cappadocia MC, 2012, J AUTISM DEV DISORD, V42, P266, DOI 10.1007/s10803-011-1241-x; Balfe Myles, 2010, BMC Res Notes, V3, P300, DOI 10.1186/1756-0500-3-300; DELONG GR, 1988, J AUTISM DEV DISORD, V18, P593; First MB, 1996, STRUCTURED CLIN INTE; Glennon T. J., 2001, WORK, V17, P183; Griffith GM, 2011, AUTISM, V16, P532; Hosmer DW, 2000, APPL LOGISTIC REGRES; Jones RB, 2012, SCHIZOPHR RES, V135, P164, DOI 10.1016/j.schres.2011.11.037; King BH, 2011, BRAIN RES, V22, P34; Kurita H, 1991, JPN J PSYCHIAT TREAT, V6, P1181; KURITA H, 1991, J AUTISM DEV DISORD, V21, P1, DOI 10.1007/BF02206993; Little Liza, 2002, Issues Compr Pediatr Nurs, V25, P43, DOI 10.1080/014608602753504847; Miyachi T, 2010, JPN J PEDIAT, V63, P133; Raja Michele, 2011, Clin Pract Epidemiol Ment Health, V7, P97, DOI 10.2174/1745017901107010097; Shtayermman Oren, 2007, Issues Compr Pediatr Nurs, V30, P87, DOI 10.1080/01460860701525089; Sigman M, 1997, HDB AUTISM PERVASIVE; Spoletini I, 2008, CRIT REV ONCOL HEMAT, V65, P143, DOI 10.1016/j.critrevonc.2007.10.005; Stone WS, 2011, N AM J MED SCI BOSTO, V4, P124; Tantam D., 1991, AUTISM ASPERGER SYND, P147, DOI 10.1017/cbo9780511526770.005; van Elst LT, 2013, EUR ARCH PSY CLIN N, V263, pS189, DOI 10.1007/s00406-013-0459-3; Zablotsky B, 2014, AUTISM, V18, P419, DOI 10.1177/1362361313477920	56	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	NOV-DEC	2014	36	6					737	742		10.1016/j.genhosppsych.2014.08.004		6	Psychiatry	Psychiatry	AU2GK	WOS:000345434400034		
J	Morioka, T; Sakabe, M; Ioka, T; Iguchi, T; Mizuta, K; Hattammaru, M; Sakai, C; Itoh, M; Sato, GE; Hashimoto, A; Fujita, M; Okumura, K; Araki, M; Xin, M; Pedersen, RA; Utset, MF; Kimura, H; Nakagawa, O				Morioka, Takashi; Sakabe, Masahide; Ioka, Tomoko; Iguchi, Tomoko; Mizuta, Ken; Hattammaru, Miwa; Sakai, Chihiro; Itoh, Munehiro; Sato, Genki E.; Hashimoto, Aya; Fujita, Masahide; Okumura, Kazuki; Araki, Mutsumi; Xin, Mei; Pedersen, Roger A.; Utset, Manuel F.; Kimura, Hiroshi; Nakagawa, Osamu			An Important Role of Endothelial Hairy-Related Transcription Factors in Mouse Vascular Development	GENESIS			English	Article						mouse embryo; vascular morphogenesis; Hrt; Hey; Robo4; Src family kinases	CONGENITAL HEART-DEFECTS; GENE-EXPRESSION; CARDIOVASCULAR-SYSTEM; INHIBITS ANGIOGENESIS; NOTCH PATHWAY; ROBO4; SRC; MORPHOGENESIS; PERMEABILITY; REQUIREMENT	The Hairy-related transcription factor family of Notch- and ALK1-downstream transcriptional repressors, called Hrt/Hey/Hesr/Chf/Herp/Gridlock, has complementary and indispensable functions for vascular development. While mouse embryos null for either Hrt1/Hey1 or Hrt2/Hey2 did not show early vascular phenotypes, Hrt1/Hey1; Hrt2/Hey2 double null mice (H1(ko)/H2(ko)) showed embryonic lethality with severe impairment of vascular morphogenesis. It remained unclear, however, whether Hrt/Hey functions are required in endothelial cells or vascular smooth muscle cells. In this study, we demonstrate that mice with endothelial-specific deletion of Hrt2/Hey2 combined with global Hrt1/Hey1 deletion (H1(ko)/H2(eko)) show abnormal vascular morphogenesis and embryonic lethality. Their defects were characterized by the failure of vascular network formation in the yolk sac, abnormalities of embryonic vascular structures and impaired smooth muscle cell recruitment, and were virtually identical to the H1(ko)/H2(ko) phenotypes. Among signaling molecules implicated in vascular development, Robo4 expression was significantly increased and activation of Src family kinases was suppressed in endothelial cells of H1(ko)/H2(eko) embryos. The present study indicates an important role of Hrt1/Hey1 and Hrt2/Hey2 in endothelial cells during early vascular development, and further suggests involvement of Robo4 and Src family kinases in the mechanisms of embryonic vascular defects caused by the Hrt/Hey deficiency. genesis 52:897-906, 2014. (c) 2014 Wiley Periodicals, Inc.	[Morioka, Takashi; Sakabe, Masahide; Ioka, Tomoko; Iguchi, Tomoko; Mizuta, Ken; Hattammaru, Miwa; Sakai, Chihiro; Itoh, Munehiro; Sato, Genki E.; Hashimoto, Aya; Fujita, Masahide; Okumura, Kazuki; Araki, Mutsumi; Nakagawa, Osamu] Nara Med Univ, Lab Cardiovasc Syst Res, Adv Med Res Ctr, Kashihara, Nara 6348521, Japan; [Morioka, Takashi; Kimura, Hiroshi] Nara Med Univ, Dept Internal Med 2, Kashihara, Nara 6348521, Japan; [Hattammaru, Miwa] Tokyo Womens Med Univ, Med Ctr East, Dept Internal Med, Tokyo, Japan; [Xin, Mei] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Pedersen, Roger A.] Univ Calif San Francisco, Dept Obstet & Gynecol, Reprod Genet Div, San Francisco, CA 94143 USA; [Utset, Manuel F.] Univ Illinois, Dept Pathol, Chicago, IL USA	Nakagawa, O (reprint author), Nara Med Univ, Lab Cardiovasc Syst Res, Adv Med Res Ctr, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	sakabe@naramed-u.ac.jp; nakagawa-nmu@umin.org			Nara Medical University; Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Ichiro Kanahara Foundation; Japan Heart Foundation; Japan Vascular Disease Research Foundation; Miyata Cardiac Research Promotion Foundation; Mother and Child Health Foundation; Naito Foundation; Novartis Foundation (Japan) for the Promotion of Science; SENSHIN Medical Research Foundation; Smoking Research Foundation; Suzuken Memorial Foundation; Uehara Memorial Foundation	Contract grant sponsors: Nara Medical University, Grant-in-Aid for Collaborative Research Projects; Contract grant sponsor: Ministry of Education, Culture, Sports, Science and Technology; Contract grant sponsor: Takeda Science Foundation; Contract grant sponsor: Astellas Foundation for Research on Metabolic Disorders; Contract grant sponsor: Ichiro Kanahara Foundation; Contract grant sponsor: Japan Heart Foundation; Contract grant sponsor: Japan Vascular Disease Research Foundation; Contract grant sponsor: Miyata Cardiac Research Promotion Foundation; Contract grant sponsor: Mother and Child Health Foundation; Contract grant sponsor: Naito Foundation; Novartis Foundation (Japan) for the Promotion of Science; Contract grant sponsor: SENSHIN Medical Research Foundation; Contract grant sponsor: Smoking Research Foundation; Suzuken Memorial Foundation; Contract grant sponsor: Uehara Memorial Foundation.	Kathiriya IS, 2004, J BIOL CHEM, V279, P54937, DOI 10.1074/jbc.M409879200; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Koch AW, 2011, DEV CELL, V20, P33, DOI 10.1016/j.devcel.2010.12.001; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Somekawa S, 2012, P NATL ACAD SCI USA, V109, P12064, DOI 10.1073/pnas.1207210109; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Chin MT, 2000, J BIOL CHEM, V275, P6381, DOI 10.1074/jbc.275.9.6381; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Okada Y, 2014, ARTERIOSCL THROM VAS, V34, P1531, DOI 10.1161/ATVBAHA.114.303818; Kokubo H, 2005, DEV BIOL, V278, P301, DOI 10.1016/j.ydbio.2004.10.025; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Heisig J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002728; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Mura M, 2012, ONCOGENE, V31, P293, DOI 10.1038/onc.2011.233; Trindade A, 2008, BLOOD, V112, P1720, DOI 10.1182/blood-2007-09-112748; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Samant GV, 2011, J BIOL CHEM, V286, P30740, DOI 10.1074/jbc.M111.220665; Benedito R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-117; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Holderfield MT, 2006, BIOCHEM BIOPH RES CO, V346, P637, DOI 10.1016/j.bbrc.2006.05.177; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Kaimachnikov NP, 2009, FEBS J, V276, P4102, DOI 10.1111/j.1742-4658.2009.07117.x; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Xin M, 2007, P NATL ACAD SCI USA, V104, P7975, DOI 10.1073/pnas.0702447104; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-954X	1526-968X		GENESIS	Genesis	NOV	2014	52	11					897	906		10.1002/dvg.22825		10	Developmental Biology; Genetics & Heredity	Developmental Biology; Genetics & Heredity	AU4IA	WOS:000345572700002		
J	Nakahara, R; Kawai, Y; Oda, A; Nishimura, M; Murakami, A; Azuma, T; Kaifu, T; Goitsuka, R				Nakahara, Ryo; Kawai, Yasuhiro; Oda, Akihisa; Nishimura, Miyuki; Murakami, Akikazu; Azuma, Takachika; Kaifu, Tomonori; Goitsuka, Ryo			Generation of a Tlx1(CreER-Venus) Knock-in Mouse Strain for the Study of Spleen Development	GENESIS			English	Article						Tlx1; spleen; tamoxifen-inducible Cre; Venus; lineage tracing; mouse	HOMEOBOX GENE NKX2-5; CELL FATE; MICE; HOX11; PRECURSORS; EXPRESSION; MUTATIONS; CRE	The spleen is a lymphoid organ that serves as a unique niche for immune reactions, extramedullary hematopoiesis, and the removal of aged erythrocytes from the circulation. While much is known about the immunological functions of the spleen, the mechanisms governing the development and organization of its stromal microenvironment remain poorly understood. Here we report the generation and analysis of a Tlx1(CreER-Venus) knock-in mouse strain engineered to simultaneously express tamoxifen-inducible CreER(T2) and Venus fluorescent protein under the control of regulatory elements of the Tlx1 gene, which encodes a transcription factor essential for spleen development. We demonstrated that Venus as well as CreER expression recapitulates endogenous Tlx1 transcription within the spleen microenvironment. When Tlx1(CreER-Venus) mice were crossed with the Cre-inducible reporter strain, Tlx1-expressing cells as well as their descendants were specifically labeled following tamoxifen administration. We also showed by cell lineage tracing that asplenia caused by Tlx1 deficiency is attributable to altered contribution of mesenchymal cells in the spleen anlage to the pancreatic mesenchyme. Thus, Tlx1(CreER-Venus) mice represent a new tool for lineage tracing and conditional gene manipulation of spleen mesenchymal cells, essential approaches for understanding the molecular mechanisms of spleen development. genesis 52:916-923, 2014. (c) 2014 Wiley Periodicals, Inc.	[Nakahara, Ryo; Kawai, Yasuhiro; Oda, Akihisa; Goitsuka, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Div Dev & Aging, Noda, Chiba 2780022, Japan; [Nishimura, Miyuki; Murakami, Akikazu; Azuma, Takachika] Tokyo Univ Sci, Res Inst Biomed Sci, Div Biotechnol, Noda, Chiba 2780022, Japan; [Kaifu, Tomonori] Tokyo Univ Sci, Res Inst Biomed Sci, Div Expt Immunol, Noda, Chiba 2780022, Japan; [Kaifu, Tomonori; Goitsuka, Ryo] Tokyo Univ Sci, Res Inst Sci & Technol, Ctr Anim Dis Models, Noda, Chiba 2780022, Japan	Goitsuka, R (reprint author), Tokyo Univ Sci, Res Inst Biomed Sci, Div Dev & Aging, 2669 Yamazaki, Noda, Chiba 2780022, Japan.	ryogoi@rs.noda.tus.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan;  [25292194];  [25111513];  [26660259]	Contract grant sponsor: Grant-in-Aid for Scientific Research, Contract grant numbers: 25292194, 25111513, 26660259; Contract grant sponsor: Ministry of Education, Culture, Sports, Science and Technology of Japan	Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Miyoshi H, 1998, J VIROL, V72, P8150; Biben C, 2000, CIRC RES, V87, P888; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Koss M, 2012, DEV CELL, V22, P913, DOI 10.1016/j.devcel.2012.02.009; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Pabst O, 1999, DEVELOPMENT, V126, P2215; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Brendolan A, 2007, BIOESSAYS, V29, P166, DOI 10.1002/bies.20528; Brendolan A, 2005, DEVELOPMENT, V132, P3113, DOI 10.1242/dev.01884; Burn SF, 2008, DEV BIOL, V318, P303, DOI 10.1016/j.ydbio.2008.03.031; Castagnaro L, 2013, IMMUNITY, V38, P782, DOI 10.1016/j.immuni.2012.12.005; Chi X, 2003, GENESIS, V35, P220, DOI 10.1002/gene.10181; DEAR TN, 1995, DEVELOPMENT, V121, P2909; Herzer U, 1999, CURR BIOL, V9, P837, DOI 10.1016/S0960-9822(99)80369-8; Hirayama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089885; Kanzler B, 2001, DEV BIOL, V234, P231, DOI 10.1006/dbio.2001.0239; Kodama S, 2005, TRENDS MOL MED, V11, P271, DOI 10.1016/j.molmed.2005.04.004; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; ROBERTS CWM, 1994, NATURE, V368, P747, DOI 10.1038/368747a0; ROBERTS CWM, 1995, AM J PATHOL, V146, P1089; Sagi B, 2012, STEM CELLS DEV, V21, P814, DOI 10.1089/scd.2011.0551	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-954X	1526-968X		GENESIS	Genesis	NOV	2014	52	11					916	923		10.1002/dvg.22829		8	Developmental Biology; Genetics & Heredity	Developmental Biology; Genetics & Heredity	AU4IA	WOS:000345572700004		
J	Yamamoto, J; Korenaga, J; Hirano, N; Kagi, H				Yamamoto, Junji; Korenaga, Jun; Hirano, Naoto; Kagi, Hiroyuki			Melt-rich lithosphere-asthenosphere boundary inferred from petit-spot volcanoes	GEOLOGY			English	Article							UPPER-MANTLE; HEAT-FLOW; PLATE FLEXURE; JAPAN TRENCH; LHERZOLITE; DISCONTINUITY; TEMPERATURE; GENERATION; ANOMALIES; OCEANWARD	Young basaltic knolls have been discovered on the old oceanic lithosphere, namely petit-spot volcanoes. Based on their geochemical signatures, they have presumably originated from partial melts in the asthenosphere. However, there is no direct information on the depth provenance of petit-spot formation. Here we report new geothermobarometric data of rare mantle xenoliths discovered from petit-spot lavas exhibiting a geotherm much hotter than expected for the ca. 140 Ma seafloor on which petit-spots were formed. Such an anomalously hot geotherm indicates that melt porosity around the lithosphere-asthenosphere boundary (LAB) must be as high as a few percent. Such high melt porosity would be possible by continuous melt replenishment. Excess pressure induced by the outer-rise topography enables horizontal melt migration along the LAB and sustains a continuous melt supply to petit-spot magmatism. Given the general age-depth relationship of ocean basins, a melt-rich boundary region could also be a global feature.	[Yamamoto, Junji] Hokkaido Univ Museum, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Yamamoto, Junji] Kyoto Univ, Inst Geothermal Sci, Beppu, Oita 8740903, Japan; [Korenaga, Jun] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Hirano, Naoto] Tohoku Univ, Ctr Northeast Asian Studies, Aoba Ku, Sendai, Miyagi 9808576, Japan; [Kagi, Hiroyuki] Univ Tokyo, Geochem Res Ctr, Bunkyo Ku, Tokyo 1130033, Japan	Yamamoto, J (reprint author), Hokkaido Univ Museum, Kita Ku, 8 Nishi,10 Kita, Sapporo, Hokkaido 0600810, Japan.				Toray Science and Technology Grant [11-5208]; Japan Society for the Promotion of Science [23654160, 25287139]; Kyoto University	Two anonymous reviewers provided thoughtful comments that improved the manuscript. This work has been funded by a Toray Science and Technology Grant (no. 11-5208) and Grants-in-Aid for Scientific Research (nos. 23654160, 25287139) from the Japan Society for the Promotion of Science. Korenaga was supported in part by a visiting professorship at Kyoto University.	Hirano N, 2008, BASIN RES, V20, P543, DOI 10.1111/j.1365-2117.2008.00363.x; Naif S, 2013, NATURE, V495, P356, DOI 10.1038/nature11939; PARSONS B, 1977, J GEOPHYS RES, V82, P803, DOI 10.1029/JB082i005p00803; Schmerr N, 2012, SCIENCE, V335, P1480, DOI 10.1126/science.1215433; Stixrude L, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB002965; Kelemen PB, 1997, PHILOS T R SOC A, V355, P283; Obayashi M, 2006, EARTH PLANET SC LETT, V243, P149, DOI 10.1016/j.epsl.2005.12.032; Rutherford MJ, 2008, REV MINERAL GEOCHEM, V69, P241, DOI 10.2138/rmg.2008.69.7; Priestley K, 2006, EARTH PLANET SC LETT, V244, P285, DOI 10.1016/j.epsl.2006.01.008; Yamano M, 2008, INT J EARTH SCI, V97, P345, DOI 10.1007/s00531-007-0280-1; Korenaga J, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005100; PITZER KS, 1994, J CHEM PHYS, V101, P3111, DOI 10.1063/1.467624; ONEILL HSC, 1981, CONTRIB MINERAL PETR, V77, P185, DOI 10.1007/BF00636522; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; Hirano N, 2006, SCIENCE, V313, P1426, DOI 10.1126/science.1128235; Sifre D, 2014, NATURE, V509, P81, DOI 10.1038/nature13245; Faul UH, 2005, EARTH PLANET SC LETT, V234, P119, DOI 10.1016/j.epsl.2005.02.008; REVENAUGH J, 1991, J GEOPHYS RES-SOL EA, V96, P19781, DOI 10.1029/91JB01487; Kawakatsu H, 2009, SCIENCE, V324, P499, DOI 10.1126/science.1169499; SPARKS DW, 1991, EARTH PLANET SC LETT, V105, P368, DOI 10.1016/0012-821X(91)90178-K; MCKENZIE D, 1984, J PETROL, V25, P713; Hirschmann MM, 2010, PHYS EARTH PLANET IN, V179, P60, DOI 10.1016/j.pepi.2009.12.003; Borghini G, 2010, J PETROL, V51, P229, DOI 10.1093/petrology/egp079; Gaherty JB, 1996, J GEOPHYS RES-SOL EA, V101, P22291, DOI 10.1029/96JB01882; Hirano N, 2013, GEOCHEM J, V47, P249; Hirano N, 2004, CONTRIB MINERAL PETR, V148, P47, DOI 10.1007/s00410-004-0593-z; Korenaga T, 2008, EARTH PLANET SC LETT, V268, P41, DOI 10.1016/j.epsl.2007.12.022; Koziol AM, 1998, AM MINERAL, V83, P213; MCKENZIE D, 1989, EARTH PLANET SC LETT, V95, P53, DOI 10.1016/0012-821X(89)90167-2; MILLER C, 1982, GEOCHEM J, V16, P263; SPENCE DA, 1990, J GEOPHYS RES-SOLID, V95, P5133, DOI 10.1029/JB095iB04p05133; Turcotte D. L., 2002, GEODYNAMICS; WELLS PRA, 1977, CONTRIB MINERAL PETR, V62, P129, DOI 10.1007/BF00372872; WYLLIE PJ, 1988, J GEOPHYS RES-SOLID, V93, P4171, DOI 10.1029/JB093iB05p04171; Yamamoto J, 2009, CHEM GEOL, V268, P313, DOI 10.1016/j.chemgeo.2009.09.009; Zhang XY, 2010, CONTRIB MINERAL PETR, V159, P175, DOI 10.1007/s00410-009-0422-5	36	2	2	GEOLOGICAL SOC AMER, INC	BOULDER	PO BOX 9140, BOULDER, CO 80301-9140 USA	0091-7613	1943-2682		GEOLOGY	Geology	NOV	2014	42	11					967	970		10.1130/G35944.1		4	Geology	Geology	AU2IC	WOS:000345440300010		
J	Saito, H; Korup, O; Uchida, T; Hayashi, S; Oguchi, T				Saito, H.; Korup, O.; Uchida, T.; Hayashi, S.; Oguchi, T.			Rainfall conditions, typhoon frequency, and contemporary landslide erosion in Japan	GEOLOGY			English	Article							DEBRIS FLOWS; SHALLOW LANDSLIDES; PREDICTION	Dealing with predicted increases in extreme weather conditions due to climate change requires robust knowledge about controls on rainfall-triggered landslides. We explore relationships between rainfall and landslide size throughout the Japanese archipelago. We test whether the total volume of landslides can be predicted directly from rainfall totals, intensity, and duration using a nationwide inventory of 4744 rainfall-triggered landslides recorded from A.D. 2001 to 2011. We find that larger landslides were more abundant at the expense of smaller ones when total, maximum, and mean rainfall intensity exceeded similar to 250 mm, similar to 35 mm/h, and similar to 4 mm/h, respectively. Frequency distributions of these rainfall parameters are peaked and heavily skewed. Yet neither the most frequent nor the most extreme values of these rainfall metrics coincide consistently with the maximum landslide volumes. A striking decrease of landslide volumes at both mean and maximum rainfall intensity, as well as duration, points to an exhaustion in hillslope geomorphic response regardless of sample size, landslide type, mobilized volume, dominant lithology, or reporting bias. Our results underscore substantial offsets between the peaks of rainfall metrics and maximum associated landslide volumes, thus complicating straightforward estimates of geomorphic work from metrics of rainstorm magnitude or frequency. Only the rainfall total appears to be a suitable monotonic predictor of landslide volumes mobilized during typhoons and frontal storms.	[Saito, H.] Kanto Gakuin Univ, Coll Econ, Yokohama, Kanagawa 2368501, Japan; [Saito, H.; Oguchi, T.] Univ Tokyo, Ctr Spatial Informat Sci, Kashiwa, Chiba 2778568, Japan; [Korup, O.] Univ Potsdam, Inst Earth & Environm Sci, D-14476 Potsdam, Germany; [Uchida, T.; Hayashi, S.] Natl Inst Land & Infrastruct Management, SABO Planning Div, Tsukuba, Ibaraki 3050804, Japan	Saito, H (reprint author), Kanto Gakuin Univ, Coll Econ, 1-50-1 Mutsuura Higashi, Yokohama, Kanagawa 2368501, Japan.				Japan Society for the Promotion of Science [23-148, 25882037]; German Research Foundation (DFG) [KO3937/6]; Potsdam Research Cluster for Georisk Analysis, Environmental Change and Sustainability (PROGRESS)	We thank James A. Spotila, Jonathan Stock, and anonymous reviewers for their valuable comments. This study was supported by a Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (23-148 and 25882037), the German Research Foundation (DFG Grant KO3937/6), and the Potsdam Research Cluster for Georisk Analysis, Environmental Change and Sustainability (PROGRESS). We computed statistics using the R software environment (http://www.r-project.org/).	MATSUMOTO J, 1989, INT J CLIMATOL, V9, P407, DOI 10.1002/joc.3370090407; Guzzetti F, 2008, LANDSLIDES, V5, P3, DOI 10.1007/s10346-007-0112-1; Iverson RM, 2000, WATER RESOUR RES, V36, P1897, DOI 10.1029/2000WR900090; Eaton LS, 2003, GEOLOGY, V31, P339, DOI 10.1130/0091-7613(2003)031<0339:RODFIL>2.0.CO;2; Kirschbaum D, 2012, J HYDROMETEOROL, V13, P1536, DOI 10.1175/JHM-D-12-02.1; Finlay PJ, 1997, CAN GEOTECH J, V34, P811, DOI 10.1139/cgj-34-6-811; PAGE MJ, 1994, GEOMORPHOLOGY, V9, P169, DOI 10.1016/0169-555X(94)90061-2; Keefer DK, 2007, SCIENCE, V316, P1136, DOI 10.1126/science.1143308; Baum R, 2010, LANDSLIDES, V7, P259, DOI 10.1007/s10346-009-0177-0; Korup O, 2012, EARTH SURF PROC LAND, V37, P92, DOI 10.1002/esp.2248; Li CJ, 2011, GEOMORPHOLOGY, V130, P221, DOI 10.1016/j.geomorph.2011.03.018; Saito H, 2010, GEOMORPHOLOGY, V118, P167, DOI 10.1016/j.geomorph.2009.12.016; Petley D, 2012, GEOLOGY, V40, P927, DOI 10.1130/G33217.1; Murakami H, 2011, J CLIMATE, V24, P1154, DOI 10.1175/2010JCLI3723.1; Wieczorek GF, 2005, S-P BKS GEOPHYS SCI, P325; Crozier MJ, 1999, EARTH SURF PROC LAND, V24, P825, DOI 10.1002/(SICI)1096-9837(199908)24:9<825::AID-ESP14>3.3.CO;2-D; Chen YC, 2013, EARTH SURF PROC LAND, V38, P372, DOI 10.1002/esp.3284; Osanai N, 2010, LANDSLIDES, V7, P325, DOI 10.1007/s10346-010-0229-5; Cruden D.M., 1996, LANDSLIDES INVESTIGA, P36; Dai FC, 2001, ENG GEOL, V59, P253, DOI 10.1016/S0013-7952(00)00077-6; IPCC, 2013, CLIM CHANG 2013 PHYS; Lin GW, 2008, ENG GEOL, V97, P32, DOI 10.1016/j.enggeo.2007.12.001; Manda A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05741; Oguchi T., 1996, U TOKYO DEP GEOGRAPH, V28, P45; Uchida T., 2012, CIVIL ENG J, V54, P10; Urita Shinji, 2011, Hydrological Research Letters, V5, DOI 10.3178/HRL.5.37	26	2	2	GEOLOGICAL SOC AMER, INC	BOULDER	PO BOX 9140, BOULDER, CO 80301-9140 USA	0091-7613	1943-2682		GEOLOGY	Geology	NOV	2014	42	11					999	1002		10.1130/G35680.1		4	Geology	Geology	AU2IC	WOS:000345440300018		
J	Nishimura, T; Okayasu, T; Saito, O; Shimokura, R; Yamashita, A; Yamanaka, T; Hosoi, H; Kitahara, T				Nishimura, Tadashi; Okayasu, Tadao; Saito, Osamu; Shimokura, Ryota; Yamashita, Akinori; Yamanaka, Toshiaki; Hosoi, Hiroshi; Kitahara, Tadashi			An examination of the effects of broadband air-conduction masker on the speech intelligibility of speech-modulated bone-conduction ultrasound	HEARING RESEARCH			English	Article							AUDITORY-CORTEX; PERCEPTION; RECOGNITION; HEARING; FREQUENCIES; NOISE	Ultrasound can be heard by bone-conduction, and speech-modulated bone-conducted ultrasound (BCU) delivers the speech information to the human ear. One of the recognition mechanisms is the demodulation of the signals. Because some of the profoundly deaf can also hear speech-modulated BCU, another mechanism may also contribution to the recognition of speech-modulated BCU. In this study, eight volunteers with normal hearing participated. The intelligibilities of speech-modulated BCU were measured using a numeral word list under masking conditions. Because the masker can mask the demodulated sounds, the evaluation of the masking reveals the contribution of the demodulation to the recognition of speech-modulated BCU. In the current results, the masking of speech-modulated BCU differed from that of original non-modulated speech. Although the masking shifted the recognition curve for the original speech upward, the same results were not observed for the speech-modulated BCU. The masking generated the difference in the correct answers among the words for the speech-modulated BCU. The current results suggested the importance of the envelope of the modulated ultrasonic signal to the recognition under masking condition. Both demodulation and direct ultrasonic stimulation contribute to the recognition of speech-modulated BCU for the normal hearing individuals, and the direct ultrasonic stimulation plays an important role in the recognition for the profoundly deaf. (C) 2014 Elsevier B.V. All rights reserved.	[Nishimura, Tadashi; Okayasu, Tadao; Saito, Osamu; Shimokura, Ryota; Yamashita, Akinori; Yamanaka, Toshiaki; Kitahara, Tadashi] Nara Med Univ, Dept Otolaryngol Head & Neck Surg, Kashihara, Nara 6348522, Japan; [Hosoi, Hiroshi] Nara Med Univ, Kashihara, Nara 6348522, Japan	Nishimura, T (reprint author), Nara Med Univ, Dept Otolaryngol Head & Neck Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	t-nishim@naramed-u.ac.jp			Japan Society for the Promotion on Science (JSPS) [20791217, 26282130]	This study was supported by Grant-in-Aid for Young Scientists (B) (20791217) and Grant-in-Aid for Scientific Research (B) (26282130) from the Japan Society for the Promotion on Science (JSPS).	Moore BCJ, 2012, J ACOUST SOC AM, V132, P1542, DOI 10.1121/1.4739444; DIRKS DD, 1982, J SPEECH HEAR DISORD, V47, P114; Studebaker GA, 1999, J ACOUST SOC AM, V105, P2431, DOI 10.1121/1.426848; Koizumi T, 2014, HEARING RES, V310, P48, DOI 10.1016/j.heares.2014.01.011; Oxenham AJ, 2011, P NATL ACAD SCI USA, V108, P7629, DOI 10.1073/pnas.1015291108; BELLUCCI RICHARD J., 1962, ANN OTOL RHINOL AND LARYNGOL, V71, P719; CORSO JF, 1963, J ACOUST SOC AM, V35, P1738, DOI 10.1121/1.1918804; Deatherage H., 1954, J ACOUST SOC AM, V26, P582; DIEROFF HG, 1975, ARCH OTO-RHINO-LARYN, V209, P277, DOI 10.1007/BF00456548; Fujimoto K, 2005, HEARING RES, V204, P210, DOI 10.1016/j.heares.2005.02.004; GAVREAU V, 1948, CR HEBD ACAD SCI, V226, P2053; HAEFF AV, 1963, SCIENCE, V139, P590, DOI 10.1126/science.139.3555.590; Hosoi H, 1998, LANCET, V351, P496, DOI 10.1016/S0140-6736(05)78683-9; Imaizumi S, 2001, NEUROREPORT, V12, P583, DOI 10.1097/00001756-200103050-00030; Japan Audiological Society, 2010, AUDIOL JPN, V46, P622; LENHARDT ML, 1991, SCIENCE, V253, P82, DOI 10.1126/science.2063208; Matsui T., 2013, P M ACOUST, V19; Nishimura T, 2011, HEARING RES, V277, P176, DOI 10.1016/j.heares.2011.01.004; Nishimura T, 2003, HEARING RES, V175, P171, DOI 10.1016/S0378-5955(02)00735-9; Nishimura T, 2009, ACTA OTO-LARYNGOL, V129, P28, DOI 10.1080/00016480902915707; Okamoto Y, 2005, HEARING RES, V208, P107, DOI 10.1016/j.heares.2005.05.007; Okayasu T, 2014, NEUROSCI LETT, V559, P117, DOI 10.1016/j.neulet.2013.11.048; Okayasu T, 2013, NEUROSCI LETT, V539, P71, DOI 10.1016/j.neulet.2013.01.040; PUMPHREY RJ, 1950, NATURE, V166, P571, DOI 10.1038/166571b0; Shimokura R., 2012, BEHAV SCI RES, V50, P187; Yamashita A, 2009, ACTA OTO-LARYNGOL, V129, P34, DOI 10.1080/00016480902926449; Yamashita A., 2009, NEUROREPORT, V21, P119	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	NOV	2014	317						41	49		10.1016/j.heares.2014.09.012		9	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	AU3XF	WOS:000345543300006		
J	Fukuzumi, M; Nakanishi, W; Ishikawa, T; Kumamoto, T				Fukuzumi, Masahiro; Nakanishi, Waka; Ishikawa, Tsutomu; Kumamoto, Takuya			Synthesis of ortho-Phenylenebis(guanidine) Derivatives with Potential Chirality	HELVETICA CHIMICA ACTA			English	Article							YLIDE-MEDIATED AZIRIDINATION; GUANIDINIUM YLIDES; INTERMEDIATE; BISGUANIDINOBENZENE; CRYSTALLIZATION; SUPERBASES; CONVERSION; SKELETON	We report the synthesis and potential chirality of ortho-phenylenebisguanidines (BGs) with substituents at C(3) and C(6). Guanidinylation of 3,6-disubstituted benzene-1,2-diamines with 2-chloro-4,5- dihydro-1,3-dimethyl-1H-imidazolium chloride gave the corresponding BGs. X-Ray crystallography showed that the two guanidine moieties occupy different faces of the benzene ring, creating potential chirality, although optical resolution of tBu-substituted BG by chiral HPLC failed. However, a methylated acyclic bisguanidinium salt (BGms) was obtained as a chiral crystal with a space group of P2(1)2(1)2(1).	[Fukuzumi, Masahiro; Nakanishi, Waka; Ishikawa, Tsutomu; Kumamoto, Takuya] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan	Kumamoto, T (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	t_kum632@musashino-u.ac.jp					Kawahata M, 2006, ACTA CRYSTALLOGR E, V62, pO3301, DOI 10.1107/S1600536806026365; PINCOCK RE, 1971, SCIENCE, V174, P1018, DOI 10.1126/science.174.4013.1018; Yang RQ, 2005, MACROMOLECULES, V38, P244, DOI 10.1021/ma047969i; Kondo Y, 2012, J ORG CHEM, V77, P7988, DOI 10.1021/jo301178b; Takahashi M, 2013, J ORG CHEM, V78, P3250, DOI 10.1021/jo400147f; Sakamoto M, 2006, J PHOTOCH PHOTOBIO C, V7, P183, DOI 10.1016/j.jphotochemrev.2006.11.002; Tsuchiya Y, 2004, J ORG CHEM, V69, P8504, DOI 10.1021/jo048813j; Yagishita F, 2012, ANGEW CHEM INT EDIT, V51, P13023, DOI 10.1002/anie.201205097; Ishikawa T, 2012, HETEROCYCLES, V85, P2837, DOI 10.3987/REV-12-748; Bhuiyan MDH, 2009, EUR J ORG CHEM, P687, DOI 10.1002/ejoc.200801032; CHEESEMAN GW, 1962, J CHEM SOC, P1170, DOI 10.1039/jr9620001170; Disadee W, 2006, J ORG CHEM, V71, P6600, DOI 10.1021/jo060531r; Eliel E.L., 1994, STEREOCHEMISTRY ORGA; Hada K, 2001, J AM CHEM SOC, V123, P7705, DOI 10.1021/ja0107024; Haga T, 2005, TETRAHEDRON, V61, P2857, DOI 10.1016/j.tet.2005.01.088; Ishikawa T, 2013, SYNLETT, V24, P2507, DOI 10.1055/s-0033-1340059; Isobe T, 1998, TETRAHEDRON-ASYMMETR, V9, P1729, DOI 10.1016/S0957-4166(98)00152-9; Isobe T, 2000, J ORG CHEM, V65, P7770, DOI 10.1021/jo000744v; Kawahata M, 2005, CRYST GROWTH DES, V5, P373, DOI 10.1021/cg049864c; KESSLER H, 1971, CHEM BER-RECL, V104, P2158, DOI 10.1002/cber.19711040716; Khantikaew I, 2012, TETRAHEDRON, V68, P878, DOI 10.1016/j.tet.2011.11.033; Kojima H, 2013, HELV CHIM ACTA, V96, P379, DOI 10.1002/hlca.201200510; Mancilha FS, 2006, EUR J ORG CHEM, P4924, DOI 10.1002/ejoc.200600376; NAEF R, 1978, HELV CHIM ACTA, V61, P2958, DOI 10.1002/hlca.19780610821; Nakanishi W, 2007, B CHEM SOC JPN, V80, P1187, DOI 10.1246/bcsj.80.1187; Nakanishi W, 2007, TETRAHEDRON LETT, V48, P8526, DOI 10.1016/j.tetlet.2007.09.144; Ohno K, 2003, HETEROCYCLES, V59, P317; OLAH GA, 1976, SYNTHESIS-STUTTGART, P42; PESIN VG, 1964, ZH OBSHCH KHIM+, V34, P1258; Wannaporn D., 2005, J ORG CHEM, V70, P9399	30	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0018-019X	1522-2675		HELV CHIM ACTA	Helv. Chim. Acta	NOV	2014	97	11					1453	1468		10.1002/hlca.201400053		16	Chemistry, Multidisciplinary	Chemistry	AU0LA	WOS:000345313000001		
J	Ayuso, E; Blouin, V; Lock, M; McGorray, S; Leon, X; Alvira, MR; Auricchio, A; Bucher, S; Chtarto, A; Clark, KR; Darmon, C; Doria, M; Fountain, W; Gao, GP; Gao, K; Giacca, M; Kleinschmidt, J; Leuchs, B; Melas, C; Mizukami, H; Muller, M; Noordman, Y; Bockstael, O; Ozawa, K; Pythoud, C; Sumaroka, M; Surosky, R; Tenenbaum, L; van der Linden, I; Weins, B; Wright, JF; Zhang, XH; Zentilin, L; Bosch, F; Snyder, RO; Moullier, P				Ayuso, Eduard; Blouin, Veronique; Lock, Martin; McGorray, Susan; Leon, Xavier; Alvira, Mauricio R.; Auricchio, Alberto; Bucher, Stephanie; Chtarto, Abdelwahed; Clark, K. Reed; Darmon, Christophe; Doria, Monica; Fountain, Will; Gao, Guangping; Gao, Kai; Giacca, Mauro; Kleinschmidt, Juergen; Leuchs, Barbara; Melas, Catherine; Mizukami, Hiroaki; Mueller, Marcus; Noordman, Yvet; Bockstael, Olivier; Ozawa, Keiya; Pythoud, Catherine; Sumaroka, Marina; Surosky, Richard; Tenenbaum, Liliane; van der Linden, Inge; Weins, Brigitte; Wright, J. Fraser; Zhang, Xinhua; Zentilin, Lorena; Bosch, Fatima; Snyder, Richard O.; Moullier, Philippe			Manufacturing and Characterization of a Recombinant Adeno-Associated Virus Type 8 Reference Standard Material	HUMAN GENE THERAPY			English	Article							LEBERS CONGENITAL AMAUROSIS; VECTOR REFERENCE-STANDARDS; GENE-TRANSFER; VIRAL VECTORS; TRANSDUCTION; HEMOPHILIA; EFFICIENCY; PARTICLES; THERAPY; CAPSIDS	Gene therapy approaches using recombinant adeno-associated virus serotype 2 (rAAV2) and serotype 8 (rAAV8) have achieved significant clinical benefits. The generation of rAAV Reference Standard Materials (RSM) is key to providing points of reference for particle titer, vector genome titer, and infectious titer for gene transfer vectors. Following the example of the rAAV2RSM, here we have generated and characterized a novel RSM based on rAAV serotype 8. The rAAV8RSM was produced using transient transfection, and the purification was based on density gradient ultracentrifugation. The rAAV8RSM was distributed for characterization along with standard assay protocols to 16 laboratories worldwide. Mean titers and 95% confidence intervals were determined for capsid particles (mean, 5.50 x 10(11) pt/ml; CI, 4.26 x 10(11) to 6.75 x 10(11) pt/ml), vector genomes (mean, 5.75 x 10(11) vg/ml; CI, 3.05 x 10(11) to 1.09 x 10(12) vg/ml), and infectious units (mean, 1.26 x 10(9) IU/ml; CI, 6.46 x 10(8) to 2.51 x 10(9) IU/ml). Notably, there was a significant degree of variation between institutions for each assay despite the relatively tight correlation of assay results within an institution. This outcome emphasizes the need to use RSMs to calibrate the titers of rAAV vectors in preclinical and clinical studies at a time when the field is maturing rapidly. The rAAV8RSM has been deposited at the American Type Culture Collection (VR-1816) and is available to the scientific community.	[Ayuso, Eduard; Leon, Xavier; Bosch, Fatima] Univ Autonoma Barcelona, Sch Vet Med, Ctr Anim Biotechnol & Gene Therapy, Bellaterra 08193, Spain; [Ayuso, Eduard; Leon, Xavier; Bosch, Fatima] Univ Autonoma Barcelona, Sch Vet Med, Dept Biochem & Mol Biol, Bellaterra 08193, Spain; [Blouin, Veronique; Darmon, Christophe; Moullier, Philippe] CHU Nantes, INSERM, UMR1089, F-44000 Nantes, France; [Blouin, Veronique; Darmon, Christophe; Moullier, Philippe] Atlantic Gene Therapies, F-44000 Nantes, France; [Lock, Martin; Alvira, Mauricio R.] Univ Penn, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA 19104 USA; [McGorray, Susan] Univ Florida, Dept Biostat, Coll Med & Publ Hlth, Gainesville, FL 32610 USA; [McGorray, Susan] Univ Florida, Dept Biostat, Coll Hlth Profess, Gainesville, FL 32610 USA; [Auricchio, Alberto] Univ Naples Federico II, Dept Translat Med, I-80131 Naples, Italy; [Auricchio, Alberto; Doria, Monica] Telethon Inst Genet & Med, TIGEM, I-80131 Naples, Italy; [Bucher, Stephanie] GENETHON, F-91000 Evry, France; [Chtarto, Abdelwahed; Melas, Catherine; Bockstael, Olivier] Free Univ Brussels, Lab Expt Neurosurg, B-1070 Brussels, Belgium; [Chtarto, Abdelwahed; Melas, Catherine; Bockstael, Olivier] Free Univ Brussels, Multidisciplinary Res Inst, B-1070 Brussels, Belgium; [Clark, K. Reed; Fountain, Will] Nationwide Childrens Hosp, Ctr Gene Therapy, Res Inst, Columbus, OH 43205 USA; [Clark, K. Reed; Fountain, Will] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Darmon, Christophe] EFS Atlantic BioGMP, F-44800 Nantes, France; [Gao, Guangping; Gao, Kai] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA 01605 USA; [Gao, Kai] Natl Inst Food & Drug Control, Div Biopharmaceut, Beijing 100050, Peoples R China; [Giacca, Mauro; Zentilin, Lorena] ICGEB, Mol Med Lab, I-34149 Trieste, Italy; [Kleinschmidt, Juergen; Leuchs, Barbara; Mueller, Marcus] German Canc Res Ctr, Res Program Infect & Canc, D-69120 Heidelberg, Germany; [Mizukami, Hiroaki; Ozawa, Keiya] Jichi Med Univ, Ctr Mol Med, Div Genet Therapeut, Shimotsuke, Tochigi 3290498, Japan; [Noordman, Yvet; van der Linden, Inge] uniQure, NL-1100 Amsterdam, Netherlands; [Pythoud, Catherine; Tenenbaum, Liliane] Univ Lausanne Hosp, Dept Clin Neurosci, Lab Cellular & Mol Neurotherapies, CH-1015 Lausanne, Switzerland; [Pythoud, Catherine; Tenenbaum, Liliane] Univ Lausanne Hosp, Dept Clin Neurosci, Neurosurg Serv, CH-1015 Lausanne, Switzerland; [Sumaroka, Marina; Wright, J. Fraser; Zhang, Xinhua] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Surosky, Richard] Sangamo Biosci Inc, Richmond, CA 94804 USA; [Weins, Brigitte] Progen Biotech GmbH, D-69123 Heidelberg, Germany; [Wright, J. Fraser] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Snyder, Richard O.] Univ Florida, Ctr Excellence Regenerat Hlth Biotechnol, Gainesville, FL 32611 USA; [Snyder, Richard O.] Univ Florida, Dept Pediat, Div Cellular & Mol Therapy, Gainesville, FL 32610 USA; [Snyder, Richard O.; Moullier, Philippe] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA	Moullier, P (reprint author), Univ Nantes, Inst Rech Therapeut, INSERM, UMR 1089, 8 Quai Moncousu 6eme Etage,BP 70721, F-44007 Nantes 1, France.	rsnyder@cerhb.ufl.edu; moullier@ufl.edu	Mizukami, Hiroaki/D-7674-2013; 	Mizukami, Hiroaki/0000-0001-8954-874X; BOSCH, FATIMA/0000-0002-7705-5515; AURICCHIO, Alberto/0000-0002-0832-2472; GIACCA, MAURO/0000-0003-2927-7225	Clinigene network of excellence (European Commission FP6, Clinigene) [LSHB-CT-2006-018933]	This work was supported by the Clinigene network of excellence (European Commission FP6, Clinigene, LSHB-CT-2006-018933). We thank Odile Cohen-Haguenauer for conceiving, writing, and submitting the Clinigene European Network of Excellence. We also thank the support of several partners of the Clinigene AAV platform to the AAV8RSM project: Robin Ali, Muriel Audit, George Dickson, Anne Douar, Amit Nathwani, Amos Panet, Thierry Vandendriessche, and Bas Blits.	Lock M, 2010, HUM GENE THER, V21, P1273, DOI 10.1089/hum.2009.223; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Sommer JM, 2003, MOL THER, V7, P122, DOI 10.1016/S1525-0016(02)00019-9; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Sonntag F, 2011, J VIROL, V85, P12686, DOI 10.1128/JVI.05359-11; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mingozzi F, 2009, BLOOD, V114, P2077, DOI 10.1182/blood-2008-07-167510; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Grimm D, 1999, GENE THER, V6, P1322, DOI 10.1038/sj.gt.3300946; Gaudet D, 2013, GENE THER, V20, P361, DOI 10.1038/gt.2012.43; Rabilloud T, 2001, PROTEOMICS, V1, P699, DOI 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.3.CO;2-3; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Ayuso E., 2012, CLINIBOOK CLIN GENE, P83; Bryant LR, 2013, PERS CONTIN PHILOS, P55; Hutchins B., 2002, BIOPROCESS J, V1, P25; Kuck D, 2007, J VIROL METHODS, V140, P17, DOI 10.1016/j.jviromet.2006.10.005; Littell R. C., 2006, SAS MIXED MODELS; Lock M, 2014, HUM GENE THER METHOD, V25, P115, DOI 10.1089/hgtb.2013.131; Mingozzi F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005795; Mohiuddin I, 2005, MOL THER, V11, P320, DOI 10.1016/j.ymthe.2004.08.030; Moullier P, 2008, MOL THER, V16, P1185, DOI 10.1038/mt.2008.125; Moullier P, 2012, METHOD ENZYMOL, V507, P297, DOI 10.1016/B978-0-12-386509-0.00015-6; Potter M., 2008, BIOPROCESS J, V7, P8; Snyder RO, 2002, CURR OPIN BIOTECH, V13, P418, DOI 10.1016/S0958-1669(02)00369-5; Tessier J, 2001, J VIROL, V75, P375, DOI 10.1128/JVI.75.1.375-383.2001; Vandenberghe LH, 2010, HUM GENE THER, V21, P1251, DOI 10.1089/hum.2010.107; Van Vliet K, 2006, MOL THER, V14, P809, DOI 10.1016/j.ymthe.2006.08.1222; Weiss Walter, 2009, Methods Mol Biol, V564, P59, DOI 10.1007/978-1-60761-157-8_4	32	4	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2014	25	11					977	987		10.1089/hum.2014.057		11	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AT2OR	WOS:000344774700374		
J	Amirhosseini, MK; Morio, T; Imai, K; Nakauchi, H; Otsu, M				Amirhosseini, Mozhgan Khalaj; Morio, Tomohiro; Imai, Kohsuke; Nakauchi, Hiromitsu; Otsu, Makoto			Modeling Platelet Abnormality in Wiskott Aldrich Syndrome using Patient-derived induced Pluripotent Stem Cells	HUMAN GENE THERAPY			English	Meeting Abstract	ESGCT and NVGCT Collaborative Congress	OCT 23-26, 2014	The Hague, NETHERLANDS	European Soc Gene & Cell Therapy, Netherlands Soc Gene & Cell Therapy					[Amirhosseini, Mozhgan Khalaj; Nakauchi, Hiromitsu; Otsu, Makoto] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy, Tokyo 1138654, Japan; [Morio, Tomohiro] Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan; [Imai, Kohsuke] Tokyo Med & Dent Univ, Dept Community Pediat, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2014	25	11				P191	A117	A117				1	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AT2OR	WOS:000344774700356		
J	Aso, M; Kuroda, M; Asada, S; Aoyagi, Y; Onitake, A; Tanaka, S; Konno, S; Tanio, M; Bujo, H; Saito, Y; Yokote, K				Aso, Masayuki; Kuroda, Masayuki; Asada, Sakiyo; Aoyagi, Yasuyuki; Onitake, Akinobu; Tanaka, Shigeaki; Konno, Shunichi; Tanio, Masami; Bujo, Hideaki; Saito, Yasushi; Yokote, Koutaro			Novel ex vivo gene manipulation technology of mature adipocytes for sustained protein replacement therapy of variety of intractable diseases	HUMAN GENE THERAPY			English	Meeting Abstract	ESGCT and NVGCT Collaborative Congress	OCT 23-26, 2014	The Hague, NETHERLANDS	European Soc Gene & Cell Therapy, Netherlands Soc Gene & Cell Therapy					[Aso, Masayuki; Asada, Sakiyo; Aoyagi, Yasuyuki; Tanaka, Shigeaki; Tanio, Masami] CellGenTech Inc, Tokyo, Japan; [Kuroda, Masayuki; Yokote, Koutaro] Chiba Univ, Chiba, Japan; [Bujo, Hideaki] Toho Univ, Ota, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2014	25	11				P009	A59	A59				1	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AT2OR	WOS:000344774700177		
J	Gill, DR; Alton, EW; Connolly, MM; Chan, M; Davidson, H; Davies, JC; Davies, LA; Gea-Sorli, S; Griesenbach, U; Hasegawa, M; Hyndman, L; Hyde, SC; Innes, AJ; Inoue, M; McLachlan, G; Meng, C; Pringle, IA; Stevenson, B; Sumner-Jones, SG; Tsugumine, S; Wasowicz, MY; Boyd, AC				Gill, D. R.; Alton, E. W.; Connolly, M. M.; Chan, M.; Davidson, H.; Davies, J. C.; Davies, L. A.; Gea-Sorli, S.; Griesenbach, U.; Hasegawa, M.; Hyndman, L.; Hyde, S. C.; Innes, A. J.; Inoue, M.; McLachlan, G.; Meng, C.; Pringle, I. A.; Stevenson, B.; Sumner-Jones, S. G.; Tsugumine, S.; Wasowicz, M. Y.; Boyd, A. C.			Development of F/HN pseudotyped Lentivirus for airway gene transfer	HUMAN GENE THERAPY			English	Meeting Abstract	ESGCT and NVGCT Collaborative Congress	OCT 23-26, 2014	The Hague, NETHERLANDS	European Soc Gene & Cell Therapy, Netherlands Soc Gene & Cell Therapy					[Gill, D. R.; Alton, E. W.; Connolly, M. M.; Chan, M.; Davidson, H.; Davies, J. C.; Davies, L. A.; Gea-Sorli, S.; Griesenbach, U.; Hyndman, L.; Hyde, S. C.; Innes, A. J.; McLachlan, G.; Meng, C.; Pringle, I. A.; Stevenson, B.; Sumner-Jones, S. G.; Wasowicz, M. Y.; Boyd, A. C.] UK Cyst Fibrosis Gene Therapy Consortium, Oxford, England; [Gill, D. R.; Alton, E. W.; Connolly, M. M.; Chan, M.; Davidson, H.; Davies, J. C.; Davies, L. A.; Gea-Sorli, S.; Griesenbach, U.; Hyndman, L.; Hyde, S. C.; Innes, A. J.; McLachlan, G.; Meng, C.; Pringle, I. A.; Stevenson, B.; Sumner-Jones, S. G.; Wasowicz, M. Y.; Boyd, A. C.] UK Cyst Fibrosis Gene Therapy Consortium, Edinburgh, Midlothian, Scotland; [Gill, D. R.; Alton, E. W.; Connolly, M. M.; Chan, M.; Davidson, H.; Davies, J. C.; Davies, L. A.; Gea-Sorli, S.; Griesenbach, U.; Hyndman, L.; Hyde, S. C.; Innes, A. J.; McLachlan, G.; Meng, C.; Pringle, I. A.; Stevenson, B.; Sumner-Jones, S. G.; Wasowicz, M. Y.; Boyd, A. C.] UK Cyst Fibrosis Gene Therapy Consortium, London, England; [Hasegawa, M.; Inoue, M.; Tsugumine, S.] DNAVEC Corp, Tsukuba, Ibaraki, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2014	25	11				OR056	A43	A43				1	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AT2OR	WOS:000344774700131		
J	Ikeda, Y; Murakami, Y; Yoshida, N; Nakatake, S; Tachibana, T; Miyazaki, M; Yoshida, K; Yonemitsu, Y; Ban, H; Ueda, Y; Inoue, M; Zhu, T; Hasegawa, M; Enaida, H; Ishibashi, T				Ikeda, Y.; Murakami, Y.; Yoshida, N.; Nakatake, S.; Tachibana, T.; Miyazaki, M.; Yoshida, K.; Yonemitsu, Y.; Ban, H.; Ueda, Y.; Inoue, M.; Zhu, T.; Hasegawa, M.; Enaida, H.; Ishibashi, T.			Phase I clinical study for patients with retinitis pigmentosa: interim report of initial 5 subjects (low-titer group)	HUMAN GENE THERAPY			English	Meeting Abstract	ESGCT and NVGCT Collaborative Congress	OCT 23-26, 2014	The Hague, NETHERLANDS	European Soc Gene & Cell Therapy, Netherlands Soc Gene & Cell Therapy					Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 8128582, Japan; Kyushu Univ, Grad Sch Pharmaceut Sci, R&D Lab Innovat Biotherapeut, Fukuoka 8128582, Japan; DNAVEC Corp, Tsukuba, Ibaraki 3002611, Japan; Saga Univ, Fac Med, Dept Ophthalmol, Saga 8498501, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2014	25	11				P154	A105	A105				1	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AT2OR	WOS:000344774700320		
J	Itaka, K; Baba, M; Uchida, S; Kataoka, K				Itaka, Keiji; Baba, Miyuki; Uchida, Satoshi; Kataoka, Kazunori			In vivo mRNA introduction using polyplex nanomicelles to treat neurological disorders	HUMAN GENE THERAPY			English	Meeting Abstract	ESGCT and NVGCT Collaborative Congress	OCT 23-26, 2014	The Hague, NETHERLANDS	European Soc Gene & Cell Therapy, Netherlands Soc Gene & Cell Therapy					[Uchida, Satoshi] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Lab Clin Biotechnol, Tokyo 1138654, Japan; [Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Tokyo 1138654, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2014	25	11				OR035	A36	A36				1	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AT2OR	WOS:000344774700110		
J	Ito, T; Koyama, Y				Ito, Tomoko; Koyama, Yoshiyuki			Development and Therapeutic Efficacy of the DNA Complex-Releasing Systems Comprising Injectable Auto-Forming Alginate Gel	HUMAN GENE THERAPY			English	Meeting Abstract	ESGCT and NVGCT Collaborative Congress	OCT 23-26, 2014	The Hague, NETHERLANDS	European Soc Gene & Cell Therapy, Netherlands Soc Gene & Cell Therapy					[Ito, Tomoko] Meiji Pharmaceut Univ, Tokyo, Japan; [Ito, Tomoko; Koyama, Yoshiyuki] Japan AntiTB Assoc, Shin Yamanote Hosp, Clin Med Engn Lab, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2014	25	11				P052	A72	A73				2	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AT2OR	WOS:000344774700219		
J	Koyama, Y; Ushigusa, T; Inaba, T; Eriguchi, KSM; Ito, T				Koyama, Yoshiyuki; Ushigusa, Takahiro; Inaba, Toshio; Eriguchi, Kikuya Sugiura Masazumi; Ito, Tomoko			Oncolytic Plasmid System; a Novel Antitumor Strategy by Plasmids Encoding Pathogenic Antigens Blocking the Immune Escape of Tumor	HUMAN GENE THERAPY			English	Meeting Abstract	ESGCT and NVGCT Collaborative Congress	OCT 23-26, 2014	The Hague, NETHERLANDS	European Soc Gene & Cell Therapy, Netherlands Soc Gene & Cell Therapy					Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Mino, Osaka, Japan; Shin Yamanote Hosp, Japan AntiTB Assoc, Clin Med Engn Lab, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2014	25	11				P118	A93	A94				2	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AT2OR	WOS:000344774700284		
J	Kuroda, M; Aoyagi, Y; Asada, S; Aso, M; Bujo, H; Saito, Y; Yokote, K				Kuroda, Masayuki; Aoyagi, Yasuyuki; Asada, Sakiyo; Aso, Masayuki; Bujo, Hideaki; Saito, Yasushi; Yokote, Koutaro			Development of ex vivo gene therapy for familial LCAT deficiency syndrome by self-transplantation of therapeutic-enzyme secreting adipocytes	HUMAN GENE THERAPY			English	Meeting Abstract	ESGCT and NVGCT Collaborative Congress	OCT 23-26, 2014	The Hague, NETHERLANDS	European Soc Gene & Cell Therapy, Netherlands Soc Gene & Cell Therapy					[Kuroda, Masayuki; Aoyagi, Yasuyuki; Asada, Sakiyo; Yokote, Koutaro] Chiba Univ, Chiba, Japan; [Aso, Masayuki] Cellgentech Inc, Inohana, Chiba, Japan; [Bujo, Hideaki] Toho Univ, Ota, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2014	25	11				OR038	A37	A37				1	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AT2OR	WOS:000344774700113		
J	Lin, HT; Otsu, M; Masaki, H; Yamaguchi, T; Schambach, A; Kaufmann, KB; Grez, M; Wada, T; Yachie, A; Nakauchi, H				Lin, Huan-Ting; Otsu, Makoto; Masaki, Hideki; Yamaguchi, Tomoyuki; Schambach, Axel; Kaufmann, Kerstin B.; Grez, Manuel; Wada, Taizo; Yachie, Akihiro; Nakauchi, Hiromitsu			Ectopic gp91phox expression is detrimental to XCGD iPS cell-derived neutrophils	HUMAN GENE THERAPY			English	Meeting Abstract	ESGCT and NVGCT Collaborative Congress	OCT 23-26, 2014	The Hague, NETHERLANDS	European Soc Gene & Cell Therapy, Netherlands Soc Gene & Cell Therapy					[Lin, Huan-Ting; Otsu, Makoto; Masaki, Hideki; Yamaguchi, Tomoyuki; Nakauchi, Hiromitsu] Univ Tokyo, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci, Tokyo 1138654, Japan; [Schambach, Axel] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Kaufmann, Kerstin B.; Grez, Manuel] Georg Speyer Haus, Frankfurt, Germany; [Wada, Taizo; Yachie, Akihiro] Kanazawa Univ, Dept Pediat, Sch Med, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan			Yachie, Akihiro/C-4660-2015					0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2014	25	11				OR007	A26	A26				1	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AT2OR	WOS:000344774700082		
J	Lin, HT; Otsu, M; Masaki, H; Yamaguchi, T; Schambach, A; Kaufmann, KB; Grez, M; Wada, T; Yachie, A; Nakauchi, H				Lin, Huan-Ting; Otsu, Makoto; Masaki, Hideki; Yamaguchi, Tomoyuki; Schambach, Axel; Kaufmann, Kerstin B.; Grez, Manuel; Wada, Taizo; Yachie, Akihiro; Nakauchi, Hiromitsu			Ectopic gp91phox expression is detrimental to XCGD iPS cell-derived neutrophils	HUMAN GENE THERAPY			English	Meeting Abstract	ESGCT and NVGCT Collaborative Congress	OCT 23-26, 2014	The Hague, NETHERLANDS	European Soc Gene & Cell Therapy, Netherlands Soc Gene & Cell Therapy					[Lin, Huan-Ting; Otsu, Makoto; Masaki, Hideki; Yamaguchi, Tomoyuki; Nakauchi, Hiromitsu] Univ Tokyo, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci, Tokyo 1138654, Japan; [Schambach, Axel] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Kaufmann, Kerstin B.; Grez, Manuel] Georg Speyer Haus, Frankfurt, Germany; [Wada, Taizo; Yachie, Akihiro] Kanazawa Univ, Dept Pediat, Sch Med, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2014	25	11				P175	A111	A112				2	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AT2OR	WOS:000344774700340		
J	Sato, N; Saga, Y; Mizukami, H; Uchibori, R; Tsukahara, T; Urabe, M; Kume, A; Suzuki, M; Ozawa, K				Sato, N.; Saga, Y.; Mizukami, H.; Uchibori, R.; Tsukahara, T.; Urabe, M.; Kume, A.; Suzuki, M.; Ozawa, K.			Elimination of cervical cancer in vivo by a short-hairpin RNA targeting human papillomavirus type 16 E6/E7	HUMAN GENE THERAPY			English	Meeting Abstract	ESGCT and NVGCT Collaborative Congress	OCT 23-26, 2014	The Hague, NETHERLANDS	European Soc Gene & Cell Therapy, Netherlands Soc Gene & Cell Therapy					[Sato, N.; Saga, Y.; Mizukami, H.; Uchibori, R.; Urabe, M.; Kume, A.; Ozawa, K.] Jichi Med Univ, Ctr Mol Med, Div Genet Therapeut, Shimotsuke, Tochigi, Japan; [Sato, N.; Saga, Y.; Suzuki, M.] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2014	25	11				P077	A81	A81				1	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AT2OR	WOS:000344774700244		
J	Wakabayashi, T; Kobayashi, H; Shimada, Y; Higuchi, T; Eto, Y; Ida, H; Ohashi, T				Wakabayashi, Taichi; Kobayashi, Hiroshi; Shimada, Yohta; Higuchi, Takashi; Eto, Yoshikatsu; Ida, Hiroyuki; Ohashi, Toya			Lentiviral ex vivo gene therapy to the murine model of MPSII	HUMAN GENE THERAPY			English	Meeting Abstract	ESGCT and NVGCT Collaborative Congress	OCT 23-26, 2014	The Hague, NETHERLANDS	European Soc Gene & Cell Therapy, Netherlands Soc Gene & Cell Therapy					[Wakabayashi, Taichi; Ida, Hiroyuki; Ohashi, Toya] Jikei Univ, Sch Med, Dept Pediat, Minato, Tokyo, Japan; [Kobayashi, Hiroshi; Shimada, Yohta; Higuchi, Takashi; Ohashi, Toya] Jikei Univ, Sch Med, Dept Gene Therapy, Res Ctr Med Sci, Minato, Tokyo, Japan; [Eto, Yoshikatsu] Inst Neurol Dis, Adv Clin Res Ctr, London, England								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2014	25	11				P024	A64	A64				1	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AT2OR	WOS:000344774700194		
J	Yamanaka, S				Yamanaka, Shinya			Keynote Lecture; Nobel Laureate for Medicine	HUMAN GENE THERAPY			English	Meeting Abstract	ESGCT and NVGCT Collaborative Congress	OCT 23-26, 2014	The Hague, NETHERLANDS	European Soc Gene & Cell Therapy, Netherlands Soc Gene & Cell Therapy					[Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068501, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2014	25	11				INV097	A22	A23				2	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AT2OR	WOS:000344774700071		
J	Yanagihara, K; Uchida, S; Ikegami, M; Meada, Y; Oba, S; Chung, U; Kataoka, K; Itaka, K				Yanagihara, Kayoko; Uchida, Satoshi; Ikegami, Masaru; Meada, Yujiro; Oba, Shinsuke; Chung, Ung-il; Kataoka, Kazunori; Itaka, Keiji			Treating bone defect by transplantation of genetically modified MSC spheroids	HUMAN GENE THERAPY			English	Meeting Abstract	ESGCT and NVGCT Collaborative Congress	OCT 23-26, 2014	The Hague, NETHERLANDS	European Soc Gene & Cell Therapy, Netherlands Soc Gene & Cell Therapy					[Yanagihara, Kayoko; Uchida, Satoshi; Ikegami, Masaru; Meada, Yujiro; Oba, Shinsuke; Chung, Ung-il; Kataoka, Kazunori; Itaka, Keiji] Univ Tokyo, Grad Sch Med, Tokyo 1138654, Japan; [Oba, Shinsuke; Chung, Ung-il; Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Tokyo 1138654, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2014	25	11				P042	A69	A70				2	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AT2OR	WOS:000344774700209		
J	Asaeda, H; Li, RD; Choi, N				Asaeda, Hitoshi; Li, Ruidong; Choi, Nakjung			Container-Based Unified Testbed for Information-Centric Networking	IEEE NETWORK			English	Article								To develop and evaluate diverse ICN protocols and applications, large-scale and extensible testbeds that facilitate realistic evaluations must be designed and deployed. We propose a container-based unified testbed for ICN, called CUTEi, which employs the Linux container lightweight virtualization mechanism to build testbed nodes. CUTEi enables testbed users to run applications and protocols for ICN in two experimentation modes using two different container designs: application-level experimentation using a "common container," and network-level experimentation using a "user container." CUTEi also implements an "on-filesystem cache" to allocate caching data on a UNIX filesystem and share the cached data with multiple containers. Thus far we have deployed the CUTEi testbed on nine sites and performed experiments using CCNx components on the testbed. Consequently, we have found that it is easy to coordinate experiments on CUTEi; further, a comparison of its data fetch performance with that of PlanetLab indicates that CUTEi is more stable for ICN experiments than PlanetLab.	[Asaeda, Hitoshi; Li, Ruidong] Natl Inst Informat & Commun Technol NICT, Tokyo, Japan; [Choi, Nakjung] Alcatel Lucent, Bell Labs, Boulogne Billancourt, France	Asaeda, H (reprint author), Natl Inst Informat & Commun Technol NICT, Tokyo, Japan.						Ahlgren Bengt, 2012, IEEE COMMUN MAG, P27; Cabral C., 2013, P ACM SIGCOMM ICN 13; Farinacci D., 2000, 2784 IETF RFC; Jacobson V., 2009, P ACM CONEXT 2009 DE; McCalpin J., STREAM SUSTAINABLE M; Quereilhac A., 2011, P SOFTCOM 2011 DALM; Trossen D., 2010, COMPUT COMMUN REV, V40, P26, DOI DOI 10.1145/1764873.1764878	7	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0890-8044	1558-156X		IEEE NETWORK	IEEE Netw.	NOV-DEC	2014	28	6					60	66				7	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Computer Science; Engineering; Telecommunications	AU4KR	WOS:000345580300011		
J	Nagahara, M; Martin, CF				Nagahara, Masaaki; Martin, Clyde F.			L-1 Control Theoretic Smoothing Splines	IEEE SIGNAL PROCESSING LETTERS			English	Article						Control theoretic splines; convex optimization; L-1 optimization; smoothing splines	SHRINKAGE	In this letter, we propose control theoretic smoothing splines with L-1 optimality for reducing the number of parameters that describes the fitted curve as well as removing outlier data. A control theoretic spline is a smoothing spline that is generated as an output of a given linear dynamical system. Conventional design requires exactly the same number of base functions as given data, and the result is not robust against outliers. To solve these problems, we propose to use L-1 optimality, that is, we use the L-1 norm for the regularization term and/or the empirical risk term. The optimization is described by a convex optimization, which can be efficiently solved via a numerical optimization software. A numerical example shows the effectiveness of the proposed method.	[Nagahara, Masaaki] Kyoto Univ, Grad Sch Informat, Kyoto 6068501, Japan; [Martin, Clyde F.] Texas Tech Univ, Dept Math & Stat, Lubbock, TX 79409 USA	Nagahara, M (reprint author), Kyoto Univ, Grad Sch Informat, Kyoto 6068501, Japan.	nagahara@ieee.org; clyde.f.martin@ttu.edu			JSPS [24560543]; MEXT [26120521]; Okawa Foundation Research Grant	This work was supported in part by the JSPS Grant-in-Aid for Scientific Research (C) under Grant 24560543, a MEXT Grant-in-Aid for Scientific Research on Innovative Areas under Grant 26120521, and by an Okawa Foundation Research Grant. The associate editor coordinating the review of this manuscript and approving it for publication was Prof. Xiao-Ping Zhang.	Nagahara M, 2014, IEEE T AUTOMAT CONTR, V59, P1899, DOI 10.1109/TAC.2013.2294622; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Buhlmann P, 2011, SPRINGER SER STAT, P1, DOI 10.1007/978-3-642-20192-9; Charles J. K., 2010, 3 DECADES PROGR CONT, P83; Egerstedt M, 2010, PRINC SER APPL MATH, P1; Egerstedt M, 2001, AUTOMATICA, V37, P1057, DOI 10.1016/S0005-1098(01)00055-3; Grant M., CVX MATLAB SOFTWARE; Grant MC, 2008, LECT NOTES CONTR INF, V371, P95, DOI 10.1007/978-1-84800-155-8_7; Kano H, 2008, AUTOMATICA, V44, P185, DOI 10.1016/j.automatica.2007.05.011; KIMELDOR.G, 1971, J MATH ANAL APPL, V33, P82, DOI 10.1016/0022-247X(71)90184-3; Nagahara M, 2013, ASIAN J CONTROL, V15, P461, DOI 10.1002/asjc.557; Nagahara M., 2011, P 55 ANN C I SYST CO; Nagahara M., 2013, P 52 IEEE C DEC CONT, P3825; Nagahara M., 2013, P 59 WORLD STAT C AU, P1137; Nesterov Yu. E., 1983, Doklady Akademii Nauk SSSR, V269; Rugh W., 1996, LINEAR SYSTEMS THEOR; Smola A., 2002, LEARNING KERNELS; Sun S, 2000, IEEE T AUTOMAT CONTR, V45, P2271, DOI 10.1109/9.895563; Takahashi S., 2004, Proceedings of the 2004 IEEE International Conference on Control Applications (IEEE Cat. No.04CH37596); Wahba G, 1990, SPLINE MODELS OBSERV	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9908	1558-2361		IEEE SIGNAL PROC LET	IEEE Signal Process. Lett.	NOV	2014	21	11					1394	1397		10.1109/LSP.2014.2337017		4	Engineering, Electrical & Electronic	Engineering	AU6GB	WOS:000345700600002		
J	Alvarez-Aguirre, A; van de Wouw, N; Oguchi, T; Nijmeijer, H				Alvarez-Aguirre, Alejandro; van de Wouw, Nathan; Oguchi, Toshiki; Nijmeijer, Henk			Predictor-Based Remote Tracking Control of a Mobile Robot	IEEE TRANSACTIONS ON CONTROL SYSTEMS TECHNOLOGY			English	Article						Mobile robots; network-induced delays; predictive state estimation; tracking control over a network	NETWORKED CONTROL-SYSTEMS; NONLINEAR PROCESSES; TIME-DELAY; TELEOPERATION; OPERATIONS; TELEMANIPULATION; STABILIZATION; COMPENSATION; INTERVALS	In this paper, we address the tracking control problem for a unicycle-type mobile robot which is remotely controlled by a two-channel, delay-inducing communication network. A predictor-based control strategy capable of controlling the negative effects of the time-delay is proposed. Moreover, conditions are provided guaranteeing the local or global asymptotic stability of the closed-loop system up to a maximum admissible delay. The applicability of the proposed predictor-controller combination is demonstrated using an interconnected robotic platform located partly in Eindhoven, the Netherlands, and Tokyo, Japan.	[Alvarez-Aguirre, Alejandro; van de Wouw, Nathan; Nijmeijer, Henk] Eindhoven Univ Technol, Dept Mech Engn, NL-5600 MB Eindhoven, Netherlands; [Oguchi, Toshiki] Tokyo Metropolitan Univ, Dept Mech Engn, Tokyo 1920397, Japan	Alvarez-Aguirre, A (reprint author), Eindhoven Univ Technol, Dept Mech Engn, NL-5600 MB Eindhoven, Netherlands.	a.alvarez.aguirre@ieee.com; n.v.d.wouw@tue.nl; t.oguchi@tmu.ac.jp; h.nijmeijer@tue.nl					Alvarez-Aguirre A., 2011, LECT NOTES ELECT ENG, P225; Hespanha JP, 2007, P IEEE, V95, P138, DOI 10.1109/JPROC.2006.887288; KRAVARIS C, 1989, AICHE J, V35, P1535, DOI 10.1002/aic.690350914; Heemels WPMH, 2010, IEEE T AUTOMAT CONTR, V55, P1781, DOI 10.1109/TAC.2010.2042352; Leonard NE, 2007, P IEEE, V95, P48, DOI 10.1109/JPROC.2006.887295; Karafyllis I, 2012, IEEE T AUTOMAT CONTR, V57, P1141, DOI 10.1109/TAC.2011.2170451; Voss HU, 2000, PHYS REV E, V61, P5115, DOI 10.1103/PhysRevE.61.5115; Hannaford B, 2002, IEEE T ROBOTIC AUTOM, V18, P1, DOI 10.1109/70.988969; Niemeyer G, 2004, INT J ROBOT RES, V23, P873, DOI 10.1177/0278364904045563; HENSON MA, 1994, IND ENG CHEM RES, V33, P1493, DOI 10.1021/ie00030a009; Nesic D, 2009, IEEE T AUTOMAT CONTR, V54, P732, DOI 10.1109/TAC.2009.2014930; Hashtrudi-Zaad K, 2002, IEEE T ROBOTIC AUTOM, V18, P108, DOI 10.1109/70.988981; [Anonymous], 2006, P IEEE INT C ROB AUT; Normey-Rico JE, 2008, CONTROL ENG PRACT, V16, P407, DOI 10.1016/j.conengprac.2007.05.006; Gao HJ, 2008, AUTOMATICA, V44, P39, DOI 10.1016/j.automatica.2007.04.020; Biesiadecki JJ, 2006, IEEE ROBOT AUTOM MAG, V13, P63, DOI 10.1109/MRA.2006.1638017; Hokayem PF, 2006, AUTOMATICA, V42, P2035, DOI 10.1016/j.automatica.2006.06.027; Smith AC, 2006, INT J ROBOT RES, V25, P797, DOI 10.1177/0278364906068393; Gu K., 2003, STABILITY TIME DELAY; Hale J. K., 1993, INTRO FUNCTIONAL DIF; Ho YF, 2000, IEEE-ASME T MECH, V5, P100; Jakubiak J., 2002, International Journal of Applied Mathematics and Computer Science, V12; Kaltenbrunner M., 2007, P 1 INT C TANG EMB I, P69, DOI DOI 10.1145/1226969.1226983; KIM WS, 1992, IEEE T ROBOTIC AUTOM, V8, P176, DOI 10.1109/70.134272; Krstic M, 2009, SYST CONTROL-FOUND A, P1, DOI 10.1007/978-0-8176-4877-0; Lefeber E., 2000, THESIS U TWENTE ENSC; Michiels W, 2007, ADV DES CONTROL, P3; Mondada F., 2009, P 9 C AUT ROB SYST C, P59; Murphy RR, 2004, IEEE ROBOT AUTOM MAG, V11, P50, DOI 10.1109/MRA.2004.1337826; Oguchi T., 2005, P ENOC EINDH NETH, P1150; Oguchi T., 2006, P 6 IFAC WORKSH TIM, P290; Postoyan R, 2012, IEEE DECIS CONTR P, P740, DOI 10.1109/CDC.2012.6426663; Sanders S, 2006, IND ROBOT, V33, P174, DOI 10.1108/01439910610659088; Sedova N., 2008, RUSSIAN MATH, V52, P68; Sedova NO, 2008, AUTOMAT REM CONTR+, V69, P968, DOI 10.1134/S0005117908060076; Siciliano B., 2008, SPRINGER HDB ROBOTIC; Siciliano B, 2009, ADV TXB CONTR SIG PR, P1; Smith OJM, 1957, CHEMICAL ENGINEERING, V53, P217; Stramigioli S, 2002, IEEE T ROBOTIC AUTOM, V18, P588, DOI 10.1109/TRA.2002.802200; Vagenas N., 1991, P 1 INT S MIN MECH A, P1; van de Wouw N, 2010, INT J ROBUST NONLIN, V20, P387, DOI 10.1002/rnc.1433; van T., 2008, THESIS U TECHNOL EIN; Whitcomb L. L., 2000, Proceedings 2000 ICRA. Millennium Conference. IEEE International Conference on Robotics and Automation. Symposia Proceedings (Cat. No.00CH37065), DOI 10.1109/ROBOT.2000.844135	43	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1063-6536	1558-0865		IEEE T CONTR SYST T	IEEE Trans. Control Syst. Technol.	NOV	2014	22	6					2087	2102		10.1109/TCST.2014.2304741		16	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	AU4JH	WOS:000345576300002		
J	Sakai, S; Sato, M				Sakai, Satoru; Sato, Masakazu			Visual Systems & Control on Polynomial Space and Its Application to Sloshing Problems	IEEE TRANSACTIONS ON CONTROL SYSTEMS TECHNOLOGY			English	Article						Continuous systems; Hilbert space; visual systems & control	KALMAN FILTER; FREE MOTION; SUPPRESSION; CONTAINER; ROBOT; TANK; FLOW	This paper proposes a novel approach for camera-based modeling and control for a large class of continuous systems and the validity is confirmed by liquid sloshing experiments. It is an unsolved problem to design a model-based control in nonplanar sloshing cases. This is because the whole shape of the liquid surface is a complex curve (a set of an infinite number of points) in coordinate spaces. This paper solves this problem. First, the whole shape of the liquid surface corresponding to the output measured by a camera is a single point in a polynomial space as well as the input and the state. Second, without any physical parameter identification, input-output modeling on polynomial space, unlike existing types of modeling, captures the whole dynamics even in nonplanar sloshing cases and is linked to design of implementable controllers. Finally, in the presence of occlusion, the nonplanar sloshing is controlled well by state estimation on polynomial space without adding any image processing technology.	[Sakai, Satoru; Sato, Masakazu] Shinshu Univ, Dept Mech Engn, Nagano 3900802, Japan	Sakai, S (reprint author), Shinshu Univ, Dept Mech Engn, Nagano 3900802, Japan.	satorusakai@gakushikai.jp; 11t115f@shinshu-u.ac.jp					van der Schaft AJ, 2002, J GEOM PHYS, V42, P166, DOI 10.1016/S0393-0440(01)00083-3; Tangpong XW, 2009, J VIB ACOUST, V131, DOI 10.1115/1.3025833; Chen SY, 2012, IEEE T IND ELECTRON, V59, P4409, DOI 10.1109/TIE.2011.2162714; Yano K, 2001, IEEE T CONTR SYST T, V9, P483, DOI 10.1109/87.918901; Feddema JT, 1997, IEEE CONTR SYST MAG, V17, P29, DOI 10.1109/37.569711; [Anonymous], 2013, ASME J COMPUT NONLIN, V8, P381; Yano K, 2005, IEEE-ASME T MECH, V10, P8, DOI 10.1109/TMECH.2004.839033; Arimoto S., 1996, CONTROL THEORY NONLI; Arnold V I, 1989, MATH METHODS CLASSIC; Bandyopadhyay B, 2009, IEEE T IND ELECTRON, V56, P3432, DOI 10.1109/TIE.2009.2026380; CROWLEY JM, 1969, IEEE T AUTOMAT CONTR, VAC14, P536, DOI 10.1109/TAC.1969.1099253; Emanouilov O. Y., 2006, P INT C MATH, P1321; Faltinsen OM, 2012, J FLUID MECH, V695, P467, DOI 10.1017/jfm.2012.38; Faltinsen O.M., 2009, SLOSHING; Feeny BF, 2013, J VIB ACOUST, V135, DOI 10.1115/1.4023056; Grundelius M., 1999, Proceedings of the 1999 IEEE International Conference on Control Applications (Cat. No.99CH36328), DOI 10.1109/CCA.1999.801220; Ibrahim RA, 2005, LIQUID SLOSHING DYNAMICS: THEORY AND APPLICATIONS, P1, DOI 10.1017/CBO9780511536656; Khalil H.K., 1996, NONLINEAR SYSTEMS; Krsti M, 1995, NONLINEAR ADAPTIVE C; Kurode S, 2013, IEEE-ASME T MECH, V18, P714, DOI 10.1109/TMECH.2011.2182056; Ljung L, 1999, SYSTEM IDENTIFICATIO; Luenverger D., 1960, OPTIMIZATION VECTOR; Peric M., 2009, ASME J OFFSHORE MECH, V131; Pridgen B., 2010, P IEEE C DEC CONTR D, P15; Richter H., 2010, ASME J DYN SYST MEAS, V132; Robu B, 2012, IEEE T CONTR SYST T, V20, P700, DOI 10.1109/TCST.2011.2144984; Sakai S, 2007, IEEE T CONTR SYST T, V15, P1038, DOI 10.1109/TCST.2007.899710; Song XJ, 2011, IEEE-ASME T MECH, V16, P551, DOI 10.1109/TMECH.2010.2046421; Strang G., 2007, COMPUTATIONAL SCI EN; Utsumi M, 2004, J APPL MECH-T ASME, V71, P724, DOI 10.1115/1.1794700; van der Schaft A, 2000, L2 GAIN PASSIVITY TE; Van Overschee P., 1996, SUBSPACE IDENTIFICAT; Williams ER, 2009, IEEE T INSTRUM MEAS, V58, P949, DOI 10.1109/TIM.2008.2008463; Zhou K., 1996, ROBUST OPTIMAL CONTR	34	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1063-6536	1558-0865		IEEE T CONTR SYST T	IEEE Trans. Control Syst. Technol.	NOV	2014	22	6					2176	2187		10.1109/TCST.2014.2309615		12	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	AU4JH	WOS:000345576300009		
J	Sahri, Z; Yusof, R; Watada, J				Sahri, Zahriah; Yusof, Rubiyah; Watada, Junzo			FINNIM: Iterative Imputation of Missing Values in Dissolved Gas Analysis Dataset	IEEE TRANSACTIONS ON INDUSTRIAL INFORMATICS			English	Article						Dissolved gas analysis (DGA); imputation ordering; iterative imputation; k-nearest neighbor (kNN); missing data imputation; missing values	FAULT-DIAGNOSIS; BAYESIAN NETWORKS; CLASSIFIER; ROBUST	Missing values are a common occurrence in a number of real world databases, and statistical methods have been developed to deal with this problem, referred to as missing data imputation. In the detection and prediction of incipient faults in power transformers using dissolved gas analysis (DGA), the problem of missing values is significant and has resulted in inconclusive decision-making. This study proposes an efficient nonparametric iterative imputation method named FINNIM, which comprises of three components: 1) the imputation ordering; 2) the imputation estimator; and 3) the iterative imputation. The relationship between gases and faults, and the percentage of missing values in an instance are used as a basis for the imputation ordering; whereas the plausible values for the missing values are estimated from k-nearest neighbor instances in the imputation estimator, and the iterative imputation allows complete and incomplete instances in a DGA dataset to be utilized iteratively for imputing all the missing values. Experimental results on both artificially inserted and actual missing values found in a few DGA datasets demonstrate that the proposed method outperforms the existing methods in imputation accuracy, classification performance, and convergence criteria at different missing percentages.	[Sahri, Zahriah] Univ Teknikal Malaysia Melaka, Durian Tunggal 76100, Malaysia; [Yusof, Rubiyah] Univ Teknol Malaysia, Kuala Lumpur 54100, Malaysia; [Watada, Junzo] Waseda Univ, Grad Sch Informat Prod & Syst, Kitakyushu, Fukuoka 8080135, Japan	Sahri, Z (reprint author), Univ Teknikal Malaysia Melaka, Durian Tunggal 76100, Malaysia.	szahriah@utem.edu.my; rubiyah.kl@utm.my; junzow@osb.att.ne.jp					Acuna E, 2004, ST CLASS DAT ANAL, P639; Bacha K, 2012, ELECTR POW SYST RES, V83, P73, DOI 10.1016/j.epsr.2011.09.012; Duval M, 2001, IEEE ELECTR INSUL M, V17, P31, DOI 10.1109/57.917529; Zhang SC, 2011, J SYST SOFTWARE, V84, P452, DOI 10.1016/j.jss.2010.11.887; Zhang H, 2011, IEEE T IND ELECTRON, V58, P5396, DOI 10.1109/TIE.2011.2107720; Garcia-Laencina PJ, 2009, NEUROCOMPUTING, V72, P1483, DOI 10.1016/j.neucom.2008.11.026; Di Zio M, 2004, J ROY STAT SOC A STA, V167, P309, DOI 10.1046/j.1467-985X.2003.00736.x; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Shi P, 2012, IEEE T IND ELECTRON, V59, P2732, DOI 10.1109/TIE.2011.2167894; Yang Z, 2009, IEEE T SYST MAN CY C, V39, P597, DOI 10.1109/TSMCC.2009.2021989; He X, 2013, IEEE T IND INFORM, V9, P1670, DOI 10.1109/TII.2013.2251891; Conversano C, 2009, J CLASSIF, V26, P361, DOI 10.1007/s00357-009-9038-8; Das S, 2014, IEEE T IND INFORM, V10, P450, DOI 10.1109/TII.2013.2272088; Ganyun LV, 2005, ELECTR POW SYST RES, V74, P1, DOI 10.1016/j.epsr.2004.07.008; Gong RS, 2008, IEEE T IND INFORM, V4, P198, DOI 10.1109/TII.2008.2002920; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Himmelspach L., 2010, P 5 IEEE INT C DIG I, P19; Hruschka ER, 2007, J INTELL INF SYST, V29, P231, DOI 10.1007/s10844-006-0016-x; Ming Z., 2010, P 2 INT C COMP AUT E, V3, P123; SHI ZB, 2009, 2009 2 IEEE INT C, P417; Song QB, 2008, J SYST SOFTWARE, V81, P2361, DOI 10.1016/j.jss.2008.05.008; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Wang XZ, 2006, Proceedings of 2006 International Conference on Machine Learning and Cybernetics, Vols 1-7, P2886; Yong-li Z., 2006, P IEEE REG 10 C TENC, P1; Zhang CQ, 2007, LECT NOTES COMPUT SC, V4426, P1080; Zhang H, 2009, IEEE T SIGNAL PROCES, V57, P3466, DOI 10.1109/TSP.2009.2020376; Zhang SC, 2011, APPL INTELL, V35, P123, DOI 10.1007/s10489-009-0207-6; Zhang S., 2010, P 9 IEEE INT C COGN, P672	28	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1551-3203	1941-0050		IEEE T IND INFORM	IEEE Trans. Ind. Inform.	NOV	2014	10	4					2093	2102		10.1109/TII.2014.2350837		10	Automation & Control Systems; Computer Science, Interdisciplinary Applications; Engineering, Industrial	Automation & Control Systems; Computer Science; Engineering	AT5PZ	WOS:000344995800012		
J	Ito, T; Wada, M; Kuma, Y; Kido-Nakahara, M; Yamada, Y; Okano, S; Oda, Y; Furue, M				Ito, Takamichi; Wada, Maiko; Kuma, Yuki; Kido-Nakahara, Makiko; Yamada, Yuichi; Okano, Shinji; Oda, Yoshinao; Furue, Masutaka			Pigmented Bowen's disease with prominent amyloid deposition on the eyelid	INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY			English	Letter									[Ito, Takamichi; Wada, Maiko; Kuma, Yuki; Kido-Nakahara, Makiko; Furue, Masutaka] Kyushu Univ, Dept Dermatol, Grad Sch Med Sci, Div Pathophysiol & Expt Pathol, Fukuoka 8128582, Japan; [Yamada, Yuichi; Oda, Yoshinao] Kyushu Univ, Dept Anat Pathol, Grad Sch Med Sci, Div Pathophysiol & Expt Pathol, Fukuoka 8128582, Japan; [Okano, Shinji] Kyushu Univ, Dept Pathol, Grad Sch Med Sci, Div Pathophysiol & Expt Pathol, Fukuoka 8128582, Japan	Ito, T (reprint author), Kyushu Univ, Dept Dermatol, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takamiti@dermatol.med.kyushu-u.ac.jp					Chuang YY, 2012, BRIT J DERMATOL, V167, P548, DOI 10.1111/j.1365-2133.2012.11066.x; Cameron A, 2010, J AM ACAD DERMATOL, V62, P597, DOI 10.1016/j.jaad.2009.06.008; RAGI G, 1988, J DERMATOL SURG ONC, V14, P765; Weedon D., 2010, WEEDONS SKIN PATHOLO, P679; Zalaudek I, 2010, J AM ACAD DERMATOL, V63, P377, DOI 10.1016/j.jaad.2009.11.697	5	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0378-6323	0973-3922		INDIAN J DERMATOL VE	Indian J. Dermatol. Venereol. Leprol.	NOV-DEC	2014	80	6					558	U158		10.4103/0378-6323.144204		3	Dermatology	Dermatology	AU0ZC	WOS:000345349700022		
J	Koike, Y; Akiyama, Y; Utani, A				Koike, Yuta; Akiyama, Yuichiro; Utani, Atsushi			Cold agglutinin disease-associated digital gangrene treated with plasmapheresis	INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY			English	Letter							CUTANEOUS NECROSIS		[Koike, Yuta; Akiyama, Yuichiro; Utani, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Dermatol, Nagasaki 8528523, Japan	Utani, A (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Dermatol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	utani@nagasaki-u.ac.jp					Berentsen S, 2010, BLOOD, V116, P3180, DOI 10.1182/blood-2010-06-288647; Berentsen S, 2012, BLOOD REV, V26, P107, DOI 10.1016/j.blre.2012.01.002; Ciejka JZ, 1999, CLIN EXP RHEUMATOL, V17, P227; Jeskowiak A, 2013, NEW ENGL J MED, V369, pE1, DOI 10.1056/NEJMicm1212538; Porras-Luque JI, 1998, BRIT J DERMATOL, V139, P1068	5	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0378-6323	0973-3922		INDIAN J DERMATOL VE	Indian J. Dermatol. Venereol. Leprol.	NOV-DEC	2014	80	6					575	576		10.4103/0378-6323.144221		2	Dermatology	Dermatology	AU0ZC	WOS:000345349700030		
J	Ratanatamskul, C; Onnum, G; Yamamoto, K				Ratanatamskul, C.; Onnum, G.; Yamamoto, K.			A prototype single-stage anaerobic digester for co-digestion of food waste and sewage sludge from high-rise building for on-site biogas production	INTERNATIONAL BIODETERIORATION & BIODEGRADATION			English	Article						Prototype single-stage anaerobic digester; Anaerobic co-digestion; Food waste; Sewage sludge; High-rise building; Biogas production	SOLID-WASTES; MANURE	At present, there has been less results from pilot-scale experiments on anaerobic co-digestion system, especially as an on-site system for high-rise building application. The objective of this study was to develop a prototype single-stage anaerobic digester for the co-digestion of food waste (FW) and sewage sludge (SWS) from high-rise building for on-site biogas production. Here, the prototype system was operated at different hydraulic retention times (HRTs) of 27, 22 and 19 days, corresponding to organic loading rates of 7.9, 10.8 and 14.0 kgCOD/m(3) d. The feed mixed waste ratio (FW/SWS) of 10:1 by weight was selected from the previous laboratory-scale experiment. The results of this study indicate that higher gas production rate was obtained at shorter hydraulic retention time (HRT) of 19 days; however, higher methane content of the biogas was obtained at longer HRT of 27 days. Therefore, enhancement of methane production from the co-digestion could be achieved with sufficient operating HRT. Moreover, the proposed prototype system could reduce total volatile solid up to 70 percent at HRT of 27 days. Up to now, the biogas from on-site production has been utilized for cooking at Chulalongkorn University as a model case study for high-rise building application. (C) 2014 Elsevier Ltd. All rights reserved.	[Ratanatamskul, C.; Onnum, G.] Chulalongkom Univ, Dept Environm Engn, Bangkok 10330, Thailand; [Yamamoto, K.] Univ Tokyo, Ctr Environm Sci, Tokyo 113, Japan	Ratanatamskul, C (reprint author), Chulalongkom Univ, Dept Environm Engn, Bangkok 10330, Thailand.	dr_chawalit@yahoo.com			Japan International Cooperation Agency (JICA) under Research and Development of Water Reuse Technology in Tropical Region (Water InTro) Project	This research work was financially supported by Japan International Cooperation Agency (JICA) under Research and Development of Water Reuse Technology in Tropical Region (Water InTro) Project.	Angelidaki I, 2005, WATER SCI TECHNOL, V52, P189; Murto M, 2004, J ENVIRON MANAGE, V70, P101, DOI 10.1016/j.jenvman.2003.11.001; Mata-Alvarez J, 2000, BIORESOURCE TECHNOL, V74, P3, DOI 10.1016/S0960-8524(00)00023-7; Zhang RH, 2007, BIORESOURCE TECHNOL, V98, P929, DOI 10.1016/j.biortech.2006.02.039; Costa JC, 2012, BIORESOURCE TECHNOL, V114, P320, DOI 10.1016/j.biortech.2012.03.011; Sosnowski P, 2003, ADV ENVIRON RES, V7, P609, DOI 10.1016/S1093-0191(02)00049-7; Kim HW, 2011, BIORESOURCE TECHNOL, V102, P7272, DOI 10.1016/j.biortech.2011.04.088; Alvarez R, 2008, RENEW ENERG, V33, P726, DOI 10.1016/j.renene.2007.05.001; APHA, 2005, STANDARD METHODS EXA; Demirel B., 2007, BIOMASS BIOENERG, P71; Digman B, 2008, ENVIRON PROG, V27, P524, DOI 10.1002/ep.10312; Estevez MM, 2014, RENEW ENERG, V66, P550, DOI 10.1016/j.renene.2014.01.001; Garcia K., 2013, INT J ENV PROTECTION, V3, P8; Pollution Control Department, 2012, THAIL STAT POLL REP; Serrano A, 2014, J ENVIRON MANAGE, V140, P76, DOI 10.1016/j.jenvman.2014.02.028; Slack RJ, 2005, SCI TOTAL ENVIRON, V337, P119, DOI 10.1016/j.scitotenv.2004.07.002; Tchobanoglous G., 1993, INTEGRATED SOLID WAS; Zhou A., 2013, J BIOTECHNOL, V142, P655	18	5	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0964-8305	1879-0208		INT BIODETER BIODEGR	Int. Biodeterior. Biodegrad.	NOV	2014	95		A		SI		176	180		10.1016/j.ibiod.2014.06.010		5	Biotechnology & Applied Microbiology; Environmental Sciences	Biotechnology & Applied Microbiology; Environmental Sciences & Ecology	AU2SR	WOS:000345468400027		
J	Takeishi, Y				Takeishi, Yasuchika			Biomarkers in Heart Failure	INTERNATIONAL HEART JOURNAL			English	Review						BNP; NT-proBNP; ST2; Troponin; H-FABP; Galectin-3; Cystatin C; Pentraxin 3	BRAIN-NATRIURETIC PEPTIDE; ACID-BINDING PROTEIN; CARDIAC TROPONIN-T; VENTRICULAR SYSTOLIC DYSFUNCTION; BNP MEASUREMENTS USEFUL; LIVER-DISEASE MELD; C-REACTIVE PROTEIN; CYSTATIN-C; CIRCULATING MICRORNAS; PROGNOSTIC VALUE	Appropriate use of biomarkers is clinically important for identifying heart failure in its early stage, optimizing risk stratification, and managing patients. This article describes established and traditional biomarkers as well as novel biomarkers reflective of myocardial stress, myocardial damage, extracellular matrix, oxidative stress, inflammation, renal function, micro RNAs, and heart failure with preserved left ventricular ejection fraction. This review focuses on the recent advances in cardiac and non-cardiac biomarkers of heart failure and their appropriate use in clinical practice.	Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima 9601295, Japan	Takeishi, Y (reprint author), Fukushima Med Univ, Dept Cardiol & Hematol, 1 Hikarigaoka, Fukushima 9601295, Japan.	takeishi@fmu.ac.jp					Abe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100618; Ahmad T, 2014, JACC-HEART FAIL, V2, P260, DOI 10.1016/j.jchf.2013.12.004; Ahmad T, JACC HEART IN PRESS; Anand IS, 2003, CIRCULATION, V107, P1278; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66743.FE; van Kimmenade RR, 2006, J AM COLL CARDIOL, V48, P1217, DOI 10.1016/j.jacc.2006.03.061; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; Koglin J, 2001, J AM COLL CARDIOL, V38, P1934, DOI 10.1016/S0735-1097(01)01672-2; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Sato Y, 2001, CIRCULATION, V103, P369; Zile MR, 2011, CIRC-HEART FAIL, V4, P246, DOI 10.1161/CIRCHEARTFAILURE.110.958199; Eurlings LWM, 2010, J AM COLL CARDIOL, V56, P2090, DOI 10.1016/j.jacc.2010.07.030; Januzzi JL, 2011, J AM COLL CARDIOL, V58, P1881, DOI 10.1016/j.jacc.2011.03.072; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Dries DL, 2000, J AM COLL CARDIOL, V35, P681, DOI 10.1016/S0735-1097(99)00608-7; Januzzi JL, 2007, J AM COLL CARDIOL, V50, P607, DOI 10.1016/j.jacc.2007.05.014; ALLES VV, 1994, BLOOD, V84, P3483; Sundstrom J, 2004, CIRCULATION, V109, P2850, DOI 10.1161/01.CIR.0000129318.79570.84; Niizeki T, 2007, J CARD FAIL, V13, P120, DOI 10.1016/j.cardfail.2006.10.014; Tsutamoto T, 1997, CIRCULATION, V96, P509; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Felker GM, 2009, AM HEART J, V158, P422, DOI 10.1016/j.ahj.2009.06.018; Kitahara T, 2007, CIRC J, V71, P929, DOI 10.1253/circj.71.929; Januzzi JL, 2013, CIRCULATION, V127, P500, DOI 10.1161/CIRCULATIONAHA.112.120485; Tijsen AJ, 2012, AM J PHYSIOL-HEART C, V303, pH1085, DOI 10.1152/ajpheart.00191.2012; Sarnak MJ, 2005, ANN INTERN MED, V142, P497; HUNT PJ, 1995, BIOCHEM BIOPH RES CO, V214, P1175, DOI 10.1006/bbrc.1995.2410; Yu CM, 1999, EUR J HEART FAIL, V1, P59, DOI 10.1016/S1388-9842(98)00010-5; Hartmann F, 2004, CIRCULATION, V110, P1780, DOI 10.1161/01.CIR.0000143059.68996.A7; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; Agewall S, 2011, EUR HEART J, V32, P404, DOI 10.1093/eurheartj/ehq456; Goren Y, 2012, EUR J HEART FAIL, V14, P147, DOI 10.1093/eurjhf/hfr155; Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824; Ellis KL, 2013, EUR J HEART FAIL, V15, P1138, DOI 10.1093/eurjhf/hft078; Hillege HL, 2000, CIRCULATION, V102, P203; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Niizeki T, 2005, CIRC J, V69, P922, DOI 10.1253/circj.69.922; Desai AS, 2013, CIRCULATION, V127, P509, DOI 10.1161/CIRCULATIONAHA.112.120493; Jourdain P, 2007, J AM COLL CARDIOL, V49, P1733, DOI 10.1016/j.jacc.2006.10.081; Laterza OF, 2002, CLIN CHEM, V48, P699; Setsuta K, 1999, AM J CARDIOL, V84, P608, DOI 10.1016/S0002-9149(99)00391-4; Roongsritong C, 2004, CHEST, V125, P1877, DOI 10.1378/chest.125.5.1877; Groenning BA, 2004, HEART, V90, P297, DOI 10.1136/hrt.2003.026021; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.60016; Krum H, 2011, CIRC-HEART FAIL, V4, P561, DOI 10.1161/CIRCHEARTFAILURE.110.960716; Arimoto T, 2005, J CARD FAIL, V11, P56, DOI 10.1016/j.cardfail.2004.03.005; Yin WH, 2004, AM HEART J, V147, P931, DOI 10.1016/j.ahj.2003.11.021; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Kamioka M, 2012, INT HEART J, V53, P306; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Sharma UC, 2004, CIRCULATION, V110, P3121, DOI 10.1161/01.CIR.0000147181.65298.4D; Weinberg EO, 2002, CIRCULATION, V106, P2961, DOI 10.1161/01.CIR.0000038705.69871.D9; Yang JA, 2012, J HEART LUNG TRANSPL, V31, P601, DOI 10.1016/j.healun.2012.02.027; Karlstrom P, 2011, EUR J HEART FAIL, V13, P1096, DOI 10.1093/eurjhf/hfr078; Maisel AS, 2012, NAT REV CARDIOL, V9, P478, DOI 10.1038/nrcardio.2012.60; Choudhary R, 2013, J CARDIOVASC TRANSL, V6, P471, DOI 10.1007/s12265-013-9465-0; Cheng JM, 2013, EUR J HEART FAIL, V15, P1350, DOI 10.1093/eurjhf/hft106; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Rauchhaus M, 2000, CIRCULATION, V102, P3060; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; MULLER MM, 1991, CLIN CHIM ACTA, V201, P1, DOI 10.1016/0009-8981(91)90019-9; Arimoto T, 2005, J CARD FAIL, V11, P595, DOI 10.1016/j.cardfail.2005.06.001; GLATZ JFC, 1994, BRIT HEART J, V71, P135; Kinugawa T, 2012, INT HEART J, V53, P182; Kobayashi S, 2011, EUR J HEART FAIL, V13, P29, DOI 10.1093/eurjhf/hfq178; LAGORIO S, 1994, OCCUP ENVIRON MED, V51, P739; Lemos JA, 2013, JAMA-J AM MED ASSOC, V309, P2262; Mueller C, 2006, AM HEART J, V151, P845, DOI 10.1016/j.ahj.2005.06.046; Nakamura Y, 2014, CIRC J, V78, P890, DOI 10.1253/circj.CJ-13-1372; Niizeki T, 2007, CIRC J, V71, P1452, DOI 10.1253/circj.71.1452; Pemberton CJ, 1998, AM J PHYSIOL-HEART C, V275, pH1200; Radauceanu A, 2008, J CARD FAIL, V14, P467, DOI 10.1016/j.cardfail.2008.02.014; Sasaki T, 2010, INT J CARDIOL, V145, P318, DOI 10.1016/j.ijcard.2009.11.042; Silverberg DS, 2003, CLIN NEPHROL, V60, pS93; Suzuki S, 2011, EUR J CLIN INVEST, V41, P759, DOI 10.1111/j.1365-2362.2010.02465.x; Tutarel O, 2013, INT J CARDIOL, V167, P63, DOI 10.1016/j.ijcard.2011.11.082; Yamaguchi H, 2004, J AM COLL CARDIOL, V43, P55, DOI 10.1016/j.jacc.2003.07.037	80	3	3	INT HEART JOURNAL ASSOC	TOKYO	UNIV TOKYO, GRADUATE SCHOOL MEDICINE, DEPT CARDIOVASCULAR MEDICINE, HONGO 7-3-1, BUNKYO-KU, TOKYO, 113-8655, JAPAN	1349-2365	1349-3299		INT HEART J	Int. Heart J.	NOV	2014	55	6					474	481				8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU3XI	WOS:000345543600002		
J	Imamura, T				Imamura, Teruhiko			Aquaporin-2-Guided Tolvaptan Therapy in Patients With Congestive Heart Failure Accompanied by Chronic Kidney Disease	INTERNATIONAL HEART JOURNAL			English	Editorial Material							VASOPRESSIN RECEPTOR ANTAGONIST; WATER CHANNEL; EXCRETION; CLONING; VOLUME; RAT		[Imamura, Teruhiko] Univ Tokyo, Dept Therapeut Strategy Heart Failure, Grad Sch Med, Tokyo 1138655, Japan	Imamura, T (reprint author), Univ Tokyo, Dept Therapeut Strategy Heart Failure, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	te.imamu@gmail.com					FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; SASAKI S, 1994, J CLIN INVEST, V93, P1250, DOI 10.1172/JCI117079; Imamura T, 2014, INT HEART J, V55, P131; Imamura T, 2014, INT HEART J, V55, P264; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Imamura T, 2013, CIRC J, V77, P397, DOI 10.1253/circj.CJ-12-0971; Kinugawa K, 2014, CIRC J, V78, P844, DOI 10.1253/circj.CJ-14-0126; Radin MJ, 2012, VET CLIN PATH, V41, P455, DOI 10.1111/j.1939-165x.2012.00488.x; Rai T, 1997, J AM SOC NEPHROL, V8, P1357; Imamura T, 2013, INT HEART J, V54, P377; Imamura T, CIRC J IN PRESS; Kinugawa K, 2013, CLIN PHARMACOL THER, V94, P449, DOI 10.1038/clpt.2013.147; Sato E, INT HEART J IN PRESS	13	1	2	INT HEART JOURNAL ASSOC	TOKYO	UNIV TOKYO, GRADUATE SCHOOL MEDICINE, DEPT CARDIOVASCULAR MEDICINE, HONGO 7-3-1, BUNKYO-KU, TOKYO, 113-8655, JAPAN	1349-2365	1349-3299		INT HEART J	Int. Heart J.	NOV	2014	55	6					482	483				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU3XI	WOS:000345543600003		
J	Sairaku, A; Yoshida, Y; Hirayama, H; Nakano, Y; Kihara, Y				Sairaku, Akinori; Yoshida, Yukihiko; Hirayama, Haruo; Nakano, Yukiko; Kihara, Yasuki			Impact of Pulmonary Vein Isolation on Fractionated Atrial Potentials and Ganglionated Plexi in Patients With Persistent Atrial Fibrillation	INTERNATIONAL HEART JOURNAL			English	Article						Ablation; Atrial substrate; Complex fractionated atrial electrocardiograms; High frequency stimulation	ELECTROGRAM FRACTIONATION; CATHETER ABLATION; SUBSTRATE	Some patients with persistent atrial fibrillation (AF) acquire long-term freedom from AF by pulmonary vein (PV) isolation alone. The aim of the present study was to evaluate the characteristics of their atrial substrate. We studied 20 patients with persistent AF to examine the distribution of fractionated atrial potentials (FAP) and that of the anatomic sites of ganglionated plexi (GPs) with vagal reflexes elicited by high frequency stimulation (HFS) with the use of the CARTO system before and after the PV isolation. Both the %FAP area defined as a proportion of the FAP area to the total left atrial area (34.3 +/- 10.3 to 21.5 +/- 10.2%; P < 0.0001) and number of GP sites with vagal reflexes (4.0 [3.0, 5.0] to 2.0 [1.0, 2.8]; P < 0.0001) were markedly decreased after the PV isolation. Seven (35%) patients had AF recurrences, and they had a greater %FAP area after the PV isolation than those without (32.8 [22.1, 37.3] versus 13.8 [10.9, 19.91%; P = 0.0049). A %FAP area after the PV isolation of > 20% was significantly associated with an AF recurrence (odds ratio 20.0, 95% confidence interval 2.26-470.34; P = 0.018). No significant difference was found between the patients with and without AF recurrence in the reduction rate of anatomic sites of GPs with a vagal reflex induced by the HFS. A more marked reduction in the FAP area by the PV isolation was significantly associated with a better outcome in patients with persistent AF.	[Sairaku, Akinori; Yoshida, Yukihiko; Hirayama, Haruo] Nagoya Daini Red Cross Hosp, Dept Cardiol, Nagoya, Aichi, Japan; [Sairaku, Akinori; Nakano, Yukiko; Kihara, Yasuki] Hiroshima Univ, Dept Cardiol, Grad Sch Med, Hiroshima 7348551, Japan	Sairaku, A (reprint author), Hiroshima Univ, Dept Cardiol, Grad Sch Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	rjrgw059@ybb.ne.jp					Jadidi AS, 2012, CIRC-ARRHYTHMIA ELEC, V5, P32, DOI 10.1161/CIRCEP.111.964197; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Narayan SM, 2011, HEART RHYTHM, V8, P244, DOI 10.1016/j.hrthm.2010.10.020; Po SS, 2009, J CARDIOVASC ELECTR, V20, P1186, DOI 10.1111/j.1540-8167.2009.01515.x; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Katritsis DG, 2011, HEART RHYTHM, V8, P672, DOI 10.1016/j.hrthm.2010.12.047; Nademanee K, 2006, HEART RHYTHM, V3, P981, DOI 10.1016/j.hrthm.2006.03.018; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI 10.1093/eurheartj/ehq278; Nakagawa H, 2009, HEART RHYTHM, V6, pS26, DOI 10.1016/j.hrthm.2009.07.029; Ouyang FF, 2004, CIRCULATION, V110, P2090, DOI 10.1161/01.CIR.0000144459.37455.EE; Wu J, 2008, J CARDIOVASC ELECTR, V19, P897, DOI 10.1111/j.1540-8167.2008.01145.x; Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955; Lin YJ, 2009, CIRC-ARRHYTHMIA ELEC, V2, P233, DOI 10.1161/CIRCEP.108.812024; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Chen J, 2009, PACE, V32, pS190, DOI 10.1111/j.1540-8159.2008.02282.x; Jackman WM, 2012, CIRC-ARRHYTHMIA ELEC, V5, P5, DOI 10.1161/CIRCEP.111.969279; Nakagawa H, 2009, CIRCULATION, V120, pS658; Roux JF, 2009, HEART RHYTHM, V6, P156, DOI 10.1016/j.hrthm.2008.10.046; Sairaku A, 2012, HEART RHYTHM, V9, P1386, DOI 10.1016/j.hrthm.2012.05.014; Scherr D, 2009, J CARDIOVASC ELECTR, V20, P13, DOI 10.1111/j.1540-8167.2008.01278.x	20	3	3	INT HEART JOURNAL ASSOC	TOKYO	UNIV TOKYO, GRADUATE SCHOOL MEDICINE, DEPT CARDIOVASCULAR MEDICINE, HONGO 7-3-1, BUNKYO-KU, TOKYO, 113-8655, JAPAN	1349-2365	1349-3299		INT HEART J	Int. Heart J.	NOV	2014	55	6					494	498				5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU3XI	WOS:000345543600006		
J	Watanabe, A; Yamashita, N; Yamashita, T				Watanabe, Atai; Yamashita, Naohide; Yamashita, Takeshi			Blood Stasis Secondary to Heart Failure Forms Warfarin-Resistant Left Atrial Thrombus	INTERNATIONAL HEART JOURNAL			English	Article						Atrial fibrillation; Anticoagulants	TRANSESOPHAGEAL ECHOCARDIOGRAPHY; THROMBOEMBOLIC RISK; APPENDAGE FUNCTION; STROKE PREVENTION; FIBRILLATION; CONTRAST	Anticoagulants such as warfarin are recommended for patients with atrial fibrillation (AF) to decrease stroke risk associated with thrombus formation in the left atrium (LA). In a subgroup of patients, however, warfarin is unable to prevent LA thrombus formation at therapeutic doses. This study characterized the clinical and echocardiographic features of patients having warfarin-resistant LA thrombus. Of the 1364 nonvalvular AF patients examined by transesophageal echocardiography, 431 received warfarin. A total of 10 patients (2.3% of warfarin-treated patients) exhibited LA thrombus formation even during warfarin treatment at a dose and duration sufficient for increasing the prothrombin time international normalized ratio (PT-INR) to the therapeutic range for >= 30 days. Categorical regression analysis revealed that decreased LA appendage (LAA) flow velocity, greater LA spontaneous echocardiographic contrast (LASEC), and lower left ventricular ejection fraction (LVEF) significantly contributed to residual LA thrombus (P < 0.05 for all). Receiver operating characteristic (ROC) curve analysis indicated that higher right ventricular systolic pressure, which suggests LA pressure (area under curve, 0.85), LV mass index (0.81), and LA dimension (0.68), as well as lower LAA flow velocity (0.92) and LVEF (0.91) predicted warfarin-resistant LA thrombus formation (all P < 0.05). These results suggest that blood stasis secondary to heart failure contributes to the formation of warfarin-resistant LA thrombus. We propose that therapies to increase LVEF should be administered together with warfarin for AF patients with heart failure to decrease stroke risk.	[Watanabe, Atai; Yamashita, Naohide] Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan; [Yamashita, Takeshi] Cardiovasc Inst, Tokyo, Japan	Watanabe, A (reprint author), Univ Tokyo, Dept Adv Med Sci, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	a-wata@ims.u-tokyo.ac.jp					Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Zabalgoitia M, 1998, J AM COLL CARDIOL, V31, P1622, DOI 10.1016/S0735-1097(98)00146-6; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Hijazi Z, 2013, EUR HEART J, V34, P1475, DOI 10.1093/eurheartj/eht024; Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; FATKIN D, 1994, J AM COLL CARDIOL, V23, P961; Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290; [Anonymous], 1998, ANN INTERN MED, V128, P639; Albertsen IE, 2013, STROKE, V44, P1329, DOI 10.1161/STROKEAHA.113.000883; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; ASCHENBERG W, 1986, J AM COLL CARDIOL, V7, P163; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; WOLF PA, 1991, STROKE, V22, P983; POLLICK C, 1991, CIRCULATION, V84, P223; [Anonymous], 1996, J AM SOC ECHOCARDIOG, V9, P556; MUGGE A, 1994, J AM COLL CARDIOL, V23, P599; Weitz JI, 2010, THROMB HAEMOSTASIS, V104, P633, DOI 10.1160/TH10-01-0066; DANIEL WG, 1988, J AM COLL CARDIOL, V11, P1204; Pozzoli M, 1991, J Am Soc Echocardiogr, V4, P435; Sugiura S, 2012, J INTERV CARD ELECTR, V34, P59, DOI 10.1007/s10840-011-9633-6; Takashima S, 2012, J CLIN NEUROL, V8, P170, DOI 10.3988/jcn.2012.8.3.170; Wann L. S., 2013, CIRCULATION, V127, P1916, DOI DOI 10.1161/CIR.0B013E318290826D	24	2	2	INT HEART JOURNAL ASSOC	TOKYO	UNIV TOKYO, GRADUATE SCHOOL MEDICINE, DEPT CARDIOVASCULAR MEDICINE, HONGO 7-3-1, BUNKYO-KU, TOKYO, 113-8655, JAPAN	1349-2365	1349-3299		INT HEART J	Int. Heart J.	NOV	2014	55	6					506	511				6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU3XI	WOS:000345543600008		
J	Nagao, M; Yamasaki, Y; Yonezawa, M; Kamitani, T; Kawanami, S; Mukai, Y; Higo, T; Yabuuchi, H; Sunagawa, K; Honda, H				Nagao, Michinobu; Yamasaki, Yuzo; Yonezawa, Masato; Kamitani, Takeshi; Kawanami, Satoshi; Mukai, Yasushi; Higo, Taiki; Yabuuchi, Hidetake; Sunagawa, Kenji; Honda, Hiroshi			Geometrical Characteristics of Left Ventricular Dyssynchrony in Advanced Heart Failure Myocardial Strain Analysis by Tagged MRI	INTERNATIONAL HEART JOURNAL			English	Article						Cross-correlation analysis	CARDIAC-RESYNCHRONIZATION THERAPY; HYPERTROPHIC CARDIOMYOPATHY; GUIDELINES; MORTALITY	The aims of this study were to quantify the geometrical differences in left ventricular (LV) dyssynchrony in patients with heart failure (HF) using cine-tagged MRI, and to investigate the relationship between dyssynchrony and major adverse cardiac events (MACE) in HF. In 67 patients with HF [mean LV ejection fraction (LVEF), 34%], cardiac MRI using a 3-Tesla scanner was performed. The dyssynchrony time between septal and lateral segments (SL-DT) and between basal and apical segments (BA-DT) was computed by cross-correlation analysis of the strain time-curves from the cine-tagged MRI. After receiving optimal medical treatment, all patients were followed-up for a mean period of 27 months. The primary endpoint was MACE that consisted of cardiac death or I-IF hospitalization or a left ventricular assist device due to refractory pump failure. Multivariate logistic regression analysis was performed to determine the ability of SL-DT, BA-DT, and HF biomarkers to predict MACE. Multivariate logistic regression analysis showed that the odds ratio to predict MACE was 0.935 for LVEF (P = 0.021), 1.016 for BA-DT (P = 0.026), and 0.971 for systolic blood pressure (P = 0.126). The results show that basal-apical dyssynchrony is an independent predictor of MACE in HF patients.	[Nagao, Michinobu; Kawanami, Satoshi] Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Fukuoka 8128582, Japan; [Yamasaki, Yuzo; Yonezawa, Masato; Kamitani, Takeshi; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka 8128582, Japan; [Mukai, Yasushi; Higo, Taiki; Sunagawa, Kenji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiol, Fukuoka 8128582, Japan; [Yabuuchi, Hidetake] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Fukuoka 8128582, Japan	Nagao, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	minagao@radiol.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25461831]	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (25461831).	Gutberlet M, 2005, EUR RADIOL, V15, P1586, DOI 10.1007/s00330-005-2768-z; Raphael CE, 2009, HEART, V95, P56, DOI 10.1136/hrt.2007.134973; Hjalmarson A, 1999, LANCET, V353, P2001; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Gersh BJ, 2011, CIRCULATION, V124, P2761, DOI 10.1161/CIR.0b013e318223e230; Kukuk GM, 2011, RADIOLOGY, V259, P421, DOI 10.1148/radiol.11101429; Beshai JF, 2007, NEW ENGL J MED, V357, P2461, DOI 10.1056/NEJMoa0706695; Arts T, 2010, IEEE T MED IMAGING, V29, P1114, DOI 10.1109/TMI.2009.2037955; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Yu CM, 2002, CIRCULATION, V105, P1195, DOI 10.1161/hc1002.105185; Okin PM, 2004, HYPERTENSION, V44, P48, DOI 10.1161/01.HYP.0000132556.91792.6a; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; Bax JJ, 2004, J AM COLL CARDIOL, V44, P1834, DOI 10.1016/j.jacc.2004.08.016; Baldasseroni Samuele, 2003, Ital Heart J, V4, P607; Fomwalt BK, 2007, J AM SOC ECHOCARDIOG, V20, P1330; Goldstein D, 2006, ISHLT MONOGRAPH SERI, V1, P77; Ka Ira PR, 2002, INT J CARDIOL, V86, P225; Nagao M, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-14; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Stahlberg M, 2005, PACE, V28, P1013, DOI 10.1111/j.1540-8159.2005.00217.x; TOPOL EJ, 1985, NEW ENGL J MED, V312, P277, DOI 10.1056/NEJM198501313120504; Yonezawa M, 2013, J NUCL CARDIOL, V20, P600, DOI 10.1007/s12350-013-9715-1	23	0	0	INT HEART JOURNAL ASSOC	TOKYO	UNIV TOKYO, GRADUATE SCHOOL MEDICINE, DEPT CARDIOVASCULAR MEDICINE, HONGO 7-3-1, BUNKYO-KU, TOKYO, 113-8655, JAPAN	1349-2365	1349-3299		INT HEART J	Int. Heart J.	NOV	2014	55	6					512	518				7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU3XI	WOS:000345543600009		
J	Tani, S; Takahashi, A; Naga, K; Hirayama, A				Tani, Shigemasa; Takahashi, Atsuhiko; Naga, Ken; Hirayama, Atsushi			Effects of the T/L-type Calcium Channel Blocker Benidipine on Albuminuria and Plasma Aldosterone Concentration A Pilot Study Involving Switching from L-type Calcium Channel Blockers to Benidipine	INTERNATIONAL HEART JOURNAL			English	Article						Cardio-renal interaction; Hypertension	CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; CHRONIC HEART-FAILURE; HYPERTENSIVE PATIENTS; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; CONTROLLED-TRIAL; RISK-FACTOR; COMBINATION	Albuminuria and a high plasma aldosterone concentration (PAC) are prognosis factors predicting a poor outcome for cardiovascular disease. We examined here the effects of benidipine, a T/L-type calcium channel blocker (CCB), on albuminuria and PAC. Thirty-one patients with essential hypertension who received an L-type CCB and achieved the target blood pressure (BP) indicated by the Treatment Guidelines of the Japan Society of Hypertension (JSH2009) were investigated. The L-type CCB under treatment was switched to benidipine at a dose in which equivalent BP reduction was expected. BP and estimated glomerular filtration rate at 6 months after switching to benidipine were not significantly different from those at baseline. The urinary-albumin-creatinine ratio (UACR) decreased significantly by 36.9% (P = 0.001). No significant change was observed in plasma renin activity (P = 0.063). The PAC of all patients decreased significantly by 11.8% (P = 0.002). When analyzed by daily doses of benidipine, the PAC appeared to have decreased in patients who received 4 mg per day of benidipine (n = 14), although statistical significance was not reached (P = 0.096). The PAC in patients who received 8 mg per day of benidipine (n = 17) was significantly reduced by 13.2% (P = 0.017). In hypertensive patients whose BP is controlled by L-type CCB, switching to the T/L-type CCB benidipine maintained BP control and reduced UACR. In addition, the high dose of benidipine reduced the PAC independent of BP control. These results suggest the T/L-type CCB benidipine may contribute to cardio-renal protection in addition to lowering BP.	[Tani, Shigemasa; Takahashi, Atsuhiko; Naga, Ken] Surugadai Nihon Univ Hosp, Dept Cardiol, Tokyo 1018309, Japan; [Tani, Shigemasa; Takahashi, Atsuhiko; Naga, Ken; Hirayama, Atsushi] Nihon Univ, Sch Med, Dept Med, Div Cardiol, Tokyo, Japan	Tani, S (reprint author), Surugadai Nihon Univ Hosp, Dept Cardiol, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018309, Japan.	tanishigem@yahoo.co.jp					Abe M, 2011, HYPERTENS RES, V34, P268, DOI 10.1038/hr.2010.221; Abe M, 2009, HYPERTENS RES, V32, P270, DOI 10.1038/hr.2009.11; Akizuki O, 2008, EUR J PHARMACOL, V584, P424, DOI 10.1016/j.ejphar.2008.02.001; Alderman MH, 1997, AM J HYPERTENS, V10, P1, DOI 10.1016/S0895-7061(96)00301-9; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Williams GH, 2004, AM J CARDIOL, V93, P990, DOI 10.1016/j.amjcard.2004.01.007; Hayashi Koichi, 2010, Keio Journal of Medicine, V59, P84; Beygui F, 2006, CIRCULATION, V114, P2604, DOI 10.1161/CIRCULATIONAHA.106.634626; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Vasan RS, 2004, NEW ENGL J MED, V351, P33, DOI 10.1056/NEJMoa033263; Yamamoto E, 2010, J HYPERTENS, V28, P1321, DOI 10.1097/HJH.0b013e3283388045; Ruggenenti P, 2012, J AM SOC NEPHROL, V23, P1917, DOI 10.1681/ASN.2012040390; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Bianchi S, 2005, AM J KIDNEY DIS, V46, P45, DOI 10.1053/j.ajkd.2005.03.007; Pratt-Ubunama MN, 2007, CHEST, V131, P453, DOI 10.1378/chest.06-1442; Guder G, 2007, CIRCULATION, V115, P1754, DOI 10.1161/CIRCULATIONAHA.106.653964; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Cohn JN, 2003, CIRCULATION, V108, P1306, DOI 10.1161/01.CIR.0000091234.45664.62; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; DUPREZ DA, 1993, AM J CARDIOL, V71, pA17, DOI 10.1016/0002-9149(93)90240-D; Fujita T, 2007, KIDNEY INT, V72, P1543, DOI 10.1038/sj.ki.5002623; Furukawa T, 2009, EUR J PHARMACOL, V613, P100, DOI 10.1016/j.ejphar.2009.04.036; Ishimitsu T, 2007, HYPERTENS RES, V30, P621, DOI 10.1291/hypres.30.621; Jones SW, 1998, J BIOENERG BIOMEMBR, V30, P299, DOI 10.1023/A:1021977304001; Kosaka H, 2010, EUR J PHARMACOL, V635, P49, DOI 10.1016/j.ejphar.2010.03.018; Matsuzaki M, 2011, J HYPERTENS, V29, P1649, DOI 10.1097/HJH.0b013e328348345d; Minami J, 2008, AM J HYPERTENS, V21, P3; Nakamura T, 2007, AM J MED SCI, V333, P321, DOI 10.1097/MAJ.0b013e318065c254; Nishigaki K, 2010, CIRC J, V74, P1943, DOI 10.1253/circj.CJ-10-0292; Persson F, 2010, DIABETES CARE, V33, P2304, DOI 10.2337/dc10-0833; Rakugi H, 2013, HYPERTENS RES, V36, P947, DOI 10.1038/hr.2013.63; Rossier MF, 1996, ENDOCRINOLOGY, V137, P4817, DOI 10.1210/en.137.11.4817; Struthers AD, 2004, CARDIOVASC RES, V61, P663, DOI 10.1016/j.cardiores.2003.11.037; Tani S, 2008, J CARDIOVASC PHARM, V52, P28, DOI 10.1097/FJC.0b013e31817d4507; Ruggenenti P, 1997, LANCET, V349, P1857; The Japanese Society of Nephrology, 2013, EV BAS CLIN PRACT GU; Agodoa L, 2007, J HYPERTENS, V25, P951; Unger T, 2011, EUR HEART J, V32, P2739, DOI 10.1093/eurheartj/ehr253	38	0	0	INT HEART JOURNAL ASSOC	TOKYO	UNIV TOKYO, GRADUATE SCHOOL MEDICINE, DEPT CARDIOVASCULAR MEDICINE, HONGO 7-3-1, BUNKYO-KU, TOKYO, 113-8655, JAPAN	1349-2365	1349-3299		INT HEART J	Int. Heart J.	NOV	2014	55	6					519	525				7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU3XI	WOS:000345543600010		
J	Sato, E; Nakamura, T; Amaha, M; Nomura, M; Matsumura, D; Yamagishi, H; Ono, Y; Ueda, Y				Sato, Eiichi; Nakamura, Tsukasa; Amaha, Mayuko; Nomura, Mayumi; Matsumura, Daisuke; Yamagishi, Hidetsugu; Ono, Yuko; Ueda, Yoshihiko			Effect of Tolvaptan in Patients With Chronic Kidney Disease Due to Diabetic Nephropathy With Heart Failure	INTERNATIONAL HEART JOURNAL			English	Article						Histopathological findings; Aquaporin-2	URINE OSMOLALITY; V-2-RECEPTOR ANTAGONIST; RECEPTOR; RATS; EXPRESSION; OPC-41061; THERAPY	The efficacy of tolvaptan for treating heart failure has already been shown. Adequate data relating to the effect of tolvaptan on the correlation of water balance in renal disease are not available. A retrospective study was conducted on the efficacy and adverse reactions of tolvaptan for treating nephrotic syndrome. The subjects were 26 patients with chronic kidney failure due to diabetic nephropathy with heart failure who were administered tolvaptan and seen between December 2011 and October 2013. The endpoints were urinary output, physical findings, and blood analyses. The expression of aquaporin-2 in the collecting duct, which is related to the action of tolvaptan, was investigated by immunohistochemistry using the kidney tissue obtained for the diagnosis. Responses were seen in 19 of the patients. In the histopathological investigation there was severe glomerulosclerosis in patients with diabetic nephropathy, but the responders were noticeable in that they only had mild tubulointerstitial damage. Non-responders exhibited profound tubulointerstitial damage. The expression of aquaporin-2 was determined in 8 patients, of which 7 were responders who tested positive for aquaporin-2. The remaining case was a non-responder who showed no expression of aquaporin-2. Tolvaptan is considered effective for some cases of nephrotic syndrome. There are no clear parameters for predicting an effect, but the present study showed that aquaporin-2 was expressed in the epithelial cells of the collecting ducts of tolvaptan responders.	[Sato, Eiichi; Nakamura, Tsukasa; Yamagishi, Hidetsugu; Ono, Yuko; Ueda, Yoshihiko] Dokkyo Med Univ, Dept Pathol, Koshigaya Hosp, Koshigaya, Saitama 3438555, Japan; [Sato, Eiichi; Nakamura, Tsukasa; Amaha, Mayuko; Nomura, Mayumi; Matsumura, Daisuke] Shinmatsudo Cent Gen Hosp, Chiba, Japan	Sato, E (reprint author), Dokkyo Med Univ, Dept Pathol, Koshigaya Hosp, 2-1-50 Minami Koshigaya, Koshigaya, Saitama 3438555, Japan.	satou@db4.so-net.ne.jp					Hirano T, 2000, J PHARMACOL EXP THER, V292, P288; Imamura T, 2013, INT HEART J, V54, P115; Yasuoka Y, 2013, CLIN EXP NEPHROL, V17, P183, DOI 10.1007/s10157-012-0686-3; Berl T, 2010, J AM SOC NEPHROL, V21, P705, DOI 10.1681/ASN.2009080857; Butler J, 2004, AM HEART J, V147, P331, DOI 10.1016/j.ahj.2003.08.012; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Yamamura Y, 1998, J PHARMACOL EXP THER, V287, P860; Otsuka T, 2013, CLIN EXP NEPHROL, V17, P834, DOI 10.1007/s10157-013-0788-6; Toka HR, 2012, J AM SOC NEPHROL, V23, P1879, DOI 10.1681/ASN.2012030323; Gheorghiade M, 2004, JAMA-J AM MED ASSOC, V291, P1963, DOI 10.1001/jama.291.16.1963; Shimizu M, 2014, PEDIATR NEPHROL, V29, P915, DOI 10.1007/s00467-013-2687-1; Bedford JJ, 2003, J AM SOC NEPHROL, V14, P2581, DOI 10.1097/01.ASN.0000089566.28106.F6; Imamura T, 2013, CIRC J, V77, P397, DOI 10.1253/circj.CJ-12-0971; Gheorghiade M, 2005, J CARD FAIL, V11, P260, DOI 10.1016/j.cardfail.2005.03.009; Brown D, 2012, AM J PHYSIOL-CELL PH, V302, pC1421, DOI 10.1152/ajpcell.00085.2012; Dohi K, 2013, CIRC J, V77, P313, DOI 10.1253/circj.CJ-12-1535; Imamura T, CIRC J IN PRESS; Iwahori T, CLIN EXP NE IN PRESS; Kwon TH, 1998, AM J PHYSIOL-RENAL, V275, pF724; Matsuzaki Masunori, 2011, Cardiovasc Drugs Ther, V25 Suppl 1, pS33, DOI 10.1007/s10557-011-6304-x; Noda Y, CLIN EXP NE IN PRESS; Semba H, 2012, INT HEART J, V53, P72; TEITELBAUM I, 1995, J CLIN INVEST, V96, P378, DOI 10.1172/JCI118044	23	1	1	INT HEART JOURNAL ASSOC	TOKYO	UNIV TOKYO, GRADUATE SCHOOL MEDICINE, DEPT CARDIOVASCULAR MEDICINE, HONGO 7-3-1, BUNKYO-KU, TOKYO, 113-8655, JAPAN	1349-2365	1349-3299		INT HEART J	Int. Heart J.	NOV	2014	55	6					533	538				6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU3XI	WOS:000345543600012		
J	Irisawa, Y; Itatani, K; Kitamura, T; Hanayama, N; Oka, N; Tomoyasu, T; Inoue, N; Hayashi, H; Inoue, T; Miyaji, K				Irisawa, Yusuke; Itatani, Keiichi; Kitamura, Tadashi; Hanayama, Naoji; Oka, Norihiko; Tomoyasu, Takahiro; Inoue, Nobuyuki; Hayashi, Hidenori; Inoue, Takamichi; Miyaji, Kagami			Aortic Regurgitation Due to Fibrous Strand Rupture in the Fenestrated Left Coronary Cusp of the Tricuspid Aortic Valve	INTERNATIONAL HEART JOURNAL			English	Article						Aortic valve regurgitation		Fenestration-related massive aortic regurgitation is rare. The underlying mechanism is reported to be rupture of the fenestrated fibrous strand, and most ruptured cords have been reported in the bicuspid valve or in the right coronary cusp of the tricuspid aortic valve. We encountered a rare case of acute aortic regurgitation due to fibrous strand rupture in the fenestrated left coronary cusp. Preoperative echocardiography detected left coronary cusp prolapse, and operative findings revealed rupture of a fibrous strand in the left coronary cusp. For cases such as this, preoperative echocardiography would be useful for appropriate diagnosis.	[Irisawa, Yusuke; Itatani, Keiichi; Kitamura, Tadashi; Hanayama, Naoji; Oka, Norihiko; Tomoyasu, Takahiro; Inoue, Nobuyuki; Hayashi, Hidenori; Inoue, Takamichi; Miyaji, Kagami] Kitasato Univ, Sch Med, Dept Cardiovasc Surg, Sagamihara, Kanagawa 2520374, Japan	Itatani, K (reprint author), Kitasato Univ, Sch Med, Dept Cardiovasc Surg & Hemodynam Anal, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	keiichiitatani@gmail.com					Akiyama K, 2004, CIRC J, V68, P439, DOI 10.1253/circj.68.439; Misawa Y, 1993, Nihon Kyobu Geka Gakkai Zasshi, V41, P2156; Nakajima M, 2002, J THORAC CARDIOV SUR, V124, P843, DOI 10.1067/mtc.2002.124296; ROBERTS WC, 1981, AM J CARDIOL, V47, P206, DOI 10.1016/0002-9149(81)90385-4; Yavuz S, 1999, J HEART VALVE DIS, V8, P284	5	0	0	INT HEART JOURNAL ASSOC	TOKYO	UNIV TOKYO, GRADUATE SCHOOL MEDICINE, DEPT CARDIOVASCULAR MEDICINE, HONGO 7-3-1, BUNKYO-KU, TOKYO, 113-8655, JAPAN	1349-2365	1349-3299		INT HEART J	Int. Heart J.	NOV	2014	55	6					550	551				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU3XI	WOS:000345543600015		
J	Yoshii, T; Miyamoto, T; Inui, A; Tanaka, Y; Yoshitake, S; Seki, M; Kobayashi, T				Yoshii, Takeshi; Miyamoto, Takashi; Inui, Akitoshi; Tanaka, Yuuki; Yoshitake, Shuichi; Seki, Mitsuru; Kobayashi, Tomio			Fontan Completion Following Flow Adjustable Bilateral Pulmonary Artery Banding	INTERNATIONAL HEART JOURNAL			English	Article						CHD; Univentricular heart; Surgery techniques; Cardiac intervention		We have performed bilateral pulmonary artery banding operations combined with planned percutaneous balloon dilatation at banding sites for patients with hypoplastic left heart syndrome and related anomalies. Here, we report a case of Fontan completion in a patient who underwent aortic arch repair and a bidirectional Glenn procedure following flow-adjustable bilateral pulmonary artery banding. The patient had a double-inlet left ventricle, a hypoplastic right ventricle, a hypoplastic aortic arch, and coarctation of the aorta. She underwent banding at 9 days of age and balloon dilatation at 2 months. The Damus-Kaye-Stansel anastomosis, aortic arch repair, and bidirectional Glenn procedure were performed at 5 months of age, and the extracardiac Fontan procedure was performed at 1.5 years.	[Yoshii, Takeshi; Miyamoto, Takashi; Inui, Akitoshi; Tanaka, Yuuki; Yoshitake, Shuichi] Gunma Childrens Med Ctr, Dept Cardiovasc Surg, Gunma, Japan; [Seki, Mitsuru; Kobayashi, Tomio] Gunma Childrens Med Ctr, Dept Cardiol, Gunma, Japan	Yoshii, T (reprint author), 779 Shimohakoda,Hokkitsu Machi, Shibukawa, Gunma 3778577, Japan.	yosiit-tky@umin.net					Hsia TY, 2006, ANN THORAC SURG, V81, pS2381, DOI 10.1016/j.athoracsur.2006.02.074; Ishizaka T, 2003, ANN THORAC SURG, V75, P277, DOI 10.1016/S0003-4975(02)04302-3; Miyamoto T, 2013, INTERACT CARDIOV TH, V16, P892, DOI 10.1093/icvts/ivt073; Pizarro C, 2003, ANN THORAC SURG, V75, P1008, DOI 10.1016/S0003-4975(02)04394-1; Sasaki Takashi, 2008, Gen Thorac Cardiovasc Surg, V56, P158, DOI 10.1007/s11748-007-0207-6; Yoshimoto Akihiro, 2013, Gen Thorac Cardiovasc Surg, V61, P340, DOI 10.1007/s11748-013-0221-9	6	2	2	INT HEART JOURNAL ASSOC	TOKYO	UNIV TOKYO, GRADUATE SCHOOL MEDICINE, DEPT CARDIOVASCULAR MEDICINE, HONGO 7-3-1, BUNKYO-KU, TOKYO, 113-8655, JAPAN	1349-2365	1349-3299		INT HEART J	Int. Heart J.	NOV	2014	55	6					552	554				3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU3XI	WOS:000345543600016		
J	Pak, M; Ito, S; Takeda, M; Watanabe, N; Sato, H; Ito, S; Adachi, T; Sugamori, T; Endo, A; Takahashi, N; Yoshitomi, H; Ishibashi, Y; Tanabe, K				Pak, Misun; Ito, Shimpei; Takeda, Masaki; Watanabe, Nobuhide; Sato, Hirotomo; Ito, Saki; Adachi, Tomoko; Sugamori, Takashi; Endo, Akihiro; Takahashi, Nobuyuki; Yoshitomi, Hiroyuki; Ishibashi, Yutaka; Tanabe, Kazuaki			A Case of Ascending Aortic Dissection and Rupture Caused by Giant Cell Arteritis	INTERNATIONAL HEART JOURNAL			English	Article						Gallium scintigraphy; Steroid therapy; Surgical therapy	INFLAMMATORY ANEURYSM; TEMPORAL ARTERITIS; FOLLOW-UP; INVOLVEMENT; DIAGNOSIS; DISEASES	Giant cell arteritis (GCA) is an autoimmune disease characterized by granulomatous inflammation in the wall of medium-sized and large-sized arteries, and it usually occurs in patients over 50 years of age.(1)) Symptoms are nonspecific, and include fatigue, fever, and headache.(2)) It is occasionally combined with aortic complications, and ruptures resulting in death. These complications occur as late events, usually several years after diagnosis and often after other symptoms have subsided.(3)) Physicians should therefore be alert for complications of the large arteries in GCA. Here we present a case of GCA combined with ascending aortic dissection and rupture 3 weeks after diagnosis.	[Pak, Misun; Ito, Shimpei; Takeda, Masaki; Watanabe, Nobuhide; Sato, Hirotomo; Ito, Saki; Adachi, Tomoko; Sugamori, Takashi; Endo, Akihiro; Takahashi, Nobuyuki; Tanabe, Kazuaki] Shimane Univ, Fac Med, Div Cardiol, Izumo, Shimane 6938501, Japan; [Yoshitomi, Hiroyuki] Shimane Univ, Fac Med, Dept Clin Lab, Izumo, Shimane 6938501, Japan; [Ishibashi, Yutaka] Shimane Univ, Fac Med, Dept Community Med Management, Izumo, Shimane 6938501, Japan	Pak, M (reprint author), Shimane Univ, Fac Med, Div Cardiol, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	pakkun@med.shimane-u.ac.jp					van Bommel EFH, 2008, VASC MED, V13, P293, DOI 10.1177/1358863X08091147; Marie I, 2009, MEDICINE, V88, P182, DOI 10.1097/MD.0b013e3181a68ae2; Gornik HL, 2008, CIRCULATION, V117, P3039, DOI 10.1161/CIRCULATIONAHA.107.760686; Nuenninghoff DM, 2003, ARTHRITIS RHEUM, V48, P3522, DOI 10.1002/art.11353; Butler N, 2010, J CARDIAC SURG, V25, P572, DOI 10.1111/j.1540-8191.2010.01100.x; EVANS JM, 1995, ANN INTERN MED, V122, P502; HEDGES AR, 1986, BRIT J SURG, V73, P374, DOI 10.1002/bjs.1800730518; KYLE V, 1991, BAILLIERE CLIN RHEUM, V5, P485, DOI 10.1016/S0950-3579(05)80067-6; Lee A, 2011, CARDIOVASC PATHOL, V20, P247, DOI 10.1016/j.carpath.2010.10.003; Martinez-Valle F, 2010, AUTOIMMUN REV, V9, P521, DOI 10.1016/j.autrev.2010.02.014; Matsumoto Y, 2010, SHINZO, V42, P458; Morinobu A, 2011, MOD RHEUMATOL, V21, P391, DOI 10.1007/s10165-010-0408-1; Ohara N, 2000, INT ANGIOL, V19, P270; Rajamurugan PSA, 2007, LUPUS, V16, P1001, DOI 10.1177/0961203307081996; Reitblat T, 2006, RHEUMATOL INT, V26, P1010, DOI 10.1007/s00296-006-0124-5; Reitblat T, 2003, ANN RHEUM DIS, V62, P257, DOI 10.1136/ard.62.3.257; Scheel AK, 2004, ANN RHEUM DIS, V63, P1507, DOI 10.1136/ard.2003.015651; Schmidt WA, 2005, BEST PRACT RES CL RH, V19, P223, DOI 10.1016/j.berh.2005.01.006; Slobodin G, 2006, CLIN EXP RHEUMATOL, V24, pS41; Warrington K J, 2007, Clin Exp Rheumatol, V25, P137	20	0	0	INT HEART JOURNAL ASSOC	TOKYO	UNIV TOKYO, GRADUATE SCHOOL MEDICINE, DEPT CARDIOVASCULAR MEDICINE, HONGO 7-3-1, BUNKYO-KU, TOKYO, 113-8655, JAPAN	1349-2365	1349-3299		INT HEART J	Int. Heart J.	NOV	2014	55	6					555	559				5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU3XI	WOS:000345543600017		
J	Homma, S; Takahashi, KI; Nihei, S; Kato, F; Sugihara, S; Nunoda, S				Homma, Satoshi; Takahashi, Ken-Ichiro; Nihei, Satomi; Kato, Fumiyo; Sugihara, Shigetaka; Nunoda, Shinichi			The Successful Management of Respiratory Complications With Long-Term, Low-Dose Macrolide Administration in Pediatric Heart Transplant Recipients	INTERNATIONAL HEART JOURNAL			English	Article						Respiratory symptoms; Adenotonsillectomy; Continuous positive airway pressure support therapy; Calcineurin inhibitors	INFECTION; CHILDREN; UPDATE	We report three pediatric heart transplant (HTx) patients whose respiratory symptoms were successfully controlled with long-term, low-dose macrolide administration (clarithromycin: CAM; approximately 2.5 mg/kg bid). The first case was an 18-year-old boy who underwent HTx at the age of three for dilated cardiomyopathy (DCM). Beginning at age 5, he had repeated fevers and respiratory symptoms. He was diagnosed with chronic sinusitis at age 11 and sinobronchial syndrome with mild bronchiectasis at age 14. Administration of long-term, low-dose CAM and otolaryngeal topical therapy led to significant improvement of his symptoms. The second case was a 7-year-old boy who underwent HTx for DCM at age one. Starting at age 4, he had repeated fevers and cough due to atelectasis and pneumonia. As antibiotics and respiratory physical therapy proved ineffective, he received long-term, low-dose CAM, resulting in successful control of his atelectasis and recurrent pneumonia. The third case was a 13-year-old boy who underwent HTx at age 6 for DCM. He had chronic sinusitis starting at age 7, and was diagnosed with obstructive sleep apnea syndrome at age 10. Adenotonsillectomy and continuous positive airway pressure support therapy were indicated. At age 13, long-term, low-dose CAM administration was started following mycoplasma infection. In all three cases, the levels of calcineurin inhibitors (cyclosporine and tacrolimus) and everolimus were kept in the optimal range with careful drug monitoring. Longterm, low-dose macrolide administration effectively prevents and treats respiratory complications in pediatric HTx patients as long as attention is paid to potential drug interactions.	[Homma, Satoshi; Takahashi, Ken-Ichiro; Nihei, Satomi; Kato, Fumiyo; Sugihara, Shigetaka] Tokyo Womens Med Univ Med Ctr East, Dept Pediat, Tokyo 1168567, Japan; [Nunoda, Shinichi] Tokyo Womens Med Univ Med Ctr East, Div Cardiovasc, Tokyo 1168567, Japan	Nunoda, S (reprint author), Tokyo Womens Med Univ Med Ctr East, Div Cardiovasc, 2-1-10 Nishiogu Arakawa Ku, Tokyo 1168567, Japan.	nunodagm@dnh.twmu.ac.jp					Vlahandonis A, 2013, SLEEP MED REV, V17, P75, DOI 10.1016/j.smrv.2012.04.004; Gennery AR, 1998, LANCET, V351, P1778, DOI 10.1016/S0140-6736(97)08486-9; Spagnolo P, 2013, EUR RESPIR J, V42, P239, DOI 10.1183/09031936.00136712; Cameron EJ, 2012, CLIN EXP ALLERGY, V42, P1302, DOI 10.1111/j.1365-2222.2012.03979.x; Green M, 2013, AM J TRANSPLANT, V13, P41, DOI 10.1111/ajt.12004; Brigden ML, 1999, CRIT CARE MED, V27, P836, DOI 10.1097/00003246-199904000-00050; Kudoh S, 1998, AM J RESP CRIT CARE, V157, P1829; Amsden GW, 2005, J ANTIMICROB CHEMOTH, V55, P10, DOI 10.1093/jac/dkh519; Crowley Seamus, 2005, Expert Rev Anti Infect Ther, V3, P923, DOI 10.1586/14787210.3.6.923; Ip M S, 1996, Respirology, V1, P107, DOI 10.1111/j.1440-1843.1996.tb00018.x; Leupold W, 1993, Kinderarztl Prax, V61, P129; Loghmanee DA, 2010, PEDIATR ANN, V39, P784, DOI 10.3928/00904481-20101116-09; Steigbigel NH, 1995, MANDELL DOUGLAS BENN, P334; Thomas B, 2007, J HEART LUNG TRANSPL, V26, P236, DOI 10.1016/j.healun.2007.01.019; Yalcin E, 2006, J CLIN PHARM THER, V31, P49, DOI 10.1111/j.1365-2710.2006.00708.x	15	0	0	INT HEART JOURNAL ASSOC	TOKYO	UNIV TOKYO, GRADUATE SCHOOL MEDICINE, DEPT CARDIOVASCULAR MEDICINE, HONGO 7-3-1, BUNKYO-KU, TOKYO, 113-8655, JAPAN	1349-2365	1349-3299		INT HEART J	Int. Heart J.	NOV	2014	55	6					560	563				4	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU3XI	WOS:000345543600018		
J	Gui, G; Adachi, F				Gui, Guan; Adachi, Fumiyuki			Sparse least mean fourth algorithm for adaptive channel estimation in low signal-to-noise ratio region	INTERNATIONAL JOURNAL OF COMMUNICATION SYSTEMS			English	Article						least mean fourth (LMF); zero-attracting LMF (ZA-LMF); reweighted ZA-LMF (RZA-LMF); L-p-norm LMF (LP-LMF); L-0-norm LMF (L0-LMF); adaptive channel estimation		Both least mean square (LMS) and least mean fourth (LMF) are popular adaptive algorithms with application to adaptive channel estimation. Because the wireless channel vector is often sparse, sparse LMS-based approaches have been proposed with different sparse penalties, for example, zero-attracting LMS and L-p-norm LMS. However, these proposed methods lead to suboptimal solutions in low signal-to-noise ratio (SNR) region, and the suboptimal solutions are caused by LMS-based algorithms that are sensitive to the scaling of input signal and strong noise. Comparatively, LMF can achieve better solution in low SNR region. However, LMF cannot exploit the sparse information because the algorithm depends only on its adaptive updating error but neglects the inherent sparse channel structure. In this paper, we propose several sparse LMF algorithms with different sparse penalties to achieve better solution in low SNR region and take the advantage of channel sparsity at the same time. The contribution of this paper is briefly summarized as follows: (1) construct the cost functions of the LMF algorithm with different sparse penalties; (2) derive their lower bounds; and (3) provide experiment results to show the performance advantage of the propose method in low SNR region. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Gui, Guan; Adachi, Fumiyuki] Tohoku Univ, Grad Sch Engn, Dept Communicat Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Gui, G (reprint author), Tohoku Univ, Grad Sch Engn, Dept Communicat Engn, Aoba Ku, 6-6-05 Aza Aoba, Sendai, Miyagi 9808579, Japan.	gui@mobile.ecei.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS) postdoctoral fellowship	The authors would like to thank the anonymous reviewers and the editor for their kind and constructive comments that helped much to improve the quality of the paper. This work was supported by the Japan Society for the Promotion of Science (JSPS) postdoctoral fellowship.	Adachi F, 2007, WIREL COMMUN MOB COM, V7, P969, DOI [10.1002/wcm.507, 10.1002/wem.507]; Gupta P, 2008, INT J COMMUN SYST, V21, P1075, DOI 10.1002/dac.938; Adachi F, 2005, IEEE WIREL COMMUN, V12, P8, DOI 10.1109/MWC.2005.1421924; Vuokko L, 2007, IEEE T ANTENN PROPAG, V55, P3361, DOI 10.1109/TAP.2007.908844; Candes EJ, 2008, J FOURIER ANAL APPL, V14, P877, DOI 10.1007/s00041-008-9045-x; Czink N, 2007, IEEE T WIREL COMMUN, V6, P1465, DOI 10.1109/TWC.2007.05595; Barton RJ, 2007, INT J COMMUN SYST, V20, P723, DOI 10.1002/dac.861; Chen HH, 2004, INT J COMMUN SYST, V17, P705, DOI 10.1002/dac.659; Chens Y, 2009, IEEE INT C AC SPEECH, V3, P3125; Eweda E, 2012, IEEE T SIGNAL PROCES, V60, P1473, DOI 10.1109/TSP.2011.2177976; Gu Y, 2009, IEEE SIGNAL PROCESSI, V16, P774; Guis G, 2013, IEEE WIR COMM NETW W, P1, DOI DOI 10.1002/DAC.253; Guis G, 2012, INT J ANTENN PROPAG, DOI [10.1002/dac.2483, DOI 10.1002/DAC.2483]; Hubscher Pedro Inacio, 2007, IEEE Transactions on Signal Processing, V55, DOI 10.1109/TSP.2007.894423; Hubscher PI, 2003, IEEE T SIGNAL PROCES, V51, P664, DOI 10.1109/TSP.2002.808126; Ijyass VT, 2012, INT J COMMUNICATION, P1; Kabaos N, 2011, INT J COMMUNICATION, V2011, P1; Sus G, 2012, IEEE T SIGNAL PROCES, V60, P2223; Taheri O, 2011, INT CONF ACOUST SPEE, P2864; WALACH E, 1984, IEEE T INFORM THEORY, V30, P275, DOI 10.1109/TIT.1984.1056886; Wyne S., 2006, IEEE 64 VEH TECHN C, P1, DOI DOI 10.1109/VTCF.2006.15; Zhang ZY, 2009, INT J COMMUN SYST, V22, P375, DOI 10.1002/dac.965	22	14	14	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1074-5351	1099-1131		INT J COMMUN SYST	Int. J. Commun. Syst.	NOV	2014	27	11					3147	3157		10.1002/dac.2531		11	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AU0II	WOS:000345306300042		
J	Ruan, JH; Wang, XP; Shi, Y				Ruan, Junhu; Wang, Xuping; Shi, Yan			A Two-Stage Approach for Medical Supplies Intermodal Transportation in Large-Scale Disaster Responses	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						large-scale disasters; medical supplies; intermodal transportation	EMERGENCY RESPONSE; RELIEF OPERATIONS; LOGISTICS; MODEL; ALLOCATION; LOCATION	We present a two-stage approach for the "helicopters and vehicles" intermodal transportation of medical supplies in large-scale disaster responses. In the first stage, a fuzzy-based method and its heuristic algorithm are developed to select the locations of temporary distribution centers (TDCs) and assign medial aid points (MAPs) to each TDC. In the second stage, an integer-programming model is developed to determine the delivery routes. Numerical experiments verified the effectiveness of the approach, and observed several findings: (i) More TDCs often increase the efficiency and utility of medical supplies; (ii) It is not definitely true that vehicles should load more and more medical supplies in emergency responses; (iii) The more contrasting the traveling speeds of helicopters and vehicles are, the more advantageous the intermodal transportation is.	[Ruan, Junhu; Wang, Xuping] Dalian Univ Technol, Inst Syst Engn, Dalian 116024, Peoples R China; [Ruan, Junhu] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA 5005, Australia; [Wang, Xuping] Dalian Univ Technol, Sch Business, Panjin 124221, Peoples R China; [Shi, Yan] Tokai Univ, Gen Educ Ctr, Kumamoto 8628652, Japan	Wang, XP (reprint author), Dalian Univ Technol, Inst Syst Engn, Dalian 116024, Peoples R China.	junhu.ruan@adelaide.edu.au; wxp@dlut.edu.cn; yshi@ktmail.tokai-u.jp			National Natural Science Foundation of China [71171029, 71471025, 71301020]; China Scholarship Council	We gratefully acknowledge the referees for their constructive comments, which greatly improved the quality of the manuscript. This work is partially supported by National Natural Science Foundation of China (No. 71171029, 71471025, 71301020), and the China Scholarship Council.	Abounacer R, 2014, COMPUT OPER RES, V41, P83, DOI 10.1016/j.cor.2013.08.001; Najafi M, 2013, TRANSPORT RES E-LOG, V49, P217, DOI 10.1016/j.tre.2012.09.001; Sheu JB, 2010, TRANSPORT RES E-LOG, V46, P1, DOI 10.1016/j.tre.2009.07.005; Galindo G, 2013, EUR J OPER RES, V230, P201, DOI 10.1016/j.ejor.2013.01.039; An S, 2013, TRANSPORT RES B-METH, V54, P1, DOI 10.1016/j.trb.2013.03.002; Ozdamar L, 2012, TRANSPORT RES E-LOG, V48, P591, DOI 10.1016/j.tre.2011.11.003; Jia HZ, 2007, COMPUT IND ENG, V52, P257, DOI 10.1016/j.cie.2006.12.007; Sheu JB, 2007, TRANSPORT RES E-LOG, V43, P687, DOI 10.1016/j.tre.2006.04.004; Mete HO, 2010, INT J PROD ECON, V126, P76, DOI 10.1016/j.ijpe.2009.10.004; Simpson NC, 2009, J OPER RES SOC, V60, pS126, DOI 10.1057/jors.2009.3; Barbarosoglu G, 2004, J OPER RES SOC, V55, P43, DOI 10.1057/palgrave.jors.2601652; Barbarosoglu G, 2002, EUR J OPER RES, V140, P118, DOI 10.1016/S0377-2217(01)00222-3; Caunhye A. M., 2012, SOCIOECONOMIC PLANNI, V46, P4, DOI DOI 10.1016/J.SEPS.2011.04.004; Fakhrzad MB, 2009, EXPERT SYST APPL, V36, P10180, DOI 10.1016/j.eswa.2008.12.013; Haghani A, 1996, TRANSPORT RES A-POL, V30, P231, DOI 10.1016/0965-8564(95)00020-8; Hestenes M. R., 1969, Journal of Optimization Theory and Applications, V4, DOI 10.1007/BF00927673; Hu ZH, 2011, EXPERT SYST APPL, V38, P2632, DOI 10.1016/j.eswa.2010.08.053; Huang M, 2012, TRANSPORT RES E-LOG, V48, P2, DOI 10.1016/j.tre.2011.05.004; Kovacs G., 2007, INT J PHYS DISTRIB, V37, P99, DOI DOI 10.1108/09600030710734820; Najafi M, 2014, OR SPECTRUM, V36, P323, DOI 10.1007/s00291-012-0317-0; Ozdamar L, 2004, ANN OPERATION RES, V129, P218; RUAN J, 2013, INT J INNOV COMPUT I, V9, P3293; Wang D, 2014, SAFETY SCI, V70, P9, DOI [10.1016/j.ssci.2014.05.0050925-75351, 10.1016/j.ssci.2014.05.005]; Wang XP, 2012, INT J PROD ECON, V140, P508, DOI 10.1016/j.ijpe.2012.07.001; Yarmand H, 2014, EUR J OPER RES, V233, P208, DOI 10.1016/j.ejor.2013.08.027	25	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2014	11	11					11081	11109		10.3390/ijerph111111081		29	Environmental Sciences	Environmental Sciences & Ecology	AU3RT	WOS:000345532000004		
J	Bekki, K; Uchiyama, S; Ohta, K; Inaba, Y; Nakagome, H; Kunugita, N				Bekki, Kanae; Uchiyama, Shigehisa; Ohta, Kazushi; Inaba, Yohei; Nakagome, Hideki; Kunugita, Naoki			Carbonyl Compounds Generated from Electronic Cigarettes	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Review						electronic cigarette; e-cigarette aerosol; carbonyl compounds	NICOTINE DELIVERY-SYSTEMS; 2,4-DINITROPHENYLHYDRAZINE; HYDROQUINONE; INDOOR; SMOKE; RISE	Electronic cigarettes (e-cigarettes) are advertised as being safer than tobacco cigarettes products as the chemical compounds inhaled from e-cigarettes are believed to be fewer and less toxic than those from tobacco cigarettes. Therefore, continuous careful monitoring and risk management of e-cigarettes should be implemented, with the aim of protecting and promoting public health worldwide. Moreover, basic scientific data are required for the regulation of e-cigarette. To date, there have been reports of many hazardous chemical compounds generated from e-cigarettes, particularly carbonyl compounds such as formaldehyde, acetaldehyde, acrolein, and glyoxal, which are often found in e-cigarette aerosols. These carbonyl compounds are incidentally generated by the oxidation of e-liquid (liquid in e-cigarette; glycerol and glycols) when the liquid comes in contact with the heated nichrome wire. The compositions and concentrations of these compounds vary depending on the type of e-liquid and the battery voltage. In some cases, extremely high concentrations of these carbonyl compounds are generated, and may contribute to various health effects. Suppliers, risk management organizations, and users of e-cigarettes should be aware of this phenomenon.	[Bekki, Kanae; Uchiyama, Shigehisa; Inaba, Yohei; Kunugita, Naoki] Natl Inst Publ Hlth, Dept Environm Hlth, Wako, Saitama 3510197, Japan; [Ohta, Kazushi; Nakagome, Hideki] Chiba Univ, Grad Sch Engn, Inage Ku, Chiba 2638522, Japan	Uchiyama, S (reprint author), Natl Inst Publ Hlth, Dept Environm Hlth, 2-3-6 Minami, Wako, Saitama 3510197, Japan.	bekki.kanae@niph.go.jp; uchiyama@niph.go.jp; uchiyama.s@chiba-u.jp; yohei_inaba@niph.go.jp; nakagome@tu.chiba-u.ac.jp; kunugita@niph.go.jp		Kunugita, Naoki/0000-0002-6516-8379	JSPS KAKENHI [25560361, 23650425]	This research was partially supported by JSPS KAKENHI Grant Numbers 25560361 and 23650425.	Leaderer BP, 1999, ENVIRON HEALTH PERSP, V107, P223; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Uchiyama S, 2013, ANAL SCI, V29, P1219; Farsalinos KE, 2014, INT J ENV RES PUB HE, V11, P4356, DOI 10.3390/ijerph110404356; Benowitz NL, 2013, JAMA-J AM MED ASSOC, V310, P685, DOI 10.1001/jama.2013.109501; Counts ME, 2005, REGUL TOXICOL PHARM, V41, P185, DOI 10.1016/j.yrtph.2004.12.002; Cobb NK, 2010, AM J PUBLIC HEALTH, V100, P2340, DOI 10.2105/AJPH.2010.199281; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Chen IL, 2013, NICOTINE TOB RES, V15, P615, DOI 10.1093/ntr/nts145; McAuley TR, 2012, INHAL TOXICOL, V24, P850, DOI 10.3109/08958378.2012.724728; Thota D, 2014, J EMERG MED, V47, P15, DOI 10.1016/j.jemermed.2013.09.034; Uchiyama S, 2010, J CHROMATOGR A, V1217, P4383, DOI 10.1016/j.chroma.2010.04.056; Dawkins L, 2013, ADDICTION, V108, P1115, DOI 10.1111/add.12150; Hua M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2324; Schripp T, 2013, INDOOR AIR, V23, P25, DOI 10.1111/j.1600-0668.2012.00792.x; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Polosa R, 2014, INT J ENV RES PUB HE, V11, P4965, DOI 10.3390/ijerph110504965; [Anonymous], 1999, Health Canada Official Method T-115, Patent No. 3200819; Zeller M, 2009, TOB CONTROL, V18, P324, DOI 10.1136/tc.2008.027318; Ohta K, 2011, BUNSEKI KAGAKU, V60, P791; Cummings KM, 2014, J THORAC ONCOL, V9, P438, DOI 10.1097/JTO.0000000000000129; Farsalinos Konstantinos E, 2014, Ther Adv Drug Saf, V5, P67, DOI 10.1177/2042098614524430; German Cancer Research Center, EL CIG OV; Health Canada, 1999, T115 HLTH CAN; International Agency for Research on Cancer (IARC), 1999, MON EV CARC RISK CHE, V71, P319; Kim AE, 2014, AM J PREV MED, V46, P409, DOI 10.1016/j.amepre.2013.11.003; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Laugesen M., 2008, SAFETY REPORT RUYAN; Modi N., CLEARING SMOKE E CIG; Monroy AE, 2012, CLIN GERIATR MED, V20, P28; Palazzolo D.L., 2013, FRONT PUBLIC HLTH, V1, DOI [10.3389/fpubh.2013.00056, DOI 10.3389/FPUBH.2013.00056]; Paradise J., 2014, AM J PUBLIC HEALTH, V104, P17; Ruiz CAJ, 2014, ARCH BRONCONEUMOL, V50, P362, DOI 10.1016/j.arbres.2014.02.006; US Food and Drug Administration, FDA WARNS HLTH RISKS; World Health Organization, 2009, WHO TECHN REPORT SER, V955, P1	35	9	9	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2014	11	11					11192	11200		10.3390/ijerph111111192		9	Environmental Sciences	Environmental Sciences & Ecology	AU3RT	WOS:000345532000011		
J	Win-Shwe, TT; Fujitani, Y; Kyi-Tha-Thu, C; Furuyama, A; Michikawa, T; Tsukahara, S; Nitta, H; Hirano, S				Win-Shwe, Tin-Tin; Fujitani, Yuji; Kyi-Tha-Thu, Chaw; Furuyama, Akiko; Michikawa, Takehiro; Tsukahara, Shinji; Nitta, Hiroshi; Hirano, Seishiro			Effects of Diesel Engine Exhaust Origin Secondary Organic Aerosols on Novel Object Recognition Ability and Maternal Behavior in BALB/C Mice	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						diesel exhaust; secondary organic aerosol; brain; memory function; maternal behavior; mice	PARTICULATE AIR-POLLUTION; ESTROGEN-RECEPTOR-ALPHA; OXIDATIVE DNA-DAMAGE; MEDIAL PREOPTIC AREA; GENE-EXPRESSION; FEMALE MICE; RESPIRATORY HEALTH; YOUNG-ADULTS; URBAN AIR; EXPOSURE	Epidemiological studies have reported an increased risk of cardiopulmonary and lung cancer mortality associated with increasing exposure to air pollution. Ambient particulate matter consists of primary particles emitted directly from diesel engine vehicles and secondary organic aerosols (SOAs) are formed by oxidative reaction of the ultrafine particle components of diesel exhaust (DE) in the atmosphere. However, little is known about the relationship between exposure to SOA and central nervous system functions. Recently, we have reported that an acute single intranasal instillation of SOA may induce inflammatory response in lung, but not in brain of adult mice. To clarify the whole body exposure effects of SOA on central nervous system functions, we first created inhalation chambers for diesel exhaust origin secondary organic aerosols (DE-SOAs) produced by oxidation of diesel exhaust particles caused by adding ozone. Male BALB/c mice were exposed to clean air (control), DE and DE-SOA in inhalation chambers for one or three months (5 h/day, 5 days/week) and were examined for memory function using a novel object recognition test and for memory function-related gene expressions in the hippocampus by real-time RT-PCR. Moreover, female mice exposed to DE-SOA for one month were mated and maternal behaviors and the related gene expressions in the hypothalamus examined. Novel object recognition ability and N-methyl-D-aspartate (NMDA) receptor expression in the hippocampus were affected in male mice exposed to DE-SOA. Furthermore, a tendency to decrease maternal performance and significantly decreased expression levels of estrogen receptor (ER)-alpha, and oxytocin receptor were found in DE-SOA exposed dams compared with the control. This is the first study of this type and our results suggest that the constituents of DE-SOA may be associated with memory function and maternal performance based on the impaired gene expressions in the hippocampus and hypothalamus, respectively.	[Win-Shwe, Tin-Tin; Michikawa, Takehiro; Nitta, Hiroshi] Natl Inst Environm Studies, Ctr Environm Hlth Sci, Tsukuba, Ibaraki 3058506, Japan; [Fujitani, Yuji; Furuyama, Akiko; Hirano, Seishiro] Natl Inst Environm Studies, Ctr Environm Risk Res, Tsukuba, Ibaraki 3058506, Japan; [Kyi-Tha-Thu, Chaw; Tsukahara, Shinji] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Sakura Ku, Saitama 3388570, Japan	Win-Shwe, TT (reprint author), Natl Inst Environm Studies, Ctr Environm Hlth Sci, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	tin.tin.win.shwe@nies.go.jp; fujitani.yuji@nies.go.jp; chawchaw25@gmail.com; kawagoe@nies.go.jp; tmichikawa@nies.go.jp; stsuka@mail.saitama-u.ac.jp; nitta@nies.go.jp; seishiro@nies.go.jp			Ministry of Environment, Japan [1313BY016]; National Institute for Environmental Studies (NIES), Tsukuba, Japan [1013BD001, 1115AA082]; JSPS KAKENHI [25340066]	This research was supported by a Research fund from The Ministry of Environment, Japan (1313BY016) to Seishiro Hirano and by grants from National Institute for Environmental Studies (NIES), Tsukuba, Japan (1013BD001, 1115AA082) and Grant-in-Aid for Scientific Research (C) JSPS KAKENHI (25340066) to Tin-Tin Win-Shwe. The authors thank Hideko Sone and Yoshika Kurokawa from NIES for supporting maternal behavior assessment.	Bos I, 2012, INHAL TOXICOL, V24, P676, DOI 10.3109/08958378.2012.714004; Wang ZS, 2011, NEUROPSYCHOPHARMACOL, V36, P772, DOI 10.1038/npp.2010.211; Win-Shwe TT, 2008, NEUROTOXICOLOGY, V29, P940, DOI 10.1016/j.neuro.2008.09.007; Chen JC, 2009, NEUROTOXICOLOGY, V30, P231, DOI 10.1016/j.neuro.2008.12.011; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Win-Shwe TT, 2013, J TOXICOL SCI, V38, P71; Win-Shwe TT, 2011, INT J MOL SCI, V12, P6267, DOI 10.3390/ijms12096267; Lim HJ, 2002, ENVIRON SCI TECHNOL, V36, P4489, DOI 10.1021/es0206487; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Ribeiro AC, 2012, P NATL ACAD SCI USA, V109, P16324, DOI 10.1073/pnas.1214094109; Fujitani Y, 2009, INHAL TOXICOL, V21, P200, DOI 10.1080/08958370802339491 ; NOIROT E, 1969, ANIM BEHAV, V17, P547, DOI 10.1016/0003-3472(69)90162-6; Pilger A, 2006, INT ARCH OCC ENV HEA, V80, P1, DOI 10.1007/s00420-006-0106-7; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Penttinen P, 2001, EUR RESPIR J, V17, P428, DOI 10.1183/09031936.01.17304280; Virtanen A, 2010, NATURE, V467, P824, DOI 10.1038/nature09455; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5070, DOI 10.1210/en.139.12.5070; Diaz EA, 2011, INHAL TOXICOL, V23, P42, DOI 10.3109/08958378.2010.578169; Peters A, 1997, LANCET, V349, P1582, DOI 10.1016/S0140-6736(97)01211-7; Wang H, 2012, ENVIRON SCI TECHNOL, V46, P704, DOI 10.1021/es203066k; Pena CJ, 2013, ENDOCRINOLOGY, V154, P4340, DOI 10.1210/en.2013-1595; Harrison RM, 2000, SCI TOTAL ENVIRON, V249, P85, DOI 10.1016/S0048-9697(99)00513-6; LOFT S, 1993, J TOXICOL ENV HEALTH, V40, P391; Youssefi S, 2012, INDOOR AIR, V22, P415, DOI 10.1111/j.1600-0668.2012.00776.x; Delfino RJ, 2008, ENVIRON HEALTH PERSP, V116, P898, DOI 10.1289/ehp.11189; Clifford A, 2012, NEUROTOXICOL TERATOL, V34, P560, DOI 10.1016/j.ntt.2012.09.004; Ranft U, 2009, ENVIRON RES, V109, P1004, DOI 10.1016/j.envres.2009.08.003; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Kilburn KH, 2000, ARCH ENVIRON HEALTH, V55, P11; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Castro LM, 1999, ATMOS ENVIRON, V33, P2771, DOI 10.1016/S1352-2310(98)00331-8; Yu S, 2007, ENVIRON SCI TECHNOL, V41, P4690, DOI 10.1021/es061535g; Win-Shwe TT, 2012, NANOTOXICOLOGY, V6, P543, DOI 10.3109/17435390.2011.590904; Weuve J, 2012, ARCH INTERN MED, V172, P219, DOI 10.1001/archinternmed.2011.683; Stern JM, 1997, DEV PSYCHOBIOL, V31, P19, DOI 10.1002/(SICI)1098-2302(199707)31:1<19::AID-DEV3>3.0.CO;2-X; Win-Shwe TT, 2009, INHAL TOXICOL, V21, P828, DOI 10.1080/08958370802538068; Win-Shwe TT, 2012, TOXICOL APPL PHARM, V262, P355, DOI 10.1016/j.taap.2012.05.015; Calderon-Garciduenas L, 2011, BRAIN COGNITION, V77, P345, DOI 10.1016/j.bandc.2011.09.006; Calderon-Garciduenas L, 2004, TOXICOL PATHOL, V32, P650, DOI 10.1080/01926230490520232; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Calderon-Garciduenas L, 2008, BRAIN COGNITION, V68, P117, DOI 10.1016/j.bandc.2008.04.008; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Costa LG, 2014, BIOMED RES INT, DOI 10.1155/2014/736385; Cruts B, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-4; DOCKERY DW, 1993, ENVIRON HEALTH PERSP, V101, P187, DOI 10.2307/3431676; FAHRBACH SE, 1985, NEUROENDOCRINOLOGY, V40, P526, DOI 10.1159/000124125; Kalinichev M, 2000, BEHAV NEUROSCI, V114, P196, DOI 10.1037/0735-7044.114.1.196; Lemos M, 2011, INHAL TOXICOL, V23, P75, DOI 10.3109/08958378.2011.601433; McDonald JD, 2012, INHAL TOXICOL, V24, P689, DOI 10.3109/08958378.2012.712164; NOIROT E, 1969, ANIM BEHAV, V17, P542, DOI 10.1016/0003-3472(69)90161-4; NUMAN M, 1986, ANN NY ACAD SCI, V474, P226, DOI 10.1111/j.1749-6632.1986.tb28014.x; Numan Michael, 2006, Behav Cogn Neurosci Rev, V5, P163, DOI 10.1177/1534582306288790; Suzuki T, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-7; Tsukue N, 2009, ARCH TOXICOL, V83, P985, DOI 10.1007/s00204-009-0459-2; von Stackelberg K, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-19; Young LJ, 1998, NEUROREPORT, V9, P933, DOI 10.1097/00001756-199803300-00031	57	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2014	11	11					11286	11307		10.3390/ijerph111111286		22	Environmental Sciences	Environmental Sciences & Ecology	AU3RT	WOS:000345532000016		
J	Mao, C; Yamada, Y; Matsuoka, T				Mao, Chanrithyrouth; Yamada, Yasuhiro; Matsuoka, Toshifumi			A preliminary assessment of geological CO2 storage in Cambodia	INTERNATIONAL JOURNAL OF GREENHOUSE GAS CONTROL			English	Article						CO2 storage; Khmer Basin; Saline aquifer; Hydrodynamic trap; Matched storage capacity; Cambodia	GAS BREAKTHROUGH EXPERIMENTS; MESOZOIC KHORAT GROUP; CARBON-DIOXIDE; CAPACITY ESTIMATION; AQUIFER DISPOSAL; CLIMATE-CHANGE; NE THAILAND; INDO-CHINA; SEQUESTRATION; RESERVOIRS	This study screens and rank Cambodian sedimentary basins in terms of their containment, capacity, and feasibility for the geological storage of CO2. The results of the screening and ranking procedure indicate that the Khmer Basin is the most suitable basin, followed by the Kampong Saom and Tonle Sap basins. A quantitative volumetric assessment-based evaluation of CO2 storage capacity is performed on these three suitable basins. The evaluation yields a range in the national CO2 storage capacity of 90 Mt (in structural traps) to 45 Gt (in hydrodynamic traps), representing low- and high-case estimates, respectively. The saline aquifers associated with this storage capacity should be considered prospective storage options as hydrodynamic traps because of containment and capacity issues associated with the structural traps. Eight major point sources of CO2 are identified that have a combined output (estimated for 2008-2024) of 43.1 Mt annually and 82 billion m(3) in place, and the potentially prospective matched storage capacity is assumed. Overall, a combination of the initial suitabilities of the basins and estimates of prospective matched storage capacity shows that the Khmer, Kampong Saom, and Tonle Sap basins may provide a solution to the problem of reducing future atmospheric emissions. The present results should assist both exploration geologists and experts in carbon capture and storage to gain a better understanding of the CO2 storage resources of Cambodia. However, the results should be regarded as preliminary because of the limited available data on which the assessments were based; future geological and geophysical data should improve the reliability of the estimates of carbon storage capacity reported here. (C) 2014 Elsevier Ltd. All rights reserved.	[Mao, Chanrithyrouth; Yamada, Yasuhiro; Matsuoka, Toshifumi] Kyoto Univ, Dept Urban Management, Nishikyo Ku, Kyoto 6158540, Japan; [Yamada, Yasuhiro] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokohama, Kanagawa 2360001, Japan	Mao, C (reprint author), Kyoto Univ, Dept Urban Management, Nishikyo Ku, Kyoto 6158540, Japan.	mao.chanrithyrouth.36a@st.kyoto-u.ac.jp; yamada.yasuhiro.2s@kyoto-u.ac.jp; matsuoka.toshifumi.7x@kyoto-u.ac.jp	Yamada, Yasuhiro/D-7890-2011				*2B1ST CONS, 2013, KBR PROVIDE CRACKER; El Tabakh M, 1999, SEDIMENT GEOL, V123, P31, DOI 10.1016/S0037-0738(98)00083-9; HOLT T, 1995, ENERG CONVERS MANAGE, V36, P535, DOI 10.1016/0196-8904(95)00061-H; Bachu S, 2003, J CAN PETROL TECHNOL, V42, P51; Hildenbrand A, 2002, GEOFLUIDS, V2, P3, DOI 10.1046/j.1468-8123.2002.00031.x; Bachu S, 2000, ENERG CONVERS MANAGE, V41, P953, DOI 10.1016/S0196-8904(99)00149-1; Morley CK, 2002, TECTONOPHYSICS, V347, P189, DOI 10.1016/S0040-1951(02)00061-6; Hildenbrand A, 2004, GEOFLUIDS, V4, P61, DOI 10.1111/j.1468-8123.2004.00073.x; Holler S, 2011, ENRGY PROCED, V4, P4897, DOI 10.1016/j.egypro.2011.02.458; Bachu S, 2003, ENVIRON GEOL, V44, P277, DOI 10.1007/s00254-003-0762-9; HOLLOWAY S, 1993, ENERG CONVERS MANAGE, V34, P925, DOI 10.1016/0196-8904(93)90038-C; VANDERMEER LGH, 1992, ENERG CONVERS MANAGE, V33, P611, DOI 10.1016/0196-8904(92)90063-3; Lepvrier C, 2004, TECTONOPHYSICS, V393, P87, DOI 10.1016/j.tecto.2004.07.030; Wilson EJ, 2003, ENVIRON SCI TECHNOL, V37, P3476, DOI 10.1021/es021038+; KOIDE H, 1992, ENERG CONVERS MANAGE, V33, P619, DOI 10.1016/0196-8904(92)90064-4; Bachu S, 2007, INT J GREENH GAS CON, V1, P430, DOI 10.1016/S1750-5836(07)00086-2; Ridd MF, 2011, P GEOLOGIST ASSOC, V122, P143, DOI 10.1016/j.pgeola.2010.08.008; Bradshaw J, 2007, INT J GREENH GAS CON, V1, P62, DOI 10.1016/S1750-5836(07)00027-8; Bradshaw J, 2004, ENERGY, V29, P1623, DOI 10.1016/j.energy.2004.03.064; Bachu S, 2005, P 7 INT C GREENH GAS, V1, P361; BACHU S, 1994, ENERG CONVERS MANAGE, V35, P269, DOI 10.1016/0196-8904(94)90060-4; Canham AC, 1996, J PETROL GEOL, V19, P321, DOI 10.1111/j.1747-5457.1996.tb00437.x; *CDRI, 2014, DEV FERT IND CAM STR; CSLF (Carbon Sequestration Leadership Forum), 2008, CSLFT200804; *EN, 2014, CAMB EN SIT; Ennis-King J., 2002, SPE AS PAC OIL GAS C; Fyhn MBW, 2010, J GEOL SOC LONDON, V167, P281, DOI 10.1144/0016-76492009-039; GIARDINI D, 1999, GLOBAL SEISMIC HAZAR; GIBSONPOOLE CM, 2008, 3 E AYSTR BAS S EABS, P455; Hall R., 1996, GEOL SOC LOND SPEC P, V106, P153, DOI DOI 10.1144/GSL.SP.1996.106.01.11; HASZELDINE RS, 2006, GLOBAL CHANGE, V11, P377; HAYASHI M, 1988, J PETROL GEOL, V11, P219, DOI 10.1111/j.1747-5457.1988.tb00815.x; HEINE C, 2007, THESIS U SYDNEY AUST; HENDRIKS CA, 2004, GLOBAL CARBON DIOXID, P71; IEA Green House Gas R&D Programme (IEA GHG), 2009, DEV STOR COEFF CARB; *IEEJ, 2011, COUNTR REP GROUP TRA; *IPCC, 2005, SPEC REP CARB DIOX C, P195; Koukouzas N, 2009, INT J GREENH GAS CON, V3, P502, DOI 10.1016/j.ijggc.2008.10.005; Meesook A, 2011, GEOLOGY OF THAILAND, P169; Meesook A, 2011, GEOLOGY OF THAILAND, P151; *MIT, 2008, CO2 THERM PROP CALC; *MME, 2009, 8 M FOC GROUP FG 8; MORTONTHOMPSON D, 1992, AAPG METHODS EXPLORA, V10; OKUI A, 1997, P PETR SYST SE AS AU, P365; Racey A, 2011, GEOLOGY OF THAILAND, P351; Racey A, 1996, J PETROL GEOL, V19, P5, DOI 10.1111/j.1747-5457.1996.tb00511.x; Ramirez A, 2010, INT J GREENH GAS CON, V4, P367, DOI 10.1016/j.ijggc.2009.10.015; Ridd MF, 2011, GEOLOGY OF THAILAND, P1; Satter A, 2008, PRACTICAL ENHANCED R; *US DOE, 2012, CARB SEQ ATL US CAN; VANDERMEER LGH, 1993, ENERG CONVERS MANAGE, V34, P959, DOI 10.1016/0196-8904(93)90042-9; VYSOTSKY VI, 1994, J PETROL GEOL, V17, P195, DOI 10.1111/j.1747-5457.1994.tb00126.x; Watcharanantakul R, 2000, MAR PETROL GEOL, V17, P937, DOI 10.1016/S0264-8172(00)00034-9; Workman D.R., 1977, GEOLOGY LAOS CAMBODI, V50; 2013, THAILAND CAMBODIA RE	55	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1750-5836	1878-0148		INT J GREENH GAS CON	Int. J. Greenh. Gas Control	NOV	2014	30						19	33		10.1016/j.ijggc.2014.08.016		15	Energy & Fuels; Engineering, Environmental	Energy & Fuels; Engineering	AU2TP	WOS:000345470700004		
J	Hasegawa, M; Nomura, T; Haga, H; Dlouhy, I; Fukutomi, H				Hasegawa, Makoto; Nomura, Takuya; Haga, Hideki; Dlouhy, Ivo; Fukutomi, Hiroshi			Microstructural control of Ti-46Al-7Nb-0.7Cr-0.2Ni-0.1Si alloy by heat treatment	INTERNATIONAL JOURNAL OF MATERIALS RESEARCH			English	Article						Titanium aluminides; Phase transformation; Microstructure	TIAL-BASED ALLOYS; GAMMA-TITANIUM ALUMINIDES; FATIGUE-CRACK GROWTH; HIGH-TEMPERATURE; CREEP-BEHAVIOR; PHASE-EQUILIBRIA; PST CRYSTALS; LAMELLAR MICROSTRUCTURES; DEFORMATION-BEHAVIOR; FRACTURE-RESISTANCE	The effects of holding temperature, time and cooling rate on the microstructure of Ti-46Al-7Nb-0.7Cr-0.2Ni-0.1Si (at.%) alloys are studied. Three kinds of segregations are found in the as-cast material. In back scattered electron images these segregations are observed as dark regions formed by the solidification process, bright regions with irregular shaped blocks and imaged regions of lighter contrast formed by the cooling process from beta phase to alpha phase and from alpha phase to (beta + gamma) two phase or (alpha + beta + gamma) three phase, respectively. Addition of small amounts of Cr, Ni and Si to the Ti-45Al-7Nb alloy shifts the (beta + gamma) two phase state and (alpha + gamma + beta) three phase state to a lower Nb concentration range. While cooling from the a single phase state to the (beta + gamma) two phase or (alpha + beta + gamma) three phase states, sequential type phase transformation occurs. The amounts of Cr, Ni and Si are too small to induce the pearlitic mode of transformation. Therefore, the sequential mode of the ternary alloy containing Nb occurs. The microstructures change depending on the cooling rate from alpha single phase region. Massive transformation occurs in the range of 300 K s(-1) to 50 K s(-1). However, the alpha phase is partially retained at the cooling rate of 300 K s(-1). A fully lamellar structure appears at cooling rates lower than 10 K s(-1).	[Hasegawa, Makoto; Nomura, Takuya; Haga, Hideki; Fukutomi, Hiroshi] Yokohama Natl Univ, Fac Engn, Div Mat Sci & Chem Engn, Yokohama, Kanagawa 240, Japan; [Dlouhy, Ivo] Inst Phys Mat, Brno, Czech Republic; [Dlouhy, Ivo] Brno Univ Technol, Fac Mech Engn, Inst Mat Sci & Engn, CS-61090 Brno, Czech Republic	Hasegawa, M (reprint author), 79-5 Tokiwadai,Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan.	hasegawa@ynu.ac.jp	Dlouhy, Ivo/C-3534-2013	Dlouhy, Ivo/0000-0002-8053-8489	JSPS; MEYS; Czech Science Foundation [13-35890S]	The authors would like to express their thanks to Dr. S. Takagi of Kanagawa Industrial Technology Center for his help in using the high frequency induction heating furnace. This research was financially supported by the "Bilateral Joint Research Program" and "Strategic Young Researcher Oversea Visits Program for Accelerating Brain Circulation" from JSPS and MEYS. The authors greatly appreciate the programs. Financial support from the project of Czech Science Foundation under number 13-35890S is also acknowledged.	Mitoraj M, 2013, INTERMETALLICS, V34, P112, DOI 10.1016/j.intermet.2012.10.014; CHAN KS, 1995, ACTA METALL MATER, V43, P439, DOI 10.1016/0956-7151(94)00278-P; NAKANO T, 1995, MAT SCI ENG A-STRUCT, V194, P43, DOI 10.1016/0921-5093(94)09658-9; Huang ZW, 2005, SCRIPTA MATER, V52, P1021, DOI 10.1016/j.scriptamat.2005.01.024; Clemens H, 2008, INTERMETALLICS, V16, P827, DOI 10.1016/j.intermet.2008.03.008; Witusiewicz VT, 2009, J ALLOY COMPD, V472, P133, DOI 10.1016/j.jallcom.2008.05.008; Hellwig A, 1998, INTERMETALLICS, V6, P79, DOI 10.1016/S0966-9795(97)00043-5; Gnanamoorthy R, 1995, MAT SCI ENG A-STRUCT, V203, P348, DOI 10.1016/0921-5093(95)09831-3; Park KS, 2002, J JPN I MET, V66, P425; RAO KTV, 1994, ACTA METALL MATER, V42, P893; ENOKI M, 1994, J JPN I MET, V58, P418; Sankaran A, 2009, INTERMETALLICS, V17, P1007, DOI 10.1016/j.intermet.2009.05.001; Stark A, 2006, ADV ENG MATER, V8, P1101, DOI 10.1002/adem.200600127; Tetsui T, 2003, INTERMETALLICS, V11, P299, DOI 10.1016/S0966-9795(02)00245-5; Takeyama M, 2005, INTERMETALLICS, V13, P993, DOI 10.1016/j.intermet.2004.12.014; Kainuma R, 2000, INTERMETALLICS, V8, P855, DOI 10.1016/S0966-9795(00)00015-7; Campbell JP, 1999, METALL MATER TRANS A, V30, P563, DOI 10.1007/s11661-999-0048-2; Witusiewicz VT, 2011, INTERMETALLICS, V19, P234, DOI 10.1016/j.intermet.2010.10.002; Hu D, 2007, INTERMETALLICS, V15, P327, DOI 10.1016/j.intermet.2006.07.007; Imayev RM, 2007, INTERMETALLICS, V15, P451, DOI 10.1016/j.intermet.2006.05.003; Wang JN, 2000, INTERMETALLICS, V8, P545, DOI 10.1016/S0966-9795(99)00153-3; ENOKI M, 1995, MAT SCI ENG A-STRUCT, V192, P420, DOI 10.1016/0921-5093(94)03244-0; Kishida K, 1998, INTERMETALLICS, V6, P679, DOI 10.1016/S0966-9795(98)00055-7; Chen GL, 2007, INTERMETALLICS, V15, P625, DOI [10.1016/j.intermet.2006.10.003, 10.1016/j.intermet2006.10.003]; Hasegawa M, 2010, J JPN I MET, V74, P481, DOI 10.2320/jinstmet.74.481; Vojtech D, 2011, INTERMETALLICS, V19, P493, DOI 10.1016/j.intermet.2010.11.025; Clemens H, 2006, INTERMETALLICS, V14, P1380, DOI 10.1016/j.intermet.2005.11.015; Imayev RM, 2005, METALL MATER TRANS A, V36A, P859, DOI 10.1007/s11661-005-0199-8; Maruyama K, 2005, INTERMETALLICS, V13, P1116, DOI 10.1016/j.intermet.2005.02.013; Werwer M, 2007, ENG FRACT MECH, V74, P2615, DOI 10.1016/j.engfracmech.2006.09.022; Chatterjee A, 2002, MAT SCI ENG A-STRUCT, V329, P840, DOI 10.1016/S0921-5093(01)01639-2; Nomoto A, 1997, J JPN I MET, V61, P378; Saage H, 2009, INTERMETALLICS, V17, P32, DOI 10.1016/j.intermet.2008.09.006; Yoshihara M, 2005, INTERMETALLICS, V13, P952, DOI 10.1016/j.intermet.2004.12.007; Hasegawa M, 2010, J JPN I MET, V74, P475, DOI 10.2320/jinstmet.74.475; Tetsui T, 2002, SCRIPTA MATER, V47, P399, DOI 10.1016/S1359-6462(02)00158-6; Beddoes J, 1995, INT MATER REV, V40, P197; Bystrzanowski S, 2005, INTERMETALLICS, V13, P515, DOI 10.1016/j.intermet.2004.09.001; Crofts PD, 1996, SCRIPTA MATER, V35, P1391, DOI 10.1016/S1359-6462(96)00323-5; Dlouhy I., 2009, METALLOFIZ NOV TEKH+, V31, P1001; Dlouhy I, 2009, DAMAGE AND FRACTURE MECHANICS, P265, DOI 10.1007/978-90-481-2669-9_28; Fukutomi H., 2005, Journal of Japan Institute of Light Metals, V55, DOI 10.2464/jilm.55.343; Hasegawa M, 2009, MAT SCI ENG A-STRUCT, V508, P106, DOI 10.1016/j.msea.2008.12.027; Hu D, 2006, INTERMETALLICS, V14, P82, DOI 10.1016/j.intermet.2005.04.016; Kikuchi M., 1994, Japanese patent, Patent No. [JP6116691, 6116691]; Kim HY, 2002, MAT SCI ENG A-STRUCT, V329, P795, DOI 10.1016/S0921-5093(01)01636-7; KIM YW, 1994, JOM-J MIN MET MAT S, V46, P30; Kobayashi S., 2001, THESIS TOKYO I TECHN; Lapin J, 2011, INTERMETALLICS, V19, P121, DOI 10.1016/j.intermet.2010.09.016; Lin JP, 2007, INTERMETALLICS, V15, P668, DOI 10.1016/j.intermet.2006.10.029; Maruyama K, 1997, MAT SCI ENG A-STRUCT, V240, P419, DOI 10.1016/S0921-5093(97)00612-6; Petzow G., 1993, TERNARY ALLOYS COMPR; RAO KTV, 1995, MAT SCI ENG A-STRUCT, V192, P474; Schillinger W, 2006, INTERMETALLICS, V14, P336, DOI 10.1016/j.intermet.2005.07.002; Takeyama M, 1998, INTERMETALLICS, V6, P643, DOI 10.1016/S0966-9795(98)00049-1; Takeyama M., 1994, Japanese patent, Patent No. [JP6279964, 6279964]; Taniguchi S, 1996, INTERMETALLICS, V4, pS85, DOI 10.1016/0966-9795(96)00017-9; Wang P., 1992, Metallurgical Transactions A (Physical Metallurgy and Materials Science), V23A, DOI 10.1007/BF02801187	58	1	1	CARL HANSER VERLAG	MUNICH	KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY	1862-5282	2195-8556		INT J MATER RES	Int. J. Mater. Res.	NOV	2014	105	11					1075	1083		10.3139/146.111115		9	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	AU3HK	WOS:000345502800004		
J	Nakamura, Y				Nakamura, Yasuhiko			Capacity choice in a duopoly with a consumer-friendly firm and an absolute profit-maximizing firm	INTERNATIONAL REVIEW OF ECONOMICS & FINANCE			English	Article						Capacity choice; Consumer-friendly firm; Quantity competition; Price competition; Extent of the importance of consumer surplus	HOLDING EXCESS CAPACITY; LABOR-MANAGED INDUSTRY; MIXED DUOPOLY; DETER ENTRY; INCENTIVES; COMPETITION	This paper studies a capacity choice problem in a duopoly with substitutable goods that is composed of one consumer-friendly firm and one standard absolute profit-maximizing firm in the contexts of both quantity competition and price competition with substitutable goods. In this paper, we assume that the consumer-friendly firm maximizes the weighted sum of its absolute profit and consumer surplus. We show that in the quantity competition, for the consumer-friendly firm, under-capacity is chosen when the extent of the importance of consumer surplus to the consumer-friendly firm is high relative to the degree of product differentiation, whereas over-capacity is chosen otherwise. Moreover, we find that in the price competition, the consumer-friendly firm chooses over-capacity when the extent of importance of consumer surplus to the consumer-friendly firm is high relative to the degree of product differentiation, whereas it chooses under-capacity otherwise. Furthermore, regardless of the extent of the importance of consumer surplus to the consumer-friendly firm and the degree of product differentiation, it is shown that in the quantity competition, the absolute profit-maximizing firm chooses over-capacity, whereas in the price competition, it chooses under-capacity. (C) 2014 Elsevier Inc. All rights reserved.	[Nakamura, Yasuhiko] Nihon Univ, Coll Econ, Tokyo 1018360, Japan	Nakamura, Y (reprint author), Nihon Univ, Coll Econ, Chiyoda Ku, 1-3-2 Misaki Cho, Tokyo 1018360, Japan.	yasuhiko.r.nakamura@gmail.com					BRANDER JA, 1983, BELL J ECON, V14, P225, DOI 10.2307/3003549; SINGH N, 1984, RAND J ECON, V15, P546, DOI 10.2307/2555525; Lu YZ, 2009, AUST ECON PAP, V48, P138, DOI 10.1111/j.1467-8454.2009.00369.x; Wang LFS, 2014, INT REV ECON FINANC, V31, P138, DOI 10.1016/j.iref.2014.01.017; DIXIT A, 1980, ECON J, V90, P95, DOI 10.2307/2231658; Barcena-Ruiz JC, 2007, EC B, V12, P1; Becchetti L., 2006, WORKING PAPER 2006 5; FERSHTMAN C, 1987, AM ECON REV, V77, P927; Goering GE, 2008, ECON MODEL, V25, P575, DOI 10.1016/j.econmod.2007.10.001; Goering GE, 2008, ECON SYST, V32, P326, DOI 10.1016/j.ecosys.2008.06.002; Goering G.E., 2007, MANAGERIAL DECISION, V28, P83, DOI 10.1002/mde.1307; Haruna S, 1996, CAN J ECON, V29, P493, DOI 10.2307/136301; Horiba Y, 2000, JPN ECON REV, V51, P207, DOI 10.1111/1468-5876.00147; Kopel M, 2012, ECON MODEL, V29, P982, DOI 10.1016/j.econmod.2012.02.008; KPMG, 2013, INTERNATIONAL SURVEY; KPMG, 2008, INTERNATIONAL SURVEY; Lambertini L., 2010, WORKING PAPER NO 723; Lien D., 2002, INT J BUSINESS EC, V1, P193; Lu YZ, 2006, MANCH SCH, V74, P266, DOI 10.1111/j.1467-9957.2006.00492.x; Lu YZ, 2005, RES EC, V59, P365, DOI 10.1016/j.rie.2005.09.004; Mukherjee A., 2014, INTERNATIONAL REVIEW, V31, P138; Nakamura Y., 2013, THEORETICAL ECONOMIC, V3, P124; Nakamura Y., 2013, MODERN ECONOMY, V5, P418; Nakamura Y., 2013, MODERN ECONOMY, V4, P273; Nakamura Y., 2013, CAPACITY CHOICE IN A; NAKAMURA Y, 2013, THEORETICAL ECONOMIC, V3, P202; Nishimori A., 2004, EC B, V12, P1; Ogawa H, 2006, EC B, V12, P1; SKLIVAS SD, 1987, RAND J ECON, V18, P452, DOI 10.2307/2555609; STEWART G, 1991, OXFORD ECON PAP, V43, P570; Tomaru Y, 2009, EC B, V29, P1904; Tsoutsoura M., 2002, WORKING PAPER; VICKERS J, 1985, ECON J, V95, P138, DOI 10.2307/2232877; VIVES X., 1986, INT J IND ORGAN, V4, P217, DOI 10.1016/0167-7187(86)90032-9; ZHANG JS, 1993, CAN J ECON, V26, P222, DOI 10.2307/135855	35	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1059-0560	1873-8036		INT REV ECON FINANC	Int. Rev. Econ. Financ.	NOV	2014	34						105	117		10.1016/j.iref.2014.07.004		13	Business, Finance; Economics	Business & Economics	AU3CW	WOS:000345491300008		
J	Tanabe, R; Tanaka, T; Serizawa, Y; Li, H				Tanabe, Ryuya; Tanaka, Tatsuji; Serizawa, Yoshizumi; Li, Hua			Integrating voltage stability assessment and enhancement into wide-area situational awareness based on international standards	INTERNATIONAL TRANSACTIONS ON ELECTRICAL ENERGY SYSTEMS			English	Article						WASA; international standards; power system stability; VSA&E	LOAD	This paper presents a platform for integrating a voltage stability assessment and enhancement (VSA&E) application into wide-area situational awareness (WASA) based on international standards. VSA&E is a key tool for maintaining and enhancing voltage security of bulk power systems. As power systems become more complicated and the penetration of renewable energies increases, system operators require powerful tools to analyze voltage security of the system based on actual online system operating conditions. We have proposed a concept of the international standard-based WASA that can provide such a next generation VSA&E application platform with no vendor lock-in. The effectiveness and practicability of the international standard-based WASA are demonstrated with VSA&E application integrated into a WASA evaluation system. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Tanabe, Ryuya] Tokyo Elect Power Co Ltd, Tokyo, Japan; [Tanaka, Tatsuji] Toshiba Co Ltd, Fuchu, Tokyo, Japan; [Serizawa, Yoshizumi] Cent Res Inst Elect Power Ind, Komae, Tokyo 201, Japan; [Li, Hua] Bigwood Syst Inc, Ithaca, NY USA	Tanabe, R (reprint author), Tokyo Elect Power Co Ltd, R&D Ctr, Power Syst Technol, Yokohama, Kanagawa 2308510, Japan.	Tanabe.ryuya@tepco.co.jp			New Energy and Industrial Technology Development Organization (NEDO) in Japan as a WASA Standardization Project	This activity for the study, standardization, and evaluation of WASA based on international standards has been commissioned and funded by the New Energy and Industrial Technology Development Organization (NEDO) in Japan as a WASA Standardization Project, and the authors wish to thank all members concerned with this activity.	[Anonymous], C372382011 IEEE, DOI [10.1109/IEEESTD.2011.5963699, DOI 10.1109/IEEESTD.2011.5963699]; [Anonymous], 2010, HARM INT EL COMM COM; [Anonymous], VOLT STAB ASS ENH AP; Chiang HD, 1997, IEEE T POWER SYST, V12, P173; [Anonymous], 2007, 623511 IEC; [Anonymous], 2003, 618501 IECTR; [Anonymous], 61850902 IEC; [Anonymous], 2012, 61850905 IECTR; [Anonymous], C3711812011 IEEE, DOI [10.1109/IEEESTD.2011.6111219, DOI 10.1109/IEEESTD.2011.6111219]; [Anonymous], C37244 IEEE; [Anonymous], C3711822011 IEEE, DOI [10.1109/IEEESTD.2011.6111222, DOI 10.1109/IEEESTD.2011.6111222]; [Anonymous], 61850904 IEC; [Anonymous], 2010, 61850901 IECTR; CHIANG HD, 1995, IEEE T POWER SYST, V10, P623, DOI 10.1109/59.387897; [Anonymous], 2008, 15882008 IEEE, DOI [10.1109/IEEESTD.2008.4579760, DOI 10.1109/IEEESTD.2008.4579760]; Chiang HD, 2011, IEEE POW EN SOC GEN; Chiang HD, 2009, IEEE POW ENG SOC GEN, DOI [10.1109/PES.2009.5275811, DOI 10.1109/PES.2009.5275811]; IEC, 2011, 61970301 IEC; IEC Standardization Management Board Smart Grid Strategic Group (SG3), 2010, ICE SMART GRID STAND; IEEE/CIGRE Joint Task Force on Stability Terms and Definitions, 2004, IEEE T POWER SYSTEMS, V19, DOI [10.1109/TPWRS.2004.825981, DOI 10.1109/TPWRS.2004.825981]; Inoue T, 1993, CIGRE SC 39 C; Ishibashi A, 2012, IEEE PES TRANSM DIST; Kundur P., 1994, POWER SYSTEM STABILI; Matsumoto S, 2012, DPSP 2012 PROT SMART; National Institute of Standards and Technology, 2010, NIST SPECIAL PUBLICA, V1108; Tanabe R, 2011, CIM US GROUP FALL M; Zhao J, 2006, IEEE POW ENG SOC GEN, DOI [10.1109/PES.2006.1709314, DOI 10.1109/PES.2006.1709314]	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2050-7038			INT T ELECTR ENERGY	Int. Trans. Electr. Energy Syst.	NOV	2014	24	11			SI		1562	1575		10.1002/etep.1731		14	Engineering, Electrical & Electronic	Engineering	AU1AQ	WOS:000345353800004		
J	Fukuda, T; Suzuki, A; Liao, YJ; Suzuki, K				Fukuda, Takeshi; Suzuki, Asumi; Liao, Yingjie; Suzuki, Katsumi			Influence of spray conditions on droplet charge per unit volume for electrospray deposition	JOURNAL OF AEROSOL SCIENCE			English	Article						Electrospray deposition; Droplet charge per unit volume; Faraday cage; Electrical polarity; Additive solvent; Polymer	ORGANIC SOLAR-CELLS; ELECTROHYDRODYNAMIC ATOMIZATION; DISCHARGE; EVAPORATION; NANOFIBERS; IONIZATION; SOLVENT; FIELD	In electrospray deposition (ESD), the droplet charge per unit volume is an important parameter for optimizing a coating condition. Previous research has investigated the electrostatic charge on droplets both theoretically and experimentally. Recently, an additive solvent technique was proposed that yields smooth organic thin films, and several types of high-performance organic devices were demonstrated. However, investigating just the droplet charge per unit volume is insufficient to understand the advantages of the additive solvent. In the present work, we investigate the influence on the droplet charge per unit volume of several parameters such as applied voltage, liquid flow rate, and spraying distance to optimize the charging conditions even at a high liquid flow rate, which leads to a high deposition rate. The escaped droplet charge per unit volume is estimated from the relationship between spraying distance and droplet charge per unit volume. In addition, we also estimate how an additive solvent and a polymer affect efficient charging in ESD. The droplet charge per unit volume becomes high upon using the additive solvent, even at a low concentration (10 vol%). The additive solvent technique is found to be a useful tool for realizing high the droplet charge per unit volume, which results in a large spray diameter. However, because of its low concentration in the solvent, the polymer has little effect on the droplet charge per unit volume. (C) 2014 Elsevier Ltd. All rights reserved.	[Fukuda, Takeshi; Suzuki, Asumi; Liao, Yingjie; Suzuki, Katsumi] Saitama Univ, Dept Funct Mat Sci, Sakura Ku, Saitama 3388570, Japan	Fukuda, T (reprint author), Saitama Univ, Dept Funct Mat Sci, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	fukuda@fms.saitama-u.ac.jp	Liao, Y.J./L-8678-2013; Fukuda, Takeshi/G-8647-2011		JSPS KAKENHI [26420267]	This work was supported by JSPS KAKENHI Grant no. (26420267).	DOLE M, 1968, J CHEM PHYS, V49, P2240, DOI 10.1063/1.1670391; Ju J, 2009, ADV MATER, V21, P4343, DOI 10.1002/adma.200900444; Kebarle P, 2009, MASS SPECTROM REV, V28, P898, DOI 10.1002/mas.20247; Fukuda T, 2011, PHYS STATUS SOLIDI-R, V5, P229, DOI 10.1002/pssr.201105232; Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719; Ganan-Calvo AM, 1997, J AEROSOL SCI, V28, P249, DOI 10.1016/S0021-8502(96)00433-8; Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7; Banerjee S, 2012, INT J ANAL CHEM, DOI 10.1155/2012/282574; Hartman RPA, 2000, J AEROSOL SCI, V31, P65, DOI 10.1016/S0021-8502(99)00034-8; Hu HQ, 2013, ACS NANO, V7, P2960, DOI 10.1021/nn400279a; Borra JP, 2004, J AEROSOL SCI, V35, P1313, DOI 10.1016/j.jaerosci.2004.05.011; DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8; Zhao XY, 2014, SOL ENERG MAT SOL C, V121, P119, DOI 10.1016/j.solmat.2013.10.020; Fukuda T, 2011, THIN SOLID FILMS, V520, P600, DOI 10.1016/j.tsf.2011.07.048; Kim HH, 2011, J AEROSOL SCI, V42, P249, DOI 10.1016/j.jaerosci.2011.01.007; Ali M, 2012, ORG ELECTRON, V13, P2130, DOI 10.1016/j.orgel.2012.06.016; HAYATI I, 1987, J COLLOID INTERF SCI, V117, P205, DOI 10.1016/0021-9797(87)90185-8; Jaworek A, 2014, J ELECTROSTAT, V72, P166, DOI 10.1016/j.elstat.2014.01.004; Jaworek A, 2008, J ELECTROSTAT, V66, P197, DOI 10.1016/j.elstat.2007.10.001; Kim JH, 2010, J ELECTROSTAT, V68, P305, DOI 10.1016/j.elstat.2010.03.002; Li KY, 2005, LANGMUIR, V21, P3786, DOI 10.1021/la047973n; Bondnar E., 2013, J COLLOID INTERF SCI, V407, P536; Deng W, 2007, J AEROSOL SCI, V38, P1062, DOI 10.1016/j.jaerosci.2007.08.005; ENGLISH WN, 1948, PHYS REV, V74, P179, DOI 10.1103/PhysRev.74.179; Fukuda T, 2013, PHYS STATUS SOLIDI-R, V7, P1055, DOI 10.1002/pssr.201308167; Fukuda T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BK12; Ganan-Calvo A.M., 2009, PHYS REV E, V79; Grimm RL, 2002, ANAL CHEM, V74, P6291, DOI 10.1021/ac025889b; Ho C S, 2003, Clin Biochem Rev, V24, P3; Jung JH, 2010, POWDER TECHNOL, V198, P439, DOI 10.1016/j.powtec.2009.12.006; Kim JS, 2010, J MECH SCI TECHNOL, V24, P301, DOI 10.1007/s12206-009-1148-z; Koishikawa Y, 2013, THIN SOLID FILMS, V545, P527, DOI 10.1016/j.tsf.2013.07.083; Lord Rayleigh FRS, 1882, PHILOS MAG, V14, P184; Yamauchi H, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.01AB16; Zhong XF, 2009, RAPID COMMUN MASS SP, V23, P689, DOI 10.1002/rcm.3914	35	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-8502	1879-1964		J AEROSOL SCI	J. Aerosol. Sci.	NOV	2014	77						38	49		10.1016/j.jaerosci.2014.07.006		12	Engineering, Chemical; Engineering, Mechanical; Environmental Sciences; Meteorology & Atmospheric Sciences	Engineering; Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AU2YP	WOS:000345480700005		
J	Kim, HJ; Han, B; Woo, CG; Kim, YJ; Ono, R; Oda, T				Kim, Hak Joon; Han, Bangwoo; Woo, Chang Gyu; Kim, Yong Jin; Ono, Ryo; Oda, Tetsuji			Performance evaluation of dry and wet electrostatic precipitators used in an oxygen-pulverized coal combustion and a CO2 capture and storage pilot plant	JOURNAL OF AEROSOL SCIENCE			English	Article						Oxy-PC combustion; Electrostatic precipitator; Collection; Corona power; Water film	COLLECTING POLYDISPERSE PARTICLES; CARBON CAPTURE; FINE; EFFICIENCY; LIMESTONE; REMOVAL; PREDICT; CORONA; MODEL	The electrical and particle collection characteristics of a 1200-m(3)/h-dry electrostatic precipitator (ESP) and a 400-m(3)/h-wet ESP for a 0.7 MW-oxygen-pulverized coal (Oxy-PC) combustion and carbon capture and storage (CCS) pilot plant were evaluated under varying air and oxygen combustion operational parameters of the ESPs. The corona current of a dry ESP reduced by oxy-firing was compared with that for the same applied voltage with air firing, which resulted in a decreased collection performance during oxy-firing at the same applied voltage. However, the decreased collection performance could be avoided by simply increasing the applied voltage to reach the same corona power consumption as with air firing because the collection performance of the ESP was an exponential function of the power consumption divided by the gas flow rate regardless of combustion conditions. The wet ESP used here had a thin water film on the collection plates due to the patented design of the collection plates, with water supplied by gravitational force from holes on the collection plates with TiO2 nanoparticles coated on ball blasted surface. The system only consumed water at a rate of 1.7 L/min/m(2). The collection efficiency of the wet ESP was higher than 90% even for fine particles and mists, which enabled an overall particle collection efficiency of 99.98% to be achieved with both the thy and wet ESPs, corresponding to total gravimetric emission of 1.8 mg/m(3) at the inlet of the CCS facility. The wet ESP had the additional effect of removing SO2 and SO3 at 64.5% and 23.1% efficiency, respectively. (C) 2014 Elsevier Ltd. All rights reserved.	[Kim, Hak Joon; Han, Bangwoo; Woo, Chang Gyu; Kim, Yong Jin] Korea Inst Machinery & Mat, Environm & Energy Syst Res Div, Taejon 305343, South Korea; [Ono, Ryo] Univ Tokyo, Dept Adv Energy, Kashiwa, Chiba 2278569, Japan; [Oda, Tetsuji] Univ Tokyo, Dept Elect Engn, Bunkyo Ku, Tokyo 1138656, Japan	Kim, YJ (reprint author), Korea Inst Machinery & Mat, Environm & Energy Syst Res Div, 104 Sinseongno, Taejon 305343, South Korea.	yjkim@kimm.re.kr	Ono, Ryo/F-5710-2013		General Research Fund of the Korea Institute of Machinery and Materials [SC1030]	This research was supported by a General Research Fund (SC1030) of the Korea Institute of Machinery and Materials.	Han B, 2010, SCI TOTAL ENVIRON, V408, P5158, DOI 10.1016/j.scitotenv.2010.07.028; Lin GY, 2013, SEP PURIF TECHNOL, V114, P99, DOI 10.1016/j.seppur.2013.04.039; Wall TF, 2007, P COMBUST INST, V31, P31, DOI 10.1016/j.proci.2006.08.123; Czakiert T, 2010, FUEL PROCESS TECHNOL, V91, P1617, DOI 10.1016/j.fuproc.2010.06.010; Chen CM, 2006, IND ENG CHEM RES, V45, P5078, DOI 10.1021/ie060196x; Kim HJ, 2012, J AIR WASTE MANAGE, V62, P905, DOI 10.1080/10962247.2012.686893; Stanger R, 2011, PROG ENERG COMBUST, V37, P69, DOI 10.1016/j.pecs.2010.04.001; Kim HJ, 2011, J AIR WASTE MANAGE, V61, P1334, DOI 10.1080/10473289.2011.603994; McCauley KJ, 2009, ENRGY PROCED, V1, P439, DOI 10.1016/j.egypro.2009.01.059; Lin GY, 2010, AEROSOL SCI TECH, V44, P38, DOI 10.1080/02786820903338298; Back A., 2011, P 12 INT C EL PREC M; BAI HL, 1995, J AIR WASTE MANAGE, V45, P908; Burchhardt U, 2009, P 1 INT OX COMB C SE; Chen JA, 2011, P COMBUST INST, V33, P2837, DOI 10.1016/j.proci.2010.06.158; Cochet R., 1961, C INT CNRS, V102, P331; EPA, 1996, 5 EPA; EPA, EPA452F03027; EPA, 1996, 8 EPA; Flagan R.C., 1988, FUNDAMENTALS AIR POL; Hinds W.C., 1999, AEROSOL TECHNOLOGY P; IEEE, 1984, 5481984 IEEE; JENNINGS SG, 1988, J AEROSOL SCI, V19, P159, DOI 10.1016/0021-8502(88)90219-4; Levasseur AA, 2009, P 34 INT TECHN C CLE; Lin GY, 2010, AEROSOL SCI TECH, V44, P1122, DOI 10.1080/02786826.2010.512320; Lin GY, 2012, AEROSOL AIR QUAL RES, V12, P697, DOI 10.4209/aaqr.2012.04.0085; Lu CY, 1998, J AEROSOL SCI, V29, P295; McDonald D.K., 2009, P 1 INT OX COMB C SE; Neundorfer Inc, ESP DES PAR THEIR EF, P1; NIST Chemistry WebBook, FLUID PROP; Noll CG, 2002, J ELECTROSTAT, V54, P245, DOI 10.1016/S0304-3886(01)00169-3; Park JH, 2002, J AEROSOL SCI, V33, P673, DOI 10.1016/S0021-8502(01)00205-1; Parker K.R., 1997, APPL ELECTROSTATIC P; Suriyawong A, 2008, FUEL, V87, P673, DOI 10.1016/j.fuel.2007.07.024; Sutherland W, 1893, PHILOS MAG, V36, P507, DOI [DOI 10.1080/14786449308620508, 10.1080/14786449308620508]; Wikipedia, 2012, Viscosity, Patent No. 101173496; Xiangron Z., 2002, J AEROSOL SCI, V33, P1595, DOI DOI 10.1016/S0021-8502(02)00104-0; Yang XF, 2009, J HAZARD MATER, V169, P941, DOI 10.1016/j.jhazmat.2009.04.054	37	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-8502	1879-1964		J AEROSOL SCI	J. Aerosol. Sci.	NOV	2014	77						116	126		10.1016/j.jaerosci.2014.07.003		11	Engineering, Chemical; Engineering, Mechanical; Environmental Sciences; Meteorology & Atmospheric Sciences	Engineering; Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AU2YP	WOS:000345480700010		
J	Ikai, S; Suzuki, T; Uchida, H; Saruta, J; Tsukinoki, K; Fujii, Y; Mimura, M				Ikai, Saeko; Suzuki, Takefumi; Uchida, Hiroyuki; Saruta, Juri; Tsukinoki, Keiichi; Fujii, Yasuo; Mimura, Masaru			Effects of Weekly One-Hour Hatha Yoga Therapy on Resilience and Stress Levels in Patients with Schizophrenia-Spectrum Disorders: An Eight-Week Randomized Controlled Trial	JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE			English	Article							SALIVARY ALPHA-AMYLASE; NERVOUS-SYSTEM; CURRENT STATE; METAANALYSIS; MANAGEMENT; BENEFITS; SCHOOL; SCALE	Objective: To examine the effects of Hatha yoga therapy on resilience, brain-derived neurotrophic factor (BDNF) levels, and salivary alpha amylase (SAA) activity in patients with schizophrenia-spectrum disorders. Design and participants: Single-blinded, randomized controlled study in which outpatients with schizophrenia or related psychotic disorders (according to International Classification of Diseases, 10th Revision) were randomly assigned to a yoga or a control group. Setting: November 2012-April 2013 at Yamanashi Prefectural Kita Hospital, Japan. Interventions: In the yoga group, patients received weekly 1-hour Hatha yoga sessions, in addition to regular treatment, for 8 weeks. Those in the control group underwent regular treatment, which included a daycare rehabilitation program. Outcome measures: Assessments included the 25-item Resilience Scale (RS), Positive and Negative Syndrome Scale (PANSS), plasma and salivary BDNF level, and SAA activity. Results: Fifty patients participated (25 in each group; mean age +/- standard deviation, 50.9 +/- 11.3 years; mean duration of illness, 25.0 +/- 10.3 years; mean total PANSS score, 78.2 +/- 17.3). No significant differences in changes in any variable from baseline to week 8 were found between the two groups (changes in the yoga group versus the control group: RS score, -1.6 +/- 19.9 versus 0.3 +/- 17.2; PANSS score, 0.5 +/- 12.0 versus 5.0 +/- 15.6; plasma BDNF, 41.6 +/- 377.0 pg/dl versus 73.4 +/- 346.0 pg/dl; SAA, -26.2 +/- 72.6 kU/l versus -13.8 +/- 68.0 kU/l, respectively). Conclusions: Adjunct yoga therapy showed no positive changes in resilience level or stress markers. Duration and intensity of yoga sessions and the focus on patients with chronic illness may explain the negative observations in light of past positive evidence regarding yoga therapy.	[Ikai, Saeko; Suzuki, Takefumi; Uchida, Hiroyuki; Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo 1608582, Japan; [Suzuki, Takefumi] Inokashira Hosp, Dept Psychiat, Tokyo, Japan; [Uchida, Hiroyuki] Ctr Addict & Mental Hlth, Geriatr Psychiat Div, Toronto, ON, Canada; [Saruta, Juri; Tsukinoki, Keiichi] Kanagawa Dent Univ, Dept Oral Sci, Grad Sch Dent, Yokohama, Kanagawa, Japan; [Saruta, Juri; Tsukinoki, Keiichi] Kanagawa Dent Univ, Res Inst Salivary Gland & Hlth Med, Grad Sch Dent, Yokohama, Kanagawa, Japan; [Fujii, Yasuo] Yamanashi Prefectural Kita Hosp, Dept Neuropsychiat, Tokyo, Yamanashi, Japan	Ikai, S (reprint author), Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	sako0609@gmail.com	Uchida, Hiroyuki/I-4867-2015	Uchida, Hiroyuki/0000-0002-0628-7036	Dainippon Sumitomo; Novartis; Janssen Pharmaceutical; Astellas; Eli Lilly; Elsevier Japan; Janssen; Meiji Seika; Otsuka; Weily Japan; Astellas Pharmaceutical; Eisai; Otsuka Pharmaceutical; GlaxoSmithKline; Shionogi; Dainippon-Sumitomo Pharma; Mochida Pharmaceutical; Meiji-Seika Pharma; Yoshitomi Yakuhin; Asahi Kasei Pharma; Daiichi Sankyo; MSD; Novartis Pharma; Pfizer; Takeda; Tanabe Mitsubishi Pharma	Dr. Ikai has received manuscript fees or speaker's honoraria from Dainippon Sumitomo, Novartis, and Janssen Pharmaceutical within the past 3 years. Dr. Suzuki has received manuscript or speaker's fees from Astellas, Dainippon Sumitomo, Eli Lilly, Elsevier Japan, Janssen, Meiji Seika, Novartis, Otsuka, and Weily Japan. Dr. Uchida has received grants from Astellas Pharmaceutical, Eisai, Otsuka Pharmaceutical, GlaxoSmithKline, Shionogi, Dainippon-Sumitomo Pharma, Eli Lilly, Mochida Pharmaceutical, Meiji-Seika Pharma, Janssen Pharmaceutical, and Yoshitomi Yakuhin and speaker's honoraria from Otsuka Pharmaceutical, Eli Lilly, Shionogi, GlaxoSmithKline, Yoshitomi Yakuhin, Dainippon-Sumitomo Pharma, Meiji-Seika Pharma, Abbvie, and Janssen Pharmaceutical within the past 3 years. Dr. Fujii has received speaking fees from Janssen Pharmaceutical and Eli Lilly within the past 3 years. Dr. Mimura has received grants and/or speaker's honoraria from Asahi Kasei Pharma, Astellas Pharmaceutical, Daiichi Sankyo, Dainippon-Sumitomo Pharma, Eisai, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceutical, Meiji-Seika Pharma, Mochida Pharmaceutical, MSD, Novartis Pharma, Otsuka Pharmaceutical, Pfizer, Shionogi, Takeda, Tanabe Mitsubishi Pharma, and Yoshitomi Yakuhin within the past 3 years.	Ahern Nancy R, 2006, Issues Compr Pediatr Nurs, V29, P103, DOI 10.1080/01460860600677643; Suzuki T, 2008, SCHIZOPHR RES, V106, P328, DOI 10.1016/j.schres.2008.08.013; Khalsa SBS, 2012, J BEHAV HEALTH SER R, V39, P80, DOI 10.1007/s11414-011-9249-8; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Vancampfort D, 2011, DISABIL REHABIL, V33, P684, DOI 10.3109/09638288.2010.509458; Noggle JJ, 2012, J DEV BEHAV PEDIATR, V33, P193, DOI 10.1097/DBP.0b013e31824afdc4; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Michalsen A, 2005, MED SCI MONITOR, V11, pCR555; Duraiswamy G, 2007, ACTA PSYCHIAT SCAND, V116, P226, DOI 10.1111/j.1600-0447.2007.01032.x; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Luthar SS, 2000, DEV PSYCHOPATHOL, V12, P857, DOI 10.1017/S0954579400004156; Behere RV, 2011, ACTA PSYCHIAT SCAND, V123, P147, DOI 10.1111/j.1600-0447.2010.01605.x; Favalli G, 2012, J PSYCHIATR RES, V46, P1, DOI 10.1016/j.jpsychires.2011.09.022; Schumacher J, 2005, Z KLIN PSYCH PSYCHIA, V53, P16; Li AW, 2012, ALTERN MED REV, V17, P21; Brown RP, 2009, ANN NY ACAD SCI, V1172, P54, DOI 10.1111/j.1749-6632.2009.04394.x; Shetty V, 2011, PSYCHONEUROENDOCRINO, V36, P193, DOI 10.1016/j.psyneuen.2010.07.008; Visceglia E, 2011, J ALTERN COMPLEM MED, V17, P601, DOI 10.1089/acm.2010.0075; Ieda M, 2014, EUR ARCH PSY CLIN N, V264, P83, DOI 10.1007/s00406-013-0411-6; Green MJ, 2011, MOL PSYCHIATR, V16, P960, DOI 10.1038/mp.2010.88; Chong CSM, 2011, ALTERN THER HEALTH M, V17, P32; Ikai S, 2013, J PSYCHIATR RES, V47, P1744, DOI 10.1016/j.jpsychires.2013.07.017; Balasubramaniam Meera, 2012, Front Psychiatry, V3, P117, DOI 10.3389/fpsyt.2012.00117; Cramer H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-32; Gururaja Derebail, 2011, Int J Yoga, V4, P7, DOI 10.4103/0973-6131.78173; Howes OD, 2004, INT J NEUROPSYCHOPH, V7, pS7, DOI 10.1017/S1461145704004122; Inada T, 2008, JPN J CLIN PSYCHOPHA, V11, P887; Inada T, 1996, EVALUATION DIAGNOSIS; Inagaki A, 1999, DOSE EQUIVALENTS PSY; Iyengar B, 1996, LIGHT YOGA; Malberg JE, 2005, CURR PHARM DESIGN, V11, P145, DOI 10.2174/1381612053382223; Naveen G H, 2013, Indian J Psychiatry, V55, pS400, DOI 10.4103/0019-5545.116313; Pan NL LC, 2006, P WORLD C EXP PAR SC, P156; Torgalsbøen Anne-Kari, 2012, Clin Schizophr Relat Psychoses, V5, P193, DOI 10.3371/CSRP.5.4.3; World Health Organization, 1992, ICD 10 CLASS MENT BE; Xie J, 2006, J NURS CHINA, V13, P9; Yagi Kohei, 2008, Seishin Shinkeigaku Zasshi, V110, P770	37	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1075-5535	1557-7708		J ALTERN COMPLEM MED	J. Altern. Complement Med.	NOV 1	2014	20	11					823	830		10.1089/acm.2014.0205		8	Integrative & Complementary Medicine	Integrative & Complementary Medicine	AU6AM	WOS:000345684500003		
J	Hudson, MJ				Hudson, Mark J.			Placing Asia in the Anthropocene: Histories, Vulnerabilities, Responses	JOURNAL OF ASIAN STUDIES			English	Article							CHINA; CLIMATE; HUMANITIES; FAUNA		Univ West Kyushu, Nishikyushu Univ, Res Inst Sustainable Environm & Cultures, Fukuoka, Japan	Hudson, MJ (reprint author), Univ West Kyushu, Nishikyushu Univ, Res Inst Sustainable Environm & Cultures, Fukuoka, Japan.	hudsonm@nisikyu-u.ac.jp					ACIA, 2005, ARCTIC CLIMATE IMPAC; AIKENS C. MELVIN, 2013, ANTHROPOCENE, V4, P46; Alcorn J. B., 2003, NAVIGATING SOCIAL EC, P299; Steffen W, 2011, PHILOS T R SOC A, V369, P842, DOI 10.1098/rsta.2010.0327; WHITE L, 1967, SCIENCE, V155, P1203, DOI 10.1126/science.155.3767.1203; Erickson CL, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P157, DOI 10.1007/978-0-387-74907-5_11; Tyedmers PH, 2005, AMBIO, V34, P635, DOI 10.1639/0044-7447(2005)034[0635:FGFF]2.0.CO;2; Morton T, 2010, PMLA, V125, P273; Pongratz J, 2011, HOLOCENE, V21, P843, DOI 10.1177/0959683610386981; [Anonymous], 2014, CTR 21 CENTURY STUDI; Ehrlich PR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2845; Palsson G, 2013, ENVIRON SCI POLICY, V28, P3, DOI 10.1016/j.envsci.2012.11.004; Berkes F, 2007, NAT HAZARDS, V41, P283, DOI 10.1007/s11069-006-9036-7; Bleed P, 2010, J ARCHAEOL METHOD TH, V17, P356, DOI 10.1007/s10816-010-9094-8; Sayre NF, 2008, ANN ASSOC AM GEOGR, V98, P120, DOI 10.1080/00045600701734356; Fuller DQ, 2011, HOLOCENE, V21, P743, DOI 10.1177/0959683611398052; Xu JC, 2007, CONSERV BIOL, V21, P318, DOI 10.1111/j.1523-1739.2006.00636.x; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; Larson C, 2014, SCIENCE, V343, P1415, DOI 10.1126/science.343.6178.1415; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Norton CJ, 2010, QUATERN INT, V211, P113, DOI 10.1016/j.quaint.2009.05.002; Madigan DJ, 2012, P NATL ACAD SCI USA, V109, P9483, DOI 10.1073/pnas.1204859109; [Anonymous], 2014, ATM CO2; Zvelebil M, 2008, MESOLITHIC EUROPE, P18; Lin JT, 2014, P NATL ACAD SCI USA, V111, P1736, DOI 10.1073/pnas.1312860111; Roberts P, 2014, P NATL ACAD SCI USA, V111, P5848, DOI 10.1073/pnas.1323465111; Gewin V, 2013, NATURE, V495, P13, DOI 10.1038/495013a; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Pauly D, 2014, FISH FISH, V15, P474, DOI 10.1111/faf.12032; Chakrabarty D, 2009, CRIT INQUIRY, V35, P197, DOI 10.1086/596640; Zalasiewicz J, 2011, PHILOS T R SOC A, V369, P1036, DOI 10.1098/rsta.2010.0315; Zalasiewicz J, 2010, ENVIRON SCI TECHNOL, V44, P2228, DOI 10.1021/es903118j; Bai XM, 2014, NATURE, V509, P158; EHRLICH PR, 1983, SCIENCE, V222, P1293, DOI 10.1126/science.6658451; Askew David, 2002, GENEALOGY JAPANESE S; AUSTIN G., 2013, LABOUR INTENSIVE IND; Bellwood P, 2004, 1 FARMERS ORIGINS AG; Berkes F., 1998, LINKING SOCIAL ECOLO; Berkes F., 2008, SACRED ECOLOGY TRADI; BRAJE TODD J., 2013, ANTHROPOCENE, V4, P14; BROOKFIELD HAROLD C., 1984, PAC VIEWPOINT, V25, P15; BRUUN OLE, 1995, ASIAN PERCEPTIONS NA; Buell Lawrence, 1995, ENV IMAGINATION THOR; Callicott J. Baird, 1989, NATURE ASIAN TRADITI; Chalecki Elizabeth L., 2013, ENV SECURITY GUIDE I; Chapin F.S., 2009, PRINCIPLES ECOSYSTEM; CHAPIN III F. STUART, 2011, J ENV STUDIES SCI, V1, P44; Chaudhuri K. N., 1990, ASIA EUROPE EC CIVIL; Chertow M., 2001, J IND ECOL, V4, P13, DOI DOI 10.1162/10881980052541927; Chew Sing C., 2001, WORLD ECOLOGICAL DEG; Childe V. Gordon, 1936, MAN MAKES HIMSELF; CORLETT RICHARD T., 2013, ELEMENTA SCI ANTHROP, V1, DOI 10.12952/journal.elementa.000016; CROSBY ALFRED W., 2004, ECOLOGICAL IMPERIALI; Diamond J., 2005, COLLAPSE SOC CHOOSE; DIBLEY BEN, 2012, AUSTRALIAN HUMANITIE, V52, P139; Edgeworth M., 2014, J CONT ARCHAEOLOGY, V1, P73; Ehrlich P., 1968, POPULATION BOMB; Ehrlich PR, 2008, DOMINANT ANIMAL HUMA; Elvin M., 1973, PATTERN CHINESE SOCI; Elvin M, 2004, RETREAT ELEPHANTS EN; Ericson SJ, 2014, J JPN STUD, V40, P1; FAZZINO DAVID, 2004, J LAND USE, V19, P435; FISCHER SHANNON, 2012, NATL GEOGRAPHIC 1113; Flenley J, 2008, QUATERN INT, V184, P1, DOI 10.1016/j.quaint.2007.08.047; FOLEY STEPHEN F., 2013, ANTHROPOCENE, V3, P83; Folke C, 2003, NAVIGATING SOCIAL EC, P352; GODWIN WILLIAM, 1820, POPULATION ENQUIRY P; Goudie A.S., 2006, HUMAN IMPACT NATURAL; Gray Timothy, 2006, G SNYDER PACIFIC RIM; HARGROVE EUGENE C., 1989, NATURE ASIAN TRADITI, pxiii; Harkin Michael Eugene, 2007, NATIVE AM ENV PERSPE; Heise UK, 2010, AM BOOK REV, V32, P3, DOI 10.1353/abr.2010.0067; Heise Ursula K, 2008, SENSE PLACE SENSE PL; HUDDLE NORIE, 1975, ISLAND DREAMS ENV CR; HUDSON MARK J., 2013, DOCUMENTA PRAEHISTOR, V40, P219; HUDSON MARK J., 2014, J CONT ARCHAEOLOGY, V1, P82; HUDSON MARK J., 2012, WILEY INTERDISCIPLIN, V3, P267; Hudson MJ, 2004, J ANTHROPOL ARCHAEOL, V23, P290, DOI 10.1016/j.jaa.2004.05.002; IRELAND CORYDON, 2013, HARVARD GAZETTE 0918; KADA YUKIKO, 2006, FORGING ENV JUSTICE, P109; Kaiman J SD, 2014, GUARDIAN; KELLY WILLIAM J., PEOPLES REP IN PRESS; King F. H., 1911, FARMERS 40 CENTURIES; Klare M, 2012, RACE WHATS LEFT GLOB; Krupnik I, 1993, ARCTIC ADAPTATIONS N; Krupnik I., 2002, EARTH IS FASTER NOW; Lansing JS, 2006, PRINC STUD COMPLEX, P1; LIGHTFOOT KENT G., 2013, ANTHROPOCENE, V4, P101; Mann C. C., 2011, 1493 UNCOVERING NEW; Marsh G.P., 1864, MAN NATURE PHYS GEOG; Martinez DP, 2005, COMPANION TO THE ANTHROPOLOGY OF JAPAN, P185; McIntosh R, 2000, WAY WIND BLOWS CLIMA; McKibben B., 1989, END NATURE; McMichael A.J., 2014, ANTHROPOCENE REV, V1, P44; MCNEELY JEFFREY A., 1995, SOUL TIGER SEARCHING; MILLER IAN JARED, 2013, JAPAN NATURES EDGE E; Mitchell L, 2013, SCIENCE, V342, P964, DOI 10.1126/science.1238920; Morris I., 2010, WHY W RULES NOW PATT; MORRIS WILLIAM, 2008, USEFUL WORK V USELES; MORTON TIMOTHY, 2013, HYPEROJECTS PHILOS E; Nash L, 2006, INESCAPABLE ECOLOGIES: A HISTORY OF ENVIRONMENT, DISEASE, AND KNOWLEDGE, P1; Nisbet MC, 2010, FRONT ECOL ENVIRON, V8, P329, DOI 10.1890/1540-9295-8.6.329; NISHIDA MASAKI, 1986, TEIJU KAKUMEI YUDO T; NUTTALL MARK, 1998, PROTECTING ARCITC IN; PELZER KJ, 1968, J ASIAN STUD, V27, P269, DOI 10.2307/2051751; POMERANZ KENNETH, 2010, QUESTIONING COLLAPSE, P71; Richards John F., 2003, UNENDING FRONTIER EN; Robinson K. S., 2005, 50 DEGREES; Robinson K. S., 2004, 40 SIGNS RAIN; Robinson KS, 2007, 60 DAYS COUNTING; ROOSEVELT ANNA C., 2013, ANTHROPOCENE, V4, P69, DOI DOI 10.1016/J.ANCENE.2014.05.001>; ROWAN RORY, 2014, C ANTHR FEM CTR 21 C; Ruddiman WF, 2005, PRINC SCI LIBR, P1; Rulli MC, 2013, P NATL ACAD SCI USA, V110, P892, DOI 10.1073/pnas.1213163110; Samways MJ, 1999, J INSECT CONSERV, V3, P65; Scott J. C., 1998, SEEING STATE CERTAIN; Shiva V., 1991, ECOLOGY POLITICS SUR; Sigerist H E, 1936, Bull N Y Acad Med, V12, P597; SNYDER GARY, 1999, G SNYDER READER PROS; Sponsel Leslie E., 1998, P376; Szanton David, 2004, POLITICS KNOWLEDGE A, P1; Terwiel B. J., 1989, TRAVELLERS EYES APPR; Thomas Keith, 1983, MAN NATURAL WORLD CH; Thomber Karen Laura, 2012, ECOAMBIGUITY ENV CRI; THOMPSON WILLIAM I., 1989, ENV PHILOS, P25; TUAN DAO THE, 2000, P INT C CHAO PHAR DE; Wackernagel M., 1996, OUR ECOLOGICAL FOOTP; Walker B. H., 2006, RESILIENCE THINKING; Walker Brett, 2009, TOXIC ARCHIPELAGO HI; Watts Jonathan, 2010, BILLION CHINESE JUMP; Welzer H., 2012, CLIMATE WARS WHY PEO; WILLIAMS TERRY TEMPEST, 2004, OPEN SPACE DEMOCRACY; YASUDA YOSHINORI, 2002, NIHON YO MORI NO KAN; YASUDA YOSHINORI, 2001, FOREST CIVLISATIONS, P171; Yeh ET, 2013, J ASIAN STUD, V72, P319, DOI 10.1017/S0021911812002227; Zalasiewicz J., 2008, GSA TODAY, V18, P4, DOI DOI 10.1130/GSAT01802A.1	136	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0021-9118	1752-0401		J ASIAN STUD	J. Asian Stud.	NOV	2014	73	4					941	962		10.1017/S0021911814001582		22	Area Studies; Asian Studies	Area Studies; Asian Studies	AU2KG	WOS:000345446500007		
J	Assmann, S				Assmann, Stephanie			Japan's Shrinking Regions in the 21st Century: Contemporary Responses to Depopulation and Socioeconomic Decline	JOURNAL OF ASIAN STUDIES			English	Book Review									[Assmann, Stephanie] Hokkaido Univ, Sapporo, Hokkaido 060, Japan	Assmann, S (reprint author), Hokkaido Univ, Sapporo, Hokkaido 060, Japan.	assmann@imc.hokudai.ac.jp					Matanle P., 2011, JAPANS SHRINKING REG	1	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0021-9118	1752-0401		J ASIAN STUD	J. Asian Stud.	NOV	2014	73	4					1135	1137		10.1017/S002191181400134X		4	Area Studies; Asian Studies	Area Studies; Asian Studies	AU2KG	WOS:000345446500045		
J	Hattori, H; Nakamura, Y; Nakajo, Y; Araki, Y; Kyono, K				Hattori, Hiromitsu; Nakamura, Yusuke; Nakajo, Yukiko; Araki, Yasuhisa; Kyono, Koichi			Deliveries of babies with normal health derived from oocytes with smooth endoplasmic reticulum clusters	JOURNAL OF ASSISTED REPRODUCTION AND GENETICS			English	Article						Smooth endoplasmic reticulum clusters; Malformation; ICSI; Pregnancy; Oocyte morphology		To examine the impact on development of derived embryos from smooth endoplasmic reticulum clusters (SERC) in human metaphase II (MII) oocytes. Retrospective analysis at Kyono ART Clinic. Comparison of embryological development, pregnancy, live birth and fetal malformation between oocytes with SERC (the SERC(+) group) and those without (the SERC(-) group) in 2,158 patients (3,758 cycles) after ICSI. Fertilization and implantation rate were significantly lower in SERC(+) MII oocytes than in SERC(-) MII oocytes. After the transfer of fresh and vitrified embryos derived from SERC(+) oocytes, 14 pregnancies resulted in 14 healthy babies, including 2 from fresh embryo transfer (ET) and 12 from vitrified-warmed ET, with no malformations. The presence of SERC in MII oocytes was associated with significantly lower fertilization rates and implantation rates than seen in SERC(-) MII oocytes within SERC (+) cycles. However, SERC had no impact on post-implantation development as well as neonatal outcome.	[Hattori, Hiromitsu; Nakamura, Yusuke; Nakajo, Yukiko; Kyono, Koichi] Kyono ART Clin, Aoba Ku, Sendai, Miyagi 9800014, Japan; [Araki, Yasuhisa] Inst Adv Reprod Med Technol, Maebashi, Gumma 3710105, Japan; [Kyono, Koichi] Kyono ART Clin Takanawa, Minato Ku, Tokyo 1080074, Japan	Kyono, K (reprint author), Kyono ART Clin, Aoba Ku, Sendai Honcho Bl,3F,1-1-1 Honcho, Sendai, Miyagi 9800014, Japan.	rec-sec@ivf-kyono.or.jp					Akarsu C, 2009, FERTIL STERIL, V92, DOI 10.1016/j.fertnstert.2009.06.048; Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, HUM REPROD, V26, P1270; Van Blerkom Jonathan, 2011, Mitochondrion, V11, P797, DOI 10.1016/j.mito.2010.09.012; Ebner T, 2008, REPROD BIOMED ONLINE, V16, P113; Manipalviratn S, 2009, FERTIL STERIL, V91, P305, DOI 10.1016/j.fertnstert.2009.01.002; Mateizel I, 2013, HUM REPROD, V28, P2111, DOI 10.1093/humrep/det241; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Shaw-Jackson C, 2014, HUM REPROD, V29, P1380, DOI 10.1093/humrep/deu101; Sa R, 2011, FERTIL STERIL, V96, P143, DOI 10.1016/j.fertnstert.2011.04.088; Otsuki J, 2004, HUM REPROD, V19, P1591, DOI 10.1093/humrep/deh258; Rienzi L, 2011, HUM REPROD UPDATE, V17, P34, DOI 10.1093/humupd/dmq029; Nakajo Y, 2013, J CLIN EMBRYOL, V16, P138; Veeck L, 1999, ATLAS HUMAN GAMETES	13	4	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1058-0468	1573-7330		J ASSIST REPROD GEN	J. Assist. Reprod. Genet.	NOV	2014	31	11					1461	1467		10.1007/s10815-014-0323-z		7	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology	AU1UR	WOS:000345406000009		
J	Seng, S; Shinpei, T; Yoshihiko, I; Masakazu, K				Seng, Set; Shinpei, Tomita; Yoshihiko, Inada; Masakazu, Kita			Development of a Handmade Conductivity Measurement Device for a Thin-Film Semiconductor and Its Application to Polypyrrole	JOURNAL OF CHEMICAL EDUCATION			English	Article						High School/Introductory Chemistry; Physical Chemistry; Polymer Chemistry; Hands-On Learning/Manipulatives; Conductivity	GENERAL-CHEMISTRY EXPERIMENT; POLYMER; PYRROLE	The precise measurement of conductivity of a semiconductor film such as polypyrrole (Ppy) should be carried out by the four-point probe method; however, this is difficult for classroom application. This article describes the development of a new, convenient, handmade conductivity device from inexpensive materials that can measure the conductivity of a thin-film semiconductor, Lessons on using the handmade device were conducted with high school students. The results show that the device was useful and trouble free for high school students to determine the electrical conductivity of Ppy.	[Seng, Set; Shinpei, Tomita; Yoshihiko, Inada; Masakazu, Kita] Okayama Univ, Fac Educ, Okayama 7008530, Japan	Seng, S (reprint author), Okayama Univ, Fac Educ, Okayama 7008530, Japan.	setseng2004@yahoo.com			Ministry of Education, Science, Sports and Culture of Japan through Japan Society for the Promotion of Science	The authors would like to thank the Ministry of Education, Science, Sports and Culture of Japan for financial support of this research through Japan Society for the Promotion of Science. We also wish to express our thanks to David Ford of The Royal University of Phnom Penh for helpful correction of our English and discussion of the present manuscript.	Agbeko JK, 2007, J CHEM EDUC, V84, P1689; Hoffman AR, 2011, J CHEM EDUC, V88, P197, DOI 10.1021/ed100004x; Kang HC, 2000, POLYMER, V41, P6931, DOI 10.1016/S0032-3861(00)00116-6; Bunting RK, 1997, J CHEM EDUC, V74, P421; Ramanaviciene A, 2006, J CHEM EDUC, V83, P1212; Li JC, 2012, PHYSCS PROC, V32, P347, DOI 10.1016/j.phpro.2012.03.568; Hasiah S., 2008, J PHYS SCI, V19, P77; HIEMENZ PC, 1972, J CHEM EDUC, V49, P263; Janusa MA, 1998, J CHEM EDUC, V75, P1463; Joo W. L., 2006, BIOMACROMOLECULES, V7, P1692; KAKOURIS C, 1992, SYNTHETIC MET, V48, P65, DOI 10.1016/0379-6779(92)90051-J; Konkov V. L., 1965, NASA TECH TRANSL, P135; KUPILA EL, 1993, SYNTHETIC MET, V55, P1402, DOI 10.1016/0379-6779(93)90258-X; Leonavicius K., 2011, LANGMUIR, V17, P10970; Morales J, 2000, J POLYM SCI POL PHYS, V38, P3247, DOI 10.1002/1099-0488(20001215)38:24<3247::AID-POLB60>3.0.CO;2-U; Peterson KI, 2008, J CHEM EDUC, V85, P1089; Puanglek N., 2010, SCI J UBU, V1, P35; RHEE HW, 1989, SYNTHETIC MET, V28, pC605; Saville P., 2005, DEFENCE R D CANADA A, P1; Seng S, 2007, J CHEM EDUC, V84, P1803; Steven W. K., 1993, J CHEM EDUC, V70, P855; Street G. B., 1983, J PHYS C SOLID STATE, V44, P599; Teerasong S, 2011, J CHEM EDUC, V88, P465, DOI 10.1021/ed100717m	23	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-9584	1938-1328		J CHEM EDUC	J. Chem. Educ.	NOV	2014	91	11					1971	1975		10.1021/ed500287q		5	Chemistry, Multidisciplinary; Education, Scientific Disciplines	Chemistry; Education & Educational Research	AT9ST	WOS:000345267100036		
J	Takeuchi, H; Suzuki, T; Bies, RR; Remington, G; Watanabe, K; Mimura, M; Uchida, H				Takeuchi, Hiroyoshi; Suzuki, Takefumi; Bies, Robert R.; Remington, Gary; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki			Dose Reduction of Risperidone and Olanzapine and Estimated Dopamine D-2 Receptor Occupancy in Stable Patients With Schizophrenia: Findings From an Open-Label, Randomized, Controlled Study	JOURNAL OF CLINICAL PSYCHIATRY			English	Article							MAINTENANCE TREATMENT; CATIE-DATA; ANTIPSYCHOTIC-DRUGS; CONTROLLED-TRIAL; POOLED ANALYSIS; PSYCHIATRY; GUIDELINES; PSYCHOSIS; RELAPSE; PHASE	Background: While acute-phase antipsychotic response has been attributed to 65%-80% dopamine D-2 receptor blockade, the degree of occupancy for relapse prevention in the maintenance treatment of schizophrenia remains unknown. Method: In this secondary study of an open-label, 28-week, randomized, controlled trial conducted between April 2009 and August 2011, clinically stable patients with schizophrenia (DSM-IV) treated with risperidone or olanzapine were randomly assigned to the reduction group (dose reduced by 50%) or maintenance group (dose kept constant). Plasma antipsychotic concentrations at peak and trough before and after dose reduction were estimated with population pharmacokinetic techniques, using 2 collected plasma samples. Corresponding dopamine D-2 occupancy levels were then estimated using the model we developed. Relapse was defined as worsening in 4 Positive and Negative Syndrome Scale-Positive subscale items: delusion, conceptual disorganization, hallucinatory behavior, and suspiciousness. Results: Plasma antipsychotic concentrations were available for 16 and 15 patients in the reduction and maintenance groups, respectively. Estimated dopamine D-2 occupancy (mean +/- SD) decreased following dose reduction from 75.6% +/- 4.9% to 66.8% +/- 6.4% at peak and 72.3% +/- 5.7% to 62.0% +/- 6.8% at trough. In the reduction group, 10 patients (62.5%) did not demonstrate continuous D-2 receptor blockade above 65% (ie, <65% at trough) after dose reduction; furthermore, 7 patients (43.8%) did not achieve a threshold of 65% occupancy even at peak. Nonetheless, only 1 patient met our relapse criteria after dose reduction during the 6 months of the study. Conclusions: The results suggest that the therapeutic threshold regarding dopamine D-2 occupancy may be lower for those who are stable in antipsychotic maintenance versus acute-phase treatment. Positron emission tomography studies are warranted to further test our preliminary findings. (C) Copyright 2014 Physicians Postgraduate Press, Inc.	[Takeuchi, Hiroyoshi; Suzuki, Takefumi; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Takeuchi, Hiroyoshi; Remington, Gary] Ctr Addict & Mental Hlth, Complex Mental Illness Program, Schizophrenia Div, Toronto, ON M5T 1R8, Canada; [Suzuki, Takefumi] Inokashira Hosp, Dept Psychiat, Tokyo, Japan; [Bies, Robert R.; Uchida, Hiroyuki] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON M5T 1R8, Canada; [Bies, Robert R.] Indiana Univ Sch Med, Div Clin Pharmacol, Indianapolis, IN 46202 USA; [Bies, Robert R.] Indiana Clin & Translat Sci Inst, Indianapolis, IN USA; [Remington, Gary] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON M5T 1R8, Canada; [Watanabe, Koichiro] Kyorin Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan	Takeuchi, H (reprint author), Ctr Addict & Mental Hlth, Complex Mental Illness Program, Schizophrenia Div, 250 Coll St, Toronto, ON M5T 1R8, Canada.	hirotak@dk9.so-net.ne.jp	Uchida, Hiroyuki/I-4867-2015	Uchida, Hiroyuki/0000-0002-0628-7036	Inokashira Hospital, Tokyo, Japan; Research Group for Schizophrenia, Tokyo, Japan	This study was supported by research funds from Inokashira Hospital, Tokyo, Japan, and Research Group for Schizophrenia, Tokyo, Japan.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Uchida H, 2011, J CLIN PSYCHOPHARM, V31, P497, DOI 10.1097/JCP.0b013e3182214aad; Uchida H, 2009, CLIN PHARMACOL THER, V86, P360, DOI 10.1038/clpt.2009.133; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Takeuchi H, 2012, SCHIZOPHR RES, V134, P219, DOI 10.1016/j.schres.2011.11.021; Naber D, 2001, SCHIZOPHR RES, V50, P79, DOI 10.1016/S0920-9964(00)00166-3; Mizrahi R, 2007, AM J PSYCHIAT, V164, P630, DOI 10.1176/appi.ajp.164.4.630; ADDINGTON D, 1990, SCHIZOPHR RES, V3, P247, DOI 10.1016/0920-9964(90)90005-R; SHEINER LB, 1977, J PHARMACOKINET BIOP, V5, P445, DOI 10.1007/BF01061728; Remington G, 2011, J CLIN PSYCHIAT, V72, P1042, DOI 10.4088/JCP.09m05866yel; Kapur S, 2003, PROG NEURO-PSYCHOPH, V27, P1081, DOI 10.1016/j.pnpbp.2003.09.004; Uchida H, 2011, J CLIN PSYCHOPHARM, V31, P318, DOI 10.1097/JCP.0b013e318218d339; Mizrahi R, 2012, BIOL PSYCHIAT, V71, P561, DOI 10.1016/j.biopsych.2011.10.009; Tsuboi T, 2013, PROG NEURO-PSYCHOPH, V45, P178, DOI 10.1016/j.pnpbp.2013.05.010; Wang CY, 2010, AM J PSYCHIAT, V167, P676, DOI 10.1176/appi.ajp.2009.09030358; Wunderink L, 2013, JAMA PSYCHIAT, V70, P913, DOI 10.1001/jamapsychiatry.2013.19; Feng Y, 2008, BRIT J CLIN PHARMACO, V66, P629, DOI 10.1111/j.1365-2125.2008.03276.x; Schooler NR, 1997, ARCH GEN PSYCHIAT, V54, P453; Miyamoto S, 2012, MOL PSYCHIATR, V17, P1206, DOI 10.1038/mp.2012.47; Takeuchi H, 2013, SCHIZOPHRENIA BULL, V39, P993, DOI 10.1093/schbul/sbt090; Sakurai H, 2013, SCHIZOPHRENIA BULL, V39, P564, DOI 10.1093/schbul/sbr189; Bigos KL, 2008, J CLIN PHARMACOL, V48, P157, DOI 10.1177/0091270007310385; Ikai S, 2012, J CLIN PSYCHIAT, V73, P1147, DOI 10.4088/JCP.12m07638; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663; Bigos KL, 2006, AM J GERIAT PSYCHIAT, V14, P993, DOI 10.1097/01.JGP.0000224330.73063.6c; CHA TA, 1992, P NATL ACAD SCI USA, V89, P7144, DOI 10.1073/pnas.89.15.7144; Falkai P, 2006, WORLD J BIOL PSYCHIA, V7, P5, DOI 10.1080/15622970500483177; Guy W., 1976, ECDEU ASSESSMENT MAN; HOGARTY GE, 1988, ARCH GEN PSYCHIAT, V45, P797; Inada T, 2009, DIEPSS 2 GENERATION; KANE JM, 1983, ARCH GEN PSYCHIAT, V40, P893; Mizuno Y, 2012, PROG NEURO-PSYCHOPH, V37, P182, DOI 10.1016/j.pnpbp.2011.12.013; Moriguchi S, 2013, J CLIN PSYCHOPHARM, V33, P682, DOI 10.1097/JCP.0b013e3182979a0a; NYBERG S, 1995, AM J PSYCHIAT, V152, P173; Rouillon F, 2008, EUR NEUROPSYCHOPHARM, V18, P646, DOI 10.1016/j.euroneuro.2008.04.012; Uchida H, 2008, J CLIN PSYCHIAT, V69, P1281; Uchida H, 2011, SCHIZOPHRENIA BULL, V37, P788, DOI 10.1093/schbul/sbp149	37	0	0	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0160-6689	1555-2101		J CLIN PSYCHIAT	J. Clin. Psychiatry	NOV	2014	75	11					1209	1214		10.4088/JCP.13m08841		6	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	AU4EK	WOS:000345561900019		
J	Tatsugami, F; Higaki, T; Kiguchi, M; Tsushima, S; Taniguchi, A; Kaichi, Y; Yamagami, T; Awai, K				Tatsugami, Fuminari; Higaki, Toru; Kiguchi, Masao; Tsushima, So; Taniguchi, Akira; Kaichi, Yoko; Yamagami, Takuji; Awai, Kazuo			Measurement of Electron Density and Effective Atomic Number by Dual-Energy Scan Using a 320-Detector Computed Tomography Scanner with Raw Data-Based Analysis: A Phantom Study	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						dual energy; computed tomography; electron density; effective atomic number; 320-detector CT	CT NUMBERS	We evaluated the accuracy of the electron densities and effective atomic numbers determined by raw data-based dual-energy analysis on a 320-detector computed tomography scanner. The mean (SD) errors between the measured and true electron densities and between the measured and true effective atomic numbers were 1.3% (1.5%) and 3.1% (3.2%), respectively. Electron densities and effective atomic numbers can be determined with high accuracy, which may help to improve accuracy in radiotherapy treatment planning.	[Tatsugami, Fuminari; Higaki, Toru; Kaichi, Yoko; Yamagami, Takuji; Awai, Kazuo] Hiroshima Univ, Dept Diagnost Radiol, Minami Ku, Hiroshima 7348551, Japan; [Kiguchi, Masao] Hiroshima Univ, Dept Radiol, Minami Ku, Hiroshima 7348551, Japan; [Tsushima, So; Taniguchi, Akira] Toshiba Med Syst Corp, Otawara, Tochigi, Japan	Tatsugami, F (reprint author), Hiroshima Univ, Dept Diagnost Radiol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	sa104@rg8.so-net.ne.jp			Toshiba Medical Systems, Ltd.	K.A. is currently receiving a research grant from Toshiba Medical Systems, Ltd. For the remaining authors, no conflicts of interest was declared.	Landry G, 2011, RADIOTHER ONCOL, V100, P375, DOI 10.1016/j.radonc.2011.08.029; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; Kalra MK, 2004, RADIOLOGY, V233, P649, DOI 10.1148/radiol.2333031150; Van Abbema JK, 2012, PHYS MEDICA, V28, P25, DOI 10.1016/j.ejmp.2011.01.004; LEHMANN LA, 1981, MED PHYS, V8, P659, DOI 10.1118/1.595025; Yu LF, 2012, AM J ROENTGENOL, V199, pS9, DOI 10.2214/AJR.12.9121; Saito M, 2012, MED PHYS, V39, P2021, DOI 10.1118/1.3694111; PARKER RP, 1979, PHYS MED BIOL, V24, P802, DOI 10.1088/0031-9155/24/4/011; ALVAREZ RE, 1976, PHYS MED BIOL, V21, P733, DOI 10.1088/0031-9155/21/5/002; Bazalova M, 2008, PHYS MED BIOL, V53, P2439, DOI 10.1088/0031-9155/53/9/015; Johnson TRC, 2012, AM J ROENTGENOL, V199, pS3, DOI 10.2214/AJR.12.9116; Simons D, 2014, EUR RADIOL, V24, P930, DOI 10.1007/s00330-013-3087-4; Torikoshi M, 2003, PHYS MED BIOL, V48, P673, DOI 10.1088/0031-9155/48/5/308	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	NOV-DEC	2014	38	6					824	827				4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU2EW	WOS:000345430200003		
J	Morisawa, N; Kido, A; Kataoka, M; Minamiguchi, S; Konishi, I; Togashi, K				Morisawa, Nobuko; Kido, Aki; Kataoka, Masako; Minamiguchi, Sachiko; Konishi, Ikuo; Togashi, Kaori			Magnetic Resonance Imaging Manifestations of Decidualized Endometriotic Cysts: Comparative Study With Ovarian Cancers Associated With Endometriotic Cysts	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						endometriotic cyst; decidual change; placenta; pregnancy; MRI	PREGNANCY MIMICKING MALIGNANCY; BENIGN; CARCINOMA	Purpose: The purpose of the study was to investigate the magnetic resonance imaging findings of decidualized endometriotic cysts in comparison with endometriotic cysts associated with ovarian cancers. Methods: Eighteen decidualized endometriotic cysts and 24 ovarian cancers were retrospectively assessed on height, signal intensity of the solid component on T2- and diffusion-weighted imaging, apparent diffusion coefficient value of the solid component, size of the lesion, and signal intensity of the intracystic fluid on T1-weighted imaging. Results: The heights of the solid components in the decidualized endometriotic cysts were inferior to 11.1 mm, significantly lower compared with the ovarian cancers. Similarly, decidualized tissues showed significantly higher signals on T2-weighted imaging and higher apparent diffusion coefficient values compared with ovarian cancers but not on diffusion-weighted imaging. The decidualized endometriotic cysts were also significantly smaller. Intracystic fluids showed higher signal in the decidualized endometriotic cysts compared with ovarian cancers on T1-weighted imaging. Conclusions: In pregnant subjects, the presence of endometriotic cysts with low-height solid component showing high signal intensities on T2-weighted imaging is highly indicative of decidualization.	[Morisawa, Nobuko; Kido, Aki; Kataoka, Masako; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto 6068507, Japan; [Minamiguchi, Sachiko] Kyoto Univ, Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 6068507, Japan; [Konishi, Ikuo] Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Kyoto 6068507, Japan	Kido, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	akikido@kuhp.kyoto-u.ac.jp					Tanaka YO, 2000, AM J ROENTGENOL, V175, P1423; Barbieri M, 2009, HUM REPROD, V24, P1818, DOI 10.1093/humrep/dep089; Huppertz B, 2008, J CLIN PATHOL, V61, P1296, DOI 10.1136/jcp.2008.055277; Sammour RN, 2005, J ULTRAS MED, V24, P1289; Fruscella E, 2004, ULTRASOUND OBST GYN, V24, P578, DOI 10.1002/uog.1736; ZAYTSEV P, 1987, AM J SURG PATHOL, V11, P526, DOI 10.1097/00000478-198707000-00004; Machida S, 2008, GYNECOL OBSTET INVES, V66, P241, DOI 10.1159/000147171; Wang PI, 2012, AM J ROENTGENOL, V198, P778, DOI 10.2214/AJR.11.7405; Fujii S, 2008, EUR RADIOL, V18, P384, DOI 10.1007/s00330-007-0769-9; Demir R, 1997, MICROSC RES TECHNIQ, V38, P29; TOGASHI K, 1991, RADIOLOGY, V180, P73; Takeuchi M, 2008, J COMPUT ASSIST TOMO, V32, P353, DOI 10.1097/RCT.0b013e3181238362; Miyakoshi K, 1998, AM J ROENTGENOL, V171, P1625; Takeuchi M, 2010, J COMPUT ASSIST TOMO, V34, P173, DOI 10.1097/RCT.0b013e3181c2f0a2; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Tamai K, 2008, EUR RADIOL, V18, P723, DOI 10.1007/s00330-007-0787-7; Clement PB, 2001, PATHOLOGY FEMALE GEN, P746; Clement PB, 2001, PATHOLOGY FEMALE GEN, P708; Mutter GL, 2001, PATHOLOGY FEMALE GEN, P406; Tanaka YO, 2002, MAGN RESON IMAGING, V20, P301, DOI 10.1016/S0730-725X(02)00499-X; Tanaka YO, 2010, AM J ROENTGENOL, V194, P355, DOI 10.2214/AJR.09.2985; Wamoto H, 2006, EUR J GYNAECOL ONCOL, V27, P301; Yoshida S, 2008, J CLIN ULTRASOUND, V36, P512, DOI 10.1002/jcu.20496	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	NOV-DEC	2014	38	6					879	884				6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU2EW	WOS:000345430200012		
J	Kitazume, Y; Ohashi, I; Katayama, T; Tsunoda, A; Kishimoto, S; Negi, M				Kitazume, Yoshio; Ohashi, Isamu; Katayama, Takashi; Tsunoda, Atsunobu; Kishimoto, Seiji; Negi, Mariko			Diffusion-Weighted Magnetic Resonance Neurography for Parapharyngeal Schwannomas: Preoperative Determination of the Originating Nerves	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						diffusion magnetic resonance imaging; neurilemmoma; ganglia; sympathetic; vagus nerve; neck; feasibility studies	CERVICAL SYMPATHETIC CHAIN; MR NEUROGRAPHY; SPACE	Objective: The aim of this study was to assess the feasibility of diffusion-weighted (DW) magnetic resonance neurography (MRN) for determining the originating nerve of parapharyngeal schwannomas preoperatively. Methods: Six patients who underwent DW-MRN preoperatively for a parapharyngeal schwannoma were studied. Prediction of the originating nerve was performed. With the conventional method, a tumor showing "separation" between the internal jugular vein and carotid artery was determined to originate from the vagus nerve, with "no separation" from the sympathetic chain. With DW-MRN, the relationships between the vagus nerve and sympathetic chain to the tumor were characterized as "connected" or "dislocated." A nerve connected to the tumor was determined as the origin. Results: Surgeries revealed that the origins included 1 vagus nerve and 5 sympathetic chains. Using a conventional method, all 6 cases were diagnosed correctly, whereas DW-MRN successfully predicted only 4 cases with a sympathetic chain origin. Conclusions: The DW-MRN is a feasible approach for determining an originating nerve.	[Kitazume, Yoshio; Ohashi, Isamu] Tokyo Med & Dent Univ Hosp, Dept Radiol, Tokyo 1138519, Japan; [Katayama, Takashi] Omori Red Cross Hosp, Dept Radiol, Tokyo, Japan; [Tsunoda, Atsunobu] Tokyo Med & Dent Univ Hosp, Dept Otolaryngol, Tokyo 1138519, Japan; [Kishimoto, Seiji] Tokyo Med & Dent Univ Hosp, Dept Head & Neck Surg, Tokyo 1138519, Japan; [Negi, Mariko] Tokyo Med & Dent Univ Hosp, Dept Human Pathol, Tokyo 1138519, Japan	Kitazume, Y (reprint author), Tokyo Med & Dent Univ Hosp, Dept Radiol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	ktzmmrad@gmail.com					Anil G, 2010, AM J NEURORADIOL, V31, P1408, DOI 10.3174/ajnr.A2212; Liu HL, 2011, EUR ARCH OTO-RHINO-L, V268, P1343, DOI 10.1007/s00405-011-1491-4; Filler A, 2009, NEUROSURGERY, V65, pA29, DOI 10.1227/01.NEU.0000351279.78110.00; Chhabra A, 2011, AM J ROENTGENOL, V197, P583, DOI 10.2214/AJR.10.6012; Dimitrijevic MV, 2010, INT J ORAL MAX SURG, V39, P983, DOI 10.1016/j.ijom.2010.06.005; Furukawa M, 1996, LARYNGOSCOPE, V106, P1548, DOI 10.1097/00005537-199612000-00021; Gupta A, 2012, OTOLARYNG CLIN N AM, V45, P1223, DOI 10.1016/j.otc.2012.08.002; Harnsberger HR, 2004, DIAGNOSTIC IMAGING H; Kehagias DT, 2001, AM J ROENTGENOL, V177, P720; Kim SH, 2010, YONSEI MED J, V51, P938, DOI 10.3349/ymj.2010.51.6.938; Ong Cheng Kang, 2010, Eur J Radiol, V74, P359, DOI 10.1016/j.ejrad.2009.05.064; Ozveren MF, 2003, NEUROSURGERY, V52, P1400; Saito DM, 2007, ARCH OTOLARYNGOL, V133, P662, DOI 10.1001/archotol.133.7.662; Takahara T, 2010, EUR RADIOL, V20, P1221, DOI 10.1007/s00330-009-1665-2; Takahara T, 2008, RADIOLOGY, V249, P653, DOI 10.1148/radiol.2492071826; Takahara T, 2011, NEURORADIOLOGY, V53, P109, DOI 10.1007/s00234-010-0713-6; Yamashita T, 2009, NEW ENGL J MED, V361, P538, DOI 10.1056/NEJMc0902318	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	NOV-DEC	2014	38	6					930	935				6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU2EW	WOS:000345430200018		
J	Matsushita, S; Matsuoka, S; Yamashiro, T; Fujikawa, A; Kurihara, Y; Yagihashi, K; Handa, H; Miyazawa, T; Nakajima, Y				Matsushita, Shoichiro; Matsuoka, Shin; Yamashiro, Tsuneo; Fujikawa, Atsuko; Kurihara, Yasuyuki; Yagihashi, Kunihiro; Handa, Hiroshi; Miyazawa, Teruomi; Nakajima, Yasuo			Quantitative Computed Tomography Assessment of Air Trapping in Relapsing Polychondritis: Correlations With Spirometric Values	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						relapsing polychondritis; air trapping; airway; computed tomography	OBSTRUCTIVE PULMONARY-DISEASE; FUNCTION TESTS; CT; MANIFESTATIONS; PREVALENCE; EMPHYSEMA	Objective: The purpose of this study was to evaluate the relationship between quantitative computed tomography (CT) parameters of air trapping obtained with inspiratory and expiratory CT and pulmonary function tests (PFTs) in patients with relapsing polychondritis (RP). Materials and Methods: This study included 23 patients with RP who underwent both CT and PFTs. In each patient, the mean lung density (MLD) was obtained by averaging CT attenuation of the lung parenchyma on both inspiratory and expiratory CT. The ratio of expiratory MLD to inspiratory MLD (E/I ratio) was also calculated. Correlations between those quantitative CT measurements and the results of PFTs were evaluated using Spearman rank correlation. Results: The expiratory MLD and E/I ratio were significantly correlated with forced expiratory volume in 1 second (FEV1) %predicted, ratio of FEV1 to FVC (FEV1/FVC), and the mid expiratory phase of forced expiratory flow (FEF25%-75%) %predicted (expiratory MLD: FEV1 %predicted, r = 0.764, P < 0.0001; FEV1/FVC, r = 0.764, P < 0.0001; FEF25%-75% %predicted, r = 0.674, P < 0.001, respectively; the E/I ratio: FEV1 %predicted, r = -0.689, P < 0.001; FEV1/FVC, r = -0.689, P < 0.001; FEF25%-75% %predicted, r = -0.586, P < 0.01, respectively). The correlation between inspiratory MLD and PFTs did not reach statistical significance. Conclusions: In RP patients, air trapping demonstrated on expiratory CT correlated with airway obstruction. This study may assist further refinement of the use of CT as quantitative evaluation for small and large airway obstruction in RP.	[Matsushita, Shoichiro; Matsuoka, Shin; Yamashiro, Tsuneo; Fujikawa, Atsuko; Kurihara, Yasuyuki; Yagihashi, Kunihiro; Nakajima, Yasuo] St Marianna Univ, Sch Med, Dept Radiol, Kawasaki, Kanagawa, Japan; [Handa, Hiroshi; Miyazawa, Teruomi] St Marianna Univ, Sch Med, Dept Internal Med, Div Resp & Infect Dis, Kawasaki, Kanagawa, Japan	Matsushita, S (reprint author), 2-16-1 Sugao,Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan.	m.sho160@gmail.com			Ministry of Health, Labor, and Welfare of the Japanese Government	Supported by a grant from the Ministry of Health, Labor, and Welfare of the Japanese Government.	Sarodia BD, 1999, CHEST, V116, P1669, DOI 10.1378/chest.116.6.1669; Eda S, 1997, AM J RESP CRIT CARE, V155, P1290; DAMIANI JM, 1979, LARYNGOSCOPE, V89, P929; Matsuoka S, 2008, AM J ROENTGENOL, V190, P762, DOI 10.2214/AJR.07.2820; MICHET CJ, 1986, ANN INTERN MED, V104, P74; Tillie-Leblond I, 1998, MEDICINE, V77, P168, DOI 10.1097/00005792-199805000-00002; Kubo K, 1999, EUR RESPIR J, V13, P252, DOI 10.1034/j.1399-3003.1999.13b06.x; Lee KS, 2006, RADIOLOGY, V240, P565, DOI 10.1148/radiol.2401050562; Behar JV, 2002, AM J ROENTGENOL, V178, P173; Matsuoka S, 2007, J COMPUT ASSIST TOMO, V31, P384, DOI 10.1097/01.rct.0000243457.00437.10; MCADAM LP, 1976, MEDICINE, V55, P193, DOI 10.1097/00005792-197605000-00001; Segel MJ, MAYO CLIN P; Shepard JO, 1998, THORACIC RADIOLOGY R, P352; Tanaka N, 2003, RADIOLOGY, V227, P776, DOI 10.1148/; Watanabel Maiko, 2008, Nihon Kokyuki Gakkai Zasshi, V46, P363; Yamashiro T, ACAD RADIOL	16	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	NOV-DEC	2014	38	6					968	971				4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU2EW	WOS:000345430200024		
J	Nomura, T; Okada, M; Nakashima, Y; Yonezawa, T; Kudomi, S; Kido, S; Matsunaga, N				Nomura, Takafumi; Okada, Munemasa; Nakashima, Yoshiteru; Yonezawa, Teppei; Kudomi, Shohei; Kido, Shoji; Matsunaga, Naofumi			The Effect of the Section Thickness Used for 2-and 3-Dimensional Quantification of Dual-Energy Perfusion Computed Tomography	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						section thickness; partial volume effect; partial volume averaging; dual-energy perfusion CT; low attenuation area; quantification; pulmonary embolism; intrapulmonary clot	ACUTE PULMONARY-EMBOLISM; SOURCE CT; VOLUME MEASUREMENTS; HELICAL CT; SPIRAL CT; EMPHYSEMA; OBSTRUCTION; MORPHOMETRY; ACCURACY; SCORES	Purpose: To retrospectively investigate the effect of the section thickness used for quantifying dual-energy perfusion computed tomography (DEpCT) during 2- and 3-dimensional evaluation. Methods: Sixty-six patients (22 males and 44 females; mean age, 59.3 years) suspected of having an acute pulmonary embolism underwent DEpCT, and 15patients were diagnosed to have intrapulmonary clots (IPCs). Two-dimensional DEpCT images were reconstructed into various section thicknesses from 1 to 10 mm at the main pulmonary artery, and the ratios of the low attenuation area (LAA) ranging from 1 to 5 HU (%LAA(5)) and 10 HU (%LAA(10)) on DEpCT were compared with the relative areas of the lung with attenuation coefficients lower than -950 HU (RA(-950)) using the lung CT images of each section thickness. Three-dimensional values of DEpCT were reconstructed with 3 different section thicknesses (1, 3, and 10 mm) and were analyzed for the presence of IPC burden using the factors suggesting IPC burden, including the right/left ventricular diameter ratio and CT obstruction index. Results: The mean attenuation and image noise were decreased as the section thickness increased. In the 2-dimensional analysis, the %LAA(5) and %LAA(10) had the smallest value at 1-mm section, and DEpCT with thinner sections had a correlation with the RA(-950) (r = 0.22-0.23, P < 0.05). The 3-dimensional values of DEpCT reconstructed with a 1- or 3-mm section thickness had a correlation with the CT obstruction index (r = 0.52-0.59, P < 0.05) and right/left ventricular diameter ratio (r = 0.60-0.68, P < 0.01). Conclusions: The thinner images should be used for 2- and 3-dimensional quantification of DEpCT.	[Nomura, Takafumi; Okada, Munemasa; Matsunaga, Naofumi] Yamaguchi Univ, Grad Sch Med, Dept Radiol, Ube, Yamaguchi 7558505, Japan; [Nakashima, Yoshiteru] Yamaguchi Grand Med Ctr, Dept Radiol, Yamaguchi, Japan; [Yonezawa, Teppei; Kudomi, Shohei] Yamaguchi Univ, Dept Radiol, Yamaguchi, Japan; [Kido, Shoji] Yamaguchi Univ, Appl Med Engn Sci Grad Sch Med, Ube, Yamaguchi 7558505, Japan	Nomura, T (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Radiol, Minamikogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	tnomura@yamaguchi-u.ac.jp					van der Meer RW, 2005, RADIOLOGY, V235, P798, DOI 10.1148/radiol.2353040893; Zhang LJ, 2009, RADIOLOGY, V252, P61, DOI 10.1148/radiol.2521081682; Schenzle JC, 2010, INVEST RADIOL, V45, P347, DOI 10.1097/RLI.0b013e3181df901d; Thieme SF, 2009, AM J ROENTGENOL, V193, P144, DOI 10.2214/AJR.08.1653; De Zordo T, 2012, EUR RADIOL, V22, P279, DOI 10.1007/s00330-011-2251-y; Park KJ, 1999, RADIOLOGY, V211, P541; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653; Winer-Muram HT, 2003, RADIOLOGY, V229, P184, DOI 10.1148/radiol.2291020859; Qanadli SD, 2001, AM J ROENTGENOL, V176, P1415; BAXTER BS, 1981, INVEST RADIOL, V16, P337, DOI 10.1097/00004424-198107000-00017; Boroto K, 2008, EUR J RADIOL, V68, P375, DOI 10.1016/j.ejrad.2008.08.016; Collomb D, 2003, EUR RADIOL, V13, P1508, DOI 10.1007/s00330-002-1804-5; DISLER DG, 1994, INVEST RADIOL, V29, P739, DOI 10.1097/00004424-199408000-00002; Ghaye B, 2006, RADIOLOGY, V239, P884, DOI 10.1148/radiol.2392050075; Kang MJ, 2010, AM J ROENTGENOL, V195, pW325, DOI 10.2214/AJR.09.3241; Madani A, 2007, RADIOLOGY, V243, P250, DOI 10.1148/radiol.2431060194; Okada M, 2013, CLIN RADIOL, V68, pE669, DOI 10.1016/j.crad.2013.07.018; Okada M, 2012, EUR J RADIOL, V81, P2892, DOI 10.1016/j.ejrad.2011.11.006; Prionas Nicolas D, 2010, J Appl Clin Med Phys, V11, P3037; VanHoe L, 1997, J COMPUT ASSIST TOMO, V21, P332, DOI 10.1097/00004728-199703000-00034	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	NOV-DEC	2014	38	6					979	984				6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU2EW	WOS:000345430200026		
J	Magli, G; Realini, E; Reguzzoni, M; Sampietro, D				Magli, Giulio; Realini, Eugenio; Reguzzoni, Mirko; Sampietro, Daniele			Uncovering a masterpiece of Roman engineering: The project of Via Appia between Colle Pardo and Terracina	JOURNAL OF CULTURAL HERITAGE			English	Article						Via Appia; Roman roads; Centuriation; Astronomical heritage	ORIENTATION	Via Appia, built around 312 BC, is an engineering masterpiece, its most striking feature being the segment between Colle Pardo and Terracina, which goes "straight" for about 61 km. We investigate this segment by GPS techniques: results lead to uncover that the original project of the road was based on a complex interplay between geometry and astronomy. The project was indeed carried out with the help of an orthogonal centuriation grid, with all probabilities starting from a node located at the south easternmost point of the grid itself. The road however does not run along the grid's diagonal: it was orientated astronomically to the setting of the star Castor at the time of construction. Since the Gemini twins were patrons of the Roman army, the project turns out to be a work entertained for both practical and symbolic reasons, during a key moment of the Roman history. (C) 2013 Elsevier Masson SAS. All rights reserved.	[Magli, Giulio] Politecn Milan, Fac Civil Architecture, I-20133 Milan, Italy; [Realini, Eugenio] Kyoto Univ, Res Inst Sustainable Humanosphere, Kyoto 6110011, Japan; [Reguzzoni, Mirko] Politecn Milan, Dept Civil & Environm Engn, I-20133 Milan, Italy; [Sampietro, Daniele] Geomat Res & Dev, I-22100 Como, Italy	Realini, E (reprint author), Kyoto Univ, Res Inst Sustainable Humanosphere, Kyoto 6110011, Japan.	giulio.magli@polimi.it; eugenio_realini@rish.kyoto-u.ac.jp; mirko@geomatica.como.polimi.it; daniele.sampietro@g-red.eu		Realini, Eugenio/0000-0003-4119-6989			Magli G, 2008, OXFORD J ARCHAEOL, V27, P63, DOI 10.1111/j.1468-0092.2007.00296.x; Belmonte JA, 2010, J HIST ASTRON, V41, P469; Ferro L, 2012, OXFORD J ARCHAEOL, V31, P381, DOI 10.1111/j.1468-0092.2012.00394.x; Bauval R., 2004, TALISMAN; Cancellieri M., 1990, QUADERNI CTR STUDIO, V10, P61; Cotte M., 2011, HERITAGE SITES ASTRO; Dall'Aglio P., 2009, AGR CENTURIATI INT J, V6; Decramer L., 1998, CAHIERS METROLOGIE, V16, P5; Defense Mapping Agency, 1987, 83502 DEF MAPP AG; Ferrar M.J., 2003, BRIT ARCHAEOLOGICAL; Hager J.W., 1989, 83582 TM DEF MAPP AG; Hannah R, 2011, NUMEN, V58, P486, DOI 10.1163/156852711X577050; Hannah R., 2009, TIME ANTIQUITY; Hofmann-Wellenhof B., 2001, GLOBAL POSITIONING S; Humm M., 1996, ANTIQUITE, V108, P693; MACBAIN B, 1980, CLASSICAL QUART, V30, P356; Magli G., 2009, MYSTERIES DISCOVERIE; Pareti L., 1959, SR, V7, P18; Pertusini L., 2010, P GIS IDEAS 2010 HAN, P67; Quilici Gigli S., 1990, QUADERNI CTR STUDIO; Quilici L., 1990, QUADERNI CTR STUDIO, P41; Rao C., 1999, LINEAR MODELS LEAST; Realini E, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/11/115010; RODRIGUEZ E., 2005, D31639 JPL; Ruggles Clive L. N., 2005, ANCIENT ASTRONOMY EN; Sanso F, 1986, LECT NOTES EARTH SCI, V7, P49; Settis S., 1983, MISURARE TERRA; SOLER T, 1988, J SURV ENG-ASCE, V114, P84; Teunissen P. J. G., 1998, GPS GEODESY; Weinstock Stefan, 1960, JRS, V50, P112, DOI 10.2307/298293	30	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	1296-2074	1778-3674		J CULT HERIT	J. Cult. Herit.	NOV-DEC	2014	15	6					665	669		10.1016/j.culher.2013.11.014		5	Archaeology; Art; Chemistry, Analytical; Geosciences, Multidisciplinary; Materials Science, Multidisciplinary; Spectroscopy	Archaeology; Art; Chemistry; Geology; Materials Science; Spectroscopy	AU3PW	WOS:000345526800011		
J	Ohata, C; Ishii, N; Furumura, M				Ohata, Chika; Ishii, Norito; Furumura, Minao			Locations of acantholysis in pemphigus vulgaris and pemphigus foliaceus	JOURNAL OF CUTANEOUS PATHOLOGY			English	Article						Acantholysis; Desmoglein1; Desmoglein3; Pemphigus foliaceus; Pemphigus vulgaris	CLINICAL PHENOTYPE; FEATURES; LESIONS	BackgroundAcantholysis in pemphigus vulgaris (PV) and pemphigus foliaceus (PF) occurs predominantly in the suprabasal area and the granular layer, respectively. However, acantholysis can occasionally be observed in unusual locations. MethodsWe retrospectively studied the acantholysis locations in 35 PV and 27 PF cases, and analyzed them using the index value of Desmoglein (Dsg) 1 and Dsg3 by enzyme-linked immunosorbent assay, clinical data, and inflammatory cells. We also analyzed the relationship between clinical subtype and various parameters. ResultsIn PV, acantholysis was noted in the suprabasal area in 3 cases, in the lower half of the epidermis in 19 cases, and throughout the epidermis in 13 cases. In PF, acantholysis was observed in the granular layer in 6 cases, in the upper half of the epidermis in 14 cases, and throughout the epidermis in 7 cases. Mean index value of Dsg1 in PV patients with acantholysis throughout the epidermis was 2-fold higher than other PV patients. Neutrophils tended to infiltrate the dermis and epidermis more in PF than in PV. ConclusionsHigher Dsg1 index values seem to correlate with acantholysis in the upper part of the epidermis in PV. Neutrophils may play some role in unusual acantholysis locations in PF.	[Ohata, Chika; Ishii, Norito; Furumura, Minao] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 8300011, Japan	Ohata, C (reprint author), Kurume Univ, Sch Med, Dept Dermatol, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	bboohay02@ybb.ne.jp	Ohata, Chika/F-3277-2015	Ohata, Chika/0000-0001-8341-7300			Kulthanan K, 2011, ASIAN PAC J ALLERGY, V29, P161; Koga H, 2012, BRIT J DERMATOL, V166, P976, DOI 10.1111/j.1365-2133.2012.10827.x; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Amagai M, 1999, J AM ACAD DERMATOL, V40, P167, DOI 10.1016/S0190-9622(99)70183-0; Amagai M, 1999, BRIT J DERMATOL, V140, P351; Uzun S, 2006, INT J DERMATOL, V45, P523, DOI 10.1111/j.1365-4632.2004.02533.x; Khaled A, 2013, J EUR ACAD DERMATOL, V27, P81, DOI 10.1111/j.1468-3083.2011.04362.x; LAUHARANTA J, 1981, ACTA DERM-VENEREOL, V61, P535; Martel P, 2002, BRIT J DERMATOL, V147, P1263, DOI 10.1046/j.1365-2133.2002.04981.x; Mazereeuw-Hautier J, 2002, J CUTAN PATHOL, V29, P52, DOI 10.1034/j.1600-0560.2002.290110.x; Ohata C, 2011, EUR J DERMATOL, V21, P392, DOI 10.1684/ejd.2011.1352; Payne AS, 2012, FITZPATRICKS DERMATO, P586; SNEDDON IB, 1979, BRIT J DERMATOL, V100, P61, DOI 10.1111/j.1365-2133.1979.tb03570.x; Wu H, 2009, LEVERS HISTOPATHOLOG, P235; Yoshida K, 2005, J AM ACAD DERMATOL, V52, P839, DOI 10.1016/j.jaad.2005.01.106	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0303-6987	1600-0560		J CUTAN PATHOL	J. Cutan. Pathol.	NOV	2014	41	11					880	889		10.1111/cup.12384		10	Dermatology; Pathology	Dermatology; Pathology	AU4PO	WOS:000345594100011		
J	Fujiwara, T; O'Hagan, D				Fujiwara, Tomoya; O'Hagan, David			Successful fluorine-containing herbicide agrochemicals	JOURNAL OF FLUORINE CHEMISTRY			English	Review						Agrochemicals; Herbicides; Organofluorine compounds; Auxins; PPO inhibitors; Cellulose biosynthesis inhibitors	ACETYL-COA CARBOXYLASE; ARABIDOPSIS-THALIANA; PHYTOENE DESATURASE; CROP PROTECTION; C-F; INHIBITION; TARGET; SOIL; METABOLISM; SYNTHASE	Of the herbicides licensed worldwide, currently around 25% contain at least one fluorine atom and many contain multiple fluorines in the form of difluoro- and trifluoromethyl groups. Fluorine-containing compounds have made a significant contribution to the development of products for the agrochemicals industry and many organofluorine entities have found stable market positions. In this review we highlight the most important fluorinated herbicides in terms of their global use. The compounds are grouped by mode of action. A synthesis route is described for each compound although the synthesis presented may not actually be the industrial process. (C) 2014 Published by Elsevier B.V.	[Fujiwara, Tomoya; O'Hagan, David] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland; [Fujiwara, Tomoya; O'Hagan, David] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; [Fujiwara, Tomoya] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama 9300194, Japan	O'Hagan, D (reprint author), Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland.	do1@st-andrews.ac.uk					Ahrens H., US Patent Appl., Patent No. [US 20040157739, 2001007422]; Polyak SW, 2012, APPL MICROBIOL BIOT, V93, P983, DOI 10.1007/s00253-011-3796-z; Grossmann K, 2010, PEST MANAG SCI, V66, P113, DOI 10.1002/ps.1860; Yu Q, 2007, PEST MANAG SCI, V63, P918, DOI 10.1002/ps.1429; Han L, 2007, B ENVIRON CONTAM TOX, V79, P445, DOI 10.1007/s00128-007-9262-z; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Wu ZH, 2012, ORG LETT, V14, P2504, DOI 10.1021/ol300684j; Dunitz JD, 2004, CHEMBIOCHEM, V5, P614, DOI 10.1002/cbic.200300801; CHAN MMY, 1990, SCIENCE, V249, P924, DOI 10.1126/science.2392684; Dayan FE, 1996, WEED SCI, V44, P797; Ahrens H, 2013, ANGEW CHEM INT EDIT, V52, P9388, DOI 10.1002/anie.201302365; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Prakash GKS, 2012, SCIENCE, V338, P1324, DOI 10.1126/science.1227859; O'Hagan D, 2010, J FLUORINE CHEM, V131, P1071, DOI 10.1016/j.jfluchem.2010.03.003; Giornal F, 2013, J FLUORINE CHEM, V152, P2, DOI 10.1016/j.jfluchem.2012.11.008; [Anonymous], 2010, Phillips McDougall-AgriService Report, P21, Patent No. 0282303; Pallett KE, 1998, PESTIC BIOCHEM PHYS, V62, P113, DOI 10.1006/pest.1998.2378; Lechelt-Kunze C, 2003, PEST MANAG SCI, V59, P847, DOI 10.1002/ps.714; Gui JH, 2014, J AM CHEM SOC, V136, P4853, DOI 10.1021/ja5007838; Wakabayashi K, 2002, PEST MANAG SCI, V58, P1149, DOI 10.1002/ps.560; Jeschke P, 2004, CHEMBIOCHEM, V5, P570, DOI 10.1002/cbic.200300833; Boger P, 2000, PEST MANAG SCI, V56, P497; Trenkamp S, 2004, P NATL ACAD SCI USA, V101, P11903, DOI 10.1073/pnas.0404600101; Fujiwara Y, 2012, J AM CHEM SOC, V134, P1494, DOI 10.1021/ja211422g; Nagib DA, 2011, NATURE, V480, P224, DOI 10.1038/nature10647; Fernandez R, 2007, TETRAHEDRON, V63, P6755, DOI 10.1016/j.tet.2007.04.075; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Nagai T, 2011, ENVIRON TOXICOL CHEM, V30, P1898, DOI 10.1002/etc.582; Calvayrac C, 2013, SCI TOTAL ENVIRON, V452, P227, DOI 10.1016/j.scitotenv.2013.02.067; Olsen JA, 2004, CHEMBIOCHEM, V5, P666, DOI 10.1002/cbic.200300907; DUKE SO, 1990, ENVIRON HEALTH PERSP, V87, P263, DOI 10.2307/3431034; Zhou QH, 2013, ANGEW CHEM INT EDIT, V52, P3949, DOI 10.1002/anie.201300763; Theodoridis G, 2006, ADV FLUORINE SCI, V2, P121, DOI 10.1016/S1872-0358(06)02004-5; Arias RS, 2006, PLANT BIOTECHNOL J, V4, P263, DOI 10.1111/j.1467-7652.2005.00179.x; Arias RS, 2005, PEST MANAG SCI, V61, P258, DOI 10.1002/ps.1022; ASHTON IA, 1994, PHYTOCHEMISTRY, V35, P587, DOI 10.1016/S0031-9422(00)90566-1; Atherton J. H., US Patent Appl., Patent No. [US 6028219A, 6034245]; Baumeister P., Eur, Patent Appl., Patent No. [EP 0584043A1, 07082224]; Bayer H. O., US Patent Appl., Patent No. [US 4046798 A, 4110104]; Begue J.-P., 2008, BIOORGANIC MED CHEM; Bell BM, 2006, ORG PROCESS RES DEV, V10, P1167, DOI 10.1021/op0601518; Brown S. M., Eur. Patent Appl., Patent No. [EP 753508A1, 9009378]; Cain P.A., Eur. Patent Appl., Patent No. [EP 527036A1, 53011]; COLLA A, 1991, SYNTHESIS-STUTTGART, P483; Cramp M. C., Eur. Patent Appl., Patent No. [EP 53011A1, 535613]; Crispino G., PCT Int. Appl, Patent No. [WO 9919308A1, 9937650]; Diehr H.J., Ger. Patent Appl, Patent No. [DE 3431917A1, 34413]; Division of the Department of Economic and Social Affairs of the United Nations Secretariat, 2013, WORLD POP PROSP 2012; Donadello G., Aus. Patent Appl., Patent No. [AU 655550B1, 678502]; Dury M., Fr. Patent Appl, Patent No. [FR 2763940A1, 3431917]; ECD-FAO, 2011, OECD FAO AGR OUTL 20; Endoh K., Eur. Patent Appl, Patent No. [EP 618199A1, 62063572]; Ford M., Eur. Patent Appl, Patent No. [EP 2070934A1, 2763940]; Ford M., PCT Int. Appl, Patent No. [WO 2009077059A1, 2003022800]; Frear DS, 1996, J AGR FOOD CHEM, V44, P3658, DOI 10.1021/jf960186e; FRIESEN GH, 1991, WEED TECHNOL, V5, P504; Fromme D. D., 2012, J AGRON, V2012; Gondar J. S., US Patent Appl, Patent No. [US 5756755A, 5792872]; Gonzalez MA, 2008, ORG PROCESS RES DEV, V12, P301, DOI 10.1021/op700281w; Goudar J. S., PCT Int. Appl, Patent No. [WO 9724337A1, 9724316]; Goudar J.S., US Patent Appl, Patent No. [US 5449784A, 5646291]; Gupta S, 2002, CHEMOSPHERE, V47, P901, DOI 10.1016/S0045-6535(02)00017-6; Hao GF, 2011, CHIMIA, V65, P961, DOI 10.2533/chimia.2011.961; Hirai K., Jpn. Kokai Tokkyo Koho, Patent No. [JP 07082224A, 10301110]; Hirai K., Eur. Patent Appl, Patent No. [EP 496347A2, 527036]; Hoshi H., US Patent Appl., Patent No. [US 5646291A, 5728881]; Jackman D. E., US Patent Appl, Patent No. [US 6222045B1, 6545172131]; Jeschke P, 2010, PEST MANAG SCI, V66, P10, DOI 10.1002/ps.1829; Johnson TC, 2009, BIOORGAN MED CHEM, V17, P4230, DOI 10.1016/j.bmc.2009.02.010; Johnson W. O., Eur. Patent Appl., Patent No. [EP 20052A1, 20040157739]; Johnston H., US Patent Appl., Patent No. [US 4491468A, 4713109]; Johnston H., Jpn. Kokai Tokkyo Koho, Patent No. [JP 54024879A, 5449784]; Katagi T, 2003, J PESTIC SCI, V28, P44, DOI 10.1584/jpestics.28.44; Kaye A. E., Eur. Patent Appl., Patent No. [EP 34413A1, 4046798]; Keifer D. W., US Patent Appl, Patent No. [US 4909831A, 496347]; KLESCHICK WA, 1992, J AGR FOOD CHEM, V40, P1083, DOI 10.1021/jf00018a035; Kolczewski S., PCT Int. Appl., Patent No. [WO 2011023667A1, 2070934]; Koskinen WC, 2006, PEST MANAG SCI, V62, P598, DOI 10.1002/ps.1196; Krieger MS, 2000, J AGR FOOD CHEM, V48, P3710, DOI 10.1021/jf991290+; Kudo N, 1999, CHEM PHARM BULL, V47, P857; Kwiatkowski S., US Patent Appl., Patent No. [US 5728881A, 5756755]; Lantzsch R., Eur. Patent Appl., Patent No. [EP 709368A1, 753508]; Lehmann H., PCT Int. Appl., Patent No. [WO 2003022800A1, 2000344707]; Liang B, 2009, CHEMOSPHERE, V77, P1614, DOI 10.1016/j.chemosphere.2009.09.033; Marzi E, 2001, EUR J ORG CHEM, P2911; Mas J.-M., PCT Int. Appl, Patent No. [WO 9724316A1, 983982]; Matsumoto M., Eur. Patent Appl, Patent No. [EP 535613A1, 54022371]; Matsumoto M., Jpn. Kokai Tokkyo Koho, Patent No. [JP 05097848A, 0584043]; McGregor S.D., US Patent Appl., Patent No. [US 4110104A, 4358308]; MONTE WT, 1989, J HETEROCYCLIC CHEM, V26, P1393; Muramoto T., Jpn. Kokai Tokkyo Koho, Patent No. [JP 2000344707A, 2011023667]; Nishii M., PCT Int. Appl., Patent No. [WO 9009378 A1, 9512597]; Nishiyama R., Jpn. Kokai Tokkyo Koho, Patent No. [JP 62063572A, 6222045]; Nishiyama R., Jpn. Kokai Tokkyo Koho, Patent No. [JP 58099403A, 6028219]; Nishiyama R., Jpn. Kokai Tokkyo Koho, Patent No. [JP 54022371A, 54024879]; Orvik J.A., PCT Int. Appl., Patent No. [WO 9512597A1, 9724337]; Pang SS, 2002, J MOL BIOL, V317, P249, DOI 10.1006/jmbi.2001.5419; Pastorio A., Eur. Patent Appl., Patent No. [EP 1528052A1, 20052]; Pearson D.L., 2010, PHILLIPS MCDOUGALL A, Patent No. WO 9937650A1; Pearson D.L., PCT Int. Appl., Patent No. [WO 9900392A1, 9919308]; Pimentel D, 2003, AM J CLIN NUTR, V78, p660S; Planker S., Eur. Patent Appl, Patent No. [EP 678502A1, 709368]; Prasad V. A., US Patent Appl, Patent No. [US 6147221A, 618199]; Prasad V. A., US Patent Appl, Patent No. [US 6031108A, 6147221]; Prasad V. A., US Patent Appl, Patent No. [US 5792872A, 5808152]; Prasad V. A., US Patent Appl, Patent No. [US 5808152A, 58099403]; Prasad V.A., US Patent Appl, Patent No. [US 6545172B1, 655550]; Prasad V.A., US Patent Appl, Patent No. [US 6034245A, 6031108]; Schmitt M., PCT Int. Appl., Patent No. [WO 2001074785A1, 2009077059]; Schnatterer A., Eur. Patent Appl, Patent No. [EP 983982A1, 9900392]; Schurter R., US Patent Appl., Patent No. [US 4713109A, 4909831]; Shida T., Eur. Patent Appl, Patent No. [EP 0282303A1, 04305556]; Sondhia S., 2009, Toxicological and Environmental Chemistry, V91, P425, DOI 10.1080/02772240802269096; Swithenbank C., US Patent Appl., Patent No. [US 4358308 A, 4491468]; Tanabe A., Jpn. Kokai Tokkyo Koho, Patent No. [JP 04305556A, 05097848]; Tomlin C. D. S., 2006, PESTICIDE MANUAL, V14; WALKER KA, 1988, BIOCHEM J, V254, P307; Wang S., 2010, NONGYAO KEXUE YU GUA, V31, P18; Wang XR, 2013, CHIRALITY, V25, P743, DOI 10.1002/chir.22207; Willms L., Ger. Patent Appl., Patent No. [DE 10301110A1, 1528052]; Willms L., PCT Int. Appl., Patent No. [WO 2001007422A1, 2001074785]; Wolt J. D., 1997, Reviews of Environmental Contamination and Toxicology, V153, P65; Xu XY, 2011, CHIRALITY, V23, P472, DOI 10.1002/chir.20949; Zhang HL, 2004, P NATL ACAD SCI USA, V101, P5910, DOI 10.1073/pnas.0400891101; Zhu H., 2010, NONGYAO, V49, P794	125	13	13	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2014	167				SI		16	29		10.1016/j.jfluchem.2014.06.014		14	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AU2TC	WOS:000345469400003		
J	Koike, T; Akita, M				Koike, Takashi; Akita, Munetaka			Recent progress in transition-metal-catalyzed trifluoromethylation of olefins using electrophilic CF3 reagents	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Trifluoromethylation; Transition metal catalyst; Alkene difunctionlalization; Electrophilic CF3 reagent; Photocatalysis; Step economy	DRIVEN PHOTOREDOX CATALYSIS; BOND FORMATION; UNACTIVATED ALKENES; ROOM-TEMPERATURE; 3-COMPONENT OXYTRIFLUOROMETHYLATION; PERFLUOROALKYLATION REACTIONS; ASYMMETRIC FLUORINATION; OXINDOLE DERIVATIVES; ACTIVATED ALKENES; ORGANIC-SYNTHESIS	For the past few years, transition-metal-catalyzed trifluoromethylation of olefins has been rapidly developing and has provided various types of organofluorine compounds containing a C(sp(3))-CF3 bond. In this review, we will concisely summarize recent development of trifluoromethylation of C=C bonds effected by a combination of transition metal catalysis and electrophilic trifluoromethylating reagents, such as Umemoto's and Togni's reagents. (C) 2014 Elsevier B.V. All rights reserved.	[Koike, Takashi; Akita, Munetaka] Tokyo Inst Technol, Chem Resources Lab, Tokyo, Japan	Akita, M (reprint author), R1-27,4259 Nagatsuta,Midori Ku, Yokohama, Kanagawa 2268503, Japan.	koike.t.ad@m.titech.ac.jp; makita@res.titech.ac.jp	Koike, Takashi/H-8045-2012; Akita, Munetaka/C-5614-2011	Koike, Takashi/0000-0002-3737-7093; Akita, Munetaka/0000-0001-7007-9621			Amii H, 2011, J SYN ORG CHEM JPN, V69, P752; Jiang XY, 2013, ANGEW CHEM INT EDIT, V52, P14177, DOI 10.1002/anie.201307595; Janson PG, 2012, ORG LETT, V14, P2882, DOI 10.1021/ol3011419; Zhu R, 2012, J AM CHEM SOC, V134, P12462, DOI 10.1021/ja305840g; Lu DF, 2013, CHEM SCI, V4, P2478, DOI 10.1039/c3sc50582k; Xuan J, 2012, ANGEW CHEM INT EDIT, V51, P6828, DOI 10.1002/anie.201200223; Wang F, 2014, ANGEW CHEM INT EDIT, V53, P1881, DOI 10.1002/anie.201309991; UMEMOTO T, 1990, TETRAHEDRON LETT, V31, P3579; Eisenberger P, 2006, CHEM-EUR J, V12, P2579, DOI 10.1002/chem.200501052; Hopkinson MN, 2014, CHEM-EUR J, V20, P3874, DOI 10.1002/chem.201304823; Dong X, 2013, CHEM-EUR J, V19, P16910, DOI 10.1002/chem.201303623; Egami H, 2013, ANGEW CHEM INT EDIT, V52, P7841, DOI 10.1002/anie.201303350; Yasu Y, 2013, ORG LETT, V15, P2136, DOI 10.1021/ol4006272; Mizuta S, 2012, CHEM-EUR J, V18, P8583, DOI 10.1002/chem.201201707; Xu J, 2011, J AM CHEM SOC, V133, P15300, DOI 10.1021/ja206330m; Shi LL, 2014, ADV SYNTH CATAL, V356, P1021, DOI 10.1002/adsc.201300995; Ignatowska J, 2007, J FLUORINE CHEM, V128, P997, DOI 10.1016/j.jfluchem.2007.04.028; Mu X, 2012, J AM CHEM SOC, V134, P878, DOI 10.1021/ja210614y; Wu XY, 2013, ANGEW CHEM INT EDIT, V52, P2198, DOI 10.1002/anie.201208971; Kong WQ, 2013, ANGEW CHEM INT EDIT, V52, P13086, DOI 10.1002/anie.201307377; Liang T, 2013, ANGEW CHEM INT EDIT, V52, P8214, DOI 10.1002/anie.201206566; Nguyen JD, 2011, J AM CHEM SOC, V133, P4160, DOI 10.1021/ja108560e; Egami H, 2013, CHEM COMMUN, V49, P7346, DOI 10.1039/c3cc43936d; Egami H, 2012, TETRAHEDRON LETT, V53, P5503, DOI 10.1016/j.tetlet.2012.07.134; Lin JS, 2014, CHEM-EUR J, V20, P1332, DOI 10.1002/chem.201303387; Chu LL, 2012, ORG LETT, V14, P2106, DOI 10.1021/ol300639a; Oh SH, 2014, ORG LETT, V16, P1310, DOI 10.1021/ol403716t; Besset T, 2012, ANGEW CHEM INT EDIT, V51, P5048, DOI 10.1002/anie.201201012; Hollingworth C, 2012, CHEM COMMUN, V48, P2929, DOI 10.1039/c2cc16158c; Ilchenko NO, 2013, J ORG CHEM, V78, P11087, DOI 10.1021/jo401831t; Li Y, 2012, ANGEW CHEM INT EDIT, V51, P8221, DOI 10.1002/anie.201202623; Jensen KH, 2008, ORG BIOMOL CHEM, V6, P4083, DOI 10.1039/b813246a; Feng C, 2012, CHEM SCI, V3, P3458, DOI 10.1039/c2sc21164e; Ma JA, 2004, CHEM REV, V104, P6119, DOI 10.1021/cr030143e; Chen ZM, 2013, ANGEW CHEM INT EDIT, V52, P9781, DOI 10.1002/anie.201304557; Li L, 2014, ORG LETT, V16, P504, DOI 10.1021/ol403391v; Muniz K, 2004, CHEM SOC REV, V33, P166, DOI 10.1039/b307102m; Yasu Y, 2012, ANGEW CHEM INT EDIT, V51, P9567, DOI 10.1002/anie.201205071; Umemoto T, 1996, CHEM REV, V96, P1757, DOI 10.1021/cr941149u; Carboni A, 2014, ORG LETT, V16, P1240, DOI 10.1021/ol500374e; Xu J, 2014, TETRAHEDRON LETT, V55, P585, DOI 10.1016/j.tetlet.2013.11.108; Wallentin CJ, 2012, J AM CHEM SOC, V134, P8875, DOI 10.1021/ja300798k; UMEMOTO T, 1993, J AM CHEM SOC, V115, P2156, DOI 10.1021/ja00059a009; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Cardona F, 2009, NAT CHEM, V1, P269, DOI [10.1038/nchem.256, 10.1038/NCHEM.256]; Koike T, 2014, TOP CATAL, V57, P967, DOI 10.1007/s11244-014-0259-7; He YT, 2014, ORG LETT, V16, P270, DOI 10.1021/ol403263c; Xu P, 2013, CHEM-EUR J, V19, P14039, DOI 10.1002/chem.201302407; Kim E, 2013, CHEM-EUR J, V19, P6209, DOI 10.1002/chem.201300564; Kieltsch I, 2007, ANGEW CHEM INT EDIT, V46, P754, DOI 10.1002/anie.200603497; He YT, 2013, CHEM COMMUN, V49, P5687, DOI 10.1039/c3cc42588f; Hari DP, 2013, ANGEW CHEM INT EDIT, V52, P4734, DOI 10.1002/anie.201210276; Yang F, 2014, CHEM COMMUN, V50, P936, DOI 10.1039/c3cc48131j; Parsons AT, 2011, ANGEW CHEM INT EDIT, V50, P9120, DOI 10.1002/anie.201104053; Yasu Y, 2014, ORG LETT, V16, P780, DOI 10.1021/ol403500y; Yoon TP, 2010, NAT CHEM, V2, P527, DOI [10.1038/nchem.687, 10.1038/NCHEM.687]; Wang X, 2011, J AM CHEM SOC, V133, P16410, DOI 10.1021/ja207775a; Wilger DJ, 2013, CHEM SCI, V4, P3160, DOI 10.1039/c3sc51209f; Egami H, 2013, ANGEW CHEM INT EDIT, V52, P4000, DOI 10.1002/anie.201210250; McDonald RI, 2011, CHEM REV, V111, P2981, DOI 10.1021/cr100371y; Egami H, 2013, J FLUORINE CHEM, V152, P51, DOI 10.1016/j.jfluchem.2013.03.009; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Shimizu M, 2005, ANGEW CHEM INT EDIT, V44, P214, DOI 10.1002/anie.200460441; Ma JA, 2008, CHEM REV, V108, pPR1, DOI 10.1021/cr800221v; Merino E, 2014, CHEM SOC REV, V43, P6598, DOI 10.1039/c4cs00025k; Yu Q, 2013, CHEM-EUR J, V19, P13304, DOI 10.1002/chem.201302169; Liu H, 2013, ADV SYNTH CATAL, V355, P617, DOI 10.1002/adsc.201200764; Ma JA, 2007, J FLUORINE CHEM, V128, P975, DOI 10.1016/j.jfluchem.2007.04.026; Mizuta S, 2013, J AM CHEM SOC, V135, P2505, DOI 10.1021/ja401022x; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293; Mizuta S, 2013, ORG LETT, V15, P1250, DOI 10.1021/ol400184t; Kong W, 2013, J AM CHEM SOC, V135, P14480, DOI 10.1021/ja403954g; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; FUCHIKAMI T, 1987, CHEM LETT, P521, DOI 10.1246/cl.1987.521; Hiyama T., 2000, ORGANOFLUORINE COMPO; Hu JB, 2009, CHEM COMMUN, P7465, DOI 10.1039/b916463d; Kamigata N., 1991, J CHEM SOC PERK T, VI, P627; KAMIGATA N, 1989, J CHEM SOC CHEM COMM, P1559, DOI 10.1039/c39890001559; Katsuyama I, 2009, J SYN ORG CHEM JPN, V67, P992; Lu QQ, 2014, ASIAN J ORG CHEM, V3, P273, DOI 10.1002/ajoc.201300236; Mace Y, 2012, EUR J ORG CHEM, P2479, DOI 10.1002/ejoc.201101535; Ojima I., 2009, FLUORINE MED CHEM CH; Schultz D.M., 2014, SCIENCE; Shibata N., 2010, BEISTEIN J ORG CHEM; Shibata N, 2008, J SYN ORG CHEM JPN, V66, P215; Shimizu R, 2012, ANGEW CHEM INT EDIT, V51, P4577, DOI 10.1002/anie.201201095; Studer A, 2012, ANGEW CHEM INT EDIT, V51, P8950, DOI 10.1002/anie.201202624; Wolfe JP, 2012, ANGEW CHEM INT EDIT, V51, P10224, DOI 10.1002/anie.201204470; Wolfe JP, 2008, SYNLETT, P2913, DOI 10.1055/s-0028-1087339; Zhu R, 2013, ANGEW CHEM INT EDIT, V52, P12655, DOI 10.1002/anie.201307790	91	16	16	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2014	167				SI		30	36		10.1016/j.jfluchem.2014.06.025		7	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AU2TC	WOS:000345469400004		
J	Zhu, W; Wang, J; Wang, SN; Gu, ZN; Acena, JL; Izawa, K; Liu, H; Soloshonok, VA				Zhu, Wei; Wang, Jiang; Wang, Shuni; Gu, Zhanni; Luis Acena, Jose; Izawa, Kunisuke; Liu, Hong; Soloshonok, Vadim A.			Recent advances in the trifluoromethylation methodology and new CF3-containing drugs	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Trifluoromethylation; Methodology; Fluorine-containing drugs; Pharmaceuticals; Biological activity	COPPER-CATALYZED TRIFLUOROMETHYLATION; CANNABINOID RECEPTOR AGONIST; BETA-AMINO ACIDS; SILVER-MEDIATED TRIFLUOROMETHYLATION; LIGHT PHOTOREDOX CATALYSIS; ENANTIOSELECTIVE ALPHA-TRIFLUOROMETHYLATION; PD(II)-CATALYZED ORTHO-TRIFLUOROMETHYLATION; IMMUNODEFICIENCY-VIRUS TYPE-1; ACHIRAL-PHASE CHROMATOGRAPHY; HYPERVALENT IODINE REAGENT	This review provides a brief assessment of the methodological field of trifluoromethylation and its possible impact on the development of new CF3-containing pharmaceuticals. Structural aspects of five new drug-candidates, [tafenoquine (aromatic CF3), roniciclib (heteroaromatic CF3), BAY-38-7271 (aliphatic CF3), sonidegib (O-CF3) and navitoclax (S-CF3)] currently under the development in phase II and III clinical studies, and their biological properties, therapeutic area and synthesis are critically discussed. (C) 2014 Elsevier B.V. All rights reserved.	[Zhu, Wei; Wang, Jiang; Wang, Shuni; Gu, Zhanni; Liu, Hong] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Luis Acena, Jose; Soloshonok, Vadim A.] Univ Basque Country, Fac Chem, UPV EHU, Dept Quim Chem 1, San Sebastian 20018, Spain; [Izawa, Kunisuke] Hamari Chem Ltd, Higashi Yodogawa Ku, Osaka 5330024, Japan; [Soloshonok, Vadim A.] Basque Fdn Sci, Ikerbasque, Bilbao 48011, Spain	Liu, H (reprint author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	hliu@mail.shcnc.ac.cn; vadym.soloshonok@ehu.es			IKERBASQUE; Basque Foundation for Science; Basque Government [SAIOTEK S-PE13UN098]; National Natural Science Foundation of China [81025017]; Hamari Chemicals (Osaka, Japan)	We thank IKERBASQUE, Basque Foundation for Science; the Basque Government (SAIOTEK S-PE13UN098), the National Natural Science Foundation of China (Grant 81025017) and Hamari Chemicals (Osaka, Japan) for financial support.	Acena JL, 2012, SYNTHESIS-STUTTGART, V44, P1591, DOI 10.1055/s-0031-1289756; Albrecht M, 2010, J FLUORINE CHEM, V131, P495, DOI 10.1016/j.jfluchem.2009.11.015; Kirk KL, 2006, J FLUORINE CHEM, V127, P1013, DOI 10.1016/j.jfluchem.2006.06.007; Janson PG, 2012, ORG LETT, V14, P2882, DOI 10.1021/ol3011419; Liu TF, 2011, ORG LETT, V13, P2342, DOI 10.1021/ol2005903; Chang Y, 2005, J FLUORINE CHEM, V126, P937, DOI 10.1016/j.jfluchem.2005.04.012; Netland PA, 2001, AM J OPHTHALMOL, V132, P472, DOI 10.1016/S0002-9394(01)01177-1; Umemoto T, 2007, J ORG CHEM, V72, P6905, DOI 10.1021/jo070896r; Kukhar VP, 2009, FUTURE MED CHEM, V1, P793, DOI [10.4155/fmc.09.70, 10.4155/FMC.09.70]; Zeng YW, 2013, J AM CHEM SOC, V135, P2955, DOI 10.1021/ja312711c; Zhang CP, 2011, CHEM COMMUN, V47, P9516, DOI 10.1039/c1cc13460d; Zhu R, 2012, J AM CHEM SOC, V134, P12462, DOI 10.1021/ja305840g; Lu DF, 2013, CHEM SCI, V4, P2478, DOI 10.1039/c3sc50582k; Lucking U, 2013, CHEMMEDCHEM, V8, P1067, DOI 10.1002/cmdc.201300096; Mauler F, 2002, J PHARMACOL EXP THER, V302, P359, DOI 10.1124/jpet.302.1.359; Ye YD, 2010, J AM CHEM SOC, V132, P14682, DOI 10.1021/ja107780w; Pan YH, 2011, GREEN CHEM, V13, P3341, DOI 10.1039/c1gc15865a; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Dubinina GG, 2008, J AM CHEM SOC, V130, P8600, DOI 10.1021/ja802946s; UMEMOTO T, 1990, TETRAHEDRON LETT, V31, P3579; Xu J, 2012, ANGEW CHEM INT EDIT, V51, P12551, DOI 10.1002/anie.201206681; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; Kawai H, 2011, ORG LETT, V13, P3596, DOI 10.1021/ol201205t; Irvine DA, 2012, BLOOD, V119, P2196, DOI 10.1182/blood-2011-10-383752; Lundgren RJ, 2010, ANGEW CHEM INT EDIT, V49, P9322, DOI 10.1002/anie.201004051; Park SJ, 2013, CHEMMEDCHEM, V8, P217, DOI 10.1002/cmdc.201200403; Yasu Y, 2013, ORG LETT, V15, P2136, DOI 10.1021/ol4006272; Mu X, 2011, CHEM-EUR J, V17, P6039, DOI 10.1002/chem.201100283; Mizuta S, 2012, CHEM-EUR J, V18, P8583, DOI 10.1002/chem.201201707; Marcocci C, 2012, J ENDOCRINOL INVEST, V35, P90, DOI 10.3275/8112; Xu J, 2011, J AM CHEM SOC, V133, P15300, DOI 10.1021/ja206330m; Pham PV, 2011, ANGEW CHEM INT EDIT, V50, P6119, DOI 10.1002/anie.201101861; Li Y, 2011, ORG LETT, V13, P6082, DOI 10.1021/ol202572u; Parsons AT, 2012, ANGEW CHEM INT EDIT, V51, P2947, DOI 10.1002/anie.201108267; Petros AM, 2006, J MED CHEM, V49, P656, DOI 10.1021/jm0507532; Grushin VV, 2006, J AM CHEM SOC, V128, P12644, DOI 10.1021/ja064935c; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Mu X, 2012, J AM CHEM SOC, V134, P878, DOI 10.1021/ja210614y; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Wu XY, 2013, ANGEW CHEM INT EDIT, V52, P2198, DOI 10.1002/anie.201208971; Li Y, 2013, CHEM COMMUN, V49, P2628, DOI 10.1039/c2cc36554e; Matousek V, 2011, ORG LETT, V13, P5762, DOI 10.1021/ol2023328; Jiang H, 2012, CHEM-EUR J, V18, P15158, DOI 10.1002/chem.201201716; Allen AE, 2010, J AM CHEM SOC, V132, P4986, DOI 10.1021/ja100748y; Soloshonok VA, 1996, TETRAHEDRON, V52, P12433, DOI 10.1016/0040-4020(96)00741-7; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Begue JP, 2006, J FLUORINE CHEM, V127, P992, DOI 10.1016/j.jfluchem.2006.05.006; Egami H, 2012, TETRAHEDRON LETT, V53, P5503, DOI 10.1016/j.tetlet.2012.07.134; Novak P, 2012, J AM CHEM SOC, V134, P16167, DOI 10.1021/ja307783w; Iqbal N, 2012, J ORG CHEM, V77, P11383, DOI 10.1021/jo3022346; Acena JL, 2010, CURR ORG CHEM, V14, P928; Tomashenko OA, 2011, ANGEW CHEM INT EDIT, V50, P7655, DOI 10.1002/anie.201101577; Turcheniuk KV, 2013, RSC ADV, V3, P6693, DOI 10.1039/c3ra22891f; Roy S, 2011, TETRAHEDRON, V67, P2161, DOI 10.1016/j.tet.2011.01.002; Deng QH, 2012, J AM CHEM SOC, V134, P10769, DOI 10.1021/ja3039773; Besset T, 2012, ANGEW CHEM INT EDIT, V51, P5048, DOI 10.1002/anie.201201012; Herrmann AT, 2012, J AM CHEM SOC, V134, P6976, DOI 10.1021/ja302552e; Bizet V, 2014, ANGEW CHEM INT EDIT, V53, P5639, DOI 10.1002/anie.201310790; Yasu Y, 2013, CHEM COMMUN, V49, P2037, DOI 10.1039/c3cc39235j; O'Hagan D, 2010, J FLUORINE CHEM, V131, P1071, DOI 10.1016/j.jfluchem.2010.03.003; Wang J, 2014, CHEM REV, V114, P2432, DOI 10.1021/cr4002879; SOLOSHONOK VA, 1994, TETRAHEDRON LETT, V35, P1055, DOI 10.1016/S0040-4039(00)79964-3; Sorochinsky AE, 2013, CHIRALITY, V25, P365, DOI 10.1002/chir.22180; Mauler F, 2003, BRAIN RES, V989, P99, DOI 10.1016/S0006-8993(03)03376-6; Shibata N, 2008, TETRAHEDRON-ASYMMETR, V19, P2633, DOI 10.1016/j.tetasy.2008.11.011; Ji YN, 2011, P NATL ACAD SCI USA, V108, P14411, DOI 10.1073/pnas.1109059108; Jiang XL, 2012, J ORG CHEM, V77, P1251, DOI 10.1021/jo202566h; Thornberry NA, 2007, CURR TOP MED CHEM, V7, P557, DOI 10.2174/156802607780091028; Liu XW, 2013, ANGEW CHEM INT EDIT, V52, P6962, DOI 10.1002/anie.201302673; Li Y, 2012, ANGEW CHEM INT EDIT, V51, P8221, DOI 10.1002/anie.201202623; Chu LL, 2010, ORG LETT, V12, P5060, DOI 10.1021/ol1023135; Fantasia S, 2010, J ORG CHEM, V75, P1779, DOI 10.1021/jo9025429; Feng C, 2012, CHEM SCI, V3, P3458, DOI 10.1039/c2sc21164e; Singh RP, 1999, J ORG CHEM, V64, P2873, DOI 10.1021/jo982494c; Wang XS, 2010, J AM CHEM SOC, V132, P3648, DOI 10.1021/ja909522s; Nagib DA, 2009, J AM CHEM SOC, V131, P10875, DOI 10.1021/ja9053338; Ueki H, 2010, TETRAHEDRON-ASYMMETR, V21, P1396, DOI 10.1016/j.tetasy.2010.04.040; Doucet H, 1999, CHEM-EUR J, V5, P1320, DOI 10.1002/(SICI)1521-3765(19990401)5:4<1320::AID-CHEM1320>3.3.CO;2-R; Li ZJ, 2013, ORG LETT, V15, P406, DOI 10.1021/ol3034059; Senecal TD, 2011, J ORG CHEM, V76, P1174, DOI 10.1021/jo1023377; Novak P, 2012, ANGEW CHEM INT EDIT, V51, P7767, DOI 10.1002/anie.201201613; Kirk KL, 2008, ORG PROCESS RES DEV, V12, P305, DOI 10.1021/op700134j; Zanardi A, 2011, J AM CHEM SOC, V133, P20901, DOI 10.1021/ja2081026; Litvinas ND, 2012, ANGEW CHEM INT EDIT, V51, P536, DOI 10.1002/anie.201106668; Niedermann K, 2012, ANGEW CHEM INT EDIT, V51, P6511, DOI 10.1002/anie.201201572; Yasu Y, 2012, ANGEW CHEM INT EDIT, V51, P9567, DOI 10.1002/anie.201205071; Ball ND, 2010, J AM CHEM SOC, V132, P2878, DOI 10.1021/ja100955x; De Vry J, 2004, J PHARMACOL EXP THER, V310, P620, DOI 10.1124/jpet.103.062836; Xu J, 2014, TETRAHEDRON LETT, V55, P585, DOI 10.1016/j.tetlet.2013.11.108; Chu LL, 2012, J AM CHEM SOC, V134, P1298, DOI 10.1021/ja209992w; Koller R, 2009, ANGEW CHEM INT EDIT, V48, P4332, DOI 10.1002/anie.200900974; Miyake Y, 2012, CHEM-EUR J, V18, P13255, DOI 10.1002/chem.201202853; Zhang CP, 2011, ANGEW CHEM INT EDIT, V50, P1896, DOI 10.1002/anie.201006823; Ye YD, 2012, ORG LETT, V14, P4979, DOI 10.1021/ol3022726; Acena JL, 2013, J FLUORINE CHEM, V155, P21, DOI 10.1016/j.jfluchem.2013.06.004; URATA H, 1991, TETRAHEDRON LETT, V32, P91, DOI 10.1016/S0040-4039(00)71226-3; YOUNG SD, 1995, ANTIMICROB AGENTS CH, V39, P2602; Ye YD, 2012, J AM CHEM SOC, V134, P9034, DOI 10.1021/ja301553c; Wang X, 2013, J AM CHEM SOC, V135, P10330, DOI 10.1021/ja4056239; Cho EJ, 2011, ORG LETT, V13, P6552, DOI 10.1021/ol202885w; Morimoto H, 2011, ANGEW CHEM INT EDIT, V50, P3793, DOI 10.1002/anie.201100633; Stanek K, 2008, J ORG CHEM, V73, P7678, DOI 10.1021/jo8014825; Capone S, 2008, HELV CHIM ACTA, V91, P2035, DOI 10.1002/hlca.200890217; Wang KP, 2013, CHEM SCI, V4, P3205, DOI 10.1039/c3sc50992c; Iqbal N, 2012, TETRAHEDRON LETT, V53, P2005, DOI 10.1016/j.tetlet.2012.02.032; Kieltsch I, 2007, ANGEW CHEM INT EDIT, V46, P754, DOI 10.1002/anie.200603497; Kondo H, 2011, ADV SYNTH CATAL, V353, P1247, DOI 10.1002/adsc.201000825; Parsons AT, 2011, ANGEW CHEM INT EDIT, V50, P9120, DOI 10.1002/anie.201104053; Nagib DA, 2011, NATURE, V480, P224, DOI 10.1038/nature10647; Wang X, 2011, J AM CHEM SOC, V133, P16410, DOI 10.1021/ja207775a; Wilger DJ, 2013, CHEM SCI, V4, P3160, DOI 10.1039/c3sc51209f; Tlili A, 2013, ANGEW CHEM INT EDIT, V52, P6818, DOI 10.1002/anie.201301438; Soloshonok VA, 2012, CHEM SOC REV, V41, P4180, DOI 10.1039/c2cs35006h; Knauber T, 2011, CHEM-EUR J, V17, P2689, DOI 10.1002/chem.201002749; Bizet V, 2014, CHEM SOC REV, V43, P2426, DOI 10.1039/c3cs60427f; Hu MY, 2012, J AM CHEM SOC, V134, P15257, DOI 10.1021/ja307058c; Egami H, 2013, ANGEW CHEM INT EDIT, V52, P4000, DOI 10.1002/anie.201210250; Zhang LS, 2013, ORG LETT, V15, P10, DOI 10.1021/ol302814x; Soloshonok VA, 2006, CHIM OGGI, V24, P44; Khan BA, 2012, CHEM-EUR J, V18, P1577, DOI 10.1002/chem.201102652; Wang JA, 2011, J ORG CHEM, V76, P684, DOI 10.1021/jo102031b; Pan SF, 2010, ACS MED CHEM LETT, V1, P130, DOI 10.1021/ml1000307; Siemeister G, 2012, MOL CANCER THER, V11, P2265, DOI 10.1158/1535-7163.MCT-12-0286; Ohkura H, 2003, TETRAHEDRON, V59, P1647, DOI 10.1016/S0040-4020(03)00138-8; Chakraborti AK, 2010, CURR MED CHEM, V17, P1563; Cheng Y, 2014, ORG LETT, V16, P2000, DOI 10.1021/ol500573f; Wu XF, 2012, CHEM-ASIAN J, V7, P1744, DOI 10.1002/asia.201200211; Prakash GKS, 1997, CHEM REV, V97, P757, DOI 10.1021/cr9408991; Ma JA, 2008, CHEM REV, V108, pPR1, DOI 10.1021/cr800221v; Merino E, 2014, CHEM SOC REV, V43, P6598, DOI 10.1039/c4cs00025k; Zhang XG, 2012, J AM CHEM SOC, V134, P11948, DOI 10.1021/ja305259n; Ye YD, 2011, ORG LETT, V13, P5464, DOI 10.1021/ol202174a; Liu H, 2013, ADV SYNTH CATAL, V355, P617, DOI 10.1002/adsc.201200764; FUCHIKAMI T, 1983, J ORG CHEM, V48, P3803, DOI 10.1021/jo00169a040; Wendt MD, 2006, J MED CHEM, V49, P1165, DOI 10.1021/jm050754u; Dai JJ, 2013, J AM CHEM SOC, V135, P8436, DOI 10.1021/ja404217t; Mizuta S, 2013, J AM CHEM SOC, V135, P2505, DOI 10.1021/ja401022x; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293; Soloshonok VA, 2007, J AM CHEM SOC, V129, P12112, DOI 10.1021/ja065603a; Mizuta S, 2013, ORG LETT, V15, P1250, DOI 10.1021/ol400184t; Xu J, 2011, CHEM COMMUN, V47, P4300, DOI 10.1039/c1cc10359h; Uraguchi D, 2008, APPL CATAL A-GEN, V342, P137, DOI 10.1016/j.apcata.2008.03.009; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Crockett M, 2007, EXPERT OPIN INV DRUG, V16, P705, DOI 10.1517/13543784.16.5.705; Chu LL, 2010, J AM CHEM SOC, V132, P7262, DOI 10.1021/ja102175w; Liu TF, 2012, ANGEW CHEM INT EDIT, V51, P540, DOI 10.1002/anie.201106673; Baasner B., 2000, HOUBEN WEYL METHODS, VE10; Bailey A.E., 2002, U.S. Patent, Patent No. 0019539; Balzarini J, 2004, CURR TOP MED CHEM, V4, P921, DOI 10.2174/1568026043388420; Banks R. E., 1994, ORGANOFLUORINE CHEM; Bell D., PCT Int. Appl., Patent No. [WO2003093239A2, 2003093239]; Benson K.R., 2000, U.S. Patent, Patent No. 6118028; Cottet F, 2002, EUR J ORG CHEM, P327; Deadman B.J., 2013, ORG BIOMOL CHEM, V11, P1700; De Vry J, 2002, EUR J PHARMACOL, V457, P147, DOI 10.1016/S0014-2999(02)02697-3; DITER P, 1994, J ORG CHEM, V59, P370, DOI 10.1021/jo00081a015; Franceschini N, 2003, EXPERT OPIN INV DRUG, V12, P1413, DOI 10.1517/13543784.12.8.1413; Frye SV, 2006, CURR TOP MED CHEM, V6, P405, DOI 10.2174/156802606776743101; FRYE SV, 1995, J MED CHEM, V38, P2621, DOI 10.1021/jm00014a015; FUCHIKAMI T, 1982, TETRAHEDRON LETT, V23, P4099, DOI 10.1016/S0040-4039(00)88357-4; FUCHIKAMI T, 1982, J AM CHEM SOC, V104, P3527, DOI 10.1021/ja00376a057; Hafner A, 2012, ANGEW CHEM INT EDIT, V51, P3713, DOI 10.1002/anie.201107414; Hayashi H., 2002, U.S. Patent, Patent No. 6417361; He Z., 2012, ANGEW CHEM INT EDIT, V51, P3944; Hiyama H., 2000, ORGANOFLUORINE COMPO; Hu B, 2014, J CHEM RES, P18, DOI 10.3184/174751914X13860924330499; Katagiri T, 2001, CHEM COMMUN, P2054, DOI 10.1039/b105602f; Kath J., U.S. Patent, Patent No. [US20050256125A1, 20050256125]; Koller R, 2009, CHEM COMMUN, P5993, DOI 10.1039/b913962a; Kruger J., U.S. Patent, Patent No. [US2013245261A1, 2013245261]; Leroux FR, 2008, BEILSTEIN J ORG CHEM, V4, DOI 10.3762/bjoc.4.13; Lin XX, 2013, TETRAHEDRON, V69, P2628, DOI 10.1016/j.tet.2013.01.041; Liu TF, 2012, EUR J ORG CHEM, P6679, DOI 10.1002/ejoc.201200648; Liu XW, 2013, SYNLETT, V24, P1882, DOI 10.1055/s-0033-1339684; Lucking U, 2013, ANGEW CHEM INT EDIT, V52, P9399, DOI 10.1002/anie.201302209; Mauler F, 2003, CNS DRUG REV, V9, P343; Mikami K, 2011, SYNTHESIS-STUTTGART, P3045, DOI 10.1055/s-0030-1260173; Mittendorf J., 2001, U.S. Patent, Patent No. 6262112; Mittendorf J., 2003, U.S. Patent, Patent No. 6545050; NAGAYA H, 1991, BIOCHEM PHARMACOL, V42, P1875, DOI 10.1016/0006-2952(91)90584-R; Nanayakkara NPD, 2008, ANTIMICROB AGENTS CH, V52, P2130, DOI 10.1128/AAC.00645-07; Ogawa S, 2010, J FLUORINE CHEM, V131, P521, DOI 10.1016/j.jfluchem.2009.12.002; Oishi M, 2009, CHEM COMMUN, P1909, DOI 10.1039/b823249k; OJIMA I, 1988, J AM CHEM SOC, V110, P150, DOI 10.1021/ja00209a024; OJIMA I, 1988, J AM CHEM SOC, V110, P5617, DOI 10.1021/ja00225a004; OJIMA I, 1989, J ORG CHEM, V54, P4511, DOI 10.1021/jo00280a014; OJIMA I, 1987, J AM CHEM SOC, V109, P7714, DOI 10.1021/ja00259a020; Park CM, 2008, J MED CHEM, V51, P6902, DOI 10.1021/jm800669s; Penning TD, 1997, J MED CHEM, V40, P1347, DOI 10.1021/jm960803q; POPOV VI, 1982, J FLUORINE CHEM, V21, P365, DOI 10.1016/S0022-1139(00)81521-3; Shimizu R, 2012, ANGEW CHEM INT EDIT, V51, P4577, DOI 10.1002/anie.201201095; Shiraki H, 2011, J MED CHEM, V54, P131, DOI 10.1021/jm100911f; SOLOSHONOK V, 1992, SYNLETT, P657; SOLOSHONOK VA, 1994, TETRAHEDRON-ASYMMETR, V5, P1091, DOI 10.1016/0957-4166(94)80059-6; SOLOSHONOK VA, 1994, TETRAHEDRON LETT, V35, P2713, DOI 10.1016/S0040-4039(00)77013-4; Soloshonok VA, 2006, ANGEW CHEM INT EDIT, V45, P766, DOI 10.1002/anie.200503373; Song WG, 2013, TETRAHEDRON-ASYMMETR, V24, P909, DOI 10.1016/j.tetasy.2013.06.008; Sorochinsky AE, 2010, J FLUORINE CHEM, V131, P127, DOI 10.1016/j.jfluchem.2009.09.015; Sorochinsky AE, 2013, SYNTHESIS-STUTTGART, V45, P141, DOI 10.1055/s-0032-1316812; Studer A, 2012, ANGEW CHEM INT EDIT, V51, P8950, DOI 10.1002/anie.201202624; Swarts F., 1892, B ACAD R BELG, V24, P309; Toulgoat F., 2014, EUR J ORG CHEM, P2415; Ugwuegbulam C.O., PCT Int. Appl., Patent No. [WO9713753A1, 9713753]; UMEMOTO T, 1994, J ORG CHEM, V59, P5692, DOI 10.1021/jo00098a030; Wzorek A, 2014, ORG BIOMOL CHEM, V12, P4738, DOI 10.1039/c4ob00831f	206	39	39	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2014	167				SI		37	54		10.1016/j.jfluchem.2014.06.026		18	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AU2TC	WOS:000345469400005		
J	Kunigami, M; Hara, S				Kunigami, Masataka; Hara, Shoji			Synthesis of fluoromethyl ethers and fluoromethyl esters by the reaction of the corresponding methylthiomethyl ethers and methylthiomethyl esters with IF5-pyridine-HF	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Stable fluorinating reagent; IF5-pyridine-HF; Fluoromethyl ether; Fluoromethyl ester	POSITRON-EMISSION-TOMOGRAPHY; TUMOR-IMAGING AGENTS; ELECTROPHILIC MONOFLUOROMETHYLATION; CARBOXYLIC-ACIDS; XENON DIFLUORIDE; D-ISOMERS; FLUORINATION; FLUORODECARBOXYLATION; O-F-18-FLUOROMETHYL; TYROSINE	Fluoromethyl ethers of various functionalized phenols were synthesized from the corresponding methylthiomethyl ethers by the reaction with IF5-pyridine-HF. A fluoromethyl ether of an aliphatic alcohol and a fluoromethyl ester of a carboxylic acid were also synthesized. (C) 2014 Elsevier B.V. All rights reserved.	[Kunigami, Masataka; Hara, Shoji] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan	Hara, S (reprint author), Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan.	shara@eng.hokudai.ac.jp					Anderson R.F., 1979, ORGANOFLUORINE CHEM, P235; Zhang MR, 2003, BIOORG MED CHEM LETT, V13, P201, DOI 10.1016/S0960-894X(02)00886-7; Park C, 2013, ORG LETT, V15, P4346, DOI 10.1021/ol401792n; Nomura Y, 2011, ANGEW CHEM INT EDIT, V50, P1885, DOI 10.1002/anie.201006218; Kilbourn MR, 2007, NUCL MED BIOL, V34, P233, DOI 10.1016/j.nucmedbio.2007.01.007; Fuchigami T, 2005, J FLUORINE CHEM, V126, P181, DOI 10.1016/j.jfluchem.2004.11.003; Rozen S, 2010, ADV SYNTH CATAL, V352, P2691, DOI 10.1002/adsc.201000482; Kuroboshi M, 2001, ADV SYNTH CATAL, V343, P235, DOI 10.1002/1615-4169(20010330)343:3<235::AID-ADSC235>3.0.CO;2-0; Ochiai M, 2009, TETRAHEDRON LETT, V50, P4792, DOI 10.1016/j.tetlet.2009.06.042; Tsukada H, 2006, EUR J NUCL MED MOL I, V33, P1017, DOI 10.1007/s00259-006-0076-8; PATRICK TB, 1983, J ORG CHEM, V48, P4158, DOI 10.1021/jo00170a072; Shimizu M, 2005, ANGEW CHEM INT EDIT, V44, P214, DOI 10.1002/anie.200460441; PATRICK TB, 1986, CAN J CHEM, V64, P138, DOI 10.1139/v86-024; Becerril M.R., 2012, J AM CHEM SOC, V134, P4026; Hara S., 2013, TETRAHEDRON, V68, P10145; Hiyama T., 2000, ORGANOFLUORINE COMPO, P212; Holton R.A., 1976, TETRAHEDRON LETT, V18, P533; Hugenberg V, 2012, J FLUORINE CHEM, V143, P238, DOI 10.1016/j.jfluchem.2012.06.015; Iimura S, 2001, BIOORG MED CHEM LETT, V11, P407, DOI 10.1016/S0960-894X(00)00682-X; Iwata R, 2003, J LABELLED COMPD RAD, V46, P555, DOI 10.1002/jlcr.696; Kawamura K, 2007, NUCL MED BIOL, V34, P571, DOI 10.1016/j.nucmedbio.2007.03.009; Kirsch P., 2004, MODERN FLUOROORGANIC, P203; Kudzma LV, 2001, J FLUORINE CHEM, V111, P11, DOI 10.1016/S0022-1139(01)00396-7; Leung JCT, 2012, ANGEW CHEM INT EDIT, V51, P10804, DOI 10.1002/anie.201206352; Lu QB, 1996, ACTA CHEM SCAND, V50, P850, DOI 10.3891/acta.chem.scand.50-0850; Munro TA, 2008, BIOORGAN MED CHEM, V16, P1279, DOI 10.1016/j.bmc.2007.10.067; Prakash GKS, 2008, ORG LETT, V10, P557, DOI 10.1021/ol702500u; Ramig K, 2002, SYNTHESIS-STUTTGART, P2627, DOI 10.1055/s-2002-35633; Reddy V.P., 2006, ADV ORGANIC SYNTHESI, P183; Ringom R, 1999, ACTA CHEM SCAND, V53, P41, DOI 10.3891/acta.chem.scand.53-0041; STAVBER S, 1993, TETRAHEDRON LETT, V34, P4355, DOI 10.1016/S0040-4039(00)79350-6; Tsukada H, 2006, J NUCL MED, V47, P679; Urakami T, 2009, NUCL MED BIOL, V36, P295, DOI 10.1016/j.nucmedbio.2008.12.012; WADE LG, 1978, TETRAHEDRON LETT, P731; Zhang W, 2007, TETRAHEDRON, V63, P10569, DOI 10.1016/j.tet.2007.08.043	35	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2014	167				SI		101	104		10.1016/j.jfluchem.2014.05.008		4	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AU2TC	WOS:000345469400013		
J	Nihei, T; Kubo, Y; Ishihara, T; Konno, T				Nihei, Takashi; Kubo, Yusuke; Ishihara, Takashi; Konno, Tsutomu			Highly regioselective S(N)2 ' reaction of beta-fluoroallylic phosphates with organocopper reagents and its application to the synthesis of fluorine-containing carbocycles	JOURNAL OF FLUORINE CHEMISTRY			English	Article						S(N)2 ' reaction; beta-Fluoroallyl phosphates; Regioselective; Ring-closing metathesis; Fluoroalkenes	RING-CLOSING METATHESIS; CATALYZED ALLYLIC ALKYLATION; ENANTIOSELECTIVE SYNTHESIS; OLEFIN-METATHESIS; GRIGNARD-REAGENTS; VINYL FLUORIDES; NITROGEN-HETEROCYCLES; ALCOHOL DERIVATIVES; STEREOGENIC CENTERS; HYDRIDE REDUCTION	Treatment of beta-fluoroallyl phosphates with 2.2 equiv. of organocuprates, prepared readily from 2.2 equiv. each of CuCN and organometallics (organolithium reagents, Grignard reagents, and organozinc reagents), in THF at -40 to 0 degrees C for 0.25 to 24 h gave gamma-products in a highly regioselective manner. Thus obtained gamma-adducts were subjected to the ring-closing metathesis, the corresponding cyclic fluoroalkenes being afforded in good yields. (C) 2014 Elsevier B.V. All rights reserved.	[Nihei, Takashi; Kubo, Yusuke; Ishihara, Takashi; Konno, Tsutomu] Kyoto Inst Technol, Dept Chem & Mat Technol, Sakyo Ku, Kyoto 6068585, Japan	Konno, T (reprint author), Kyoto Inst Technol, Dept Chem & Mat Technol, Sakyo Ku, Kyoto 6068585, Japan.	konno@kit.ac.jp					MARSHALL JA, 1989, CHEM REV, V89, P1503, DOI 10.1021/cr00097a006; BACKVALL JE, 1990, J AM CHEM SOC, V112, P6615; PERSSON ESM, 1995, CHEM-EUR J, V1, P351, DOI 10.1002/chem.19950010605; Schrock RR, 2003, ANGEW CHEM INT EDIT, V42, P4592, DOI 10.1002/anie.200300576; Kacprzynski MA, 2004, J AM CHEM SOC, V126, P10676, DOI 10.1021/ja0478779; Falciola CA, 2006, ANGEW CHEM INT EDIT, V45, P5995, DOI 10.1002/anie.200601855; Murphy KE, 2005, ORG LETT, V7, P1255, DOI 10.1021/ol047331r; Lopez F, 2006, CHEM COMMUN, P409, DOI 10.1039/b513887f; Marhold M, 2004, TETRAHEDRON LETT, V45, P57, DOI 10.1016/j.tetlet.2003.10.127; Tranel F, 2004, J FLUORINE CHEM, V125, P1593, DOI 10.1016/j.jfluchem.2004.09.001; Murphy KE, 2003, J AM CHEM SOC, V125, P4690, DOI 10.1021/ja0300618; Falck JR, 2006, J ORG CHEM, V71, P8178, DOI 10.1021/jo061445u; van Zijl AW, 2007, J ORG CHEM, V72, P2558, DOI 10.1021/jo0625655; Deiters A, 2004, CHEM REV, V104, P2199, DOI 10.1021/cr0200872; Grubbs RH, 1998, TETRAHEDRON, V54, P4413, DOI 10.1016/S0040-4020(97)10427-6; Salim SS, 2003, ORG LETT, V5, P3403, DOI 10.1021/ol035065w; BACKVALL JE, 1994, J ORG CHEM, V59, P4126; Kimura M, 2004, ORG LETT, V6, P4651, DOI 10.1021/ol0481941; Luchaco-Cullis CA, 2001, ANGEW CHEM INT EDIT, V40, P1456, DOI 10.1002/1521-3773(20010417)40:8<1456::AID-ANIE1456>3.0.CO;2-T; Feng C, 2013, J ORG CHEM, V78, P3755, DOI 10.1021/jo400248y; Fananas-Mastral M, 2012, ANGEW CHEM INT EDIT, V51, P1922, DOI 10.1002/anie.201107840; Yamanaka M, 2004, J AM CHEM SOC, V126, P6287, DOI 10.1021/ja049211k; Larsen AO, 2004, J AM CHEM SOC, V126, P11130, DOI 10.1021/ja046245j; Trnka TM, 2001, ACCOUNTS CHEM RES, V34, P18, DOI 10.1021/ar000114f; Nakamura E, 2000, ANGEW CHEM INT EDIT, V39, P3750, DOI 10.1002/1521-3773(20001103)39:21<3750::AID-ANIE3750>3.0.CO;2-L; Lee Y, 2008, J AM CHEM SOC, V130, P446, DOI 10.1021/ja0782192; De Matteis V, 2006, J ORG CHEM, V71, P7527, DOI 10.1021/jo060893z; De Matteis V, 2004, TETRAHEDRON LETT, V45, P959, DOI 10.1016/j.tetlet.2003.11.093; Connon SJ, 2003, ANGEW CHEM INT EDIT, V42, P1900, DOI 10.1002/anie.200200556; Armstrong SK, 1998, J CHEM SOC PERK T 1, P371; Baeza A, 2007, EUR J ORG CHEM, P1101, DOI 10.1002/ejoc.200600822; CHEREST M, 1968, TETRAHEDRON LETT, P2199; Coquerel Y, 2008, EUR J ORG CHEM, P1125, DOI 10.1002/ejoc.200700696; DENMARK SE, 1990, J ORG CHEM, V55, P1984, DOI 10.1021/jo00294a006; Donohoe TJ, 2006, ANGEW CHEM INT EDIT, V45, P2664, DOI 10.1002/anie.200503512; De Matteis V, 2007, EUR J ORG CHEM, P2667, DOI 10.1002/ejoc.200601119; Ernet T, 1997, SYNTHESIS-STUTTGART, P953; Francesch A, 1997, J ORG CHEM, V62, P310, DOI 10.1021/jo961355x; HARNDEN MR, 1988, J CHEM SOC PERK T 1, P2777, DOI 10.1039/p19880002777; Haufe G, 1999, ORG SYNTH, V76, P159; Kimura H., 2005, TETRAHEDRON, V61, P11141; Konno T, 2012, ORG BIOMOL CHEM, V10, P8154, DOI 10.1039/c2ob25718a; NAKAMURA E, 1989, J AM CHEM SOC, V111, P3091, DOI 10.1021/ja00190a068; Nakamura Y, 2002, J FLUORINE CHEM, V117, P143, DOI 10.1016/S0022-1139(02)00150-1; Oishi S, 2002, ORG LETT, V4, P1055, DOI 10.1021/ol016835b; PERSSON ESM, 1995, ACTA CHEM SCAND, V49, P899, DOI 10.3891/acta.chem.scand.49-0899; Phillips A.J., 1999, ALDRICHIM ACTA, V32, P197; Sano S, 2002, TETRAHEDRON LETT, V43, P9183, DOI 10.1016/S0040-4039(02)02269-4; SHINADA T, 1995, SYNLETT, P1247; Soorukram D, 2006, ANGEW CHEM INT EDIT, V45, P3686, DOI 10.1002/anie.200600247; Takeuchi Y, 1996, TETRAHEDRON, V52, P225, DOI 10.1016/0040-4020(95)00910-Z; De Matteis V, 2006, EUR J ORG CHEM, P1166, DOI 10.1002/ejoc.200500826; Wong OA, 2009, J ORG CHEM, V74, P8377, DOI 10.1021/jo901553t; Yamanaka M, 2003, J COMPUT CHEM, V24, P1401, DOI 10.1002/jcc.10132; Yamazaki T, 1999, ISRAEL J CHEM, V39, P193; Yamazaki T, 1997, TETRAHEDRON LETT, V38, P6705, DOI 10.1016/S0040-4039(97)01570-0	56	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2014	167				SI		110	121		10.1016/j.jfluchem.2014.06.012		12	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AU2TC	WOS:000345469400015		
J	Inoue, M; Shiosaki, M; Muramaru, H				Inoue, Munenori; Shiosaki, Masahiro; Muramaru, Hajime			Synthesis of ethyl 3,3,3-trifluoropropionate from 2-bromo-3,3, 3-trifluoropropene	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Ethyl 3,3,3-trifluoropropionate; 2-Bromo-3,3,3-trifluoropropene; Bromination; Alkali metal ethoxide	CONVENIENT SYNTHESIS; CARBONYL-COMPOUNDS; ARYL HALIDES; ACID; TRIFLUOROMETHYL; DERIVATIVES; ACETALS; ALDOL; 2-BROMO-3,3,3-TRIFLUOROPROPENE; EQUIVALENT	A facile synthesis of ethyl 3,3,3-trifluoropropionate is described. Commercially available 2-bromo-3,3,3-trifluoropropene was used as a starting material, which was allowed to react with bromine to produce 2,2,3-tribromo-1,1,1-trifluoropropane. The resulting tribromide was treated with 3 equiv. of potassium ethoxide, giving rise to ethyl 3,3,3-trifluoropropionate in 60% overall yield in 2 steps. The reaction proceeded via an alkoxide-induced tandem reaction mechanism. (C)2014 Elsevier B.V. All rights reserved.	[Inoue, Munenori; Shiosaki, Masahiro] Sagami Chem Res Inst, Ayase, Kanagawa 2521193, Japan; [Muramaru, Hajime] Tosoh Finechem Corp, Minato Ku, Tokyo 1050014, Japan	Inoue, M (reprint author), Sagami Chem Res Inst, 2743-1 Hayakawa, Ayase, Kanagawa 2521193, Japan.	inoue@sagami.or.jp					Andres JI, 2012, J MED CHEM, V55, P8685, DOI 10.1021/jm300912k; YAMAZAKI T, 1995, J ORG CHEM, V60, P6046, DOI 10.1021/jo00124a013; Sato K, 2009, J ORG CHEM, V74, P3815, DOI 10.1021/jo9004348; Grosjean S, 2010, TETRAHEDRON, V66, P9912, DOI 10.1016/j.tet.2010.10.059; Hong J, 2013, RSC ADV, V3, P1069, DOI 10.1039/c2ra22195k; Konno T, 2012, J FLUORINE CHEM, V144, P147, DOI 10.1016/j.jfluchem.2012.08.006; Ichikawa J, 2003, J ORG CHEM, V68, P7800, DOI 10.1021/jo03718j; Augustine JK, 2012, TETRAHEDRON LETT, V53, P4422, DOI 10.1016/j.tetlet.2012.06.037; Yamanaka H, 1996, TETRAHEDRON LETT, V37, P1829, DOI 10.1016/0040-4039(96)00129-3; Huang J, 2007, ORG LETT, V9, P4343, DOI 10.1021/o17019839; Hirotaki K, 2013, ORG LETT, V15, P1226, DOI 10.1021/ol400141y; Numata Y, 2011, CHEM COMMUN, V47, P6159, DOI 10.1039/c1cc11130b; BOUILLON JP, 1991, J CHEM SOC PERK T 1, P2147, DOI 10.1039/p19910002147; BROWN F, 1953, J CHEM SOC, P2087, DOI 10.1039/jr9530002087; DOLBIER WR, 1982, J FLUORINE CHEM, V20, P637, DOI 10.1016/S0022-1139(00)82289-7; Drakesmith F.G., 1967, J ORG CHEM, V33, P280; Feng DM, 2005, BIOORG MED CHEM LETT, V15, P2385, DOI 10.1016/j.bmcl.2005.02.077; Franck X, 2006, ANGEW CHEM INT EDIT, V45, P5174, DOI 10.1002/anie.200600927; FUCHIKAMI T, 1984, SYNTHESIS-STUTTGART, P766; HENNE AL, 1951, J AM CHEM SOC, V73, P2323, DOI 10.1021/ja01149a122; HENNE AL, 1952, J AM CHEM SOC, V74, P650, DOI 10.1021/ja01123a020; HENNE AL, 1951, J AM CHEM SOC, V73, P1042, DOI 10.1021/ja01147a047; Hong F, 1996, CHEM COMMUN, P57, DOI 10.1039/cc9960000057; Jiang B, 2001, TETRAHEDRON LETT, V42, P4083, DOI 10.1016/S0040-4039(01)00636-0; JIANG B, 1991, J ORG CHEM, V56, P7336, DOI 10.1021/jo00026a028; Jiang BA, 2003, CHEM COMMUN, P536, DOI 10.1039/b210642f; Katritzky AR, 1996, J FLUORINE CHEM, V80, P145, DOI 10.1016/S0022-1139(96)03494-X; Kobayashi O, 2009, J FLUORINE CHEM, V130, P591, DOI 10.1016/j.jfluchem.2009.03.002; Komata T, 2008, J FLUORINE CHEM, V129, P35, DOI 10.1016/j.jfluchem.2007.08.007; Komata T., 2006, PCT Int. Appl., Patent No. [W02006046417, 2006046417]; Komatsu Y, 1999, J ORG CHEM, V64, P8369, DOI 10.1021/jo990463r; PETERS HM, 1971, J CHEM ENG DATA, V16, P376, DOI 10.1021/je60050a037; Ramachandran PV, 2010, ORG LETT, V12, P4474, DOI 10.1021/ol1016178; RAUNIO EK, 1971, J ORG CHEM, V36, P345, DOI 10.1021/jo00801a023; Romero FA, 2004, J MED CHEM, V47, P4483, DOI 10.1021/jm0400653; Shabashov D, 2007, J ORG CHEM, V72, P7720, DOI 10.1021/jo701387m; Shi G.-q., 1996, J ORG CHEM, V61, P3260; Shimada T, 2006, ORG LETT, V8, P1129, DOI 10.1021/ol0531435; YOKOZAWA T, 1984, TETRAHEDRON LETT, V25, P3991, DOI 10.1016/0040-4039(84)80048-9; YOKOZAWA T, 1984, TETRAHEDRON LETT, V25, P3987, DOI 10.1016/0040-4039(84)80047-7	40	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2014	167				SI		135	138		10.1016/j.jfluchem.2014.07.009		4	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AU2TC	WOS:000345469400018		
J	Egami, H; Shimizu, R; Usui, Y; Sodeoka, M				Egami, Hiromichi; Shimizu, Ryo; Usui, Yoshihiko; Sodeoka, Mikiko			Oxy-trifluoromethylation of alkenes and its application to the synthesis of beta-trifluoromethylstyrene derivatives	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Trifluoromethyl; Catalysis; Togni's reagent; Styrene; Diene	COPPER-CATALYZED TRIFLUOROMETHYLATION; ELECTROPHILIC TRIFLUOROMETHYLATION; ENANTIOSELECTIVE TRIFLUOROMETHYLATION; 3-COMPONENT OXYTRIFLUOROMETHYLATION; ALPHA,BETA-UNSATURATED ESTERS; MEDIATED FORMATION; FACILE SYNTHESIS; BOND FORMATION; SALT SYSTEM; FLUORINE	Oxy-trifluoromethylation of di-substituted styrenes and dienes was achieved by using Cu/Togni's reagent system. Not only gem-di-substituted styrenes, but also a beta-methylstyrene derivative were transformed to the corresponding oxy-trifluoromethylation products. 1,4-Addition products were obtained selectively in the reaction of mono-substituted dienes. These reactions provide a new approach for the synthesis of beta-trifluoromethyl styrene derivatives. (C) 2014 The Authors. Published by Elsevier B.V.	[Egami, Hiromichi; Shimizu, Ryo; Usui, Yoshihiko; Sodeoka, Mikiko] RIKEN, Synthet Organ Chem Lab, Wako, Saitama 3510198, Japan; [Egami, Hiromichi; Sodeoka, Mikiko] Japan Sci & Technol Agcy, ERATO, Sodeoka Live Cell Chem Project, Wako, Saitama 3510198, Japan; [Shimizu, Ryo; Usui, Yoshihiko; Sodeoka, Mikiko] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan; [Sodeoka, Mikiko] RIKEN, Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan	Sodeoka, M (reprint author), RIKEN, Synthet Organ Chem Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	sodeoka@riken.jp	Sodeoka, Mikiko/A-9952-2008; Egami, Hiromichi/F-7744-2012; 	Sodeoka, Mikiko/0000-0002-1344-364X; Egami, Hiromichi/0000-0002-7784-4987			Amii H, 2011, J SYN ORG CHEM JPN, V69, P752; Jiang XY, 2013, ANGEW CHEM INT EDIT, V52, P14177, DOI 10.1002/anie.201307595; Janson PG, 2012, ORG LETT, V14, P2882, DOI 10.1021/ol3011419; Liu TF, 2011, ORG LETT, V13, P2342, DOI 10.1021/ol2005903; Dubbaka SR, 2005, CHEM-EUR J, V11, P2633, DOI 10.1002/chem.200400838; Zhu R, 2012, J AM CHEM SOC, V134, P12462, DOI 10.1021/ja305840g; Lu DF, 2013, CHEM SCI, V4, P2478, DOI 10.1039/c3sc50582k; UMEMOTO T, 1990, TETRAHEDRON LETT, V31, P3579; Eisenberger P, 2006, CHEM-EUR J, V12, P2579, DOI 10.1002/chem.200501052; Egami H, 2013, ANGEW CHEM INT EDIT, V52, P7841, DOI 10.1002/anie.201303350; Zhang CP, 2011, CHEM COMMUN, V47, P6632, DOI 10.1039/c1cc11765c; Ono T, 1996, J FLUORINE CHEM, V80, P163, DOI 10.1016/S0022-1139(96)03392-1; Matousek V, 2013, J ORG CHEM, V78, P6763, DOI 10.1021/jo400774u; Parsons AT, 2012, ANGEW CHEM INT EDIT, V51, P2947, DOI 10.1002/anie.201108267; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Egami H, 2013, CHEM COMMUN, V49, P7346, DOI 10.1039/c3cc43936d; Egami H, 2012, TETRAHEDRON LETT, V53, P5503, DOI 10.1016/j.tetlet.2012.07.134; Roy S, 2011, TETRAHEDRON, V67, P2161, DOI 10.1016/j.tet.2011.01.002; Deb A, 2013, ANGEW CHEM INT EDIT, V52, P9747, DOI 10.1002/anie.201303576; Prakash GKS, 2012, ORG LETT, V14, P1146, DOI 10.1021/ol300076y; Li Y, 2012, ANGEW CHEM INT EDIT, V51, P8221, DOI 10.1002/anie.201202623; Yajima T, 2005, TETRAHEDRON, V61, P10203, DOI 10.1016/j.tet.2005.08.039; Shimizu R, 2010, TETRAHEDRON LETT, V51, P5947, DOI 10.1016/j.tetlet.2010.09.027; Yasu Y, 2012, ANGEW CHEM INT EDIT, V51, P9567, DOI 10.1002/anie.201205071; Umemoto T, 1996, CHEM REV, V96, P1757, DOI 10.1021/cr941149u; Jeschke P, 2004, CHEMBIOCHEM, V5, P570, DOI 10.1002/cbic.200300833; Koller R, 2009, ANGEW CHEM INT EDIT, V48, P4332, DOI 10.1002/anie.200900974; UMEMOTO T, 1993, J AM CHEM SOC, V115, P2156, DOI 10.1021/ja00059a009; Omote M, 2012, ORG LETT, V14, P2286, DOI 10.1021/ol300670n; Shimizu M, 2001, J AM CHEM SOC, V123, P6947, DOI 10.1021/ja016077k; Stanek K, 2008, J ORG CHEM, V73, P7678, DOI 10.1021/jo8014825; Wang XP, 2013, BEILSTEIN J ORG CHEM, V9, P2635, DOI 10.3762/bjoc.9.299; UNEYAMA K, 1992, B CHEM SOC JPN, V65, P1976, DOI 10.1246/bcsj.65.1976; Kim E, 2013, CHEM-EUR J, V19, P6209, DOI 10.1002/chem.201300564; Kieltsch I, 2007, ANGEW CHEM INT EDIT, V46, P754, DOI 10.1002/anie.200603497; He YT, 2013, CHEM COMMUN, V49, P5687, DOI 10.1039/c3cc42588f; Yasu Y, 2014, ORG LETT, V16, P780, DOI 10.1021/ol403500y; He ZB, 2012, ANGEW CHEM INT EDIT, V51, P3944, DOI 10.1002/anie.201200140; Egami H, 2013, ANGEW CHEM INT EDIT, V52, P4000, DOI 10.1002/anie.201210250; Egami H, 2013, J FLUORINE CHEM, V152, P51, DOI 10.1016/j.jfluchem.2013.03.009; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Wu XF, 2012, CHEM-ASIAN J, V7, P1744, DOI 10.1002/asia.201200211; Shimizu M, 2005, ANGEW CHEM INT EDIT, V44, P214, DOI 10.1002/anie.200460441; Prakash GKS, 1997, CHEM REV, V97, P757, DOI 10.1021/cr9408991; UMEMOTO T, 1987, B CHEM SOC JPN, V60, P3307, DOI 10.1246/bcsj.60.3307; Yu Q, 2013, CHEM-EUR J, V19, P13304, DOI 10.1002/chem.201302169; Zheng Y, 2010, ADV SYNTH CATAL, V352, P2745, DOI 10.1002/adsc.201000545; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293; Xu J, 2011, CHEM COMMUN, V47, P4300, DOI 10.1039/c1cc10359h; Fang ZX, 2014, ORG LETT, V16, P1522, DOI 10.1021/ol5004498; Miyazaki A, 2012, HETEROCYCLES, V86, P979, DOI 10.3987/COM-12-S(N)101; Begue J.-P., 2008, BIOORGANIC MED CHEM; Chen Q, 2007, TETRAHEDRON, V63, P11965, DOI 10.1016/j.tet.2007.09.013; Egami H, 2014, ANGEW CHEM INT EDIT, V53, P8294, DOI 10.1002/anie.201309260; FUCHIKAMI T, 1987, CHEM LETT, P521, DOI 10.1246/cl.1987.521; FUCHIKAMI T, 1981, SYNTHESIS-STUTTGART, P365; FUJITA M, 1986, TETRAHEDRON LETT, V27, P3659, DOI 10.1016/S0040-4039(00)84874-1; Gouverneur V., 2012, FLUORINE PHARMACHEUT; KITAZUME T, 1982, CHEM LETT, P1453, DOI 10.1246/cl.1982.1453; Krisch P., 2004, MODERN FLUOROORGANIC; Liang T., 2013, ANGEW CHEM INT EDIT, V52, P8164; Liu TF, 2012, EUR J ORG CHEM, P6679, DOI 10.1002/ejoc.201200648; Ojima I., 2009, FLUORINE MED CHEM CH; SATO Y, 1993, B CHEM SOC JPN, V66, P1840, DOI 10.1246/bcsj.66.1840; Schlosser M, 2006, ANGEW CHEM INT EDIT, V45, P5432, DOI 10.1002/anie.200600449; Shimizu R, 2012, ANGEW CHEM INT EDIT, V51, P4577, DOI 10.1002/anie.201201095; Studer A, 2012, ANGEW CHEM INT EDIT, V51, P8950, DOI 10.1002/anie.201202624; Umemoto T., 1999, J FLUORINE CHEM, V98, P75; UMEMOTO T, 1994, J ORG CHEM, V59, P5692, DOI 10.1021/jo00098a030; Yajima T, 2003, TETRAHEDRON LETT, V44, P7027, DOI 10.1016/S0040-4039(03)01783-0; Zhu R, 2013, ANGEW CHEM INT EDIT, V52, P12655, DOI 10.1002/anie.201307790	71	7	7	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2014	167				SI		172	178		10.1016/j.jfluchem.2014.05.009		7	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AU2TC	WOS:000345469400024		
J	Ono, T; Ohta, K				Ono, Taizo; Ohta, Kazutoku			Spectroscopic observation of charge transfer complex formation of persistent perfluoroalkyl radical with aromatics, olefin, and ether	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Persistent perfluoroalkyl radical; Charge transfer complex; Beer's law; UV-vis spectroscopy	HEXAFLUOROBENZENE; TRIFLUOROMETHYL; FLUORINE	Charge transfer interaction of a persistent perfluoroalkyl radical, perfluoro-3-ethyl-2,4-dimethyl-3-pentyl (PFR-1), with benzene and methyl substituted benzenes (toluene, m-xylene, mesitylene), 1-decene, and diethyl ether was investigated by UV-vis spectrophotometric measurement. It was found that the aromatic and oleflnic pi-electrons and also the unshared electron pair of ether can interact with the low-lying radical orbital of PFR-1 through CT complex formation. The Beer's law was confirmed in the range of 5-20 mM of PFR-1 for the aromatics and 5-40 mM for 1-decene and diethyl ether. The red shift of lambda(max) occurred with increasing number of methyl substituents on the benzene ring. (C) 2014 Elsevier B.V. All rights reserved.	[Ono, Taizo; Ohta, Kazutoku] Natl Inst Adv Ind Sci & Technol, Res Inst Instrumentat Frontier, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Ono, T (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Instrumentat Frontier, Moriyama Ku, 2266-98 Anagahora, Nagoya, Aichi 4638560, Japan.	t.ono@aist.go.jp					Alaaeddine A., 2013, MACROMOLECULES, V46, P3092; Dolbier WR, 1996, CHEM REV, V96, P1557, DOI 10.1021/cr941142c; Schlosser M, 1996, TETRAHEDRON, V52, P99, DOI 10.1016/0040-4020(95)00886-D; Boschet F, 2012, MACROMOL RAPID COMM, V33, P302, DOI 10.1002/marc.201100737; SCHERER KV, 1985, J AM CHEM SOC, V107, P718, DOI 10.1021/ja00289a042; BEAUMONT TG, 1968, NATURE, V218, P865, DOI 10.1038/218865a0; Okazaki M, 2009, APPL MAGN RESON, V36, P89, DOI 10.1007/s00723-009-0005-7; Ono T., 2007, P INT S ECOTOPIA SCI, P85; Ono T., 2001, US Patent, Patent No. [2001-352475, 2001352475]; Ono T., 1996, J CHEM SOC CHEM COMM, P1579; Ono T., 1996, J CHEM SOC CHEM COMM, P763; Ono T, 1999, J FLUORINE CHEM, V97, P173, DOI 10.1016/S0022-1139(99)00046-9; Ono T., 2001, US Patent, Patent No. [2001-352474, 2001352474]; Ono T, 2002, TETRAHEDRON LETT, V43, P7961, DOI 10.1016/S0040-4039(02)01863-4; Patil Y., 2012, ACS MACRO LETT, V1, P315; PATRICK CR, 1960, NATURE, V187, P1021, DOI 10.1038/1871021a0; Yokoyama H, 2008, APPL MAGN RESON, V33, P197, DOI 10.1007/s00723-008-0069-9	17	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2014	167				SI		198	202		10.1016/j.jfluchem.2014.07.034		5	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AU2TC	WOS:000345469400028		
J	Chopin, N; Pilet, G; Morita, Y; Medebielle, M				Chopin, Nicolas; Pilet, Guillaume; Morita, Yasushi; Medebielle, Maurice			Trifluoromethyl-derived enaminones and their difluoroboron complexes: Synthesis, crystal structure and electrochemistry properties	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Enaminone; Difluoroboron; Single-crystal X-ray diffraction; Cyclic voltammetry	CHARGE-TRANSFER COMPLEXES; FLUORESCENT BF2 COMPLEXES; HYDROGEN-BONDED NETWORKS; SUPER-ELECTRON-DONORS; METAL-COMPLEXES; ELECTROGENERATED CHEMILUMINESCENCE; BORON COMPLEXES; TTF-IMIDAZOLE; SOLID-STATE; ENAMINOKETONATOBORON DIFLUORIDES	Twelve trifluoromethylated enaminones including seven N,O-bidentate, three N,O,O- and one N,N,O-tridentate, and one N,N,O,O-tetradentate ligands that can include multiple coordination centers as well as redox-active and photosensitive units have been prepared. Seven new difluoroboron complexes 23-29 were prepared by the reaction of BF3 center dot OEt2 in acetonitrile in the presence of Et3N with five bidentate ligands, one tridentate ligand and one tetradentate ligand. Their crystal structure, UV-vis absorption and redox properties have been studied. The role of the trifluoromethyl and difluoroboron moieties and their ability to form F-H intra- and inter-complexes bonds leading to multidimensional networks have been also featured. (C) 2014 Elsevier B.V. All rights reserved.	[Chopin, Nicolas; Medebielle, Maurice] Univ Lyon 1, Inst Chim & Biochim Mol & Supramol, Equipe Synth Mol Interet & Therapeut SMITH, UMR CNRS UCBL INSA Lyon 5246, F-69622 Villeurbanne, France; [Pilet, Guillaume] Univ Lyon 1, Lab MultiMat & Interfaces, UMR CNRS UCBL 5615, Grp Cristallog & Ingn Mol, F-69622 Villeurbanne, France; [Morita, Yasushi] Osaka Univ, Dept Chem, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Morita, Yasushi] Aichi Inst Technol, Toyota, Aichi 4700392, Japan	Medebielle, M (reprint author), Univ Lyon 1, Inst Chim & Biochim Mol & Supramol, Equipe Synth Mol Interet & Therapeut SMITH, UMR CNRS UCBL INSA Lyon 5246, Batiment Curien,43 Bd 11 Novembre 1918, F-69622 Villeurbanne, France.	maurice.medebielle@univ-lyon1.fr	Morita, Yasushi/B-1121-2008; Medebielle, Maurice/G-6357-2010	Morita, Yasushi/0000-0002-2124-0201; 	CNRS (PICS CNRS) [05871]; Region Rhone-Alpes; CNRS; Universite Claude Bernard Lyon 1	N. Chopin is grateful to the CNRS (PICS CNRS no. 05871) for support of a three months research stay (October 2012 to January 2013) at Osaka University and to the Region Rhone-Alpes for a PhD fellowship (ENAMBRIMOLE CIBLE project). Additional support was provided by CNRS and the Universite Claude Bernard Lyon 1.	Panini P, 2012, CRYSTENGCOMM, V14, P1972, DOI 10.1039/c2ce06254b; Zatsikha YV, 2013, TETRAHEDRON, V69, P2233, DOI 10.1016/j.tet.2013.01.050; Chopin N, 2013, J FLUORINE CHEM, V155, P89, DOI 10.1016/j.jfluchem.2013.06.009; Azov VA, 2003, HELV CHIM ACTA, V86, P2149, DOI 10.1002/hlca.200390172; Guerro M, 2009, TETRAHEDRON, V65, P6123, DOI 10.1016/j.tet.2009.05.041; Gao NX, 2014, DALTON T, V43, P7121, DOI 10.1039/c4dt00138a; Kubota Y, 2012, ORG LETT, V14, P4682, DOI 10.1021/ol302179r; Broggi J, 2014, ANGEW CHEM INT EDIT, V53, P384, DOI 10.1002/anie.201209060; Aakeroy CB, 2010, CRYSTENGCOMM, V12, P22, DOI 10.1039/b919819a; [Anonymous], 2009, CRYSALISPRO V 1 171; Chopin N, 2011, J FLUORINE CHEM, V132, P850, DOI 10.1016/j.jfluchem.2011.05.011; Ziessel R, 2007, NEW J CHEM, V31, P496, DOI 10.1039/b617972j; Reichenbacher K, 2005, CHEM SOC REV, V34, P22, DOI 10.1039/b406892k; WIBERG N, 1968, ANGEW CHEM INT EDIT, V7, P766, DOI 10.1002/anie.196807661; Tadokoro M, 2000, COORDIN CHEM REV, V198, P205, DOI 10.1016/S0010-8545(99)00223-4; Liu G, 2011, CHEM COMMUN, V47, P6763, DOI 10.1039/c1cc10665a; Biradha K, 2011, CRYST GROWTH DES, V11, P875, DOI 10.1021/cg101241x; Chopra D, 2011, CRYSTENGCOMM, V13, P2175, DOI 10.1039/c0ce00538j; Yoshii R, 2014, MACROMOLECULES, V47, P2268, DOI 10.1021/ma500082e; Zhou Y, 2008, ORG LETT, V10, P633, DOI 10.1021/ol702963w; Morita Y, 2013, B CHEM SOC JPN, V86, P183, DOI 10.1246/bcsj.20120241; Ulrich G, 2008, ANGEW CHEM INT EDIT, V47, P1184, DOI 10.1002/anie.200702070; Kubota Y, 2013, J ORG CHEM, V78, P7058, DOI 10.1021/jo400879g; Kubota Y, 2010, ORG LETT, V12, P4010, DOI 10.1021/ol101612z; Murata T, 2004, ANGEW CHEM INT EDIT, V43, P6343, DOI 10.1002/anie.200460801; Murata T, 2007, J AM CHEM SOC, V129, P10837, DOI 10.1021/ja072607m; Murata T, 2005, TETRAHEDRON, V61, P6056, DOI 10.1016/j.tet.2005.04.030; Zhang XF, 2013, J ORG CHEM, V78, P9153, DOI 10.1021/jo401379g; Loudet A, 2007, CHEM REV, V107, P4891, DOI 10.1021/cr078381n; Kubota Y, 2011, ORG LETT, V13, P6544, DOI 10.1021/ol202819w; Yoshii R, 2013, CHEM-EUR J, V19, P4506, DOI 10.1002/chem.201203703; Itoh K, 2003, AUST J CHEM, V56, P1209, DOI 10.1071/CH02158; Morita Y, 2010, J AM CHEM SOC, V132, P6944, DOI 10.1021/ja102030w; Lai RY, 2003, J PHYS CHEM B, V107, P5036, DOI 10.1021/jp034578h; Medebielle M, 2008, J FLUORINE CHEM, V129, P930, DOI 10.1016/j.jfluchem.2008.06.029; Aakeroy CB, 2001, AUST J CHEM, V54, P409, DOI 10.1071/CH01133; Melot BC, 2013, ACCOUNTS CHEM RES, V46, P1226, DOI 10.1021/ar300088q; Sartin MM, 2008, J PHYS CHEM C, V112, P10833, DOI 10.1021/jp8011848; Koyama Y, 2013, ORG LETT, V15, P4686, DOI 10.1021/ol401984j; Brammer L, 2004, CHEM SOC REV, V33, P476, DOI 10.1039/b313412c; Doni E, 2014, CHEM COMMUN, V50, P6073, DOI 10.1039/c3cc48969h; Bessette A, 2014, CHEM SOC REV, V43, P3342, DOI 10.1039/c3cs60411j; Mee SPH, 2005, CHEM-EUR J, V11, P3294, DOI 10.1002/chem.200401162; Pavlishchuk VV, 2000, INORG CHIM ACTA, V298, P97, DOI 10.1016/S0020-1693(99)00407-7; Xia M, 2008, J FLUORINE CHEM, V129, P402, DOI 10.1016/j.jfluchem.2008.01.019; Murata T, 2010, CRYST GROWTH DES, V10, P4898, DOI 10.1021/eg100958r; Macedo FP, 2008, EUR J INORG CHEM, P3200, DOI 10.1002/ejic.200800243; Murphy JA, 2014, J ORG CHEM, V79, P3731, DOI 10.1021/jo500071u; Qi HL, 2013, J AM CHEM SOC, V135, P13558, DOI 10.1021/ja406731f; Atugawa T., 1996, B CHEM SOC JPN, V69, P2487; Benniston AC, 2008, EUR J ORG CHEM, P2705, DOI 10.1002/ejoc.200800191; Cascarano G., 1996, ACTA CRYSTALLOGR A, VA52; Chopin N, 2012, EUR J INORG CHEM, P5058, DOI 10.1002/ejic.201200737; Chopin N., 2012, EUR J INORG CHEM, V7, P1093; Chopin N., EUR J INORG CH UNPUB; Cline MR, 2007, BIOCHEMISTRY-US, V46, P1981, DOI 10.1021/bi061269j; DEMEULEN.J, 1965, ACTA CRYSTALLOGR, V19, P1014, DOI 10.1107/S0365110X65004802; Dhanunjayarao K., 2014, EUR J INORG CHEM, P539; Pilet G, 2008, DALTON T, P5621, DOI 10.1039/b805071f; Gerus II, 2001, SYNTHESIS-STUTTGART, P431; Guerro M, 2011, TETRAHEDRON, V67, P3427, DOI 10.1016/j.tet.2011.03.041; Hang T., 2009, ARKIVOC, V14, P156; HOJO M, 1976, CHEM LETT, P499, DOI 10.1246/cl.1976.499; ITOH K, 1992, J CHEM SOC CHEM COMM, P1608, DOI 10.1039/c39920001608; Itoh K, 2002, HETEROCYCLES, V57, P2065; Itoh K, 2004, HELV CHIM ACTA, V87, P292, DOI 10.1002/hlca.200490027; Itoh K, 2002, NEW J CHEM, V26, P1070, DOI 10.1039/b110975h; Keller H, 1996, TETRAHEDRON, V52, P4637, DOI 10.1016/0040-4020(96)00168-8; Lemal D.M., 1968, CHEM AMINO GROUP, P701; Martins M.A.P., 1994, QUIM NOVA, V17, P24; Martins M.A.P., 1994, QUIM NOVA, V17, P298; Massue J., 2013, EUR J INORG CHEM, P5701; Massue J, 2012, ORG LETT, V14, P230, DOI 10.1021/ol203014e; Mastropietro TF, 2012, CRYST GROWTH DES, V12, P2173, DOI 10.1021/cg300369w; MATTHEWS DP, 1987, J HETEROCYCLIC CHEM, V24, P689; Miyazaki E, 2007, CHEM LETT, V36, P1102, DOI 10.1246/cl.2007.1102; Morita Y., 2002, J CHEM SOC P1, V1, P2598; Morita Y, 2008, CHEM LETT, V37, P24, DOI 10.1246/cl.2008.24; Morita Y, 2008, SOLID STATE SCI, V10, P1720, DOI 10.1016/j.solidstatesciences.2008.01.010; Morita Y, 2005, B CHEM SOC JPN, V78, P2014, DOI 10.1246/bcsj.78.2014; Morita Y, 2005, J ORG CHEM, V70, P2739, DOI 10.1021/jo047768c; Morita Y, 2004, CHEM LETT, V33, P188, DOI 10.1246/cl.2004.188; Murata T, 2012, EUR J ORG CHEM, P4123, DOI 10.1002/ejoc.201200426; Murata T, 2010, PHYSICA B, V405, pS41, DOI 10.1016/j.physb.2009.10.022; Murata T, 2006, CRYST GROWTH DES, V6, P1043, DOI 10.1021/cg0600602; Murata T, 2007, CHEM COMMUN, P4009, DOI 10.1039/b707113b; Murata T, 2011, CRYSTENGCOMM, V13, P3689, DOI 10.1039/c1ce05326d; Murata T, 2008, CRYST GROWTH DES, V8, P3058, DOI 10.1021/cg800202n; Philp D, 1996, ANGEW CHEM INT EDIT, V35, P1154, DOI 10.1002/anie.199611541; Pilet G, 2009, EUR J INORG CHEM, P4718, DOI 10.1002/ejic.200900575; Turanova OA, 2010, RUSS J GEN CHEM+, V80, P258, DOI 10.1134/S1070363210020131; Watkin D.J., 1999, CRYSTALS; WINBERG HE, 1965, J AM CHEM SOC, V87, P2055, DOI 10.1021/ja01087a040; Yakiyama Y, 2011, EUR J INORG CHEM, P3438, DOI 10.1002/ejic.201100488; Yao QC, 2013, J ORGANOMET CHEM, V743, P1, DOI 10.1016/j.jorganchem.2013.06.012; Zhou Y, 2008, J ORG CHEM, V73, P1571, DOI 10.1021/jo702265x; Ziessel R, 2006, J ORG CHEM, V71, P3093, DOI 10.1021/jo0600151	97	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	NOV	2014	167				SI		211	225		10.1016/j.jfluchem.2014.07.005		15	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AU2TC	WOS:000345469400030		
J	Okuda, K; Hirota, T; Sasaki, K				Okuda, Kensuke; Hirota, Takashi; Sasaki, Kenji			Polycyclic N-Heterocyclic Compounds. Part 79: Synthesis of 2,4-Disubstituted 6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-d]pyrimidines as Potential Antiplatelet Aggregators	JOURNAL OF HETEROCYCLIC CHEMISTRY			English	Article							VIVO ANTITHROMBOTIC EVALUATION; RESERPINE-INDUCED HYPOTHERMIA; 3D QSAR ANALYSIS; ANTIDEPRESSIVE EVALUATION; PLATELET-AGGREGATION; INHIBITORY-ACTIVITY; DISCOVERY; DESIGN; AGENTS; AMINES	Libraries of tricyclic 2-substituted 4-alkylamino-6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-d]pyrimidines were synthesized as part of our research to develop new effective antiplatelet drugs. Several alkyl and aryl groups were used as substituents at the 2-position. Evaluation of the effects of the newly synthesized compounds on collagen-induced platelet aggregation revealed several promising antiplatelet candidates with potencies superior to aspirin.	[Okuda, Kensuke] Gifu Pharmaceut Univ, Lab Med & Pharmaceut Chem, Gifu 5011196, Japan; [Hirota, Takashi; Sasaki, Kenji] Okayama Univ, Fac Pharmaceut Sci, Lab Pharmaceut Chem, Kita Ku, Okayama 7008530, Japan	Okuda, K (reprint author), Gifu Pharmaceut Univ, Lab Med & Pharmaceut Chem, Gifu 5011196, Japan.	okuda@gifu-pu.ac.jp					Chen HF, 2011, EUR J MED CHEM, V46, P5609, DOI 10.1016/j.ejmech.2011.09.030; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178; Hsieh PW, 2010, BIOORGAN MED CHEM, V18, P7621, DOI 10.1016/j.bmc.2010.08.039; Sunada Y, 2009, ANGEW CHEM INT EDIT, V48, P9511, DOI 10.1002/anie.200905025; Liu GC, 2011, TETRAHEDRON, V67, P5156, DOI 10.1016/j.tet.2011.05.056; Ihmaid S, 2010, EUR J MED CHEM, V45, P4934, DOI 10.1016/j.ejmech.2010.07.066; Cheng SL, 2009, EUR J MED CHEM, V44, P4904, DOI 10.1016/j.ejmech.2009.08.002; Davenport A. J., 2009, PCT Int Appl, Patent No. 2009135842; Gui L, 2012, MEDCHEMCOMM, V3, P102, DOI 10.1039/c1md00222h; HIROTA T, 1990, J HETEROCYCLIC CHEM, V27, P759; HIROTA T, 1986, J HETEROCYCLIC CHEM, V23, P1685; HIROTA T, 1991, J HETEROCYCLIC CHEM, V28, P257; HIROTA T, 1990, HETEROCYCLES, V31, P153; lebocka-Tilk H., 1988, J ORG CHEM, V53, P1153; Li CY, 2011, EUR J MED CHEM, V46, P5598, DOI 10.1016/j.ejmech.2011.09.027; LIU HJ, 1979, SYNTHETIC COMMUN, V9, P31, DOI 10.1080/00397917908065638; Ohtomo H, 2007, TETRAHEDRON, V63, P12541, DOI 10.1016/j.tet.2007.10.024; POSSANZINI M, 1990, CHROMATOGRAPHIA, V29, P151, DOI 10.1007/BF02268702; Rafferty M, 2010, CURR MED CHEM, V17, P4578, DOI 10.2174/092986710794182962; SASAKI K, 1990, J HETEROCYCLIC CHEM, V27, P1771; Sasaki K, 1996, J HETEROCYCLIC CHEM, V33, P1663; SASAKI K, 1993, J HETEROCYCLIC CHEM, V30, P989; Wang H, 2011, BIOORGAN MED CHEM, V19, P871, DOI 10.1016/j.bmc.2010.12.005; Yao K, 2011, EUR J MED CHEM, V46, P3237, DOI 10.1016/j.ejmech.2011.04.037; Zhang XY, 2010, BIOORGAN MED CHEM, V18, P1536, DOI 10.1016/j.bmc.2010.01.009	26	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-152X	1943-5193		J HETEROCYCLIC CHEM	J. Heterocycl. Chem.	NOV	2014	51	6					1607	1614		10.1002/jhet.1714		8	Chemistry, Organic	Chemistry	AU2OL	WOS:000345457700007		
J	Kurasawa, Y; Yoshida, K; Yamazaki, N; Kaji, E; Sasaki, K; Zamami, Y; Fujii, T; Zhao, M; Ito, H; Fukaya, H				Kurasawa, Yoshihisa; Yoshida, Kiminari; Yamazaki, Naoki; Kaji, Eisuke; Sasaki, Kenji; Zamami, Yoshito; Fujii, Takatoshi; Zhao, Min; Ito, Hideyuki; Fukaya, Haruhiko			Quinolone Analogs 13: Synthesis of Novel 1,1 '-(2-Methylenepropane-1,3-diyl)di(4-quinolone-3-carboxylate) and Related Compounds	JOURNAL OF HETEROCYCLIC CHEMISTRY			English	Article							NITROGEN-BRIDGED HETEROCYCLES; ACIDS; DERIVATIVES; AGENTS	The reaction of the 4-hydroxyquinoline-3-carboxylate 6 with pentaerythritol tribromide gave the 1,1-(2-methylenepropane-1,3-diyl)di(4-quinolone-3-carboxylate) 11, whose reaction with bromine afforded the 1,1-(2-bromo-2-bromomethylpropane-1,3-diyl)di(4-quinolone-3-carboxylate) 12. Compound 12 was transformed into the (Z)-1,1-(2-acetoxymethylpropene-1,3-diyl)di(4-quinolone-3-carboxylate) 13 or (E)-1,1-[2-(imidazol-1-ylmethyl)propene-1,3-diyl]di(4-quinolone-3-carboxylate) 14. Hydrolysis of the dimer (Z)-13 or (E)-14 with potassium hydroxide provided the (E)-1,1-(2-hydroxymethylpropene-1,3-diyl)di(4-quinolone-3-carboxylic acid) 15 or (Z)-1,1-[2-(imidazol-1-ylmethyl)propene-1,3-diyl]di(4-quinolone-3-carboxylic acid) 16, respectively. The nuclear Overhauser effect (NOE) spectral data supported that those hydrolysis resulted in the geometrical conversion of (Z)-13 into (E)-15 or (E)-14 into (Z)-16.	[Kurasawa, Yoshihisa; Yoshida, Kiminari; Yamazaki, Naoki] Iwakli Meisei Univ, Sch Pharm, Iwaki, Fukushima 9708551, Japan; [Kaji, Eisuke] Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan; [Sasaki, Kenji] Okayama Univ, Ctr Fac Dev, Okayama 7008530, Japan; [Sasaki, Kenji; Zamami, Yoshito; Fujii, Takatoshi; Zhao, Min; Ito, Hideyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Fukaya, Haruhiko] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan	Kurasawa, Y (reprint author), Iwakli Meisei Univ, Sch Pharm, Iwaki, Fukushima 9708551, Japan.	kura77@iwakimu.ac.jp; sasaki-k@cc.okayama-u.ac.jp					HAYAKAWA I, 1984, CHEM PHARM BULL, V32, P4907; MATSUMOTO J, 1984, J MED CHEM, V27, P292, DOI 10.1021/jm00369a011; [Anonymous], 2001, PNU183792292422, V23; Boteva AA, 2009, CHEM HETEROCYCL COM+, V45, P757; Grohe K., 1987, LIEBIGS ANN CHEM, P29; IMAI T, 1981, CAN J CHEM, V59, P2503, DOI 10.1139/v81-360; Kakehi A, 2005, CHEM PHARM BULL, V53, P1430, DOI 10.1248/cpb.53.1430; Kakehi A, 2003, CHEM PHARM BULL, V51, P75, DOI 10.1248/cpb.51.75; Kurasawa Y, 2012, J HETEROCYCLIC CHEM, V49, P288, DOI 10.1002/jhet.774; Kurasawa Y, 2003, J HETEROCYCLIC CHEM, V40, P837; Kurasawa Y, 2010, J HETEROCYCLIC CHEM, V47, P657, DOI 10.1002/jhet.297; Kurasawa Y, 2001, HETEROCYCLES, V54, P359; Kurasawa Y, 2000, J HETEROCYCLIC CHEM, V37, P791; Kurasawa Y, 2005, J HETEROCYCLIC CHEM, V42, P249; Kurasawa Y, 2002, HETEROCYCLES, V56, P291; Kurasawa Y, 2007, J HETEROCYCLIC CHEM, V44, P1231; Kurasawa Y, 2005, J HETEROCYCLIC CHEM, V42, P551; Kurasawa Y, 2002, HETEROCYCLES, V58, P359; Kurasawa Y, 2000, J HETEROCYCLIC CHEM, V37, P1257; Matsumoto J., 1968, J MED CHEM, V11, P160; Miyamoto M., 1990, J MED CHEM, V33, P1645; Sheu JY, 1998, J HETEROCYCLIC CHEM, V35, P955; WENTLAND MP, 1993, J MED CHEM, V36, P1580, DOI 10.1021/jm00063a008; WISE R, 1983, ANTIMICROB AGENTS CH, V23, P559; Xianming H., 1995, SYNTHESIS-STUTTGART, P533	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-152X	1943-5193		J HETEROCYCLIC CHEM	J. Heterocycl. Chem.	NOV	2014	51	6					1720	1726		10.1002/jhet.1861		7	Chemistry, Organic	Chemistry	AU2OL	WOS:000345457700021		
J	Kurasawa, Y; Yoshida, K; Yamazaki, N; Sasaki, K; Zamami, Y; Min, Z; Togi, A; Ito, H; Kaji, E; Fukaya, H				Kurasawa, Yoshihisa; Yoshida, Kiminari; Yamazaki, Naoki; Sasaki, Kenji; Zamami, Yoshito; Min, Zhao; Togi, Atsumi; Ito, Hideyuki; Kaji, Eisuke; Fukaya, Haruhiko			Quinolone Analogs 16: A Facile D-H Exchange for 3-H Proton of 2-Substituted 4-Quinolones in Acidic Media	JOURNAL OF HETEROCYCLIC CHEMISTRY			English	Article							DERIVATIVES	The 4-quinolones having the urea or carbamate moiety at the 2-position showed the facile deuterium-hydrogen (D-H) exchange of the 3-H proton in deuteriotrifluoroacetic acid-deuteriodimethyl sulfoxide (3:1) at 60 degrees C, whereas the 4-quinolones possessing the carboxylate or carbohydrazide group at the 2-position and 2-substituted 4-methoxyquinolines represented no D-H exchange of the 3-H proton under the same condition. The aforementioned D-H exchange was found to require both the tautomerization of the 4-quinolone into 4-hydroxyquinoline in strongly acidic media and the nitrogen functional group at the 2-position.	[Kurasawa, Yoshihisa; Yoshida, Kiminari; Yamazaki, Naoki] Iwaki Meisei Univ, Sch Pharm, Iwaki, Fukushima 9708551, Japan; [Sasaki, Kenji] Okayama Univ, Ctr Fac Dev, Kita Ku, Okayama 7008530, Japan; [Sasaki, Kenji; Zamami, Yoshito; Min, Zhao; Togi, Atsumi; Ito, Hideyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan; [Kaji, Eisuke] Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan; [Fukaya, Haruhiko] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan	Kurasawa, Y (reprint author), Iwaki Meisei Univ, Sch Pharm, Iwaki, Fukushima 9708551, Japan.	kura77@iwakimu.ac.jp					ALBERT A, 1965, J CHEM SOC, P4653, DOI 10.1039/jr9650004653; BORROR AL, 1965, J ORG CHEM, V30, P243, DOI 10.1021/jo01012a056; Elguero J., 1976, ADV HETEROCYCLIC S1, P10; Greenhill J. V., 1969, J CHEM SOC B, V3, P299; Kim HS, 1997, J HETEROCYCLIC CHEM, V34, P1029; Kurasawa Y, 2012, J HETEROCYCLIC CHEM, V49, P1323, DOI 10.1002/jhet.922; Kurasawa Y, 1998, J HETEROCYCLIC CHEM, V35, P1333; Kurasawa Y., J HETEROCYC IN PRESS; KURASAWA Y, 1985, CHEM PHARM BULL, V33, P1249; REIMLING.H, 1971, CHEM BER-RECL, V104, P2793, DOI 10.1002/cber.19711040917; Wong J. L., 1973, CHEM COMMUN, P684; YAMAZAKI M, 1970, CHEM PHARM BULL, V18, P908	12	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-152X	1943-5193		J HETEROCYCLIC CHEM	J. Heterocycl. Chem.	NOV	2014	51	6					1821	1829		10.1002/jhet.1933		9	Chemistry, Organic	Chemistry	AU2OL	WOS:000345457700038		
J	Fukuoka, N; Enomoto, T				Fukuoka, Nobuyuki; Enomoto, Toshiki			Relationship between the concentration of pectin-like substances and the severity of internal browning in radish (Raphanus sativus L.) roots induced by high soil temperature	JOURNAL OF HORTICULTURAL SCIENCE & BIOTECHNOLOGY			English	Article							POLYPHENOL OXIDASE; HYDROGEN-PEROXIDE; JAPANESE PEAR; HIGHER-PLANTS; CELL-WALLS; FRUIT; METABOLISM; MECHANISMS; WATERCORE; STRESS	In white radish (Raphanus sativus L.) roots, internal browning (IB), a physiological disorder characterised by a brown discolouration in the central stele, is frequently associated with summer-sown crops. In this study, nine cultivars of white radish were studied to clarify the association between pectin-like substances and the severity of IB. Radish cultivars could be classified into three types according to the severity of the IB disorder: resistant, moderately susceptible, or susceptible. An increase in the severity of the disorder was accompanied by a parallel increase in polyphenol oxidase activity. The mean cell length in each IB-resistant cultivar was < 135 mu m, while the mean cell length in each moderately susceptible or susceptible cultivar, with one exception, was 1.2- to 1.8-times larger. Although there was no association between the severity of IB and the concentration of water-soluble pectin or pectic acid, the IB-resistant cultivars contained a higher concentration of protopectin than the moderately susceptible or susceptible cultivars. These results suggest that IB in radish roots is closely associated with the concentration of protopectin, which varies according to cell size.	[Fukuoka, Nobuyuki; Enomoto, Toshiki] Ishikawa Prefectural Univ, Nonoichi, Ishikawa 9218836, Japan	Fukuoka, N (reprint author), Ishikawa Prefectural Univ, 1-308 Suematsu, Nonoichi, Ishikawa 9218836, Japan.	nfukuoka@ishikawa-pu.ac.jp					VAUGHN KC, 1984, PHYSIOL PLANTARUM, V60, P106, DOI 10.1111/j.1399-3054.1984.tb04258.x; Foyer CH, 1997, PHYSIOL PLANTARUM, V100, P241, DOI 10.1034/j.1399-3054.1997.1000205.x; Vicente AR, 2006, POSTHARVEST BIOL TEC, V40, P116, DOI 10.1016/j.postharvbio.2005.12.012; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; KOUKOL J, 1961, J BIOL CHEM, V236, P2692; Zhu ZJ, 2004, PLANT SCI, V167, P527, DOI 10.1016/j.plantsci.2004.04.020; Asada K, 1987, PHOTOINHIBITION, P227; ASAMIZU T, 1984, PLANTA, V160, P469, DOI 10.1007/BF00429765; CARLSON DG, 1985, J AM SOC HORTIC SCI, V110, P634; Casado J., 2004, OPTIONS MEDITERRANEE, V58, P161; Chikezie P. C., 2013, American Journal of Plant Physiology, V8, P84, DOI 10.3923/ajpp.2013.84.92; Chun J-P., 2003, J JAPANESE SOC HORTI, V76, P488; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Endou T., 2001, J AGR SCI, V56, P23; Foyer C. H., 1991, CURRENT TOPICS PLANT, V6, P131; Fujino T, 1998, PLANT CELL PHYSIOL, V39, P1315; Fukuoka N., 1996, SAND DUNE RES, V43, P19; Fukuoka N, 2007, J JPN SOC HORTIC SCI, V76, P144, DOI 10.2503/jjshs.76.144; Fukuoka N., 1990, B ISHIKAWA AGR COLL, V20, P23; Fukuoka N, 2001, PLANT SCI, V161, P117, DOI 10.1016/S0168-9452(01)00402-2; Fukuoka N, 2002, J HORTIC SCI BIOTECH, V77, P456; HYODO H, 1978, PLANT PHYSIOL, V62, P31, DOI 10.1104/pp.62.1.31; Ikeshita Y, 2010, SCI HORTIC-AMSTERDAM, V126, P8, DOI 10.1016/j.scienta.2010.05.017; Imahori Y, 2000, J JPN SOC HORTIC SCI, V69, P690; Inari T., 2001, B GIFU WOMENS U, V30, P1; Kato Y., 2001, B FAC ED HIROSAKI U, V85, P115; Kawashiro H., 1988, B CHIBA AGR EXP STN, V29, P63; KAWASHIRO H., 1990, J JAPANESE SOC HORTI, V59, P340; KRAUSE GH, 1988, PHYSIOL PLANTARUM, V74, P566, DOI 10.1111/j.1399-3054.1988.tb02020.x; Li JinCai, 2004, Horticultural Research (Japan), V3, P301, DOI 10.2503/hrj.3.301; Panavas T, 1998, PLANT SCI, V133, P125, DOI 10.1016/S0168-9452(98)00034-X; Renard CMGC, 2005, J SCI FOOD AGR, V85, P310, DOI 10.1002/jsfa.1987; SAKUMA F, 1995, J JPN SOC HORTIC SCI, V64, P243; VAUGHN KC, 1981, PROTOPLASMA, V108, P319, DOI 10.1007/BF02224426; YAMAKI S, 1977, SCI HORTIC-AMSTERDAM, V6, P45, DOI 10.1016/0304-4238(77)90077-2	35	0	0	HEADLEY BROTHERS LTD	ASHFORD	INVICTA PRESS, ASHFORD TN24 8HH, KENT, ENGLAND	1462-0316			J HORTIC SCI BIOTECH	J. Horticult. Sci. Biotechnol.	NOV	2014	89	6					625	630				6	Horticulture	Agriculture	AU3FB	WOS:000345496800005		
J	Sumitomo, K; Yamagata, A; Oda, A; Hisamatsu, T				Sumitomo, K.; Yamagata, A.; Oda, A.; Hisamatsu, T.			Identification of high long-day leaf number cultivars and prevention of premature budding by cold pre-treatment for fine control of flowering in summer-to-autumn-flowering chrysanthemum (Chrysanthemum morifolium Ramat.)	JOURNAL OF HORTICULTURAL SCIENCE & BIOTECHNOLOGY			English	Article							INITIATION	When maintained continuously under long-day (non-inductive) photoperiodic conditions, chrysanthemum (Chrysanthemum morifolium Ramat.), a short-day plant, eventually initiates flower buds. This floral initiation termed 'premature budding' in commercial chrysanthemum production. Premature budding, which reduces cut-flower quality, is often observed in summer-to-autumn-flowering cultivars. The timing of flower initiation under non-inductive photoperiods depends on the number of leaves that a plant has formed below the terminal flower bud. This leaf number indicates whether a cultivar will form flower buds prematurely during a non-inductive photoperiod. Two summer-flowering, ten summer-to-autumn-flowering, and six autumn-flowering chrysanthemum cultivars were grown under controlled conditions to measure the number of leaves produced under a non-inductive photoperiod with a night-break. The average number of leaves per plant ranged from 13.8 for 'Tasogare', to 69.1 for 'Furamu'. These data can be used to identify cultivars that will exhibit minimal flower-bud formation under night-break conditions. The numbers of leaves were greater in plants subjected to a 12-week cold treatment prior to planting, suggesting that premature budding could be inhibited by a prolonged cold pre-treatment. We also examined whether the cold treatment of stock plants was an effective means to prevent premature budding. The incidence of premature budding was reduced in rooted cuttings obtained from cold-treated stock plants of the summer-to-autumn-flowering cultivars 'Nagano Queen', 'Ariesu', 'Sei-un', 'Oruka', and 'Floral Yuka'. Without a cold treatment, cuttings from these cultivars showed premature budding. This result suggests that a prolonged cold pre-treatment of stock plants could prevent both premature budding and reduced cut-flower quality in summer-to-autumn-flowering chrysanthemum cultivars.	[Sumitomo, K.; Yamagata, A.; Oda, A.; Hisamatsu, T.] NARO Inst Floricultural Sci NIFS, Tsukuba, Ibaraki 3058519, Japan	Hisamatsu, T (reprint author), NARO Inst Floricultural Sci NIFS, 2-1 Fujimoto, Tsukuba, Ibaraki 3058519, Japan.	tamotsu@affrc.go.jp			NARO	This work was supported by NARO. We wish to acknowledge the skillful assistance of Mr. H. Mogi and Ms. S. Kamei in these investigations, and Japan Agribio Co. Ltd., Seikoen Co. Ltd., the National Federation of Agricultural Cooperative Associations, and Koido Bishoen for the donation of plants.	COCKSHULL KE, 1979, ANN BOT-LONDON, V44, P451; COCKSHULL KE, 1985, HORTSCIENCE, V20, P296; COCKSHULL KE, 1976, J HORTIC SCI, V51, P441; Kawata J, 1982, ACTA HORTIC, V125, P93; Kawata J., 1987, B NATL RES I VEGET A, P187; LANGTON FA, 1977, SCI HORTIC-AMSTERDAM, V7, P277, DOI 10.1016/0304-4238(77)90024-3; Nozaki K., 2008, Journal of Applied Horticulture (Lucknow), V10, P8; Okada M., 1959, J JAPANESE SOC HORTI, V28, P208; SCHWABE WW, 1950, J EXP BOT, V1, P329, DOI 10.1093/jxb/1.3.329; Sumitomo K, 2013, J HORTIC SCI BIOTECH, V88, P361; Sumitomo K, 2009, PLANT SCI, V176, P643, DOI 10.1016/j.plantsci.2009.02.003; VINCE DAPHNE, 1959, JOUR HORT SCI, V34, P199; Votruba R., 1982, ACTA HORTIC, V125, P111	13	0	0	HEADLEY BROTHERS LTD	ASHFORD	INVICTA PRESS, ASHFORD TN24 8HH, KENT, ENGLAND	1462-0316			J HORTIC SCI BIOTECH	J. Horticult. Sci. Biotechnol.	NOV	2014	89	6					647	654				8	Horticulture	Agriculture	AU3FB	WOS:000345496800008		
J	Wakui, K				Wakui, Keiko			Study of structural chromosome abnormalities to increase the understanding of human genetic diversity: a commentary on signature of backward replication slippage at the copy number variation junction	JOURNAL OF HUMAN GENETICS			English	Editorial Material							REARRANGEMENTS		Shinshu Univ, Sch Med, Dept Med Genet, Matsumoto, Nagano 390, Japan	Wakui, K (reprint author), Shinshu Univ, Sch Med, Dept Med Genet, Matsumoto, Nagano 390, Japan.	kwakui@shinshu-u.ac.jp					Ordulu Z, 2014, AM J HUM GENET, V94, P695, DOI 10.1016/j.ajhg.2014.03.020; Liu PF, 2012, CURR OPIN GENET DEV, V22, P211, DOI 10.1016/j.gde.2012.02.012; Le Scouarnec S, 2012, HEREDITY, V108, P75, DOI 10.1038/hdy.2011.100; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Barber JCK, 2005, J MED GENET, V42, P609, DOI 10.1136/jmg.2004.026955; Kurahashi H, 2009, J HUM GENET, V54, P253, DOI 10.1038/jhg.2009.35; Liehr T, 2014, BENIGN AND PATHOLOGICAL CHROMOSOMAL IMBALANCES: MICROSCOPIC AND SUBMICROSCOPIC COPY NUMBER VARIATIONS (CNVS) IN GENETICS AND COUNSELING, P1; Nishimura-Tadaki A, 2011, J HUM GENET, V56, P156, DOI 10.1038/jhg.2010.155; Ohye T, 2014, J HUM GENET, V59, P247, DOI 10.1038/jhg.2014.20; Wakui K, 2002, J HUM GENET, V47, P511, DOI 10.1007/s100380200076	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	NOV	2014	59	11					591	592		10.1038/jhg.2014.83		2	Genetics & Heredity	Genetics & Heredity	AU4CQ	WOS:000345557000001		
J	Fukao, T; Akiba, K; Goto, M; Kuwayama, N; Morita, M; Hori, T; Aoyama, Y; Venkatesan, R; Wierenga, R; Moriyama, Y; Hashimoto, T; Usuda, N; Murayama, K; Ohtake, A; Hasegawa, Y; Shigematsu, Y; Hasegawa, Y				Fukao, Toshiyuki; Akiba, Kazuhisa; Goto, Masahiro; Kuwayama, Nobuki; Morita, Mikiko; Hori, Tomohiro; Aoyama, Yuka; Venkatesan, Rajaram; Wierenga, Rik; Moriyama, Yohsuke; Hashimoto, Takashi; Usuda, Nobuteru; Murayama, Kei; Ohtake, Akira; Hasegawa, Yuki; Shigematsu, Yosuke; Hasegawa, Yukihiro			The first case in Asia of 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency (HSD10 disease) with atypical presentation	JOURNAL OF HUMAN GENETICS			English	Article							17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 10; COA THIOLASE DEFICIENCY; COMPLEX-I DEFICIENCY; ISOLEUCINE METABOLISM; MENTAL-RETARDATION; MITOCHONDRIAL; MUTATIONS; HSD17B10; PROTEIN; GENE	2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (2M3HBD) deficiency (HSD10 disease) is a rare inborn error of metabolism, and <30 cases have been reported worldwide. This disorder is typically characterized by progressive neurodegenerative disease from 6 to 18 months of age. Here, we report the first patient with this disorder in Asia, with atypical clinical presentation. A 6-year-old boy, who had been well, presented with severe ketoacidosis following a 5-day history of gastroenteritis. Urinary organic acid analysis showed elevated excretion of 2-methyl-3-hydroxybutyrate and tiglylglycine. He was tentatively diagnosed with beta-ketothiolase (T2) deficiency. However, repeated enzyme assays using lymphocytes showed normal T2 activity and no T2 mutation was found. Instead, a hemizygous c. 460G>A (p.A154T) mutation was identified in the HSD17B10 gene. This mutation was not found in 258 alleles from Japanese subjects (controls). A normal level of the HSD17B10 protein was found by immunoblot analysis but no 2M3HBD enzyme activity was detected in enzyme assays using the patient's fibroblasts. These data confirmed that this patient was affected with HSD10 disease. He has had no neurological regression until now. His fibroblasts showed punctate and fragmented mitochondrial organization by MitoTracker staining and had relatively low respiratory chain complex IV activity to those of other complexes.	[Fukao, Toshiyuki; Kuwayama, Nobuki; Morita, Mikiko; Hori, Tomohiro] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu 5011194, Japan; [Fukao, Toshiyuki; Aoyama, Yuka] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Med Informat Sci Div, Gifu 5011194, Japan; [Akiba, Kazuhisa] Tokyo Metropolitan Childrens Med Ctr, Dept Gen Pediat, Tokyo, Japan; [Goto, Masahiro; Ohtake, Akira; Hasegawa, Yukihiro] Tokyo Metropolitan Childrens Med Ctr, Dept Endocrinol & Metab, Tokyo, Japan; [Venkatesan, Rajaram; Wierenga, Rik] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Venkatesan, Rajaram; Wierenga, Rik] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Moriyama, Yohsuke; Hashimoto, Takashi; Usuda, Nobuteru] Fujita Hlth Univ, Sch Med, Dept Anat & Cell Biol, Toyoake, Aichi 47011, Japan; [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba, Japan; [Ohtake, Akira] Saitama Med Univ, Dept Pediat, Moroyama, Saitama, Japan; [Hasegawa, Yuki] Shimane Univ, Sch Med, Dept Pediat, Izumo, Shimane, Japan; [Shigematsu, Yosuke] Univ Fukui, Fac Med Sci, Dept Hlth Sci, Eiheiji Cho, Japan	Fukao, T (reprint author), Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Med Informat Sci Div, Dept Pediat,Grad Sch Med, Gifu 5011194, Japan.	toshi-gif@umin.net					Bernier FP, 2002, NEUROLOGY, V59, P1406; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Kirby DM, 1999, NEUROLOGY, V52, P1255; Rauschenberger K, 2010, EMBO MOL MED, V2, P51, DOI 10.1002/emmm.200900055; Deutschmann AJ, 2014, HUM MOL GENET, V23, P3618, DOI 10.1093/hmg/ddu072; Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Zschocke J, 2012, J INHERIT METAB DIS, V35, P81, DOI 10.1007/s10545-011-9415-4; Fukao T, 1997, PEDIATR RES, V42, P498, DOI 10.1203/00006450-199710000-00013; Benach J, 2002, BIOCHEMISTRY-US, V41, P14659, DOI 10.1021/bi0203684; Cazorla MR, 2007, PEDIATR NEUROL, V36, P264, DOI 10.1016/j.pediatrneurol.2006.11.014; Ensenauer R, 2002, ANN NEUROL, V51, P656, DOI 10.1002/ana.10169; Fukao T, 1998, HUM MUTAT, V12, P245, DOI 10.1002/(SICI)1098-1004(1998)12:4<245::AID-HUMU5>3.0.CO;2-E; Fukao T, 2001, MOL GENET METAB, V72, P109, DOI 10.1006/mgme.2000.3113; Garcia-Villoria J, 2010, EUR J HUM GENET, V18, P1353, DOI 10.1038/ejhg.2010.118; Garcia-Villoria J, 2009, CLIN BIOCHEM, V42, P27, DOI 10.1016/j.clinbiochem.2008.10.006; Lenski C, 2007, AM J HUM GENET, V80, P372, DOI 10.1086/511527; Mitchell G. A., 2001, METABOLIC MOL BASES, V2, P2327; Ofman R, 2003, AM J HUM GENET, V72, P1300, DOI 10.1086/375116; Olpin SE, 2002, J INHERIT METAB DIS, V25, P477, DOI 10.1023/A:1021251202287; Perez-Cerda Celia, 2005, Pediatr Res, V58, P488, DOI 10.1203/01.pdr.0000176916.94328.cd; Poll-The BT, 2004, MOL GENET METAB, V81, P295, DOI 10.1016/j.ymgme.2003.11.013; Sass JO, 2004, BRAIN DEV-JPN, V26, P12, DOI 10.1016/S0387-7604(03)00071-8; Seaver LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027348; Sutton VR, 2003, J INHERIT METAB DIS, V26, P69, DOI 10.1023/A:1024083715568; Yang SY, 2007, MOL GENET METAB, V92, P36, DOI 10.1016/j.ymgme.2007.06.001; Yang SY, 2005, TRENDS ENDOCRIN MET, V16, P167, DOI 10.1016/j.tem.2005.03.006; Yang SY, 2009, P NATL ACAD SCI USA, V106, P14820, DOI 10.1073/pnas.0902377106; Yang SY, 2011, MOL CELL ENDOCRINOL, V343, P1, DOI 10.1016/j.mce.2011.06.011; Zschocke J, 2000, PEDIATR RES, V48, P852, DOI 10.1203/00006450-200012000-00025	31	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	NOV	2014	59	11					609	614		10.1038/jhg.2014.79		6	Genetics & Heredity	Genetics & Heredity	AU4CQ	WOS:000345557000004		
J	Okamoto, N; Miya, F; Tsunoda, T; Yanagihara, K; Kato, M; Saitoh, S; Yamasaki, M; Kanemura, Y; Kosaki, K				Okamoto, Nobuhiko; Miya, Fuyuki; Tsunoda, Tatsuhiko; Yanagihara, Keiko; Kato, Mitsuhiro; Saitoh, Shinji; Yamasaki, Mami; Kanemura, Yonehiro; Kosaki, Kenjiro			KIF1A mutation in a patient with progressive neurodegeneration	JOURNAL OF HUMAN GENETICS			English	Article							TRANSPORT; MOTOR	Kinesins are a large superfamily of molecular motors. They move along microtubule filaments and are powered by the hydrolysis of ATP. This transport system is essential for neuronal function and survival. KIF1A belongs to the kinesin 3 family and involves in the anterograde transport of synaptic vesicle precursors along axons. Several studies confirmed that KIF1A mutations cause spastic paraplegia and sensory neuropathy in an autosomal-recessive fashion. A missense mutation in the KIF1A gene (p.Thr99Met) has been reported in a patient with intellectual disability (ID), axial hypotonia and peripheral spasticity. Mild atrophy of the cerebellar vermis was found on magnetic resonance imaging. The mutation was heterozygous and de novo. We identified the second patient with the p.T99M mutation in the KIF1A gene by whole-exome sequencing. He showed severe ID, spasticity, optic atrophy, neurogenic bladder, growth failure and progressive cerebellar atrophy. The p.T99M mutation may be a common recurrent mutation. We suppose that this specific mutation of KIF1A shows a novel neurodegenerative syndrome.	[Okamoto, Nobuhiko] Osaka Med Ctr, Dept Med Genet, Osaka 5941101, Japan; [Okamoto, Nobuhiko; Yanagihara, Keiko] Res Inst Maternal & Child Hlth, Osaka 5941101, Japan; [Miya, Fuyuki; Tsunoda, Tatsuhiko] RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Yanagihara, Keiko] Osaka Med Ctr, Dept Pediat Neurol, Osaka 5941101, Japan; [Kato, Mitsuhiro] Yamagata Univ, Fac Med, Dept Pediat, Yamagata 990, Japan; [Saitoh, Shinji] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi, Japan; [Yamasaki, Mami] Takatsuki Gen Hosp, Dept Pediat Neurosurg, Osaka, Japan; [Kanemura, Yonehiro] Natl Hosp Org, Osaka Natl Hosp, Inst Clin Res, Div Regenerat Med, Osaka, Japan; [Kanemura, Yonehiro] Natl Hosp Org, Osaka Natl Hosp, Dept Neurosurg, Osaka, Japan; [Kosaki, Kenjiro] Keio Univ, Sch Med, Ctr Med Genet, Tokyo, Japan	Okamoto, N (reprint author), Osaka Med Ctr, Dept Med Genet, Izumi Ku, 840 Murodo Cho, Osaka 5941101, Japan.	okamoto@osaka.email.ne.jp	Tsunoda, Tatsuhiko/K-2061-2014		Ministry of Health, Labour and welfare in Japan	This study was supported by the Health and Labour Research Grants in 2013 by Ministry of Health, Labour and welfare in Japan.	Klebe S, 2012, EUR J HUM GENET, V20, P645, DOI 10.1038/ejhg.2011.261; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Erlich Y, 2011, GENOME RES, V21, P658, DOI 10.1101/gr.117143.110; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Riviere JB, 2011, AM J HUM GENET, V89, P219, DOI 10.1016/j.ajhg.2011.06.013	6	6	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	NOV	2014	59	11					639	641		10.1038/jhg.2014.80		3	Genetics & Heredity	Genetics & Heredity	AU4CQ	WOS:000345557000008		
J	Sunohara, D; Nishimata, S; Kondo, A; Ishii, C; Kashiwagi, Y; Kawashima, H				Sunohara, Daisuke; Nishimata, Shigeo; Kondo, Atsushi; Ishii, Chiako; Kashiwagi, Yasuyo; Kawashima, Hisashi			Current status of pediatric human immunodeficiency virus infection in Japan	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Review						Pediatric HIV; AIDS; Co-infection; Mother-to-child transmission	TO-CHILD TRANSMISSION; HEPATITIS-C; HIV-1-INFECTED CHILDREN; DISEASE PROGRESSION; HIV; LIVER; COHORT; HCV	There are currently very few English reports about Japanese pediatric human immunodeficiency virus (HIV). In this study, we introduce our experience with pediatric HIV in a single hospital, and review the present status of HIV infections in children in Japan. In Japan, the main infection routes of HIV include sexual activity, mother-to-child transmission (MTCT), blood or blood product transfusion, and drug use. Most pediatric HIV patients have been infected by MTCT in recent years. One survey showed that in Japan, 52 babies were infected by MTCT between 1984 and 2011. Only 2 cases of pediatric HIV infection have been reported since 2010. The MTCT rate has decreased to 0.5% owing to several preventive interventions. In addition, the HIV antibody test is now performed in more than 98.3% of pregnant women in Japan. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Sunohara, Daisuke; Nishimata, Shigeo; Kondo, Atsushi; Ishii, Chiako; Kashiwagi, Yasuyo; Kawashima, Hisashi] Tokyo Med Univ, Dept Pediat, Shinjuku Ku, Tokyo 1600023, Japan	Kawashima, H (reprint author), Tokyo Med Univ, Dept Pediat, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	hisashi@tokyo-med.ac.jp					Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; [Anonymous], 2007, DEL FUND HLTH SERV S, P1; [Anonymous], 2014, 2013 HLTH LABOUR WEL; Tubiana R, 2010, CLIN INFECT DIS, V50, P585, DOI 10.1086/650005; Gray L, 2001, PEDIATRICS, V108, P116; Alatrakchi N, 2005, J INFECT DIS, V191, P702, DOI 10.1086/427778; Meintjes G, 2012, CURR HIV-AIDS REP, V9, P238, DOI 10.1007/s11904-012-0129-5; Bulterys M, 2000, J ACQ IMMUN DEF SYND, V25, P261; [Anonymous], 2014, AIDS INF; Bierhoff E, 1997, VIRCHOWS ARCH, V430, P271, DOI 10.1007/BF01092749; Dunn DT, 2003, LANCET, V362, P1605; Kinai E, 2010, TOKYOSYONIKAIKAIHOU, V28, P56; Matthews LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018736; Ministry of Health Labour and Welfare AIDS Trend Committee, 2014, GUID ANT HIV MED; Moriuchi M, 2011, SYOUNIKASHINRYO, V74, P1379; Okuma K, 2013, J JPN PEDIAT SOC, V117, P1625; Rouet F, 2003, PEDIATRICS, V112, pE289, DOI 10.1542/peds.112.4.e289; Thorne C, 2007, DRUG SAFETY, V30, P203, DOI 10.2165/00002018-200730030-00004; Walubo A, 2007, EXPERT OPIN DRUG MET, V3, P583, DOI 10.1517/17425225.3.4.583; Yee TT, 2000, GUT, V47, P845, DOI 10.1136/gut.47.6.845	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	NOV	2014	20	11					661	665		10.1016/j.jiac.2014.07.019		5	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DC	WOS:000345558200001		
J	Wakabayashi, H; Oda, H; Yamauchi, K; Abe, F				Wakabayashi, Hiroyuki; Oda, Hirotsugu; Yamauchi, Koji; Abe, Fumiaki			Lactoferrin for prevention of common viral infections	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Review						Lactoferrin; Virus; Norovirus; Gastroenteritis; Interferon; NK	RESPIRATORY SYNCYTIAL VIRUS; INHIBITS ENTEROVIRUS-71 INFECTION; CHRONIC HEPATITIS-C; IN-VITRO INFECTION; BOVINE LACTOFERRIN; TYPE-1 INFECTION; INFLUENZA-VIRUS; DOUBLE-BLIND; STRUCTURAL POLYPEPTIDES; ROTAVIRUS INFECTION	Although lactoferrin has many biological functions, the host-protective effects against pathogenic microorganisms including bacteria, fungi, and viruses are regarded as one of the most important. Here, we review research on the protective role of lactoferrin administration against common viral infections. Many studies have shown the in vitro antiviral activity of lactoferrin against viral pathogens that cause common infections such as the common cold, influenza, gastroenteritis, summer cold, and herpes, where lactoferrin inhibits mainly viral attachment to the target cells. Recently, studies indicating the in vivo protective effects of lactoferrin by oral administration against common viral infections have been increasing. For instance, norovirus is an extremely important emerging human pathogen that causes a majority of gastroenteritis outbreaks worldwide that may be a target candidate for lactoferrin. Lactoferrin consumption reduced the incidence of noroviral gastroenteritis in children and a similar effect was observed in a wide range of ages in a preliminary survey. A recent in vitro study reported that lactoferrin inhibits both cellular attachment of the murine norovirus, a virus closely-related to the human norovirus, and viral replication in the cells by inducing antiviral cytokines interferon (IFN)-alpha/beta. Lactoferrin administration also enhances NK cell activity and Th1 cytokine responses, which lead to protection against viral infections. In conclusion, lactoferrin consumption may protect the host from viral infections through inhibiting the attachment of a virus to the cells, replication of the virus in the cells, and enhancement of systemic immune functions. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Wakabayashi, Hiroyuki; Oda, Hirotsugu; Yamauchi, Koji; Abe, Fumiaki] Morinaga Milk Ind Co Ltd, Food Sci & Technol Inst, Zama, Kanagawa 2528583, Japan	Wakabayashi, H (reprint author), Morinaga Milk Ind Co Ltd, Food Sci & Technol Inst, 5-1-83 Higashihara, Zama, Kanagawa 2528583, Japan.	h_wakaby@morinagamilk.co.jp					Ammendolia MG, 2007, ANTIVIR RES, V73, P151, DOI 10.1016/j.antiviral.2006.09.002; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; Shin K, 2005, J MED MICROBIOL, V54, P717, DOI 10.1099/jmm.0.46018-0; Pietrantoni A, 2003, ANTIMICROB AGENTS CH, V47, P2688, DOI 10.1128/AAC.47.8.2688-2691.2003; Wakabayashi H, 2006, CLIN VACCINE IMMUNOL, V13, P239, DOI 10.1128/CVI.13.2.239-245.2006; Tanaka K, 1999, JPN J CANCER RES, V90, P367; Sano H, 2003, EUR J IMMUNOL, V33, P2894, DOI 10.1002/eji.200324218; Baveye S, 1999, CLIN CHEM LAB MED, V37, P281, DOI 10.1515/CCLM.1999.049; Chen HL, 2008, VACCINE, V26, P891, DOI 10.1016/j.vaccine.2007.12.013; Chierici R, 2001, ADV NUTR RES, V10, P247; Kozu T, 2009, CANCER PREV RES, V2, P975, DOI 10.1158/1940-6207.CAPR-08-0208; van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4; McCann KB, 2003, J APPL MICROBIOL, V95, P1026, DOI 10.1046/j.1365-2672.2003.02071.x; Superti F, 1997, MED MICROBIOL IMMUN, V186, P83, DOI 10.1007/s004300050049; Gualdi L, 2013, ANTIVIR RES, V99, P188, DOI 10.1016/j.antiviral.2013.05.013; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Ammendolia MG, 2012, PATHOG GLOB HEALTH, V106, P12, DOI 10.1179/2047773212Y.0000000004; Marchetti M, 1999, MED MICROBIOL IMMUN, V187, P199, DOI 10.1007/s004300050093; Pietrantoni A, 2010, BIOMETALS, V23, P465, DOI 10.1007/s10534-010-9323-3; Johansson C, 2007, J VIROL, V81, P954, DOI 10.1128/JVI.01995-06; Berlutti F, 2011, MOLECULES, V16, P6992, DOI 10.3390/molecules16086992; Siciliano R, 1999, BIOCHEM BIOPH RES CO, V264, P19, DOI 10.1006/bbrc.1999.1318; Wakabayashi H, 2006, INT DAIRY J, V16, P1241, DOI 10.1016/j.idairyj.2006.06.013; Arnold D, 2002, ANTIVIR RES, V53, P153, DOI 10.1016/S0166-3542(01)00197-8; Di Biase AM, 2003, J MED VIROL, V69, P495, DOI 10.1002/jmv.10337; Egashira M, 2007, ACTA PAEDIATR, V96, P1238; Furlund CB, 2012, NUTR RES, V32, P503, DOI 10.1016/j.nutres.2012.06.006; Grover M, 1997, ACTA PAEDIATR, V86, P315, DOI 10.1111/j.1651-2227.1997.tb08896.x; HASEGAWA K, 1994, JPN J MED SCI BIOL, V47, P73; Ishikawa H, 2013, BIOCHEM BIOPH RES CO, V434, P791, DOI 10.1016/j.bbrc.2013.04.013; Jenssen H, 2008, ANTIVIR RES, V79, P192, DOI 10.1016/j.antiviral.2008.03.004; Kuhara T, 2006, J INTERF CYTOK RES, V26, P489, DOI 10.1089/jir.2006.26.489; Lampis G, 2001, ANTIVIR CHEM CHEMOTH, V12, P125; Lin TY, 2002, J INFECT DIS, V186, P1161, DOI 10.1086/343809; LU L, 1987, Cancer Research, V47, P4184; LU L, 1985, BLOOD, V65, P91; Marchetti M, 1996, ANTIVIR RES, V29, P221, DOI 10.1016/0166-3542(95)00840-3; Marchetti M, 1998, BIOMETALS, V11, P89, DOI 10.1023/A:1009217709851; Marr AK, 2009, BIOCHIMIE, V91, P160, DOI 10.1016/j.biochi.2008.05.016; Moriuchi M, 2009, 50 JAP SOC CLIN VIR, pS56; Ochoa TJ, 2013, J PEDIATR-US, V162, P349, DOI 10.1016/j.jpeds.2012.07.043; Oda H., 2013, Milk Science, V62, P105; Oda H, 2012, JPN J COMPLEMENT ALT, V9, P121; Pietrantoni A, 2006, ANTIVIR RES, V69, P98, DOI 10.1016/j.antiviral.2005.10.006; Pietrantoni A, 2012, BIOCHEM CELL BIOL, V90, P442, DOI [10.1139/o11-072, 10.1139/O11-072]; Portelli J, 1998, J MED MICROBIOL, V47, P1015; Seganti L, 2001, INT J IMMUNOPATH PH, V14, P71; Shestakov A, 2012, ANTIVIR RES, V93, P340, DOI 10.1016/j.antiviral.2012.01.003; Superti F, 2001, BBA-GEN SUBJECTS, V1528, P107, DOI 10.1016/S0304-4165(01)00178-7; Taha SH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-330; Ueno H, 2006, CANCER SCI, V97, P1105, DOI 10.1111/j.1349-7006.2006.00274.x; Vitetta L, 2013, COMPLEMENT THER MED, V21, P164, DOI 10.1016/j.ctim.2012.12.006; Wakabayashi H, 2004, BIOSCI BIOTECH BIOCH, V68, P537, DOI 10.1271/bbb.68.537; Weng TY, 2005, ANTIVIR RES, V67, P31, DOI 10.1016/j.antiviral.2005.03.005; Xu M, 2000, Environ Health Prev Med, V4, P212, DOI 10.1007/BF02931260; Yamamoto H, 2010, J HEALTH SCI, V56, P613, DOI 10.1248/jhs.56.613; Yen Meng-Hsiu, 2011, Chang Gung Med J, V34, P395; Zavaleta N, 2007, J PEDIATR GASTR NUTR, V44, P258, DOI 10.1097/MPG.0b013e31802c41b7	58	4	5	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	NOV	2014	20	11					666	671		10.1016/j.jiac.2014.08.003		6	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DC	WOS:000345558200002		
J	Tasaka, S; Kobayashi, S; Yagi, K; Asami, T; Namkoong, H; Yamasawa, W; Ishii, M; Hasegawa, N; Betsuyaku, T				Tasaka, Sadatomo; Kobayashi, Seiki; Yagi, Kazuma; Asami, Takahiro; Namkoong, Ho; Yamasawa, Wakako; Ishii, Makoto; Hasegawa, Naoki; Betsuyaku, Tomoko			Serum (1 -> 3) beta-D-glucan assay for discrimination between Pneumocystis jirovecii pneumonia and colonization	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Pneumocystis pneumonia; Colonization; Polymerase chain reaction; Bronchoalveolar lavage; (1 -> 3)-beta-D-glucan	HIV-INFECTED PATIENTS; REAL-TIME PCR; DIAGNOSIS; CARINII; DNA; METAANALYSIS; AIDS	Polymerase chain reaction (PCR) technique is being increasingly used for the microbiological diagnosis of Pneumocystis pneumonia (PCP). As PCR is highly sensitive, it can be positive even in a patient with Pneumocystis colonization. In this study, we evaluated whether the beta-D-glucan assay could be used to differentiate between PCP and Pneumocystis jirovecii colonization in immunocompromised patients with pulmonary infiltrates. We retrospectively evaluated data from 166 consecutive patients who underwent bronchoalveolar lavage for the diagnosis of PCP. Serum levels of beta-D-glucan in the negative, colonization, probable PCP, and definite PCP groups were 20.2 +/- 6.3, 48.8 +/- 15.9, 89.9 +/- 20.2, 224.9 +/- 25.9 pg/mL, respectively. The beta-D-glucan levels in the definite PCP group were significantly higher than those in the other 3 groups (p < 0.001). Serum b-D-glucan levels in patients with either definite or probable PCP (173.1 +/- 18.8 pg/mL) were significantly greater than those in patients with colonization who had positive PCR results but improved without anti-PCP treatment (p < 0.002). The cut-off level for discrimination was estimated to be 33.5 pg/mL, with which the positive predictive value was 0.925. These results indicate that beta-D-glucan is a useful marker to differentiate between PCP and Pneumocystis colonization. A positive beta-D-glucan assay result might be a good indication to begin anti-PCP treatment. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Tasaka, Sadatomo; Yagi, Kazuma; Asami, Takahiro; Namkoong, Ho; Ishii, Makoto; Betsuyaku, Tomoko] Keio Univ, Sch Med, Div Pulm Med, Tokyo 1608582, Japan; [Kobayashi, Seiki] Keio Univ, Sch Med, Dept Trop Med & Parasitol, Tokyo 1608582, Japan; [Yamasawa, Wakako] Keio Univ, Sch Med, Dept Lab Med, Tokyo 1608582, Japan; [Hasegawa, Naoki] Keio Univ, Sch Med, Ctr Infect Control & Infect Dis, Tokyo 1608582, Japan	Tasaka, S (reprint author), Keio Univ, Sch Med, Div Pulm Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tasaka@cpnet.med.keio.ac.jp					Huggett JF, 2008, THORAX, V63, P154, DOI 10.1136/thx.2007.081687; OBAYASHI T, 1995, LANCET, V345, P17, DOI 10.1016/S0140-6736(95)91152-9; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Reid AB, 2011, CURR OPIN INFECT DIS, V24, P534, DOI 10.1097/QCO.0b013e32834cac17; Azoulay E, 2009, CHEST, V135, P655, DOI 10.1378/chest.08-1309; Tasaka S, 2007, CHEST, V131, P1173, DOI 10.1378/chest.06-1467; Damiani C, 2013, J CLIN MICROBIOL, V51, P3380, DOI 10.1128/JCM.01554-13; Onishi A, 2012, J CLIN MICROBIOL, V50, P7, DOI 10.1128/JCM.05267-11; WAKEFIELD AE, 1990, LANCET, V336, P451, DOI 10.1016/0140-6736(90)92008-6; Catherinot E, 2010, INFECT DIS CLIN N AM, V24, P107, DOI 10.1016/j.idc.2009.10.010; Maskell NA, 2003, THORAX, V58, P594, DOI 10.1136/thorax.58.7.594; Ponce CA, 2010, CLIN INFECT DIS, V50, P347, DOI 10.1086/649868; LIMPER AH, 1989, AM REV RESPIR DIS, V140, P1204; Watanabe T, 2009, CLIN INFECT DIS, V49, P1128, DOI 10.1086/605579; Lu Y, 2011, J CLIN MICROBIOL, V49, P4361, DOI 10.1128/JCM.06066-11; Matsumura Y, 2012, CLIN MICROBIOL INFEC, V18, P591, DOI 10.1111/j.1469-0691.2011.03605.x; MATSUMOTO Y, 1989, J PROTOZOOL, V36, pS21, DOI 10.1111/j.1550-7408.1989.tb05814.x; Nakamura H, 2009, INTERNAL MED, V48, P195, DOI 10.2169/internalmedicine.48.1680	18	2	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	NOV	2014	20	11					678	681		10.1016/j.jiac.2014.07.001		4	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DC	WOS:000345558200004		
J	Negoro, S; Shimohata, T; Hatayama, S; Sato, Y; Matsumoto, M; Iba, H; Aihara, M; Uebanso, T; Hamada, Y; Nishikawa, Y; Yamasaki, S; Mawatari, K; Takahashi, A				Negoro, Sachie; Shimohata, Takaaki; Hatayama, Syo; Sato, Yuri; Matsumoto, Mari; Iba, Hitomi; Aihara, Mutsumi; Uebanso, Takashi; Hamada, Yasuhiro; Nishikawa, Yoshikazu; Yamasaki, Shinji; Mawatari, Kazuaki; Takahashi, Akira			Campylobacter jejuni infection suppressed Cl- secretion induced by CFTR activation in T-84 cells	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Campylobacter jejuni; CFTR; Diarrhea; Short-circuit current; Efflux assay	CYSTIC-FIBROSIS; ESCHERICHIA-COLI; ION-TRANSPORT; DIARRHEA; MUCIN; PATHOPHYSIOLOGY; ENTEROTOXIN; ENTERITIS; CHANNEL; CYCLASE	Campylobacter jejuni causes foodborne disease associated with abdominal pain, gastroenteritis, and diarrhea. These symptoms are induced by bacterial adherence and invasion of host epithelial cells. C. jejuni infection can occur with a low infective dose, suggesting that C. jejuni may have evolved strategies to cope with the bacterial clearance system in the gastrointestinal tract. The mucosa layer is the first line of defense against bacteria. Mucus conditions are maintained by water and anion (especially Cl-) movement. Cystic fibrosis transmembrane conductance regulator (CFTR) is the main Cl- channel transporting Cl- to the lumen. Mutations in CFTR result in dehydrated secreted mucus and bacterial accumulation in the lungs, and recent studies suggest that closely related pathogenic bacteria also may survive in the intestine. However, the relationship between C. jejuni infection and CFTR has been little studied. Here, we used an I-125(-) efflux assay and measurement of short-circuit current to measure Cl- secretion in C. jejuni-infected T-84 human intestinal epithelial cells. The basic state of Cl- secretion was unchanged by C. jejuni infection, but CFTR activator was observed to induce Cl- secretion suppressed in C. jejuni-infected T-84 cells. The suppression of activated Cl- secretion was bacterial dose-dependent and duration-dependent. A similar result was observed during infection with other C. jejuni strains. The mechanism of suppression may occur by affecting water movement or mucus condition in the intestinal tract. A failure of mucus barrier function may promote bacterial adhesion or invasion of host intestinal epithelial cells, thereby causing bacterial preservation in the host intestinal tract. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Negoro, Sachie; Shimohata, Takaaki; Hatayama, Syo; Sato, Yuri; Matsumoto, Mari; Iba, Hitomi; Aihara, Mutsumi; Uebanso, Takashi; Mawatari, Kazuaki; Takahashi, Akira] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Prevent Environm & Nutr, Tokushima 7708503, Japan; [Hamada, Yasuhiro] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Therapeut Nutr, Tokushima 7708503, Japan; [Nishikawa, Yoshikazu] Osaka City Univ, Grad Sch Human Life Sci, Dept Food & Human Hlth Sci, Sumiyoshi Ku, Osaka 5588585, Japan; [Yamasaki, Shinji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Vet Sci, Izumisano, Osaka 5988531, Japan	Shimohata, T (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Prevent Environm & Nutr, Kuramoto cho 3-18-15, Tokushima 7708503, Japan.	c201231009@tokushima-u.ac.jp; shimohata@nutr.med.tokushima-u.ac.jp; c201331016@tokushima-u.ac.jp; c201002011@tokushima-u.ac.jp; ma11230911@gmail.com; iba.hitomi@tokushima-u.ac.jp; aiharam@nutr.med.tokushima-u.ac.jp; uebanso@nutr.med.tokushima-u.ac.jp; hamada@nutr.med.tokushima-u.ac.jp; nisikawa@life.osaka-cu.ac.jp; shinji@vet.osakafu-u.ac.jp; mawatari@nutr.med.tokushima-u.ac.jp; akiratak@nutr.med.tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24115516, 26560046]	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (24115516) and Grant-in-Aid for challenging Exploratory Research (26560046) form the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Musch MW, 2013, DIGEST DIS SCI, V58, P668, DOI 10.1007/s10620-012-2509-5; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; KIMBERG DV, 1971, J CLIN INVEST, V50, P1218, DOI 10.1172/JCI106599; Tu QV, 2008, J MED MICROBIOL, V57, P795, DOI 10.1099/jmm.0.47752-0; KLEIN A, 1993, EUR J BIOCHEM, V211, P491, DOI 10.1111/j.1432-1033.1993.tb17575.x; Zielenski J, 1995, ANNU REV GENET, V29, P777; Thielman NM, 2004, NEW ENGL J MED, V350, P38, DOI 10.1056/NEJMcp031534; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; BLACK RE, 1988, J INFECT DIS, V157, P472; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Watson RO, 2005, CELL MICROBIOL, V7, P655, DOI 10.1111/j.1462-5822.2005.00498.x; HUGDAHL MB, 1988, INFECT IMMUN, V56, P1560; Field Michael, 2003, Journal of Clinical Investigation, V111, P931, DOI 10.1172/JCI200318326; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI200213870; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Rajagopal M, 2014, AM J PHYSIOL-CELL PH, V306, pC263, DOI 10.1152/ajpcell.00381.2012; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; FIELD M, 1978, P NATL ACAD SCI USA, V75, P2800, DOI 10.1073/pnas.75.6.2800; Friedman CR, 2000, EPIDEMIOLOGY CAMPYLO, P121; LENCER WI, 1992, J CELL BIOL, V117, P1197, DOI 10.1083/jcb.117.6.1197; Li Z, 1999, INFECT IMMUN, V67, P5938; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Marchelletta RR, 2013, GASTROENTEROLOGY, V145, P1358, DOI 10.1053/j.gastro.2013.08.054; Takahashi A, 2006, FEMS MICROBIOL LETT, V258, P92, DOI 10.1111/j.1574-6968.2006.00204.x; Tanoue N, 2005, FEMS MICROBIOL LETT, V242, P195, DOI 10.1016/j.femsle.2004.11.009; VENGLARIK CJ, 1990, AM J PHYSIOL, V259, pC358; WALKER RI, 1986, MICROBIOL REV, V50, P81	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	NOV	2014	20	11					682	688		10.1016/j.jiac.2014.07.007		7	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DC	WOS:000345558200005		
J	Komeda, T; Ishii, S; Itoh, Y; Ariyasu, Y; Sanekata, M; Yoshikawa, T; Shimada, J				Komeda, Takuji; Ishii, Shingo; Itoh, Yumiko; Ariyasu, Yasuyuki; Sanekata, Masaki; Yoshikawa, Takayoshi; Shimada, Jingoro			Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (I): A drug use investigation	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Influenza; Peramivir; Post-marketing surveillance; Safety profile	INFLUENZA-A H1N1; CRITICALLY-ILL PATIENTS; VIRUS-INFECTION; OSELTAMIVIR; RWJ-270201; ZANAMIVIR	Peramivir is the only intravenous formulation among anti-influenza neuraminidase inhibitors currently available. Peramivir was approved for manufacturing and marketing in Japan in January 2010. We conducted a drug use investigation of peramivir from October 2010 to February 2012 and evaluated its safety and effectiveness under routine clinical settings. We collected data of 1309 patients from 189 facilities across Japan and examined safety in 1174 patients and effectiveness in 1158 patients. In total, 143 adverse events were observed with an incidence rate of 7.33% (86/1174). Of these, 78 events were adverse drug reactions (ADRs) with an incidence rate of 4.34% (51/1174). The most frequently reported ADRs were diarrhea, vomiting, and nausea, with incidence rates of 1.87% (22/1174), 0.85% (10/1174), and 0.68% (8/1174), respectively. Moreover, no ADR was reported as serious. ADR onset was within 3 days after the start of peramivir administration in 91.0% (71 events) of the 78 ADRs, and ADRs were resolved or improved within 7 days after onset in 96.2% (75 events) of the 78 ADRs. Neither patient characteristics nor treatment factors appeared to significantly affect drug safety. With regard to effectiveness, the median time to alleviation of both influenza symptoms and fever was 3 days, including the first day of administration. The present study demonstrates the safety and effectiveness of peramivir under routine clinical settings. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Komeda, Takuji; Ishii, Shingo; Itoh, Yumiko; Ariyasu, Yasuyuki; Sanekata, Masaki; Yoshikawa, Takayoshi] Shionogi & Co Ltd, Pharmacovigilance, Chuo Ku, Osaka 5410045, Japan; [Shimada, Jingoro] St Marianna Univ, Sch Med, Dept Microbiol, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan	Komeda, T (reprint author), Shionogi & Co Ltd, Pharmacovigilance, Chuo Ku, 1-8 Doshomachi 3 Chome, Osaka 5410045, Japan.	takuji.komeda@shionogi.co.jp			Shionogi & Co., Ltd. (Osaka, Japan)	We would like to thank the 189 facilities and their physicians for participating in this investigation and providing valuable data. This survey was conducted with a grant from Shionogi & Co., Ltd. (Osaka, Japan).	Kohno S, 2011, ANTIMICROB AGENTS CH, V55, P2803, DOI [10.1128/AAC.01718-10, 10.1128/AAC.00360-11]; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P433; Bantia S, 2001, ANTIMICROB AGENTS CH, V45, P1162, DOI 10.1128/AAC.45.4.1162-1167.2001; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Rodriguez A, 2011, J ANTIMICROB CHEMOTH, V66, P1140, DOI 10.1093/jac/dkq511; Gubareva LV, 2001, ANTIMICROB AGENTS CH, V45, P3403, DOI 10.1128/AAC.45.12.3403-3408.2001; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Bantia S, 2006, ANTIVIR RES, V69, P39, DOI 10.1016/j.antiviral.2005.10.002; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Kohno S, 2010, ANTIMICROB AGENTS CH, V54, P4568, DOI 10.1128/AAC.00474-10; Yang SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029652; Yu H, 2010, BMJ-BRIT MED J, V341, pc4779	13	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	NOV	2014	20	11					689	695		10.1016/j.jiac.2014.07.006		7	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DC	WOS:000345558200006		
J	Ozawa, D; Yano, H; Hidaka, H; Kakuta, R; Komatsu, M; Endo, S; Kanamori, H; Kaku, M; Katori, Y				Ozawa, Daiki; Yano, Hisakazu; Hidaka, Hiroshi; Kakuta, Risako; Komatsu, Mayumi; Endo, Shiro; Kanamori, Hajime; Kaku, Mitsuo; Katori, Yukio			Twelve-year survey (2001-2012) of the antimicrobial susceptibility of Streptococcus pneumoniae isolates from otorhinolaryngology clinics in Miyagi Prefecture, Japan	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Streptococcus pneumoniae; Antimicrobial susceptibility; Minimum inhibitory concentration; Acute otitis media; Upper respiratory tract infection	PNEUMOCOCCAL CONJUGATE VACCINE; ACUTE OTITIS-MEDIA; RESISTANT; CHILDREN; EFFICACY; DISEASE; FIELD; LIFE; ERA	Introduction: Streptococcus pneumoniae is one of the most common bacteria causing otorhinolaryngological infections, such as acute otitis media and upper respiratory tract infection. Our group surveyed the drug susceptibility profile of S. pneumoniae isolates from otorhinolaryngology patients. Materials and methods: A total of 41,069 S. pneumoniae isolates were detected at Miyagi Medical Association Health Center between May 2001 and December 2012. Specimens were obtained from patients at 40 otorhinolaryngology outpatient clinics in Miyagi Prefecture, Japan. The minimum inhibitory concentrations (MICs) of 8 antimicrobial agents were measured using the broth microdilution method according to Clinical and Laboratory Standards Institute guidelines. Results: In children aged 0-2 years old, the MIC50 values of penicillins decreased after 2010 (PCG: 1 mu g/ml (2010) to 0.06 mu g/ml (2012); ABPC: 1 mu g/ml (2010) to 0.25 mu g/ml (2012)). The prevalence of penicillin-resistant S. pneumoniae (PRSP) decreased from 35.2% (2010) to 14.6% (2012) in rhinorrhea specimens and from 43.4% (2010) to 14.3% (2012) in otorrhea specimens. Susceptibility to cephems (ceftriaxone and cefditoren) and carbapenems (panipenem) also showed improvement after 2010. For macrolides (clarithromycin) and lincosamides (clindamycin), MIC50 values increased in all age groups during the study period, and a high level of resistance was seen until 2012. There were no marked changes of susceptibility to fluoroquinolones (LVFX) during the study period. Conclusion: Improvement of susceptibility of S. pneumoniae to beta-lactams occurred after 2010 in Miyagi Prefecture, Japan. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Ozawa, Daiki; Hidaka, Hiroshi; Kakuta, Risako; Katori, Yukio] Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi 9808575, Japan; [Ozawa, Daiki; Yano, Hisakazu; Kakuta, Risako; Endo, Shiro; Kanamori, Hajime; Kaku, Mitsuo] Tohoku Univ, Grad Sch Med, Dept Infect Control & Lab Diagnost, Sendai, Miyagi 9808575, Japan; [Komatsu, Mayumi] Miyagi Med Assoc Hlth Ctr, Dept Clin Lab, Sendai, Miyagi, Japan	Ozawa, D (reprint author), Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808575, Japan.	daiki-oz@med.tohoku.ac.jp					ALHO OP, 1991, INT J PEDIATR OTORHI, V21, P7, DOI 10.1016/0165-5876(91)90054-F; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Faden H, 1997, J INFECT DIS, V175, P1440; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Fani F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r115; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Palmu AAI, 2004, PEDIATR INFECT DIS J, V23, P732, DOI 10.1097/01.inf.0000133049.30299.5d; Taylor S, 2012, CLIN INFECT DIS, V54, P1765, DOI 10.1093/cid/cis292; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817; Asahi Y, 1999, ANTIMICROB AGENTS CH, V43, P1252; Clinical and Laboratory Standards Institute, 2006, M7A7 CLIN LAB STAND, V26; Inoue Matsuhisa, 2006, Journal of Infection and Chemotherapy, V12, P9, DOI 10.1007/s10156-005-0421-z; Kamiya Hitoshi, 2007, Kansenshogaku Zasshi, V81, P59; Konno M, 1997, J INFECT CHEMOTHER, V3, P190, DOI 10.1007/BF02490033; Lynch JP, 2002, CLIN INFECT DIS, V34, pS27, DOI 10.1086/324527; Nagai K, 2001, J ANTIMICROB CHEMOTH, V48, P9115; Nuermberger E, 2004, CLIN INFECT DIS, V38, P99, DOI 10.1086/380126; Sluijter M, 1998, J CLIN MICROBIOL, V36, P2248; Sunakawa Keisuke, 2007, Ann Clin Microbiol Antimicrob, V6, P7, DOI 10.1186/1476-0711-6-7; Tajima T, 2013, J INFECT CHEMOTHER, V19, P510, DOI 10.1007/s10156-013-0593-x; Ubukata K, 2004, ANTIMICROB AGENTS CH, V48, P1488, DOI 10.1128/AAC.48.5.1488-1494.2004; Yano H, 2013, J CLIN MICROBIOL, V51, P3542, DOI 10.1128/JCM.01108-13; Yano H, 2000, J CLIN MICROBIOL, V38, P625	25	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	NOV	2014	20	11					702	708		10.1016/j.jiac.2014.07.014		7	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DC	WOS:000345558200008		
J	Kittaka, S; Hasegawa, S; Ito, Y; Ohbuchi, N; Suzuki, E; Kawano, S; Aoki, Y; Nakatsuka, K; Kudo, K; Wakiguchi, H; Kajimoto, M; Matsushige, T; Ichiyama, T				Kittaka, Setsuaki; Hasegawa, Shunji; Ito, Yoshinori; Ohbuchi, Noriko; Suzuki, Eitaro; Kawano, Shoji; Aoki, Yoshiharu; Nakatsuka, Kenji; Kudo, Keiko; Wakiguchi, Hiroyuki; Kajimoto, Madoka; Matsushige, Takeshi; Ichiyama, Takashi			Serum levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in human herpesvirus-6-infected infants with or without febrile seizures	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Human herpesvirus-6; Blood-brain barrier; Matrix metalloproteinase-9; Tissue inhibitor of metalloproteinases-1; Febrile seizures; Exanthema subitum	SUBACUTE SCLEROSING-PANENCEPHALITIS; TUMOR-NECROSIS-FACTOR; EPSTEIN-BARR-VIRUS; REAL-TIME PCR; MATRIX METALLOPROTEINASES; ENCEPHALOPATHY; TIMP-1; DEGRADATION; INFECTION	Human herpesvirus-6 (HHV-6) is a cause of exanthema subitum and, sometimes, of febrile seizures. However, the pathogenesis of febrile seizures associated with HHV-6 infection remains unclear. We investigated serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1) levels in infants with HHV-6 infection. Serum levels of both MMP-9 and TIMP-1 were significantly higher in infants with HHV-6 infection than in controls. Serum TIMP-1 levels were significantly higher in infants with febrile seizures than in infants without febrile seizures. Serum MMP-9/TIMP-1 ratios were significantly lower in infants with febrile seizures than in infants without febrile seizures. In infants with HHV-6 infection, positive correlations were found between serum MMP-9 concentrations and the white blood cells (WBC) count, and between serum TIMP-1 concentrations and the WBC count. Positive correlations were also found between the amounts of HHV-6 DNA and the ratios of MMP-9/TIMP-1 in infants with HHV-6 infection. In conclusion, we suggest that high serum levels of MMP-9 and TIMP-1 in infants with HHV-6 infection may induce dysfunction of the bloodebrain barrier, eventually causing febrile seizures. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Kittaka, Setsuaki; Hasegawa, Shunji; Kudo, Keiko; Wakiguchi, Hiroyuki; Kajimoto, Madoka; Matsushige, Takeshi; Ichiyama, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Pediat, Ube, Yamaguchi 7558505, Japan; [Ito, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan; [Ohbuchi, Noriko] Yamaguchi Red Cross Hosp, Dept Pediat, Yamaguchi, Japan; [Suzuki, Eitaro] Suzuki Pediat Clin, Dept Pediat, Tokyo, Japan; [Kawano, Shoji] Shimonoseki City Hosp, Dept Pediat, Shimonoseki, Yamaguchi, Japan; [Aoki, Yoshiharu] Nagato Gen Hosp, Dept Pediat, Nagato, Yamaguchi, Japan; [Nakatsuka, Kenji] Toyoura Hosp, Dept Pediat, Shimonoseki, Yamaguchi, Japan	Kittaka, S (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Pediat, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	setsuaki@yamaguchi-u.ac.jp					Chandler S, 1997, J NEUROIMMUNOL, V72, P155, DOI 10.1016/S0165-5728(96)00179-8; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Kimura H, 2005, J INFECT DIS, V191, P531, DOI 10.1086/427239; Yoshikawa T, 2000, BRAIN DEV-JPN, V22, P307, DOI 10.1016/S0387-7604(00)00113-3; Asaoka K, 2004, INTERNAL MED, V43, P42, DOI 10.2169/internalmedicine.43.42; Ichiyama T, 2007, PEDIATR INFECT DIS J, V26, P542, DOI 10.1097/INF.0b013e31803994a0; Forster C, 2007, J PHYSIOL-LONDON, V580, P937, DOI 10.1113/jphysiol.2007.129007; Ichiyama T, 2006, J NEUROIMMUNOL, V172, P182, DOI 10.1016/j.jneuroim.2005.10.010; Suenaga N, 2008, J NEUROL SCI, V266, P126, DOI 10.1016/j.jns.2007.09.011; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Yamamoto S, 2006, J SURG RES, V134, P307, DOI 10.1016/j.jss.2005.11.588; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Lukes A, 1999, MOL NEUROBIOL, V19, P267, DOI 10.1007/BF02821717; Millichap JG, 2006, PEDIATR NEUROL, V35, P165, DOI 10.1016/j.pediatrneurol.2006.06.004; Chao C, 2009, AM J INFECT DIS, V5, P314, DOI DOI 10.3844/AJIDSP.2009.307.313; Ichiyama T, 2008, J INFECTION, V56, P376, DOI 10.1016/j.jinf.2008.02.014; Ichiyama T, 2009, J NEUROL, V256, P1846, DOI 10.1007/s00415-009-5207-2; Ichiyama T, 2007, J NEUROL SCI, V252, P45, DOI 10.1016/j.jns.2006.10.005; Johnatty RN, 1997, J IMMUNOL, V158, P2327; Kelly EAB, 2000, AM J RESP CRIT CARE, V162, P1157; Krizanac-Bengez L, 2006, AM J PHYSIOL-CELL PH, V291, P740; Murphy G, 1997, MATRIX BIOL, V15, P511, DOI 10.1016/S0945-053X(97)90025-1; Sellner J, 2006, NEUROBIOL DIS, V21, P647, DOI 10.1016/j.nbd.2005.09.007; Shinji K, 2010, J MED VIROL, V82, P1410; Shiraishi M, 2008, J NEUROIMMUNOL, V196, P147, DOI 10.1016/j.jneuroim.2008.02.012; Sunagawa S, 2009, BRAIN DEV-JPN, V31, P588, DOI 10.1016/j.braindev.2008.09.001; Wada K, 2007, J CLIN MICROBIOL, V45, P1426, DOI 10.1128/JCM.01515-06; Wada K, 2009, MICROBIOL IMMUNOL, V53, P22, DOI 10.1111/j.1348-0421.2008.00090.x	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	NOV	2014	20	11					716	721		10.1016/j.jiac.2014.07.017		6	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DC	WOS:000345558200010		
J	Tachibana, T; Orita, Y; Abe-Fujisawa, I; Ogawara, Y; Matsuyama, Y; Shimizu, A; Nakada, M; Sato, Y; Nishizaki, K				Tachibana, Tomoyasu; Orita, Yorihisa; Abe-Fujisawa, Iku; Ogawara, Yuya; Matsuyama, Yuko; Shimizu, Aiko; Nakada, Michihiro; Sato, Yasuharu; Nishizaki, Kazunori			Prognostic factors and effects of early surgical drainage in patients with peritonsillar abscess	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Peritonsillar abscess; Prognostic factors; Incision and drainage; Symptom relief; Overall recovery time	CLINICAL-FEATURES; NEEDLE ASPIRATION; EXPERIENCE	Peritonsillar abscess is a frequently encountered otorhinolaryngological emergency, but the characteristics of patients with this disease have not been described in detail. The objective of this study was to delineate prognostic factors associated with peritonsillar abscess and the effects of early surgical drainage for the treatment of peritonsillar abscess. We conducted a retrospective analysis of the medical records of 240 consecutive patients with PTA during the period from 2007 to 2013. Univariate analysis indicated that the period between symptom onset and relief was significantly longer in patients with high levels of C-reactive protein (CRP) (>8.53 mg/dL, p = 0.0073) and without early surgical drainage of pus (p < 0.0001). Multivariate analysis identified both of these values as independently associated with longer duration of symptoms (high CRP, P < 0.0001; no early drainage, P < 0.0001). Univariate analysis indicated that the duration between symptom onset and complete recovery from the disease was significantly longer with age >= 40 years (P = 0.0004), no history of recurrent tonsillitis (P = 0.022), high CRP level (P = 0.0017), and no early surgical drainage of the abscess (P = 0.0014). Multivariate analysis identified older age (P = 0.0004), high CRP level (P = 0.0001), and no early drainage (P < 0.0001) as independently associated with longer duration between symptom onset and complete recovery. Early surgical drainage of the abscess is important for the treatment of peritonsillar abscess. Patients >40 years old with peritonsillar abscess and high CRP levels should be recognized as a high-risk group. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Tachibana, Tomoyasu; Abe-Fujisawa, Iku; Ogawara, Yuya; Matsuyama, Yuko; Shimizu, Aiko] Himeji Red Cross Hosp, Dept Otolaryngol, Himeji, Hyogo 6708540, Japan; [Orita, Yorihisa; Nishizaki, Kazunori] Univ Grad Sch Med Dent & Pharmaceut Sci, Dept Otolaryngol Head & Neck Surg, Kita Ku, Okayama 7008558, Japan; [Nakada, Michihiro] Nakada ENT Clin, Himeji, Hyogo 6700808, Japan; [Sato, Yasuharu] Univ Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Kita Ku, Okayama 7008558, Japan	Tachibana, T (reprint author), Himeji Red Cross Hosp, Dept Otolaryngol, 12-1 Shimoteno 1 Chome, Himeji, Hyogo 6708540, Japan.	tomoyasutachibana@hotmail.co.jp					Steyer TE, 2002, AM FAM PHYSICIAN, V65, P93; Hsiao HJ, 2012, PEDIATR NEONATOL, V53, P366, DOI 10.1016/j.pedneo.2012.08.006; Powell J, 2012, CLIN OTOLARYNGOL, V37, P136, DOI 10.1111/j.1749-4486.2012.02452.x; Albertz N, 2012, ACTA OTO-LARYNGOL, V132, P1102, DOI 10.3109/00016489.2012.684399; Chau JKM, 2014, LARYNGOSCOPE, V124, P97, DOI 10.1002/lary.24283; DILKES MG, 1990, ARCH EMERG MED, V7, P212; Franzese CB, 2003, AM J OTOLARYNG, V24, P169, DOI 10.1016/S0196-0709(03)32428-1; Hanna BC, 2006, J INFECTION, V52, P247, DOI 10.1016/j.jinf.2005.07.002; Ito K, 2011, AURIS NASUS LARYNX, V38, P284, DOI 10.1016/j.anl.2010.06.004; Klug TE, 2013, EUR ARCH OTO-RHINO-L, V270, P3163, DOI 10.1007/s00405-013-2474-4; Kordeluk S, 2011, OTOLARYNG HEAD NECK, V145, P940, DOI 10.1177/0194599811415802; Lamkin Roland H, 2006, Ear Nose Throat J, V85, P660; Lin YY, 2011, CAN MED ASSOC J, V183, P1276, DOI 10.1503/cmaj.100066; Marom T, 2010, AM J OTOLARYNG, V31, P162, DOI 10.1016/j.amjoto.2008.12.003; Matsuda Akifumi, 2002, Ear Nose Throat J, V81, P384; Mehanna HM, 2002, POSTGRAD MED J, V78, P545, DOI 10.1136/pmj.78.923.545; Papacharalampous GX, 2011, CASE REPORT MED, V2011; Sibbitt RR, 2008, OTOLARYNG HEAD NECK, V139, P307, DOI 10.1016/j.otohns.2008.04.003; Sowerby LJ, 2013, J OTOLARYNGOL-HEAD N, V42, DOI 10.1186/1916-0216-42-5; Watanabe T, 2010, ANN OTO RHINOL LARYN, V119, P662	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	NOV	2014	20	11					722	725		10.1016/j.jiac.2014.07.018		4	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DC	WOS:000345558200011		
J	Muranaka, T; Takahashi, S; Hirose, T; Hattori, A				Muranaka, Takashi; Takahashi, Satoshi; Hirose, Takaoki; Hattori, Atsuo			Urethral polyp-like lesions on prostatic urethra caused by Chlamydia trachomatis infection: A case report	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Chlamydia trachomatis; Urethral polyp-like lesion; Hematospermia		Urethral polyp is one of differential diagnoses for the male patients complain of gross-hematuria and/or hematospermia. However, there have been limited numbers of case reports including infectious etiology. Here we reported clinical course and pathological findings of one rare case who was diagnosed and treated as urethral polyp-like lesions on the prostatic urethra caused by Chlamydia trachomatis infection. A 25 year-old man who had a past history of frequent sexual intercourse with unspecified female sexual partner visited the clinic. His chief complaint was gross-hematuria and hematospermia. Endoscopic findings showed that nonspecific hemorrhagic polyp-like lesions. To determine the pathological findings including malignant diseases and diagnosis, transurethral resection was performed. Because the pathological findings were similar to those of chlamydial proctitis, additional examination was done. As the results, nucleic acid amplification test of C. trachomatis in urine specimen was positive and immunohistochemical staining of specific chlamydia antigen in resected specimen was also positive. Treatment by orally minocyline 100 mg twice daily for 4 weeks was introduced. After the treatment, symptom was disappeared and nucleic acid amplification test of C. trachomatis in urine specimen turned to be negative. No recurrence was reported 2 years posttreatment. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Muranaka, Takashi; Hirose, Takaoki] Hokkaido Social Hlth Insurance Hosp, Dept Urol, Sapporo, Hokkaido, Japan; [Takahashi, Satoshi] Sapporo Med Univ, Dept Urol, Sch Med, Sapporo, Hokkaido 0608543, Japan; [Hattori, Atsuo] Hokkaido Social Hlth Insurance Hosp, Dept Pathol, Sapporo, Hokkaido, Japan	Takahashi, S (reprint author), Sapporo Med Univ, Dept Urol, Sch Med, Chuo Ku, S1,W16, Sapporo, Hokkaido 0608543, Japan.	stakahas@sapmed.ac.jp					Furuya R, 2006, INT J UROL, V13, P466, DOI 10.1111/j.1442-2042.2006.01317.x; Furuya Seiji, 2002, Hinyokika Kiyo, V48, P337; Isozaki Y, 2009, GASTROENTEROL ENDOSC, V51, P1707; Kuwata Y, 2000, NISHI NIHON HINYOKIK, V62, P207; Ootani A, 2011, INTESTINE, V15, P81	5	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	NOV	2014	20	11					726	728		10.1016/j.jiac.2014.07.002		3	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DC	WOS:000345558200012		
J	Nishimura, S; Kou, T; Kato, H; Watanabe, M; Uno, S; Senoh, M; Fukuda, T; Hata, A; Yazumi, S				Nishimura, Satoshi; Kou, Tadayuki; Kato, Haru; Watanabe, Masaki; Uno, Shoichi; Senoh, Mitsutoshi; Fukuda, Tadashi; Hata, Atsuko; Yazumi, Shujiro			Fulminant pseudomembranous colitis caused by Clostridium difficile PCR ribotype 027 in a healthy young woman in Japan	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Pseudomembranous colitis; Clostiridium difficile; PCR ribotype 027	INFECTION; SPREAD; STRAIN	In the past two decades, Clostridium difficile polymerase chain reaction ribotype 027 strain has rapidly emerged as the leading cause of antibiotic-associated colitis in North America and Europe; however, it has been reported only occasionally in Japan. We report a case of fulminant pseudomembranous colitis caused by this strain in a healthy young woman in Japan without any previous medical history. The strain isolated from our patient was susceptible to both gatifloxacin and moxifloxacin, thus representing a historic strain. The acquisition of fluoroquinolone resistance was reported as the important key genetic event linked to the virulence of this strain. It is noteworthy that the fluoroquinolone-susceptible 027 strain caused fulminant colitis in a healthy young woman in a non-endemic area. Our experience suggests that C. difficile PCR ribotype 027 has the potential virulence factors that are not associated with a fluoroquinolone resistance-conferring mutation. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Nishimura, Satoshi; Kou, Tadayuki; Watanabe, Masaki; Yazumi, Shujiro] Kitano Hosp, Tazuke Kofukai Med Res Inst, Ctr Digest Dis, Osaka 5308480, Japan; [Kato, Haru; Senoh, Mitsutoshi; Fukuda, Tadashi] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Uno, Shoichi; Hata, Atsuko] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Infect Dis, Osaka 5308480, Japan	Yazumi, S (reprint author), Kitano Hosp, Tazuke Kofukai Med Res Inst, Ctr Digest Dis, Kita Ku, 2-4-20 Ohgimach, Osaka 5308480, Japan.	s-yazumi@kitano-hp.or.jp					Kuipers EJ, 2008, LANCET, V371, P1486, DOI 10.1016/S0140-6736(08)60635-2; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Kato H, 2010, J MED MICROBIOL, V59, P556, DOI 10.1099/jmm.0.016147-0; Hoover DG, 2013, INFECT DIS CLIN N AM, V27, P675, DOI 10.1016/j.idc.2013.05.004; Sawabe E, 2007, EUR J CLIN MICROBIOL, V26, P695, DOI 10.1007/s10096-007-0355-8; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Clements ACA, 2010, LANCET INFECT DIS, V10, P395, DOI 10.1016/S1473-3099(10)70080-3; Pacheco SM, 2013, CURR OPIN GASTROEN, V29, P42, DOI 10.1097/MOG.0b013e32835a68d4; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Asai T, 2013, J VET MED SCI, V75, P539, DOI 10.1292/jvms.12-0353; Kato H, 2007, EUROSURVEILLANCE, V12; Kelly Ciarán P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Nakamura I, 2014, J INFECT CHEMOTHER, V20, P380, DOI 10.1016/j.jiac.2013.11.009	13	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	NOV	2014	20	11					729	731		10.1016/j.jiac.2014.07.004		3	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DC	WOS:000345558200013		
J	Mandai, S; Kasagi, Y; Kusaka, K; Shikuma, S; Akita, W; Kuwahara, M				Mandai, Shintaro; Kasagi, Yuri; Kusaka, Keita; Shikuma, Satomi; Akita, Wataru; Kuwahara, Michio			Helicobacter cinaedi kidney cyst infection and bacteremia in a patient with autosomal dominant polycystic kidney disease	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Bacteremia; Chronic kidney disease; Cyst infection; Helicobacter cinaedi; Polycystic kidney disease	IMMUNOCOMPROMISED PATIENTS; CAMPYLOBACTER-CINAEDI; IDENTIFICATION; CELLULITIS; BLOOD	A 48-year-old man with autosomal dominant polycystic kidney disease (ADPKD) was admitted to our hospital with a 5-day history of lower right back pain, high-grade fever, and arthralgia. He was diagnosed with right kidney cyst infection and bacteremia due to Helicobacter cinaedi (H. cinaedi) based on these symptoms, highly elevated CRP (32.25 mg/dL), abdominal magnetic resonance imaging findings, and the identification of H. cinaedi from blood cultures using PCR and sequence analysis of the 16S ribosomal DNA gene. Intravenous cefotaxime 0.5 g twice daily followed by meropenem 0.5 g twice daily and ciprofloxacin 200 mg twice daily were partially effective; oral doxycycline added at 200 mg/day finally eradicated the infection. Total duration of antimicrobial therapy was 9 weeks. H. cinaedi infections typically present as bacteremia with or without cellulitis in immunocompromised patients such as those with AIDS or malignant disease. To our knowledge, this is the first report describing an ADPKD patient with H. cinaedi cyst infection. Although H. cinaedi infections are increasingly recognized, even in immunocompetent subjects, numerous cases may still be overlooked given that this bacterium is slow-growing, and is difficult to culture, be Gram-stained, and identify on phenotypic tests. Consideration of this bacterium as a possible pathogen and sufficient duration of incubation with molecular testing are necessary in treating ADPKD patients with cyst infection. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Mandai, Shintaro; Kasagi, Yuri; Kusaka, Keita; Shikuma, Satomi; Akita, Wataru; Kuwahara, Michio] Shuuwa Gen Hosp, Dept Nephrol, Kasukabe, Saitama 3440035, Japan	Mandai, S (reprint author), Shuuwa Gen Hosp, Dept Nephrol, 1200 Yaharashinden, Kasukabe, Saitama 3440035, Japan.	shintaro_mandai@yahoo.co.jp					Sallee M, 2009, CLIN J AM SOC NEPHRO, V4, P1183, DOI 10.2215/CJN.01870309; VANDAMME P, 1990, J CLIN MICROBIOL, V28, P1016; Matsumoto T, 2007, J CLIN MICROBIOL, V45, P2853, DOI 10.1128/JCM.00465-07; Kitamura T, 2007, J CLIN MICROBIOL, V45, P31, DOI 10.1128/JCM.01507-06; GEBHART CJ, 1989, J CLIN MICROBIOL, V27, P1692; Kolbert CP, 1999, CURR OPIN MICROBIOL, V2, P299, DOI 10.1016/S1369-5274(99)80052-6; KIEHLBAUCH JA, 1994, ANN INTERN MED, V121, P90; ORLICEK SL, 1993, J CLIN MICROBIOL, V31, P569; Minauchi K, 2010, INTERNAL MED, V49, P1733, DOI 10.2169/internalmedicine.49.3649; QUINN TC, 1984, ANN INTERN MED, V101, P187; FICK GM, 1995, J AM SOC NEPHROL, V5, P2048; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Suwabe T, 2012, CLIN EXP NEPHROL, V16, P892, DOI 10.1007/s10157-012-0650-2; Tanaka Takashi, 2007, Kansenshogaku Zasshi, V81, P700	14	4	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	NOV	2014	20	11					732	734		10.1016/j.jiac.2014.07.012		3	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DC	WOS:000345558200014		
J	Haque, A; Yoshizumi, A; Saga, T; Ishii, Y; Tateda, K				Haque, Anwarul; Yoshizumi, Ayumi; Saga, Tomoo; Ishii, Yoshikazu; Tateda, Kazuhiro			ESBL-producing Enterobacteriaceae in environmental water in Dhaka, Bangladesh	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Environmental water; ESBL; Multilocus sequence typing; Bangladesh	NDM-1-PRODUCING KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; BETA-LACTAMASES; PREVALENCE; EMERGENCE; INFECTIONS; DISSEMINATION; HOSPITALS; DIVERSITY	Pathogens encoding extended-spectrum beta-lactamase (ESBL) genes represent a threat for failure of empirical antibiotic therapy and are associated with high mortality, morbidity and expenses. We examined surface water in Dhaka, capital of Bangladesh and isolated ESBL-producing Escherichia coli, Klebsiella pneumoniae and Enterobacter cloacae, suggesting the potential role of water for the dissemination and transmission of resistant genes among microorganisms. E. coli found most prevalent among isolated Enterobacteriaceae from environmental water. Molecular and genetic analysis revealed CTX-M-type and SHV-type ESBL genes in isolates that may influence the spread of multidrug resistant pathogenic bacteria causing human and animal infections in Bangladesh. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Haque, Anwarul; Yoshizumi, Ayumi; Saga, Tomoo; Ishii, Yoshikazu; Tateda, Kazuhiro] Toho Univ, Sch Med, Dept Microbiol & Infect Dis, Ota Ku, Tokyo 1438540, Japan	Ishii, Y (reprint author), Toho Univ, Sch Med, Dept Microbiol & Infect Dis, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan.	yishii@med.toho-u.ac.jp					Saladin M, 2002, FEMS MICROBIOL LETT, V209, P161, DOI 10.1111/j.1574-6968.2002.tb11126.x; Lee MY, 2011, INT J ANTIMICROB AG, V38, P160, DOI 10.1016/j.ijantimicag.2011.03.020; Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355; Chen Y, 2014, CLIN MICROBIOL INFEC, V20, P52, DOI 10.1111/1469-0691.12188; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Ishii Y, 2005, J CLIN MICROBIOL, V43, P1072, DOI 10.1128/JCM.43.3.1072-1075.2005; Arpin C, 2012, ANTIMICROB AGENTS CH, V56, P3432, DOI 10.1128/AAC.00230-12; ARLET G, 1995, FEMS MICROBIOL LETT, V134, P203, DOI 10.1111/j.1574-6968.1995.tb07938.x; Poirel L, 2011, J ANTIMICROB CHEMOTH, V66, P2781, DOI 10.1093/jac/dkr384; Hasan B, 2012, EMERG INFECT DIS, V18, P2055, DOI 10.3201/eid1812.120513; Falagas ME, 2009, J HOSP INFECT, V73, P345, DOI 10.1016/j.jhin.2009.02.021; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Ko KS, 2008, DIAGN MICR INFEC DIS, V61, P453, DOI 10.1016/j.diagmicrobio.2008.03.005; Kamruzzaman M, 2013, DIAGN MICR INFEC DIS, V76, P222, DOI 10.1016/j.diagmicrobio.2013.02.016; Rimrang B, 2012, J ANTIMICROB CHEMOTH, V67, P2626, DOI 10.1093/jac/dks267; Islam MA, 2012, EUR J CLIN MICROBIOL, V31, P2593, DOI 10.1007/s10096-012-1601-2; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Zurfluh K, 2013, APPL ENVIRON MICROB, V79, P3021, DOI 10.1128/AEM.00054-13; Nielsen JB, 2011, EUR J CLIN MICROBIOL, V30, P773, DOI 10.1007/s10096-011-1153-x; Chang CL, 2013, J HOSP INFECT, V85, P118, DOI 10.1016/j.jhin.2013.06.010; Chen CH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-417; Clinical and Laboratory Standards Institute, 2003, M7A2 CLIN LAB STAND; Coque TM, 2008, EUROSURVEILLANCE, P13; Hernandez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076150; Hu LH, 2013, DIAGN MICR INFEC DIS, V75, P373, DOI 10.1016/j.diagmicrobio.2013.01.006; Kanamori H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037967; Rahman MM, 2004, INT J ANTIMICROB AG, V24, P508, DOI 10.1016/j.ijantimicag.2004.05.007; Xu L, 2005, J MED MICROBIOL, V54, P1183, DOI 10.1099/jmm.0.46160-0	28	5	5	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	NOV	2014	20	11					735	737		10.1016/j.jiac.2014.07.003		3	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DC	WOS:000345558200015		
J	Naitoh, S; Tomita, K; Sakai, K; Yamasaki, A; Kawasaki, Y; Shimizu, E				Naitoh, Satoko; Tomita, Katsuyuki; Sakai, Keita; Yamasaki, Akira; Kawasaki, Yuji; Shimizu, Eiji			THE EFFECT OF BODY POSITION ON PULMONARY FUNCTION, CHEST WALL MOTION, AND DISCOMFORT IN YOUNG HEALTHY PARTICIPANTS	JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS			English	Article						Posture; Pulmonary Function Tests	LATERAL DECUBITUS POSITION; CHRONIC HEART-FAILURE; RESPIRATORY-FUNCTION; RIB CAGE; DISEASE; MECHANICS; LUNG; MANAGEMENT; POSTURE	Objective: The purpose of this study was to investigate the effect of different recumbent positions on pulmonary function, chest wall motion, and feelings of discomfort in young nonobese healthy volunteers. Methods: Twenty healthy volunteers (age, 28.0 +/- 1.4 years; height, 167.5 +/- 10.1 cm; weight, 62.3 +/- 10.2 kg) were studied in the sitting position and in the following 6 recumbent positions: supine, left retroversion at a 45 degrees tilt, left anteversion at a 45 degrees tilt, right retroversion at a 45 degrees tilt, right anteversion at a 45 degrees tilt, and prone. After 5 minutes of a selected position, pulmonary functions, including vital capacity (VC), forced expiratory volume in 1 second, maximal inspiratory and expiratory mouth pressures (MIP and MEP, respectively), and breathing pattern components at the chest wall were assessed. Discomfort was assessed using a modified Borg scale. Results: When participants changed position from sitting to each of the 6 recumbent positions, forced expiratory volume in 1 second values decreased significantly (P < .05). None of the participants showed changes in the MIP or MEP in any of the 6 recumbent positions. Rib cage motion was restricted in all recumbent positions except supine, left anteversion at a 45 degrees tilt, and prone. In all 6 recumbent positions, discomfort was experienced during the pulmonary tests. However, in the left retroversion at a 45 degrees tilt position, no discomfort was experienced during the MIP and MEP assessments. Conclusion: In young, nonobese, healthy volunteers, recumbent positions caused diminished pulmonary functions and induced feelings of discomfort.	[Naitoh, Satoko] Santerion Yodoe Nursing Home, Dept Rehabil, Yonago, Tottori, Japan; [Tomita, Katsuyuki] Yonago Med Ctr, Dept Resp Med, Yonago, Tottori 6830006, Japan; [Sakai, Keita] YMCA Coll Med Human Serv, Dept Phys Therapy, Yonago, Tottori, Japan; [Yamasaki, Akira; Shimizu, Eiji] Tottori Univ, Fac Med, Dept Multidisciplinary Internal Med, Div Med Oncol & Mol Respirol, Yonago, Tottori 683, Japan	Tomita, K (reprint author), Yonago Med Ctr, Dept Resp Med, 4-17-1 Kuzumo, Yonago, Tottori 6830006, Japan.	Tomita-katsuyuki@nho-yonago.jp					BEHRAKIS PK, 1983, CHEST, V83, P643, DOI 10.1378/chest.83.4.643; GILMARTIN JJ, 1986, AM REV RESPIR DIS, V134, P683; Pelosi P, 1998, AM J RESP CRIT CARE, V157, P387; Leung RST, 2003, J AM COLL CARDIOL, V41, P227, DOI 10.1016/S0735-1097(02)02717-1; MASARSKY CS, 1988, J MANIP PHYSIOL THER, V11, P505; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; HIXON TJ, 1976, J SPEECH HEAR RES, V19, P297; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; ASHUTOSH K, 1975, CHEST, V67, P553, DOI 10.1378/chest.67.5.553; ATTINGER EO, 1956, J CLIN INVEST, V35, P904, DOI 10.1172/JCI103343; Badr C, 2002, AUST J PHYSIOTHER, V48, P95; BARNAS GM, 1993, ANESTHESIOLOGY, V78, P251, DOI 10.1097/00000542-199302000-00007; Casaburi R, 2009, NEW ENGL J MED, V360, P1329, DOI 10.1056/NEJMct0804632; DON HF, 1975, J APPL PHYSIOL, V39, P390; Dougherty PE, 2011, J MANIP PHYSIOL THER, V34, P413, DOI 10.1016/j.jmpt.2011.05.004; Faggiano P, 1998, CARDIOLOGY, V89, P1, DOI 10.1159/000006735; FIZ JA, 1991, INT J OBESITY, V15, P655; LALLOO UG, 1991, RESPIRATION, V58, P122; LUMB AB, 1991, ANESTH ANALG, V73, P422; Osterhouse MD, 2005, J MANIP PHYSIOL THER, V28, P356, DOI 10.1016/j.jmpt.2005.04.004; Palermo P, 2005, CHEST, V128, P1511, DOI 10.1378/chest.128.3.1511; PIERSON DJ, 1976, CHEST, V70, P17, DOI 10.1378/chest.70.1.17; Tomei M, 2010, RESP PHYSIOL NEUROBI, V172, P184; TOWNSEND MC, 1984, AM REV RESPIR DIS, V130, P123; Vitacca M, 1996, GERONTOLOGY, V42, P46	26	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0161-4754			J MANIP PHYSIOL THER	J. Manip. Physiol. Ther.	NOV-DEC	2014	37	9					719	725		10.1016/j.jmpt.2014.10.005		7	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	Health Care Sciences & Services; Integrative & Complementary Medicine; Rehabilitation	AU4PJ	WOS:000345593500013		
J	Ikeda, N; Xu, XM				Ikeda, Noriaki; Xu, Xiaomeng			Canonical functions, differential graded symplectic pairs in supergeometry, and Alexandrov-KontsevichSchwartz- Zaboronsky sigma models with boundaries	JOURNAL OF MATHEMATICAL PHYSICS			English	Article							TOPOLOGICAL FIELD-THEORIES; NONLINEAR GAUGE-THEORY; POISSON MANIFOLDS; LIE ALGEBROIDS; BIALGEBROIDS; QUANTIZATION; FORMALISM; GEOMETRY; GRAVITY	Consistent boundary conditions for Alexandrov-Kontsevich-Schwartz-Zaboronsky (AKSZ) sigma models and the corresponding boundary theories are analyzed. As their mathematical structures, we introduce a generalization of differential graded symplectic manifolds, called twisted QP manifolds, in terms of graded symplectic geometry, canonical functions, and QP pairs. We generalize the AKSZ construction of topological sigma models to sigma modelswithWess-Zumino terms and show that all the twisted Poisson-like structures known in the literature can actually be naturally realized as boundary conditions for AKSZ sigma models. (C) 2014 AIP Publishing LLC.	[Ikeda, Noriaki] Ritsumeikan Univ, Dept Math Sci, Kusatsu, Shiga 5258577, Japan; [Ikeda, Noriaki] Kyoto Sangyo Univ, Maskawa Inst Sci & Culture, Kyoto 6038555, Japan; [Xu, Xiaomeng] Univ Geneva, Sect Math, CH-1211 Geneva 4, Switzerland	Ikeda, N (reprint author), Ritsumeikan Univ, Dept Math Sci, Kusatsu, Shiga 5258577, Japan.	nikeda@se.ritsumei.ac.jp; Xiaomeng.Xu@unige.ch			Swiss National Science Foundation [PDFMP2-141756]	The authors would like to thank J. Stasheff for valuable discussions and comments. N. Ikeda would like to thank the organizers of The 33rd Winter School Geometry and Physics, Srni, Czech Republic, where part of this work was performed. X.-M. Xu is grateful to Zhangju Liu for his patient guidance throughout his study at Peking University. He also would like to thank Jianghua Lu for hospitality during his visit to the University of Hong Kong, where part of this work was performed. X.-M. Xu is supported by Grant No. PDFMP2-141756 of the Swiss National Science Foundation.	Alekseev A, 2002, CAN J MATH, V54, P3, DOI 10.4153/CJM-2002-001-5; Severa P, 2001, PROG THEOR PHYS SUPP, P145; Roytenberg D, 2007, LETT MATH PHYS, V79, P143, DOI 10.1007/s11005-006-0134-y; HATA H, 1994, ANN PHYS-NEW YORK, V229, P177, DOI 10.1006/aphy.1994.1006; IKEDA N, 1993, PROG THEOR PHYS, V90, P237; Cattaneo AS, 2011, REV MATH PHYS, V23, P669, DOI 10.1142/S0129055X11004400; Alexandrov M, 1997, INT J MOD PHYS A, V12, P1405, DOI 10.1142/S0217751X97001031; Roytenberg D, 2002, LETT MATH PHYS, V61, P123, DOI 10.1023/A:1020708131005; Cattaneo AS, 2014, COMMUN MATH PHYS, V332, P535, DOI 10.1007/s00220-014-2145-3; Klimcik C, 2002, J GEOM PHYS, V43, P341, DOI 10.1016/S0393-0440(02)00027-X; Fernandes RL, 2002, ADV MATH, V170, P119, DOI 10.1006/aima.2001.2070; Cattaneo AS, 2000, COMMUN MATH PHYS, V212, P591, DOI 10.1007/s002200000229; Fiorenza D, 2013, INT J GEOM METHODS M, V10, DOI 10.1142/S0219887812500788; Pantev T, 2013, PUBL MATH-PARIS, P271, DOI 10.1007/s10240-013-0054-1; Liu ZJ, 1997, J DIFFER GEOM, V45, P547; Kontsevich M, 2003, LETT MATH PHYS, V66, P157, DOI 10.1023/B:MATH.0000027508.00421.bf; Cattaneo AS, 2001, LETT MATH PHYS, V56, P163, DOI 10.1023/A:1010963926853; COURANT TJ, 1990, T AM MATH SOC, V319, P631, DOI 10.2307/2001258; Bousso R, 2002, REV MOD PHYS, V74, P825, DOI 10.1103/RevModPhys.74.825; SCHALLER P, 1994, MOD PHYS LETT A, V9, P3129, DOI 10.1142/S0217732394002951; Vaintrob AY, 1997, RUSS MATH SURV+, V52, P428, DOI 10.1070/RM1997v052n02ABEH001802; Bouwknegt P, 2013, REV MATH PHYS, V25, DOI 10.1142/S0129055X13300045; Calaque D., ARXIV13063235MATHAG; Carmeli C, 2011, EMS SER LECT MATH, P1, DOI 10.4171/097; Cattaneo A. S., 2011, P CORF SUMM I 2011 S; DORFMAN IY, 1987, PHYS LETT A, V125, P240, DOI 10.1016/0375-9601(87)90201-5; Fiorenza D., ARXIV13085264HEPTH; Fregier Y., ARXIV13014864MATHQA; Fregier Y., ARXIV12022896MATHQA; Grutzmann M, 2011, J GEOM PHYS, V61, P476, DOI 10.1016/j.geomphys.2010.10.016; Hansen M., 2010, ARXIV09040711HEPTH, P115; Hofman C., ARXIVHEPTH0209148; Ikeda N, 2011, COMMUN MATH PHYS, V303, P317, DOI 10.1007/s00220-011-1194-0; Ikeda N., ARXIV12043714HEPTH; IKEDA N, 1994, ANN PHYS-NEW YORK, V235, P435, DOI 10.1006/aphy.1994.1104; Ikeda N., ARXIV13080100MATHPH; Ikeda N, 2003, INT J MOD PHYS A, V18, P2689, DOI 10.1142/S0217751X03015155; Kosmann-Schwarzbach Y, 2011, PROG MATH, V287, P243, DOI 10.1007/978-0-8176-4735-3_12; KOSMANNSCHWARZBACH Y, 1990, ANN I H POINCARE-PHY, V53, P35; Kosmann-Schwarzbach Y, 2004, LETT MATH PHYS, V69, P61, DOI 10.1007/s11005-004-0608-8; Lang H.-L., ARXIV13124096; Lu JH, 1997, DUKE MATH J, V86, P261, DOI 10.1215/S0012-7094-97-08608-7; Park J.-S., 2001, SYMPLECTIC GEOMETRY, P311, DOI 10.1142/9789812799821_0010; Roytenberg D., ARXIVMATHDG9910078; SCHWARZ A, 1993, COMMUN MATH PHYS, V158, P373, DOI 10.1007/BF02108080; Terashima Y, 2008, J SYMPLECT GEOM, V6, P1; Varadarajan V. S., 2004, COURANT LECT NOTES S; Voronov Theodore, 2002, CONT MATH, V315, P131; Xu XM, 2014, J GEOM PHYS, V82, P124, DOI 10.1016/j.geomphys.2014.03.002	49	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0022-2488	1089-7658		J MATH PHYS	J. Math. Phys.	NOV	2014	55	11							113505	10.1063/1.4900834		21	Physics, Mathematical	Physics	AU5JO	WOS:000345643100032		
J	Nakamura, S				Nakamura, Shu			Modified wave operators for discrete Schrodinger operators with long-range perturbations	JOURNAL OF MATHEMATICAL PHYSICS			English	Article								We consider the scattering theory for discrete Schrodinger operators on Z(d) with long-range potentials. We prove the existence of modified wave operators constructed in terms of solutions of a Hamilton-Jacobi equation on the torus T-d. (C) 2014 AIP Publishing LLC.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Nakamura, S (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	shu@ms.u-tokyo.ac.jp			JSPS [21244008]	The research was in part supported by JSPS Grant Kiban (A) 21244008.	DOLLARD JD, 1964, J MATH PHYS, V5, P729, DOI 10.1063/1.1704171; Isozaki H, 2012, ANN HENRI POINCARE, V13, P751, DOI 10.1007/s00023-011-0141-0; De Monvel AB, 1999, REV MATH PHYS, V11, P1061; Craig W, 1995, COMMUN PUR APPL MATH, V48, P769, DOI 10.1002/cpa.3160480802; Gerard C., 1997, SCATTERING THEORY CL; HORMANDER L, 1976, MATH Z, V146, P69, DOI 10.1007/BF01213717; Hormander L., 1990, ANAL LINEAR PARTIAL, VI; Oppenheim A. V., 1999, DISCRETE TIME SIGNAL; Reed M., 1979, METHODS MODERN MATH, V3; Yafaev D., 2009, MATH SCATTERING THEO	10	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0022-2488	1089-7658		J MATH PHYS	J. Math. Phys.	NOV	2014	55	11							112101	10.1063/1.4900896		8	Physics, Mathematical	Physics	AU5JO	WOS:000345643100008		
J	Takemura, K				Takemura, Kouichi			Multi-indexed Jacobi polynomials and Maya diagrams	JOURNAL OF MATHEMATICAL PHYSICS			English	Article							ORTHOGONAL POLYNOMIALS	Multi-indexed Jacobi polynomials are defined by the Wronskian of four types of eigenfunctions of the Poschl-Teller Hamiltonian. We give a correspondence between multi-indexed Jacobi polynomials and pairs of Maya diagrams, and we show that any multi-indexed Jacobi polynomial is essentially equal to some multi-indexed Jacobi polynomial of two types of eigenfunction. As an application, we show a Wronskian-type formula of some special eigenstates of the deformed Poschl-Teller Hamiltonian. (C) 2014 AIP Publishing LLC.	Chuo Univ, Fac Sci & Technol, Dept Math, Bunkyo Ku, Tokyo 1128551, Japan	Takemura, K (reprint author), Chuo Univ, Fac Sci & Technol, Dept Math, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	takemura@math.chuo-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [22740107]; Chuo University Grant for Special Research	The author is grateful to Satoru Odake and Ryu Sasaki for valuable comments and fruitful discussions. He also thanks C.-L. Ho for hospitality during his visit in Taipei in August 2013 where this work was started. Thanks are due to the referee for valuable comments, especially for indicating the paper by Felder, Hemery, and Veselov.<SUP>3</SUP> He is supported in part by the grant-in-aid for Young Scientists from the Japan Society for the Promotion of Science (JSPS), No. 22740107 and by Chuo University Grant for Special Research.	ADLER VE, 1994, THEOR MATH PHYS+, V101, P1381, DOI 10.1007/BF01035458; Gomez-Ullate D, 2010, J APPROX THEORY, V162, P987, DOI 10.1016/j.jat.2009.11.002; Odake S, 2009, PHYS LETT B, V679, P414, DOI 10.1016/j.physletb.2009.08.004; Gomez-Ullate D, 2013, FOUND COMPUT MATH, V13, P615, DOI 10.1007/s10208-012-9128-6; Gomez-Ullate D, 2009, J MATH ANAL APPL, V359, P352, DOI 10.1016/j.jmaa.2009.05.052; Marquette I, 2013, J MATH PHYS, V54, DOI 10.1063/1.4798807; Sasaki R, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/31/315204; KREIN MG, 1957, DOKL AKAD NAUK SSSR+, V113, P970; Felder G, 2012, PHYSICA D, V241, P2131, DOI 10.1016/j.physd.2012.08.008; Crum M. M., 1955, QUART J MATH OXFORD, V6, P121, DOI DOI 10.1093/QMATH/6.1.121; Gomez-Ullate D, 2014, J MATH PHYS, V55, DOI 10.1063/1.4871443; Hirota R, 2004, DIRECT METHOD SOLITO; Ho C.- L., 2013, J PHYS A, V46; Miwa T, 2000, SOLITONS DIFFERENTIA; Odake S, 2011, PHYS LETT B, V702, P164, DOI 10.1016/j.physletb.2011.06.075; Odake S, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/4/045204; Odake S, 2014, J MATH PHYS, V55, DOI 10.1063/1.4859795; Odake S, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/24/245201; Quesne C., 2008, J PHYS A, V41; Sasaki R, 2012, SYMMETRY INTEGR GEOM, V8, DOI 10.3842/SIGMA.2012.085	20	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0022-2488	1089-7658		J MATH PHYS	J. Math. Phys.	NOV	2014	55	11							113501	10.1063/1.4899082		10	Physics, Mathematical	Physics	AU5JO	WOS:000345643100028		
J	Kim, HN; Lee, HJ; Lee, SN; Kim, JK; Chai, KK; Yoon, HK; Kang, YH; Cho, HS				Kim, Ha Neol; Lee, Hyun Jin; Lee, Sang Nam; Kim, Jong Kyu; Chai, Kwan Kyo; Yoon, Hwan Ki; Kang, Yong Heack; Cho, Hyun Seok			Experimental evaluation of the performance of solar receivers for compressed air	JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY			English	Article						Cavity; Compressed air; Concentrated solar power (CSP); Extended surface; Solar receiver	HYBRID GAS-TURBINE; SYSTEMS; DESIGN	A challenging issue that arises in achieving a combined cycle with concentrated solar power technology is the development of a solar receiver for compressed air. A solar receiver transfers heat from concentrated solar radiation to compressed air so that the air temperature is sufficiently increased to drive an air turbine. Using a simple modular extension, we have developed three solar receivers for compressed air based on the concept of the tubular receiver. Conventional tubular receivers are generally applied in liquid fluids, such as water or molten salt. Cavities and extended surfaces were designed and incorporated into the developed tubular receivers to improve the heat transfer to air. The receivers were also subjected to performance evaluation tests, which were conducted in the solar furnace of the Korea Institute of Energy Research, with ambient air compressed at 5 bar and expressed in terms of outlet temperature and receiver efficiency. Test results indicated the thermal characteristics of the three solar receivers for their proper use and facilitated the comparison of their performances. The results also provided a guideline to construct and simulate a solar receiver system composed of a series of receiver modules. The problems identified in this study can help improve the solar receiver system.	[Kim, Ha Neol; Lee, Hyun Jin; Lee, Sang Nam; Kim, Jong Kyu; Chai, Kwan Kyo; Yoon, Hwan Ki; Kang, Yong Heack] Korea Inst Energy Res, Solar Thermal Lab, Taejon 305343, South Korea; [Cho, Hyun Seok] Niigata Univ, Dept Chem & Chem Engn, Niigata 9502181, Japan	Lee, HJ (reprint author), Korea Inst Energy Res, Solar Thermal Lab, Taejon 305343, South Korea.	hj.lee@kier.re.kr			Research and Development Program of the KIER [B2-2415-02, B4-2441-01]	This work was conducted under the framework of the Research and Development Program of the KIER (B2-2415-02 and B4-2441-01).	Amsbeck L., 2008, P 14 SOLARPACES S LA; Lim S, 2014, APPL THERM ENG, V62, P566, DOI 10.1016/j.applthermaleng.2013.10.025; Buck R, 2002, J SOL ENERG-T ASME, V124, P2, DOI 10.1115/1.1445444; Kribus A, 1999, SOL ENERGY, V67, P3, DOI 10.1016/S0038-092X(00)00056-6; Fisher U, 2004, J SOL ENERG-T ASME, V126, P872, DOI 10.1115/1.1763602; Lee H, 2014, ENERGY, V66, P63, DOI 10.1016/j.energy.2013.04.081; Avila-Marin AL, 2011, SOL ENERGY, V85, P891, DOI 10.1016/j.solener.2011.02.002; Hoffschmidt B, 2003, J SOL ENERG-T ASME, V125, P87, DOI 10.1115/1.1530627; Heller P, 2006, SOL ENERGY, V80, P1225, DOI [10.1016/j.solener.2005.04.020, 10.1016/j.solener.2006.04.020]; Schwarzbozl P, 2006, SOL ENERGY, V80, P1231, DOI 10.1016/j.solener.2005.09.007; Hischier I, 2012, J SOL ENERG-T ASME, V134, DOI 10.1115/1.4005446; Barigozzi G, 2012, SOL ENERGY, V86, P2116, DOI 10.1016/j.solener.2012.04.014; Cho H. S., 2012, J KOREAN SOLAR ENERG, V32, P207; Han I.S., 2014, J CERAMIC SOC JAPAN, V126, P502; Hischier I, 2009, Journal of Thermal Science and Engineering Applications, V1, DOI 10.1115/1.4001259; International Energy Agency (IEA), 2010, TECHN ROADM CONC SOL, VIEA Publications; Kennedy C., 2005, NRELCP52036581; Kribus A, 1996, J SOL ENERG-T ASME, V118, P151, DOI 10.1115/1.2870891; Lee H. J., 2013, P KSES 2013 SPRING A, P120; Lee H. J., 2011, T KSME B, V35, P989; Lovegrove K, 2012, WOODHEAD PUBL SER EN, P1, DOI 10.1533/9780857096173; Romero-Alvarez M., 2007, ENERGY EFFICIENCY RE	22	0	0	KOREAN SOC MECHANICAL ENGINEERS	SEOUL	KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1738-494X	1976-3824		J MECH SCI TECHNOL	J. Mech. Sci. Technol.	NOV	2014	28	11					4789	4795		10.1007/s12206-014-1046-x		7	Engineering, Mechanical	Engineering	AU1ZF	WOS:000345415300047		
J	Horikawa, M; Inai, M; Oguri, Y; Kuroda, E; Tanaka, M; Suzuki, S; Ito, T; Takahashi, S; Kaku, H; Tsunoda, T				Horikawa, Mitsuyo; Inai, Makoto; Oguri, Yuki; Kuroda, Eri; Tanaka, Masami; Suzuki, Shinya; Ito, Takuya; Takahashi, Shigeru; Kaku, Hiroto; Tsunoda, Tetsuto			Isolation and Total Syntheses of Cytotoxic Cryptolactones A(1), A(2), B-1, and B-2: alpha,beta-Unsaturated delta-Lactones from a Cryptomyzus sp Aphid	JOURNAL OF NATURAL PRODUCTS			English	Article							RUGULACTONE; INHIBITORS; PIGMENT	The cryptolactones A(1), A(2), B-1, and B-2, which are a,b-unsaturated d-lactones, were isolated from a Cryptomyzus sp. aphid. The structures were established by 1-D and 2-D NMR spectra and CI-HRMS. Their absolute configurations were determined with the Kusumi-Mosher method, combined with asymmetric total syntheses. The syntheses were accomplished with the Mukaiyama aldol reaction and olefin metathesis, which utilized the second-generation Grubbs catalyst for the key steps. These compounds exhibited cytotoxic activity against human promyelocytic leukemia HL-60 cells with IC50 values of 0.97-5.3 mu M.	[Horikawa, Mitsuyo; Oguri, Yuki; Kuroda, Eri; Tanaka, Masami; Suzuki, Shinya; Ito, Takuya; Kaku, Hiroto; Tsunoda, Tetsuto] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 7708514, Japan; [Inai, Makoto] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan; [Takahashi, Shigeru] Utsunomiya Univ, Fac Agr, Utsunomiya, Tochigi 3218505, Japan	Horikawa, M (reprint author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 7708514, Japan.	horikawa@ph.bunri-u.ac.jp; tsunoda@ph.bunri-u.ac.jp			MEXT (the Ministry of Education, Culture, Sports, Science and Technology of Japan) [22590032, 25460030]; MEXT	This work was supported partially by a Grant-in-Aid for Scientific Research (C, 22590032 and 25460030) from MEXT (the Ministry of Education, Culture, Sports, Science and Technology of Japan). We are also thankful to the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2008-2012.	FU X, 1993, PHYTOCHEMISTRY, V33, P1272; Grkovic T, 2011, J NAT PROD, V74, P1015, DOI 10.1021/np100918z; FANG XP, 1991, J NAT PROD, V54, P1034, DOI 10.1021/np50076a017; MIURA K, 1991, B CHEM SOC JPN, V64, P1542, DOI 10.1246/bcsj.64.1542; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Horikawa M, 2011, J NAT PROD, V74, P1812, DOI 10.1021/np2001286; Horikawa M, 2004, TETRAHEDRON, V60, P1229, DOI 10.1016/j.tet.2003.11.061; KOSHINO H, 1992, BIOSCI BIOTECH BIOCH, V56, P1096; Lu Da Yong, 2005, BMC Pharmacology, V5, P11, DOI 10.1186/1471-2210-5-11; Mohapatra DK, 2009, TETRAHEDRON LETT, V50, P5941, DOI 10.1016/j.tetlet.2009.08.028; Mohapatra DK, 2012, HELV CHIM ACTA, V95, P1226, DOI 10.1002/hlca.201100466; Mohapatra DK, 2014, BIOORG MED CHEM LETT, V24, P1389, DOI 10.1016/j.bmcl.2014.01.030; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukaiyama T, 2004, ANGEW CHEM INT EDIT, V43, P5590, DOI 10.1002/anie.200300641; Nishimura T, 2013, TETRAHEDRON, V69, P1808, DOI 10.1016/j.tet.2012.12.070; Sabitha G, 2009, SYNTHESIS-STUTTGART, P3301, DOI 10.1055/s-0029-1216936; White AD, 1996, J MED CHEM, V39, P4382, DOI 10.1021/jm960404v	17	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0163-3864	1520-6025		J NAT PROD	J. Nat. Prod.	NOV	2014	77	11					2459	2464		10.1021/np500542x		6	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AU2UE	WOS:000345472100019		
J	Oku, N; Matoba, S; Yamazaki, YM; Shimasaki, R; Miyanaga, S; Igarashi, Y				Oku, Naoya; Matoba, Shouhei; Yamazaki, Yohko Momose; Shimasaki, Ryoko; Miyanaga, Satoshi; Igarashi, Yasuhiro			Complete Stereochemistry and Preliminary Structure-Activity Relationship of Rakicidin A, a Hypoxia-Selective Cytotoxin from Micromonospora sp.	JOURNAL OF NATURAL PRODUCTS			English	Article							STREPTOMYCES SP; ABSOLUTE-CONFIGURATION; CANCER; DEPSIPEPTIDE; VINYLAMYCIN; REVISION; ACIDS	The complete stereochemistry of rakicidin A, a hypoxia-selective cytotoxin produced by Micromonospora sp., was unambiguously established by extensive chemical degradation and derivatization studies. During the PGME derivatization-based configurational analysis of 3-hydroxy-2,4,16-trimethylheptadecanoic acid, an irregular ?d distribution was observed, which necessitated further acylation of the 3-hydroxy group to resolve the inconsistency. A hydrogenated derivative of rakicidin A, its ring-opened product, and two congeners with different alkyl chain lengths were tested for hypoxia-selective cytotoxicity. The results indicated that both the conjugated diene unit and appropriate chain length are essential for the unique activity of rakicidin A.	[Oku, Naoya; Matoba, Shouhei; Shimasaki, Ryoko; Miyanaga, Satoshi; Igarashi, Yasuhiro] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama 9390398, Japan; [Oku, Naoya; Matoba, Shouhei; Shimasaki, Ryoko; Miyanaga, Satoshi; Igarashi, Yasuhiro] Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama 9390398, Japan; [Yamazaki, Yohko Momose] Inst Microbial Chem, Shinagawa Ku, Tokyo 1410021, Japan	Igarashi, Y (reprint author), Toyama Prefectural Univ, Biotechnol Res Ctr, 5180 Kurokawa, Imizu, Toyama 9390398, Japan.	yas@pu-toyama.ac.jp			Research Supporters Association for Toyama Prefectural University [FY2011]	This work was supported by a fund from Research Supporters Association for Toyama Prefectural University FY2011.	Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Igarashi Y, 2005, J ANTIBIOT, V58, P350; Takeuchi M, 2011, CANCER SCI, V102, P591, DOI 10.1111/j.1349-7006.2010.01813.x; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Igarashi M, 1999, J ANTIBIOT, V52, P873; Kato A, 1997, J AM CHEM SOC, V119, P6680, DOI 10.1021/ja970895o; Carr G, 2012, ORG LETT, V14, P2822, DOI 10.1021/ol301043p; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; NAGAI Y, 1995, TETRAHEDRON LETT, V36, P1853, DOI 10.1016/0040-4039(95)00132-V; McBrien KD, 1995, J ANTIBIOT, V48, P1446; Igarashi Y, 2010, J ANTIBIOT, V63, P563, DOI 10.1038/ja.2010.70; Exner CJ, 2011, CHEM-EUR J, V17, P4246, DOI 10.1002/chem.201003264; Harada K, 1996, TETRAHEDRON LETT, V37, P3001, DOI 10.1016/0040-4039(96)00484-4; Hu JF, 2000, EUR J ORG CHEM, P3353; Kajiura T., 2001, [No title captured], Patent No. [WO01/68121A1, 0168121]; Luoto Kaisa R, 2013, Genome Integr, V4, P5, DOI 10.1186/2041-9414-4-5; Nishioka H., 1998, [No title captured], Patent No. [JP10147594-A, 10147594]; Sajiki H, 2003, CHEM PHARM BULL, V51, P320; TROST BM, 1986, J ORG CHEM, V51, P2370, DOI 10.1021/jo00362a036; Turk JA, 2003, J ORG CHEM, V68, P7841, DOI 10.1021/jo034738l; Yamazaki Y, 2007, BIOL PHARM BULL, V30, P261, DOI 10.1248/bpb.30.261	22	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0163-3864	1520-6025		J NAT PROD	J. Nat. Prod.	NOV	2014	77	11					2561	2565		10.1021/np500276c		5	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AU2UE	WOS:000345472100031		
J	Nakamura, Y; Murakami, N; Iida, T; Asano, S; Ozeki, S; Nagai, T				Nakamura, Yutaka; Murakami, Nobuyuki; Iida, Takahiro; Asano, Satoshi; Ozeki, Satoru; Nagai, Toshiro			Growth hormone treatment for osteoporosis in patients with scoliosis of Prader-Willi syndrome	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							BONE-MINERAL DENSITY; BODY-MASS INDEX; THERAPY; CHILDREN; PREVALENCE; BENEFITS; OBESITY; ADULTS; TRIAL	Background Patients with Prader-Willi syndrome (PWS) have fragile bones. Osteoporosis is a major concern in scoliosis surgery. Our aim was to investigate bone mineral density (BMD) in PWS patients and to verify the efficacy of and scoliosis deterioration with growth hormone (GH) administration for osteoporosis. Methods We followed 148 PWS patients who underwent lumbar spine (L2-4) BMD testing. Sixty-four patients had scoliosis, and 84 were non-scoliosis patients. Patients were treated with GH (0.245 mg/kg/week) until they reached a skeletal age of 17 years for males and 15 years for females. We also evaluated the effect of GH treatment on BMD in 101 patients (60 males, 41 females) undergoing BMD testing more than twice. The mean patient age was 5.4 years. The mean duration of GH administration was 54 months. Results Mean lumbar BMD was 0.567 g/cm(2). Fifty patients (33.8 %) had osteoporosis and 41 (27.7 %) had osteopenia. There was no significant difference in mean BMD between patients with scoliosis (0.598 g/cm(2)) and without scoliosis (0.548 g/cm(2)). GH treatment caused a significant increase in Z score (pre-GH: mean -2.28 vs. post-GH: mean -1.53, P<0.001). There was no statistical difference in the prevalence of scoliosis between the GH treatment group (45/112, 40.1 %) and non-treatment group (19/36, 52.8 %). Conclusions Among patients with PWS, 61.5 % had low BMDs. GH administration significantly improved the lumbar BMD (Z score). There were no statistically significant differences in the prevalence of scoliosis among patients who received GH treatment compared to patients who did not.	[Nakamura, Yutaka; Iida, Takahiro; Ozeki, Satoru] Dokkyo Med Univ, Dept Orthopaed Surg, Koshigaya Hosp, Koshigaya, Saitama 3438555, Japan; [Nakamura, Yutaka; Asano, Satoshi] Higashi Saitama Gen Hosp, Saitama Spine Ctr, Satte, Saitama 3400153, Japan; [Murakami, Nobuyuki; Nagai, Toshiro] Dokkyo Med Univ, Dept Paediat, Koshigaya Hosp, Koshigaya, Saitama 3438555, Japan	Nakamura, Y (reprint author), Dokkyo Med Univ, Dept Orthopaed Surg, Koshigaya Hosp, 2-1-50 Minami Koshigaya, Koshigaya, Saitama 3438555, Japan.	nakayuta@dokkyomed.ac.jp					Accadbled F, 2008, SPINE, V33, P394, DOI 10.1097/BRS.0b013e318163fa24; Carrel AL, 2002, J CLIN ENDOCR METAB, V87, P1581, DOI 10.1210/jc.87.4.1581; Myers SE, 2007, AM J MED GENET A, V143A, P443, DOI 10.1002/ajmg.a.31468; Butler MG, 2001, AM J MED GENET, V103, P216, DOI 10.1002/ajmg.1556.abs; GLASTRE C, 1990, J CLIN ENDOCR METAB, V70, P1330; Hoybye C, 2002, J CLIN ENDOCR METAB, V87, P3590, DOI 10.1210/jc.87.8.3590; Butler JV, 2002, DEV MED CHILD NEUROL, V44, P248, DOI 10.1017/S001216220100202X; Mogul HR, 2008, J CLIN ENDOCR METAB, V93, P1238, DOI 10.1210/jc.2007-2212; Vestergaard P, 2004, J PEDIATR-US, V144, P614, DOI 10.1016/j.jpeds.2004.01.056; Odent T, 2008, PEDIATRICS, V122, pE499, DOI 10.1542/peds.2007-3487; Nagai T, 2006, AM J MED GENET A, V140A, P1623, DOI 10.1002/ajmg.a.31295; van Wijngaarden RFAD, 2008, ARCH DIS CHILD, V93, P1012, DOI 10.1136/adc.2007.123836; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Casey RW, 2008, CAN J UROL, V15, P71; Docquier Pierre-Louis, 2004, Acta Orthop Belg, V70, P299; Hiroyuki Tanaka J., 2009, CLIN CALCIUM, V19, P984; HOLM VA, 1981, DEV MED CHILD NEUROL, V23, P192; Kroonen LT, 2006, J PEDIATR ORTHOPED, V26, P673; Nakamura Y, 2012, EUR SPINE J S4, V21, P483; Nakamura Y, 2009, SPINE J, V9, P809, DOI 10.1016/j.spinee.2009.06.017; Orimo H, 1996, OSTEOPOROSIS JAPAN, V4, P643; Orito S, 2009, J BONE MINER METAB, V27, P698, DOI 10.1007/s00774-009-0094-2; Tanaka H, 2005, PEDIAT JAPAN S, V46, P17; van Mil EGAH, 2001, J PEDIATR-US, V139, P708, DOI 10.1067/mpd.2001.118399; van Wijngaarden RFAD, 2009, J CLIN ENDOCR METAB, V94, P3763, DOI 10.1210/jc.2009-0270	25	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					877	882		10.1007/s00776-014-0641-0		6	Orthopedics	Orthopedics	AU1OE	WOS:000345389200004		
J	Takahashi, N; Arai, I; Kayama, S; Ichiji, K; Fukuda, H; Konno, S				Takahashi, Naoto; Arai, Itaru; Kayama, Satoru; Ichiji, Kenji; Fukuda, Hironari; Konno, Shin-ichi			One-year follow-up for the therapeutic efficacy of pregabalin in patients with leg symptoms caused by lumbar spinal stenosis	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							NEUROPATHIC PAIN; PHARMACOLOGICAL MANAGEMENT; EPIDURAL PRESSURE; GUIDELINES; SURGERY; COMPLICATIONS; FUSION; TRENDS; TRIAL	Background Pregabalin is a well-accepted treatment option for patients with neuropathic pain. However, the therapeutic efficacy of pregabalin for reducing the incidence of spinal surgery to treat leg symptoms in patients with lumbar spinal stenosis remains unknown. The purpose of this study was to analyze the therapeutic efficacy of pregabalin for reducing the incidence of spinal surgery for leg symptoms in patients with lumbar spinal stenosis during the first year of treatment. Methods Consecutive patients diagnosed with lumbar spinal stenosis at our hospital from January to June 2009 were treated with nonsteroidal anti-inflammatory drug monotherapy and formed the control group (n = 47; 22 males, 25 females). Patients diagnosed with lumbar spinal stenosis at our hospital between August 2010 and October 2011 were treated with a nonsteroidal anti-inflammatory drug and pregabalin combination therapy and formed the pregabalin group (n = 49; 27 males, 22 females). The proportions of patients who underwent spinal surgery during the first year of treatment were assessed and compared between the two groups using the Mann-Whitney U test. In addition, the periods in which patients decided to undergo spinal surgery were compared using the KaplanMeier method. Results Six patients (12.2 %) in the pregabalin group and 22 patients (46.8 %) in the control group underwent spinal surgery during the first year of treatment (P = 0.0035). The period in which patients decided to undergo spinal surgery was significantly delayed in the pregabalin group compared with the control group in those for whom spinal surgery was necessary (P = 0.0128). Conclusions Nonsteroidal anti-inflammatory drug and pregabalin combination therapy may result in a lower incidence of spinal surgery during the first year of treatment or a delayed period before undergoing spinal surgery if necessary compared with nonsteroidal anti-inflammatory drug monotherapy in patients with leg symptoms caused by lumbar spinal stenosis.	[Takahashi, Naoto; Arai, Itaru; Kayama, Satoru; Ichiji, Kenji; Fukuda, Hironari] Southern Tohoku Gen Hosp, Dept Orthopaed Surg, Fukushima, Japan; [Takahashi, Naoto; Fukuda, Hironari; Konno, Shin-ichi] Fukushima Med Univ, Sch Med, Dept Orthopaed Surg, Fukushima 9601295, Japan	Takahashi, N (reprint author), Fukushima Med Univ, Sch Med, Dept Orthopaed Surg, 1 Hikarigaoka, Fukushima 9601295, Japan.	naotot211@aol.com					Alvarez J.A., 1998, AM FAM PHYSICIAN, V57, P1839; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; DEYO RA, 1993, SPINE, V18, P1463; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Takahashi K, 1995, SPINE, V20, P2746, DOI 10.1097/00007632-199512150-00017; Szpalski M, 2003, EUR SPINE J, V12, pS170, DOI 10.1007/s00586-003-0612-1; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Jansson KA, 2009, J BONE JOINT SURG BR, V91B, P210, DOI 10.1302/0301-620X.91B2.21119; Park DK, 2010, SPINE, V35, P439, DOI 10.1097/BRS.0b013e3181bdafb9; Malmivaara A, 2007, SPINE, V32, P1, DOI 10.1097/01.brs.0000251014.81875.6d; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; VERBIEST H, 1954, J BONE JOINT SURG BR, V36, P230; Beith ID, 2011, PAIN, V152, P1511, DOI 10.1016/j.pain.2011.02.033; Kovacs FM, 2011, SPINE, V36, pE1335, DOI 10.1097/BRS.0b013e31820c97b1; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136; TAKAHASHI K, 1995, SPINE, V20, P650, DOI 10.1097/00007632-199503150-00003; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Moulin DE, 2007, PAIN RES MANAG, V12, P13; Carragee EJ, 2009, SPINE, V34, P423, DOI 10.1097/BRS.0b013e318198c962; Kobayashi S, 2005, SPINE, V30, P276, DOI 10.1097/01.brs.0000152377.72468.f4; Porter RW, 1996, SPINE, V21, P2046, DOI 10.1097/00007632-199609010-00024; RA Deyo, 2005, SPINE, V30, P1446; Takahashi Naoto, 2014, Fukushima J Med Sci, V60, P35; Tan T, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1079; VERBIEST H, 1955, J BONE JOINT SURG BR, V37, P576; Weinstein JN, 2007, NEW ENGL J MED, V356, P2257, DOI 10.1056/NEJMoa070302	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					893	899		10.1007/s00776-014-0642-z		7	Orthopedics	Orthopedics	AU1OE	WOS:000345389200006		
J	Takenaga, T; Goto, H; Nozaki, M; Yoshida, M; Nishiyama, T; Otsuka, T				Takenaga, Tetsuya; Goto, Hideyuki; Nozaki, Masahiro; Yoshida, Masahito; Nishiyama, Takeshi; Otsuka, Takanobu			Ultrasound imaging of the humeral capitellum: a cadaveric study	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							OSTEOCHONDRITIS-DISSECANS; ELBOW; CAPITULUM; INJURIES	Background Ultrasound is suitable for routine examinations of capitellar osteochondritis dissecans because it can visualize both the subchondral bone and the overlying articular cartilage non-invasively. The radial head interferes with the sonographically visible area of the articular surface of the humeral capitellum, although the precise extent of this is currently unknown. This study aimed to investigate the visible area of the humeral capitellum using both anterior and posterior ultrasonographic scans. Methods Twelve elbows were used from cadavers with a mean age of 85.6 years. After marking a 45 degrees angle in the anterior capitellum in a caudal direction using a drill, anterior and posterior, long-axis ultrasonographic scans were performed with the cadaveric elbows bent. The elbow-flexion angle at which the 45 degrees point was obscured by the radial head was measured and these ultrasonic measurements were then verified by macroscopic observation. Results The elbow-flexion angle at which the 45 degrees point was obscured by the radial head was 24 degrees in anterior scans and 102 degrees in posterior scans. These ultrasonic measurements corresponded to the macroscopic measurements. The results showed that anterior, long-axis ultrasound scans could visualize the capitellum from 45 degrees through the rest of the anterior area at 24 degrees flexion of the elbow: the radial head obscured the area of the capitellum that is 21 degrees anterior to the elbow flexion angle. Similarly, posterior long-axis scans could visualize the capitellum from 45 degrees through the rest of the posterior area at 102 degrees flexion of the elbow: the radial head obscured the area of the capitellum that is 57 degrees posterior to the elbow flexion angle. The radial head obscured a 78 degrees (21 degrees +/- 57 degrees) arc of the capitellum in ultrasonography. Conclusions This study thus clarified the area of the humeral capitellum visible in both anterior and posterior ultrasound scans in the sagittal plane.	[Takenaga, Tetsuya; Goto, Hideyuki; Nozaki, Masahiro; Yoshida, Masahito; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Nishiyama, Takeshi] Aichi Med Univ, Dept Publ Hlth, Nagakute, Aichi 48011, Japan	Takenaga, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	take10280425@yahoo.co.jp					Cain EL, 2003, AM J SPORT MED, V31, P621; BARR LL, 1991, AM J ROENTGENOL, V157, P793; Takahara M, 2007, J BONE JOINT SURG AM, V89A, P1205, DOI 10.2106/JBJS.F.00622; Baker CL, 2010, AM J SPORT MED, V38, P1917, DOI 10.1177/0363546509354969; Puchwein P, 2013, ORTHOPEDICS, V36, pE51, DOI 10.3928/01477447-20121217-18; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Shimada K, 2005, CLIN ORTHOP RELAT R, P140, DOI 10.1097/01.blo.0000160025.14363.f9; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Matsuura T, 2008, AM J SPORT MED, V36, P868, DOI 10.1177/0363546507312168; JOBE FW, 1986, CLIN SPORT MED, V5, P621; Bowen RE, 2001, J PEDIATR ORTHOPED, V21, P298, DOI 10.1097/00004694-200105000-00007; JACKSON D W, 1989, Arthroscopy, V5, P129, DOI 10.1016/0749-8063(89)90008-X; Kijowski R, 2004, SKELETAL RADIOL, V33, P685, DOI 10.1007/s00256-004-0853-z; Maezawa S, 1985, RINSHOU SEIKEIGEKA, V20, P1157; Panner HJ, 1929, ACTA RADIOL, V10, P234, DOI 10.3109/00016922909132178; Parker Laurence, 2008, J Am Coll Radiol, V5, P182, DOI 10.1016/j.jacr.2007.07.016; SMITH MGH, 1964, J BONE JOINT SURG BR, V46, P50; Takahara M, 1998, J BONE JOINT SURG AM, V80A, P892; Takahara M, 2000, AM J ROENTGENOL, V174, P411	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					907	912		10.1007/s00776-014-0637-9		6	Orthopedics	Orthopedics	AU1OE	WOS:000345389200008		
J	Uchiyama, S; Sekijima, Y; Tojo, K; Sano, K; Imaeda, T; Moriizumi, T; Ikeda, S; Kato, H				Uchiyama, Shigeharu; Sekijima, Yoshiki; Tojo, Kana; Sano, Kenji; Imaeda, Toshihiko; Moriizumi, Tetsuji; Ikeda, Shu-ichi; Kato, Hiroyuki			Effect of synovial transthyretin amyloid deposition on preoperative symptoms and postoperative recovery of median nerve function among patients with idiopathic carpal tunnel syndrome	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							PRIMARY SYSTEMIC AMYLOIDOSIS; INITIAL MANIFESTATION; NATURAL-HISTORY; POLYNEUROPATHY; NEUROPATHY; RELEASE; PATHOGENESIS; CONDUCTION; SURGERY; WRIST	Background The clinical characteristics of wild-type transthyretin amyloid deposition among patients with carpal tunnel syndrome (CTS) have not been well investigated. Methods One-hundred and seven patients with idiopathic CTS who underwent carpal tunnel release were enrolled. They underwent physical examination of the hand, nerve-conduction study, and magnetic resonance imaging (MRI) study of the wrist, and completed a patient-oriented questionnaire. The tests, except for MRI, were repeated 1, 3, and 6 months postoperatively. Synovial tissue was obtained during surgery and analyzed by Congo red and immunohistochemical staining. Ordinal logistic regression analysis was used to evaluate the significance of different clinical and subjective findings between patients with and without amyloid deposition. Postoperative improvements were also compared. Results Wild-type transthyretin amyloid deposition was observed for 38 patients. Greater symptom severity and 2-point discrimination scores, and larger cross-sectional areas of the carpal tunnel, were significantly correlated with a larger amount of preoperative amyloid deposition. However, the presence and amount of preoperative amyloid deposition did not affect postoperative improvements in physical findings and nerve-conduction studies. Conclusions Although transthyretin amyloid deposition can worsen CTS symptoms, postoperative improvements were similar for patients with and without this deposition.	[Uchiyama, Shigeharu; Kato, Hiroyuki] Shinshu Univ, Dept Orthopaed Surg, Sch Med, Matsumoto, Nagano 3908621, Japan; [Sekijima, Yoshiki; Tojo, Kana; Ikeda, Shu-ichi] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Nagano 3908621, Japan; [Sekijima, Yoshiki] Shinshu Univ Hosp, Div Clin & Mol Genet, Matsumoto, Nagano 3908621, Japan; [Sano, Kenji] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano 3908621, Japan; [Imaeda, Toshihiko] Kinjo Gakuin Univ, Dept Food & Nutr Environm, Moriyama Ku, Nagoya, Aichi 4638521, Japan; [Moriizumi, Tetsuji] Shinshu Univ, Sch Med, Dept Anat, Matsumoto, Nagano 3908621, Japan	Uchiyama, S (reprint author), Shinshu Univ, Dept Orthopaed Surg, Sch Med, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	sigeuti@shinshu-u.ac.jp					Ando Y, 2012, CURR MED CHEM, V19, P2312; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; Sekijima Y, 2011, HUM PATHOL, V42, P1785, DOI 10.1016/j.humpath.2011.03.004; Koyama S, 2012, CLIN NEUROL NEUROSUR, V114, P707, DOI 10.1016/j.clineuro.2011.11.030; Pensy RA, 2011, J HAND SURG-EUR VOL, V36E, P642, DOI 10.1177/1753193411410155; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Padua L, 1997, ITAL J NEUROL SCI, V18, P145, DOI 10.1007/BF02048482; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; Uchiyama S, 2005, J NEUROL NEUROSUR PS, V76, P1103, DOI 10.1136/jnnp.2004.051060; Uchiyama S, 2010, J ORTHOP SCI, V15, P1, DOI 10.1007/s00776-009-1416-x; Cappellari M, 2011, J PERIPHER NERV SYST, V16, P119, DOI 10.1111/j.1529-8027.2011.00331.x; Uchiyama S, 2013, ARTHROSCOPY, V29, P860, DOI 10.1016/j.arthro.2013.01.027; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Hund E, 2001, NEUROLOGY, V56, P431; Chiotis K, 2013, ARCH PHYS MED REHAB, V94, P737, DOI 10.1016/j.apmr.2012.11.017; Sekijima Y, 2008, CURR PHARM DESIGN, V14, P3219, DOI 10.2174/138161208786404155; Kodaira M, 2008, J PERIPHER NERV SYST, V13, P148, DOI 10.1111/j.1529-8027.2008.00170.x; KELLY JJ, 1979, ANN NEUROL, V6, P1, DOI 10.1002/ana.410060102; KERR CD, 1992, J HAND SURG-AM, V17A, P1028; KYLE RA, 1989, AM J CLIN PATHOL, V91, P393; Plante-Bordeneuve V, 2011, LANCET NEUROL, V10, P1086, DOI 10.1016/S1474-4422(11)70246-0; RUKAVINA JG, 1993, MEDICINE, V72, P45; STEIN K, 1987, VIRCHOWS ARCH A, V412, P37, DOI 10.1007/BF00750729; Sueyoshi T, 2011, HUM PATHOL, V42, P1259, DOI 10.1016/j.humpath.2010.11.017; Takei Y, 2002, AMYLOID, V9, P252, DOI 10.3109/13506120209114102; Tojo K, 2010, AMYLOID, V17, P32, DOI 10.3109/13506121003619369; Tsujii M, 2009, J MAGN RESON IMAGING, V29, P1102, DOI 10.1002/jmri.21459; Uchiyama S, 2002, CLIN NEUROPHYSIOL, V113, P64, DOI 10.1016/S1388-2457(01)00719-2; Uchiyama S, 2007, J ORTHOP SCI, V12, P249, DOI 10.1007/s00776-007-1128-z	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					913	919		10.1007/s00776-014-0635-y		7	Orthopedics	Orthopedics	AU1OE	WOS:000345389200009		
J	Inoue, K; Suenaga, N; Oizumi, N; Sakamoto, Y; Sakurai, G; Miyoshi, N; Taniguchi, N; Tanaka, Y				Inoue, Kazuya; Suenaga, Naoki; Oizumi, Naomi; Sakamoto, Yoshihiro; Sakurai, Goro; Miyoshi, Naoki; Taniguchi, Noboru; Tanaka, Yasuhito			Suprascapular notch variations: a 3DCT study	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							POSTERIOR LONGITUDINAL LIGAMENT; ARTHROSCOPIC DECOMPRESSION; NERVE ENTRAPMENT; CLASSIFICATION; OSSIFICATION; NEUROPATHY; PROPOSAL; ANATOMY; FORAMEN; SPINE	Background Although cadaveric studies have revealed suprascapular notch shape variations, few have investigated the association between suprascapular notch variation and age or gender. The purpose of this study was to investigate suprascapular notch shape variations by use of three-dimensional computed tomography (3DCT) and to determine if there was any association with age or gender. Methods Three-dimensional CT images of 762 shoulders of 762 patients were analyzed in this study. Participants comprised 404 men and 358 women, with an average age of 58.2 +/- 19.1 years. Suprascapular notch shape variations were classified into six types on the basis of Rengachary's classification. Results Of the total study population, 11.4 % were classified as type I, 23.5 % as type II, 30.1 % as type III, 14.8 % as type IV, 15.9 % as type V, and 4.3 % as type VI. Average age was 56.5 +/- 20.5 years for type I, 57.0 +/- 19.5 years for type II, 55.5 +/- 20.0 years for type III, 56.4 +/- 18.5 years for type IV, 65.5 +/- 14.4 years for type V, and 68.0 +/- 13.4 years for type VI. Statistically significant age differences were found between types I-IV and V, between types I-IV and VI, and between the non-ossification group (types I-IV) and the ossification group (types V and VI). Male-to-female ratio among each type, and between the non-ossification group and the ossification group, were not statistically significantly different. Conclusions Our results suggest that transverse scapular ligament ossification is associated with aging whereas individual variation explains differences among types I, II, III, and IV. Three-dimensional CT provides useful information for arthroscopic resection of the transverse scapular ligament, when the wide variety of suprascapular notch shape variations is considered.	[Inoue, Kazuya; Sakamoto, Yoshihiro; Tanaka, Yasuhito] Nara Med Univ, Dept Orthopaed Surg, Kashihara, Nara 6345822, Japan; [Suenaga, Naoki; Oizumi, Naomi] Hokushin Hosp, Upper Extrem Ctr Joint Replacement & Endoscop Sur, Siroisi Ku, Sapporo, Hokkaido 0030823, Japan; [Sakurai, Goro] Nishinarachuo Hosp, Dept Orthopaed Surg, Nara 6310022, Japan; [Miyoshi, Naoki] Asahikawa Med Coll, Dept Orthoped Surg, Asahikawa, Hokkaido 0788510, Japan; [Taniguchi, Noboru] Miyazaki Univ, Dept Orthopaed Surg, Kiyotake, Miyazaki 8891692, Japan	Inoue, K (reprint author), Nara Med Univ, Dept Orthopaed Surg, 840 Shijoutyou, Kashihara, Nara 6345822, Japan.	kaz_inoue12@ybb.ne.jp					Agrawal V, 2009, ARTHROSCOPY, V25, P325, DOI 10.1016/j.arthro.2008.06.014; Albino P, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-172; Polguj M, 2012, SKELETAL RADIOL, V41, P1631, DOI 10.1007/s00256-012-1460-z; Ghodadra N, 2009, ARTHROSCOPY, V25, P439, DOI 10.1016/j.arthro.2008.10.024; Shah AA, 2011, J SHOULDER ELB SURG, V20, P975, DOI 10.1016/j.jse.2010.10.032; Polguj M, 2011, SURG RADIOL ANAT, V33, P781, DOI 10.1007/s00276-011-0821-y; Ticker JB, 1998, J SHOULDER ELB SURG, V7, P472, DOI 10.1016/S1058-2746(98)90197-5; Lafosse L, 2007, ARTHROSCOPY, V23, P34, DOI 10.1016/j.arthro.2006.10.003; Kim TJ, 2008, JOINT BONE SPINE, V75, P471, DOI 10.1016/j.jbspin.2007.07.019; Bhatia DN, 2006, ARTHROSCOPY, V22, P1009, DOI 10.1016/j.arthro.2006.05.012; Barber FA, 2008, ARTHROSCOPY, V24, DOI 10.1016/j.arthro.2007.05.004; Bayramoglu A, 2003, KNEE SURG SPORT TR A, V11, P393, DOI 10.1007/s00167-003-0378-3; Bhatia Sanjeev, 2012, Arthrosc Tech, V1, pe187, DOI 10.1016/j.eats.2012.07.004; CALLAHAN JD, 1991, J NEUROSURG, V74, P893, DOI 10.3171/jns.1991.74.6.0893; CLEIN LJ, 1975, J NEUROSURG, V43, P337, DOI 10.3171/jns.1975.43.3.0337; Dunkelgrun Martin, 2003, Bull Hosp Jt Dis, V61, P118; EDELSON JG, 1995, J BONE JOINT SURG BR, V77B, P505; Hosseini H, 2007, ARTHROSCOPY, V23, DOI 10.1016/j.arthro.2006.07.033; KOPELL HP, 1959, SURG GYNECOL OBSTET, V109, P92; Natsis K, 2007, CLIN ANAT, V20, P135, DOI 10.1002/ca.20318; Oizumi N, 2012, J SHOULDER ELB SURG, V21, P759, DOI 10.1016/j.jse.2011.08.063; Polguj M, 2013, ARCH MED SCI, V9, P177, DOI 10.5114/aoms.2013.33173; RENGACHARY SS, 1979, NEUROSURGERY, V5, P447; Romeo Anthony A, 2010, J Shoulder Elbow Surg, V19, P118, DOI 10.1016/j.jse.2010.01.006; Sangam Muralidhar Reddy, 2013, J Clin Diagn Res, V7, P189, DOI 10.7860/JCDR/2013/4838.2723; Sergides Neoptolemos N, 2009, Cases J, V2, P8200, DOI 10.4076/1757-1626-2-8200; Thompson WA, 1959, NEW ENGL J MED, V18, P1261; Topper S M, 1998, Am J Orthop (Belle Mead NJ), V27, P151; TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71; Urguden M, 2004, KNEE SURG SPORT TR A, V12, P241, DOI 10.1007/s00167-003-0442-z	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					920	924		10.1007/s00776-014-0636-x		5	Orthopedics	Orthopedics	AU1OE	WOS:000345389200010		
J	Kita, K; Tanaka, Y; Toritsuka, Y; Yonetani, Y; Kanamoto, T; Amano, H; Nakamura, N; Horibe, S				Kita, Keisuke; Tanaka, Yoshinari; Toritsuka, Yukiyoshi; Yonetani, Yasukazu; Kanamoto, Takashi; Amano, Hiroshi; Nakamura, Norimasa; Horibe, Shuji			Patellofemoral chondral status after medial patellofemoral ligament reconstruction using second-look arthroscopy in patients with recurrent patellar dislocation	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							SOFT-TISSUE RESTRAINTS; TERM-FOLLOW-UP; ARTICULAR-CARTILAGE; TENDON AUTOGRAFT; REPAIR; GRAFT; KNEE; TRANSLATION; PRESSURE; STRENGTH	Background Most patients with recurrent patellar dislocation show cartilage damage in the patellofemoral joint. Medial patellofemoral ligament reconstruction has become one of the most important surgical techniques for treating recurrent patellar dislocation. However, patellofemoral chondral status after this reconstruction has not been elucidated. The purpose of this study was to investigate the effects of medial patellofemoral ligament reconstruction on articular cartilage in the patellofemoral joint by comparing the arthroscopic chondral status at the time of reconstruction with that at second-look arthroscopy. Methods Participants in the present study comprised 31 patients (22 females, 9 males; 32 knees) who underwent second-look arthroscopy at a median of 12 months (range 6-40 months) after dual tunnel medial patellofemoral ligament reconstruction using a double-looped autologous semitendinosus tendon graft. Median age at the time of initial surgery was 20 years (range 13-43 years). The patellofemoral joint was divided into six portions, comprising the medial facet of the patella, central ridge, lateral facet of the patella, anterior medial femoral condyle, femoral groove, and anterior lateral femoral condyle. Chondral status in each portion according to the International Cartilage Repair Society classification was retrospectively evaluated at the time of initial surgery and second-look arthroscopy. Results Before medial patellofemoral ligament reconstruction, chondral lesions were observed in the patellofemoral joint in 31 knees (97 %). At the central ridge of the patella, chondral damage was observed in 22 knees (69 %) at initial surgery and damaged cartilages showed recovery in 6 knees. No significant difference in the alteration of chondral status was seen for the medial facet, lateral facet of the patella, anterior medial femoral condyle, femoral groove, and anterior lateral femoral condyle. Conclusions According to short-term results, the patellofemoral chondral status after medial patellofemoral ligament reconstruction was not altered at second-look arthroscopy in most part of patellofemoral joint. At the central ridge of the patella, significant improvement of the International Cartilage Repair Society grading was observed.	[Kita, Keisuke; Tanaka, Yoshinari; Kanamoto, Takashi; Amano, Hiroshi] Osaka Rosai Hosp, Dept Sports Orthopaed, Kita Ku, Sakai, Osaka 5918025, Japan; [Toritsuka, Yukiyoshi] Kansai Rosai Hosp, Dept Sports Orthopaed, Amagasaki, Hyogo 6608511, Japan; [Yonetani, Yasukazu] Osaka Univ, Dept Orthopaed Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Nakamura, Norimasa] Osaka Hlth Sci Univ, Dept Rehabil Sci, Kita Ku, Osaka 5300043, Japan; [Horibe, Shuji] Osaka Prefecture Univ, Fac Comprehens Rehabil, Habikino, Osaka 5838555, Japan	Kita, K (reprint author), Osaka Rosai Hosp, Dept Sports Orthopaed, Kita Ku, 1179-3 Nagasone Cho, Sakai, Osaka 5918025, Japan.	keikita@hera.eonet.ne.jp; yoshi-tanaka@orh.go.jp; toritsuka@kanrou.net; yonechanosk@gmail.com; takanamoto2@gmail.com; h-amano@umin.ac.jp; viader7jp@yahoo.co.jp; s-horibe@rehab.osakafu-u.ac.jp					Smith GD, 2005, ARTHROSCOPY, V21, P1462, DOI 10.1016/j.arthro.2005.09.007; Mountney J, 2005, J BONE JOINT SURG BR, V87B, P36; Christiansen SE, 2008, ARTHROSCOPY, V24, P82, DOI 10.1016/j.arthro.2007.08.005; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P58; Servien E, 2011, AM J SPORT MED, V39, P134, DOI 10.1177/0363546510381362; Toritsuka Y, 2011, KNEE, V18, P214, DOI 10.1016/j.knee.2010.05.007; Desio SM, 1998, AM J SPORT MED, V26, P59; Elias JJ, 2006, AM J SPORT MED, V34, P1478, DOI 10.1177/0363546506287486; Shah JN, 2012, AM J SPORT MED, V40, P1916, DOI 10.1177/0363546512442330; Bicos J, 2007, AM J SPORT MED, V35, P484, DOI 10.1177/0363546507299237; Sandmeier RH, 2000, AM J SPORT MED, V28, P345; Kita K, 2012, KNEE SURG SPORT TR A, V20, P829, DOI 10.1007/s00167-011-1609-7; Nomura E, 2005, OSTEOARTHR CARTILAGE, V13, P1029, DOI 10.1016/j.joca.2005.07.004; Nakagawa K, 2002, J BONE JOINT SURG BR, V84B, P861, DOI 10.1302/0301-620X.84B6.12804; Beck P, 2007, AM J SPORT MED, V35, P1557, DOI 10.1177/0363546507300872; Schottle PB, 2007, AM J SPORT MED, V35, P801, DOI 10.1177/0363546506296415; Nomura E, 2007, AM J SPORT MED, V35, P1851, DOI 10.1177/0363546507306161; Panni AS, 2011, AM J SPORT MED, V39, P2647, DOI 10.1177/0363546511420079; Stephen JM, 2014, AM J SPORT MED, V42, P364, DOI 10.1177/0363546513509230; Drez D, 2001, ARTHROSCOPY, V17, P298, DOI 10.1053/jars.2001.21490; Ostermeier S, 2007, CLIN BIOMECH, V22, P327, DOI 10.1016/j.clinbiomech.2006.10.002; Newman AP, 1998, AM J SPORT MED, V26, P309; Arendt EA, 2009, ORTHOP TRAUMATOL-SUR, V95, pS97, DOI 10.1016/j.otsr.2009.09.002; Camanho GL, 2007, ARTHROSCOPY, V23, pe1; CONLAN T, 1993, J BONE JOINT SURG AM, V75A, P682; Dejour H, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P19, DOI 10.1007/BF01552649; Gomes JLE, 2008, ORTHOPEDICS, V31, P322; Lenschow S, 2013, ARTHROSCOPY, V29, P766, DOI 10.1016/j.arthro.2012.12.004; Melegari TM, 2008, AM J SPORT MED, V36, P747, DOI 10.1177/0363546508314410; Nakamura N, 2008, KNEE SURG SPORT TR A, V16, P843, DOI 10.1007/s00167-008-0565-3; Nomura E, 2004, AM J SPORT MED, V32, P498, DOI 10.1177/0095399703258677; Tateishi T, 2011, KNEE SURG SPORT TR A, V19, P400, DOI 10.1007/s00167-010-1235-9; Teitge RA, 2004, ORTHOPEDICS, V27, P1037	33	0	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					925	932		10.1007/s00776-014-0612-5		8	Orthopedics	Orthopedics	AU1OE	WOS:000345389200011		
J	Nakagawa, Y; Mukai, S; Yamada, S; Matsuoka, M; Tarumi, E; Hashimoto, T; Tamura, C; Imaizumi, A; Nishihira, J; Nakamura, T				Nakagawa, Yasuaki; Mukai, Shogo; Yamada, Shigeru; Matsuoka, Masayuki; Tarumi, Eri; Hashimoto, Tadashi; Tamura, Chieko; Imaizumi, Atsushi; Nishihira, Jun; Nakamura, Takashi			Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							POSTMENOPAUSAL WOMEN; INDUCED ARTHRITIS; CELLS; SUPPRESSION; EFFICACY; HEALTH; SAFETY	Background We previously developed a surface-controlled water-dispersible form of curcumin and named it Theracurmin (R) (Theracurmin; Theravalues, Tokyo, Japan). The area under the blood concentration-time curve of Theracurmin in humans was 27-fold higher than that of curcumin powder. We determined the clinical effects of orally administered Theracurmin in patients with knee osteoarthritis during 8 weeks of treatment. Methods Fifty patients with knee osteoarthritis of Kellgren-Lawrence grade II or III and who were aged more than 40 years were enrolled in this randomized, double-blind, placebo-controlled, prospective clinical study. Placebo or Theracurmin containing 180 mg/day of curcumin was administered orally every day for 8 weeks. To monitor adverse events, blood biochemistry analyses were performed before and after 8 weeks of each intervention. The patients' knee symptoms were evaluated at 0, 2, 4, 6, and 8 weeks by the Japanese Knee Osteoarthritis Measure, the knee pain visual analog scale (VAS), the knee scoring system of the Japanese Orthopedic Association, and the need for nonsteroidal anti-inflammatory drugs. Results At 8 weeks after treatment initiation, knee pain VAS scores were significantly lower in the Theracurmin group than in the placebo group, except in the patients with initial VAS scores of 0.15 or less. Theracurmin lowered the celecoxib dependence significantly more than placebo. No major side effects were observed with Theracurmin treatment. Conclusion Theracurmin shows modest potential for the treatment of human knee osteoarthritis.	[Nakagawa, Yasuaki; Mukai, Shogo; Yamada, Shigeru; Matsuoka, Masayuki; Tarumi, Eri; Nakamura, Takashi] Natl Hosp Org, Dept Orthoped Surg, Kyoto Med Ctr, Fushimi Ku, Kyoto 6128555, Japan; [Hashimoto, Tadashi; Tamura, Chieko; Imaizumi, Atsushi] Theravalues Corp, Tokyo, Japan; [Nishihira, Jun] Hokkaido Informat Univ, Fac Med Informat, Ebetsu, Hokkaido, Japan	Nakagawa, Y (reprint author), Natl Hosp Org, Dept Orthoped Surg, Kyoto Med Ctr, Fushimi Ku, 1-1 Fukakusa Mukaihata Cho, Kyoto 6128555, Japan.	yanakaga@kyotolan.hosp.go.jp			Theravalues Corporation (Tokyo, Japan)	We thank Mrs. Kaori Akiyoshi for technical assistance in this study. This research was financially supported by Theravalues Corporation (Tokyo, Japan).	Ahmed S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2982; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Mathy-Hartert M, 2009, INFLAMM RES, V58, P899, DOI 10.1007/s00011-009-0063-1; Felson DT, 2000, ANN INTERN MED, V133, P726; Wongcharoen W, 2009, INT J CARDIOL, V133, P145, DOI 10.1016/j.ijcard.2009.01.073; Gupta SC, 2012, CLIN EXP PHARMACOL P, V39, P283, DOI 10.1111/j.1440-1681.2011.05648.x; Akazawa N, 2012, NUTR RES, V32, P795, DOI 10.1016/j.nutres.2012.09.002; Milacic V, 2008, CANCER RES, V68, P7283, DOI 10.1158/0008-5472.CAN-07-6246; Menon VP, 2007, ADV EXP MED BIOL, V595, P105; Belcaro G, 2010, ALTERN MED REV, V15, P337; Huang G, 2013, J CLIN IMMUNOL, V33, P550, DOI 10.1007/s10875-012-9839-0; Sasaki H, 2011, BIOL PHARM BULL, V34, P660, DOI 10.1248/bpb.34.660; SMALLEY WE, 1995, AM J EPIDEMIOL, V141, P539; Kumar D, 2012, EXPERT OPIN THER TAR, V16, P959, DOI 10.1517/14728222.2012.710603; Chandran B, 2012, PHYTOTHER RES, V26, P1719, DOI 10.1002/ptr.4639; Lev-Ari S, 2006, RHEUMATOLOGY, V45, P171, DOI 10.1093/rheumatology/kei132; Akai M, 2005, J RHEUMATOL, V32, P1524; Banji D, 2011, INDIAN J PHARMACOL, V43, P546, DOI 10.4103/0253-7613.84970; Belcaro G, 2010, Panminerva Med, V52, P55; Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065; Khalife S, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3222; Matsuno H, 1997, ARCH PHYS MED REHAB, V78, P745, DOI 10.1016/S0003-9993(97)90083-6; Mobasheri A, 2012, INT J MOL SCI, V13, P4202, DOI 10.3390/ijms13044202; Rajasekaran S.A., 2011, WORLD J GASTROINTEST, V15, P1; Rao CV, 2007, ADV EXP MED BIOL, V595, P213; Sugawara J, 2012, AM J HYPERTENS, V25, P651, DOI 10.1038/ajh.2012.24; Wandel S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4675; Yang Q, 2012, PHARMACOLOGY, V26, P77	28	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					933	939		10.1007/s00776-014-0633-0		7	Orthopedics	Orthopedics	AU1OE	WOS:000345389200012		
J	Kumahashi, N; Uchio, Y; Kitamura, N; Satake, S; Iwamoto, M; Yasuda, K				Kumahashi, Nobuyuki; Uchio, Yuji; Kitamura, Nobuto; Satake, Shigeru; Iwamoto, Mikio; Yasuda, Kazunori			Biomechanical comparison of the strength of adhesion of polymethylmethacrylate cement to zirconia ceramic and cobalt-chromium alloy components in a total knee arthroplasty	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							HIP-PROSTHESIS; ALUMINA; POLYETHYLENE; REPLACEMENT; 10-YEAR; METAL	Purpose The purpose of this study was to clarify the biomechanical characteristics of cement-material interfaces for the zirconia ceramic and cobalt-chromium (Co-Cr) alloy femoral components used for total knee arthroplasty. Methods In the first sub-study, we compared the strength of adhesion of the cement to flat plates, by tensile testing under dry and moistened conditions. In the second substudy, we compared the maximum load of the cement-component complex by tensile testing. In the third substudy, we compared the fatigue characteristics of the cement-component complex by use of a dynamic tensile testing machine. Results Under dry conditions, the maximum strength of adhesion to the zirconia ceramic plate was the same as that to the Co-Cr alloy plate. Under moistened conditions, however, the strength of adhesion to the zirconia ceramic plate was significantly lower (p = 0.0017) whereas the strength of adhesion to the Co-Cr alloy plate was not reduced. Maximum load for the cement-component complexes for zirconia ceramic and Co-Cr alloy was no different under both dry and moistened conditions. Fatigue testing showed that cement-zirconia adhesion was stronger than cement-Co-Cr alloy adhesion (p = 0.0161). Conclusions The strength of adhesion of cement to zirconia ceramic is substantially weaker under wet conditions than under dry conditions. The mechanical properties of cement-zirconia ceramic component complexes and cement-Co-Cr alloy component complexes are equivalent.	[Kumahashi, Nobuyuki; Uchio, Yuji] Shimane Univ, Dept Orthoped, Sch Med, Izumo, Shimane 6938501, Japan; [Kumahashi, Nobuyuki; Yasuda, Kazunori] Hokkaido Univ, Dept Sports Med, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Satake, Shigeru; Iwamoto, Mikio] KYOCERA Med Corp, Design & Dev Dept, Yodogawa Ku, Osaka 5320003, Japan	Kumahashi, N (reprint author), Shimane Univ, Dept Orthoped, Sch Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	n-kuma@med.shimane-u.ac.jp	Yasuda, Kazunori/C-9998-2009				AGATHOPOULOS S, 1995, J BIOMED MATER RES, V29, P421, DOI 10.1002/jbm.820290402; Akagi M, 2000, J BONE JOINT SURG AM, V82A, P1626; Rahaman MN, 2007, J AM CERAM SOC, V90, P1965, DOI 10.1111/j.1551-2916.2007.01725.x; SEMLITSCH M, 1977, J BIOMED MATER RES, V11, P537, DOI 10.1002/jbm.820110409; Han HS, 2007, J BONE JOINT SURG BR, V89B, P1457, DOI 10.1302/0301-620X.89B11.19840; Bal B Sonny, 2006, J Knee Surg, V19, P89; Cacciafesta V, 1998, AM J ORTHOD DENTOFAC, V113, P402; CHRISTEL PS, 1992, CLIN ORTHOP RELAT R, P10; Crookshank M, 2012, P I MECH ENG H, V226, P320, DOI 10.1177/0954411912438038; DAVIDSON JA, 1993, CLIN ORTHOP RELAT R, P361; DORLOT JM, 1992, CLIN ORTHOP RELAT R, P47; Kamishima T, 2010, CLIN RADIOL, V65, P387, DOI 10.1016/j.crad.2009.12.007; Kasahara T, 2005, CHUBU SEISAISHI, V48, P647; Majima T, 2008, KNEE SURG SPORT TR A, V16, P152, DOI 10.1007/s00167-007-0435-4; MITTELMEIER H, 1992, CLIN ORTHOP RELAT R, P64; NIZARD RS, 1992, CLIN ORTHOP RELAT R, P53; OONISHI H, 1992, CLIN ORTHOP RELAT R, P95; Vicente A, 2010, MED ORAL PATOL ORAL, V15, pE820, DOI 10.4317/medoral.15.e820; WINTER M, 1992, CLIN ORTHOP RELAT R, P73; Yasuda K, 2007, TECH KNEE SURG, V6, P213, DOI 10.1097/btk.0b013e318160e937; Yasuda Kazunori, 1993, Bulletin Hospital for Joint Diseases, V53, P15	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					940	947		10.1007/s00776-014-0639-7		8	Orthopedics	Orthopedics	AU1OE	WOS:000345389200013		
J	Yanagisawa, S; Ohsawa, T; Saito, K; Kobayashi, T; Tajika, T; Yamamoto, A; Shitara, H; Takagishi, K				Yanagisawa, Shinya; Ohsawa, Takashi; Saito, Kenichi; Kobayashi, Tsutomu; Tajika, Tsuyoshi; Yamamoto, Atsushi; Shitara, Hitoshi; Takagishi, Kenji			Population-based study of the relationship between medial meniscus radial displacement, determined by use of ultrasound screening, and knee pain	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							JOINT SPACE; RADIOGRAPHIC ASSESSMENT; OSTEOARTHRITIS; ASSOCIATION; COMMUNITY; FEATURES	Purpose The purpose of this population-based study was to clarify the incidence of knee pain by use of ultrasound (US). Methods Medical check-ups were conducted for residents of a mountain village in Japan. The subjects were 149 males and 252 females (802 knees) with a mean age of 63.5 +/- 12.5 years. US was used to evaluate the medial joint space of both knees, with and without weight-bearing. For each patient, medial radial displacement of the medial meniscus (MRD) and number of osteophytes were evaluated. A questionnaire was used to determine whether the subjects were currently experiencing knee pain while walking, climbing stairs, or resting that had lasted more than one month. A visual analog scale was used to assess knee pain. The subjects were divided into two groups, those with knee pain (P group) and those without knee pain (non-P group), on the basis of whether a visual analog scale (VAS) was less than or more than 20 mm during walking, climbing stairs, or resting. Logistic regression analysis was used to identify the factors associated with knee pain. Results Significantly different weight-bearing MRD (WMRD), osteophytes, and pain while walking, climbing stairs, or resting (p<0.01) were found between the two groups. Logistic regression analysis showed that WMRD was significantly associated with knee pain during walking or while climbing stairs. Conclusion We found that WMRD was significantly associated with knee pain while walking or climbing stairs, which are weight-bearing activities. On the basis of the findings of this study, we believe US is a useful tool for evaluating the factors associated with knee pain in a population-based study.	[Yanagisawa, Shinya; Ohsawa, Takashi; Saito, Kenichi; Kobayashi, Tsutomu; Tajika, Tsuyoshi; Yamamoto, Atsushi; Shitara, Hitoshi; Takagishi, Kenji] Gunma Univ, Dept Orthopaed Surg, Grad Sch Med, Maebashi, Gumma 371, Japan	Yanagisawa, S (reprint author), Gunma Univ, Dept Orthopaed Surg, Grad Sch Med, Maebashi, Gumma 371, Japan.	yanashin87@yahoo.co.jp					Wenger A, 2012, EUR RADIOL, V22, P211, DOI 10.1007/s00330-011-2234-z; Lanyon P, 1998, ANN RHEUM DIS, V57, P595, DOI 10.1136/ard.57.10.595; DAVIS MA, 1992, J RHEUMATOL, V19, P1943; Dye SF, 1998, AM J SPORT MED, V26, P773; Torres L, 2006, OSTEOARTHR CARTILAGE, V14, P1033, DOI 10.1016/j.joca.2006.03.015; Naredo E, 2005, OSTEOARTHR CARTILAGE, V13, P568, DOI 10.1016/j.joca.2005.02.008; Kornaat PR, 2006, RADIOLOGY, V239, P811, DOI 10.1148/radiol.2393050253; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Kawaguchi K, 2012, ARTHRITIS RHEUM-US, V64, P173, DOI 10.1002/art.33319; Hunter DJ, 2006, ARTHRITIS RHEUM, V54, P2488, DOI 10.1002/art.22016; Bergstrom G, 1986, J RHEUMATOL, V25, P333; Boxheimer L, 2006, RADIOLOGY, V238, P221; DACRE JE, 1991, BRIT J RHEUMATOL, V30, P426; Freidman L, 2001, SKELETAL RADIOL, V30, P361; Heppelmann B, 1997, J Peripher Nerv Syst, V2, P5; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; MCALINDON TE, 1992, BRIT J RHEUMATOL, V31, P189; Neogi T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2844; OReilly SC, 1996, ANN RHEUM DIS, V55, P931, DOI 10.1136/ard.55.12.931; Sugita T, 2001, CLIN ORTHOP RELAT R, P171; VANHOLSBEECK M, 1992, RADIOL CLIN N AM, V30, P907; Verdonk P, 2004, KNEE SURG SPORT TR A, V12, P411, DOI 10.1007/s00167-004-0500-1; Yanagisawa S, 2014, J ORTHOP SCI, V19, P270, DOI 10.1007/s00776-013-0524-9	23	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					954	958		10.1007/s00776-014-0628-x		5	Orthopedics	Orthopedics	AU1OE	WOS:000345389200015		
J	Goto, E; Teranishi, T; Tsuji, M; Ando, M				Goto, Eiji; Teranishi, Tadashi; Tsuji, Muneharu; Ando, Mifumi			Long-term clinical results of Charnley total hip arthroplasty using a matte satin-finished stem: a 30-year average follow-up study	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							LOW-FRICTION ARTHROPLASTY; CEMENTED ACETABULAR COMPONENTS; FEMORAL COMPONENT; FIXATION; WEAR; POLYETHYLENE; MINIMUM; OSTEOLYSIS; SOCKET	Background Although 50 years have passed since Charnley started performing total hip arthroplasties, there are relatively few patient studies with a follow-up period of over 30 years. We studied radiograms of patients who had undergone Charnley total hip arthroplasty between 1975 and 1981 and evaluated the results at 26-35 years (mean 30.5 years) after the operation. Methods The operations were performed in 87 joints of 82 patients (26 males and 56 females) aged 26-81 years (mean age 56 years) at the time of surgery. A monoblock-type Charnley stem with a 22-mm head was used in all patients. The stem had a matte satin surface finish and a flange or round-back shoulder. The socket was made of ultra-high-density polyethylene without a flange. All operations were performed by one surgeon using the original Charnley method in all patients, excluding the first five. Results Thirty years after the operation, 48 patients have died, 5 had an infection, 9 were lost to follow-up, and 20 patients with 24 joints are still alive. In 77 patients (82 joints), after excluding the 5 with infection, the socket and stem survival rates were 54 and 75 % at 30 years after the operation when radiographic loosening or revision surgery was defined as the end point. With revision surgery as the end point, the rates were 68 and 82 %, respectively. Conclusions These results were as favorable as those with surgical techniques (including the first-generation cement technique) and implants in the early period. Although new techniques and implants have since been introduced, their long-term results should exceed those in this study. The results of this study should provide a valuable index with which to compare the long-term studies of current total hip arthroplasty.	[Goto, Eiji; Teranishi, Tadashi; Tsuji, Muneharu] Toyooka Chuo Hosp, Dept Orthopaed Surg, Asahikawa, Hokkaido 0788237, Japan; [Ando, Mifumi] Hagean Clin, Kushiro, Hokkaido 0801408, Japan	Goto, E (reprint author), Toyooka Chuo Hosp, Dept Orthopaed Surg, 7-2 Toyooka, Asahikawa, Hokkaido 0788237, Japan.	egoto@potato.hokkai.net					Ando M, 1985, RINSYOU SEIKEIGEKA, V20, P1077; Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902; Wroblewski BM, 2000, J BONE JOINT SURG BR, V82B, P842, DOI 10.1302/0301-620X.82B6.10072; Callaghan JJ, 2004, J BONE JOINT SURG AM, V86A, P690; Sochart DH, 1999, CLIN ORTHOP RELAT R, P135; Sporer SM, 1999, J BONE JOINT SURG AM, V81A, P481; Oparaugo PC, 2001, ACTA ORTHOP SCAND, V72, P22, DOI 10.1080/000164701753606644; LIVERMORE J, 1990, J BONE JOINT SURG AM, V72A, P518; Johanson PE, 2012, CLIN ORTHOP RELAT R, V470, P3083, DOI 10.1007/s11999-012-2400-x; Callaghan JJ, 2009, J BONE JOINT SURG AM, V91A, P2617, DOI 10.2106/JBJS.H.01201; Smith SW, 1998, J BONE JOINT SURG AM, V80A, P1632; Howie DW, 1998, J BONE JOINT SURG BR, V80B, P573, DOI 10.1302/0301-620X.80B4.8629; Callaghan JF, 2008, J BONE JOINT SURG AM, V90A, P299, DOI 10.2106/JBJS.G.00095; CHARNLEY J, 1972, Journal of Bone and Joint Surgery British Volume, V54, P61; Charnley J, 1982, Hip, P42; Charnley J., 1979, LOW FRICTION ARTHROP; Crites BM, 2000, CLIN ORTHOP RELAT R, P114; DALL DM, 1993, J BONE JOINT SURG BR, V75, P259; Gilbody J, 2011, J BONE JOINT SURG BR, V93B, P435, DOI 10.1302/0301-620X.93B4.25642; HARRIS WH, 1986, J BONE JOINT SURG AM, V68A, P1064; HODGKINSON JP, 1993, J BONE JOINT SURG BR, V75, P464; HODGKINSON JP, 1988, CLIN ORTHOP RELAT R, P105; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karrholm J, SWEDISH HIP ARTHROPL; KOBAYASHI S, 1990, J BONE JOINT SURG BR, V72, P439; Okamoto T, 1997, J BONE JOINT SURG BR, V79B, P83, DOI 10.1302/0301-620X.79B1.6771; RANAWAT CS, 1988, ORTHOP CLIN N AM, V19, P599; SCHMALZRIED TP, 1992, CLIN ORTHOP RELAT R, P60; Wroblewski BM, 2007, J BONE JOINT SURG BR, V89B, P1015, DOI 10.1302/0301-620X.89B8; WROBLEWSKI BM, 1984, J BONE JOINT SURG BR, V66, P639	30	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					959	964		10.1007/s00776-014-0619-y		6	Orthopedics	Orthopedics	AU1OE	WOS:000345389200016		
J	Niikura, T; Sakurai, A; Oe, K; Shibanuma, N; Tsunoda, M; Maruo, A; Shoda, E; Lee, SY; Sakai, Y; Kurosaka, M				Niikura, Takahiro; Sakurai, Atsushi; Oe, Keisuke; Shibanuma, Nao; Tsunoda, Masaya; Maruo, Akihiro; Shoda, Etsuo; Lee, Sang Yang; Sakai, Yoshitada; Kurosaka, Masahiro			Clinical and radiological results of locking plate fixation for periprosthetic femoral fractures around hip arthroplasties: a retrospective multi-center study	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							3-YEAR FOLLOW-UP; FEMUR FRACTURES; COMPRESSION PLATES; VANCOUVER TYPE-B1; SHAFT FRACTURES; IMPLANT; B1; OSTEOSYNTHESIS; STABILIZATION; ADJACENT	Background Osteosynthesis of periprosthetic femoral fractures around hip arthroplasties is challenging, and locking plate fixation has been found to be a reasonable treatment. However, there is a paucity of evidence of the extent to which patients recover their activities of daily living (ADL). The purpose of this study was to study the clinical results, particularly recovery of ADL, radiological results, and potential complications arising from the use of locking plate fixation for periprosthetic femoral fractures around hip arthroplasties. Methods We conducted a retrospective, multi-center study. Patients with periprosthetic femoral fractures around hip arthroplasties who were treated by osteosynthesis with use of locking plates and who underwent follow-up for at least 6 months postoperatively were enrolled in the study. For each patient, recovery of ADL, in terms of social and ambulatory recovery and Parker mobility score, were compared before fracture and at last follow-up. Postoperative complications were investigated. Bony union, loss of reduction, and malunion were assessed radiologically. Results Thirty-two patients were enrolled in this study. Mean follow-up was 25.1 months. For 84.4, 68.8, and 53.1 % of patients, respectively, social status, ambulation, and Parker mobility score at last follow-up were determined to be equal to that before the fracture. Bony union was observed for 30 patients within the follow-up period. Four patients had not achieved bony union 6 months postoperatively. There was no loss of reduction, malunion, or implant breakage, and no infection. For one patient each, partial pullout of the locking screws and a supracondylar fracture at the plate end were observed, and additional surgery was required. Conclusions Our results reveal that locking plate fixation provided sufficient stability for satisfactory recovery of ADL for most elderly patients with periprosthetic femoral fractures around hip arthroplasties.	[Niikura, Takahiro; Lee, Sang Yang; Kurosaka, Masahiro] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Sakurai, Atsushi; Oe, Keisuke] Awaji Med Ctr, Dept Orthopaed Surg, Sumoto, Japan; [Shibanuma, Nao] Kobe Kaisei Hosp, Dept Orthopaed Surg, Kobe, Hyogo, Japan; [Tsunoda, Masaya] Sanda Municipal Hosp, Dept Orthopaed Surg, Sanda, Japan; [Maruo, Akihiro] Steel Mem Hirohata Hosp, Dept Orthopaed Surg, Himeji, Hyogo, Japan; [Shoda, Etsuo] Hyogo Prefectural Nishinomiya Hosp, Dept Orthopaed Surg, Nishinomiya, Hyogo, Japan; [Sakai, Yoshitada] Kobe Univ, Div Rehabil Med, Grad Sch Med, Kobe, Hyogo 657, Japan	Niikura, T (reprint author), Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	tniikura@med.kobe-u.ac.jp					Ehlinger M, 2011, ORTHOP TRAUMATOL-SUR, V97, P622, DOI 10.1016/j.otsr.2011.01.017; Bryant GK, 2009, INJURY, V40, P1180, DOI 10.1016/j.injury.2009.02.017; Chakravarthy J, 2007, INJURY, V38, P725, DOI 10.1016/j.injury.2007.02.038; El-Zayat BF, 2012, ORTHOP TRAUMATOL-SUR, V98, P765, DOI 10.1016/j.otsr.2012.05.014; Kaab MJ, 2006, ARCH ORTHOP TRAUM SU, V126, P105, DOI 10.1007/s00402-005-0075-4; Haddad FS, 2002, J BONE JOINT SURG AM, V84A, P945; Xue HM, 2011, J ARTHROPLASTY, V26, P467, DOI 10.1016/j.arth.2010.03.031; Wood GCA, 2011, J ARTHROPLASTY, V26, P886, DOI 10.1016/j.arth.2010.07.002; Dijkman BG, 2010, J ORTHOP TRAUMA, V24, pS76, DOI 10.1097/BOT.0b013e3181ca3f97; Tsiridis E, 2005, ACTA ORTHOP, V76, P531, DOI 10.1080/17453670510041529; Erhardt JB, 2008, ARCH ORTHOP TRAUM SU, V128, P409, DOI 10.1007/s00402-007-0396-6; Buttaro MA, 2007, J BONE JOINT SURG AM, V89A, P1964, DOI 10.2106/JBJS.F.01224; Ricci WM, 2005, J BONE JOINT SURG AM, V87A, P2240, DOI 10.2106/JBJS.D.01911; Ruchholtz S, 2013, INJURY, V44, P239, DOI 10.1016/j.injury.2012.10.035; Graham SM, 2013, J ORTHOP SCI, V18, P426, DOI 10.1007/s00776-013-0359-4; Ebraheim NA, 2009, J TRAUMA, V66, P1152, DOI 10.1097/TA.0b013e318182561f; Froberg L, 2012, ACTA ORTHOP, V83, P648, DOI 10.3109/17453674.2012.747925; Laurer HL, 2011, ARCH ORTHOP TRAUM SU, V131, P983, DOI 10.1007/s00402-011-1272-y; Apivatthakakul T, 2012, ARCH ORTHOP TRAUM SU, V132, P813, DOI 10.1007/s00402-012-1489-4; Gautier E, 2003, INJURY, V34, P63, DOI 10.1016/j.injury.2003.09.026; PARKER MJ, 1993, J BONE JOINT SURG BR, V75, P797; Ehlinger M, 2010, ORTHOP TRAUMATOL-SUR, V96, P304, DOI 10.1016/j.otsr.2009.09.017; Kobbe P, 2008, INJURY, V39, P472, DOI 10.1016/j.injury.2007.10.034; Ebraheim NA, 2013, ORTHOP SURG, V5, P183, DOI 10.1111/os.12052; JOHANSSON JE, 1981, J BONE JOINT SURG AM, V63, P1435; Masri BA, 2004, CLIN ORTHOP RELAT R, P80; O'Toole RV, 2006, CLIN ORTHOP RELAT R, P203, DOI 10.1097/01.blo.0000223987.59702.17; Parvizi J, 2011, J ORTHOP TRAUMA, V25, pS77, DOI 10.1097/BOT.0b013e31821b8c3b; Wagner Michael, 2003, Injury, V34 Suppl 2, pB31	29	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					984	990		10.1007/s00776-014-0622-3		7	Orthopedics	Orthopedics	AU1OE	WOS:000345389200020		
J	Tsuda, Y; Yasunaga, H; Horiguchi, H; Fushimi, K; Kawano, H; Tanaka, S				Tsuda, Yusuke; Yasunaga, Hideo; Horiguchi, Hiromasa; Fushimi, Kiyohide; Kawano, Hirotaka; Tanaka, Sakae			Effects of fondaparinux on pulmonary embolism following hemiarthroplasty for femoral neck fracture: a retrospective observational study using the Japanese Diagnosis Procedure Combination database	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; SURGERY; PREVENTION; HIP; TRIAL; OUTCOMES; ASPIRIN; RISK	Background Pulmonary embolism (PE) is recognized as an important complication in patients undergoing hip fracture surgery. However, clinical evidence demonstrating the effectiveness of pharmacological thromboprophylaxis, including fondaparinux, is limited because the occurrence of postoperative PE after hemiarthroplasty is very low. The goal of this study was to analyze the effect of fondaparinux in reducing PE following hemiarthroplasty for femoral neck fracture using large-scale retrospective data. Methods Employing data from the Japanese Diagnosis Procedure Combination database from July 1 to December 31 between 2007 and 2010, we retrospectively identified 22,776 patients who underwent hemiarthroplasty for femoral neck fracture; we included those who received mechanical prophylaxis alone (n = 17,984) and those who received both mechanical prophylaxis and pharmacological prophylaxis with fondaparinux (n = 4,792). Logistic regression analysis was performed to compare the occurrence of postoperative PE with adjustment for sex, age, comorbidities, and type and duration of anesthesia. Results The mean age of the patients was 79.5 +/- 9.4 years. Overall, postoperative PE occurred in 189 (0.83 %) patients. The rate of postoperative PE in the fondaparinux group (0.61 %) was lower than in the control group (0.89 %), although the difference was not significant in the univariate analysis (odds ratio [OR] 0.68; p = 0.055). In the multivariate analysis, the fondaparinux group showed a significantly lower rate of postoperative PE than the group receiving mechanical prophylaxis alone (OR 0.67; p = 0.047). General anesthesia and a longer duration of anesthesia were significant risk factors for postoperative PE. Conclusions Fondaparinux combined with mechanical prophylaxis is more effective in preventing postoperative PE following hemiarthroplasty for femoral neck fracture than mechanical prophylaxis alone.	[Tsuda, Yusuke] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Orthopaed Surg & Musculoskeletal Oncol, Bunkyo Ku, Tokyo 1130021, Japan; [Tsuda, Yusuke; Kawano, Hirotaka; Tanaka, Sakae] Univ Tokyo, Dept Orthopaed Surg, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Yasunaga, Hideo; Horiguchi, Hiromasa] Univ Tokyo, Dept Clin Epidemiol & Hlth Econ, Sch Publ Hlth, Bunkyo Ku, Tokyo 1138655, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Bunkyo Ku, Tokyo 1130034, Japan	Tsuda, Y (reprint author), Univ Tokyo, Dept Orthopaed Surg, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ytsuda-tuk@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan [H22-Policy-031, H23-Nanchi-032]; Ministry of Education, Culture, Sports, Science and Technology, Japan [22390131]; Council for Science and Technology Policy, Japan (Funding Program for World-Leading Innovative R&D on Science and Technology FIRST program) [0301002001001]	This study was funded by grants from the Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation grant number H22-Policy-031; Research on Intractable Diseases grant number H23-Nanchi-032); the Ministry of Education, Culture, Sports, Science and Technology, Japan (Scientific Research B, No. 22390131); and the Council for Science and Technology Policy, Japan (Funding Program for World-Leading Innovative R&D on Science and Technology FIRST program grant number 0301002001001).	Wattanakit K, 2008, J AM SOC NEPHROL, V19, P135, DOI 10.1681/ASN.2007030308; Piazza G, 2012, AM J MED, V125, P709, DOI 10.1016/j.amjmed.2011.12.004; O'Brien J, 2000, LANCET, V355, P1295; McNamara I, 2009, ACTA ORTHOP, V80, P687, DOI 10.3109/17453670903448273; Khatod M, 2012, J ARTHROPLASTY, V27, P167, DOI 10.1016/j.arth.2011.04.006; Schneider D, 2006, J NATL MED ASSOC, V98, P1967; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Yasunaga H, 2013, ANN SURG, V257, P640, DOI 10.1097/SLA.0b013e31826fd541; Arcelus JI, 2008, THROMB HAEMOSTASIS, V99, P546, DOI 10.1160/TH07-10-0611; Dahl OE, 2005, THROMB HAEMOSTASIS, V93, P860, DOI 10.1160/TH04-11-0769; Eriksson BI, 2001, NEW ENGL J MED, V345, P1298, DOI 10.1056/NEJMoa011100; JORGENSEN PS, 1992, CLIN ORTHOP RELAT R, P95; Nagase Yuichi, 2011, J Bone Joint Surg Am, V93, pe146, DOI 10.2106/JBJS.J.01365; KAWASAKI T, 1995, THROMB RES, V79, P147, DOI 10.1016/0049-3848(95)00100-6; Kitamukai O, 2003, INTERNAL MED, V42, P1090, DOI 10.2169/internalmedicine.42.1090; Orimo H, 2009, ARCH OSTEOPOROS, V4, P71; POWERS PJ, 1989, ARCH INTERN MED, V149, P771, DOI 10.1001/archinte.149.4.771; Rosencher N, 2005, J THROMB HAEMOST, V3, P2006, DOI 10.1111/j.1538-7836.2005.01545.x; Sasaki S, 2009, J ORTHOP SCI, V14, P491, DOI 10.1007/s00776-009-1365-4; Sasaki S, 2011, J ORTHOP SCI, V16, P64, DOI 10.1007/s00776-010-0011-5; Yasunaga H, 2012, BMC HEALTH SERV RES, V28, P129; Ytter YF, 2012, CHEST S, V141, pe278S	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					991	996		10.1007/s00776-014-0607-2		6	Orthopedics	Orthopedics	AU1OE	WOS:000345389200021		
J	Shimose, S; Kubo, T; Fujimori, J; Furuta, T; Ochi, M				Shimose, Shoji; Kubo, Tadahiko; Fujimori, Jun; Furuta, Taisuke; Ochi, Mitsuo			A novel assessment method of serum alkaline phosphatase for the diagnosis of osteosarcoma in children and adolescents	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							BONE TURNOVER MARKERS	Background A high serum alkaline phosphatase (ALP) level is valuable for the diagnosis of osteosarcoma in adults, but its use in teenagers is problematic because ALP levels are affected by age, gender, and pubertal stage. Because serum acid phosphatase (ACP) shows the same tetraphasic pattern as serum ALP in children and adolescents, we presumed that serum levels of ALP and ACP would have a strong correlation and that the ratio of ALP to ACP (ALP/ACP) would show little variation and would be useful for the diagnosis of osteosarcoma in teenagers. The purpose of this study was to evaluate the correlation between the serum levels of ALP and ACP and to investigate the validity of ALP/ACP in the differential diagnosis of osteosarcoma in children and adolescents. Methods We retrospectively examined 538 patients aged 1-18 years, including 24 with osteosarcomas, 8 with other malignant bone tumors, 56 with benign bone tumors, and with 450 non-tumor lesions (controls). We evaluated the serum levels of ALP and ACP, both obtained by preoperative examination. Results There were significant correlations between the serum ALP and ACP levels in the controls (r = 0.805 in males and r = 0.860 in females). The ratios of ALP to ACP in the controls showed little variation with age. In ROC curve analysis, to discriminate between the osteosarcomas and the controls, the cutoff levels of serum ALP and ALP/ACP were 956 (U/l) and 50.9 in males and 748 (U/l) and 43.3 in females, respectively. The sensitivity and specificity of serum ALP and ALP/ACP in the differential diagnosis of osteosarcoma were 50.0 and 89.0 %, and 60.0 and 94.1 %, respectively in males, and 61.5 and 72.7 %, and 69.2 and 84.2 %, respectively, in females. Conclusions The results suggest that ALP/ACP is more useful than the serum ALP level in diagnosing osteosarcoma because it is little affected by the age.	[Shimose, Shoji; Kubo, Tadahiko; Fujimori, Jun; Furuta, Taisuke; Ochi, Mitsuo] Hiroshima Univ, Dept Orthopaed Surg, Inst Biomed & Hlth Sci, Minami Ku, Hiroshima 7348551, Japan	Shimose, S (reprint author), Hiroshima Univ, Dept Orthopaed Surg, Inst Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	shimose@hiroshima-u.ac.jp; kubot@hiroshima-u.ac.jp; junfujimori14@hotmail.com; fu09100913@yahoo.co.jp; ochim@hiroshima-u.ac.jp					van Coeverden SCCM, 2002, CLIN ENDOCRINOL, V57, P107, DOI 10.1046/j.1365-2265.2002.01573.x; Bramer JAM, 2009, EJSO-EUR J SURG ONC, V35, P1030, DOI 10.1016/j.ejso.2009.01.011; Szulc P, 2000, OSTEOPOROSIS INT, V11, P281, DOI 10.1007/s001980070116; Bacci G, 2006, CANCER, V106, P1154, DOI 10.1002/cncr.21724; Rauchenzauner M, 2007, J CLIN ENDOCR METAB, V92, P443, DOI 10.1210/jc.2006-1706; Ambroszkiewicz J, 2010, ADV MED SCI-POLAND, V55, P266, DOI 10.2478/v10039-010-0043-2; Limmahakhun S, 2011, ASIAN PAC J CANCER P, V12, P1717; CHEN J, 1979, CLIN CHEM, V25, P719; FLEISHER GA, 1977, CLIN CHEM, V23, P469; Ford Samuel, 2004, Sarcoma, V8, P13, DOI 10.1080/13577140410001679202; Han J, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-37; SCHIELE F, 1988, CLIN CHEM, V34, P685; Turan Serap, 2011, J Clin Res Pediatr Endocrinol, V3, P7, DOI 10.4274/jcrpe.v3i1.02; Wang JS, 2007, ONCOLOGY-BASEL, V72, P338, DOI 10.1159/000113063	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					997	1003		10.1007/s00776-014-0617-0		7	Orthopedics	Orthopedics	AU1OE	WOS:000345389200022		
J	Matsuura, Y; Kuniyoshi, K; Suzuki, T; Ogawa, Y; Sukegawa, K; Rokkaku, T; Takahashi, K				Matsuura, Yusuke; Kuniyoshi, Kazuki; Suzuki, Takane; Ogawa, Yasufumi; Sukegawa, Koji; Rokkaku, Tomoyuki; Takahashi, Kazuhisa			Accuracy of specimen-specific nonlinear finite element analysis for evaluation of distal radius strength in cadaver material	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; EXPERIMENTAL VALIDATION; OSTEOPOROTIC FRACTURES; MECHANICAL-PROPERTIES; CORTICAL BONE; PREDICTION; MODEL; BIOMECHANICS; SPINE	Distal radius fracture, which often occurs in the setting of osteoporosis, can lead to permanent deformity and disability. Great effort has been directed toward developing noninvasive methods for evaluating the distal radius strength, with the goal of assessing fracture risk. The aim of this study was to evaluate distal radius strength using a finite element model and to gauge the accuracy of finite element model measurement using cadaver material. Ten wrists were obtained from cadavers with a mean age of 89.5 years at death. CT images of each wrist in an extended position were obtained. CT-based finite element models were prepared with Mechanical Finder software. Fracture on the models was simulated by applying a mechanical load to the palm in a direction parallel to the forearm axis, after which the fracture load and the site at which the fracture began were identified. For comparison, the wrists were fractured using a universal testing machine and the fracture load and the site of fracture were identified. The fracture load was 970.9 N in the finite element model group and 990.0 N in the actual measurement group. The site of the initial fracture was extra-articular to the distal radius in both groups. The finite element model was predictive for distal radius fracture when compared to the actual measurement. In this study, a finite element model for evaluation of distal radius strength was validated and can be used to predict fracture risk. We conclude that a finite element model is useful for the evaluation of distal radius strength. Knowing distal radius strength might avoid distal radius fracture because appropriate antiosteoporotic treatment can be initiated.	[Matsuura, Yusuke; Kuniyoshi, Kazuki; Ogawa, Yasufumi; Sukegawa, Koji; Takahashi, Kazuhisa] Chiba Univ, Dept Orthoped Surg, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan; [Suzuki, Takane] Chiba Univ, Dept Bioenvironm Med, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan; [Rokkaku, Tomoyuki] Chiba Aoba Municipal Hosp, Dept Orthoped Surg, Chuo Ku, Chiba 2600852, Japan	Matsuura, Y (reprint author), Chiba Univ, Dept Orthoped Surg, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	y-m-1211@khaki.plala.or.jp					Siris ES, 2004, ARCH INTERN MED, V164, P1108, DOI 10.1001/archinte.164.10.1108; CHOI K, 1990, J BIOMECH, V23, P1103, DOI 10.1016/0021-9290(90)90003-L; Imai K, 2006, SPINE, V31, P1789, DOI 10.1097/01.brs.0000225993.57349.df; Silva MJ, 1998, J ORTHOPAED RES, V16, P300, DOI 10.1002/jor.1100160305; DeGoede KM, 2003, J BIOMECH, V36, P1043, DOI 10.1016/S0021-9290(03)00034-4; Silva MJ, 2007, INJURY, V38, P69, DOI 10.1016/j.injury.2007.08.014; Ota T, 1999, J BONE MINER METAB, V17, P108, DOI 10.1007/s007740050072; KEYAK JH, 1993, J BIOMED ENG, V15, P505, DOI 10.1016/0141-5425(93)90066-8; Keyak JH, 2001, MED ENG PHYS, V23, P657, DOI 10.1016/S1350-4533(01)00094-7; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Taddei F, 2006, J BIOMECH, V39, P2457, DOI 10.1016/j.jbiomech.2005.07.018; Vogt MT, 2002, J AM GERIATR SOC, V50, P97, DOI 10.1046/j.1532-5415.2002.50014.x; Anderson AE, 2005, J BIOMECH ENG-T ASME, V127, P364, DOI 10.1115/1.1894148; Crawford RP, 2003, BONE, V33, P744, DOI 10.1016/S8756-3282(03)00210-2; FAULKNER KG, 1991, RADIOLOGY, V179, P669; Cody DD, 1999, J BIOMECH, V32, P1013, DOI 10.1016/S0021-9290(99)00099-8; MCBROOM RJ, 1985, J BONE JOINT SURG AM, V67A, P1206; Davison KS, 2006, SEMIN ARTHRITIS RHEU, V36, P22, DOI 10.1016/j.semarthrit.2006.04.002; Edwards WB, 2012, MED ENG PHYS, V34, P290, DOI 10.1016/j.medengphy.2011.07.016; Gray HA, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2913335; Gupta S, 2004, P I MECH ENG H, V218, P127, DOI 10.1243/095441104322984022; HAYES WC, 1991, RADIOL CLIN N AM, V29, P1; KATSAMANIS F, 1990, J BIOMECH, V23, P1173, DOI 10.1016/0021-9290(90)90010-Z; Keyak JH, 2001, MED ENG PHYS, V23, P1651; Keyak JH, 1998, J BIOMECH, V31, P125; Liebschner MAK, 2003, SPINE, V28, P559, DOI 10.1097/00007632-200303150-00009; Muller M, 2008, MED ENG PHYS, V30, P761, DOI 10.1016/j.medengphy.2007.08.006; Overaker DW, 1999, J BIOMECH ENG-T ASME, V121, P542, DOI 10.1115/1.2835085; Roux JP, 2009, J BONE MINER RES, V25, P356; Varga P, 2009, J BIOMECH, V42, P1726, DOI 10.1016/j.jbiomech.2009.04.017	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					1012	1018		10.1007/s00776-014-0616-1		7	Orthopedics	Orthopedics	AU1OE	WOS:000345389200024		
J	Kawamura, D; Funakoshi, T; Mizumoto, S; Sugahara, K; Iwasaki, N				Kawamura, Daisuke; Funakoshi, Tadanao; Mizumoto, Shuji; Sugahara, Kazuyuki; Iwasaki, Norimasa			Sulfation patterns of exogenous chondroitin sulfate affect chondrogenic differentiation of ATDC5 cells	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							MESENCHYMAL STEM-CELLS; EMBRYONIC PIG BRAIN; GROWTH-FACTOR; SPONDYLOEPIPHYSEAL DYSPLASIA; NEURITOGENIC ACTIVITY; HYBRID CHAINS; LINE ATDC5; OMANI-TYPE; GLYCOSAMINOGLYCANS; INVOLVEMENT	Background Chondroitin sulfate (CS) has been used in cartilage tissue engineering techniques as a positive modulator of scaffolds. CS is a linear polysaccharide consisting of variously sulfated repeating disaccharides. The sulfation patterns of CS are closely related to their biological functions, but only monosulfated CS has been applied to scaffolds. In this study, we investigated the effects of various sulfation patterns of CS on chondrogenic differentiation using ATDC5 chondroprogenitor cells. Methods Disaccharide composition analysis of CS produced by ATDC5 cells at various differentiation steps was performed using high-performance liquid chromatography. ATDC5 cells were cultured with exogenously added, variously sulfated CS. Cell proliferation was analyzed by the 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt (WST-8) assay. Extracellular matrix production was evaluated by Alcian blue staining. Alkaline phosphatase (ALP) activity was evaluated using an ALP assay kit. Expression of chondrogenic markers was evaluated by real-time reverse transcription polymerase chain reaction (RT-PCR) or an enzyme-linked immunosorbent assay (ELISA) using a Type II Collagen Detection kit. Results The major components of CS produced by ATDC5 cells were 4-O-monosulfated disaccharides throughout chondrogenic differentiation. Low proportions of 4,6-O-disulfated disaccharides were also detected. Compared to the control group, which did not contain GAGs, the WST-8 assay indicated fewer viable cells when treated with CS-E, which are rich in 4,6-O-disulfated disaccharides. CS-E significantly enhanced Alcian blue staining in a dose-dependent manner and decreased ALP activity after 21 days of culture. Real-time RT-PCR showed that CS-E significantly enhanced all chondrogenic markers, col2a1, aggrecan, and sox9, either at day 4 or day 14 of culture. The results of ELISA analysis confirmed that CS-E significantly enhanced the production of type II collagen. Conclusions ATDC5 cells produced four different monosulfated or disulfated disaccharides in their extracellular matrices. The sulfation patterns of exogenously added CS affected chondrogenic differentiation of ATDC5 cells. In particular, CS-E rich in disulfated disaccharides significantly promoted chondrogenic differentiation of ATDC5 cells. Thus, CS containing this disulfated structure may be a useful scaffold component for enhancing chondrogenesis in cartilage tissue engineering.	[Kawamura, Daisuke; Funakoshi, Tadanao; Iwasaki, Norimasa] Hokkaido Univ, Dept Orthopaed Surg, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Mizumoto, Shuji] Meijo Univ, Dept Pathobiochem, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan; [Sugahara, Kazuyuki] Hokkaido Univ, Proteoglycan Signaling & Therapeut Res Grp, Grad Sch Life Sci, Sapporo, Hokkaido 0608638, Japan	Iwasaki, N (reprint author), Hokkaido Univ, Dept Orthopaed Surg, Grad Sch Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	niwasaki@med.hokudai.ac.jp					Akiyama H, 2000, CELL STRUCT FUNCT, V25, P195, DOI 10.1247/csf.25.195; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Bayliss MT, 1999, J BIOL CHEM, V274, P15892, DOI 10.1074/jbc.274.22.15892; van Roij MHH, 2008, AM J MED GENET A, V146A, P2376, DOI 10.1002/ajmg.a.32482; Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002; Park JS, 2010, J BIOMED MATER RES A, V92A, P806, DOI 10.1002/jbm.a.32388; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; Tuysuz B, 2009, CLIN GENET, V75, P375, DOI 10.1111/j.1399-0004.2009.01167.x; Phornphutkul C, 2004, J ENDOCRINOL, V183, P477, DOI 10.1677/joe.1.05873; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Iida A, 2013, HUM MUTAT, V34, P1381, DOI 10.1002/humu.22377; Mizumoto S, 2013, J BIOL CHEM, V288, P10953, DOI 10.1074/jbc.R112.437038; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Miyazaki T, 2008, J CELL PHYSIOL, V217, P769, DOI 10.1002/jcp.21557; BELL E, 1991, J CELL BIOCHEM, V45, P239, DOI 10.1002/jcb.240450302; Chen WC, 2011, J BIOSCI BIOENG, V111, P226, DOI 10.1016/j.jbiosc.2010.10.002; ELIAKIM R, 1986, P NATL ACAD SCI USA, V83, P461, DOI 10.1073/pnas.83.2.461; Ul Haque MF, 1998, NAT GENET, V20, P157; Kasahara Y, 2008, J BIOMED MATER RES A, V86A, P127, DOI 10.1002/jbm.a.31259; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Shukunami C, 2000, FEBS LETT, V469, P83, DOI 10.1016/S0014-5793(00)01251-5; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321; Tsuchida K, 2001, J BIOL CHEM, V276, P37155, DOI 10.1074/jbc.M105818200; Uygun BE, 2009, TISSUE ENG PT A, V15, P3499, DOI 10.1089/ten.TEA.2008.0405	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					1028	1035		10.1007/s00776-014-0643-y		8	Orthopedics	Orthopedics	AU1OE	WOS:000345389200026		
J	Asanuma, Y; Fujimoto, H; Nakabayashi, H; Akeda, K; Asanuma, K; Tanaka, M; Nagakura, T; Miura, Y; Iino, T; Ogawa, K; Kasai, Y; Sudo, A				Asanuma, Yumiko; Fujimoto, Hajime; Nakabayashi, Hiroshi; Akeda, Koji; Asanuma, Kunihiro; Tanaka, Masaru; Nagakura, Takeshi; Miura, Yoshihiro; Iino, Takahiro; Ogawa, Kunikazu; Kasai, Yuichi; Sudo, Akihiro			Extradural cryptococcoma at the sacral spine without bone involvement in an immunocompetent patient	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							PULMONARY CRYPTOCOCCOSIS; INFECTION; SKULL; NEOFORMANS; MENINGORADICULITIS; MANAGEMENT; MECHANISMS; GRANULOMA; DISEASE; MASS		[Asanuma, Yumiko; Tanaka, Masaru; Nagakura, Takeshi; Miura, Yoshihiro; Ogawa, Kunikazu] Mie Chuo Med Ctr, Dept Orthoped Surg, Tsu, Mie 5141101, Japan; [Fujimoto, Hajime] Mie Chuo Med Ctr, Dept Resp Med, Tsu, Mie 5141101, Japan; [Nakabayashi, Hiroshi] Mie Chuo Med Ctr, Dept Pathol, Tsu, Mie 5141101, Japan; [Akeda, Koji; Asanuma, Kunihiro; Iino, Takahiro; Kasai, Yuichi; Sudo, Akihiro] Mie Univ, Dept Orthoped Surg, Tsu, Mie 514, Japan	Asanuma, Y (reprint author), Mie Chuo Med Ctr, Dept Orthoped Surg, 2158-5 Hisai Myojincho, Tsu, Mie 5141101, Japan.	yumikoab@gmail.com					Baddley JW, 2008, EUR J CLIN MICROBIOL, V27, P937, DOI 10.1007/s10096-008-0529-z; IGEL HJ, 1966, J INFECT DIS, V116, P75; Dichgans M, 1998, CLIN INFECT DIS, V26, P524, DOI 10.1086/517109; Nguyen MH, 2010, J INFECTION, V61, P419, DOI 10.1016/j.jinf.2010.08.004; Pappas PG, 2001, CLIN INFECT DIS, V33, P690, DOI 10.1086/322597; Li Shu Shun, 2010, Proc Am Thorac Soc, V7, P186, DOI 10.1513/pats.200907-063AL; Olszewski MA, 2010, FUTURE MICROBIOL, V5, P1269, DOI [10.2217/fmb.10.93, 10.2217/FMB.10.93]; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Lui G, 2006, QJM-INT J MED, V99, P143, DOI 10.1093/qjmed/hcl014; ARMONDA RA, 1993, NEUROSURGERY, V32, P1034; Benesova P, 2007, APMIS, V115, P177, DOI 10.1111/j.1600-0463.2007.apm_513.x; CARTON CA, 1951, J NEUROSURG, V8, P143, DOI 10.3171/jns.1951.8.2.0143; Ching NC, 2004, PEDIATR INFECT DIS J, V23, P589, DOI 10.1097/01.inf.0000130740.01940.b6; Committee for Guidelines for Management of Deep-seated Mycoses, 2007, GUID MAN DEEP SEAT M; Deus-Silva L, 2004, ARQ NEURO-PSIQUIAT, V62, P147, DOI 10.1590/S0004-282X2004000100026; FUJITA NK, 1981, ANN INTERN MED, V94, P382; GALLOWAY DC, 1981, J NEUROSURG, V54, P690, DOI 10.3171/jns.1981.54.5.0690; Gultasli NZ, 2007, DIAGN INTERV RADIOL, V13, P64; Kumari R, 2010, BRIT J RADIOL, V83, pE14, DOI 10.1259/bjr/50945216; LITVINOFF J, 1978, J NEUROSURG, V49, P921, DOI 10.3171/jns.1978.49.6.0921; Nadrous HF, 2003, CHEST, V124, P2143, DOI 10.1378/chest.124.6.2143; Noh HM, 1999, SKELETAL RADIOL, V28, P49; PIROFSKI LA, 1990, REV INFECT DIS, V12, P964; Rao S B, 1970, Neurol India, V18, P192; REEVES DL, 1967, J NEUROSURG, V27, P70, DOI 10.3171/jns.1967.27.1.0070; REINIG JW, 1984, SKELETAL RADIOL, V11, P221; Zahra LV, 2004, MYCOSES, V47, P168	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					1040	1045		10.1007/s00776-013-0413-2		6	Orthopedics	Orthopedics	AU1OE	WOS:000345389200028		
J	Sasaki, N; Tsuda, E; Yamamoto, Y; Maeda, S; Ishibashi, Y				Sasaki, Norihiro; Tsuda, Eiichi; Yamamoto, Yuji; Maeda, Shugo; Ishibashi, Yasuyuki			Severe valgus knee deformity caused by chondronecrosis after using a radiofrequency device	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							DISCOID LATERAL MENISCUS; TERM-FOLLOW-UP; ARTICULAR-CARTILAGE; MENISCECTOMY; CHILDREN; OSTEONECROSIS; CHONDROLYSIS; RESECTION; BIPOLAR; ENERGY		[Sasaki, Norihiro; Tsuda, Eiichi; Yamamoto, Yuji; Maeda, Shugo; Ishibashi, Yasuyuki] Hirosaki Univ, Grad Sch Med, Dept Orthopaed Surg, Hirosaki, Aomori 0368562, Japan	Sasaki, N (reprint author), Hirosaki Univ, Grad Sch Med, Dept Orthopaed Surg, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	norisasa@cc.hirosaki-u.ac.jp					Aglietti P, 1999, Am J Knee Surg, V12, P83; AICHROTH PM, 1991, J BONE JOINT SURG BR, V73, P932; Allen RT, 2006, ARTHROSCOPY, V22, P385, DOI 10.1016/j.arthro.2005.12.007; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; WASHINGTON ER, 1995, J BONE JOINT SURG AM, V77, P1357; Raber DA, 1998, J BONE JOINT SURG AM, V80A, P1579; Habata T, 2006, ARTHROSCOPY, V22, P1339, DOI 10.1016/j.arthro.2006.07.039; Lee DH, 2009, ARTHROSCOPY, V25, P496, DOI 10.1016/j.arthro.2008.10.025; Bonutti PM, 2006, J BONE JOINT SURG AM, V88A, P69, DOI 10.2106/JBJS.F00533; Voss JR, 2006, AM J VET RES, V67, P1708, DOI 10.2460/ajvr.67.10.1708; Lu Y, 2001, AM J SPORT MED, V29, P42; Cook JL, 2004, AM J VET RES, V65, P604, DOI 10.2460/ajvr.2004.65.604; Ding J, 2009, ARTHROSCOPY, V25, P1423, DOI 10.1016/j.arthro.2009.06.024; Encalada I, 2004, ARTHROSCOPY, V20, P632, DOI 10.1016/j.arthro.2004.04.075; Ishida K, 2006, KNEE SURG SPORT TR A, V14, P1266, DOI 10.1007/s00167-006-0091-0; Kaplan LD, 2003, AM J SPORT MED, V31, P392; Mariani PP, 2008, KNEE SURG SPORT TR A, V16, P574, DOI 10.1007/s00167-008-0508-z; Okazaki K, 2006, ARTHROSCOPY, V22, P967, DOI 10.1016/j.arthro.2006.04.107; WROBLE RR, 1992, CLIN ORTHOP RELAT R, P180	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					1046	1050		10.1007/s00776-013-0403-4		5	Orthopedics	Orthopedics	AU1OE	WOS:000345389200029		
J	Toda, K				Toda, Katsuhiro			Comment on Nakamura et al.: Investigation of chronic musculoskeletal pain (third report): with special reference to the importance of neuropathic pain and psychogenic pain	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Editorial Material									Fukuyama Rehabil Hosp, Dept Rehabil, Fukuyama, Hiroshima 7200031, Japan	Toda, K (reprint author), Fukuyama Rehabil Hosp, Dept Rehabil, 4-1-15 Miyoshi Chou, Fukuyama, Hiroshima 7200031, Japan.	goutattack@yahoo.co.jp					Japan Society of Pain Clinicians, 2012, GUID PRESCR OP AN CH; Loeser JD, 2011, IASP TAXONOMY; Nakamura M, 2014, J ORTHOP SCI, V19, P667, DOI 10.1007/s00776-014-0567-6	3	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					1056	1056		10.1007/s00776-014-0670-8		1	Orthopedics	Orthopedics	AU1OE	WOS:000345389200031		
J	Nakamura, M; Ushida, T; Toyama, Y				Nakamura, Masaya; Ushida, Takahiro; Toyama, Yoshiaki			Comment on Nakamura et al.: Investigation of chronic musculoskeletal pain (third report): with special reference to the importance of neuropathic pain and psychogenic pain Reply	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Editorial Material									[Nakamura, Masaya; Toyama, Yoshiaki] Keio Univ, Dept Orthopaed Surg, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Ushida, Takahiro] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi 48011, Japan	Nakamura, M (reprint author), Keio Univ, Dept Orthopaed Surg, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	masa@a8.keio.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	NOV	2014	19	6					1057	1057		10.1007/s00776-014-0625-0		1	Orthopedics	Orthopedics	AU1OE	WOS:000345389200032		
J	Kaneishi, K				Kaneishi, Keisuke			Importance of Nasal Cavity Care for Relieving Dyspnea in Patients With Advanced Cancer	JOURNAL OF PAIN AND SYMPTOM MANAGEMENT			English	Letter									JCHO Tokyo Shinjuku Med Ctr, Palliat Care Unit, Tokyo, Japan	Kaneishi, K (reprint author), JCHO Tokyo Shinjuku Med Ctr, Palliat Care Unit, Tokyo, Japan.	kankannjp@yahoo.co.jp		Kaneishi, Keisuke/0000-0003-1869-6758			Bjork-Eriksson T, 2000, RHINOLOGY, V38, P200; DAS SK, 1984, J LARYNGOL OTOL, V98, P989, DOI 10.1017/S002221510014784X	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0885-3924	1873-6513		J PAIN SYMPTOM MANAG	J. Pain Symptom Manage.	NOV	2014	48	5					E4	E5		10.1016/j.jpainsymman.2014.08.005		3	Health Care Sciences & Services; Medicine, General & Internal; Clinical Neurology	Health Care Sciences & Services; General & Internal Medicine; Neurosciences & Neurology	AU2FW	WOS:000345432800003		
J	Nitto, T; Sawaki, K				Nitto, Takeaki; Sawaki, Kohei			Molecular Mechanisms of the Antileukemia Activities of Retinoid and Arsenic	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						acute promyelocytic leukemia; all-trans retinoic acid; arsenic trioxide; retinoic acid receptor; epigenetics	ACUTE PROMYELOCYTIC LEUKEMIA; BINDING-PROTEIN-EPSILON; REFRACTORY JAPANESE PATIENTS; ALPHA FUSION PROTEIN; RAR-ALPHA; T(15-17) TRANSLOCATION; TRANSCRIPTION FACTOR; HISTONE DEACETYLASE; INDUCED DEGRADATION; TRIOXIDE THERAPY	Acute promyelocytic leukemia (APL) is characterized by the occurrence of translocations between chromosomes 15 and 17, resulting in generation of a fusion protein of promyelocytic leukemia (PML) and retinoid A receptor (RAR) alpha. APL cells are unable to differentiate into mature granulocytes since PML-RAR alpha functions as a strong transcriptional repressor for a gene involved in granulocyte differentiation. All-trans retinoic acid (ATRA) is the first agent that has been developed to target specific disease-causing molecules, i.e., ATRA suppresses abnomial functions of oncogenic proteins. Moreover, ATRA facilitates the differentiation of APL cells toward mature granulocytes by changing epigenetic modifiers from corepressor complexes to co-activator complexes on target genes after binding to the ligand-binding domain at the RAR alpha moiety of the PML-RAR alpha oncoprotein. On the other hand, arsenic trioxide (ATO), another promising agent used to treat APL, directly binds to the PML moiety of the PML-RAR alpha protein, causing oxidation and multimerization. ATO enhances the conjugation of small ubiquitin-like modifiers to PML-RAR alpha, followed by ubiquitination and degradation, relieving the genes associated with granulocytic differentiation from suppressive restraint by the oncoprotein. Recent clinical studies have demonstrated that combination therapy with both ATRA and ATO is useful to achieve remission.	[Nitto, Takeaki; Sawaki, Kohei] Yokohama Coll Pharm, Lab Pharmacotherapy, Yokohama, Kanagawa 2450066, Japan	Nitto, T (reprint author), Yokohama Coll Pharm, Lab Pharmacotherapy, Yokohama, Kanagawa 2450066, Japan.	nitto@hamayaku.ac.jp					Zhong S, 2000, NAT CELL BIOL, V2, pE85; Chen GQ, 1997, BLOOD, V89, P3345; Huang EY, 2000, GENE DEV, V14, P45; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Isakson P, 2010, BLOOD, V116, P2324, DOI 10.1182/blood-2010-01-261040; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Arteaga MF, 2013, CANCER CELL, V23, P376, DOI 10.1016/j.ccr.2013.02.014; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Duprez E, 1999, J CELL SCI, V112, P381; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Grignani F, 1998, NATURE, V391, P815; Nervi C, 1998, BLOOD, V92, P2244; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Raelson JV, 1996, BLOOD, V88, P2826; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; PEREZ A, 1993, EMBO J, V12, P3171; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; Shen ZX, 1997, BLOOD, V89, P3354; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; DE LUCA LM, 1991, FASEB J, V5, P2924; Ablain J, 2014, NAT MED, V20, P167, DOI 10.1038/nm.3441; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Wang KK, 2010, CANCER CELL, V17, P186, DOI 10.1016/j.ccr.2009.12.045; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Tarkanyi I, 2005, LEUKEMIA, V19, P1806, DOI 10.1038/sj.leu.2403923; Park DJ, 1999, J CLIN INVEST, V103, P1399, DOI 10.1172/JCI2887; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Shigeno K, 2005, INT J HEMATOL, V82, P224, DOI 10.1532/IJH97.05044; Kamashev D, 2004, J EXP MED, V199, P1163, DOI 10.1084/jem.20032226; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Lin RJ, 1998, NATURE, V391, P811; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807; Cote S, 2000, BLOOD, V96, P3200; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Chen JD, 1996, P NATL ACAD SCI USA, V93, P7567, DOI 10.1073/pnas.93.15.7567; Chih DY, 1997, BLOOD, V90, P2987; DANIEL MT, 1993, BLOOD, V82, P1858; FENAUX P, 1992, BLOOD, V80, P2176; Ferbeyre G, 2002, LEUKEMIA, V16, P1918, DOI 10.1038/sj.leu.2402722; JANSEN JH, 1995, P NATL ACAD SCI USA, V92, P7401, DOI 10.1073/pnas.92.16.7401; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lallemand-Breitenbach V, 1999, J EXP MED, V189, P1043, DOI 10.1084/jem.189.7.1043; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lekstrom-Himes J, 1999, BLOOD, V93, P3096; Lengfelder E, 2013, EXPERT REV ANTICANC, V13, P1035, DOI 10.1586/14737140.2013.833681; Licht JD, 2006, CANCER CELL, V9, P73, DOI 10.1016/j.ccr.2006.01.024; Ohnishi K, 2002, LEUKEMIA, V16, P617, DOI 10.1038/sj/leu/2402426; Rochette-Egly Cécile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Sun HD, 1992, CHIN J INTEGRAT CHIN, V12, P170; Tarrade A, 2005, ONCOGENE, V24, P2277, DOI 10.1038/sj.onc.1208402; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P6462, DOI 10.1073/pnas.94.12.6462	59	2	3	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	NOV	2014	126	3					179	185		10.1254/jphs.14R15CP		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU4AQ	WOS:000345551900001		
J	Mori, MX; Inoue, R				Mori, Masayuki X.; Inoue, Ryuji			New Experimental Trends for Phosphoinositides Research on Ion Transporter/Channel Regulation	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						phosphoinositide; channel/transporter; PI-turnover; Ca2+ signal; membrane lipid	VOLTAGE-SENSING PHOSPHATASE; PHOSPHOLIPASE-C ACTIVITY; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE PIP2; RECEPTOR-MEDIATED INHIBITION; ACTIVATED PROTEIN-KINASE; RECTIFIER K+ CHANNEL; NERVE GROWTH-FACTOR; POTASSIUM CHANNELS; CATION CHANNEL; MUSCARINIC MODULATION	Phosphoinositides(4,5)-bisphosphates [PI(4,5)P-2] critically controls membrane excitability, the disruption of which leads to pathophysiological states. PI(4,5)P-2 plays a primary role in regulating the conduction and gating properties of ion channels/transporters, through electrostatic and hydrophobic interactions that allow direct associations. In recent years, the development of many molecular tools have brought deep insights into the mechanisms underlying PI(4,5)P-2-mediated regulation. This review summarizes the methods currently available to manipulate the cell membrane PI(4,5)P-2 level including pharmacological interventions as well as newly designed molecular tools. We concisely introduce materials and experimental designs suitable for the study of PI(4,5)P-2-mediated regulation of ion-conducting molecules, in order to assist researchers who are interested in this area. It is our further hope that the knowledge introduced in this review will help to promote our understanding about the pathology of diseases such as cardiac arrhythmias, bipolar disorders, and Alzheimer's disease which are somehow associated with a disruption of PI(4,5)P-2 metabolism.	[Mori, Masayuki X.] Kyoto Univ, Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan; [Inoue, Ryuji] Fukuoka Univ, Sch Med, Dept Physiol, Fukuoka 8140180, Japan	Mori, MX (reprint author), Kyoto Univ, Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan.	mxmori@sbchem.kyoto-u.ac.jp; inouery@fukuoka-u.ac.jp			Japan Society for Promotion of Sciences; Naito Foundation	We thank Dr. Onur K. Polat for critical comments on the manuscript. This work is supported in part by grants-in-aid to M.X.M. and R.I. from the Japan Society for Promotion of Sciences and Naito Foundation.	Abderemane-Ali F, 2013, J BIOL CHEM, V287, P36158; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507; Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; Brady JD, 2006, P NATL ACAD SCI USA, V103, P15635, DOI 10.1073/pnas.0603344103; Suh BC, 2007, J GEN PHYSIOL, V130, P241, DOI 10.1085/jgp.200709821; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Bae YS, 2003, MOL PHARMACOL, V63, P1043, DOI 10.1124/mol.63.5.1043; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V455, P157, DOI 10.1007/s00424-007-0275-6; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Saleh SN, 2009, J PHYSIOL-LONDON, V587, P5361, DOI 10.1113/jphysiol.2009.180331; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Le Blanc C, 2004, CIRC RES, V95, P300, DOI 10.1161/01.RES.0000138017.76125.8b; Coburn RF, 2009, J CELL PHYSIOL, V221, P544, DOI 10.1002/jcp.21899; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Xie LH, 1999, P NATL ACAD SCI USA, V96, P15292, DOI 10.1073/pnas.96.26.15292; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Schiekel J, 2013, CARDIOVASC RES, V97, P97, DOI 10.1093/cvr/cvs285; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Kooijman EE, 2009, BIOCHEMISTRY-US, V48, P9360, DOI 10.1021/bi9008616; Hossain MI, 2008, J BIOL CHEM, V283, P18248, DOI 10.1074/jbc.M706184200; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Mo G, 2013, MOL PHARMACOL, V83, P640, DOI 10.1124/mol.112.082099; Okamura Y, 2011, PHYSIOLOGY, V26, P6, DOI 10.1152/physiol.00035.2010; Suh BC, 2010, NEURON, V67, P224, DOI 10.1016/j.neuron.2010.07.001; Halstead JR, 2005, TRENDS PHARMACOL SCI, V26, P654, DOI 10.1016/j.tips.2005.10.004; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fujita F, 2013, J NEUROSCI, V33, P6154, DOI 10.1523/JNEUROSCI.5672-12.2013; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Lopes CMB, 2005, J PHYSIOL-LONDON, V564, P117, DOI 10.1113/jphysiol.2004.081935; Hardie RC, 2004, J BIOL CHEM, V279, P47773, DOI 10.1074/jbc.M407525200; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Ellenbroek WG, 2011, BIOPHYS J, V101, P2178, DOI 10.1016/j.bpj.2011.09.039; POWIS G, 1994, CANCER RES, V54, P2419; Voets T, 2003, J GEN PHYSIOL, V121, P245, DOI 10.1085/jgp.20028752; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600763; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P11384, DOI 10.1073/pnas.1202194109; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Kurokawa T, 2012, P NATL ACAD SCI USA, V109, P10089, DOI 10.1073/pnas.1203799109; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005; Kruse M, 2012, J GEN PHYSIOL, V140, P189, DOI 10.1085/jgp.201210806; Villalba-Galea CA, 2013, J GEN PHYSIOL, V142, P543, DOI 10.1085/jgp.201310993; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; Lacroix J, 2011, J BIOL CHEM, V286, P17945, DOI 10.1074/jbc.M110.201749; Itsuki K, 2014, J GEN PHYSIOL, V143, P183, DOI 10.1085/jgp.201311033; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Itsuki K, 2012, CHANNELS, V6, P206, DOI 10.4161/chan.20883; Mogami H, 1997, BIOCHEM J, V324, P645; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; AUGERT G, 1989, J BIOL CHEM, V264, P2574; Bushman JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063733; Can A, 2014, PHARMACOL BIOCHEM BE, V123, P3, DOI 10.1016/j.pbb.2014.02.004; Carr DB, 2007, J NEUROPHYSIOL, V97, P3432, DOI 10.1152/jn.00828.2006; Cho H, 2001, BRIT J PHARMACOL, V134, P1066, DOI 10.1038/sj.bjp.0704347; Clarke JH, 2010, ADV ENZYME REGUL, V50, P12, DOI 10.1016/j.advenzreg.2009.10.006; Dickson EL, 2013, P NATL ACAD SCI USA, V111, pE2281; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Falkenburger BH, 2009, J GEN PHYSIOL, V135, P99; FERBY IM, 1994, J BIOL CHEM, V269, P30485; FUKAMI K, 1988, P NATL ACAD SCI USA, V85, P9057, DOI 10.1073/pnas.85.23.9057; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.biochem.56.1.615; Gwanyanya A, 2006, AM J PHYSIOL-CELL PH, V291, pC627, DOI 10.1152/ajpcell.00074.2006; Heilmeyer LMG, 2003, IUBMB LIFE, V55, P59, DOI 10.1080/1521654031000090896; Hirdes W, 2004, J PHYSIOL-LONDON, V559, P67, DOI 10.1113/jphysiol.2004.066944; Ichishima K, 2010, BRIT J PHARMACOL, V161, P193, DOI 10.1111/j.1476-5381.2010.00896.x; Imai Y, 2012, J PHYSIOL-LONDON, V590, P1101, DOI 10.1113/jphysiol.2011.221358; Ju M, 2010, J PHYSIOL-LONDON, V588, P1419, DOI 10.1113/jphysiol.2009.185256; Lindner M, 2011, J PHYSIOL-LONDON, V589, P3149, DOI 10.1113/jphysiol.2011.208983; Obulchov AG, 2005, J NEUROSCI, V25, P1234; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rodriguez-Menchaca AA, 2012, P NATL ACAD SCI USA, V109, pE2399, DOI 10.1073/pnas.1207901109; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rusinova R, 2013, J GEN PHYSIOL, V141, P673, DOI 10.1085/jgp.201310960; Sarmento MJ, 2013, BIOCHIM BIOPHYS ACTA, V1838, P822; SCHACHT J, 1976, J NEUROCHEM, V27, P1119, DOI 10.1111/j.1471-4159.1976.tb00318.x; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Tian L, 2008, J BIOL CHEM, V283, P3067, DOI 10.1074/jbc.M706826200; Ueno T, 2011, SCI SIGNAL, V4, pra87; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Vaithianathan T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/jgp.200709913; Varnai P, 2007, PFLUG ARCH EUR J PHY, V455, P69, DOI 10.1007/s00424-007-0270-y; VICKERS JD, 1993, J PHARMACOL EXP THER, V266, P1156; Wang CA, 2008, MOL PHARMACOL, V73, P1185, DOI 10.1124/mol.107.043067; WELSH GI, 1994, BIOCHEM J, V303, P15; Wright BD, 2014, NEURON, V82, P836, DOI 10.1016/j.neuron.2014.04.006; Xie J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00146; Yamamoto S, 2008, BIOMED RES-TOKYO, V29, P307; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Yudin Y, 2011, J PHYSIOL-LONDON, V589, P6007, DOI 10.1113/jphysiol.2011.220228; Zaika O, 2006, J PHYSIOL-LONDON, V575, P49, DOI 10.1113/jphysiol.2006.114074; Zhang G, 2007, EUR J NEUROSCI, V31, P225; Zhang YX, 2006, J GEN PHYSIOL, V128, P185, DOI 10.1085/jgp.200609493	132	1	1	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	NOV	2014	126	3					186	197		10.1254/jphs.14R14CP		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU4AQ	WOS:000345551900002		
J	Fukuda, M; Aoki, T; Manabe, T; Maekawa, A; Shirakawa, T; Kataoka, H; Takagi, Y; Miyamoto, S; Narumiya, S				Fukuda, Miyuki; Aoki, Tomohiro; Manabe, Toshiaki; Maekawa, Akiko; Shirakawa, Takayuki; Kataoka, Hiroharu; Takagi, Yasushi; Miyamoto, Susumu; Narumiya, Shuh			Exacerbation of Intracranial Aneurysm and Aortic Dissection in Hypertensive Rat Treated With the Prostaglandin F-Receptor Antagonist AS604872	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						prostaglandin F-2 alpha receptor (FP); A5604872; intracranial aneurysm; aortic dissection; chronic inflammation	WALL SHEAR-STRESS; NF-KAPPA-B; CEREBRAL ANEURYSMS; CHRONIC INFLAMMATION; COLLAGEN; CANCER; ATHEROSCLEROSIS; DIFFERENTIATION; PREVALENCE; EXPRESSION	Intraeranial aneurysm (IA) and aortic dissection are both complications of hypertension and characterized by degeneration of the media. Given the involvement of prostaglandin F-2 alpha and its receptor, FP, in extracellular matrix remodeling in a mouse model of pulmonary fibrosis, here we induced hypertension and IA in rats by salt loading and hemi-lateral ligation of renal and carotid arteries and examined effects of a selective FP antagonist, AS604872, on these vascular events. AS604872 significantly accelerated degeneration of the media in both cerebral artery and aorta as evidenced by thinning of the media and disruption of the elastic lamina and promoted IA and aortic dissection. Notably, AS604872 induced expression of pro-inflammatory genes such as E-selectin in lesions and significantly enhanced macrophage infiltration. Suppression of surface expression of E-selectin with cimetidine prevented macrophage infiltration and aortic dissection. Thus, A5604872 exacerbates vascular inflammation in hypertensive rats and facilitates IA and aortic dissection. These results demonstrate that both IA and aortic dissection are caused by chronic inflammation of the arterial wall, which is worsened by A5604872, cautioning that other FP antagonists may share such deleterious actions in vascular homeostasis and suggesting that AS604872 can be used to make models of these vascular diseases with extensive degeneration.	[Fukuda, Miyuki; Takagi, Yasushi; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Dept Neurosurg,Sakyo Ku, Kyoto 6068507, Japan; [Fukuda, Miyuki; Aoki, Tomohiro; Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Core Res Evolut Sci & Technol CREST,Sakyo Ku, Kyoto 6068507, Japan; [Fukuda, Miyuki; Aoki, Tomohiro; Shirakawa, Takayuki; Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068315, Japan; [Aoki, Tomohiro; Maekawa, Akiko; Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Innovat Ctr Immunoregulatory Technol & Drugs AK P, Sakyo Ku, Kyoto 6068501, Japan; [Manabe, Toshiaki] Shiga Med Ctr, Res Inst, Moriyama, Shiga 5248524, Japan; [Kataoka, Hiroharu] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Suita, Osaka 5658565, Japan	Narumiya, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Konoe Cho Yoshida, Kyoto 6068315, Japan.	snaru@mfour.med.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24890097]; Fujiwara Memorial Foundation; Core Research for Evolutional Science and Technology (CREST) on Chronic Inflammation, Japan Science, and Technology Agency	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#24890097, T.A.); a research grant from the Fujiwara Memorial Foundation (M.F.); and by Core Research for Evolutional Science and Technology (CREST) on Chronic Inflammation, Japan Science, and Technology Agency (S.N.). We thank the Division of Electron Microscopic Study, Center for Anatomical Studies, Kyoto University Graduate School of Medicine for electron microscopy, N. Asamoto for animal care, and T. Arai and A. Washimi for secretarial assistance.	ADAMS WJ, 1994, LANCET, V344, P1768, DOI 10.1016/S0140-6736(94)92907-6; Aikawa M, 1995, J Atheroscler Thromb, V2, P14; Kobayashi K, 2000, CANCER RES, V60, P3978; Aoki T, 2009, STROKE, V40, P942, DOI 10.1161/STROKEAHA.108.532556; Oga T, 2009, NAT MED, V15, P1426, DOI 10.1038/nm.2066; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; Jou LD, 2008, AM J NEURORADIOL, V29, P1761, DOI 10.3174/ajnr.A1180; Yu Y, 2009, P NATL ACAD SCI USA, V106, P7985, DOI 10.1073/pnas.0811834106; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Yamashiro S, 2007, J NEUROL NEUROSUR PS, V78, P497, DOI 10.1136/jnnp.2006.098871; Esaki Y, 2010, P NATL ACAD SCI USA, V107, P12233, DOI 10.1073/pnas.0915112107; Luo F, 2009, AGEING RES REV, V8, P31, DOI 10.1016/j.arr.2008.08.001; Aoki T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/535921; Aoki T, 2007, CIRCULATION, V116, P2830, DOI 10.1161/CIRCULATIONAHA.107.728303; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Honda T, 2006, J EXP MED, V203, P325, DOI 10.1084/jem.20051310; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Mashimo T, 2012, CELL REPORTS, V2, P685, DOI 10.1016/j.celrep.2012.08.009; Iwamoto H, 1999, STROKE, V30, P1390; Rinkel GJE, 1998, STROKE, V29, P251; Hirata T, 2011, CHEM REV, V111, P6209, DOI 10.1021/cr200010h; HASHIMOTO N, 1978, SURG NEUROL, V10, P3; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Aoki T, 2007, STROKE, V38, P162, DOI 10.1161/01.STR.0000252129.18605.c8; Aoki T, 2010, EXPERT OPIN THER TAR, V14, P265, DOI 10.1517/14728221003586836; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Dolan JM, 2013, ANN BIOMED ENG, V41, P1411, DOI 10.1007/s10439-012-0695-0; Takeuchi S, 2010, WORLD NEUROSURG, V73, P174, DOI 10.1016/j.surneu.2009.03.030; Frosen J, 2004, STROKE, V35, P2287, DOI 10.1161/01.STR.0000140636.30204.da; Aoki T, 2011, BRIT J PHARMACOL, V163, P1237, DOI 10.1111/j.1476-5381.2011.01358.x; Chyatte D, 1999, NEUROSURGERY, V45, P1137, DOI 10.1097/00006123-199911000-00024; Cirillo R, 2007, AM J OBSTET GYNECOL, V197, p[54, e1]; Del Porto F, 2014, CARDIOLOGY, V127, P123, DOI 10.1159/000355253; Ishii T, 2000, HUM PATHOL, V31, P640, DOI 10.1053/hupa.2000.7642; Kanematsu Y, 2011, STROKE, V42, P173, DOI 10.1161/STROKEAHA.110.590976; KUROO M, 1991, J BIOL CHEM, V266, P3768; NEURATH MF, 1993, ANN RHEUM DIS, V52, P278, DOI 10.1136/ard.52.4.278; Patel Pawan D, 2008, Ther Adv Cardiovasc Dis, V2, P439, DOI 10.1177/1753944708090830; Sadowitz B, 2012, J SURG RES, V173, pE63, DOI 10.1016/j.jss.2011.09.025; Wiebers DO, 2002, J NEUROSURG, V96, P50, DOI 10.3171/jns.2002.96.1.0050; Wiebers DO, 2002, J NEUROSURG, V96, P8; Yao CC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2684	43	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	NOV	2014	126	3					230	242		10.1254/jphs.14148FP		13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU4AQ	WOS:000345551900006		
J	Nishizawa, D; Fukuda, K; Kasai, S; Ogai, Y; Hasegawa, J; Sato, N; Yamada, H; Tanioka, F; Sugimura, H; Hayashida, M; Ikeda, K				Nishizawa, Daisuke; Fukuda, Ken-ichi; Kasai, Shinya; Ogai, Yasukazu; Hasegawa, Junko; Sato, Naomi; Yamada, Hidetaka; Tanioka, Fumihiko; Sugimura, Haruhiko; Hayashida, Masakazu; Ikeda, Kazutaka			Association Between KCNJ6 (GIRK2) Gene Polymorphism rs2835859 and Post-operative Analgesia, Pain Sensitivity, and Nicotine Dependence	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						G-protein-activated inwardly rectifying potassium (GIRK) channel; single-nucleotide polymorphism; opioid analgesia; pain; susceptibility to nicotine dependence	RECTIFYING POTASSIUM CHANNELS; MU-OPIOID RECEPTOR; GATED K+ CHANNELS; WHOLE-GENOME ASSOCIATION; OOCYTE EXPRESSION SYSTEM; SUBUNIT KNOCKOUT MICE; FALSE DISCOVERY RATE; INDUCED ANTINOCICEPTION; FAGERSTROM TEST; LINKAGE-DISEQUILIBRIUM	G-protein-activated inwardly rectifying potassium (GIRK) channels are expressed in many tissues and activated by several Gib, protein coupled receptors, such as opioid and dopamine receptors, and thus are known to be involved in the modulation of opioid-induced analgesia, pain, and reward. We focused on a GIRK-channel subunit that plays a pivotal role in the brain, GIRK2, and investigated the contribution of genetic variations of the GIRK2 (KCNJ6) gene to individual differences in the sensitivity to opioid analgesia. In our initial linkage disequilibrium analysis, a total of 27 single-nucleotide polymorphisms (SNPs) were selected within and around the regions of the KCNJ6 gene. Among them, the rs2835859 SNP, for which associations with analgesia and pain have not been previously reported, was selected in the exploratory study as a potent candidate SNP associated with opioid analgesic sensitivity. The results were corroborated in further confirmatory study. Interestingly, this SNP was also found to be associated with sensitivity to both cold and mechanical pain, susceptibility to nicotine dependence, and successful smoking cessation. The results indicate that this SNP could serve as a marker that predicts sensitivity to analgesic and pain and susceptibility to nicotine dependence.	[Nishizawa, Daisuke; Kasai, Shinya; Ogai, Yasukazu; Hasegawa, Junko; Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Tokyo 1568506, Japan; [Fukuda, Ken-ichi] Tokyo Dent Coll, Dept Dent Anesthesiol, Tokyo 1010061, Japan; [Sato, Naomi] Hamamatsu Univ Sch Med, Dept Clin Nursing, Hamamatsu, Shizuoka 4313192, Japan; [Sato, Naomi; Yamada, Hidetaka; Sugimura, Haruhiko] Hamamatsu Univ Sch Med, Dept Tumor Pathol, Hamamatsu, Shizuoka 4313192, Japan; [Tanioka, Fumihiko] Iwata City Hosp, Dept Pathol, Iwata 4388550, Japan; [Hayashida, Masakazu] Juntendo Univ, Sch Med, Dept Anesthesiol & Pain Med, Tokyo 1138431, Japan	Ikeda, K (reprint author), Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Tokyo 1568506, Japan.	ikeda-kz@igakuken.or.jp			MEXT KAKENHI [20602020, 20390162, 23390377, 26293347, 26860360, S-001]; Ministry of Health, Labour and Welfare (MHLW) of Japan [H21-3jigan-ippan-011, H22-Iyaku-015, H25-Iyaku-020]; National Cancer Center Research and Development Fund; Smoking Research Foundation; Astellas Foundation for Research on Metabolic Disorders	We thank Mr. Michael Arends for his assistance with editing the manuscript. We are grateful to the volunteers for their participation in this study and the anesthesiologists and surgeons at Tokyo Dental College, Chiba, Japan and clinicians at Iwata City Hospital for collecting the clinical data. This work was supported by grants from the MEXT KAKENHI (No. 20602020,20390162,23390377,26293347, 26860360, and S-001); the Ministry of Health, Labour and Welfare (MHLW) of Japan (No. H21-3jigan-ippan-011, H22-Iyaku-015, and H25-Iyaku-020); Grants-in-Aid for the U.S.-Japan Cooperative Medical Science Program, National Cancer Center Research and Development Fund, Smoking Research Foundation, and Astellas Foundation for Research on Metabolic Disorders.	Nishizawa D, 2014, MOL PSYCHIATR, V19, P55, DOI 10.1038/mp.2012.164; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Inanobe A, 1999, J NEUROSCI, V19, P1006; Kawakami N, 1999, ADDICT BEHAV, V24, P155, DOI 10.1016/S0306-4603(98)00127-0; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Mitrovic I, 2003, P NATL ACAD SCI USA, V100, P271, DOI 10.1073/pnas.0136822100; Bisgaard T, 2001, PAIN, V90, P261, DOI 10.1016/S0304-3959(00)00406-1; Corey S, 1998, J BIOL CHEM, V273, P27499, DOI 10.1074/jbc.273.42.27499; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Klepstad P, 2004, ACTA ANAESTH SCAND, V48, P1232, DOI 10.1111/j.1399-6576.2004.00517.x; Fukuda K, 2009, PAIN, V147, P194, DOI 10.1016/j.pain.2009.09.004; Marker CL, 2004, J NEUROSCI, V24, P2806, DOI 10.1523/JNEUROSCI.5251-03.2004; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Kreienkamp HJ, 1997, FEBS LETT, V419, P92, DOI 10.1016/S0014-5793(97)01437-3; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; McAllister SD, 1999, J PHARMACOL EXP THER, V291, P618; Nyholt DR, 2001, HUM GENET, V109, P564, DOI 10.1007/s00439-001-0611-4; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Biala G, 2005, PHARMACOL REP, V57, P755; Kobayashi T, 2006, CURR PHARM DESIGN, V12, P4513, DOI 10.2174/138161206779010468; Kobayashi T, 2002, BRIT J PHARMACOL, V135, P313, DOI 10.1038/sj.bjp.0704475; Bunemann M, 2001, J BIOL CHEM, V276, P47512, DOI 10.1074/jbc.M108652200; Pillai G, 1998, NEUROPHARMACOLOGY, V37, P983, DOI 10.1016/S0028-3908(98)00092-6; Berrendero F, 2005, J NEUROSCI, V25, P1103, DOI 10.1523/JNEUROSCI.3008-04.2005; Berrendero F, 2002, J NEUROSCI, V22, P10935; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; Marker CL, 2005, J NEUROSCI, V25, P3551, DOI 10.1523/JNEUROSCI.4899-04.2005; Liao YJ, 1996, J NEUROSCI, V16, P7137; Blednow YA, 2003, P NATL ACAD SCI USA, V100, P277, DOI 10.1073/pnas.012682399; Bruehl S, 2013, PAIN, V154, P2853, DOI 10.1016/j.pain.2013.08.026; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Etter JF, 1999, ADDICTION, V94, P269, DOI 10.1046/j.1360-0443.1999.94226910.x; Fernandez-Fernandez JM, 1999, J PHYSIOL-LONDON, V515, P631, DOI 10.1111/j.1469-7793.1999.631ab.x; Hill KG, 2003, PSYCHOPHARMACOLOGY, V169, P108, DOI 10.1007/s00213-003-1472-4; Ho BY, 1999, RECEPTOR CHANNEL, V6, P363; Ikeda K, 2000, NEUROSCI RES, V38, P113, DOI 10.1016/S0168-0102(00)00144-9; Ikeda K, 1997, MOL BRAIN RES, V45, P117, DOI 10.1016/S0169-328X(96)00252-5; Ikeda M, 2007, GENES BRAIN BEHAV, V6, P107, DOI 10.1111/j.1601-183X.2006.00237.x; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; LESAGE F, 1995, J BIOL CHEM, V270, P28660; Lotsch J, 2010, PHARMACOGENET GENOM, V20, P291, DOI 10.1097/FPC.0b013e3283386bda; Marker CL, 2002, NEUROREPORT, V13, P2509, DOI 10.1097/01.wnr.0000048541.12213.bb; Martikainen IK, 2004, NEUROSCI LETT, V361, P140, DOI 10.1016/j.neulet.2003.12.060; Moolchan ET, 2002, ADDICT BEHAV, V27, P101, DOI 10.1016/S0306-4603(00)00171-4; Morgan AD, 2003, NEUROPSYCHOPHARMACOL, V28, P932, DOI 10.1038/sj.npp.1300100; Nishizawa D, 2010, METHODS MOL BIOL, V617, P395, DOI 10.1007/978-1-60327-323-7_29; Nishizawa D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007060; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13; Perneger TV, 1998, BRIT MED J, V316, P1236; Rommelspacher H, 2001, ALCOHOL, V24, P129, DOI 10.1016/S0741-8329(01)00139-2; Sato N, 2010, J HUM GENET, V55, P755, DOI 10.1038/jhg.2010.108; Saugstad JA, 1996, J NEUROSCI, V16, P5979; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; SVRAKIC DM, 1993, ARCH GEN PSYCHIAT, V50, P991; Wickman K, 2000, J NEUROSCI, V20, P5608	61	3	3	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	NOV	2014	126	3					253	263		10.1254/jphs.14189FP		11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU4AQ	WOS:000345551900008		
J	Kanbara, T; Nakamura, A; Takasu, K; Ogawa, K; Shibasaki, M; Mori, T; Suzuki, T; Hasegawa, M; Sakaguchi, G; Kanemasa, T				Kanbara, Tomoe; Nakamura, Atsushi; Takasu, Keiko; Ogawa, Koichi; Shibasaki, Masahiro; Mori, Tomohisa; Suzuki, Tsutomu; Hasegawa, Minoru; Sakaguchi, Gaku; Kanemasa, Toshiyuki			The Contribution of Gi/o Protein to Opioid Antinociception in an Oxaliplatin-Induced Neuropathy Rat Model	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						opioid; antinociception; oxaliplatin; neuropathy; Gi/o protein	PAINFUL PERIPHERAL NEUROPATHY; ADVANCED COLORECTAL-CANCER; DIFFERENTIAL ACTIVATION; RECEPTOR AGONISTS; SPINAL-CORD; MORPHINE; OXYCODONE; NEUROTOXICITY; CHEMOTHERAPY; MOUSE	Oxaliplatin is a chemotherapeutic agent that induces chronic refractory neuropathy. To determine whether opioids effectively relieve this chronic neuropathy, we investigated the efficacies of morphine, oxycodone, and fentanyl, and the mechanisms underlying opioid antinociception, in oxaliplatin-induced neuropathy in rats. Rats exhibited significant mechanical allodynia following 2 weeks of chronic oxaliplatin administration. Within the range of doses that did not induce sedation and/or muscle rigidity, morphine (3 mg/kg, subcutaneously, s.c.) and oxycodone (0.3 - 0.56 mg/kg, s.c.) completely reversed oxaliplatin-induced mechanical allodynia, whereas fentanyl (0.017 - 0.03 mg/kg, s.c.) showed partial antinociception. The antinociception of the optimal doses of morphine and oxycodone were completely inhibited by pertussis toxin (PTX; 0.5 mu g/rat, i.c.v.), a Gi/o protein inhibitor, while the partial effect of fentanyl was not affected in the oxaliplatin model. In the [S-35]-GTP gamma S binding assay, activation of mu-opioid receptor by fentanyl, but not by morphine or oxycodone, in the mediodorsal thalamus was significantly reduced in oxaliplatin-treated rats. These results indicate that the lower antinociceptive potency of fentanyl in the oxaliplatin model might in part result from the loss of PTX-sensitive Gi/o protein activation, and the degree of Gi/o protein activation might be related to the potency of antinociception by opioids in this model.	[Kanbara, Tomoe; Nakamura, Atsushi; Takasu, Keiko; Ogawa, Koichi; Hasegawa, Minoru; Sakaguchi, Gaku; Kanemasa, Toshiyuki] Shionogi & Co Ltd, Discovery Res Labs, Pain & Neurol, Toyonaka, Osaka 5610825, Japan; [Kanbara, Tomoe; Nakamura, Atsushi; Shibasaki, Masahiro; Mori, Tomohisa; Suzuki, Tsutomu] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Toxicol, Shinagawa Ku, Tokyo 1428501, Japan	Kanemasa, T (reprint author), Shionogi & Co Ltd, Discovery Res Labs, Pain & Neurol, 1-1,3 Chome,Futaba Cho, Toyonaka, Osaka 5610825, Japan.	toshiyuki.kanemasa@shionogi.co.jp					Ali BH, 2010, BASIC CLIN PHARMACOL, V106, P272, DOI 10.1111/j.1742-7843.2009.00512.x; Hartmann JT, 2003, EXPERT OPIN PHARMACO, V4, P889, DOI 10.1517/14656566.4.6.889; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Madia PA, 2012, PHARMACOL BIOCHEM BE, V101, P155, DOI 10.1016/j.pbb.2011.11.001; Meyer L, 2011, PAIN, V152, P170, DOI 10.1016/j.pain.2010.10.015; Cavaletti G, 2001, EUR J CANCER, V37, P2457, DOI 10.1016/S0959-8049(01)00300-8; Sanchez-Blazquez P, 2001, BRAIN RES BULL, V54, P229, DOI 10.1016/S0361-9230(00)00448-2; Cascinu S, 2002, J CLIN ONCOL, V20, P3478, DOI 10.1200/JCO.2002.07.061; Saif MW, 2010, ANTICANCER RES, V30, P2927; Argyriou AA, 2007, ACTA ONCOL, V46, P1131, DOI 10.1080/02841860701355055; Pasetto LM, 2006, CRIT REV ONCOL HEMAT, V59, P159, DOI 10.1016/j.critrevonc.2006.01.001; Ling B, 2007, PAIN, V128, P225, DOI 10.1016/j.pain.2006.09.016; Krishnan AV, 2005, MUSCLE NERVE, V32, P51, DOI 10.1002/mus.20340; Nagashima M, 2014, SUPPORT CARE CANCER, V22, P1579, DOI 10.1007/s00520-014-2132-4; Xiao WH, 2012, NEUROSCIENCE, V203, P194, DOI 10.1016/j.neuroscience.2011.12.023; Saidak Z, 2006, BRIT J PHARMACOL, V147, P671, DOI 10.1038/sj.bjp.0706661; Ozaki S, 2003, NEUROSCIENCE, V116, P89, DOI 10.1016/S0306-4522(02)00699-1; Argyriou AA, 2008, CANCER TREAT REV, V34, P368, DOI 10.1016/j.ctrv.2008.01.003; Argyriou AA, 2013, CANCER-AM CANCER SOC, V119, P438, DOI 10.1002/cncr.27732; Sakurai M, 2009, PAIN, V147, P165, DOI 10.1016/j.pain.2009.09.003; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Ding Z, 2009, BRIT J PHARMACOL, V157, P831, DOI 10.1111/j.1476-5381.2009.00209.x; Extra JM, 1998, SEMIN ONCOL, V25, P13; Goode TL, 1997, LIFE SCI, V60, pPL107; Kanbara T, 2014, NEUROSCI LETT, V580, P119, DOI 10.1016/j.neulet.2014.08.005; Minami K, 2009, J PHARMACOL SCI, V111, P60, DOI 10.1254/jphs.09139FP; Nakamura Atsushi, 2011, J Pain Palliat Care Pharmacother, V25, P318, DOI 10.3109/15360288.2011.620689; Nakamura A, 2014, BRIT J PHARMACOL, V171, P253, DOI 10.1111/bph.12441; Nakamura A, 2013, BRIT J PHARMACOL, V168, P375, DOI 10.1111/j.1476-5381.2012.02139.x; Narita M, 1999, BRIT J PHARMACOL, V126, P451, DOI 10.1038/sj.bjp.0702330; Narita M, 2001, J NEUROSCI, V21, P3715; Paxinos G., 2006, RAT BRAIN STEREOTAXI; Renn CL, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-29; Sanchez-Blazquez P, 1999, J PHARMACOL EXP THER, V291, P12; Tseng LF, 1996, J PHARMACOL EXP THER, V279, P39; Zheng H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177089	36	1	1	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	NOV	2014	126	3					264	273		10.1254/jphs.14133FP		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU4AQ	WOS:000345551900009		
J	Ioroi, T; Akao, M; Iguchi, M; Kato, M; Kimura, T; Izumi, Y; Akaike, A; Kume, T				Ioroi, Tadaaki; Akao, Masaharu; Iguchi, Moritake; Kato, Masashi; Kimura, Takeshi; Izumi, Yasuhiko; Akaike, Akinori; Kume, Toshiaki			Serofendic Acid Protects Against Myocardial Ischemia-Reperfusion Injury in Rats	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						serofendic acid; myocardial ischemia; reperfusion; mitochondrial ATP-sensitive potassium channel; cardiac myocyte	SENSITIVE POTASSIUM CHANNELS; FETAL CALF SERUM; MITOCHONDRIAL PERMEABILITY TRANSITION; K-ATP CHANNEL; OXIDATIVE STRESS; CARDIAC MYOCYTES; DEATH PATHWAY; POSSIBLE MECHANISM; CELL-DEATH; CARDIOPROTECTION	We previously reported that serofendic acid, a lipophilic extract of fetal calf serum, protects against oxidative stress in primary culture of neonatal rat cardiomyocytes. However, the effect of serofendic acid on myocardial ischemia-reperfusion injury in vivo is yet to be determined. In the present study, we investigated the effect of intravenous administration of serofendic acid on ischemia-reperfusion injury induced by transient occlusion of the left coronary artery in rats. The rat heart was subjected to 25-min ischemia followed by 2-h reperfusion. Bolus intravenous administration of serofendic acid (1 - 10 mg/kg) given twice reduced the infarct volume in a dose-dependent manner. The protective effect of serofendic acid was abolished by pretreatment with 5-hydroxydecanoate, a blocker of mitochondrial ATP-sensitive potassium channels. For further testing of the protective effect of serofendic acid at the subcellular level, we monitored mitochondrial membrane potential (MMP) in individual cells using real-time two-photon imaging of Langendorff-perfused rat heart. A 25-mM no-flow ischemia, followed by reperfusion caused progressive MMP loss. Serofendic acid significantly reduced the number of cells undergoing MMP loss. These results suggest that serofendic acid protected cardiac myocytes against myocardial ischemia-reperfusion injury by preserving the functional integrity of mitochondria.	[Ioroi, Tadaaki; Izumi, Yasuhiko; Akaike, Akinori; Kume, Toshiaki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan; [Akao, Masaharu; Iguchi, Moritake; Kato, Masashi; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan; [Akao, Masaharu; Iguchi, Moritake] Natl Hosp Org Kyoto Med Ctr, Dept Cardiol, Fushimi Ku, Kyoto 6128555, Japan; [Akaike, Akinori] Nagoya Univ, Grad Sch Pharmaceut Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Kato, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	akao@kuhp.kyoto-u.ac.jp; tkume@pharm.kyoto-u.ac.jp			Ministry of Education, Culture, Sport, Science and Technology of Japan; Takeda Science Foundation; Kanae Foundation for the Promotion of Medical Science; Suzuken Memorial Foundation	This work was supported by research grants (Grants-in-Aid for Scientific Research) from the Ministry of Education, Culture, Sport, Science and Technology of Japan and grants from the Takeda Science Foundation, from the Kanae Foundation for the Promotion of Medical Science, and from the Suzuken Memorial Foundation.	Akao M, 2003, CIRC RES, V92, P195, DOI 10.1161/01.RES.0000051862.16691.F9; Akao M, 2007, CARDIOVASC DRUG REV, V25, P333; Liu YG, 1998, CIRCULATION, V97, P2463; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Osakada F, 2004, J PHARMACOL EXP THER, V311, P51, DOI 10.1124/jpet.104.070334; Matsumoto-Ida M, 2006, CIRCULATION, V114, P1497, DOI 10.1161/CIRCULATIONAHA.106.628834; Garlid KD, 1997, CIRC RES, V81, P1072; Murata M, 2001, CIRC RES, V89, P891, DOI 10.1161/hh2201.100205; O'Rourke B, 2004, CIRC RES, V94, P420, DOI 10.1161/01.RES.0000117583.66950.43; Mariot P, 1998, DIABETES, V47, P365, DOI 10.2337/diabetes.47.3.365; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Teshima Y, 2003, STROKE, V34, P1796, DOI 10.1161/01.STR.0000077017.60947.AE; Inserte J, 2009, CARDIOVASC RES, V83, P169, DOI 10.1093/cvr/cvp109; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Prasad A, 2009, CIRCULATION, V120, P2105, DOI 10.1161/CIRCULATIONAHA.108.814640; Hausenloy DJ, 2003, CARDIOVASC RES, V60, P617, DOI 10.1016/j.cardiores.2003.09.025; Fryer RM, 2000, AM J PHYSIOL-HEART C, V278, pH305; Murphy E, 2004, CIRC RES, V94, P7, DOI 10.1161/01.RES.0000108082.76667.F4; Akao M, 2002, J AM COLL CARDIOL, V40, P803, DOI 10.1016/S0735-1097(02)02007-7; Akao M, 2001, CIRC RES, V88, P1267, DOI 10.1161/hh1201.092094; O'Rourke B, 2000, CIRC RES, V87, P845; Kume T, 2002, P NATL ACAD SCI USA, V99, P3288, DOI 10.1073/pnas.052693999; Akao M, 2003, CIRC RES, V92, P186, DOI 10.1161/01.RES.0000051861.21316.E9; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; GROSS GJ, 1995, BASIC RES CARDIOL, V90, P85, DOI 10.1007/BF00789438; Kume T, 2005, NEUROSCI LETT, V383, P199, DOI 10.1016/j.neulet.2005.04.015; Kume T, 2006, EUR J PHARMACOL, V542, P69, DOI 10.1016/j.ejphar.2006.04.038; Miura T, 2000, J AM COLL CARDIOL, V35, P238, DOI 10.1016/S0735-1097(99)00493-3; PRATZ J, 1991, J PHARMACOL EXP THER, V258, P216; Taguchi R, 2003, EUR J PHARMACOL, V477, P195, DOI 10.1016/j.ejphar.2003.08.027; Takeda T, 2006, J AM COLL CARDIOL, V47, P1882, DOI 10.1016/j.jacc.2005.12.055; Tanno M, 2000, J CARDIOVASC PHARM, V35, P345, DOI 10.1097/00005344-200003000-00001; Teshima Y, 2003, BRAIN RES, V990, P45, DOI 10.1016/S0006-8993(03)03383-3; Wang YG, 2005, VASC PHARMACOL, V42, P253, DOI 10.1016/j.vph.2005.02.008; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	38	2	2	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	NOV	2014	126	3					274	280		10.1254/jphs.14139FP		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU4AQ	WOS:000345551900010		
J	Daikoku, T; Yoshida, Y; Okuda, T; Shiraki, K				Daikoku, Tohru; Yoshida, Yoshihiro; Okuda, Tomoko; Shiraki, Kimiyasu			Characterization of Susceptibility Variants of Influenza Virus Grown in the Presence of T-705	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						influenza virus; T-705; favipiravir	RNA-POLYMERASE; IN-VITRO; SUBUNIT; ACYCLOVIR; FAVIPIRAVIR; RESISTANCE; PB2	T-705 (favipiravir) is a potent inhibitor of RNA polymerases of influenza viruses. Susceptibility variants were isolated during passages in the presence of T-705. Nine variants with 0.4 to 2.1 times the 50% inhibitory concentration for plaque formation of the parent A/PR/8/34 (H1N1) strain had amino acid variations in the PB1, PB2, and PA genes of the RNA polymerase complex. However, the variation patterns in the RNA polymerase complex indicated that T-705 does not work as a mutagen, and resistant mutants were not isolated, possibly because a mutation leading to resistance would be lethal to the RNA polymerase function.	[Daikoku, Tohru; Yoshida, Yoshihiro; Okuda, Tomoko; Shiraki, Kimiyasu] Toyama Univ, Dept Virol, Toyama 9300194, Japan	Shiraki, K (reprint author), Toyama Univ, Dept Virol, 2630 Sugitani, Toyama 9300194, Japan.	kshiraki@med.u-toyama.ac.jp			Toyama Chemical Co.; Japan Society for the Promotion of Science [25293108, 25461508]	We thank Dr. Takehiro Himaki and Mrs. Miho Himaki for their helpful assistance and discussion and Ms. Katherine Ono for editing the manuscript. This work was partly supported by Toyama Chemical Co. and Grants-in-Aid (25293108, 25461508) from Japan Society for the Promotion of Science.	Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; Sangawa H, 2013, ANTIMICROB AGENTS CH, V57, P5202, DOI 10.1128/AAC.00649-13; Sasadeusz JJ, 1997, J VIROL, V71, P3872; Baranovich T, 2013, J VIROL, V87, P3741, DOI 10.1128/JVI.02346-12; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Boivin S, 2011, J BIOL CHEM, V286, P10439, DOI 10.1074/jbc.M110.182964; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198; Binh NT, 2014, BIOCHEM BIOPH RES CO, V443, P975, DOI 10.1016/j.bbrc.2013.12.071; Ida M, 1999, ANTIVIR RES, V40, P155, DOI 10.1016/S0166-3542(98)00057-6; Jin ZN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068347; Kamiyama T, 2001, J GEN VIROL, V82, P2761; Kurokawa M, 2010, ANTIVIR RES, V85, P373, DOI 10.1016/j.antiviral.2009.11.001	15	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	NOV	2014	126	3					281	284		10.1254/jphs.14156SC		4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU4AQ	WOS:000345551900011		
J	Kurokawa, K; Mizuno, K; Ohkuma, S				Kurokawa, Kazuhiro; Mizuno, Koji; Ohkuma, Seitaro			Increase of Type 2 Ryanodine Receptors in Mouse Nucleus Accumbens in the Development and Expression of Morphine-Induced Place Preference	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Type 2 ryanodine receptor; morphine; conditioned place preference	VENTRAL TEGMENTAL AREA; DOPAMINE D-1 RECEPTORS; CHANNELS; CA(V)1.3; DANTROLENE; PROJECTION; CALCIUM	The present study investigated the effect of ryanodine receptors (RyRs) in the development and expression of morphine-induced conditioned place preference (CPP). Type 2 RyRs (RyRs-2) in the nucleus accumbens (NAcc) significantly increased in morphine-conditioned mice, whereas type 1, 2, and 3 RyRs in the frontal cortex and ventral tegmental area showed no changes. Intracerebroventricular pretreatment with dantrolene, a RyRs antagonist, during the conditioning phase of CPP, dose-dependently inhibited morphine-induced CPP. The expression of morphine-induced CPP was abolished by dantrolene administration before the post-conditioning test. These findings suggest that RyRs-2 in the NAcc participate in the development and expression of morphine-induced CPP.	[Kurokawa, Kazuhiro; Mizuno, Koji; Ohkuma, Seitaro] Kawasaki Med Univ, Dept Pharmacol, Kurashiki, Okayama 7010192, Japan	Ohkuma, S (reprint author), Kawasaki Med Univ, Dept Pharmacol, Matsushima 577, Kurashiki, Okayama 7010192, Japan.	sohkuma@bcc.kawasaki-m.ac.jp			Kawasaki Medical University [25B-7]	This work was supported in part by a Research Project Grant from Kawasaki Medical University (25B-7). All authors declare that no conflict of interests in this study.	Shibasaki M, 2010, SYNAPSE, V64, P440, DOI 10.1002/syn.20745; Kim S, 2007, J BIOL CHEM, V282, P32877, DOI 10.1074/jbc.M701418200; Giordano TP, 2010, J NEUROSCI, V30, P17051, DOI 10.1523/JNEUROSCI.2255-10.2010; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237; Clements MA, 2013, J NEUROSCI, V33, P2697, DOI 10.1523/JNEUROSCI.4759-12.2013; Schierberl K, 2011, J NEUROSCI, V31, P13562, DOI 10.1523/JNEUROSCI.2315-11.2011; SHARP AH, 1993, J NEUROSCI, V13, P3051; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Kobayashi S, 2009, J AM COLL CARDIOL, V53, P1993, DOI 10.1016/j.jacc.2009.01.065; Kurokawa K, 2011, J PHARMACOL SCI, V117, P87, DOI 10.1254/jphs.11106FP; Kurokawa K, 2010, J NEUROCHEM, V115, P1206, DOI 10.1111/j.1471-4159.2010.07010.x; Narita M, 2010, ADDICT BIOL, V15, P434, DOI 10.1111/j.1369-1600.2010.00249.x; Shibasaki M, 2009, NEUROSCIENCE, V163, P731, DOI 10.1016/j.neuroscience.2009.07.017; Tarragon E, 2012, BEHAV BRAIN RES, V233, P554, DOI 10.1016/j.bbr.2012.05.046; Ziviani E, 2011, EMBO J, V30, P194, DOI 10.1038/emboj.2010.279	15	0	0	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	NOV	2014	126	3					285	290		10.1254/jphs.14147SC		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU4AQ	WOS:000345551900012		
J	Suzuki, M; Miyahara, T; Tokumoto, H; Hakamatsuka, T; Goda, Y; Ozeki, Y; Sasaki, N				Suzuki, Mariko; Miyahara, Taira; Tokumoto, Hiroko; Hakamatsuka, Takashi; Goda, Yukihiro; Ozeki, Yoshihiro; Sasaki, Nobuhiro			Transposon-mediated mutation of CYP76AD3 affects betalain synthesis and produces variegated flowers in four o'clock (Mirabilis jalapa)	JOURNAL OF PLANT PHYSIOLOGY			English	Article						Betalain; En/Spm (CACTA) transposable element; Four o'clock; Mirabilis jalapa	GENOME SEQUENCE; DOPA 4,5-DIOXYGENASE; COLOR INTENSITY; PLANT PIGMENTS; BIOSYNTHESIS; INHERITANCE; IDENTIFICATION; ANTHOCYANIN; EVOLUTION; GLUCOSE	The variegated flower colors of many plant species have been shown to result from the insertion or excision of transposable elements into genes that encode enzymes involved in anthocyanin synthesis. To date, however, it has not been established whether this phenomenon is responsible for the variegation produced by other pigments such as betalains. During betalain synthesis in red beet, the enzyme CYP76AD1 catalyzes the conversion of L-dihydroxyphenylalanine (DOPA) to cyclo-DOPA. RNA sequencing (RNA-seq) analysis indicated that the homologous gene in four o'clock (Mirabilis jalapa) is CYP76AD3. Here, we show that in four o'clock with red perianths, the CYP76AD3 gene consists of one intron and two exons; however, in a mutant with a perianth showing red variegation on a yellow background, a transposable element, dTmj1, had been excised from the intron. This is the first report that a transposition event affecting a gene encoding an enzyme for betalain synthesis can result in a variegated flower phenotype. (C) 2014 Elsevier GmbH. All rights reserved.	[Suzuki, Mariko; Miyahara, Taira; Ozeki, Yoshihiro; Sasaki, Nobuhiro] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Tokumoto, Hiroko; Hakamatsuka, Takashi] Natl Inst Hlth Sci, Div Pharmacognosy Phytochem & Narcot, Setagaya Ku, Tokyo 1588501, Japan; [Goda, Yukihiro] Natl Inst Hlth Sci, Div Drugs, Setagaya Ku, Tokyo 1588501, Japan	Ozeki, Y (reprint author), Tokyo Univ Agr & Technol, Fac Engn, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	ozeky@cc.tuat.ac.jp	Ozeki, Yoshihiro/C-2052-2013	Ozeki, Yoshihiro/0000-0002-3002-368X			Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Takahashi R, 2012, PLANT GENOME-US, V5, P62, DOI 10.3835/plantgenome2011.11.0028; Gandia-Herrero F, 2013, TRENDS PLANT SCI, V18, P334, DOI 10.1016/j.tplants.2013.01.003; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Hatlestad GJ, 2012, NAT GENET, V44, P816, DOI 10.1038/ng.2297; Strack D, 2003, PHYTOCHEMISTRY, V62, P247, DOI 10.1016/S0031-9422(02)00564-2; Clement JS, 1996, BOT ACTA, V109, P360; Iida S, 2004, ADV BIOPHYS, V38, P141, DOI 10.1016/S0065-227X(04)80136-9; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Nishizaki Y, 2013, PLANT CELL, V25, P4150, DOI 10.1105/tpc.113.113167; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; ENGELS JMM, 1975, EUPHYTICA, V24, P1, DOI 10.1007/BF00147161; Gandia-Herrero F., 2005, NATURE, V437, P344; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Kaul S, 2000, NATURE, V408, P796; Kiernan FP, 1926, J HERED, V17, P383; Momose M, 2013, BREEDING SCI, V63, P435, DOI 10.1270/jsbbs.63.435; Nelson O, 1988, PLANT TRANSPOSABLE E; Peterson T, 2013, METHODS MOL BIOL, V1057, P1, DOI 10.1007/978-1-62703-568-2; PIATTELLI M., 1965, PHYTOCHEM ISTRY, V4, P817, DOI 10.1016/S0031-9422(00)86258-5; Ping-Fang T., 2006, ACTA GENET SIN, V33, P765; Sasaki N, 2004, FEBS LETT, V568, P159, DOI 10.1016/j.febslet.2004.04.097; Sasaki N, 2009, PLANT CELL PHYSIOL, V50, P1012, DOI 10.1093/pcp/pcp053; Sasaki N, 2005, PLANT CELL PHYSL, V46, P671; Sasaki N, 2012, PLANT BIOTECHNOL-NAR, V29, P223, DOI 10.5511/plantbiotechnology.12.0120a; Sekiguchi H, 2010, J AGR FOOD CHEM, V58, P12504, DOI 10.1021/jf1030086; SPITTERS CJT, 1975, EUPHYTICA, V24, P323, DOI 10.1007/BF00028197; Yagi M, 2013, DNA RES	32	3	3	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0176-1617	1618-1328		J PLANT PHYSIOL	J. Plant Physiol.	NOV 1	2014	171	17					1586	1590		10.1016/j.jplph.2014.07.010		5	Plant Sciences	Plant Sciences	AU5FL	WOS:000345632500005		
J	Yamamoto, T; Yoshimatsu, H; Koshima, I				Yamamoto, Takumi; Yoshimatsu, Hidehiko; Koshima, Isao			Navigation lymphatic supermicrosurgery for iatrogenic lymphorrhea: Supermicrosurgical lymphaticolymphatic anastomosis and lymphaticovenular anastomosis under indocyanine green lymphography navigation	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Lymphorrhea; Indocyanine green (ICG); Cyst; Supermicrosurgery; Anastomosis; Lymphedema	LOWER-EXTREMITY LYMPHEDEMA; DERMAL BACKFLOW PATTERNS; ARTERIAL RECONSTRUCTION; SUBCLINICAL LYMPHEDEMA; MANAGEMENT; GROIN; FISTULAS	Background: Lymphorrhea can occur after surgical intervention to the lymphatic system. Most cases with lymphorrhea can be treated conservatively, but some cases are refractory to conservative treatments and require further surgical treatments. Methods: Eight patients developed inguinal lymphorrhea after surgical intervention in the groin region. Navigation lymphatic supermicrosurgery (NLS) was performed for the treatment of iatrogenic lymphorrhea refractory to conservative treatments. Lymphatic vessels ruptured in a lymphorrhea lesion were identified under intraoperative indocyanine green (ICG) lymphography navigation and were anastomosed to a recipient vessel; an intact lymphatic vessel or a vein was selected as a recipient. Feasibility and efficacy of the method were evaluated. Results: Among eight inguinal lymphorrhea patients, four patients with refractory lymphorrhea underwent NLS under local anesthesia. In all cases, a lymphatic vessel that caused an intractable lymphorrhea was successfully anastomosed to a recipient vessel (to an intact lymphatic vessel in one case, and to a venule in three cases), and the lymphorrhea was completely cured without lymphorrhea recurrence or lymphedema development. Treatment duration in NLS was significantly shorter than that in conservative treatments (5.0 +/- 2.4 vs. 30.0 +/- 8.1 days, P = 0.006). Conclusions: Intraoperative ICG lymphography helps a surgeon to find lymphatic vessels in and near a lymphorrhea lesion, which allows secure and easier treatment for an intractable lymphorrhea with preservation of lymph drainage function. (C) 2014 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Yamamoto, Takumi; Yoshimatsu, Hidehiko; Koshima, Isao] Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo 1138655, Japan; [Yamamoto, Takumi] Noda Hosp, Dept Plast Surg, Chiba, Japan	Yamamoto, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tyamamoto-tky@umin.ac.jp					Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P1541, DOI 10.1016/j.bjps.2011.05.025; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; ROBERTS JR, 1993, AM J SURG, V165, P341, DOI 10.1016/S0002-9610(05)80839-6; Yamamoto T, 2013, MICROSURG, V33, P130, DOI 10.1002/micr.22040; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P812, DOI 10.1016/j.bjps.2010.10.011; Campisi CC, 2013, CURR OPIN OTOLARYNGO, V21, P150, DOI 10.1097/MOO.0b013e32835e9d97; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; BAUMEISTER RG, 1990, PLAST RECONSTR SURG, V85, P64, DOI 10.1097/00006534-199001000-00012; Boccardo F, 2013, MICROSURGERY; KWAAN JHM, 1979, ARCH SURG-CHICAGO, V114, P1416; Twine CP, 2013, ANN VASC SURG, V27, P1207, DOI 10.1016/j.avsg.2013.01.003; Van den Brande P, 2012, ANN VASC SURG, V26, P833, DOI 10.1016/j.avsg.2012.02.009; Yamamoto T, 2013, ANN PLAS SURG, V71, P538, DOI 10.1097/SAP.0b013e318250f0a0; Yamamoto T, 2013, MICROSURGERY; Yamamoto T, 2013, J PLAST RECONSTR AES; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314E, DOI 10.1097/PRS.0b013e3182268da8; Yamamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059523; Yamamoto T, 2013, ANN PLAST SURG, V71, P59; Yamamoto T, 2012, ANN PLAST SURG; Yamamoto T, 2013, J VASC SURG VEN 0718; Yamamoto T, 2013, ANN PLAST SURG; Yamamoto T, 2013, PLAST RECONSTR SURG, V132, p472E, DOI 10.1097/PRS.0b013e31829acdd0	23	7	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	NOV	2014	67	11					1573	1579		10.1016/j.bjps.2014.06.007		7	Surgery	Surgery	AU3PY	WOS:000345527100029		
J	Yamamoto, T; Yamashita, M; Furuya, M; Hayashi, A; Koshima, I				Yamamoto, Takumi; Yamashita, Marie; Furuya, Megumi; Hayashi, Akitatsu; Koshima, Isao			Mono-canalization of adhered lymphatic vessels for lymphatic supermicrosurgery	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter							ANASTOMOSIS; LYMPHEDEMA		[Yamamoto, Takumi; Yamashita, Marie; Furuya, Megumi; Hayashi, Akitatsu; Koshima, Isao] Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138655, Japan	Yamamoto, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tyamamoto-tky@umin.ac.jp					Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Yamamoto T, 2013, MICROSURG, V33, P130, DOI 10.1002/micr.22040; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Yamamoto T, 2014, MICROSURGERY; Yamamoto T, 2014, MICROSURG, V34, P404, DOI 10.1002/micr.22215	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	NOV	2014	67	11					E291	E292		10.1016/j.bjps.2014.07.022		2	Surgery	Surgery	AU3PY	WOS:000345527100012		
J	Yamamoto, T; Gutierrez, JLA; Koshima, I				Yamamoto, Takumi; Gutierrez, Jose Luis Alvarado; Koshima, Isao			Incisionless osteotomy for contouring the skull: Pinhole osteo-chipping with irrigation for the esthetic treatment of a benign frontal osteoma	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter							OF-THE-LITERATURE		[Yamamoto, Takumi; Gutierrez, Jose Luis Alvarado; Koshima, Isao] Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Yamamoto, Takumi] Noda Hosp, Dept Plast Surg, Chiba, Japan	Yamamoto, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan.	tyamamoto-tky@umin.ac.jp					Viswanatha B, 2012, ACTA OTORHINOLARYNGO, V32, P202; Patel TR, 2004, PLAST RECONSTR SURG, V114, P648, DOI 10.1097/01.PRS.0000130935.83413.6B; Boffano P, 2012, J ORAL MAXIL SURG, V70, P1093, DOI 10.1016/j.joms.2011.05.006; Buch B, 2001, SADJ, V56, P242; Haddad FS, 1997, SURG NEUROL, V48, P143, DOI 10.1016/S0090-3019(96)00485-5	5	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	NOV	2014	67	11					E270	E272		10.1016/j.bjps.2014.05.056		3	Surgery	Surgery	AU3PY	WOS:000345527100003		
J	Yamashita, M; Yamamoto, T; Yamamoto, N; Furuya, M; Ishiura, R; Hayashi, A				Yamashita, Marie; Yamamoto, Takumi; Yamamoto, Nana; Furuya, Megumi; Ishiura, Ryohei; Hayashi, Akitatsu			Diascopic indocyanine green lymphography for deep lymphatic visualization	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter							LOWER-EXTREMITY LYMPHEDEMA; DERMAL BACKFLOW PATTERNS		[Yamashita, Marie; Yamamoto, Takumi; Furuya, Megumi; Ishiura, Ryohei; Hayashi, Akitatsu] Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Yamamoto, Nana] Toranomon Gen Hosp, Dept Plast Surg, Tokyo, Japan	Yamashita, M (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan.	tyamamoto-tky@umin.ac.jp					Yamamoto T, 2014, ANN PLAS SURG, V72, P67, DOI 10.1097/SAP.0b013e3182605580; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Yamamoto T, 2014, MICROSURG, V34, P23, DOI 10.1002/micr.22115; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314E, DOI 10.1097/PRS.0b013e3182268da8	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	NOV	2014	67	11					E293	E294		10.1016/j.bjps.2014.07.029		2	Surgery	Surgery	AU3PY	WOS:000345527100013		
J	Wakabayashi, I				Wakabayashi, Ichiro			Light-to-Moderate Alcohol Drinking Reduces the Impact of Obesity on the Risk of Diabetes Mellitus	JOURNAL OF STUDIES ON ALCOHOL AND DRUGS			English	Article							CORONARY-HEART-DISEASE; INSULIN SENSITIVITY; METABOLIC SYNDROME; INVERSE ASSOCIATION; JAPANESE MEN; CONSUMPTION; METAANALYSIS; WOMEN; HEMOGLOBIN; PREVALENCE	Objective: Light-to-moderate alcohol drinking has been shown to reduce the risk of type 2 diabetes, for which obesity is a primary risk factor. The aim of this study was to determine whether drinking alcohol influences the relationship between obesity and hyperglycemia. Method: The relationships of adiposity indices with hyperglycemia were compared among middle-aged Japanese men (N = 12,627) who were non-, light-to-moderate (<22 g ethanol/day), heavy (>= 22 and <44 g ethanol/day), and very heavy (>= 44 g ethanol/day) drinkers. Results: There were significant positive correlations of hemoglobin A1c with body mass index (BMI) and waist-to-height ratio (WHtR), which were significantly weaker in light-to-moderate and heavy drinkers than in nondrinkers but were not significantly different in very heavy drinkers compared with nondrinkers. Odds ratios (ORs) for hyperglycemia in subjects with versus those without high BMI or WHtR were significantly higher than reference level of 1.00 in all the drinker groups significantly lower in light-to-moderate and heavy drinkers compared with nondrinkers; however they were not significantly different in very heavy drinkers compared with nondrinkers. ORs of the interaction term consisting of alcohol drinking and high adiposity index were significantly lower than the reference level in the light-to-moderate and heavy drinkers (OR with 95% confidence interval: high BMI, 0.61 [0.41,0.91] in light-to-moderate drinkers and 0.64 [0.48, 0.85] in heavy drinkers; high WHtR, 0.57 [0.38, 0.85] in light-to-moderate drinkers and 0.66 [0.50, 0.88] in heavy drinkers) but were not significantly different from the reference level in very heavy drinkers (high BMI, 0.90 [0.65, 1.25]; high WHtR, 1.04 [0.74, 1.46]). Conclusions: The associations between obesity and hyperglycemia were weaker in light-to-moderate drinkers than in nondrinkers. Thus, light-to-moderate drinking may reduce the impact of obesity on the risk for diabetes.	Hyogo Coll Med, Dept Environm & Prevent Med, Nishinomiya, Hyogo 6638501, Japan	Wakabayashi, I (reprint author), Hyogo Coll Med, Dept Environm & Prevent Med, Mukogawa Cho 1-1, Nishinomiya, Hyogo 6638501, Japan.	wakabaya@hyo-med.ac.jp					American Diabetes Association, 2010, DIABETES CARE S1, V33, pS62, DOI DOI 10.2337/DC10-S062; Sekikawa A, 2000, J DIABETES COMPLICAT, V14, P78, DOI 10.1016/S1056-8727(00)00074-X; Yeomans MR, 2010, PHYSIOL BEHAV, V100, P82, DOI 10.1016/j.physbeh.2010.01.012; Chen CC, 2012, NUTR RES, V32, P24, DOI 10.1016/j.nutres.2011.11.004; McCarron P, 2001, PUBLIC HEALTH, V115, P12, DOI 10.1038/sj.ph.1900724; Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Harding AH, 2002, EUR J CLIN NUTR, V56, P882, DOI 10.1038/sj.ejcn.1601408; Neumann T, 2013, INT J ENV RES PUB HE, V10, P4186, DOI 10.3390/ijerph10094186; Gulliford MC, 2001, EUR J CLIN NUTR, V55, P615, DOI 10.1038/sj.ejcn.1601233; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Wakabayashi I, 2012, OBESITY FACTS, V5, P60, DOI 10.1159/000336067; Howard AA, 2004, ANN INTERN MED, V140, P211; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Huxley R, 2006, BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Caro JJ, 2002, DIABETES CARE, V25, P476, DOI 10.2337/diacare.25.3.476; Suter PM, 2005, CRIT REV CL LAB SCI, V42, P197, DOI 10.1080/10408360590913542; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Rimm EB, 1999, BRIT MED J, V319, P1523; Arai H, 2006, J ATHEROSCLER THROMB, V13, P202; Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; Beulens JWJ, 2008, EUR J CLIN NUTR, V62, P1098, DOI 10.1038/sj.ejcn.1602821; Bonnet F, 2012, DIABETOLOGIA, V55, P3228, DOI 10.1007/s00125-012-2701-3; Ho JE, 2003, STROKE, V34, P2812, DOI 10.1161/01.STR.0000102901.41780.5C; Hsieh SD, 2006, PREV MED, V42, P135, DOI 10.1016/j.ypmed.2005.08.007; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; Lieber CS, 2000, ANNU REV NUTR, V20, P395, DOI 10.1146/annurev.nutr.20.1.395; LIEBER CS, 1991, AM J CLIN NUTR, V54, P976; Paulson QX, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-14; SIMMONS D, 1990, DIABETIC MED, V7, P238; Matsuzawa Y, 2002, CIRC J, V66, P987; Wakabayashi I, 2011, OBESITY, V19, P1881, DOI 10.1038/oby.2011.132	32	1	1	ALCOHOL RES DOCUMENTATION INC CENT ALCOHOL STUD RUTGERS UNIV	PISCATAWAY	C/O DEIRDRE ENGLISH, 607 ALLISON RD, PISCATAWAY, NJ 08854-8001 USA	1937-1888	1938-4114		J STUD ALCOHOL DRUGS	J. Stud. Alcohol Drugs	NOV	2014	75	6					1032	1038				7	Substance Abuse; Psychology	Substance Abuse; Psychology	AU3WH	WOS:000345541000017		
J	Kawanaka, H; Akahoshi, T; Itoh, S; Iguchi, T; Harimoto, N; Uchiyama, H; Yoshizumi, T; Shirabe, K; Takenaka, K; Maehara, Y				Kawanaka, Hirofumi; Akahoshi, Tomohiko; Itoh, Shinji; Iguchi, Tomohiro; Harimoto, Norifumi; Uchiyama, Hideaki; Yoshizumi, Tomoharu; Shirabe, Ken; Takenaka, Kenji; Maehara, Yoshihiko			Optimizing Risk Stratification in Portal Vein Thrombosis after Splenectomy and its Primary Prophylaxis with Antithrombin III Concentrates and Danaparoid Sodium in Liver Cirrhosis with Portal Hypertension	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							LAPAROSCOPIC SPLENECTOMY; HYPERSPLENISM; ANTICOAGULATION; TRANSPLANTATION; GENERATION; COAGULOPATHY; DISORDERS; DISEASE; PLASMA; DRUGS	BACKGROUND: Decreased antithrombin III (ATIII) activity and large splenic vein diameter (SVD) are risk factors for portal vein thrombosis (PVT) after splenectomy in liver cirrhosis with portal hypertension. Antithrombin III concentrates can prevent PVT. This study was designed to stratify risks for PVT after splenectomy in cirrhotic patients and to develop prophylactic protocols for PVT. STUDY DESIGN: In 53 patients (testing cohort), the cutoff level of preoperative ATIII activity (<= 60%) was evaluated for administration of ATIII concentrates. Antithrombin III activity and SVD were re-evaluated as criteria for prophylaxis of PVT. In 57 patients (validation cohort), the risk stratification of PVT and prophylactic protocols were validated. RESULTS: In the testing cohort, 10 (19%) of 53 patients had PVT. Risk level of PVT was stratified and prophylactic protocols were developed. Patients at low risk (ATIII activity >= 70% and SVD <10 mm) were not treated; those at high risk (ATIII activity <70% or SVD >= 10 mm) received ATIII concentrates (1,500 U/day) for 3 days; and those at highest risk (SVD >= 15 mm) received ATIII concentrates for 3 days, followed by danaparoid sodium (2,500 U/day) for 14 days and warfarin. In the validation cohort, 0 of 14 low-risk and 2 of 32 high-risk patients had PVT. Although 8 of 11 patients at highest risk had temporary PVT, it disappeared within 3 months postoperatively. Finally, only 2 (3.5%) of 57 patients had PVT. CONCLUSIONS: Risk stratification of PVT after splenectomy and prophylaxis with ATIII concentrates and danaparoid sodium dramatically reduced the incidence of PVT. (C) 2014 by the American College of Surgeons	[Kawanaka, Hirofumi; Iguchi, Tomohiro; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Multidisciplinary Treatment, Fukuoka 8128582, Japan; [Kawanaka, Hirofumi; Akahoshi, Tomohiko; Itoh, Shinji; Iguchi, Tomohiro; Harimoto, Norifumi; Yoshizumi, Tomoharu; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Uchiyama, Hideaki; Takenaka, Kenji] Fukuoka City Hosp, Dept Surg, Fukuoka, Japan	Kawanaka, H (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Multidisciplinary Treatment, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	harrykw@v102.vaio.ne.jp					Akahoshi T, 2012, J GASTROEN HEPATOL, V27, P286, DOI 10.1111/j.1440-1746.2011.06870.x; Amitrano L, 2010, J CLIN GASTROENTEROL, V44, P448, DOI 10.1097/MCG.0b013e3181b3ab44; Tripodi A, 2009, GASTROENTEROLOGY, V137, P2105, DOI 10.1053/j.gastro.2009.08.045; Amitrano L, 2000, HEPATOLOGY, V31, P345, DOI 10.1002/hep.510310213; Delgado MG, 2012, CLIN GASTROENTEROL H, V10, P776, DOI 10.1016/j.cgh.2012.01.012; Senzolo M, 2012, J THROMB HAEMOST, V10, P1823, DOI 10.1111/j.1538-7836.2012.04824.x; Kawanaka H, 2010, ANN SURG, V251, P76, DOI 10.1097/SLA.0b013e3181bdf8ad; Tripodi A, 2006, HEPATOLOGY, V44, P440, DOI 10.1002/hep.21266; Shahani T, 2014, J THROMB HAEMOST, V12, P36, DOI 10.1111/jth.12412; Kinjo N, 2010, BRIT J SURG, V97, P910, DOI 10.1002/bjs.7002; Kawanaka H, 2009, J HEPATO-BILIARY-PAN, V16, P749, DOI 10.1007/s00534-009-0149-8; Amitrano L, 2004, J HEPATOL, V40, P736, DOI 10.1016/j.jhep.2004.01.001; Tripodi A, 2005, HEPATOLOGY, V41, P553, DOI 10.1002/hep.20569; Sugawara Y, 2000, J AM COLL SURGEONS, V190, P446, DOI 10.1016/S1072-7515(99)00294-X; Francoz C, 2005, GUT, V54, P691, DOI 10.1136/gut.2004.042796; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Gando S, 2006, AM J HEMATOL, V81, P907, DOI 10.1002/ajh.20969; Ikegami T, 2008, HEPATOL RES, V38, P1159, DOI 10.1111/j.1872-034X.2008.00384.x; Lisman T, 2013, J HEPATOL, V59, P358, DOI 10.1016/j.jhep.2013.03.027; Martinez M, 2014, HEPATOLOGY, V60, P425, DOI 10.1002/hep.26998; Pannach S, 2013, THROMB HAEMOSTASIS, V110, P626, DOI 10.1160/TH13-05-0407; Potze W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088390; Potze W, 2013, BRIT J HAEMATOL, V163, P666, DOI 10.1111/bjh.12593; Scherer R, 1997, INTENS CARE MED, V23, P1150, DOI 10.1007/s001340050472; Senzolo M, 2009, HPB, V11, P459, DOI 10.1111/j.1477-2574.2009.00079.x; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; Uehara H, 2009, SURG LAPARO ENDO PER, V19, P484, DOI 10.1097/SLE.0b013e3181bc3f90; Villa E, 2012, GASTROENTEROLOGY, V143, p[1253, e1]; Yoshida D, 2012, HEPATOL INT, V6, P657, DOI 10.1007/s12072-011-9315-6; Yoshizumi T, 2008, TRANSPL INT, V21, P833, DOI 10.1111/j.1432-2277.2008.00678.x	30	4	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	NOV	2014	219	5					865	874		10.1016/j.jamcollsurg.2014.07.939		10	Surgery	Surgery	AU2EM	WOS:000345429100006		
J	Harada, N; Ishizawa, T; Inoue, Y; Aoki, T; Sakamoto, Y; Hasegawa, K; Sugawara, Y; Tanaka, M; Fukayama, M; Kokudo, N				Harada, Nobuhiro; Ishizawa, Takeaki; Inoue, Yosuke; Aoki, Taku; Sakamoto, Yoshihiro; Hasegawa, Kiyoshi; Sugawara, Yasuhiko; Tanaka, Mariko; Fukayama, Masashi; Kokudo, Norihiro			Acoustic Radiation Force Impulse Imaging of the Pancreas for Estimation of Pathologic Fibrosis and Risk of Postoperative Pancreatic Fistula	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							PROSPECTIVE RANDOMIZED-TRIAL; ISGPF CLASSIFICATION SCHEME; DISTAL PANCREATECTOMY; PANCREATICOGASTROSTOMY RECONSTRUCTION; TRANSIENT ELASTOGRAPHY; NONINVASIVE ASSESSMENT; MULTIVARIATE-ANALYSIS; ANASTOMOTIC LEAK; FATTY PANCREAS; PANCREATICODUODENECTOMY	BACKGROUND: We sought to evaluate whether pancreatic elasticity, measured using acoustic radiation force impulse (ARFI) imaging, can determine the degree of pancreatic fibrosis and risk of pancreatic fistula (PF) in patients undergoing pancreatic resection. Although soft pancreatic texture is a reliable predictor of postoperative PF, noninvasive, quantitative methods of assessing pancreatic hardness have not been established. STUDY DESIGN: Shear wave velocity (SWV) of the pancreas was preoperatively measured by ARFI imaging in 62 patients undergoing pancreatic resection. Correlations of SWV with pathologic degree of fibrosis in the resected pancreas, exocrine function of the remnant pancreas, and the incidence of postoperative PF were determined. RESULTS: The SWV was positively correlated with the degree of pancreatic fibrosis (Spearman's rank correlation coefficient [rho] = 0.660, p < 0.001) and inversely correlated with postoperative amylase concentrations and daily output of pancreatic juice. The incidence of postoperative PF was significantly higher in the 32 patients with soft (SWV < 1.54 m/s) than in the 30 with hard (SWV >= 1.54 m/s) pancreata (63% vs 17%, p < 0.001). Multivariate analysis showed that a soft pancreas (SWV < 1.54 m/s) was an independent predictor of postoperative PF (odds ratio 38.3; 95% CI 5.82 to 445; p = 0.001). CONCLUSIONS: Pancreatic elasticity on preoperative ARFI imaging accurately reflected the pathologic degree of fibrosis and exocrine function of the pancreas, enabling surgeons to adopt appropriate surgical procedures according to the risk of postoperative PF in each patient undergoing pancreatic resection. (C) 2014 by the American College of Surgeons	[Harada, Nobuhiro; Ishizawa, Takeaki; Inoue, Yosuke; Aoki, Taku; Sakamoto, Yoshihiro; Hasegawa, Kiyoshi; Sugawara, Yasuhiko; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo 1138655, Japan; [Tanaka, Mariko; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1138655, Japan	Kokudo, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	KOKUDO-2SU@h.u-tokyo.ac.jp					Yashima Y, 2012, J GASTROENTEROL, V47, P427, DOI 10.1007/s00535-011-0491-x; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Friedrich-Rust M, 2012, ULTRASONICS, V52, P69, DOI 10.1016/j.ultras.2011.06.012; Akamatsu N, 2010, J HEPATO-BIL-PAN SCI, V17, P322, DOI 10.1007/s00534-009-0248-6; Diener MK, 2011, LANCET, V377, P1514, DOI 10.1016/S0140-6736(11)60237-7; Hamilton NA, 2012, ANN SURG, V255, P1037, DOI 10.1097/SLA.0b013e31825659ef; Pratt WB, 2008, WORLD J SURG, V32, P419, DOI 10.1007/s00268-007-9388-5; Kennedy EP, 2011, J HEPATO-BIL-PAN SCI, V18, P769, DOI 10.1007/s00534-011-0429-y; Vermehren J, 2012, LIVER INT, V32, P852, DOI 10.1111/j.1478-3231.2011.02736.x; Friedrich-Rust M, 2009, RADIOLOGY, V252, P595, DOI 10.1148/radiol.2523081928; Piscaglia F, 2014, EUR J RADIOL, V83, P450, DOI 10.1016/j.ejrad.2013.06.009; Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; Fahey BJ, 2005, ULTRASOUND MED BIOL, V31, P1185, DOI 10.1016/j.ultrasmedbio.2005.05.004; Pratt WB, 2007, ANN SURG, V245, P443, DOI 10.1097/01.sla.0000251708.70219.d2; Zhang P, 2013, HEPATOB PANCREAT DIS, V12, P165, DOI 10.1016/S1499-3872(13)60027-2; Lee TK, 2014, J ULTRAS MED, V33, P781, DOI 10.7863/ultra.33.5.781; Dong X, 2011, PANCREAS, V40, P222, DOI 10.1097/MPA.0b013e3181f82f3c; Guzman-Aroca F, 2012, EUR RADIOL, V22, P2525, DOI 10.1007/s00330-012-2505-3; Kawai M, 2011, J HEPATO-BIL-PAN SCI, V18, P601, DOI 10.1007/s00534-011-0373-x; Wada K, 2006, SURGERY, V139, P735, DOI 10.1016/j.surg.2005.11.001; Muscari F, 2006, SURGERY, V139, P591, DOI 10.1016/j.surg.005.08.012; Peng SY, 2007, ANN SURG, V245, P692, DOI 10.1097/01.sla.0000255588.50964.5d; Meng W, 2011, ULTRASOUND MED BIOL, V37, P1436, DOI 10.1016/j.ultrasmedbio.2011.05.022; Sledzianowski JF, 2005, SURGERY, V137, P180, DOI 10.1016/j.surg.2004.06.063; Poon RTP, 2007, ANN SURG, V246, P425, DOI 10.1097/SLA.0b013e3181492c28; Topal B, 2013, LANCET ONCOL, V14, P655, DOI 10.1016/S1470-2045(13)70126-8; Yamashita S, 2013, BRIT J SURG, V100, P1220, DOI 10.1002/bjs.9185; Toshima T, 2011, J GASTROENTEROL, V46, P705, DOI 10.1007/s00535-010-0365-7; Mathur A, 2007, ANN SURG, V246, P1058, DOI 10.1097/SLA.0b013e31814a6906; Fuks D, 2009, AM J SURG, V197, P702, DOI 10.1016/j.amjsurg.2008.03.004; Gaujoux S, 2010, SURGERY, V148, P15, DOI 10.1016/j.surg.2009.12.005; Mckay A, 2006, BRIT J SURG, V93, P929, DOI 10.1002/bjs.5407; Yang YM, 2005, WORLD J GASTROENTERO, V11, P2456; Yeh TS, 1997, J SURG RES, V67, P119, DOI 10.1006/jsre.1996.4974; D'Onofrio M, 2013, J ULTRAS MED, V32, P647; Hasegawa K, 2008, AM J SURG, V196, P3, DOI 10.1016/j.amjsurg.2007.05.050; Heng CAK, 2010, ANZ J SURG, V80, P619, DOI 10.1111/j.1445-2197.2010.05337.x; Ke S, 2013, SURGERY, V153, P743, DOI 10.1016/j.surg.2013.02.008; KLOPPEL G, 1991, PANCREAS, V6, P266, DOI 10.1097/00006676-199105000-00003; KONISHI T, 1995, ANN SURG, V221, P165, DOI 10.1097/00000658-199502000-00006; Mishra PK, 2011, DIGEST SURG, V28, P281, DOI 10.1159/000329584; Son CY, 2012, J GASTROEN HEPATOL, V27, P130, DOI 10.1111/j.1440-1746.2011.06814.x; Yeo CJ, 1997, ANN SURG, V226, P248, DOI 10.1097/00000658-199709000-00004; Yeo CJ, 1995, ANN SURG, V222, P588; Yoshioka R, 2010, WORLD J SURG, V34, P121, DOI 10.1007/s00268-009-0300-3	46	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	NOV	2014	219	5					887	U336		10.1016/j.jamcollsurg.2014.07.940		13	Surgery	Surgery	AU2EM	WOS:000345429100008		
J	Honda, M; Wakita, T; Onishi, Y; Nunobe, S; Hiki, N; Miura, A; Nishigori, T; Kusanagi, H; Yamamoto, T; Kobayashi, K; Boddy, A; Fukuhara, S				Honda, Michitaka; Wakita, Takafumi; Onishi, Yoshihiro; Nunobe, Souya; Hiki, Naoki; Miura, Akinori; Nishigori, Tatsuto; Kusanagi, Hiroshi; Yamamoto, Takatsugu; Kobayashi, Kenji; Boddy, Alexander; Fukuhara, Shunichi			Development and Validation of a Symptom Scale to Evaluate Postoperative Patients with Esophagogastric Cancer	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							QUALITY-OF-LIFE; EARLY GASTRIC-CANCER; PSYCHOMETRIC VALIDATION; FUNCTIONAL ASSESSMENT; QUESTIONNAIRE MODULE; ESOPHAGEAL CANCER; HEALTH SURVEY; GASTRECTOMY; RECONSTRUCTION; SURGERY	BACKGROUND: Postgastrectomy or esophagectomy symptoms can be a significant burden for patients. However, no standard scale for evaluating these symptoms has been established. We recently developed a postoperative symptom-specific scale. STUDY DESIGN: After a draft scale was prepared based on a pilot study, psychometric methods were used to assess its reliability and validity. This study involved specialized and multifaceted discussions by a team consisting of gastrointestinal surgeons, gastroenterologists, psychologists, and epidemiologic researchers. The draft questionnaire included 40 questions and 3 domains. A factor analysis was carried out to refine the items and subscale design. To assess the reliability, Cronbach's alpha and score distributions were estimated. To assess the criterion-related validity, the correlations with the Short Form (SF)-12, Gastrointestinal Symptom Rating Scale (GSRS), endoscopic findings, and nutritional indicators were analyzed. RESULTS: A total of 344 patients were enrolled in this study. In an exploratory factor analysis (principal factor method), the eigenvalue attenuation data showed 4 domains. The final scale, named the Esophagus and Stomach Surgery Symptom Scale (ES4), included 23 items and 4 domains; 7 items for cervico-thoracic symptoms, 6 for abdominal hypersensitivity symptoms, 4 for abdominal distention symptoms, and 6 items for systemic symptoms. Cronbach's alphas for these domains were 0.82, 0.81, 0.79, and 0.74, respectively. The scale scores were normally distributed, and there were significant associations with the endoscopic findings, nutritional indicators, the summary score of the SF-12, and the GSRS. CONCLUSIONS: The ES4 scale has high psychometric validity and can evaluate the profiles and severity of postoperative symptoms. This scale is applicable as an outcomes measure for various interventional studies on esophagogastric surgery aimed at alleviating postoperative symptoms. (C) 2014 by the American College of Surgeons	[Honda, Michitaka; Nunobe, Souya; Hiki, Naoki] Japanese Fdn Canc Res, Canc Inst Ariake Hosp, Gastroenterol Ctr, Dept Surg Gastroenterol, Tokyo 1358550, Japan; [Miura, Akinori] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Surg, Tokyo, Japan; [Yamamoto, Takatsugu] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan; [Kobayashi, Kenji] St Lukes MediLocus, Dept Gen Internal Med, Tokyo, Japan; [Wakita, Takafumi] Kansai Univ, Dept Sociol, Osaka, Japan; [Onishi, Yoshihiro] Inst Hlth Outcomes & Proc Evaluat Res I Hope Int, Kyoto, Japan; [Nishigori, Tatsuto] Tenri Hosp, Dept Surg, Nara, Japan; [Boddy, Alexander] Univ Hosp Leicester NHS Trust, Dept Surg, Leicester, Leics, England; [Kusanagi, Hiroshi] Kameda Med Ctr, Dept Surg, Chiba, Japan; [Fukuhara, Shunichi] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan; [Fukuhara, Shunichi] Fukushima Med Univ, Ctr Innovat Clin Res, Fukushima, Japan	Honda, M (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Ctr, Dept Gastroenterol Surg,Koto Ku, 3-10-6 Ariake, Tokyo 1358550, Japan.	michitakahonda@jfcr.or.jp	Boddy, Alex/B-6098-2014	Boddy, Alex/0000-0001-7243-0155			AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Kono K, 2003, AM J SURG, V185, P150, DOI 10.1016/S0002-9610(02)01211-4; Nunobe S, 2007, GASTRIC CANCER, V10, P167, DOI 10.1007/s10120-007-0434-7; Blazeby JM, 2004, EUR J CANCER, V40, P2260, DOI 10.1016/j.ejca.2004.05.023; Nunobe S, 2007, INT J CLIN ONCOL, V12, P433, DOI 10.1007/s10147-007-0706-6; Mine S, 2010, J AM COLL SURGEONS, V211, P628, DOI 10.1016/j.jamcollsurg.2010.07.003; Bonomi AE, 1996, QUAL LIFE RES, V5, P309, DOI 10.1007/BF00433915; CELLA DF, 1993, J CLIN ONCOL, V11, P570; Suzukamo Y, 2011, J CLIN EPIDEMIOL, V64, P301, DOI 10.1016/j.jclinepi.2010.04.017; Morita S, 2008, PSYCHO-ONCOL, V17, P474, DOI 10.1002/pon.1256; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Vickery CW, 2001, EUR J CANCER, V37, P966, DOI 10.1016/S0959-8049(00)00417-2; Blazeby JM, 2003, EUR J CANCER, V39, P1384, DOI 10.1016/S0959-8049(03)00270-3; Karanicolas PJ, 2013, ANN SURG, V257, P1039, DOI 10.1097/SLA.0b013e31828c4a19; Namikawa T, 2012, AM J SURG, V204, P203, DOI 10.1016/j.amjsurg.2011.09.035; Rumsfeld JS, 2013, CIRCULATION, V127, P2233, DOI 10.1161/CIR.0b013e3182949a2e; Nakamura M, 2011, J AM COLL SURGEONS, V213, P508, DOI 10.1016/j.jamcollsurg.2011.07.007; Blazeby JM, 2000, CANCER, V88, P1781; Hiki N, 2008, SURG ENDOSC, V22, P1729, DOI 10.1007/s00464-007-9696-8; Strong V, 2013, WORLD J SURG, V37, P1773, DOI 10.1007/s00268-013-2070-1; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; EYPASCH E, 1995, BRIT J SURG, V82, P216, DOI 10.1002/bjs.1800820229; Health USDo Human Services FDACfDE Research, 2006, HEALTH QUAL LIFE OUT, V4, P79; Miyoshi K, 2001, Gastric Cancer, V4, P156, DOI 10.1007/PL00011739; Nakamura M, 2008, J CLIN NURS, V17, P1440, DOI 10.1111/j.1365-2702.2007.02179.x; SIGSTAD H, 1970, Acta Medica Scandinavica, V188, P479; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Ukleja Andrew, 2005, Nutr Clin Pract, V20, P517, DOI 10.1177/0115426505020005517; Wang H, 2011, QUAL LIFE RES, V20, P179, DOI 10.1007/s11136-010-9742-1; Wyrwich KW, 2013, QUAL LIFE RES, V22, P475, DOI 10.1007/s11136-012-0175-x	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	NOV	2014	219	5					895	903		10.1016/j.jamcollsurg.2014.05.017		9	Surgery	Surgery	AU2EM	WOS:000345429100009		
J	Chei, CL; Raman, P; Yin, ZX; Shi, XM; Zeng, Y; Matchar, DB				Chei, Choy-Lye; Raman, Prassanna; Yin, Zhao-Xue; Shi, Xiao-Ming; Zeng, Yi; Matchar, David B.			Vitamin D Levels and Cognition in Elderly Adults in China	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						vitamin D; cognition; elderly; oldest old; China	OLDER-ADULTS; D DEFICIENCY; IMPAIRMENT; ASSOCIATION; DEMENTIA; RISK; POPULATION; DECLINE	ObjectivesTo evaluate the association between vitamin D level and cognitive impairment in individuals aged 60 and older. DesignCross-sectional cohort study. SettingChinese Longitudinal Healthy Longevity Survey, a community-based cohort study in areas in China where the density of centenarians is exceptionally high. ParticipantsIndividuals with mean age of 84.912.7 (N=2,004). MeasurementsParticipants' cognitive state was evaluated using the Mini-Mental State Examination (MMSE). Vitamin D was measured in plasma using an enzyme-linked immunoassay. ResultsThe cross-sectional association between quartiles of plasma vitamin D level and cognitive impairment (MMSE score <18) was modeled using logistic regressions. Plasma vitamin D levels were lower in individuals with cognitive impairment (31.9 +/- 15.3nmol/L) than in those without (45.6 +/- 19.6nmol/L). There was a reverse association between plasma vitamin D and cognitive impairment. After adjusting for age, sex, chronic conditions, smoking and drinking habits, outdoor activities, depression, and activity of daily living limitations, the association remained significant. The multivariable-adjusted odds ratio for lowest versus highest vitamin D levels was 2.15 (95% confidence interval (CI)=1.05-4.41) for cognitive impairment, and the multivariable odds ratio associated with a 1-standard deviation decrement in plasma vitamin D was 1.32 (95% CI=1.00-1.74) for cognitive impairment. ConclusionLow plasma vitamin D levels were associated with greater odds of cognitive impairment. Further prospective studies in Asian populations are needed to examine the causal direction of this association.	[Chei, Choy-Lye; Raman, Prassanna; Matchar, David B.] Duke NUS Grad Med Sch Singapore, Singapore 169857, Singapore; [Chei, Choy-Lye] Univ Tsukuba, Fac Med, Dept Publ Hlth Med, Tsukuba, Ibaraki, Japan; [Yin, Zhao-Xue; Shi, Xiao-Ming] Chinese Ctr Dis Control & Prevent, Div Noncommunicable Dis Control & Community Hlth, Beijing, Peoples R China; [Zeng, Yi] Duke Univ, Sch Med, Ctr Study Aging & Human Dev, Durham, NC USA; [Zeng, Yi] Duke Univ, Sch Med, Div Geriatr, Durham, NC USA; [Zeng, Yi] Peking Univ, Natl Sch Dev, Ctr Study Hlth Aging & Dev Studies, Beijing 100871, Peoples R China; [Matchar, David B.] Duke Univ, Sch Med, Ctr Clin Hlth Policy Res, Durham, NC USA; [Matchar, David B.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	Matchar, DB (reprint author), Duke NUS Grad Med Sch Singapore, Program Hlth Serv & Syst Res, 8 Coll Rd, Singapore 169857, Singapore.	david.matchar@duke-nus.edu.sg			National Medical Research Council (NMRC); Singapore Ministry of Health NMRC under STaR Award Grant as part of the project Establishing a Practical and Theoretical Foundation for Comprehensive and Integrated Community, Policy and Academic Efforts to Improve Dementia Care in Singapore [NMRC/STaR/0005/2009]; National Institute of Aging, National Institute of Health [RO1AG023627]; National Natural Science Foundation of China [81273160]	We would like to thank the National Medical Research Council (NMRC) for funding part of the research, and we are grateful to those who assisted in the data collection in China. This research was supported by the Singapore Ministry of Health NMRC under its STaR Award Grant as part of the project Establishing a Practical and Theoretical Foundation for Comprehensive and Integrated Community, Policy and Academic Efforts to Improve Dementia Care in Singapore (NMRC/STaR/0005/2009). The research is also supported by the National Institute of Aging, National Institute of Health (RO1AG023627), and the National Natural Science Foundation of China (81273160).	Annweiler C, 2010, NEUROLOGY, V74, P27, DOI 10.1212/WNL.0b013e3181beecd3; Kalueff AV, 2004, BIOCHEMISTRY-MOSCOW+, V69, P738, DOI 10.1023/B:BIRY.0000040196.65686.2f; Llewellyn DJ, 2009, J GERIATR PSYCH NEUR, V22, P188, DOI 10.1177/0891988708327888; Llewellyn DJ, 2011, J GERONTOL A-BIOL, V66, P59, DOI 10.1093/gerona/glq185; Dickens AP, 2011, CNS DRUGS, V25, P629, DOI 10.2165/11593080-000000000-00000; Llewellyn DJ, 2010, ARCH INTERN MED, V170, P1135, DOI 10.1001/archinternmed.2010.173; Slinin Y, 2012, J GERONTOL A-BIOL, V67, P1092, DOI 10.1093/gerona/gls075; Peterson A, 2012, J NUTR HEALTH AGING, V16, P898, DOI 10.1007/s12603-012-0378-4; Przybelski RJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P202, DOI 10.1016/j.abb.2006.12.018; Schottker B, 2013, EUR J EPIDEMIOL, V28, P267, DOI 10.1007/s10654-013-9769-z; van der Schaft J, 2013, AGEING RES REV, V12, P1013, DOI 10.1016/j.arr.2013.05.004; ZHANG MY, 1990, ANN NEUROL, V27, P428, DOI 10.1002/ana.410270412; Breitling LP, 2012, EXP GERONTOL, V47, P122, DOI 10.1016/j.exger.2011.11.004; Annweiler C, 2012, EUR J NEUROL, V19, P1023, DOI 10.1111/j.1468-1331.2012.03675.x; Tsiaras WG, 2011, ACTA DERM-VENEREOL, V91, P115, DOI 10.2340/00015555-0980; Levey AS, 1999, ANN INTERN MED, V130, P461; Forman JP, 2005, HYPERTENSION, V46, P676, DOI 10.1161/01.HYP.0000182662.82666.37; Etgen T, 2012, DEMENT GERIATR COGN, V33, P297, DOI 10.1159/000339702; Wilkins CH, 2006, AM J GERIAT PSYCHIAT, V14, P1032, DOI 10.1097/01.JGP.0000240986.74642.7c; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Chan R, 2011, J AFFECT DISORDERS, V130, P251, DOI 10.1016/j.jad.2010.10.029; van Schoor NM, 2011, BEST PRACT RES CL EN, V25, P671, DOI 10.1016/j.beem.2011.06.007; Sun Q, 2012, STROKE, V43, P1470, DOI 10.1161/STROKEAHA.111.636910; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gu D, 2002, HLTH LONGEVITY CHINA, P35; Huang CQ, 2009, DEMENT GERIATR COGN, V27, P111, DOI 10.1159/000194660; Li LW, 2009, SOC SCI MED, V68, P220, DOI 10.1016/j.socscimed.2008.10.013; Mayeux R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006239; Okuno Junko, 2013, Nihon Ronen Igakkai Zasshi, V50, P515; Yin ZX, 2012, AGE AGEING, V41, P600, DOI 10.1093/ageing/afs033	30	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	NOV	2014	62	11					2125	2129		10.1111/jgs.13082		5	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	AU3GO	WOS:000345500700013		
J	Kuniaki, O; Kiyotaka, O; Sachiko, O; Junko, S; Takashi, Y; Yuko, T; Ayako, K; Kazuki, K; Germaine, C				Kuniaki, Otsuka; Kiyotaka, Okajima; Sachiko, Oinuma; Junko, Sasaki; Takashi, Yamanaka; Yuko, Takahashi; Ayako, Kokaji; Kazuki, Kitamura; Germaine, Cornelissen			AGING AND CIRCADIAN DISRUPTION OF BLOOD PRESSURE OBSERVED USING 7-DAY/24-HOUR AMBULATORY BLOOD PRESSURE MONITORING	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter									[Kuniaki, Otsuka; Kiyotaka, Okajima] Tokyo Womens Med Univ, Dept Chron & Gerontol, Med Ctr East, Arakawa Ku, Tokyo, Japan; [Sachiko, Oinuma; Junko, Sasaki] Tokyo Womens Med Univ, Dept Home Med Care, Med Ctr East, Arakawa Ku, Tokyo, Japan; [Takashi, Yamanaka] Univ Tokyo, Ctr Home Care Med, Bunkyo Ku, Tokyo, Japan; [Yuko, Takahashi; Ayako, Kokaji; Kazuki, Kitamura] Hlth & Welf Ctr, Tosa Dist, Japan; [Germaine, Cornelissen] Univ Minnesota, Halberg Chronobiol Ctr, Minneapolis, MN USA	Kuniaki, O (reprint author), Tokyo Womens Med Univ, Dept Chron & Gerontol, Med Ctr East, Arakawa Ku, Tokyo, Japan.						Richards J, 2013, AM J PHYSIOL-REG I, V304, pR1053, DOI 10.1152/ajpregu.00066.2013; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; BINGHAM C, 1982, CHRONOBIOLOGIA, V9, P397; Cornelissen G, 1997, J MED ENG TECHNOL, V21, P111; Halberg F, 1982, HORMONES DEV AGING, P451; Halberg F, 2013, AM J PHYSIOL-HEART C, V305, pH279, DOI 10.1152/ajpheart.00212.2013; Otsuka K, 2004, BIOMED PHARMACOTHER, V58, pS48, DOI 10.1016/S0753-3322(04)80010-6; Saito K, 1994, RECENT ADV TIME SERI; Seven-day Otsuka K., 2009, JPN J GERIATR, V46, P488; Watanabe Y, 2013, CLIN EXP HYPERTENS, V35, P257, DOI 10.3109/10641963.2013.780073	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	NOV	2014	62	11					2213	2215		10.1111/jgs.13115		3	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	AU3GO	WOS:000345500700031		
J	Ithnin, AM; Noge, H; Kadir, HA; Jazair, W				Ithnin, Ahmad Muhsin; Noge, Hirofumi; Kadir, Hasannuddin Abdul; Jazair, Wira			An overview of utilizing water-in-diesel emulsion fuel in diesel engine and its potential research study	JOURNAL OF THE ENERGY INSTITUTE			English	Article						Combustion efficiency; Diesel engine; Exhaust gas emission; Micro-explosion; Water-in-diesel emulsion fuel	MICRO-EXPLOSION; OIL EMULSION; EMISSION CHARACTERISTICS; 3-PHASE EMULSIONS; PERFORMANCE; COMBUSTION; DROPLETS; EMULSIFICATION; PRESSURE; IGNITION	The need for more efficient energy usage and a less polluted environment are the prominent research areas that are currently being investigated by many researchers worldwide. Water-in-diesel emulsion fuel (W/D) is a promising alternative fuel that could fulfills such requests in that it can improve the combustion efficiency of a diesel engine and reduce harmful exhaust emission, especially nitrogen oxides (NOx) and particulate matter (PM). To date, there have been many W/D emulsion fuel studies, especially regarding performance, emissions and micro-explosion phenomena. This review paper gathers and discusses the recent advances in emulsion fuel studies in respect of the impact of W/D emulsion fuel on the performance and emission of diesel engines, micro-explosion phenomena especially the factors that affecting the onset and strength of micro-explosion process, and proposed potential research area in W/D emulsion fuel study. There is an inconsistency in the results reported from previous studies especially for the thermal efficiency, brake power, torque and specific fuel consumption. However, it is agreed by most of the studies that W/D does result in an improvement in these measurements when the total amount of diesel fuel in the emulsion is compared with that of the neat diesel fuel. NOx and PM exhaust gas emissions are greatly reduced by using the W/D emulsion fuel. Unburnt hydrocarbon (UHC) and carbon monoxide (CO) exhaust emissions are found to be increased by using the W/D emulsion fuel. The inconsistency of the experimental result can be related to the effects of the onset and the strength of the micro-explosion process. The factors that affect these measurements consist of the size of the dispersed water particle, droplet size of the emulsion, water-content in the emulsion, ambient temperature, ambient pressure, type and percentage of surfactant, type of diesel engine and engine operating conditions. Durability testing and developing the fuel production device that requires no/less surfactant are the potential research area that can be explored in future. (C) 2014 Energy Institute. Published by Elsevier Ltd. All rights reserved.	[Ithnin, Ahmad Muhsin] Univ Teknol Malaysia, Kuala Lumpur 54100, Malaysia; [Noge, Hirofumi] Maizuru Natl Coll Technol, Maizuru, Kyoto 6258511, Japan; [Kadir, Hasannuddin Abdul] Univ Teknol Malaysia, Johor Baharu 81310, Johor, Malaysia; [Jazair, Wira] Univ Teknol Malaysia, Malaysia Japan Int Inst Technol, Kuala Lumpur 54100, Malaysia	Jazair, W (reprint author), Univ Teknol Malaysia, Malaysia Japan Int Inst Technol, Int Campus,Jalan Semarak, Kuala Lumpur 54100, Malaysia.	muhsinsk8@yahoo.com.my; noge@maizuru-ct.ac.jp; hasannuddinabdkadir@gmail.com; wira@ic.utm.my			Malaysia-Japan International Institute of Technology (MJIIT), UniversitiTeknologi Malaysia (UTM)	The authors would like to express their gratitude to the Malaysia-Japan International Institute of Technology (MJIIT), UniversitiTeknologi Malaysia (UTM) for the financial support.	Abu-Zaid M, 2004, HEAT MASS TRANSFER, V40, P737, DOI 10.1007/s00231-003-0473-5; AHMAD I, 1994, J PROPUL POWER, V10, P744, DOI 10.2514/3.23789; Tan TW, 2010, BIOTECHNOL ADV, V28, P628, DOI 10.1016/j.biotechadv.2010.05.012; Lif A, 2006, ADV COLLOID INTERFAC, V123, P231, DOI 10.1016/j.cis.2006.05.004; Srivastava A, 2000, RENEW SUST ENERG REV, V4, P111, DOI 10.1016/S1364-0321(99)00013-1; Jegannathan KR, 2008, CRIT REV BIOTECHNOL, V28, P253, DOI 10.1080/07388550802428392 ; Basha JS, 2011, INT J GREEN ENERGY, V8, P332, DOI 10.1080/15435075.2011.557844; Kadota T, 2002, PROG ENERG COMBUST, V28, P385, DOI 10.1016/S0360-1285(02)00005-9; Zeng YB, 2007, P COMBUST INST, V31, P2185, DOI 10.1016/j.proci.2006.07.237; Lin CY, 2003, FUEL, V82, P1367, DOI 10.1016/S0016-2361(03)00021-8; Mura E, 2010, ATOMIZATION SPRAY, V20, P791, DOI 10.1615/AtomizSpr.v20.i9.40; Maiboom A, 2011, FUEL, V90, P3179, DOI 10.1016/j.fuel.2011.06.014; Ghojel JI, 2010, ENERG FUEL, V24, P3860, DOI 10.1021/ef1001875; Abu-Zaid M, 2004, ENERG CONVERS MANAGE, V45, P697, DOI 10.1016/S0196-8904(03)00179-1; Watanabe H, 2010, ENERGY, V35, P806, DOI 10.1016/j.energy.2009.08.021; Fahd MEA, 2013, APPL ENERG, V102, P1042, DOI 10.1016/j.apenergy.2012.06.041; Morozumi Y, 2010, ENERG FUEL, V24, P1854, DOI 10.1021/ef9014026; Lif A, 2010, COLLOID SURFACE A, V354, P91, DOI 10.1016/j.colsurfa.2009.08.020; Attia AMA, 2014, FUEL, V116, P703, DOI 10.1016/j.fuel.2013.08.057; Nadeem M, 2006, FUEL, V85, P2111, DOI 10.1016/j.fuel.2006.03.013; Alahmer A, 2010, ENERG CONVERS MANAGE, V51, P1708, DOI 10.1016/j.enconman.2009.11.044; Mura E, 2012, EXP THERM FLUID SCI, V43, P63, DOI 10.1016/j.expthermflusci.2012.03.027; Tauzia X, 2010, ENERGY, V35, P3628, DOI 10.1016/j.energy.2010.05.007; Kumar MS, 2006, FUEL, V85, P2646, DOI 10.1016/j.fuel.2006.05.023; Subramanian KA, 2011, ENERG CONVERS MANAGE, V52, P849, DOI 10.1016/j.enconman.2010.08.010; ANTONOV VN, 1983, CHEM TECH FUELS OIL+, V19, P606, DOI 10.1007/BF00730207; Ballester JM, 1996, FUEL, V75, P695, DOI 10.1016/0016-2361(95)00309-6; Barker T, 2007, CLIMATE CHANGE 2007, P12; Barnes A., 2000, 20000119 SAE; Bedford F., 2000, 20000129 SAE, P1; Belkadi A, 2013, HOUILLE BLANCHE, P52, DOI 10.1051/lhb/2013016; Bertola A., 2003, 20030131 SAE; Cemenska R.A., 1999, FUEL EMULSION BLENDI; Chen LJ, 1997, COLLOID SURFACE A, V122, P161, DOI 10.1016/S0927-7757(96)03851-4; Christensen M., 1999, 19990101 SAE; Coon C.W., 1981, 810250 SAE, P21; Cui X., 2009, 20090126 SAE; De Vita A, 1989, 890450 SAE; Dec J. E., 1997, 970873 SAE, DOI [10.4271/970873., DOI 10.4271/970873]; Dryer FL, 1976, S INT COMBUST, V16, P279; Duffy K.P., 1998, 982460 SAE; Farfaletti A, 2005, ENVIRON SCI TECHNOL, V39, P6792, DOI 10.1021/es048345v; Fu WB, 2002, FUEL PROCESS TECHNOL, V79, P107, DOI 10.1016/S0378-3820(02)00106-6; Fuchihata M., 2000, T JPN SOC MECH ENG-B, V66, P1544; Ganesan S., 2001, 20012800 SAE, P223; Hagos FY, 2011, COMMUN SOFTW NETWORK, P314; Henningsen S., 1994, 941783 SAE; Heywood J.B., 1988, INTERNAL COMBUSTION; Hsu B.D., 1986, 860300 SAE; Ivanov V.M., 1965, NASA TECH TRANSL; Jazair W, 2011, J MEK, P32; Jeong IC, 2008, INT J AUTO TECH-KOR, V9, P735, DOI 10.1007/s12239-008-0087-5; Jiao J., 2003, AAPS PHARMSCI, V5, P62, DOI 10.1208/ps050107; Kessler A., 1996, EMULSION FUEL FEEDIN; Koc A.B., 2012, FUEL PROCESS TECHNOL, V109, P70; Kumar M.S., 2005, 20050117 SAE; Kumar M.S., 2009, J POWER ENERGY, V223, P729; Kumar N, 2004, 280040 SAE; Kunz G., 1990, METHOD APPARATUS PRO; Lemenand T, 2014, INT J HEAT MASS TRAN, V71, P228, DOI 10.1016/j.ijheatmasstransfer.2013.12.015; Lin CY, 2004, FUEL, V83, P537, DOI 10.1016/j.fuel.2003.08.012; Miyauchi T., 1981, S INT COMBUSTION, V18, P43, DOI 10.1016/S0082-0784(81)80009-4; Mukerjee P., 1971, NATL STAND REF DATA, V36; Mura E., 2013, EXP THERM F IN PRESS; Murayama T., 1979, 780224 SAE; Nazha M.A.A., 2001, 20010119 SAE; Nazha M.A.A., 1984, S COMBUST, P2001; Noge H., 2012, INT C ADV ENG CIV EN, P160; Ocampo-Barrera R, 2001, COMBUST FLAME, V126, P1845, DOI 10.1016/S0010-2180(01)00295-4; Ochoterena R, 2010, FUEL, V89, P122, DOI 10.1016/j.fuel.2009.06.039; Park J.-K., 2012, T KOREAN SOC MECH B, V36, P945; Park J.W., 2000, 2000 FISITA WORLD AU, P1; Park K, 2004, KSME INT J, V18, P2049; Psota M., 1997, 971657 SAE; Schramm J., 2003, 20030131 SAE; Selim M.Y.E., 2007, 20072401 SAE; Selim MYE, 2001, APPL THERM ENG, V21, P1565, DOI 10.1016/S1359-4311(01)00019-9; Selim MYE, 2010, ENERG SOURCE PART A, V32, P256, DOI 10.1080/15567030802467621; Sheng H, 1995, 950855 SAE; Sherman P., 1983, ENCY EMULSION TECHNO; Shimada, 1993, EMULSION FUEL ENGINE; So M.S., 2005, ENERG FUEL, V19, P1468; Solomon S, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P19; Subramanian K.A., 2001, 20010102 SAE; Subramanian K.A., 2008, 20080106 SAE; Tanaka H, 2006, JSME INT J B-FLUID T, V49, P1345, DOI 10.1299/jsmeb.49.1345; Tarlet D, 2009, INT J THERM SCI, V48, P449, DOI 10.1016/j.ijthermalsci.2008.05.005; Taylor P., 1983, COMBUST SCI TECHNOL, V33, P299; Transfer H., 1996, INT COMMUN HEAT MASS, V23, P823; Tsue M, 1998, TWENTY-SEVENTH SYMPOSIUM (INTERNATIONAL) ON COMBUSTION, VOLS 1 AND 2, P2587; Tsukahara M., 1989, 891841 SAE; Tzirakis E., 2006, 20060133 SAE; Udayakumar R., 2003, 20030102 SAE; Ulrich A., 1992, METHOD APPARATUS PRO; Watanabe H, 2010, COMBUST FLAME, V157, P839, DOI 10.1016/j.combustflame.2010.01.013; Yang WM, 2013, APPL ENERGY; Yoshimoto Y., 1996, 962022 SAE, V163-171	97	7	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1743-9671	1746-0220		J ENERGY INST	J. Energy Inst.	NOV	2014	87	4					273	288		10.1016/j.joei.2014.04.002		16	Energy & Fuels	Energy & Fuels	AU2ZB	WOS:000345481800001		
J	Fujimoto, H; Miyayama, T; Sanada, N; Adachi, C				Fujimoto, Hiroshi; Miyayama, Takuya; Sanada, Noriaki; Adachi, Chihaya			Origin of external quantum efficiency degradation in organic light-emitting diodes with a DC magnetron sputtered cathode	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							INDIUM TIN OXIDE; BUFFER LAYER; AL CATHODE; DEVICES; DEPOSITION; ELECTRODES; OLEDS; FILMS; ANODE	This paper characterizes changes in organic light-emitting diodes to better understand the origin of the decrease in external quantum efficiency (eta(ext)) when switching the cathode deposition method from evaporation to DC magnetron sputtering. An increase of driving voltage and a hole-barrier-dependent decrease of eta(ext) when the Al cathode is sputtered suggest that disruption of carrier balance and penetration of holes from the emissive layer (EML) into the electron transport layer (ETL) are significant sources of the device degradation. When the ETL was doped with Li, degradation was suppressed and the increase in driving voltage was drastically reduced although eta(ext) still decreased by 5%-7%. Analysis of the films by time-of-flight secondary ion mass spectrometry indicates that Li diffuses into the EML when Al is sputtered, and Li is shown to act as an exciton quencher that can decrease eta(ext). Doping of the ETL is also used to significantly suppress the performance reduction with sputtered cathodes even when using a phosphorescent emitter having high eta(ext). (C) 2014 American Vacuum Society.	[Fujimoto, Hiroshi; Adachi, Chihaya] Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, Fukuoka 8190395, Japan; [Fujimoto, Hiroshi; Adachi, Chihaya] Kyushu Univ, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan; [Fujimoto, Hiroshi; Adachi, Chihaya] Fukuoka I3 Ctr Organ Photon & Elect Res I3 OPERA, Nishi Ku, Fukuoka 8190388, Japan; [Miyayama, Takuya; Sanada, Noriaki] ULVAC PHI Inc, Chigasaki, Kanagawa 2538522, Japan; [Adachi, Chihaya] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2 CNER, Nishi Ku, Fukuoka 8190395, Japan	Fujimoto, H (reprint author), Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, Fukuoka 8190395, Japan.	adachi@cstf.kyushu-u.ac.jp			Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST); International Institute for Carbon Neutral Energy Research (WPI-I2 CNER) - Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported in part by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) and the International Institute for Carbon Neutral Energy Research (WPI-I<SUP>2</SUP> CNER) sponsored by Ministry of Education, Culture, Sports, Science and Technology (MEXT). H.F. also thanks Kohei Tsugita, Tomohiko Edura and Masaki Numata from Kyushu University for their support in this study. The help of William J. Potscavage, Jr., of Kyusyu University in the preparation of this manuscript is gratefully acknowledged.	Fujimoto H, 2014, ORG ELECTRON, V15, P2783, DOI 10.1016/j.orgel.2014.08.021; Lee JH, 2012, J MATER CHEM, V22, P15262, DOI 10.1039/c2jm32438e; Kido J, 1998, APPL PHYS LETT, V73, P2866, DOI 10.1063/1.122612; Ninomiya S, 2007, NUCL INSTRUM METH B, V256, P493, DOI 10.1016/j.nimb.2006.12.047; Baldo MA, 2000, PHYS REV B, V62, P10958, DOI 10.1103/PhysRevB.62.10958; Gil TH, 2009, PLASMA PROCESS POLYM, V6, pS808, DOI 10.1002/ppap.200932105; Fujimoto H, 2014, J VAC SCI TECHNOL B, V32, DOI 10.1116/1.4871756; Aziz H, 1999, SCIENCE, V283, P1900, DOI 10.1126/science.283.5409.1900; Gil TH, 2010, ORG ELECTRON, V11, P322, DOI 10.1016/j.orgel.2009.11.011; Dobbertin T, 2003, APPL PHYS LETT, V83, P5071, DOI 10.1063/1.1634688; Popovic ZD, 2002, IEEE J SEL TOP QUANT, V8, P362, DOI 10.1109/2944.999191; Walzer K, 2007, CHEM REV, V107, P1233, DOI 10.1021/cr050156n; Chung CH, 2005, THIN SOLID FILMS, V491, P294, DOI 10.1016/j.tsf.2005.06.003; Fujimoto H, 2013, ORG ELECTRON, V14, P2994, DOI 10.1016/j.orgel.2013.08.020; Suzuki H, 1996, APPL PHYS LETT, V68, P2276, DOI 10.1063/1.115883; Suzuki H, 1996, APPL PHYS LETT, V69, P1611, DOI 10.1063/1.117047; Parthasarathy G, 1998, APPL PHYS LETT, V72, P2138, DOI 10.1063/1.121301; Hung LS, 1999, APPL PHYS LETT, V74, P3209, DOI 10.1063/1.124107; Dangtip S, 2008, J PHYS CONF SER, V100, DOI 10.1088/1742-6596/100/4/042011; Kawamura Y, 2004, JPN J APPL PHYS 1, V43, P7729, DOI 10.1143/JJAP.43.7729; Gu G, 1998, APPL PHYS LETT, V73, P2399, DOI 10.1063/1.122446; Hung LS, 1999, J APPL PHYS, V86, P4607, DOI 10.1063/1.371410; Kim HK, 2004, APPL PHYS LETT, V85, P4295, DOI 10.1063/1.1815394; Kim HK, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2178483; Kim HK, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1923182; Lee Y, 2009, THIN SOLID FILMS, V517, P4019, DOI 10.1016/j.tsf.2009.01.185; Meyer B. J., 2008, ADV MATER, V20, P3839; Miyaguchi S., 2007, PIONEER R D, V17, P8; Ohsawa N., 2013, SID, V13, P923; Prakash S, 2008, SID INT SYMP DIG TEC, V39, P2046; Richter B., 2011, IEEE INT SOL STAT CI, P314; Tak YH, 2013, PROC SPIE, V8829, DOI 10.1117/12.2026859	32	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	NOV	2014	32	6							060603	10.1116/1.4897920		6	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	AU3KU	WOS:000345512800057		
J	Kato, H; Takahashi, J; Nishikawa, H				Kato, Hijiri; Takahashi, Junichi; Nishikawa, Hiroyuki			Fabrication of polydimethylsiloxane microlens arrays on a plastic film by proton beam writing	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							MICROSTRUCTURES; RESISTS; OPTICS; PDMS	This paper reports the fabrication of polydimethylsiloxane (PDMS) microlens arrays (MLAs) on a 5-13 mu m-thick PDMS layer on polyethylene terephthalate (PET) films using proton beam writing (PBW). The PBW is performed with a focused 1.3 mu m beam with an energy of 1.0MeV. The sensitivity of the PDMS layer on an indium tin oxide (ITO)-coated PET film is improved compared to that on a bare PET film. The arrays of the PDMS microlenses with diameters of 20 mu m and a height of 4.5 mu m are fabricated by changing the proton beam fluence. The ITO layer on the PET film provides substrate conductivity for PDMS and the transparency required for flexible optofluidic devices. The patterning of 35 x 35 MLAs is demonstrated in an area of 1.0 x 1.0 mm(2) within 16 min. The PDMS MLAs can be transferred to a Ni mold by electroplating and are then duplicated by ultraviolet imprint lithography on PET films. (C) 2014 American Vacuum Society.	[Kato, Hijiri; Takahashi, Junichi; Nishikawa, Hiroyuki] Shibaura Inst Technol, Dept Elect Engn, Koto Ku, Tokyo 1358548, Japan	Kato, H (reprint author), Shibaura Inst Technol, Dept Elect Engn, Koto Ku, 3-7-5 Toyosu, Tokyo 1358548, Japan.	nishi@shibaura-it.ac.jp			MEXT; Adaptable and Seamless Technology Transfer Program through Target-driven R&D (ASTEP) from the Japan Science and Technology Agency	This work was partially supported by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2011-2014), and by the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (ASTEP) from the Japan Science and Technology Agency (2013-2014).	Psaltis D, 2006, NATURE, V442, P381, DOI 10.1038/nature05060; Ziegler JF, 2010, NUCL INSTRUM METH B, V268, P1818, DOI 10.1016/j.nimb.2010.02.091; POPOVIC ZD, 1988, APPL OPTICS, V27, P1281, DOI 10.1364/AO.27.001281; Wilbur JL, 1996, CHEM MATER, V8, P1380, DOI 10.1021/cm950579d; Watt F, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70129-3; Arai Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.012601; Bettiol AA, 2004, P SOC PHOTO-OPT INS, V5347, P255, DOI 10.1117/12.524300; Dutta RK, 2007, NUCL INSTRUM METH B, V260, P464, DOI 10.1016/j.nimb.2007.02.064; Furuta Y, 2007, J VAC SCI TECHNOL B, V25, P2171, DOI 10.1116/1.2806974; Menzel F, 2011, NUCL INSTRUM METH B, V269, P2427, DOI 10.1016/j.nimb.2011.02.060; Nishikawa H, 2009, J PHOTOPOLYM SCI TEC, V22, P239, DOI 10.2494/photopolymer.22.239; Saito K, 2013, NUCL INSTRUM METH B, V306, P284, DOI 10.1016/j.nimb.2012.12.032; Seki Y, 2009, MICROELECTRON ENG, V86, P945, DOI 10.1016/j.mee.2009.01.013; Szilasi SZ, 2011, MICROELECTRON ENG, V88, P2885, DOI 10.1016/j.mee.2011.03.007; Tsuchiya R., 2011, T MAT RES SOC JPN, V36, P325; Uchiya N, 2007, NUCL INSTRUM METH B, V260, P405, DOI 10.1016/j.nimb.2007.02.053; van Kan JA, 2008, NUCL INSTRUM METH B, V266, P1676, DOI 10.1016/j.nimb.2007.12.081; van Kan JA, 2007, NUCL INSTRUM METH B, V260, P460, DOI 10.1016/j.nimb.2007.02.063; van Kan JA, 2014, APPL SURF SCI, V310, P100, DOI 10.1016/j.apsusc.2014.04.147	19	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	NOV	2014	32	6							06F506	10.1116/1.4900419		5	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	AU3KU	WOS:000345512800009		
J	Moro, M; Taniguchi, J; Hiwasa, S				Moro, Masatoshi; Taniguchi, Jun; Hiwasa, Shin			Fabrication of antireflection structure film by roll-to-roll ultraviolet nanoimprint lithography	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							ANODIC POROUS ALUMINA; SURFACE; OPTIMIZATION; MOLDS; BEAM	Antireflection (AR) films are useful in preventing the reflection of light from the displays of mobile phones and tablet computers. In particular, films with an AR structure known as the moth-eye structure show excellent performance in preventing light reflection. In a previous study, the authors reported the fabrication of an AR structure by oxygen ion-beam irradiation of glassy carbon (GC). The fabricated pattern consisted of a series of self-assembled conical structures and it had a low-reflection surface. In this study, the authors transferred this AR structure onto a polymer film by roll-to-roll ultraviolet nanoimprint lithography using a replica mold produced from a GC master mold with the AR structure. As a result, the authors were able to produce high-performance AR film at a feed rate of 1.8 m/min. The reflectivity of the film was about 0.1% and its transmittance was about 95% at visible wavelengths. (C) 2014 American Vacuum Society.	[Moro, Masatoshi; Taniguchi, Jun] Tokyo Univ Sci, Dept Appl Elect, Katsushika ku, Tokyo 1258585, Japan; [Hiwasa, Shin] Autex Inc, Shinjuku Ku, Tokyo 1620067, Japan	Moro, M (reprint author), Tokyo Univ Sci, Dept Appl Elect, Katsushika ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	junt@te.noda.tus.ac.jp					Abu Talip N. B., 2014, JPN J APPL PHYS PT 1, V53; Abu Talip NB, 2013, MICROELECTRON ENG, V110, P163, DOI 10.1016/j.mee.2013.03.041; Taniguchi J, 2009, J VAC SCI TECHNOL B, V27, P2841, DOI 10.1116/1.3237141; Yamada N, 2011, PROG PHOTOVOLTAICS, V19, P134, DOI 10.1002/pip.994; Chen Q, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3171930; Yanagishita T, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.022001; Chou SY, 1997, J VAC SCI TECHNOL B, V15, P2897, DOI 10.1116/1.589752; Yamada N, 2011, OPT EXPRESS, V19, pA118, DOI 10.1364/OE.19.00A118; Tan H, 1998, J VAC SCI TECHNOL B, V16, P3926, DOI 10.1116/1.590438; CLAPHAM PB, 1973, NATURE, V244, P281, DOI 10.1038/244281a0; Yoshikawa H, 2013, MICROELECTRON ENG, V112, P273, DOI 10.1016/j.mee.2013.03.117; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Stuart C, 2009, ACS NANO, V3, P2062, DOI 10.1021/nn9008356; Taguchi T., 2010, SID INT S, V41, P1196; Takahashi J, 2010, J VAC SCI TECHNOL B, V28, pC6M23, DOI 10.1116/1.3503896; Taniguchi J, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.4758922; Taniguchi J, 2009, J NANOSCI NANOTECHNO, V9, P445, DOI 10.1166/jnn.2009.J039; Velkova V, 2010, MICROELECTRON ENG, V87, P2139, DOI 10.1016/j.mee.2010.01.015; Yajima K, 2013, MICROELECTRON ENG, V110, P188, DOI 10.1016/j.mee.2013.03.104; Yanagishita T, 2006, JPN J APPL PHYS 2, V45, pL804, DOI 10.1143/JJAP.45.L804; Yanagishita T, 2008, J VAC SCI TECHNOL B, V26, P1856, DOI 10.1116/1.2998731; Yanagishita T, 2007, CHEM LETT, V36, P530, DOI 10.1246/cl.2007.530	22	2	2	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	NOV	2014	32	6							06FG09	10.1116/1.4901877		9	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	AU3KU	WOS:000345512800045		
J	Nishitani, T; Tabuchi, M; Amano, H; Maekawa, T; Kuwahara, M; Meguro, T				Nishitani, Tomohiro; Tabuchi, Masao; Amano, Hiroshi; Maekawa, Takuya; Kuwahara, Makoto; Meguro, Takashi			Photoemission lifetime of a negative electron affinity gallium nitride photocathode	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							ENERGY RECOVERY; GAAS; SURFACES; CS	A photocathode electron source using p-type GaN semiconductor with a negative electron affinity (NEA) surface has been studied for its ability to maintain an extended NEA state. The key technology of NEA photocathodes is the formation of electric dipoles by cesium and gallium atoms on the surface, which makes it possible for photoexcited electrons in the conduction band minimum to escape into the vacuum. This means that in order to keep the electron energy spread as small as possible, the excitation photon energy should be tuned to the band gap energy. However, the NEA surface is damaged by the adsorption of residual gas and the back-bombardment of ionized residual gas by photoelectrons. The p-type GaN semiconductor was measured time evolution in quantum yield during NEA surface activation, and a lifetime of quantum yield of excitation energy corresponding to the band gap energy in comparison to the p-type GaAs as the conventional NEA photocathode. In NEA surface activation process, the quantum yield of the GaN was more than 3 orders of magnitude higher than that of the GaAs by only cesium deposition. The exposure amount of cesium in the NEA surface activation of the GaAs was 1.5 times as that of the GaN, even though the quantum yield of the GaAs was the same value as the GaN. Lifetime of NEA-photocathodes using the GaN was 21 times longer than that using the GaAs. The decrease of quantum yield of the GaAs was well correlated in the form of the exponential decrease function with a decrease time of 4.4 h, while the decrease of quantum yield of the GaN was well correlated in the form of the exponential decrease function with two decrease times of 47 and 174 h. (C) 2014 American Vacuum Society.	[Nishitani, Tomohiro; Tabuchi, Masao] Nagoya Univ, Synchrotron Radiat Res Ctr, Nagoya, Aichi 4648603, Japan; [Amano, Hiroshi; Maekawa, Takuya] Nagoya Univ, Grad Sch Engn, Dept Elect Engn & Comp Sci, Nagoya, Aichi 4648603, Japan; [Kuwahara, Makoto] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan; [Meguro, Takashi] Tokyo Univ Sci, Fac Sci Div 2, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan	Nishitani, T (reprint author), Nagoya Univ, Synchrotron Radiat Res Ctr, Furo Cho, Nagoya, Aichi 4648603, Japan.	t.nishitani@nusr.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	The authors thank the staff of the Radiation Lab., Institute of Physical and Chemical Research (RIKEN), for their kind cooperation in developing the NEA surface activation system. This work was partly supported by the Regional Innovation Strategy Support Program "Aichi Knowledge Hub Nanotechnology Innovation Strategy Promotion Region" of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	[Anonymous], 2007, INT LINEAR COLLIDER, V3, P32; Machuca F, 2002, J VAC SCI TECHNOL B, V20, P2721, DOI 10.1116/1.1521742; Kuwahara M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737177; MONEMAR B, 1974, PHYS REV B, V10, P676, DOI 10.1103/PhysRevB.10.676; Gruner SM, 2002, REV SCI INSTRUM, V73, P1402, DOI 10.1063/1.1420754; Orlov DA, 2004, NUCL INSTRUM METH A, V532, P418, DOI 10.1016/j.nima.2004.06.048; SU CY, 1983, J APPL PHYS, V54, P1413, DOI 10.1063/1.332166; SOMMER AH, 1970, APPL PHYS LETT, V17, P273, DOI 10.1063/1.1653398; Sinclair CK, 2007, PHYS REV SPEC TOP-AC, V10, DOI 10.1103/PhysRevSTAB.10.023501; LAUTENSCHLAGER P, 1987, PHYS REV B, V35, P9174, DOI 10.1103/PhysRevB.35.9174; Neil GR, 2000, PHYS REV LETT, V84, P662, DOI 10.1103/PhysRevLett.84.662; Aulenbacher K, 2002, J APPL PHYS, V92, P7536, DOI 10.1063/1.1521526; Chanlek N, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/5/055110; Gian W., 1996, MATER RES SOC S P, V423, P475; Iijima H., 2011, P INT PART ACC C THP, P3158; MIYAO M, 1988, APPL SURF SCI, V33-4, P364, DOI 10.1016/0169-4332(88)90328-5; Nishitani T, 2005, J APPL PHYS, V97, DOI 10.1063/1.1886888; Nishitani T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.06FF02; Pastuszka S, 2000, J APPL PHYS, V88, P6788, DOI 10.1063/1.1311307; SLD Collaboration, 1993, PHYS REV LETT, V70, P23; SPICER WE, 1993, P SOC PHOTO-OPT INS, V2022, P18, DOI 10.1117/12.158575	21	1	1	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	NOV	2014	32	6							06F901	10.1116/1.4901566		5	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	AU3KU	WOS:000345512800019		
J	Ohya, K				Ohya, Kaoru			Simulation of insulating-layer charging on a conductive substrate irradiated by ion and electron beams	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							MONTE-CARLO-SIMULATION; EMISSION; RESIST; MICROSCOPY; TARGET; FILMS	A comparative study of the charging characteristics of insulating thin layers on a conductive substrate by ion and electron beam irradiation was performed by simulation. A 100-nm or thinner SiO2 layer on a Si substrate was irradiated with 30-keV He, Ne, and Ga ions and 0.5-10 keV electrons. Most of the He ions and high-energy (> 4 keV) electrons passed through the 100-nm-thick layer and reached the substrate. This strongly relaxed the positive charging effect of the ions and caused slightly positive charging by the electrons. Because of the negligible contribution of projectile charges, the charging is solely attributed to secondary electron (SE) emission. For Ga ions and low-energy (< 1.5 keV) electrons, positive charging was substantially enhanced because of the successive injection of positive ions into the layer and the emission of excess SEs over the injecting electrons (SE yield > 1), respectively. For Ne ions, positive charging proceeded gradually even when all the SEs were reabsorbed by the surface, as was the case for Ga ions. However, positive charging with low-energy electrons reached a steady state as a result of a balance between the injected electrons and the ejecting SEs. A transition from positive to negative charging occurred for intermediate-energy electrons because the SE yield was less than unity. When layer thickness was decreased, positive charging by Ne and Ga ions was suppressed because of a decrease in the number of accumulated charges. However, positive charging with high-energy electrons subsequently changed to negative charging. (C) 2014 American Vacuum Society.	Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan	Ohya, K (reprint author), Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan.	ohya@ee.tokushima-u.ac.jp			JSPS KAKENHI [24560029]	The author thanks T. Nagai for performing a number of calculations on electron-induced secondary electron emission. This work was supported by JSPS KAKENHI Grant No. 24560029.	Bai M, 1999, J VAC SCI TECHNOL B, V17, P2893, DOI 10.1116/1.591091; Cazaux J, 2010, J ELECTRON SPECTROSC, V176, P58, DOI 10.1016/j.elspec.2009.06.004; Ohya K, 2013, NUCL INSTRUM METH B, V315, P295, DOI 10.1016/j.nimb.2013.03.033; Li WQ, 2010, APPL SURF SCI, V256, P3482, DOI 10.1016/j.apsusc.2009.12.061; Ohya K, 2008, SURF COAT TECH, V202, P5310, DOI 10.1016/j.surfcoat.2008.06.008; Zhang HB, 2012, J ELECTRON MICROSC, V61, P85, DOI 10.1093/jmicro/dfr099; Cazaux J, 2012, J ELECTRON MICROSC, V61, P261, DOI 10.1093/jmicro/dfs048; Ganachaud JP, 1997, PHYS STATUS SOLIDI B, V199, P175, DOI 10.1002/1521-3951(199701)199:1<175::AID-PSSB175>3.0.CO;2-#; Hagstrum H. D., 1977, INELASTIC ION SURFAC, P1; Hasselkamp D., 1992, PARTICLE INDUCED ELE, VII; Hill R, 2012, ADV IMAG ELECT PHYS, V170, P65, DOI 10.1016/B978-0-12-394396-5.00002-6; Joy DC, 2013, SPRINGERBRIEF MATER, P1, DOI 10.1007/978-1-4614-8660-2; Joy D. C., 1998, DATABASE ELECT SOLID; Kotera M, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3662079; Kotera M, 2001, J VAC SCI TECHNOL B, V19, P2516, DOI 10.1116/1.1421570; LIU W, 1995, J VAC SCI TECHNOL B, V13, P1979, DOI 10.1116/1.588118; Maas D. J., 2013, SURFACE SCI TECHNIQU, P461; Nastasi M., 1996, ION SOLID INTERACTIO, P88, DOI 10.1017/CBO9780511565007.006; Ohya K., 2013, COMMUNICATION; Ohya Kaoru, 2011, e-Journal of Surface Science and Nanotechnology, V9, DOI 10.1380/ejssnt.2011.112; Ohya K, 2010, J ELECTRON MICROSC, V59, pS189, DOI 10.1093/jmicro/dfq047; Ohya K, 2004, APPL SURF SCI, V237, P606, DOI 10.1016/j.apsusc.2004.06.133; Ohya K, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3643752; Renoud R, 2005, J EUR CERAM SOC, V25, P2805, DOI 10.1016/j.jeurceramsoc.2005.03.144; Rosler M., 1991, PARTICLE INDUCED ELC; Schou J., 1996, PHYSICAL PROCESSES I, P177; Winter H., 2007, SLOW HEAVY PARTICLE; Yao N, 2007, FOCUSED ION BEAM SYS; Yasuda M, 2008, JPN J APPL PHYS, V47, P4890, DOI 10.1143/JJAP.47.4890; Yasuda M, 2008, J APPL PHYS, V104, DOI 10.1063/1.3041648	30	1	1	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	NOV	2014	32	6							06FC01	10.1116/1.4896337		8	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	AU3KU	WOS:000345512800022		
J	Takai, R; Yasuda, M; Tochino, T; Kawata, H; Hirai, Y				Takai, Rina; Yasuda, Masaaki; Tochino, Takamitsu; Kawata, Hiroaki; Hirai, Yoshihiko			Computational study of the demolding process in nanoimprint lithography	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							MOLECULAR-DYNAMICS; IMPRINT LITHOGRAPHY; SIMULATION; DEFORMATION	The demolding process in nanoimprint lithography is studied using molecular dynamics simulations. The difference in the mold separation behaviors between molecular dynamics and continuous mechanics simulations is shown, and the effect that the molecular size of the polymer resist has upon the demolding force is explained from the perspective of the molecular behavior. Depending upon the correlation between the type of resist molecule and the mold cavity size, the demolding force originates from the molecular flow, molecular stretching, or the friction between the resist and mold sidewall. When the molecular size is comparable to the cavity size, the resist is deformed by molecular stretching and the demolding force is at its largest. (C) 2014 American Vacuum Society.	[Takai, Rina; Yasuda, Masaaki; Tochino, Takamitsu; Kawata, Hiroaki; Hirai, Yoshihiko] Osaka Prefecture Univ, Dept Phys & Elect, Sakai, Osaka 5998531, Japan	Takai, R (reprint author), Osaka Prefecture Univ, Dept Phys & Elect, Sakai, Osaka 5998531, Japan.	yasuda@pe.osakafu-u.ac.jp					Hirai Y, 2001, J VAC SCI TECHNOL B, V19, P2811, DOI 10.1116/1.1415510; Kang JH, 2007, TRIBOL LETT, V25, P93, DOI 10.1007/s11249-006-9053-4; Hirai Y, 2004, J VAC SCI TECHNOL B, V22, P3288, DOI 10.1116/1.1826058; Houle FA, 2007, J VAC SCI TECHNOL B, V25, P1179, DOI 10.1116/1.2746336; CHOU SY, 1995, APPL PHYS LETT, V67, P3114, DOI 10.1063/1.114851; Kang JH, 2010, APPL SURF SCI, V257, P1562, DOI 10.1016/j.apsusc.2010.08.096; Chou SY, 1996, J VAC SCI TECHNOL B, V14, P4129, DOI 10.1116/1.588605; Song Z, 2008, J VAC SCI TECHNOL B, V26, P598, DOI 10.1116/1.2890693; Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85; Okada O, 2000, COMPUT THEOR POLYM S, V10, P371, DOI 10.1016/S1089-3156(00)00002-7; Ortiz M, 1999, INT J NUMER METH ENG, V44, P1267, DOI 10.1002/(SICI)1097-0207(19990330)44:9<1267::AID-NME486>3.3.CO;2-Z; Kim S, 2013, TRIBOL LETT, V49, P421, DOI 10.1007/s11249-012-0084-8; Shiotsu T, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4832215; Taga A, 2010, J VAC SCI TECHNOL B, V28, pC6M68, DOI 10.1116/1.3511434; Tallal J, 2006, MICROELECTRON ENG, V83, P851, DOI 10.1016/j.mee.2006.01.011; Wu CD, 2011, ADV SCI LETT, V4, P36, DOI 10.1166/asl.2011.1193; Yang S, 2014, APPL SURF SCI, V301, P189, DOI 10.1016/j.apsusc.2014.02.037; Yang S, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.06FH03; Yasuda M, 2011, MICROELECTRON ENG, V88, P2188, DOI 10.1016/j.mee.2011.01.016	19	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	NOV	2014	32	6							06FG02	10.1116/1.4897138		5	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	AU3KU	WOS:000345512800038		
J	Tochino, T; Shiotsu, T; Uemura, K; Yasuda, M; Kawata, H; Hirai, Y				Tochino, Takamitsu; Shiotsu, Takahiro; Uemura, Kimiaki; Yasuda, Masaaki; Kawata, Hiroaki; Hirai, Yoshihiko			Impact of resist shrinkage on the template release process in nanoimprint lithography	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							FLASH IMPRINT LITHOGRAPHY; UV NANOIMPRINT; PHOTOPOLYMERS; DEPENDENCE; FORCE; STEP	Template release in nanoimprint lithography was computationally studied. The impact of resist shrinkage on template release load is described. The resist shrinkage affects the state of the boundary status between resist and template, and is a factor that influences whether the resist adheres to or separates from the template. When the resist fully adheres to the template, the release load increases due to residual stress as the residual layer becomes thinner. This is because compressive stress at the residual layer is induced by resist shrinkage in the pattern cavity. In addition, the release load increases when the resist partially adheres to the template, a consequence of the decrease in interfacial area. This is because the decrement of interface area due to concentration of stress. (C) 2014 American Vacuum Society.	[Tochino, Takamitsu; Shiotsu, Takahiro; Uemura, Kimiaki; Yasuda, Masaaki; Kawata, Hiroaki; Hirai, Yoshihiko] Osaka Prefecture Univ, Sakai, Osaka 5998531, Japan	Tochino, T (reprint author), Osaka Prefecture Univ, Sakai, Osaka 5998531, Japan.	hirai@pe.osakafu-u.ac.jp					Wang QH, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/10/105021; Amirsadeghi A, 2012, LANGMUIR, V28, P11546, DOI 10.1021/la300256k; Hsueh CH, 2006, MAT SCI ENG A-STRUCT, V433, P316, DOI 10.1016/j.mseas.2006.06.106; Suzuki R, 2012, J PHOTOPOLYM SCI TEC, V25, P211, DOI 10.2494/photopolymer.25.211; Park S, 2009, APPL PHYS A-MATER, V97, P395, DOI 10.1007/s00339-009-5224-0; Amirsadeghi A, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/11/115013; Taylor H, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/6/067002; Hirai Y, 2003, J VAC SCI TECHNOL B, V21, P2765, DOI 10.1116/1.1629289; Ortiz M, 1999, INT J NUMER METH ENG, V44, P1267, DOI 10.1002/(SICI)1097-0207(19990330)44:9<1267::AID-NME486>3.3.CO;2-Z; Suzuki R, 2010, J PHOTOPOLYM SCI TEC, V23, P51, DOI 10.2494/photopolymer.23.51; Amirsadeghi A, 2011, APPL SURF SCI, V258, P1272, DOI 10.1016/j.apsusc.2011.09.090; Johnson S, 2005, J VAC SCI TECHNOL B, V23, P2553, DOI 10.1116/1.2102971; Colburn M, 2001, J VAC SCI TECHNOL B, V19, P2685, DOI 10.1116/1.1420199; Geiser V, 2010, MACROMOL SYMP, V296, P144, DOI 10.1002/masy.201051022; Hiroshima H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.06GK09; Horiba A, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.06FJ06; Kawata H, 2009, MICROELECTRON ENG, V86, P700, DOI 10.1016/j.mee.2008.11.030; Nishino T, 2011, J PHOTOPOLYM SCI TEC, V24, P101, DOI 10.2494/photopolymer.24.101; Shiotsu T, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4832215; Wang Q, 2011, J PHOTOPOLYM SCI TEC, V24, P95; Wang Q, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.06GL04; Wang Q, 2010, J PHOTOPOLYM SCI TEC, V23, P33; Young WB, 2006, INT POLYM PROC, V21, P290	23	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	NOV	2014	32	6							06FG08	10.1116/1.4901874		7	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	AU3KU	WOS:000345512800044		
J	Ueda, N; Sasago, M; Kikuta, H; Kawata, H; Hirai, Y				Ueda, Naoki; Sasago, Masaru; Kikuta, Hisao; Kawata, Hiroaki; Hirai, Yoshihiko			Built-in lens mask lithography (challenge for high-definition lens-less lithography)	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							COHERENCE HOLOGRAPHY	A novel technique of photolithography using a proximity exposure system-named built-in lens mask lithography-is proposed. The built-in lens mask having complex optical transmittance emulates the optical propagation plane in the focusing of an image having an arbitrary pattern. The complex transmittance of the built-in lens mask is computationally obtained for an arbitrarily designed pattern and the transmittance and phase shift are binarized, which is easily achieved using conventional phase mask technology. The performance of built-in lens mask lithography is numerically studied and experimentally confirmed using a conventional proximity exposure system. The results of the numerical study and experiments agree and confirm the enhancement of the critical resolved feature size to 3.0 mu m at a focal length of 55 mu m using the built-in lens mask. (C) 2014 American Vacuum Society.	[Ueda, Naoki; Sasago, Masaru; Kikuta, Hisao; Kawata, Hiroaki; Hirai, Yoshihiko] Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, Sakai, Osaka 5998531, Japan	Hirai, Y (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, 1-1 Gakuencho, Sakai, Osaka 5998531, Japan.	hirai@pe.osakafu-u.ac.jp			Semiconductor Technology Academic Research Center (STARC)	A part of this work was supported by Semiconductor Technology Academic Research Center (STARC).	LEVENSON MD, 1982, IEEE T ELECTRON DEV, V29, P1828, DOI 10.1109/T-ED.1982.21037; Assafrao AC, 2012, PROC SPIE, V8326, DOI 10.1117/12.916368; Kawata H., 1989, Microelectronic Engineering, V9, DOI 10.1016/0167-9317(89)90008-7; Stuerzebecher L, 2010, OPT EXPRESS, V18, P19485, DOI 10.1364/OE.18.019485; Born M., 1999, PRINCIPLES OPTICS; Leontowich AFG, 2011, APPL PHYS A-MATER, V103, P1, DOI 10.1007/s00339-010-6172-4; Naik DN, 2012, OPT EXPRESS, V20, P19658, DOI 10.1364/OE.20.019658; Sato T, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.4767440; Singh RK, 2011, OPT EXPRESS, V19, P11558, DOI 10.1364/OE.19.011558; Smith HI, 1996, J VAC SCI TECHNOL B, V14, P4318, DOI 10.1116/1.589044; Voelkel R, 2012, PROC SPIE, V8326, DOI 10.1117/12.916509	11	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	NOV	2014	32	6							06F702	10.1116/1.4900604		7	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	AU3KU	WOS:000345512800017		
J	Unno, N; Makela, T; Taniguchi, J				Unno, Noriyuki; Makela, Tapio; Taniguchi, Jun			Thermal roll-to-roll imprinted nanogratings on plastic film	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							NANOIMPRINT LITHOGRAPHY; FABRICATION	Nanogratings can be used in various fields, such as optics, electronics, or energy conversion. In the next generation, the desired area of nanogratings will be in excess of 1 m(2) and there is therefore a demand for an effective nanopatterning technique capable of fabricating future devices on this scale at low cost and in high volume. The roll-to-roll nanoimprint (R2RNIL) technique has received much attention because of its simplicity and high throughput. Thermal R2RNIL (T-R2RNIL), in particular, is expected to provide a major breakthrough because, for example, the costs of materials for the technique are much lower than those for ultraviolet R2RNIL, which requires a photocurable resin. Furthermore, T-R2RNIL is a dry process and is therefore more suited to industrial application. In T-R2RNIL with a nanograting mold, understanding the replication behavior, which varies with the process temperature, is a key to obtaining the required features. The authors examined T-R2RNIL high-speed patterning of nanogratings on a cellulose acetate film at various process temperatures and feature sizes of the mold. The replication behavior of a nanograting mold was found to differ from that of a micrograting mold. In addition, the depth of the imprinted pattern could be controlled by varying the process temperature and the pressure. This controllability permits the ready fabrication of nanogratings of various heights from a single mold. (C) 2014 American Vacuum Society.	[Unno, Noriyuki; Taniguchi, Jun] Tokyo Univ Sci, Dept Appl Elect, Katsushika Ku, Tokyo 1258585, Japan; [Makela, Tapio] VTT Printed & Hybrid Funct, FIN-02044 Espoo, Finland; [Taniguchi, Jun] Tokyo Univ Sci, Dept Appl Elect, Katsushika Ku, Tokyo 1258585, Japan	Unno, N (reprint author), Tokyo Univ Sci, Dept Appl Elect, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	n.unno@rs.tus.ac.jp					Kang MG, 2010, SOL ENERG MAT SOL C, V94, P1179, DOI 10.1016/j.solmat.2010.02.039; Makela T, 2011, MICROELECTRON ENG, V88, P2045, DOI 10.1016/j.mee.2011.02.016; Ahn SH, 2008, ADV MATER, V20, P2044, DOI 10.1002/adma.200702650; SCANDOLA M, 1985, POLYMER, V26, P1953, DOI 10.1016/0032-3861(85)90173-9; Makela T, 2008, JPN J APPL PHYS, V47, P5142, DOI 10.1143/JJAP.47.5142; Chou SY, 1996, J VAC SCI TECHNOL B, V14, P4129, DOI 10.1116/1.588605; Tan H, 1998, J VAC SCI TECHNOL B, V16, P3926, DOI 10.1116/1.590438; Yoshikawa H, 2013, MICROELECTRON ENG, V112, P273, DOI 10.1016/j.mee.2013.03.117; Yusof NBA, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JK03; Gains M. D., 2006, J VAC SCI TECHNOL B, V24, P2960; Kamata Y, 2011, IEEE T MAGN, V47, P51, DOI 10.1109/TMAG.2010.2077274; Wang ZY, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3572336	12	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	NOV	2014	32	6							06FG03	10.1116/1.4897132		5	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	AU3KU	WOS:000345512800039		
J	Yamamoto, M; Asayama, Y; Yasuda, M; Kawata, H; Hirai, Y				Yamamoto, Masaya; Asayama, Yoshiki; Yasuda, Masaaki; Kawata, Hiroaki; Hirai, Yoshihiko			Defect formation and transformation in graphene under electron irradiation: A molecular dynamics study	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							BEAM; DEPOSITION; SYSTEMS; RIBBONS; STATE	Molecular dynamics simulations were performed to study defect formation and transformation in graphene under electron irradiation. The single-vacancy was the most frequently formed defect and the number of defects did not depend on the defect formation energy for normal incidence. The single-vacancy transformed to other types of defects and migrated in graphene by heating. The recovery energies of adatom-vacancy and pentagon-heptagon defects were relatively small. The Stone-Wales defect was the most stable, and did not easily recover. In the single atomic chain formation process from graphene by electron irradiation, competition between defect formation by electron collision and the recovery by heating was observed. (C) 2014 American Vacuum Society.	[Yamamoto, Masaya; Asayama, Yoshiki; Yasuda, Masaaki; Kawata, Hiroaki; Hirai, Yoshihiko] Osaka Prefecture Univ, Dept Phys & Elect, Sakai, Osaka 5998531, Japan	Yamamoto, M (reprint author), Osaka Prefecture Univ, Dept Phys & Elect, Sakai, Osaka 5998531, Japan.	yasuda@pe.osakafu-u.ac.jp			Japan Society for the Promotion of Science [25249052]	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grant No. 25249052. The atomic structure video was produced with Visual Molecular Dynamics.<SUP>30</SUP>	Nakada K, 1996, PHYS REV B, V54, P17954, DOI 10.1103/PhysRevB.54.17954; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Krasheninnikov AV, 2007, NAT MATER, V6, P723, DOI 10.1038/nmat1996; Ponomarenko LA, 2008, SCIENCE, V320, P356, DOI 10.1126/science.1154663; Mott NF, 1929, P R SOC LOND A-CONTA, V124, P425, DOI 10.1098/rspa.1929.0127; BRENNER DW, 1990, PHYS REV B, V42, P9458, DOI 10.1103/PhysRevB.42.9458; Lu Y, 2011, NANO LETT, V11, P5184, DOI 10.1021/nl2023756; Song B, 2011, NANO LETT, V11, P2247, DOI 10.1021/nl200369r; BRENNER DW, 1993, PHYS REV LETT, V70, P2174, DOI 10.1103/PhysRevLett.70.2174; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; TERSOFF J, 1988, PHYS REV B, V37, P6991, DOI 10.1103/PhysRevB.37.6991; Krasheninnikov AV, 2010, J APPL PHYS, V107, DOI 10.1063/1.3318261; Lemme MC, 2009, ACS NANO, V3, P2674, DOI 10.1021/nn900744z; TERSOFF J, 1989, PHYS REV B, V39, P5566, DOI 10.1103/PhysRevB.39.5566; Girifalco LA, 2000, PHYS REV B, V62, P13104, DOI 10.1103/PhysRevB.62.13104; Asayama Y, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.4765630; Bell DC, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455301; Chihara Y, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3662409; Hu YH, 2006, CHEM PHYS LETT, V422, P137, DOI 10.1016/j.cplett.2006.02.049; Jang I, 2004, NANO LETT, V4, P109, DOI 10.1021/nl034946t; Kotakoski J, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.105505; Ohishi M, 2007, JPN J APPL PHYS 2, V46, pL605, DOI 10.1143/JJAP.46.L605; Pregler SK, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.224106; Pregler SK, 2007, NUCL INSTRUM METH B, V262, P240, DOI 10.1016/j.nimb.2007.05.030; Seitz F., 1956, SOLID STATE PHYS; Wakabayashi K, 1999, PHYS REV B, V59, P8271, DOI 10.1103/PhysRevB.59.8271; Yasuda M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3549728; Yasuda M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205406; Yazyev OV, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.115418	29	3	3	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	NOV	2014	32	6							06FK01	10.1116/1.4897304		5	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	AU3KU	WOS:000345512800053		
J	Yoshida, K; Murakami, K; Fujita, J				Yoshida, Konomi; Murakami, Katsuhisa; Fujita, Jun-ichi			In-situ visualization of local magnetic fields using low-energy electron beam in scanning electron microscope	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							SPIN-WAVE; HOLOGRAPHY	This study demonstrates clear visualization of the magnetic field around a two-dimensional magnetic material using the Lorentz deflection of a primary electron beam with low accelerating voltage. A horizontal or vertical grid, positioned downstream of the specimen, appears on the scanning microscope image where the field of view shows both the specimen edge and the grid below. An observed deformation in the grid shape is strongly correlated with the local magnetic field and is related to the beam deflection induced by the Lorentz force. A detection sensitivity of similar to 0.5 G is achieved using a primary electron beam with an energy of 1 keV. (C) 2014 American Vacuum Society.	[Yoshida, Konomi] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058571, Japan; Univ Tsukuba, Tsukuba Res Ctr Interdisciplinary Mat Sci TIMS, Tsukuba, Ibaraki 3058571, Japan	Yoshida, K (reprint author), Univ Tsukuba, Inst Appl Phys, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058571, Japan.	fujita@bk.tsukuba.ac.jp			Japanese Society for the Promotion of Science [26107506]	This work was supported by the Japanese Society for the Promotion of Science Grants-in-Aid for Scientific Research (Kakenhi) (Grant No. 26107506).	Sato N, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.063001; FADDEEV LD, 1981, PHYS LETT A, V85, P375, DOI 10.1016/0375-9601(81)90335-2; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; Tada K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.217203; MOLLENSTEDT G, 1956, Z PHYS, V145, P377, DOI 10.1007/BF01326780; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Zhang LW, 2002, SCIENCE, V298, P805, DOI 10.1126/science.1077346; Dunin-Borkowski RE, 2004, MICROSC RES TECHNIQ, V64, P390, DOI 10.1002/jemt.20098; Podbielski J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.167207; Nitta J, 1999, APPL PHYS LETT, V75, P695, DOI 10.1063/1.124485; GRUNDY PJ, 1968, ADV PHYS, V17, P153, DOI 10.1080/00018736800101286; Katine JA, 2000, PHYS REV LETT, V84, P3149, DOI 10.1103/PhysRevLett.84.3149; FINK HW, 1990, PHYS REV LETT, V65, P1204, DOI 10.1103/PhysRevLett.65.1204; Deo N, 2005, J MATER SCI-MATER EL, V16, P387, DOI 10.1007/s10854-005-2302-8; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; DYSON FJ, 1956, PHYS REV, V102, P1217, DOI 10.1103/PhysRev.102.1217; Lehmann M, 2002, MICROSC MICROANAL, V8, P447, DOI 10.1017/S1431927602020147; Shimizu T, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3675547; Chia HJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.087206; TONOMURA A, 1987, REV MOD PHYS, V59, P639, DOI 10.1103/RevModPhys.59.639; Fujita JI, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.06FG02; Fujita J, 2007, J VAC SCI TECHNOL B, V25, P2624, DOI 10.1116/1.2800332; Fujita JI, 2007, JPN J APPL PHYS 2, V46, pL498, DOI 10.1143/JJAP.46.L498; Fujita J, 2008, J VAC SCI TECHNOL B, V26, P2069, DOI 10.1116/1.2991517; McCartney MR, 2007, ANNU REV MATER RES, V37, P729, DOI 10.1146/annurev.matsci.37.052506.084219; WOHLLEBE.D, 1967, J APPL PHYS, V38, P3341, DOI 10.1063/1.1710111	26	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	NOV	2014	32	6							06FC02	10.1116/1.4897504		6	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	AU3KU	WOS:000345512800023		
J	Tateishi, K; Ohtani, N; Ohta, M				Tateishi, Kanako; Ohtani, Nobuyo; Ohta, Mitsuaki			Physiological effects of interactions between female dog owners with neuroticism and their dogs	JOURNAL OF VETERINARY BEHAVIOR-CLINICAL APPLICATIONS AND RESEARCH			English	Article						neuroticism; urinary cortisol; heart rate variability; dog; command communication	HEART-RATE-VARIABILITY; POWER SPECTRUM ANALYSIS; MENTAL STRESS; CORTISOL SECRETION; BEHAVIOR PROBLEMS; COMPUTER-WORK; RESPONSES; PRESSURE; PERSONALITY; OXYTOCIN	The aim of this study was to investigate the physiological effects of the relationship between dog owners with neuroticism and their dogs using noninvasive procedures to measure urinary cortisol and heart rate variability (HRV). Owner personalities were tested via the NEO Five-Factor Inventory and this study focused only on the dimension of neuroticism with 12-item scales. The 24 participating owners and their dogs were randomly divided into experimental and control groups. Each participant and their dog stayed in the test room for 80 minutes. The behavioral test included 2 resting times (R1 and R2, respectively), 2 command-communication times, a separation time, and a free time. In the control group, the command-communication times were changed to noncommunication times. Each participant wore a chest heart rate transmitter and a wrist watch monitor (RS800CX; Polar Electro) during the experiment. HRV is a quantitative parameter of autonomic activity. The spectral analysis of HRV is divided into 2 major oscillatory components: the high-frequency (HF) domain, which reflects parasympathetic activity and the low-frequency (LF) domain, which reflects both sympathetic and parasympathetic activities. The LF to HF ratio reflects sympathetic activity. In the experimental group, the neuroticism scores showed a positive significant correlation with a change in the HF power and a negative correlation with the ratio of the change in the LF to HF ratio. No correlations were found in the control group. Next, all participants were divided into 2 groups according to the HRV in R1 and R2. One group included participants whose HF increased in R2, and the other included participants whose HF decreased in R2. The neuroticism scores were significantly higher in the experimental subjects whose HF increased in R2 than in those whose HF decreased in R2. High neuroticism scores indicate individuals that may be sensitive to daily stresses. Our results showed that a parasympathetic activation occurred in owners with high neuroticism scores 10 minutes after a command-communication interaction with their dogs. This suggests that daily command communication based interactions with their dogs could improve the owner's health for the better. (C) 2014 Elsevier Inc. All rights reserved.	[Tateishi, Kanako] Azabu Univ, Grad Sch Vet Sci, Dept Anim Sci & Biotechnol, Sagamihara, Kanagawa 2525201, Japan; [Ohtani, Nobuyo; Ohta, Mitsuaki] Azabu Univ, Sch Vet Med, Dept Anim Sci & Biotechnol, Sagamihara, Kanagawa 2525201, Japan	Ohtani, N (reprint author), Azabu Univ, Sch Vet Med, Dept Anim Sci & Biotechnol, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	ohtani@azabu-u.ac.jp			Promotion and Mutual Aid Corporation for Private School of Japan	This research was supported by a Grant-in-Aid for Matching Fund Subsidy for Private Universities from The Promotion and Mutual Aid Corporation for Private School of Japan.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Aliabadi I., 2010, THESIS U VIENNA AUST; Kotrschal K, 2009, BEHAV PROCESS, V81, P383, DOI 10.1016/j.beproc.2009.04.001; Antelmi I, 2004, AM J CARDIOL, V93, P381, DOI 10.1016/j.amjcard.2003.09.065; Saleem S, 2012, J PAK MED ASSOC, V62, P422; Dishman RK, 2000, INT J PSYCHOPHYSIOL, V37, P121, DOI 10.1016/S0167-8760(00)00085-4; Hanss R, 2007, ACTA ANAESTH SCAND, V51, P1297, DOI 10.1111/j.1399-6576.2007.01455.x; Wahlstrom J, 2002, EUR J APPL PHYSIOL, V87, P257, DOI 10.1007/s00421-002-0611-7; Gunthert KC, 1999, J PERS SOC PSYCHOL, V77, P1087, DOI 10.1037/0022-3514.77.5.1087; Wedl M, 2010, INTERACT STUD, V11, P482, DOI 10.1075/is.11.3.09wed; MCCRATY R, 1995, AM J CARDIOL, V76, P1089, DOI 10.1016/S0002-9149(99)80309-9; Odendaal JSJ, 2003, VET J, V165, P296, DOI 10.1016/S1090-0233(02)00237-X; Mroczek DK, 2004, J PERS, V72, P355, DOI 10.1111/j.0022-3506.2004.00265.x; Arhant C, 2010, APPL ANIM BEHAV SCI, V123, P131, DOI 10.1016/j.applanim.2010.01.003; PAGANI M, 1986, CIRC RES, V59, P178; Garde AH, 2002, EUR J APPL PHYSIOL, V87, P456, DOI 10.1007/s00421-002-0656-7; Hjortskov N, 2004, EUR J APPL PHYSIOL, V92, P84, DOI 10.1007/s00421-004-1055-z; Beerda B, 1996, HORM BEHAV, V30, P272, DOI 10.1006/hbeh.1996.0033; Jagoe A, 1996, APPL ANIM BEHAV SCI, V47, P31, DOI 10.1016/0168-1591(95)01008-4; Hennessy MB, 1998, APPL ANIM BEHAV SCI, V61, P63, DOI 10.1016/S0168-1591(98)00179-8; Brosschot JF, 2007, INT J PSYCHOPHYSIOL, V63, P39, DOI 10.1016/j.ijpsycho.2006.07.016; Lucini D, 2002, HYPERTENSION, V39, P184, DOI 10.1161/hy0102.100784; Allen K, 2002, PSYCHOSOM MED, V64, P727, DOI 10.1097/01.PSY.0000024236.11538.41; Taelman J, 2009, IFMBE PROC, V22, P1366; Handlin L, 2011, ANTHROZOOS, V24, P301, DOI 10.2752/175303711X13045914865385; Suls J, 2005, PSYCHOL BULL, V131, P260, DOI 10.1037/0033-2909.131.2.260; Beerda B, 1999, PHYSIOL BEHAV, V66, P243, DOI 10.1016/S0031-9384(98)00290-X; Barker SB, 2010, ANTHROZOOS, V23, P79, DOI 10.2752/175303710X12627079939341; Bennett PC, 2007, APPL ANIM BEHAV SCI, V102, P65, DOI 10.1016/j.applanim.2006.03.009; Costa P., 1992, REVISED NEO PERSONAL; Costa P.T., 1989, NFO PI NEO FFI MANUA; Fauchier L, 1998, J AUTONOM NERV SYST, V73, P1, DOI 10.1016/S0165-1838(98)00110-6; Handlin L, 2012, ANTHROZOOS, V25, P215, DOI 10.2752/175303712X13316289505468; Hoffman C.L., 2013, J HUM ANIM INTERACT, V1, P20; Horsten M, 1999, PSYCHOSOM MED, V61, P49; JONES CA, 1990, DOMEST ANIM ENDOCRIN, V7, P559, DOI 10.1016/0739-7240(90)90013-P; Kingwell BA, 2001, CLIN AUTON RES, V11, P313, DOI 10.1007/BF02332977; Kis A., 2012, INTERACT STUDIES, V13, P371; Kolevska J, 2003, ACTA VET BRNO, V72, P599; Motooka M, 2006, MED J AUSTRALIA, V184, P60; OFarrell V, 1997, APPL ANIM BEHAV SCI, V52, P205, DOI 10.1016/S0168-1591(96)01123-9; Polheber J.P., 2013, J BEHAV MED; Roeser K, 2012, PHYSIOL BEHAV, V106, P151, DOI 10.1016/j.physbeh.2012.01.023; Schoberl I, 2012, ANTHROZOOS, V25, P199, DOI 10.2752/175303712X13316289505422; Shimonaka Y, 1999, NEO PI R NEO FFI MAN; Camm AJ, 1996, CIRCULATION, V93, P1043; Tateishi K., 2010, 12 INT IAHAIO C STOC; Voss A., 2013, C P ANN INT C IEEE E, P5574; Zverev Y., 1999, Central African Journal of Medicine, V45, P312	49	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1558-7878	1878-7517		J VET BEHAV	J. Vet. Behav.-Clin. Appl. Res.	NOV-DEC	2014	9	6					304	310		10.1016/j.jveb.2014.08.005		7	Behavioral Sciences; Veterinary Sciences	Behavioral Sciences; Veterinary Sciences	AU3YM	WOS:000345546500006		
J	Nomaki, H; Chikaraishi, Y; Tsuchiya, M; Toyofuku, T; Ohkouchi, N; Uematsu, K; Tame, A; Kitazato, H				Nomaki, Hidetaka; Chikaraishi, Yoshito; Tsuchiya, Masashi; Toyofuku, Takashi; Ohkouchi, Naohiko; Uematsu, Katsuyuki; Tame, Akihiro; Kitazato, Hiroshi			Nitrate uptake by foraminifera and use in conjunction with endobionts under anoxic conditions	LIMNOLOGY AND OCEANOGRAPHY			English	Article							NITROGEN ISOTOPIC COMPOSITION; AMINO-ACIDS; GLOBOBULIMINA-TURGIDA; DENITRIFICATION; SURVIVAL; STORAGE	Among eukaryotes, some benthic foraminiferal species have been reported to be capable of nitrate respiration, although little is known about their denitrification processes. In this study, we incubated the shallow-water benthic foraminifer Ammonia beccarii with isotopically labeled sodium nitrate (-73 parts per thousand, 0 parts per thousand, or +73 parts per thousand) under oxic or anoxic conditions to investigate how nitrate is used in foraminiferal cells and whether those signatures remain in amino acids. The delta N-15 values of amino acids from bulk cells incubated under anoxic conditions were correlated with those of nitrate in seawater and were enriched in N-15 by up to, similar to 50% compared to the isotopic compositions in seawater. There was no such relationship or enrichment in the cases of organic matter in the calcite tests under oxic or anoxic conditions or bulk cells under oxic conditions, suggesting that benthic foraminifera take up ambient nitrate under anoxic conditions and use it for denitrification; the remaining N-15-enriched intracellular nitrate pool is used for amino acid synthesis, probably by endosymbiotic microbes, as suggested by observation of the cellular ultrastructure. The degree of N-15 enrichment may depend on denitrification rates of the intracellular nitrate pool. Because the amino acids in the calcite test are synthesized by foraminifera, they were not enriched in N-15, even under anoxic conditions. Thus, differences between amino acid delta N-15 of bulk foraminiferal cells and organic matter in tests may serve as a proxy for denitrification in foraminiferal cells and microbial amino acid synthesis under oxygen-depleted conditions.	[Nomaki, Hidetaka; Chikaraishi, Yoshito; Tsuchiya, Masashi; Toyofuku, Takashi; Ohkouchi, Naohiko; Kitazato, Hiroshi] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Uematsu, Katsuyuki; Tame, Akihiro] Marine Works, Yokosuka, Kanagawa, Japan	Nomaki, H (reprint author), Japan Agcy Marine Earth Sci & Technol, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan.	nomakih@jamstec.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [B 22740340, A 21244079]	We thank Yoko Sasaki for her skillful work in the amino acid extraction and derivatization and Nanami Kishigami and Kaya Okuizumi for their help during incubation experiments. We also thank the editor and two anonymous reviewers for their constructive comments on our manuscript. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Young Scientists B 22740340 to H.N., and Scientific Research A 21244079 to H.K.).	McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; Bernhard JM, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001949; Nardelli MP, 2014, BIOGEOSCIENCES, V11, P4029, DOI 10.5194/bg-11-4029-2014; Metges CC, 1996, J MASS SPECTROM, V31, P367, DOI 10.1002/(SICI)1096-9888(199604)31:4<367::AID-JMS310>3.0.CO;2-V; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Hogslund S, 2008, J EXP MAR BIOL ECOL, V359, P85, DOI 10.1016/j.jembe.2008.02.015; Glud RN, 2009, LIMNOL OCEANOGR, V54, P723, DOI 10.4319/lo.2009.54.3.0723; Pina-Ochoa E, 2010, MAR ECOL PROG SER, V417, P39, DOI 10.3354/meps08805; Bernhard JM, 2012, ISME J, V6, P951, DOI 10.1038/ismej.2011.171; Braeckman U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059289; Koho KA, 2011, FEMS MICROBIOL ECOL, V75, P273, DOI 10.1111/j.1574-6941.2010.01010.x; Toyofuku T, 2000, PALEOCEANOGRAPHY, V15, P456, DOI 10.1029/1999PA000460; Bernhard JM, 2000, NATURE, V403, P77, DOI 10.1038/47476; Bernhard JM, 2010, ENVIRON MICROBIOL, V12, P2107, DOI 10.1111/j.1462-2920.2009.02073.x; Bernhard JM, 2006, J GEOPHYS RES-BIOGEO, V111, DOI [10.1029/2005JG000158, 10.1029/2005GJ000158]; Chikaraishi Y, 2010, EARTH LIFE ISOTOPES, P367; Chikaraishi Y, 2011, ECOL RES, V26, P835, DOI 10.1007/s11284-011-0844-1; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740; Grasshoff K., 1983, METHODS SEAWATER ANA; Hood E.M., 2010, ICPO PUBLICATION SER, V134; Koho KA, 2012, CELL ORIG LIFE EXTRE, V21, P251; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; Risgaard-Petersen N, 2006, NATURE, V443, P93, DOI 10.1038/nature05070	23	4	4	AMER SOC LIMNOLOGY OCEANOGRAPHY	WACO	5400 BOSQUE BLVD, STE 680, WACO, TX 76710-4446 USA	0024-3590	1939-5590		LIMNOL OCEANOGR	Limnol. Oceanogr.	NOV	2014	59	6					1879	1888		10.4319/lo.2014.59.6.1879		10	Limnology; Oceanography	Marine & Freshwater Biology; Oceanography	AU2QK	WOS:000345462700005		
J	Fuwa, H; Sato, M; Sasaki, M				Fuwa, Haruhiko; Sato, Mizuho; Sasaki, Makoto			Programmed Cell Death Induced by (-)-8,9-Dehydroneopeltolide in Human Promyelocytic Leukemia HL-60 Cells under Energy Stress Conditions	MARINE DRUGS			English	Article						macrolide; apoptosis; programmed cell death; mitochondria; cytotoxicity; energy stress	BIOLOGICAL EVALUATION; CYTOCHROME-C; ENDONUCLEASE-G; CANCER-CELLS; APOPTOSIS; MITOCHONDRIA; (+)-NEOPELTOLIDE; NEOPELTOLIDE; GLYCOLYSIS; METABOLISM	(+)-Neopeltolide is a marine macrolide natural product that exhibits potent antiproliferative activity against several human cancer cell lines. Previous study has established that this natural product primarily targets the complex III of the mitochondrial electron transport chain. However, the biochemical mode-of-actions of neopeltolide have not been investigated in detail. Here we report that (-)-8,9-dehydroneopeltolide (8,9-DNP), a more accessible synthetic analogue, shows potent cytotoxicity against human promyelocytic leukemia HL-60 cells preferentially under energy stress conditions. Nuclear morphology analysis, as well as DNA ladder assay, indicated that 8,9-DNP induced significant nuclear condensation/fragmentation and DNA fragmentation, and these events could be suppressed by preincubating the cells with a pan-caspase inhibitor, N-benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone (zVAD). Immunoblot analysis demonstrated the release of cytochrome c from the mitochondria and the cleavage of full-length caspase-3 and poly(ADP-ribose) polymerase (PARP). These results indicated that 8,9-DNP induced caspase-dependent apoptotic programmed cell death under energy stress conditions. It was also found that 8,9-DNP induced non-apoptotic cell death in the presence/absence of zVAD under energy stress conditions. Immunoblot analysis showed the intracytosolic release of apoptosis-inducing factor (AIF), although it did not further translocate to the nucleus. It appears most likely that, in the presence of zVAD, 8,9-DNP triggered necrotic cell death as a result of severe intracellular ATP depletion.	[Fuwa, Haruhiko; Sato, Mizuho; Sasaki, Makoto] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan	Fuwa, H (reprint author), Tohoku Univ, Grad Sch Life Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	hfuwa@m.tohoku.ac.jp; b3bm1016@s.tohoku.ac.jp; masasaki@m.tohoku.ac.jp	Fuwa, Haruhiko/D-1773-2010		Japan Society for Promotion of Science [23681045]; Ministry of Education, Culture, Sports, Science and Technology, Japan [24102507, 26102708]	This work was supported in part by a Grant-in-Aid for Young Scientists (A) from the Japan Society for Promotion of Science (No. 23681045) and by Grants-in-Aid for Scientific Research on Innovative Areas "Chemical Biology of Natural Products" from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Nos. 24102507 and 26102708).	Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Zhang ZL, 1998, NATURE, V392, P677; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Fuwa H, 2013, CHEM-EUR J, V19, P8100, DOI 10.1002/chem.201300664; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Tominaga H, 1999, ANAL COMMUN, V36, P47, DOI 10.1039/a809656b; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Youngsaye W, 2007, ANGEW CHEM INT EDIT, V46, P9211, DOI 10.1002/anie.200704122; Granchi C, 2012, CHEMMEDCHEM, V7, P1318, DOI 10.1002/cmdc.201200176; Scotland S, 2013, LEUKEMIA, V27, P2129, DOI 10.1038/leu.2013.107; Cui Y, 2012, J ORG CHEM, V77, P2225, DOI 10.1021/jo2023685; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Fuwa H, 2010, ANGEW CHEM INT EDIT, V49, P3041, DOI 10.1002/anie.201000624; Eguchi Y, 1997, CANCER RES, V57, P1835; Izuishi K, 2000, CANCER RES, V60, P6201; Slee EA, 1996, BIOCHEM J, V315, P21; Wright AE, 2007, J NAT PROD, V70, P412, DOI 10.1021/np060597h; Custar DW, 2008, J AM CHEM SOC, V130, P804, DOI 10.1021/ja710080q; Ulanovskaya OA, 2008, NAT CHEM BIOL, V4, P418, DOI 10.1038/nchembio.94; Momose I, 2010, BIOCHEM BIOPH RES CO, V392, P460, DOI 10.1016/j.bbrc.2010.01.050; Custar DW, 2009, J AM CHEM SOC, V131, P12406, DOI 10.1021/ja904604x; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Fuwa H, 2014, BIOORG MED CHEM LETT, V24, P2415, DOI 10.1016/j.bmcl.2014.04.031; Suganuma K, 2010, LEUKEMIA LYMPHOMA, V51, P2112, DOI 10.3109/10428194.2010.512966; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Susin SA, 1999, NATURE, V397, P441; Fuwa H, 2009, CHEM-EUR J, V15, P12807, DOI 10.1002/chem.200901675; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Xu RH, 2005, CANCER RES, V65, P613; Fuwa H, 2008, ANGEW CHEM INT EDIT, V47, P4737, DOI 10.1002/anie.200801399; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Polverino AJ, 1997, J BIOL CHEM, V272, P7013; Ogita M, 2009, J ANTIBIOT, V62, P145, DOI 10.1038/ja.2009.2; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Nicholls D. G., 2012, METHODS MOL BIOL, V810; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Sahra I. B., 2010, CANCER RES, V70, DOI DOI 10.1158/0008-5472.CAN-09-2782	46	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-3397			MAR DRUGS	Mar. Drugs	NOV	2014	12	11					5576	5589		10.3390/md12115576		14	Chemistry, Medicinal	Pharmacology & Pharmacy	AU3RN	WOS:000345531400013		
J	Yamada, T; Tominari, Y; Tanaka, S; Mizuno, M; Fukunaga, K				Yamada, Toshiki; Tominari, Yukihiro; Tanaka, Shukichi; Mizuno, Maya; Fukunaga, Kaori			Vibration Modes at Terahertz and Infrared Frequencies of Ionic Liquids Consisting of an Imidazolium Cation and a Halogen Anion	MATERIALS			English	Article						ionic liquid; imidazolium cation; halogen anion; THz spectroscopy; far-infrared spectroscopy; infrared spectroscopy	AB-INITIO; DIELECTRIC-RELAXATION; WATER MIXTURES; HYDROGEN-BONDS; COMBINED THZ; SPECTROSCOPY; DYNAMICS; RAMAN; CATALYSIS; SALTS	The terahertz and infrared frequency vibration modes of room-temperature ionic liquids with imidazolium cations and halogen anions were extensively investigated. There is an intermolecular vibrational mode between the imidazolium ring of an imidazolium cation, a halogen atomic anion with a large absorption coefficient and a broad bandwidth in the low THz frequency region (13-130 cm(-1)), the intramolecular vibrational modes of the alkyl-chain part of an imidazolium cation with a relatively small absorption coefficient in the mid THz frequency region (130-500 cm(-1)), the intramolecular skeletal vibrational modes of an imidazolium ring affected by the interaction between the imidazolium ring, and a halogen anion with a relatively large absorption coefficient in a high THz frequency region (500-670 cm(-1)). Interesting spectroscopic features on the interaction between imidazolium cations and halogen anions was also obtained from spectroscopic studies at IR frequencies (550-3300 cm(-1)). As far as the frequency of the intermolecular vibrational mode is concerned, we found the significance of the reduced mass in determining the intermolecular vibration frequency.	[Yamada, Toshiki; Tominari, Yukihiro; Tanaka, Shukichi] Natl Inst Informat & Commun Technol, Adv ICT Res Inst, Kobe, Hyogo 6512492, Japan; [Mizuno, Maya; Fukunaga, Kaori] Natl Inst Informat & Commun Technol, Appl Electromagnet Res Inst, Koganei, Tokyo 1848795, Japan	Yamada, T (reprint author), Natl Inst Informat & Commun Technol, Adv ICT Res Inst, 588-2 Iwaoka, Kobe, Hyogo 6512492, Japan.	toshiki@nict.go.jp; tominari@nict.go.jp; tanakas@nict.go.jp; mmizuno@nict.go.jp; kaori@nict.go.jp					AIMONE L, 1977, J CHEM SOC FARAD T 2, V73, P1607, DOI 10.1039/f29777301607; Turton DA, 2009, J AM CHEM SOC, V131, P11140, DOI 10.1021/ja903315v; Greaves TL, 2008, CHEM REV, V108, P206, DOI 10.1021/cr068040u; Xiao D, 2009, J PHYS CHEM B, V113, P6426, DOI 10.1021/jp8102595; Tsuzuki S, 2005, J PHYS CHEM B, V109, P16474, DOI 10.1021/jp0533628; Jeon Y, 2008, J PHYS CHEM B, V112, P4735, DOI 10.1021/jp7120752; Koeberg M, 2007, CHEM PHYS LETT, V439, P60, DOI 10.1016/j.cplett.2007.03.075; Parvulescu VI, 2007, CHEM REV, V107, P2615, DOI 10.1021/cr050948h; Castner EW, 2011, ANNU REV PHYS CHEM, V62, P85, DOI [10.1146/annurev-physchem-032210-103421, 10.1146/annurev.physchem.032210-103421]; Fumino K, 2008, ANGEW CHEM INT EDIT, V47, P8731, DOI 10.1002/anie.200803446; Yokozeki A, 2007, PHYS CHEM CHEM PHYS, V9, P5018, DOI 10.1039/b706497g; Kuwabata S, 2010, J PHYS CHEM LETT, V1, P3177, DOI 10.1021/jz100876m; Fumino K, 2013, ANGEW CHEM INT EDIT, V52, P2368, DOI 10.1002/anie.201207065; Armand M, 2009, NAT MATER, V8, P621, DOI [10.1038/nmat2448, 10.1038/NMAT2448]; Fumino K, 2012, ANGEW CHEM INT EDIT, V51, P6236, DOI 10.1002/anie.201200508; Berg RW, 2005, J PHYS CHEM B, V109, P19018, DOI 10.1021/jp050691r; Cha S, 2014, PHYS CHEM CHEM PHYS, V16, P9591, DOI 10.1039/c4cp00589a; Fujii K, 2006, J PHYS CHEM B, V110, P8179, DOI 10.1021/jp0612477; Fumino K, 2008, ANGEW CHEM INT EDIT, V47, P3830, DOI 10.1002/anie.200705736; Wang H, 2012, CHEM SOC REV, V41, P1519, DOI 10.1039/c2cs15311d; Wulf A, 2010, CHEMPHYSCHEM, V11, P349, DOI 10.1002/cphc.200900680; Turner EA, 2003, J PHYS CHEM A, V107, P2277, DOI 10.1021/jp021694w; ELAIWI A, 1995, J CHEM SOC DALTON, P3467, DOI 10.1039/dt9950003467; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Stoppa A, 2008, J PHYS CHEM B, V112, P4854, DOI 10.1021/jp800852z; Del Popolo MG, 2005, J PHYS CHEM B, V109, P5895, DOI 10.1021/jp044414g; Fuse N, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.102402; Johnson CJ, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4838475; Kruger M, 2011, IEEE T THZ SCI TECHN, V1, P313, DOI 10.1109/TTHZ.2011.2159540; Kruger M, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3352585; Wang Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2161174; Wasserscheid P., 2008, IONIC LIQUIDS SYNTHE; Wulf A, 2010, ANGEW CHEM INT EDIT, V49, P449, DOI 10.1002/anie.200905437; Yamamoto K, 2007, J PHYS CHEM B, V111, P4854, DOI 10.1021/jp067171w	34	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1996-1944			MATERIALS	Materials	NOV	2014	7	11					7409	7422		10.3390/ma7117409		14	Materials Science, Multidisciplinary	Materials Science	AU3RW	WOS:000345532200016		
J	Iwao, Y; Shiga, K; Shiroshita, A; Yoshikawa, T; Sakiie, M; Ueno, T; Ueno, S; Ijiri, TW; Sato, K				Iwao, Yasuhiro; Shiga, Keiko; Shiroshita, Ayumi; Yoshikawa, Tomoyasu; Sakiie, Maho; Ueno, Tomoyo; Ueno, Shuichi; Ijiri, Takashi W.; Sato, Ken-ichi			The need of MMP-2 on the sperm surface for Xenopus fertilization: Its role in a fast electrical block to polyspermy	MECHANISMS OF DEVELOPMENT			English	Article						Fertilization; Membrane binding/fusion; Polyspermy block; Egg activation	CROSS-SPECIES FERTILIZATION; KINASE-DEPENDENT ACTIVATION; OVIDUCTAL PARS RECTA; TYROSINE KINASE; DISCOGLOSSUS-PICTUS; VITELLINE ENVELOPE; UROPLAKIN-III; NEWT EGGS; MATRIX METALLOPROTEINASES; MEMBRANE MICRODOMAINS	Monospermic fertilization in the frog, Xenopus laevis, is ensured by a fast-rising, positive fertilization potential to prevent polyspermy on the fertilized egg, followed by a slow block with the formation of a fertilization envelope over the egg surface. In this paper, we found that not only the enzymatic activity of sperm matrix metalloproteinase-2 (MMP-2) was necessary for a sperm to bind and/or pass through the extracellular coat of vitelline envelope, but also the hemopexin (HPX) domain of MMP-2 on the sperm surface was involved in binding and membrane fusion between the sperm and eggs. A peptide with a partial amino acid sequence of the HPX domain caused egg activation accompanied by an increase in [Ca2+](i) in a voltage-dependent manner, similar to that in fertilization. The membrane microdomain (MD) of unfertilized eggs bound the HPX peptide, and this was inhibited by ganglioside GM1 distributed in the MD. The treatment of sperm with GM1 or anti-MMP-2 HPX antibody allows the sperm to fertilize an egg clamped at 0 mV, which untreated sperm cannot achieve. We propose a model accounting for the mechanism of voltage-dependent fertilization based on an interaction between the positively charged HPX domain in the sperm membrane and negatively-charged GM1 in the egg plasma membrane. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Iwao, Yasuhiro; Shiga, Keiko; Shiroshita, Ayumi; Yoshikawa, Tomoyasu; Sakiie, Maho; Ueno, Tomoyo; Ueno, Shuichi] Yamaguchi Univ, Grad Sch Med, Lab Mol Dev Biol, Yamaguchi 7538512, Japan; [Ijiri, Takashi W.; Sato, Ken-ichi] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Lab Cell Signaling & Dev, Kyoto 6038555, Japan	Iwao, Y (reprint author), Yamaguchi Univ, Grad Sch Med, Lab Mol Dev Biol, Yamaguchi 7538512, Japan.	iwao@yamaguchi-u.ac.jp			MEXT [22112518, 24112712, 22112522, 24112714]	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from MEXT (22112518, 24112712 to Y.I., 22112522, 24112714 to K.S.).	Cohen R, 2014, DEV CELL, V28, P310, DOI 10.1016/j.devcel.2014.01.005; Mizote A, 1999, DEV BIOL, V208, P79, DOI 10.1006/dbio.1999.9195; Ueda Y, 2002, DEV BIOL, V243, P55, DOI 10.1006/dbio.2001.0541; IWAO Y, 1994, DEV GROWTH DIFFER, V36, P469; Shiomi T, 2010, PATHOL INT, V60, P477, DOI 10.1111/j.1440-1827.2010.02547.x; GREY RD, 1982, DEV BIOL, V89, P475, DOI 10.1016/0012-1606(82)90335-9; Wong JL, 2006, CURR TOP DEV BIOL, V72, P1, DOI 10.1016/S0070-2153(05)72001-9; Ueda Y, 2003, DEV BIOL, V264, P289, DOI 10.1016/j.ydbio.2003.08.007; Beek J, 2012, REPRODUCTION, V144, P687, DOI 10.1530/REP-12-0311; Hedrick JL, 2008, INT J DEV BIOL, V52, P683, DOI 10.1387/ijdb.082580jh; Ratzan WJ, 2011, J CELL PHYSIOL, V226, P2740, DOI 10.1002/jcp.22854; Sato KI, 2000, DEV BIOL, V224, P453, DOI 10.1006/dbio.2000.9782; Iwao Y, 2012, REPRODUCTION, V144, P11, DOI 10.1530/REP-12-0104; Buchman-Shaked O, 2002, J ANDROL, V23, P702; Campanella C, 1997, MOL REPROD DEV, V47, P323, DOI 10.1002/(SICI)1098-2795(199707)47:3<323::AID-MRD11>3.0.CO;2-Z; Campanella C, 2011, MOL REPROD DEV, V78, P161, DOI 10.1002/mrd.21282; CHARBONNEAU M, 1983, DEV BIOL, V98, P304, DOI 10.1016/0012-1606(83)90361-5; Correa LM, 2000, DEV BIOL, V225, P124, DOI 10.1006/dbio.2000.9825; CROSS NL, 1980, DEV BIOL, V75, P187, DOI 10.1016/0012-1606(80)90154-2; ELINSON RP, 1986, INT REV CYTOL, V101, P59, DOI 10.1016/S0074-7696(08)60246-6; Ferrer M, 2012, CELL TISSUE RES, V349, P881, DOI 10.1007/s00441-012-1429-1; Glahn D, 2003, DEV GROWTH DIFFER, V45, P187; GREY RD, 1976, DEV BIOL, V54, P52, DOI 10.1016/0012-1606(76)90285-2; Hasan AKMM, 2011, MOL REPROD DEV, V78, P814, DOI 10.1002/mrd.21336; Hasan AKMM, 2014, DEVELOPMENT, V141, P1705, DOI 10.1242/dev.105510; Hasan AKMM, 2005, DEV BIOL, V286, P483, DOI 10.1016/j.ydbio.2005.08.020; Hasan AKMM, 2007, GENES CELLS, V12, P251, DOI 10.1111/j.1365-2443.2007.01048.x; Iwao Y, 2000, FERTILIZATION IN PROTOZOA AND METAZOAN ANIMALS, P147; Iwao Y, 2014, SEXUAL REPROD ANIMAL, P171; IWAO Y, 1993, DEV BIOL, V160, P15, DOI 10.1006/dbio.1993.1282; IWAO Y, 1989, DEV BIOL, V134, P446, DOI 10.1016/0012-1606(89)90117-6; IWAO Y, 1989, DEV BIOL, V134, P438, DOI 10.1016/0012-1606(89)90116-4; Iwao Y, 1996, DEV BIOL, V177, P558, DOI 10.1006/dbio.1996.0185; IWAO Y, 1990, DEV BIOL, V142, P301, DOI 10.1016/0012-1606(90)90351-I; IWAO Y, 1985, DEV GROWTH DIFFER, V27, P323; JAFFE LA, 1983, DEV BIOL, V98, P319, DOI 10.1016/0012-1606(83)90362-7; JAFFE LA, 1982, J CELL BIOL, V92, P616, DOI 10.1083/jcb.92.3.616; Kato KH, 1998, DEV GROWTH DIFFER, V40, P221; Kubo H, 2008, ZOOL SCI, V25, P80, DOI 10.2108/zsj.25.80; Kubo H, 2010, MOL REPROD DEV, V77, P728, DOI 10.1002/mrd.21211; Matsubara T, 2007, LANGMUIR, V23, P708, DOI 10.1021/la0619064; Maturi G, 1998, DEV BIOL, V204, P210, DOI 10.1006/dbio.1998.9083; Nagai K, 2009, DEV GROWTH DIFFER, V51, P499, DOI 10.1111/j.1440-169X.2009.01112.x; NUCCITELLI R, 1993, DEV BIOL, V158, P200, DOI 10.1006/dbio.1993.1179; ROE JL, 1988, J CELL BIOL, V107, P539, DOI 10.1083/jcb.107.2.539; Sakakibara K, 2005, J BIOL CHEM, V280, P15029, DOI 10.1074/jbc.M410538200; Sato K, 2002, DEVELOPMENT, V129, P885; Sato K, 2001, DEV GROWTH DIFFER, V43, P55; Sato Ken-ichi, 2006, V322, P395; Sato K, 1999, DEV BIOL, V209, P308, DOI 10.1006/dbio.1999.9255; Shilling FM, 1997, DEV BIOL, V186, P155, DOI 10.1006/dbio.1997.8586; Shilling FM, 1998, DEV BIOL, V202, P113, DOI 10.1006/dbio.1998.8982; STEWARTSAVAGE J, 1987, DEV BIOL, V120, P434, DOI 10.1016/0012-1606(87)90247-8; TALEVI R, 1989, DEVELOPMENT, V105, P343; Wagner J, 2004, CELL CALCIUM, V35, P433, DOI 10.1016/j.ceca.2003.10.009; WYRICK RE, 1974, P NATL ACAD SCI USA, V71, P2067, DOI 10.1073/pnas.71.5.2067	56	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4773	1872-6356		MECH DEVELOP	Mech. Dev.	NOV	2014	134						80	95		10.1016/j.mod.2014.09.005		16	Developmental Biology	Developmental Biology	AU4KI	WOS:000345579200007		
J	Tsujimoto, T; Yamamoto-Honda, R; Kajio, H; Kishimoto, M; Noto, H; Hachiya, R; Kimura, A; Kakei, M; Noda, M				Tsujimoto, Tetsuro; Yamamoto-Honda, Ritsuko; Kajio, Hiroshi; Kishimoto, Miyako; Noto, Hiroshi; Hachiya, Remi; Kimura, Akio; Kakei, Masafumi; Noda, Mitsuhiko			Seasonal Variations of Severe Hypoglycemia in Patients With Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, and Non-diabetes Mellitus	MEDICINE			English	Article							CRITICALLY-ILL PATIENTS; PHYSICAL-ACTIVITY; INTENSIVE TREATMENT; SEPSIS; RISK; COMPLICATIONS; EPIDEMIOLOGY; MORTALITY; HBA(1C); INSULIN	Blood glucose control in patients with diabetes mellitus (DM) is reportedly influenced by the seasons, with hemoglobin A1c (HbA1c) levels decreasing in the summer or warm season and increasing in the winter or cold season. In addition, several studies have shown that sepsis is also associated with the seasons. Although both blood glucose control and sepsis can strongly affect the occurrence of severe hypoglycemia, few studies have examined the seasonal variation of severe hypoglycemia. The aim of the present study is to examine the association between severe hypoglycemia and the seasons in patients with type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), and non-diabetes mellitus (non-DM). We retrospectively reviewed all the patients with severe hypoglycemia at a national center in Japan between April 1, 2006 and March 31, 2012. A total of 57,132 consecutive cases that had visited the emergency room by ambulance were screened, and 578 eligible cases of severe hypoglycemia were enrolled in this study. The primary outcome was to assess the seasonality of severe hypoglycemia. In the T1DM group (n = 88), severe hypoglycemia occurred significantly more often in the summer than in the winter (35.2% in summer vs 18.2% in winter, P = 0.01), and the HbA1c levels were highest in the winter and lowest in the summer (9.1% [7.6%-10.1%] in winter vs 7.7% [7.1%-8.3%] in summer, P = 0.13). In the non-DM group (n = 173), severe hypoglycemia occurred significantly more often in the winter than in the summer (30.6% in winter vs 19.6% in summer, P = 0.01), and sepsis as a complication occurred significantly more often in winter than in summer (24.5% in winter vs 5.9% in summer, P = 0.02). In the T2DM group (n = 317), the occurrence of severe hypoglycemia and the HbA1c levels did not differ significantly among the seasons. The occurrence of severe hypoglycemia might be seasonal and might fluctuate with temperature changes. Patients should be treated more carefully during the season in which severe hypoglycemia is more common.	[Tsujimoto, Tetsuro; Yamamoto-Honda, Ritsuko; Kajio, Hiroshi; Kishimoto, Miyako; Noto, Hiroshi; Hachiya, Remi] Natl Ctr Global Hlth & Med, Dept Diabet Endocrinol & Metab, Tokyo 1628655, Japan; [Tsujimoto, Tetsuro; Kakei, Masafumi] Jichi Med Univ, Grad Sch Med, Div Gen Med, Shimotsuke, Tochigi, Japan; [Yamamoto-Honda, Ritsuko; Kishimoto, Miyako; Noto, Hiroshi; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Diabet Res Ctr, Tokyo 1628655, Japan; [Kimura, Akio] Natl Ctr Global Hlth & Med, Ctr Hosp, Dept Emergency Med & Crit Care, Tokyo 1628655, Japan; [Kakei, Masafumi] Jichi Med Univ, Sch Med, Saitama Med Ctr, Dept Comprehens Med 1, Saitama, Japan	Noda, M (reprint author), Natl Ctr Global Hlth & Med, Dept Diabet Res, Diabet Res Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	mnoda@hosp.ncgm.go.jp					American Diabetes Association, 2012, DIABETES CARE S1, V35, pS11, DOI DOI 10.2337/DC12-S011; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Ishii H, 2001, DIABETES CARE, V24, P1503, DOI 10.2337/diacare.24.8.1503; Herbst A, 2006, ARCH PEDIAT ADOL MED, V160, P573, DOI 10.1001/archpedi.160.6.573; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Sohmiya M, 2004, DIABETES CARE, V27, P1238, DOI 10.2337/diacare.27.5.1238; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Hodgin KE, 2008, CURR PHARM DESIGN, V14, P1833, DOI 10.2174/138161208784980590; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; Hermanides J, 2010, CRIT CARE MED, V38, P1430, DOI 10.1097/CCM.0b013e3181de562c; TATTERSALL RB, 1991, DIABETIC MED, V8, P49; Merrill RM, 2005, AM J HEALTH BEHAV, V29, P371; Ma Y, 2006, EUR J CLIN NUTR, V60, P519, DOI 10.1038/sj.ejcn.1602346; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795; Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Tsujimoto T, 2014, DIABETES CARE, V37, P217, DOI 10.2337/dc13-0701; Sakura H, 2010, DIABETES RES CLIN PR, V88, P65, DOI 10.1016/j.diabres.2009.12.011; Bonds DE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b4909; Danai PA, 2007, CRIT CARE MED, V35, P410, DOI 10.1097/01.CCM.0000253405.17038.43; DANNENBERG AL, 1989, AM J EPIDEMIOL, V129, P76; Dasgupta K, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-81; SHAMOON H, 1993, NEW ENGL J MED, V329, P977; Gikas Aristofanis, 2009, Prim Care Diabetes, V3, P111, DOI 10.1016/j.pcd.2009.05.004; Goto A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4533; Gruden G, 2012, DIABETES CARE, V35, P125, DOI 10.2337/dc11-1739; Hashimoto T, 2013, INTERNAL MED, V52, P2721, DOI 10.2169/internalmedicine.52.0495; Higgins Trefor, 2009, J Diabetes Sci Technol, V3, P668; Liang WW, 2007, DIABETES CARE, V30, P2501, DOI 10.2337/dc07-0597; MALOUF R, 1985, ANN NEUROL, V17, P421, DOI 10.1002/ana.410170502; Mianowska B, 2011, DIABETOLOGIA, V54, P749, DOI 10.1007/s00125-010-2013-4; Nordfeldt S, 2000, J PEDIATR ENDOCR MET, V13, P529; Rossing P, 2001, DIABETIC MED, V18, P199, DOI 10.1046/j.1464-5491.2001.00446.x; Walker BR, 1997, J CLIN ENDOCR METAB, V82, P4015, DOI 10.1210/jc.82.12.4015	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	NOV	2014	93	23							e148	10.1097/MD.0000000000000148		6	Medicine, General & Internal	General & Internal Medicine	AU3NU	WOS:000345521300008		
J	Calvopina, M; Romero, D; Castaneda, B; Hashiguchi, Y; Sugiyama, H				Calvopina, Manuel; Romero, Daniel; Castaneda, Byron; Hashiguchi, Yoshihisa; Sugiyama, Hiromu			Current status of Paragonimus and paragonimiasis in Ecuador	MEMORIAS DO INSTITUTO OSWALDO CRUZ			English	Review						Paragonimus; paragonimiasis; review; epidemiology; zoonoses; Ecuador	HUMAN PULMONARY PARAGONIMIASIS; TRICLABENDAZOLE; MEXICANUS	A review of national and international publications on paragonimiasis in Ecuador, epidemiological records from the Ministry of Public Health and unpublished research data was conducted to summarise the current status of the parasite/disease. The purpose of the review is to educate physicians, policy-makers and health providers on the status of the disease and to stimulate scientific investigators to conduct further research. Paragonimiasis was first diagnosed in Ecuador 94 years ago and it is endemic to both tropical and subtropical regions in 19 of 24 provinces in the Pacific Coast and Amazon regions. Paragonimus mexicanus is the only known species in the country, with the mollusc Aroapyrgus colombiensis and the crabs Moreirocarcinus emarginatus, Hypolobocera chilensis and Hypolobocera aequatorialis being the primary and secondary intermediate hosts, respectively. Recent studies found P. mexicanus metacercariae in Trichodactylus faxoni crabs of the northern Amazon. Chronic pulmonary paragonimiasis is commonly misdiagnosed and treated as tuberculosis and although studies have demonstrated the efficacy of praziquantel and triclabendazole for the treatment of human infections, neither drug is available in Ecuador. Official data recorded from 1978-2007 indicate an annual incidence of 85.5 cases throughout the 19 provinces, with an estimated 17.2% of the population at risk of infection. There are no current data on the incidence/prevalence of infection, nor is there a national control programme.	[Calvopina, Manuel; Romero, Daniel; Castaneda, Byron; Hashiguchi, Yoshihisa] Univ Cent Ecuador, Ctr Biomed, Quito, Ecuador; [Hashiguchi, Yoshihisa] Secretaria Nacl Educ Super Ciencia Tecnol & Innov, Proyecto Prometeo, Quito, Ecuador; [Hashiguchi, Yoshihisa] Kochi Univ, Dept Parasitol, Kochi Med Sch, Kochi 780, Japan; [Sugiyama, Hiromu] Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan	Calvopina, M (reprint author), Univ Cent Ecuador, Ctr Biomed, Quito, Ecuador.	manuelcalvopina@gmail.com					Acha P, 2003, PARASITOSIS, VIII, P158; Amunarriz M, 1991, ESTUDIOS PATOLOGIAS, P77; Amunarriz M, 1991, TROP MED PARASITOL, V42, P160; Arzube R. M.E., 1978, REVISTA ECUATORIANA DE HIGIENE Y MEDICINA TROPICAL, V31, P73; Blair D, 1997, PARASITOLOGY, V15, P411; Brenes R.R., 1980, Brenesia, V18, P353; Calvopina M, 1998, T ROY SOC TROP MED H, V92, P566, DOI 10.1016/S0035-9203(98)90919-1; Calvopina M, 2003, T ROY SOC TROP MED H, V97, P451; Calvopina M, 1993, B CHIL PARASITOL, V17, P44; Calvopina M, 1995, ED MED CONTIN, V49, P18; Calvopina M, 1994, ED MED CONTIN, V44, P17; Carvajal Huerta L., 1979, REVISTA ECUATORIANA DE HIGIENE Y MEDICINA TROPICAL, V32, P69; Diaz G, 1991, B EPIDEMIOLOGICO; Fernandez T, 1990, REV FACULTAD CIEN ME, V2, P17; GUEVARA A, 1995, MEM I OSWALDO CRUZ, V90, P497; Guevara GA, 1999, VOZANDES, V12, P46; Heinert JF, 1922, ANALES SOC MED QUIRU, V2, P43; INEC - Instituto Nacional de Estadisticas y Censos/Ecuador, 2010, 7 CENS POBL 6 VIV; Iwagami M, 2003, J HELMINTHOL, V77, P33, DOI 10.1079/JOH2002147; KNOBLOCH J, 1984, T ROY SOC TROP MED H, V78, P835, DOI 10.1016/0035-9203(84)90038-5; Liu CT, 2012, KOREAN J PARASITOL, V50, P349, DOI 10.3347/kjp.2012.50.4.349; Lopez-Caballero J, 2013, MOL ECOL RESOUR, V13, P1125, DOI 10.1111/1755-0998.12093; MALEK EA, 1985, J PARASITOL, V71, P253, DOI 10.2307/3281912; MIYAZAKI I, 1968, Japanese Journal of Parasitology, V17, P445; Miyazaki I, 1980, OCCASIONAL PUBLICATI, V2; Miyazaki I, 1969, JPN J PARASITOL, V18, P23; Montalvan JA, 1968, REV FACULTAD CIEN ME, V3, P1; Palacios M, 1978, REV FACULTAD CIEN ME, V2, P57; Paredes L, 1978, REV ECUAT HIG MED TR, V31, P63; Penafiel W, 1981, REV FAC CIENCIAS MED, V6, P253; Rodriguez J, 1963, REV ECUAT MED CIENC, V1, P20; Savioli L., 2010, WORKING OVERCOME GLO; Severo LC, 2004, TRATADO MED TROPICAL, P299; Toscano C, 1994, PARAGONIMIASIS TUBER; Vaca O, 1989, ACTUALIDAD, V14, P19; VIEIRA JC, 1992, TROP MED PARASITOL, V43, P249; VOELKER J, 1979, TROPENMED PARASITOL, V30, P249; Waikagul Jitra, 2003, Bulletin of the Central Research Institute Fukuoka University Series E Interdisciplinary Sciences, V1, P259; World Health Organization. (WHO), 2011, REP WHO EXP CONS FOO; Yokogawa M., 1971, Revista euat Hig Med trop, V28, P75; Yokogawa M, 1983, PATHOBIOLOGICAL STUD	41	1	1	FUNDACO OSWALDO CRUZ	RIO DE JANEIRO, RJ	AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL	0074-0276	1678-8060		MEM I OSWALDO CRUZ	Mem. Inst. Oswaldo Cruz	NOV	2014	109	7					849	855		10.1590/0074-0276140042		7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	AU2FD	WOS:000345430900002		
J	Matsui, Y; Kikuchi, T; Inoue, T; Muraoka, O; Yamada, T; Tanaka, R				Matsui, Yuuki; Kikuchi, Takashi; Inoue, Takanobu; Muraoka, Osamu; Yamada, Takeshi; Tanaka, Reiko			Carapanolides J-L from the Seeds of Carapa guianensis (Andiroba) and Their Effects on LPS-Activated NO Production	MOLECULES			English	Article						Carapa guianensis; andiroba; seeds; gedunin; phragmalin; limonoids; NO production	BIOLOGICAL-ACTIVITIES; IN-VITRO; LIMONOIDS; MELIACEAE; AUBLET	A novel gedunin and two novel phragmalin-type limonoids, named carapanolides J-L (compounds 1-3) as well as a known gedunin-type limonoid 4 were isolated from the seeds of Carapa guianensis (andiroba). Their structures were determined on the basis of 1D and 2D NMR spectroscopy and HRFABMS. Compounds 1-4 were evaluated for their effects on the production of NO in LPS-activated mouse peritoneal macrophages.	[Matsui, Yuuki; Kikuchi, Takashi; Inoue, Takanobu; Yamada, Takeshi; Tanaka, Reiko] Osaka Univ Pharmaceut Sci, Med Chem Lab, Takatsuki, Osaka 5691094, Japan; [Muraoka, Osamu] Kinki Univ, Fac Pharmaceut Sci, Higashiosaka, Osaka 5778502, Japan	Tanaka, R (reprint author), Osaka Univ Pharmaceut Sci, Med Chem Lab, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan.	tanakar@gly.oups.ac.jp					Inoue T, 2012, TETRAHEDRON LETT, V53, P6685, DOI 10.1016/j.tetlet.2012.09.108; Ravangpai W, 2011, BIOORG MED CHEM LETT, V21, P4485, DOI 10.1016/j.bmcl.2011.06.010; Penido C, 2005, INFLAMM RES, V54, P295, DOI 10.1007/s00011-005-1357-6; Penido C, 2006, INFLAMM RES, V55, P457, DOI 10.1007/s00011-006-5161-8; Kirkeboen KA, 1999, ACTA ANAESTH SCAND, V43, P275; Inoue T, 2014, FITOTERAPIA, V96, P56, DOI 10.1016/j.fitote.2014.04.006; Tan QG, 2011, CHEM REV, V111, P7437, DOI 10.1021/cr9004023; Yamada T, 2011, BIOORGAN MED CHEM, V19, P4106, DOI 10.1016/j.bmc.2011.05.008; Ferraris FK, 2011, INT IMMUNOPHARMACOL, V11, P1, DOI 10.1016/j.intimp.2010.09.010; Inoue T, 2013, ORG LETT, V15, P3018, DOI 10.1021/ol400924u; Bickii J, 2000, J ETHNOPHARMACOL, V69, P27, DOI 10.1016/S0378-8741(99)00117-8; Tanaka Y, 2011, TETRAHEDRON, V67, P782, DOI 10.1016/j.tet.2010.11.028; Costa-Silva H, 2008, J ETHNOPHARMACOL, V116, P495; Malathi R., 2007, ACTA CRYSTALLOGR, VE63, P2483; Miranda RNC, 2012, J ETHNOPHARMACOL, V142, P679, DOI 10.1016/j.jep.2012.05.037; Prophiro J.S., 2012, PARASITOL RES, V110, P7699; Yamasaki F, 2013, J NAT MED-TOKYO, V67, P212, DOI 10.1007/s11418-012-0647-x	17	3	3	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	NOV	2014	19	11					17130	17140		10.3390/molecules191117130		11	Chemistry, Organic	Chemistry	AU4FC	WOS:000345564300004		
J	Ochiai, T; Ichihashi, E; Nishida, N; Machida, T; Uchida, Y; Hayashi, Y; Morito, Y; Fujishima, A				Ochiai, Tsuyoshi; Ichihashi, Erina; Nishida, Naoki; Machida, Tadashi; Uchida, Yoshitsugu; Hayashi, Yuji; Morito, Yuko; Fujishima, Akira			Field Performance Test of an Air-Cleaner with Photocatalysis-Plasma Synergistic Reactors for Practical and Long-Term Use	MOLECULES			English	Article						photocatalysis; plasma treatment; synergy; air-cleaner; field test; total suspended particulates; total volatile organic compounds; long-term usability	NONTHERMAL PLASMA; ENVIRONMENTAL PURIFICATION; PRODUCTS; TIO2; CO; NANOPARTICLES; ACETALDEHYDE; CHEMISTRY; OXIDATION; DISCHARGE	A practical and long-term usable air-cleaner based on the synergy of photocatalysis and plasma treatments has been developed. A field test of the air-cleaner was carried out in an office smoking room. The results were compared to previously reported laboratory test results. Even after a treatment of 12,000 cigarettes-worth of tobacco smoke, the air-cleaner maintained high-level air-purification activity (98.9% +/- 0.1% and 88% +/- 1% removal of the total suspended particulate (TSP) and total volatile organic compound (TVOC) concentrations, respectively) at single-pass conditions. Although the removal ratio of TSP concentrations was 98.6% +/- 0.2%, the ratio of TVOC concentrations was 43.8% after a treatment of 21,900 cigarettes-worth of tobacco smoke in the field test. These results indicate the importance of suitable maintenance of the reactors in the air-cleaner during field use.	[Ochiai, Tsuyoshi; Fujishima, Akira] Kanagawa Acad Sci & Technol, Takatsu Ku, Kawasaki, Kanagawa 2130012, Japan; [Ochiai, Tsuyoshi; Morito, Yuko; Fujishima, Akira] Tokyo Univ Sci, Photocatalysis Int Res Ctr, Noda, Chiba 2788510, Japan; [Ichihashi, Erina; Hayashi, Yuji] Im PACT World Co Ltd, Tama Ku, Kawasaki, Kanagawa 2140003, Japan; [Nishida, Naoki; Machida, Tadashi; Uchida, Yoshitsugu] Tanashin Denki Co Ltd, Setagaya Ku, Tokyo 1580081, Japan; [Morito, Yuko] U VIX Corp, Meguro Ku, Tokyo 1520034, Japan	Ochiai, T (reprint author), Kanagawa Acad Sci & Technol, Takatsu Ku, KSP East 407,3-2-1 Sakado, Kawasaki, Kanagawa 2130012, Japan.	pg-ochiai@newkast.or.jp; ichihashi@impact-world.jp; nishidan@tanashin.co.jp; machida@tanashin.co.jp; uchiday@tanashin.co.jp; hayashi@impact-world.jp; y.morito@u-vix.com; fujishima_akira@admin.tus.ac.jp					Ochiai T, 2012, J PHOTOCH PHOTOBIO C, V13, P247, DOI 10.1016/j.jphotochemrev.2012.07.001; Ochiai T, 2011, CATAL SCI TECHNOL, V1, P1324, DOI 10.1039/c1cy00185j; Assadi AA, 2014, CHEM ENG J, V254, P124, DOI 10.1016/j.cej.2014.05.101; Hofer M, 2011, J EUR CERAM SOC, V31, P2887, DOI 10.1016/j.jeurceramsoc.2011.07.016; Uhde E, 2007, ATMOS ENVIRON, V41, P3111, DOI 10.1016/j.atmosenv.2006.05.082; Sano T, 2006, J MOL CATAL A-CHEM, V245, P235, DOI 10.1016/j.molcata.2005.10.002; Wolkoff P, 2006, INDOOR AIR, V16, P7, DOI 10.1111/j.1600-0668.2005.00393.x; Assadi AA, 2014, CHEM ENG J, V258, P119, DOI 10.1016/j.cej.2014.07.050; Batterman S, 2005, ENVIRON SCI TECHNOL, V39, P7260, DOI 10.1021/es048951q; Caballero-Manrique G, 2014, INT J HYDROGEN ENERG, V39, P12859, DOI 10.1016/j.ijhydene.2014.06.089; Chan D, 2014, APPL CATAL B-ENVIRON, V156, P153, DOI 10.1016/j.apcatb.2014.03.009; Chen X, 2001, APPL CATAL A-GEN, V219, P25, DOI 10.1016/S0926-860X(01)00644-5; Cho MS, 2012, ATMOS ENVIRON, V63, P276, DOI 10.1016/j.atmosenv.2012.08.049; Klett C, 2014, J HAZARD MATER, V279, P356, DOI 10.1016/j.jhazmat.2014.07.014; Knudsen HN, 1999, ATMOS ENVIRON, V33, P1217, DOI 10.1016/S1352-2310(98)00278-7; Lee H., 2015, CHEM ENG J, V259, P761; Najafabadi MM, 2014, J ELECTROSTAT, V72, P402, DOI 10.1016/j.elstat.2014.06.005; Ochiai T., 2014, AM J ANAL CHEM, V5, P467; Ochiai T, 2012, CHEM ENG J, V209, P313, DOI 10.1016/j.cej.2012.07.139; Ochiai T, 2011, ELECTROCHEMISTRY, V79, P838, DOI 10.5796/electrochemistry.79.838; Reshetenko TV, 2014, J POWER SOURCES, V269, P344, DOI 10.1016/j.jpowsour.2014.06.146	21	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	NOV	2014	19	11					17424	17434		10.3390/molecules191117424		11	Chemistry, Organic	Chemistry	AU4FC	WOS:000345564300021		
J	Horikoshi, S; Serpone, N				Horikoshi, Satoshi; Serpone, Nick			Coupled Microwave/Photoassisted Methods for Environmental Remediation	MOLECULES			English	Review						photocatalyst; TiO2; microwave; non-thermal effect; wastewater treatment; microwave discharge electrodeless lamp	AQUEOUS TIO2 DISPERSIONS; MICROWAVE/UV-ILLUMINATION METHOD; PHOTOCATALYTIC DEGRADATION; ASSISTED DEGRADATION; ORGANIC-SYNTHESIS; TITANIUM-DIOXIDE; BISPHENOL-A; 2,4-DICHLOROPHENOXYACETIC ACID; PERFLUOROOCTANOIC ACID; DIELECTRIC-PROPERTIES	The microwave-induced acceleration of photocatalytic reactions was discovered serendipitously in the late 1990s. The activity of photocatalysts is enhanced significantly by both microwave radiation and UV light. Particularly relevant, other than as a heat source, was the enigmatic phenomenon of the non-thermal effect(s) of the microwave radiation that facilitated photocatalyzed reactions, as evidenced when examining various model contaminants in aqueous media. Results led to an examination of the possible mechanism(s) of the microwave effect(s). In the present article we contend that the microwaves' non-thermal effect(s) is an important factor in the enhancement of TiO2-photoassisted reactions involving the decomposition of organic pollutants in model wastewaters by an integrated (coupled) microwave-/UV-illumination method (UV/MW). Moreover, such coupling of no less than two irradiation methods led to the fabrication and ultimate investigation of microwave discharged electrodeless lamps (MDELs) as optimal light sources; their use is also described. The review focuses on the enhanced activity of photocatalytic reactions when subjected to microwave radiation and concentrates on the authors' research of the past few years.	[Horikoshi, Satoshi] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyodaku, Tokyo 1028554, Japan; [Serpone, Nick] Univ Pavia, Dipartimento Chim, PhotoGreen Lab, I-27100 Pavia, Italy	Horikoshi, S (reprint author), Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyodaku, 7-1 Kioicho, Tokyo 1028554, Japan.	horikosi@sophia.ac.jp; nick.serpone@unipv.it			Japan Society for the Promotion of Science (JSPS) [C-25420820]; Sophia University-wide Collaborative Research Fund	This article would not have been possible without the fruitful collaboration of many University and industrial researchers, and not least without the cooperation of many students whose names appear in many of the earlier publications. One of us (SH) is grateful to the Japan Society for the Promotion of Science for financial support (JSPS; Grant-in-aid for Scientific Research No. C-25420820). A grant from the Sophia University-wide Collaborative Research Fund to S.H is also appreciated. One of us (NS) thanks Albini of the University of Pavia (Italy) for his continued hospitality during the many winter semesters in his PhotoGreen Laboratory.	Konstantinou IK, 2004, APPL CATAL B-ENVIRON, V49, P1, DOI 10.1016/j.apcatb.2003.11.010; Muller TS, 1998, CHEMOSPHERE, V36, P2043, DOI 10.1016/S0045-6535(97)10089-3; BAHNEMANN DW, 1987, J PHYS CHEM-US, V91, P3782, DOI 10.1021/j100298a014; Hori H, 2004, ENVIRON SCI TECHNOL, V38, P6118, DOI 10.1021/es049719n; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; HASHIMOTO K, 1984, J PHYS CHEM-US, V88, P4083, DOI 10.1021/j150662a046; Horikoshi S, 2003, ENVIRON SCI TECHNOL, V37, P5813, DOI 10.1021/es030326i; Horikoshi S, 2011, J PHOTOCH PHOTOBIO A, V222, P97, DOI 10.1016/j.jphotochem.2011.05.007; Terashima Y, 2006, WATER SCI TECHNOL, V54, P55, DOI 10.2166/wst.2006.858; BARBENI M, 1987, CHEMOSPHERE, V16, P1165, DOI 10.1016/0045-6535(87)90054-3; Hori H, 2005, ENVIRON SCI TECHNOL, V39, P2383, DOI 10.1021/es0484754; SERPONE N, 1995, J PHYS CHEM-US, V99, P16655, DOI 10.1021/j100045a027; Key BD, 1997, ENVIRON SCI TECHNOL, V31, P2445, DOI 10.1021/es961007c; GEDYE R, 1986, TETRAHEDRON LETT, V27, P279, DOI 10.1016/S0040-4039(00)83996-9; Kuznetsov VN, 2009, J PHYS CHEM C, V113, P15110, DOI 10.1021/jp901034t; [Anonymous], 2007, R170322007 JAP STAND; Houde M, 2006, ENVIRON SCI TECHNOL, V40, P3463, DOI 10.1021/es052580b; Horikoshi S, 2003, CHEM PHYS LETT, V376, P475, DOI 10.1016/S0009-2614(03)01007-8; Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k; Kabra K, 2004, IND ENG CHEM RES, V43, P7683, DOI 10.1021/ie0498551; Anpo M, 2000, PURE APPL CHEM, V72, P1265, DOI 10.1351/pac200072071265; Horikoshi S, 2013, J PHOTOCH PHOTOBIO A, V265, P20, DOI 10.1016/j.jphotochem.2013.05.010; Schultz MM, 2003, ENVIRON ENG SCI, V20, P487, DOI 10.1089/109287503768335959; Bhatkhande DS, 2002, J CHEM TECHNOL BIOT, V77, P102, DOI 10.1002/jctb.532; Horikoshi S, 2003, J PHOTOCH PHOTOBIO A, V159, P289, DOI 10.1016/S1010-6030(03)00185-0; GIGUERE RJ, 1986, TETRAHEDRON LETT, V27, P4945, DOI 10.1016/S0040-4039(00)85103-5; Horikoshi S, 2007, J PHOTOCH PHOTOBIO A, V188, P1, DOI 10.1016/j.jphotochem.2006.11.010; ATKINSON A, 1995, BIOCHEM BIOPH RES CO, V210, P424, DOI 10.1006/bbrc.1995.1678; CHAMARRO E, 1993, J CHEM TECHNOL BIOT, V57, P273; Chen J, 2007, J ENVIRON SCI-CHINA, V19, P387, DOI 10.1016/S1001-0742(07)60064-3; DOLIVEIRA JC, 1993, J PHOTOCH PHOTOBIO A, V72, P261, DOI 10.1016/1010-6030(93)80022-2; Fujishima A., 1999, TIO2 PHOTOCATALYSIS; Ge M., 2006, P ASME 2006 MULT NAN, P10016; Horikoshi S, 2009, APPL CATAL B-ENVIRON, V91, P362, DOI 10.1016/j.apcatb.2009.06.008; Horikoshi S, 2009, J PHYS CHEM C, V113, P5649, DOI 10.1021/jp810002z; Horikoshi S., 2014, UNPUB; Horikoshi S, 2009, PHOTOCH PHOTOBIO SCI, V8, P1087, DOI 10.1039/b818491g; Horikoshi S., 2008, J JPN SOC COLOR MAT, V82, P51; Horikoshi S, 2009, J PHOTOCH PHOTOBIO C, V10, P96, DOI 10.1016/j.jphotochemrev.2009.06.001; Horikoshi S, 2009, CHEM PHYS LETT, V470, P304, DOI 10.1016/j.cplett.2009.01.051; Horikoshi S, 2009, APPL CATAL B-ENVIRON, V89, P284, DOI 10.1016/j.apcatb.2009.02.019; Horikoshi S, 2008, NEW J CHEM, V32, P2257, DOI 10.1039/b810142f; Horikoshi S, 2002, ENVIRON SCI TECHNOL, V36, P1357, DOI 10.1021/es010941r; Kingston H. M., 1997, MICROWAVE ENHANCED C; Konstantinou K., 2003, APPL CATAL B-ENVIRON, V42, P319; Loupy A, 2006, CHIM OGGI, V24, P36; Mailhot G, 1999, APPL ORGANOMET CHEM, V13, P53; MINERO C, 1993, CHEMOSPHERE, V26, P2103, DOI 10.1016/0045-6535(93)90337-5; NOME F, 1982, J PHYS CHEM-US, V86, P1881, DOI 10.1021/j100207a030; PELIZZETTI E, 1993, COORDIN CHEM REV, V125, P183, DOI 10.1016/0010-8545(93)85017-X; PELIZZETTI E, 1991, NEW J CHEM, V15, P351; SABIN F, 1992, J PHOTOCH PHOTOBIO A, V63, P99, DOI 10.1016/1010-6030(92)85157-P; TUNESI S, 1987, CHEMOSPHERE, V16, P1447, DOI 10.1016/0045-6535(87)90084-1; Watanabe N, 2003, NEW J CHEM, V27, P836, DOI 10.1039/b211963n; Zhou QX, 2007, J CHROMATOGR A, V1147, P10, DOI 10.1016/j.chroma.2007.02.081	55	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	NOV	2014	19	11					18102	18128		10.3390/molecules191118102		27	Chemistry, Organic	Chemistry	AU4FC	WOS:000345564300060		
J	Nosaka, Y; Nishikawa, M; Nosaka, AY				Nosaka, Yoshio; Nishikawa, Masami; Nosaka, Atsuko Y.			Spectroscopic Investigation of the Mechanism of Photocatalysis	MOLECULES			English	Review						ESR; NMR; OH radical; superoxide radical; H2O2; acetaldehyde; metal doped TiO2; glutathione; amino acids; visible-light responsive photocatalysts	VISIBLE-LIGHT IRRADIATION; TIO2 PHOTOCATALYSIS; CHEMILUMINESCENCE PHOTOMETRY; AQUEOUS SUSPENSION; RADICAL FORMATION; TITANIUM-DIOXIDE; ESR SPECTROSCOPY; QUANTITATIVE DETECTION; WO3 PHOTOCATALYSTS; HYDROGEN-PEROXIDE	Reaction mechanisms of various kinds of photocatalysts have been reviewed based on the recent reports, in which various spectroscopic techniques including luminol chemiluminescence photometry, fluorescence probe method, electron spin resonance (ESR), and nuclear magnetic resonance (NMR) spectroscopy were applied. The reaction mechanisms elucidated for bare and modified TiO2 were described individually. The modified visible light responsive TiO2 photocatalysts, i.e., Fe(III)-deposited metal-doped TiO2 and platinum complex-deposited TiO2, were studied by detecting paramagnetic species with ESR, center dot O-2(-) (or H2O2) with chemiluminescence photometry, and OH radicals with a fluorescence probe method. For bare TiO2, the difference in the oxidation mechanism for the different crystalline form was investigated by the fluorescence probe method, while the adsorption and decomposition behaviors of several amino acids and peptides were investigated by H-1-NMR spectroscopy.	[Nosaka, Yoshio; Nishikawa, Masami; Nosaka, Atsuko Y.] Nagaoka Univ Technol, Nagaoka, Niigata 9402188, Japan	Nosaka, Y (reprint author), Nagaoka Univ Technol, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	nosaka@nagaokaut.ac.jp; nishikawa@nagaokaut.ac.jp; aynosaka@mst.nagaokaut.ac.jp					Nishikawa M, 2012, J PHYS CHEM C, V116, P14900, DOI 10.1021/jp3020657; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Zhang J, 2013, J PHYS CHEM C, V117, P1383, DOI 10.1021/jp3105166; Louit G, 2005, RADIAT PHYS CHEM, V72, P119, DOI 10.1016/j.radphyschem.2004.09.007; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; Henderson MA, 2011, SURF SCI REP, V66, P185, DOI 10.1016/j.surfrep.2011.01.001; Irie H, 2008, CHEM PHYS LETT, V457, P202, DOI 10.1016/j.cplett.2008.04.006; Ikeda K, 1997, J PHYS CHEM B, V101, P2617, DOI 10.1021/jp9627281; Nosaka Y, 2003, PHYS CHEM CHEM PHYS, V5, P4731, DOI 10.1039/b307433a; Zhang J, 2014, J PHYS CHEM C, V118, P10824, DOI 10.1021/jp501214m; Macyk W, 2001, CHEM-EUR J, V7, P1862, DOI 10.1002/1521-3765(20010504)7:9<1862::AID-CHEM1862>3.3.CO;2-7; Yu H, 2010, J PHYS CHEM C, V114, P16481, DOI 10.1021/jp1071956; Hirakawa T, 2007, APPL CATAL A-GEN, V325, P105, DOI 10.1016/j.apcata.2007.03.015; Dadjour MF, 2006, WATER RES, V40, P1137, DOI 10.1016/j.watres.2005.12.047; Ohno T, 2001, J PHYS CHEM B, V105, P2417, DOI 10.1021/jp003211z; Nishikawa M, 2012, J PHYS CHEM A, V116, P9674, DOI 10.1021/jp307304y; Matsushita M, 2007, CATAL TODAY, V120, P240, DOI 10.1016/j.cattod.2006.07.046; Fenoglio I, 2009, CHEM-EUR J, V15, P4614, DOI 10.1002/chem.200802542; Nishikawa M, 2014, APPL CATAL B-ENVIRON, V160, P722, DOI 10.1016/j.apcatb.2014.05.020; Liu M, 2013, J AM CHEM SOC, V135, P10064, DOI 10.1021/ja401541k; Maldotti A, 2002, CHEM REV, V102, P3811, DOI 10.1021/cr010364p; Burgeth G, 2002, COORDIN CHEM REV, V230, P41; Horie M, 2012, CHEM RES TOXICOL, V25, P605, DOI 10.1021/tx200470e; Fujishima A, 2008, SURF SCI REP, V63, P515, DOI 10.1016/j.surfrep.2008.10.001; Nosaka Y, 2011, J PHYS CHEM C, V115, P21283, DOI 10.1021/jp2070634; Nosaka AY, 2006, J PHYS CHEM B, V110, P8380, DOI 10.1021/jp060894v; Niishiro R, 2007, J PHYS CHEM C, V111, P17420, DOI 10.1021/jp074707k; Hirakawa T, 2008, J PHYS CHEM C, V112, P15818, DOI 10.1021/jp8055015; Nakabayashi Y, 2013, J PHYS CHEM C, V117, P23832, DOI 10.1021/jp408244h; Anpo M, 2010, NANOSTRUCT SCI TECHN, P1, DOI 10.1007/978-0-387-48444-0; Bard A.J., 1985, STANDARD POTENTIALS; Gerald L.N., 2006, RADIAT PHYS CHEM, V75, P473; Imanishi A, 2014, J PHYS CHEM LETT, V5, P2108, DOI 10.1021/jz5004704; Ishibai Y, 2008, APPL CATAL B-ENVIRON, V79, P117, DOI 10.1016/j.apcatb.2007.09.040; Ishiguro H, 2011, PHOTOCH PHOTOBIO SCI, V10, P1825, DOI 10.1039/c1pp05192j; Kaneko M, 2002, PHOTOCATALYSIS SCI T; Koizumi Y, 2013, J PHYS CHEM A, V117, P7705, DOI 10.1021/jp404891h; Koppen S, 2008, J PHYS CHEM C, V112, P13600, DOI 10.1021/jp803354z; MASTIKHIN VM, 1991, PROG NUCL MAG RES SP, V23, P259, DOI 10.1016/0079-6565(91)80006-N; Nosaka AY, 2013, PHOTOCATALYSIS WATER, P3; Nosaka AY, 2012, J PHYS CHEM B, V116, P11098, DOI 10.1021/jp3057338; Nosaka AY, 2014, J PHYS CHEM B, V118, P7561, DOI 10.1021/jp503546z; Nosaka Y, 1997, J PHYS CHEM B, V101, P5822, DOI 10.1021/jp970400h; Oguma J, 2013, APPL CATAL B-ENVIRON, V129, P282, DOI 10.1016/j.apcatb.2012.09.034; Oropeza FE, 2011, CHEM PHYS LETT, V515, P249, DOI 10.1016/j.cplett.2011.09.017; Petkovic J., 2011, J PHYS C SER, V304, P1; Pichat P., 2013, PHOTOCATALYSIS WATER	47	3	3	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	NOV	2014	19	11					18248	18267		10.3390/molecules191118248		20	Chemistry, Organic	Chemistry	AU4FC	WOS:000345564300068		
J	Ifuku, S				Ifuku, Shinsuke			Chitin and Chitosan Nanofibers: Preparation and Chemical Modifications	MOLECULES			English	Review						chitin; chitosan; nanofiber; chemical modification	OPTICALLY TRANSPARENT COMPOSITES; DRUG CONTROLLED-RELEASE; ALPHA-CHITIN; BACTERIAL CELLULOSE; UNIFORM WIDTH; IMPROVE DISPERSIBILITY; MECHANICAL-PROPERTIES; BETA-CHITIN; ACID; PHTHALOYLATION	Chitin nanofibers are prepared from the exoskeletons of crabs and prawns, squid pens and mushrooms by a simple mechanical treatment after a series of purification steps. The nanofibers have fine nanofiber networks with a uniform width of approximately 10 nm. The method used for chitin-nanofiber isolation is also successfully applied to the cell walls of mushrooms. Commercial chitin and chitosan powders are also easily converted into nanofibers by mechanical treatment, since these powders consist of nanofiber aggregates. Grinders and high-pressure waterjet systems are effective for disintegrating chitin into nanofibers. Acidic conditions are the key factor to facilitate mechanical fibrillation. Surface modification is an effective way to change the surface property and to endow nanofiber surface with other properties. Several modifications to the chitin NF surface are achieved, including acetylation, deacetylation, phthaloylation, naphthaloylation, maleylation, chlorination, TEMPO-mediated oxidation, and graft polymerization. Those derivatives and their properties are characterized.	Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808550, Japan	Ifuku, S (reprint author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, 4-101 Koyama Cho Minami, Tottori 6808550, Japan.	sifuku@chem.tottori-u.ac.jp					Abe K, 2014, CELLULOSE, V21, P535, DOI 10.1007/s10570-013-0095-0; Worley SD, 2003, SURF COAT INT PT B-C, V86, P273, DOI 10.1007/BF02699499; Ito I, 2014, CARBOHYD POLYM, V101, P464, DOI 10.1016/j.carbpol.2013.09.074; Ivshina TN, 2009, APPL BIOCHEM MICRO+, V45, P313, DOI 10.1134/S0003683809030132; Ifuku S, 2011, CARBOHYD POLYM, V84, P762, DOI 10.1016/j.carbpol.2010.04.039; Ifuku S, 2009, BIOMACROMOLECULES, V10, P1584, DOI 10.1021/bm900163d; Raabe D, 2005, ACTA MATER, V53, P4281, DOI 10.1016/j.actamat.2005.05.027; WORLEY SD, 1988, CRIT REV ENV CONTR, V18, P133; Nogi M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2403901; Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006; Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719; Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7; Kurita K, 2002, BIOMACROMOLECULES, V3, P1, DOI 10.1021/bm0101163; Azuma K, 2012, CARBOHYD POLYM, V87, P1399, DOI 10.1016/j.carbpol.2011.09.036; MICHALENKO GO, 1976, J GEN MICROBIOL, V92, P251; Zivanovic S, 2003, J FOOD SCI, V68, P1860, DOI 10.1111/j.1365-2621.2003.tb12343.x; Muzzarelli RAA, 2011, TOP GEOBIOL, V34, P1, DOI 10.1007/978-90-481-9684-5_1; Dutta AK, 2013, CARBOHYD POLYM, V97, P363, DOI 10.1016/j.carbpol.2013.05.010; Ifuku S, 2011, GREEN CHEM, V13, P1708, DOI 10.1039/c1gc15321h; Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P; Azuma K, 2014, J BIOMED NANOTECHNOL, V10, P2891, DOI 10.1166/jbn.2014.1882; Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087; Nakagaito AN, 2005, APPL PHYS A-MATER, V80, P93, DOI 10.1007/s00339-004-2932-3; Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7; Fan YM, 2010, CARBOHYD POLYM, V79, P1046, DOI 10.1016/j.carbpol.2009.10.044; Ding FY, 2014, NANOSCALE, V6, P9477, DOI 10.1039/c4nr02814g; Ifuku S, 2012, NANOSCALE, V4, P3308, DOI 10.1039/c2nr30383c; PETER MG, 1995, J MACROMOL SCI PURE, VA32, P629, DOI 10.1080/10601329508010276; Nakagaito AN, 2013, J BIOBASED MATER BIO, V7, P152, DOI 10.1166/jbmb.2013.1271; Kocer HB, 2011, ACS APPL MATER INTER, V3, P2845, DOI 10.1021/am200351w; Mahdavinia GR, 2004, EUR POLYM J, V40, P1399, DOI 10.1016/j.europolymj.2004.01.039; Ifuku S, 2014, CARBOHYD POLYM, V101, P714, DOI 10.1016/j.carbpol.2013.09.076; Kim DY, 2002, CELLULOSE, V9, P361, DOI 10.1023/A:1021140726936; Min BM, 2004, POLYMER, V45, P7137, DOI 10.1016/j.polymer.2004.08.048; Azuma K, 2012, CARBOHYD POLYM, V90, P197, DOI 10.1016/j.carbpol.2012.05.023; Ifuku S, 2013, CARBOHYD POLYM, V98, P1198, DOI 10.1016/j.carbpol.2013.07.033; Wang Q, 2007, EUR J PHARM BIOPHARM, V66, P398, DOI 10.1016/j.ejpb.2006.11.011; Ifuku S, 2011, MATERIALS, V4, P1417, DOI 10.3390/ma4081417; Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597; Chen PY, 2008, ACTA BIOMATER, V4, P587, DOI 10.1016/j.actbio.2007.12.010; Fan YM, 2008, BIOMACROMOLECULES, V9, P1919, DOI 10.1021/bm800178b; Muzzarelli RAA, 2012, CARBOHYD POLYM, V87, P995, DOI 10.1016/j.carbpol.2011.09.063; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; Ifuku S, 2007, BIOMACROMOLECULES, V8, P1973, DOI 10.1021/bm070113b; Abe K, 2007, BIOMACROMOLECULES, V8, P3276, DOI 10.1021/bm700624p; Azuma K., 2014, Bioactive Carbohydrates and Dietary Fibre, V3, P1; BEMILLER JN, 1962, J ORG CHEM, V27, P1161, DOI 10.1021/jo01051a009; Das P, 2012, BIOMACROMOLECULES, V13, P4205, DOI 10.1021/bm3014796; DUTTA A, 2013, DIR DEV, P1; Dutta A.K., CARBOHYDR POLYM, V115, P342; Fan Y, 2008, BIOMACROMOLECULES, V9, P192, DOI 10.1021/bm700966g; Gopalan N. K., 2003, BIOMACROMOLECULES, V4, P657; Ifuku S, 2012, CARBOHYD POLYM, V89, P865, DOI 10.1016/j.carbpol.2012.04.022; Ifuku S, 2011, GREEN CHEM, V13, P1499, DOI 10.1039/c0gc00860e; Ifuku S, 2010, BIOMACROMOLECULES, V11, P1326, DOI 10.1021/bm100109a; Ifuku S., 2013, J CHITIN CHITOSAN SC, V1, P1; Ifuku S, 2014, RSC ADV, V4, P19246, DOI 10.1039/c4ra01975j; Ifuku S., 2013, BIOPOLYMER NANOCOMPO, V2, P11; Ifuku S., 2012, J NANOMATER, V2012, P1; Ifuku S, 2012, CARBOHYD POLYM, V90, P623, DOI 10.1016/j.carbpol.2012.05.087; Ifuku S., 2014, REACT FUNCT IN PRESS; Ito I., 2014, J CHITIN CHITOSAN SC, V2, P82; Iwamoto S, 2005, APPL PHYS A-MATER, V81, pCP8, DOI 10.1007/s00339-005-3316-z; Jang SI, 2012, MOLECULES, V17, P2992, DOI 10.3390/molecules17032992; Loria-Bastarrachea MI, 2002, J APPL POLYM SCI, V83, P386, DOI 10.1002/app.10026; Muzzarelli R. A. A., 2012, POLYM SCI COMPREHENS, V10, P153; ShimaharaK Takiguchi Y., 1998, METHOD ENZYMOL, V6, P417; Torres-Rendon JG, 2014, BIOMACROMOLECULES, V15, P2709, DOI 10.1021/bm500566m; Wang LL, 2006, CELLULOSE, V13, P191, DOI 10.1007/s10570-005-9043-y; Wang Q, 2008, J BIOMED MATER RES A, V85A, P881, DOI 10.1002/jbm.a.31544; Yano I., 1977, KAGAKU TO SEIBUTSU, V15, P328	71	9	10	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	NOV	2014	19	11					18367	18380		10.3390/molecules191118367		14	Chemistry, Organic	Chemistry	AU4FC	WOS:000345564300075		
J	Sasaki, N; Nishizaki, Y; Ozeki, Y; Miyahara, T				Sasaki, Nobuhiro; Nishizaki, Yuzo; Ozeki, Yoshihiro; Miyahara, Taira			The Role of Acyl-Glucose in Anthocyanin Modifications	MOLECULES			English	Review						acyltransferase; anthocyanin; Arabidopsis; carnation; delphinium; glucosyltransferase	CARBOXYPEPTIDASE-LIKE PROTEIN; P-HYDROXYBENZOYL-GLUCOSE; ARABIDOPSIS-THALIANA; UDP-GLUCOSE; SERINE CARBOXYPEPTIDASE; DIANTHUS-CARYOPHYLLUS; CENTAUREA-CYANUS; SALICYLIC-ACID; DEPENDENT GLUCOSYLTRANSFERASE; 5-AROMATIC ACYLTRANSFERASE	Higher plants can produce a wide variety of anthocyanin molecules through modification of the six common anthocyanin aglycons that they present. Thus, hydrophilic anthocyanin molecules can be formed and stabilized by glycosylation and acylation. Two types of glycosyltransferase (GT) and acyltransferase (AT) have been identified, namely cytoplasmic GT and AT and vacuolar GT and AT. Cytoplasmic GT and AT utilize UDP-sugar and acyl-CoA as donor molecules, respectively, whereas both vacuolar GT and AT use acyl-glucoses as donor molecules. In carnation plants, vacuolar GT uses aromatic acyl-glucoses as the glucose donor in vivo; independently, vacuolar AT uses malylglucose, an aliphatic acyl-glucose, as the acyl-donor. In delphinium and Arabidopsis, p-hydroxybenzoylglucose and sinapoylglucose are used in vivo as bi-functional donor molecules by vacuolar GT and AT, respectively. The evolution of these enzymes has allowed delphinium and Arabidopsis to utilize unique donor molecules for production of highly modified anthocyanins.	[Sasaki, Nobuhiro] Iwate Biotechnol Res Ctr, Kitakami, Iwate 0240003, Japan; [Nishizaki, Yuzo; Ozeki, Yoshihiro; Miyahara, Taira] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan	Ozeki, Y (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Nakacho, Koganei, Tokyo 1848588, Japan.	n-sasaki@ibrc.or.jp; ynishizak@nihs.go.jp; ozeky@cc.tuat.ac.jp; miyahara@cc.tuat.ac.jp	Ozeki, Yoshihiro/C-2052-2013	Ozeki, Yoshihiro/0000-0002-3002-368X	 [23370016]	This work was supported by Grant-in-Aid for Scientific Research (B) (23370016) to Y.O.	Luang S, 2013, J BIOL CHEM, V288, P10111, DOI 10.1074/jbc.M112.423533; Lehfeldt C, 2000, PLANT CELL, V12, P1295, DOI 10.1105/tpc.12.8.1295; Fujiwara H, 1997, EUR J BIOCHEM, V249, P45, DOI 10.1111/j.1432-1033.1997.t01-1-00045.x; Kubo H, 2007, J PLANT RES, V120, P445, DOI 10.1007/s10265-006-0067-7; Honda T, 2002, HETEROCYCLES, V56, P633; Li AX, 2000, P NATL ACAD SCI USA, V97, P6902, DOI 10.1073/pnas.110154197; Nakatsuka T, 2011, PLANT BIOTECHNOL-NAR, V28, P173, DOI 10.5511/plantbiotechnology.10.1101b; Yoshida K, 2009, NAT PROD REP, V26, P884, DOI 10.1039/b800165k; Nakatsuka T, 2010, J PLANT PHYSIOL, V167, P231, DOI 10.1016/j.jplph.2009.08.007; Hause B, 2002, PLANTA, V215, P26, DOI 10.1007/s00425-001-0716-y; Veitch NC, 2008, NAT PROD REP, V25, P555, DOI 10.1039/b718040n; Fraser CM, 2007, PLANT PHYSIOL, V144, P1986, DOI 10.1104/pp.107.098970; Miyahara T, 2013, J PLANT PHYSIOL, V170, P619, DOI 10.1016/j.jplph.2012.12.001; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Matsuba Y, 2010, PLANT CELL, V22, P3374, DOI 10.1105/tpc.110.077487; Hall D, 2007, PLANT J, V49, P579, DOI 10.1111/j.1365-313X.2006.02987.x; Meissner D, 2008, PLANTA, V228, P663, DOI 10.1007/s00425-008-0768-3; Landmann C, 2007, PLANTA, V226, P417, DOI 10.1007/s00425-007-0492-4; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Lee S, 2012, PLANT J, V72, P411, DOI 10.1111/j.1365-313X.2012.05096.x; D'Auria JC, 2007, FEBS LETT, V581, P872, DOI 10.1016/j.febslet.2007.01.060; Baumert A, 2005, PHYTOCHEMISTRY, V66, P1334, DOI 10.1016/j.phytochem.2005.02.031; Bloor SJ, 2002, PHYTOCHEMISTRY, V59, P343, DOI 10.1016/S0031-9422(01)00460-5; Lunkenbein S, 2006, PLANT PHYSIOL, V140, P1047, DOI 10.1104/pp.105.074955; Abe Y, 2008, BIOCHEM BIOPH RES CO, V373, P473, DOI 10.1016/j.bbrc.2008.04.153; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Luo J, 2007, PLANT J, V50, P678, DOI 10.1111/j.1365-313X.2007.03079.x; Ford CM, 1998, J BIOL CHEM, V273, P9224, DOI 10.1074/jbc.273.15.9224; Fukuchi-Mizutani M, 2003, PLANT PHYSIOL, V132, P1652, DOI 10.1104/pp.102.018242; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; Nishizaki Y, 2013, PLANT CELL, V25, P4150, DOI 10.1105/tpc.113.113167; Fujiwara H, 1998, PLANT J, V16, P421, DOI 10.1046/j.1365-313x.1998.00312.x; Liu YJ, 2012, J BIOL CHEM, V287, P44406, DOI 10.1074/jbc.M112.403071; Bloor SJ, 1998, PHYTOCHEMISTRY, V49, P225, DOI 10.1016/S0031-9422(97)01051-0; BOKERN M, 1988, PLANTA, V174, P101, DOI 10.1007/BF00394880; D'Abrosca B, 2010, NAT PROD COMMUN, V5, P99; Dean JV, 2008, PHYSIOL PLANTARUM, V132, P417, DOI [10.1111/j.1399-3054.2007.01041.x, 10.1111/j.1399-3054.2007.01041.X]; Eudes A, 2008, J BIOL CHEM, V283, P15451, DOI 10.1074/jbc.M709591200; Frohlich B, 2002, PLANTA, V216, P168, DOI 10.1007/s00425-002-0877-3; GLASSGEN WE, 1992, PLANTA, V186, P582; GOTO T, 1991, ANGEW CHEM INT EDIT, V30, P17, DOI 10.1002/anie.199100171; Haiter J.H.B., 2009, ANTHOYCANINS BIOSYNT, P1; Hashimoto F, 2002, BIOSCI BIOTECH BIOCH, V66, P1652, DOI 10.1271/bbb.66.1652; Kita M, 2000, FEBS LETT, V469, P173, DOI 10.1016/S0014-5793(00)01275-8; Lee H, 1999, J BIOL CHEM, V274, P36637, DOI 10.1074/jbc.274.51.36637; Lee Y, 2005, J PLANT BIOL, V48, P356; Li AX, 1999, PLANT PHYSIOL, V121, P453, DOI 10.1104/pp.121.2.453; Lim EK, 2001, J BIOL CHEM, V276, P4344, DOI 10.1074/jbc.M007263200; Matsuba Y, 2008, PLANT BIOTECHNOL, V25, P369, DOI 10.5511/plantbiotechnology.25.369; Miyahara T, 2012, J PLANT PHYSIOL, V169, P1321, DOI 10.1016/j.jplph.2012.05.004; Miyahara T., 2014, PLANT BIOTE IN PRESS; Mock H.-P., 1993, PHYTOCHEMISTRY, V32, P515; Nakayama M, 2000, PHYTOCHEMISTRY, V55, P937, DOI 10.1016/S0031-9422(00)00263-6; Nishizaki Y, 2014, J EXP BOT, V65, P2495, DOI 10.1093/jxb/eru134; Ogata J., 2004, PLANT BIOTECHNOL, V21, P367, DOI 10.5511/plantbiotechnology.21.367; Okamura M, 2013, EUPHYTICA, V191, P45, DOI 10.1007/s10681-012-0859-x; Ozeki Y., 2011, PLANT METABOLISM BIO, P321; Sasaki N., 2014, PLANT CELL IN PRESS; SHARMA V, 1985, PLANTA, V163, P563, DOI 10.1007/BF00392714; Shirley AM, 2001, PLANT J, V28, P83, DOI 10.1046/j.1365-313X.2001.01123.x; Taguchi G, 2000, PLANT SCI, V157, P105, DOI 10.1016/S0168-9452(00)00270-3; TAKEDA K, 1988, PHYTOCHEMISTRY, V27, P1228; Takeda K, 2005, PHYTOCHEMISTRY, V66, P1607, DOI 10.1016/j.phytochem.2005.04.002; Tamura T., 1983, TETRAHEDRON LETT, V24, P5749; Teng XF, 2008, HELV CHIM ACTA, V91, P1305, DOI 10.1002/hlca.200890142; TERAHARA N, 1986, PHYTOCHEMISTRY, V25, P1715, DOI 10.1016/S0031-9422(00)81242-X; TERAHARA N, 1986, PHYTOCHEMISTRY, V25, P2906, DOI 10.1016/S0031-9422(00)83769-3; Umemoto N., 2009, P 5 INT WORKSH ANTH, P115; YAMAGUCHI M, 1995, PHYTOCHEMISTRY, V39, P311, DOI 10.1016/0031-9422(94)00967-X; Yonekura-Sakakibara K, 2012, PLANT J, V69, P154, DOI 10.1111/j.1365-313X.2011.04779.x; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x; Yonekura-Sakakibara Keiko, 2009, P169, DOI 10.1007/978-0-387-77335-3_6	74	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	NOV	2014	19	11					18747	18766		10.3390/molecules191118747		20	Chemistry, Organic	Chemistry	AU4FC	WOS:000345564300099		
J	Wang, L; Switalska, M; Wang, N; Du, ZJ; Fukumoto, Y; Diep, NK; Kiguchi, R; Nokami, J; Wietrzyk, J; Inokuchi, T				Wang, Li; Switalska, Marta; Wang, Ning; Du, Zhen-Jun; Fukumoto, Yuta; Diep, Nguyen Kim; Kiguchi, Ryo; Nokami, Junzo; Wietrzyk, Joanna; Inokuchi, Tsutomu			Design, Synthesis, and Biological Evaluation of Artemisinin-Indoloquinoline Hybrids as Potent Antiproliferative Agents	MOLECULES			English	Article						artemisinin; indoloquinoline; hybrid; antiproliferative activity; cytotoxicity	DIHYDROARTEMISININ INDUCES APOPTOSIS; TOPOISOMERASE-II INHIBITORS; CRYPTOLEPIS-SANGUINOLENTA; CANCER-CELLS; IN-VITRO; ANTIPLASMODIAL ACTIVITY; ALKALOIDS CRYPTOLEPINE; QINGHAOSU ARTEMISININ; ANTIFUNGAL ACTIVITIES; ANTICANCER ACTIVITY	A series of artemisinin-indoloquinoline hybrids were designed and synthesized in an attempt to develop potent and selective anti-tumor agents. Compounds 7a-7f, 8 and 9 were prepared and characterized. Their antiproliferative activities against MV4-11, HCT-116, A549, and BALB/3T3 cell lines in vitro were tested. Nearly all of the tested compounds (7-9, except for compounds 7d and 7e against HCT-116) showed an increased antitumor activity against HCT-116 and A549 cell lines when compared to the dihydroartemisinin control. Especially for the artemisinin-indoloquinoline hybrid 8, with an 11-aminopropylamino-10H-indolo[3,2-b] quinoline substituent, the antiproliferative activity against the A549 cell line had improved more than ten times. The IC50 value of hybrid 8 against A549 cell lines was decreased to 1.328 +/- 0.586 mu M, while dihydroartemisin showed IC50 value of >20 mu M in the same cell line. Thus, these results have proven that the strategy of introducing a planar basic fused aromatic moiety, such as the indoloquinoline skeleton, could improve the antiproliferative activity and selectivity towards cancer cell lines.	[Wang, Li; Wang, Ning; Fukumoto, Yuta; Diep, Nguyen Kim; Kiguchi, Ryo; Inokuchi, Tsutomu] Okayama Univ, Grad Sch Nat Sci & Technol, Div Chem & Biotechnol, Kita Ku, Okayama 7008530, Japan; [Switalska, Marta; Wietrzyk, Joanna] Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland; [Du, Zhen-Jun; Nokami, Junzo] Okayama Univ Sci, Fac Engn, Dept Appl Chem, Kita Ku, Okayama 7000005, Japan	Wietrzyk, J (reprint author), Polish Acad Sci, Inst Immunol & Expt Therapy, 12 R Weigl St, PL-53114 Wroclaw, Poland.	liwang_512@163.com; switalska@iitd.pan.wroc.pl; wn12171982@sina.com; duzhenjun@hotmail.com; en422758@s.okayama-u.ac.jp; Nguyen-Kim.Diep@unilever.com; a-k_g.dempsey.20_49@docomo.ne.jp; nogami@dac.ous.ac.jp; wietrzyk@iitd.pan.wroc.pl; inokuchi@cc.okayama-u.ac.jp			Okayama University; Adaptable and Seamless Technology Transfer Program of JST [AS242Z02199Q]	We are grateful to Okayama University for its support and to the Advanced Science Research Center for the NMR experiments. We are thankful to X.-Q. Yu, Sichuan University, for the HRMS analyses. This study was partially supported by the Adaptable and Seamless Technology Transfer Program of JST, No. AS242Z02199Q.	Afzal O., 2014, EUR J MED C IN PRESS; Alexandra P., 2000, PLANTA MED, V66, P30; Yang Z, 2012, CURR MED CHEM, V19, P4541; Buragohain P, 2014, BIOORG MED CHEM LETT, V24, P237, DOI 10.1016/j.bmcl.2013.11.032; Primik MF, 2010, INORG CHEM, V49, P11084, DOI 10.1021/ic101633z; Riechert-Krause F, 2013, BIOCHEMISTRY-US, V52, P41, DOI 10.1021/bi301381h; Blazquez AG, 2013, BIOORGAN MED CHEM, V21, P4432, DOI 10.1016/j.bmc.2013.04.059; Filak LK, 2013, ORGANOMETALLICS, V32, P903, DOI 10.1021/om3012272; Godlewska J, 2005, ANTICANCER RES, V25, P2857; Cimanga K, 1996, TETRAHEDRON LETT, V37, P1703, DOI 10.1016/0040-4039(96)00112-8; Lavrado J, 2010, CURR MED CHEM, V17, P2348; Wang N, 2014, EUR J MED CHEM, V78, P314, DOI 10.1016/j.ejmech.2014.03.038; Lu WJ, 2013, MED CHEM RES, V22, P4492, DOI 10.1007/s00044-012-0443-x; Beauchard A, 2009, EUR J MED CHEM, V44, P3858, DOI 10.1016/j.ejmech.2009.04.012; Soomro S, 2011, J CELL MOL MED, V15, P1122, DOI 10.1111/j.1582-4934.2010.01120.x; Cimanga K, 1998, PHYTOMEDICINE, V5, P209, DOI 10.1016/S0944-7113(98)80030-5; Li W, 2012, DNA CELL BIOL, V31, P1046, DOI 10.1089/dna.2011.1432; Dassonneville L, 2000, EUR J PHARMACOL, V409, P9, DOI 10.1016/S0014-2999(00)00805-0; Paulo A, 2000, PLANTA MED, V66, P30, DOI 10.1055/s-2000-11106; Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412; Guittat L, 2003, BIOCHIMIE, V85, P535, DOI 10.1016/S0300-9084(03)00035-X; Yang XL, 2009, BIOORG MED CHEM LETT, V19, P4385, DOI 10.1016/j.bmcl.2009.05.076; Sidoryk K, 2014, EUR J MED CHEM, V78, P304, DOI 10.1016/j.ejmech.2014.03.060; Sidoryk K, 2012, J MED CHEM, V55, P5077, DOI 10.1021/jm300468t; Morrissey C, 2010, ANTI-CANCER DRUG, V21, P423, DOI 10.1097/CAD.0b013e328336f57b; Lee S, 2007, MINI-REV MED CHEM, V7, P411, DOI 10.2174/138955707780363837; Wang L, 2012, BIOORGAN MED CHEM, V20, P4820, DOI 10.1016/j.bmc.2012.05.054; Jones M, 2009, BIOORG MED CHEM LETT, V19, P2033, DOI 10.1016/j.bmcl.2009.02.028; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; Cimanga K, 1997, J NAT PROD, V60, P688, DOI 10.1021/np9605246; Lai HC, 2013, INVEST NEW DRUG, V31, P230, DOI 10.1007/s10637-012-9873-z; Cimanga K, 1996, PLANTA MED, V62, P22, DOI 10.1055/s-2006-957789; Lu JJ, 2008, CANCER BIOL THER, V7, P1017, DOI 10.4161/cbt.7.7.6035; Lavrado J, 2011, J MED CHEM, V54, P734, DOI 10.1021/jm101383f; Kaczmarek L, 1999, BIOORGAN MED CHEM, V7, P2457, DOI 10.1016/S0968-0896(99)00200-X; Xie LJ, 2011, ARCH PHARM, V344, P639, DOI 10.1002/ardp.201000391; Filak LK, 2012, INORG CHIM ACTA, V393, P252, DOI 10.1016/j.ica.2012.06.004; Parvatkar PT, 2011, CURR ORG CHEM, V15, P1036; Arcamone F., 1981, ANTICANCER ANTIBIOTI, P1; Bailly C, 2000, ANTI-CANCER DRUG DES, V15, P191; Chen H, 2010, J CANCER RES CLIN, V136, P897, DOI 10.1007/s00432-009-0731-0; Chien CM, 2008, CHEM-BIOL INTERACT, V176, P40, DOI 10.1016/j.cbi.2008.06.008; Dhanabal T., 2009, BIOORGAN MED CHEM, V17, P7209; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Kumar EVKS, 2008, MINI-REV MED CHEM, V8, P538; LUO XD, 1987, MED RES REV, V7, P29, DOI 10.1002/med.2610070103; Marques O., 2014, CANC LETT, V28, P1; Osiadacz J, 2000, BIOORGAN MED CHEM, V8, P937, DOI 10.1016/S0968-0896(00)00031-6; Poespoprodjo JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084976; Rahier NJ, 2012, ANTICANCER AGENTS FROM NATURAL PRODUCTS, 2ND EDITION, P5; Seville S, 2007, BIOORGAN MED CHEM, V15, P6353, DOI 10.1016/j.bmc.2007.06.062; Wang ZH, 2012, MOL PHARMACEUT, V9, P2646, DOI 10.1021/mp3002107; Xie LJ, 2011, CHEM PHARM BULL, V59, P984; Yang Y, 2014, INT J PHARMACEUT, V467, P113, DOI 10.1016/j.ijpharm.2014.03.044	54	3	4	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	NOV	2014	19	11					19021	19035		10.3390/molecules191119021		15	Chemistry, Organic	Chemistry	AU4FC	WOS:000345564300115		
J	Watanabe, Y; Kubota, Y; Fuma, S; Kouichi, M; Ichikawa, S; Kubota, M; Yoshida, S				Watanabe, Yoshito; Kubota, Yoshihisa; Fuma, Shoichi; Kouichi, Maruyama; Ichikawa, San'ei; Kubota, Masahide; Yoshida, Satoshi			Cytokinesis block micronucleus assay in field plants for monitoring radiation-induced genotoxicity of the environment	MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS			English	Article						Plant genotoxicity; Biomonitoring; Japanese cedar (Cryptomeria japonica); Ionizing radiation	VICIA-FABA ROOTS; CHROMOSOME-ABERRATIONS; DOSE-RATE; BINUCLEATE CELLS; GAMMA-RADIATION; RADIOACTIVE-WASTE; HUMAN-LYMPHOCYTES; INDUCTION; IRRADIATION; ALLIUM	Effective biomonitoring for detection of radiation-induced genotoxicity of contaminants in natural environments involves testing of field plants for cytogenetic changes. To increase the efficiency and precision of cytogenetic analyses of field plants that have naturally high individual variability, an improved micronucleus assay is proposed that employs a cytokinesis block technique similar to the lymphocyte test system used in mammals. In seed embryonic meristems of the Japanese cedar, application of a methylxanthine derivative, 3-isobutyl-1-methylxanthine (IBMX), was found to be effective in inhibiting cytokinesis to make once-divided cells easily recognizable by their binucleate appearance. In the meristem of IBMX-treated seminal roots from X-ray-irradiated seeds, variation in micronucleus frequency in the binucleate cell population was reduced compared to that in the total cell population. The highest efficiency of measurement of micronucleus frequencies was obtained in the root meristems where 0.2- to 1.5-mm-long seminal roots were incubated with IBMX for 24 h. This result indicated that this root elongation stage corresponded to the first divisions of the root meristematic cells, and was therefore suitable for obtaining reliable estimations of accumulated genetic damage in the seeds. This cytokinesis block assay applied specifically at the root elongation stage was then used to examine dose-response relationships in Japanese cedar seeds irradiated either acutely with X-rays or chronically with gamma-rays. The resulting dose-response curve for the acute X-ray irradiation was fitted onto a linear-quadratic regression curve, whereas the dose-response curve for the chronic gamma-irradiation matched a linear regression line better. Both dose-response curves were consistent with the target theory of classical radiation biology. The good agreement of the micronucleus data to a simple dose-response model indicates the proposed accuracy of the cytokinesis block micronucleus assay for plant monitoring. (C) 2014 Elsevier B.V. All rights reserved.	[Watanabe, Yoshito; Kubota, Yoshihisa; Fuma, Shoichi; Kouichi, Maruyama; Yoshida, Satoshi] Natl Inst Radiol Sci, Inage Ku, Chiba 2638555, Japan; [Ichikawa, San'ei; Kubota, Masahide] Japan Wildlife Res Ctr, Sumida Ku, Tokyo 1308606, Japan	Watanabe, Y (reprint author), Natl Inst Radiol Sci, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	y_nabe@nirs.go.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of the Environment, Japan	This research was carried out as a part of the Project for Environmental Dynamics and Radiation Effects in National Institute of Radiological Sciences funded by the Ministry of Education, Culture, Sports, Science, and Technology, Japan and was supported partly by the Ministry of the Environment, Japan for sample collection.	Tanaka K, 2009, RADIAT RES, V171, P290, DOI 10.1667/RR1238.1; MA TH, 1995, MUTAT RES-ENVIR MUTA, V334, P185, DOI 10.1016/0165-1161(95)90010-1; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Fenech M, 2003, MUTAT RES-GEN TOX EN, V534, P65, DOI 10.1016/S1383-5718(02)00249-8; RANK J, 1993, HEREDITAS, V118, P49, DOI 10.1111/j.1601-5223.1993.t01-3-00049.x; Rank J, 1997, MUTAT RES-GEN TOX EN, V390, P121, DOI 10.1016/S0165-1218(97)00008-6; HUBER R, 1994, MUTAT RES, V306, P135, DOI 10.1016/0027-5107(94)90024-8; FENECH M, 1986, MUTAT RES, V161, P193, DOI 10.1016/0027-5107(86)90010-2; Zaka R, 2002, MUTAT RES-GEN TOX EN, V517, P87, DOI 10.1016/S1383-5718(02)00056-6; Vral A, 2011, MUTAGENESIS, V26, P11, DOI 10.1093/mutage/geq078; DAVIDSON D, 1984, ENVIRON EXP BOT, V24, P167, DOI 10.1016/0098-8472(84)90018-2; Davidson D., 1981, ENVIRON EXP BOT, V21, P55; DAVIDSON D, 1980, PROTOPLASMA, V102, P281, DOI 10.1007/BF01279592; EVANS HJ, 1959, INT J RADIAT BIOL RE, V1, P216, DOI 10.1080/09553005914550311; Geraskin SA, 2003, J ENVIRON RADIOACTIV, V66, P171, DOI 10.1016/S0265-931X(02)00122-4; Geras'kin SA, 2007, RADIAT ENVIRON BIOPH, V46, P31, DOI 10.1007/s00411-006-0082-z; Geras'kin SA, 2005, MUTAT RES-GEN TOX EN, V583, P55, DOI 10.1016/j.mrgentox.2005.02.003; GRANT WF, 1982, MUTAT RES, V99, P273, DOI 10.1016/0165-1110(82)90046-X; Grenet J, 1992, Cytobios, V69, P35; Hase Y, 2002, INT J RADIAT BIOL, V78, P799, DOI 10.1080/09553000210152971; KIHLMAN BA, 1978, HEREDITAS, V88, P35; LORENZ R, 1994, INT J RADIAT BIOL, V66, P319, DOI 10.1080/09553009414551251; MA TH, 1982, MUTAT RES, V99, P257, DOI 10.1016/0165-1110(82)90045-8; MARSHALL I, 1983, INT J RADIAT BIOL, V44, P151, DOI 10.1080/09553008314550951; RIZZONI M, 1987, MUTAT RES, V176, P205, DOI 10.1016/0027-5107(87)90051-0; Sorensen KJ, 2000, MUTAT RES-FUND MOL M, V457, P125, DOI 10.1016/S0027-5107(00)00136-6; Tucker JD, 1998, MUTAT RES-FUND MOL M, V400, P321, DOI 10.1016/S0027-5107(98)00048-7; VASILENKO A, 1995, RADIAT ENVIRON BIOPH, V34, P107, DOI 10.1007/BF01275215; WELLWOOD CA, 1977, CAN J GENET CYTOL, V19, P461	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1383-5718	1879-3592		MUTAT RES-GEN TOX EN	Mutat. Res. Genet. Toxicol. Environ. Mutagen.	NOV 1	2014	774						41	46		10.1016/j.mrgentox.2014.08.009		6	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	AU3XH	WOS:000345543500006		
J	Ishikawa, T; Sagae, Y; Naitoh, Y; Kawakami, Y; Itoh, H; Yamamoto, K; Yakushi, K; Kishida, H; Sasaki, T; Ishihara, S; Tanaka, Y; Yonemitsu, K; Iwai, S				Ishikawa, Takahiro; Sagae, Yuto; Naitoh, Yota; Kawakami, Yohei; Itoh, Hirotake; Yamamoto, Kaoru; Yakushi, Kyuya; Kishida, Hideo; Sasaki, Takahiko; Ishihara, Sumio; Tanaka, Yasuhiro; Yonemitsu, Kenji; Iwai, Shinichiro			Optical freezing of charge motion in an organic conductor	NATURE COMMUNICATIONS			English	Article							TO-METAL TRANSITION; DENSITY-WAVE; INSULATOR; STATE; FIELD; MANGANITE	Dynamical localization, that is, reduction of the intersite electronic transfer integral t by an alternating electric field, E(omega), is a promising strategy for controlling strongly correlated systems with a competing energy balance between t and the Coulomb repulsion energy. Here we describe a charge localization induced by the 9.3MVcm(-1) instantaneous electric field of a 1.5 cycle (7 fs) infrared pulse in an organic conductor alpha-(bis[ethylenedithio]-tetrathiafulvalene) I-2(3). A large reflectivity change of >25% and a coherent charge oscillation along the time axis reflect the opening of the charge ordering gap in the metallic phase. This optical freezing of charges, which is the reverse of the photoinduced melting of electronic orders, is attributed to the similar to 10% reduction of t driven by the strong, high-frequency (omega >= t/(h) over bar) electric field.	[Ishikawa, Takahiro; Sagae, Yuto; Naitoh, Yota; Kawakami, Yohei; Itoh, Hirotake; Ishihara, Sumio; Iwai, Shinichiro] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan; [Itoh, Hirotake; Iwai, Shinichiro] Japan Sci & Technol Agcy, CREST, Sendai, Miyagi 9808578, Japan; [Yamamoto, Kaoru] Okayama Univ Sci, Dept Appl Phys, Okayama 7000005, Japan; [Yakushi, Kyuya] Toyota Phys & Chem Res Inst, Nagakute, Aichi 4801192, Japan; [Kishida, Hideo] Nagoya Univ, Dept Appl Phys, Nagoya, Aichi 4648603, Japan; [Sasaki, Takahiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Tanaka, Yasuhiro; Yonemitsu, Kenji] Chuo Univ, Dept Phys, Tokyo 1128551, Japan	Iwai, S (reprint author), Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan.	s-iwai@m.tohoku.ac.jp	Tanaka, Yasuhiro/A-5494-2010; Sasaki, Takahiko/F-1231-2010	Sasaki, Takahiko/0000-0002-0767-5428	 [23244062]	We are grateful to T. Oka (University of Tokyo) and Y. Kayanuma (Tokyo Institute of Technology) for their insightful discussions. This work was supported by Grant-in-Aid for Scientific Research (A) No. 23244062.	Perfetti L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.067402; Schmitt F, 2008, SCIENCE, V321, P1649, DOI 10.1126/science.1160778; Basov DN, 2011, REV MOD PHYS, V83, P471, DOI 10.1103/RevModPhys.83.471; Tsuji N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.236401; Yue Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.075134; Stojchevska L, 2014, SCIENCE, V344, P177, DOI 10.1126/science.1241591; Iwai S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.097402; Miyano K, 1997, PHYS REV LETT, V78, P4257, DOI 10.1103/PhysRevLett.78.4257; Nishioka K, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.024706; Chollet M, 2005, SCIENCE, V307, P86, DOI 10.1126/science.1105067; DUNLAP DH, 1986, PHYS REV B, V34, P3625, DOI 10.1103/PhysRevB.34.3625; Liu MK, 2012, NATURE, V487, P345, DOI 10.1038/nature11231; Kawakami Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.246402; GROSSMANN F, 1991, PHYS REV LETT, V67, P516, DOI 10.1103/PhysRevLett.67.516; Okamoto H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.037401; Kawakami Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.066403; Mori T, 1999, B CHEM SOC JPN, V72, P179, DOI 10.1246/bcsj.72.179; Yonemitsu K, 2008, PHYS REP, V465, P1, DOI 10.1016/j.physrep.2008.04.008; Ivek T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.206406; Yang LX, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.207001; Tanaka Y, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.034708; Kakiuchi T, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.113702; Kim KW, 2012, NAT MATER, V11, P497, DOI [10.1038/nmat3294, 10.1038/NMAT3294]; BENDER K, 1984, MOL CRYST LIQ CRYST, V108, P359, DOI 10.1080/00268948408078687; Kayanuma Y, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.010101; DRESSEL M, 1994, J PHYS I, V4, P579, DOI 10.1051/jp1:1994162; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Polli D, 2007, NAT MATER, V6, P643, DOI 10.1038/nmat1979; Cavalleri A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.237401; Demsar J, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.041101; Hellmann S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2078; Iwai S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.057401; Kaiser S, 2014, SCI REP-UK, V4, DOI 10.1038/srep03823; Koshihara S., 2006, J PHYS SOC JPN, V75; Tsuji N, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.155124; Yamamoto K, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.074709	36	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5528	10.1038/ncomms6528		6	Multidisciplinary Sciences	Science & Technology - Other Topics	AU5BP	WOS:000345622500005		
J	Iwamoto, T; Akasaka, N; Ishida, S				Iwamoto, Takeaki; Akasaka, Naohiko; Ishida, Shintaro			A heavy analogue of the smallest bridgehead alkene stabilized by a base	NATURE COMMUNICATIONS			English	Article							POTENTIAL-ENERGY SURFACE; SILICON CLUSTER; BREDT RULE; CHEMISTRY; COMPOUND; PHASE; BOND; REARRANGEMENT; EXPLORATION; MOLECULE	Bicyclo[1.1.0]but-1(2)-ene (BBE), one of the smallest bridgehead alkenes and C4H4 isomers, exists theoretically as a reactive intermediate, but has not been observed experimentally. Here we successfully synthesize the silicon analogue of BBE, tetrasilabicyclo[1.1.0]but-1(2)-ene (Si4BBE), in a base-stabilized form. The results of X-ray diffraction analysis and theoretical study indicate that Si4BBE predominantly exists as a zwitterionic structure involving a tetrasilahomocyclopropenylium cation and a silyl anion rather than a bicyclic structure with a localized highly strained double bond. The reaction of base-stabilized Si4BBE with triphenylborane affords the [2 + 2] cycloadduct of Si4BBE and the dimer of an isomer of Si4BBE, tetrasilabicyclo[1.1.0]butan-2-ylidene (Si4BBY). The facile isomerization between Si4BBE and Si4BBY is supported by theoretical calculations and trapping reactions. Structure and properties of a heavy analogue of the smallest bridgehead alkene are disclosed.	[Iwamoto, Takeaki; Akasaka, Naohiko; Ishida, Shintaro] Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan	Iwamoto, T (reprint author), Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, 6-3 Aramakiazaaoba, Sendai, Miyagi 9808578, Japan.	iwamoto@m.tohoku.ac.jp	Ishida, Shintaro/M-3342-2015	Ishida, Shintaro/0000-0001-7832-912X	JSPS KAKENHI [25248010, 25708004, 25620020]; MEXT KAKENHI [24109004]	This work was supported by JSPS KAKENHI grant number 25248010 (T.I.), 25708004 and 25620020 (S.I.), and MEXT KAKENHI grant number 24109004 (T.I.) (Grant-in-Aid for Scientific Research on Innovative Areas 'Stimuli-responsive Chemical Species').	Abersfelder K, 2012, J AM CHEM SOC, V134, P16008, DOI 10.1021/ja307344f; Kira M, 1999, J AM CHEM SOC, V121, P9722, DOI 10.1021/ja9925305; Suzuki K, 2011, SCIENCE, V331, P1306, DOI 10.1126/science.1199906; Abersfelder K, 2010, SCIENCE, V327, P564, DOI 10.1126/science.1181771; Iwamoto T, 2009, J AM CHEM SOC, V131, P3156, DOI 10.1021/ja8093313; Dinadayalane TC, 2004, J PHYS CHEM A, V108, P11433, DOI 10.1021/jp0467696; Cowley MJ, 2013, NAT CHEM, V5, P876, DOI [10.1038/nchem.1751, 10.1038/NCHEM.1751]; Cowley MJ, 2014, CHEM-EUR J, V20, P9221, DOI 10.1002/chem.201402750; Wang YZ, 2008, SCIENCE, V321, P1069, DOI 10.1126/science.1160768; Cremer D, 2006, PHYS CHEM CHEM PHYS, V8, P5304, DOI 10.1039/b609284e; WIBERG N, 1986, ANGEW CHEM INT EDIT, V25, P79, DOI 10.1002/anie.198600791; Tsurusaki A, 2013, J AM CHEM SOC, V135, P16340, DOI 10.1021/ja409074m; Kira M, 2006, ADV ORGANOMET CHEM, V54, P73, DOI 10.1016/S0065-3055(05)54003-6; Nied D, 2010, J AM CHEM SOC, V132, P10264, DOI 10.1021/ja104810u; Lyon JT, 2009, J AM CHEM SOC, V131, P1115, DOI 10.1021/ja807518y; WIBERG N, 1993, ANGEW CHEM INT EDIT, V32, P1054, DOI 10.1002/anie.199310541; Haertelt M, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3682323; Abersfelder K, 2011, ANGEW CHEM INT EDIT, V50, P7936, DOI 10.1002/anie.201102623; BILLUPS WE, 1989, CHEM REV, V89, P1147, DOI 10.1021/cr00095a011; Borst MLG, 2005, J ORG CHEM, V70, P8110, DOI 10.1021/jo0513010; BREDT J, 1924, LIEBIGS ANN CHEM, V437, P1, DOI DOI 10.1002/JLAC.19244370102; DYER SF, 1977, J AM CHEM SOC, V99, P8104, DOI 10.1021/ja00466a082; Fischer G, 2005, ANGEW CHEM INT EDIT, V44, P7884, DOI 10.1002/anie.200501289; Haunschild R, 2009, MOL PHYS, V107, P911, DOI 10.1080/00268970802680505; Inoue S, 2008, ORGANOMETALLICS, V27, P6056, DOI 10.1021/om800912v; Ishida S, 2013, ANGEW CHEM INT EDIT, V52, P2507, DOI 10.1002/anie.201208506; Iwamoto T, 2000, SCIENCE, V290, P504, DOI 10.1126/science.290.5491.504; Jana A, 2013, ANGEW CHEM INT EDIT, V52, P12179, DOI 10.1002/anie.201306780; JONES R, 1986, ANGEW CHEM INT EDIT, V25, P173, DOI 10.1002/anie.198601731; Jutzi P, 2009, J AM CHEM SOC, V131, P12137, DOI 10.1021/ja902153u; Kaftory M, 1998, CHEM FUNCT, V2, P181, DOI 10.1002/0470857250.ch5; KEESE R, 1975, ANGEW CHEM INT EDIT, V14, P528, DOI 10.1002/anie.197505281; Killmar H., 1981, J AM CHEM SOC, V103, P5292; KOBRICH G, 1973, ANGEW CHEM INT EDIT, V12, P464, DOI 10.1002/anie.197304641; Leszczynska K, 2012, ANGEW CHEM INT EDIT, V51, P6785, DOI 10.1002/anie.201202277; MAIER G, 1988, ANGEW CHEM INT EDIT, V27, P309, DOI 10.1002/anie.198803093; OHMS U, 1984, Z KRISTALLOGR, V166, P213, DOI 10.1524/zkri.1984.166.3-4.213; Okazaki R., 1996, ADV ORGANOMET CHEM, V39, P231, DOI DOI 10.1016/S0065-3055(08)60469-4; Scheschkewitz D, 2005, ANGEW CHEM INT EDIT, V44, P2954, DOI 10.1002/anie.200462730; Sekiguchi A, 2000, J AM CHEM SOC, V122, P11250, DOI 10.1021/ja002344v; SHEA KJ, 1980, TETRAHEDRON, V36, P1683, DOI 10.1016/0040-4020(80)80067-6; Ueba-Ohshima K, 2008, ORGANOMETALLICS, V27, P320, DOI 10.1021/om7011375; YATES BF, 1989, CHEM PHYS LETT, V155, P563, DOI 10.1016/0009-2614(89)87474-3	43	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5353	10.1038/ncomms6353		7	Multidisciplinary Sciences	Science & Technology - Other Topics	AU6UO	WOS:000345739800001		
J	Miura, R; Imamura, S; Ohta, R; Ishii, A; Liu, X; Shimada, T; Iwamoto, S; Arakawa, Y; Kato, YK				Miura, R.; Imamura, S.; Ohta, R.; Ishii, A.; Liu, X.; Shimada, T.; Iwamoto, S.; Arakawa, Y.; Kato, Y. K.			Ultralow mode-volume photonic crystal nanobeam cavities for high-efficiency coupling to individual carbon nanotube emitters	NATURE COMMUNICATIONS			English	Article							SPONTANEOUS EMISSION; QUANTUM-DOT; MICROCAVITY; EXCITONS; NANOCAVITY; DRIVEN; LASERS; SCALE	The unique emission properties of single-walled carbon nanotubes are attractive for achieving increased functionality in integrated photonics. In addition to being room-temperature telecom-band emitters that can be directly grown on silicon, they are ideal for coupling to nanoscale photonic structures. Here we report on high-efficiency coupling of individual air-suspended carbon nanotubes to silicon photonic crystal nanobeam cavities. Photoluminescence images of dielectric-and air-mode cavities reflect their distinctly different mode profiles and show that fields in the air are important for coupling. We find that the air-mode cavities couple more efficiently, and estimated spontaneous emission coupling factors reach a value as high as 0.85. Our results demonstrate advantages of ultralow mode-volumes in air-mode cavities for coupling to low-dimensional nanoscale emitters.	[Miura, R.; Imamura, S.; Ishii, A.; Liu, X.; Shimada, T.; Kato, Y. K.] Univ Tokyo, Inst Engn Innovat, Tokyo 1138656, Japan; [Ohta, R.; Iwamoto, S.; Arakawa, Y.] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan	Kato, YK (reprint author), Univ Tokyo, Inst Engn Innovat, Tokyo 1138656, Japan.	ykato@sogo.t.u-tokyo.ac.jp	Kato, Yuichiro/B-5051-2008; Shimada, Takashi/B-6058-2008	Kato, Yuichiro/0000-0002-9942-1459; Shimada, Takashi/0000-0001-6647-5541	KAKENHI [24340066, 24654084, 26610080, 26870167]; Asahi Glass Foundation; Canon Foundation; KDDI Foundation; Project for Developing Innovation Systems; Photon Frontier Network Program of MEXT, Japan; MERIT; JSPS Research Fellowship; SCOPE	This work was supported by SCOPE, KAKENHI (24340066, 24654084, 26610080, 26870167), Asahi Glass Foundation, Canon Foundation, KDDI Foundation, as well as the Project for Developing Innovation Systems and the Photon Frontier Network Program of MEXT, Japan. A.I. is supported by MERIT and JSPS Research Fellowship.	Watahiki R, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4757876; Gong YY, 2010, OPT EXPRESS, V18, P8781, DOI 10.1364/OE.18.008781; Quan QM, 2011, OPT EXPRESS, V19, P18529, DOI 10.1364/OE.19.018529; Nomura M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.195313; Notomi M, 2008, OPT EXPRESS, V16, P11095, DOI 10.1364/OE.16.011095; Noury A, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/21/215201; Miyauchi Y, 2013, NAT PHOTONICS, V7, P715, DOI [10.1038/nphoton.2013.179, 10.1038/NPHOTON.2013.179]; Mann D, 2007, NAT NANOTECHNOL, V2, P33, DOI 10.1038/nnano.2006.169; Eichenfield M, 2009, NATURE, V459, P550, DOI 10.1038/nature08061; Hausmann BJM, 2013, NANO LETT, V13, P5791, DOI 10.1021/nl402174g; Ohno Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.235427; Legrand D, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4801984; Gaufres E, 2010, OPT EXPRESS, V18, P5740, DOI 10.1364/OE.18.005740; Strauf S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127404; Imamura S, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802930; Gan XT, 2012, NANO LETT, V12, P5626, DOI 10.1021/nl302746n; Hofmann MS, 2013, NAT NANOTECHNOL, V8, P502, DOI [10.1038/nnano.2013.119, 10.1038/NNANO.2013.119]; vanExter MP, 1996, PHYS REV A, V54, P3553, DOI 10.1103/PhysRevA.54.3553; Ohta R, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3579535; YOKOYAMA H, 1989, J APPL PHYS, V66, P4801, DOI 10.1063/1.343793; Gabor NM, 2009, SCIENCE, V325, P1367, DOI 10.1126/science.1176112; Moritsubo S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.247402; Stich D, 2014, NAT PHOTONICS, V8, P139, DOI [10.1038/nphoton.2013.316, 10.1038/NPHOTON.2013.316]; Zhang YN, 2011, OPT EXPRESS, V19, P9371, DOI 10.1364/OE.19.009371; Barkelid M, 2014, NAT PHOTONICS, V8, P48, DOI [10.1038/nphoton.2013.311, 10.1038/NPHOTON.2013.311]; Fujiwara M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824207; Lefebvre J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.217401; Riedrich-Moller J, 2012, NAT NANOTECHNOL, V7, P69, DOI [10.1038/nnano.2011.190, 10.1038/NNANO.2011.190]; Sarpkaya I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3152; Solomon GS, 2001, PHYS REV LETT, V86, P3903, DOI 10.1103/PhysRevLett.86.3903; Wu SF, 2014, 2D MATER, V1, DOI 10.1088/2053-1583/1/1/011001; Xia FN, 2008, NAT NANOTECHNOL, V3, P609, DOI 10.1038/nnano.2008.241	32	9	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5580	10.1038/ncomms6580		5	Multidisciplinary Sciences	Science & Technology - Other Topics	AU6WA	WOS:000345740900002		
J	Miyazaki, H; Oyama, F; Inoue, R; Aosaki, T; Abe, T; Kiyonari, H; Kino, Y; Kurosawa, M; Shimizu, J; Ogiwara, I; Yamakawa, K; Koshimizu, Y; Fujiyama, F; Kaneko, T; Shimizu, H; Nagatomo, K; Yamada, K; Shimogori, T; Hattori, N; Miura, M; Nukina, N				Miyazaki, Haruko; Oyama, Fumitaka; Inoue, Ritsuko; Aosaki, Toshihiko; Abe, Takaya; Kiyonari, Hiroshi; Kino, Yoshihiro; Kurosawa, Masaru; Shimizu, Jun; Ogiwara, Ikuo; Yamakawa, Kazuhiro; Koshimizu, Yoshinori; Fujiyama, Fumino; Kaneko, Takeshi; Shimizu, Hideaki; Nagatomo, Katsuhiro; Yamada, Katsuya; Shimogori, Tomomi; Hattori, Nobutaka; Miura, Masami; Nukina, Nobuyuki			Singular localization of sodium channel beta 4 subunit in unmyelinated fibres and its role in the striatum	NATURE COMMUNICATIONS			English	Article							D1 DOPAMINE-RECEPTOR; WHITE-MATTER; IMMUNOCYTOCHEMICAL LOCALIZATION; ULTRASTRUCTURAL-LOCALIZATION; SUBCELLULAR-LOCALIZATION; FLUORESCENT PROTEIN; NEURITE OUTGROWTH; PURKINJE NEURONS; TRANSGENIC MICE; BASAL GANGLIA	Voltage-gated Na+ channel beta-subunits are multifunctional molecules that modulate Na+ channel activity and regulate cell adhesion, migration and neurite outgrowth. beta-subunits including beta 4 are known to be highly concentrated in the nodes of Ranvier and axon initial segments in myelinated axons. Here we show diffuse beta 4 localization in striatal projection fibres using transgenic mice that express fluorescent protein in those fibres. These axons are unmyelinated, forming large, inhibitory fibre bundles. Furthermore, we report beta 4 dimer expression in the mouse brain, with high levels of beta 4 dimers in the striatal projection fascicles, suggesting a specific role of beta 4 in those fibres. Scn4b-deficient mice show a resurgent Na+ current reduction, decreased repetitive firing frequency in medium spiny neurons and increased failure rates of inhibitory postsynaptic currents evoked with repetitive stimulation, indicating an in vivo channel regulatory role of beta 4 in the striatum.	[Miyazaki, Haruko; Kino, Yoshihiro; Kurosawa, Masaru; Nukina, Nobuyuki] Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Bunkyo Ku, Tokyo 1138421, Japan; [Miyazaki, Haruko; Oyama, Fumitaka; Kino, Yoshihiro; Kurosawa, Masaru; Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan; [Miyazaki, Haruko; Kino, Yoshihiro; Kurosawa, Masaru; Shimogori, Tomomi; Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Mol Mech Thalamus Dev, Wako, Saitama 3510198, Japan; [Miyazaki, Haruko; Kino, Yoshihiro; Kurosawa, Masaru; Fujiyama, Fumino; Nukina, Nobuyuki] JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan; [Oyama, Fumitaka] Kogakuin Univ, Dept Appl Chem, Hachioji, Tokyo 1920015, Japan; [Inoue, Ritsuko; Aosaki, Toshihiko; Miura, Masami] Tokyo Metropolitan Inst Gerontol, Neurophysiol Res Grp, Itabashi Ku, Tokyo 1730015, Japan; [Abe, Takaya; Kiyonari, Hiroshi] RIKEN, Ctr Dev Biol, Lab Anim Resources & Genet Engn, Chuou ku, Kobe, Hyogo 6500047, Japan; [Shimizu, Jun] Univ Tokyo, Dept Neurol, Bunkyo Ku, Tokyo 1138654, Japan; [Ogiwara, Ikuo; Yamakawa, Kazuhiro] RIKEN, Brain Sci Inst, Neurogenet Lab, Wako, Saitama 3510198, Japan; [Koshimizu, Yoshinori; Fujiyama, Fumino; Kaneko, Takeshi] Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Kyoto 6068501, Japan; [Fujiyama, Fumino] Doshisha Univ, Grad Sch Brain Sci, Lab Neural Circuitry, Kizugawa, Kyoto 6190225, Japan; [Shimizu, Hideaki] RIKEN, Ctr Life Sci Technol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Nagatomo, Katsuhiro; Yamada, Katsuya] Hirosaki Univ, Sch Med, Dept Physiol, Hirosaki, Aomori 0368562, Japan; [Hattori, Nobutaka] Juntendo Univ, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138421, Japan	Nukina, N (reprint author), Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	nnukina@juntendo.ac.jp	Yamakawa, Kazuhiro/N-5050-2015		CREST from JST; Ministry of Health, Welfare and Labor; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22110004, 22240037, 24659436, 25253066]	We thank Dr Mika Tanaka (RIKEN BSI) for supporting the generation of Scn4b-Venus transgenic mice. We thank Takumi Akagi (RIKEN BSI) for technical support and advice on EM analysis. We thank Dr Toshihiko Hosoya (RIKEN BSI) for teaching the technique of fluorescence in situ hybridization. We thank Dr Jun-ichi Miyazaki (Osaka University) for providing the CAG-Cre deleter mouse and Dr Shigeyoshi Itohara (RIKEN BSI) for providing the CAG-Cre and CAG-FLPe deleter mouse. This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to N.N. (22110004 for Scientific Research on Innovated Areas 'Foundation of Synapse and Neurocircuit Pathology', 22240037, 24659436, 25253066), by CREST from JST to N.N. and by a Grant-in-Aid for the Research on Measures for Ataxic Diseases from the Ministry of Health, Welfare and Labor to N.N.	Brackenbury WJ, 2013, P NATL ACAD SCI USA, V110, P1089, DOI 10.1073/pnas.1208767110; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Khaliq ZM, 2003, J NEUROSCI, V23, P4899; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Wilson CJ, 1996, J NEUROSCI, V16, P2397; SUTKOWSKI EM, 1990, J BIOL CHEM, V265, P12393; Cruz JS, 2011, LIFE SCI, V89, P564, DOI 10.1016/j.lfs.2011.05.016; Brackenbury WJ, 2008, J NEUROSCI, V28, P3246, DOI 10.1523/JNEUROSCI.5446-07.2008; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729; Bonfanti L, 2011, EUR J NEUROSCI, V34, P930, DOI 10.1111/j.1460-9568.2011.07832.x; Raman IM, 1997, J NEUROSCI, V17, P4517; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Bean BP, 2005, NEURON, V45, P185, DOI 10.1016/j.neuron.2005.01.006; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Cannon SC, 2010, J CLIN INVEST, V120, P80, DOI 10.1172/JCI41340; Buffington SA, 2013, J NEUROSCI, V33, P6191, DOI 10.1523/JNEUROSCI.4051-12.2013; Medeiros-Domingo A, 2007, CIRCULATION, V116, P134, DOI 10.1161/CIRCULATIONAHA.106.659086; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; HUANG Q, 1992, P NATL ACAD SCI USA, V89, P11988, DOI 10.1073/pnas.89.24.11988; Grieco TM, 2005, NEURON, V45, P233, DOI 10.1016/j.neuron.2004.12.035; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Bant JS, 2010, P NATL ACAD SCI USA, V107, P12357, DOI 10.1073/pnas.1005633107; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854; Oliva M, 2012, EPILEPSIA, V53, P1849, DOI 10.1111/j.1528-1167.2012.03631.x; Oyama F, 2006, J NEUROCHEM, V98, P518, DOI 10.1111/j.1471-4159.2006.03893.x; Wang SSH, 2008, J NEUROSCI, V28, P4047, DOI 10.1523/JNEUROSCI.5559-05.2008; NAMBU A, 1994, J NEUROPHYSIOL, V72, P1127; Yu FH, 2003, J NEUROSCI, V23, P7577; Goldfarb M, 2012, CELL MOL LIFE SCI, V69, P1067, DOI 10.1007/s00018-011-0832-1; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Tan BH, 2010, HEART RHYTHM, V7, P771, DOI 10.1016/j.hrthm.2010.01.032; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; Brackenbury WJ, 2010, P NATL ACAD SCI USA, V107, P2283, DOI 10.1073/pnas.0909434107; Wilde AAM, 2011, CIRC RES, V108, P884, DOI 10.1161/CIRCRESAHA.110.238469; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Chen CL, 2002, P NATL ACAD SCI USA, V99, P17072, DOI 10.1073/pnas.212638099; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E; Bokil H, 2001, J NEUROSCI, V21; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Caille I, 1996, BRAIN RES, V730, P17, DOI 10.1016/0006-8993(96)00424-6; Durieux PF, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00040; Kim JH, 2010, J NEUROSCI, V30, P15479, DOI 10.1523/JNEUROSCI.3982-10.2010; Klinger AB, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-69; Koshimizu Y, 2008, EUR J NEUROSCI, V28, P2053, DOI 10.1111/j.1460-9568.2008.06502.x; Martin FC, 2005, MOVEMENT DISORD, V20, P298, DOI 10.1002/mds.20331; Mengual E, 2002, SYNAPSE, V43, P151, DOI 10.1002/syn.10033; Miyazaki H, 2007, BIOCHEM BIOPH RES CO, V361, P43, DOI 10.1016/j.bbrc.2007.06.170; Pissadaki EK, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00013; Sakurai T, 2001, J CELL BIOL, V154, P1259, DOI 10.1083/jcb.200104122; SESACK SR, 1994, J NEUROSCI, V14, P88; SHENG M, 1994, J NEUROSCI, V14, P2408; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Yang ZL, 2013, CEREBELLUM, V12, P862, DOI 10.1007/s12311-013-0499-2	56	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5525	10.1038/ncomms6525		15	Multidisciplinary Sciences	Science & Technology - Other Topics	AU5BP	WOS:000345622500002		
J	Nakajima, A; Ishihara, S; Imoto, D; Sawai, S				Nakajima, Akihiko; Ishihara, Shuji; Imoto, Daisuke; Sawai, Satoshi			Rectified directional sensing in long-range cell migration	NATURE COMMUNICATIONS			English	Article							DICTYOSTELIUM-DISCOIDEUM CELLS; CYCLIC-AMP; EUKARYOTIC CHEMOTAXIS; LEADING-EDGE; SIGNALING SYSTEM; RAS ACTIVATION; NEUTROPHIL CHEMOTAXIS; MEDIATED ACTIVATION; TEMPORAL GRADIENTS; CHEMICAL GRADIENTS	How spatial and temporal information are integrated to determine the direction of cell migration remains poorly understood. Here, by precise microfluidics emulation of dynamic chemoattractant waves, we demonstrate that, in Dictyostelium, directional movement as well as activation of small guanosine triphosphatase Ras at the leading edge is suppressed when the chemoattractant concentration is decreasing over time. This 'rectification' of directional sensing occurs only at an intermediate range of wave speed and does not require phosphoinositide-3-kinase or F-actin. From modelling analysis, we show that rectification arises naturally in a single-layered incoherent feedforward circuit with zero-order ultrasensitivity. The required stimulus time-window predicts similar to 5 s transient for directional sensing response close to Ras activation and inhibitor diffusion typical for protein in the cytosol. We suggest that the ability of Dictyostelium cells to move only in the wavefront is closely associated with rectification of adaptive response combined with local activation and global inhibition.	[Nakajima, Akihiko; Ishihara, Shuji; Imoto, Daisuke; Sawai, Satoshi] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Tokyo 1538902, Japan; [Nakajima, Akihiko; Ishihara, Shuji; Sawai, Satoshi] Univ Tokyo, Res Ctr Complex Syst Biol, Tokyo 1538902, Japan; [Ishihara, Shuji] Meiji Univ, Sch Sci & Technol, Dept Phys, Kawasaki, Kanagawa 2148571, Japan; [Sawai, Satoshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Sawai, S (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Tokyo 1538902, Japan.	cssawai@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [23111506, 25111704, 22680024, 25710022, 23870006, 25840069]; Japan Science and Technology Agency (JST) Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science and Technology, Japan; Human Frontier Science Programme (RGY) [70/2008]; Scientific Research on Innovative Areas [25103008]; MEXT/JSPS [24115503]; JST CREST	We thank Prof Shoji Takeuchi (University of Tokyo) for technical advice on microfluidics, Prof Richard A. Firtel (University of California, San Diego) and Dr Xuehua Xu (NIH) for the GFP-RBD construct, Mai Honda-Kitahara and Nao Shimada for their assistance in plasmid construction and cell transformation and other members of the Sawai lab for discussion and suggestions. This work was supported by grants from the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research on Innovative Areas (23111506, 25111704) (to S.S.), JSPS Grant-in-Aid for Young Scientists (A) (22680024, 25710022) (to S.S.), JSPS Grant-in-Aid for Young Scientists (Startup) and (B) (23870006, 25840069) (to A.N.), Japan Science and Technology Agency (JST) Precursory Research for Embryonic Science and Technology (PRESTO) (to S.S.), Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan and in part by the Human Frontier Science Programme (RGY 70/2008) and JSPS Grant-in-Aid for Scientific Research on Innovative Areas (25103008) (to S. S. and S.I.). S.I. is also supported by MEXT/JSPS (24115503) and partly by JST CREST 'Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics'.	ALCANTARA F, 1974, J GEN MICROBIOL, V85, P321; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Sawai S, 2005, NATURE, V433, P323, DOI 10.1038/nature03228; Xu X, 2007, J CELL BIOL, V178, P141, DOI 10.1083/jcb.200611096; Kortholt A, 2013, J CELL SCI, V126, P4502, DOI 10.1242/jcs.132340; Lusche DF, 2009, CELL MOTIL CYTOSKEL, V66, P567, DOI 10.1002/cm.20367; Kashikar ND, 2012, J CELL BIOL, V198, P1075, DOI 10.1083/jcb.201204024; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Nishikawa M, 2014, BIOPHYS J, V106, P723, DOI 10.1016/j.bpj.2013.12.023; Charest PG, 2010, DEV CELL, V18, P737, DOI [10.1016/j.devcel.2010.03.017, 10.1016/j.devce1.2010.03.017]; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Decave E, 2002, BIOPHYS J, V82, P2383; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Reichman-Fried M, 2004, DEV CELL, V6, P589, DOI 10.1016/S1534-5807(04)00074-7; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Cai HQ, 2010, J CELL BIOL, V190, P233, DOI 10.1083/jcb.201001129; Kortholt A, 2011, EMBO REP, V12, P1273, DOI 10.1038/embor.2011.210; Taniguchi D, 2013, P NATL ACAD SCI USA, V110, P5016, DOI 10.1073/pnas.1218025110; Levchenko A, 2002, BIOPHYS J, V82, P50; Decave E, 2003, J CELL SCI, V116, P4331, DOI 10.1242/jcs.00726; FISHER PR, 1989, J CELL BIOL, V108, P973, DOI 10.1083/jcb.108.3.973; Phillips JE, 2012, P NATL ACAD SCI USA, V109, P10990, DOI 10.1073/pnas.1206350109; VARNUM B, 1985, J CELL BIOL, V101, P1, DOI 10.1083/jcb.101.1.1; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Albrecht E, 1998, P NATL ACAD SCI USA, V95, P5039, DOI 10.1073/pnas.95.9.5039; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; Meier B, 2011, P NATL ACAD SCI USA, V108, P11417, DOI 10.1073/pnas.1014853108; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Kae H, 2004, EMBO REP, V5, P602, DOI 10.1038/sj.embor.7400151; Arai Y, 2010, P NATL ACAD SCI USA, V107, P12399, DOI 10.1073/pnas.0908278107; Irimia D, 2010, ANNU REV BIOMED ENG, V12, P259, DOI 10.1146/annurev-bioeng-070909-105241; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Kae H, 2007, EMBO REP, V8, P477, DOI 10.1038/sj.embor.7400936; Korohoda W, 2002, CELL MOTIL CYTOSKEL, V53, P1, DOI 10.1002/cm.10052; Zwier JM, 2004, J MICROSC-OXFORD, V216, P15, DOI 10.1111/j.0022-2720.2004.01390.x; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; VANHAASTERT PJM, 1983, J CELL BIOL, V96, P1559, DOI 10.1083/jcb.96.6.1559; Shibata T, 2013, BIOPHYS J, V105, P2199, DOI 10.1016/j.bpj.2013.09.024; Ebrahimzadeh PR, 2000, J LEUKOCYTE BIOL, V67, P651; FUTRELLE RP, 1982, J CELL BIOCHEM, V18, P197, DOI 10.1002/jcb.1982.240180207; FUTRELLE RP, 1982, J CELL BIOL, V92, P807, DOI 10.1083/jcb.92.3.807; Geiger J, 2003, CELL MOTIL CYTOSKEL, V56, P27, DOI 10.1002/cm.10133; GERISCH G, 1975, BIOCHEM BIOPH RES CO, V65, P364, DOI 10.1016/S0006-291X(75)80102-1; Goldstein RE, 1996, PHYS REV LETT, V77, P775, DOI 10.1103/PhysRevLett.77.775; HOFER T, 1994, APPL MATH LETT, V7, P1, DOI 10.1016/0893-9659(94)90020-5; Ibidi GmbH, 2012, 11 IB GMBH; Iglesias P. A., 2012, SCI SIGNAL, V5, ppe8; LAUFFENBURGER D, 1987, J CELL SCI, V88, P415; Levine H, 2013, PHYS TODAY, V66, P24; McQuade KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059275; Meili R., 2000, CURR BIOL, V10, P708; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Potma EO, 2001, BIOPHYS J, V81, P2010; Ruchira, 2004, J BIOL CHEM, V279, P10013; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Takeda K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002413; Tani T, 1999, J EXP BIOL, V202, P1; TOMCHIK KJ, 1981, SCIENCE, V212, P443, DOI 10.1126/science.6259734; VICKER MG, 1994, J CELL SCI, V107, P659; Wang CJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002449; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Zhang S, 2008, CURR BIOL, V18, P1587, DOI 10.1016/j.cub.2008.08.069	70	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5367	10.1038/ncomms6367		14	Multidisciplinary Sciences	Science & Technology - Other Topics	AU5NZ	WOS:000345655100007		
J	Rodrigues, P; Macaya, I; Bazzocco, S; Mazzolini, R; Andretta, E; Dopeso, H; Mateo-Lozano, S; Bilic, J; Carton-Garcia, F; Nieto, R; Suarez-Lopez, L; Afonso, E; Landolfi, S; Hernandez-Losa, J; Kobayashi, K; Ramon y Cajal, S; Tabernero, J; Tebbutt, NC; Mariadason, JM; Schwartz, S; Arango, D				Rodrigues, Paulo; Macaya, Irati; Bazzocco, Sarah; Mazzolini, Rocco; Andretta, Elena; Dopeso, Higinio; Mateo-Lozano, Silvia; Bilic, Josipa; Carton-Garcia, Fernando; Nieto, Rocio; Suarez-Lopez, Lucia; Afonso, Elsa; Landolfi, Stefania; Hernandez-Losa, Javier; Kobayashi, Kazuto; Ramon y Cajal, Santiago; Tabernero, Josep; Tebbutt, Niall C.; Mariadason, John M.; Schwartz, Simo, Jr.; Arango, Diego			RHOA inactivation enhances Wnt signalling and promotes colorectal cancer	NATURE COMMUNICATIONS			English	Article							LYSOPHOSPHATIDIC ACID RECEPTORS; INTESTINAL EPITHELIAL-CELLS; ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; TUMOR PROGRESSION; COLON-CARCINOMA; SMALL GTPASES; IN-VIVO; CATENIN; TUMORIGENESIS	Activation of the small GTPase RHOA has strong oncogenic effects in many tumour types, although its role in colorectal cancer remains unclear. Here we show that RHOA inactivation contributes to colorectal cancer progression/metastasis, largely through the activation of Wnt/beta-catenin signalling. RhoA inactivation in the murine intestine accelerates the tumorigenic process and in human colon cancer cells leads to the redistribution of beta-catenin from the membrane to the nucleus and enhanced Wnt/beta-catenin signalling, resulting in increased proliferation, invasion and de-differentiation. In mice, RHOA inactivation contributes to colon cancer metastasis and reduced RHOA levels were observed at metastatic sites compared with primary human colon tumours. Therefore, we have identified a new mechanism of activation of Wnt/beta-catenin signalling and characterized the role of RHOA as a novel tumour suppressor in colorectal cancer. These results constitute a shift from the current paradigm and demonstrate that RHO GTPases can suppress tumour progression and metastasis.	[Rodrigues, Paulo; Macaya, Irati; Bazzocco, Sarah; Mazzolini, Rocco; Andretta, Elena; Dopeso, Higinio; Mateo-Lozano, Silvia; Bilic, Josipa; Carton-Garcia, Fernando; Nieto, Rocio; Afonso, Elsa; Arango, Diego] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Res Inst VHIR, CIBBIM Nanomed,Grp Mol Oncol, Barcelona 08035, Spain; [Rodrigues, Paulo; Macaya, Irati; Bazzocco, Sarah; Mazzolini, Rocco; Andretta, Elena; Dopeso, Higinio; Mateo-Lozano, Silvia; Bilic, Josipa; Carton-Garcia, Fernando; Nieto, Rocio; Suarez-Lopez, Lucia; Afonso, Elsa; Schwartz, Simo, Jr.; Arango, Diego] CIBER BBN, Barcelona 28029, Spain; [Suarez-Lopez, Lucia; Schwartz, Simo, Jr.] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Res Inst VHIR, CIBBIM Nanomed,Grp Drug Delivery & Targeting, Barcelona 08035, Spain; [Landolfi, Stefania; Hernandez-Losa, Javier; Ramon y Cajal, Santiago] Vall dHebron Hosp, Dept Pathol, Barcelona 08035, Spain; [Kobayashi, Kazuto] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Mol Genet, Fukushima 9601295, Japan; [Tabernero, Josep] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Res Inst VHIR, Dept Med Oncol, Barcelona 08035, Spain; [Tabernero, Josep] Univ Autonoma Barcelona, Inst Oncol VHIO, Barcelona 08035, Spain; [Tebbutt, Niall C.; Mariadason, John M.] Austin Hlth, Ludwig Inst Canc Res, Melbourne Branch, Heidelberg, Vic 3084, Australia	Arango, D (reprint author), Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Res Inst VHIR, CIBBIM Nanomed,Grp Mol Oncol, Passeig Vall dHebron 119-129, Barcelona 08035, Spain.	diego.arango@vhir.org	Schwartz, Simo/H-7776-2012; 	Landolfi, Stefania/0000-0002-1059-635X	Spanish Ministry for Economy and Competitiveness [CP05/00256, TRA2009 0093, SAF2008 00789, PI12/03103, PI12/01095]; Association for International Cancer Research [AICR13-0245]; Fundacion Mutua Madrilena; Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR 157]	This study was partially funded by grants of the Spanish Ministry for Economy and Competitiveness (CP05/00256, TRA2009 0093, SAF2008 00789, PI12/03103 and PI12/01095), the Association for International Cancer Research (AICR13-0245), Fundacion Mutua Madrilena and Agencia de Gestio d'Ajuts Universitaris i de Recerca (SGR 157) to Diego Arango.	Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Ordonez-Moran P, 2008, J CELL BIOL, V183, P697, DOI 10.1083/jcb.200803020; Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008.CAN-05-1947; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Arango D, 2005, GASTROENTEROLOGY, V129, P874, DOI 10.1053/j.gastro.2005.06.066; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Dopeso H, 2009, CANCER RES, V69, P7430, DOI 10.1158/0008-5472.CAN-09-0706; Rusovici R, 2007, BBA-GEN SUBJECTS, V1770, P1194, DOI 10.1016/j.bbagen.2007.04.008; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Rath N, 2012, EMBO REP, V13, P900, DOI 10.1038/embor.2012.127; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ucb796; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Ohata H, 2012, CANCER RES, V72, P5101, DOI 10.1158/0008-5472.CAN-11-3812; Bakker ERM, 2013, CARCINOGENESIS, V34, P2629, DOI 10.1093/carcin/bgt215; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Kamai T, 2003, BJU INT, V91, P234, DOI 10.1046/j.1464-4096.2003.03063.x; Olson MF, 1998, NATURE, V394, P295; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Horiuchi A, 2003, LAB INVEST, V83, P861, DOI 10.1097/01.LAB.0000073128.16098.31; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Malvezzi M, 2012, ANN ONCOL, V23, P1044, DOI 10.1093/annonc/mds024; Bellovin DI, 2006, ONCOGENE, V25, P6959, DOI 10.1038/sj.onc.1209682; Leve F, 2012, J CELL BIOCHEM, V113, P2549, DOI 10.1002/jcb.24153; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Lee JJ, 2009, NEW ENGL J MED, V360, P1679; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Sanno H, 2010, J NEUROSCI, V30, P4221, DOI 10.1523/JNEUROSCI.3318-09.2010; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Mardilovich K, 2012, FUTURE ONCOL, V8, P165, DOI [10.2217/fon.11.143, 10.2217/FON.11.143]; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Melendez J, 2013, GASTROENTEROLOGY, V145, P808, DOI 10.1053/j.gastro.2013.06.021; NUSRAT A, 1995, P NATL ACAD SCI USA, V92, P10629, DOI 10.1073/pnas.92.23.10629; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Hirai A, 1997, J BIOL CHEM, V272, P13; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; CHANG EH, 1982, P NATL ACAD SCI-BIOL, V79, P4848, DOI 10.1073/pnas.79.16.4848; Contos JJA, 2000, MOL PHARMACOL, V58, P1188; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Defeo D., 1981, BIOCHEMISTRY-US, V78, P3328; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Faried A, 2005, EJSO, V31, P410, DOI 10.1016/j.ejso.2004.12.014; Larriba MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023524; Luo FJ, 2011, ONCOL REP, V26, P125, DOI 10.3892/or.2011.1288; Malliri A, 2003, CURR OPIN CELL BIOL, V15, P583, DOI 10.1016/S0955-0674(03)00098-X; Mariadason JM, 2001, CANCER RES, V61, P3465; Mazzolini R, 2012, P NATL ACAD SCI USA, V109, P1530, DOI 10.1073/pnas.1108411109; Pope J. L., 2014, MOL CANC, V13, P167; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Tatsuta M, 2005, CANCER LETT, V219, P137, DOI 10.1016/j.canlet.2004.06.028; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wang HB, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-123; Weber JD, 1997, J BIOL CHEM, V272, P32966, DOI 10.1074/jbc.272.52.32966; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037823	70	4	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5458	10.1038/ncomms6458		15	Multidisciplinary Sciences	Science & Technology - Other Topics	AU5KW	WOS:000345646700001		
J	Sato, Y; Hayashi, K; Amano, Y; Takahashi, M; Yonemura, S; Hayashi, I; Hirose, H; Ohno, S; Suzuki, A				Sato, Yoshinori; Hayashi, Kenji; Amano, Yoshiko; Takahashi, Mikiko; Yonemura, Shigenobu; Hayashi, Ikuko; Hirose, Hiroko; Ohno, Shigeo; Suzuki, Atsushi '			MTCL1 crosslinks and stabilizes non-centrosomal microtubules on the Golgi membrane	NATURE COMMUNICATIONS			English	Article							ALPHA-TUBULIN; NONCENTROSOMAL MICROTUBULES; CELLS; NUCLEATION; APPARATUS; DYNAMICS; ORGANIZATION; COMPLEX; ENDS; ACETYLTRANSFERASE	Recent studies have revealed the presence of a microtubule subpopulation called Golgi-derived microtubules that support Golgi ribbon formation, which is required for maintaining polarized cell migration. CLASPs and AKAP450/CG-NAP are involved in their formation, but the underlying molecular mechanisms remain unclear. Here, we find that the microtubule-crosslinking protein, MTCL1, is recruited to the Golgi membranes through interactions with CLASPs and AKAP450/CG-NAP, and promotes microtubule growth from the Golgi membrane. Correspondingly, MTCL1 knockdown specifically impairs the formation of the stable perinuclear microtubule network to which the Golgi ribbon tethers and extends. Rescue experiments demonstrate that besides its crosslinking activity mediated by the N-terminal microtubule-binding region, the C-terminal microtubule-binding region plays essential roles in these MTCL1 functions through a novel microtubule-stabilizing activity. These results suggest that MTCL1 cooperates with CLASPs and AKAP450/CG-NAP in the formation of the Golgi-derived microtubules, and mediates their development into a stable microtubule network.	[Sato, Yoshinori; Hayashi, Kenji; Amano, Yoshiko; Suzuki, Atsushi '] Yokohama City Univ, Grad Sch Med Sci, Mol Cellular Biol Lab, Tsurumi ku, Yokohama, Kanagawa 2300045, Japan; [Sato, Yoshinori; Hirose, Hiroko; Ohno, Shigeo] Yokohama City Univ, Grad Sch Med Sci, Dept Mol Biol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Takahashi, Mikiko] Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, Tokyo 1648530, Japan; [Yonemura, Shigenobu] RIKEN, Ctr Dev Biol, Elect Microscope Lab, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Hayashi, Ikuko] Yokohama City Univ, Grad Sch Med Life Sci, Mol Med Biosci Lab, Tsurumi ku, Yokohama, Kanagawa 2300045, Japan	Suzuki, A (reprint author), Yokohama City Univ, Grad Sch Med Sci, Mol Cellular Biol Lab, Tsurumi ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	abell@tsurumi.yokohama-cu.ac.jp			KAKENHI [21116004]; Special Coordination Fund for Promoting Science and Technology 'Creation and Innovation Centers for Advanced Interdisciplinary' of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Strategic Research Promotion of Yokohama City University, Japan [IR2504]	We thank M. Murata (The University of Tokyo, Japan) for the GT-EGFP expression vector gift, and A. Akhmanova (The Utrecht University, The Netherlands) for the EGFP-CLASP2 gift. We also thank T. Igarashi, R. Hayashi and T. Chiaki from Leica Microsystems for their technical help in obtaining super-resolution images. This research was supported by KAKENHI (to A.S. Grant Number 21116004) and the Special Coordination Fund for Promoting Science and Technology 'Creation and Innovation Centers for Advanced Interdisciplinary' (to A.S.) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and partly supported by a grant for 2013 Strategic Research Promotion (No. IR2504) of Yokohama City University, Japan (to A.S).	Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Keating TJ, 1999, BIOL CELL, V91, P321, DOI 10.1016/S0248-4900(99)80093-8; Zhu XD, 2013, HISTOCHEM CELL BIOL, V140, P361, DOI 10.1007/s00418-013-1119-4; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Yamashita K, 2010, BIOCHEM BIOPH RES CO, V391, P812, DOI 10.1016/j.bbrc.2009.11.144; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Sato Y, 2013, J CELL SCI, V126, P4671, DOI 10.1242/jcs.127845; Wei JH, 2010, TRAFFIC, V11, P1391, DOI 10.1111/j.1600-0854.2010.01114.x; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Maia ARR, 2013, CYTOSKELETON, V70, P32, DOI 10.1002/cm.21079; Tanaka N, 2012, P NATL ACAD SCI USA, V109, P20029, DOI 10.1073/pnas.1218017109; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Kano F, 2000, J CELL BIOL, V149, P357, DOI 10.1083/jcb.149.2.357; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Jiang K, 2014, DEV CELL, V28, P295, DOI 10.1016/j.devcel.2014.01.001; Bechstedt S, 2012, DEV CELL, V23, P181, DOI 10.1016/j.devcel.2012.05.006; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Hurtado L, 2011, J CELL BIOL, V193, P917, DOI 10.1083/jcb.201011014; Minin AA, 1997, J CELL SCI, V110, P2495; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Inoko A, 2012, J CELL BIOL, V197, P391, DOI 10.1083/jcb.201106101; BRE MH, 1990, J CELL BIOL, V111, P3013, DOI 10.1083/jcb.111.6.3013; CHAPIN SJ, 1991, NATURE, V349, P24, DOI 10.1038/349024a0; Chausovsky A, 2000, NAT CELL BIOL, V2, P797; Du QS, 2002, CURR BIOL, V12, P1928, DOI 10.1016/S0960-9822(02)01298-8; Haren L, 2002, J CELL SCI, V115, P1815; Luke MR, 2003, J BIOL CHEM, V278, P4216, DOI 10.1074/jbc.M210387200; Mimori-Kiyosue Y., J CELL BIOL, V168, P141; Moynihan KL, 2009, MOL BIOL CELL, V20, P4790, DOI 10.1091/mbc.E09-07-0560; SKOUFIAS DA, 1990, J CELL BIOL, V111, P1929, DOI 10.1083/jcb.111.5.1929; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; Tanaka J, 1999, BIOCHEM BIOPH RES CO, V264, P938, DOI 10.1006/bbrc.1999.1617; THYBERG J, 1993, CELL TISSUE RES, V273, P457, DOI 10.1007/BF00333700	38	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	NOV	2014	5								5266	10.1038/ncomms6266		14	Multidisciplinary Sciences	Science & Technology - Other Topics	AU6AY	WOS:000345685600001		
J	Nakajima, K; Kho, DH; Yanagawa, T; Harazono, Y; Gao, XG; Hogan, V; Raz, A				Nakajima, Kosei; Kho, Dhong Hyo; Yanagawa, Takashi; Harazono, Yosuke; Gao, Xiaoge; Hogan, Victor; Raz, Avraham			Galectin-3 Inhibits Osteoblast Differentiation through Notch Signaling	NEOPLASIA			English	Article							METASTATIC BREAST-CANCER; POLYMERASE-CHAIN-REACTION; PROSTATE-CANCER; BONE-METASTASIS; SKELETAL COMPLICATIONS; CELL-LINE; EXPRESSION; PROTEIN; ANGIOGENESIS; OSTERIX	Patients with bone cancer metastasis suffer from unbearable pain and bone fractures due to bone remodeling. This is caused by tumor cells that disturb the bone microenvironment. Here, we have investigated the role of tumor-secreted sugar-binding protein, i.e., galectin-3, on osteoblast differentiation and report that it downregulates the expression of osteoblast differentiation markers, e.g., RUNX2, SP7, ALPL, COL1A1, IBSP, and BGLAP, of treated human fetal osteoblast (hFOB) cells. Co-culturing of hFOB cells with human breast cancer BT-549 and prostate cancer LNCaP cells harboring galectin-3 has resulted in inhibition of osteoblast differentiation by the secreted galectin-3 into culture medium. The inhibitory effect of galectin-3 was found to be through its binding to Notch1 in a sugar-dependent manner that has led to accelerated Notch1 cleavage and activation of Notch signaling. Taken together, our findings show that soluble galectin-3 in the bone microenvironment niche regulates bone remodeling through Notch signaling, suggesting a novel bone metastasis therapeutic target.	[Nakajima, Kosei; Kho, Dhong Hyo; Harazono, Yosuke; Gao, Xiaoge; Hogan, Victor; Raz, Avraham] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Sch Med, Detroit, MI 48201 USA; [Nakajima, Kosei; Kho, Dhong Hyo; Harazono, Yosuke; Gao, Xiaoge; Hogan, Victor; Raz, Avraham] Wayne State Univ, Karmanos Canc Inst, Dept Pathol, Sch Med, Detroit, MI 48201 USA; [Yanagawa, Takashi] Gunma Univ, Grad Sch Med, Dept Orthoped Surg, Maebashi, Gunma, Japan	Raz, A (reprint author), Wayne State Univ, Karmanos Canc Inst, Dept Oncol, 110 E Warren Ave, Detroit, MI 48201 USA.	raza@karmanos.org			National Institutes of Health (NIH)/National Cancer Institute [R37 CA46120]	This work was supported by National Institutes of Health (NIH)/National Cancer Institute (R37 CA46120; A.R.).	Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Smith MR, 2012, LANCET, V379, P39, DOI 10.1016/S0140-6736(11)61226-9; Eckhardt BL, 2012, NAT REV DRUG DISCOV, V11, P479, DOI 10.1038/nrd2372; Lu XH, 2006, J BIOL CHEM, V281, P6297, DOI 10.1074/jbc.M507804200; Barrett-Lee P, 2014, LANCET ONCOL, V15, P114, DOI 10.1016/S1470-2045(13)70539-4; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Straube T, 2013, TRAFFIC, V14, P1014, DOI 10.1111/tra.12086; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.3.CO;2-Z; Zhu J, 2011, J CELL BIOCHEM, V112, P1749, DOI 10.1002/jcb.23094; Bu GJ, 2008, INT J CANCER, V123, P1034, DOI 10.1002/ijc.23625; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hamaoka T, 2004, J CLIN ONCOL, V22, P2942, DOI 10.1200/jco.2004.08.181; Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; Sturge J, 2011, NAT REV CLIN ONCOL, V8, P357, DOI 10.1038/nrclinonc.2011.67; Wang Y, 2009, AM J PATHOL, V174, P1515, DOI 10.2353/ajpath.2009.080816; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; LIU F, 1994, DEV BIOL, V166, P220, DOI 10.1006/dbio.1994.1309; Balan V, 2013, ONCOTARGET, V4, P542; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Suva LJ, 2011, NAT REV ENDOCRINOL, V7, P208, DOI 10.1038/nrendo.2010.227; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Gilbert L, 2000, ENDOCRINOLOGY, V141, P3956, DOI 10.1210/en.141.11.3956; Rampal R, 2005, J BIOL CHEM, V280, P32133, DOI 10.1074/jbc.M506104200; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Hou XH, 2012, J BIOL CHEM, V287, P474, DOI 10.1074/jbc.M111.317578; Salie R, 2010, BONE, V46, P680, DOI 10.1016/j.bone.2009.10.022; Wang Y, 2013, ONCOGENE, V32, P5058, DOI 10.1038/onc.2012.528; Glinskii OV, 2012, NEOPLASIA, V14, P65, DOI 10.1593/neo.111544; Glinskii OV, 2005, NEOPLASIA, V7, P522, DOI 10.1593/neo.04646; Edwards JR, 2011, NAT REV RHEUMATOL, V7, P235, DOI 10.1038/nrrheum.2011.23; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Stillman BN, 2006, J IMMUNOL, V176, P778; Balan V, 2012, J BIOL CHEM, V287, P5192, DOI 10.1074/jbc.C111.331686; Berruti A, 2000, J UROLOGY, V164, P1248, DOI 10.1016/S0022-5347(05)67149-2; Canalis E, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.117pe17; Eichner A, 2002, EXP CELL RES, V275, P132, DOI 10.1006/excr.2002.5488; KAIGHN ME, 1979, INVEST UROL, V17, P16; Koizumi M, 2010, BMC CANCER, V21, P381; Mendoza-Villanueva D, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3048; Muller H, 2012, ARTERIOSCL THROM VAS, V32, P442, DOI 10.1161/ATVBAHA.111.239830; Nangia-Makker P, 2010, INT J CANCER, V127, P2530, DOI 10.1002/ijc.25254; Nangia-Makker Pratima, 2008, Cancer Microenviron, V1, P43, DOI 10.1007/s12307-008-0003-6; Orgaz JL, 2011, MELANOMA RES, V21, P285, DOI 10.1097/CMR.0b013e32834495c3; Peng YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056451; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; Tao JN, 2011, CANCER CELL, V19, P159, DOI 10.1016/j.ccr.2011.01.043	56	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1522-8002	1476-5586		NEOPLASIA	Neoplasia	NOV	2014	16	11					939	949		10.1016/j.neo.2014.09.005		11	Oncology	Oncology	AU3MH	WOS:000345516900006		
J	Kawakami, S; Kinoshita, Y; Maruki-Uchida, H; Yanae, K; Sai, M; Ito, T				Kawakami, Shinpei; Kinoshita, Yosuke; Maruki-Uchida, Hiroko; Yanae, Koji; Sai, Masahiko; Ito, Tatsuhiko			Piceatannol and Its Metabolite, Isorhapontigenin, Induce SIRT1 Expression in THP-1 Human Monocytic Cell Line	NUTRIENTS			English	Article						piceatannol; isorhapontigenin; resveratrol; sirtuin 1; THP-1	PASSIFLORA-EDULIS SEEDS; CALORIE RESTRICTION; RESVERATROL; PROTECTS; RATS; DIET	Piceatannol is a phytochemical that is present in large amounts in passion fruit (Passiflora edulis) seeds, and is an analog of resveratrol. Recently, the absorption and metabolism of piceatannol were investigated in rats, and isorhapontigenin, O-methyl piceatannol, was detected as a piceatannol metabolite in rat plasma. To elucidate the function of piceatannol and its metabolites, we investigated the expression of sirtuin 1 (SIRT1) in THP-1 monocytic cells after treatment with piceatannol and its metabolites, and compared their effects with those of resveratrol and its metabolites. Piceatannol and resveratrol upregulated the expression levels of SIRT1 mRNA and SIRT1 protein. An extract of passion fruit seeds, which contained high levels of piceatannol, also upregulated SIRT1 mRNA expression. As for the metabolites, isorhapontigenin upregulated SIRT1 mRNA expression, whereas resveratrol glucuronides and sulfate did not affect SIRT1 expression. These findings indicate that after intake of piceatannol, not only piceatannol itself, but also its metabolite, isorhapontigenin, contributed to the upregulation of SIRT1 expression.	[Kawakami, Shinpei; Kinoshita, Yosuke; Maruki-Uchida, Hiroko; Yanae, Koji; Sai, Masahiko; Ito, Tatsuhiko] Morinaga & Co Ltd, Res Inst, Tsuzuki Ku, Yokohama, Kanagawa 2308504, Japan	Maruki-Uchida, H (reprint author), Morinaga & Co Ltd, Res Inst, Tsuzuki Ku, 2-1-1 Shimosueyoshi, Yokohama, Kanagawa 2308504, Japan.	s-kawakami-jf@morinaga.co.jp; y-kinoshita-jg@morinaga.co.jp; h-uchida-ji@morinaga.co.jp; k-yanae-ja@morinaga.co.jp; m-sai-ia@morinaga.co.jp; t-ito-jj@morinaga.co.jp					Andrade JMO, 2014, EUR J NUTR, V53, P1503, DOI 10.1007/s00394-014-0655-6; Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003; Piotrowska H, 2012, MUTAT RES-REV MUTAT, V750, P60, DOI 10.1016/j.mrrev.2011.11.001; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Matsui Y, 2010, J AGR FOOD CHEM, V58, P11112, DOI 10.1021/jf102650d; Hoshino J, 2010, J MED CHEM, V53, P5033, DOI 10.1021/jm100274c; Xiong SQ, 2011, J BIOL CHEM, V286, P5289, DOI 10.1074/jbc.M110.163667; Gualdoni GA, 2014, BBA-GEN SUBJECTS, V1840, P95, DOI 10.1016/j.bbagen.2013.09.009; Setoguchi Y, 2014, J AGR FOOD CHEM, V62, P2541, DOI 10.1021/jf404694y; Yun JM, 2012, J NUTR BIOCHEM, V23, P699, DOI 10.1016/j.jnutbio.2011.03.012; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Wang GL, 2009, BIOCHEM BIOPH RES CO, V380, P644, DOI 10.1016/j.bbrc.2009.01.163; Sano S, 2011, J AGR FOOD CHEM, V59, P6209, DOI 10.1021/jf104959t; Kuhnle G, 2000, BIOCHEM BIOPH RES CO, V272, P212, DOI 10.1006/bbrc.2000.2750; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P482, DOI 10.1002/mnfr.200500003; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Baur JA, 2010, BBA-PROTEINS PROTEOM, V1804, P1626, DOI 10.1016/j.bbapap.2009.10.025; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Kwon JY, 2012, J BIOL CHEM, V287, P11566, DOI 10.1074/jbc.M111.259721; Breitenstein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053106; de Kreutzenberg SV, 2010, DIABETES, V59, P1006, DOI 10.2337/db09-1187; Eseberri I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063918; Kahyo T, 2008, J PHARMACOL SCI, V108, P364, DOI 10.1254/jphs.08203FP; Kinoshita Y, 2013, BIOCHEM BIOPH RES CO, V430, P1164, DOI 10.1016/j.bbrc.2012.12.017; Kitada M, 2013, BBA-GEN SUBJECTS, V1830, P4820, DOI 10.1016/j.bbagen.2013.06.014; la Porte C, 2010, CLIN PHARMACOKINET, V49, P449, DOI 10.2165/11531820-000000000-00000; Maruki-Uchida H, 2013, BIOL PHARM BULL, V36, P845, DOI 10.1248/bpb.b12-00708; Takeda-Watanabe A, 2012, BIOCHEM BIOPH RES CO, V427, P191, DOI 10.1016/j.bbrc.2012.09.042	28	5	5	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-6643			NUTRIENTS	Nutrients	NOV	2014	6	11					4794	4804		10.3390/nu6114794		11	Nutrition & Dietetics	Nutrition & Dietetics	AU3RM	WOS:000345531300011		
J	Masuyama, Y				Masuyama, Yutaka			The work achieved with the sail dynamometer boat "Fujin", and the role of full scale tests as the bridge between model tests and CFD	OCEAN ENGINEERING			English	Article; Proceedings Paper	3rd International Conference on Innovation in High Performance Sailing Yachts (Innov'sail)	JUN 26-28, 2013	Lorient, FRANCE			Sail performance; Sail dynamometer boat; Full scale test; Tacking simulation; CFD validation		The work achieved with the sail dynamometer boat Fujin was reported. At first, the sail shapes and performance for upwind conditions were measured in steady sailing conditions. The results were compared with the numerical calculations. The database of three-dimensional coordinates of the sail shapes was also tabulated with the aerodynamic coefficients. The sail shape database provides a good benchmark for the validation of sail CFD in full scale level. Then, the aerodynamic force variation during tacking maneuvers was measured by Fujin, and a new simulation model of tacking maneuver was proposed. The simulated results showed good agreement with the measured data. Finally, the scale effect problem of wind tunnel tests was discussed. Wind Tunnel tests using model sails are performed at the region of critical Reynolds number. Therefore, the wind tunnel test had to be performed very carefully. On the other hand, the full scale tests using a sail dynamometer boat are free from scale effect problems and appear more promising. (C) 2014 Elsevier Ltd. All rights reserved.	Kanazawa Inst Technol, Actual Seas Ship & Marine Res Lab, Housu, Ishikawa 9270024, Japan	Masuyama, Y (reprint author), Kanazawa Inst Technol, Actual Seas Ship & Marine Res Lab, Housu, Ishikawa 9270024, Japan.	masuyama@neptune.kanazawa-it.ac.jp					Masuyama Y, 2009, J MAR SCI TECHNOL, V14, P137, DOI 10.1007/s00773-009-0056-3; Fossati F., 2013, P 3 INT C INN HIG PE, P255; Fukasawa T, 1993, P AER ICAHE 93; Hamamoto M., 1988, J SOC NAVAL ARCHIT J, P173; Hansen H., 2003, INT J SMALL CRAFT B1, V145, P23; Hochkirch K., 1999, P 14 CHES SAIL YACHT, P33; Hoerner S.F., 1975, HOERNER FLUID DYN, P4; Krebber B., 2006, P 2 HIGH PERF YACHT; Masuyama Y., 1995, P 12 CHES SAIL YACHT, P117; Masuyama Y., 1997, P 13 CHES SAIL YACHT, P23; Masuyama Y., 2008, P 3 HIGH PERF YACHT, P138; Masuyama Y., 2011, T SNAME, V119, P2011; Masuyama Y., 2007, P 18 CHES SAIL YACHT, P11; Masuyama Y., 2010, J SAILBOAT TECHNOL S, V2010; Masuyama Y., 1993, P 11 CHES SAIL YACHT, P161; Milgram J. H., 1993, P 11 CHES SAIL YACHT, P65; Tahara Y., 2003, J SOC NAVAL ARCHIT J, V194, P1; Tahara Y., 2012, P 4 HIGH PERF YACHT, P38; Tahara Y, 1996, J SOC NAVAL ARCHIT J, V180, P59; Viola IM, 2012, J SHIP RES, V56, P197, DOI 10.5957/JOSR.56.4.110003	20	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0029-8018			OCEAN ENG	Ocean Eng.	NOV 1	2014	90				SI		72	83		10.1016/j.oceaneng.2014.06.037		12	Engineering, Marine; Engineering, Civil; Engineering, Ocean; Oceanography	Engineering; Oceanography	AU2WC	WOS:000345474400009		
J	Mehr, MY; van Driel, WD; Udono, H; Zhang, GQ				Mehr, M. Yazdan; van Driel, W. D.; Udono, H.; Zhang, G. Q.			Surface aspects of discolouration in Bisphenol A Polycarbonate (BPA-PC), used as lens in LED-based products	OPTICAL MATERIALS			English	Article						Bisphenol A Polycarbonate (BPA-PC); XPS; Discolouration; LED lens	THERMAL-DEGRADATION; PHOTOCHEMISTRY; OXYGEN	The surface-related reactions during discolouration of Bisphenol A Polycarbonate (BPA-PC), used as LED lens plates, under thermal stress are studied. X-ray photoelectron spectroscopy (XPS) has been used to monitor the changes in the surface chemistry of BPA-PC plates over a temperature range of 100-140 degrees C for a period up to 3000 h. Increasing time under thermal stress is associated with the discolouration, and increase in the yellowing index (YI) of PC plastic lens. The XPS results show that discolouration is associated with oxidation at the surface, finding a significant increase in the signal ratio O-1s/C-1s in the XPS spectra of degraded specimens. During thermal ageing, the C H concentration decreases and new oxide features C=O and O-C=O form, with the latter being a support for oxidation at the surface being a major reaction during discolouration. Results also show that irradiation with blue light during thermal ageing accelerates the kinetics of discolouration and the increased O-1s/C-1s ratio in XPS spectra. (C) 2014 Elsevier B.V. All rights reserved.	[Mehr, M. Yazdan] Mat Innovat Inst M2i, Delft, Netherlands; [Mehr, M. Yazdan; van Driel, W. D.; Zhang, G. Q.] Delft Univ Technol, EEMCS Fac, Delft, Netherlands; [van Driel, W. D.; Zhang, G. Q.] Philips Lighting, Eindhoven, Netherlands; [Udono, H.] Ibaraki Univ, Coll Engn, Hitachi, Ibaraki, Japan	Mehr, MY (reprint author), Mat Innovat Inst M2i, Delft, Netherlands.	m.yazdanmehr@tudelft.nl			Research Program of the Materials innovation institute M2i [M71.9.10380]	This research was carried out under project number M71.9.10380 in the framework of the Research Program of the Materials innovation institute M2i (www.m2i.n1). The authors would like to thank M2i for funding this project. Authors would also like to acknowledge "TNO innovation for life" company for SPD measurements. Authors would also like to thank Mr. Tazezaki in Ibaraki University for his assistance in doing XPS analyses.	ABBAS KB, 1980, POLYMER, V21, P936, DOI 10.1016/0032-3861(80)90251-7; American Society for Testing and Materials, 1970, D192570 ASTM; LEMAIRE J, 1986, POLYM DEGRAD STABIL, V15, P1, DOI 10.1016/0141-3910(86)90002-9; CLARK DT, 1984, POLYM DEGRAD STABIL, V8, P195, DOI 10.1016/0141-3910(84)90018-1; Davis A, 1968, J CHEM SOC B, P41; FACTOR A, 1994, POLYM DEGRAD STABIL, V45, P127, DOI 10.1016/0141-3910(94)90188-0; FACTOR A, 1980, POLYM DEGRAD STABIL, V2, P203, DOI 10.1016/0141-3910(80)90029-4; FACTOR A, 1987, MACROMOLECULES, V20, P2461, DOI 10.1021/ma00176a023; Factor A, 1996, ADV CHEM SER, V249, P59; MEHR MY, 2013, J OPT MAT, V35, P504; MONTAUDO G, 1992, POLYM DEGRAD STABIL, V37, P91, DOI 10.1016/0141-3910(92)90097-O; Pickett Polym J., 2011, POLYM DEGRAD STABIL, V96, P2253; Rivaton A, 2002, POLYM DEGRAD STABIL, V75, P17, DOI 10.1016/S0141-3910(01)00201-4; RIVATON A, 1986, POLYM DEGRAD STABIL, V14, P1, DOI 10.1016/0141-3910(86)90018-2; RIVATON A, 1995, POLYM DEGRAD STABIL, V49, P163, DOI 10.1016/0141-3910(95)00069-X; RIVATON A, 1983, POLYM PHOTOCHEM, V3, P463, DOI 10.1016/0144-2880(83)90102-1; RUFUS IB, 1994, J APPL POLYM SCI, V51, P1549, DOI 10.1002/app.1994.070510904	17	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	NOV	2014	37						155	159		10.1016/j.optmat.2014.05.015		5	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	AT8KF	WOS:000345181600027		
J	Sakuma, T; Minowa, S; Katsumata, T; Komuro, S; Aizawa, H				Sakuma, Takashi; Minowa, Shunsuke; Katsumata, Toru; Komuro, Shuji; Aizawa, Hiroaki			Compositional variation of photoluminescence from Mn doped MgAl2O4 spinel	OPTICAL MATERIALS			English	Article						Mn doped spinel; Photoluminescence spectrum; Composition; Fluorescence thermometer; Phosphor	GROWTH	Spinel (MgAl2O4) crystals doped with 1.0% Mn have been grown by floating zone (FZ) technique with various Mg compositions, x = MgO/Al2O3, from 0.2 to 1.0. Compositional variations of photoluminescence are evaluated for a fluorescence thermometer application using crystals grown. Strong photoluminescence (PL) peak is observed at lambda from 512 to 520 nm from the crystals grown from compositions, x, from 0.3 to 1.0. Peak wavelength of PL increases linearly from 512 to 520 nm with x. Weak PL peaking at lambda= 750 nm is also observed from the specimens. Compositional variations of PL are considered to be due to the variation of crystal field surrounding the Mn2+ ions. The variation of crystal field strength agrees with the compositional variation of lattice constant. (C) 2014 Elsevier B.V. All rights reserved.	[Sakuma, Takashi; Minowa, Shunsuke] Toyo Univ, Grad Sch Engn, Kawagoe, Saitama 3508585, Japan; [Katsumata, Toru; Komuro, Shuji; Aizawa, Hiroaki] Toyo Univ, Fac Sci & Engn, Kawagoe, Saitama 3508585, Japan	Katsumata, T (reprint author), Toyo Univ, Fac Sci & Engn, 2100 Kujirai, Kawagoe, Saitama 3508585, Japan.	katsumat@toyo.jp					Aizawa H., 2002, REV SCI INSTUM, V73, P3889; Aizawa H., 2002, SENSOR ACTUAT A-PHYS, V3481, P42; Uchiyama H, 2003, REV SCI INSTRUM, V74, P3883, DOI 10.1063/1.1589582; Tomita A, 2004, J LUMIN, V109, P19, DOI 10.1016/j.jlumin.2003.12.049; Garapon C, 1998, OPT MATER, V10, P177, DOI 10.1016/S0925-3467(98)00011-1; Grattan K T V, 1995, FIBER OPTIC FLUORESC; Jouini A, 2006, J CRYST GROWTH, V287, P313, DOI 10.1016/j.jcrysgro.2005.11.027; Jouini A, 2006, J CRYST GROWTH, V293, P517, DOI 10.1016/j.jcrysgro.2006.05.081; Kaminska K., 2002, J ALLOY COMPD, V341, P193; Levin Ernest M., 1969, AM CERAM SOC BULL, V1, p[110, 259]	10	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	NOV	2014	37						302	305		10.1016/j.optmat.2014.06.014		4	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	AT8KF	WOS:000345181600053		
J	Kiyokawa, Y; Inoue, H; Katsumata, T; Komuro, S; Aizawa, H				Kiyokawa, Yuka; Inoue, Hirofumi; Katsumata, Toru; Komuro, Shuji; Aizawa, Hiroaki			Thermal stability and annealing behavior of photoluminescence from Eu doped YAG	OPTICAL MATERIALS			English	Article						Eu doped YAG; Photoluminescence spectrum; Annealing; Optical absorption spectrum; Fluorescence thermometer	FIBEROPTIC THERMOMETER APPLICATION; SENSOR HEAD; CRYSTALS	Eu2O3 doped Y3Al5O12 (YAG) crystals have been grown using a floating zone technique and evaluated thermal stability and annealing behavior of PL for a fluorescence thermo-sensor application. Color of the crystals grown varies from deep purple to colorless with O-2 concentration of the growth atmosphere and annealing in air. Photoluminescence (PL) peaking at lambda = 590, 607, 624, 647 and 709 nm due to Eu3+ ions are observed from the crystals under UV excitation. Anomalous temperature dependence of PL intensity, which is observed in as-grown crystals, is improved greatly by annealing through the heat cycle. From annealing behavior of optical absorption spectra, residual Eu2+ ions are suggested to be responsible for the de-coloration and the improvement of anomalous temperature dependence of Eu doped YAG crystals. (C) 2014 Elsevier B.V. All rights reserved.	[Kiyokawa, Yuka] Toyo Univ, Grad Sch Engn, Kawagoe, Saitama 3508585, Japan; [Inoue, Hirofumi; Katsumata, Toru; Komuro, Shuji; Aizawa, Hiroaki] Toyo Univ, Fac Sci & Engn, Kawagoe, Saitama 3508585, Japan	Katsumata, T (reprint author), Toyo Univ, Fac Sci & Engn, 2100 Kujirai, Kawagoe, Saitama 3508585, Japan.	katsumat@toyo.jp			MEXT (Ministry of Education Culture, Sports, Science and Technology)	The authors thank Kota Mori and Yosuke Arai of Crystal Engineering Laboratory, Toyo University, for their assistances in specimen preparations and X-ray powder diffraction measurements. The present study was partially supported as "High-Tech Research Center" Project for Private Universities: matching found subsidy from MEXT (Ministry of Education Culture, Sports, Science and Technology), 2004-2008.	Aizawa H, 2002, REV SCI INSTRUM, V73, P3089, DOI 10.1063/1.1491998; Uchiyama H, 2003, REV SCI INSTRUM, V74, P3883, DOI 10.1063/1.1589582; Aizawa H, 2002, SENSOR ACTUAT A-PHYS, V101, P42, DOI 10.1016/S0924-4247(02)00148-6; Kissel T, 2013, MATER CHEM PHYS, V140, P435, DOI 10.1016/j.matchemphys.2013.02.065; Aizawa H, 2006, MEASUREMENT, V39, P147, DOI 10.1016/j.measurement.2005.10.004; DIEKE GH, 1963, APPL OPTICS, V2, P675, DOI 10.1364/AO.2.000675; Grattan K T V, 1995, FIBER OPTIC FLUORESC; Shen YH, 2003, SENSOR ACTUAT A-PHYS, V109, P53, DOI 10.1016/j.sna.2003.09.006	8	2	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	NOV	2014	37						493	497		10.1016/j.optmat.2014.07.012		5	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	AT8KF	WOS:000345181600085		
J	Zamurueva, OV; Myronchuk, GL; Lakshminarayana, G; Parasyuk, OV; Piskach, LV; Fedorchuk, AO; AlZayed, NS; El-Naggar, AM; Kityk, IV				Zamurueva, O. V.; Myronchuk, G. L.; Lakshminarayana, G.; Parasyuk, O. V.; Piskach, L. V.; Fedorchuk, A. O.; AlZayed, N. S.; El-Naggar, A. M.; Kityk, I. V.			Structural and optical features of novel Tl1-xIn1-xGexSe2 chalcogenide crystals	OPTICAL MATERIALS			English	Article						Optoelectronic materials; Optical absorption; Chalcogenide crystals	TLGAS2 SINGLE-CRYSTALS; ABSORPTION-EDGE; HIGH-PRESSURES; TLINS2; TEMPERATURES; SELENIDE; GLASSES; LATTICE; GESE2; RULE	The novel infrared Tl1-xIn1-xGexSe2 single crystals were synthesized by the modified Bridgman-Stockbarger method. The parameters of their energy band structure were determined. The temperature changes of the infrared parameters were studied and the phonon subsystem were evaluated. Analysis of the data is performed following the model of intrinsic defect states. The band structure calculation have established a principal role of the phonon subsystem for the observed effects. (C) 2014 Elsevier B.V. All rights reserved.	[Zamurueva, O. V.; Myronchuk, G. L.; Kityk, I. V.] Eastern European Univ, Dept Phys, UA-43025 Lutsk, Ukraine; [Lakshminarayana, G.] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan; [Lakshminarayana, G.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Parasyuk, O. V.; Piskach, L. V.] Eastern European Univ, Dept Inorgan & Phyg Chem, UA-43025 Lutsk, Ukraine; [Kityk, I. V.] Czestochowa Tech Univ, Dept Elect Engn, Czestochowa, Poland; [Fedorchuk, A. O.] Natl Univ Vet Med & Biotechnol, Dept Inorgan & Organ Chem, UA-79010 Lvov, Ukraine; [AlZayed, N. S.; El-Naggar, A. M.] King Saud Univ, Coll Sci, Dept Phys & Astron, Riyadh 11451, Saudi Arabia	Myronchuk, GL (reprint author), Eastern European Univ, Dept Phys, 13 Voli Ave, UA-43025 Lutsk, Ukraine.		Kityk, Iwan/M-4032-2015				ABDULLAEVA SG, 1983, PHYS STATUS SOLIDI B, V119, P41, DOI 10.1002/pssb.2221190103; Abdullaev G.B., 1977, DOKL AKAD NAUK AZER, V33, P26; Adamiv VT, 1997, OPT MATER, V8, P207, DOI 10.1016/S0925-3467(97)00017-7; Agaeva M.F., 1979, FIZ TEKH POLUPROV, V13, P597; Aliev V. A., 1987, Soviet Physics - Solid State, V29; ALLAKHVERDIEV KR, 1982, PHYS STATUS SOLIDI B, V113, pK43, DOI 10.1002/pssb.2221130153; KURIK MV, 1971, PHYS STATUS SOLIDI A, V8, P9, DOI 10.1002/pssa.2210080102; Grande T, 1999, J SOLID STATE CHEM, V145, P167, DOI 10.1006/jssc.1999.8235; Grzechnik A, 2000, J SOLID STATE CHEM, V150, P121, DOI 10.1006/jssc.1999.8557; URBACH F, 1953, PHYS REV, V92, P1324, DOI 10.1103/PhysRev.92.1324; Fedorchuk AO, 2013, MATER CHEM PHYS, V139, P92, DOI 10.1016/j.matchemphys.2012.12.058; Myronchuk GL, 2013, J MATER SCI-MATER EL, V24, P3555, DOI 10.1007/s10854-013-1285-0; Rincon C, 2001, J APPL PHYS, V90, P4423, DOI 10.1063/1.1405144; Myronchuk G, 2013, CRYST RES TECHNOL, V48, P464, DOI 10.1002/crat.201300126; BAKHYSHOV AE, 1979, PHYS STATUS SOLIDI B, V95, pK121, DOI 10.1002/pssb.2220950246; BLACHNIK R, 1983, Z NATURFORSCH B, V38, P139; Bonch-Bruyevich V.L., 1981, ELECTRON THEORY OF D; Dennier P.D., 1976, PHYS REV B, V14, P3635; DITTMAR G, 1976, ACTA CRYSTALLOGR B, V32, P2726, DOI 10.1107/S0567740876008704; Gurbulak B, 2005, CZECH J PHYS, V55, P93, DOI 10.1007/s10582-005-0011-4; Gurbulak B, 2001, PHYSICA B, V293, P289, DOI 10.1016/S0921-4526(00)00521-4; Guseinov G.D., 1985, SOV PHYS SEMICOND, V19, P445; HANIAS M, 1989, PHYSICA B, V160, P154, DOI 10.1016/0921-4526(89)90050-1; HANIAS MP, 1992, MATER RES BULL, V27, P25, DOI 10.1016/0025-5408(92)90039-3; Kateliar J.A., 1939, KRISTALLOGRAFIYA, V101, P396; Kityk IV, 2004, J MOD OPTIC, V51, P1179, DOI 10.1080/09500340310001641913; Kityk IV, 2000, OPT MATER, V13, P449, DOI 10.1016/S0925-3467(99)00099-3; Kityk IV, 2003, J OPT A-PURE APPL OP, V5, P61, DOI 10.1088/1464-4258/5/1/309; Wasylak J, 1999, J APPL PHYS, V85, P425, DOI 10.1063/1.369402; MAMEDOV KK, 1986, PHYS STATUS SOLIDI A, V94, P115, DOI 10.1002/pssa.2210940112; Man L.I., 1976, KRISTALLOGRAFIYA, V21, P826; Martienssen H. W., 1957, J PHYS CHEM SOLIDS, V2, P257, DOI DOI 10.1016/0022-3697(57)90070-7; Moss T.S., 1959, OPTICAL PROCESS SEMI, P247; Mozolyuk MY, 2011, J ALLOY COMPD, V509, P2693, DOI 10.1016/j.jallcom.2010.11.112; MULLER D, 1973, Z ANORG ALLG CHEM, V398, P207, DOI 10.1002/zaac.19733980215; Pankove J.I., 1975, OPTICAL PROCESSES SE, P35; SAMARAS I, 1990, MATER RES BULL, V25, P1, DOI 10.1016/0025-5408(90)90155-U; Smith R.A., 1953, J PHYS SOC JPN, P81; SUMI H, 1971, J PHYS SOC JPN, V31, P342, DOI 10.1143/JPSJ.31.342; Wasim SM, 1998, J APPL PHYS, V84, P5823, DOI 10.1063/1.368851; Yakobson A.M., 1978, FIZ TEKH POLUPROV, V12, P520; YANG Z, 1995, J APPL PHYS, V78, P1958, DOI 10.1063/1.360167	42	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	NOV	2014	37						614	620		10.1016/j.optmat.2014.08.004		7	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	AT8KF	WOS:000345181600103		
J	Lupei, A; Lupei, V; Gheorghe, C; Hau, S; Ikesue, A				Lupei, A.; Lupei, V.; Gheorghe, C.; Hau, S.; Ikesue, A.			Multicenters in Ce3+ visible emission of YAG ceramics	OPTICAL MATERIALS			English	Article						YAG ceramics; Ce3+ spectroscopy; Luminescence; Ce3+ multicenters	DOPED YAG; SCINTILLATION PROPERTIES; DEFECTS; LUMINESCENCE; SPECTRA; GARNETS; 1ST-PRINCIPLES; TRANSITIONS; Y3AL5O12; CRYSTALS	New aspects on the Ce3+ in YAG transparent ceramics, obtained from absorption and emission spectra in the 10-300 K range, under different visible excitation wavelengths, along with emission decays are presented. The spectra and lifetime of regular Ce-Y(3+) center are similar to those reported for single crystals. In the attempt to reveal perturbed Ce3+ centers by defects, the 5d --> 4f emission spectra under pulsed 532 nm (5 ns) excitation (below the Ce3+ absorption band) were recorded. The spectra and decays (at different wavelengths) are function on temperature, revealing at least three types of Ce3+ new emitting centers. The low temperature spectra, different from those of Ce-Y(3+) center, are dominated by a set of strongly perturbed centers with very short lifetimes. At least two other types of perturbed centers were separated by using wavelength and temperature dependences of decays. The spectral characteristics of these perturbed Ce3+ centers by lattice defects are analyzed in terms of the effects of the structural changes induced by Ce3+ doping on the interaction with defects, by using recent reported results. (C) 2014 Elsevier B.V. All rights reserved.	[Lupei, A.; Lupei, V.; Gheorghe, C.; Hau, S.] Natl Inst Laser Plasma & Radiat Phys, Magurele 077125, Romania; [Ikesue, A.] World Lab Co Ltd, Atsuta Ku, Nagoya, Aichi 4568587, Japan	Lupei, A (reprint author), Natl Inst Laser Plasma & Radiat Phys, Magurele 077125, Romania.	aurelia.lupei@inflpr.ro	Gheorghe, Cristina/C-2258-2011	Gheorghe, Cristina/0000-0002-6745-9647	CNCSIS - UEFISCSU project [PNII - PCE-IDEI 35/2011]	This work was supported by CNCSIS - UEFISCSU, project PNII - PCE-IDEI 35/2011. The authors thanks to Dr. M. Enculescu from NIMF, Magurele-Bucharest for some spectroscopic measurements.	Allison SW, 2009, J APPL PHYS, V105, DOI 10.1063/1.3077262; Ikesue A, 1996, J AM CERAM SOC, V79, P359, DOI 10.1111/j.1151-2916.1996.tb08129.x; Zorenko Y, 2013, OPT MATER, V35, P2049, DOI 10.1016/j.optmat.2012.07.009; Munoz-Garcia AB, 2011, J PHYS CHEM A, V115, P815, DOI 10.1021/jp108554j; Lupei A, 1998, J PHYS-CONDENS MAT, V10, P9701, DOI 10.1088/0953-8984/10/43/013; Ghigna P, 2011, OPT MATER, V34, P19, DOI 10.1016/j.optmat.2011.07.015; Laguta VV, 2007, RADIAT MEAS, V42, P835, DOI 10.1016/j.radmeas.2007.02.033; Lupei V, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.092102; Zhao W, 2011, OPT MATER, V33, P684, DOI 10.1016/j.optmat.2010.10.007; Tanner PA, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/21/216213; Mihokova E, 2007, J LUMIN, V126, P77, DOI 10.1016/j.jlumin.2006.05.004; Zorenko Y, 2005, J LUMIN, V114, P85, DOI 10.1016/j.jlumin.2004.12.002; Feofilov SP, 2012, J LUMIN, V132, P3082, DOI 10.1016/j.jlumin.2012.06.030; Przybylinska H, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.045114; Patel AP, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3002303; Przybylinska H, 2014, OPT MATER, V36, P1515, DOI 10.1016/j.optmat.2014.04.015; Stanek CR, 2007, NUCL INSTRUM METH A, V579, P27, DOI 10.1016/j.nima.2007.04.006; Seijo L, 2014, PHYS CHEM CHEM PHYS, V16, P3830, DOI 10.1039/c3cp53549e; Ashurov M.Kh., 1977, PHYS STATUS SOLIDI, V42, P101; Hermann G.F., 1966, J APPL PHYS, V37, P1312; Ikesue A., 2013, CERAMIC LASERS; Kaminska A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075483; Liu GK, 2014, J LUMIN, V152, P7, DOI 10.1016/j.jlumin.2013.12.010; LUPEI A, 1993, PHYS REV B, V47, P14084, DOI 10.1103/PhysRevB.47.14084; Lupei A., 2014, INT C LUM WROCL 13 1, pP25; LUPEI V, 1993, J PHYS-CONDENS MAT, V5, pL35, DOI 10.1088/0953-8984/5/3/003; Lupei V., 1995, PHYS REV B, V95, P8; Munoz-Garcia AB, 2012, J MATER CHEM, V22, P19888, DOI 10.1039/c2jm34479c; Pankratov V, 2007, RADIAT MEAS, V42, P679, DOI 10.1016/j.radmeas.2007.02.046; Przybylinska H, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4812190; Robins D.J., 1979, J ELECTROCHEM SOC, V126, P1550; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Suchocki A., 2014, INT C LUM WROCL 13 1, P1; VORONKO YK, 1975, PHYS STATUS SOLIDI A, V27, P257, DOI 10.1002/pssa.2210270130; Xu J, 2014, OPT MATER, V36, P1954, DOI 10.1016/j.optmat.2014.02.008; Zorenko Y, 2012, OPT MATER, V34, P1314, DOI 10.1016/j.optmat.2012.02.007; Zorenko Y, 2009, OPT MATER, V31, P1845, DOI 10.1016/j.optmat.2008.11.026; Zorenko Y, 2011, J LUMIN, V131, P17, DOI 10.1016/j.jlumin.2010.08.015	38	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	NOV	2014	37						727	733		10.1016/j.optmat.2014.09.001		7	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	AT8KF	WOS:000345181600119		
J	Nishino, K; Shimamoto, H; Kakimoto, N; Tsujimoto, T; Chindasombatjaroen, J; Murakami, S; Furukawa, S				Nishino, Kanako; Shimamoto, Hiroaki; Kakimoto, Naoya; Tsujimoto, Tomomi; Chindasombatjaroen, Jira; Murakami, Shumei; Furukawa, Souhei			Influence of an object's z-axis location and location on the axial plane on the voxel value representation and uniformity in cone beam computed tomography	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Article							PERFORMANCE EVALUATION; DENTAL USE; CT; MULTISLICE; SCANNER; DENSITY; REGION	Objective. This study aimed to determine the influence of an object's z-axis location and location on the axial plane on the voxel values in cone beam computed tomography. Study Design. The CTP401 and CTP486 of the Catphan 500 phantom were scanned with an Alphard-3030 at 6 locations in the z-axis. Results. In CTP401, the voxel values of 3 inserts showed the lowest values when the center of the radiation field corresponded to under 2 or 4 cm of the z-axis center of CTP401. In CTP486, the voxel values showed the lowest values when the center of the radiation field corresponded to under 2 or 4 cm of the z-axis center of CTP486. On the same axial plane, the voxel values at the center showed significantly lower values than the off-center locations (P = .002). Conclusions. The voxel values in the Alphard-3030 changed based on the z-axis location of the radiation field and were nonuniform on the same axial plane.	[Nishino, Kanako; Shimamoto, Hiroaki; Kakimoto, Naoya; Tsujimoto, Tomomi; Murakami, Shumei; Furukawa, Souhei] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Radiol, Suita, Osaka 5650871, Japan; [Chindasombatjaroen, Jira] Mahidol Univ, Dept Oral & Maxillofacial Radiol, Fac Dent, Bangkok 10700, Thailand	Shimamoto, H (reprint author), Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Radiol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	h-shima@dent.osaka-u.ac.jp					White SC, 2008, HEALTH PHYS, V95, P628, DOI 10.1097/01.HP.0000326340.81581.1a; De Vos W, 2009, INT J ORAL MAX SURG, V38, P609, DOI 10.1016/j.ijom.2009.02.028; Lagravere MO, 2008, DENTOMAXILLOFAC RAD, V37, P305, DOI 10.1259/dmfr/65993482; Katsumata A, 2007, ORAL SURG ORAL MED O, V104, P829, DOI 10.1016/j.tripleo.2006.12.005; Mozzo P, 1998, EUR RADIOL, V8, P1558, DOI 10.1007/s003300050586; Garcia-Ramirez JL, 2002, INT J RADIAT ONCOL, V52, P1123, DOI 10.1016/S0360-3016(01)02779-1; Yamashina A, 2008, DENTOMAXILLOFAC RAD, V37, P245, DOI 10.1259/dmfr/45926904; Hua Y, 2009, CLIN ORAL IMPLAN RES, V20, P767, DOI 10.1111/j.1600-0501.2008.01677.x; Swennen GRJ, 2006, AM J ORTHOD DENTOFAC, V130, P410, DOI 10.1016/j.ajodo.2005.11.035; Naitoh M, 2004, INT J ORAL MAX IMPL, V19, P239; Arai Y, 1999, DENTOMAXILLOFAC RAD, V28, P245, DOI 10.1038/sj.dmfr.4600448; Miracle AC, 2009, AM J NEURORADIOL, V30, P1285, DOI 10.3174/ajnr.A1654; Araki K, 2013, CLIN ORAL IMPLAN RES, V24, P862, DOI 10.1111/j.1600-0501.2011.02373.x; Chindasombatjaroen J, 2011, J COMPUT ASSIST TOMO, V35, P662, DOI 10.1097/RCT.0b013e31822d9725; Malteni R., 2013, ORAL SURG ORAL MED O, V116, P105; McCollough CH, 1999, MED PHYS, V26, P2223, DOI 10.1118/1.598777; Naitoh M, 2014, ORAL RADIOL, V30, P147, DOI 10.1007/s11282-013-0152-2; Oliveira ML, 2013, OR SURG OR MED OR PA, V115, P558, DOI 10.1016/j.oooo.2013.01.021; Pauwels R, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120135; The Phantom Laboratory, CATPH 500 MAN	20	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	NOV	2014	118	5					619	624		10.1016/j.oooo.2014.08.010		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU2GA	WOS:000345433300021		
J	Nobusawa, A; Sano, T; Yokoo, S; Oyama, T				Nobusawa, Aiko; Sano, Takaaki; Yokoo, Satoshi; Oyama, Tetsunari			Ameloblastic carcinoma developing in preexisting ameloblastoma with a mutation of the p53 gene: a case report	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Article							SQUAMOUS-CELL CARCINOMA; EX AMELOBLASTOMA; FUNCTIONAL ASSAY; SECONDARY TYPE; TP53 MUTATION; NECK-CANCER; HEAD	Objective. Ameloblastic carcinoma is a rare malignant odontogenic tumor. Here we present a case of a large ameloblastic carcinoma, which developed in a preexisting ameloblastoma in the right submandibular region. Study Design. The patient was an 84-year-old woman who had received several surgical procedures for ameloblastoma, including a segmental mandibulectomy. The dimensions of the tumor were 12 x 8 x 5 cm, and both benign ameloblastoma and ameloblastic carcinoma were observed histologically. Based on histologic diagnosis, immunohistochemical staining and sequence analysis for p53 were performed. Results. Overexpression of p53 was observed only in the ameloblastic carcinoma. Additionally, a mutation of the p53 gene (TP53) in exon 5 was found by sequence analysis in the ameloblastic carcinoma. Conclusions. This is the first case of ameloblastic carcinoma with a mutation of the p53 gene that has been associated with carcinomatous transformation.	[Nobusawa, Aiko; Sano, Takaaki; Oyama, Tetsunari] Gunma Univ, Grad Sch Med, Dept Diagnost Pathol, Maebashi, Gunma 3718511, Japan; [Nobusawa, Aiko; Yokoo, Satoshi] Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, Maebashi, Gunma 3718511, Japan	Nobusawa, A (reprint author), Gunma Univ, Grad Sch Med, Dept Diagnost Pathol, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	n.aiko@gunma-u.ac.jp					Abiko Y, 2007, ORAL SURG ORAL MED O, V103, P72, DOI 10.1016/j.tripleo.2006.01.021; Akrish S, 2007, J ORAL MAXIL SURG, V65, P777, DOI 10.1016/j.joms.2005.11.116; Nobusawa A, 2013, EUR J NUCL MED MOL I, V40, P1692, DOI 10.1007/s00259-013-2477-9; Bosch FX, 2004, INT J CANCER, V111, P530, DOI 10.1002/ijc.11698; Yoon HJ, 2009, ORAL SURG ORAL MED O, V108, P904, DOI 10.1016/j.tripleo.2009.06.045; Alsner J, 2001, RADIOTHER ONCOL, V59, P179, DOI 10.1016/S0167-8140(01)00301-2; Marin MC, 2000, NAT GENET, V25, P47; Appel T, 2004, Mund Kiefer Gesichtschir, V8, P167, DOI 10.1007/s10006-004-0539-7; Barnes L, 2005, WHO CLASSIFICATION T; Bello IO, 2009, ORAL ONCOL, V45, P760, DOI 10.1016/j.oraloncology.2008.11.011; Benlyazid A, 2007, ORAL SURG ORAL MED O, V104, pE17, DOI 10.1016/j.tripleo.2007.05.026; Casaroto AR, 2012, ANTICANCER RES, V32, P1515; Chiba I, 1998, INT J CANCER, V77, P839, DOI 10.1002/(SICI)1097-0215(19980911)77:6<839::AID-IJC7>3.0.CO;2-V; Erber R, 1998, ONCOGENE, V16, P1671, DOI 10.1038/sj.onc.1201690; Kaira K, 2007, CLIN CANCER RES, V13, P6369, DOI 10.1158/1078-0432.CCR-07-1294; Karakida K, 2010, ORAL SURG ORAL MED O, V110, pE33, DOI 10.1016/j.tripleo.2010.08.018; Lin ZT, 2013, J CRANIO MAXILL SURG, V41, P190, DOI 10.1016/j.jcms.2012.07.012; Monti P, 2003, ONCOGENE, V22, P5252, DOI 10.1038/sj.onc.1206511; Nagai MA, 1998, INT J CANCER, V76, P13, DOI 10.1002/(SICI)1097-0215(19980330)76:1<13::AID-IJC3>3.0.CO;2-0; Pundir Siddharth, 2011, J Oral Maxillofac Pathol, V15, P201, DOI 10.4103/0973-029X.84501; SAKURAI S, 1995, PATHOL INT, V45, P51, DOI 10.1111/j.1440-1827.1995.tb03379.x; Shibata T, 2002, J ORAL PATHOL MED, V31, P534, DOI 10.1034/j.1600-0714.2002.00006.x; Xie TX, 2013, LARYNGOSCOPE, V123, P1416, DOI 10.1002/lary.23846; Yoshioka Y, 2013, J ORAL MAXIL SURG, V71, pE58, DOI 10.1016/j.joms.2012.09.005	24	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	NOV	2014	118	5					E146	E150		10.1016/j.oooo.2014.03.021		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU2GA	WOS:000345433300003		
J	Nokami, T; Matsumoto, K; Itoh, T; Fukaya, Y; Itoh, T				Nokami, Toshiki; Matsumoto, Kuninobu; Itoh, Taka-aki; Fukaya, Yukinobu; Itoh, Toshiyuki			Synthesis of Ionic Liquids Equipped with 2-Methoxyethoxymethyl/Methoxymethyl Groups Using a Simple Microreactor System	ORGANIC PROCESS RESEARCH & DEVELOPMENT			English	Article							LIPASE CATALYZED REACTION; PROCESS INTENSIFICATION; SOLVENT SYSTEM; REACTORS; DESIGN; FLOW	A simple microreactor system has been utilized for the continuous flow synthesis of novel ionic liquids having a (2-methoxyethoxy)methyl or methoxymethyl substituent. Conversion rates of N-bases and tributylphosphine in the microreactor system are faster than those in the batch system because of less diffusion distance in the tube reactor. This method allows us to prepare ionic liquids in efficient yields with high purity.	[Nokami, Toshiki; Matsumoto, Kuninobu; Itoh, Taka-aki; Fukaya, Yukinobu; Itoh, Toshiyuki] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6800909, Japan; [Nokami, Toshiki; Fukaya, Yukinobu; Itoh, Toshiyuki] Tottori Univ, Grad Sch Engn, Ctr Res Green Sustainable Chem, Tottori 6800909, Japan	Nokami, T (reprint author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, 4-101 Koyamacho Minami, Tottori 6800909, Japan.	tnokami@chem.tottori-u.ac.jp; titoh@chem.tottori-u.ac.jp			Center for Research on Green Sustainable Chemistry (GSC), Tottori University from the MEXT; Tottori Prefecture Promotion Program for the Environmental Study of Art and Science; Kyoto Technoscience Center	We acknowledge financial support from the Center for Research on Green Sustainable Chemistry (GSC), Tottori University from the MEXT. T.N. thanks the Tottori Prefecture Promotion Program for the Environmental Study of Art and Science and the Kyoto Technoscience Center for financial support. The authors thank Professor Hiroki Sakaguchi and Professor Hiroyuki Usui of Tottori University for fruitful discussion.	Plechkova NV, 2008, CHEM SOC REV, V37, P123, DOI 10.1039/b006677j; McQuade DT, 2013, J ORG CHEM, V78, P6384, DOI 10.1021/jo400583m; Abe Y, 2012, IND ENG CHEM RES, V51, P9952, DOI 10.1021/ie202740u; Iken H, 2012, TETRAHEDRON LETT, V53, P3474, DOI 10.1016/j.tetlet.2012.04.119; Abe Y, 2010, GREEN CHEM, V12, P1976, DOI 10.1039/c0gc00151a; Ranke J, 2007, CHEM REV, V107, P2183, DOI 10.1021/cr050942s; Nagy KD, 2012, ORG PROCESS RES DEV, V16, P976, DOI 10.1021/op200349f; Itoh T, 2006, CHEM-EUR J, V12, P9228, DOI 10.1002/chem.200601043; Yoshida JI, 2011, CHEMSUSCHEM, V4, P331, DOI 10.1002/cssc.201000271; Chowdhury S, 2007, TETRAHEDRON, V63, P2363, DOI 10.1016/j.tet.2006.11.001; Hallett JP, 2011, CHEM REV, V111, P3508, DOI 10.1021/cr1003248; Renken A, 2007, CHEM ENG PROCESS, V46, P840, DOI 10.1016/j.cep.2007.05.020; Yoshiyama K, 2013, CHEM LETT, V42, P663, DOI 10.1246/cl.130171; Snead DR, 2013, CHEM SCI, V4, P2822, DOI 10.1039/c3sc50859e; Kude K, 2011, HETEROATOM CHEM, V22, P397, DOI 10.1002/hc.20696; Itoh T, 2007, TETRAHEDRON LETT, V48, P7774, DOI 10.1016/j.tetlet.2007.09.010; Usui H, 2011, J POWER SOURCES, V196, P3911, DOI 10.1016/j.jpowsour.2010.12.027; Lowe H, 2009, CHEM ENG J, V155, P548, DOI 10.1016/j.cej.2009.07.022; Wiles C, 2012, GREEN CHEM, V14, P38, DOI 10.1039/c1gc16022b; Gonzalez MA, 2009, ORG PROCESS RES DEV, V13, P64, DOI 10.1021/op8001917; Ibara C, 2012, SCI CHINA CHEM, V55, P1627, DOI 10.1007/s11426-012-4629-3; Kawatsura M, 2011, CHEM LETT, V40, P953, DOI 10.1246/cl.2011.953; Wasserscheid P., 2008, IONIC LIQUIDS SYNTHE; Waterkamp DA, 2007, GREEN CHEM, V9, P1084, DOI 10.1039/b616882e; Wiles C, 2011, MICRO REACTION TECHNOLOGY IN ORGANIC SYNTHESIS, P1; Wilms D, 2009, ORG PROCESS RES DEV, V13, P961; Yoshida J., 2008, FLASH CHEM FAST ORGA	27	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1083-6160	1520-586X		ORG PROCESS RES DEV	Org. Process Res. Dev.	NOV	2014	18	11					1367	1371		10.1021/op500131u		5	Chemistry, Applied; Chemistry, Organic	Chemistry	AU4AS	WOS:000345552100013		
J	Ouchi, T; Battilocchio, C; Hawkins, JM; Ley, SV				Ouchi, Takashi; Battilocchio, Claudio; Hawkins, Joel M.; Ley, Steven V.			Process Intensification for the Continuous Flow Hydrogenation of Ethyl Nicotinate	ORGANIC PROCESS RESEARCH & DEVELOPMENT			English	Article							ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC HYDROGENATION; CHEMISTRY; REACTOR; MICROREACTOR; ARTEMISININ; PERSPECTIVE; INTEGRATION; REDUCTIONS	Here we report a process intensification study for the selective, partial, and full hydrogenation of ethyl nicotinate using a trickle bed reactor for meso-flow transformations (HEL FlowCAT). The process achieved a throughput of 1219 g d(-1) (78 g h(-1) of product per g of active catalyst) for the partial hydrogenation to ethyl 1,4,5,6-tetrahydropyridine-3-carboxylate, whereas the productivity for the full hydrogenation process reached a 1959 g d(-1) of throughput (408 g h(-1) of product per g of active catalyst) on this laboratory-scale flow chemistry platform.	[Ouchi, Takashi; Battilocchio, Claudio; Ley, Steven V.] Univ Cambridge, Dept Chem, Innovat Technol Ctr, Cambridge CB2 1EW, England; [Ouchi, Takashi] Takeda Pharmaceut Co Ltd, CMC Ctr, Chem Dev Labs, Yodogawaku Osaka 5328686, Japan; [Hawkins, Joel M.] Pfizer Worldwide Res & Dev, Groton, CT 06340 USA	Ley, SV (reprint author), Univ Cambridge, Dept Chem, Innovat Technol Ctr, Lensfield Rd, Cambridge CB2 1EW, England.	svl1000@cam.ac.uk			Takeda Pharmaceutical Company Limited; Pfizer Worldwide Research and Development; EPSRC	We are grateful to Takeda Pharmaceutical Company Limited (T.O.), Pfizer Worldwide Research and Development (C.B. and J.M.H.), and the EPSRC (S.V.L.) for financial support. We are also grateful to Dr. David Cork (Takeda Pharmaceutical Company Limited) for helpful discussion; Jasbir Singh, Andrew Coleman, Roderick Mcintosh, Mark Appleton (H.E.L. Group), Bashir Harji (Cambridge Reactor Design, CRD), and Steve Hawker (Johnson & Matthey) for their technical support.	Newton S, 2012, ADV SYNTH CATAL, V354, P1805, DOI 10.1002/adsc.201200073; He Z, 2014, ANGEW CHEM INT EDIT, V53, P3353, DOI 10.1002/anie.201310572; Broom T, 2014, ORG PROCESS RES DEV, V18, P1354, DOI 10.1021/op400090a; Newman SG, 2014, GREEN CHEM, V16, P176, DOI 10.1039/c3gc41942h; Jimenez-Gonzalez C, 2011, ORG PROCESS RES DEV, V15, P900, DOI 10.1021/op100327d; Baumann M, 2013, BEILSTEIN J ORG CHEM, V9, P1613, DOI 10.3762/bjoc.9.184; Newton S, 2014, ANGEW CHEM INT EDIT, V53, P4915, DOI 10.1002/anie.201402056; Pastre JC, 2013, CHEM SOC REV, V42, P8849, DOI 10.1039/c3cs60246j; Ingham RJ, 2014, BEILSTEIN J ORG CHEM, V10, P641, DOI 10.3762/bjoc.10.56; [Anonymous], 2009, [No title captured], Patent No. 2074108; Knudsen KR, 2007, ADV SYNTH CATAL, V349, P535, DOI 10.1002/adsc.200600558; Prat D, 2013, ORG PROCESS RES DEV, V17, P1517, DOI 10.1021/op4002565; Hartman RL, 2011, ANGEW CHEM INT EDIT, V50, P7502, DOI 10.1002/anie.201004637; Deadman BJ, 2013, GREEN CHEM, V15, P2050, DOI 10.1039/c3gc40967h; Alvarez AJ, 2010, CRYST GROWTH DES, V10, P2219, DOI 10.1021/cg901496s; Malet-Sanz L, 2012, J MED CHEM, V55, P4062, DOI 10.1021/jm2006029; Johnson MD, 2012, ORG PROCESS RES DEV, V16, P1017, DOI 10.1021/op200362h; Levesque F, 2012, ANGEW CHEM INT EDIT, V51, P1706, DOI 10.1002/anie.201107446; Blaser HU, 1999, J MOL CATAL A-CHEM, V139, P253, DOI 10.1016/S1381-1169(98)00200-3; Hartwig J, 2013, ANGEW CHEM INT EDIT, V52, P9813, DOI 10.1002/anie.201302239; Stankiewicz A, 2002, IND ENG CHEM RES, V41, P1920, DOI 10.1021/ie011025p; Viviano M, 2011, ORG PROCESS RES DEV, V15, P858, DOI 10.1021/op2001047; Alfonsi K, 2008, GREEN CHEM, V10, P31, DOI 10.1039/b711717e; Dugger RW, 2005, ORG PROCESS RES DEV, V9, P253, DOI 10.1021/op050021j; Wiles C, 2012, GREEN CHEM, V14, P38, DOI 10.1039/c1gc16022b; [Anonymous], 2002, [No title captured], Patent No. 00232869; Wegner J, 2012, ADV SYNTH CATAL, V354, P17, DOI 10.1002/adsc.201100584; Battilocchio C., 2012, SYNTHESIS-STUTTGART, P635; Baxendale IR, 2013, J CHEM TECHNOL BIOT, V88, P519, DOI 10.1002/jctb.4012; Cambridge Reactor Design, CHAM AD REACT TECHN; Carter CF, 2010, ORG BIOMOL CHEM, V8, P1588, DOI 10.1039/b924309g; Cooper CGF, 2012, ORG PROCESS RES DEV, V16, P1090, DOI 10.1021/op2001222; Cossy J, 2005, CHEM REC, V5, P70, DOI 10.1002/tcr.20035; Fan XL, 2012, ORG PROCESS RES DEV, V16, P1039, DOI 10.1021/op200373m; Hawkins J. M., 2011, 242 ACS NAT M EXP DE; HEL Group, FLOWCAT OV; Hessell V., 2013, CHEMSUSCHEM, P746; Irfan M, 2009, EUR J ORG CHEM, P1327, DOI 10.1002/ejoc.200801131; Kim H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1264; Lei AW, 2006, EUR J ORG CHEM, P4343, DOI 10.1002/ejoc.200600558; Nightingale AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4777; Rincon JA, 2011, ORG PROCESS RES DEV, V15, P1428, DOI 10.1021/op200162c; Saaby S, 2005, CHEM COMMUN, P2909, DOI 10.1039/b504854k; Sedelmeier J, 2013, ORG LETT, V15, P5546, DOI 10.1021/ol402706a	44	8	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1083-6160	1520-586X		ORG PROCESS RES DEV	Org. Process Res. Dev.	NOV	2014	18	11					1560	1566		10.1021/op500208j		7	Chemistry, Applied; Chemistry, Organic	Chemistry	AU4AS	WOS:000345552100039		
J	Baseer, N; Al-Baloushi, AS; Watanabe, M; Shehab, SAS; Todd, AJ				Baseer, Najma; Al-Baloushi, Abdullah S.; Watanabe, Masahiko; Shehab, Safa A. S.; Todd, Andrew J.			Selective innervation of NK1 receptor-lacking lamina I spinoparabrachial neurons by presumed nonpeptidergic A delta nociceptors in the rat	PAIN			English	Article						Cholera toxin B subunit; Dorsal horn; Lamina I projection neuron; Spinal cord; Transganglionic tracing	LUMBAR SPINAL-CORD; PRIMARY SENSORY NEURONS; VESICULAR GLUTAMATE TRANSPORTERS; PRIMARY AFFERENT NEURONS; WHEAT-GERM-AGGLUTININ; ROOT GANGLION NEURONS; NEUROKININ 1 RECEPTOR; TOXIN B-SUBUNIT; MYELINATED PRIMARY AFFERENTS; PERIPHERAL-NERVE INJURY	Fine myelinated (A delta) nociceptors are responsible for fast, well-localised pain, but relatively little is known about their postsynaptic targets in the spinal cord, and therefore about their roles in the neuronal circuits that process nociceptive information. Here we show that transganglionically transported cholera toxin B subunit (CTb) labels a distinct set of afferents in lamina I that are likely to correspond to A delta nociceptors, and that most of these lack neuropeptides. The vast majority of lamina I projection neurons can be retrogradely labelled from the lateral parabrachial area, and these can be divided into 2 major groups based on expression of the neurokinin 1 receptor (NK1r). We show that CTb-labelled afferents form contacts on 43% of the spinoparabrachial lamina I neurons that lack the NK1r, but on a significantly smaller proportion (26%) of those that express the receptor. We also confirm with electron microscopy that these contacts are associated with synapses. Among the spinoparabrachial neurons that received contacts from CTb-labelled axons, contact density was considerably higher on NK1r-lacking cells than on those with the NK1r. By comparing the density of CTb contacts with those from other types of glutamatergic bouton, we estimate that nonpeptidergic A delta nociceptors may provide over half of the excitatory synapses on some NK1r-lacking spinoparabrachial cells. These results provide further evidence that synaptic inputs to dorsal horn projection neurons are organised in a specific way. Taken together with previous studies, they suggest that both NK1r(+) and NK1r-lacking lamina I projection neurons are directly innervated by A delta nociceptive afferents. (C) 2014 The Authors. Published by Elsevier B.V. on behalf of International Association for the Study of Pain. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).	[Baseer, Najma; Todd, Andrew J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Al-Baloushi, Abdullah S.; Shehab, Safa A. S.] United Arab Emirates Univ, Dept Anat, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan	Shehab, SAS (reprint author), United Arab Emirates Univ, Dept Anat, Coll Med & Hlth Sci, POB 17666, Al Ain, U Arab Emirates.	shehab@uaeu.ac.ae; andrew.todd@glasgow.ac.uk	WATANABE, Masahiko/A-4055-2012; Todd, Andrew/A-6855-2011		Wellcome Trust [102645]; Khyber Medical University, Pakistan; United Arab Emirates University [31M070]	The authors thank Mr. R. Kerr and Mrs. C. Watt for expert technical assistance. Financial support from the Wellcome Trust (grant number 102645), the Khyber Medical University, Pakistan, and the United Arab Emirates University (grant #31M070) is gratefully acknowledged.	Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Andrew D, 2010, J PHYSIOL-LONDON, V588, P117, DOI 10.1113/jphysiol.2009.181511; Du Beau A, 2012, NEUROSCIENCE, V227, P67, DOI 10.1016/j.neuroscience.2012.09.037; LIGHT AR, 1979, J COMP NEUROL, V186, P133, DOI 10.1002/cne.901860203; Polgar E, 2010, BRAIN RES, V1308, P58, DOI 10.1016/j.brainres.2009.10.041; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Todd AJ, 2005, NEUROSCIENCE, V131, P209, DOI 10.1016/j.neuroscience.2004.11.001; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008; ROBERTSON B, 1985, NEUROSCIENCE, V14, P895, DOI 10.1016/0306-4522(85)90152-6; Bao L, 2002, EUR J NEUROSCI, V16, P175, DOI 10.1046/j.1460-9568.2002.02080.x; Puskar Z, 2001, NEUROSCIENCE, V102, P167, DOI 10.1016/S0306-4522(00)00445-0; Torsney C, 2011, J NEUROSCI, V31, P5158, DOI 10.1523/JNEUROSCI.6241-10.2011; Suzuki R, 2002, NAT NEUROSCI, V5, P1319, DOI 10.1038/nn966; JU G, 1987, CELL TISSUE RES, V247, P417; Hughes DI, 2003, J NEUROSCI, V23, P9491; Tong YG, 1999, J COMP NEUROL, V404, P143; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Bester H, 2000, J NEUROPHYSIOL, V83, P2239; DING YQ, 1995, BRAIN RES, V674, P336, DOI 10.1016/0006-8993(95)00022-I; GIBSON SJ, 1984, J NEUROSCI, V4, P3101; Polgar E, 2006, NEUROSCIENCE, V139, P687, DOI 10.1016/j.neuroscience.2005.12.021; Todd AJ, 2002, J NEUROSCI, V22, P4103; Torsney C, 2006, J NEUROSCI, V26, P1833, DOI 10.1523/JNEUROSCI.4584-05.2006; LAMOTTE CC, 1991, J COMP NEUROL, V311, P546, DOI 10.1002/cne.903110409; Lawson SN, 1997, J PHYSIOL-LONDON, V505, P177, DOI 10.1111/j.1469-7793.1997.00177.x; CUELLO AC, 1979, P NATL ACAD SCI USA, V76, P3532, DOI 10.1073/pnas.76.7.3532; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Polgar E, 2008, J NEUROSCI, V28, P13150, DOI 10.1523/JNEUROSCI.4053-08.2008; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Lawson SN, 2002, J PHYSIOL-LONDON, V540, P989, DOI 10.1113/jphysiol.2001.013086; Naim M, 1997, J NEUROSCI, V17, P5536; Andrew D, 2009, J PHYSIOL-LONDON, V587, P2005, DOI 10.1113/jphysiol.2009.170290; Morris JL, 2005, J COMP NEUROL, V483, P1, DOI 10.1002/cne.20399; Al-Khater KM, 2009, J COMP NEUROL, V515, P629, DOI 10.1002/cne.22081; Baseer N, 2012, J NEUROSCI, V32, P11854, DOI 10.1523/JNEUROSCI.2707-12.2012; LYNN B, 1982, BRAIN RES, V238, P29, DOI 10.1016/0006-8993(82)90768-5; Koerber HR, 2002, PHYSIOL BEHAV, V77, P589, DOI 10.1016/S0031-9384(02)00904-6; Shehab SAS, 2011, J NEUROSCI METH, V198, P213, DOI 10.1016/j.jneumeth.2011.04.002; WOOLF CJ, 1992, NATURE, V355, P75, DOI 10.1038/355075a0; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Landry M, 2004, J COMP NEUROL, V468, P380, DOI 10.1002/cne.10988; BURGESS PR, 1967, J PHYSIOL-LONDON, V190, P541; Shehab SAS, 2003, BRAIN RES, V964, P218, DOI 10.1016/S0006-8993(02)04001-5; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Sardella TCP, 2011, NEUROSCIENCE, V192, P708, DOI 10.1016/j.neuroscience.2011.07.011; Takamori S, 2001, J NEUROSCI, V21; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; Woodbury CJ, 2008, J COMP NEUROL, V508, P500, DOI 10.1002/cne.21693; FLEISCHER E, 1983, BRAIN RES, V267, P81, DOI 10.1016/0006-8993(83)91041-7; Spike RC, 2003, EUR J NEUROSCI, V18, P2433, DOI 10.1046/j.1460-9568.2003.02981.x; Treede RD, 1998, J NEUROPHYSIOL, V80, P1082; Woodbury CJ, 2003, J NEUROSCI, V23, P601; Ptak K, 2002, EUR J NEUROSCI, V16, P2245, DOI 10.1046/j.1460-9568.2002.02305.x; Shehab SAS, 2004, J COMP NEUROL, V474, P427, DOI 10.1002/cne.20147; BROWN AG, 1981, J PHYSIOL-LONDON, V316, P469; HOKFELT T, 1975, SCIENCE, V190, P889, DOI 10.1126/science.242075; Keller AF, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-27; Lawson SN, 1996, J COMP NEUROL, V365, P355; Polgar E, 2010, NEUROSCIENCE, V167, P1192, DOI 10.1016/j.neuroscience.2010.03.028; Ringkamp M, 2013, WALL MELZACKS TXB PA, V6th, P1; RIVEROMELIAN C, 1992, NEUROSCI LETT, V145, P114, DOI 10.1016/0304-3940(92)90216-T; ROBERTSON B, 1989, J NEUROCYTOL, V18, P77, DOI 10.1007/BF01188426; ROBERTSON B, 1991, J NEUROCYTOL, V20, P387, DOI 10.1007/BF01355535; ROBERTSON B, 1992, BRAIN RES, V590, P207, DOI 10.1016/0006-8993(92)91097-X; Saeed AW, 2013, J COMP NEUROL, V521, P1915, DOI 10.1002/cne.23267; SHORTLAND P, 1989, J COMP NEUROL, V289, P416, DOI 10.1002/cne.902890307; Todd AJ, 1997, J NEUROSCI METH, V73, P149, DOI 10.1016/S0165-0270(97)02222-X; Wang HF, 1998, NEUROSCIENCE, V87, P275, DOI 10.1016/S0306-4522(98)00061-X; WOOLF CJ, 1995, J COMP NEUROL, V360, P121, DOI 10.1002/cne.903600109	71	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3959	1872-6623		PAIN	Pain	NOV	2014	155	11					2291	2300		10.1016/j.pain.2014.08.023		10	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	AU1YM	WOS:000345413400012		
J	Maruo, T; Nakae, A; Maeda, L; Kenrin, S; Takahashi, K; Morris, S; Hosomi, K; Kanatani, H; Matsuzaki, T; Saitoh, Y				Maruo, Tomoyuki; Nakae, Aya; Maeda, Lynn; Kenrin, Shi; Takahashi, Kayoko; Morris, Shayne; Hosomi, Koichi; Kanatani, Hiroshi; Matsuzaki, Taiga; Saitoh, Youichi			Validity, Reliability, and Assessment Sensitivity of the Japanese Version of the Short-Form McGill Pain Questionnaire 2 in Japanese Patients with Neuropathic and Non-Neuropathic Pain	PAIN MEDICINE			English	Article						Neuropathic Pain; Short-Form McGill Pain Questionnaire 2; Reliability and Validity	HEALTH SURVEY; VALIDATION; SF-36	ObjectiveThe objective of this study was to define the validity, reliability, and assessment sensitivity of the Japanese version of the Short-Form McGill Pain Questionnaire 2 (SF-MPQ-2-J). DesignThis is a cross-sectional study. Patients and MethodsThe original SF-MPQ-2 was translated into Japanese to create the SF-MPQ-2-J, and the cross-cultural equivalence of assessment tool for Japanese patients was validated. The reliability of the SF-MPQ-2-J was assessed using internal consistency, reliability coefficients (Cronbach's ), and reproducibility coefficients (intraclass correlation coefficient) obtained using 234 patients with chronic pain. SF-MPQ-2-J validity was assessed based on associations identified between total and subscale scores compared with other assessment methods. A confirmatory factor analysis (CFA) was also performed to test the theoretical structure of the SF-MPQ-2-J. ResultsThe internal consistencies calculated included continuous pain, =0.893; intermittent pain, =0.875; predominantly neuropathic pain, =0.917; affective descriptors, =0.857; and total score, =0.907. The reproducibility coefficients calculated included continuous pain, =0.81; intermittent pain, =0.78; predominantly neuropathic pain, =0.85; affective descriptors, =0.75; and total score, =0.83. The CFA showed that the model fit of the readily interpretable subscales was acceptable, and the goodness of fit index value was 0.917. In addition, the mean predominantly neuropathic pain subscale score was found to be significantly higher for patients with neuropathic pain vs non-neuropathic pain. ConclusionThese findings suggest that the reliability and validity of the SF-MPQ-2-J are excellent, and the SF-MPQ-2-J represents a cross-cultural equivalent to SF-MPQ-2. Consequently, the latter is suitable for research and clinical use, and for discriminating neuropathic pain from non-neuropathic pain.	[Maruo, Tomoyuki; Hosomi, Koichi; Matsuzaki, Taiga; Saitoh, Youichi] Osaka Univ, Grad Sch Med, Dept Neuromodulat & Neurosurg, Suita, Osaka 5650871, Japan; [Maruo, Tomoyuki; Morris, Shayne; Hosomi, Koichi; Saitoh, Youichi] Osaka Univ, Grad Sch Med, Dept Neurosurg, Suita, Osaka 5650871, Japan; [Nakae, Aya] Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care, Suita, Osaka 5650871, Japan; [Kenrin, Shi] Osaka Univ, Grad Sch Med, Dept Orthopaed, Suita, Osaka 5650871, Japan; [Maeda, Lynn] Nishinomiya Municipal Cent Hosp, Dept Anesthesia & Pain Management, Nishinomiya, Hyogo, Japan; [Takahashi, Kayoko] Kitasato Univ, Sch Allied Hlth Sci, Dept Occupat Therapy, Sagamihara, Kanagawa 228, Japan; [Kanatani, Hiroshi; Matsuzaki, Taiga] Teijin Pharma Ltd, Home Healthcare Res & Dev Planning Dept, Tokyo, Japan	Saitoh, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Neuromodulat & Neurosurg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	neurosaitoh@mbk.nifty.com			Japanese Ministry of Health, Labor, and Welfare; Health and Labor Science Research Grant; Japanese Ministry of Education, Culture, Sports, Science, and Technology Scientific Research Grant from the Strategic Research Program for Brain Sciences	We thank Ms. Keiko Sano, Ms. Teruko Sakurai, and Ms. Atsuyo Kimura for assistance with the collection and input of data from patients. This study was partly supported by the Japanese Ministry of Health, Labor, and Welfare with a Health and Labor Science Research Grant and by a Japanese Ministry of Education, Culture, Sports, Science, and Technology Scientific Research Grant from the Strategic Research Program for Brain Sciences.	Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Bullinger M, 1998, J CLIN EPIDEMIOL, V51, P913, DOI 10.1016/S0895-4356(98)00082-1; Krause SJ, 2003, CLIN J PAIN, V19, P306, DOI 10.1097/00002508-200309000-00004; Arimura T, 2012, PAIN MED, V13, P541, DOI 10.1111/j.1526-4637.2012.01333.x; Dworkin RH, 2009, PAIN, V144, P35, DOI 10.1016/j.pain.2009.02.007; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; Grafton KV, 2005, CLIN J PAIN, V21, P73, DOI 10.1097/00002508-200501000-00009; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Galer BS, 1997, NEUROLOGY, V48, P332; Backonja MM, 2004, J PAIN, V5, P491, DOI 10.1016/j.jpain.2004.09.001; Adelmanesh F, 2012, PAIN MED, V13, P1631, DOI 10.1111/j.1526-4637.2012.01517.x; Lynch ME, 2003, CLIN J PAIN, V19, P323, DOI 10.1097/00002508-200309000-00007; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Yamashiro K, 2011, CLIN J PAIN, V27, P338, DOI 10.1097/AJP.0b013e318204858a; Hasegawa M, 2001, PAIN MED, V2, P52, DOI 10.1046/j.1526-4637.2001.002001052.x; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Nunnally J. C., 1994, PSYCHOMETRIC THEORY; Zinke JL, 2010, CLIN J PAIN, V26, P153, DOI 10.1097/AJP.0b013e3181b99f56	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-2375	1526-4637		PAIN MED	Pain Med.	NOV	2014	15	11					1930	1937		10.1111/pme.12468		8	Medicine, General & Internal	General & Internal Medicine	AU4EI	WOS:000345561700012		
J	Agematsu, S; Sano, H; Sashida, K				Agematsu, Sachiko; Sano, Hiroyoshi; Sashida, Katsuo			NATURAL ASSEMBLAGES OF HINDEODUS CONODONTS FROM A PERMIAN-TRIASSIC BOUNDARY SEQUENCE, JAPAN	PALAEONTOLOGY			English	Article						apparatus; conodont; Hindeodus; natural assemblage; ozarkodinids; Triassic	GLOBAL STRATOTYPE SECTION; MINO TERRANE; UPPER ORDOVICIAN; MASS EXTINCTION; MEISHAN SECTION; SOUTH CHINA; APPARATUS; ARCHITECTURE; COMPLEX; BIOSTRATIGRAPHY	Hindeodus parvus and Hindeodus typicalis occur in a deep-water chert and claystone section in the Mino Terrane, Japan, which has been identified as a Jurassic accretionary complex. Conodont fossils are preserved as natural assemblages of impression fossils on bedding planes in claystone. In this study, 13 assemblages of Hindeodus species were recognized, comprising at most 13 elements which generally maintain the original composition and structure of an apparatus. We discriminated pairs of carminiscaphate P-1, angulate P-2 and makellate M elements, as well as a single alate S-0 element and two digyrate and four bipennate elements constituting the S array. Although the digyrate and bipennate elements are preserved in the S-2 and S3-4 positions, respectively, a pair of S-1 elements was not found due to incompleteness in the natural assemblages. The conodont biostratigraphy indicates that the lithological boundary between chert and claystone units in the study section corresponds exactly to the Permian-Triassic boundary.	[Agematsu, Sachiko; Sashida, Katsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan; [Sano, Hiroyoshi] Kyushu Univ, Dept Earth & Planetary Sci, Fukuoka 8128581, Japan	Agematsu, S (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan.	agematsu@geol.tsukuba.ac.jp; sano@geo.kyushu-u.ac.jp; sashida@geol.tsukuba.ac.jp			 [21740368]	We are much indebted to R. J. Aldridge, M. A. Purnell and two anonymous reviewers for reading our manuscript and offering useful suggestions. We also thank A. Yao and K. Kuwahara for comments on radiolarians. This work was supported by Grants-in-Aid for Scientific Research (no. 21740368) to SA.	Agematsu S, 2008, PALAEONTOLOGY, V51, P1201, DOI 10.1111/j.1475-4983.2008.00804.x; Aldridge RJ, 2013, PALAEONTOLOGY, V56, P261, DOI 10.1111/j.1475-4983.2012.01194.x; ALDRIDGE RJ, 1995, PHILOS T ROY SOC B, V347, P275, DOI 10.1098/rstb.1995.0027; Aldridge R.J., 1987, P63; Angiolini L, 1998, RIV ITAL PALEONTOL S, V104, P329; Metcalfe I, 2009, J ASIAN EARTH SCI, V36, P407, DOI 10.1016/j.jseaes.2009.07.009; Kozur HW, 2007, GLOBAL PLANET CHANGE, V55, P155, DOI 10.1016/j.gloplacha.2006.06.011; Aljinovic D, 2006, RIV ITAL PALEONTOL S, V112, P35; Perri MC, 2003, COUR FOR SEKENBG, V245, P281; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Metcalfe I, 2012, J ASIAN EARTH SCI, V50, P141, DOI 10.1016/j.jseaes.2012.01.002; Sano H, 2010, PALEONTOL RES, V14, P293, DOI 10.2517/1342-8144-14.4.293; Goudemand N, 2012, PALAEONTOLOGY, V55, P1021, DOI 10.1111/j.1475-4983.2012.01174.x; Yin HF, 2001, EPISODES, V24, P102; Nicoll RS, 2002, J ASIAN EARTH SCI, V20, P609, DOI 10.1016/S1367-9120(02)00021-4; Korte C, 2010, J ASIAN EARTH SCI, V39, P215, DOI 10.1016/j.jseaes.2010.01.005; Mei SL, 1998, PALAEOGEOGR PALAEOCL, V143, P213, DOI 10.1016/S0031-0182(98)00112-6; Jiang HS, 2007, GLOBAL PLANET CHANGE, V55, P39, DOI 10.1016/j.gloplacha.2006.06.007; Lai XL, 2001, PALAEOGEOGR PALAEOCL, V171, P63, DOI 10.1016/S0031-0182(01)00269-3; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Lehrmann DJ, 2007, PALAEOGEOGR PALAEOCL, V252, P200, DOI 10.1016/j.palaeo.2006.11.044; Chen J, 2009, J ASIAN EARTH SCI, V36, P442, DOI 10.1016/j.jseaes.2008.08.002; Bond DPG, 2010, GEOL SOC AM BULL, V122, P1265, DOI 10.1130/B30042.1; Orchard MJ, 1998, RIV ITAL PALEONTOL S, V104, P341; Orchard MJ, 2007, PALAEOGEOGR PALAEOCL, V252, P93, DOI 10.1016/j.palaeo.2006.11.037; Bender H., 1965, GEOL JB, V82, P331; Bitter F., 1985, GEOLOGICA PALAEONTOL, V19, P81; Donoghue PCJ, 2008, J SYST PALAEONTOL, V6, P119, DOI 10.1017/S1477201907002234; DZIK J, 1976, Acta Palaeontologica Polonica, V21, P395; ISHIGA H, 1986, Journal of Geosciences Osaka City University, V29, P89; JONES G, 1993, J GEOL SOC LONDON, V150, P1167, DOI 10.1144/gsjgs.150.6.1167; Koike Toshio, 2004, Paleontological Research, V8, P241, DOI 10.2517/prpsj.8.241; Kozur H., 1995, GEOLOGIJA, V37, P173; Kozur Heinz, 1996, Geologia Croatica, V49, P81; Kozur H., 1995, Palaeoworld, V6, P64; KOZUR H, 1976, P K NED AKAD B PHYS, V79, P123; KOZUR H. W., 1975, GEOLOGISCHE PALAONTO, V5, P1; Kozur Heinz W., 2004, Hallesches Jahrbuch fuer Geowissenschaften Reihe B Geologie Palaeontologie Mineralogie, V18, P39; Kuwahara Kiyoko, 2010, Journal of the Geological Society of Japan, V116, P159; Kuwahara K., 1998, EARTH SCI, V52, P391; Matsuda T., 1981, Journal of Geosciences Osaka City University, V24, P75; Orchard Michael J., 1999, Bollettino della Societa Paleontologica Italiana, V37, P475; Orchard M.J., 1994, Canadian Society of Petroleum Geologists Memoir, V17, P823; PERRI M C, 1987, Rivista Italiana di Paleontologia e Stratigrafia, V93, P291; Purnell MA, 1998, PALAEONTOLOGY, V41, P57; PURNELL MA, 1993, J PALEONTOL, V67, P875; Purnell MA, 2000, J PALEONTOL, V74, P113, DOI 10.1666/0022-3360(2000)074<0113:OAANIC>2.0.CO;2; Repetski J. E., 1998, 7 INT CON S HELD EUR, P91; REXROAD CB, 1964, J PALEONTOL, V38, P667; SANO H, 1992, PALAEOGEOGR PALAEOCL, V96, P41, DOI 10.1016/0031-0182(92)90058-D; SANO H, 1988, Journal of the Geological Society of Japan, V94, P697; SEPKOSKI JJ, 1989, J GEOL SOC LONDON, V146, P7, DOI 10.1144/gsjgs.146.1.0007; Stouge S., 1988, Palaeontographia Italica, V75, P89; Sweet W. C., 1977, CATALOGUE CONODONTS, VIII, P203; Sweet W. C., 1981, TREATISE INVERT W S2, P166; Sweet W. C., 1970, U KANSAS DEP GEOLOGY, V4, P207; SWEET W. C., 1988, OXFORD MONOGRAPHS GE, V10; Sweet W.C., 1970, U KANSAS PALEONTOLOG, V49, P1; Tolmacheva TY, 2002, PALAEONTOLOGY, V45, P209, DOI 10.1111/1475-4983.00234; Wakita K., 1988, B GEOL SURV JPN, V39, P675; Wang C.Y., 1996, PERMOPHILES, V29, P30; YOUNGQUIST WALTER, 1949, JOUR PALEONTOL, V23, P617	62	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0031-0239	1475-4983		PALAEONTOLOGY	Paleontology	NOV	2014	57	6					1277	1289		10.1111/pala.12114		13	Paleontology	Paleontology	AU4GK	WOS:000345568000009		
J	Lee, A; Furuya, S; Morise, M; Iltis, P; Altenmuller, E				Lee, Andre; Furuya, Shinichi; Morise, Masanori; Iltis, Peter; Altenmueller, Eckart			Quantification of instability of tone production in embouchure dystonia	PARKINSONISM & RELATED DISORDERS			English	Article						Movement disorders; Motor control; Musicians; Task-specificity; Frequency analysis	FOCAL DYSTONIA; MUSICIANS; PIANISTS	Introduction: Musician's dystonia is a task-specific loss of voluntary motor control of the fingers or the embouchure. In contrast to pianists' dystonia, which can be objectively assessed based on movement kinematics and muscular activities, no objective quantitative measure has been established for embouchure dystonia. Methods: We focused on acoustic signals, and investigated, whether the fluctuation of the time-varying fundamental frequency of a note can provide an objective and reliable measure of embouchure dystonia. Results: A comparison between patients with embouchure dystonia and healthy controls found a significantly higher variability of the fundamental frequency for the patients. Conclusion: The present findings propose a new quantification and objectivation method for embouchure dystonia. (C) 2014 Elsevier Ltd. All rights reserved.	[Lee, Andre; Furuya, Shinichi; Iltis, Peter; Altenmueller, Eckart] Univ Mus Drama & Media Hannover, Inst Mus Physiol & Musicians Med, D-30175 Hannover, Germany; [Morise, Masanori] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008510, Japan; [Iltis, Peter] Gordon Coll, Dept Kinesiol, Wenham, MA 01984 USA	Lee, A (reprint author), Univ Mus Drama & Media Hannover, Inst Mus Physiol & Musicians Med, Emmichpl 1, D-30175 Hannover, Germany.	eckart.altenmueller@hmtm-hannover.de			University of music, drama and media, Hannover, Germany	University of music, drama and media, Hannover, Germany.	Altenmuller E, 2009, J HAND THER, V22, P144, DOI 10.1016/j.jht.2008.11.007; Altenmüller Eckart, 2011, MMW Fortschr Med, V153, P42; Altenmuller E, 2009, J HAND THER, V22, P155; Hirata Y, 2004, NEUROREPORT, V15, P815, DOI 10.1097/01.wnr.0000120962.11505.32; Altenmuller E, 2010, MED PROBL PERFORM AR, V25, P3; Jabusch HC, 2004, MOVEMENT DISORD, V19, P171, DOI 10.1002/mds.10671; Jabusch HC, 2005, MOVEMENT DISORD, V20, P1623, DOI 10.1002/mds.20631; Frucht SJ, 2009, MOVEMENT DISORD, V24, P1752, DOI 10.1002/mds.22550; Frucht SJ, 2001, MOVEMENT DISORD, V16, P899, DOI 10.1002/mds.1167; Furuya S, 2013, NEUROSCIENCE, V247, P152, DOI 10.1016/j.neuroscience.2013.05.025; Furuya S, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00050; Kawahara H, 2011, SADHANA-ACAD P ENG S, V36, P713, DOI 10.1007/s12046-011-0043-3	12	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	NOV	2014	20	11					1161	1164		10.1016/j.parkreldis.2014.08.007		4	Clinical Neurology	Neurosciences & Neurology	AU2ZN	WOS:000345483000010		
J	Takuma, K; Hara, Y; Kataoka, S; Kawanai, T; Maeda, Y; Watanabe, R; Takano, E; Hayata-Takano, A; Hashimoto, H; Ago, Y; Matsuda, T				Takuma, Kazuhiro; Hara, Yuta; Kataoka, Shunsuke; Kawanai, Takuya; Maeda, Yuko; Watanabe, Ryo; Takano, Erika; Hayata-Takano, Atsuko; Hashimoto, Hitoshi; Ago, Yukio; Matsuda, Toshio			Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						Autism spectrum disorders; Valproic acid; Sodium butyrate; Histone deacetylase; Dendritic spines; Hippocampus	METHAMPHETAMINE-INDUCED IMPAIRMENT; ALZHEIMERS-DISEASE; RAT MODEL; HISTONE ACETYLATION; BEHAVIORAL DEFICITS; MEMORY FORMATION; HDAC INHIBITORS; MICE; MECHANISMS; CHROMATIN	We recently showed that prenatal exposure to valproic acid (VPA) in mice causes autism-like behavioral abnormalities, including social interaction deficits, anxiety-like behavior and spatial learning disability, in male offspring. In the present study, we examined the effect of prenatal VPA on cognitive function and whether the effect is improved by chronic treatment with WA and sodium butyrate, histone deacetylase inhibitors. In addition, we examined whether the cognitive dysfunction is associated with hippocampal dendritic morphological changes. Mice given prenatal exposure to VPA exhibited novel object recognition deficits at 9 weeks of age, and that the impairment was blocked by chronic (5-week) treatment with WA (30 mg/kg/d, i.p.) or sodium butyrate (1.2 g/kg/d, i.p.) starting at 4 weeks of age. In agreement with the behavioral findings, the mice prenatally exposed to VPA showed a decrease in dendritic spine density in the hippocampal CM region, and the spine loss was attenuated by chronic treatment with sodium butyrate or VPA. Furthermore, acute treatment with sodium butyrate, but not VPA, significantly increased acetylation of histone H3 in the hippocampus at 30 mm, suggesting the difference in the mechanism for the effects of chronic VPA and sodium butyrate. These findings suggest that prenatal VPA-induced cognitive dysfunction is associated with changes in hippocampal dendritic spine morphology. (C) 2014 Elsevier Inc. All rights reserved.	[Takuma, Kazuhiro; Hara, Yuta; Kataoka, Shunsuke; Kawanai, Takuya; Maeda, Yuko; Watanabe, Ryo; Takano, Erika; Ago, Yukio; Matsuda, Toshio] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Med Pharmacol, Suita, Osaka 5650871, Japan; [Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka 5650871, Japan; [Hayata-Takano, Atsuko; Hashimoto, Hitoshi] Chiba Univ, Hamamatsu Univ Sch Med, Kanazawa Univ, United Grad Sch Child Dev,Osaka Univ, Suita, Osaka 5650871, Japan; [Hayata-Takano, Atsuko; Hashimoto, Hitoshi] Univ Fukui, Suita, Osaka 5650871, Japan	Matsuda, T (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Med Pharmacol, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	matsuda@phs.osaka-u.ac.jp	Hashimoto, Hitoshi/D-1209-2010	Hashimoto, Hitoshi/0000-0001-6548-4016	Funding Program for Next Generation World-Leading Researchers - Japan Society for the Promotion of Science (JSPS);  [25460099];  [13J05359];  [11J03070];  [26-6142];  [13J05377]	A part of this work was supported by Grants in Aid for Scientific Research (C) (25460099) and Grand-in-Aid for JSPS Fellows (13J05359, 11J03070, 26-6142, 13J05377), and the Funding Program for Next Generation World-Leading Researchers granted by the Japan Society for the Promotion of Science (JSPS) (H.H).	Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Edalatmanesh MA, 2013, BRAIN RES, V1526, P15, DOI 10.1016/j.brainres.2013.06.024; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Kataoka S, 2013, INT J NEUROPSYCHOPH, V16, P91, DOI 10.1017/S1461145711001714; Carter AS, 2007, J AUTISM DEV DISORD, V37, P86, DOI 10.1007/s10803-006-0331-7; Ricobaraza A, 2012, HIPPOCAMPUS, V22, P1040, DOI 10.1002/hipo.20883; Williams G, 2001, DEV MED CHILD NEUROL, V43, P202, DOI 10.1017/S001216220100038X; Ricobaraza A, 2009, NEUROPSYCHOPHARMACOL, V34, P1721, DOI 10.1038/npp.2008.229; Pragnya B, 2014, BEHAV BRAIN RES, V270, P86, DOI 10.1016/j.bbr.2014.04.045; Graff J, 2013, ANNU REV PHARMACOL, V53, P311, DOI 10.1146/annurev-pharmtox-011112-140216; Velazquez-Zamora DA, 2012, BRAIN RES, V1470, P1, DOI 10.1016/j.brainres.2012.06.012; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Gomez-Pinilla F, 2011, EUR J NEUROSCI, V33, P383, DOI 10.1111/j.1460-9568.2010.07508.x; Roullet FI, 2010, NEUROSCIENCE, V170, P514, DOI 10.1016/j.neuroscience.2010.06.069; Langdon KD, 2013, J CEREBR BLOOD F MET, V33, P872, DOI 10.1038/jcbfm.2013.21; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Gandal MJ, 2010, BIOL PSYCHIAT, V68, P1100, DOI 10.1016/j.biopsych.2010.09.031; Clark RE, 2000, J NEUROSCI, V20, P8853; Mizoguchi H, 2008, PSYCHOPHARMACOLOGY, V196, P233, DOI 10.1007/s00213-007-0955-0; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Merino-Serrais P, 2011, HIPPOCAMPUS, V21, P1037, DOI 10.1002/hipo.20861; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Wang WB, 2014, J NEUROSCI, V34, P2130, DOI 10.1523/JNEUROSCI.3324-13.2014; Roullet FI, 2013, NEUROTOXICOL TERATOL, V36, P47, DOI 10.1016/j.ntt.2013.01.004; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Bremner JD, 2006, ANN NY ACAD SCI, V1071, P80, DOI 10.1196/annals.1364.008; Bringas ME, 2013, NEUROSCIENCE, V241, P170, DOI 10.1016/j.neuroscience.2013.03.030; Graff J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1997; Ham Y, 2012, J PHARM SCI, V118, P543; Henry Thomas R, 2003, Psychopharmacol Bull, V37 Suppl 2, P5; Ito Y, 2007, J PHARMACOL EXP THER, V320, P819, DOI 10.1124/jpet.106.114108; Kim JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104927; Mehta MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026077; Reul JMHM, 2009, EPIGENETICS, V4, P434; Williams PG, 1997, DEV MED CHILD NEUROL, V39, P632; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49; Yochum CL, 2008, BRAIN RES, V1203, P126, DOI 10.1016/j.brainres.2008.01.055	41	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	NOV	2014	126						43	49		10.1016/j.pbb.2014.08.013		7	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	AU2TU	WOS:000345471200006		
J	Koganemaru, G; Abe, H; Kuramashi, A; Ebihara, K; Matsuo, H; Funahashi, H; Yasuda, K; Ikeda, T; Nishimori, T; Ishida, Y				Koganemaru, Go; Abe, Hiroshi; Kuramashi, Aid; Ebihara, Kosuke; Matsuo, Hisae; Funahashi, Hideki; Yasuda, Kazuya; Ikeda, Tetsuya; Nishimori, Toshikazu; Ishida, Yasushi			Effects of cabergoline and rotigotine on tacrine-induced tremulous jaw movements in rats	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						Cabergoline; Rotigotine; Tacrine; Tremulous jaw movement; c-Fos; Parkinsonism	C-FOS EXPRESSION; PARKINSONIAN TREMOR; TARDIVE-DYSKINESIA; RECEPTOR AGONISTS; DOPAMINE AGONISTS; MOUTH MOVEMENTS; MODEL; PILOCARPINE; IMMUNOREACTIVITY; STIMULATION	Objectives: We examined the effects of two dopamine agonists, cabergoline and rotigotine, on tacrine-induced tremor and c-Fos expression in rats. Methods: Rats received intraperitoneal injection of cabergoline (0.5, 1.0, or 5.0 mg/kg), rotigotine (1.0, 2.5, or 10.0 mg/kg), or vehicle 30 min before intraperitoneal injection of tacrine (5.0 mg/kg). The number of tremulous jaw movements (TJMs) after tacrine administration was counted for 5 min. Animals were sacrificed 2 h later under deep anesthesia, and the brain sections were immunostained in order to evaluate the c-Fos expression. Results: Induction of TJMs by tacrine was dose-dependently reduced by pretreatment with cabergoline and rotigotine. The number of c-Fos-positive cells was significantly enhanced in the medial striatum, nucleus accumbens core, and nucleus accumbens shell after tacrine administration, and the enhanced expression of c-Fos in these three regions was significantly attenuated by cabergoline, while rotigotine suppressed c-Fos expression in two regions except the nucleus accumbens core. Conclusions: These results suggest that tacrine-induced TJMs would be relieved by either cabergoline or rotigotine and that anticholinesterase-induced TJMs and the ameliorating effects of dopamine agonists would relate to neuronal activation in the striatum and nucleus accumbens. (C) 2014 Elsevier Inc. All rights reserved.	[Koganemaru, Go; Abe, Hiroshi; Kuramashi, Aid; Ebihara, Kosuke; Matsuo, Hisae; Funahashi, Hideki; Nishimori, Toshikazu; Ishida, Yasushi] Miyazaki Univ, Dept Psychiat, Fac Med, Miyazaki 8891692, Japan; [Yasuda, Kazuya] Univ Miyazaki Hosp, Fac Med, Dept Pharm, Miyazaki 8891692, Japan; [Ikeda, Tetsuya] Miyazaki Univ, Fac Med, Div Neurobiol, Miyazaki 8891692, Japan	Abe, H (reprint author), Miyazaki Univ, Dept Psychiat, Fac Med, 5200 Kihara, Miyazaki 8891692, Japan.	abehiro@med.miyazaki-u.ac.jp					Scheller D, 2009, N-S ARCH PHARMACOL, V379, P73, DOI 10.1007/s00210-008-0341-4; Podurgiel SJ, 2013, NEUROSCIENCE, V250, P507, DOI 10.1016/j.neuroscience.2013.07.008; Kvernmo T, 2006, CLIN THER, V28, P1065, DOI 10.1016/j.clinthera.2006.08.004; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; BERNARD V, 1993, EUR J NEUROSCI, V5, P1218, DOI 10.1111/j.1460-9568.1993.tb00976.x; ROBERTSON GS, 1992, NEUROSCIENCE, V49, P285, DOI 10.1016/0306-4522(92)90096-K; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Ikarashi Y, 1997, NEUROCHEM INT, V30, P191, DOI 10.1016/S0197-0186(96)00024-1; Joyce JN, 2007, CURR OPIN PHARMACOL, V7, P100, DOI 10.1016/j.coph.2006.11.004; Betz AJ, 2009, NEUROSCIENCE, V163, P97, DOI 10.1016/j.neuroscience.2009.05.040; Carriero DL, 1997, PHARMACOL BIOCHEM BE, V58, P851, DOI 10.1016/S0091-3057(97)98986-3; Cook DF, 1998, EUR J PHARMACOL, V349, P41, DOI 10.1016/S0014-2999(98)00184-8; Cousins MS, 1997, EUR J PHARMACOL, V322, P137, DOI 10.1016/S0014-2999(97)00008-3; Cousins MS, 1999, PHARMACOL BIOCHEM BE, V62, P439, DOI 10.1016/S0091-3057(98)00214-7; Finn M, 1997, PHARMACOL BIOCHEM BE, V57, P243, DOI 10.1016/S0091-3057(96)00385-1; GLASSMAN RB, 1980, PSYCHOPHARMACOLOGY, V69, P19, DOI 10.1007/BF00426516; KELLEY AE, 1989, PSYCHOPHARMACOLOGY, V99, P542, DOI 10.1007/BF00589906; Malik P, 2004, PHARMACOL BIOCHEM BE, V78, P805, DOI 10.1016/j.pbb.2004.05.019; Mayorga AJ, 1999, EUR J PHARMACOL, V364, P7, DOI 10.1016/S0014-2999(98)00811-5; Mayorga AJ, 1997, PHARMACOL BIOCHEM BE, V56, P273, DOI 10.1016/S0091-3057(96)00225-0; Mayorga AJ, 1999, PSYCHOPHARMACOLOGY, V143, P72, DOI 10.1007/s002130050921; Mayorga AJ, 1999, BRAIN RES, V829, P180, DOI 10.1016/S0006-8993(99)01352-9; Miwa H, 2009, PARKINSONISM RELAT D, V15, P30, DOI 10.1016/j.parkreldis.2008.02.008; Miwa H, 2008, PARKINSONISM RELAT D, V14, P33, DOI 10.1016/j.parkreldis.2007.05.008; RUPNIAK NMJ, 1983, PSYCHOPHARMACOLOGY, V79, P226, DOI 10.1007/BF00427817; Salamone John D, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS130, DOI 10.1016/j.parkreldis.2008.04.017; SALAMONE JD, 1986, PSYCHOPHARMACOLOGY, V88, P467; Salamone JD, 1998, PROG NEUROBIOL, V56, P591, DOI 10.1016/S0301-0082(98)00053-7; Salamone JD, 2005, BEHAV BRAIN RES, V156, P173, DOI 10.1016/j.bbr.2004.05.019; SALAMONE JD, 1990, PSYCHOPHARMACOLOGY, V102, P529, DOI 10.1007/BF02247136; Simola N, 2004, EXP NEUROL, V189, P182, DOI 10.1016/j.expneurol.2004.05.027; VahidAnsari F, 1996, EUR J NEUROSCI, V8, P2605, DOI 10.1111/j.1460-9568.1996.tb01555.x	32	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	NOV	2014	126						103	108		10.1016/j.pbb.2014.09.015		6	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	AU2TU	WOS:000345471200014		
J	Park, MK; Choi, JK; Kim, HJ; Nakahata, N; Lim, KM; Kim, SY; Lee, CH				Park, Mi Kyung; Choi, Jin Kyu; Kim, Hyun Ji; Nakahata, Norimichi; Lim, Kyung Min; Kim, Soo Youl; Lee, Chang Hoon			Novel inhibitory effects of cardamonin on thromboxane A(2)-induced scratching response: Blocking of G(h)/transglutaminase-2 binding to thromboxane A(2) receptor	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						Cardamonin; Itching; TXA(2) receptor; U46619; Antipruritic; Gh/Transglutaminase-2	ALPINIA-KATSUMADAI; ATOPIC-DERMATITIS; ITCH; MICE; EXPRESSION; PLATELETS; MIGRATION; PRURITUS; KINASE; CELLS	Alpinia katsumadai is known to suppress thromboxane A(2) (TXA(2)) receptor agonist-induced scratching in mice. The specific components of A. katsumadai responsible for these biological effects, however, are not known. In the present study, we investigated whether cardamonin (CDN), one of major principles of A. katsumadai, has suppressive effects on TXA(2)-induced scratching in mice. Scratching induced by U46619 (the TXA(2) receptor agonist) at a dose of 10 nmol/site was shown to be suppressed by CDN (0.1 nmo1-0.5 nmol/site). Suppression of the U46619-induced scratching response by CDN was found to be unrelated to competition with the ligand at the TXA(2) receptor, since CDN did not suppress [H-3] SQ29548 (the TXA(2) receptor antagonist) binding to TXA(2) receptor. TXA(2) receptor expression in A549, HaCaT, and SH-SY5Y cell lines was examined and determined to be significant in the A549 and SH-SY5Y cell lines. Further, binding of high molecular G protein G(h)/transglutaminase-2 (G(h)/Tgase-2) to TXA(2) receptor was confirmed in the A549 and SH-SY5Y cells by co-immunoprecipitation. CON suppressed the binding of TXA(2) receptor with G(h)/Tgase-2, which also acts as a G protein involved in TXA(2) signaling. These results suggested that CDN suppresses TXA(2) receptor agonist-induced scratching by suppressing TXA(2) signaling, specifically via blocking of the binding of G(h)/Tgase-2 to TXA(2) receptor. (C) 2014 Elsevier Inc. All rights reserved.	[Park, Mi Kyung; Kim, Hyun Ji; Lee, Chang Hoon] Dongguk Univ, Coll Pharm, R FIND Team BK21PLUS, Seoul 100715, South Korea; [Choi, Jin Kyu] Seoul Natl Univ, Coll Vet Med, Seoul 151742, South Korea; [Nakahata, Norimichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Cellular Signaling, Sendai, Miyagi 980, Japan; [Lim, Kyung Min] Ewha Womans Univ, Coll Pharm, Seoul 151742, South Korea; [Kim, Soo Youl] Natl Canc Ctr, Goyang 410769, South Korea	Lee, CH (reprint author), Dongguk Univ, Coll Pharm, Seoul 100715, South Korea.	uatheone@dongguk.edu			Dongguk University	This work was supported by the Dongguk University Research Fund of 2010.	Kim HJ, 2010, J DERMATOL SCI, V57, P57, DOI 10.1016/j.jdermsci.2009.09.007; Park MK, 2013, LIFE SCI, V92, P154, DOI 10.1016/j.lfs.2012.11.009; Andoh T, 2007, J INVEST DERMATOL, V127, P2042, DOI 10.1038/sj.jid.5700810; Park MK, 2013, EUR J CANCER, V49, P1692, DOI 10.1016/j.ejca.2012.11.036; LaMotte RH, 2014, NAT REV NEUROSCI, V15, P19, DOI 10.1038/nrn3641; Kang SK, 2004, J BIOL CHEM, V279, P36593, DOI 10.1074/jbc.M402084200; Jeffry J, 2011, PHYSIOLOGY, V26, P286, DOI 10.1152/physiol.00007.2011; Akiyama T, 2013, NEUROSCIENCE, V250, P697, DOI 10.1016/j.neuroscience.2013.07.035; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Narumiya S, 1999, PHYSIOL REV, V79, P1193; Chakraborty R, 2013, MOL CELL BIOL, V33, P184, DOI 10.1128/MCB.00725-12; Choi JK, 2009, J DERMATOL SCI, V53, P81, DOI 10.1016/j.jdermsci.2008.07.008; Choi JK, 2010, BIOMOL THER, V18, P159, DOI 10.4062/biomolther.2010.18.2.159; Guerrero JA, 2007, BRIT J CLIN PHARMACO, V64, P133, DOI 10.1111/j.1365-2125.2007.02881.x; Kim HJ, 2010, BIOMOL THER, V18, P316, DOI 10.4062/biomolther.2010.18.3.316; Kim K, 2012, BIOMOL THER, V20, P506, DOI 10.4062/biomolther.2012.20.6.506; Kleyn CE, 2012, BRIT J DERMATOL, V166, P994, DOI 10.1111/j.1365-2133.2012.10849.x; Lee CH, 2010, BIOMOL THER, V18, P246, DOI 10.4062/biomolther.2010.18.3.246; Lim KM, 2012, ARCH PHARM RES, V35, P393, DOI 10.1007/s12272-012-0321-6; Ohkubo S, 1996, PROSTAGLANDINS, V52, P403, DOI 10.1016/S0090-6980(96)00105-0; Zhang ZB, 2003, CIRC RES, V92, P1153, DOI 10.1161/01.RES.0000071749.22027.45	22	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	NOV	2014	126						131	135		10.1016/j.pbb.2014.09.011		5	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	AU2TU	WOS:000345471200018		
J	Takano, M; Kakizoe, S; Kawami, M; Nagai, J; Patanasethanont, D; Sripanidkulchai, B; Yumoto, R				Takano, M.; Kakizoe, S.; Kawami, M.; Nagai, J.; Patanasethanont, D.; Sripanidkulchai, B.; Yumoto, R.			Modulation of P-glycoprotein function and multidrug resistance in cancer cells by Thai plant extracts	PHARMAZIE			English	Article							KAEMPFERIA-PARVIFLORA EXTRACTS; MULTIPLE-DRUG RESISTANCE; TRANSPORTERS; EFFLUX; MECHANISMS; EXPRESSION; FLAVONOIDS; LINE; CHEMOTHERAPY; PACLITAXEL	The effects of ethanol extracts from Thai plants belonging to the families of Annonaceae, Rutaceae, and Zingiberaceae on P-glycoprotein (P-gp) function and multidrug resistance were examined in paclitaxel-resistant HepG2 (PR-HepG2) cells. All the extracts tested, significantly increased the accumulation of [H-3]paclitaxel, a P-gp substrate, in the cells. Among nine extracts, Z01 and Z02, extracts from Curcuma comosa and Kaempferia marginata (Zingiberaceae family), respectively, potently increased the accumulation. In addition, Z01 and Z02 increased the accumulation of other P-gp substrates, rhodamine 123 and doxorubicin, in PR-HepG2 cells in a concentration-dependent manner. Increased accumulation of rhodamine 123 and doxorubicin by Z01 and Z02 was also confirmed by confocal laser scanning microscopy. The effect of Z01 and Z02 pretreatment on the expression of MDR1 mRNA was also examined. The expression of MDR1 mRNA was not affected by the treatment of PR-HepG2 cells with these extracts for 48 hours. Cytotoxicity of paclitaxel was examined by XTT and protein assays in the absence and presence of Z02. Z02 potentiated the cytotoxicity of paclitaxel in PR-HepG2 cells. These results suggest that Curcuma comosa and Kaempferia marginata belonging to Zingiberaceae are useful sources to search for new P-gp modulator(s) that can be used to overcome multidrug resistance of cancer cells.	[Takano, M.; Kakizoe, S.; Kawami, M.; Nagai, J.; Yumoto, R.] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmaceut & Therapeut, Hiroshima 7348553, Japan; [Patanasethanont, D.] Khon Kaen Univ, Fac Pharmaceut Sci, Khon Kaen, Thailand; [Sripanidkulchai, B.] Khon Kaen Univ, Ctr Res & Dev Herbal Hlth Prod, Khon Kaen, Thailand	Takano, M (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmaceut & Therapeut, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	takanom@hiroshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS)	We thank the Analysis Center of Life Science, Hiroshima University, for the use of their facilities. This work was supported in part by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS).	Abuznait AH, 2011, FOOD CHEM TOXICOL, V49, P2765, DOI 10.1016/j.fct.2011.08.004; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416,9.1.105; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tian R, 2005, DRUG METAB DISPOS, V33, P547, DOI 10.1124/dmd.104.002485; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; Friedenberg WR, 2006, CANCER, V106, P830, DOI 10.1002/cncr.21666; Takano M, 2006, PHARMACOL THERAPEUT, V109, P137, DOI 10.1016/j.pharmthera.2005.06.005; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Morjani H, 2010, METHODS MOL BIOL, V596, P433, DOI 10.1007/978-1-60761-416-6_19; Zastre JA, 2009, J NEUROSCI RES, V87, P1023, DOI 10.1002/jnr.21898; Thongnest S, 2005, J NAT PROD, V68, P1632, DOI 10.1021/np050186l; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Bansal T, 2009, J PHARM PHARM SCI, V12, P46; Gillet JP, 2007, BBA-REV CANCER, V1775, P237, DOI 10.1016/j.bbcan.2007.05.002; CRITCHFIELD JW, 1994, BIOCHEM PHARMACOL, V48, P1437, DOI 10.1016/0006-2952(94)90568-1; VERWEIJ J, 1991, BRIT J CANCER, V64, P361, DOI 10.1038/bjc.1991.307; Alvarez AI, 2010, J PHARM SCI-US, V99, P598, DOI 10.1002/jps.21851; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Patanasethanont D, 2007, EUR J PHARMACOL, V566, P67, DOI 10.1016/j.ejphar.2007.04.001; Ozben T, 2006, FEBS LETT, V580, P2903, DOI 10.1016/j.febslet.2006.02.020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Zhou SF, 2007, DRUG DISCOV TODAY, V12, P664, DOI 10.1016/j.drudis.2007.06.004; Kawami M, 2010, DRUG METAB PHARMACOK, V25, P155; Nakamura S, 2008, CHEM PHARM BULL, V56, P1604, DOI 10.1248/cpb.56.1604; Patanasethanont D, 2007, J PHARM SCI-US, V96, P223, DOI 10.1002/jps.20769; Takano M, 2009, DRUG METAB PHARMACOK, V24, P418; Yumoto R, 2013, DRUG METAB PHARMACOK, V28, P159, DOI 10.2133/dmpk.DMPK-12-NT-056	27	0	0	GOVI-VERLAG  PHARMAZEUTISCHER VERLAG GMBH	ESCHBORN	PHARMAZEUTISCCARL MANNICH STR 26, D-65760 ESCHBORN, GERMANY	0031-7144			PHARMAZIE	Pharmazie	NOV	2014	69	11					823	828		10.1691/ph.2014.4619		6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AU4UN	WOS:000345606900008		
J	Mukai, M; Tanaka, S; Yamamoto, K; Murata, M; Okada, K; Isobe, T; Shigeyama, M; Hichiya, H; Hanioka, N				Mukai, M.; Tanaka, S.; Yamamoto, K.; Murata, M.; Okada, K.; Isobe, T.; Shigeyama, M.; Hichiya, H.; Hanioka, N.			In vitro glucuronidation of propofol in microsomal fractions from human liver, intestine and kidney: tissue distribution and physiological role of UGT1A9	PHARMAZIE			English	Article							GLUCURONOSYL TRANSFERASE 1A; UDP-GLUCURONOSYLTRANSFERASES; MASS-SPECTROMETRY; QUANTIFICATION; POLYMORPHISMS; METABOLISM; PREDICTION; CLEARANCE; ISOFORMS; PROTEIN	Propofol (2,6-diisopropylphenol) is intravenously administered for anesthetic induction and maintenance, and is rapidly metabolized into its glucuronide, mainly by UDP-glucuronosyltransferase 1A9 (UGT1A9). In this study, propofol glucuronidation by liver microsomes (HLM), intestinal microsomes (HIM) and kidney microsomes (HKM) of humans were examined. The expression of UGT1A9 protein in HLM, HIM and HKM was analyzed by immunoblotting. The staining band intensities for UGT1A9 of HIM and HKM were 12% and 119% those of HLM, respectively. The kinetics of propofol glucuronidation by HLM and HKM exhibited substrate inhibition, whereas the kinetics by HIM followed the Michaelis-Menten model. The K-m, V-max and CLint values of HLM were 41.8 mu M, 5.21 nmol/min/mg protein and 126 mu l/min/mg protein, respectively. The K-m value of HIM was significantly higher (6.7-fold) than that of HLM, and the V-max and CLint values were significantly lower (56% and 8.3%, respectively) than those of HLM. The K-m value of HKM was comparable to that of HLM, and the V-max and CLint values were significantly higher (2.1- and 3.7-fold, respectively) than those of HLM, respectively. These findings suggest that UGT1A9 expressed in the kidney as well as in the liver plays an important role in propofol glucuronidation. The information gained in this study should contribute to an appropriate use of drugs metabolized by UGT1A9.	[Mukai, M.; Tanaka, S.; Yamamoto, K.] Okayama Univ, Fac Pharmaceut Sci, Okayama 700, Japan; [Murata, M.] Yokohama Coll Pharm, Lab Pharmaceut, Yokohama, Kanagawa 2450066, Japan; [Okada, K.; Isobe, T.; Shigeyama, M.] Yokohama Coll Pharm, Lab Clin Pharmaceut, Yokohama, Kanagawa 2450066, Japan; [Hichiya, H.; Hanioka, N.] Yokohama Coll Pharm, Lab Biochem Toxicol, Yokohama, Kanagawa 2450066, Japan	Hanioka, N (reprint author), Yokohama Coll Pharm, Lab Biochem Toxicol, Totsuka Ku, 601 Matano Cho, Yokohama, Kanagawa 2450066, Japan.	nhanioka@hamayaku.ac.jp			JSPS KAKENHI [23590148]	This work was supported in part by JSPS KAKENHI Grant (23590148).	Fallon JK, 2013, DRUG METAB DISPOS, V41, P2076, DOI 10.1124/dmd.113.053801; Yamanaka H, 2007, DRUG METAB DISPOS, V35, P1642, DOI 10.1124/dmd.107.016097; Obach RS, 1997, J PHARMACOL EXP THER, V283, P46; Gill KL, 2012, DRUG METAB DISPOS, V40, P825, DOI 10.1124/dmd.111.043984; Harbourt DE, 2012, ANAL CHEM, V84, P98, DOI 10.1021/ac201704a; Kiang TKL, 2005, PHARMACOL THERAPEUT, V106, P97, DOI 10.1016/j.pharmthera.2004.10.013; Villeneuve L, 2003, J PHARMACOL EXP THER, V307, P117, DOI 10.1124/jpet.103.054072; Izukawa T, 2009, DRUG METAB DISPOS, V37, P1759, DOI 10.1124/dmd.109.027227; Soars MG, 2002, J PHARMACOL EXP THER, V301, P382, DOI 10.1124/jpet.301.1.382; Cheng ZQ, 1999, DRUG METAB DISPOS, V27, P1165; Court MH, 2005, METHOD ENZYMOL, V400, P104, DOI 10.1016/S0076-6879(05)00007-8; Girard H, 2004, PHARMACOGENETICS, V14, P501, DOI 10.1097/01.fpc.0000114754.08559.27; Jinno H, 2003, J PHARMACOL EXP THER, V306, P688, DOI 10.1124/jpet.103.051250; LANGLEY MS, 1988, DRUGS, V35, P334, DOI 10.2165/00003495-198835040-00002; Murayama N, 2007, XENOBIOTICA, V37, P717, DOI 10.1080/00498250701449431; Oda S, 2012, DRUG METAB DISPOS, V40, P1620, DOI 10.1124/dmd.112.045625; Oluro S, 2009, DRUG METAB DISPOS, V37, P32; Shimizu M, 2003, BIOL PHARM BULL, V26, P216, DOI 10.1248/bpb.26.216; Vanlersberghe C., 2008, V182, P227	19	1	1	GOVI-VERLAG  PHARMAZEUTISCHER VERLAG GMBH	ESCHBORN	PHARMAZEUTISCCARL MANNICH STR 26, D-65760 ESCHBORN, GERMANY	0031-7144			PHARMAZIE	Pharmazie	NOV	2014	69	11					829	832		10.1691/ph.2014.4564		4	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AU4UN	WOS:000345606900009		
J	Nagai, K; Yoshida, S; Konishi, H				Nagai, K.; Yoshida, S.; Konishi, H.			Gender differences in the gene expression profiles of glucose transporter GLUT class I and SGLT in mouse tissues	PHARMAZIE			English	Article								Glucose transporters play key roles in controlling blood sugar levels and are recognized as the pharmacological targets of antidiabetic agents. In the present study, we compared the gene expression profiles of glucose transporter GLUT class I and SGLT isoforms in the skeletal muscle, heart, liver, kidney, and brain of male and female mice. The expression profiles of GLUT1-4 and SGLT1-2 in male mouse tissues were similar to those previously reported. Significant gender differences were observed in mRNA expression in terms of individual these glucose transport systems and the tissues examined. Especially, all of the corresponding mRNAs of renal GLUT class I and SGLT isoforms were expressed at higher levels in female mice than in male mice. However, no significant differences were observed in serum glucose concentrations between male and female mice. These results strongly suggest that prominent gender differences exist in the gene expression profiles of these glucose transporters in mouse tissues, and that the quantitative and functional multiplicities of glucose transporters may contribute to the successful regulation of blood glucose concentrations irrespective of gender differences.	[Nagai, K.; Yoshida, S.; Konishi, H.] Osaka Ohtani Univ, Fac Pharm, Lab Clin Pharm & Therapeut, Tondabayashi 5848540, Japan	Nagai, K (reprint author), Osaka Ohtani Univ, Fac Pharm, Lab Clin Pharm & Therapeut, 3-11-1 Nishikiori Kita, Tondabayashi 5848540, Japan.	nagaika@osaka-ohtani.ac.jp					Muller V, 2002, KIDNEY INT, V62, P1364, DOI 10.1046/j.1523-1755.2002.00590.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Cuypers J, 2013, ACTA CLIN BELG, V68, P287, DOI 10.2143/ACB.3349; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; Bady I, 2006, DIABETES, V55, P988, DOI 10.2337/diabetes.55.04.06.db05-1386; Cappel David A, 2013, Mol Metab, V2, P457, DOI 10.1016/j.molmet.2013.08.007; Dobson SP, 1996, FEBS LETT, V393, P179, DOI 10.1016/0014-5793(96)00879-4; Nagai K, 2014, FUND CLIN PHARMACOL, V28, P217, DOI 10.1111/fcp.12011; Neugarten J, 1997, J AM SOC NEPHROL, V8, P1240; Rossi MC, 2013, DIABETES CARE, V36, P3162, DOI 10.2337/dc13-0184; Tielmans A, 2007, PRESSE MED, V36, P269, DOI 10.1016/j.lpm.2006.10.017	11	0	0	GOVI-VERLAG  PHARMAZEUTISCHER VERLAG GMBH	ESCHBORN	PHARMAZEUTISCCARL MANNICH STR 26, D-65760 ESCHBORN, GERMANY	0031-7144			PHARMAZIE	Pharmazie	NOV	2014	69	11					856	859		10.1691/ph.2014.4647		4	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AU4UN	WOS:000345606900014		
J	Goto, S; Shimizu, M; Kawahara, G				Goto, Susumu; Shimizu, Masaki; Kawahara, Genta			Turbulent mixing in a precessing sphere	PHYSICS OF FLUIDS			English	Article							FLUID CYLINDER; INERTIA WAVES; SHEAR LAYERS; FLOW; DRIVEN; SHELLS; RESONANCE; ENERGY; INSTABILITIES; DYNAMOS	By numerically simulating turbulent flows at high Reynolds numbers in a precessing sphere, we propose a method to enhance the mixing of a fluid confined within a smooth cavity by its rotational motion alone. To precisely evaluate the mixing efficiency, we extend the quantification method proposed by Danckwerts ["The definition and measurement of some characteristics of mixtures," Appl. Sci. Res. A 3, 279-296 (1952)] to the case in which only a finite number of fluid particle trajectories can be known. Our accurate numerical tracking of fluid particles in the flow, which is controlled by the Reynolds number (an indicator of the spin rate) and the Poincare number (the precession rate), shows the following results. First, the mixing process on the time scale normalized by the spin period is independent of the Reynolds number as long as it is high enough for the flow to be developed turbulence. Second, fastest mixing is achieved under weak precession (Poincare number approximate to 0.1); in such cases, perfect mixing requires only 10-15 spins of the container. Third, the power to sustain turbulence is a weakly increasing function of the Poincare number, and the energy efficiency of the mixing is also maximized when the Poincare number is about 0.1. Fourth, efficient mixing driven by the weak precession arises from the effective cooperation of complex large-scale flow and small-scale turbulence, which itself is sustained by the large-scale flow. (C) 2014 AIP Publishing LLC.	[Goto, Susumu; Shimizu, Masaki; Kawahara, Genta] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	Goto, S (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	goto@me.es.osaka-u.ac.jp			JSPS [24360071, 24540416]	This work was partly supported by JSPS Grants-in-Aid for Scientific Research 24360071 and 24540416.	Nore C, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016317; Taylor GI, 1923, PHILOS T R SOC LOND, V223, P289, DOI 10.1098/rsta.1923.0008; BUSSE FH, 1968, J FLUID MECH, V33, P739, DOI 10.1017/S0022112068001655; MALKUS WVR, 1968, SCIENCE, V160, P259, DOI 10.1126/science.160.3825.259; Tilgner A, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1852576; ZANDBERGEN PJ, 1987, ANNU REV FLUID MECH, V19, P465, DOI 10.1146/annurev.fluid.19.1.465; Lorenzani S, 2003, J FLUID MECH, V492, P363, DOI 10.1017/S002211200300572X; BATCHELOR GK, 1959, J FLUID MECH, V5, P113, DOI 10.1017/S002211205900009X; DANCKWERTS PV, 1952, APPL SCI RES, V3, P279; Wu CC, 2009, GEOPHYS ASTRO FLUID, V103, P467, DOI 10.1080/03091920903311788; MANASSEH R, 1992, J FLUID MECH, V243, P261, DOI 10.1017/S0022112092002726; MANASSEH R, 1994, J FLUID MECH, V265, P345, DOI 10.1017/S0022112094000868; Lagrange R, 2011, J FLUID MECH, V666, P104, DOI 10.1017/S0022112010004040; Hollerbach R, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.053020; Meunier P, 2008, J FLUID MECH, V599, P405, DOI 10.1017/S0022112008000335; Lagrange R, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2963969; Manasseh R, 1996, J FLUID MECH, V315, P151, DOI 10.1017/S0022112096002388; MATSUSHIMA T, 1995, J COMPUT PHYS, V120, P365, DOI 10.1006/jcph.1995.1171; VANYO J, 1995, GEOPHYS J INT, V121, P136, DOI 10.1111/j.1365-246X.1995.tb03516.x; Mouhali W, 2012, EXP FLUIDS, V53, P1693, DOI 10.1007/s00348-012-1385-2; Goto S, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4874695; KOBINE JJ, 1995, J FLUID MECH, V303, P233, DOI 10.1017/S0022112095004253; BATCHELOR GK, 1952, PROC R SOC LON SER-A, V213, P349, DOI 10.1098/rspa.1952.0130; GANS RF, 1971, J FLUID MECH, V45, P111, DOI 10.1017/S0022112071003021; GIRIMAJI SS, 1990, J FLUID MECH, V220, P427, DOI 10.1017/S0022112090003330; Goto S, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2746040; Goto S, 2011, J FLUID MECH, V683, P417, DOI 10.1017/jfm.2011.299; Goto S, 2007, J FLUID MECH, V586, P59, DOI 10.1017/S0022112007007240; HOLLERBACH R, 1995, J FLUID MECH, V298, P327, DOI 10.1017/S0022112095003338; Kida S., 2008, J PHYS SOC JPN, V77; Kida S, 2011, J PHYS CONF SER, V318, DOI 10.1088/1742-6596/318/7/072031; Kobine JJ, 1996, J FLUID MECH, V319, P387, DOI 10.1017/S0022112096007380; Koike Y., 2012, P JSST 2012; Lorenzani S, 2001, J FLUID MECH, V447, P111, DOI 10.1017/SO02211200100581X; Noir J., 2001, J FLUID MECH, V437, P282; Noir J, 2013, J FLUID MECH, V737, P412, DOI 10.1017/jfm.2013.524; Noir J., 2001, Geophysical Research Letters, V28, DOI 10.1029/2001GL012956; Noir J, 2003, GEOPHYS J INT, V154, P407, DOI 10.1046/j.1365-246X.2003.01934.x; Tilgner A, 2007, GEOPHYS ASTRO FLUID, V101, P1, DOI 10.1080/03091920601045324; Tilgner A, 2001, J FLUID MECH, V426, P387, DOI 10.1017/S0022112000002536; Tilgner A, 1999, GEOPHYS J INT, V136, P629, DOI 10.1046/j.1365-246x.1999.00769.x; Tilgner A, 1999, J FLUID MECH, V379, P303, DOI 10.1017/S0022112098003425; VANYO JP, 1973, J APPL MECH-T ASME, V40, P851; Vanyo JP, 2000, GEOPHYS J INT, V142, P409, DOI 10.1046/j.1365-246x.2000.00170.x; VANYO JP, 1971, J APPL MECH, V38, P674; VANYO JP, 1991, GEOPHYS ASTRO FLUID, V59, P209, DOI 10.1080/03091929108227780	46	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	1070-6631	1089-7666		PHYS FLUIDS	Phys. Fluids	NOV	2014	26	11							115106	10.1063/1.4901449		24	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AU4KD	WOS:000345578700031		
J	Mamori, H; Fukagata, K				Mamori, Hiroya; Fukagata, Koji			Drag reduction effect by a wave-like wall-normal body force in a turbulent channel flow	PHYSICS OF FLUIDS			English	Article							TRANSVERSE TRAVELING-WAVE; BOUNDED FLOWS; SKIN FRICTION; FEEDBACK-CONTROL; LORENTZ FORCE; OSCILLATIONS; MECHANISMS; EQUATIONS; MOTION; ONSET	Skin-friction drag reduction effect of a wave-like wall-normal body force in a fully developed turbulent channel flow is investigated by means of direct numerical simulation. The flow rate is kept constant; the bulk Reynolds number is set at 5600, which corresponds to the friction Reynolds number of about 180 in the uncontrolled flow. An exponential decay of the wall-normal body force is assumed so that the body force acts in the regions near the walls only. The friction drag is found to decrease when the wave travels in the upstream direction at slower wavespeeds than the bulk-mean velocity; the maximum drag reduction rate of about 40% is achieved in the case of a stationary control input. The net energy saving rate, however, is found to be mostly negative and, if positive, subtle. Visualization of the flow field shows attenuation of streamwise vortical structures and existence of spanwise roller-like vortices. The spanwise roller-like vortices are found to produce a negative Reynolds shear stress in the regions near the walls, which contributes to the reduction of friction drag. A linear analysis reveals that the spanwise roller-like vortices are well described by a linearized Navier-Stokes equation. (C) 2014 AIP Publishing LLC.	[Mamori, Hiroya] Tokyo Univ Agr & Technol, Dept Mech Syst Engn, Koganei, Tokyo 1848588, Japan; [Fukagata, Koji] Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Mamori, H (reprint author), Tokyo Univ Agr & Technol, Dept Mech Syst Engn, 2-24-16 Nakacho, Koganei, Tokyo 1848588, Japan.	mamori@cc.tuat.ac.jp; fukagata@mech.keio.ac.jp	Fukagata, Koji/B-4280-2010	Fukagata, Koji/0000-0003-4805-238X	Japan Society for the Promotion of Science (JSPS) [20246036, 25420129, 11J03928, 25889018]	The authors are grateful to Dr. Shinnosuke Obi (Keio University), Dr. Nobuhide Kasagi and Dr. Yosuke Hasegawa (The University of Tokyo), and Dr. Kaoru Iwamoto (Tokyo University of Agriculture and Technology) for fruitful discussions. This work was partly supported through Grant-in-Aid for Scientific Research (A) (No. 20246036), Grant-in-Aid for Scientific Research (C) (No. 25420129), and Grant-in-Aid for JSPS Fellows (No. 11J03928), and Grant-in-Aid for Research Activity Start-up (No. 25889018) by Japan Society for the Promotion of Science (JSPS).	Touber E, 2012, J FLUID MECH, V693, P150, DOI 10.1017/jfm.2011.507; Karniadakis GE, 2003, ANNU REV FLUID MECH, V35, P45, DOI 10.1146/annurev.fluid.35.101101.161213; Berger TW, 2000, PHYS FLUIDS, V12, P631, DOI 10.1063/1.870270; Du YQ, 2002, J FLUID MECH, V457, P1, DOI 10.1017/S0022112001007613; Nakanishi R, 2012, INT J HEAT FLUID FL, V35, P152, DOI 10.1016/j.ijheatfluidflow.2012.01.007; Fukagata K, 2002, PHYS FLUIDS, V14, pL73, DOI 10.1063/1.1516779; Fukagata K, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2205307; HUSSAIN AKM, 1970, J FLUID MECH, V41, P241, DOI 10.1017/S0022112070000605; Quadrio M, 2009, J FLUID MECH, V627, P161, DOI 10.1017/S0022112009006077; Hoepffner J, 2009, J FLUID MECH, V635, P171, DOI 10.1017/S0022112009007629; Quadrio M, 2011, PHILOS T R SOC A, V369, P1428, DOI 10.1098/rsta.2010.0366; Mamori H, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046304; Pang JG, 2004, PHYS FLUIDS, V16, pL35, DOI 10.1063/1.1689711; Quadrio M, 2004, J FLUID MECH, V521, P251, DOI 10.1017/S0022112004001855; Kasagi N, 2009, ANNU REV FLUID MECH, V41, P231, DOI 10.1146/annurev.fluid.010908.165221; SPALART PR, 1991, J COMPUT PHYS, V96, P297, DOI 10.1016/0021-9991(91)90238-G; Fukagata K, 2003, INT J HEAT FLUID FL, V24, P480, DOI 10.1016/S0142-727X(03)00058-4; Du YQ, 2000, SCIENCE, V288, P1230, DOI 10.1126/science.288.5469.1230; CHOI H, 1994, J FLUID MECH, V262, P75, DOI 10.1017/S0022112094000431; Lee C, 1998, J FLUID MECH, V358, P245, DOI 10.1017/S002211209700815X; JUNG WJ, 1992, PHYS FLUIDS A-FLUID, V4, P1605, DOI 10.1063/1.858381; Min T, 2006, J FLUID MECH, V558, P309, DOI 10.1017/S0022112006000206; Jovanovic MR, 2005, J FLUID MECH, V534, P145, DOI [10.1017/S0022112005004295, 10.1017/S002112005004295]; DUKOWICZ JK, 1992, J COMPUT PHYS, V102, P336, DOI 10.1016/0021-9991(92)90376-A; Fukagata K., 2005, P 6 S SMART CONTR TU, P143; Huang LP, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3291071; Kajishima T., 1999, T JSME B, V65, P1607; Kasagi N, 2009, SPRINGER PROC PHYS, V132, P189, DOI 10.1007/978-3-642-03085-7_48; Lee C, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.3006057; Lieu BK, 2010, J FLUID MECH, V663, P100, DOI 10.1017/S002211201000340X; Mamori H, 2011, J PHYS CONF SER, V318, DOI 10.1088/1742-6596/318/2/022030; Mamori H, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4851256; Moarref M., 2012, J FLUID MECH, V707, P205; Moarref R, 2010, J FLUID MECH, V663, P70, DOI 10.1017/S0022112010003393; Moser R. D., 1999, PHYS FLUIDS, V11, P942; Quadrio M, 2007, J FLUID MECH, V576, P425, DOI 10.1017/S0022112007004727; Ricco P, 2008, INT J HEAT FLUID FL, V29, P891, DOI 10.1016/j.ijheatfluidflow.2007.12.005; Tomiyama N, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4826887; Yakeno A, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4893903	39	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	1070-6631	1089-7666		PHYS FLUIDS	Phys. Fluids	NOV	2014	26	11							115104	10.1063/1.4901186		22	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AU4KD	WOS:000345578700029		
J	Kobayashi, Y; Huang, X; Takasugi, M; Chiba, K; Kato, T; Shirahata, T; Ino, C				Kobayashi, Y.; Huang, X.; Takasugi, M.; Chiba, K.; Kato, T.; Shirahata, T.; Ino, C.			Antimicrobial effects on Porphyromonas gingivalis by KAMPO (traditional Japanese herbal medicine) formulas containing Rhei rhizoma, and its active components	PLANTA MEDICA			English	Meeting Abstract	62nd International Congress and Annual Meeting of the Society-of-Medicinal-Plant-and-Natural-Product-Research	AUG 31-SEP 04, 2014	Guimaraes, PORTUGAL	Soc Med Plant & Nat Prod Res		periodontitis; Porphyromonas gingivalis; Kampo; Rhei rhizoma; Daiokanzoto; Rhein; aloe-emodin; triclosan			[Kobayashi, Y.; Huang, X.; Takasugi, M.; Chiba, K.; Kato, T.; Shirahata, T.; Ino, C.] Kitasato Univ, Sch Pharm, Tokyo, Japan							Dilshad SMR, 2008, J ETHNOPHARMACOL, V117, P393, DOI 10.1016/j.jep.2008.02.011; Lorenzi H., 2008, MEDICINAL PLANTS OF, P544; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Sen S., 2010, IJPSR, V3, P91	4	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	NOV	2014	80	16				P1C7	1402	1403				2	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AU4AB	WOS:000345550400158		
J	Kuchta, K; Matsuura, N; Rauwald, HW; Iinuma, M				Kuchta, K.; Matsuura, N.; Rauwald, H. W.; Iinuma, M.			Effects of Leonurus japonicus Houtt. and its N-containing constituents leonurine and stachydrine on the activity of PPAR alpha, beta/delta and gamma in a newly developed in vitro luciferase reporter gene assay	PLANTA MEDICA			English	Meeting Abstract	62nd International Congress and Annual Meeting of the Society-of-Medicinal-Plant-and-Natural-Product-Research	AUG 31-SEP 04, 2014	Guimaraes, PORTUGAL	Soc Med Plant & Nat Prod Res		Leonurus japonicus Houtt.; leonurine; stachydrine; diabetes; PPAR alpha; PPAR beta/delta; PPAR gamma; luciferase reporter gene assay	CARDIACA		[Kuchta, K.] Sanyo Gakuen Univ Coll, Dept Nutr, Naka Ku, Okayama 7038501, Japan; [Matsuura, N.] Okayama Univ Sci, Dept Life Sci, Kita Ku, Okayama 7000005, Japan; [Rauwald, H. W.] Univ Leipzig, Dept Pharmaceut Biol, D-04103 Leipzig, Germany; [Iinuma, M.] Gifu Pharmaceut Univ, Dept Pharmacognosy, Gifu 5011196, Japan							Kuchta K, 2012, PHARMAZIE, V67, P973, DOI 10.1691/ph.2012.1856; Kuchta K, 2014, FITOTERAPIA, V96, P8, DOI 10.1016/j.fitote.2014.03.023; Matsuura N, 2013, BIOSCI BIOTECH BIOCH, V77, P2430, DOI 10.1271/bbb.130541; Yang SZ, 1998, THE DIVINE FARMERS M, P30	4	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	NOV	2014	80	16				P1L24	1419	1419				1	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AU4AB	WOS:000345550400208		
J	Rezgui, A; Mitaine-Offer, AC; Miyamoto, T; Tanaka, C; Paululat, T; Lacaille-Dubois, MA				Rezgui, A.; Mitaine-Offer, A. C.; Miyamoto, T.; Tanaka, C.; Paululat, T.; Lacaille-Dubois, M. A.			New steroidal glycosides from Dracaena marginata, Dracaena fragrans and Allium flavum	PLANTA MEDICA			English	Meeting Abstract	62nd International Congress and Annual Meeting of the Society-of-Medicinal-Plant-and-Natural-Product-Research	AUG 31-SEP 04, 2014	Guimaraes, PORTUGAL	Soc Med Plant & Nat Prod Res		Saponins; Dracaena; Allium; spirostane; furostane; 2D NMR	SAPONINS		[Rezgui, A.; Mitaine-Offer, A. C.; Lacaille-Dubois, M. A.] Univ Bourgogne, Lab Pharmacognosie, EA 4267, FDE UFC,UFR Pharm, F-21079 Dijon, France; [Miyamoto, T.; Tanaka, C.] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan; [Paululat, T.] Univ Siegen, OC 2, Nat Wissensch Tech Fak, D-57076 Siegen, Germany							Adao CR, 2012, CHEM BIODIVERS, V9, P58, DOI 10.1002/cbdv.201100005; Huang HC, 2013, MOLECULES, V18, P8752, DOI 10.3390/molecules18088752; Lanzotti V, 2012, PHYTOCHEM REV, V11, P179, DOI 10.1007/s11101-012-9247-3; Sadeghi M, 2013, FOOD CHEM, V141, P1512, DOI 10.1016/j.foodchem.2013.04.009	4	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	NOV	2014	80	16				P1L55	1429	1429				1	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AU4AB	WOS:000345550400238		
J	Barbisan, F; Duarte, T; Ribeiro, E; Duarte, M; Montano, M; Cattani, M; Aigaki, T; da Cruz, I				Barbisan, F.; Duarte, T.; Ribeiro, E.; Duarte, M.; Montano, M.; Cattani, M.; Aigaki, T.; da Cruz, I			Guarana effect on inflammatory and antiinflammatory cytokines is influenced by Ala16Val-SOD2 gene polymorphism	PLANTA MEDICA			English	Meeting Abstract	62nd International Congress and Annual Meeting of the Society-of-Medicinal-Plant-and-Natural-Product-Research	AUG 31-SEP 04, 2014	Guimaraes, PORTUGAL	Soc Med Plant & Nat Prod Res		Guarana Ala16VAL cytokine SOD 2 inflammatory			[Barbisan, F.; Duarte, T.; Duarte, M.; da Cruz, I] Univ Fed Santa Maria, Pharmacol Grad Program, BR-97105900 Santa Maria, RS, Brazil; [Barbisan, F.; Duarte, T.; Duarte, M.; Montano, M.; Cattani, M.; da Cruz, I] Univ Fed Santa Maria, Biogen Lab, BR-97105900 Santa Maria, RS, Brazil; [Ribeiro, E.] State Univ Amazonas, Open Univ Age 3, BR-69065001 Manaus, Amazonas, Brazil; [Cattani, M.; Aigaki, T.] Tokyo Metropolitan Univ, Hachioji, Tokyo 1920397, Japan							Montano MAE, 2012, CYTOKINE, V60, P30, DOI 10.1016/j.cyto.2012.05.022; Suleiman L, 2014, EUR FOOD RES TECHNOL, V1, P1	2	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	NOV	2014	80	16				P1L109	1446	1446				1	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AU4AB	WOS:000345550400292		
J	Barbisan, F; Manica-Cattani, MF; Aigaki, T; Trindade, L; Algarve, T; Ribeiro, EE; da Cruz, IB				Barbisan, F.; Manica-Cattani, M. F.; Aigaki, T.; Trindade, L.; Algarve, T.; Ribeiro, E. E.; da Cruz, I. B.			Guarana supplementaion in diets different macronutrient proportions affect positively Drosophila melanogaster survival exposured to paraquat	PLANTA MEDICA			English	Meeting Abstract	62nd International Congress and Annual Meeting of the Society-of-Medicinal-Plant-and-Natural-Product-Research	AUG 31-SEP 04, 2014	Guimaraes, PORTUGAL	Soc Med Plant & Nat Prod Res		Drosophila melanogaster; guarana diets; paraquat toxicity			[Barbisan, F.] Univ Fed Santa Maria, Pharmacol Grad Program, BR-97105900 Santa Maria, RS, Brazil; [Barbisan, F.; Manica-Cattani, M. F.; Algarve, T.; da Cruz, I. B.] Univ Fed Santa Maria, Biogen Lab, BR-97105900 Santa Maria, RS, Brazil; [Ribeiro, E. E.] State Univ Amazonas, Open Univ Age 3, BR-69065001 Manaus, Amazonas, Brazil; [Manica-Cattani, M. F.; Aigaki, T.; Trindade, L.] Tokyo Metropolitan Univ, Hachioji, Tokyo 1920397, Japan							Bazzell B, 2013, J EXP BIOL, V216, P859, DOI 10.1242/jeb.078758; Ruden DM, 2005, ANNU REV NUTR, V25, P499, DOI [10.1146/annurev.nutr.25.050304.092708, 10.1146/annurev.nutr.25..050304.092708]	2	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	NOV	2014	80	16				P1L124	1451	1451				1	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AU4AB	WOS:000345550400307		
J	Shu, JC; Kuchta, K; Lin, Y; He, YJ; Lv, X; Kobayashi, Y				Shu, J. C.; Kuchta, K.; Lin, Y.; He, Y. J.; Lv, X.; Kobayashi, Y.			Modulation of apoptosis-related growth factor expression by curcumin induces apoptosis in hepatic stellate cells	PLANTA MEDICA			English	Meeting Abstract	62nd International Congress and Annual Meeting of the Society-of-Medicinal-Plant-and-Natural-Product-Research	AUG 31-SEP 04, 2014	Guimaraes, PORTUGAL	Soc Med Plant & Nat Prod Res		Curcumin; hepatic stellate cells; apoptosis; Bcl-2; p53; Fas			[Shu, J. C.; He, Y. J.; Lv, X.] Jinan Univ, Guangzhou Red Cross Hosp, Dept Gastroenterol, Guangzhou 510220, Guangdong, Peoples R China; [Kuchta, K.] Sanyo Gakuen Univ Coll, Dept Nutr, Naka, Ibaraki, Japan; [Lin, Y.] Med Corp Soujikai, Chuo Ku, Osaka 5410046, Japan; [Kobayashi, Y.] Shimane univ, Fac Med, Izumo, Shimane 6938501, Japan								0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	NOV	2014	80	16				P2P8	1472	1472				1	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AU4AB	WOS:000345550400371		
J	Kuchta, K; Wang, R; Lin, Y; Rauwald, HW; Fang, L; Qiao, H; Kobayashi, Y				Kuchta, K.; Wang, R.; Lin, Y.; Rauwald, H. W.; Fang, L.; Qiao, H.; Kobayashi, Y.			Classical TCM Brassica campestris L. pollen preparations and a newly developed phytosterol enriched refined extract significantly improve benign prostatic hyperplasia (BPH) in a rat model	PLANTA MEDICA			English	Meeting Abstract	62nd International Congress and Annual Meeting of the Society-of-Medicinal-Plant-and-Natural-Product-Research	AUG 31-SEP 04, 2014	Guimaraes, PORTUGAL	Soc Med Plant & Nat Prod Res		Brassica campestris L.; Brassicaceae; pollen; TCM; phytosterols; benign prostatic hyperplasia			[Kuchta, K.] Sanyo Gakuen Univ Coll, Dept Nutr, Naka, Ibaraki 7038501, Japan; [Wang, R.; Fang, L.; Qiao, H.] Zhejiang Key Lab Tradit Chinese Med, Hangzhou 310052, Zhejiang, Peoples R China; [Lin, Y.] Med Corp Soujikai, Chuo Ku, Osaka 5410046, Japan; [Rauwald, H. W.] Univ Leipzig, Dept Pharmaceut Biol, D-04103 Leipzig, Germany; [Kobayashi, Y.] Shimane Univ, Fac Med, Izumo, Shimane 6938501, Japan								0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	NOV	2014	80	16				P2B97	1513	1513				1	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AU4AB	WOS:000345550400500		
J	Ishiguro, K; Okumura, M; Miyawaki, M; Oku, H				Ishiguro, K.; Okumura, M.; Miyawaki, M.; Oku, H.			Development of an assay method to search for compounds inhibiting stress-enhanced allergy	PLANTA MEDICA			English	Meeting Abstract	62nd International Congress and Annual Meeting of the Society-of-Medicinal-Plant-and-Natural-Product-Research	AUG 31-SEP 04, 2014	Guimaraes, PORTUGAL	Soc Med Plant & Nat Prod Res		allergy; stress; blood flow; natural medicine; assay method	BLOOD-FLOW DECREASE; EGG WHITE LYSOZYME		[Ishiguro, K.; Okumura, M.; Miyawaki, M.; Oku, H.] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Nishinomiya, Hyogo 6638179, Japan							Castilla-Ortega E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025522; Ishiguro K, 2005, BIOL PHARM BULL, V28, P1490, DOI 10.1248/bpb.28.1490; Oku H, 2007, BIOL PHARM BULL, V30, P1324, DOI 10.1248/bpb.30.1324	3	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	NOV	2014	80	16				P2020	1524	1525				2	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AU4AB	WOS:000345550400539		
J	Kuchta, K; Wang, R; Lin, Y; Rauwald, HW; Fang, L; Qiao, H; Kobayashi, Y				Kuchta, K.; Wang, R.; Lin, Y.; Rauwald, H. W.; Fang, L.; Qiao, H.; Kobayashi, Y.			Ginkgolic acids in Ginkgo biloba L. leaf TCM extracts: Simultaneous HPLC quantification of all five derivatives using ginkgoneolic acid as a single marker compound	PLANTA MEDICA			English	Meeting Abstract	62nd International Congress and Annual Meeting of the Society-of-Medicinal-Plant-and-Natural-Product-Research	AUG 31-SEP 04, 2014	Guimaraes, PORTUGAL	Soc Med Plant & Nat Prod Res		Ginkgo biloba L.; Ginkgoaceae; Ginkgolic acid derivatives; Relative correlation factor; HPLC; Quantitative analysis			[Kuchta, K.] Sanyo Gakuen Univ Coll, Dept Nutr, Naka, Ibaraki 7038501, Japan; [Wang, R.; Fang, L.; Qiao, H.] Zhejiang Key Lab Tradit Chinese Med, Hangzhou 310052, Zhejiang, Peoples R China; [Lin, Y.] Med Corp Soujikai, Osaka, Chuo 5410046, Japan; [Rauwald, H. W.] Univ Leipzig, Dept Pharmaceut Biol, D-04103 Leipzig, Germany; [Kobayashi, Y.] Shimane Univ, Fac Med, Izumo, Shimane 6938501, Japan								0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	NOV	2014	80	16				P2019	1524	1524				1	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AU4AB	WOS:000345550400538		
J	Yusakul, G; Udomsin, O; Tanaka, H; Morimoto, S; Juengwatanatrakul, T; Putalun, W				Yusakul, G.; Udomsin, O.; Tanaka, H.; Morimoto, S.; Juengwatanatrakul, T.; Putalun, W.			Enzyme-linked immunosorbent assay by enhanced chemiluminescence detection for standardization of miroestrol in Pueraria candollei	PLANTA MEDICA			English	Meeting Abstract	62nd International Congress and Annual Meeting of the Society-of-Medicinal-Plant-and-Natural-Product-Research	AUG 31-SEP 04, 2014	Guimaraes, PORTUGAL	Soc Med Plant & Nat Prod Res		Pueraria candollei; miroestrol; Enzyme-Linked Immunosorbent Assay; Enhanced chemiluminescence			[Yusakul, G.; Udomsin, O.; Putalun, W.] Khon Kaen Univ, Fac Pharmaceut Sci, Khon Kaen 40002, Thailand; [Yusakul, G.; Udomsin, O.; Putalun, W.] Khon Kaen Univ, Res Grp Pharmaceut Act Nat Prod Using Pharmaceut, Natl Res Univ, Khon Kaen 40002, Thailand; [Tanaka, H.; Morimoto, S.] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan; [Juengwatanatrakul, T.] Ubon Rachathani Univ, Fac Pharmaceut Sci, Ubon Ratchathani 34190, Thailand							Yusakul G, 2011, FITOTERAPIA, V82, P203, DOI 10.1016/j.fitote.2010.09.009; Chansakaow S, 2000, J NAT PROD, V63, P173, DOI 10.1021/np990547v; Yusakul G, 2013, ANAL CHIM ACTA, V785, P104, DOI 10.1016/j.aca.2013.04.053	3	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	NOV	2014	80	16				P2037	1529	1529				1	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AU4AB	WOS:000345550400555		
J	Oku, H; Abe, M; Maruyama, K; Yagi, T; Ishiguro, K				Oku, H.; Abe, M.; Maruyama, K.; Yagi, T.; Ishiguro, K.			Mechanism of the purgative action of multiflorin A	PLANTA MEDICA			English	Meeting Abstract	62nd International Congress and Annual Meeting of the Society-of-Medicinal-Plant-and-Natural-Product-Research	AUG 31-SEP 04, 2014	Guimaraes, PORTUGAL	Soc Med Plant & Nat Prod Res		Multiflorin A; purgative action; Rosa multiflora; small intestine; proteome analysis; calreticulin; acetyltransferase			[Oku, H.; Abe, M.; Maruyama, K.; Yagi, T.; Ishiguro, K.] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Nishinomiya, Hyogo 6638179, Japan							TAKAGI S, 1976, YAKUGAKU ZASSHI, V96, P1217	1	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	NOV	2014	80	16				P2055	1535	1535				1	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AU4AB	WOS:000345550400571		
J	Moody, J; Fukushi, Y; Tahara, S; Olatunji, B				Moody, J.; Fukushi, Y.; Tahara, S.; Olatunji, B.			Bioactivity-monitored isolation of antibacterial principles of Treculia africana stem bark	PLANTA MEDICA			English	Meeting Abstract	62nd International Congress and Annual Meeting of the Society-of-Medicinal-Plant-and-Natural-Product-Research	AUG 31-SEP 04, 2014	Guimaraes, PORTUGAL	Soc Med Plant & Nat Prod Res		Treculia africana; Moraceae; licoagrochalcone A; antibacterial activity			[Moody, J.; Olatunji, B.] Univ lbadan, Fac Pharm, Dept Pharmacognosy, Ibadan, Nigeria; [Fukushi, Y.; Tahara, S.] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan							Irvine F. R., 1961, WOODY PLANTS OF GHAN	1	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	NOV	2014	80	16				LP27	1546	1546				1	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	AU4AB	WOS:000345550400609		
J	Nakae, K; Ikegaya, Y; Ishikawa, T; Oba, S; Urakubo, H; Koyama, M; Ishii, S				Nakae, Ken; Ikegaya, Yuji; Ishikawa, Tomoe; Oba, Shigeyuki; Urakubo, Hidetoshi; Koyama, Masanori; Ishii, Shin			A Statistical Method of Identifying Interactions in Neuron-Glia Systems Based on Functional Multicell Ca2+Imaging	PLOS COMPUTATIONAL BIOLOGY			English	Article							SYNAPTIC-TRANSMISSION; PREFRONTAL CORTEX; TIME-SERIES; ASTROCYTES; CONNECTIVITY; NETWORKS; INFORMATION; SYNAPSES; BRAIN; MODULATION	Crosstalk between neurons and glia may constitute a significant part of information processing in the brain. We present a novel method of statistically identifying interactions in a neuron-glia network. We attempted to identify neuron-glia interactions from neuronal and glial activities via maximum-a-posteriori (MAP)-based parameter estimation by developing a generalized linear model (GLM) of a neuron-glia network. The interactions in our interest included functional connectivity and response functions. We evaluated the cross-validated likelihood of GLMs that resulted from the addition or removal of connections to confirm the existence of specific neuron-to-glia or glia-to-neuron connections. We only accepted addition or removal when the modification improved the cross-validated likelihood. We applied the method to a high-throughput, multicellular in vitro Ca2+ imaging dataset obtained from the CA3 region of a rat hippocampus, and then evaluated the reliability of connectivity estimates using a statistical test based on a surrogate method. Our findings based on the estimated connectivity were in good agreement with currently available physiological knowledge, suggesting our method can elucidate undiscovered functions of neuron-glia systems.	[Nakae, Ken; Oba, Shigeyuki; Urakubo, Hidetoshi; Koyama, Masanori; Ishii, Shin] Kyoto Univ, Grad Sch Informat, Integrated Syst Biol Lab, Sakyo Ku, Kyoto, Japan; [Ikegaya, Yuji; Ishikawa, Tomoe] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, Tokyo, Japan; [Ikegaya, Yuji] Ctr Informat & Neural Networks, Suita, Osaka, Japan	Nakae, K (reprint author), Kyoto Univ, Grad Sch Informat, Integrated Syst Biol Lab, Sakyo Ku, Kyoto, Japan.	ikegaya@mol.f.u-tokyo.ac.jp; ishii@i.kyoto-u.ac.jp			MEXT KAKENHI Grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan [22115012]; Strategic Research Program for Brain Sciences (SRPBS) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; CREST from Japan Science and Technology Agency, Japan	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, 'Mesoscopic neurocircuitry: towards understanding of the functional and structural basis of brain information processing' (MEXT KAKENHI Grant Number 22115012), and the Strategic Research Program for Brain Sciences (SRPBS) (http://brainprogram.mext.go.jp/missionG/), both of which are from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and partly by CREST (http://www.jst.go.jp/kisoken/crest/project/35/35_03.html) from Japan Science and Technology Agency, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Bernardinelli Y, 2011, J NEUROSCI, V31, P8905, DOI 10.1523/JNEUROSCI.6341-10.2011; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; Araque A, 1998, J NEUROSCI, V18, P6822; Haustein MD, 2014, NEURON, V82, P413, DOI 10.1016/j.neuron.2014.02.041; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Zorec R, 2012, ASN NEURO, V4, P103, DOI 10.1042/AN20110061; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3956-04.2005; Okatan M, 2005, NEURAL COMPUT, V17, P1927, DOI 10.1162/0899766054322973; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Newman EA, 2005, J NEUROSCI, V25, P5502, DOI 10.1523/JNEUROSCI.1354-05.2005; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5; Takata N, 2011, J NEUROSCI, V31, P18155, DOI 10.1523/JNEUROSCI.5289-11.2011; Stevenson IH, 2009, IEEE T NEUR SYS REH, V17, P203, DOI 10.1109/TNSRE.2008.2010471; Valdes-Sosa PA, 2011, NEUROIMAGE, V58, P339, DOI 10.1016/j.neuroimage.2011.03.058; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Ikegaya Y, 2013, CEREB CORTEX, V23, P293, DOI 10.1093/cercor/bhs006; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Lungarella M, 2007, INT J BIFURCAT CHAOS, V17, P903, DOI 10.1142/S0218127407017628; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Mishchenko Y, 2011, ANN APPL STAT, V5, P1229, DOI 10.1214/09-AOAS303; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Grun S, 2009, J NEUROPHYSIOL, V101, P1126, DOI 10.1152/jn.00093.2008; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Bushong EA, 2002, J NEUROSCI, V22, P183; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Bishop C. M., 2006, PATTERN RECOGNITION, V1; BUZSAKI G., 2009, RHYTHMS BRAIN; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Cengiz P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084294; Chen Z, 2011, IEEE T NEUR SYS REH, V19, P121, DOI 10.1109/TNSRE.2010.2086079; De Pitta M, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00098; Fields RD, 2004, SCI AM, V290, P54; Friston Karl J, 2011, Brain Connect, V1, P13, DOI 10.1089/brain.2011.0008; Gomez-Gonzalo M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000352; Granger CW, 1969, ECONOMETRICA, V85, P424; Hamilton J. D., 1994, TIME SERIES ANAL, V2; Kim S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001110; Kobayashi R, 2013, J COMPUT NEUROSCI, V85, P1; Louis S, 2010, FRONT COMPUT NEUROSC, V4; Nimmerjahn A, 2009, NEURON, V62, P400, DOI 10.1016/j.neuron.2009.03.019; Sasaki T, 2011, CEREB CORTEX, V21, P1889, DOI 10.1093/cercor/bhq256; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; Schipke CG, 2004, GLIA, V47, P226, DOI 10.1002/glia.20029; Shepherd GM, 2004, SYNAPTIC ORG BRAIN, V4; Shimazaki H, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002385; Stetter O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002653; Stevenson IH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002775; Takahashi N, 2011, CURR PROTOC NEUROSCI, V2, P1; Takahashi N, 2007, NEUROSCI RES, V58, P219, DOI 10.1016/j.neures.2007.03.001; Wahba G, 1990, SPLINE MODELS OBSERV; Wright S. J., 1999, NUMERICAL OPTIMIZATI, V2; Zhang Q, 2005, J NEURAL TRANSM, V112, P121, DOI 10.1007/s00702-004-0119-x; Zhao MY, 2012, J COMPUT NEUROSCI, V32, P479, DOI 10.1007/s10827-011-0365-5	76	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-734X	1553-7358		PLOS COMPUT BIOL	PLoS Comput. Biol.	NOV	2014	10	11							e1003949	10.1371/journal.pcbi.1003949		16	Biochemical Research Methods; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Mathematical & Computational Biology	AU2NE	WOS:000345454400030		
J	Maekawa, H; Kaneko, Y				Maekawa, Hiromi; Kaneko, Yoshinobu			Inversion of the Chromosomal Region between Two Mating Type Loci Switches the Mating Type in Hansenula polymorpha	PLOS GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; KLUYVEROMYCES-LACTIS; TRANSCRIPTION FACTOR; FACTOR RECEPTOR; FISSION YEAST; GENE ENCODES; LIFE-STYLE; EVOLUTION; EXPRESSION; PHEROMONE	Yeast mating type is determined by the genotype at the mating type locus (MAT). In homothallic (self-fertile) Saccharomycotina such as Saccharomyces cerevisiae and Kluveromyces lactis, high-efficiency switching between a and alpha mating types enables mating. Two silent mating type cassettes, in addition to an active MAT locus, are essential components of the mating type switching mechanism. In this study, we investigated the structure and functions of mating type genes in H. polymorpha (also designated as Ogataea polymorpha). The H. polymorpha genome was found to harbor two MAT loci, MAT1 and MAT2, that are similar to 18 kb apart on the same chromosome. MAT1-encoded alpha 1 specifies alpha cell identity, whereas none of the mating type genes were required for a identity and mating. MAT1-encoded alpha 2 and MAT2-encoded a1 were, however, essential for meiosis. When present in the location next to SLA2 and SUI1 genes, MAT1 or MAT2 was transcriptionally active, while the other was repressed. An inversion of the MAT intervening region was induced by nutrient limitation, resulting in the swapping of the chromosomal locations of two MAT loci, and hence switching of mating type identity. Inversion-deficient mutants exhibited severe defects only in mating with each other, suggesting that this inversion is the mechanism of mating type switching and homothallism. This chromosomal inversion-based mechanism represents a novel form of mating type switching that requires only two MAT loci.	[Maekawa, Hiromi; Kaneko, Yoshinobu] Osaka Univ, Grad Sch Engn, Yeast Genet Resources Lab, Osaka, Japan	Maekawa, H (reprint author), Osaka Univ, Grad Sch Engn, Yeast Genet Resources Lab, Osaka, Japan.	hmaekawa@bio.eng.osaka-u.ac.jp			Institute Fermentation, Osaka, Japan (IFO); Ministry of Education, Culture, Sports, Science and Technology of Japan	The work was financially supported by Institute Fermentation, Osaka, Japan (IFO). It was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to HM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews BJ, 1985, CELL, V40, P759; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Barsoum E, 2011, EUKARYOT CELL, V10, P1545, DOI 10.1128/EC.05158-11; Saraya R, 2012, FEMS YEAST RES, V12, P271, DOI 10.1111/j.1567-1364.2011.00772.x; Lu SF, 2000, APPL MICROBIOL BIOT, V54, P499, DOI 10.1007/s002530000369; HABER JE, 1979, GENETICS, V93, P13; HERMAN A, 1966, GENETICS, V53, P727; RINE J, 1987, GENETICS, V116, P9; TODA T, 1991, GENE DEV, V5, P60, DOI 10.1101/gad.5.1.60; Reedy JL, 2009, CURR BIOL, V19, P891, DOI 10.1016/j.cub.2009.04.058; Jones SK, 2011, FUNGAL GENET BIOL, V48, P668, DOI 10.1016/j.fgb.2011.04.001; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; FABER KN, 1994, CURR GENET, V25, P305, DOI 10.1007/BF00351482; Astrom SU, 1998, GENETICS, V148, P1021; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Barsoum E, 2010, GENE DEV, V24, P33, DOI 10.1101/gad.557310; RINE J, 1979, GENETICS, V93, P877; NAKAYAMA N, 1987, EMBO J, V6, P249; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Raudaskoski M, 2010, EUKARYOT CELL, V9, P847, DOI 10.1128/EC.00319-09; HICKS JB, 1977, GENETICS, V85, P373; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Kiel JAKW, 2007, FEMS YEAST RES, V7, P1114, DOI 10.1111/j.1567-1364.2007.00232.x; LORENTZ A, 1994, GENE, V143, P139, DOI 10.1016/0378-1119(94)90619-X; SILVERMAN M, 1980, CELL, V19, P845, DOI 10.1016/0092-8674(80)90075-6; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Yun SH, 2000, FUNGAL GENET BIOL, V31, P7, DOI 10.1006/fgbi.2000.1226; Arcangioli B, 2004, MOL BIOL SCHIZOSACCH, P129, DOI 10.1007/978-3-662-10360-9_9.; BURKHOLDER AC, 1985, NUCLEIC ACIDS RES, V13, P8463, DOI 10.1093/nar/13.23.8463; Chitrampalam P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056895; HAGEN DC, 1986, P NATL ACAD SCI USA, V83, P1418, DOI 10.1073/pnas.83.5.1418; Hansen H, 1996, NONCONVENTIONAL YEAS, P293, DOI 10.1007/978-3-642-79856-6_9.; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Hickman MA, 2010, P NATL ACAD SCI USA, V107, P19384, DOI 10.1073/pnas.1006436107; KITAMURA K, 1991, EMBO J, V10, P3743; Klar AJS, 1979, GENETICS, P759; Lahtchev K, 2002, HANSENULA POLYMORPHA: BIOLOGY AND APPLICATIONS, P8; Merlini L, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130008; Poggeler S, 2007, SEX IN FUNGI: MOLECULAR DETERMINATION AND EVOLUTIONARY IMPLICATIONS, P171; Ravin NV, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-837; Sambrook J., 2001, MOL CLONING; Sangwallek J, 2013, ARCH MICROBIOL, V195, P843, DOI 10.1007/s00203-013-0933-3; [Anonymous], 1991, METHOD ENZYMOL; Sherwood RK, 2014, NATURE, V506, P387, DOI 10.1038/nature12891; TANAKA K, 1993, MOL CELL BIOL, V13, P80; van Zutphen T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-1; Yun SH, 1999, P NATL ACAD SCI USA, V96, P5592, DOI 10.1073/pnas.96.10.5592	47	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	NOV	2014	10	11							e1004796	10.1371/journal.pgen.1004796		13	Genetics & Heredity	Genetics & Heredity	AU2NL	WOS:000345455200039		
J	Kaido, M; Abe, K; Mine, A; Hyodo, K; Taniguchi, T; Taniguchi, H; Mise, K; Okuno, T				Kaido, Masanori; Abe, Kazutomo; Mine, Akira; Hyodo, Kiwamu; Taniguchi, Takako; Taniguchi, Hisaaki; Mise, Kazuyuki; Okuno, Tetsuro			GAPDH-A Recruits a Plant Virus Movement Protein to Cortical Virus Replication Complexes to Facilitate Viral Cell-to-Cell Movement	PLOS PATHOGENS			English	Article							NECROTIC-MOSAIC-VIRUS; CHLOROPLAST PHOSPHOGLYCERATE KINASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ENDOPLASMIC-RETICULUM; RNA REPLICATION; INTRACELLULAR-TRANSPORT; INTERCELLULAR MOVEMENT; NICOTIANA-BENTHAMIANA; TRANSGENIC TOBACCO; SATELLITE RNA	The formation of virus movement protein (MP)-containing punctate structures on the cortical endoplasmic reticulum is required for efficient intercellular movement of Red clover necrotic mosaic virus (RCNMV), a bipartite positive-strand RNA plant virus. We found that these cortical punctate structures constitute a viral replication complex (VRC) in addition to the previously reported aggregate structures that formed adjacent to the nucleus. We identified host proteins that interacted with RCNMV MP in virus-infected Nicotiana benthamiana leaves using a tandem affinity purification method followed by mass spectrometry. One of these host proteins was glyceraldehyde 3-phosphate dehydrogenase-A (NbGAPDH-A), which is a component of the Calvin-Benson cycle in chloroplasts. Virus-induced gene silencing of NbGAPDH-A reduced RCNMV multiplication in the inoculated leaves, but not in the single cells, thereby suggesting that GAPDH-A plays a positive role in cell-to-cell movement of RCNMV. The fusion protein of NbGAPDH-A and green fluorescent protein localized exclusively to the chloroplasts. In the presence of RCNMV RNA1, however, the protein localized to the cortical VRC as well as the chloroplasts. Bimolecular fluorescence complementation assay and GST pulldown assay confirmed in vivo and in vitro interactions, respectively, between the MP and NbGAPDH-A. Furthermore, gene silencing of NbGAPDH-A inhibited MP localization to the cortical VRC. We discuss the possible roles of NbGAPDH-A in the RCNMV movement process.	[Kaido, Masanori; Abe, Kazutomo; Mine, Akira; Hyodo, Kiwamu; Mise, Kazuyuki; Okuno, Tetsuro] Kyoto Univ, Grad Sch Agr, Plant Pathol Lab, Kyoto, Japan; [Taniguchi, Takako; Taniguchi, Hisaaki] Univ Tokushima, Inst Enzyme Res, Tokushima 770, Japan	Kaido, M (reprint author), Kyoto Univ, Grad Sch Agr, Plant Pathol Lab, Kyoto, Japan.	kaido@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science [22580047, 25450058]	This study was supported in part by a Grant-in-Aid (22580047) for Scientific Research C and a Grant-in-Aid (25450058) for Scientific Research C from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Wang RYL, 2008, CELL HOST MICROBE, V3, P178, DOI 10.1016/j.chom.2008.02.005; Huang YW, 2012, CURR OPIN VIROL, V2, P676, DOI 10.1016/j.coviro.2012.10.002; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; HAMAMOTO H, 1993, BIO-TECHNOL, V11, P930, DOI 10.1038/nbt0893-930; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Sambade A, 2008, TRAFFIC, V9, P2073, DOI 10.1111/j.1600-0854.2008.00824.x; Lin SS, 2000, VIROLOGY, V271, P46, DOI 10.1006/viro.2000.0302; Schoelz JE, 2011, MOL PLANT, V4, P813, DOI 10.1093/mp/ssr070; Cheng SF, 2013, PLANT PHYSIOL, V163, P1598, DOI 10.1104/pp.113.229666; PRICE GD, 1995, PLANTA, V195, P369; Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12; Igarashi A, 2009, VIROLOGY, V386, P407, DOI 10.1016/j.virol.2009.01.039; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Tilsner J, 2012, CURR OPIN VIROL, V2, P705, DOI 10.1016/j.coviro.2012.09.007; Tilsner J, 2013, J CELL BIOL, V201, P981, DOI 10.1083/jcb.201304003; Harries PA, 2010, MOL PLANT MICROBE IN, V23, P1381, DOI 10.1094/MPMI-05-10-0121; Bamunusinghe D, 2009, VIROLOGY, V393, P272, DOI 10.1016/j.virol.2009.08.002; Laliberte JF, 2010, ANNU REV PHYTOPATHOL, V48, P69, DOI 10.1146/annurev-phyto-073009-114239; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49; den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012; Li JF, 2013, PLANT CELL, V25, P1507, DOI 10.1105/tpc.113.112235; Lucas WJ, 2006, VIROLOGY, V344, P169, DOI 10.1016/j.virol.2005.09.026; Figge RM, 1999, MOL BIOL EVOL, V16, P429; Choi SH, 2012, J VIROL, V86, P4823, DOI 10.1128/JVI.00018-12; Harries PA, 2009, P NATL ACAD SCI USA, V106, P17594, DOI 10.1073/pnas.0909239106; Ueki S, 2011, MOL PLANT, V4, P782, DOI 10.1093/mp/ssr060; Mine A, 2012, CURR OPIN VIROL, V2, P669, DOI 10.1016/j.coviro.2012.09.014; Tilsner J, 2012, PLANT PHYSIOL, V158, P1359, DOI 10.1104/pp.111.189605; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Bhat S, 2013, PLANT PHYSIOL, V161, P134, DOI 10.1104/pp.112.207860; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Boyko V, 2007, PLANT J, V51, P589, DOI 10.1111/j.1365-313X.2007.03163.x; Christensen N, 2009, TRAFFIC, V10, P536, DOI 10.1111/j.1600-0854.2009.00889.x; Dohi K, 2001, ARCH VIROL, V146, P1607, DOI 10.1007/s007050170082; FUJIWARA T, 1993, PLANT CELL, V5, P1783; GIESMANCOOKMEYER D, 1993, PLANT CELL, V5, P973; Heinlein M, 1998, PLANT CELL, V10, P1107; Hyodo K, 2014, J GEN PLANT PATHOL, V80, P123, DOI 10.1007/s10327-014-0505-7; Hyodo K, 2013, J VIROL, V87, P163, DOI 10.1128/JVI.02383-12; Iwakawa H, 2011, J VIROL, V85, P497, DOI 10.1128/JVI.01754-10; JOSHI S, 1983, VIROLOGY, V127, P100, DOI 10.1016/0042-6822(83)90375-6; Kaido Masanori, 1997, Annals of the Phytopathological Society of Japan, V63, P95; Kaido M, 2011, VIROLOGY, V413, P205, DOI 10.1016/j.virol.2011.02.008; Kaido M, 2009, VIROLOGY, V395, P232, DOI 10.1016/j.virol.2009.09.022; Kawai T, 2014, J JPN SOC HORTIC SCI, V83, P23, DOI 10.2503/jjshs1.CH-091; Kawakami S, 2004, P NATL ACAD SCI USA, V101, P6291, DOI 10.1073/pnas.0401221101; Kusumanegara K, 2012, VIROLOGY, V433, P131, DOI 10.1016/j.virol.2012.07.017; Lin JW, 2007, NUCLEIC ACIDS RES, V35, P424, DOI 10.1093/nar/gkl1061; Liu Chengke, 2013, Front Plant Sci, V4, P12, DOI 10.3389/fpls.2013.00012; Liu JZ, 2005, PLANT PHYSIOL, V138, P1853, DOI 10.1104/pp.105.065722; LOMMEL SA, 1988, NUCLEIC ACIDS RES, V16, P8587, DOI 10.1093/nar/16.17.8587; MESHI T, 1987, EMBO J, V6, P2557; Michelet L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00470; Mine A, 2012, J VIROL, V86, P12091, DOI 10.1128/JVI.01659-12; Mine A, 2010, J VIROL, V84, P6070, DOI 10.1128/JVI.00054-10; Mine A, 2010, VIROLOGY, V407, P213, DOI 10.1016/j.virol.2010.07.038; Mizumoto H, 2003, J VIROL, V77, P12113, DOI 10.1128/JVI.77.22.12113-12121.2003; Mizumoto H, 2006, J VIROL, V80, P3781, DOI 10.1128/JVI.80.8.3781-3791.2006; NavasCastillo J, 1997, VIROLOGY, V228, P92, DOI 10.1006/viro.1996.8369; Niehl A, 2011, PROTOPLASMA, V248, P75, DOI 10.1007/s00709-010-0246-1; Okamoto K, 2008, VIROLOGY, V375, P205, DOI 10.1016/j.virol.2008.02.004; Okuno T, 2013, ADV VIRUS RES, V87, P36; OSMAN TAM, 1992, J GEN VIROL, V73, P223, DOI 10.1099/0022-1317-73-2-223; Prasanth KR, 2011, J VIROL, V85, P8829, DOI 10.1128/JVI.00556-11; SHIH MC, 1986, CELL, V47, P73, DOI 10.1016/0092-8674(86)90367-3; Sit TL, 1998, SCIENCE, V281, P829, DOI 10.1126/science.281.5378.829; Szecsi J, 1999, MOL PLANT MICROBE IN, V12, P143, DOI 10.1094/MPMI.1999.12.2.143; Takeda A, 2005, EMBO J, V24, P3147, DOI 10.1038/sj.emboj.7600776; Tamai A, 2001, MOL PLANT MICROBE IN, V14, P126, DOI 10.1094/MPMI.2001.14.2.126; Tatsuta M, 2005, J VIROL, V79, P978, DOI 10.1128/JVI.79.2.978-986.2005; Tremblay D, 2005, VIROLOGY, V333, P10, DOI 10.1016/j.virol.2004.12.019; Turner KA, 2004, VIROLOGY, V320, P276, DOI 10.1016/j.virol.2003.12.006; Waigmann E, 2004, CRIT REV PLANT SCI, V23, P195, DOI 10.1080/07352680452807; WATANABE Y, 1984, VIROLOGY, V133, P18, DOI 10.1016/0042-6822(84)90421-5; XIONG Z, 1993, VIROLOGY, V192, P27, DOI 10.1006/viro.1993.1004; XIONG ZG, 1991, VIROLOGY, V182, P388, DOI 10.1016/0042-6822(91)90687-7	76	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7366	1553-7374		PLOS PATHOG	PLoS Pathog.	NOV	2014	10	11							e1004505	10.1371/journal.ppat.1004505		22	Microbiology; Parasitology; Virology	Microbiology; Parasitology; Virology	AU3LX	WOS:000345515800030		
J	Li, XY; Shi, JZ; Guo, J; Deng, GH; Zhang, QY; Wang, JL; He, XJ; Wang, KC; Chen, JM; Li, YY; Fan, J; Kong, HU; Gu, CY; Guan, YT; Suzuki, Y; Kawaoka, Y; Liu, LL; Jiang, YP; Tian, GB; Li, YB; Bu, ZG; Chen, HL				Li, Xuyong; Shi, Jianzhong; Guo, Jing; Deng, Guohua; Zhang, Qianyi; Wang, Jinliang; He, Xijun; Wang, Kaicheng; Chen, Jiming; Li, Yuanyuan; Fan, Jun; Kong, Huiui; Gu, Chunyang; Guan, Yuantao; Suzuki, Yasuo; Kawaoka, Yoshihiro; Liu, Liling; Jiang, Yongping; Tian, Guobin; Li, Yanbing; Bu, Zhigao; Chen, Hualan			Genetics, Receptor Binding Property, and Transmissibility in Mammals of Naturally Isolated H9N2 Avian Influenza Viruses	PLOS PATHOGENS			English	Article							RESPIRATORY DROPLET TRANSMISSION; A H7N9 VIRUS; HUMAN INFECTION; AIRBORNE TRANSMISSION; DOMESTIC POULTRY; MOLECULAR-BASIS; A/H5N1 VIRUS; HONG-KONG; H5N1; CHINA	H9N2 subtype influenza viruses have been detected in different species of wild birds and domestic poultry in many countries for several decades. Because these viruses are of low pathogenicity in poultry, their eradication is not a priority for animal disease control in many countries, which has allowed them to continue to evolve and spread. Here, we characterized the genetic variation, receptor-binding specificity, replication capability, and transmission in mammals of a series of H9N2 influenza viruses that were detected in live poultry markets in southern China between 2009 and 2013. Thirty-five viruses represented 17 genotypes on the basis of genomic diversity, and one specific "internal-gene-combination'' predominated among the H9N2 viruses. This gene combination was also present in the H7N9 and H10N8 viruses that have infected humans in China. All of the 35 viruses preferentially bound to the human-like receptor, although two also retained the ability to bind to the avian-like receptor. Six of nine viruses tested were transmissible in ferrets by respiratory droplet; two were highly transmissible. Some H9N2 viruses readily acquired the 627K or 701N mutation in their PB2 gene upon infection of ferrets, further enhancing their virulence and transmission in mammals. Our study indicates that the widespread dissemination of H9N2 viruses poses a threat to human health not only because of the potential of these viruses to cause an influenza pandemic, but also because they can function as "vehicles'' to deliver different subtypes of influenza viruses from avian species to humans.	[Li, Xuyong; Shi, Jianzhong; Guo, Jing; Deng, Guohua; Zhang, Qianyi; Wang, Jinliang; He, Xijun; Li, Yuanyuan; Fan, Jun; Kong, Huiui; Gu, Chunyang; Guan, Yuantao; Liu, Liling; Jiang, Yongping; Tian, Guobin; Li, Yanbing; Bu, Zhigao; Chen, Hualan] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Li, Xuyong; Guo, Jing] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China; [Wang, Kaicheng; Chen, Jiming] China Anim Hlth & Epidemiol Ctr, Lab Avian Dis Surveillance, Qingdao, Peoples R China; [Suzuki, Yasuo] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 487, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Japan	Chen, HL (reprint author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	chenhualan@caas.cn			China Agriculture Research System [CARS-42-G08]; Ministry of Science and Technology [2012ZX10004214]	This work was supported by the China Agriculture Research System (CARS-42-G08), by the Ministry of Science and Technology (2012ZX10004214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Zhang PH, 2009, J VIROL, V83, P8428, DOI 10.1128/JVI.00659-09; Govorkova EA, 2001, ANTIMICROB AGENTS CH, V45, P2723, DOI 10.1128/AAC.45.10.2723-2732.2001; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; Fan SF, 2009, VIROLOGY, V384, P28, DOI 10.1016/j.virol.2008.11.044; Yu H, 2008, VET MICROBIOL, V131, P82, DOI 10.1016/j.vetmic.2008.02.024; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; BEAN WJ, 1989, J INFECT DIS, V159, P1050; Vines A, 1998, J VIROL, V72, P7626; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Li J, 2011, J GEN VIROL, V92, P1435, DOI 10.1099/vir.0.030718-0; Smeenk CA, 1996, VIRUS RES, V44, P79, DOI 10.1016/0168-1702(96)01329-9; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Zhang H, 2014, J GEN VIROL, V95, P779, DOI 10.1099/vir.0.061721-0; Sun YP, 2011, P NATL ACAD SCI USA, V108, P4164, DOI 10.1073/pnas.1019109108; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Blair PJ, 2013, J INFECT PUBLIC HEAL, V6, P69, DOI 10.1016/j.jiph.2012.11.005; [Anonymous], 2014, CUM NUMB CONF HUM CA; Zhang Y, 2012, J VIROL, V86, P9666, DOI 10.1128/JVI.00958-12; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Coman A, 2013, J INFECT PUBLIC HEAL, V6, P438, DOI 10.1016/j.jiph.2013.05.003; Deng GH, 2013, J VIROL, V87, P9452, DOI 10.1128/JVI.00776-13; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Mok CKP, 2014, J VIROL, V88, P3568, DOI 10.1128/JVI.02740-13; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Wang GJ, 2014, J VIROL, V88, P3953, DOI 10.1128/JVI.03292-13; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Yuan J, 2013, CLIN INFECT DIS, V57, P1367, DOI 10.1093/cid/cit479; Okoye J, 2013, J MED VIROL, V85, P670, DOI 10.1002/jmv.23520; CDC, 2012, H5N1 GEN CHANG INV T; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Gillim-Ross L, 2008, J VIROL, V82, P10854, DOI 10.1128/JVI.01206-08; Gray GC, 2011, J CLIN VIROL, V51, P132, DOI 10.1016/j.jcv.2011.03.011; HOMME PJ, 1970, AVIAN DIS, V14, P240, DOI 10.2307/1588468; Lin Z, 2014, ARCH VIROL, P2575; Linster M, 2014, CELL, V157, P329, DOI 10.1016/j.cell.2014.02.040; Lu XH, 2001, J VIROL, V75, P4896, DOI 10.1128/JVI.75.10.4896-4901.2001; Nam JH, 2011, J VIROL, V85, P13271, DOI 10.1128/JVI.05038-11; Pawar SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036374; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Uyeki TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043948; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wang Q, 2014, SEROLOGICAL VIROLOGI; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; World Health Organization, 2014, CONF HUM CAS AV INFL; World Health Organization, 2014, INFL HUM AN INT; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015	64	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7366	1553-7374		PLOS PATHOG	PLoS Pathog.	NOV	2014	10	11							e1004508	10.1371/journal.ppat.1004508		12	Microbiology; Parasitology; Virology	Microbiology; Parasitology; Virology	AU3LX	WOS:000345515800031		
J	Izumi, S; Saitoh, E				Izumi, Shin-ichi; Saitoh, Eiichi			A Brief History and International Perspective of the Japanese Association of Rehabilitation Medicine: The 50th Anniversary in 2013	PM&R			English	Editorial Material									[Izumi, Shin-ichi] Tohoku Univ, Grad Sch Med, Dept Phys Med & Rehabil, Tohoku, Japan; [Saitoh, Eiichi] Fujita Hlth Univ, Sch Med, Dept Rehabil Med, Fujita, Japan	Izumi, S (reprint author), Tohoku Univ, Grad Sch Med, Dept Phys Med & Rehabil, Tohoku, Japan.	izumis@med.tohoku.ac.jp					Izumi S, 2005, JPN J REHABIL MED, V42, P199; World Health Organization, 2001, INT CLASS FUNCT DIS	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	NOV	2014	6	11					1044	1047		10.1016/j.pmrj.2014.10.002		4	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AU4YJ	WOS:000345614000012		
J	Takebayashi, T; Amano, S; Hanada, K; Umeji, A; Takahashi, K; Koyama, T; Domen, K				Takebayashi, Takashi; Amano, Satoru; Hanada, Keisuke; Umeji, Atsushi; Takahashi, Kayoko; Koyama, Tetsuo; Domen, Kazuhisa			Therapeutic Synergism in the Treatment of Post-stroke Arm Paresis Utilizing Botulinum Toxin, Robotic Therapy, and Constraint-induced Movement Therapy	PM&R			English	Article							UPPER-LIMB; STROKE; PATIENT	Botulinum toxin type A (BtxA) injection, constraint-induced movement therapy (CIMT), and robotic therapy (RT) each represent promising approaches to enhance arm motor recovery after stroke. To provide more effective treatment for a 50-year-old man with severe left spastic hemiparesis, we attempted to facilitate CIMT with adaptive approaches to extend the wrist and fingers using RT for 10 consecutive weeks after BtxA injection. This combined treatment resulted in substantial improvements in arm function and the amount of arm use in activities of daily living, and may be effective for stroke patients with severe arm paresis. However, we were unable to sufficiently prove the efficacy of combined treatment based only on a single case. To fully elucidate the efficacy of the combined approach for patients with severe hemiparesis after stroke, future studies of a larger number of patients are needed.	[Takebayashi, Takashi; Amano, Satoru; Hanada, Keisuke; Umeji, Atsushi] Hosp Hyogo, Coll Med, Dept Rehabil, Nishinomiya, Hyogo 6638501, Japan; [Takahashi, Kayoko] Kitasato Univ, Dept Allied Hlth Sci, Sagamihara, Kanagawa 228, Japan; [Koyama, Tetsuo] Nishinomiya Kyoritsu Neurosurg Hosp, Dept Rehabil Med, Nishinomiya, Hyogo, Japan; [Domen, Kazuhisa] Hyogo Coll Med, Dept Rehabil Med, Nishinomiya, Hyogo 6638501, Japan	Takebayashi, T (reprint author), Hosp Hyogo, Coll Med, Dept Rehabil, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	takshi77@hyo-med.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [23300203]	This work was supported in part by a Grant-in-Aid for Scientific Research (B), Japan Society for the Promotion of Science (KAKENHI [23300203]).	DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Lang CE, 2008, ARCH PHYS MED REHAB, V89, P1693, DOI 10.1016/j.apmr.2008.02.022; Miller EL, 2010, STROKE, V41, P2402, DOI 10.1161/STR.0b013e3181e7512b; Feys HM, 1998, STROKE, V29, P785; Wolf SL, 2001, STROKE, V32, P1635; van der Lee JH, 2004, STROKE, V35, P1410, DOI 10.1161/01.STR.0000126900.24964.7e; Taub E, 2013, ARCH PHYS MED REHAB, V94, P86, DOI 10.1016/j.apmr.2012.07.029; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Bohannon R. W., 1987, PHYS THER, V67, P206; Heieh YW, 2012, STROKE, V43, P2729; Kagawa S, 2013, J STROKE CEREBROVASC, V22, P364, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.021; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Morris D M, 2006, Eura Medicophys, V42, P257; Mehrholz J, 2008, COCHRANE DATABASE SY, V4; Muraoka Yoshihiro, 2002, Frontiers of Medical and Biological Engineering, V11, P323; ROBBINS-THOMSON S, 1992, European Journal of Plastic Surgery, V15, P144; Sun SF, 2010, NEUROREHAB NEURAL RE, V24, P34, DOI 10.1177/1545968309341060; Takebayashi T, 2013, CLIN REHABIL, V27, P318; Tumer- Stokes L, 2002, CONCISE GUIDANCE GOO	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	NOV	2014	6	11					1054	1058		10.1016/j.pmrj.2014.04.014		5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AU4YJ	WOS:000345614000014		
J	Tadano, T; Zhu, R; Suzuki, S; Hoshi, T; Sasaki, D; Hagiwara, T; Sawaguchi, T				Tadano, Tsuyoshi; Zhu, Rui; Suzuki, Shota; Hoshi, Toru; Sasaki, Daisuke; Hagiwara, Toshiki; Sawaguchi, Takashi			Thermal degradation of transparent poly(methyl methacrylate)/silica nanoparticle hybrid films	POLYMER DEGRADATION AND STABILITY			English	Article						Thermal degradation; Silica; Poly(methyl methacrylate); Nanoparticle	POLYMER NANOCOMPOSITES	Using thermogravimetric (TG/DTG) analysis, we evaluated the thermal degradation characteristics of transparent poly(methyl methacrylate) (PMMA)/silica nanoparticle hybrid films obtained by well dispersing surface-unmodified silica (SiO2) nanoparticles, of average particle size approximately 15 nm, in poly(methyl methacrylate), of weight-average molecular weight (M-w) 9.6 x 10(4) as synthesized by radical solution polymerization of methyl methacrylate (MMA). The TG/DTG curve of a secondary aggregated opaque hybrid film, comprising SiO2 nanoparticles of size greater than several hundreds of nanometers, was in substantial agreement with that of pure PMMA. What was surprising, however, was that in the transparent hybrid, weight reduction due to cleavage of head-to-head bonds in PMMA occurring around 200 degrees C was nearly completely absent, and DTG peaks originating from cleavage of head-to-tail bonds and allylic-position cleavage of terminal vinylidene double bonds increased. These thermal degradation behaviors can be explained by the hypothesis of a specific chemical reaction between tertiary terminal macroradicals produced by cleavage of head-to-head bonds and silanol (SiOH) on the SiO2 nanoparticle surface. (C) 2014 Elsevier Ltd. All rights reserved.	[Tadano, Tsuyoshi] NIKICA SEIKO CO LTD, Setagaya Ku, Tokyo 1540003, Japan; [Zhu, Rui; Suzuki, Shota] Nihon Univ, Grad Sch Sci & Technol, Dept Mat & Appl Chem, Chiyoda Ku, Tokyo 1018308, Japan; [Hoshi, Toru; Sasaki, Daisuke; Hagiwara, Toshiki; Sawaguchi, Takashi] Nihon Univ, Dept Mat & Appl Chem, Coll Sci & Technol, Chiyoda Ku, Tokyo 1018308, Japan	Sawaguchi, T (reprint author), Nihon Univ, Dept Mat & Appl Chem, Coll Sci & Technol, Chiyoda Ku, 1-8-14 Kandasurugadai, Tokyo 1018308, Japan.	t-tadano@nikkaseiko.co.jp; sawaguchi.takashi@nihon-u.ac.jp					Jancar J, 2010, POLYMER, V51, P3321, DOI 10.1016/j.polymer.2010.04.074; ASAKURA S, 1954, J CHEM PHYS, V22, P1255; KASHIWAGI T, 1986, MACROMOLECULES, V19, P2160, DOI 10.1021/ma00162a010; Tadano T, 2014, CHEM LETT, V43, P705, DOI 10.1246/cl.140049; Meth JS, 2011, MACROMOLECULES, V44, P8301, DOI 10.1021/ma201714u; Vaia RA, 2007, CHEM MATER, V19, P2736, DOI 10.1021/cm062693+; Tadano T, 2014, POLYM J, V46, P342, DOI 10.1038/pj.2014.6; ASAKURA S, 1958, J POLYM SCI, V33, P183, DOI 10.1002/pol.1958.1203312618; Bhattachaya SN, 2008, POLYM NANOCOMPOSITES; Tadano T, 2014, POLYM UNPUB; Thuzyo K., 1965, KOLLOID Z Z POLYM, V201, P66	11	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	NOV	2014	109				SI		7	12		10.1016/j.polymdegradstab.2014.06.009		6	Polymer Science	Polymer Science	AU2UM	WOS:000345472900002		
J	Kiuchi, Y; Iji, M; Yanagisawa, T; Shukichi, T				Kiuchi, Yukihiro; Iji, Masatoshi; Yanagisawa, Tsunenori; Shukichi, Tanaka			Flame-retarding polylactic-acid composite formed by dual use of aluminum hydroxide and phenol resin	POLYMER DEGRADATION AND STABILITY			English	Article						Flame retardancy; Polylactic acid; Aluminum hydroxide; Phenol novolac resin; Tr-phenol methane resin	CRYSTALLIZATION KINETICS; FLAMMABILITY PROPERTIES; DEGRADATION; POLYMERS; NOVOLAC	Flame retardancy of polylactic acid (PLA) was improved by dual use of aluminum hydroxide (AH) and phenol resin as safe flame retardants to allow PLA to be widely applied in durable products including electronic devices. Adding more than 50 weight-percent (wt%) of a specific AH which contains a low concentration of alkali elements sufficiently improved the flame retardancy of PLA. However, other important characteristics of the resulting PLA composites, such as flexural strength and fluidity, were decreased owing to the high concentration of AH. On the other hand, the simultaneous addition of phenol resins (including phenol novolac resin and tri-phenol methane resin) and the specific AH improved the flame retardancy of the PLA composites. This enhancement effect on flame retardancy, which was mainly due to the formation of homogeneous char layers produced by the phenol resins on the surface of the PLA composites during combustion, permitted the specific AH concentration to be reduced, thereby improving these characteristics of the composites. In particular, a high-molecular-weight phenol novolac resin (HMw PN resin) showed highly flame-retarding effect. While using phenol resins adversely affected the action of an organic crystalline nucleus agent for PLA, the use of HMw PN resin improved the problem because its concentration in the PLA composite was reduced due to its highly flame-retarding effect. (C) 2013 Elsevier Ltd. All rights reserved.	[Kiuchi, Yukihiro; Iji, Masatoshi; Yanagisawa, Tsunenori; Shukichi, Tanaka] NEC Corp Ltd, Smart Energy Res Labs, Tsukuba, Ibaraki 3058501, Japan	Kiuchi, Y (reprint author), NEC Corp Ltd, Smart Energy Res Labs, 34 Miyukigaoka, Tsukuba, Ibaraki 3058501, Japan.	qti@da.jp.nec.com					FISCHER EW, 1973, KOLLOID Z Z POLYM, V251, P980, DOI 10.1007/BF01498927; Kolstad JJ, 1996, J APPL POLYM SCI, V62, P1079, DOI 10.1002/(SICI)1097-4628(19961114)62:7<1079::AID-APP14>3.0.CO;2-1; MAKINO K, 1985, CHEM PHARM BULL, V33, P1195; Nam JY, 2006, POLYMER, V47, P1340, DOI 10.1016/j.polymer.2005.12.066; Kimura K, 2005, FUJITSU SCI TECH J, V41, P173; Serizawa S, 2006, J APPL POLYM SCI, V100, P618, DOI 10.1002/app.23377; OUCHI K, 1966, CARBON, V4, P59, DOI 10.1016/0008-6223(66)90009-1; VANKREVELEN DW, 1975, POLYMER, V16, P615, DOI 10.1016/0032-3861(75)90157-3; BALLISTRERI A, 1988, J POLYM SCI POL CHEM, V26, P2113, DOI 10.1002/pola.1988.080260810; Canaud C, 2001, MACROMOL MATER ENG, V286, P377, DOI 10.1002/1439-2054(20010701)286:7<377::AID-MAME377>3.0.CO;2-S; Liu MF, 2011, POLYMER, V52, P3092, DOI 10.1016/j.polymer.2011.05.001; Iji M, 2004, J MATER SCI-MATER EL, V15, P175, DOI 10.1023/B:JMSE.0000011358.70618.00; Lee K, 2003, POLYM DEGRAD STABIL, V81, P173, DOI 10.1016/S0141-3910(03)00087-9; MARCHAL A, 1994, POLYM DEGRAD STABIL, V44, P263, DOI 10.1016/0141-3910(94)90088-4; STINSON JM, 1995, J VINYL ADDIT TECHN, V1, P94; Tsuji H, 1999, EDITORIAL ADVISORY B, V4, P27; Vink Erwin TH, 2010, IND BIOTECHNOLOGY, V6, P212; Weil ED, 1998, J FIRE SCI, V16, P383, DOI 10.1177/073490419801600505	18	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	NOV	2014	109				SI		336	342		10.1016/j.polymdegradstab.2013.05.013		7	Polymer Science	Polymer Science	AU2UM	WOS:000345472900040		
J	Han, WJ; Xin, YR; Hasegawa, U; Uyama, H				Han, Wenjuan; Xin, Yuanrong; Hasegawa, Urara; Uyama, Hiroshi			Enzyme immobilization on polymethacrylate-based monolith fabricated via thermally induced phase separation	POLYMER DEGRADATION AND STABILITY			English	Article						Immobilized enzyme; Monolith; Thermally induced phase separation; Horseradish peroxidase; Polymethacrylate	HORSERADISH-PEROXIDASE; RADICAL POLYMERIZATION; P-CHLOROPHENOL; POROUS SILICON; NANOPARTICLES; SUPPORT; BIOCATALYSIS; SCAFFOLDS; REMOVAL; PERFORMANCE	Polymer-based monolithic materials with interconnected porous structure have received much attention as high-performance matrices for enzyme immobilization. The present work describes immobilization of horseradish peroxidase (HRP) onto a polymethacrylate-based monolith which was fabricated by thermally induced phase separation (TIPS) method. The poly(glycidyl methacrylate-co-methyl methacrylate) (PGM) monolith was modified with adipic acid dihydrazide (AADH) and ethylenediaminetetraacetic dianhydride (EDTAD) to yield carboxyl group-bearing PGM (PGM-COOH) monolith. This monolith was reacted with N-hydroxysuccinimide (NHS) to activate the carboxyl groups on the monolith and further modified with HRP. The immobilized HRP showed much higher thermal stability than the free one. Furthermore, the immobilized HRP could be reused for at least 6 times with the remaining activity of 52%. The PGM monolith may have a high potential as a solid support for enzyme immobilization. (C) 2014 Elsevier Ltd. All rights reserved.	[Han, Wenjuan; Xin, Yuanrong; Hasegawa, Urara; Uyama, Hiroshi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Hasegawa, Urara] Osaka Univ, Grad Sch Engn, Frontier Res Base Global Young Researchers, Suita, Osaka 5650871, Japan	Uyama, H (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	uyama@chem.eng.osaka-u.ac.jp			Japan Society for the Promotion of Science [21350124]; Project for Creating Start-ups from Advanced Research and Technology, MEXT	This study is financially supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 21350124) and a Project for Creating Start-ups from Advanced Research and Technology, MEXT.	Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Li JH, 2009, POLYMER, V50, P1526, DOI 10.1016/j.polymer.2009.01.049; Wu LL, 2005, J MEMBRANE SCI, V250, P167, DOI 10.1016/j.memsci.2004.10.024; Pierre SJ, 2006, ADV MATER, V18, P1822, DOI 10.1002/adma.200600293; Zhang F, 2010, J PHYS CHEM C, V114, P8469, DOI 10.1021/jp101073b; Zou YJ, 2008, BIOSENS BIOELECTRON, V23, P1010, DOI 10.1016/j.bios.2007.10.009; NAKAMOTO S, 1992, WATER RES, V26, P49, DOI 10.1016/0043-1354(92)90110-P; Wan Y, 2008, CHEM MATER, V20, P932, DOI 10.1021/cm7024125; Nandi M, 2014, RSC ADV, V4, P20847, DOI 10.1039/c4ra02057j; Yoneda S, 2014, POLYMER, V55, P3212, DOI 10.1016/j.polymer.2014.05.031; Monzo A, 2009, TRAC-TREND ANAL CHEM, V28, P854, DOI 10.1016/j.trac.2009.03.002; Wan Y, 2008, POLYM DEGRAD STABIL, V93, P1736, DOI 10.1016/j.polymdegradstab.2008.08.001; Bornscheuer UT, 2003, ANGEW CHEM INT EDIT, V42, P3336, DOI 10.1002/anie.200301554; Taqieddin E, 2004, BIOMATERIALS, V25, P1937, DOI 10.1016/j.biomaterials.2003.08.034; Nordborg A, 2009, ANAL BIOANAL CHEM, V394, P71, DOI 10.1007/s00216-009-2636-9; Bayramoglu G, 2008, J HAZARD MATER, V156, P148, DOI 10.1016/j.jhazmat.2007.12.008; Pollard DJ, 2007, TRENDS BIOTECHNOL, V25, P66, DOI 10.1016/j.tibtech.2006.12.005; Lei CH, 2002, J AM CHEM SOC, V124, P11242, DOI 10.1021/ja026855o; Kanamori K, 2006, ADV MATER, V18, P2407, DOI 10.1002/adma.200601026; Sun XX, 2014, COLLOID POLYM SCI, V292, P1073, DOI 10.1007/s00396-013-3155-y; Lai YC, 2005, PROCESS BIOCHEM, V40, P1167, DOI 10.1016/j.procbio.2004.04.009; Okada K, 2011, CHEM COMMUN, V47, P7422, DOI 10.1039/c1cc12402a; Zhang JL, 2010, LANGMUIR, V26, P6083, DOI 10.1021/la904014z; Colard CAL, 2009, ADV MATER, V21, P2894, DOI 10.1002/adma.200803007; Letant SE, 2004, ADV MATER, V16, P689, DOI 10.1002/adma.200306173; Luckarift HR, 2004, NAT BIOTECHNOL, V22, P211, DOI 10.1038/nbt931; Garcia-Galan C, 2011, ADV SYNTH CATAL, V353, P2885, DOI 10.1002/adsc.201100534; DeLouise LA, 2005, ANAL CHEM, V77, P1950, DOI 10.1021/ac0486185; Patel AC, 2006, NANO LETT, V6, P1042, DOI 10.1021/nl0604560; Woodley JM, 2008, TRENDS BIOTECHNOL, V26, P321, DOI 10.1016/j.tibtech.2008.03.004; Klein MP, 2012, BIOMACROMOLECULES, V13, P2456, DOI 10.1021/bm3006984; MIRON T, 1982, ANAL BIOCHEM, V126, P433, DOI 10.1016/0003-2697(82)90540-1; Svec F, 2010, J CHROMATOGR A, V1217, P902, DOI 10.1016/j.chroma.2009.09.073; Lv YQ, 2014, BIOTECHNOL BIOENG, V111, P50, DOI 10.1002/bit.25005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082; Azevedo AM, 2004, J MOL CATAL B-ENZYM, V28, P121, DOI 10.1016/j.molcatb.2004.02.005; Juang RS, 2001, BIORESOURCE TECHNOL, V80, P187, DOI 10.1016/S0960-8524(01)00090-6; Bandari R, 2008, J CHROMATOGR A, V1191, P268, DOI 10.1016/j.chroma.2007.11.016; Cao LQ, 2005, CURR OPIN CHEM BIOL, V9, P217, DOI 10.1016/j.cbpa.2005.02.014; Chen B, 2008, LANGMUIR, V24, P13457, DOI 10.1021/la8019952; Dai CF, 2010, POLYM DEGRAD STABIL, V95, P600; Hasegawa G, 2011, POLYMER, V52, P4644, DOI 10.1016/j.polymer.2011.08.028; Hosoda N, 2014, POLYM J, V46, P301, DOI 10.1038/pj.2014.1; Mateo C, 2000, BIOMACROMOLECULES, V1, P739, DOI 10.1021/bm000071q; Park SB, 2013, POLYM DEGRAD STABIL, V99, P99; Park SB, 2013, POLYMER, V54, P6114, DOI 10.1016/j.polymer.2013.09.014; Shum AWT, 2005, POLYM DEGRAD STABIL, V87, P487, DOI 10.1016/j.polymdegradstab.2004.10.005; Sun XX, 2013, POLYM J, V45, P1101, DOI 10.1038/pj.2013.18; Walsh Z, 2008, CHEM COMMUN, P6504, DOI 10.1039/b816958f	50	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	NOV	2014	109				SI		362	366		10.1016/j.polymdegradstab.2014.05.032		5	Polymer Science	Polymer Science	AU2UM	WOS:000345472900044		
J	Ali, MA; Tateyama, S; Kaneko, T				Ali, Mohammad Asif; Tateyama, Seiji; Kaneko, Tatsuo			Syntheses of rigid-rod but degradable biopolyamides from itaconic acid with aromatic diamines	POLYMER DEGRADATION AND STABILITY			English	Article						Itaconic acid; Bioplastics; Polyamides; Heterocycles; Biodegradation	POLYMERS; POLYCONDENSATION; POLYMERIZATION; POLYAMIDE-6; MECHANISM	Highly-thermostable but degradable polyamides have been synthesized by a polycondensation of bio-derived itaconic acid salts with aromatic diamines to form heterocyclic pyrrolidone ring in the polymer backbone. The molecular weight was greater than 33,600 g/mol. Glass transition temperatures, T-g, and 10% weight loss temperatures, T-10, ranged 156-242 degrees C and 370-400 degrees C, respectively, which were higher than those of conventional bio-based plastics. However their processability was too low to process the fiber as specimens of mechanical tests. We then incorporated an appropriate amount of aliphatic moiety into the aromatic backbones to prepare the high-performance and processable polyamides with T-g over 115 degrees C and T-10 over 355 degrees C. The processed fibers showed tensile strength and Young's modulus ranged 20-58 MPa and 0.2-2.3 GPa, respectively. The degradation behaviors inside soil and under ultraviolet-irradiation in water were additionally found. (C) 2014 Elsevier Ltd. All rights reserved.	[Ali, Mohammad Asif; Tateyama, Seiji; Kaneko, Tatsuo] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan	Kaneko, T (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	kaneko@jaist.ac.jp			 [24655099]	This research was mainly financially supported by Grant-in-Aid for Challenging Exploratory Research (24655099).	Ali MA, 2013, MACROMOLECULES, V46, P3719, DOI 10.1021/ma400395b; Sousa AF, 2008, CHEMSUSCHEM, V1, P1020, DOI 10.1002/cssc.200800178; Okuda T, 2012, MACROMOLECULES, V45, P4166, DOI 10.1021/ma300387j; Wu ZG, 2002, J APPL POLYM SCI, V83, P2403, DOI 10.1002/app.10198; Baschek G, 1999, POLYMER, V40, P3433, DOI 10.1016/S0032-3861(98)00560-6; Pang XA, 2010, BIOTECHNOL J, V5, P1125, DOI 10.1002/biot.201000135; Vouyiouka SN, 2005, PROG POLYM SCI, V30, P10, DOI 10.1016/j.progpolymsci.2004.11.001; Okada M, 2002, PROG POLYM SCI, V27, P87, DOI 10.1016/S0079-6700(01)00039-9; Garcia JM, 2010, PROG POLYM SCI, V35, P623, DOI 10.1016/j.progpolymsci.2009.09.002; van Beilen JB, 2008, PLANT J, V54, P684, DOI 10.1111/j.1365-313X.2008.03431.x; Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435; Kaneko T, 2006, NAT MATER, V5, P966, DOI 10.1038/nmat1778; Wojtecki RJ, 2011, NAT MATER, V10, P14, DOI [10.1038/nmat2891, 10.1038/NMAT2891]; Klun U, 2003, POLYM DEGRAD STABIL, V79, P99, DOI 10.1016/S0141-3910(02)00260-4; Ayadi F, 2012, POLYMER, V44, P1; Biondi G, 2008, MACROMOL MATER ENG, V293, P361, DOI 10.1002/mame.200700363; Coltelli MB, 2006, MACROMOLECULES, V39, P2153, DOI 10.1021/ma051893o; ELLIS TS, 1991, MACROMOLECULES, V24, P3845, DOI 10.1021/ma00013a017; Gallagher T, 2010, J ORG CHEM, V75, P3766, DOI 10.1021/jo100514a; Hao YJ, 2013, IND ENG CHEM RES, V52, P6410, DOI 10.1021/ie302879t; Ishihara K, 2000, MACROMOLECULES, V33, P3511, DOI 10.1021/ma000085o; Lakshmi SN, 2007, PROG POLYM SCI, V32, P768; MARVEL CS, 1959, J ORG CHEM, V24, P599, DOI 10.1021/jo01087a006; MORGAN PW, 1977, MACROMOLECULES, V10, P1381, DOI 10.1021/ma60060a040; Mralidharao D, 2007, AFR J BIOTECHNOL, V18, P2140; Papaspyrides CD, 2006, POLYMER, V47, P1020, DOI 10.1016/j.polymer.2005.12.041; Sheng SR, 2009, EUR POLYM J, V45, P230, DOI 10.1016/j.eurpolymj.2008.10.023; Shere AJ, 1996, MACROMOLECULES, V29, P2088, DOI 10.1021/ma951777t; Steiger MG, 2013, FRONT MICROBIOL, V4, P1; Wang HM, 2000, POLYM COMPOSITE, V21, P114, DOI 10.1002/pc.10170	30	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	NOV	2014	109				SI		367	372		10.1016/j.polymdegradstab.2014.05.031		6	Polymer Science	Polymer Science	AU2UM	WOS:000345472900045		
J	Danjo, T; Enomoto-Rogers, Y; Takemura, A; Iwata, T				Danjo, Takahiro; Enomoto-Rogers, Yukiko; Takemura, Akio; Iwata, Tadahisa			Syntheses and properties of glucomannan acetate butyrate mixed esters	POLYMER DEGRADATION AND STABILITY			English	Article						Glucomannan; Mixed esters; Acetate butyrate; Film; Properties	FATTY-ACID ESTERS; KONJAC GLUCOMANNAN; MECHANICAL-PROPERTIES; STARCH; OLIGOSACCHARIDES; MANNAN; ACETYLATION; DERIVATIVES	Glucomannan acetate butyrate mixed esters (GMAcBus) were prepared from konjac glucomannan (GM) with acetic acid, butyric acid, and trifluoroacetic anhydride. Eight GMAcBus were prepared with different degrees of substitution (DS) of acetyl group and butyryl group. The DS ratio of the two substituents could be controlled by the in-feed molar ratio of two carboxylic acids. Structural characterization of GMAcBus were carried out by H-1 NMR analysis. Thermal properties were investigated by thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), and dynamic mechanical analysis (DMA). The decomposition temperature of GMAcBus (ca. 360 degrees C) was improved from that of GM (274 degrees C), and the temperature was independent of the DS ratio. DSC thermograms showed no melting point for all samples, indicating GMAcBus were all amorphous. The glass transition temperature (T-g) of GMAcBus increased with increasing DS of acetyl group in a range between the T(g)s of GMBu (107 degrees C) and GMAc (178 degrees C). All GMAcBus formed transparent films upon solvent-casting. Tensile tests of the films revealed that tensile strength increased with increasing DS of acetyl group, and film elongation tended to increase with increasing DS of butyryl group. Thermal and tensile properties of GMAcBus could be controlled by the DS ratio of acetyl and butyryl groups. (C) 2014 Elsevier Ltd. All rights reserved.	[Danjo, Takahiro; Enomoto-Rogers, Yukiko; Takemura, Akio; Iwata, Tadahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo 1138657, Japan	Iwata, T (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atiwata@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [22245026]	This study was supported by a Grant-in-Aid for Scientific Research (A) (No.22245026) (to T.I.) from the Japan Society for the Promotion of Science (JSPS) and a Grant-in-Aid from the Research Fellowships of JSPS for Young Scientists (Y.E-R).	Crepy L, 2011, CARBOHYD POLYM, V83, P1812, DOI 10.1016/j.carbpol.2010.10.045; Edgar KJ, 2001, PROG POLYM SCI, V26, P1605, DOI 10.1016/S0079-6700(01)00027-2; Koroskenyi B, 2001, BIOMACROMOLECULES, V2, P824, DOI 10.1021/bm010014c; Katsuraya K, 2003, CARBOHYD POLYM, V53, P183, DOI 10.1016/S0144-8617(03)00039-0; KATO K, 1969, AGR BIOL CHEM TOKYO, V33, P1446; Chen ZG, 2006, J CHEM TECHNOL BIOT, V81, P1225, DOI 10.1002/jctb.1522; Fundador NGV, 2012, CARBOHYD POLYM, V87, P170, DOI 10.1016/j.carbpol.2011.07.034; Fundador NGV, 2012, POLYMER, V53, P3885, DOI 10.1016/j.polymer.2012.06.038; Enomoto-Rogers Y, 2014, CARBOHYD POLYM, V101, P592, DOI 10.1016/j.carbpol.2013.09.103; Zhang YQ, 2005, CARBOHYD POLYM, V60, P27, DOI 10.1016/j.carbpol.2004.11.003; MAEDA M, 1980, AGR BIOL CHEM TOKYO, V44, P245; Aburto J, 1999, J APPL POLYM SCI, V74, P1440, DOI 10.1002/(SICI)1097-4628(19991107)74:6<1440::AID-APP17>3.0.CO;2-V; Sugimoto M, 2010, CARBOHYD POLYM, V79, P948, DOI 10.1016/j.carbpol.2009.10.014; Liu JY, 2012, CARBOHYD POLYM, V89, P158, DOI 10.1016/j.carbpol.2012.02.065; SMITH F, 1959, J AM CHEM SOC, V81, P1715, DOI 10.1021/ja01516a048; MORITA H, 1956, ANAL CHEM, V28, P64, DOI 10.1021/ac60109a019; BOURNE EJ, 1949, J CHEM SOC, P2976, DOI 10.1039/jr9490002976; Enomoto-Rogers Y, 2013, CARBOHYD POLYM, V92, P1827, DOI 10.1016/j.carbpol.2012.11.043; Fisher JF, 1959, RECENT ADV CHEM CELL, P188; KISHIDA N, 1978, AGR BIOL CHEM TOKYO, V42, P1645; Mark J. E., 2009, POLYM DATA HDB; MOROOKA T, 1984, J APPL POLYM SCI, V29, P3981, DOI 10.1002/app.1984.070291230; SAGAR AD, 1995, J APPL POLYM SCI, V58, P1647, DOI 10.1002/app.1995.070580927; SHIMAHARA H, 1975, AGR BIOL CHEM TOKYO, V39, P293; TAKAHASHI R, 1984, AGR BIOL CHEM TOKYO, V48, P2943; Yang BY, 2008, STARCH-STARKE, V60, P146, DOI 10.1002/star.200700692	26	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	NOV	2014	109				SI		373	378		10.1016/j.polymdegradstab.2014.05.023		6	Polymer Science	Polymer Science	AU2UM	WOS:000345472900046		
J	Mizuno, S; Katsumata, S; Hiroe, A; Tsuge, T				Mizuno, Shoji; Katsumata, Shiori; Hiroe, Ayaka; Tsuge, Takeharu			Biosynthesis and thermal characterization of polyhydroxyalkanoates bearing phenyl and phenylalkyl side groups	POLYMER DEGRADATION AND STABILITY			English	Article						Polyhydroxyalkanoate; Aromatic side group; L-phenylalanine; Cinnamic acid; Glass transition temperature	PSEUDOMONAS-PUTIDA; MECHANICAL-PROPERTIES; ESCHERICHIA-COLI; ACIDS; POLYESTERS; CHROMOSOME; COPOLYMERS; OLEOVORANS	Polyhydroxyalkanoate (PHA) synthase 1 (PhaCl(PS)) from Pseudomonas sp. 61-3 is a broad-substrate-specific enzyme. In this study, by employing Ralstonia eutropha PHB-4 recombinant expressing PhaCl(PS), a novel type of 3-hydroxybutyrate (3HB)-based PHA copolymer, poly(3HB-co-3-hydroxy-3-phenylpropionate) [P(3HB-co-3H3PhP)], bearing phenyl side groups, was synthesized. The 3H3PhP fraction was increased up to 8.9 mol% by feeding 3H3PhP precursors. As the phenyl side group was introduced into P(3HB), the melting temperature and the enthalpy of fusion decreased, while the glass transition temperature (T-g) increased, demonstrating a distinct thermal behavior as a result of the phenyl side group. Furthermore, PHAs bearing phenylalkyl side groups were synthesized from omega-phenyl-alkanoates by Pseudomonas putida KT2440, and their thermal properties were characterized. Based on the measured and predicted T-g values, the effect of the alkyl chain length in the aromatic side group on T-g was investigated. This study demonstrates the role that aromatic side groups play in the thermal properties of PHAs. (C) 2014 Elsevier Ltd. All rights reserved.	[Mizuno, Shoji; Katsumata, Shiori; Hiroe, Ayaka; Tsuge, Takeharu] Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tsuge, T (reprint author), Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	tsuge.t.aa@m.titech.ac.jp	Tsuge, Takeharu/F-6618-2011	Tsuge, Takeharu/0000-0002-6296-6500	JST, CREST;  [KAKENHI 23658271]	We thank T. Fukui (Tokyo Institute of Technology) and H. Abe (RIKEN Institute) for their valuable discussions, K. Matsumoto (Kaneka Corp., Japan) for providing the plasmid pNS2X-sacBR1, and Y. Nakamura (Tokyo Institute of Technology) for NMR analysis. This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI 23658271) and partially supported by JST, CREST.	Yamada M, 2011, J BIOTECHNOL, V154, P255, DOI 10.1016/j.jbiotec.2011.05.011; Park WH, 1998, MACROMOLECULES, V31, P1480, DOI 10.1021/ma9714528; Sandoval A, 2005, APPL MICROBIOL BIOT, V67, P97, DOI 10.1007/s00253-004-1752-x; KIM YB, 1991, MACROMOLECULES, V24, P5256, DOI 10.1021/ma00019a004; Abraham GA, 2001, BIOMACROMOLECULES, V2, P562, DOI 10.1021/bm010018h; Watanabe Y, 2012, J BIOSCI BIOENG, V113, P286, DOI 10.1016/j.jbiosc.2011.10.015; Abe H, 2012, POLYMER, V53, P3026, DOI 10.1016/j.polymer.2012.04.043; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shozui F, 2011, POLYM DEGRAD STABIL, V96, P499, DOI 10.1016/j.polymdegradstab.2011.01.007; Kato M, 1996, APPL MICROBIOL BIOT, V45, P363; Tsuge T, 2005, MACROMOL BIOSCI, V5, P112, DOI 10.1002/mabi.200400152; Shen R, 2014, SCI CHINA LIFE SCI, V57, P4, DOI 10.1007/s11427-013-4596-8; FRIEDRICH B, 1981, J BACTERIOL, V147, P198; Kim DY, 2000, INT J BIOL MACROMOL, V28, P23, DOI 10.1016/S0141-8130(00)00150-1; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Tsuge T, 2004, MACROMOL BIOSCI, V4, P238, DOI 10.1002/mabi.200300077; FRITZSCHE K, 1990, MAKROMOL CHEM, V191, P1957; Tsuge T, 2010, POLYM DEGRAD STABIL, V95, P1345, DOI 10.1016/j.polymdegradstab.2010.01.028; Tsuda M, 1998, GENE, V207, P33, DOI 10.1016/S0378-1119(97)00601-X; Abe H, 2002, BIOMACROMOLECULES, V3, P133, DOI 10.1021/bm0155975; COWIE JMG, 1977, POLYMER, V18, P612, DOI 10.1016/0032-3861(77)90065-9; Curley JM, 1996, MACROMOLECULES, V29, P1762, DOI 10.1021/ma951185a; Fox T. G., 1956, B AM PHYS SOC, V1, P123; Garcia B, 1999, J BIOL CHEM, V274, P29228, DOI 10.1074/jbc.274.41.29228; Hazer B, 1996, POLYMER, V37, P5951, DOI 10.1016/S0032-3861(96)00570-8; Iwata T, 2005, MACROMOL SYMP, V224, P11, DOI 10.1002/masy.200550602; Saika A, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-6; Satkowski MM, 2001, BIOPOLYMERS B, V3b, P231; Song JJ, 2001, J MICROBIOL BIOTECHN, V11, P435; Tanadchangsaeng N, 2009, BIOMACROMOLECULES, V10, P2866, DOI 10.1021/bm900696c; Tobin KM, 2005, FEMS MICROBIOL LETT, V253, P111, DOI 10.1016/j.femsle.2005.09.025; Ward PG, 2005, INT J BIOL MACROMOL, V35, P127, DOI 10.1016/j.ijbiomac.2005.01.001	32	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	NOV	2014	109				SI		379	384		10.1016/j.polymdegradstab.2014.05.020		6	Polymer Science	Polymer Science	AU2UM	WOS:000345472900047		
J	Funabashi, M; Ohara, K; Kunioka, M				Funabashi, Masahiro; Ohara, Keiichi; Kunioka, Masao			Accuracy of biobased carbon content of determination of plastic products and related materials by accelerator mass spectrometry	POLYMER DEGRADATION AND STABILITY			English	Article						Biobased content; Biobased carbon content; Biobased synthetic polymer content; Biobased mass content; Accelerator mass spectrometry (AMS); ISO 16620	COMPOSITES; BIOMASS; RATIO	Biobased content of plastic products and related materials were determined according to ISO 16620 series. Biobased carbon content of sample was determined from percent modern carbon (pMC). pMC was determined by carbon-14 (C-14) concentration measured by accelerator mass spectrometry (AMS). The error of pMC was discussed. The error of biobased carbon content was also discussed in order to confirm repeatability, reproducibility and accuracy. The standard deviation of pMC of samples shown in this study is less than 1% except for rubber/polymer composite samples. The standard deviation of pMC of rubber/polymer composites is less than 3%. When the pMC of source material was employed as a reference of pMC, the derived biobased carbon content from pMC agree well with theoretical value within 3% error. Biobased synthetic polymer content of sample was determined from biobased carbon content. Biobased mass content of sample was determined from biobased carbon content. Accuracies of biobased synthetic polymer content and biobased mass content for composite samples with two components were less than 3%. (C) 2014 Elsevier Ltd. All rights reserved.	[Funabashi, Masahiro; Kunioka, Masao] Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki 3058565, Japan; [Ohara, Keiichi] Inst Accelerator Anal Ltd, Shirakawa Anal Ctr, Shirakawa, Fukushima 9610835, Japan	Funabashi, M (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, 1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	m.funabashi@aist.go.jp			New Energy and Industrial Technology Development Organization (NEDO), Japan [08003626-0]; Japan BioPlastics Association (JBPA)	The authors wish to acknowledge financial support for the project "Development of Preparatory Basic Bioenergy Technologies: Accelerated Technology Development for Biofuel: R&D of Method to Measure Biomass Carbon Ratio of Bio-polyolefin (08003626-0)" from the New Energy and Industrial Technology Development Organization (NEDO), Japan and the Japan BioPlastics Association (JBPA).	[Anonymous], 2011, 161372011 CENTS; [Anonymous], 2012, D6866122010 ASTM; Flores ED, 2009, J APPL POLYM SCI, V112, P3410, DOI 10.1002/app.29777; Funabashi M, 2009, B CHEM SOC JPN, V82, P1538, DOI 10.1246/bcsj.82.1538; Kunioka M, 2014, POLYMERS-BASEL, V6, P423, DOI 10.3390/polym6020423; Kunioka M, 2007, J POLYM ENVIRON, V15, P281, DOI 10.1007/s10924-007-0071-6; Kunioka Masao, 2013, Radioisotopes, V62, P901; Onishi T, 2010, POLYM DEGRAD STABIL, V95, P1276, DOI 10.1016/j.polymdegradstab.2010.03.011	8	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	NOV	2014	109				SI		385	392		10.1016/j.polymdegradstab.2014.05.018		8	Polymer Science	Polymer Science	AU2UM	WOS:000345472900048		
J	Kunioka, M; Masuda, T; Tachibana, Y; Funabashi, M; Oishi, A				Kunioka, Masao; Masuda, Takashi; Tachibana, Yuya; Funabashi, Masahiro; Oishi, Akihiro			Highly selective synthesis of biomass-based 1,4-butanediol monomer by alcoholysis of 1,4-diacetoxybutane derived from furan	POLYMER DEGRADATION AND STABILITY			English	Article						Biomass-based monomer; Biobased monomer; 1,4-Butanediol; 1,4-Diacetoxybutane; Furan	ACCELERATOR MASS-SPECTROMETRY; DECARBONYLATION; COMPOSITES; POLYESTERS; CONVERSION	Biomass-based 1,4-butanediol (BD) was produced with high selectivity from diacetoxybutane (DAB) and alcohol using a KHSO4 catalyst, which could be recycled. The DAB used in this reaction could be produced from furan, which, in turn, can be easily produced from furfural. The conversion of furfural to BD was carried out under mild conditions such as low H-2 pressure (0.69 MPa). These processes produce not only tetrahydrofuran (THF) but also alkyl esters, which are industrial important chemicals. Alkyl esters are alternatives to benzene, toluene and xylene (BTX) solvents. It was confirmed that the BD synthesized in this paper was entirely biobased because its biobased carbon content was 99.63%, as determined by accelerator mass spectrometry based on ASTM D6866. (C) 2014 Elsevier Ltd. All rights reserved.	[Kunioka, Masao; Masuda, Takashi; Funabashi, Masahiro; Oishi, Akihiro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Tachibana, Yuya] Gunma Univ, Grad Sch Engn, Dept Chem & Chem Biol, Kiryu, Gumma 3768515, Japan	Kunioka, M (reprint author), Natl Inst Adv Ind Sci & Technol, Higashi 1-1-1, Tsukuba, Ibaraki 3058565, Japan.	m.kunioka@aist.go.jp	Tachibana, Yuya/I-5584-2012	Tachibana, Yuya/0000-0002-4567-7061			Adams R., 1941, ORG SYNTH, V1, P280; Amada Y, 2012, CHEMSUSCHEM, V5, P1991, DOI 10.1002/cssc.201200121; [Anonymous], 2012, 6866612 ASTM; JUNG KJ, 1988, BIOMASS, V16, P89, DOI 10.1016/0144-4565(88)90018-2; Zhang B, 2012, GREEN CHEM, V14, P3402, DOI 10.1039/c2gc36270h; LEJEMBLE P, 1984, BIOMASS, V4, P263, DOI 10.1016/0144-4565(84)90039-8; Pan T, 2013, CHEMSUSCHEM, V6, P47, DOI 10.1002/cssc.201200652; Fujimaki T, 1998, POLYM DEGRAD STABIL, V59, P209, DOI 10.1016/S0141-3910(97)00220-6; Calabia BP, 2013, POLYMERS-BASEL, V5, P128, DOI 10.3390/polym5010128; Bark MJ, 2010, United State Patents, Patent No. [US 7,858,350 B2, 7858350]; Funabashi M, 2009, B CHEM SOC JPN, V82, P1538, DOI 10.1246/bcsj.82.1538; Harold Gunardson, 1998, BUTANEDIOL DERIVATIV, P204; Kunioka M, 2007, J POLYM ENVIRON, V15, P281, DOI 10.1007/s10924-007-0071-6; Kunioka Masao, 2013, Radioisotopes, V62, P901; Kunioka M, 2010, APPL MICROBIOL BIOT, V87, P491, DOI 10.1007/s00253-010-2630-3; O'Young L, 2003, U.S Patent, Patent No. [6,555,720 81, 20036555720]; Starr D., 1943, ORG SYNTH, VII, P566; Tachibana Y, 2010, BIOMACROMOLECULES, V11, P2780; Tachibana Y, 2012, ACS SYM SER, V1105, P91; Tanoue Y, 2000, J HETEROCYCLIC CHEM, V37, P1351	20	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	NOV	2014	109				SI		393	397		10.1016/j.polymdegradstab.2014.05.011		5	Polymer Science	Polymer Science	AU2UM	WOS:000345472900049		
J	Ilham, M; Nakanomori, S; Kihara, T; Hokamura, A; Matsusaki, H; Tsuge, T; Mizuno, K				Ilham, Mulyana; Nakanomori, Satoko; Kihara, Takahiro; Hokamura, Ayaka; Matsusaki, Hiromi; Tsuge, Takeharu; Mizuno, Kouhei			Characterization of polyhydroxyalkanoate synthases from Halomonas sp. O-1 and Halomonas elongata DSM2581: Site-directed mutagenesis and recombinant expression	POLYMER DEGRADATION AND STABILITY			English	Article						Polyhydroxyalkanoate; 3-Hydroxyvalerate; Halotolerant; Halomonas; phaC	RALSTONIA-EUTROPHA; GENOME SEQUENCE; ACIDS; POLY(3-HYDROXYBUTYRATE); BACTERIUM; PHA; POLY(BETA-HYDROXYBUTYRATE); HYDROXYBUTYRATE; BIOSYNTHESIS; ACCUMULATION	Polyhydroxyalkanoates (PHAs) are a group of microbial intracellular biopolyesters that have wide potential applications for the plastics industry. Here, we report the results of molecular analyses of PHA synthases from Halomonas species, which are halophilic eubacteria known as promising industrial PHA producers, but the PHA synthase gene of Halomonas has not been cloned previously. In this study, the putative PHA synthase genes (phaC1 and phaC2) from two Halomonas strains (a new isolate, Halomonas sp. O-1, and the genome-sequenced strain, Halomonas elongata DSM2581) were cloned and characterized. We identified a gene related to the H. elongata DSM2581 PHA synthase gene (phaC1(He)) in the Halomonas sp. O-1 genome (phaC1(HO1)). PHA synthases usually contain a lipase box-like sequence Gly-X-Cys-X-Gly in their active sites. However, the equivalent sequence found in PhaC1(HO1) and PhaC1(He), was determined to be Ser-X-Cys-X-Gly, with serine replacing the first glycine. The cloned phaC1(HO1) and phaC1(He) genes were found to be functional when expressed in Escherichia coli JM109 and Ralstonia eutropha PHB(-)4. Site-directed mutagenesis studies showed that the cysteine in the Ser-X-Cys-X-Gly sequence was the catalytic center of Halomonas PhaC1 proteins and that replacement of serine with glycine slightly affected PHA biosynthesis and copolymer composition. In addition, a second potential PHA synthase gene (phaC2) was cloned and its polymerization activity was evaluated. The results herein provide an important molecular basis for PHA production by Halomonas species. (C) 2014 Elsevier Ltd. All rights reserved.	[Ilham, Mulyana; Tsuge, Takeharu] Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Nakanomori, Satoko; Kihara, Takahiro; Mizuno, Kouhei] Kitakyushu Natl Coll Technol, Dept Mat Sci & Chem Engn, Kokuraminami Ku, Kitakyushu, Fukuoka 8020985, Japan; [Hokamura, Ayaka; Matsusaki, Hiromi] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Higashi Ku, Kumamoto 8628502, Japan	Tsuge, T (reprint author), Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	tsuge.t.aa@m.titech.ac.jp; mizuno@kct.ac.jp	Tsuge, Takeharu/F-6618-2011	Tsuge, Takeharu/0000-0002-6296-6500	 [KAKENHI 25340128]	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI 25340128) to K. Mizuno.	Spiekermann P, 1999, ARCH MICROBIOL, V171, P73, DOI 10.1007/s002030050681; STEINBUCHEL A, 1992, FEMS MICROBIOL LETT, V103, P217, DOI 10.1111/j.1574-6968.1992.tb05841.x; Wolfe-Simon F, 2011, SCIENCE, V332, P1163, DOI 10.1126/science.1197258; Simon-Colin C, 2008, J APPL MICROBIOL, V104, P1425, DOI 10.1111/j.1365-2672.2007.03667.x; Mata JA, 2002, SYST APPL MICROBIOL, V25, P360, DOI 10.1078/0723-2020-00122; KIRK RG, 1972, J ULTRA MOL STRUCT R, V41, P80, DOI 10.1016/S0022-5320(72)90040-8; Kawata Y, 2010, BIOSCI BIOTECH BIOCH, V74, P175, DOI 10.1271/bbb.90459; RODRIGUEZVALERA F, 1992, FEMS MICROBIOL LETT, V103, P181, DOI 10.1111/j.1574-6968.1992.tb05836.x; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1111/j.1574-6968.1995.tb07528.x; Quelas JI, 2013, J BACTERIOL, V195, P3145, DOI 10.1128/JB.02203-12; Kato M, 1996, APPL MICROBIOL BIOT, V45, P363; Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254; Kulkarni SO, 2010, BIORESOURCE TECHNOL, V101, P9765, DOI 10.1016/j.biortech.2010.07.089; York GM, 2001, J BACTERIOL, V183, P2394, DOI 10.1128/JB.183.7.2394-2397.2001; Yu J, 2002, PROCESS BIOCHEM, V37, P731, DOI 10.1016/S0032-9592(01)00264-3; Quillaguaman J, 2005, J APPL MICROBIOL, V99, P151, DOI 10.1111/j.1365-2672.2005.02589.x; Choi J, 1999, APPL MICROBIOL BIOT, V51, P13, DOI 10.1007/s002530051357; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; LILLO JG, 1990, APPL ENVIRON MICROB, V56, P2517; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450; KARR DB, 1983, APPL ENVIRON MICROB, V46, P1339; Hyakutake M, 2011, BIOSCI BIOTECH BIOCH, V75, P1615, DOI 10.1271/bbb.110229; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Cai L, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-88; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FERNANDEZCASTILLO R, 1986, APPL ENVIRON MICROB, V51, P214; GERNGROSS TU, 1994, BIOCHEMISTRY-US, V33, P9311, DOI 10.1021/bi00197a035; Guzmán Daniel, 2012, Aquat Biosyst, V8, P9, DOI 10.1186/2046-9063-8-9; Kawata Y, 2012, J BACTERIOL, V194, P2738, DOI 10.1128/JB.00237-12; Oren Aharon, 2008, Saline Systems, V4, P2, DOI 10.1186/1746-1448-4-2; Simon R, 1983, NAT BIOTECHNOL, P784; Steinbuchel A, 1998, POLYM DEGRAD STABIL, V59, P177, DOI 10.1016/S0141-3910(97)00173-0; Takase K, 2003, J BIOCHEM, V133, P139, DOI 10.1093/jb/mvg015	34	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	NOV	2014	109				SI		416	423		10.1016/j.polymdegradstab.2014.04.024		8	Polymer Science	Polymer Science	AU2UM	WOS:000345472900052		
J	Khattab, SMR; Kodaki, T				Khattab, Sadat Mohammad Rezq; Kodaki, Tsutomu			Efficient bioethanol production by overexpression of endogenous Saccharomyces cerevisiae xylulokinase and NADPH-dependent aldose reductase with mutated strictly NADP(+)-dependent Pichia stipitis xylitol dehydrogenase	PROCESS BIOCHEMISTRY			English	Article						Bioethanol; Xylose fermentation; Cofactor requirement; Xylose reductase; Xylitol dehydrogenase	PREFERRING XYLOSE REDUCTASE; ETHANOL-PRODUCTION; METABOLIC PATHWAY; FERMENTATION; EXPRESSION; STRAINS; GENES; GLUCOSE; YEAST; GRE3	Development of efficient xylose-fermenting Saccharomyces cerevisiae strain has involved a large number of trials that focus on improving ethanol production from glucose and xylose present in lignocellulosic hydrolysates. In this study, a recombinant S. cerevisiae strain (SK-NY) overexpressing GRE3-encoded NADPH-dependent aldose reductase and xylulokinase with a mutated strictly NADP(+)-dependent Pichia stipitis xylitol dehydrogenase was constructed and its fermentation efficiency was compared with that of an isogenic constructed reference strain expressing P. stipitis xylose reductase instead of the GRE3 gene. Strain SK-NY efficiently fermented xylose and glucose mixture and the ethanol production by SK-NY was 21.4% higher than that of the reference strain. Interestingly, the yield of ethanol production by SK-NY strain increased from 0.395 g ethanol/g sugar to 0.435 g ethanol/g sugar after glucose depletion. Furthermore, xylitol accumulation by SK-NY strain (0.6% of total sugar) was considerably lower than that of the reference strain (4.8% of total sugar). These improvements may be influenced by the effective regeneration of NADPH/NADP(+) cofactors by GRE3 gene and the mutated strictly NADP(+)-dependent P. stipitis xylitol dehydrogenase. (C) 2014 Elsevier Ltd. All rights reserved.	[Khattab, Sadat Mohammad Rezq; Kodaki, Tsutomu] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan; [Khattab, Sadat Mohammad Rezq] Al Azhar Univ, Fac Sci, Assiut Branch, Assiut 71524, Egypt	Kodaki, T (reprint author), Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan.	kodaki@iae.kyoto-u.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) of Japan [P09014]; Ministry of Education, Culture, Sports, Science and Technology in Japan [23603003]; Iwatani Foundation [09-3610]	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) of Japan (P09014), a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan (23603003), and the Iwatani Foundation (09-3610).	[Anonymous], 1991, METHODS ENZYMOL; Matsushika A, 2008, APPL MICROBIOL BIOT, V81, P243, DOI 10.1007/s00253-008-1649-1; Toivari MH, 2004, APPL ENVIRON MICROB, V70, P3681, DOI [10.1128/AEM.70.6.3681-3686.2004, 10.1128/aem.70.6.3681-3686.2004]; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Watanabe S, 2007, MICROBIOL-SGM, V153, P3044, DOI 10.1099/mic.0.2007/007856-0; Bera AK, 2011, J IND MICROBIOL BIOT, V38, P617, DOI 10.1007/s10295-010-0806-6; Watanabe S, 2007, J BIOTECHNOL, V130, P316, DOI 10.1016/j.jbiotec.2007.04.019; Eliasson A, 2001, ENZYME MICROB TECH, V29, P288, DOI 10.1016/S0141-0229(01)00386-6; Lee SH, 2012, J BIOTECHNOL, V158, P184, DOI 10.1016/j.jbiotec.2011.06.005; Matsushika A, 2008, J BIOSCI BIOENG, V105, P296, DOI 10.1263/jbb.105.296; Jeppsson M, 2003, YEAST, V20, P1263, DOI 10.1002/yea.1043; KOTTER P, 1993, APPL MICROBIOL BIOT, V38, P776; Traff KL, 2001, APPL ENVIRON MICROB, V67, P5668, DOI 10.1128/AEM.67.12.5668-5674.2001; Kim SR, 2013, FEMS YEAST RES, V13, P312, DOI 10.1111/1567-1364.12036; Walfridsson M, 1997, APPL MICROBIOL BIOT, V48, P218, DOI 10.1007/s002530051041; Michnick S, 1997, YEAST, V13, P783, DOI 10.1002/(SICI)1097-0061(199707)13:9<783::AID-YEA128>3.0.CO;2-W; TANTIRUNGKIJ M, 1993, J FERMENT BIOENG, V75, P83, DOI 10.1016/0922-338X(93)90214-S; Khattab SMR, 2013, J BIOTECHNOL, V165, P153, DOI 10.1016/j.jbiotec.2013.03.009; Sedlak M, 2004, YEAST, V21, P671, DOI 10.1002/yea.1060; Watanabe S, 2005, J BIOL CHEM, V280, P10340, DOI 10.1074/jbc.M409443200; Garay-Arroyo A, 1999, YEAST, V15, P879, DOI 10.1002/(SICI)1097-0061(199907)15:10A<879::AID-YEA428>3.3.CO;2-H; BATT CA, 1986, BIOTECHNOL BIOENG, V28, P549, DOI 10.1002/bit.260280411; HOSAKA K, 1992, J BIOCHEM-TOKYO, V111, P352; KANG YS, 1990, MOL CELL BIOL, V10, P2582; Khattab SMR, 2011, BIOCHEM BIOPH RES CO, V404, P634, DOI 10.1016/j.bbrc.2010.12.028; Kreger-van Rij NJW, 1984, YEASTS TAXONOMIC STU, p[45, 385]; Krishnan MS, 2000, APPL BIOCHEM BIOTECH, V84-6, P525, DOI 10.1385/ABAB:84-86:1-9:525; KUHN A, 1995, APPL ENVIRON MICROB, V61, P1580; NIKAWA JI, 1987, MOL CELL BIOL, V7, P3629; Hasunuma T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-2; Traff-Bjerre KL, 2004, YEAST, V21, P141, DOI 10.1002/yea.1072; VANZYL C, 1993, APPL ENVIRON MICROB, V59, P1487; Watanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P1365, DOI 10.1271/bbb.701041	33	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-5113	1873-3298		PROCESS BIOCHEM	Process Biochem.	NOV	2014	49	11					1838	1842		10.1016/j.procbio.2014.07.017		5	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Engineering, Chemical	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Engineering	AU2ZL	WOS:000345482800007		
J	Iwasa, K; Yamamoto, S; Takahashi, M; Suzuki, S; Yagishita, S; Awaji, T; Maruyama, K; Yoshikawa, K				Iwasa, K.; Yamamoto, S.; Takahashi, M.; Suzuki, S.; Yagishita, S.; Awaji, T.; Maruyama, K.; Yoshikawa, K.			Prostaglandin F-2 alpha FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article						Prostaglandin F-2 alpha receptor (FP); Multiple sclerosis (MS); Cuprizone (CPZ); Demyelination; Neuroinflammation	CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; OLIGODENDROCYTE PRECURSOR CELLS; ACID-INDUCED SEIZURE; GLUTAMATE EXCITOTOXICITY; MICROGLIAL TOXICITY; ACTIVATED MICROGLIA; BRAIN-DAMAGE; AXON GROWTH	Previously, we have demonstrated that prostamide/PGF synthase, which catalyzes the reduction of prostaglandin (PG) H-2 to PGF(2 alpha) is constitutively expressed in myelin sheaths and cultured oligodendrocytes, suggesting that PGF(2 alpha) has functional significance in myelin-forming oligodendrocytes. To investigate the effects of PGF(2 alpha)/FP receptor signaling on demyelination, we administrated FP receptor agonist and antagonist to cuprizone-exposed mice, a model of multiple sclerosis. Mice were fed a diet containing 0.2% cuprizone for 5 weeks, which induces severe demyelination, glial activation, proinflammatory cytokine expression, and motor dysfunction. Administration of the FP receptor antagonist AL-8810 attenuated cuprizone-induced demyelination, glial activation, and TNF alpha expression in the corpus callosum, and also improved the motor function. These data suggest that during cuprizone-induced demyelination, PGF(2 alpha)/FP receptor signaling contributes to glial activation, neuroinflammation, and demyelination, resulting in motor dysfunction. Thus, FP receptor inhibition may be a useful symptomatic treatment in multiple sclerosis. (C) 2014 Elsevier Ltd. All rights reserved.	[Iwasa, K.; Yamamoto, S.; Takahashi, M.; Suzuki, S.; Yagishita, S.; Awaji, T.; Maruyama, K.; Yoshikawa, K.] Saitama Med Univ, Fac Med, Dept Pharmacol, Moroyama, Saitama 3500495, Japan	Yoshikawa, K (reprint author), Saitama Med Univ, Fac Med, Dept Pharmacol, 38 Moro Hongo, Moroyama, Saitama 3500495, Japan.	keisukey@saitama-med.ac.jp			MEXT KAKENHI [25870677]; Foundation for Pharmacology Research Association; Special Foundation Yokoyama Clinical Pharmacology Research Grants Fund	This research was supported by MEXT KAKENHI Grant number 25870677, grants from Foundation for Pharmacology Research Association and Special Foundation Yokoyama Clinical Pharmacology Research Grants Fund.	Axelsson M, 2011, J NEUROL, V258, P882, DOI 10.1007/s00415-010-5863-2; Skripuletz T, 2013, BRAIN, V136, P147, DOI 10.1093/brain/aws262; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Pitt D, 2000, NAT MED, V6, P67; Rasmussen S, 2007, BRAIN, V130, P2816, DOI 10.1093/brain/awm219; Ambrosini E, 2005, J NEUROPATH EXP NEUR, V64, P706, DOI 10.1097/01.jnen.0000173893.01929.fc; Li JR, 2008, J NEUROSCI, V28, P5321, DOI 10.1523/JNEUROSCI.3995-07.2008; Palumbo S, 2012, J NEUROCHEM, V121, P418, DOI 10.1111/j.1471-4159.2011.07363.x; Piekorz RP, 2005, MOL ENDOCRINOL, V19, P431, DOI 10.1210/me.2004-0302; Franco-Pons N, 2007, TOXICOL LETT, V169, P205, DOI 10.1016/j.toxlet.2007.01.010; Hellberg MR, 2001, J OCUL PHARMACOL TH, V17, P421, DOI 10.1089/108076801753266802; Liu LP, 2010, NAT NEUROSCI, V13, P319, DOI 10.1038/nn.2491; Stangel M, 2012, CURR PHARM DESIGN, V18, P4471; Farooqui M, 2007, BRIT J CANCER, V97, P1523, DOI 10.1038/sj.bjc.6604057; Holley JE, 2003, NEUROPATH APPL NEURO, V29, P434, DOI 10.1046/j.1365-2990.2003.00491.x; Yoshikawa K, 2011, PROSTAG LEUKOTR ESS, V85, P43, DOI 10.1016/j.plefa.2011.04.022; McKeon RJ, 1999, J NEUROSCI, V19, P10778; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Glabinski AR, 1997, AM J PATHOL, V150, P617; Benardais K, 2013, NEUROTOX RES, V24, P244, DOI 10.1007/s12640-013-9380-9; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Besancon E, 2008, TRENDS PHARMACOL SCI, V29, P268, DOI 10.1016/j.tips.2008.02.003; Bramow S, 2010, BRAIN, V133, P2983, DOI 10.1093/brain/awq250; Howell OW, 2010, J NEUROPATH EXP NEUR, V69, P1017, DOI 10.1097/NEN.0b013e3181f3a5b1; Caminero A, 2011, J NEUROIMMUNOL, V234, P1, DOI 10.1016/j.jneuroim.2011.03.004; Taylor DL, 2010, J NEUROSCI RES, V88, P1632, DOI 10.1002/jnr.22335; Nair A, 2008, CELL MOL LIFE SCI, V65, P2702, DOI 10.1007/s00018-008-8059-5; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Narumiya S, 2009, J MOL MED-JMM, V87, P1015, DOI 10.1007/s00109-009-0500-1; Steelman AJ, 2012, NEUROSCI RES, V72, P32, DOI 10.1016/j.neures.2011.10.002; BLAKEMOR.WF, 1973, J NEUROL SCI, V20, P73, DOI 10.1016/0022-510X(73)90119-6; Dore-Duffy P, 2005, MICROVASC RES, V69, P79, DOI 10.1016/j.mvr.2004.11.004; DOREDUFFY P, 1986, NEUROLOGY, V36, P1587; DOREDUFFY P, 1991, NEUROLOGY, V41, P322; FAWCETT JW, 1989, DEV BIOL, V135, P449, DOI 10.1016/0012-1606(89)90193-0; FOKSEANG J, 1995, BRAIN RES, V689, P207, DOI 10.1016/0006-8993(95)00575-B; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Kim HJ, 2008, BRAIN RES, V1193, P153, DOI 10.1016/j.brainres.2007.12.017; Kim YT, 2012, NEUROBIOL DIS, V48, P58, DOI 10.1016/j.nbd.2012.06.003; Kitanaka J, 1996, BRAIN RES, V707, P282, DOI 10.1016/0006-8993(95)01256-7; Lassmann H., 2014, GLIA; Liang YB, 2003, J BIOL CHEM, V278, P27267, DOI 10.1074/jbc.M301009200; Moriuchi H, 2008, J BIOL CHEM, V283, P792, DOI 10.1074/jbc.M705638200; Palumbo S, 2011, PROSTAG LEUKOTR ESS, V85, P29, DOI 10.1016/j.plefa.2011.04.001; Rose JW, 2004, J NEUROIMMUNOL, V149, P40, DOI 10.1016/j.jneuroim.2003.12.021; Saleem S, 2009, NEUROTOX RES, V15, P62, DOI 10.1007/s12640-009-9007-3; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; SMITH ME, 1987, J NEUROSCI RES, V18, P203, DOI 10.1002/jnr.490180129; Sobel RA, 2001, BRAZ J MED BIOL RES, V34, P603, DOI 10.1590/S0100-879X2001000500007; Taylor LC, 2010, NEUROBIOL DIS, V39, P127, DOI 10.1016/j.nbd.2010.03.016; Torkildsen O, 2008, Acta Neurol Scand Suppl, V188, P72, DOI 10.1111/j.1600-0404.2008.01036.x; Xu W, 2009, BIOCHEM BIOPH RES CO, V381, P625, DOI 10.1016/j.bbrc.2009.02.102; Yoshikawa K, 2006, J BIOL CHEM, V281, P14663, DOI 10.1074/jbc.M511089200; Yoshikawa K, 2013, PROSTAG LEUKOTR ESS, V88, P373, DOI 10.1016/j.plefa.2013.02.007; Yoshikawa K, 2011, BRAIN RES, V1367, P22, DOI 10.1016/j.brainres.2010.10.019	57	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	NOV	2014	91	5					175	182		10.1016/j.plefa.2014.08.004		8	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	AU2XJ	WOS:000345477600001		
J	Kayama, M; Akiyama, T; Ohashi, A; Horikoshi, N; Kido, Y; Murakata, T; Kawakami, N				Kayama, Mami; Akiyama, Tsuyoshi; Ohashi, Akiko; Horikoshi, Naoko; Kido, Yoshifumi; Murakata, Tazuko; Kawakami, Norito			Experiences of Municipal Public Health Nurses Following Japan's Earthquake, Tsunami, and Nuclear Disaster	PUBLIC HEALTH NURSING			English	Article						earthquake; nuclear accident; professionalism; public health nurse; qualitative research	POSTTRAUMATIC GROWTH	ObjectiveThe purpose of this study was to explore the experiences of municipal public health nurses in the wake of the March 2011 massive earthquake and tsunami and resulting nuclear accident in Fukushima, Japan, from the time of the disaster until December 2013. Design and SampleThirty-two public health nurses working in three cities in Fukushima prefecture were divided into four focus groups and took part in interviews, which were analyzed using a qualitative descriptive method. ResultsTwo major themes were extracted: (1) experiences of difficulties and dilemmas, and (2) professional challenges and the meaning of excellence as a public health nurse. Subjects recounted their experiences based on the timeline of events. The process of overcoming various dilemmasbetween prescribed roles and actual needs on the ground, being both civil servants and private citizens with families, and having to be publicly accountable while lacking adequate informationcaused participants to reexamine the meaning of excellence in the practice of public health. ConclusionThe strenuous and complex demands of extended disaster management caused subjects to grow professionally. Helping them process their emotions should also help these nurses give focus to their posttraumatic growth, and strengthen their sense of professionalism.	[Kayama, Mami; Ohashi, Akiko; Kido, Yoshifumi; Murakata, Tazuko] St Lukes Int Univ, Coll Nursing, Tokyo 1040044, Japan; [Akiyama, Tsuyoshi] NTT Med Ctr Tokyo, Dept Neuropsychiat, Tokyo, Japan; [Akiyama, Tsuyoshi] NTT Med Ctr Tokyo, Dept Psychosomat Med, Tokyo, Japan; [Horikoshi, Naoko] Fukushima Med Univ, Fukushima Hlth Management Survey, Radiat Med Sci Ctr, Fukushima, Japan; [Kawakami, Norito] Univ Tokyo, Grad Sch Med, Tokyo, Japan	Kayama, M (reprint author), St Lukes Int Univ, Coll Nursing, Chuo Ku, 10-1 Akashi Cho, Tokyo 1040044, Japan.	mkayama@slcn.ac.jp			Japanese Ministry of the Environment	This research was supported by the Study of the Health Effects of Radiation organized by the Japanese Ministry of the Environment (PI Kawakami N.). I thank Dr. Kiyomi Asahara, Prof Kevin Seaver, and Dr. Nozomu Asukai who were important advisors for this study.	Tanaka S, 2012, P JPN ACAD B-PHYS, V88, P471, DOI 10.2183/pjab.88.471; Arnold D, 2005, J HUMANIST PSYCHOL, V45, P239, DOI 10.1177/0022167805274729; Arnold L, 2006, MEASURING MED PROFES, P15; Cruess R., 2006, MED J AUSTRALIA, V177, P208; Given L., 2008, SAGE ENCY QUALITATIV, P697; Gregg M. F., 2011, CONDUCT REPORT QUALI; Miles M., 1994, QUALITATIVE DATA ANA; Ministry of Internal Affairs and Communications, 2012, MUN NUMB EV FUK PREF; National Child Traumatic Stress Network and National Center for PTSD, 2006, PSYCH 1 AID FIELD OP; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Tomczyk D, 2008, AAOHN J, V56, P243; Yoshioka-Maeda Kyoko, 2006, J Nurs Manag, V14, P483, DOI 10.1111/j.1365-2934.2006.00688.x	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0737-1209	1525-1446		PUBLIC HEALTH NURS	Public Health Nurs.	NOV-DEC	2014	31	6					517	525		10.1111/phn.12140		9	Public, Environmental & Occupational Health; Nursing	Public, Environmental & Occupational Health; Nursing	AU3JW	WOS:000345510000006		
J	Yokoyama, Y; Hirano, K; Sato, M; Abe, A; Uebayashi, M; Kishi, E; Sato, M; Kuroda, Y; Nakaita, I; Fukushima, F				Yokoyama, Yoshie; Hirano, Kayoko; Sato, Mari; Abe, Akiko; Uebayashi, Mihoko; Kishi, Emiko; Sato, Mutsuko; Kuroda, Yuuko; Nakaita, Ikumi; Fukushima, Fujio			Activities and Health Status of Dispatched Public Health Nurses after the Great East Japan Earthquake	PUBLIC HEALTH NURSING			English	Article						dispatch; Great East Japan Earthquake; public health nurses	DISASTER	ObjectiveThis study aimed to elucidate the actual activities conducted by public health nurses during their dispatch and their health status during and after dispatch to the three prefectures most severely affected by the Great East Japan Earthquake. SampleA survey request was sent to a total of 2,237 facilities. Of these, 778 facilities returned questionnaires from dispatched public health nurses. ResultsThe participants of this study were 1,570 dispatched health nurses who participated in activities mostly at evacuation centers, followed by evacuees' homes. After dispatch, an earlier postdisaster phase at the start of dispatch was independently associated with poor subjective well-being, low mood, worsened sleep state, and intense fatigue. Work hours per day were associated with poor subjective well-being and intense fatigue after dispatch. ConclusionResults suggest that the factor that most strongly affected the postdispatch health of the nurses was the phase that they began their dispatch.	[Yokoyama, Yoshie] Osaka City Univ, Dept Publ Hlth Nursing, Osaka 5450051, Japan; [Hirano, Kayoko] Nagasaki Univ, Nagasaki 852, Japan; [Sato, Mari; Abe, Akiko] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan; [Uebayashi, Mihoko] Iwate Prefectural Univ, Takizawa, Iwate, Japan; [Kishi, Emiko] Teikyo Univ, Tokyo 173, Japan; [Sato, Mutsuko] Kyorin Univ, Tokyo, Japan; [Kuroda, Yuuko] Fukushima Prefectural Sch Nursing, Fukushima, Japan; [Nakaita, Ikumi] Japanese Nursing Assoc, Tokyo, Japan; [Fukushima, Fujio] Natl Inst Publ Hlth, Saitama, Japan	Yokoyama, Y (reprint author), Osaka City Univ, Dept Publ Hlth Nursing, Abeno Ku, 1-5-17 Asahi Machi, Osaka 5450051, Japan.	yyokoyama@nurs.osaka-cu.ac.jp			Ministry of Health, Labor and Welfare of Japanese Government	We thank dispatched health nurses and local public health nurses in the disaster-affected area for cooperation with this study. This study was supported by a Health Science Research Grant from the Ministry of Health, Labor and Welfare of Japanese Government.	Aitken P., 2012, EMERGING HLTH THREAT, V2012, P5, DOI [10.3402/ehtj.v5i0.18147, DOI 10.3402/EHTJ.V5I0.18147]; Nishizawa M, 2012, CURR HYPERTENS REP, V14, P375, DOI 10.1007/s11906-012-0298-z; Nakano M, 2012, CIRC J, V76, P1283, DOI 10.1253/circj.CJ-12-0261; Fushimi Masahito, 2012, Prehosp Disaster Med, V27, P416, DOI 10.1017/S1049023X12001070; Igusa R, 2012, TOHOKU J EXP MED, V227, P179, DOI 10.1620/tjem.227.179; Kanamori H, 2011, INFECT CONT HOSP EP, V32, P824, DOI 10.1086/661224; Kazama JJ, 2011, LANCET, V377, P1652, DOI 10.1016/S0140-6736(11)60673-9; Kyutoku Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031014; Matsuda Y., 2012, BMC PUBLIC HEALTH, V12, P1471; Meguro K, 2011, NEUROLOGY, V77, pE12, DOI 10.1212/WNL.0b013e31822511a5; Ministry of Health Labor and Welfare, 2012, 143 REP 2011 PAC COA; Nishi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035248; Ochi S, 2013, PLOS CURR, V13, P5; Ogawa S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000830	14	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0737-1209	1525-1446		PUBLIC HEALTH NURS	Public Health Nurs.	NOV-DEC	2014	31	6					537	544		10.1111/phn.12141		8	Public, Environmental & Occupational Health; Nursing	Public, Environmental & Occupational Health; Nursing	AU3JW	WOS:000345510000008		
J	Walsh, L; Zhang, W; Shore, RE; Auvinen, A; Laurier, D; Wakeford, R; Jacob, P; Gent, N; Anspaugh, LR; Schuz, J; Kesminiene, A; van Deventer, E; Tritscher, A; Perez, MDR				Walsh, L.; Zhang, W.; Shore, R. E.; Auvinen, A.; Laurier, D.; Wakeford, R.; Jacob, P.; Gent, N.; Anspaugh, L. R.; Schuz, J.; Kesminiene, A.; van Deventer, E.; Tritscher, A.; Perez, M. del Rosario			A Framework for Estimating Radiation-Related Cancer Risks in Japan from the 2011 Fukushima Nuclear Accident	RADIATION RESEARCH			English	Article							ATOMIC-BOMB SURVIVORS; POWER-PLANT ACCIDENT; THYROID-CANCER; BREAST-CANCER; INCIDENCE RATES; MCIJ PROJECT; CHERNOBYL ACCIDENT; POOLED ANALYSIS; EXPOSURE; POPULATION	We present here a methodology for health risk assessment adopted by the World Health Organization that provides a framework for estimating risks from the Fukushima nuclear accident after the March 11, 2011 Japanese major earthquake and tsunami. Substantial attention has been given to the possible health risks associated with human exposure to radiation from damaged reactors at the Fukushima Daiichi nuclear power station. Cumulative doses were estimated and applied for each post-accident year of life, based on a reference level of exposure during the first year after the earthquake. A lifetime cumulative dose of twice the first year dose was estimated for the primary radionuclide contaminants (Cs-134 and Cs-137) and are based on Chernobyl data, relative abundances of cesium isotopes, and cleanup efforts. Risks for particularly radiosensitive cancer sites (leukemia, thyroid and breast cancer), as well as the combined risk for all solid cancers were considered. The male and female cumulative risks of cancer incidence attributed to radiation doses from the accident, for those exposed at various ages, were estimated in terms of the lifetime attributable risk (LAR). Calculations of LAR were based on recent Japanese population statistics for cancer incidence and current radiation risk models from the Life Span Study of Japanese A-bomb survivors. Cancer risks over an initial period of 15 years after first exposure were also considered. LAR results were also given as a percentage of the lifetime baseline risk (i.e., the cancer risk in the absence of radiation exposure from the accident). The LAR results were based on either a reference first year dose (10 mGy) or a reference lifetime dose (20 mGy) so that risk assessment may be applied for relocated and non-relocated members of the public, as well as for adult male emergency workers. The results show that the major contribution to LAR from the reference lifetime dose comes from the first year dose. For a dose of 10 mGy in the first year and continuing exposure, the lifetime radiation-related cancer risks based on lifetime dose (which are highest for children under 5 years of age at initial exposure), are small, and much smaller than the lifetime baseline cancer risks. For example, after initial exposure at age 1 year, the lifetime excess radiation risk and baseline risk of all solid cancers in females were estimated to be 0.7 . 10(-2) and 29.0 . 10(-2), respectively. The 15 year risks based on the lifetime reference dose are very small. However, for initial exposure in childhood, the 15 year risks based on the lifetime reference dose are up to 33 and 88% as large as the 15 year baseline risks for leukemia and thyroid cancer, respectively. The results may be scaled to particular dose estimates after consideration of caveats. One caveat is related to the lack of epidemiological evidence defining risks at low doses, because the predicted risks come from cancer risk models fitted to a wide dose range (0-4 Gy), which assume that the solid cancer and leukemia lifetime risks for doses less than about 0.5 Gy and 0.2 Gy, respectively, are proportional to organ/tissue doses: this is unlikely to seriously underestimate risks, but may overestimate risks. This WHO-HRA framework may be used to update the risk estimates, when new population health statistics data, dosimetry information and radiation risk models become available. (C) 2014 by Radiation Research Society	[Walsh, L.] BfS Fed Off Radiat Protect, D-85764 Oberschleissheim, Germany; [Zhang, W.; Gent, N.] Publ Hlth England, London, England; [Shore, R. E.] Radiat Effects Res Fdn, Hiroshima, Japan; [Auvinen, A.] Radiat & Nucl Safety Author, Helsinki, Finland; [Auvinen, A.] Univ Tampere, FIN-33101 Tampere, Finland; [Laurier, D.] Inst Radioprotect & Surete Nucl, Fontenay Aux Roses, France; [Wakeford, R.] Univ Manchester, Ctr Occupat & Environm Hlth, Inst Populat Hlth, Manchester, Lancs, England; [Jacob, P.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Neuherberg, Germany; [Jacob, P.] Inst Radiat Protect, Neuherberg, Germany; [Anspaugh, L. R.] Univ Utah, Div Radiobiol, Salt Lake City, UT 84112 USA; [Schuz, J.; Kesminiene, A.] Int Agcy Res Canc, Sect Environm & Radiat, F-69372 Lyon, France; [van Deventer, E.; Tritscher, A.; Perez, M. del Rosario] WHO, CH-1211 Geneva, Switzerland	Walsh, L (reprint author), BfS Fed Off Radiat Protect, Ingolstaedter Landstr 1, D-85764 Oberschleissheim, Germany.	lwalsh@bfs.de			Japanese Ministry of Health, Labour and Welfare (MHLW); U.S. Department of Energy (DOE); National Academy of Sciences	The authors would like to thank Ms. A. Pruss-Ustun for useful discussions and Dr. Simon Bouffler for critically reading the manuscript. This article makes use of data (RP 1-75) obtained from the Radiation Effects Research Foundation (RERF) in Hiroshima and Nagasaki, Japan. RERF is a private, nonprofit foundation funded by the Japanese Ministry of Health, Labour and Welfare (MHLW) and the U.S. Department of Energy (DOE), the latter through the National Academy of Sciences. The data include information obtained from the Hiroshima and Nagasaki City Prefecture Tumor Registries and the Hiroshima and Nagasaki Tissue Registries. The conclusions in this report are those of the authors and do not necessarily reflect the scientific judgment of RERF or its funding agencies.	RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Matsuda T, 2012, JPN J CLIN ONCOL, V42, P139, DOI 10.1093/jjco/hyr184; Furukawa K, 2013, INT J CANCER, V132, P1222, DOI 10.1002/ijc.27749; [Anonymous], 2008, EFF ION RAD; [Anonymous], 2011, FIN REP INT MISS SUP; Jacob P, 2006, RADIAT RES, V165, P1, DOI 10.1667/RR3479.1; THOMAS D, 1992, HEALTH PHYS, V63, P259, DOI 10.1097/00004032-199209000-00001; Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038; Evangeliou N, 2014, ENVIRON INT, V64, P17, DOI 10.1016/j.envint.2013.11.020; HILDRETH NG, 1989, NEW ENGL J MED, V321, P1281, DOI 10.1056/NEJM198911093211901; [Anonymous], 2013, REP UN SCI COMM EFF, V2; Jacob P, 2009, OCCUP ENVIRON MED, V66, P789, DOI 10.1136/oem.2008.043265; HARACH HR, 1985, CANCER, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; [Anonymous], 2011, 402R11001 EPA; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; [Anonymous], 2011, CANC STAT JAP TABL D; Ten Hoeve JE, 2012, ENERG ENVIRON SCI, V5, P8743, DOI 10.1039/c2ee22019a; Jung KW, 2013, CANCER RES TREAT, V45, P1, DOI 10.4143/crt.2013.45.1.1; Harada KH, 2014, P NATL ACAD SCI USA, V111, pE914, DOI 10.1073/pnas.1315684111; TOKUNAGA M, 1994, RADIAT RES, V138, P209, DOI 10.2307/3578591; [Anonymous], 2014, EFF AT RAD UNSCEAR 2; Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2; Masson O, 2011, ENVIRON SCI TECHNOL, V45, P7670, DOI 10.1021/es2017158; Endo S, 2012, J ENVIRON RADIOACTIV, V111, P18, DOI 10.1016/j.jenvrad.2011.11.006; Brito JP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4706; Center for Cancer Control and Information Services, CANC STAT JAP TABL D; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Daniels RD, 2011, OCCUP ENVIRON MED, V68, P457, DOI 10.1136/oem.2009.054684; DELIDES GS, 1987, NEOPLASMA, V34, P119; Dickman PW, 2003, INT J CANCER, V106, P580, DOI 10.1002/ijc.11258; Dose and Risk Calculation (DCAL) Software, 2006, DOS RISK CALC DCAL S; Douple EB, 2011, DISASTER MED PUBLIC, V5, pS122, DOI 10.1001/dmp.2011.21; Etherington G, 2014, INT J RADIAT BIOL, V16, P1; Forman D., 2013, CANC INCIDENCE 5 CON; Haddy N, 2010, CANCER CAUSE CONTROL, V21, P1807, DOI 10.1007/s10552-010-9607-5; Hayashi Y, 2010, CANCER-AM CANCER SOC, V116, P1646, DOI 10.1002/cncr.24872; Heidenreich WF, 1999, RADIAT RES, V151, P617, DOI 10.2307/3580038; Holmberg E, 2001, BRIT J CANCER, V85, P362, DOI 10.1054/bjoc.2001.1868; Hsu WL, 2013, RADIAT RES, V179, P361, DOI 10.1667/RR2892.1; IAEA, 2013, JOINT RAD EM MAN PLA; IARC Monographs on the evaluation of carcinogenic risks to humans, 2012, IARC MON EV CARC RIS, V100; International Commission on Radiological Protection, 2007, ANN ICRP, V103, P1; Kamada N, 2012, J ENVIRON RADIOACTIV, V110, P84, DOI 10.1016/j.jenvrad.2012.02.007; Kellerer AM, 2001, RADIAT ENVIRON BIOPH, V40, P249, DOI 10.1007/s004110100106; Mabuchi K, 2013, RADIAT RES, V179, P254, DOI 10.1667/RR3121.1; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Matsuda N, 2013, RADIAT RES, V179, P663, DOI 10.1667/RR3232.1; Matsuda T, 2010, JPN J CLIN ONCOL, V40, P1192, DOI 10.1093/jjco/hyq109; Ministry of Education/Culture/Sports/Science/Technology, 2011, READ RAD LEV FALL PR; National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Ohnishi T, 2012, RADIAT RES, V177, P1, DOI 10.1667/RR2830.1; P Jacob, 2014, RADIAT ENVIRON BIOPH, V53, P291; P Jacob, 2014, RADIAT ENVIRON BIOPH, V53, P403; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; United Nations, 2010, REP UN SCI COMM EFF; United Nations Scientific Committee on the Effects of Atomic Radiation, 2011, SOURC EFF ION RAD UN, V2; Wakeford R, 2011, J RADIOL PROT, V31, P167, DOI 10.1088/0952-4746/31/2/E02; Wakeford R., 2012, Annals of the ICRP, V41, P98, DOI 10.1016/j.icrp.2012.06.036; Walsh L, 2009, RADIAT RES, V172, P509, DOI 10.1667/RR1198.1; Walsh L, 2013, RADIAT ENVIRON BIOPH, V52, P135, DOI 10.1007/s00411-012-0441-x; Weiss W, 2012, J RADIOL PROT, V32, pN113, DOI 10.1088/0952-4746/32/1/N113; WHO, 2013, HLTH RISK ASS NUCL A; WHO, 2012, PREL DOS EST NUCL AC	64	1	1	RADIATION RESEARCH SOC	LAWRENCE	810 E TENTH STREET, LAWRENCE, KS 66044 USA	0033-7587	1938-5404		RADIAT RES	Radiat. Res.	NOV	2014	182	5					556	572		10.1667/RR13779.1		17	Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	AU4TL	WOS:000345604200008		
J	Sato, K; Adachi, T				Sato, Keita; Adachi, Takehiko			Continuous Versus Single-Injection Sciatic Nerve Block Added to Continuous Femoral Nerve Block for Analgesia After Total Knee Arthroplasty Reply	REGIONAL ANESTHESIA AND PAIN MEDICINE			English	Letter							PALSY		[Sato, Keita] Tokyo Womens Med Univ, Dept Anesthesiol, Tokyo, Japan; [Adachi, Takehiko] Kitano Hosp, Dept Anesthesiol, Osaka, Japan	Sato, K (reprint author), Tokyo Womens Med Univ, Dept Anesthesiol, Tokyo, Japan.						Nercessian OA, 2005, J ARTHROPLASTY, V20, P1068, DOI 10.1016/j.arth.2005.02.010; Zywiel MG, 2011, J ARTHROPLASTY, V26, P379, DOI 10.1016/j.arth.2010.03.020; Sato K, 2014, REGION ANESTH PAIN M, V39, P225, DOI 10.1097/AAP.0000000000000076; KRACKOW KA, 1993, CLIN ORTHOP RELAT R, P223; Sinha SK, 2012, ANESTH ANALG, V115, P202, DOI 10.1213/ANE.0b013e3182536193	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1098-7339	1532-8651		REGION ANESTH PAIN M	Region. Anesth. Pain Med.	NOV-DEC	2014	39	6					559	560				3	Anesthesiology	Anesthesiology	AT4SZ	WOS:000344933500023		
J	Ota, T; Ahmed, OS; Franklin, SE; Wulder, MA; Kajisa, T; Mizoue, N; Yoshida, S; Takao, G; Hirata, Y; Furuya, N; Sano, T; Heng, S; Vuthy, M				Ota, Tetsuji; Ahmed, Oumer S.; Franklin, Steven E.; Wulder, Michael A.; Kajisa, Tsuyoshi; Mizoue, Nobuya; Yoshida, Shigejiro; Takao, Gen; Hirata, Yasumasa; Furuya, Naoyuki; Sano, Takio; Heng, Sokh; Vuthy, Ma			Estimation of Airborne Lidar-Derived Tropical Forest Canopy Height Using Landsat Time Series in Cambodia	REMOTE SENSING			English	Article						Landsat time series; airborne Lidar; canopy height; random forest	RESOLUTION SATELLITE IMAGERY; TM TASSELED CAP; BIOMASS ESTIMATION; SOUTHEAST-ASIA; ABOVEGROUND BIOMASS; BRITISH-COLUMBIA; WESTERN OREGON; CARBON STOCKS; DISTURBANCE; INVENTORY	In this study, we test and demonstrate the utility of disturbance and recovery information derived from annual Landsat time series to predict current forest vertical structure (as compared to the more common approaches, that consider a sample of airborne Lidar and single-date Landsat derived variables). Mean Canopy Height (MCH) was estimated separately using single date, time series, and the combination of single date and time series variables in multiple regression and random forest (RF) models. The combination of single date and time series variables, which integrate disturbance history over the entire time series, overall provided better MCH prediction than using either of the two sets of variables separately. In general, the RF models resulted in improved performance in all estimates over those using multiple regression. The lowest validation error was obtained using Landsat time series variables in a RF model (R-2 = 0.75 and RMSE = 2.81 m). Combining single date and time series data was more effective when the RF model was used (opposed to multiple regression). The RMSE for RF mean canopy height prediction was reduced by 13.5% when combining the two sets of variables as compared to the 3.6% RMSE decline presented by multiple regression. This study demonstrates the value of airborne Lidar and long term Landsat observations to generate estimates of forest canopy height using the random forest algorithm.	[Ota, Tetsuji; Mizoue, Nobuya; Yoshida, Shigejiro] Kyushu Univ, Fac Agr, Fukuoka 8128581, Japan; [Ahmed, Oumer S.] Trent Univ, Dept Geog, Geomat Remote Sensing & Land Resources Lab, Peterborough, ON K9J 7B8, Canada; [Franklin, Steven E.] Trent Univ, Dept Geog, Dept Environm & Resource Studies Sci, Peterborough, ON K9J 7B8, Canada; [Franklin, Steven E.] Trent Univ, Off President, Peterborough, ON K9J 7B8, Canada; [Wulder, Michael A.] Nat Resources Canada, Pacific Forestry Ctr, Canadian Forest Serv, Victoria, BC V8Z 1M5, Canada; [Kajisa, Tsuyoshi] Kagoshima Univ, Fac Agr, Kagoshima 8908580, Japan; [Takao, Gen; Hirata, Yasumasa] Forestry & Forest Prod Res Inst, Dept Forest Management, Tsukuba, Ibaraki 3058687, Japan; [Furuya, Naoyuki] Hokkaido Res Ctr, Forestry & Forest Prod Res Inst, Sapporo, Hokkaido 0628516, Japan; [Sano, Takio] Asia Air Survey Co LTD, Asao Ku, Kawasaki, Kanagawa 2150004, Japan; [Heng, Sokh; Vuthy, Ma] Forestry Adm, Forest Wildlife Res & Dev Inst, Khan Sen Sok 12157, Phnom Penh, Cambodia	Ota, T (reprint author), Kyushu Univ, Fac Agr, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	chochoji1983@gmail.com; osahmed@trentu.ca; sfranklin@trentu.ca; Mike.Wulder@NRCan-RNCan.gc.ca; k2083442@agri.kagoshima-u.ac.jp; mizoue@agr.kyushu-u.ac.jp; syoshida@agr.kyushu-u.ac.jp; takaogen@affrc.go.jp; hirat09@affrc.go.jp; nfuruya@affrc.go.jp; tk.sano@ajiko.co.jp; sokhhengpiny@yahoo.com; vuthydalin@yahoo.com		Wulder, Michael/0000-0002-6942-1896	Technology development for circulatory food production systems responsive to climate change from Ministry of Agriculture, Forestry and Fisheries, Japan; NSERC (Natural Sciences and Engineering Research Council)	This research has been supported by Technology development for circulatory food production systems responsive to climate change from Ministry of Agriculture, Forestry and Fisheries, Japan and NSERC (Natural Sciences and Engineering Research Council) discovery grant awarded to Steven E. Franklin. The authors also acknowledge the valuable discussions with Joanne C. White at Canadian Forest Service, Natural Resources Canada.	Ahmed OS, 2014, CAN J REMOTE SENS, V39, P521, DOI 10.5589/m14-004; Ahmed O.S., 2014, ISPRS J PHO IN PRESS; Ahmed OS, 2014, PHOTOGRAMM ENG REM S, V80, P953, DOI 10.14358/PERS.80.10.953; Kennedy RE, 2007, REMOTE SENS ENVIRON, V110, P370, DOI 10.1016/j.rse.2007.03.010; Duro DC, 2012, REMOTE SENS ENVIRON, V118, P259, DOI 10.1016/j.rse.2011.11.020; CRIST EP, 1984, IEEE T GEOSCI REMOTE, V22, P256, DOI 10.1109/TGRS.1984.350619; Schroeder TA, 2006, REMOTE SENS ENVIRON, V103, P16, DOI 10.1016/j.rse.2006.03.008; Kuhn M, 2008, J STAT SOFTW, V28, P1; White JC, 2011, CAN J REMOTE SENS, V37, P234; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Helmer EH, 2010, REMOTE SENS ENVIRON, V114, P2457, DOI 10.1016/j.rse.2010.05.021; Hudak AT, 2008, REMOTE SENS ENVIRON, V112, P2232, DOI 10.1016/j.rse.2007.10.009; McInerney DO, 2009, INT J REMOTE SENS, V30, P4937, DOI 10.1080/01431160903022936; Fox J, 2005, ENVIRON MANAGE, V36, P394, DOI 10.1007/s00267-003-0288-7; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Hudak AT, 2002, REMOTE SENS ENVIRON, V82, P397, DOI 10.1016/S0034-4257(02)00056-1; Cohen WB, 2002, ECOSYSTEMS, V5, P122, DOI 10.1007/s10021-001-0060-X; Wulder MA, 2008, FOREST CHRON, V84, P221; Axelsson PE, 1999, ISPRS J PHOTOGRAMM, V54, P138, DOI 10.1016/S0924-2716(99)00008-8; Canty MJ, 2004, REMOTE SENS ENVIRON, V91, P441, DOI 10.1016/j.rse.2003.10.024; Padoch C, 2007, GEOGR TIDSSKR, V107, P29; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Palminteri S, 2012, REMOTE SENS ENVIRON, V127, P98, DOI 10.1016/j.rse.2012.08.014; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Lu DS, 2004, FOREST ECOL MANAG, V198, P149, DOI 10.1016/j.foreco.2004.03.048; Durbha SS, 2007, REMOTE SENS ENVIRON, V107, P348, DOI 10.1016/j.rse.2006.09.031; Asner GP, 2012, BIOGEOSCIENCES, V9, P2683, DOI 10.5194/bg-9-2683-2012; Gomez C, 2011, REMOTE SENS ENVIRON, V115, P1665, DOI 10.1016/j.rse.2011.02.025; Markham BL, 2004, IEEE T GEOSCI REMOTE, V42, P2691, DOI 10.1109/TGRS.2004.840720; Bruun TB, 2009, HUM ECOL, V37, P375, DOI 10.1007/s10745-009-9257-y; Song C, 2007, REMOTE SENS ENVIRON, V106, P228, DOI 10.1016/j.rse.2006.08.008; Hunter MO, 2013, BIOGEOSCIENCES, V10, P8385, DOI 10.5194/bg-10-8385-2013; Wulder MA, 2003, CAN J REMOTE SENS, V29, P536; Duncanson LI, 2010, CAN J REMOTE SENS, V36, P129; Donoghue DNM, 2007, REMOTE SENS ENVIRON, V110, P509, DOI 10.1016/j.rse.2007.02.032; Cohen WB, 1998, PHOTOGRAMM ENG REM S, V64, P293; Stone Christine, 2011, New Zealand Journal of Forestry Science, V41, P191; Wulder MA, 2012, REMOTE SENS ENVIRON, V122, P2, DOI 10.1016/j.rse.2012.01.010; Pflugmacher D, 2012, REMOTE SENS ENVIRON, V122, P146, DOI 10.1016/j.rse.2011.09.025; Moeser D, 2014, AGR FOREST METEOROL, V197, P158, DOI 10.1016/j.agrformet.2014.06.008; Hansen MJ, 2001, REMOTE SENS ENVIRON, V77, P50, DOI 10.1016/S0034-4257(01)00193-6; Gleason CJ, 2012, REMOTE SENS ENVIRON, V125, P80, DOI 10.1016/j.rse.2012.07.006; Falkowski MJ, 2009, REMOTE SENS ENVIRON, V113, P946, DOI 10.1016/j.rse.2009.01.003; Mon MS, 2012, FOREST ECOL MANAG, V267, P190, DOI 10.1016/j.foreco.2011.11.036; Cohen WB, 2004, BIOSCIENCE, V54, P535, DOI 10.1641/0006-3568(2004)054[0535:LRIEAO]2.0.CO;2; Gillanders SN, 2008, PROG PHYS GEOG, V32, P503, DOI 10.1177/0309133308098363; Maltamo M, 2006, FORESTRY, V79, P217, DOI 10.1093/forestry/cpl007; Cohen WB, 2010, REMOTE SENS ENVIRON, V114, P2911, DOI 10.1016/j.rse.2010.07.010; Woodcock CE, 2008, SCIENCE, V320, P1011, DOI 10.1126/science.320.5879.1011a; Powell SL, 2010, REMOTE SENS ENVIRON, V114, P1053, DOI 10.1016/j.rse.2009.12.018; Frazier RJ, 2014, ISPRS J PHOTOGRAMM, V92, P137, DOI 10.1016/j.isprsjprs.2014.03.003; Asner Gregory P, 2012, Carbon Balance Manag, V7, P2, DOI 10.1186/1750-0680-7-2; Breiman L., RANDOM FORESTS CLASS; Chavez PS, 1996, PHOTOGRAMM ENG REM S, V62, P1025; Chen G, 2011, INT J GEOGR INF SCI, V25, P877, DOI 10.1080/13658816.2010.496729; Chen G, 2011, PHOTOGRAMM ENG REM S, V77, P733; CRIST EP, 1985, REMOTE SENS ENVIRON, V17, P301, DOI 10.1016/0034-4257(85)90102-6; DFW, 1999, FOR COV ASS CAMB KHM; Franklin S. E., 2007, UNDERSTANDING FOREST; Gao F, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3104620; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Hilker T, 2008, CAN J REMOTE SENS, V34, P5; Kajisa T, 2007, J FOREST RES-JPN, V12, P435, DOI 10.1007/s10310-007-0030-z; Kajisa T, 2009, J FOREST RES-JPN, V14, P203, DOI 10.1007/s10310-009-0125-9; Li AM, 2011, REMOTE SENS ENVIRON, V115, P1837, DOI 10.1016/j.rse.2011.03.001; Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1016/J.MEMSCI.2010.02.036; Morsdorf F, 2010, REMOTE SENS ENVIRON, V114, P1403, DOI 10.1016/j.rse.2010.01.023; Powell SL, 2008, REMOTE SENS ENVIRON, V112, P1895, DOI 10.1016/j.rse.2007.09.010; Price KP, 1998, INT J REMOTE SENS, V19, P1627, DOI 10.1080/014311698215405; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1	71	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-4292			REMOTE SENS-BASEL	Remote Sens.	NOV	2014	6	11					10750	10772		10.3390/rs61110750		23	Remote Sensing	Remote Sensing	AU3RG	WOS:000345530700024		
J	Abe, Y; Hosoda, H; Arikawa, Y; Nagai, T; Kojima, S; Sakata, S; Inoue, H; Iwasa, Y; Iwano, K; Yamanoi, K; Fujioka, S; Nakai, M; Sarukura, N; Shiraga, H; Norimatsu, T; Azechi, H				Abe, Y.; Hosoda, H.; Arikawa, Y.; Nagai, T.; Kojima, S.; Sakata, S.; Inoue, H.; Iwasa, Y.; Iwano, K.; Yamanoi, K.; Fujioka, S.; Nakai, M.; Sarukura, N.; Shiraga, H.; Norimatsu, T.; Azechi, H.			Characterizing a fast-response, low-afterglow liquid scintillator for neutron time-of-flight diagnostics in fast ignition experiments	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								The characteristics of oxygen-enriched liquid scintillators with very low afterglow are investigated and optimized for application to a single-hit neutron spectrometer for fast ignition experiments. It is found that 1,2,4-trimethylbenzene has better characteristics as a liquid scintillator solvent than the conventional solvent, p-xylene. In addition, a benzophenon-doped BBQ liquid scintillator is shown to demonstrate very rapid time response, and therefore has potential for further use in neutron diagnostics with fast time resolution. (C) 2014 AIP Publishing LLC.	[Abe, Y.; Hosoda, H.; Arikawa, Y.; Nagai, T.; Kojima, S.; Sakata, S.; Inoue, H.; Iwasa, Y.; Iwano, K.; Yamanoi, K.; Fujioka, S.; Nakai, M.; Sarukura, N.; Shiraga, H.; Norimatsu, T.; Azechi, H.] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan	Abe, Y (reprint author), Osaka Univ, Inst Laser Engn, 2-6 Yamada Oka, Suita, Osaka 5650871, Japan.	abe-y@ile.osaka-u.ac.jp	Sarukura, Nobuhiko/F-3276-2015; Azechi, Hiroshi/H-5876-2015; Nakai, Mitsuo/I-6758-2015; Norimatsu, Takayoshi/I-5710-2015; Shiraga, Hiroyuki/I-9565-2015; Fujioka, Shinsuke/J-5530-2015; Yamanoi, Kohei/B-2150-2013; Arikawa, Yasunobu/L-8760-2015	Sarukura, Nobuhiko/0000-0003-2353-645X; Nakai, Mitsuo/0000-0001-6076-756X; Fujioka, Shinsuke/0000-0001-8406-1772; Yamanoi, Kohei/0000-0003-4492-4099; Arikawa, Yasunobu/0000-0002-3142-3060	Japan Society for the Promotion of Science [24244095, 23360413, 24686103, 25630419]; Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	This work was partly supported by the Japan Society for the Promotion of Science under a grant-in-aid for Scientific Research, Contract (A) Nos. 24244095 and (B) No. 23360413, a grant-in-aid for Young Scientists (A) No. 24686103, a grant-in-aid for Challenging Exploratory Research No. 25630419, and also the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) project on "Promotion of relativistic nuclear physics with ultra-intense laser."	TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; Arikawa Y, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4732180; Lauck R, 2009, IEEE T NUCL SCI, V56, P989, DOI 10.1109/TNS.2008.2009449; Nagai T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.080208	4	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E126	10.1063/1.4896957		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000146		
J	Akiyama, T; Yasuhara, R; Kawahata, K; Okajima, S; Nakayama, K				Akiyama, T.; Yasuhara, R.; Kawahata, K.; Okajima, S.; Nakayama, K.			Dispersion interferometer using modulation amplitudes on LHD	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							LASER	Since a dispersion interferometer is insensitive to mechanical vibrations, a vibration compensation system is not necessary. The CO2 laser dispersion interferometer with phase modulations on the Large Helical Device utilizes the new phase extraction method which uses modulation amplitudes and can improve a disadvantage of the original dispersion interferometer: measurement errors caused by variations of detected intensities. The phase variation within +/- 2 x 10(17) m(-3) is obtained without vibration compensation system. The measured line averaged electron density with the dispersion interferometer shows good agreement with that with the existing far infrared laser interferometer. Fringe jump errors in high density ranging up to 1.5 x 10(20) m(-3) can be overcome by a sufficient sampling rate of about 100 kHz. (C) 2014 AIP Publishing LLC.	[Akiyama, T.; Yasuhara, R.; Kawahata, K.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Okajima, S.; Nakayama, K.] Chubu Univ, Kasugai, Aichi 4878501, Japan	Akiyama, T (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	takiyama@lhd.nifs.ac.jp					Akiyama T, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2786938; Akiyama T, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/01/C01055; Akiyama Tsuyoshi, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.S1041; Akiyama T, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2229275; Akiyama T, 2003, REV SCI INSTRUM, V74, P2695, DOI 10.1063/1.1564276; Alum Kh. P., 1981, Soviet Technical Physics Letters, V7; HOPF FA, 1980, OPT LETT, V5, P386, DOI 10.1364/OL.5.000386; Urabe K, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/26/262001; Bagryansky PA, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2202922; Shi YJ, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2185492; DRACHEV VP, 1993, REV SCI INSTRUM, V64, P1010, DOI 10.1063/1.1144170; Fuchs C, 1998, PHYS REV LETT, V81, P1626, DOI 10.1103/PhysRevLett.81.1626; Bamford DJ, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4819028; Brandi F, 2007, OPT LETT, V32, P2327, DOI 10.1364/OL.32.002327; Kawano Y, 2001, REV SCI INSTRUM, V72, P1068, DOI 10.1063/1.1321743; Kornejew P., 2012, P 39 EPS C PLASM PHY, pP5037; Lizunov A, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2969466; Park HK, 1999, REV SCI INSTRUM, V70, P710, DOI 10.1063/1.1149364	18	2	2	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D301	10.1063/1.4886777		7	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000002		
J	Arikawa, Y; Nagai, T; Abe, Y; Kojima, S; Sakata, S; Inoue, H; Utsugi, M; Iwasa, Y; Murata, T; Sarukura, N; Nakai, M; Shiraga, H; Fujioka, S; Azechi, H				Arikawa, Y.; Nagai, T.; Abe, Y.; Kojima, S.; Sakata, S.; Inoue, H.; Utsugi, M.; Iwasa, Y.; Murata, T.; Sarukura, N.; Nakai, M.; Shiraga, H.; Fujioka, S.; Azechi, H.			Development of multichannel low-energy neutron spectrometer	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							DETECTOR	A multichannel low-energy neutron spectrometer for down-scattered neutron (DSN) measurements in inertial confinement fusion (ICF) experiments has been developed. Our compact-size 256-channel lithium-glass-scintillator-based spectrometer has been implemented and tested in ICF experiments with the GEKKO XII laser. We have performed time calibration of the 256-channel analog-to-digital convertor system used for DSN measurements via X-ray pulse signals. We have clearly observed the DD-primary fusion neutron signal and have successfully studied the detector's impulse response. Our detector is soon to be implemented in future ICF experiments. (C) 2014 AIP Publishing LLC.	[Arikawa, Y.; Nagai, T.; Abe, Y.; Kojima, S.; Sakata, S.; Inoue, H.; Utsugi, M.; Iwasa, Y.; Sarukura, N.; Nakai, M.; Shiraga, H.; Fujioka, S.; Azechi, H.] Osaka Univ, Inst Laser Engn, Suita, Osaka 565, Japan; [Murata, T.] Kumamoto Univ, Kumamoto 8608555, Japan	Arikawa, Y (reprint author), Osaka Univ, Inst Laser Engn, 2-6 Yamada Oka, Suita, Osaka 565, Japan.	arikawa-y@ile.osaka-u.ac.jp	Sarukura, Nobuhiko/F-3276-2015; Azechi, Hiroshi/H-5876-2015; Nakai, Mitsuo/I-6758-2015; Shiraga, Hiroyuki/I-9565-2015; Fujioka, Shinsuke/J-5530-2015; Arikawa, Yasunobu/L-8760-2015	Sarukura, Nobuhiko/0000-0003-2353-645X; Nakai, Mitsuo/0000-0001-6076-756X; Fujioka, Shinsuke/0000-0001-8406-1772; Arikawa, Yasunobu/0000-0002-3142-3060	GEKKO XII operation group; LFEX development and operation group; target fabrication group of the Institute of Laser Engineering, Osaka University; plasma diagnostics operation group of the Institute of Laser Engineering, Osaka University; Japan Society for the Promotion of Science [24244095, 23360413, 24686103, 25630419]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), NIFS collaboration research program [NIFS KUGK057, KUGK070]	The authors gratefully acknowledge the support of the GEKKO XII operation group, the LFEX development and operation group, the target fabrication group, and the plasma diagnostics operation group of the Institute of Laser Engineering, Osaka University. This work was partly supported by the Japan Society for the Promotion of Science under Grants-in-Aid for Scientific Research (A) No. 24244095 and (B) No. 23360413, Grant-in-Aid for Young Scientists (A) No. 24686103, Grant-in-Aid for Challenging Exploratory Research No. 25630419, and the support of the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) project on "Promotion of relativistic nuclear physics with ultra-intense lasers," NIFS collaboration research program NIFS KUGK057, KUGK070.	Frenje JA, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/4/043014; Hurricane OA, 2014, NATURE, V506, P343, DOI 10.1038/nature13008; Sangster TC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.185006; Arikawa Y, 2013, EPJ WEB CONF, V59, DOI 10.1051/epjconf/20135913011; Arikawa Y, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3254444; Bleuel DL, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4733741; Brown F.B., 2002, LAUR023199; Frenje JA, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2956837; Izumi N, 1999, REV SCI INSTRUM, V70, P1221, DOI 10.1063/1.1149430; Rygg JR, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.195001; Shiraga H, 2012, HIGH ENERG DENS PHYS, V8, P227, DOI 10.1016/j.hedp.2012.03.008	11	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E125	10.1063/1.4895826		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000145		
J	Cui, ZY; Dong, CF; Zhou, HY; Morita, S; Sun, P; Fu, BZ; Lu, P; Ding, XT; Yang, QW; Duan, XR				Cui, Zhengying; Dong, Chunfeng; Zhou, Hangyu; Morita, Shigeru; Sun, Ping; Fu, Bingzhong; Lu, Ping; Ding, Xuantong; Yang, Qingwei; Duan, Xuru			First measurements of highly ionized impurity emission distribution by grazing-incidence flat-field extreme ultraviolet spectrometer in HL-2A	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							PLASMA; TRANSPORT; TOKAMAK; EDGE	A space-resolved grazing-incidence flat-field extreme ultraviolet (EUV) spectrometer has been developed in the HL-2A tokamak to measure vertical impurity emission profiles with simultaneous spectral, temporal, and spatial resolution. The spectrometer working in the wavelength range of 30-500 angstrom has been equipped with a gold-coated varied-line-spacing holographic grating with curvature of 5606 mm and a back illuminated charge-coupled device with size of 6.6 x 26.6 mm(2) (255 x 1024 pixels). A lower half of the HL-2A plasma with averaged minor radius of 40 cm is observed when the spectrometer with horizontal dispersion is placed at a distance of 7.5 m away from the plasma center. An excellent spatial resolution of 12 mm is achieved when a space-resolved slit with vertical width of 0.5 mm is adopted. The radial profiles of intrinsic impurities in several ionization stages have been measured with high throughput and extremely low stray light. (C) 2014 AIP Publishing LLC.	[Cui, Zhengying; Dong, Chunfeng; Zhou, Hangyu; Sun, Ping; Fu, Bingzhong; Lu, Ping; Ding, Xuantong; Yang, Qingwei; Duan, Xuru] Southwestern Inst Phys, Chengdu 610041, Peoples R China; [Morita, Shigeru] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Cui, ZY (reprint author), Southwestern Inst Phys, POB 432, Chengdu 610041, Peoples R China.	cuizy@swip.ac.cn			National Natural Science Foundation of China [11375057, 11175061]; National Magnetic Confinement Fusion Science Program [2014GB108003]; JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC) [11261140328]	The authors would like to acknowledge Dr. Motoshi Goto from NIFS for his effort on data acquisition system. The authors are also thankful to the HL-2A team for their technical supports. This work is partially supported by the National Natural Science Foundation of China under Grant Nos. 11375057 and 11175061, National Magnetic Confinement Fusion Science Program 2014GB108003, and also by the JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC: No. 11261140328).	Morita S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093017; ISLER RC, 1984, NUCL FUSION, V24, P1599, DOI 10.1088/0029-5515/24/12/008; Beiersdorfer P, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2953488; Cui ZY, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3378288; Chowdhuri MB, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2437742; Dong CF, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3299060; Morita S, 2003, REV SCI INSTRUM, V74, P2375, DOI 10.1063/1.1556942; Cui ZY, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093001; CASTRACANE J, 1987, PLASMA PHYS CONTR F, V29, P759, DOI 10.1088/0741-3335/29/6/006; Chowdhuri MB, 2008, APPL OPTICS, V47, P135, DOI 10.1364/AO.47.000135; Cui XW, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/12/125201; Cui ZY, 2006, CHINESE PHYS LETT, V23, P2143, DOI 10.1088/0256-307X/23/8/050; Dong CF, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3658050; Dong CF, 2011, PLASMA SCI TECHNOL, V13, P140, DOI 10.1088/1009-0630/13/2/03; FONCK RJ, 1982, APPL OPTICS, V21, P2115, DOI 10.1364/AO.21.002115; Reinke ML, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3494380; STANGEBY PC, 1990, J NUCL MATER, V176, P51, DOI 10.1016/0022-3115(90)90028-L; Wang EH, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4705290; Zhou HY, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4729671	19	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E426	10.1063/1.4891708		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000174		
J	Furui, H; Nagashima, Y; Takase, Y; Ejiri, A; Kakuda, H; Sonehara, M; Oosako, T; Tsujii, N; Hiratsuka, J; Imamura, K; Inada, T; Nakamura, K; Nakanishi, A; Shinya, T; Togashi, H; Tsuda, S; Wakatsuki, T; Yamaguchi, T				Furui, H.; Nagashima, Y.; Takase, Y.; Ejiri, A.; Kakuda, H.; Sonehara, M.; Oosako, T.; Tsujii, N.; Hiratsuka, J.; Imamura, K.; Inada, T.; Nakamura, K.; Nakanishi, A.; Shinya, T.; Togashi, H.; Tsuda, S.; Wakatsuki, T.; Yamaguchi, T.			Local current density measurement using a Rogowski probe in Tokyo Spherical Tokamak-2	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								A Rogowski probe consisting of a small multi-layer Rogowski coil, five magnetic pick-up coils, and a Langmuir probe was developed to measure the local current density and its direction. It can be moved along the major radius and can be turned around its axis. This probe was used to measure the current density profile near the last closed flux surface of Ohmic plasmas in Tokyo Spherical Tokamak-2. The current density profile was measured successfully with a signal to noise ratio of greater than 20. (C) 2014 AIP Publishing LLC.	[Furui, H.; Takase, Y.; Ejiri, A.; Kakuda, H.; Sonehara, M.; Oosako, T.; Tsujii, N.; Hiratsuka, J.; Imamura, K.; Inada, T.; Nakamura, K.; Nakanishi, A.; Shinya, T.; Togashi, H.; Tsuda, S.; Wakatsuki, T.; Yamaguchi, T.] Univ Tokyo, Kashiwa, Chiba 2778561, Japan; [Nagashima, Y.] Kyushu Univ, Kasuga, Fukuoka 8168680, Japan	Yamaguchi, T (reprint author), Univ Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 2778561, Japan.	furui@fusion.k.u-tokyo.ac.jp	Kyushu, RIAM/F-4018-2015		Japan Society for the Promotion of Science [23360409, 21226021]; National Institute for Fusion Science Collaborative Research Program [NIFSKOAR12]	This work is supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research 23360409 and 21226021, and by National Institute for Fusion Science Collaborative Research Program NIFSKOAR12. We appreciate many suggestions by Mr. A. Saito for technical support in fabricating the probe.	Takase Y, 2001, NUCL FUSION, V41, P1543, DOI 10.1088/0029-5515/41/11/303; Bongard MW, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3475539; Bongard MW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.035003; Ejiri A., 2003, Nuclear Fusion, V43, DOI 10.1088/0029-5515/43/7/306; Furui H., 2014, PLASMA FUSION RES, V9; LAO LL, 1985, NUCL FUSION, V25, P1611, DOI 10.1088/0029-5515/25/11/007; Narayanan R, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2173032; Rogowsfti W., 1912, Archiv fur Elektrotechnik, V1, DOI 10.1007/BF01656479; Torbert E, 2003, REV SCI INSTRUM, V74, P5097, DOI 10.1063/1.1626010	9	2	2	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D813	10.1063/1.4887277		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000067		
J	Furui, H; Nagashima, Y; Takase, Y; Ejiri, A; Kakuda, H; Sonehara, M; Oosako, T; Tsujii, N; Hiratsuka, J; Imamura, K; Inada, T; Nakamura, K; Nakanishi, A; Shinya, T; Togashi, H; Tsuda, S; Wakatsuki, T; Yamaguchi, T				Furui, H.; Nagashima, Y.; Takase, Y.; Ejiri, A.; Kakuda, H.; Sonehara, M.; Oosako, T.; Tsujii, N.; Hiratsuka, J.; Imamura, K.; Inada, T.; Nakamura, K.; Nakanishi, A.; Shinya, T.; Togashi, H.; Tsuda, S.; Wakatsuki, T.; Yamaguchi, T.			Local current density measurement using a Rogowski probe in the Tokyo Spherical Tokamak-2 vol 85, 11D813, 2014	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Correction									[Furui, H.; Takase, Y.; Ejiri, A.; Kakuda, H.; Sonehara, M.; Oosako, T.; Tsujii, N.; Hiratsuka, J.; Imamura, K.; Inada, T.; Nakamura, K.; Nakanishi, A.; Shinya, T.; Togashi, H.; Tsuda, S.; Wakatsuki, T.; Yamaguchi, T.] Univ Tokyo, Kashiwa, Chiba 2778561, Japan; [Nagashima, Y.] Kyushu Univ, Fukuoka 8168680, Japan	Furui, H (reprint author), Univ Tokyo, 5-1-5 Kasshiwanoha, Kashiwa, Chiba 2778561, Japan.	furui@fusion.k.u-tokyo.ac.jp	Kyushu, RIAM/F-4018-2015				Furui H, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4887277	1	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11								10.1063/1.4898800		1	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000236		
J	Huang, XL; Morita, S; Oishi, T; Goto, M; Zhang, HM				Huang, X. L.; Morita, S.; Oishi, T.; Goto, M.; Zhang, H. M.			Coaxial pellets for metallic impurity injection on the large helical device	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							TUNGSTEN; FUSION	Two coaxial pellets with tungsten inserted into graphite carbon and polyethylene (PE) tubes are compared for tungsten spectroscopic study in the Large Helical Device. The tungsten pellet with carbon tube causes plasma collapse, while that with PE tube smoothly ablates without collapse. The deposition profile of the pellets is analyzed with a help of pellet ablation spectroscopy. It is found that the tungsten pellet with carbon tube can significantly penetrate into the core plasma and leads to the plasma collapse. A tungsten spectrum with radial profile is successfully observed when the tungsten pellet with PE tube is used. (C) 2014 AIP Publishing LLC.	[Huang, X. L.; Morita, S.; Oishi, T.; Goto, M.; Zhang, H. M.] Grad Univ Adv Studies, Dept Fus Sci, Toki, Gifu 5095292, Japan; [Morita, S.; Oishi, T.; Goto, M.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Huang, XL (reprint author), Grad Univ Adv Studies, Dept Fus Sci, Toki, Gifu 5095292, Japan.	huang.xianli@nifs.ac.jp			LHD project [NIFS13ULPP010]; JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC) [11261140328]; JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NRF) [2012K2A2A6000443];  [23340183]	The authors thank all the members of the LHD experiment group for their cooperation including technical supports. This work was partially supported by LHD project (NIFS13ULPP010), Grant-in-Aid for Scientific Research (B) 23340183, and JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC: No. 11261140328, NRF: No. 2012K2A2A6000443).	Morisaki T, 2003, J NUCL MATER, V313, P548, DOI 10.1016/S0022-3115(02)01467-8; Morita S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093017; Clementson J, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3499607; Clementson J, 2013, AIP CONF PROC, V1525, P78, DOI 10.1063/1.4802294; Suzuki C, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/17/175004; Neu R, 2002, PLASMA PHYS CONTR F, V44, P811, DOI 10.1088/0741-3335/44/6/313; Matthews GF, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014001; Morita S, 2013, AIP CONF PROC, V1545, P143, DOI 10.1063/1.4815848; Katai R, 2007, JPN J APPL PHYS 1, V46, P3667, DOI 10.1143/JJAP.46.3667; Pitts RA, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014001; BILLMEYER FW, 1957, J APPL PHYS, V28, P1114, DOI 10.1063/1.1722589; Chowdhuri M B, 2007, PLASMA FUSION RES, V2, pS1060, DOI DOI 10.1585/PFR.2.S1060; Chowdhuri MB, 2008, APPL OPTICS, V47, P135, DOI 10.1364/AO.47.000135; Dong CF, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4733733; Huang XL, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4872384; Morita S, 2011, PLASMA SCI TECHNOL, V13, P290, DOI 10.1088/1009-0630/13/3/05; Nozato H, 2003, REV SCI INSTRUM, V74, P2032, DOI 10.1063/1.1535251; PARKS PB, 1988, NUCL FUSION, V28, P477, DOI 10.1088/0029-5515/28/3/012	18	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E818	10.1063/1.4892440		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000224		
J	Idei, H; Nagata, K; Mishra, K; Yamamoto, MK; Itado, T; Akimoto, R; Hanada, K; Zushi, H				Idei, H.; Nagata, K.; Mishra, K.; Yamamoto, M. K.; Itado, T.; Akimoto, R.; Hanada, K.; Zushi, H.			Adaptive array technique for differential-phase reflectometry in QUEST	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							PROFILE MEASUREMENTS; TOKAMAK	A Phased Array Antenna (PAA) was considered as launching and receiving antennae in reflectometry to attain good directivity in its applied microwave range. A well-focused beam was obtained in a launching antenna application, and differential-phase evolution was properly measured by using a metal reflector plate in the proof-of-principle experiment at low power test facilities. Differential-phase evolution was also evaluated by using the PAA in the Q-shu University Experiment with Steady State Spherical Tokamak (QUEST). A beam-forming technique was applied in receiving phased-array antenna measurements. In the QUEST device that should be considered as a large oversized cavity, standing wave effect was significantly observed with perturbed phase evolution. A new approach using derivative of measured field on propagating wavenumber was proposed to eliminate the standing wave effect. (C) 2014 AIP Publishing LLC.	[Idei, H.; Hanada, K.; Zushi, H.] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168560, Japan; [Nagata, K.; Mishra, K.; Itado, T.; Akimoto, R.] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Yamamoto, M. K.] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto 6110011, Japan	Idei, H (reprint author), Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168560, Japan.	idei@triam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015; Idei, Hiroshi/F-3291-2015		Collaborative Research Program of the Research Institute for Applied Mechanics, Kyushu University; NIFS;  [B21360452]	The author (H.I.) would like to express thanks to the QUEST team for fruitful discussions. This work was supported by Grant-in-aid for Scientific Research (B21360452), and was supported in part by the Collaborative Research Program of the Research Institute for Applied Mechanics, Kyushu University. This work was also performed in part with the support and under the auspices of the NIFS Collaboration Research Program.	Mazzucato E, 1998, REV SCI INSTRUM, V69, P2201, DOI 10.1063/1.1149121; DELALUNA E, 1995, PLASMA PHYS CONTR F, V37, P925, DOI 10.1088/0741-3335/37/9/001; HANSON GR, 1995, REV SCI INSTRUM, V66, P863, DOI 10.1063/1.1146187; Idei H., 2010, J PLASMA FUSION RES, V9, P112; Idei H, 2012, PLASMA FUSION RES, V7; Mishra K, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4889903; Peebles WA, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3464266; Shevchenko V, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.265005	8	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D842	10.1063/1.4891710		5	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000096		
J	Isobe, M; Ogawa, K; Miyake, H; Hayashi, H; Kobuchi, T; Nakano, Y; Watanabe, K; Uritani, A; Misawa, T; Nishitani, T; Tomitaka, M; Kumagai, T; Mashiyama, Y; Ito, D; Kono, S; Yamauchi, M; Takeiri, Y				Isobe, M.; Ogawa, K.; Miyake, H.; Hayashi, H.; Kobuchi, T.; Nakano, Y.; Watanabe, K.; Uritani, A.; Misawa, T.; Nishitani, T.; Tomitaka, M.; Kumagai, T.; Mashiyama, Y.; Ito, D.; Kono, S.; Yamauchi, M.; Takeiri, Y.			Wide dynamic range neutron flux monitor having fast time response for the Large Helical Device	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							CALIBRATION	A fast time response, wide dynamic range neutron flux monitor has been developed toward the LHD deuterium operation by using leading-edge signal processing technologies providing maximum counting rate up to similar to 5 x 10(9) counts/s. Because a maximum total neutron emission rate over 1 x 10(16) n/s is predicted in neutral beam-heated LHD plasmas, fast response and wide dynamic range capabilities of the system are essential. Preliminary tests have demonstrated successful performance as a wide dynamic range monitor along the design. (C) 2014 AIP Publishing LLC.	[Isobe, M.; Ogawa, K.; Miyake, H.; Hayashi, H.; Kobuchi, T.; Takeiri, Y.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Isobe, M.; Takeiri, Y.] Grad Univ Adv Studies, Dept Fus Sci, Toki, Gifu 5095292, Japan; [Nakano, Y.; Watanabe, K.; Uritani, A.] Nagoya Univ, Dept Mat Phys & Energy Engn, Nagoya, Aichi 4648603, Japan; [Misawa, T.] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan; [Nishitani, T.] Japan Atom Energy Agcy, Rokkasho 0393212, Japan; [Tomitaka, M.; Kumagai, T.; Mashiyama, Y.; Ito, D.; Kono, S.] Toshiba Co Ltd, Fuchu, Tokyo 1838511, Japan; [Yamauchi, M.] Toshiba Nucl Engn Serv Corp, Yokohama, Kanagawa 2358523, Japan	Isobe, M (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	isobe@nifs.ac.jp			LHD project [ULGG801]; NIFS Collaboration Research program [KOAH029]; JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC) [11261140328, 2012K2A2A6000443]; JSPS [26289359]	This work was supported by the LHD project budget (ULGG801). This work was partly performed with the support and under the auspices of the NIFS Collaboration Research program (KOAH029), and under the Visiting Researchers Program of Kyoto University Research Reactor Institute. M.I. also wishes to thank generous supports by the JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC: No. 11261140328, NRF: No. 2012K2A2A6000443) and JSPS Grant-in-Aid for Scientific Research (B) Grant No. 26289359.	Iiyoshi A, 1999, NUCL FUSION, V39, P1245, DOI 10.1088/0029-5515/39/9Y/313; NISHITANI T, 1992, REV SCI INSTRUM, V63, P5270, DOI 10.1063/1.1143439; ENDO Y, 1982, IEEE T NUCL SCI, V29, P714, DOI 10.1109/TNS.1982.4335943; ENGLAND AC, 1986, REV SCI INSTRUM, V57, P1754, DOI 10.1063/1.1139171; Hendel H. W., 1982, Proceedings of the Fourth ASTM-EURATOM Symposium on Reactor Dosimetry. Radiation Metrology Techniques, Data Bases, and Standardization (NUREG/CP-0029); Isobe M, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3492383; Kaneko O, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104015; KOBAYASHI K, 1979, NUCL SCI ENG, V71, P143; Nakano Y., PLASMA FUSI IN PRESS; Nishimura K., 2008, PLASMA FUSION RES, V3, pS1024; Nishio N, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3478997; Nishio Naoto, 2011, Plasma and Fusion Research, V6, DOI 10.1585/pfr.6.2405115; Nishitani T., 1992, J JPN SOC PLASMA SCI, V68, P6; STRACHAN JD, 1990, REV SCI INSTRUM, V61, P3501, DOI 10.1063/1.1141558; Takeiri Y., 2013, JOINT 19 INT STELL H, pB14	15	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E114	10.1063/1.4891049		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000134		
J	Kamio, S; Takahashi, H; Kubo, S; Shimozuma, T; Yoshimura, Y; Igami, H; Ito, S; Kobayashi, S; Mizuno, Y; Okada, K; Osakabe, M; Mutoh, T				Kamio, S.; Takahashi, H.; Kubo, S.; Shimozuma, T.; Yoshimura, Y.; Igami, H.; Ito, S.; Kobayashi, S.; Mizuno, Y.; Okada, K.; Osakabe, M.; Mutoh, T.			Electron cyclotron beam measurement system in the Large Helical Device	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							LHD	In order to evaluate the electron cyclotron (EC) heating power inside the Large Helical Device vacuum vessel and to investigate the physics of the interaction between the EC beam and the plasma, a direct measurement system for the EC beam transmitted through the plasma column was developed. The system consists of an EC beam target plate, which is made of isotropic graphite and faces against the EC beam through the plasma, and an IR camera for measuring the target plate temperature increase by the transmitted EC beam. This system is applicable to the high magnetic field (up to 2.75 T) and plasma density (up to 0.8 x 10(19) m(-3)). This system successfully evaluated the transmitted EC beam profile and the refraction. (C) 2014 AIP Publishing LLC.	[Kamio, S.; Takahashi, H.; Kubo, S.; Shimozuma, T.; Yoshimura, Y.; Igami, H.; Ito, S.; Kobayashi, S.; Mizuno, Y.; Okada, K.; Osakabe, M.; Mutoh, T.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Kamio, S (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	kamio@nifs.ac.jp			NIFS [ULRR701, 804]	The authors gratefully acknowledge the LHD experimental group for their operation of LHD, and the heating and diagnostic devices. This work was supported by NIFS Grant Nos. ULRR701 and 804.	Takahashi H, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4884365; Shimozuma T, 2010, FUSION SCI TECHNOL, V58, P530; Shimozuma T, 2008, J PHYS CONF SER, V123, DOI 10.1088/1742-6596/123/1/012022; Takahashi H, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073034; Yamada H, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/9/094021; Igami H, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/11/115005; Kaneko O, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104015; Kubo S, 2005, PLASMA PHYS CONTR F, V47, pA81, DOI 10.1088/0741-3335/47/5A/008; Kubo S., 2008, P 22 IAEA FUS EN C I, V83; Shimozuma T, 2006, FUSION SCI TECHNOL, V50, P403; Takahashi H., EPJ WEB C IN PRESS; Yoshimura Y., 2005, Journal of Physics: Conference Series, V25, DOI 10.1088/1742-6596/25/1/024; Yoshimura Y, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/6/063004	13	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E822	10.1063/1.4893432		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000228		
J	Kenmochi, N; Minami, T; Takahashi, C; Tei, S; Mizuuchi, T; Kobayashi, S; Nagasaki, K; Nakamura, Y; Okada, H; Kado, S; Yamamoto, S; Ohshima, S; Konoshima, S; Shi, N; Zang, L; Ohtani, Y; Kasajima, K; Sano, F				Kenmochi, N.; Minami, T.; Takahashi, C.; Tei, S.; Mizuuchi, T.; Kobayashi, S.; Nagasaki, K.; Nakamura, Y.; Okada, H.; Kado, S.; Yamamoto, S.; Ohshima, S.; Konoshima, S.; Shi, N.; Zang, L.; Ohtani, Y.; Kasajima, K.; Sano, F.			First measurement of time evolution of electron temperature profiles with Nd:YAG Thomson scattering system on Heliotron	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								A Nd:YAG Thomson scattering system has been developed for Heliotron J. The system consists of two 550 mJ 50 Hz lasers, large collection optics, and 25 radial channel (similar to 1 cm spatial resolution) interference polychromators. This measurement system achieves a S/N ratio of similar to 50 for low-density plasma (n(e) similar to 0.5 x 10(19) m(-3)). A time evolution of electron temperature profiles was measured with this system for a high-intensity gas-puff (HIGP) fueling neutral-beam-injection plasma. The peripheral temperature of the higher-density phase after HIGP recovers to the low-density pre-HIGP level, suggesting that improving particle transport in the HIGP plasma may be possible. (C) 2014 AIP Publishing LLC.	[Kenmochi, N.; Tei, S.; Zang, L.; Ohtani, Y.; Kasajima, K.] Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto 6110011, Japan; [Minami, T.; Takahashi, C.; Mizuuchi, T.; Kobayashi, S.; Nagasaki, K.; Nakamura, Y.; Okada, H.; Kado, S.; Yamamoto, S.; Ohshima, S.; Konoshima, S.; Shi, N.; Sano, F.] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan	Kenmochi, N (reprint author), Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto 6110011, Japan.	kemmchi.naoki.62r@st.kyoto-u.ac.jp			Collaboration Program of the Laboratory for Complex Energy Process, Institute of Advanced Energy, Kyoto University; NIFS Collaborative Research Program [NIFS10KUHK030, NIFS09KUHL, NIFS10KUHL033]	This work was supported by the Collaboration Program of the Laboratory for Complex Energy Process, Institute of Advanced Energy, Kyoto University, and the NIFS Collaborative Research Program (NIFS10KUHK030, NIFS09KUHL, and NIFS10KUHL033).	Sano F, 2005, NUCL FUSION, V45, P1557, DOI 10.1088/0029-5515/45/12/011; CARLSTROM TN, 1990, REV SCI INSTRUM, V61, P2858, DOI 10.1063/1.1141806; Kenmochi N., 2013, PLASMA FUSION RES, V8; Minami T, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3496977; Mizuuchi T., 2012, IAEA FEC2012 8 13 OC; Mizuuchi T, 2011, J NUCL MATER, V415, pS443, DOI 10.1016/j.jnucmat.2010.10.027	6	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D819	10.1063/1.4890255		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000073		
J	Kishimoto, S; Mitsui, T; Haruki, R; Yoda, Y; Taniguchi, T; Shimazaki, S; Ikeno, M; Saito, M; Tanaka, M				Kishimoto, S.; Mitsui, T.; Haruki, R.; Yoda, Y.; Taniguchi, T.; Shimazaki, S.; Ikeno, M.; Saito, M.; Tanaka, M.			Nuclear resonant scattering measurements on Fe-57 by multichannel scaling with a 64-pixel silicon avalanche photodiode linear-array detector	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							SYNCHROTRON-RADIATION; X-RAY	We developed a silicon avalanche photodiode (Si-APD) linear-array detector for use in nuclear resonant scattering experiments using synchrotron X-rays. The Si-APD linear array consists of 64 pixels (pixel size: 100 x 200 mu m(2)) with a pixel pitch of 150 mu m and depletion depth of 10 mu m. An ultrafast frontend circuit allows the X-ray detector to obtain a high output rate of >10(7) cps per pixel. High-performance integrated circuits achieve multichannel scaling over 1024 continuous time bins with a 1 ns resolution for each pixel without dead time. The multichannel scaling method enabled us to record a time spectrum of the 14.4 keV nuclear radiation at each pixel with a time resolution of 1.4 ns (FWHM). This method was successfully applied to nuclear forward scattering and nuclear small-angle scattering on Fe-57. (C) 2014 AIP Publishing LLC.	[Kishimoto, S.; Haruki, R.] High Energy Accelerator Org, Inst Mat Struct Sci, KEK, Tsukuba, Ibaraki 3050801, Japan; [Mitsui, T.] JAEA, Kansai Photon Sci Inst, Sayo, Hyogo 6795198, Japan; [Yoda, Y.] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Taniguchi, T.; Shimazaki, S.; Ikeno, M.; Saito, M.; Tanaka, M.] High Energy Accelerator Org, Inst Particle & Nucl Studies, KEK, Tsukuba, Ibaraki 3050801, Japan	Kishimoto, S (reprint author), High Energy Accelerator Org, Inst Mat Struct Sci, KEK, 1-1 Oho, Tsukuba, Ibaraki 3050801, Japan.	syunji.kishimoto@kek.jp			Japan Society for the Promotion of Science	S.K. thanks Mr. K. Watanabe for his help on preparing the control software. The experiments were executed under the approval of the SPring-8 Advisory Committee (Proposal No. 2013A1174) and the Photon Factory Advisory Committee (Proposal No. 2012G063). This study was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science.	[Anonymous], 2009, PHOTON FACTORY ACTIV, P119; Shvydko YV, 1996, PHYS REV B, V54, P14942, DOI 10.1103/PhysRevB.54.14942; SATOW Y, 1989, REV SCI INSTRUM, V60, P2390, DOI 10.1063/1.1140728; HASTINGS JB, 1991, PHYS REV LETT, V66, P770, DOI 10.1103/PhysRevLett.66.770; Schlage K, 2013, J ELECTRON SPECTROSC, V189, P187, DOI 10.1016/j.elspec.2013.02.005; Seto M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.217602; Firestone R. B., 1996, TABLE ISOTOPES, P252; Kishimoto S, 2013, NUCL INSTRUM METH A, V731, P53, DOI 10.1016/j.nima.2013.06.023; KISHIMOTO S, 1992, REV SCI INSTRUM, V63, P824, DOI 10.1063/1.1142619; Kishimoto S, 2010, NUCL INSTRUM METH A, V623, P608, DOI 10.1016/j.nima.2010.03.086; Kishimoto S, 2011, NUCL INSTRUM METH A, V650, P98, DOI 10.1016/j.nima.2010.12.165; Knoll G. F., 2010, RAD DETECTION MEASUR, P718; Leupold O, 2003, STRUCT CHEM, V14, P97, DOI 10.1023/A:1021625211669; Mitsui T, 2004, JPN J APPL PHYS 1, V43, P389, DOI 10.1143/JJAP.43.389; Uchida T, 2008, IEEE T NUCL SCI, V55, P1631, DOI 10.1109/TNS.2008.920264; Yoda Y, 2007, AIP CONF PROC, V879, P926	16	2	2	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							113102	10.1063/1.4900862		5	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000242		
J	Ko, WH; Lee, HH; Jeon, YM; Ida, K; Lee, JH; Yoon, SW; Lee, KD; Bae, YS; Oh, YK; Kwak, JG				Ko, Won-Ha; Lee, H. H.; Jeon, Y. M.; Ida, K.; Lee, J. H.; Yoon, S. W.; Lee, K. D.; Bae, Y. S.; Oh, Y. K.; Kwak, J. G.			Rotation characteristics during the resonant magnetic perturbation induced edge localized mode suppression on the KSTAR	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								Measuring rotation profiles with a reliable spatial resolution is one of the critical diagnostics in understanding the plasma behavior especially for the edge transport. In the KSTAR experiments, it has been consistently observed from the charge exchange spectroscopy measurements that the magnetic perturbations not only suppresses edge localized modes (ELMs) but also reduces toroidal rotations. In this paper, toroidal velocities of the carbon impurity and their profile evolutions during ELMy and ELM-suppressed phases are presented. The rotation profiles are shown to collapse immediately after an ELM burst and continue to build up until the next burst that accompanies another collapse. Toroidal rotations following the resonant magnetic perturbations applications are observed to be reduced along with the ELMs suppressed. (C) 2014 AIP Publishing LLC.	[Ko, Won-Ha; Lee, H. H.; Jeon, Y. M.; Lee, J. H.; Yoon, S. W.; Lee, K. D.; Bae, Y. S.; Oh, Y. K.; Kwak, J. G.] Natl Fus Res Inst, Taejon, South Korea; [Ko, Won-Ha; Lee, J. H.] Korea Univ Sci & Technol UST, Taejon, South Korea; [Ida, K.] Natl Inst Fus Sci, Nagoya, Aichi, Japan	Ko, WH (reprint author), Natl Fus Res Inst, Taejon, South Korea.	whko@nfri.re.kr			Korean Ministry of Science, ICT and Future Planning of Republic of Korea	The authors would like to express appreciation to Dr. C. Bae for his revision of this paper. This work was supported by the Korean Ministry of Science, ICT and Future Planning of Republic of Korea.	Lee H, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3606438; Ko WH, 2010, IEEE T PLASMA SCI, V38, P996, DOI 10.1109/TPS.2010.2042182; Yoshinuma M, 2010, FUSION SCI TECHNOL, V58, P375; Jeon YM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.035004; Yoshida M, 2007, NUCL FUSION, V47, P856, DOI 10.1088/0029-5515/47/8/017; Ko WH, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3496991; Yoon SW, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/11/113009	7	3	3	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E413	10.1063/1.4890402		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000161		
J	Kogi, Y; Higashi, T; Matsukawa, S; Mase, A; Kohagura, J; Nagayama, Y; Kawahata, K; Kuwahara, D; Yoshikawa, M				Kogi, Y.; Higashi, T.; Matsukawa, S.; Mase, A.; Kohagura, J.; Nagayama, Y.; Kawahata, K.; Kuwahara, D.; Yoshikawa, M.			Validation experiment of a numerically processed millimeter-wave interferometer in a laboratory	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								We propose a new interferometer system for density profile measurements. This system produces multiple measurement chords by a leaky-wave antenna driven by multiple frequency inputs. The proposed system was validated in laboratory evaluation experiments. We confirmed that the interferometer generates a clear image of a Teflon plate as well as the phase shift corresponding to the plate thickness. In another experiment, we confirmed that quasi-optical mirrors can produce multiple measurement chords; however, the finite spot size of the probe beam degrades the sharpness of the resulting image. (C) 2014 AIP Publishing LLC.	[Kogi, Y.; Higashi, T.; Matsukawa, S.] Fukuoka Inst Technol, Dept Informat Elect, Fukuoka 8110295, Japan; [Mase, A.] Kyushu Univ, Art Sci & Technol Ctr Cooperat Res, Fukuoka 8160811, Japan; [Kohagura, J.; Yoshikawa, M.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan; [Nagayama, Y.; Kawahata, K.] Natl Inst Fus Sci, Gifu 5095202, Japan; [Kuwahara, D.] Tokyo Univ Agr & Technol, Koganei, Tokyo 1848588, Japan	Kogi, Y (reprint author), Fukuoka Inst Technol, Dept Informat Elect, Fukuoka 8110295, Japan.	kogi@fit.ac.jp			NIFS [NIFS13KUGM079];  [22760658];  [13305428]	This study was supported by a Grant-in-Aid for Scientific Research (22760658, 13305428) and was performed with the support and under the auspices of the NIFS Collaboration Research program (NIFS13KUGM079). Part of the experimental results in this research was obtained using the Electronics Research Laboratory, Fukuoka Institute of Technology. The authors express their deep appreciation to Mr. S. TobiMatsu for fabricating the parabolic mirrors.	TAMANO T, 1995, PHYS PLASMAS, V2, P2321, DOI 10.1063/1.871256; Hutchinson I.H., 2002, PRINCIPLES PLASMA DI; Kogi Y, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4734488; Mase A, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/01/C01089; Yoneyama T., 1990, Transactions of the Institute of Electronics, Information and Communication Engineers C-I, VJ73C-I; Yoshikawa M, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3464577; Yoshikawa M, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2956832	7	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D411	10.1063/1.4893430		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000015		
J	Kojima, S; Arikawa, Y; Nishimura, Y; Togawa, H; Zhang, Z; Ikenouchi, T; Ozaki, T; Morace, A; Nagai, T; Abe, Y; Sakata, S; Inoue, H; Utsugi, M; Nakai, M; Nishimura, H; Shiraga, H; Kato, R; Fujioka, S; Azechi, H				Kojima, Sadaoki; Arikawa, Yasunobu; Nishimura, Yasuhiko; Togawa, Hiromi; Zhang, Zhe; Ikenouchi, Takahito; Ozaki, Tetsuo; Morace, Alessio; Nagai, Takahiro; Abe, Yuki; Sakata, Shouhei; Inoue, Hiroaki; Utsugi, Masaru; Nakai, Mitsuo; Nishimura, Hiroaki; Shiraga, Hiroyuki; Kato, Ryukou; Fujioka, Shinsuke; Azechi, Hiroshi			Accuracy evaluation of a Compton X-ray spectrometer with bremsstrahlung X-rays generated by a 6 MeV electron bunch	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							IGNITION; LASER	A Compton-scattering-based X-ray spectrometer is developed to obtain the energy distribution of fast electrons produced by intense laser and matter interactions. Bremsstrahlung X-rays generated by fast electrons in a material are used to measure fast electrons' energy distribution in matter. In the Compton X-ray spectrometer, X-rays are converted into recoil electrons by Compton scattering in a converter made from fused silica glass, and a magnet-based electron energy analyzer is used to measure the energy distribution of the electrons that recoil in the direction of the incident X-rays. The spectrum of the incident X-rays is reconstructed from the energy distribution of the recoil electrons. The accuracy of this spectrometer is evaluated using a quasi-monoenergetic 6 MeV electron bunch that emanates from a linear accelerator. An electron bunch is injected into a 1.5 mm thick tungsten plate to produce bremsstrahlung X-rays. The spectrum of these bremsstrahlung X-rays is obtained in the range from 1 to 9MeV. The energy of the electrons in the bunch is estimated using a Monte Carlo simulation of particle-matter interactions. The result shows that the spectrometer's energy accuracy is +/- 0.5 MeV for 6.0 MeV electrons. (C) 2014 AIP Publishing LLC.	[Kojima, Sadaoki; Arikawa, Yasunobu; Zhang, Zhe; Ikenouchi, Takahito; Morace, Alessio; Nagai, Takahiro; Abe, Yuki; Sakata, Shouhei; Inoue, Hiroaki; Utsugi, Masaru; Nakai, Mitsuo; Nishimura, Hiroaki; Shiraga, Hiroyuki; Fujioka, Shinsuke; Azechi, Hiroshi] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Nishimura, Yasuhiko; Togawa, Hiromi] Toyota Tech Dev Corp, Toyota, Aichi 4700334, Japan; [Ozaki, Tetsuo] Natl Inst Nat Sci, Toki, Gifu 5095292, Japan; [Kato, Ryukou] Osaka Univ, Inst Sci & Ind Res, Suita, Osaka 5650871, Japan	Kojima, S (reprint author), Osaka Univ, Inst Laser Engn, 2-6 Yamada Oka, Suita, Osaka 5650871, Japan.	kojima-s@ile.osaka-u.ac.jp	Azechi, Hiroshi/H-5876-2015; Nakai, Mitsuo/I-6758-2015; Nishimura, Hiroaki/I-4908-2015; Shiraga, Hiroyuki/I-9565-2015; Fujioka, Shinsuke/J-5530-2015; Arikawa, Yasunobu/L-8760-2015	Nakai, Mitsuo/0000-0001-6076-756X; Fujioka, Shinsuke/0000-0001-8406-1772; Arikawa, Yasunobu/0000-0002-3142-3060	Japan Society for the Promotion of Science [24244095, 23360413, 24686103, 25630419]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)	The authors gratefully acknowledge the technical support of the Toyota Technical Development Corp. This work was partly supported by the Japan Society for the Promotion of Science under contracts of Grant-in-Aid for Scientific Research (A) No. 24244095 and (B) No. 23360413, Grant-in-Aid for Young Scientists (A) No. 24686103, Grant-in-Aid for Challenging Exploratory Research No. 25630419, and the auspices of the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) project for the "Promotion of relativistic nuclear physics with ultra-intense laser."	Kodama R, 2001, NATURE, V412, P798, DOI 10.1038/35090525; SCHIFF LI, 1951, PHYS REV, V83, P252, DOI 10.1103/PhysRev.83.252; Chen CD, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3183693; Theobald W, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3566082; Bahk SW, 2005, APPL PHYS B-LASERS O, V80, P823, DOI 10.1007/s00340-005-1803-8; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; KOCH HW, 1959, REV MOD PHYS, V31, P920, DOI 10.1103/RevModPhys.31.920; Bethe H, 1934, P R SOC LOND A-CONTA, V146, P0083, DOI 10.1098/rspa.1934.0140; Azechi H, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/10/104024; Basov N. G., 1992, Journal of Soviet Laser Research, V13, DOI 10.1007/BF01124892; Briesmeister J. F., 1988, LA12625M LOS AL NAT; Fujioka S, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3494383; Gunther MM, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3613923; King JA, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1923178; Kojima S., 2014, PLASMA FUSION RES, V9; Miyanaga N, 2006, J PHYS IV, V133, P81, DOI 10.1051/jp4:2006133016; Shiraga H, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/12/124029; Stephens RB, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1896952; Westover B, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3594622	19	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D634	10.1063/1.4894447		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000051		
J	Kuwahara, D; Ito, N; Nagayama, Y; Yoshinaga, T; Yamaguchi, S; Yoshikawa, M; Kohagura, J; Sugito, S; Kogi, Y; Mase, A				Kuwahara, D.; Ito, N.; Nagayama, Y.; Yoshinaga, T.; Yamaguchi, S.; Yoshikawa, M.; Kohagura, J.; Sugito, S.; Kogi, Y.; Mase, A.			Development of horn antenna mixer array with internal local oscillator module for microwave imaging diagnostics	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								A new antenna array is proposed in order to improve the sensitivity and complexity of microwave imaging diagnostics systems such as a microwave imaging reflectometry, a microwave imaging interferometer, and an electron cyclotron emission imaging. The antenna array consists of five elements: a horn antenna, a waveguide-to-microstrip line transition, a mixer, a local oscillation (LO) module, and an intermediate frequency amplifier. By using an LO module, the LO optics can be removed, and the supplied LO power to each element can be equalized. We report details of the antenna array and characteristics of a prototype antenna array. (C) 2014 AIP Publishing LLC.	[Kuwahara, D.] Tokyo Univ Agr & Technol, Dept Mech Syst Engn, Koganei, Tokyo 1848588, Japan; [Ito, N.] Ube Natl Coll Technol, Dept Intelligent Syst Engn, Ube, Yamaguchi 7558555, Japan; [Nagayama, Y.] Natl Inst Nat Sci, Natl Inst Fus Sci, Dept Hel Plasma Res, Toki, Gifu 5095292, Japan; [Yoshinaga, T.] Natl Def Acad, Dept Appl Phys, Yokosuka, Kanagawa 2390811, Japan; [Yamaguchi, S.] Kansai Univ, Dept Pure & Appl Phys, Suita, Osaka 5648680, Japan; [Yoshikawa, M.; Kohagura, J.] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058577, Japan; [Sugito, S.] Inst Mol Sci, Equipment Dev Ctr, Okazaki, Aichi 4448585, Japan; [Kogi, Y.] Fukuoka Inst Technol, Dept Informat Elect, Fukuoka 8110295, Japan; [Mase, A.] Kyushu Univ, Art Sci & Technol Ctr Cooperat Res, Kasuga, Fukuoka 8168580, Japan	Kuwahara, D (reprint author), Tokyo Univ Agr & Technol, Dept Mech Syst Engn, Koganei, Tokyo 1848588, Japan.	dkuwahar@cc.tuat.ac.jp			Sasakawa Scientific Research Grant from the Japan Science Society; NIFS collaboration research program [NIFS13KUGM078]	This work was supported by the Sasakawa Scientific Research Grant from the Japan Science Society and the NIFS collaboration research program (NIFS13KUGM078).	KUWAHARA D., 2009, J PLASMA FUSION RES, V8, P649; Kuwahara D, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3491223; Nagayama Y, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4729259; Ponchak G. E., 1986, 88905 NASA, P88905; Tobias B., 2012, PLASMA FUSION RES, V6; Zhang D., 2014, BIOMED ENG-APP BAS C, V26	6	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D805	10.1063/1.4885471		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000059		
J	Lee, JH; Oh, S; Lee, WR; Ko, WH; Kim, KP; Lee, KD; Jeon, YM; Yoon, SW; Cho, KW; Narihara, K; Yamada, I; Yasuhara, R; Hatae, T; Yatsuka, E; Ono, T; Hong, JH				Lee, J. H.; Oh, S.; Lee, W. R.; Ko, W. H.; Kim, K. P.; Lee, K. D.; Jeon, Y. M.; Yoon, S. W.; Cho, K. W.; Narihara, K.; Yamada, I.; Yasuhara, R.; Hatae, T.; Yatsuka, E.; Ono, T.; Hong, J. H.			Edge profile measurements using Thomson scattering on the KSTAR tokamak	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								In the KSTAR Tokamak, a "Tangential Thomson Scattering" (TTS) diagnostic system has been designed and installed to measure electron density and temperature profiles. In the edge system, TTS has 12 optical fiber bundles to measure the edge profiles with 10-15 mm spatial resolution. These 12 optical fibers and their spatial resolution are not enough to measure the pedestal width with a high accuracy but allow observations of L-H transition or H-L transitions at the edge. For these measurements, the prototype ITER edge Thomson Nd:YAG laser system manufactured by JAEA in Japan is installed. In this paper, the KSTAR TTS system is briefly described and some TTS edge profiles are presented and compared against the KSTAR Charge Exchange Spectroscopy and other diagnostics. The future upgrade plan of the system is also discussed in this paper. (C) 2014 AIP Publishing LLC.	[Lee, J. H.; Oh, S.; Lee, W. R.; Ko, W. H.; Kim, K. P.; Lee, K. D.; Jeon, Y. M.; Yoon, S. W.; Cho, K. W.] Natl Fus Res Inst, Taejon, South Korea; [Lee, J. H.; Ko, W. H.] UST, Dept Nucl Fus & Plasma Sci, Taejon, South Korea; [Narihara, K.; Yamada, I.; Yasuhara, R.] Natl Inst Fus Sci, Nagoya, Aichi, Japan; [Hatae, T.; Yatsuka, E.; Ono, T.] Japan Atom Energy Agcy, Naka, Ibaraki, Japan; [Hong, J. H.] Korea Adv Inst Sci & Technol, Dept Phys, Taejon, South Korea	Lee, JH (reprint author), Natl Fus Res Inst, Taejon, South Korea.	jhleel@nfri.re.kr			Ministry of Education Science and Technology of Republic of Korea	This work was supported by the Ministry of Education Science and Technology of Republic of Korea. The authors would like to thank all the NFRI teams, NIFS Thomson Team, JAEA Thomson Team and Dr. C. Bae.	Hatae T, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4738658; Arends E. R., 2003, DENSITY GRADIENTS SP, P94; Hutchinson I. H., 2002, PRINCIPLES PLASMA DI, P273, DOI 10.1017/CBO9780511613630.009; Lee J. H., 2012, JINST, V7; Lee JH, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3494275; Lee WR, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4752408; Oh S, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3464472	7	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D407	10.1063/1.4890258		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000011		
J	Makino, R; Kubo, S; Kobayashi, K; Kobayashi, S; Shimozuma, T; Yoshimura, Y; Igami, H; Takahashi, H; Mutoh, T				Makino, R.; Kubo, S.; Kobayashi, K.; Kobayashi, S.; Shimozuma, T.; Yoshimura, Y.; Igami, H.; Takahashi, H.; Mutoh, T.			Power and polarization monitor development for high power millimeter-wave	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							CURRENT DRIVE	A new type monitor of power and polarization states of millimeter-waves has been developed to be installed at a miter-bend, which is a part of transmission lines of millimeter-waves, for electron cyclotron resonance heating on the Large Helical Device. The monitor measures amplitudes and phase difference of the electric field of the two orthogonal polarizations which are needed for calculation of the power and polarization states of waves. The power and phase differences of two orthogonal polarizations were successfully detected simultaneously. (C) 2014 AIP Publishing LLC.	[Makino, R.; Kubo, S.; Kobayashi, K.] Nagoya Univ, Dept Energy Engn & Sci, Nagoya, Aichi 4648603, Japan; [Kubo, S.; Kobayashi, S.; Shimozuma, T.; Yoshimura, Y.; Igami, H.; Takahashi, H.; Mutoh, T.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Makino, R (reprint author), Nagoya Univ, Dept Energy Engn & Sci, Nagoya, Aichi 4648603, Japan.	makino.ryohhei@ms.nifs.ac.jp			NIFS [ULRR701, ULRR804, KEKO00]; JSPS KAKENHI [21360455]	The authors would like to thank staffs of ECRH group of the LHD team for discussions and performing experiments. This work was supported by NIFS under ULRR701, ULRR804, KEKO00, and JSPS KAKENHI Grant No. 21360455.	Felici F, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3073735; Prater R, 2004, PHYS PLASMAS, V11, P2349, DOI 10.1063/1.1690762; Born M., 1974, PRINCIPLES OPTICS, P25; DOANE JL, 1992, INT J INFRARED MILLI, V13, P1727, DOI 10.1007/BF01010741; Makino R., 2014, PLASMA FUSION RES, V9; Notake T, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1848657; Shimozuma T., 2009, J MICROWAVE POWER EE, V43, P1; Stix T.H., 1992, WAVES PLASMAS	8	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D831	10.1063/1.4891162		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000085		
J	Minami, R; Imai, T; Kariya, T; Numakura, T; Eguchi, T; Kawarasaki, R; Nakazawa, K; Kato, T; Sato, F; Nanzai, H; Uehara, M; Endo, Y; Ichimura, M				Minami, R.; Imai, T.; Kariya, T.; Numakura, T.; Eguchi, T.; Kawarasaki, R.; Nakazawa, K.; Kato, T.; Sato, F.; Nanzai, H.; Uehara, M.; Endo, Y.; Ichimura, M.			Soft x-ray intensity profile measurements of electron cyclotron heated plasmas using semiconductor detector arrays in GAMMA 10 tandem mirror	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								Temporally and spatially resolved soft x-ray analyses of electron cyclotron heated plasmas are carried out by using semiconductor detector arrays in the GAMMA 10 tandem mirror. The detector array has 16-channel for the measurements of plasma x-ray profiles so as to make x-ray tomographic reconstructions. The characteristics of the detector array make it possible to obtain spatially resolved plasma electron temperatures down to a few tens eV and investigate various magnetohydrodynamic activities. High power electron cyclotron heating experiment for the central-cell region in GAMMA 10 has been started in order to reduce the electron drag by increasing the electron temperature. (C) 2014 AIP Publishing LLC.	[Minami, R.; Imai, T.; Kariya, T.; Numakura, T.; Eguchi, T.; Kawarasaki, R.; Nakazawa, K.; Kato, T.; Sato, F.; Nanzai, H.; Uehara, M.; Endo, Y.; Ichimura, M.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan	Minami, R (reprint author), Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan.	minami@prc.tsukuba.ac.jp			National Institute for Fusion Science (NIFS) Collaborative program [NIFS11KUGM050]; Ministry of Education, Science, Sports and Culture of Japan [23560997]	The author thanks the members of the GAMMA 10 group of the University of Tsukuba for their collaboration and valuable discussion during this study. This work is partially supported by the National Institute for Fusion Science (NIFS) Collaborative program (NIFS11KUGM050) and the grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (Grant No. 23560997).	[Anonymous], 2013, T FUSION SCI TECH; CHO T, 1995, REV SCI INSTRUM, V66, P540, DOI 10.1063/1.1146345; HIRATA M, 1992, NUCL INSTRUM METH B, V66, P479, DOI 10.1016/0168-583X(92)95422-N; KARIYA T, 2007, T FUSION SCI TECH, V51, P397; Minami R, 2011, J INFRARED MILLIM TE, V32, P311, DOI 10.1007/s10762-010-9719-8	5	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D807	10.1063/1.4885495		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000061		
J	Minami, T; Itoh, Y; Yamada, I; Yasuhara, R; Funaba, H; Nakanishi, H; Hatae, T				Minami, T.; Itoh, Y.; Yamada, I.; Yasuhara, R.; Funaba, H.; Nakanishi, H.; Hatae, T.			Improving measurement accuracy by optimum data acquisition for Nd:YAG Thomson scattering system	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								A new high speed Nd:YAG Thomson scattering AD Convertor (HYADC) that can directly convert the detected scattered light signal into a digital signal is under development. The HYADC is expected to improve a signal to noise ratio of the Nd: YAG Thomson scattering measurement. The data storage of the HYADC which is required for the direct conversion of whole plasma discharge is drastically reduced by a ring buffer memory and a stop trigger system. Data transfer of the HYADC is performed by the SiTCP. The HYADC is easily expandable to a multi-channel system by the distributed data processing, and is very compact and easy to implement as a built-in system of the polychromators. (C) 2014 AIP Publishing LLC.	[Minami, T.] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 611011, Japan; [Itoh, Y.; Yamada, I.; Yasuhara, R.; Funaba, H.; Nakanishi, H.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Hatae, T.] Japan Atom Energy Agcy, Naka, Ibaraki 8011, Japan	Minami, T (reprint author), Kyoto Univ, Inst Adv Energy, Uji, Kyoto 611011, Japan.	minami@iae.kyoto-u.ac.jp			NIFS [NIFS12KEMH001]; JAEA collaborative research program	I greatly appreciate late Professor Terumichi for a suggestion about the significance of the data acquisition system to study the physics. I pay tribute to the professor. This work is supported by the NIFS collaborative research program (NIFS12KEMH001) and was supported by the JAEA collaborative research program.	BLACK WC, 1980, IEEE J SOLID-ST CIRC, V15, P1022, DOI 10.1109/JSSC.1980.1051512; Hsieh C. L., 1990, 19905GAA20094; Minami T, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3496977; Scannell R, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2971971; Tomohisa U., 2008, IEEE T NUCL SCI, V55, P1631	5	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D837	10.1063/1.4891416		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000091		
J	Mishra, K; Idei, H; Zushi, H; Nagata, K; Akimoto, R; Yamamoto, MK; Hanada, K; Hasegawa, M; Nakamura, K; Fujisawa, A; Nagashima, Y; Banerjee, S; Onchi, T; Kuzmin, A				Mishra, Kishore; Idei, H.; Zushi, H.; Nagata, K.; Akimoto, R.; Yamamoto, M. K.; Hanada, K.; Hasegawa, M.; Nakamura, K.; Fujisawa, A.; Nagashima, Y.; Banerjee, S.; Onchi, T.; Kuzmin, A.			Thermal imaging of plasma with a phased array antenna in QUEST	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							ELECTRON; EMISSION	A thermal imaging system to measure plasma Electron Bernstein Emission (EBE) emanating from the mode conversion region in overdense plasma is discussed. Unlike conventional ECE/EBE imaging, this diagnostics does not employ any active mechanical scanning mirrors or focusing optics to scan for the emission cones in plasma. Instead, a standard 3 x 3 waveguide array antenna is used as a passive receiver to collect emission from plasma and imaging reconstruction is done by accurate measurements of phase and intensity of these signals by heterodyne detection technique. A broad-band noise source simulating the EBE, is installed near the expected mode conversion region and its position is successfully reconstructed using phase array technique which is done in post processing. (C) 2014 AIP Publishing LLC.	[Mishra, Kishore; Nagata, K.; Akimoto, R.; Banerjee, S.] Kyushu Univ, IGSES, Fukuoka 8168580, Japan; [Idei, H.; Zushi, H.; Hanada, K.; Hasegawa, M.; Nakamura, K.; Fujisawa, A.; Nagashima, Y.; Onchi, T.; Kuzmin, A.] Kyushu Univ, RIAM, Fukuoka 8168580, Japan; [Yamamoto, M. K.] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto 6110011, Japan	Mishra, K (reprint author), Kyushu Univ, IGSES, Fukuoka 8168580, Japan.	mishra@triam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015		Collaborative Research Program of the Research Institute for Applied Mechanics, Kyushu University, Japan; NIFS Collaboration Research Program [NIFS11KUTR06 3];  [S24226020];  [A21246139]	Authors (K.M. and H.I.) would like to thank V. F. Shevchenko, Culham Science Center, UK for his valuable suggestions and useful discussions during his visit to QUEST. This work is supported by Grant-in-aid for Scientific Research (S24226020, A21246139) and in part by the Collaborative Research Program of the Research Institute for Applied Mechanics, Kyushu University, Japan. This work is also performed with the support and under the auspices of the NIFS Collaboration Research Program (NIFS11KUTR06 3).	Laqua HP, 1998, PHYS REV LETT, V81, P2060, DOI 10.1103/PhysRevLett.81.2060; Klimanov I, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2042667; Shevchenko VF, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/2/022004; Shiraiwa S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.185003; de la Luna E, 2003, REV SCI INSTRUM, V74, P1414, DOI 10.1063/1.1538354; Freethy SJ, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/12/124010; Hanada Kazuaki, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.S1007; Idei H., 2010, J PLASMA FUSION RES, V9, P112; Idei H., 2012, P 24 IAEA FUS EN C; Laqua HP, 2007, PLASMA PHYS CONTR F, V49, pR1, DOI 10.1088/0741-3335/49/4/R01; Shevchenko V, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.265005; Zajac J, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4733530	12	2	2	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E808	10.1063/1.4889903		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000214		
J	Mitsui, T				Mitsui, Tadashi			Compact and high-efficiency device for Raman scattering measurement using optical fibers	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							SCANNING TUNNELING MICROSCOPE; QUANTUM DOTS; GRAPHENE	We describe the design and development of a high-efficiency optical measurement device for operation within the small bore of a high-power magnet at low temperature. For the high-efficiency measurement of light emitted from this small region, we designed a compact confocal optics with lens focusing and tilting systems, and used a piezodriven translation stage that allows micron-scale focus control of the sample position. We designed a measurement device that uses 10 m-long optical fibers in order to avoid the influence of mechanical vibration and magnetic field leakage of high-power magnets, and we also describe a technique for minimizing the fluorescence signal of optical fibers. The operation of the device was confirmed by Raman scattering measurements of monolayer graphene on quartz glass with a high signal-to-noise ratio. (C) 2014 AIP Publishing LLC.	Natl Inst Mat Sci, Adv Key Technol Div, Surface Phys & Struct Unit, Tsukuba, Ibaraki 3050003, Japan	Mitsui, T (reprint author), Natl Inst Mat Sci, Adv Key Technol Div, Surface Phys & Struct Unit, Sakura 3-13, Tsukuba, Ibaraki 3050003, Japan.	MITSUI.Tadashi@nims.go.jp			Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government [25610078]	The authors thank K. Saitou and Delta Optics, Inc. for their help in manufacturing the optical device. The author gratefully acknowledges the expertise of their late group leader, Dr. T. Takamasu, to whom this article is dedicated. The author thank Dr. Y. Imanaka, Dr. K. Takehana, and Dr. T. Chikyow for fruitful discussions. This work was supported by a Grant-in-Aid for Exploratory Research (25610078) from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government.	Metzger C, 2010, NANO LETT, V10, P6, DOI 10.1021/nl901625v; Sadowski ML, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266405; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Atature M, 2006, SCIENCE, V312, P551, DOI 10.1126/science.1126074; Ortner G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.157401; Xu XD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.097401; Bayer M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195315; BESOCKE K, 1987, SURF SCI, V181, P145, DOI 10.1016/0039-6028(87)90151-8; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; POHL DW, 1987, REV SCI INSTRUM, V58, P54, DOI 10.1063/1.1139566; Casiraghi C, 2009, NANO LETT, V9, P1433, DOI 10.1021/nl8032697; Babinski A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075310; Bayer M, 2002, PHYSICA E, V13, P123, DOI 10.1016/S1386-9477(01)00501-X; BROCKENBROUGH RT, 1993, REV SCI INSTRUM, V64, P2225, DOI 10.1063/1.1143965; CURTIS R, 1993, REV SCI INSTRUM, V64, P2687, DOI 10.1063/1.1143857; Dubois C, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2194489; Faugeras C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.186803; Faugeras C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.036807; Karrai K, 2004, NATURE, V427, P135, DOI 10.1038/nature02109; LYDING JW, 1988, REV SCI INSTRUM, V59, P1897, DOI 10.1063/1.1140047; Meyer C, 2003, APPL PHYS LETT, V83, P2420, DOI 10.1063/1.1608491; Meyer C, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1927105; Rizo PJ, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3046283	24	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							113111	10.1063/1.4902342		7	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000251		
J	Mukai, K; Peterson, BJ; Pandya, SN; Sano, R				Mukai, K.; Peterson, B. J.; Pandya, S. N.; Sano, R.			In situ calibration of an infrared imaging video bolometer in the Large Helical Device	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								The InfraRed imaging Video Bolometer (IRVB) is a powerful diagnostic to measure multidimensional radiation profiles in plasma fusion devices. In the Large Helical Device (LHD), four IRVBs have been installed with different fields of view to reconstruct three-dimensional profiles using a tomography technique. For the application of the measurement to plasma experiments using deuterium gas in LHD in the near future, the long-term effect of the neutron irradiation on the heat characteristics of an IRVB foil should be taken into account by regular in situ calibration measurements. Therefore, in this study, an in situ calibration system was designed. (C) 2014 AIP Publishing LLC.	[Mukai, K.; Peterson, B. J.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Pandya, S. N.; Sano, R.] Grad Univ Adv Studies, Toki, Gifu 5095292, Japan	Mukai, K (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	mukai.kiyofumi@LHD.nifs.ac.jp			NIFS/NINS [NIFS13ULHH026, NIFS13GGHH001]	The authors are grateful to the LHD experimental group for their excellent arrangement of the experiments. This work was supported by NIFS/NINS (NIFS13ULHH026, NIFS13GGHH001).	Mukai K., 2014, PLASMA FUSION RES, V9; Pandya SN, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4873713; Peterson Byron J., 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.S2095; Peterson BJ, 2001, REV SCI INSTRUM, V72, P923, DOI 10.1063/1.1319597; Peterson BJ, 2000, REV SCI INSTRUM, V71, P3696, DOI 10.1063/1.1290044; Sano R., 2012, PLASMA FUSION RES, V7	6	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E435	10.1063/1.4896959		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000183		
J	Nakano, Y; Yamazaki, A; Watanabe, K; Uritani, A; Ogawa, K; Isobe, M				Nakano, Y.; Yamazaki, A.; Watanabe, K.; Uritani, A.; Ogawa, K.; Isobe, M.			Study on in situ calibration for neutron flux monitor in the Large Helical Device based on Monte Carlo calculations	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							ABSOLUTE CALIBRATION; SIMULATIONS; JT-60U	Neutron monitoring is important to manage safety of fusion experiment facilities because neutrons are generated in fusion reactions. Monte Carlo simulations play an important role in evaluating the influence of neutron scattering from various structures and correcting differences between deuterium plasma experiments and in situ calibration experiments. We evaluated these influences based on differences between the both experiments at Large Helical Device using Monte Carlo simulation code MCNP5. A difference between the both experiments in absolute detection efficiency of the fission chamber between O-ports is estimated to be the biggest of all monitors. We additionally evaluated correction coefficients for some neutron monitors. (C) 2014 AIP Publishing LLC.	[Nakano, Y.; Yamazaki, A.; Watanabe, K.; Uritani, A.] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan; [Ogawa, K.; Isobe, M.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Nakano, Y (reprint author), Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan.	nakano.yuuji@c.mbox.nagoya-u.ac.jp			NIFS Collaboration Research Programs [NIFS12KOAH029, NIFS10KLFH002]	This work is performed with the support of the NIFS Collaboration Research Programs (NIFS12KOAH029 and NIFS10KLFH002).	JARVIS ON, 1994, PLASMA PHYS CONTR F, V36, P209, DOI 10.1088/0741-3335/36/2/002; NISHITANI T, 1992, REV SCI INSTRUM, V63, P5270, DOI 10.1063/1.1143439; BARNES CW, 1990, REV SCI INSTRUM, V61, P3151, DOI 10.1063/1.1141671; Hoek M, 1996, NUCL INSTRUM METH A, V368, P804, DOI 10.1016/0168-9002(95)00667-2; Nishio N, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3478997; Nishio Naoto, 2011, Plasma and Fusion Research, V6, DOI 10.1585/pfr.6.2405115; X-5 Monte Carlo Team, 2003, LAUR031087 X 5 MONT	7	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E116	10.1063/1.4891598		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000136		
J	Nishiura, M; Doi, K; Taniike, A; Matsuki, T; Shimazoe, K; Mushiake, T; Yoshino, M; Nagasaka, T; Fujimoto, Y; Fujioka, K; Tanaka, T; Kisaki, M; Yamaoka, H; Matsumoto, Y; Wada, M				Nishiura, M.; Doi, K.; Taniike, A.; Matsuki, T.; Shimazoe, K.; Mushiake, T.; Yoshino, M.; Nagasaka, T.; Fujimoto, Y.; Fujioka, K.; Tanaka, T.; Kisaki, M.; Yamaoka, H.; Matsumoto, Y.; Wada, M.			Ion-induced gamma-ray detection of fast ions escaping from fusion plasmas	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								A 12 x 12 pixel detector has been developed and used in a laboratory experiment for lost fast-ion diagnostics. With gamma rays in the MeV range originating from nuclear reactions Be-9(alpha, n gamma) C-12, Be-9(d, n gamma)C-12, and C-12(d, p gamma)C-13, a high purity germanium (HPGe) detector measured a fine-energy-resolved spectrum of gamma rays. The HPGe detector enables the survey of background-gamma rays and Doppler-shifted photo peak shapes. In the experiments, the pixel detector produces a gammaray image reconstructed from the energy spectrum obtained from total photon counts of irradiation passing through the detector's lead collimator. From gamma-ray image, diagnostics are able to produce an analysis of the fast ion loss onto the first wall in principle. (C) 2014 AIP Publishing LLC.	[Nishiura, M.; Mushiake, T.] Univ Tokyo, Grad Sch Frontier Sci, Chiba 2778561, Japan; [Doi, K.; Wada, M.] Doshisha Univ, Grad Sch Sci & Engn, Kyotanabe 6100321, Japan; [Taniike, A.; Matsuki, T.] Kobe Univ, Grad Sch Maritime Sci, Kobe, Hyogo 6580022, Japan; [Shimazoe, K.] Univ Tokyo, Grad Sch Engn, Tokyo 1138654, Japan; [Yoshino, M.] Furukawa Co Ltd, Tsukuba, Ibaraki 3050856, Japan; [Nagasaka, T.; Tanaka, T.; Kisaki, M.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Fujimoto, Y.; Fujioka, K.] Osaka Univ, Inst Laser Engn, Osaka 5650871, Japan; [Yamaoka, H.] RIKEN, RIKEN SPring Ctr 8, Sayo, Hyogo 6795148, Japan; [Matsumoto, Y.] Tokushima Bunri Univ, Tokushima 7708514, Japan	Nishiura, M (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Chiba 2778561, Japan.	nishiura@ppl.k.u-tokyo.ac.jp			National Institute for Fusion Science NIFS13JSPS KAKENHI [24360384, 25630423]	This work was supported by National Institute for Fusion Science NIFS13JSPS KAKENHI Grant Nos. 24360384 and 25630423.	Kiptily VG, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/8/084001; Kiptily VG, 2006, PLASMA PHYS CONTR F, V48, pR59, DOI 10.1088/0741-3335/48/8/R01; Bonheure G, 2003, REV SCI INSTRUM, V74, P1726, DOI 10.1063/1.1538363; NAMITO Y, 1994, NUCL INSTRUM METH A, V349, P489, DOI 10.1016/0168-9002(94)91215-7; Nishiura M, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2228743; Nishiura M, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3485118; Shimazoe K, 2010, IEEE T NUCL SCI, V57, P782, DOI 10.1109/TNS.2010.2043262; Taniike A., 2014, COMMUNICATION; WINTERBON KB, 1975, NUCL PHYS A, V246, P293, DOI 10.1016/0375-9474(75)90647-8	9	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E804	10.1063/1.4886764		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000210		
J	Ogawa, K; Isobe, M; Takada, E; Uchida, Y; Ochiai, K; Tomita, H; Uritani, A; Kobuchi, T; Takeiri, Y				Ogawa, K.; Isobe, M.; Takada, E.; Uchida, Y.; Ochiai, K.; Tomita, H.; Uritani, A.; Kobuchi, T.; Takeiri, Y.			Progress in development of the neutron profile monitor for the large helical device	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							COLLIMATOR; JT-60U; JET	The neutron profile monitor stably operated at a high-count-rate for deuterium operations in the Large Helical Device has been developed to enhance the research on the fast-ion confinement. It is composed of a multichannel collimator, scintillation-detectors, and a field programmable gate array circuit. The entire neutron detector system was tested using an accelerator-based neutron generator. This system stably acquires the pulse data without any data loss at high-count-rate conditions up to 8 x 10(5) counts per second. (C) 2014 AIP Publishing LLC.	[Ogawa, K.; Isobe, M.; Kobuchi, T.; Takeiri, Y.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Isobe, M.; Takeiri, Y.] Grad Univ Adv Studies SOKENDAI, Toki, Gifu 5095292, Japan; [Takada, E.; Uchida, Y.] Toyama Coll, Natl Inst Technol, Toyama 9398630, Japan; [Ochiai, K.] Japan Atom Energy Agcy, Fus Res & Dev Directorate, Naka, Ibaraki 3191195, Japan; [Tomita, H.; Uritani, A.] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Ogawa, K (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	ogawa.kunihiro@lhd.nifs.ac.jp			JSPS [26289359]; NIFS Collaboration Research programs [KOAH029]; LHD project [ULHH802, ULGG801]; Japan/U.S. Cooperation in Fusion Research and Development; JSPS-NRF-NSFC [11261140328]	This research was supported by JSPS grants-in-aid for Scientific Research Grant No. 26289359, by NIFS Collaboration Research programs (KOAH029), by the LHD project budget (ULHH802 and ULGG801), and Japan/U.S. Cooperation in Fusion Research and Development. This work was also partly supported by the JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC: No. 11261140328). One of the authors, K. Ogawa, is pleased to acknowledge the assistance of S. Conroy, L. Giacomelli, and V. Kiptily of Culham Centre for Fusion Energy, L. Roquemore and D. Darrow of Princeton Plasma Physics Laboratory, and G. Q. Zhong of the Chinese Institute of Plasma Physics in discussing the design of a multichannel collimator and detectors, T. Honda of OHYO KOKEN Kogyo Co., LTD. in discussing the PSD ability of the scintillator, A. Okada of Hamamatsu Photonics in providing background knowledge about the gain stability of the photomultiplier, M. Riva of the Italian National Agency for New Technologies, Energy and Sustainable Economic Development in discussing the FPGA logic, and J. Takeuchi, O. Fujioka, M. Wake, and R. Murali of National Instruments for joint development of the FPGA circuit.	Adams M., 1993, NUCL INSTRUM METH A, V329, P277; Riva M, 2011, FUSION ENG DES, V86, P1191, DOI [10.1016/j.fusengdes.2011.02.038, 10.1016/gusengdes.2011.02.038]; Giacomelli L, 2005, NUCL FUSION, V45, P1191, DOI 10.1088/0029-5515/45/9/019; Ishikawa M, 2002, REV SCI INSTRUM, V73, P4237, DOI 10.1063/1.1518145; Ishikawa M, 2005, NUCL FUSION, V45, P1474, DOI 10.1088/0029-5515/45/12/002; Isobe M, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3492383; Javis O. N., 1997, FUSION ENG DES, V34-35, P59; Knoll G. F., 1999, RAD DETECTION MEASUR, P230; Marocco D, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/03/C03033; Roquemore AL, 1997, REV SCI INSTRUM, V68, P544, DOI 10.1063/1.1147648; ROQUEMORE AL, 1990, REV SCI INSTRUM, V61, P3163, DOI 10.1063/1.1141674; Sasao M, 1997, FUSION ENG DES, V34-35, P595, DOI 10.1016/S0920-3796(96)00590-X; X-5 Monte Carlo Team, 2003, LAUR031987 X 5 MONT	13	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E110	10.1063/1.4890399		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000130		
J	Ohshima, S; Kobayashi, S; Yamamoto, S; Nagasaki, K; Mizuuchi, T; Kado, S; Okada, H; Minami, T; Lee, HY; Zang, L; Kenmochi, N; Kasajima, K; Ohtani, Y; Shi, N; Nagae, Y; Konoshima, S; Sano, F				Ohshima, S.; Kobayashi, S.; Yamamoto, S.; Nagasaki, K.; Mizuuchi, T.; Kado, S.; Okada, H.; Minami, T.; Lee, H. Y.; Zang, L.; Kenmochi, N.; Kasajima, K.; Ohtani, Y.; Shi, N.; Nagae, Y.; Konoshima, S.; Sano, F.			Highly time-resolved evaluation technique of instantaneous amplitude and phase difference using analytic signals for multi-channel diagnostics	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							HELIOTRON-J	A fluctuation analysis technique using analytic signals is proposed. Analytic signals are suitable to characterize a single mode with time-dependent amplitude and frequency, such as an MHD mode observed in fusion plasmas since the technique can evaluate amplitude and frequency at a specific moment without limitations of temporal and frequency resolutions, which is problematic in Fourier-based analyses. Moreover, a concept of instantaneous phase difference is newly introduced, and error of the evaluated phase difference and its error reduction techniques using conditional/ensemble averaging are discussed. These techniques are applied to experimental data of the beam emission spectroscopic measurement in the Heliotron J device, which demonstrates that the technique can describe nonlinear evolution of MHD instabilities. This technique is widely applicable to other diagnostics having necessity to evaluate phase difference. (C) 2014 AIP Publishing LLC.	[Ohshima, S.; Kobayashi, S.; Yamamoto, S.; Nagasaki, K.; Mizuuchi, T.; Kado, S.; Okada, H.; Minami, T.; Zang, L.; Shi, N.; Konoshima, S.; Sano, F.] Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan; [Zang, L.; Kenmochi, N.; Kasajima, K.; Ohtani, Y.; Nagae, Y.] Kyoto Univ, Grad Sch Energy Sci, Kyoto 6110011, Japan; [Lee, H. Y.] Korea Adv Inst Sci & Technol, Taejon 305701, South Korea	Ohshima, S (reprint author), Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan.	ohshima@iae.kyoto-u.ac.jp			Laboratory for Complex Energy Processes, IAE, Kyoto University; NIFS [NIFS10KUHL030, NIFS11KUHL043, NIFS12KUHL047]	The authors are grateful to the Heliotron J staff for their arrangement and support of the experiments. This work is performed with the support and under the auspices of the Collaboration Program of the Laboratory for Complex Energy Processes, IAE, Kyoto University and the NIFS Collaborative Research Program (NIFS10KUHL030, NIFS11KUHL043, and NIFS12KUHL047).	Sano F, 2005, NUCL FUSION, V45, P1557, DOI 10.1088/0029-5515/45/12/011; Heidbrink WW, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2838239; Obiki T, 2000, PLASMA PHYS CONTR F, V42, P1151, DOI 10.1088/0741-3335/42/11/302; Cohen L., 1995, TIME FREQUENCY ANAL; Kobayashi S, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4734039; Yamamoto S, 2007, FUSION SCI TECHNOL, V51, P92	6	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E814	10.1063/1.4891102		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000220		
J	Oishi, T; Morita, S; Huang, XL; Zhang, HM; Goto, M				Oishi, T.; Morita, S.; Huang, X. L.; Zhang, H. M.; Goto, M.			Line spectrum and ion temperature measurements from tungsten ions at low ionization stages in large helical device based on vacuum ultraviolet spectroscopy in wavelength range of 500-2200 angstrom	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							DIVERTOR	Vacuum ultraviolet spectra of emissions released from tungsten ions at lower ionization stages were measured in the Large Helical Device (LHD) in the wavelength range of 500-2200 angstrom using 3 m normal incidence spectrometer. Tungsten ions were distributed in the LHD plasma by injecting a pellet consisting of a small piece of tungsten metal and polyethylene tube. Many lines having different wavelengths from intrinsic impurity ions were observed just after the tungsten pellet injection. Doppler broadening of a tungsten candidate line was successfully measured and the ion temperature was obtained. (C) 2014 AIP Publishing LLC.	[Oishi, T.; Morita, S.; Goto, M.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Oishi, T.; Morita, S.; Huang, X. L.; Zhang, H. M.; Goto, M.] Grad Univ Adv Studies, Dept Fus Sci, Toki, Gifu 5095292, Japan	Oishi, T (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	oishi@LHD.nifs.ac.jp			LHD [NIFS13ULPP010]; JSPS-NRF-NSFC A3 Foresight Program in the Field of Plasma Physics (NSFC) [26800282, 11261140328]	The authors thank all the members of the LHD team for their cooperation with the LHD operation. This work is partially conducted under the LHD project financial support (NIFS13ULPP010). This work was also supported by Grant-in-Aid for Young Scientists (B) 26800282 and partially supported by the JSPS-NRF-NSFC A3 Foresight Program in the Field of Plasma Physics (NSFC: No. 11261140328).	[Anonymous], 1999, NUCL FUSION, V39, P2137; Clementson J, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/14/144009; Roth J, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/10/103001; Neu R, 2005, NUCL FUSION, V45, P209, DOI 10.1088/0029-5515/45/3/007; Kramida A., 2013, NIST ATOMIC SPECTRA; Morita S., 2013, AIP C P, V1545, P143; Nozato H, 2003, REV SCI INSTRUM, V74, P2032, DOI 10.1063/1.1535251; Oishi T., 2013, PLASMA FUSION RES, V8; Oishi T, 2014, J KOREAN PHYS SOC, V64, P840, DOI 10.3938/jkps.64.840; Radtke R, 2007, ATOMIC PLASMA MAT IN, V13, P45	10	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E415	10.1063/1.4885470		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000163		
J	Okada, K; Nishiura, M; Kubo, S; Shimozuma, T; Yoshimura, Y; Igami, H; Takahashi, H; Tanaka, K; Kobayashi, S; Ito, S; Mizuno, Y; Ogasawara, S				Okada, K.; Nishiura, M.; Kubo, S.; Shimozuma, T.; Yoshimura, Y.; Igami, H.; Takahashi, H.; Tanaka, K.; Kobayashi, S.; Ito, S.; Mizuno, Y.; Ogasawara, S.			Development of fast steering mirror control system for plasma heating and diagnostics	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							ECRH; LHD	A control system for a fast steering mirror has been newly developed for the electron cyclotron heating (ECH) launchers in the large helical device. This system enables two-dimensional scan during a plasma discharge and provides a simple feedback control function. A board mounted with a field programmable gate array chip has been designed to realize feedback control of the ECH beam position to maintain higher electron temperature by ECH. The heating position is determined by a plasma diagnostic signal related to the electron temperature such as electron cyclotron emission and Thomson scattering. (C) 2014 AIP Publishing LLC.	[Okada, K.; Kubo, S.; Shimozuma, T.; Yoshimura, Y.; Igami, H.; Takahashi, H.; Tanaka, K.; Kobayashi, S.; Ito, S.; Mizuno, Y.; Ogasawara, S.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Nishiura, M.] Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Energy, Kashiwa, Chiba 2778561, Japan	Okada, K (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	okada.kohta@LHD.nifs.ac.jp			National Institute for Fusion Science [ULRR804]; JSPS KAKENHI [24360384, 24360385, 25630423]	This work is supported by the National Institute for Fusion Science under Grant No. ULRR804 and JSPS KAKENHI Grant Nos. 24360384, 24360385, and 25630423.	Alberti S, 2005, NUCL FUSION, V45, P1224, DOI 10.1088/0029-5515/45/11/002; Treutterer W, 2014, FUSION ENG DES, V89, P146, DOI 10.1016/j.fusengdes.2014.01.001; Igami H, 2014, AIP CONF PROC, V1580, P490, DOI 10.1063/1.4864595; Kubo S, 2005, PLASMA PHYS CONTR F, V47, pA81, DOI 10.1088/0741-3335/47/5A/008; Lohr J, 2012, EPJ WEB CONF, V32, DOI 10.1051/epjconf/20123202009; Nishiura M, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/2/023006; Shimozuma T, 2010, FUSION SCI TECHNOL, V58, P38; Stober J, 2012, EPJ WEB CONF, V32, DOI 10.1051/epjconf/20123202011	8	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E811	10.1063/1.4891044		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000217		
J	Onchi, T; Fujisawa, A; Sanpei, A				Onchi, T.; Fujisawa, A.; Sanpei, A.			A prototype diagnostics system to detect ultraviolet emission for plasma turbulence	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							ANOMALOUS TRANSPORT; TOKAMAKS	A system to detect ultraviolet emissions from plasma is developed for multi-point measurement, the target of which is the imaging of turbulence with a high temporal resolution. A fluorescent glass, which converts ultraviolet emissions to visible light with a wavelength of approximately 540 nm, is utilized in the system. Following the conversion, the fluorescent light is transferred with fibre optics, and is converted to electric signals in a location that is sufficiently distant from an electrically noisy environment around the plasma device. This paper describes a prototype system of this diagnostic method and discusses the spectral analysis obtained using a low-aspect-ratio reversed field pinch RELAX. (C) 2014 AIP Publishing LLC.	[Onchi, T.; Fujisawa, A.] Kyushu Univ, Res Inst Appl Mech, Kasuga, Fukuoka 8168580, Japan; [Sanpei, A.] Kyoto Inst Technol, Dept Elect, Sakyo Ku, Kyoto 6068585, Japan	Onchi, T (reprint author), Kyushu Univ, Res Inst Appl Mech, 6-1 Kasuga Kohen, Kasuga, Fukuoka 8168580, Japan.		Kyushu, RIAM/F-4018-2015		JSPF, Japan [23246162]; NIFS [65 2012, 77 2013]	The authors are grateful to Dr. S. Masamune and Dr. H. Himura of Kyoto Institute of Technology, Dr. S. Ohshima of Kyoto University, Dr. Y. Nagashima of Kyushu University, and Dr. A. Shimizu and Dr. B. Peterson of NIFS. This work is in part supported by Grant-in-Aid for Scientific Research of JSPF, Japan (23246162), and by bilateral research conducted by NIFS (Nos. 65 2012 and 77 2013).	Diamond PH, 2005, PLASMA PHYS CONTR F, V47, pR35, DOI 10.1088/0741-3335/47/5/R01; Fujisawa A, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/1/013001; LIEWER PC, 1985, NUCL FUSION, V25, P543, DOI 10.1088/0029-5515/25/5/004; Delgado-Aparicio LF, 2004, REV SCI INSTRUM, V75, P4020, DOI 10.1063/1.1787902; Masamune S, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.123501; NAGAYAMA Y, 1988, PHYS REV LETT, V61, P1839, DOI 10.1103/PhysRevLett.61.1839; Oki K, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.075005; Onchi T, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3455216; Shesterikov I, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.055006; WOOTTON AJ, 1990, PHYS FLUIDS B-PLASMA, V2, P2879, DOI 10.1063/1.859358	10	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							113502	10.1063/1.4900660		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000260		
J	Ozaki, T; Kojima, S; Arikawa, Y; Shiraga, H; Sakagami, H; Fujioka, S; Kato, R				Ozaki, T.; Kojima, S.; Arikawa, Y.; Shiraga, H.; Sakagami, H.; Fujioka, S.; Kato, R.			An electron/ion spectrometer with the ability of low energy electron measurement for fast ignition experiments	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								An electron energy spectrometer (ESM) is one of the most fundamental diagnostics in the fast ignition experiment. It is necessary to observe the spectra down to a low energy range in order to obtain the accurate deposition efficiency toward the core. Here, we realize the suitable ESM by using a ferrite magnet with a moderate magnetic field of 0.3 T and a rectangular magnetic circuit covered with a steel plate in the inlet side. (C) 2014 AIP Publishing LLC.	[Ozaki, T.; Sakagami, H.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Kojima, S.; Arikawa, Y.; Shiraga, H.; Fujioka, S.] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Kato, R.] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Kato, R (reprint author), Osaka Univ, Inst Sci & Ind Res, 8-1 Mihogaoka, Osaka 5670047, Japan.	ozaki@nifs.ac.jp	Shiraga, Hiroyuki/I-9565-2015; Fujioka, Shinsuke/J-5530-2015; Arikawa, Yasunobu/L-8760-2015	Fujioka, Shinsuke/0000-0001-8406-1772; Arikawa, Yasunobu/0000-0002-3142-3060	 [NIFS13KUGK068];  [NIFS12UJHH003];  [24561028]	Authors thank for FIREX Group, GXII-LFEX Team about supporting the experiments. This work is supported by budgets of NIFS13KUGK068, NIFS12UJHH003 and the Grant-in-Aid for Scientific Research (24561028).	Nakanii N, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2940217; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; Tanaka KA, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1824371; Kodama R, 2002, NATURE, V418, P933, DOI 10.1038/418933a; Azechi H, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/1/012002; Chen H, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2953679; Kojima S., 2013, COMMUNICATION; Ozaki Tetsuo, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.S2098; Ozaki T., 2013, PLASMA FUSION RES, V8; Tanaka KA, 2004, PLASMA PHYS CONTR F, V46, pB41, DOI 10.1088/0741-3335/46/12B/004	10	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E113	10.1063/1.4891043		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000133		
J	Pablant, NA; Bell, RE; Bitter, M; Delgado-Aparicio, L; Hill, KW; Lazerson, S; Morita, S				Pablant, N. A.; Bell, R. E.; Bitter, M.; Delgado-Aparicio, L.; Hill, K. W.; Lazerson, S.; Morita, S.			Tomographic inversion techniques incorporating physical constraints for line integrated spectroscopy in stellarators and tokamaks	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							PLASMA	Accurate tomographic inversion is important for diagnostic systems on stellarators and tokamaks which rely on measurements of line integrated emission spectra. A tomographic inversion technique based on spline optimization with enforcement of constraints is described that can produce unique and physically relevant inversions even in situations with noisy or incomplete input data. This inversion technique is routinely used in the analysis of data from the x-ray imaging crystal spectrometer (XICS) installed at the Large Helical Device. The XICS diagnostic records a 1D image of line integrated emission spectra from impurities in the plasma. Through the use of Doppler spectroscopy and tomographic inversion, XICS can provide profile measurements of the local emissivity, temperature, and plasma flow. Tomographic inversion requires the assumption that these measured quantities are flux surface functions, and that a known plasma equilibrium reconstruction is available. In the case of low signal levels or partial spatial coverage of the plasma cross-section, standard inversion techniques utilizing matrix inversion and linear-regularization often cannot produce unique and physically relevant solutions. The addition of physical constraints, such as parameter ranges, derivative directions, and boundary conditions, allow for unique solutions to be reliably found. The constrained inversion technique described here utilizes a modified Levenberg-Marquardt optimization scheme, which introduces a condition avoidance mechanism by selective reduction of search directions. The constrained inversion technique also allows for the addition of more complicated parameter dependencies, for example, geometrical dependence of the emissivity due to asymmetries in the plasma density arising from fast rotation. The accuracy of this constrained inversion technique is discussed, with an emphasis on its applicability to systems with limited plasma coverage. (C) 2014 AIP Publishing LLC.	[Pablant, N. A.; Bell, R. E.; Bitter, M.; Delgado-Aparicio, L.; Hill, K. W.; Lazerson, S.] Princeton Plasma Phys Lab, Princeton, NJ 08543 USA; [Morita, S.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Pablant, NA (reprint author), Princeton Plasma Phys Lab, POB 451, Princeton, NJ 08543 USA.				(U.S.) Department of Energy (DOE) [DE-AC02-09CH11466]; Princeton University	The authors would like to thank M. Reinke for many discussions on inversion methods and M. Goto, T. Oishi, and the LHD experiment group for their support in the installation of the XICS diagnostic and LHD operation. Research supported by the (U.S.) Department of Energy (DOE) under Contract No. DE-AC02-09CH11466 with Princeton University.	Lazerson SA, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/8/084004; Reinke ML, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4758281; Bell RE, 1997, REV SCI INSTRUM, V68, P1273, DOI 10.1063/1.1147885; Bitter M, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3490016; Condrea I, 2000, PHYS PLASMAS, V7, P3641, DOI 10.1063/1.1287417; Markwardt C. B., ASP C SERIES, V411, P251; Pablant NA, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4744935	7	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E424	10.1063/1.4891977		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000172		
J	Sakata, S; Arikawa, Y; Kojima, S; Ikenouchi, T; Nagai, T; Abe, Y; Inoue, H; Morace, A; Utsugi, M; Kato, R; Nishimura, H; Nakai, M; Shiraga, H; Fujioka, S; Azechi, H				Sakata, S.; Arikawa, Y.; Kojima, S.; Ikenouchi, T.; Nagai, T.; Abe, Y.; Inoue, H.; Morace, A.; Utsugi, M.; Kato, R.; Nishimura, H.; Nakai, M.; Shiraga, H.; Fujioka, S.; Azechi, H.			Photonuclear reaction based high-energy x-ray spectrometer to cover from 2 MeV to 20 MeV	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							LASERS	A photonuclear-reaction-based hard x-ray spectrometer is developed to measure the number and energy spectrum of fast electrons generated by interactions between plasma and intense laser light. In this spectrometer, x-rays are converted to neutrons through photonuclear reactions, and the neutrons are counted with a bubble detector that is insensitive to x-rays. The spectrometer consists of a bundle of hard x-ray detectors that respond to different photon-energy ranges. Proof-of-principle experiment was performed on a linear accelerator facility. A quasi-monoenergetic electron bunch (N-e = 1.0 x 10(-6) C, E-e = 16 +/- 0.32 MeV) was injected into a 5-mm-thick lead plate. Bremsstrahlung x-rays, which emanate from the lead plate, were measured with the spectrometer. The measured spectral shape and intensity agree fairly well with those computed with a Monte Carlo simulation code. The result shows that high-energy x-rays can be measured absolutely with a photon-counting accuracy of 50%-70% in the energy range from 2 MeV to 20 MeV with a spectral resolution (Delta h nu/h nu) of about 15%. Quantum efficiency of this spectrometer was designed to be 10(-7), 10(-4), 10(-5), respectively, for 2-10, 11-15, and 15-25 MeV of photon energy ranges. (C) 2014 AIP Publishing LLC.	[Sakata, S.; Arikawa, Y.; Kojima, S.; Ikenouchi, T.; Nagai, T.; Abe, Y.; Inoue, H.; Morace, A.; Utsugi, M.; Nishimura, H.; Nakai, M.; Shiraga, H.; Fujioka, S.; Azechi, H.] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Kato, R.] Osaka Univ, Inst Sci & Ind Res, Ibaraki 5650047, Japan	Sakata, S (reprint author), Osaka Univ, Inst Laser Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sakata-s@ile.osaka-u.ac.jp	Azechi, Hiroshi/H-5876-2015; Nakai, Mitsuo/I-6758-2015; Nishimura, Hiroaki/I-4908-2015; Shiraga, Hiroyuki/I-9565-2015; Fujioka, Shinsuke/J-5530-2015; Arikawa, Yasunobu/L-8760-2015	Nakai, Mitsuo/0000-0001-6076-756X; Fujioka, Shinsuke/0000-0001-8406-1772; Arikawa, Yasunobu/0000-0002-3142-3060	Japan Society for the Promotion of Science [24244095, 23360413, 24686103, 25630419]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); NIFS Collaboration Research program [NIFS12KUGK057]	The authors gratefully acknowledge the support of the GEKKO XII operation group, the LFEX development and operation group, the target fabrication group, and the plasma diagnostics operation group of the Institute of Laser Engineering, Osaka University. This work was partly supported by the Japan Society for the Promotion of Science under the contracts of Grant-in-Aid for Scientific Research (A) No. 24244095 and (B) No. 23360413, Grant-in-Aid for Young Scientists (A) No. 24686103, Grant-in-Aid for Challenging Exploratory Research No. 25630419, and the auspices of the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) project on "Promotion of relativistic nuclear physics with ultra-intense laser," and NIFS Collaboration Research program (NIFS12KUGK057).	Ma T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.115004; Ledingham KWD, 2003, SCIENCE, V300, P1107, DOI 10.1126/science.1080552; Ing H, 1997, RADIAT MEAS, V27, P1, DOI 10.1016/S1350-4487(96)00156-4; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; Fujioka S, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/12/124042; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Beg FN, 1997, PHYS PLASMAS, V4, P447, DOI 10.1063/1.872103; Chen CD, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2964231; Gunther MM, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3613923; Kishida N, 2005, AIP CONF PROC, V769, P199; Miyanaga N, 2006, J PHYS IV, V133, P81, DOI 10.1051/jp4:2006133016; Phillips TW, 1999, REV SCI INSTRUM, V70, P1213, DOI 10.1063/1.1149337; Shiraga H, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/12/124029; Spencer I, 2002, REV SCI INSTRUM, V73, P3801, DOI 10.1063/1.1511802; TAKEDA S, 1985, IEEE T NUCL SCI, V32, P3219, DOI 10.1109/TNS.1985.4334325	15	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D629	10.1063/1.4893943		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000046		
J	Sano-Furukawa, A; Hattori, T; Arima, H; Yamada, A; Tabata, S; Kondo, M; Nakamura, A; Kagi, H; Yagi, T				Sano-Furukawa, A.; Hattori, T.; Arima, H.; Yamada, A.; Tabata, S.; Kondo, M.; Nakamura, A.; Kagi, H.; Yagi, T.			Six-axis multi-anvil press for high-pressure, high-temperature neutron diffraction experiments	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							POWDER DIFFRACTION; APPARATUS; CELL	We developed a six-axis multi-anvil press, ATSUHIME, for high-pressure and high-temperature in situ time-of-flight neutron powder diffraction experiments. The press has six orthogonally oriented hydraulic rams that operate individually to compress a cubic sample assembly. Experiments indicate that the press can generate pressures up to 9.3 GPa and temperatures up to 2000 K using a 6-6-type cell assembly, with available sample volume of about 50 mm(3). Using a 6-8-type cell assembly, the available conditions expand to 16 GPa and 1273 K. Because the six-axis press has no guide blocks, there is sufficient space around the sample to use the aperture for diffraction and place an incident slit, radial collimators, and a neutron imaging camera close to the sample. Combination of the six-axis press and the collimation devices realized high-quality diffraction pattern with no contamination from the heater or the sample container surrounding the sample. This press constitutes a new tool for using neutron diffraction to study the structures of crystals and liquids under high pressures and temperatures. (C) 2014 AIP Publishing LLC.	[Sano-Furukawa, A.; Hattori, T.] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Ibaraki 3191195, Japan; [Sano-Furukawa, A.; Hattori, T.] Japan Atom Energy Agcy, J PARC Ctr, Ibaraki 3191195, Japan; [Arima, H.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Yamada, A.] Univ Shiga Prefecture, Hikone, Shiga 5228533, Japan; [Tabata, S.; Kondo, M.; Nakamura, A.] Sumitomo Heavy Ind Co Ltd, Saijo, Ehime 7920001, Japan; [Kagi, H.; Yagi, T.] Univ Tokyo, Grad Sch Sci, Geochem Res Ctr, Tokyo 1130033, Japan	Sano-Furukawa, A (reprint author), Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Ibaraki 3191195, Japan.	sano.asami@jaea.go.jp	Arima, Hiroshi/C-4203-2015; Sano-Furukawa, Asami/D-6895-2015		JSPS [19GS0205]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [20103001]	The authors thank H. Kaneko for providing the heating program. This work was supported by JSPS Grant-in-Aid for Scientific Research on Innovative Areas (Grants No. 19GS0205) and Grant-in-Aid for Creative Scientific Research (No. 20103001) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The experiments were performed with the approval of the Neutron Science Proposal Review Committee of J-PARC, MLF (Proposal No. 2013I0011).	Abe J, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3384238; BALCHAN AS, 1961, REV SCI INSTRUM, V32, P308, DOI 10.1063/1.1717350; Brown JM, 1999, J APPL PHYS, V86, P5801, DOI 10.1063/1.371596; BESSON JM, 1992, PHYSICA B, V180, P907, DOI 10.1016/0921-4526(92)90505-M; KAWAI N, 1970, REV SCI INSTRUM, V41, P1178, DOI 10.1063/1.1684753; Nishiyama N, 2008, HIGH PRESSURE RES, V28, P307, DOI 10.1080/08957950802250607; Hattori T., DESIGN PERFORM UNPUB; Ito E, 2009, PHYS EARTH PLANET IN, V174, P264, DOI 10.1016/j.pepi.2008.11.007; Katsura T, 2004, PHYS EARTH PLANET IN, V143, P497, DOI 10.1016/j.pepi.2003.07.025; Klotz S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2976128; Komatsu K, 2013, HIGH PRESSURE RES, V33, P208, DOI 10.1080/08957959.2012.762914; Manthilake MAGM, 2012, HIGH PRESSURE RES, V32, P195, DOI 10.1080/08957959.2012.680450; Okuchi T, 2010, J PHYS CONF SER, V215, DOI 10.1088/1742-6596/215/1/012188; SHIMOMURA O, 1986, PHYSICA B & C, V139, P292, DOI 10.1016/0378-4363(86)90581-4; Tange T., 2008, HIGH PRESSURE RES, V28, P245; Utsumi W, 2009, NUCL INSTRUM METH A, V600, P50, DOI 10.1016/j.nima.2008.11.065; Uwatoko Y., 2008, REV HIGH PRESSURE SC, V18, P230, DOI DOI 10.4131/JSHPREVIEW.18.230	17	4	4	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							113905	10.1063/1.4901095		8	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000271		
J	Shimizu, A; Ido, T; Kurachi, M; Makino, R; Nishiura, M; Kato, S; Nishizawa, A; Hamada, Y				Shimizu, A.; Ido, T.; Kurachi, M.; Makino, R.; Nishiura, M.; Kato, S.; Nishizawa, A.; Hamada, Y.			2D potential measurements by applying automatic beam adjustment system to heavy ion beam probe diagnostic on the Large Helical Device	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							TRANSPORT; PLASMA	Two-dimensional potential profiles in the Large Helical Device (LHD) were measured with heavy ion beam probe (HIBP). To measure the two-dimensional profile, the probe beam energy has to be changed. However, this task is not easy, because the beam transport line of LHD-HIBP system is very long (similar to 20 m), and the required beam adjustment consumes much time. To reduce the probe beam energy adjustment time, an automatic beam adjustment system has been developed. Using this system, required time to change the probe beam energy is dramatically reduced, such that two-dimensional potential profiles were able to be successfully measured with HIBP by changing the probe beam energy shot to shot. (C) 2014 AIP Publishing LLC.	[Shimizu, A.; Ido, T.; Kato, S.; Hamada, Y.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Kurachi, M.; Makino, R.] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Nishiura, M.] Univ Tokyo, Grad Sch Frontier Sci, Chiba 2778561, Japan; [Nishizawa, A.] Pesco Corp Ltd, Toki, Gifu 5095123, Japan	Shimizu, A (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshi, Toki, Gifu 5095292, Japan.	akihiro@nifs.ac.jp			NIFS [ULHH 020, ULHH 023]; JSPS KAKENHI [24561031, 25820441]	This work was supported by the NIFS under Contract Nos. ULHH 020 and 023, and by JSPS KAKENHI Grant Nos. 24561031 and 25820441. The authors are grateful for the continuous support of the scientific and technical staff in the LHD experiment group.	BEIDLER CD, 1995, PLASMA PHYS CONTR F, V37, P463, DOI 10.1088/0741-3335/37/4/007; Burrell KH, 1997, PHYS PLASMAS, V4, P1499, DOI 10.1063/1.872367; CROWLEY TP, 1994, IEEE T PLASMA SCI, V22, P291, DOI 10.1109/27.310636; Fujisawa A, 1999, PHYS REV LETT, V82, P2669, DOI 10.1103/PhysRevLett.82.2669; Ido T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.055006; Ido T, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2338311; JOBES FC, 1969, PHYS REV LETT, V22, P1042, DOI 10.1103/PhysRevLett.22.1042; Shimizu A., 2007, J PLASMA FUSION RES, V2, pS1098; Shimizu A., P 23 IAEA FUS EN C D	9	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D853	10.1063/1.4891975		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000107		
J	Shinohara, K; Ishii, K; Ochiai, K; Baba, M; Sukegawa, A; Sasao, M; Kitajima, S				Shinohara, K.; Ishii, K.; Ochiai, K.; Baba, M.; Sukegawa, A.; Sasao, M.; Kitajima, S.			Evaluation of two-stage system for neutron measurement aiming at increase in count rate at Japan Atomic Energy Agency-Fusion Neutronics Source	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							EMISSION PROFILE; JT-60U; MONITOR	In order to increase the count rate capability of a neutron detection system as a whole, we propose a multi-stage neutron detection system. Experiments to test the effectiveness of this concept were carried out on Fusion Neutronics Source. Comparing four configurations of alignment, it was found that the influence of an anterior stage on a posterior stage was negligible for the pulse height distribution. The two-stage system using 25 mm thickness scintillator was about 1.65 times the count rate capability of a single detector system for d-D neutrons and was about 1.8 times the count rate capability for d-T neutrons. The results suggested that the concept of a multi-stage detection system will work in practice. (C) 2014 AIP Publishing LLC.	[Shinohara, K.; Ochiai, K.; Sukegawa, A.] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan; [Ishii, K.; Kitajima, S.] Tohoku Univ, Dept Quantum Sci & Energy Engn, Sendai, Miyagi 9808579, Japan; [Baba, M.] Tohoku Univ, Ctr Cyclotron & Radioisotope, Sendai, Miyagi 9808578, Japan; [Sasao, M.] Doshisha Univ, Org Res Initiat & Dev, Kyoto 6028580, Japan	Shinohara, K (reprint author), Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan.	shinohara.koji@jaea.go.jp			 [22560825]	The authors would like to thank the FNS group for their contribution to the successful completion of the experiments at the FNS. This work was supported by Grant-in-Aid for Scientific Research (C) (Grant No. 22560825).	ADAMS JM, 1993, NUCL INSTRUM METH A, V329, P277, DOI 10.1016/0168-9002(93)90947-G; Ishii Keiichi, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.S1043; Ishii K, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3496986; Ishikawa M, 2002, REV SCI INSTRUM, V73, P4237, DOI 10.1063/1.1518145; Ishikawa M, 2005, NUCL FUSION, V45, P1474, DOI 10.1088/0029-5515/45/12/002; Ishikawa M, 2006, NUCL FUSION, V46, pS898, DOI 10.1088/0029-5515/46/10/S05; Ishikawa M, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2221927; Itoga T, 2007, RADIAT PROT DOSIM, V126, P380, DOI 10.1093/rpd/ncm141; Jarvis ON, 1997, FUSION ENG DES, V34-35, P59, DOI 10.1016/S0920-3796(96)00672-2; Mayer J. W., 1977, ION BEAM HDB MAT ANA, P125; Nakagawa T., 1990, M90099 JAERI; Nakamura T., 1983, P INT ION ENG C ISIA, V1, P567; ROQUEMORE AL, 1990, REV SCI INSTRUM, V61, P3163, DOI 10.1063/1.1141674; Sakane H., ION BEAM HDB MAT ANA, P19428; Shinohara K, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2971975; Shinohara K, 2002, NUCL FUSION, V42, P942, DOI 10.1088/0029-5515/42/8/302; Suzuki T., 2007, NUCL FUSION, V48	17	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E823	10.1063/1.4893941		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000229		
J	Shumack, AE; Rzadkiewicz, J; Chernyshova, M; Jakubowska, K; Scholz, M; Byszuk, A; Cieszewski, R; Czarski, T; Dominik, W; Karpinski, L; Kasprowicz, G; Pozniak, K; Wojenski, A; Zabolotny, W; Conway, NJ; Dalley, S; Figueiredo, J; Nakano, T; Tyrrell, S; Zastrow, KD; Zoita, V				Shumack, A. E.; Rzadkiewicz, J.; Chernyshova, M.; Jakubowska, K.; Scholz, M.; Byszuk, A.; Cieszewski, R.; Czarski, T.; Dominik, W.; Karpinski, L.; Kasprowicz, G.; Pozniak, K.; Wojenski, A.; Zabolotny, W.; Conway, N. J.; Dalley, S.; Figueiredo, J.; Nakano, T.; Tyrrell, S.; Zastrow, K. -D.; Zoita, V.		JET EFDA Contributors	X-ray crystal spectrometer upgrade for ITER-like wall experiments at JET	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							MONOCHROMATORS	The high resolution X-Ray crystal spectrometer at the JET tokamak has been upgraded with the main goal of measuring the tungsten impurity concentration. This is important for understanding impurity accumulation in the plasma after installation of the JET ITER-like wall (main chamber: Be, divertor: W). This contribution provides details of the upgraded spectrometer with a focus on the aspects important for spectral analysis and plasma parameter calculation. In particular, we describe the determination of the spectrometer sensitivity: important for impurity concentration determination.	[Shumack, A. E.; Conway, N. J.; Dalley, S.; Tyrrell, S.; Zastrow, K. -D.; JET EFDA Contributors] JET EFDA, Culham Sci Ctr, Abingdon OX14 3DB, Oxon, England; [Shumack, A. E.] FOM Inst DIFFER, NL-3430 BE Nieuwegein, Netherlands; [Rzadkiewicz, J.] Natl Ctr Nucl Res, PL-05400 Otwock, Poland; [Chernyshova, M.; Jakubowska, K.; Czarski, T.; Karpinski, L.] Inst Plasma Phys & Laser Microfus, PL-01497 Warsaw, Poland; [Jakubowska, K.] Univ Bordeaux, CNRS, CEA, CELIA,UMR 5107, F-33405 Talence, France; [Scholz, M.] Inst Nucl Phys PAN, PL-31342 Krakow, Poland; [Byszuk, A.; Cieszewski, R.; Kasprowicz, G.; Pozniak, K.; Wojenski, A.; Zabolotny, W.] Warsaw Univ Technol, Inst Elect Syst, PL-00665 Warsaw, Poland; [Dominik, W.] Warsaw Univ, Inst Expt Phys, Fac Phys, PL-00681 Warsaw, Poland; [Figueiredo, J.] EFDA CSU, Culham Sci Ctr, Abingdon OX14 3DB, Oxon, England; [Figueiredo, J.] Inst Super Tecn, Inst Plasmas Fusao Nucl, Assoc EURATOM IST, P-1049001 Lisbon, Portugal; [Nakano, T.] Japan Atom Energy Agcy, Naka, Ibaraki, Japan; [Zoita, V.] Assoc EURATOM MEdC, Natl Inst Laser Plasma & Radiat Phys, Magurele, Romania	Shumack, AE (reprint author), JET EFDA, Culham Sci Ctr, Abingdon OX14 3DB, Oxon, England.	amy.shumack@ccfe.ac.uk		Zabolotny, Wojciech/0000-0002-6833-4846; Figueiredo, J./0000-0003-1356-7666	EURATOM	This work was supported by EURATOM and carried out within the framework of the European Fusion Development Agreement. The views and opinions expressed herein do not necessarily reflect those of the European Commission.	Pamela J, 2007, J NUCL MATER, V363, P1, DOI 10.1016/j.jnucmat.2006.12.056; Pitts RA, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014001; Bartiromo R., 1983, P COURS DIAGN FUS RE, VI, P123; BARTIROMO R, 1989, REV SCI INSTRUM, V60, P237, DOI 10.1063/1.1140415; BOEUF A, 1978, J APPL CRYSTALLOGR, V11, P442, DOI 10.1107/S0021889878013564; Chernyshova M, 2014, J INSTRUM, V9, DOI 10.1088/1748-0221/9/03/C03003; del Rio MS, 1997, P SOC PHOTO-OPT INS, V3151, P312, DOI 10.1117/12.294490; EGERT G, 1970, J APPL CRYSTALLOGR, V3, P214, DOI 10.1107/S0021889870006076; Kasprowicz G, 2011, PROC SPIE, V8008, DOI 10.1117/12.905492; Nakano T., 2014, P 41 EPS C PLASM PHY, V38F; Pozniak K, 2011, PROC SPIE, V8008, DOI 10.1117/12.905600; Rzadkiewicz J., 2013, NUCL INSTRUM METHO A, V720, P36; Weller A., 1987, JETIR8710; WHITE JE, 1950, J APPL PHYS, V21, P855, DOI 10.1063/1.1699774; Zachariasen W. H., 1967, THEORY XRAY DIFFRACT	15	5	5	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E425	10.1063/1.4891182		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000173		
J	Takemura, Y; Ohdachi, S; Watanabe, KY; Du, XD				Takemura, Y.; Ohdachi, S.; Watanabe, K. Y.; Du, X. D.			Development of 2D soft X-ray measurement system in the large helical device	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							TOKAMAK; CAMERA	A fast two-dimensional soft X-ray camera using silicon photo diode array is being developed in order to investigate high frequency MHD instability with high mode number. The advantage of the adopted diode is a large sensor area of 10 mm x 10 mm and small diode capacitance which enable us to measure signals with the short response time. The characteristic of the prototype is summarized as follows: Channel number is 6 x 8 = 48, detection range 1 similar to 10 keV, the spatial resolution 128 mm at the plasma location, and frequency range DC similar to 100 kHz. Synthetic image of the prototype in the Large Helical Device is estimated by using perturbation model of MHD mode. (C) 2014 AIP Publishing LLC.	[Takemura, Y.; Ohdachi, S.; Watanabe, K. Y.] Natl Inst Fus Sci, Gifu, Japan; [Ohdachi, S.; Du, X. D.] Grad Univ Adv Studies, Dept Fus Sci, Gifu, Japan	Takemura, Y (reprint author), Natl Inst Fus Sci, Gifu, Japan.				NIFS [ULPP021, ULPP036]; Ministry of Education, Culture, Sports, Science and Technology [26249144]; JSPS-NRF-NSFC A3 Foresight Program [11261140328]; NIFS/NINS	The authors are grateful to the LHD operation group for their technical support. This work was supported by NIFS budget codes ULPP021 and ULPP036, and is also partially supported by Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research (A), 26249144, by the JSPS-NRF-NSFC A3 Foresight Program (NSFC: No. 11261140328), and by NIFS/NINS under the project Formation of International Scientific Base and Network.	CAMACHO JF, 1986, REV SCI INSTRUM, V57, P417, DOI 10.1063/1.1138902; EDWARDS AW, 1986, REV SCI INSTRUM, V57, P2142, DOI 10.1063/1.1139200; Fuchs G., 1999, P 26 EPS C CONTR FUS, V23, P757; Ohdachi S, 2001, REV SCI INSTRUM, V72, P724, DOI 10.1063/1.1324741; Ohdachi S, 2010, CONTRIB PLASM PHYS, V50, P552, DOI 10.1002/ctpp.200900051; Stratton BC, 2004, REV SCI INSTRUM, V75, P3959, DOI 10.1063/1.1787930; VONGOELE.S, 1974, PHYS REV LETT, V33, P1201, DOI 10.1103/PhysRevLett.33.1201; VONGOELER S, 1990, REV SCI INSTRUM, V61, P3055, DOI 10.1063/1.1141725	8	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E410	10.1063/1.4890261		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000158		
J	Terasaka, K; Yoshimura, S; Kato, Y; Furuta, K; Aramaki, M; Morisaki, T; Tanaka, MY				Terasaka, K.; Yoshimura, S.; Kato, Y.; Furuta, K.; Aramaki, M.; Morisaki, T.; Tanaka, M. Y.			High-impedance wire grid method to study spatiotemporal behavior of hot electron clump generated in a plasma	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							TOMOGRAPHY; TOKAMAK	High-impedance Wire Grid (HIWG) detector has been developed to study spatiotemporal behavior of a hot electron clump generated in an electron cyclotron resonance (ECR) plasma. By measuring the floating potentials of the wire electrodes, and generating structure matrix made of geometrical means of the floating potentials, the HIWG detector reconstructs the spatial distribution of high-temperature electron clump at an arbitrary instant of time. Time slices of the spike event in floating potential revealed the growth and decay process of a hot spot occurs in an ECR plasma. (C) 2014 AIP Publishing LLC.	[Terasaka, K.; Kato, Y.; Tanaka, M. Y.] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Yoshimura, S.; Morisaki, T.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Furuta, K.] Nagoya Univ, Dept Phys, Nagoya, Aichi 4648602, Japan; [Aramaki, M.] Nihon Univ, Coll Ind Technol, Narashino, Chiba 2758575, Japan	Terasaka, K (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan.	terasaka@aees.kyushu-u.ac.jp			LHD Research Collaboration Program [NIFS11KOAP025]; JSPS KAKENHI [2324112, 24540544, 25800306]	This work was carried out under LHD Research Collaboration Program (NIFS11KOAP025), and partially supported by JSPS KAKENHI Grant Nos. 2324112 (Grant-in-Aid for Scientific Research A), 24540544 (Grant-in-Aid for Scientific Research C), and 25800306 (Grant-in-Aid for Young Scientists B). One of the authors (M. Y. Tanaka) would like to thank Professor A. Tsushima at Yokohama National University for useful discussions and information on this subject.	Antar GY, 2001, PHYS PLASMAS, V8, P1612, DOI 10.1063/1.1363663; Bonomo F, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2012108; CAMACHO JF, 1986, REV SCI INSTRUM, V57, P417, DOI 10.1063/1.1138902; MARTIN WC, 1960, J RES NBS A PHYS CH, V64, P19, DOI 10.6028/jres.064A.003; TANAKA M, 1991, J PHYS SOC JPN, V60, P1600, DOI 10.1143/JPSJ.60.1600; Tanaka MY, 1998, REV SCI INSTRUM, V69, P980, DOI 10.1063/1.1148607; Tanaka Y., 2007, PLASMA FUSION RES, V2, pS1090, DOI 10.1585/pfr.2.S1090; Tsushima A, 1996, JPN J APPL PHYS 1, V35, P3618, DOI 10.1143/JJAP.35.3618; Wang L., 1991, REV SCI INSTRUM, V62, P842, DOI 10.1063/1.1142047; Yoshimura S., IEEE T PLAS IN PRESS; Yoshimura S., 2014, JPS C P, V1	11	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							113503	10.1063/1.4901096		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000261		
J	Dinh, TH; Suzuki, Y; Hirose, R; Hara, H; Ohashi, H; Li, BW; Dunne, P; O'Sullivan, G; Sunahara, A; Higashiguchi, T				Thanh Hung Dinh; Suzuki, Yuhei; Hirose, Ryoichi; Hara, Hiroyuki; Ohashi, Hayato; Li, Bowen; Dunne, Padraig; O'Sullivan, Gerry; Sunahara, Atsushi; Higashiguchi, Takeshi			Note: Development of a volume-limited dot target for a high brightness extreme ultraviolet microplasma source	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								We report on production of volume-limited dot targets based on electron beam lithographic and sputtering technologies for use in efficient high brightness extreme ultraviolet microplasma sources. We successfully produced cylindrical tin (Sn) targets with diameters of 10, 15, and 20 mu m and a height of 150 nm. The calculated spectrum around 13.5 nm was in good agreement with that obtained experimentally. (c) 2014 AIP Publishing LLC.	[Thanh Hung Dinh; Suzuki, Yuhei; Hara, Hiroyuki; Higashiguchi, Takeshi] Utsunomiya Univ, Dept Adv Interdisciplinary Sci, Utsunomiya, Tochigi 3218585, Japan; [Thanh Hung Dinh; Suzuki, Yuhei; Hara, Hiroyuki; Higashiguchi, Takeshi] Utsunomiya Univ, Ctr Opt Res CORE, Utsunomiya, Tochigi 3218585, Japan; [Hirose, Ryoichi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Ohashi, Hayato] Toyama Univ, Grad Sch Sci & Engn Res, Toyama 9308555, Japan; [Li, Bowen; Dunne, Padraig; O'Sullivan, Gerry] Univ Coll Dublin, Sch Phys, Dublin 4, Ireland; [Sunahara, Atsushi] Inst Laser Technol, Suita, Osaka 5650871, Japan	Dinh, TH (reprint author), Utsunomiya Univ, Dept Adv Interdisciplinary Sci, Yoto 7-1-2, Utsunomiya, Tochigi 3218585, Japan.	dinh@cc.utsunomiya-u.ac.jp; higashi@cc.utsunomiya-u.ac.jp	Li, Bowen/A-2133-2013; 	Li, Bowen/0000-0002-0336-2096; SUNAHARA, ATSUSHI/0000-0001-7543-5226	Cooperative Research Program of "Network Joint Research Center for Materials and Devices" [2014169]; Science Foundation Ireland International Co-operation Strategic Award [13/ISCA/2846]	The authors are grateful to Dr. Jynichiro Sugisaka, Masato Kawasaki, and Goki Arai for their unparalleled technical support. A part of this work was performed under "Project for Bio-Imaging and Sensing at Utsunomiya University" from MEXT and was performed under the Cooperative Research Program of "Network Joint Research Center for Materials and Devices" (under Contract Subject "2014169"). The UCD group was supported by Science Foundation Ireland International Co-operation Strategic Award 13/ISCA/2846.	Sandberg RL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.098103; Purvis MA, 2013, NAT PHOTONICS, V7, P796, DOI [10.1038/nphoton.2013.217, 10.1038/NPHOTON.2013.217]; Takman PAC, 2007, J MICROSC-OXFORD, V226, P175, DOI 10.1111/j.1365-2818.2007.01765.x; Sakdinawat A, 2010, NAT PHOTONICS, V4, P840, DOI 10.1038/nphoton.2010.267; Tay NB, 2011, TRIBOL LETT, V44, P167, DOI 10.1007/s11249-011-9835-1; Banine VY, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/25/253001; Higashiguchi T, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3673912; Higashiguchi T, 2013, OPT EXPRESS, V21, P31837, DOI 10.1364/OE.21.031837; Li BW, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4789982; Mizoguchi H, 2013, PROC SPIE, V8679, DOI 10.1117/12.2014139; Roy A, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4893611; Sunahara A, 2008, J PHYS CONF SER, V112, DOI 10.1088/1742-6596/112/4/042048; Wagner C, 2010, NAT PHOTONICS, V4, P24; Yuspeh S, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3589359	14	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							116104	10.1063/1.4901934		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000302		
J	Togashi, H; Ejiri, A; Hiratsuka, J; Nakamura, K; Takase, Y; Yamaguchi, T; Furui, H; Imamura, K; Inada, T; Kakuda, H; Nakanishi, A; Oosako, T; Shinya, T; Sonehara, M; Tsuda, S; Tsujii, N; Wakatsuki, T; Hasegawa, M; Nagashima, Y; Narihara, K; Yamada, I; Tojo, H				Togashi, H.; Ejiri, A.; Hiratsuka, J.; Nakamura, K.; Takase, Y.; Yamaguchi, T.; Furui, H.; Imamura, K.; Inada, T.; Kakuda, H.; Nakanishi, A.; Oosako, T.; Shinya, T.; Sonehara, M.; Tsuda, S.; Tsujii, N.; Wakatsuki, T.; Hasegawa, M.; Nagashima, Y.; Narihara, K.; Yamada, I.; Tojo, H.			Demonstration of improvement in the signal-to-noise ratio of Thomson scattering signal obtained by using a multi-pass optical cavity on the Tokyo Spherical Tokamak-2	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								The multi-pass Thomson scattering (TS) scheme enables obtaining many photons by accumulating multiple TS signals. The signal-to-noise ratio (SNR) depends on the accumulation number. In this study, we performed multi-pass TS measurements for ohmically heated plasmas, and the relationship between SNR and the accumulation number was investigated. As a result, improvement of SNR in this experiment indicated similar tendency to that calculated for the background noise dominant situation. (C) 2014 AIP Publishing LLC.	[Togashi, H.; Ejiri, A.; Nakamura, K.; Takase, Y.; Yamaguchi, T.; Furui, H.; Imamura, K.; Inada, T.; Nakanishi, A.; Oosako, T.; Shinya, T.; Tsuda, S.; Tsujii, N.] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Hiratsuka, J.; Kakuda, H.; Sonehara, M.; Wakatsuki, T.] Univ Tokyo, Grad Sch Sci, Tokyo 1130033, Japan; [Hasegawa, M.; Nagashima, Y.; Narihara, K.] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan; [Yamada, I.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Tojo, H.] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan	Togashi, H (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan.	togashi@fusion.k.u-tokyo.ac.jp	Kyushu, RIAM/F-4018-2015		Japan Society for the Promotion of Science (JSPS) [24656556, 21226021]; National Institute for Fusion Science (NIFS) [NIFS12KUTR078]	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research Nos. 24656556 and 21226021 and by the National Institute for Fusion Science (NIFS) Collaborative Research Program No. NIFS12KUTR078.	Kantor MY, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/5/055002; Hatae T., 2004, J PLASMA FUSION RES, V80, P870, DOI 10.1585/jspf.80.870; Togashi H., 2014, PLASMA FUSION RES, V9; Togashi H, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4878260; Yoshikawa M., 2013, PLASMA FUSION RES, V8	5	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D846	10.1063/1.4891707		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000100		
J	Tojo, H; Yamada, I; Yasuhara, R; Yatsuka, E; Funaba, H; Hatae, T; Hayashi, H; Itami, K				Tojo, H.; Yamada, I.; Yasuhara, R.; Yatsuka, E.; Funaba, H.; Hatae, T.; Hayashi, H.; Itami, K.			Signal evaluations using singular value decomposition for Thomson scattering diagnostics	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								This paper provides a novel method for evaluating signal intensities in incoherent Thomson scattering diagnostics. A double-pass Thomson scattering system, where a laser passes through the plasma twice, generates two scattering pulses from the plasma. Evaluations of the signal intensities in the spectrometer are sometimes difficult due to noise and stray light. We apply the singular value decomposition method to Thomson scattering data with strong noise components. Results show that the average accuracy of the measured electron temperature (T-e) is superior to that of temperature obtained using a low-pass filter (<20 MHz) or without any filters. (C) 2014 AIP Publishing LLC.	[Tojo, H.; Yatsuka, E.; Hatae, T.; Itami, K.] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan; [Yamada, I.; Yasuhara, R.; Funaba, H.; Hayashi, H.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Tojo, H (reprint author), Japan Atom Energy Agcy, 801-1 Mukoyama, Naka, Ibaraki 3110193, Japan.	tojo.hiroshi@jaea.go.jp					Furno I, 2005, PLASMA PHYS CONTR F, V47, P49, DOI 10.1088/0741-3335/47/1/004; Hatae T, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2228347; Hiratsuka Junichi, 2011, Plasma and Fusion Research, V6, DOI 10.1585/pfr.6.1202133; Togashi H, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4878260; W.H. Press, 2007, ART SCI COMPUTING; Yamada I., 2013, P 40 EPS C PLASM PHY	6	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D865	10.1063/1.4896478		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000119		
J	Tomita, H; Yamashita, F; Nakayama, Y; Morishima, K; Yamamoto, Y; Sakai, Y; Cheon, MS; Isobe, M; Ogawa, K; Hayashi, S; Kawarabayashi, J; Iguchi, T				Tomita, H.; Yamashita, F.; Nakayama, Y.; Morishima, K.; Yamamoto, Y.; Sakai, Y.; Cheon, M. S.; Isobe, M.; Ogawa, K.; Hayashi, S.; Kawarabayashi, J.; Iguchi, T.			Progress in development of neutron energy spectrometer for deuterium plasma operation in KSTAR	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							EMISSION PROFILES	Two types of DD neutron energy spectrometer (NES) are under development for deuterium plasma operation in KSTAR to understand behavior of beam ions in the plasma. One is based on the state-of-the-art nuclear emulsion technique. The other is based on a coincidence detection of a recoiled proton and a scattered neutron caused by an elastic scattering of an incident DD neutron, which is called an associated particle coincidence counting-NES. The prototype NES systems were installed at J-port in KSTAR in 2012. During the 2012 and 2013 experimental campaigns, multiple shots-integrated neutron spectra were preliminarily obtained by the nuclear emulsion-based NES system. (C) 2014 AIP Publishing LLC.	[Tomita, H.; Yamashita, F.; Nakayama, Y.; Morishima, K.; Yamamoto, Y.; Sakai, Y.; Hayashi, S.; Kawarabayashi, J.; Iguchi, T.] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Cheon, M. S.] Natl Fus Res Inst, ITER Korea, Diagnost Technol Team, Taejon 305333, South Korea; [Isobe, M.] Grad Univ Adv Studies, Toki, Gifu 5095292, Japan; [Isobe, M.; Ogawa, K.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Tomita, H (reprint author), Nagoya Univ, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	tomita@nagoya-u.jp			NIFS Collaboration Research program [NIFS12KOAH029]; JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC) [11261140328]; Japan in the Area of Fusion Energy Research and Related Fields	This work is performed with the support and under the auspices of the NIFS Collaboration Research program (NIFS12KOAH029) and Cooperation between Japan and Korea in the Area of Fusion Energy Research and Related Fields. Also, this work is partly supported by the JSPS-NRF-NSFC A3 Foresight Program in the field of Plasma Physics (NSFC: No. 11261140328).	Hellesen C, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/8/084006; Chen Z, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/6/063023; GORINI G, 1992, REV SCI INSTRUM, V63, P4548, DOI 10.1063/1.1143663; Morishima K., 2010, J INSTRUM, V5; Morishima K, 2013, RADIAT MEAS, V50, P237, DOI 10.1016/j.radmeas.2012.06.016; Shibata Y, 2001, REV SCI INSTRUM, V72, P828, DOI 10.1063/1.1323240; Sjostrand H, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2336459; STRACHAN JD, 1978, PHYS LETT A, V66, P295, DOI 10.1016/0375-9601(78)90242-6; Tomita H, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3464260; Wolle B, 1996, NUCL INSTRUM METH A, V368, P425, DOI 10.1016/0168-9002(95)00768-7; Yamamoto Y., 2014, PROG NUCL SCI TECH, V4, P679	11	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E120	10.1063/1.4893004		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000140		
J	Uchida, Y; Takada, E; Fujisaki, A; Isobe, M; Ogawa, K; Shinohara, K; Tomita, H; Kawarabayashi, J; Iguchi, T				Uchida, Y.; Takada, E.; Fujisaki, A.; Isobe, M.; Ogawa, K.; Shinohara, K.; Tomita, H.; Kawarabayashi, J.; Iguchi, T.			A study on fast digital discrimination of neutron and gamma-ray for improvement neutron emission profile measurement	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							PULSE-SHAPE DISCRIMINATION; ORGANIC SCINTILLATORS; MONITOR	Neutron and gamma-ray (n-gamma) discrimination with a digital signal processing system has been used to measure the neutron emission profile in magnetic confinement fusion devices. However, a sampling rate must be set low to extend the measurement time because the memory storage is limited. Time jitter decreases a discrimination quality due to a low sampling rate. As described in this paper, a new charge comparison method was developed. Furthermore, automatic n-gamma discrimination method was examined using a probabilistic approach. Analysis results were investigated using the figure of merit. Results show that the discrimination quality was improved. Automatic discrimination was applied using the EM algorithm and k-means algorithm. (C) 2014 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 Unported License.	[Uchida, Y.; Takada, E.; Fujisaki, A.] Toyama Coll, Natl Inst Technol, Toyama 9398630, Japan; [Isobe, M.; Ogawa, K.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Isobe, M.] Grad Univ Adv Studies SOKENDAI, Toki, Gifu 5095292, Japan; [Shinohara, K.] Japan Atom Energy Agcy, Naka, Ibaraki 3110913, Japan; [Tomita, H.; Kawarabayashi, J.; Iguchi, T.] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Uchida, Y (reprint author), Toyama Coll, Natl Inst Technol, 13 Hongo Machi, Toyama 9398630, Japan.	h1312101@mailg.nc-toyama.ac.jp			NIFS Collaboration Research programs [NIFS12KOAH029]	This research was supported by NIFS Collaboration Research programs (NIFS12KOAH029). The authors thank the Japan Atomic Energy Agency for providing JT-60U measurement data. One author, Y.U., is deeply grateful to the LHD team for development of the system and software.	Riva M, 2011, FUSION ENG DES, V86, P1191, DOI [10.1016/j.fusengdes.2011.02.038, 10.1016/gusengdes.2011.02.038]; Belli F, 2008, NUCL INSTRUM METH A, V595, P512, DOI 10.1016/j.nima.2008.06.045; Bertalot L, 2006, NUCL PHYS B-PROC SUP, V150, P78, DOI 10.1016/j.nuclphysbps.2004.07.003; Bishop C. M., 2006, PATTERN RECOGNITION; Esposito B, 2004, NUCL INSTRUM METH A, V518, P626, DOI 10.1016/j.nima.2003.11.103; Esposito B, 2004, REV SCI INSTRUM, V75, P3550, DOI 10.1063/1.1785278; Esposito B., 2009, NUCL INSTRUM METH A, V598, P551; Giacomelli L, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3519016; Ishii K, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3496986; Ishikawa M, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2221927; Itoga T, 2007, RADIAT PROT DOSIM, V126, P380, DOI 10.1093/rpd/ncm141; Pereira RC, 2006, FUSION ENG DES, V81, P1873, DOI 10.1016/j.fusengdes.2006.04.017; Shinohara K., 2013, PLASMA FUSION RES, V8	13	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E118	10.1063/1.4891711		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000138		
J	Uematsu, Y; Ivancic, S; Iwawaki, T; Habara, H; Lei, AL; Theobald, W; Tanaka, KA				Uematsu, Y.; Ivancic, S.; Iwawaki, T.; Habara, H.; Lei, A. L.; Theobald, W.; Tanaka, K. A.			Measuring the strong electrostatic and magnetic fields with proton radiography for ultra-high intensity laser channeling on fast ignition	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								In order to investigate the intense laser propagation and channel formation in dense plasma, we conducted an experiment with proton deflectometry on the OMEGA EP Laser facility. The proton image was analyzed by tracing the trajectory of mono-energetic protons, which provides understanding the electric and magnetic fields that were generated around the channel. The estimated field strengths (E similar to 10(11) V/m and B similar to 10(8) G) agree with the predictions from 2D-Particle-in-cell (PIC) simulations, indicating the feasibility of the proton deflectometry technique for over-critical density plasma. (C) 2014 AIP Publishing LLC.	[Uematsu, Y.; Iwawaki, T.; Habara, H.; Tanaka, K. A.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Ivancic, S.; Theobald, W.] Univ Rochester, Laser Energet Lab, Rochester, NY 14623 USA; [Lei, A. L.] Shanghai Inst Laser Plasma, Shanghai 201800, Peoples R China	Uematsu, Y (reprint author), Osaka Univ, Grad Sch Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	habara@eei.eng.osaka-u.ac.jp			Japan/U.S. Cooperation in Fusion Research and Development; Japan Society for the Promotion of Science [22246122, 23360412]	This work was fully supported by Japan/U.S. Cooperation in Fusion Research and Development in 2012 and 2013. Part of this work was performed under "ASHULA" Asian Core Program and Grants-in-Aid for Scientific Research, type A (Grant No. 22246122) and type B (Grant No. 23360412) by Japan Society for the Promotion of Science.	KESSLER TJ, 1993, P SOC PHOTO-OPT INS, V1870, P95, DOI 10.1117/12.154474; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; Radha PB, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1882333; Mackinnon AJ, 2004, REV SCI INSTRUM, V75, P3531, DOI 10.1063/1.1788893; Lei AL, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066403; Willingale L, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.105002; Hey DS, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2901603; Ivancic S, 2013, B AM PHYS SOC, V58, P373; Pape S L, 2010, HIGH ENERGY DENSITY, V6, P365; Town R. P. J., 2005, B AM PHYS SOC, V50, P123	10	3	3	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E612	10.1063/1.4890575		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000199		
J	Ward, JM; Maimaiti, A; Le, VH; Chormaic, SN				Ward, J. M.; Maimaiti, A.; Le, Vu H.; Chormaic, S. Nic			Contributed Review: Optical micro- and nanofiber pulling rig	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Review							EVANESCENT FIELD; SILICA NANOWIRES; FIBER NANOWIRES; KNOT RESONATORS; TAPERED FIBER; FABRICATION; SHAPE; MICROHEATER; SENSITIVITY; COUPLERS	We review the method of producing adiabatic optical micro-and nanofibers using a hydrogen/oxygen flame brushing technique. The flame is scanned along the fiber, which is being simultaneously stretched by two translation stages. The tapered fiber fabrication is reproducible and yields highly adiabatic tapers with either exponential or linear profiles. Details regarding the setup of the flame brushing rig and the various parameters used are presented. Information available from the literature is compiled and further details that are necessary to have a functioning pulling rig are included. This should enable the reader to fabricate various taper profiles, while achieving adiabatic transmission of similar to 99% for fundamental mode propagation. Using this rig, transmissions ranging from 85% to 95% for higher order modes in an optical nanofiber have been obtained. (C) 2014 AIP Publishing LLC.	[Ward, J. M.; Maimaiti, A.; Le, Vu H.; Chormaic, S. Nic] OIST Grad Univ, Light Matter Interact Unit, Onna Son, Okinawa 9040495, Japan; [Maimaiti, A.] Natl Univ Ireland Univ Coll Cork, Dept Phys, Cork, Ireland	Ward, JM (reprint author), OIST Grad Univ, Light Matter Interact Unit, 1919-1 Tancha, Onna Son, Okinawa 9040495, Japan.		Nic Chormaic, Sile/B-4780-2015; Maimaiti, Aili/B-1668-2015	Maimaiti, Aili/0000-0002-4668-2153	OIST Graduate University	The authors wish to thank Alan Curtis for early contributions to building the fiber rig and Mary Frawley for useful discussions on higher order mode propagation. This work is funded through OIST Graduate University.	Spillane SM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.043902; BILODEAU F, 1988, J LIGHTWAVE TECHNOL, V6, P1476, DOI 10.1109/50.7904; Yokota H, 1997, OPT REV, V4, P104; TAKEUCHI Y, 1994, APPL OPTICS, V33, P1029, DOI 10.1364/AO.33.001029; Ravets S, 2013, J OPT SOC AM A, V30, P2361, DOI 10.1364/JOSAA.30.002361; Ward JM, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2239033; Sumetsky M, 2006, J LIGHTWAVE TECHNOL, V24, P242, DOI 10.1109/JLT.2005.861127; BIRKS TA, 1992, J LIGHTWAVE TECHNOL, V10, P432, DOI 10.1109/50.134196; Brambilla G, 2009, ADV OPT PHOTONICS, V1, P107, DOI 10.1364/AOP.1.000107; Brambilla G, 2004, OPT EXPRESS, V12, P2258, DOI 10.1364/OPEX.12.002258; Dimmick TE, 1999, APPL OPTICS, V38, P6845, DOI 10.1364/AO.38.006845; Orucevic F, 2007, OPT EXPRESS, V15, P13624, DOI 10.1364/OE.15.013624; Phelan CF, 2013, OPT EXPRESS, V21, P27093, DOI 10.1364/OE.21.027093; Knight JC, 1997, OPT LETT, V22, P1129, DOI 10.1364/OL.22.001129; Bures J, 1999, J OPT SOC AM A, V16, P1992, DOI 10.1364/JOSAA.16.001992; Ding L, 2010, APPL OPTICS, V49, P2441, DOI 10.1364/AO.49.002441; Petcu-Colan A, 2011, J NONLINEAR OPT PHYS, V20, P293, DOI 10.1142/S0218863511006170; Jiang XS, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2207986; Brambilla G, 2006, ELECTRON LETT, V42, P517, DOI 10.1049/el:20060611; LACROIX S, 1986, OPT LETT, V11, P671, DOI 10.1364/OL.11.000671; Xin HB, 2011, OPT EXPRESS, V19, P13285, DOI 10.1364/OE.19.013285; Tong LM, 2003, NATURE, V426, P816, DOI 10.1038/nature02193; Sumetsky M, 2004, OPT EXPRESS, V12, P3521, DOI 10.1364/OPEX.12.003521; Frawley MC, 2012, OPT COMMUN, V285, P4648, DOI 10.1016/j.optcom.2012.05.016; Wang PF, 2011, OPT LETT, V36, P2233, DOI 10.1364/OL.36.002233; KENNY RP, 1991, ELECTRON LETT, V27, P1654, DOI 10.1049/el:19911034; Brambilla G, 2005, ELECTRON LETT, V41, P400, DOI 10.1049/el:20058381; Balykin VI, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.011401; Xiao LM, 2011, OPT LETT, V36, P1098, DOI 10.1364/OL.36.001098; Chryssou E., 1999, OPT ENG, V38, P1645; Clohessy M., 2005, ELECTRON LETT, V41, P954; Connolly E. W., 2009, PARTIAL FULFIL UNPUB; Cronin A, 2005, P SOC PHOTO-OPT INS, V5827, P505, DOI 10.1117/12.605004; Davila L. P., 2008, CERAMIC GLASS MAT; Deasy K., 2010, QUANTUM COMMUN QUANT, V6, P200; Glassman I, 2008, COMBUSTION, 4TH EDITION, P1; Graf J. C., SBMO IEEE MTT S INT; Grellier J. C., 1998, OPT COMMUN, V152, P324; Harun SW, 2013, OPTIK, V124, P538, DOI 10.1016/j.ijleo.2011.12.054; Kien F. L., 2004, OPT COMMUN, V242, P445, DOI 10.1016/j.optcom.2004.08.044; Kumar R., ARXIV13116860; Latifi H., 2012, PHOTONIC SENSORS, V2, P340; Lee CL, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4734501; Love J. D., 1991, IEE PROC-J, V138, P5; Lutzler C., 2012, MASTERARBEIT P UNPUB; Masalov AV, 2013, LASER PHYS LETT, V10, DOI 10.1088/1612-2011/10/7/075203; Morrissey MJ, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3117201; Murugan GS, 2008, JPN J APPL PHYS, V47, P6716, DOI 10.1143/JJAP.47.6716; Nayak KP, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053003; Nayak KP, 2011, OPT EXPRESS, V19, P14040, DOI 10.1364/OE.19.014040; Nayak KP, 2013, OPT EXPRESS, V21, P2480, DOI 10.1364/OE.21.002480; O'Shea DG, 2007, IEEE PHOTONIC TECH L, V19, P1720, DOI 10.1109/LPT.2007.906111; Pricking S, 2010, OPT EXPRESS, V18, P3426, DOI 10.1364/OE.18.003426; Ravets S, 2013, OPT EXPRESS, V21, P18325, DOI 10.1364/OE.21.018325; Sague G, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/11/113008; Sague G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.163602; Shi L, 2006, OPT EXPRESS, V14, P5055, DOI 10.1364/OE.14.005055; Snyder W., 1983, OPTICAL WAVEGUIDE TH; Sorensen H. L., 2014, J LIGHTWAVE TECHNOL, V32, P10; Stiebeiner A, 2010, OPT EXPRESS, V18, P22677, DOI 10.1364/OE.18.022677; Sumetsky M, 2007, OPT LETT, V32, P754, DOI 10.1364/OL.32.000754; Tong LM, 2005, NANOTECHNOLOGY, V16, P1445, DOI 10.1088/0957-4484/16/9/004; VARSHNEYA AK, 1993, FUNDAMENTALS INORGAN; Vukovic N, 2008, IEEE PHOTONIC TECH L, V20, P1264, DOI 10.1109/LPT.2008.926037; Warken F., 2007, ERLANGUNG DR R UNPUB; Warken F, 2008, PHOTONIC SPECTRA, V42, P73	66	15	15	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							111501	10.1063/1.4901098		10	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000239		
J	Williams, GJ; Maddox, BR; Chen, H; Kojima, S; Millecchia, M				Williams, G. Jackson; Maddox, Brian R.; Chen, Hui; Kojima, Sadaoki; Millecchia, Matthew			Calibration and equivalency analysis of image plate scanners	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								A universal procedure was developed to calibrate image plate scanners using radioisotope sources. Techniques to calibrate scanners and sources, as well as cross-calibrate scanner models, are described to convert image plate dosage into physical units. This allows for the direct comparison of quantitative data between any facility and scanner. An empirical relation was also derived to establish sensitivity response settings for arbitrary gain settings. In practice, these methods may be extended to any image plate scanning system. (C) 2014 AIP Publishing LLC.	[Williams, G. Jackson; Maddox, Brian R.; Chen, Hui] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Kojima, Sadaoki] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Millecchia, Matthew] Univ Rochester, Laser Energet Lab, Rochester, NY 14623 USA	Williams, GJ (reprint author), Lawrence Livermore Natl Lab, 7000 East Ave, Livermore, CA 94550 USA.	williams270@llnl.gov			U.S. Department of Energy (DOE) by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; LLNL LDRD program [12-ERD-066]; U.S. Department of Energy Office of Inertial Confinement Fusion [DE-FC52-08NA28302]; University of Rochester; New York State Energy Research and Development Authority	The authors acknowledge Y. Arikawa from ILE, K. Austin, L. Caldeira, J. Park, and G. Stone from LLNL, and M. Rowland, C. Sorce, and D. Walker from LLE for experimental support. This work was performed under the auspices of the U.S. Department of Energy (DOE) by Lawrence Livermore National Laboratory under Contract No. DE-AC52-07NA27344 and funded by the LLNL LDRD program (12-ERD-066). Portions of this work were performed at LLE and supported by the U.S. Department of Energy Office of Inertial Confinement Fusion under Cooperative Agreement No. DE-FC52-08NA28302, the University of Rochester, and the New York State Energy Research and Development Authority. The mention of commercial products does not represent an endorsement by the authors or their institutions.	Amemiya, 1988, NATURE, V336, P89; Meadowcroft AL, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3013123; Mancic A, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2949388; Maddox BR, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3531979; Chen H, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2885045; Tanaka KA, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1824371; Gales G., 2004, REV SCI INSTRUM, V75, P4001; Izumi N., 2006, REV SCI INSTRUM, V77; Sonoda, RADIOLOGY, V148, P833	9	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11E604	10.1063/1.4886390		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000191		
J	Yasuhara, R; Sakamoto, R; Yamada, I; Motojima, G; Hayashi, H				Yasuhara, R.; Sakamoto, R.; Yamada, I.; Motojima, G.; Hayashi, H.			Short-interval multi-laser Thomson scattering measurements of hydrogen pellet ablation in LHD	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							POWER	Thomson scattering forms an important aspect of measuring the electron density and temperature profiles of plasmas. In this study, we demonstrate Thomson scattering measurements obtained over a short interval (< 1 ms) by using an event triggering system with a multi-laser configuration. We attempt to use our system to obtain the electron temperature and density profiles before and immediately after pellet injection into the large helical device. The obtained profiles exhibit dramatic changes after pellet injection as per our shot-by-shot measurements. We believe that this measurement technique will contribute towards a better understanding of the physics of the pellet deposition. (C) 2014 AIP Publishing LLC.	[Yasuhara, R.; Sakamoto, R.; Yamada, I.; Motojima, G.; Hayashi, H.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Yasuhara, R (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	yasuhara@nifs.ac.jp	Sakamoto, Ryuichi/E-7557-2013	Sakamoto, Ryuichi/0000-0002-4453-953X	MEXT [23760813]; LHD project [NIFS11ULHH005]	This work was supported by a Grant-in-Aid for Young Scientists (B), Grant No. 23760813 from MEXT and has been partially carried out with financial support from the LHD project (Grant No. NIFS11ULHH005).	Yasuhara R, 2008, OPT LETT, V33, P1711, DOI 10.1364/OL.33.001711; Banerjee S, 2012, OPT LETT, V37, P2175, DOI 10.1364/OL.37.002175; Bayramian A, 2008, J OPT SOC AM B, V25, pB57, DOI 10.1364/JOSAB.25.000B57; Goto M, 2007, PLASMA PHYS CONTR F, V49, P1163, DOI 10.1088/0741-3335/49/8/005; Narihara K, 2001, REV SCI INSTRUM, V72, P1122, DOI 10.1063/1.1319368; Gibson KJ, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/12/124041; Naylor G, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3479120; Valovic M, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/7/075006; Yasuhara R., 2012, PLASMA FUSION RES, V7	9	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D822	10.1063/1.4890251		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000076		
J	Yoshikawa, M; Yasuhara, R; Nagasu, K; Shimamura, Y; Shima, Y; Kohagura, J; Sakamoto, M; Nakashima, Y; Imai, T; Ichimura, M; Yamada, I; Funaba, H; Kawahata, K; Minami, T				Yoshikawa, M.; Yasuhara, R.; Nagasu, K.; Shimamura, Y.; Shima, Y.; Kohagura, J.; Sakamoto, M.; Nakashima, Y.; Imai, T.; Ichimura, M.; Yamada, I.; Funaba, H.; Kawahata, K.; Minami, T.			First results of electron temperature measurements by the use of multi-pass Thomson scattering system in GAMMA 10	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								A multi-pass Thomson scattering (TS) has the advantage of enhancing scattered signals. We constructed a multi-pass TS system for a polarisation-based system and an image relaying system modelled on the GAMMA 10 TS system. We undertook Raman scattering experiments both for the multipass setting and for checking the optical components. Moreover, we applied the system to the electron temperature measurements in the GAMMA 10 plasma for the first time. The integrated scattering signal was magnified by approximately three times by using the multi-pass TS system with four passes. The electron temperature measurement accuracy is improved by using this multi-pass system. (C) 2014 AIP Publishing LLC.	[Yoshikawa, M.; Nagasu, K.; Shimamura, Y.; Shima, Y.; Kohagura, J.; Sakamoto, M.; Nakashima, Y.; Imai, T.; Ichimura, M.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan; [Yasuhara, R.; Yamada, I.; Funaba, H.; Kawahata, K.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Minami, T.] Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan	Yoshikawa, M (reprint author), Univ Tsukuba, Plasma Res Ctr, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	yosikawa@prc.tsukuba.ac.jp			NIFS Collaborative Research Program [NIFS-KOAH025]	The authors thank the members of the GAMMA 10 group of the University of Tsukuba for their collaboration. This study was conducted with the support and under the auspices of the NIFS Collaborative Research Program, NIFS-KOAH025.	TAMANO T, 1995, PHYS PLASMAS, V2, P2321, DOI 10.1063/1.871256; Kantor MY, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/5/055002; Hatae T, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2228347; Hiratsuka Junichi, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.044; Togashi H., 2014, PLASMA FUSION RES, V9; Yamada I, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4740525; Yasuhara R, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4734495; Yoshikawa M., 2013, PLASMA FUSION RES, V8; Yoshikawa M, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4734490; Yoshikawa Masayuki, 2011, Plasma and Fusion Research, V6, DOI 10.1585/pfr.6.1202095; Yoshikawa M, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/03/C03003; Yoshikawa M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073031	12	3	3	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D801	10.1063/1.4885542		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000055		
J	Yun, GS; Lee, W; Choi, MJ; Lee, J; Kim, M; Leem, J; Nam, Y; Choe, GH; Park, HK; Park, H; Woo, DS; Kim, KW; Domier, CW; Luhmann, NC; Ito, N; Mase, A; Lee, SG				Yun, G. S.; Lee, W.; Choi, M. J.; Lee, J.; Kim, M.; Leem, J.; Nam, Y.; Choe, G. H.; Park, H. K.; Park, H.; Woo, D. S.; Kim, K. W.; Domier, C. W.; Luhmann, N. C., Jr.; Ito, N.; Mase, A.; Lee, S. G.			Quasi 3D ECE imaging system for study of MHD instabilities in KSTAR	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								A second electron cyclotron emission imaging (ECEI) system has been installed on the KSTAR tokamak, toroidally separated by 1/16th of the torus from the first ECEI system. For the first time, the dynamical evolutions of MHD instabilities from the plasma core to the edge have been visualized in quasi-3D for a wide range of the KSTAR operation (B-0 = 1.7 similar to 3.5 T). This flexible diagnostic capability has been realized by substantial improvements in large-aperture quasi-optical microwave components including the development of broad-band polarization rotators for imaging of the fundamental ordinary ECE as well as the usual 2nd harmonic extraordinary ECE. (C) 2014 AIP Publishing LLC.	[Yun, G. S.; Choi, M. J.; Lee, J.; Kim, M.; Leem, J.; Nam, Y.; Choe, G. H.] Pohang Univ Sci & Technol, Dept Phys, Pohang 790784, South Korea; [Lee, W.; Park, H. K.] Ulsan Natl Inst Sci & Technol, Ulsan 689798, South Korea; [Park, H.; Woo, D. S.; Kim, K. W.] Kyungpook Natl Univ, Sch Elect Engn, Taegu 702701, South Korea; [Domier, C. W.; Luhmann, N. C., Jr.] Univ Calif Davis, Dept Elect & Comp Engn, Davis, CA 95616 USA; [Ito, N.] Kyushu Univ, KASTEC, Kasuga, Fukuoka 8128581, Japan; [Mase, A.] Ube Natl Coll Technol, Ube, Yamaguchi 7558555, Japan; [Lee, S. G.] Natl Fus Res Inst, Taejon 305333, South Korea	Yun, GS (reprint author), Pohang Univ Sci & Technol, Dept Phys, Pohang 790784, South Korea.	gunsu@postech.ac.kr			National Research Foundation of Korea [NRF-2014M1A7A1A03029881]; BK21+ Advanced Nuclear Program, U.S. DOE [DE-FG-02-99ER54531]; Japan-Korea Fusion Collaboration Program [KHGJ-01]	We thank Mr. Yong-sun Kim and the KSTAR diagnostic team for their strong technical assistance. This work was supported by National Research Foundation of Korea under Grant No. NRF-2014M1A7A1A03029881 and BK21+ Advanced Nuclear Program, U.S. DOE under Contract No. DE-FG-02-99ER54531, and Japan-Korea Fusion Collaboration Program under Contract No. KHGJ-01.	Choi MJ, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/8/083010; Classen IGJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.035001; Yun GS, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.045004; Lee J, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4883180; Yun GS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.145003; Park HK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.195003; Tobias BJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.075003; CHEN CC, 1973, IEEE T MICROW THEORY, VMT21, P1; Classen IGJ, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3483214; Jiang M, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4828671; Lee J, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/01/C01037; Lee W., PLASMA PHYS IN PRESS; Lee W, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/10/C10018; Ming X., 2011, PLASMA SCI TECHNOL, V13, P167; Nam Y, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4732852; Park H., 2004, REV SCI INSTRUM, V75, P3875; Shen Z., 2007, PLASMA FUSION RES, V2, pS1030, DOI 10.1585/pfr.2.S1030; Tobias B, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3460456; Yun GS, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3483209	19	3	3	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	NOV	2014	85	11							11D820	10.1063/1.4890401		3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	AU5KO	WOS:000345646000074		
J	Ahamed, F; Ahmed, ZF; Hossain, MY; Ohtomi, J				Ahamed, Ferdous; Ahmed, Zoarder Faruque; Hossain, Md. Yeamin; Ohtomi, Jun			Population Biology of the Indian River Shad, Gudusia chapra (Clupeidae) in the Old Brahmaputra River, North-Eastern Bangladesh	SAINS MALAYSIANA			English	Article						Clupeidae; gonadosomatic; Gudusia chapra; index; management; population biology	PLESIONIKA-MARTIA DECAPODA; CENTRAL MEDITERRANEAN SEA; 1ST SEXUAL-MATURITY; INDEX-BASED SIZE; REPRODUCTIVE-BIOLOGY; TRACHYSALAMBRIA-CURVIROSTRIS; LENGTH RELATIONSHIPS; CARIDEAN SHRIMP; NW BANGLADESH; GROWTH	Population biology including population structure, reproduction, length-weight relationship and condition factor of a commercially important clupeid freshwater fish, Gudusia chapra was studied in the Old Brahmaputra River, Bangladesh during January-December 2009. In the present study, a total of 2032 specimens (1091 male; 941 female) were collected. The overall sex ratio showed significant difference from the expected value 1:1 (male: female = 1:0.86, chi(2) = 11.07, p<0.001). Length-frequency distribution showed a size predominance of females over males, where mean female size consistently exceeded that of males throughout the year. Female size at first sexual maturity was estimated as 8.3 cm in standard length (SL). Monthly gonadosomatic index (GSI) was higher during March-September with a peak in April, indicating this was the main spawning season. The allometric coefficient b of the length-weight relationship (LWR) indicated negative allometric growth in males and females, but the analysis of covariance (ANCOVA) showed significant differences in slope and intercept between the sexes (p<0.001). Fulton's condition factor by months and SLs varied in both sexes and was attributed to variations in GSI with maturity.	[Ahamed, Ferdous] Patuakhali Sci & Technol Univ, Dept Fisheries Management, Patuakhali 8602, Bangladesh; [Ahmed, Zoarder Faruque] Bangladesh Agr Univ, Dept Fisheries Management, Mymensingh 2202, Bangladesh; [Hossain, Md. Yeamin] Rajshahi Univ, Fac Agr, Dept Fisheries, Rajshahi 6205, Bangladesh; [Ohtomi, Jun] Kagoshima Univ, Fac Fisheries, Kagoshima 8900056, Japan	Ahamed, F (reprint author), Patuakhali Sci & Technol Univ, Dept Fisheries Management, Patuakhali 8602, Bangladesh.	ferdous_bau04@yahoo.com					Ahamed F, 2012, J CRUSTACEAN BIOL, V32, P733, DOI 10.1163/193724012X645853; Ahmed ZF, 2007, FOLIA ZOOL, V56, P429; ALLEN J. A., 1966, P45; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Sani R, 2010, J APPL ICHTHYOL, V26, P456, DOI 10.1111/j.1439-0426.2009.01388.x; Hossain MY, 2006, J APPL ICHTHYOL, V22, P304, DOI 10.1111/j.1439-0426.2006.00803.x; BAUER RT, 1992, INVERTEBR REPROD DEV, V22, P193, DOI 10.1080/07924259.1992.9672272; GABALLA AAFA, 1990, MAR BIOL, V107, P417, DOI 10.1007/BF01313423; Utagawa K, 1999, FISHERIES SCI, V65, P73; BAGENAL T.B., 1978, INT BIOL PROGRAMME H, V3, P101; Cha HK, 2004, J MAR BIOL ASSOC UK, V84, P351, DOI 10.1017/S0025315404009270h; Chilari A, 2005, J CRUSTACEAN BIOL, V25, P233, DOI 10.1651/C-2513; Choi JH, 2005, CRUSTACEANA, V78, P947, DOI 10.1163/156854005775197262; Chondar S.L., 1976, AGRA U J RES SCI, V25, P103; CHONDAR SL, 1977, P INDIAN ACAD SCI B, V86, P245; CHONDAR SL, 1975, ZOOL J LINN SOC-LOND, V56, P207, DOI 10.1111/j.1096-3642.1975.tb00264.x; Colloca F, 2002, J CRUSTACEAN BIOL, V22, P775, DOI 10.1651/0278-0372(2002)022[0775:LCOTDW]2.0.CO;2; Craig JF, 2004, FISH RES, V66, P271, DOI 10.1016/S0165-7836(03)00196-6; DAILEY MD, 1986, FISH B-NOAA, V84, P915; Daniels R, 2002, FRESHWATER FISHES PE; Hamilton F., 1822, FISHES GANGES, P1; Hossain MY, 2009, J APPL ICHTHYOL, V25, P117, DOI 10.1111/j.1439-0426.2008.01168.x; Hossain M.Y., 2011, J APPL ICHTHYOL, V28, P275; Hossain MY, 2012, J APPL ICHTHYOL, V28, P601, DOI 10.1111/j.1439-0426.2012.01954.x; Hossain MY, 2010, J APPL ICHTHYOL, V26, P550, DOI 10.1111/j.1439-0426.2010.01454.x; Jayaram K., 1999, FRESHWATER FISHES IN; Jhingran A.G., 1967, P IND NAT SCI ACAD B; Kabir A.K.M.A., 1998, BANGLADESH J FISH RE, V2, P195; Kibria G., 2005, NAGA, V28, P43; Kikuchi T., 1962, Records of Oceanographic Works in Japan Special, VNo. 6, P135; King M., 1995, FISHERIES BIOL ASSES, P341; Lucifora LO, 1999, MAR FRESHWATER RES, V50, P629, DOI 10.1071/MF98167; Maiorano P, 2002, MAR BIOL, V141, P527, DOI 10.1007/s00227-002-0851-4; Menon A.G.K., 1999, MISCELLANEOUS PUBLIC, V175, P234; MORALESNIN B, 1990, J FISH BIOL, V36, P191, DOI 10.1111/j.1095-8649.1990.tb05595.x; MUSTAFA S, 1983, Zeitschrift fuer Angewandte Zoologie, V70, P133; Narejo N. T., 2000, Pakistan Journal of Zoology, V32, P307; Newman SJ, 2000, FISH RES, V48, P1, DOI 10.1016/S0165-7836(00)00115-6; Oh CW, 2002, J CRUSTACEAN BIOL, V22, P357, DOI 10.1651/0278-0372(2002)022[0357:GARBOT]2.0.CO;2; Ohtomi J, 1997, J CRUSTACEAN BIOL, V17, P81, DOI 10.2307/1549465; Quddus M.M.A., 1990, J ZOOL, V5, P55; Rahman A.K.A., 1989, FRESHWATER FISHES BA, P364; Shrestha J, 1994, FISHES FISHING IMPLE, P150; Sokal R., 1981, BIOMETRY; Talwar PK, 1991, INLAND FISHES INDIA; Tesch F. W., 1971, METHODS ASSESSMENT F, P99; Thilsted S.H, 2003, SMALL IND SPEC FISH; Thilsted S.H., 1997, NAGA NEWSLETTER  JUL, P13; Vinci G. K., 2005, Indian Journal of Fisheries, V52, P73; Whitehead P. J. P., 1985, FAO FISH SYNOP, V7, P1; WOOTTON R. J., 1990, ECOLOGY TELEOST FISH; Yamada R, 2007, MAR BIOL, V151, P961, DOI 10.1007/s00227-006-0536-5; Zar JH, 1984, BIOSTATISTICAL ANAL	53	0	0	UNIV KEBANGSAAN MALAYSIA	SELANGOR	FACULTY SCIENCE & TECHNOLOGY, BANGI, SELANGOR, 43600, MALAYSIA	0126-6039			SAINS MALAYS	Sains Malays.	NOV	2014	43	11					1645	1655				11	Multidisciplinary Sciences	Science & Technology - Other Topics	AU3TA	WOS:000345535300002		
J	Unno, J; Kanno, A; Masamune, A; Kasajima, A; Fujishima, F; Ishida, K; Hamada, S; Kume, K; Kikuta, K; Hirota, M; Motoi, F; Unno, M; Shimosegawa, T				Unno, Jun; Kanno, Atsushi; Masamune, Atsushi; Kasajima, Atsuko; Fujishima, Fumiyoshi; Ishida, Kazuyuki; Hamada, Shin; Kume, Kiyoshi; Kikuta, Kazuhiro; Hirota, Morihisa; Motoi, Fuyuhiko; Unno, Michiaki; Shimosegawa, Tooru			The usefulness of endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of pancreatic neuroendocrine tumors based on the World Health Organization classification	SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY			English	Article						endoscopic ultrasonography; endoscopic ultrasound-guided fine needle aspiration; Ki67; pancreatic neuroendocrine tumors	ENDOCRINE TUMORS; AUTOIMMUNE PANCREATITIS; GASTROINTESTINAL TUMORS; EUS-FNA; BIOPSY; CYTOLOGY; LESIONS; CANCER; ULTRASONOGRAPHY; ENDOSONOGRAPHY	Background. We assessed the controversial topic of using 22-gauge needles in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for the diagnosis and evaluation of Ki67 labeling indices (Ki67LI) of pancreatic neuroendocrine tumors (pNET). Methods. Thirty-eight patients with pNET who underwent EUS-FNA between January 1, 2008 and December 31, 2012 were enrolled in this study. When available, the Ki67LI and WHO classifications obtained by EUS-FNA and surgical resection were compared. Results. EUS-FNA with a 22-gauge needle acquired sufficient histological sample to correctly diagnose pNET in 35 cases (92.1%). Both EUS-FNA and surgical histological specimens were available for 19 cases, and grading classes of the 2 procedures were consistent in 17 cases (89.5%) according to the WHO classification based on the Ki67LI. Tumor size was associated with a difference in the Ki67LI between the 2 procedures, although the Ki67LI was almost completely consistent for tumors less than 18 mm in size. Conclusions. EUS-FNA with a 22-gauge needle is a safe and highly accurate technique for the diagnosis of pNET. There was a clear correlation between the Ki67LI of histological specimens acquired by EUS-FNA and surgery. EUS-FNA with a 22-gauge needle is useful to predict the WHO classification of pNET.	[Unno, Jun; Kanno, Atsushi; Masamune, Atsushi; Hamada, Shin; Kume, Kiyoshi; Kikuta, Kazuhiro; Hirota, Morihisa; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 9808574, Japan; [Kasajima, Atsuko; Fujishima, Fumiyoshi; Ishida, Kazuyuki] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808574, Japan; [Motoi, Fuyuhiko; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Sendai, Miyagi 9808574, Japan; [Ishida, Kazuyuki] Iwate Med Univ, Sch Med, Dept Diagnost Pathol, Morioka, Iwate 020, Japan	Kanno, A (reprint author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	atsushih@med.tohoku.ac.jp					Reid MD, 2014, ENDOCR PATHOL, V25, P65, DOI 10.1007/s12022-013-9295-2; Gress FG, 1997, GASTROINTEST ENDOSC, V45, P243, DOI 10.1016/S0016-5107(97)70266-9; O'Toole D, 2010, ENDOCR-RELAT CANCER, V17, P847, DOI 10.1677/ERC-09-0204; Duerr EM, 2008, ENDOCR-RELAT CANCER, V15, P243, DOI 10.1677/ERC-07-0194; Figueiredo FAF, 2009, GASTROINTEST ENDOSC, V70, P907, DOI 10.1016/j.gie.2009.05.020; Oberg K, 2010, SEMIN ONCOL, V37, P594, DOI 10.1053/j.seminoncol.2010.10.014; Kanno A, 2012, GASTROINTEST ENDOSC, V76, P594, DOI 10.1016/j.gie.2012.05.014; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Levy MJ, 2006, ENDOSCOPY, V38, pS30, DOI 10.1055/s-2006-946648; Larghi A, 2012, GASTROINTEST ENDOSC, V76, P570, DOI 10.1016/j.gie.2012.04.477; Ramage JK, 2005, GUT, V54, DOI 10.1136/gut.2004.053314; Plockinger U, 2004, NEUROENDOCRINOLOGY, V80, P394, DOI 10.1159/000085237; Gornals J, 2011, REV ESP ENFERM DIG, V103, P123, DOI 10.4321/s1130-01082011000300003; Kloppel G, 2009, NEUROENDOCRINOLOGY, V90, P162, DOI 10.1159/000182196; Mizuno N, 2009, J GASTROENTEROL, V44, P742, DOI 10.1007/s00535-009-0062-6; Metz DC, 2008, GASTROENTEROLOGY, V135, P1469, DOI 10.1053/j.gastro.2008.05.047; Atiq M, 2012, DIGEST DIS SCI, V57, P791, DOI 10.1007/s10620-011-1912-7; Lewis RB, 2010, RADIOGRAPHICS, V30, P1445, DOI 10.1148/rg.306105523; Iwashita T, 2012, CLIN GASTROENTEROL H, V10, P316, DOI 10.1016/j.cgh.2011.09.032; Rindi G, 2006, VIRCHOWS ARCH, V449, P395, DOI 10.1007/s00428-006-0250-1; Kloppel G, 2004, ANN NY ACAD SCI, V1014, P13, DOI 10.1196/annals.1294.002; Chatzipantelis P, 2009, CANCER CYTOPATHOL, V117, P211, DOI 10.1002/cncy.20025; Chatzipantelis P, 2008, CANCER CYTOPATHOL, V114, P255, DOI 10.1002/cncr.23637; Varadarajulu S, 2004, ENDOSCOPY, V36, P397, DOI 10.1055/s-2004-814316; Katanuma A, 2013, DIGEST DIS SCI, V58, P2093, DOI 10.1007/s10620-013-2590-4; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Chang KJ, 1997, GASTROINTEST ENDOSC, V45, P387, DOI 10.1016/S0016-5107(97)70149-4; Faigel DO, 1997, J CLIN ONCOL, V15, P1439; Ardengh JC, 2004, GASTROINTEST ENDOSC, V60, P378; Artale S, 2005, ANTICANCER RES, V25, P4463; Bajetta E, 2005, ANN ONCOL, V16, P1374, DOI 10.1093/annonc/mdi258; Batcher E, 2011, ENDOCR RES, V36, P35, DOI 10.3109/07435800.2010.525085; Binmoeller KF, 1997, ENDOSCOPY, V29, P384, DOI 10.1055/s-2007-1004220; Bosman FT, 2010, WHO CLASSIFICATION T; Chang F, 2006, CYTOPATHOLOGY, V17, P10, DOI 10.1111/j.1365-2303.2006.00311.x; Davies Karen, 2009, Curr Gastroenterol Rep, V11, P119; Gress FG, 1997, ANN INTERN MED, V127, P604; Hasegawa T, 2014, ENDOSCOPY, V46, P32, DOI 10.1055/s-0033-1344958; Ishikawa T, 2010, GASTROINTEST ENDOSC, V71, P951, DOI 10.1016/j.gie.2009.12.023; Ito T, 2007, J GASTROENTEROL, V42, P497, DOI 10.1007/s00535-007-2056-6; Itoi T, 2009, GASTROINTEST ENDOSC, V69, P509, DOI 10.1016/j.gie.2008.07.017; Jani N, 2008, GASTROINTEST ENDOSC, V67, P44, DOI 10.1016/j.gie.2007.07.046; Levy MJ, 2005, GASTROINTEST ENDOSC, V61, P467, DOI 10.1016/S0016-5107(04)02802-0; Martin RCG, 2011, J GASTROINTEST SURG, V15, P175, DOI 10.1007/s11605-010-1380-y; Nakayama Y, 2010, PANCREAS, V39, P1147, DOI 10.1097/MPA.0b013e3181e78120; O'Grady HL, 2008, EJSO-EUR J SURG ONC, V34, P324, DOI 10.1016/j.ejso.2007.07.209; Pais SA, 2010, GASTROINTEST ENDOSC, V71, P1185, DOI 10.1016/j.gie.2009.12.006	47	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0036-5521	1502-7708		SCAND J GASTROENTERO	Scand. J. Gastroenterol.	NOV	2014	49	11					1367	1374		10.3109/00365521.2014.934909		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU4TD	WOS:000345603400013		
J	Fushimi, Y; Takagi, M; Uno, S; Kokushi, E; Nakamura, M; Hasunuma, H; Shinya, U; Deguchi, E; Fink-Gremmels, J				Fushimi, Yasuo; Takagi, Mitsuhiro; Uno, Seiichi; Kokushi, Emiko; Nakamura, Masayuki; Hasunuma, Hiroshi; Shinya, Urara; Deguchi, Eisaburo; Fink-Gremmels, Johanna			Measurement of Sterigmatocystin Concentrations in Urine for Monitoring the Contamination of Cattle Feed	TOXINS			English	Article						cattle; sterigmatocystin; urine; LC-MS/MS	ZEARALENONE CONCENTRATIONS; MYCOTOXINS	This study aimed (1) at determining the levels of the fungal toxin sterigmatocystin (STC) in the feed and urine of cattle and (2) at evaluating the effects of supplementing the feed with a mycotoxin adsorbent (MA) on STC concentrations in urine. Two herds of female Japanese Black cattle were used in this study. The cattle in each herd were fed a standard ration containing rice straw from different sources and a standard concentrate; two groups of cattle from each herd (n = six per group) received the commercial MA, mixed with the concentrate or given as top-dressing, whereas a third group received no supplement and served as control. Urine and feed samples were collected at various time points throughout the experiment. STC concentrations were measured using liquid chromatography-tandem mass spectrometry (LC-TMS). STC concentrations in straw were higher in Herd 1 (range 0.15-0.24 mg/kg DM) than in Herd 2 (range <0.01-0.06 mg/kg DM). In Herd 1, STC concentrations in urine significantly declined 2 weeks after replacing the contaminated feed, whereas MA supplementation had no effect. In conclusion, mycotoxins in urine samples are useful biological markers for monitoring the systemic exposure of cattle to multiple mycotoxins, as well as evaluating the effectiveness of interventions.	[Fushimi, Yasuo; Takagi, Mitsuhiro; Shinya, Urara; Deguchi, Eisaburo] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi 7538515, Japan; [Fushimi, Yasuo; Hasunuma, Hiroshi] Shepherd Cent Livestock Clin, Kagoshima 8991611, Japan; [Takagi, Mitsuhiro; Deguchi, Eisaburo] Kagoshima Univ, Joint Fac Vet Med, Kagoshima 8900065, Japan; [Uno, Seiichi; Kokushi, Emiko] Kagoshima Univ, Fac Fisheries, Kagoshima 8900056, Japan; [Nakamura, Masayuki] Kagoshima Univ, Fac Agr, Kagoshima 8900056, Japan; [Shinya, Urara] Soo Agr Mutual Aid Assoc, Kagoshima 8998212, Japan; [Fink-Gremmels, Johanna] Univ Utrecht, Fac Vet Med, NL-104 Yalelaan, Netherlands	Takagi, M (reprint author), Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi 7538515, Japan.	yf19801113@hotmail.com; mtakagi@agri.kagoshima-u.ac.jp; uno@fish.kagoshima-u.ac.jp; kokushi@fish.kagoshima-u.ac.jp; masa@agri.kagoshima-u.ac.jp; hasu@fa3.so-net.ne.jp; urara@nosai-soo.com; deguchi@agri.kagoshima-u.ac.jp; J.Fink@uu.nl			Japan Society for the Promotion of Science (JSPS) [23580441]; Ito Foundation	This study was supported by a Grant-in-Aid for Scientific Research (number 23580441) to M. Takagi from the Japan Society for the Promotion of Science (JSPS) and the Ito Foundation.	Versilovskis A, 2010, MOL NUTR FOOD RES, V54, P136, DOI 10.1002/mnfr.200900345; Streit E, 2012, TOXINS, V4, P788, DOI 10.3390/toxins4100788; Fink-Gremmels J, 2008, FOOD ADDIT CONTAM, V25, P172, DOI 10.1080/02652030701823142; Warth B, 2012, J AGR FOOD CHEM, V60, P9352, DOI 10.1021/jf302003n; Monbaliu S, 2010, J AGR FOOD CHEM, V58, P66, DOI 10.1021/jf903859z; Takagi M, 2011, J ANIM SCI, V89, P287, DOI 10.2527/jas.2010-3306; Solfrizzo M, 2011, ANAL BIOANAL CHEM, V401, P2831, DOI 10.1007/s00216-011-5354-z; PRELUSKY DB, 1989, J CHROMATOGR-BIOMED, V494, P267, DOI 10.1016/S0378-4347(00)82675-4; Hasunuma H, 2012, J ANIM SCI, V90, P1610, DOI 10.2527/jas.2011-4579; Van Pamel E, 2011, J AGR FOOD CHEM, V59, P9747, DOI 10.1021/jf202614h; Miles CO, 1996, J AGR FOOD CHEM, V44, P3244, DOI 10.1021/jf9601325; VESONDER RF, 1985, APPL ENVIRON MICROB, V49, P234; Wilkinson HH, 2004, MYCOLOGIA, V96, P1190, DOI 10.2307/3762134; Rank C, 2011, FUNGAL BIOL-UK, V115, P406, DOI 10.1016/j.funbio.2011.02.013; HSIEH DPH, 1973, BIOCHEM BIOPH RES CO, V52, P992, DOI 10.1016/0006-291X(73)91035-8; EFSA Panel on Contaminants in the Food Chain, SCI OP RISK PUBL AN; FAMIC (Food and Agricultural Materials Inspection Center Japan), SHIR; Kusunoki Masahiro, 2011, Environmental Health and Preventive Medicine, V16, P224, DOI 10.1007/s12199-010-0190-x; Marroquin-Cardona A, 2009, FOOD ADDIT CONTAM A, V26, P733, DOI 10.1080/02652030802641872; Padilla L, 2007, J ANIM SCI, V85, P3367, DOI 10.2527/jas.2007-0060	20	0	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-6651			TOXINS	Toxins	NOV	2014	6	11					3117	3128		10.3390/toxins6113117		12	Toxicology	Toxicology	AU3RK	WOS:000345531100005		
J	Enomoto, Y; Yamashita, S; Yoshinaga, Y; Fukami, Y; Miyahara, S; Nabeshima, K; Iwasaki, A				Enomoto, Yasuko; Yamashita, Shin-ichi; Yoshinaga, Yasuteru; Fukami, Yasuyoshi; Miyahara, So; Nabeshima, Kazuki; Iwasaki, Akinori			Downregulation of DYRK2 can be a predictor of recurrence in early stage breast cancer	TUMOR BIOLOGY			English	Article						Breast cancer; DYRK2; Prognostic factor	EXPRESSION; PROTEIN; KINASES; FAMILY	This study investigated the potential of DYRK2, a dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase gene, to predict disease-free survival for patients with early stage breast cancer. Two hundred and seventy-four patients with breast cancer underwent surgery from January 2000 to December 2009. All patients were in stage I or II. Immunohistochemical (IHC) analysis was used to determine the expression of DYRK2, which was examined for its association with clinicopathological factors or prognosis. A total of 85 of 274 cases (31 %) were DYRK2 positive. No correlation was found between DYRK2 expression by IHC and clinicopathological factors such as tumor size, histological grade, hormone receptor status, and HER2 status; however, lymph node involvement was closely associated with DYRK2 expression. Ten-year disease-free survival in the DYRK2-positive group without node metastasis (95.9 %) was significantly better than that in the DYRK2-negative group (87.3 %, p = 0.015). These data show that DYRK2 expression is associated with lymph node involvement and is a possible predictive factor of breast cancer recurrence.	[Enomoto, Yasuko; Yamashita, Shin-ichi; Yoshinaga, Yasuteru; Fukami, Yasuyoshi; Miyahara, So; Iwasaki, Akinori] Fukuoka Univ, Fac Med, Dept Gen Thorac Breast & Pediat Surg, Jonan Ku, Fukuoka 8140180, Japan; [Nabeshima, Kazuki] Fukuoka Univ, Fac Med, Dept Pathol, Fukuoka 8140180, Japan	Yamashita, S (reprint author), Fukuoka Univ, Fac Med, Dept Gen Thorac Breast & Pediat Surg, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	yamashi1@fukuoka-u.ac.jp					Perez M, 2012, J MOL CELL BIOL, V4, P316, DOI 10.1093/jmcb/mjs047; Kim C, 2010, NAT REV CLIN ONCOL, V7, P340, DOI 10.1038/nrclinonc.2010.61; Mimoto R, 2013, CANCER LETT, V339, P214, DOI 10.1016/j.canlet.2013.06.005; Jung HY, 2013, J BIOL CHEM, V288, P7252, DOI 10.1074/jbc.M112.416792; FISHER B, 1983, CANCER, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; Taira N, 2012, J CLIN INVEST, V122, P859, DOI 10.1172/JCI60818; Yoshida K, 2008, BIOCHEM PHARMACOL, V76, P1389, DOI 10.1016/j.bcp.2008.05.021; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Domagala W, 1996, CLIN CANCER RES, V2, P147; Mulligan J.M., 2014, J NATL CANC I, V106; Taira N, 2007, MOL CELL, V25, P794; Yamashita S, 2009, J THORAC CARDIOV SUR, V138, P1303, DOI 10.1016/j.jtcvs.2009.08.003; Yamashita SI, 2009, ANTICANCER RES, V29, P2753	13	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1010-4283	1423-0380		TUMOR BIOL	Tumor Biol.	NOV	2014	35	11					11021	11025		10.1007/s13277-014-2413-z		5	Oncology	Oncology	AU1YJ	WOS:000345413100049		
J	Inoue, H; Tsuchiya, H; Miyazaki, Y; Kikuchi, K; Ide, F; Sakashita, H; Kusama, K				Inoue, Harumi; Tsuchiya, Hozumi; Miyazaki, Yuji; Kikuchi, Kentaro; Ide, Fumio; Sakashita, Hideaki; Kusama, Kaoru			Podoplanin expressing cancer-associated fibroblasts in oral cancer	TUMOR BIOLOGY			English	Article						Podoplanin; Alpha-smooth muscle actin (alpha-SMA); Cancer-associated fibroblast (CAF); Myofibroblast; Oral squamous cell carcinoma (OSCC)	SQUAMOUS-CELL CARCINOMA; PREDICTS POOR-PROGNOSIS; LUNG ADENOCARCINOMA; MEMBRANE-PROTEIN; RECEPTOR CLEC-2; TUMOR; MARKER; STROMA; IDENTIFICATION; MYOFIBROBLAST	Podoplanin is a mucin-type glycoprotein widely used as a lymphatic endothelial marker. It is well known that podoplanin is expressed in various neoplasms including oral squamous cell carcinoma (OSCC). Apart from podoplanin expression in cancer cells, recent studies have suggested that podoplanin expression in stromal cancer-associated fibroblasts (CAFs) may be an indicator of poor prognosis in various cancers. In the present study, we performed immunohistochemical analyses of podoplanin and alpha-smooth muscle actin (alpha-SMA) in OSCC in order to clarify the significance of podoplanin-positive CAFs. Paraffin-embedded tissue specimens of 69 primary and 29 corresponding metastatic lesions in lymph nodes were examined immunohistochemically using antibodies against podoplanin and alpha-SMA. Podoplanin-positive stromal fibroblasts were detected in 51 (73.9 %) of the 69 primary OSCCs and 24 (82.8 %) of the 29 lymph nodes metastases. alpha-SMA immunoreactivity was observed in 39 (56.5 %) of the primaries and 24 (82.8 %) of the metastases. Further examination showed that 38 (74.5 %) of the primary lesions and 23 (95.8 %) of the metastases with podoplanin positivity were also positive for alpha-SMA. In addition, the intensity of alpha-SMA immunoreactivity increased as that of podoplanin became stronger. Podoplanin-positive CAFs are considered to be myofibroblasts that may contribute to progression of oral cancer.	[Inoue, Harumi; Tsuchiya, Hozumi; Miyazaki, Yuji; Kikuchi, Kentaro; Ide, Fumio; Kusama, Kaoru] Meikai Univ, Div Pathol, Dept Diagnost & Therapeut Sci, Sch Dent, Sakado, Saitama 3500283, Japan; [Sakashita, Hideaki] Meikai Univ, Dept Diagnost & Therapeut Sci, Sch Dent, Sakado, Saitama 3500283, Japan	Inoue, H (reprint author), Meikai Univ, Div Pathol, Dept Diagnost & Therapeut Sci, Sch Dent, Sakado, Saitama 3500283, Japan.	harumi-i@dent.meikai.ac.jp					Neri S, 2012, ANN SURG ONCOL, V19, P3953, DOI 10.1245/s10434-012-2421-4; Shimada Y, 2009, CANCER SCI, V100, P2054, DOI 10.1111/j.1349-7006.2009.01295.x; Inoue H, 2012, J ORAL SCI, V54, P241; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; Hinz B, 2001, MOL BIOL CELL, V12, P2730; Mishima K, 2006, ACTA NEUROPATHOL, V111, P483, DOI 10.1007/s00401-006-0063-y; Chuang WY, 2009, HISTOL HISTOPATHOL, V24, P1021; Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Ono S, 2013, CHEST, V143, P963, DOI 10.1378/chest.12-0913; Kawaguchi H, 2008, J CLIN ONCOL, V26, P354, DOI 10.1200/JCO.2007.13.4072; Yamanashi T, 2009, ONCOLOGY-BASEL, V77, P53, DOI 10.1159/000226112; Routray S, 2014, ORAL DIS, V20, P246, DOI 10.1111/odi.12107; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Yuan P, 2006, CANCER, V107, P563, DOI 10.1002/cncr.22061; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Schoppmann SF, 2013, CLIN EXP METASTAS, V30, P441, DOI 10.1007/s10585-012-9549-2; Niemiec JA, 2014, APPL IMMUNOHISTO M M, V22, P10, DOI 10.1097/PAI.0b013e318286030d; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kitano H, 2010, ARCH PATHOL LAB MED, V134, P1520, DOI 10.1043/2009-0114-OA.1; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Ito S, 2012, BIOCHEM BIOPH RES CO, V422, P194, DOI 10.1016/j.bbrc.2012.04.158; Schoppmann SF, 2012, BREAST CANCER RES TR, V134, P237, DOI 10.1007/s10549-012-1984-x; Williams MC, 1996, AM J RESP CELL MOL, V14, P577; Durchdewald M, 2008, CANCER RES, V68, P6877, DOI 10.1158/0008-5472.CAN-08-0299; Gonzalez-Alva P, 2010, J ORAL PATHOL MED, V39, P103, DOI 10.1111/j.1600-0714.2009.00818.x; Sonne SB, 2006, VIRCHOWS ARCH, V449, P200, DOI 10.1007/s00428-006-0223-4; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Rahadiani N, 2010, ANN SURG ONCOL, V17, P1311, DOI 10.1245/s10434-009-0895-5; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Costea DE, 2013, CANCER RES, V73, P3888, DOI 10.1158/0008-5472.CAN-12-4150; Dumoff KL, 2006, MODERN PATHOL, V19, P708, DOI 10.1038/modpathol.3800580; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Inoue H, 2012, TUMOR BIOL, V33, P183, DOI 10.1007/s13277-011-0261-7; Kikuchi K, 2012, J ORAL SCI, V54, P165; Meulmeester E, 2010, CELL CYCLE, V9, P2499; Miyazaki Yuji, 2009, J Oral Sci, V51, P283; Oe S, 2010, INT J GYNECOL PATHOL, V29, P405, DOI 10.1097/PGP.0b013e3181d3261e; Okamoto E, 2010, J ORAL PATHOL MED, V39, P110, DOI 10.1111/j.1600-0714.2009.00851.x; Oku Y, 2008, ORAL ONCOL, P251; Pula B, 2013, INT J ONCOL, V42, P1849, DOI 10.3892/ijo.2013.1887; Rodrigo JP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-48; Sinzelle E, 2000, HISTOPATHOLOGY, V37, P93; WATANABE M, 1988, CANCER RES, V48, P6411	48	2	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1010-4283	1423-0380		TUMOR BIOL	Tumor Biol.	NOV	2014	35	11					11345	11352		10.1007/s13277-014-2450-7		8	Oncology	Oncology	AU1YJ	WOS:000345413100086		
J	Matsuda, T; Kanayama, H; Ono, Y; Kawauchi, A; Mizoguchi, H; Nakagawa, K; Iwamura, M; Shigeta, M; Habuchi, T; Terachi, T				Matsuda, Tadashi; Kanayama, Hiroomi; Ono, Yoshinari; Kawauchi, Akihiro; Mizoguchi, Hiroaki; Nakagawa, Ken; Iwamura, Masatsugu; Shigeta, Masanobu; Habuchi, Tomonori; Terachi, Toshiro		Referee Comm Endoscopic Surg Skill	Reliability of Laparoscopic Skills Assessment on Video: 8-Year Results of the Endoscopic Surgical Skill Qualification System in Japan	JOURNAL OF ENDOUROLOGY			English	Article							TECHNICAL SKILLS; RESIDENTS; VALIDITY	Background and Purpose: The Japanese Urological Association and Japanese Society of Endourology established a urologic laparoscopic skills qualification system called the Endoscopic Surgical Skill Qualification (ESSQ) System in Urological Laparoscopy in 2004. The reliability of video assessments by referees was evaluated. Materials and Methods: Videos of nephrectomies or adrenalectomies performed by the applicants were assessed by two referees selected among a pool of 42 referees. From 2004 to 2011, 1308 urologists applied and 60.2% were qualified after video assessments. The results of skills assessments on 1220 videos that had fixed points by two referees were analyzed statistically. Results: The average number of videos that each referee assessed was 58.1, with a range of 16 to 87. The accordance rate of the results of the video assessment, pass or fail, by the two referees was 68.9%. The scores of the video assessment by each referee averaged 62.7 +/- 2.4 (standard deviation) (full score was set at 75 points and >= 60 points was needed to pass). There was a statistically significant difference in the average video assessment score among the referees (P<0.001), and five referees showed significantly higher or lower average scores than the other referees. The percentage qualification of the final decision made by the Referee Committee on the videos originally assessed by each referee showed no significant differences among the 42 referees. The accordance rate of the results from the video assessment by each referee with the final decision by the committee showed a statistically significant positive correlation with the number of videos assessed by each referee (r=0.404, P=0.0080). Conclusions: The ESSQ system showed moderate reliability for the video assessments by the referees. It was concluded that the video assessments by the referees were fair for all applicants, because the final qualification rates showed no significant differences among the referees.	[Matsuda, Tadashi] Kansai Med Univ, Dept Urol & Androl, Hirakata, Osaka 5731010, Japan; [Kanayama, Hiroomi] Univ Tokushima, Grad Sch Med, Dept Urol, Tokushima 770, Japan; [Ono, Yoshinari] Aichi Shukutoku Univ, Sch Med Welf, Dept Hlth & Med Sci, Nagakute, Aichi, Japan; [Kawauchi, Akihiro] Shiga Univ Med Sci, Dept Urol, Otsu, Shiga 52021, Japan; [Mizoguchi, Hiroaki] Mizoguchi Urol Clin, Buzen, Japan; [Nakagawa, Ken] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan; [Iwamura, Masatsugu] Kitasato Univ, Sch Med, Dept Urol, Sagamihara, Kanagawa 228, Japan; [Shigeta, Masanobu] Natl Hosp Org, Kure Med Ctr, Dept Urol, Kure, Japan; [Shigeta, Masanobu] Chugoku Canc Ctr, Kure, Japan; [Habuchi, Tomonori] Akita Univ, Grad Sch Med, Dept Urol, Akita 010, Japan; [Terachi, Toshiro] Tokai Univ, Sch Med, Dept Urol, Isehara, Kanagawa 25911, Japan	Matsuda, T (reprint author), Kansai Med Univ, Dept Urol & Androl, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan.	matsudat@takii.kmu.ac.jp					WINCKEL CP, 1994, AM J SURG, V167, P423, DOI 10.1016/0002-9610(94)90128-7; Seymour NE, 2004, SURG ENDOSC, V18, P592, DOI 10.1007/s00464-002-8927-2; Aggarwal R, 2004, BRIT J SURG, V91, P1549, DOI 10.1002/bjs.4816; Habuchi T, 2012, SURG ENDOSC, V26, P1656, DOI 10.1007/s00464-011-2088-0; Vassiliou MC, 2005, AM J SURG, V190, P107, DOI 10.1016/j.amjsurg.2005.04.004; Larson JL, 2005, SURGERY, V138, P640, DOI 10.1016/j.surg.2005.07.017; Eubanks TR, 1999, J AM COLL SURGEONS, V189, P566, DOI 10.1016/S1072-7515(99)00218-5; Feldman LS, 2004, J AM COLL SURGEONS, V198, P105, DOI 10.1016/j.jamcollsurg.2003.08.020; Iwanaka T, 2011, PEDIATR SURG INT, V27, P727, DOI 10.1007/s00383-011-2871-y; Kimura T, 2010, ASIAN J ENDOSC SURG, V3, P66; Martin JA, 1997, BRIT J SURG, V84, P273, DOI 10.1002/bjs.1800840237; Matsuda T, 2006, J UROLOGY, V176, P2168, DOI 10.1016/j.juro.2006.07.034	12	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0892-7790	1557-900X		J ENDOUROL	J. Endourol.	NOV 1	2014	28	11					1374	1378		10.1089/end.2014.0092		5	Urology & Nephrology	Urology & Nephrology	AS0PM	WOS:000343979900022		
J	De Vos, A; Burignat, S; Gluck, R; Mogensen, TA; Axelsen, HB; Thomsen, MK; Rotenberg, E; Yokoyama, T				De Vos, Alexis; Burignat, Stephane; Glueck, Robert; Mogensen, Torben Aegidius; Axelsen, Holger Bock; Thomsen, Michael Kirkedal; Rotenberg, Eva; Yokoyama, Tetsuo			Designing Garbage-Free Reversible Implementations of the Integer Cosine Transform	ACM JOURNAL ON EMERGING TECHNOLOGIES IN COMPUTING SYSTEMS			English	Article						Reversible computation; integer cosine transform; garbage-free multiplication	COMPUTATION	Discrete linear transformations are important tools in information processing. Many such transforms are injective and therefore prime candidates for a physically reversible implementation into hardware. We present here reversible integer cosine transformations on n input integers. The resulting reversible circuit is able to perform both the forward transform and the inverse transform. The detailed structure of such a reversible design strongly depends on the odd prime factors of the determinant of the transform: whether those are of the form 2(k) +/- 1 or of the form 2(k) +/- 2(l) +/- 1 or neither of these forms.	[De Vos, Alexis] IMEC, Leuven, Belgium; [De Vos, Alexis; Burignat, Stephane] Univ Ghent, B-9000 Ghent, Belgium; [Glueck, Robert; Mogensen, Torben Aegidius; Axelsen, Holger Bock; Thomsen, Michael Kirkedal; Rotenberg, Eva] Kobenhavs Univ, Copenhagen, Denmark; [Thomsen, Michael Kirkedal] Univ Bremen, D-28359 Bremen, Germany; [Yokoyama, Tetsuo] Nanzan Univ, Nagoya, Aichi, Japan	De Vos, A (reprint author), Univ Ghent, CMST, IMEC Vzw, Sint Pietersnieuwstr 41, B-9000 Ghent, Belgium.	alex@elis.ugent.be			Danish Council for Strategic Research, under the MicroPower research project; Research Foundation Flanders (FWO), under the RevLogic research grant; European Commission (7th Framework Programme)	This work is supported by the Danish Council for Strategic Research, under the MicroPower research project, by the Research Foundation Flanders (FWO), under the RevLogic research grant, and by the European Commission (7th Framework Programme).	Malvar HS, 2003, IEEE T CIRC SYST VID, V13, P598, DOI 10.1109/TCSVT.2003.814964; BENNETT CH, 1989, SIAM J COMPUT, V18, P766, DOI 10.1137/0218053; Axelsen HB, 2007, LECT NOTES COMPUT SC, V4649, P56; Axelsen Holger Bock, 2013, LECT NOTES COMPUTER, V7581, P171; BENNETT CH, 1973, IBM J RES DEV, V17, P525; Burignat S., 2013, LECT NOTES COMPUTER, V7581, P160; De Vos A., 2010, REVERSIBLE COMPUTING; KOMATSU K, 1998, ACOUST SPEECH SIG PR, P1769; Markov IL, 2012, QUANTUM INF COMPUT, V12, P361; Mogensen T. AE., 2014, ACM J EMERG TECH COM, V11, P2; Mogensen T. AE., 2013, LECT NOTES COMPUTER, V7948, P70; Perumalla KS, 2014, CH CRC COMP SCI SER, P1; Rotenberg Eva, 2013, LECT NOTES COMPUTER, V7948, P46; Wille R., 2010, DESIGN FLOW REVERSIB; Yokoyama T., 2008, P COMP FRONT, P43, DOI 10.1145/1366230.1366239; Yokoyama T, 2012, 2012 THIRD INTERNATIONAL CONFERENCE ON NETWORKING AND COMPUTING (ICNC 2012), P379, DOI 10.1109/ICNC.2012.73	16	0	0	ASSOC COMPUTING MACHINERY	NEW YORK	2 PENN PLAZA, STE 701, NEW YORK, NY 10121-0701 USA	1550-4832	1550-4840		ACM J EMERG TECH COM	ACM J. Emerg. Technol. Comput. Syst.	NOV	2014	11	2							11	10.1145/2629532		15	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic; Nanoscience & Nanotechnology	Computer Science; Engineering; Science & Technology - Other Topics	AT6RT	WOS:000345067100004		
J	Nguyen, TD; Van Meter, R				Trung Duc Nguyen; Van Meter, Rodney			A Resource-Efficient Design for a Reversible Floating Point Adder in Quantum Computing	ACM JOURNAL ON EMERGING TECHNOLOGIES IN COMPUTING SYSTEMS			English	Article						Reversible circuit; quantum computing; low-power computing; nano technology; IEEE-754 specification; floating-point arithmetic	NETWORKS; LOGIC	Reversible logic has applications in low-power computing and quantum computing. However, there are few existing designs for reversible floating-point adders and none suitable for quantum computation. In this article, we propose a resource-efficient reversible floating-point adder, suitable for binary quantum computation, improving the design of Nachtigal et al. [2011]. Our work focuses on improving the reversible designs of the alignment unit and the normalization unit, which are the most expensive parts. By changing a few elements of the existing algorithm, including the circuit designs of the RLZC (reversible leading zero counter) and converter, we have reduced the cost by about 68%. We also propose quantum designs adapted to use gates from fault-tolerant libraries. The KQ for our fault-tolerant design is almost 60 times as expensive as for a 32-bit fixed-point addition. We note that the floating-point representation makes in-place, truly reversible arithmetic impossible, requiring us to retain both inputs, which limits the sustainability of its use for quantum computation.	[Trung Duc Nguyen; Van Meter, Rodney] Keio Univ, Fac Environm & Informat Studies, Fujisawa, Kanagawa, Japan	Nguyen, TD (reprint author), Keio Univ, Fac Environm & Informat Studies, 5322 Endo, Fujisawa, Kanagawa, Japan.	deplop@sfc.wide.ad.jp			Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)	This research is supported by the Cabinet Office, Government of Japan and the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program).	Amy M., 2013, ARXIVQUANTPH12060758; FREDKIN E, 1982, INT J THEOR PHYS, V21, P219, DOI 10.1007/BF01857727; Vedral V, 1996, PHYS REV A, V54, P147, DOI 10.1103/PhysRevA.54.147; Kassal I, 2011, ANNU REV PHYS CHEM, V62, P185, DOI 10.1146/annurev-physchem-032210-103512; Beckman D, 1996, PHYS REV A, V54, P1034, DOI 10.1103/PhysRevA.54.1034; Giovannetti V, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.160501; BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457; Jordan SP, 2012, SCIENCE, V336, P1130, DOI 10.1126/science.1217069; PERES A, 1985, PHYS REV A, V32, P3266, DOI 10.1103/PhysRevA.32.3266; [Anonymous], 2008, P754 IEEE; Brown KL, 2010, ENTROPY-SWITZ, V12, P2268, DOI 10.3390/e12112268; Choi B.-S., 2012, J EMERG TECHNOL COMP, V8, P24; Clader B. D., 2013, ARXIV13012340; Cuccaro S. A., 2004, NEW QUANTUM RIPPLE C; Devitt Simon J., 2013, REP PROGR PHYS, V76, P7; Draper TG, 2006, QUANTUM INFORM COMPU, V6, P351; Giovannetti V, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.052310; Gorgin S, 2007, I C COMP SYST APPLIC, P479, DOI 10.1109/AICCSA.2007.370925; Haghparast M, 2008, WORLD APPL SCI J, V3, P974; Harrow AW, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.150502; Hashmi I, 2010, 23RD INTERNATIONAL CONFERENCE ON VLSI DESIGN, P93, DOI 10.1109/VLSI.Design.2010.35; Jozsa Richard, 2003, QUANTPH0302134 ARXIV; Lloyd Seth, 2013, ARXIV13070411; Matsumoto K., 2008, ARXIVQUANTPH08063834; Nachtigal M., 2011, P 11 IEEE INT C NAN; Preskill John, 1997, ARXIVQUANTPH9712048V; Preskill John, 1997, ARXIVQUANTPH9705031V; Raussendorf R, 2012, PHILOS T R SOC A, V370, P4541, DOI 10.1098/rsta.2011.0494; Steane Andrew M., 2003, PHYS REV A, V68, P4; Takahashi Y, 2009, IEICE T FUND ELECTR, VE92A, P1276, DOI 10.1587/transfun.E92.A.1276; Takahashi Y, 2005, QUANTUM INFORM COMPU, V5, P440; Terhal B. M., 2013, ARXIV13023428QUANTPH; Thapliyal Himanshu, 2009, P IEEE ANN S VLSI; Thapliyal Himanshu, 2011, P 11 IEEE INT C NAN; Van Meter Rodney, 2005, PHYS REV A, V71, P5	35	0	0	ASSOC COMPUTING MACHINERY	NEW YORK	2 PENN PLAZA, STE 701, NEW YORK, NY 10121-0701 USA	1550-4832	1550-4840		ACM J EMERG TECH COM	ACM J. Emerg. Technol. Comput. Syst.	NOV	2014	11	2							13	10.1145/2629525		18	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic; Nanoscience & Nanotechnology	Computer Science; Engineering; Science & Technology - Other Topics	AT6RT	WOS:000345067100006		
J	Ye, XC; Li, J; Xu, L				Ye, Xiucai; Li, Jie; Xu, Li			Distributed Separate Coding for Continuous Data Collection in Wireless Sensor Networks	ACM TRANSACTIONS ON SENSOR NETWORKS			English	Article						Design; Performance; Wireless sensor networks; distributed separate coding; mobile base station; continuous data collection; success ratio of data collection	STORAGE; EFFICIENT; SYSTEMS	In this article, we present a novel distributed separate coding (DSC) scheme for continuous data collection in wireless sensor networks with a mobile base station (mBS). By separately encoding a certain number of data segments in a combined segment and doing decoding-free data replacement in the buffers of each sensor node, the DSC scheme is shown as an efficient method for continuously collecting data segments with a high success ratio. The proposed DSC scheme has a salient feature: with a minimum buffer size 2 in each sensor node, by querying any m-1 sensor nodes, the mBS can reconstruct the m latest data segments with high probability, where m is the number of latest data segments in a time interval t in which n(t) (m <= n(t)) data segments are generated. The necessary storage space in each sensor node can be adjusted by changing the number of sensor nodes queried by the mBS. Furthermore, the transmission cost for data submission to the mBS can be reduced with some additional storage space in each sensor node. The comprehensive performance evaluation has been conducted through computer simulation. It is shown that the proposed DSC scheme outperforms the existing scheme significantly.	[Ye, Xiucai] Univ Tsukuba, Grad Sch Syst & Informat Engn, Dept Comp Sci, Tsukuba, Ibaraki 3058573, Japan; [Li, Jie] Univ Tsukuba, Fac Engn Informat & Syst, Grad Sch Syst & Informat Engn, Dept Comp Sci,Div Informat Engn, Tsukuba, Ibaraki 3058573, Japan; [Xu, Li] Fujian Normal Univ, Key Lab Network Secur & Cryptol, Fuzhou 3050007, Peoples R China	Li, J (reprint author), Univ Tsukuba, Fac Engn Informat & Syst, Grad Sch Syst & Informat Engn, Dept Comp Sci,Div Informat Engn, Tenotai 1-1-1, Tsukuba, Ibaraki 3058573, Japan.	yexiucai@osdp.cs.tsukuba.ac.jp; lijie@cs.tsukuba.ac.jp; xuli@fjnu.edu.cn			Japan Society for Promotion of Science (JSPS); Collaboration Research Grant of National Institute of Informatics (NII), Japan; National Natural Science Foundation of China [61072080]; Natural Science Foundation of Fujian Province [2013J01222]; Fujian Normal University Innovative Research Team [IRTL1207]	The authors thank Dr. Jianping Pan for the valuable discussions. The authors would also like to thank the associate editor and the anonymous reviewers for their helpful suggestions and comments that improved the quality of the article. This work is partially supported by Grant-in-Aid for Scientific Research of Japan Society for Promotion of Science (JSPS), Collaboration Research Grant of National Institute of Informatics (NII), Japan, and National Natural Science Foundation of China (Nos. 61072080), Natural Science Foundation of Fujian Province (No. 2013J01222), Fujian Normal University Innovative Research Team (No. IRTL1207).	Acedanski S., 2005, P 1 WORKSH NETW COD; Akyildiz IF, 2002, COMPUT NETW, V38, P393, DOI 10.1016/S1389-1286(01)00302-4; Dimakis AG, 2006, IEEE T INFORM THEORY, V52, P2809, DOI 10.1109/TIT.2006.874535; Intanagonwiwat C, 2003, IEEE ACM T NETWORK, V11, P2, DOI 10.1109/TNET.2002.808417; Younis O, 2004, IEEE T MOBILE COMPUT, V3, P366, DOI 10.1109/TMC.2004.41; Dimakis AG, 2010, IEEE T INFORM THEORY, V56, P4539, DOI 10.1109/TIT.2010.2054295; Kong ZN, 2010, IEEE J SEL AREA COMM, V28, P261, DOI 10.1109/JSAC.2010.100215; Culler D, 2004, COMPUTER, V37, P41, DOI 10.1109/MC.2004.93; Lindsey S, 2002, AEROSP CONF PROC, P1125; Bahl P., 2004, P 10 INT C MOB COMP, P112; Burkhard W. A., 1993, P 23 INT S FAULT TOL; Costello Jr D.J., 2004, ERROR CONTROL CODING; Di Francesco M, 2011, ACM T SENSOR NETWORK, V8, DOI 10.1145/1993042.1993049; Dimakis A., 2005, P 4 INT S INF PROC S, P111; Estrin D., 1999, P ACM MOBICOM 99; Gentle J. E., 1998, NUMERICAL LINEAR ALG; Kamra A., 2006, P ACM SIGCOM 06; Krishnamachari B., 2002, P 22 INT C DISTR COM, P575; Kubiatowicz J., 2000, P IACM ASPLOS 2012; Lin C., 2006, P IWCMC 06; Lin Y., 2007, P IEEE INFOCOM 2007; Mainwaring A., 2002, P 1 ACM INT WORKSH W, P88, DOI DOI 10.1145/570738.570751; Ngai E. C., 2012, P IEEE INFOCOM 2012; Rahmati A., 2007, P MOBISYS 2007; Suli E, 2003, INTRO NUMERICAL ANAL; Tolle G., 2005, SONOMA REDWOODS DATA; Wang D., 2013, ACM T SENSOR NETWORK, V9, P3; Wang D., 2008, ACM T SENSOR NETWORK, V4, P1, DOI 10.1145/1362542.1362545; Williams S., 2010, DEV MOBILE ARCTIC SE	29	0	0	ASSOC COMPUTING MACHINERY	NEW YORK	2 PENN PLAZA, STE 701, NEW YORK, NY 10121-0701 USA	1550-4859	1550-4867		ACM T SENSOR NETWORK	ACM Trans. Sens. Netw.	NOV	2014	11	1							17	10.1145/2629658		26	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	AT5XF	WOS:000345012500017		
J	Obora, Y				Obora, Yasushi			Recent Advances in alpha-Alkylation Reactions using Alcohols with Hydrogen Borrowing Methodologies	ACS CATALYSIS			English	Review						alpha-alkyladion; hydrogen borrowing; alcohol; ketone; methanol	IRIDIUM-CATALYZED ALKYLATION; MEERWEIN-PONNDORF-VERLEY; SECONDARY ALCOHOLS; GUERBET REACTION; BETA-ALKYLATION; SELECTIVE HOMOLOGATION; NICKEL NANOPARTICLES; DIMETHYL-SULFOXIDE; PT/CEO2 CATALYST; METHYL KETONES	This paper summarizes recent advances in a-alkylation reactions based on hydrogen borrowing methodologies using alcohol as an alkylating agent. This review provides a summary of recent progress toward the a-alkylation of carbonyl substrates, as well as relatively unactivated substrates bearing fewer acidic a-hydrogens, such as acetonitriles, acetamides, esters, methylpyrimidines, and methylquinolines. A summary of recent improvements in a-methylation strategies based on hydrogen borrowing methodologies has also been provided. Particular emphasis has been placed on highly practical and green chemistry approaches involving modified catalytic systems, including metal-supported heterogeneous catalysts and nanoparticle-based catalysts, as well as reactions conducted in the absence of a transition-metal catalyst. A review of recent achievements in methylation strategies using methanol as a methyl source, and their application to the a-methylation of ketones using transition-metal catalyzed hydrogen borrowing methodology, has also been documented.	Kansai Univ, Dept Chem & Mat Engn, Fac Chem Mat & Bioengn, Suita, Osaka 5648680, Japan	Obora, Y (reprint author), Kansai Univ, Dept Chem & Mat Engn, Fac Chem Mat & Bioengn, Suita, Osaka 5648680, Japan.	obora@kansai-u.ac.jp			KAKENHI; MEXT	This work was supported by Grant-in Aid for Scientific Research (KAKENHI) and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2010-2014).	ABAD A, 1985, CHEM IND-LONDON, P29; Ahn JH, 2009, ANGEW CHEM INT EDIT, V48, P3814, DOI 10.1002/anie.200900541; Alonso F, 2008, EUR J ORG CHEM, P4908, DOI 10.1002/ejoc.200800729; Bahn S, 2011, CHEMCATCHEM, V3, P1853, DOI 10.1002/cctc.201100255; Shimizu K, 2009, ANGEW CHEM INT EDIT, V48, P3982, DOI 10.1002/anie.200901057; Guillena G, 2007, ANGEW CHEM INT EDIT, V46, P2358, DOI 10.1002/anie.200603794; Bhat S, 2012, CHEM COMMUN, V48, P4701, DOI 10.1039/c2cc31055d; Kwon MS, 2005, ANGEW CHEM INT EDIT, V44, P6913, DOI 10.1002/anie.200502422; Crabtree RH, 2011, ORGANOMETALLICS, V30, P17, DOI 10.1021/om1009439; Grigg R, 2009, TETRAHEDRON, V65, P4375, DOI 10.1016/j.tet.2009.03.065; ODonnell MJ, 1996, J AM CHEM SOC, V118, P6070, DOI 10.1021/ja9601245; Jensen T, 2009, J ORG CHEM, V74, P3990, DOI 10.1021/jo900341w; Kwon MS, 2005, ORG LETT, V7, P1077, DOI 10.1021/ol047381w; Blank B, 2009, ADV SYNTH CATAL, V351, P2903, DOI 10.1002/adsc.200900548; Cho CS, 2001, J ORG CHEM, V66, P9020, DOI 10.1021/jo0108459; Moran J, 2011, NAT CHEM, V3, P287, DOI [10.1038/nchem.1001, 10.1038/NCHEM.1001]; Watson AJA, 2010, SCIENCE, V329, P635, DOI 10.1126/science.1191843; Langer R, 2013, CHEM-EUR J, V19, P3407, DOI 10.1002/chem.201204003; Kim H, 2007, J AM CHEM SOC, V129, P2269, DOI 10.1021/ja068346i; Ortega N, 2013, ORG LETT, V15, P1776, DOI 10.1021/ol400639m; Cho CS, 2005, J MOL CATAL A-CHEM, V240, P55, DOI 10.1016/j.molcata.2005.06.043; Dixit M, 2013, CATAL COMMUN, V33, P80, DOI 10.1016/j.catcom.2012.12.027; Blank B, 2008, ADV SYNTH CATAL, V350, P749, DOI 10.1002/adsc.200700596; Ogo S, 2011, APPL CATAL A-GEN, V402, P188, DOI 10.1016/j.apcata.2011.06.006; Cho CS, 2002, TETRAHEDRON LETT, V43, P7987, DOI 10.1016/S0040-4039(02)01625-8; Rueping M, 2012, GREEN CHEM, V14, P55, DOI 10.1039/c1gc15764g; Sawaguchi T, 2011, CHEM LETT, V40, P1055, DOI 10.1246/cl.2011.1055; Yamada YMA, 2006, ORG LETT, V8, P1375, DOI 10.1021/ol060166q; Koda K, 2009, CHEM LETT, V38, P838, DOI 10.1246/cl.2009.838; Cho CS, 2005, B KOR CHEM SOC, V26, P1611; Onodera G, 2006, ANGEW CHEM INT EDIT, V45, P3819, DOI 10.1002/anie.200600677; Palomo C, 2004, CHEM SOC REV, V33, P65, DOI 10.1039/b202901d; Lofberg C, 2006, J ORG CHEM, V71, P8023, DOI 10.1021/jo061113p; Grigg R, 2009, TETRAHEDRON, V65, P7468, DOI 10.1016/j.tet.2009.07.027; Magnus P, 2001, TETRAHEDRON LETT, V42, P4127, DOI 10.1016/S0040-4039(01)00693-1; Xu C, 2011, ORGANOMETALLICS, V30, P6499, DOI 10.1021/om200883e; Iuchi Y, 2010, J ORG CHEM, V75, P1803, DOI 10.1021/jo9027165; Aramoto H, 2009, J ORG CHEM, V74, P628, DOI 10.1021/jo801966u; Xu C, 2012, J ORGANOMET CHEM, V700, P214, DOI 10.1016/j.jorganchem.2011.11.033; CHANG CD, 1977, J CATAL, V47, P249, DOI 10.1016/0021-9517(77)90172-5; Kose O, 2010, ORG BIOMOL CHEM, V8, P896, DOI 10.1039/b914618k; COOK FL, 1974, J ORG CHEM, V39, P3416, DOI 10.1021/jo00937a026; Casiraghi G, 2011, CHEM REV, V111, P3076, DOI 10.1021/cr100304n; Guillena G, 2010, CHEM REV, V110, P1611, DOI 10.1021/cr9002159; Dobereiner GE, 2010, CHEM REV, V110, P681, DOI 10.1021/cr900202j; Obora Y, 2012, J ORG CHEM, V77, P9429, DOI 10.1021/jo3019347; Kawahara R, 2010, J AM CHEM SOC, V132, P15108, DOI 10.1021/ja107274w; Kuwahara T, 2012, ORG LETT, V14, P4703, DOI 10.1021/ol302145a; FRIEDMAN L, 1960, J ORG CHEM, V25, P877, DOI 10.1021/jo01076a001; GRIGG R, 1981, TETRAHEDRON LETT, V22, P4107, DOI 10.1016/S0040-4039(01)82078-5; Pan SG, 2013, ACS CATAL, V3, P704, DOI 10.1021/cs400066q; Li Y, 2014, ORG LETT, V16, P66, DOI 10.1021/ol403040g; Barreiro EJ, 2011, CHEM REV, V111, P5215, DOI 10.1021/cr200060g; Matsu-ura T, 2006, J ORG CHEM, V71, P8306, DOI 10.1021/jo061400t; Polshettiwar V, 2009, GREEN CHEM, V11, P1313, DOI 10.1039/b913079a; Haynes A, 2006, TOP ORGANOMETAL CHEM, V18, P179, DOI 10.1007/3418_021; Cui XJ, 2011, CHEM-EUR J, V17, P1021, DOI 10.1002/chem.201001915; Alonso F, 2011, ACCOUNTS CHEM RES, V44, P379, DOI 10.1021/ar1001582; Rodriguez-Lugo RE, 2013, NAT CHEM, V5, P342, DOI [10.1038/nchem.1595, 10.1038/NCHEM.1595]; Taguchi K, 2004, J AM CHEM SOC, V126, P72, DOI 10.1021/ja037552c; Fujita K, 2005, ORG LETT, V7, P4017, DOI 10.1021/ol051517o; Cha JS, 2006, ORG PROCESS RES DEV, V10, P1032, DOI 10.1021/op068002c; Hamid MHSA, 2007, ADV SYNTH CATAL, V349, P1555, DOI 10.1002/adsc.200600638; Ouali A, 2009, CHEMCATCHEM, V1, P504, DOI 10.1002/cctc.200900237; Anxionnat B, 2013, ORG LETT, V15, P3876, DOI 10.1021/ol401610e; Martinez R, 2005, TETRAHEDRON LETT, V46, P3683, DOI 10.1016/j.tetlet.2005.03.158; Schonherr H, 2013, ANGEW CHEM INT EDIT, V52, P12256, DOI 10.1002/anie.201303207; Blank B, 2009, CHEM-EUR J, V15, P3790, DOI 10.1002/chem.200802318; Black PJ, 2006, ORG BIOMOL CHEM, V4, P116, DOI 10.1039/b511053j; Martinez R, 2006, TETRAHEDRON, V62, P8988, DOI 10.1016/j.tet.2006.07.013; Guo L, 2013, ORG LETT, V15, P1144, DOI 10.1021/ol400360g; Buil ML, 2013, ACS CATAL, V3, P2072, DOI 10.1021/cs4005375; Jones JH, 2000, PLATIN MET REV, V44, P94; Chaudhari C, 2013, TETRAHEDRON LETT, V54, P6490, DOI 10.1016/j.tetlet.2013.09.077; Yamaguchi R, 2010, HETEROCYCLES, V81, P1093, DOI 10.3987/REV-09-665; Carlini C, 2004, J MOL CATAL A-CHEM, V212, P65, DOI 10.1016/j.molcata.2003.10.045; Cho CS, 2003, ORGANOMETALLICS, V22, P3608, DOI 10.1021/om030307h; Kim S, 2009, TETRAHEDRON, V65, P1461, DOI 10.1016/j.tet.2008.12.005; Miller JS, 2001, ACCOUNTS CHEM RES, V34, P563, DOI 10.1021/ar0000354; Xu Q, 2014, ANGEW CHEM INT EDIT, V53, P225, DOI 10.1002/anie.201308642; Motokura K, 2004, J AM CHEM SOC, V126, P5662, DOI 10.1021/ja049181l; Suzuki T, 2011, CHEM REV, V111, P1825, DOI 10.1021/cr100378r; Alonso F, 2010, MOL DIVERS, V14, P411, DOI 10.1007/s11030-009-9195-z; Nielsen M, 2013, NATURE, V495, P85, DOI 10.1038/nature11891; Carlini C, 2003, J MOL CATAL A-CHEM, V204, P721, DOI 10.1016/S1381-1169(03)00357-1; Gunanathan C, 2013, SCIENCE, V341, P249, DOI 10.1126/science.1229712; Chaudhari C, 2014, CATAL SCI TECHNOL, V4, P1064, DOI 10.1039/c3cy00911d; Slatford PA, 2006, TETRAHEDRON LETT, V47, P6787, DOI 10.1016/j.tetlet.2006.07.069; Blank B, 2010, J AM CHEM SOC, V132, P924, DOI 10.1021/ja9095413; Anxionnat B, 2011, ORG LETT, V13, P4084, DOI 10.1021/ol2015972; Schranck J, 2013, ANGEW CHEM INT EDIT, V52, P7642, DOI 10.1002/anie.201303015; Anxionnat B, 2012, EUR J ORG CHEM, P4453, DOI 10.1002/ejoc.201200850; Arseniyadis S., 1984, ORG REACTIONS, V31, P1, DOI DOI 10.1002/0471264180.OR031.01; BATTERHA.TJ, 1967, J CHEM SOC B, P171, DOI 10.1039/j29670000171; BIBBY CE, 1977, J CHEM SOC DALTON, P872, DOI 10.1039/dt9770000872; Caine D, 1991, COMPREHENSIVE ORGANI, V3, P1; Cannon J G, 1985, Prog Drug Res, V29, P303; Cano R, 2012, CHEM COMMUN, V48, P7628, DOI 10.1039/c2cc33101b; CARFAGNA C, 1991, J ORG CHEM, V56, P261, DOI 10.1021/jo00001a049; Challis B. C., 1970, CHEM AMIDES, P731; Chan LKM, 2014, ANGEW CHEM INT EDIT, V53, P761, DOI 10.1002/anie.201307950; Chaudhari C, 2014, TOP CATAL, V57, P1042, DOI 10.1007/s11244-014-0268-6; Corma A, 2011, J CATAL, V279, P319, DOI 10.1016/j.jcat.2011.01.029; CRABTREE R, 1979, ACCOUNTS CHEM RES, V12, P331, DOI 10.1021/ar50141a005; DEGRAAUW CF, 1994, SYNTHESIS-STUTTGART, P1007, DOI 10.1055/s-1994-25625; FISCHER A, 1977, J ORGANOMET CHEM, V136, P323, DOI 10.1016/S0022-328X(00)93739-2; Haw JF, 2003, ACCOUNTS CHEM RES, V36, P317, DOI 10.1021/ar020006o; Kraft P., 2000, ANGEW CHEM INT EDIT, V39, P2980, DOI 10.1002/1521-3773(20000901)39:17<2980::AID-ANIE2980>3.0.CO;2-#; Kuwahara T, 2013, CHEM LETT, V42, P1163, DOI 10.1246/cl.130465; Kuwahara T, 2013, RSC ADV, V3, P13702, DOI 10.1039/c3ra42834f; Lamb GW, 2008, CHIM OGGI, V26, P17; Langer R., 2011, ACCOUNTS CHEM RES, V44, P588; LANGHALS E, 1990, TETRAHEDRON LETT, V31, P859, DOI 10.1016/S0040-4039(00)94647-1; Ledger AEW, 2009, DALTON T, P716, DOI 10.1039/b813543f; Liang YF, 2013, RSC ADV, V3, P7739, DOI 10.1039/c3ra23221b; Lofberg C, 2006, CHEM COMMUN, P5000, DOI 10.1039/b614098j; Maitlis PM, 1996, J CHEM SOC DALTON, P2187, DOI 10.1039/dt9960002187; MARUOKA K, 1994, SYNTHESIS-STUTTGART, P1283; Morita M, 2007, CHEM COMMUN, P2850, DOI 10.1039/b702293j; Motokura K, 2006, CHEM-EUR J, V12, P8228, DOI 10.1002/chem.200600317; Nixon TD, 2009, DALTON T, P753, DOI 10.1039/b813383b; Obora Y, 2011, ANGEW CHEM INT EDIT, V50, P8618, DOI 10.1002/anie.201104452; Obora Y, 2011, SYNLETT, P30, DOI 10.1055/s-0030-1259094; Ogawa S, 2014, CHEM COMMUN, V50, P2491, DOI 10.1039/c3cc49626k; Otera J., 2000, MODERN CARBONYL CHEM; Ourida S., 2011, TOP ORGANOMETAL CHEM, V34, P77; Patai S., 1979, CHEM ACID DERIVATIVE, P267; Rappoport Z., 1970, PATAIS CHEM FUNCTION; Ravi S, 2001, J INDIAN I SCI, V81, P299; SEEBACH D, 1993, HELV CHIM ACTA, V76, P1564, DOI 10.1002/hlca.19930760415; SHANNON M, 1984, EUR J PHARMACOL, V102, P23, DOI 10.1016/0014-2999(84)90333-9; Takeuchi R, 2006, SYNTHESIS-STUTTGART, P3349, DOI 10.1055/s-2006-950284; THIERY A, 1986, ZBL MIKROBIOL, V141, P575; Weissermel K., 2010, IND ORGANIC CHEM; Williams AS, 1999, SYNTHESIS-STUTTGART, P1707	135	16	16	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	NOV	2014	4	11					3972	3981		10.1021/cs501269d		10	Chemistry, Physical	Chemistry	AT0QD	WOS:000344639300020		
J	Hara, T; Fujita, N; Ichikuni, N; Wilson, K; Lee, AF; Shimazu, S				Hara, Takayoshi; Fujita, Nozomi; Ichikuni, Nobuyuki; Wilson, Karen; Lee, Adam F.; Shimazu, Shogo			Efficient 1,4-Addition of Enones and Boronic Acids Catalyzed by a Ni-Zn Hydroxyl Double Salt-Intercalated Anionic Rhodium(III) Complex	ACS CATALYSIS			English	Article						Ni-Zn hydroxyl double salt; anion exchange; intercalation rhodium; rhodium; 1,4-addition	ALPHA,BETA-UNSATURATED CARBONYL-COMPOUNDS; MIXED BASIC SALT; ASYMMETRIC 1,4-ADDITION; ARYLBORONIC ACIDS; HETEROGENEOUS CATALYST; GRAFTED HYDROTALCITE; ORGANOBORON REAGENTS; CONJUGATE ADDITION; EXCHANGE REACTIONS; LIGANDS	Intercalation of an in situ prepared [Rh(OH)(6)](3) complex into an anion exchangeable NiZn layered hydroxy double salt (Rh/NiZn) was demonstrated. The resulting Rh/NiZn effectively catalyzed the 1,4-addition of diverse enones and phenylboronic acids to their corresponding beta-substituted carbonyl compounds. In the case of 2-cyclohexen-1-one and phenylboronic acid, a turnover frequency (TOF) of 920 h1 based on Rh was achieved. The [Rh(OH)(6)](3) complex maintained its original monomeric trivalent state within the NiZn interlayer following catalysis, attributable to a strong electrostatic interaction between the NiZn host and anionic Rh(III) complex.	[Hara, Takayoshi; Fujita, Nozomi; Ichikuni, Nobuyuki; Shimazu, Shogo] Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Inage Ku, Chiba 2638522, Japan; [Wilson, Karen; Lee, Adam F.] Aston Univ, Sch Engn & Appl Sci, European Bioenergy Res Inst, Birmingham B4 7ET, W Midlands, England	Shimazu, S (reprint author), Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Inage Ku, 1-33 Yayoi, Chiba 2638522, Japan.	shimazu@faculty.chiba-u.jp	Karen, Wilson/A-1061-2009	Karen, Wilson/0000-0003-4873-708X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25420824]; EPSRC [EP/G007594/4]; Royal Society	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (25420824). The Rh K-edge XAFS experiments were conducted at a facility in the Photon Factory (KEK-PF, Proposal No. 2012G596). We are also grateful to Mr. Muneharu Nozawa and Ms. Tomoko Fukusaki for their invaluable contributions to the work described here. A.F.L. thanks the EPSRC for the award of a Leadership Fellowship (EP/G007594/4), and K.W. thanks the Royal Society for the award of an Industry Fellowship.	Motokura K, 2011, GREEN CHEM, V13, P2416, DOI 10.1039/c1gc15146k; Yasukawa T, 2012, J AM CHEM SOC, V134, P16963, DOI 10.1021/ja307913e; Itooka R, 2003, J ORG CHEM, V68, P6000, DOI 10.1021/jo02070067; Morioka H, 1999, INORG CHEM, V38, P4211, DOI 10.1021/ic9812149; Yang JH, 2007, CHEM MATER, V19, P2679, DOI 10.1021/cm070259h; Tian P, 2012, ACS CATAL, V2, P95, DOI 10.1021/cs200562n; Rojas R, 2004, J SOLID STATE CHEM, V177, P3392, DOI 10.1016/j.jssc.2004.05.055; KING RB, 1995, INORG CHIM ACTA, V237, P65, DOI 10.1016/0020-1693(95)04643-N; Kaneda K, 2006, B CHEM SOC JPN, V79, P981, DOI 10.1246/bcsj.79.981; Hayashi T, 2003, CHEM REV, V103, P2829, DOI 10.1021/cr020022z; Hara T, 2011, CATAL SCI TECHNOL, V1, P1376, DOI 10.1039/c1cy00223f; Korenaga T, 2013, J ORG CHEM, V78, P9975, DOI 10.1021/jo4014707; Edwards HJ, 2010, CHEM SOC REV, V39, P2093, DOI 10.1039/b919762c; Dai ZM, 2009, J ORGANOMET CHEM, V694, P1049, DOI 10.1016/j.jorganchem.2008.09.048; Oliver SRJ, 2009, CHEM SOC REV, V38, P1868, DOI 10.1039/b710339p; Komarneni S, 1996, J MATER RES, V11, P1866, DOI 10.1557/JMR.1996.0236; Richardson-Chong SSD, 2012, IND ENG CHEM RES, V51, P2913, DOI 10.1021/ie202036y; Miyaura N, 2008, B CHEM SOC JPN, V81, P1535, DOI 10.1246/bcsj.81.1535; Rajamathi JT, 2008, LANGMUIR, V24, P11164, DOI 10.1021/la801730u; Sathisha TV, 2012, J ELECTROANAL CHEM, V674, P57, DOI 10.1016/j.jelechem.2012.03.020; Defieber C, 2008, ANGEW CHEM INT EDIT, V47, P4482, DOI 10.1002/anie.200703612; Bull RMR, 2011, J MATER CHEM, V21, P1822, DOI 10.1039/c0jm03020a; YAMANAKA S, 1992, SOLID STATE IONICS, V53, P527, DOI 10.1016/0167-2738(92)90424-N; Hara T, 2009, GREEN CHEM, V11, P2034, DOI 10.1039/b918350g; Choy JH, 1998, MATER LETT, V34, P356, DOI 10.1016/S0167-577X(97)00191-2; Jana R, 2009, ORG LETT, V11, P971, DOI 10.1021/ol802927v; Kandare E, 2006, INORG CHEM, V45, P3766, DOI 10.1021/ic060071k; He S, 2013, CHEM COMMUN, V49, P5912, DOI 10.1039/c3cc42137f; Kandare E, 2005, J PHYS CHEM B, V109, P8469, DOI 10.1021/jp0465433; Tronto J, 2006, J PHYS CHEM SOLIDS, V67, P978, DOI 10.1016/j.jpcs.2006.01.014; Sakai M, 1997, ORGANOMETALLICS, V16, P4229, DOI 10.1021/om9705113; Wang Q, 2012, CHEM REV, V112, P4124, DOI 10.1021/cr200434v; Chen Q, 2013, CHEM COMMUN, V49, P6433, DOI 10.1039/c3cc42673d; Nishizawa H, 1998, J SOLID STATE CHEM, V141, P229, DOI 10.1006/jssc.1998.7962; MEYN M, 1993, INORG CHEM, V32, P1209, DOI 10.1021/ic00059a030; Hayashi T, 2002, J AM CHEM SOC, V124, P5052, DOI 10.1021/ja012711i; Arizaga Gregorio Guadalupe Carbajal, 2007, Solid State Ionics: Diffusion and Reactions, V178, DOI 10.1016/j.ssi.2007.04.016; Arulraj J, 2007, SOLID STATE SCI, V9, P812, DOI 10.1016/j.solidstatesciences.2007.06.007; Baes Jr C.F., 1976, HYDROLYSIS CATIONS; Choy JH, 1997, B KOR CHEM SOC, V18, P450; Delorme F, 2009, J SOLID STATE CHEM, V182, P2350, DOI 10.1016/j.jssc.2009.05.031; Dolzhenko VD, 2002, RUSS J INORG CHEM+, V47, P692; Fairhurst NWG, 2013, SYNLETT, V24, P496, DOI 10.1055/s-0032-1318135; Forano C., 1992, EXPANDED CLAYS OTHER, P108; Fujita N, 2006, TETRAHEDRON LETT, V47, P5083, DOI 10.1016/j.tetlet.2006.05.075; FUJITSU H, 1981, J ORG CHEM, V46, P5353, DOI 10.1021/jo00339a020; Handa P, 2008, ARKIVOC, P107; Handa P, 2008, MICROPOR MESOPOR MAT, V116, P424, DOI 10.1016/j.micromeso.2008.05.002; Hara T, 2010, CHEM LETT, V39, P304, DOI 10.1246/cl.2010.304; Itaoka R., 2001, CHEM LETT, V30, P722; Ivanon-Emin B. N., 1971, RUSS J INORG CHEM, V16, P1474; Jana R, 2011, J ORG CHEM, V76, P8376, DOI 10.1021/jo201476h; Kantam ML, 2008, HELV CHIM ACTA, V91, P1947, DOI 10.1002/hlca.200890208; Khiar N, 2013, J ORG CHEM, V78, P6510, DOI 10.1021/jo400700m; Lederer M, 1997, J CHROMATOGR A, V769, P325, DOI 10.1016/S0021-9673(96)01083-7; Lee AF, 2006, CATAL COMMUN, V7, P566, DOI 10.1016/j.catcom.2006.01.025; Neatu F, 2008, CATAL TODAY, V139, P161, DOI 10.1016/j.cattod.2008.07.028; Nityashree N, 2013, J PHYS CHEM SOLIDS, V74, P1164, DOI 10.1016/j.jpcs.2013.03.015; Omwoma S, 2014, COORDIN CHEM REV, V258, P58, DOI 10.1016/j.ccr.2013.08.039; Otomaru Y, 2004, ORG LETT, V6, P3357, DOI 10.1021/ol048695m; Rajamathi JT, 2009, SOLID STATE SCI, V11, P2080, DOI 10.1016/j.solidstatesciences.2009.09.001; Rajamathi JT, 2005, SOLID STATE SCI, V7, P195, DOI 10.1016/j.solidstatesciences.2004.10.034; Rojas R, 2008, MICROPOR MESOPOR MAT, V112, P262, DOI 10.1016/j.micromeso.2007.09.042; Rojas R, 2002, J MATER CHEM, V12, P1071, DOI 10.1039/b110145e; SCHMIDTK.HH, 1965, Z PHYS CHEM NEUE FOL, V45, P305; Takaya H, 2013, SYNLETT, V24, P1910, DOI 10.1055/s-0033-1339473; Uozumi Y, 2002, ADV SYNTH CATAL, V344, P274, DOI 10.1002/1615-4169(200206)344:3/4<274::AID-ADSC274>3.0.CO;2-S; YAMANAKA S, 1995, MATER RES SOC SYMP P, V371, P131	68	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	NOV	2014	4	11					4040	4046		10.1021/cs501267h		7	Chemistry, Physical	Chemistry	AT0QD	WOS:000344639300028		
J	Seki, M				Seki, Masahiko			Efficient Catalytic System for Ru-Catalyzed C-H Arylation and Application to a Practical Synthesis of a Pharmaceutical	ACS CATALYSIS			English	Article						C-H activation; direct arylation; ruthenium; sulfonic acids; biaryls; heterocycles	II RECEPTOR BLOCKERS; BOND ACTIVATION; ORGANIC HALIDES; FUNCTIONALIZATION; ALKENYLATION; IMINES	A series of K salts of sulfonic acids have been tested as a cocatalyst for Ru-catalyzed CH arylation. Among them, K 2, 4, 6-trimethylbenzenesulfonate (TMBSK) was found to be most active, and generality of the reaction was confirmed for a variety of nitrogen-containing heterocycles to give corresponding functionalized biaryls in high yields. The present methodology was applied to a practical synthesis of Candesartan Cilexetil	API Corp, Healthcare Business Div 2, Proc R&D Dept, Chiyoda Ku, Tokyo 1010047, Japan	Seki, M (reprint author), API Corp, Healthcare Business Div 2, Proc R&D Dept, Chiyoda Ku, Kaiteki Bldg,1-13-4 Uchikanda, Tokyo 1010047, Japan.	seki.masahiko@mm.api-corp.co.jp					Pozgan F, 2009, ADV SYNTH CATAL, V351, P1737, DOI 10.1002/adsc.200900350; KUBO K, 1993, J MED CHEM, V36, P2343, DOI 10.1021/jm00068a011; Oi S, 2001, ORG LETT, V3, P2579, DOI 10.1021/ol016257z; Ackermann L, 2011, ORG LETT, V13, P3332, DOI 10.1021/ol2010648; Hatano M, 2008, J AM CHEM SOC, V130, P16858, DOI 10.1021/ja806875c; Ackermann L, 2010, CHEM COMMUN, V46, P4866, DOI 10.1039/c0cc00778a; Ackermann L, 2011, CHEM REV, V111, P1315, DOI 10.1021/cr100412j; Arockiam P, 2009, GREEN CHEM, V11, P1871, DOI 10.1039/b913115a; Ackermann L, 2010, TOP CURR CHEM, V292, P211, DOI 10.1007/128_2009_9; Oi S, 2002, ORG LETT, V4, P1783, DOI 10.1021/ol025851l; Arockiam PB, 2010, ANGEW CHEM INT EDIT, V49, P6629, DOI 10.1002/anie.201002870; Seki M, 2011, J ORG CHEM, V76, P10198, DOI 10.1021/jo202041e; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Ackermann L, 2009, ANGEW CHEM INT EDIT, V48, P9792, DOI 10.1002/anie.200902996; Arockiam PB, 2012, CHEM REV, V112, P5879, DOI [10.1021/cr300153j, 10.1021/cr300153J]; Seki M, 2014, RSC ADV, V4, P29131, DOI 10.1039/c4ra03679d; Seki M, 2011, ACS CATAL, V1, P607, DOI 10.1021/cs200044t; Li B, 2011, ACS CATAL, V1, P1221, DOI 10.1021/ns200331m; Ferrer Flegeau Emmanuel, 2011, J Am Chem Soc, V133, P10161, DOI 10.1021/ja201462n; Naka T., 2002, U.S. patent, Patent No. 20020151723; Seki M, SYNTHESIS IN PRESS, DOI [10.1055/s-0034-1378585, DOI 10.1055/S-0034-1378585]; Seki M, 2012, SYNTHESIS-STUTTGART, V44, P3231, DOI 10.1055/s-0032-1317131; Seki M, 2012, J SYN ORG CHEM JPN, V70, P1295; Sheldon RA, 2007, GREEN CHEM, V9, P1273, DOI 10.1039/b713736m	24	5	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	NOV	2014	4	11					4047	4050		10.1021/cs501328x		4	Chemistry, Physical	Chemistry	AT0QD	WOS:000344639300029		
J	Park, S; Zheng, LJ; Kumakiri, S; Sakashita, S; Otomo, H; Ikehata, K; Sugiyama, H				Park, Soyoung; Zheng, Linjie; Kumakiri, Shunsuke; Sakashita, Sohei; Otomo, Haruka; Ikehata, Keiichi; Sugiyama, Hiroshi			Development of DNA-Based Hybrid Catalysts through Direct Ligand Incorporation: Toward Understanding of DNA-Based Asymmetric Catalysis	ACS CATALYSIS			English	Article						DNA; hybrid catalyst; asymmetric catalysis; Friedel-Crafts reaction; direct ligand incorporation	FRIEDEL-CRAFTS ALKYLATIONS; BUILDING-BLOCKS; BOND FORMATION; WATER; ENANTIOSELECTIVITY; SITE; COMPLEXES; ENZYMES; RNA	We have developed a DNA-based hybrid catalyst containing an intrastrand bipyridine ligand through direct ligand incorporation and successfully performed asymmetric intramolecular FriedelCrafts alkylations. This is the first report on the DNA hybrid catalyst system where an intrastrand ligand is covalently introduced into the phosphate backbone. We have generated a series of active site to investigate the structural details of DNA hybrid catalysts and demonstrated that catalytic properties of DNA hybrid catalysts are governed by the disposition of the metal-binding site in the DNA duplex, the size of catalytic cavity, and the composition of nucleobases in the catalytic pocket.	[Park, Soyoung; Zheng, Linjie; Kumakiri, Shunsuke; Sakashita, Sohei; Otomo, Haruka; Ikehata, Keiichi; Sugiyama, Hiroshi] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Sugiyama, Hiroshi] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto 6068501, Japan; [Sugiyama, Hiroshi] Japan Sci & Technol Corp JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Park, S (reprint author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kitashirakawa Oiwakecho, Kyoto 6068502, Japan.	oleesy@kuchem.kyoto-u.ac.jp; hs@kuchem.kyoto-u.ac.jp	Sugiyama, Hiroshi/C-7687-2011		Japan Science and Technology Corporation (JST); WPI program (iCeMS, Kyoto University)	We express our sincere thanks for the CREST grant from the Japan Science and Technology Corporation (JST), grants from the WPI program (iCeMS, Kyoto University), and for the global COE program from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Wilking M, 2013, ORG BIOMOL CHEM, V11, P6940, DOI 10.1039/c3ob41366g; Wang CH, 2012, ANGEW CHEM INT EDIT, V51, P9352, DOI 10.1002/anie.201204850; Evans DA, 2007, J AM CHEM SOC, V129, P10029, DOI 10.1021/ja072976i; Narlikar GJ, 1997, ANNU REV BIOCHEM, V66, P19, DOI 10.1146/annurev.biochem.66.1.19; Garo F, 2012, ANGEW CHEM INT EDIT, V51, P916, DOI 10.1002/anie.201103295; Park S, 2010, ANGEW CHEM INT EDIT, V49, P3870, DOI 10.1002/anie.200905382; Roe S, 2010, CHEM COMMUN, V46, P4309, DOI 10.1039/c0cc00194e; Roelfes G, 2005, ANGEW CHEM INT EDIT, V44, P3230, DOI 10.1002/anie.200500298; Jakobsen U, 2007, NUCLEOS NUCLEOT NUCL, V26, P1419, DOI 10.1080/15257770701539260; Park S, 2012, MOLECULES, V17, P12792, DOI 10.3390/molecules171112792; Boersma AJ, 2007, ORG LETT, V9, P3647, DOI 10.1021/ol7015274; Coquiere D, 2007, ANGEW CHEM INT EDIT, V46, P9308, DOI 10.1002/anie.200703459; Serganov A, 2005, NAT STRUCT MOL BIOL, V12, P218, DOI 10.1038/nsmb906; Toscano MD, 2007, ANGEW CHEM INT EDIT, V46, P3212, DOI 10.1002/anie.200604205; Roelfes G, 2007, MOL BIOSYST, V3, P126, DOI 10.1039/b614527b; Gjonaj L, 2013, CHEMCATCHEM, V5, P1718, DOI 10.1002/cctc.201300082; Fournier P, 2009, ANGEW CHEM INT EDIT, V48, P4426, DOI 10.1002/anie.200900713; Boersma AJ, 2010, NAT CHEM, V2, P991, DOI [10.1038/nchem.819, 10.1038/NCHEM.819]; Wang CH, 2012, CHEM COMMUN, V48, P6232, DOI 10.1039/c2cc31320k; Boersma AJ, 2010, CHEM SOC REV, V39, P2083, DOI 10.1039/b811349c; Boersma AJ, 2009, ANGEW CHEM INT EDIT, V48, P3346, DOI 10.1002/anie.200900371; Boersma AJ, 2008, J AM CHEM SOC, V130, P11783, DOI 10.1021/ja803170m; Langenegger SM, 2005, CHEMBIOCHEM, V6, P848, DOI 10.1002/cbic.200400370; Silverman SK, 2010, ANGEW CHEM INT EDIT, V49, P7180, DOI 10.1002/anie.200906345; Oelerich J, 2013, CHEM SCI, V4, P2013, DOI 10.1039/c3sc00100h; Park S, 2012, CHEM COMMUN, V48, P10398, DOI 10.1039/c2cc35625b; Dijk EW, 2008, TETRAHEDRON-ASYMMETR, V19, P2374, DOI 10.1016/j.tetasy.2008.10.004; Langenegger SM, 2004, CHEM COMMUN, P2792, DOI 10.1039/b412831a; Park S, 2013, BIOMATER SCI-UK, V1, P1034, DOI 10.1039/c3bm60134j; Petrova GP, 2014, CHEM PHYS LETT, V600, P87, DOI 10.1016/j.cplett.2014.03.060; Oltra NS, 2008, CHEM COMMUN, P6039, DOI 10.1039/b814489c; Rosati F, 2009, CHEM-EUR J, V15, P9596, DOI 10.1002/chem.200900456; Shibata N, 2007, SYNLETT, P1153, DOI 10.1055/s-2007-977429	33	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	NOV	2014	4	11					4070	4073		10.1021/cs501086f		4	Chemistry, Physical	Chemistry	AT0QD	WOS:000344639300033		
J	Mori, K; Kakudo, H; Yamashita, H				Mori, Kohsuke; Kakudo, Hiroki; Yamashita, Hiromi			Creation of Nickel-Based Active Species within a Macroreticular Acidic Resin: A Noble-Metal-Free Heterogeneous Catalyst for Visible-Light-Driven H-2 Evolution from Water	ACS CATALYSIS			English	Article						acidic resin; Ni complex; H-2 production; photocatalysis; visible-light; noble-metal-free	PHOTOCATALYTIC HYDROGEN EVOLUTION; AQUEOUS-SOLUTIONS; EFFICIENT CATALYST; SOLAR-ENERGY; COMPLEXES; NANOPARTICLES; REDUCTION; SYSTEMS; LIGAND; PD	An acidic resin bearing -SO3 functional groups within its macroreticular structure acts as an efficient support for in situ formation of a noble-metal-free Ni-based catalyst responsible for visible-light-driven H-2 production from water. Characterization by means of XAFS revealed that simple ion-exchange of the resin with a trinuclear Ni complex, Ni(NiL2)(2)C(l)2 (L = beta-mercaptoethylamine), affords monomeric Ni(II) species involving beta-mercaptoethylamine and aqua ligands in an octahedral coordination geometry, which is easily transformed into real active species containing a TEOA ligand during the initial induction period of the photocatalytic reaction. Such in situ-generated Ni species offer a simple and efficient photocatalytic system whose activity is five times greater than that of its homogeneous counterpart, enabling efficient H-2 production when xanthene dye is employed as a visible-light-responsive photosensitizer. The acidity of the resins as well as beta-mercaptoethylamine and the TEOA ligands were found to be key factors in achieving efficient catalytic performance. Moreover, leaching and agglomeration of the active Ni species were not observed, and the recovered catalyst could be recycled without significant loss of activity.	[Mori, Kohsuke; Kakudo, Hiroki; Yamashita, Hiromi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan; [Mori, Kohsuke; Yamashita, Hiromi] Kyoto Univ, ESICB, Kyoto 6158520, Japan	Mori, K (reprint author), Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	mori@mat.eng.osaka-u.ac.jp; yamashita@mat.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [252892890]; JSPS Asian CORE Program; MEXT	The present work was supported by the Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (252892890) and JSPS Asian CORE Program. A part of this work was also performed under a management of 'Elements Strategy Initiative for Catalysts & Batteries (ESICB)' supported by MEXT.	Wang DH, 2014, CHEM COMMUN, V50, P1754, DOI 10.1039/c3cc48141g; COLPAS GJ, 1991, INORG CHEM, V30, P920, DOI 10.1021/ic00005a010; Maeda K, 2007, J PHYS CHEM C, V111, P7851, DOI 10.1021/jp070911w; Wang CJ, 2013, CHEM COMMUN, V49, P11251, DOI 10.1039/c3cc46623j; Streich D, 2010, CHEM-EUR J, V16, P60, DOI 10.1002/chem.200902489; Ozawa H, 2011, CHEM COMMUN, V47, P2227, DOI 10.1039/c0cc04708b; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Lei P, 2008, J AM CHEM SOC, V130, P26, DOI 10.1021/ja0776780; KIRCH M, 1979, HELV CHIM ACTA, V62, P1345, DOI 10.1002/hlca.19790620449; Han ZJ, 2013, J AM CHEM SOC, V135, P14659, DOI 10.1021/ja405257s; Mori K, 2013, ACS CATAL, V3, P1114, DOI 10.1021/cs400148n; Mori K, 2010, ANGEW CHEM INT EDIT, V49, P8598, DOI 10.1002/anie.201004942; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Leadbeater NE, 2002, CHEM REV, V102, P3217, DOI 10.1021/cr010361c; Mori K, 2010, J PHYS CHEM LETT, V1, P1675, DOI 10.1021/jz100509x; Asakura H, 2012, J PHYS CHEM A, V116, P4029, DOI 10.1021/jp211627v; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Kilgore UJ, 2011, INORG CHEM, V50, P10908, DOI 10.1021/ic201461a; McNamara CA, 2002, CHEM REV, V102, P3275, DOI 10.1021/cr0103571; Dong JF, 2012, CHEMSUSCHEM, V5, P2133, DOI 10.1002/cssc.201200490; Eisenberg R, 2009, SCIENCE, V324, P44, DOI 10.1126/science.1172247; Tinker LL, 2009, J MATER CHEM, V19, P3328, DOI 10.1039/b818112h; Esswein AJ, 2007, CHEM REV, V107, P4022, DOI 10.1021/cr050193e; Zhang W, 2011, J AM CHEM SOC, V133, P20680, DOI 10.1021/ja208555h; McNamara WR, 2011, J AM CHEM SOC, V133, P15368, DOI 10.1021/ja207842r; Arakawa H, 2000, CATAL SURV JPN, V4, P75, DOI 10.1023/A:1019096323694; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; Tran PD, 2010, ENERG ENVIRON SCI, V3, P727, DOI 10.1039/b926749b; Roth WJ, 2014, CHEM REV, V114, P4807, DOI 10.1021/cr400600f; Zhang F, 2012, CHEM SCI, V3, P476, DOI 10.1039/c1sc00689d; DuBois MR, 2009, CHEM SOC REV, V38, P62, DOI 10.1039/b801197b; Lazarides T, 2009, J AM CHEM SOC, V131, P9192, DOI 10.1021/ja903044n; Han JY, 2012, RSC ADV, V2, P8293, DOI 10.1039/c2ra21422a; SHIMIDZU T, 1985, J AM CHEM SOC, V107, P35, DOI 10.1021/ja00287a007; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Hong JD, 2013, CHEMSUSCHEM, V6, P2263, DOI 10.1002/cssc.201300647; BARD AJ, 1995, ACCOUNTS CHEM RES, V28, P141, DOI 10.1021/ar00051a007; Graetzel M, 1981, ACCOUNTS CHEM RES, V14, P376, DOI 10.1021/ar00072a003; Mori K, 2013, CHEM-ASIAN J, V8, P3207, DOI 10.1002/asia.201301016; TURNER MA, 1990, INORG CHEM, V29, P3331, DOI 10.1021/ic00343a015; Wang M, 2009, DALTON T, P6458, DOI 10.1039/b903809d	42	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	NOV	2014	4	11					4129	4135		10.1021/cs501119d		7	Chemistry, Physical	Chemistry	AT0QD	WOS:000344639300039		
J	Masubuchi, Y; Watanabe, H				Masubuchi, Yuichi; Watanabe, Hiroshi			Origin of Stress Overshoot under Start-up Shear in Primitive Chain Network Simulation	ACS MACRO LETTERS			English	Article							ENTANGLED CIS-POLYISOPRENE; POLYMER-CHAINS; VISCOELASTICITY; ORIENTATION; STRETCH; MELTS; FLOW	Birefringence measurement demonstrates that the segment orientation of entangled polymers overshoots on start-up of fast shear [Pearson et al. J. Rheol 1989 33, 517-535]. The stress-optical rule holds for those polymers, so that the overshoot of orientation results, in the overshoot of shear stress. On the other hand, an opposite result was deduced from the recent molecular dynamics,simulation for bead spring chain [Lu et al. ACS Macro Lett. 2014 3, 569-573]: the evolution of segment orientation does not overshoot but the chain stretch induces the stress overshoot, even at the shear rate gamma smaller than the reciprocal time, 1/tau(R). In this study, we performed the primitive chain network simulation to find that our simulation reproduces the overshoot of both stress increase but no overshoot. Our result is thus fully consistent and orientation and the chain stretch exhibits a slight, monotonic with the experiment.	[Masubuchi, Yuichi; Watanabe, Hiroshi] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan	Masubuchi, Y (reprint author), Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan.	mas@scl.kyoto-u.ac.jp	Masubuchi, Yuichi/B-6063-2008; Masubuchi, Yuichi/C-2231-2008	Masubuchi, Yuichi/0000-0002-1306-3823; Masubuchi, Yuichi/0000-0002-1306-3823	JSPS [26288059]	Y.M. is financially supported by Grant-in-Aid for Scientific Research (B) No. 26288059 from JSPS.	Watanabe H, 2002, MACROMOLECULES, V35, P8802, DOI 10.1021/ma020562y; PEARSON DS, 1989, J RHEOL, V33, P517; Horio K, 2014, MACROMOLECULES, V47, P246, DOI 10.1021/ma402100t; Masubuchi Y, 2003, J CHEM PHYS, V119, P6925, DOI 10.1063/1.1605382; Yaoita T, 2012, MACROMOLECULES, V45, P2773, DOI 10.1021/ma202525v; Uneyama T, 2009, J POLYM SCI POL PHYS, V47, P1039, DOI 10.1002/polb.21708; Graham RS, 2003, J RHEOL, V47, P1171, DOI 10.1122/1.1595099; Cao J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.028302; Watanabe H, 1999, PROG POLYM SCI, V24, P1253, DOI 10.1016/S0079-6700(99)00029-5; Lu YY, 2014, ACS MACRO LETT, V3, P569, DOI 10.1021/mz500260h; Lu YY, 2014, MACROMOLECULES, V47, P5432, DOI 10.1021/ma500131f; Furuichi K, 2008, RHEOL ACTA, V47, P591, DOI 10.1007/s00397-008-0258-3; JANESCHITZKRIEG.H, 1969, ADV POLYM SCI, V6, P170; Masubuchi Y, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3225994; Masubuchi Y, 2008, J NON-NEWTON FLUID, V149, P87, DOI 10.1016/j.jnnfm.2007.02.014; Masubuchi Y, 2001, J CHEM PHYS, V115, P4387, DOI 10.1063/1.1389858; ZEBROWSKI BE, 1985, J POLYM SCI POL PHYS, V23, P575, DOI 10.1002/pol.1985.180230313	17	5	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	NOV	2014	3	11					1183	1186		10.1021/mz500627r		4	Polymer Science	Polymer Science	AT9RW	WOS:000345264800018		
J	Itadani, S; Takahashi, S; Ima, M; Sekiguchi, T; Fujita, M; Nakayama, Y; Takeuchi, J				Itadani, Satoshi; Takahashi, Shinya; Ima, Masaki; Sekiguchi, Tetsuya; Fujita, Manabu; Nakayama, Yoshisuke; Takeuchi, Jun			Discovery of Highly Potent Dual CysLT(1) and CysLT(2) Antagonist	ACS MEDICINAL CHEMISTRY LETTERS			English	Article						Cysteinyl leukotrienes; CysLT(1); CysLT(2); dual antagonist; asthma	CYSTEINYL-LEUKOTRIENE RECEPTOR; ASTHMATIC-PATIENTS; EXPRESSION; CELLS; DERIVATIVES; LTE4	The benzoxazine derivative, (2S)-4-(3-carboxypropyl)-8-{[4-(4-phenylbutoxy)benzoyl]amino}-3,4-dihydro-2H-1,4-benzoxazine-2-carboxylic acid (19, ONO-2050297), was identified as the first potent dual CysLT(1) and CysLT(2) antagonist with IC50 values of 0.017 mu M (CysLT(1)) and 0.00087 mu M (CysLT(2)), respectively.	[Itadani, Satoshi; Takahashi, Shinya; Ima, Masaki; Sekiguchi, Tetsuya; Nakayama, Yoshisuke; Takeuchi, Jun] Ono Pharmaceut Co Ltd, Med Chem Res Labs, Shimamoto, Osaka 6188585, Japan; [Fujita, Manabu] Ono Pharmaceut Co Ltd, Dept Biol & Pharmacol, Shimamoto, Osaka 6188585, Japan	Itadani, S (reprint author), Ono Pharmaceut Co Ltd, Med Chem Res Labs, 3-1-1 Sakurai, Shimamoto, Osaka 6188585, Japan.	itadani@ono.co.jp					Akai Y, 2012, CHEM PHARM BULL, V60, P1461; Ando K, 2004, ORG BIOMOL CHEM, V2, P625, DOI 10.1039/b312682j; Mellor EA, 2003, P NATL ACAD SCI USA, V100, P11589, DOI 10.1073/pnas.2034927100; Mita H, 2001, CLIN EXP ALLERGY, V31, P1714, DOI 10.1046/j.1365-2222.2001.01184.x; Higashi N, 2004, J ALLERGY CLIN IMMUN, V113, P277, DOI 10.1016/j.jaci.2003.10.068; Wunder F, 2010, BRIT J PHARMACOL, V160, P399, DOI 10.1111/j.1476-5381.2010.00730.x; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Capra V, 2007, MED RES REV, V27, P469, DOI 10.1002/med.20071; Ni NC, 2011, J PHARMACOL EXP THER, V339, P768, DOI 10.1124/jpet.111.186031; Lynch KR, 1999, NATURE, V399, P789; Nothacker HP, 2000, MOL PHARMACOL, V58, P1601; Figueroa DJ, 2003, CLIN EXP ALLERGY, V33, P1380, DOI 10.1046/j.1365-2222.2003.01786.x; Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Sjostrom M, 2003, ARTERIOSCL THROM VAS, V23, pE37, DOI 10.1161/01.ATV.0000082689.46538.DF; Green SA, 2004, THORAX, V59, P100, DOI 10.1136/thx.2004.006825; Back M, 1996, EUR J PHARMACOL, V317, P107, DOI 10.1016/S0014-2999(96)00700-5; Back M, 2002, LIFE SCI, V71, P611, DOI 10.1016/S0024-3205(02)01733-2; Dahlen SE, 2006, EUR J PHARMACOL, V533, P40, DOI 10.1016/j.ejphar.2005.12.070; Dong XW, 2013, EUR J MED CHEM, V62, P754, DOI 10.1016/j.ejmech.2013.01.041; Evans JF, 2002, PROSTAG OTH LIPID M, V68-9, P587, DOI 10.1016/S0090-6980(02)00057-6; Gauvreau G. M., 2000, BIOCHEM BIOPH RES CO, V274, P316; Kumlin M., 2000, AM J RESP CRIT CARE, V161, pS102; Montuschi P., 2010, PHARMACEUTICALS, V3, P1792; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Tanaka H, 1999, ALLERGY, V54, P489, DOI 10.1034/j.1398-9995.1999.00011.x; Tsuji E, 2003, ORG BIOMOL CHEM, V1, P3139, DOI 10.1039/b307468d	26	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-5875			ACS MED CHEM LETT	ACS Med. Chem. Lett.	NOV	2014	5	11					1230	1234		10.1021/ml500298y		5	Chemistry, Medicinal	Pharmacology & Pharmacy	AT5IM	WOS:000344977100014		
J	Watanabe, M; Kasai, M; Tomizawa, H; Aoki, M; Eiho, K; Isobe, Y; Asano, S				Watanabe, Manabu; Kasai, Mai; Tomizawa, Hideyuki; Aoki, Masamitsu; Eiho, Kazuo; Isobe, Yoshiaki; Asano, Shigehiro			Dihydropyrrolo[2,3-d]pyrimidines: Selective Toll-Like Receptor 9 Antagonists from Scaffold Morphing Efforts	ACS MEDICINAL CHEMISTRY LETTERS			English	Article						Toll-like receptor 9; sepsis; autoimmune disease; dihydropyrrolo[2,3-d]pyrimidine; LLE	PATHOGEN RECOGNITION; INNATE IMMUNITY; DESIGN; POTENT; MODEL; TLR9; DNA	Toll-like receptors (TLRs) play important roles in the innate immune system. In fact, recognition of endogenous immune complexes containing self-nucleic acids as pathogen- or damage-associated molecular patterns contributes to certain autoimmune diseases, and inhibition of these recognition signals is expected to have therapeutic value. We identified dihydropyrrolo[2,3-d]pyrimidines as novel selective TLR9 antagonists with high aqueous solubility. A structureactivity relationship study of a known TLR9 antagonist led to the promising compound 18, which showed potent TLR9 antagonistic activity, sufficient aqueous solubility for parenteral formulation, and druggable properties. Compound 18 suppressed the production of the proinflammatory cytokine IL-6 in CpG-induced mouse model. It is therefore believed that compound 18 has great potential in the treatment of TLR9-mediated systemic uncontrollable inflammatory response like sepsis.	[Watanabe, Manabu; Kasai, Mai; Tomizawa, Hideyuki; Aoki, Masamitsu; Eiho, Kazuo; Isobe, Yoshiaki] Sumitomo Dainippon Pharma Co Ltd, Konohana Ku, Osaka 5540022, Japan; [Asano, Shigehiro] Sumitomo Dainippon Pharma Co Ltd, Suita, Osaka 5640053, Japan	Asano, S (reprint author), Sumitomo Dainippon Pharma Co Ltd, 33-94 Enoki Cho, Suita, Osaka 5640053, Japan.	shigehiro-asano@ds-pharma.co.jp					Parkinson T, 2008, CURR OPIN MOL THER, V10, P21; Plitas G, 2008, J EXP MED, V205, P1277, DOI 10.1084/jem.20080162; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Santiago-Raber ML, 2010, J AUTOIMMUN, V34, P339, DOI 10.1016/j.jaut.2009.11.001; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Calcaterra C, 2008, J IMMUNOL, V181, P6132; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Hemmi H, 2000, NATURE, V408, P740; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Lindau D, 2011, EUR J IMMUNOL, V41, P669, DOI 10.1002/eji.201040593; Ishikawa M, 2011, J MED CHEM, V54, P1539, DOI 10.1021/jm101356p; Jiang WW, 2013, J INVEST DERMATOL, V133, P1777, DOI 10.1038/jid.2013.57; Ryckmans T, 2009, BIOORG MED CHEM LETT, V19, P4406, DOI 10.1016/j.bmcl.2009.05.062; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Cheng HM, 2013, ACS MED CHEM LETT, V4, P91, DOI 10.1021/ml300309h; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bhagat L., 2013, ANN M FED CLIN IMM S; Franklin BS, 2011, P NATL ACAD SCI USA, V108, P3689, DOI 10.1073/pnas.1015406108; Hogue R., 2013, J IMMUNOL, V190, P4297; Johnson TW, 2011, J MED CHEM, V54, P3393, DOI 10.1021/jm200208d; Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1; Liprd G. B., 2008, Quinazoline Derivative Useful as Toll-Like Receptor Antagonist, Patent No. [WO 2008152471, 2008152471]; Miranda-Hernandez Socorro, 2013, Am J Clin Exp Immunol, V2, P75; Takemura S., 2013, Thiophene Derivative Having TLR-Inhibiting Activity, Patent No. [WO 2013161871, 2013161871]; Wang DQ, 2009, J MED CHEM, V52, P551, DOI 10.1021/jm8014316	27	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-5875			ACS MED CHEM LETT	ACS Med. Chem. Lett.	NOV	2014	5	11					1235	1239		10.1021/ml003184		5	Chemistry, Medicinal	Pharmacology & Pharmacy	AT5IM	WOS:000344977100015		
J	Meshcheryakov, VA; Yoon, YH; Matsunami, H; Wolf, M				Meshcheryakov, Vladimir A.; Yoon, Young-Ho; Matsunami, Hideyuki; Wolf, Matthias			Purification, crystallization and preliminary X-ray crystallographic analysis of the flagellar accessory protein FlaH from the methanogenic archaeon Methanocaldococcus jannaschii	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article							UNIQUE MOTILITY STRUCTURE; INSIGHTS; PHENIX	The flagellar accessory protein FlaH is thought to be one of the essential components of an archaeal motility system. However, to date biochemical and structural information about this protein has been limited. Here, the crystallization of FlaH from the hyperthermophilic archaeon Methanocaldococcus jannaschii is reported. Protein crystals were obtained by the vapour-diffusion method. These crystals belonged to space group P3(1)21, with unit-cell parameters a = b = 131.42, c = 89.35 angstrom. The initial solution of the FlaH structure has been determined by multiple-wavelength anomalous dispersion phasing using a selenomethionine-derivatized crystal.	[Meshcheryakov, Vladimir A.; Wolf, Matthias] Grad Univ, Okinawa Inst Sci & Technol, Mol Cryo Elect Microscopy Unit, Kunigami, Okinawa 9040495, Japan; [Yoon, Young-Ho; Matsunami, Hideyuki] Grad Univ, Okinawa Inst Sci & Technol, Transmembrane Trafficking Unit, Kunigami, Okinawa 9040495, Japan	Wolf, M (reprint author), Grad Univ, Okinawa Inst Sci & Technol, Mol Cryo Elect Microscopy Unit, 1919-1 Tancha, Kunigami, Okinawa 9040495, Japan.	matthias.wolf@oist.jp	MATSUNAMI, Hideyuki/E-6632-2010	MATSUNAMI, Hideyuki/0000-0001-5814-3766			Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Reindl S, 2013, MOL CELL, V49, P1069, DOI 10.1016/j.molcel.2013.01.014; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cohen-Krausz S, 2008, J MOL BIOL, V375, P1113, DOI 10.1016/j.jmb.2007.10.048; Desmond E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-106; Ghosh A, 2011, BIOCHEM J, V437, P43, DOI 10.1042/BJ20110410; Jarrell KF, 2007, ARCHAEA: MOLECULAR AND CELLULAR BIOLOGY, P385; Jarrell KF, 1996, J BACTERIOL, V178, P5057; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Thomas NA, 2001, FEMS MICROBIOL REV, V25, P147, DOI 10.1111/j.1574-6976.2001.tb00575.x; Thomas NA, 2001, J BACTERIOL, V183, P7154, DOI 10.1128/JB.183.24.7154-7164.2001; Trachtenberg S, 2005, J MOL BIOL, V346, P665, DOI 10.1016/j.jmb.2004.12.010	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-3091			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	NOV	2014	70		11				1543	1545		10.1107/S2053230X14019980		3	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	AT2UE	WOS:000344790900018		
J	Goda, T; Kjall, P; Ishihara, K; Richter-Dahlfors, A; Miyahara, Y				Goda, Tatsuro; Kjall, Peter; Ishihara, Kazuhiko; Richter-Dahlfors, Agneta; Miyahara, Yuji			Biomimetic Interfaces Reveal Activation Dynamics of C-Reactive Protein in Local Microenvironments	ADVANCED HEALTHCARE MATERIALS			English	Article							SURFACE-PLASMON RESONANCE; PHOSPHORYLCHOLINE; POLYMER; ANTIBODY; CA2+; PHOSPHOCHOLINE; IMMUNOSENSOR; RECOGNITION; DELIVERY; CALCIUM		[Goda, Tatsuro; Kjall, Peter; Richter-Dahlfors, Agneta] Karolinska Inst, Dept Neurosci, Swedish Med Nanosci Ctr, SE-17177 Stockholm, Sweden; [Goda, Tatsuro; Miyahara, Yuji] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan; [Ishihara, Kazuhiko] Univ Tokyo, Dept Mat Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan	Goda, T (reprint author), Karolinska Inst, Dept Neurosci, Swedish Med Nanosci Ctr, Retzius Vag 8, SE-17177 Stockholm, Sweden.	goda.bsr@tmd.ac.jp	Goda, Tatsuro/B-6484-2011; 	Goda, Tatsuro/0000-0003-2688-8186; Richter-Dahlfors, Agneta/0000-0002-5479-7591	JSPS [G2303]; MEXT [2306]; JSTCREST; Swedish Medical Nanoscience Center, VINNOVA, Carl Bennet AB	The authors acknowledge Dr. Lars-Olof Hansson at Karolinska University Laboratory for fruitful discussions. The authors thank OBOE IPR AB for the rights of using the organic electronic ion pumps and Acreo Swedish ICT AB for their production. The authors thank Dr. Tilo Moede at Karolinska Institutet for support on TIRF measurement. This research was financed by JSPS program on Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (G2303), MEXT Grant-in-Aid for Scientific Research on Innovative Areas (2306), JSTCREST "Creation of Nanosystems with Novel Function through Process Integration", and the Swedish Medical Nanoscience Center, VINNOVA, Carl Bennet AB. The copyright of this article was changed after online publication.	McDonnell JM, 2001, CURR OPIN CHEM BIOL, V5, P572, DOI 10.1016/S1367-5931(00)00251-9; Goto Y, 2008, BIOMACROMOLECULES, V9, P828, DOI 10.1021/bm701161d; Park J, 2004, ANAL CHEM, V76, P2649, DOI 10.1021/ac035321i; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Park J, 2007, COLLOID SURFACE B, V55, P164, DOI 10.1016/j.colsurfb.2006.11.032; Bini A, 2008, ANAL BIOANAL CHEM, V390, P1077, DOI 10.1007/s00216-007-1736-7; HUANG C, 1978, P NATL ACAD SCI USA, V75, P308, DOI 10.1073/pnas.75.1.308; Thompson D, 1999, STRUCT FOLD DES, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Wang MS, 2011, ANAL BIOANAL CHEM, V401, P1309, DOI 10.1007/s00216-011-5174-1; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Kurosawa S, 2004, BIOSENS BIOELECTRON, V20, P1134, DOI 10.1016/j.bios.2004.05.016; Ishihara K, 2011, BBA-GEN SUBJECTS, V1810, P268, DOI 10.1016/j.bbagen.2010.04.008; Christodoulides N, 2005, LAB CHIP, V5, P261, DOI 10.1039/b414194f; Chen M, 2009, SCIENCE, V323, P1698, DOI 10.1126/science.1169399; Iwasaki Y, 2005, ANAL BIOANAL CHEM, V381, P534, DOI 10.1007/s00216-004-2805-9; Simon DT, 2009, NAT MATER, V8, P742, DOI [10.1038/nmat2494, 10.1038/NMAT2494]; Isaksson J, 2007, NAT MATER, V6, P673, DOI 10.1038/nmat1963; McGrath FDG, 2006, J IMMUNOL, V176, P2950; VOLANAKIS JE, 1979, NATURE, V281, P155, DOI 10.1038/281155a0; Kitano H, 2003, LANGMUIR, V19, P10260, DOI 10.1021/la0349673; Agrawal A, 2009, ADV EXP MED BIOL, V653, P98; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Atsumi H, 2009, TETRAHEDRON LETT, V50, P2177, DOI 10.1016/j.tetlet.2009.02.152; Christopeit T, 2009, ANAL BIOCHEM, V391, P39, DOI 10.1016/j.ab.2009.04.037; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Isaksson J, 2008, ORG ELECTRON, V9, P303, DOI 10.1016/j.orgel.2007.11.011; Iwasaki Y., 2012, SCI TECHNOL ADV MAT, V13; Kim E, 2011, CHEM COMMUN, V47, P11900, DOI 10.1039/c1cc15079k; KINOSHITA CM, 1989, BIOCHEMISTRY-US, V28, P9840, DOI 10.1021/bi00451a044; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Mi LZ, 1997, BIOPHYS J, V73, P446; Richter-Dahlfors A, 2012, CURR OPIN MICROBIOL, V15, P15, DOI 10.1016/j.mib.2011.10.009; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; SCHWALBE RA, 1992, BIOCHEMISTRY-US, V31, P4907, DOI 10.1021/bi00135a023; Tybrandt K, 2009, ADV MATER, V21, P4442, DOI 10.1002/adma.200900187	36	8	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2192-2640	2192-2659		ADV HEALTHC MATER	Adv. Healthc. Mater.	NOV	2014	3	11					1733	1738		10.1002/adhm.201300625		6	Engineering, Biomedical; Nanoscience & Nanotechnology; Materials Science, Biomaterials	Engineering; Science & Technology - Other Topics; Materials Science	AT3TJ	WOS:000344857000003		
J	Sasaki, M; Karikkineth, BC; Nagamine, K; Kaji, H; Torimitsu, K; Nishizawa, M				Sasaki, Masato; Karikkineth, Bijoy Chandapillai; Nagamine, Kuniaki; Kaji, Hirokazu; Torimitsu, Keiichi; Nishizawa, Matsuhiko			Highly Conductive Stretchable and Biocompatible Electrode-Hydrogel Hybrids for Advanced Tissue Engineering	ADVANCED HEALTHCARE MATERIALS			English	Article							DOUBLE-NETWORK HYDROGELS; SKELETAL-MUSCLE TISSUE; NEURITE OUTGROWTH; NEURAL TISSUE; POLY 3,4-ETHYLENEDIOXYTHIOPHENE; ELASTIC CONDUCTORS; AXONAL GROWTH; IN-VITRO; STIMULATION; FILMS	Hydrogel-based, molecular permeable electronic devices are considered to be promising for electrical stimulation and recording of living tissues, either in vivo or in vitro. This study reports the fabrication of the first hydrogel-based devices that remain highly electrically conductive under substantial stretch and bending. Using a simple technique involving a combination of chemical polymerization and electropolymerization of poly (3,4-ethylenedioxythiophene) (PEDOT), a tight bonding of a conductive composite of PEDOT and polyurethane (PU) to an elastic double-network hydrogel is achieved to make fully organic PEDOT/PU-hydrogel hybrids. Their response to repeated bending, mechanical stretching, hydration-dessication cycles, storage in aqueous condition for up to 6 months, and autoclaving is assessed, demonstrating excellent stability, without any mechanical or electrical damage. The hybrids exhibit a high electrical conductivity of up to 120 S cm(-1) at 100% elongation. The adhesion, proliferation, and differentiation of neural and muscle cells cultured on these hybrids are demonstrated, as well as the fabrication of 3D hybrids, advancing the field of tissue engineering with integrated electronics.	[Sasaki, Masato; Karikkineth, Bijoy Chandapillai; Nagamine, Kuniaki; Kaji, Hirokazu; Torimitsu, Keiichi; Nishizawa, Matsuhiko] Tohoku Univ, Grad Sch Engn, Dept Bioengn & Robot, Sendai, Miyagi 9808579, Japan; [Nishizawa, Matsuhiko] JST CREST, Chiyoda Ku, Tokyo 1020075, Japan	Karikkineth, BC (reprint author), Tohoku Univ, Grad Sch Engn, Dept Bioengn & Robot, 6-6-01 Aoba, Sendai, Miyagi 9808579, Japan.	bijoyck@biomems.mech.tohoku.ac.jp; nishizawa@biomems.mech.tohoku.ac.jp			Ministry of Education, Science, and Culture, Japan; Japan Society for Promotion of Science	Authors express appreciation to Dr. Tashiro, SIJ Technology Corporation, for his kind cooperation. This work was partly supported by Regional Innovation Strategy Support Program "Knowledge-based Medical Device Cluster/Miyagi Area" and Creation of Innovation Centers for Advanced Interdisciplinary Research Areas "R&D Center of Excellence for Integrated Microsystems Tohoku University" from the Ministry of Education, Science, and Culture, Japan. B. C. K. thanks the Japan Society for Promotion of Science for the research opportunity and financial support.	Abidian MR, 2012, ADV HEALTHC MATER, V1, P762, DOI 10.1002/adhm.201200182; VANDENBURGH H, 1979, SCIENCE, V203, P265, DOI 10.1126/science.569901; Boonen KJM, 2010, J BIOMECH, V43, P1514, DOI 10.1016/j.jbiomech.2010.01.039; Kim Y, 2013, NATURE, V500, P59, DOI 10.1038/nature12401; STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2; Green RA, 2010, ACTA BIOMATER, V6, P63, DOI 10.1016/j.actbio.2009.06.030; Hardy JG, 2013, CURR OPIN BIOTECH, V24, P847, DOI [10.1016/j.copbio.2013.03.011, 10.1016/j.dopbio.2013.03.011]; Lipomi DJ, 2012, CHEM MATER, V24, P373, DOI 10.1021/cm203216m; Abidian MR, 2010, SMALL, V6, P421, DOI 10.1002/smll.200901868; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Kros A, 2005, SENSOR ACTUAT B-CHEM, V106, P289, DOI 10.1016/j.snb.2004.08.011; Mawad D, 2012, ADV FUNCT MATER, V22, P2692, DOI 10.1002/adfm.201102373; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/nmat2745, 10.1038/NMAT2745]; Quigley AF, 2009, ADV MATER, V21, P4393, DOI 10.1002/adma.200901165; Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002; Sekine S, 2010, J AM CHEM SOC, V132, P13174, DOI 10.1021/ja1062357; Lacour SP, 2010, MED BIOL ENG COMPUT, V48, P945, DOI 10.1007/s11517-010-0644-8; Chun KY, 2010, NAT NANOTECHNOL, V5, P853, DOI [10.1038/nnano.2010.232, 10.1038/NNANO.2010.232]; Nakajima T, 2009, MACROMOLECULES, V42, P2184, DOI 10.1021/ma802148p; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Sakar MS, 2012, LAB CHIP, V12, P4976, DOI 10.1039/c2lc40338b; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Green RA, 2012, MACROMOL BIOSCI, V12, P494, DOI 10.1002/mabi.201100490; Kim DH, 2008, ADV MATER, V20, P4887, DOI 10.1002/adma.200801788; Cheong GLM, 2014, ACTA BIOMATER, V10, P1216, DOI 10.1016/j.actbio.2013.12.032; Shepard JA, 2012, BIOTECHNOL BIOENG, V109, P830, DOI 10.1002/bit.24355; Morimoto Y, 2013, BIOMATERIALS, V34, P9413, DOI 10.1016/j.biomaterials.2013.08.062; Kim DH, 2012, P NATL ACAD SCI USA, V109, P19910, DOI 10.1073/pnas.1205923109; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Lee JY, 2012, IEEE T NANOBIOSCI, V11, P15, DOI 10.1109/TNB.2011.2159621; HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121; Larkin LM, 2006, IN VITRO CELL DEV-AN, V42, P75; Hansen TS, 2007, ADV FUNCT MATER, V17, P3069, DOI 10.1002/adfm.200601243; Sekitani T, 2009, NAT MATER, V8, P494, DOI [10.1038/nmat2459, 10.1038/NMAT2459]; Gilmore KJ, 2009, BIOMATERIALS, V30, P5292, DOI 10.1016/j.biomaterials.2009.06.059; Xie JW, 2009, ADV FUNCT MATER, V19, P2312, DOI 10.1002/adfm.200801904; Hassarati RT, 2014, J POLYM SCI POL PHYS, V52, P666, DOI 10.1002/polb.23465; Jun I, 2009, BIOMATERIALS, V30, P2038, DOI 10.1016/j.biomaterials.2008.12.063; Yu XJ, 1999, TISSUE ENG, V5, P291, DOI 10.1089/ten.1999.5.291; Viventi J, 2011, NAT NEUROSCI, V14, P1599, DOI 10.1038/nn.2973; Richardson-Burns SM, 2007, J NEURAL ENG, V4, pL6, DOI 10.1088/1741-2560/4/2/L02; Ido Y, 2012, ACS MACRO LETT, V1, P400, DOI 10.1021/mz2002406; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Broda CR, 2011, J BIOMED MATER RES A, V98A, P509, DOI 10.1002/jbm.a.33128; Nagamine K, 2011, LAB CHIP, V11, P513, DOI [10.1039/c0lc00364f, 10.1039/c01c00364f]; Park M, 2012, NAT NANOTECHNOL, V7, P803, DOI [10.1038/nnano.2012.206, 10.1038/NNANO.2012.206]; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Asano T, 2012, BIOTECHNOL BIOENG, V109, P199, DOI 10.1002/bit.23285; Baek S, 2013, J MATER CHEM B, V1, P3803, DOI 10.1039/c3tb20152j; Chen YM, 2009, J BIOMED MATER RES A, V88A, P74, DOI 10.1002/jbm.a.31869; Duffy RM, 2014, WIRES NANOMED NANOBI, V6, P178, DOI 10.1002/wnan.1254; Mannoor MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1767; Miriani Rachel M, 2008, Conf Proc IEEE Eng Med Biol Soc, V2008, P1841, DOI 10.1109/IEMBS.2008.4649538; Muskovich M, 2012, ADV HEALTHC MATER, V1, P248, DOI 10.1002/adhm.201200071; Powell CA, 2002, AM J PHYSIOL-CELL PH, V283, pC1557, DOI 10.1152/ajpcell.00595.2001; Shestakova P, 2011, CHEM-EUR J, V17, P14867, DOI 10.1002/chem.201101334; Tang-Schomer M. D., 2013, ADV FUNCT MATER, V24, P1934; Urdaneta MG, 2007, ADV MATER, V19, P2629, DOI 10.1002/adma.200601808; VANDENBURGH HH, 1988, IN VITRO CELL DEV B, V24, P609; Wilks Seth J, 2011, Conf Proc IEEE Eng Med Biol Soc, V2011, P5412, DOI 10.1109/IEMBS.2011.6091338	62	6	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2192-2640	2192-2659		ADV HEALTHC MATER	Adv. Healthc. Mater.	NOV	2014	3	11					1919	1927		10.1002/adhm.201400209		9	Engineering, Biomedical; Nanoscience & Nanotechnology; Materials Science, Biomaterials	Engineering; Science & Technology - Other Topics; Materials Science	AT3TJ	WOS:000344857000026		
J	Fukagawa, H; Shimizu, T; Kamada, T; Kiribayashi, Y; Osada, Y; Hasegawa, M; Morii, K; Yamamoto, T				Fukagawa, Hirohiko; Shimizu, Takahisa; Kamada, Taisuke; Kiribayashi, Yukihiro; Osada, Yoshichika; Hasegawa, Munehiro; Morii, Katsuyuki; Yamamoto, Toshihiro			Highly Efficient and Stable Phosphorescent Organic Light-Emitting Diodes Utilizing Reverse Intersystem Crossing of the Host Material	ADVANCED OPTICAL MATERIALS			English	Article							TRIPLET ENERGY; ELECTROLUMINESCENT DEVICES; BLUE; GREEN; OLEDS; ELECTROPHOSPHORESCENCE; COMPLEXES; MOLECULES; EMISSION; SINGLET	Phosphorescent organic-light emitting diodes (PHOLEDs) exhibit an internal quantum efficiency of 100% and their early practical realization is expected. One of the main challenges in PHOLEDs is to improve the operational stability of green and blue devices. Triplet exciton dynamics in stable PHOLEDs, which are different from those in unstable PHOLEDs, are shown. An efficient and stable green PHOLED is demonstrated by employing a suitable host that surrounds the phosphorescent dopant. The transient photoluminescence characteristics show that the triplet excitons of the host, which are generally unstable, are rapidly transferred to the dopant and emit phosphorescence in the stable PHOLED. Most of the triplet excitons of the host in the stable PHOLED are transferred to the dopant within 10 ns, following the Forster process by utilizing reverse intersystem crossing from the triplet state to the singlet state. The findings also provide a design strategy for hosts to enable realization of highly stable full-color PHOLEDs.	[Fukagawa, Hirohiko; Shimizu, Takahisa; Yamamoto, Toshihiro] Japan Broadcasting Corp NHK, Sci & Technol Res Labs, Setagaya Ku, Tokyo 1578510, Japan; [Shimizu, Takahisa; Kiribayashi, Yukihiro; Osada, Yoshichika] Tokyo Univ Sci, Tokyo 1628610, Japan; [Hasegawa, Munehiro; Morii, Katsuyuki] Nippon Shokubai Co Ltd, Suita, Osaka 5648512, Japan	Fukagawa, H (reprint author), Japan Broadcasting Corp NHK, Sci & Technol Res Labs, Setagaya Ku, 1-10-11 Kinuta, Tokyo 1578510, Japan.	fukagawa.h-fe@nhk.or.jp			Strategic Information and Communications R&D Promotion Programme (SCOPE) of the Ministry of Internal Affairs and Communication of Japan	Part of this work was supported by the Strategic Information and Communications R&D Promotion Programme (SCOPE) of the Ministry of Internal Affairs and Communication of Japan. The authors thank K. Tokumaru for stimulating discussions regarding this work. The authors also thank Nissan Chemical Industries, Ltd., for supplying SHI-2530-B10SI and Kanto Chemical Co., Inc., for supplying HTEB-2.	Fan C, 2014, ANGEW CHEM INT EDIT, V53, P2147, DOI 10.1002/anie.201308046; Yook KS, 2012, ADV MATER, V24, P3169, DOI 10.1002/adma.201200627; Baldo MA, 2000, PHYS REV B, V62, P10958, DOI 10.1103/PhysRevB.62.10958; Uoyama H, 2012, NATURE, V492, P234, DOI 10.1038/nature11687; Cho YJ, 2014, ADV MATER, V26, P4050, DOI 10.1002/adma.201400347; Adachi C, 2001, J APPL PHYS, V90, P5048, DOI 10.1063/1.1409582; Xiao LX, 2011, ADV MATER, V23, P926, DOI 10.1002/adma.201003128; POPE M, 1963, J CHEM PHYS, V38, P2042, DOI 10.1063/1.1733929; Kondakov DY, 2009, J APPL PHYS, V106, DOI 10.1063/1.3273407; Jeon WS, 2009, ORG ELECTRON, V10, P240, DOI 10.1016/j.orgel.2008.11.012; Ren XF, 2004, CHEM MATER, V16, P4743, DOI 10.1021/cm049402m; Seino Y, 2014, ADV MATER, V26, P1612, DOI 10.1002/adma.201304253; Wang K, 2013, ADV FUNCT MATER, V23, P2672, DOI 10.1002/adfm.201202981; Kawamura Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.017404; Fukagawa H, 2012, ADV MATER, V24, P5099, DOI 10.1002/adma.201202167; Son YH, 2013, J MATER CHEM C, V1, P5008, DOI 10.1039/c3tc30671b; Tanaka I, 2004, CHEM PHYS LETT, V400, P86, DOI 10.1016/j.cplett.2004.08.148; Park YS, 2013, ADV FUNCT MATER, V23, P4914, DOI 10.1002/adfm.201300547; Tokito S, 2003, APPL PHYS LETT, V83, P569, DOI 10.1063/1.1594834; Baldo MA, 1998, NATURE, V395, P151; Baldo MA, 1999, APPL PHYS LETT, V75, P4, DOI 10.1063/1.124258; Tang KC, 2004, CHEM PHYS LETT, V386, P437, DOI 10.1016/j.cplett.2004.01.098; Endo A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3558906; Sun YR, 2006, NATURE, V440, P908, DOI 10.1038/nature04645; Fery C, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2133922; Kondakov DY, 2007, J APPL PHYS, V101, DOI 10.1063/1.2430922; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55; Fukagawa H, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.052104; Kanno H, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2643908; Kera S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121305; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE; Monkman A. P., 2013, ISRN MAT SCI; Seo S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.042102; Suzuki K., P SPIE; TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799	35	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2195-1071			ADV OPT MATER	Adv. Opt. Mater.	NOV	2014	2	11					1070	1075		10.1002/adom.201400242		6	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	AU0WE	WOS:000345342100009		
J	Iritani, E; Katagiri, N; Nakajima, R; Hwang, KJ; Cheng, TW				Iritani, Eiji; Katagiri, Nobuyuki; Nakajima, Ryota; Hwang, Kuo-Jen; Cheng, Tung-Wen			Cake Properties of Nanocolloid Evaluated by Variable Pressure Filtration Associated with Reduction in Cake Surface Area	AICHE JOURNAL			English	Article						ultrafiltration; variable pressure filtration; cake surface area; specific cake resistance; porosity	DEAD-END ULTRAFILTRATION; FILTER CAKE; FLUX DECLINE; ULTRACENTRIFUGATION METHOD; PORE-BLOCKING; MEMBRANES; COMPRESSIBILITY; PERMEABILITY; SUSPENSION; BEHAVIORS	A potential method has been developed for evaluating simultaneously both the average specific resistance and average porosity of the filter cake formed in unstirred dead-end ultrafiltration of nanocolloids such as bovine serum albumin solution and silica sol. The method consists of variable pressure filtration followed by constant pressure filtration. The relation between the average specific cake resistance and the pressure drop across the cake was determined from the evolution of the filtration rate with time in the course of the variable pressure filtration period, based on the compressible cake filtration model. The average porosity was evaluated from the significant flux decline caused by a sudden reduction in the cake surface area in the middle of the constant pressure filtration period. The pressure dependences of both the average specific cake resistance and average cake porosity were obtained from only two runs which differed from each other in the pressure profiles. (C) 2014 American Institute of Chemical Engineers	[Iritani, Eiji; Katagiri, Nobuyuki; Nakajima, Ryota] Nagoya Univ, Dept Chem Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Hwang, Kuo-Jen; Cheng, Tung-Wen] Tamkang Univ, Dept Chem & Mat Engn, New Taipei City, Taiwan	Iritani, E (reprint author), Nagoya Univ, Dept Chem Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	iritani@nuce.nagoya-u.ac.jp			The Ministry of Education, Culture, Sports, Science and Technology, Japan; The Ministry of the Environment, Japan; The Steel Foundation for Environmental Protection Technology	This work has been partially supported by a Grant-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology, Japan and from The Ministry of the Environment, Japan, and by The Steel Foundation for Environmental Protection Technology. The authors wish to acknowledge with sincere gratitude the financial support leading to the publication of this article.	Nakakura H, 1997, J CHEM ENG JPN, V30, P1020, DOI 10.1252/jcej.30.1020; Ruth BF, 1935, IND ENG CHEM, V27, P708, DOI 10.1021/ie50306a024; IRITANI E, 1993, J MEMBRANE SCI, V81, P1, DOI 10.1016/0376-7388(93)85026-S; Iritani E, 2013, DRY TECHNOL, V31, P146, DOI 10.1080/07373937.2012.683123; REIHANIAN H, 1983, J MEMBRANE SCI, V16, P237, DOI 10.1016/S0376-7388(00)81313-7; Iritani E, 2002, CHEM ENG SCI, V57, P53, DOI 10.1016/S0009-2509(01)00362-1; Olivier J, 2007, SEPAR SCI TECHNOL, V42, P1667, DOI 10.1080/01496390701242186; Mendret J, 2009, J MEMBRANE SCI, V333, P20, DOI 10.1016/j.memsci.2009.01.035; Sperry DR, 1921, J IND ENG CHEM-US, V13, P1163, DOI 10.1021/ie50144a034; IRITANI E, 1995, CHEM ENG RES DES, V73, P551; Mohammadi T, 2005, DESALINATION, V184, P367, DOI 10.1016/j.desal.2005.02.060; SUKI A, 1984, J MEMBRANE SCI, V21, P269, DOI 10.1016/S0376-7388(00)80218-5; Iritani E, 2012, SEP PURIF TECHNOL, V92, P143, DOI 10.1016/j.seppur.2011.05.011; TILLER FM, 1962, AICHE J, V8, P445, DOI 10.1002/aic.690080405; MURASE T, 1987, J CHEM ENG JPN, V20, P246, DOI 10.1252/jcej.20.246; Sarkar B, 2013, J FOOD ENG, V116, P333, DOI 10.1016/j.jfoodeng.2012.12.013; IRITANI E, 1991, J CHEM ENG JPN, V24, P177, DOI 10.1252/jcej.24.177; Iritani E, 2014, AICHE J, V60, P289, DOI 10.1002/aic.14262; Thekkedath A, 2007, CR CHIM, V10, P803, DOI 10.1016/j.crci.2007.02.008; SHIRATO M, 1969, AICHE J, V15, P405, DOI 10.1002/aic.690150320; Iritani E, 2011, J CHEM ENG JPN, V44, P14, DOI 10.1252/jcej.10we186; Loginov M, 2012, SEP PURIF TECHNOL, V92, P168, DOI 10.1016/j.seppur.2011.05.019; MURASE T, 1989, J CHEM ENG JPN, V22, P65, DOI 10.1252/jcej.22.65; Lodge B, 2004, J MEMBRANE SCI, V231, P91, DOI 10.1016/j.memsci.2003.09.026; Iritani E, 2007, J MEMBRANE SCI, V300, P36, DOI 10.1016/j.memsci.2007.04.041; Iritani E, 2008, SEP PURIF TECHNOL, V63, P379, DOI 10.1016/j.seppur.2008.05.021; Chen W, 2006, DRY TECHNOL, V24, P1251, DOI 10.1080/07373930600840401; IRITANI E, 1994, J CHEM ENG JPN, V27, P357, DOI 10.1252/jcej.27.357; MURASE T, 1989, J CHEM ENG JPN, V22, P373, DOI 10.1252/jcej.22.373; TILLER FM, 1960, AICHE J, V6, P595, DOI 10.1002/aic.690060418; Iritani E, 2012, SEP SCI TECHNOL, V47, P2281, DOI 10.1080/01496395.2012.672356; Iritani E, 2001, J SOC POWDER TECHNOL, V38, P548; Leu WF, 1980, J CHIN INST CHEM ENG, V11, P61; Shirato M, 1968, J CHEM ENG JAPAN, V1, P86, DOI 10.1252/jcej.1.86; Shirato M, 1987, FILTRATION, P299; Tarleton ES, 2007, SOLID LIQUID SEPARAT; Tiller FM, 1980, P INT S FIN PART PRO, V2, P1549	37	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-1541	1547-5905		AICHE J	AICHE J.	NOV	2014	60	11					3869	3877		10.1002/aic.14601		9	Engineering, Chemical	Engineering	AT9FH	WOS:000345232800018		
J	Watanabe, T; Sakai, Y; Nagata, K; Terashima, O				Watanabe, Tomoaki; Sakai, Yasuhiko; Nagata, Kouji; Terashima, Osamu			Experimental Study on the Reaction Rate of a Second-Order Chemical Reaction in a Planar Liquid Jet	AICHE JOURNAL			English	Article						transport phenomena; diffusion (mass transfer, heat transfer); fluid mechanics; mixing; turbulence	DIRECT NUMERICAL-SIMULATION; TURBULENT FLOWS; SCHMIDT NUMBER; CLOSURE MODELS; MIXING LAYER; DIFFUSION; FIELD	Instantaneous concentrations of reactive species are simultaneously measured in a planar liquid jet with a second-order chemical reaction A+B -> R to investigate the statistical properties of the chemical reaction rate and the validity of models which have been proposed for concentration correlation. The jet flow contains the reactant A, and the ambient flow contains the reactant B. The results show that the concentration correlation of the reactants makes a negative contribution to the mean reaction rate, and this contribution is important in the downstream direction. The concentration correlation changes owing to the chemical reaction. The effects of the chemical reaction on the concentration correlation change with the flow location and the Damkohler number. The concentration correlation predicted by the Toor's model and the three-environment model are compared with the experimental results. The results show that these models fail to accurately estimate the concentration correlation. (C) 2014 American Institute of Chemical Engineers	[Watanabe, Tomoaki; Sakai, Yasuhiko; Nagata, Kouji; Terashima, Osamu] Nagoya Univ, Dept Mech Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Watanabe, T (reprint author), Japan Soc Promot Sci, Tokyo, Japan.	watanabe.tomoaki@c.nagoya-u.jp			JSPS KAKENHI [25002531]; MEXT KAKENHI [25289030, 25289031, 25630052]	The authors would like to thank Dr. Takashi Kubo (Meijo University) and Mr. Takahiro Naito (Nagoya University) for their help in this study. KN acknowledges Prof. Satoru Komori (Kyoto University) for providing the key idea of this study and many valuable comments. The authors also acknowledge anonymous referees for valuable comments. This work was supported by JSPS KAKENHI Grant Number 25002531 and MEXT KAKENHI Grant Numbers 25289030, 25289031, and 25630052.	Klein M, 2003, INT J HEAT FLUID FL, V24, P785, DOI 10.1016/S0142-727X(03)00089-4; da Silva CB, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2912513; Zhdanov V, 2011, INT J HEAT MASS TRAN, V54, P3245, DOI 10.1016/j.ijheatmasstransfer.2011.04.006; Fabregat A, 2010, INT J HEAT MASS TRAN, V53, P4248, DOI 10.1016/j.ijheatmasstransfer.2010.05.051; TOOR HL, 1969, IND ENG CHEM FUND, V8, P655, DOI 10.1021/i160032a009; Veynante D, 2002, PROG ENERG COMBUST, V28, P193, DOI 10.1016/S0360-1285(01)00017-X; BILGER RW, 1991, J FLUID MECH, V233, P211, DOI 10.1017/S0022112091000460; BOURNE JR, 1985, CHEM ENG COMMUN, V37, P293, DOI 10.1080/00986448508911287; Brown RJ, 1991, J FLUID MECH, V312, P373; BROWNE LWB, 1984, J FLUID MECH, V149, P355, DOI 10.1017/S002211208400269X; Chorny A, 2012, CHEM ENG SCI, V68, P541, DOI 10.1016/j.ces.2011.10.015; Combest DP, 2011, IND ENG CHEM RES, V50, P8817, DOI 10.1021/ie200055s; DAVIES AE, 1975, PHYS FLUIDS, V18, P770, DOI 10.1063/1.861237; de Bruyn Kops SM, 2001, PHYS FLUIDS, V13, P1450, DOI 10.1063/1.1359185; Deo RC, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2959171; DUTTA A, 1989, AICHE J, V35, P2013, DOI 10.1002/aic.690351212; Fox R.O., 2003, COMPUTATIONAL MODELS; GIBSON CH, 1972, COMBUST SCI TECHNOL, V6, P29, DOI 10.1080/00102207208952300; HILL JC, 1976, ANNU REV FLUID MECH, V8, P135, DOI 10.1146/annurev.fl.08.010176.001031; KOMORI S, 1991, J FLUID MECH, V228, P629, DOI 10.1017/S0022112091002847; KOMORI S, 1993, AICHE J, V39, P1611, DOI 10.1002/aic.690391005; KOMORI S, 1994, J CHEM ENG JPN, V27, P742, DOI 10.1252/jcej.27.742; Kubo Takashi, 2012, Journal of Fluid Science and Technology, V7, DOI 10.1299/jfst.7.25; Kubo T., 2009, J FLUID SCI TECHNOL, V4, P368; Naito T, 2013, P 4 INT C JETS WAK S; Naito T, J FLUID SCI IN PRESS; NAKAMURA I, 1987, J FLUID MECH, V178, P379, DOI 10.1017/S0022112087001277; PATTERSON GK, 1981, CHEM ENG COMMUN, V8, P25, DOI 10.1080/00986448108912575; Pope S. B., 2000, TURBULENT FLOWS; Stanley SA, 2002, J FLUID MECH, V450, P377, DOI 10.1017/S0022112001006644; TOOR HL, 1993, AICHE J, V39, P1603, DOI 10.1002/aic.690391004; WANG DM, 1993, CHEM ENG SCI, V48, P3907, DOI 10.1016/0009-2509(93)80369-2; Watanabe T, 2012, EXP FLUIDS, V53, P1369, DOI 10.1007/s00348-012-1365-6; Watanabe T, 2014, J FLUID MECH, V754, P98, DOI 10.1017/jfm.2014.387; Watanabe T, 2013, PHYS SCRIPTA, VT155, DOI 10.1088/0031-8949/2013/T155/014039; Yimer I, 2002, CAN AERONAUT SPACE J, V48, P195, DOI DOI 10.5589/Q02-024	36	6	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-1541	1547-5905		AICHE J	AICHE J.	NOV	2014	60	11					3969	3988		10.1002/aic.14610		20	Engineering, Chemical	Engineering	AT9FH	WOS:000345232800026		
J	Matsuda, J; Shimizu, T; Kittaka, T; Fukuda, M; Akimoto, H				Matsuda, Junna; Shimizu, Tetsunosuke; Kittaka, Tadahiro; Fukuda, Makiko; Akimoto, Hiroshi			Cardiopulmonary arrest due to early hyperkalemia after liver injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							HEMORRHAGIC-SHOCK; TRAUMA	Hyperkalemia due to crush syndrome after trauma is a well-known fatal clinical condition, but early hyperkalemia with hemorrhage after trauma is a rare phenomenon. We report on a 5-year-old boy who bruised from the lumbers, had cardiopulmonary arrest caused by hyperkalemia, and underwent perihepatic packing twice before being discharged without any neurologic deficits. Clinicians should be vigilant for signs of hyperkalemia accompanying hemorrhagic shock, even in the early phase of trauma.	[Matsuda, Junna; Shimizu, Tetsunosuke; Kittaka, Tadahiro; Fukuda, Makiko; Akimoto, Hiroshi] Osaka Mishima Emergency Crit Care Ctr, Osaka, Japan	Matsuda, J (reprint author), Osaka Mishima Emergency Crit Care Ctr, Osaka, Japan.	0315shimizu@gmail.com					Perkins RM, 2007, CLIN J AM SOC NEPHRO, V2, P313, DOI 10.2215/CJN.03070906; Rocha JA, 2009, CLINICS, V64, P591, DOI 10.1590/S1807-59322009000600016; Rocha JA, 2010, J TRAUMA, V68, P1335, DOI 10.1097/TA.0b013e3181dbbb36; Stockinger ZT, 2004, J AM COLL SURGEONS, V198, P227, DOI 10.1016/j.jamcollsurg.2003.10.012	4	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	NOV	2014	32	11							1440.e1	10.1016/j.ajem.2014.04.012		2	Emergency Medicine	Emergency Medicine	AT4ZC	WOS:000344951600052		
J	Ishii, K				Ishii, K.			PET Approaches for Diagnosis of Dementia	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Review							CEREBRAL GLUCOSE-METABOLISM; POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; NORMAL-PRESSURE HYDROCEPHALUS; ALZHEIMERS ASSOCIATION WORKGROUPS; PROGRESSIVE SUPRANUCLEAR PALSY; PITTSBURGH COMPOUND-B; LEWY BODY DISEASES; FDG-PET; FRONTOTEMPORAL DEMENTIA	There is increasing use of neuroimaging modalities, including PET, for diagnosing dementia. For example, FDG-PET demonstrates hypometabolic regions in the posterior cingulate gyri, precuneus, and parietotemporal association cortices, while amyloid PET indicates amyloid deposition in Alzheimer disease and mild cognitive impairment due to Alzheimer disease. Furthermore, the use of combination PET with structural MR imaging can improve the diagnostic accuracy of dementia. In other neurodegenerative dementias, each disease exhibits a specific metabolic reduction pattern. In dementia with Lewy bodies, occipital glucose metabolism is decreased, while in frontotemporal dementia, frontal and anterior temporal metabolism is predominantly decreased. These FDG-PET findings and positive or negative amyloid deposits are important biomarkers for various neurodegenerative dementias.	[Ishii, K.] Kinki Univ Hosp, Neurocognit Disorders Ctr, Osaka, Japan	Ishii, K (reprint author), Kinki Univ, Fac Med, Dept Radiol, 377-2 Ohnohigashi, Osaka 5898511, Japan.	kishii@hbhc.jp			JSPS KAKENHI [50534103]; 21st Century Research and Development Incentive Wages at Kinki University	This work was supported by JSPS KAKENHI grant number 50534103 and 21st Century Research and Development Incentive Wages at Kinki University.	Bohnen NI, 2011, J NUCL MED, V52, P848, DOI 10.2967/jnumed.111.089946; Agdeppa ED, 2001, J NEUROSCI, V21, part. no.; Maldjian JA, 2012, AM J NEURORADIOL, V33, P1975, DOI 10.3174/ajnr.A3113; Gomperts SN, 2012, MOVEMENT DISORD, V27, P965, DOI 10.1002/mds.25048; Kono AK, 2007, EUR J NUCL MED MOL I, V34, P1490, DOI 10.1007/s00259-007-0380-y; Moulin-Romsee G, 2005, EUR J NEUROL, V12, P254, DOI 10.1111/j.1468-1331.2004.00940.x; Karow DS, 2010, RADIOLOGY, V256, P932, DOI 10.1148/radiol.10091402; Nelissen N, 2009, J NUCL MED, V50, P1251, DOI 10.2967/jnumed.109.063305; Kudo Y, 2007, J NUCL MED, V48, P553, DOI 10.2967/jnumed.106.037556; Ishii K, 2002, ANN NUCL MED, V16, P515, DOI 10.1007/BF02988628; Shin J, 2011, J ALZHEIMERS DIS, V26, P135, DOI 10.3233/JAD-2011-0008; Treglia G, 2012, J NEUROIMAGING, V22, P111, DOI 10.1111/j.1552-6569.2010.00532.x; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; Ishii K, 1998, NEUROLOGY, V51, P125; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; Yuan Y, 2009, AM J NEURORADIOL, V30, P404, DOI 10.3174/ajnr.A1357; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Johnson KA, 2013, J NUCL MED, V54, P476, DOI 10.2967/jnumed.113.120618; Choi SR, 2009, J NUCL MED, V50, P1887, DOI 10.2967/jnumed.109.065284; Hosaka K, 2002, J NEUROL SCI, V199, P67, DOI 10.1016/S0022-510X(02)00102-8; Rowe CC, 2008, LANCET NEUROL, V7, P129, DOI 10.1016/S1474-4422(08)70001-2; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Fujishiro H, 2010, NEUROSCI LETT, V486, P19, DOI 10.1016/j.neulet.2010.09.036; MINOSHIMA S, 1994, J NUCL MED, V35, P949; Kanda T, 2008, EUR J NUCL MED MOL I, V35, P2227, DOI 10.1007/s00259-008-0871-5; Silverman DHS, 2002, J NUCL MED, V43, P253; Engler H, 2008, EUR J NUCL MED MOL I, V35, P100, DOI 10.1007/s00259-007-0523-1; MINOSHIMA S, 1995, J NUCL MED, V36, P1238; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Cselenyi Z, 2012, J NUCL MED, V53, P415, DOI 10.2967/jnumed.111.094029; Nyberg S, 2009, EUR J NUCL MED MOL I, V36, P1859, DOI 10.1007/s00259-009-1182-1; Mevel K, 2007, NEUROIMAGE, V37, P18, DOI 10.1016/j.neuroimage.2007.04.048; Albin RL, 1996, NEUROLOGY, V47, P462; [Anonymous], 1994, J NEUROL NEUROSURG P, p[57, 416]; Gomperts SN, 2008, NEUROLOGY, V71, P903, DOI 10.1212/01.wnl.0000326146.60732.d6; Rinne JO, 2012, ACTA NEUROPATHOL, V124, P833, DOI 10.1007/s00401-012-1051-z; Jack CR, 2010, BRAIN, V133, P3336, DOI 10.1093/brain/awq277; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Ossenkoppele R, 2013, NEUROLOGY, V80, P359, DOI 10.1212/WNL.0b013e31827f0889; Rabinovici GD, 2010, BRAIN, V133, P512, DOI 10.1093/brain/awp326; Ishii K, 1998, J NUCL MED, V39, P1875; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Choo IH, 2013, J ALZHEIMERS DIS, V33, P929, DOI 10.3233/JAD-2012-121489; Calcagni ML, 2012, EUR J NUCL MED MOL I, V39, P236, DOI 10.1007/s00259-011-1950-6; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Rabinovici GD, 2007, NEUROLOGY, V68, P1205, DOI 10.1212/01.wnl.0000259035.98480.ed; Shaffer JL, 2013, RADIOLOGY, V266, P583, DOI 10.1148/radiol.12120010; Shimada H, 2013, MOVEMENT DISORD, V28, P169, DOI 10.1002/mds.25286; Ishii K, 2007, J NUCL MED, V48, P704, DOI 10.2967/junmed.106.035691; Drzezga A, 2005, NEUROLOGY, V64, P102; Hashimoto Masaaki, 2010, Cerebrospinal Fluid Res, V7, P18, DOI 10.1186/1743-8454-7-18; Hirono N, 2000, DEMENT GERIATR COGN, V11, P139, DOI 10.1159/000017227; Hirono N, 2002, NEUROLOGY, V58, P743; Ishii K, 2006, EUR J NUCL MED MOL I, V33, P575, DOI 10.1007/s00259-005-0015-0; Ishii K, 1998, DEMENT GERIATR COGN, V9, P317, DOI 10.1159/000017083; JAGUST WJ, 1985, J NEUROL NEUROSUR PS, V48, P1091, DOI 10.1136/jnnp.48.11.1091; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pe, DOI DOI 10.1016/J.JALZ.2013.01.002; Juh R, 2004, EUR J RADIOL, V51, P223, DOI 10.1016/S0720-048X(03)00214-6; Juh R, 2005, NEUROSCI LETT, V383, P22, DOI 10.1016/j.neulet.2005.03.057; Kawachi T, 2006, EUR J NUCL MED MOL I, V33, P801, DOI 10.1007/s00259-005-0050-x; Klein RC, 2005, MOVEMENT DISORD, V20, P1021, DOI 10.1002/mds.20493; Lucignani G, 2009, EUR J NUCL MED MOL I, V36, P1185, DOI 10.1007/s00259-009-1148-3; Matsunari I, 2007, J NUCL MED, V48, P1961, DOI 10.2967/jnumed.107.042820; McKeith I, 2007, LANCET NEUROL, V6, P305, DOI 10.1016/S1474-4422(07)70057-1; MCKHANN G, 1984, NEUROLOGY, V34, P939; Uemura T, 2011, AM J NEURORADIOL, V32, P556, DOI 10.3174/ajnr.A2342; Zhang DQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033182	69	1	1	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	NOV	2014	35	11					2030	2038		10.3174/ajnr.A3695		9	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AT8QQ	WOS:000345197700003		
J	Fudaba, H; Shimomura, T; Abe, T; Matsuta, H; Momii, Y; Sugita, K; Ooba, H; Kamida, T; Hikawa, T; Fujiki, M				Fudaba, H.; Shimomura, T.; Abe, T.; Matsuta, H.; Momii, Y.; Sugita, K.; Ooba, H.; Kamida, T.; Hikawa, T.; Fujiki, M.			Comparison of Multiple Parameters Obtained on 3T Pulsed Arterial Spin-Labeling, Diffusion Tensor Imaging, and MRS and the Ki-67 Labeling Index in Evaluating Glioma Grading	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; BRAIN-TUMORS; CEREBRAL GLIOMAS; PERFUSION MRI; BLOOD-FLOW; ASTROCYTOMAS; COEFFICIENT; PERFORMANCE; ACCURACY	BACKGROUND AND PURPOSE: Pulsed arterial spin-labeling, DTI, and MR spectroscopy provide useful data for tumor evaluation. We evaluated multiple parameters by using these pulse sequences and the Ki-67 labeling index in newly diagnosed supratentorial gliomas. MATERIALS AND METHODS: All 32 patients, with grade II (3 each of diffuse astrocytoma, oligodendroglioma, and oligoastrocytoma), grade III (3 anaplastic astrocytomas, 4 anaplastic oligodendrogliomas, and 1 anaplastic oligoastrocytoma), and grade IV (14 glioblastomas and 1 glioblastoma with an oligodendroglioma component) cases underwent pulsed arterial spin-labeling, DTI, and MR spectroscopy studies by using 3T MR imaging. The following variables were used to compare the tumors: relative cerebral blood flow, fractional anisotropy; ADC tumor/normal ratios; and the Cho/Cr, NAA/Cho, NAA/Cr, and lactate/Cr ratios. A logistic regression and receiver operating characteristic analysis were used to assess parameters with a high sensitivity and specificity to identify the threshold values for separate grading. We compared the Ki-67 index with various MR imaging parameters in tumor specimens. RESULTS: Significant correlations were observed between the Ki-67 index and the mean, maximum, and minimum ADC, Cho/Cr, and lactate/Cr ratios. The receiver operating characteristic analysis showed that the combination of the minimum ADC and Cho/Cr ratios could differentiate low-grade and high-grade gliomas, with a sensitivity and specificity of 87.0% and 88.9%, respectively. The mean and maximum relative cerebral blood flow ratios were used to classify glioblastomas from other-grade astrocytomas, with a sensitivity and specificity of 92.9% and 83.3%, respectively. CONCLUSIONS: Our findings indicate that pulsed arterial spin-labeling, DTI, and MR spectroscopy are useful for predicting glioma grade. Additionally, the parameters obtained on DTI and MR spectroscopy closely correlated with the proliferative potential of gliomas.	[Fudaba, H.; Shimomura, T.; Abe, T.; Matsuta, H.; Momii, Y.; Sugita, K.; Ooba, H.; Kamida, T.; Hikawa, T.; Fujiki, M.] Oita Univ, Fac Med, Dept Neurosurg, Oita 8795593, Japan	Fudaba, H (reprint author), Oita Univ, Fac Med, Dept Neurosurg, Oita 8795593, Japan.	fudaba@oita-u.ac.jp			Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology	This work was supported by a grant from the Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology.	Knopp EA, 1999, RADIOLOGY, V211, P791; Yang D, 2002, NEURORADIOLOGY, V44, P656, DOI 10.1007/s00234-002-0816-9; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; ARONEN HJ, 1994, RADIOLOGY, V191, P41; Weber MA, 2006, NEUROLOGY, V66, P1899, DOI 10.1212/01.wnl.0000219767.49705.9c; Law M, 2003, AM J NEURORADIOL, V24, P1989; Luh WM, 1999, MAGNET RESON MED, V41, P1246, DOI 10.1002/(SICI)1522-2594(199906)41:6<1246::AID-MRM22>3.0.CO;2-N; Li XJ, 2002, J MAGN RESON IMAGING, V16, P229, DOI 10.1002/jmri.10147; Jarnum H, 2010, NEURORADIOLOGY, V52, P307, DOI 10.1007/s00234-009-0616-6; Di Costanzo A, 2006, NEURORADIOLOGY, V48, P622, DOI 10.1007/s00234-006-0102-3; Chawla S, 2007, AM J NEURORADIOL, V28, P1683, DOI 10.3174/ajnr.A0673; Fink JR, 2012, J MAGN RESON IMAGING, V35, P56, DOI 10.1002/jmri.22801; Noguchi T, 2008, AM J NEURORADIOL, V29, P688, DOI [10.3174/ajnr.A0903, 10.3174/ainr.A0903]; Lee EJ, 2008, AM J NEURORADIOL, V29, P1872, DOI 10.3174/ajnr.A1254; Warmuth C, 2003, RADIOLOGY, V228, P523, DOI 10.1148/radiol.2282020409; Liu X, 2011, NEURO-ONCOLOGY, V13, P447, DOI 10.1093/neuonc/noq197; Guillevin R, 2008, J NEURO-ONCOL, V87, P181, DOI 10.1007/s11060-007-9508-y; Hirai T, 2011, AM J NEURORADIOL, V32, P2073, DOI 10.3174/ajnr.A2725; Zou QG, 2011, CLIN RADIOL, V66, P953, DOI 10.1016/j.crad.2011.05.001; Roy B, 2013, NEURORADIOLOGY, V55, P603, DOI 10.1007/s00234-013-1145-x; Cha S, 2002, RADIOLOGY, V223, P11, DOI 10.1148/radiol.2231010594; Server A, 2011, EUR J RADIOL, V80, P462, DOI 10.1016/j.ejrad.2010.07.017; Zikou AK, 2012, CLIN NEUROL NEUROSUR, V114, P607, DOI 10.1016/j.clineuro.2011.12.022; Johannessen AL, 2006, PATHOL ONCOL RES, V12, P143; Calvar JA, 2005, J NEURO-ONCOL, V72, P273, DOI 10.1007/s11060-004-3342-2; Kim MJ, 2008, ACTA RADIOL, V49, P450, DOI 10.1080/02841850701881820; Kim HS, 2007, AM J NEURORADIOL, V28, P1693, DOI 10.3174/ajnr.A0674; Kimura H, 2006, AM J NEURORADIOL, V27, P85; Magalhaes A, 2005, ACAD RADIOL, V12, P51, DOI 10.1016/j.acra.2004.10.057; Sharma S, 2006, J NEURO-ONCOL, V79, P19, DOI 10.1007/s11060-006-9120-6; Yin Yue, 2012, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V34, P503, DOI 10.3881/j.issn.1000-503X.2012.05.012	31	2	2	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	NOV	2014	35	11					2091	2098		10.3174/ajnr.A4018		8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AT8QQ	WOS:000345197700013		
J	Ohta, T; Murao, K; Miyake, K; Takemoto, K; Nakazawa, K				Ohta, T.; Murao, K.; Miyake, K.; Takemoto, K.; Nakazawa, K.			Risk Factors for Early Hemorrhagic Complications after Endovascular Coiling of Ruptured Intracranial Aneurysms	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; CEREBRAL ANEURYSM; EMBOLIZATION; GROWTH; TRIAL	BACKGROUND AND PURPOSE: The risk factors of early hemorrhagic complications after endovascular coiling are not well-known. We identified the factors affecting early hemorrhagic complications, defined as any expansion or appearance of hemorrhage shown by head CT in the initial 48 hours after coiling. MATERIALS AND METHODS: We retrospectively reviewed a series of 93 patients who underwent coiling for a ruptured saccular aneurysm between 2006 and 2012 at our hospital. RESULTS: Five patients showed early hemorrhagic complications, and all involved an expansion of the existing intracerebral hematoma immediately after coiling. The associated risk factors were accompanying intracerebral hemorrhage at onset (P < .001), postoperative antiplatelet therapy (P < .001), and thromboembolic complications (P =.044). In the accompanying intracerebral hemorrhage group, the associated risk factors were postoperative antiplatelet therapy (P = .044) and earlier initiation of coiling (9.8 +/- 6.5 versus 28.1 +/- 24.0 hours, P = .023). Early hemorrhagic complications were significant risk factors for worse clinical outcome (modified Rankin Scale, 2.02 +/- 2.21 versus 4.4 +/- 2.30, P = .022). None of the 93 patients showed further hemorrhage after the initial 48 hours after coiling. CONCLUSIONS: The accompanying intracerebral hemorrhage at onset, thromboembolic complications, postoperative antiplatelet therapy, and earlier initiation of coiling were the risk factors for early hemorrhagic complications.	[Ohta, T.; Murao, K.; Miyake, K.; Takemoto, K.; Nakazawa, K.] Shiroyama Hosp, Dept Neuroendovasc Treatment, Habikino, Osaka 5830872, Japan	Ohta, T (reprint author), Shiroyama Hosp, Dept Neuroendovasc Treatment, 2-8-1 Habikino, Habikino, Osaka 5830872, Japan.	tsuyoshi@ya2.so-net.ne.jp					Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Naidech AM, 2009, STROKE, V40, P2398, DOI 10.1161/STROKEAHA.109.550939; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Flibotte JJ, 2004, NEUROLOGY, V63, P1059; Cho YD, 2012, NEURORADIOLOGY, V54, P719, DOI 10.1007/s00234-011-0950-3; [Anonymous], 1988, J NEUROSURG, V68, P985; Jartti P, 2010, ACTA RADIOL, V51, P1043, DOI 10.3109/02841851.2010.508172; Dmytriw AA, 2014, J NEUROINTERV SURG, V6, P16, DOI 10.1136/neurintsurg-2012-010588; Egashira Y, 2013, J NEUROSURG, V118, P1003, DOI 10.3171/2012.11.JNS12610; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Guresir E, 2008, NEUROSURGERY, V63, P1093; Guresir E, 2008, NEUROSURGERY, V63, P1088; Kang DH, 2010, ACTA NEUROCHIR, V152, P771, DOI 10.1007/s00701-009-0593-x; Klompenhouwer EG, 2011, AM J NEURORADIOL, V32, P570, DOI 10.3174/ajnr.A2326; Kwon BJ, 2008, NEUROSURGERY, V63, P676, DOI 10.1227/01.NEU.0000325500.73330.C2; Nagasaka T, 2011, J STROKE CEREBROVASC, V20, P208, DOI 10.1016/j.jstrokecerebrovasdis.2009.11.021; Nievas MC, 2005, NEUROL RES, V27, P755, DOI 10.1179/016164105X35620; Ryu Chang-Woo, 2011, Neurointervention, V6, P17, DOI 10.5469/neuroint.2011.6.1.17; Willinsky RA, 2009, AM J NEURORADIOL, V30, P1035, DOI 10.3174/ajnr.A1488; Zang PZ, 2011, NEUROL INDIA, V59, P369, DOI 10.4103/0028-3886.82736	21	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	NOV	2014	35	11					2136	2139		10.3174/ajnr.A4033		4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AT8QQ	WOS:000345197700020		
J	Illies, T; Saring, D; Kinoshita, M; Fujinaka, T; Bester, M; Fiehler, J; Tomiyama, N; Watanabe, Y				Illies, T.; Saering, D.; Kinoshita, M.; Fujinaka, T.; Bester, M.; Fiehler, J.; Tomiyama, N.; Watanabe, Y.			Cerebral Aneurysm Pulsation: Do Iterative Reconstruction Methods Improve Measurement Accuracy In Vivo?	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							CT ANGIOGRAPHY; IMPROVED DELINEATION; MODEL; ALGORITHMS; NOISE; VITRO	BACKGROUND AND PURPOSE: Electrocardiogram-gated 4D-CTA is a promising technique allowing new insight into aneurysm pathophysiology and possibly improving risk prediction of cerebral aneurysms. Due to the extremely small pulsational excursions (<0.1 mm in diameter), exact segmentation of the aneurysms is of critical importance. In vitro examinations have shown improvement of the accuracy of vessel delineation by iterative reconstruction methods. We hypothesized that this improvement shows a measurable effect on aneurysm pulsations in vivo. MATERIALS AND METHODS: Ten patients with cerebral aneurysms underwent 4D-CTA. Images were reconstructed with filtered back-projection and iterative reconstruction. The following parameters were compared between both groups: image noise, absolute aneurysm volumes, pulsatility, and sharpness of aneurysm edges. RESULTS: In iterative reconstruction images, noise was significantly reduced (mean, 9.8 +/- 4.0 Hounsfield units versus 8.0 +/- 2.5 Hounsfield units; P = .04), but the sharpness of aneurysm edges just missed statistical significance (mean, 3.50 +/- 0.49 mm versus 3.42 +/- 0.49 mm; P = .06). Absolute volumes (mean, 456.1 +/- 775.2 mm(3) versus 461.7 +/- 789.9 mm(3); P = .31) and pulsatility (mean, 1.099 +/- 0.088 mm(3) versus 1.095 +/- 0.082 mm(3); P = .62) did not show a significant difference between iterative reconstruction and filtered back-projection images. CONCLUSIONS: CT images reconstructed with iterative reconstruction methods show a tendency toward shorter vessel edges but do not affect absolute aneurysm volumes or pulsatility measurements in vivo.	[Illies, T.; Bester, M.; Fiehler, J.] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, D-20355 Hamburg, Germany; [Saering, D.] Univ Med Ctr Hamburg Eppendorf, Dept Med Informat, D-20355 Hamburg, Germany; [Kinoshita, M.; Fujinaka, T.] Osaka Univ, Grad Sch Med, Dept Neurosurg, Osaka, Japan; [Tomiyama, N.; Watanabe, Y.] Osaka Univ, Grad Sch Med, Dept Radiol, Osaka, Japan	Illies, T (reprint author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Martinistr 52, D-20355 Hamburg, Germany.	tillies@uke.de			Japanese German Radiology Affiliation	This work was supported by a grant of the Japanese German Radiology Affiliation.	Machida H, 2013, AM J NEURORADIOL, V34, P971, DOI 10.3174/ajnr.A3320; Ziegler A, 2007, MED PHYS, V34, P585, DOI 10.1118/1.2409481; Kato Y, 2004, MINIM INVAS NEUROSUR, V47, P131, DOI 10.1055/s-2004-818492; Suzuki S, 2013, AM J ROENTGENOL, V200, P652, DOI 10.2214/AJR.12.8689; Beister M, 2012, PHYS MEDICA, V28, P94, DOI 10.1016/j.ejmp.2012.01.003; Umeda Y, 2011, STROKE, V42, P815, DOI 10.1161/STROKEAHA.110.591008; Hayakawa M, 2005, AM J NEURORADIOL, V26, P1366; Kuroda J, 2012, STROKE, V43, P61, DOI 10.1161/STROKEAHA.111.626846; Yaghmai V, 2007, J VASC INTERV RADIOL, V18, P785, DOI 10.1016/j.jvir.2007.02.037; Machida H, 2013, AM J ROENTGENOL, V200, P442, DOI 10.2214/AJR.11.7826; Ishida F, 2005, NEUROSURGERY, V57, P460, DOI 10.1227/01.NEU.0000170540.17300.DD; Matsumoto Masato, 2006, Neurosurgery, V58, pE1003, DOI 10.1227/01.NEU.0000217323.32623.F7; Park JK, 2009, J MAGN RESON IMAGING, V30, P1179, DOI 10.1002/jmri.21942; SPRAWLS P, 1992, RADIOGRAPHICS, V12, P1041; STEIGER H J, 1989, Heart and Vessels, V5, P41, DOI 10.1007/BF02058357; Suzuki S, 2012, EUR J RADIOL, V81, P3348, DOI 10.1016/j.ejrad.2012.02.009	16	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	NOV	2014	35	11					2159	2163		10.3174/ajnr.A4000		5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AT8QQ	WOS:000345197700024		
J	Yamamoto, N; Minami, S; Fujii, M				Yamamoto, Nobuko; Minami, Shujiro; Fujii, Masato			Clinicopathologic study of salivary duct carcinoma and the efficacy of androgen deprivation therapy	AMERICAN JOURNAL OF OTOLARYNGOLOGY			English	Article							OF-THE-LITERATURE; PHASE-II; GLAND CARCINOMAS; BREAST-CANCER; EXPRESSION; RECEPTOR; CISPLATIN	Objective: Salivary duct carcinoma is a rare and aggressive tumor of the salivary glands. The objectives of this study were to investigate the clinicopathological features of salivary duct carcinoma and to determine whether androgen deprivation therapy should be recommended. Study design and Methods: The clinical records of seven patients diagnosed with salivary duct carcinoma between 2002 and 2012 were retrospectively assessed. Tumor specimens were examined for overexpression of human epidermal growth factor receptor 2 (HER2) and androgen receptor by immunohistochemistry. A case of androgen receptor-positive salivary duct carcinoma who received androgen deprivation therapy is presented. Results: Of the seven patients, 43% had recurrences and metastases, and the 5-year survival rate was 68.6%. All patients were androgen receptor-positive, and 71% were HER2-positive. One patient, a 66-year-old man with androgen receptor-positive salivary duct carcinoma, received oral bicalutimide for 14 months and practically all lung metastases disappeared. Conclusion: Androgen receptor is often overexpressed in salivary duct carcinoma. Androgen deprivation therapy is safe and should be considered for patients with androgen receptor-positive salivary duct carcinoma. (C) 2014 Elsevier Inc. All rights reserved.	[Yamamoto, Nobuko; Minami, Shujiro] Natl Tokyo Med Ctr, Dept Otolaryngol, Meguro Ku, Tokyo, Japan; [Fujii, Masato] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Meguro Ku, Tokyo, Japan	Yamamoto, N (reprint author), Saiseikai Cent Hosp, Dept Otolaryngol, Minato Ku, 1-4-17 Mita, Tokyo 1080073, Japan.	nobukoy@a2.keio.jp					Jaspers HCJ, 2011, J CLIN ONCOL, V29, pE473, DOI 10.1200/JCO.2010.32.8351; Soper MS, 2014, HEAD NECK-J SCI SPEC, V36, pE4, DOI 10.1002/hed.23383; LICITRA L, 1991, CANCER, V68, P1874, DOI 10.1002/1097-0142(19911101)68:9<1874::AID-CNCR2820680904>3.0.CO;2-S; Locati LD, 2009, ORAL ONCOL, V45, P986, DOI 10.1016/j.oraloncology.2009.05.635; Lewis JE, 1996, CANCER, V77, P223, DOI 10.1002/(SICI)1097-0142(19960115)77:2<223::AID-CNCR1>3.0.CO;2-N; Laurie SA, 2006, J CLIN ONCOL, V24, P2673, DOI 10.1200/JCO.2005.05.3026; Jaehne M, 2005, CANCER, V103, P2526, DOI 10.1002/cncr.21116; Park S, 2010, ANN ONCOL, V21, P488, DOI 10.1093/annonc/mdp510; Nabili V, 2007, HEAD NECK-J SCI SPEC, V29, P907, DOI 10.1002/hed.20614; Guzzo M, 1997, HEAD NECK-J SCI SPEC, V19, P126, DOI 10.1002/(SICI)1097-0347(199703)19:2<126::AID-HED7>3.0.CO;2-6; Glisson B, 2004, CLIN CANCER RES, V10, P944, DOI 10.1158/1078-0432.CCR-03-0253; Licitra L, 1996, ANN ONCOL, V7, P640; Williams MD, 2007, AM J SURG PATHOL, V31, P1645; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Prat A, 2008, HEAD NECK-J SCI SPEC, V30, P680, DOI 10.1002/hed.20714; Haddad R, 2003, ORAL ONCOL, V39, P724, DOI 10.1016/S1368-8375(03)00097-6; Fan CY, 2000, AM J SURG PATHOL, V24, P579, DOI 10.1097/00000478-200004000-00014; Nashed M, 2009, J LARYNGOL OTOL, V123, P250, DOI 10.1017/S0022215108002314; Skalova A, 2003, HISTOPATHOLOGY, V42, P348, DOI 10.1046/j.1365-2559.2003.01600.x; Antony Joyce, 2012, Head Neck Pathol, V6, P1, DOI 10.1007/s12105-011-0281-z; BARNES L, 1994, ORAL SURG ORAL MED O, V78, P64, DOI 10.1016/0030-4220(94)90119-8; Glisson B, 2005, J CLIN ONCOL, V23, P5532; Locati LD, ANTIANDROGEN THERAPY; Moriki T, 2001, CANCER CYTOPATHOL, V93, P344, DOI 10.1002/cncr.9050	24	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0196-0709	1532-818X		AM J OTOLARYNG	Am. J. Otolaryngol.	NOV-DEC	2014	35	6					731	735		10.1016/j.amjoto.2014.07.007		5	Otorhinolaryngology	Otorhinolaryngology	AT9RF	WOS:000345263200009		
J	Oguri, G; Nakajima, T; Yamamoto, Y; Takano, N; Tanaka, T; Kikuchi, H; Morita, T; Nakamura, F; Yamasoba, T; Komuro, I				Oguri, Gaku; Nakajima, Toshiaki; Yamamoto, Yumiko; Takano, Nami; Tanaka, Tomofumi; Kikuchi, Hironobu; Morita, Toshihiro; Nakamura, Fumitaka; Yamasoba, Tatsuya; Komuro, Issei			Effects of methylglyoxal on human cardiac fibroblast: roles of transient receptor potential ankyrin 1 (TRPA1) channels	AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY			English	Article						human cardiac fibroblast; transient receptor potential ankyrin 1 channels; methylglyoxal	SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; HIGH GLUCOSE; DIABETES-MELLITUS; HEART-FAILURE; DIASTOLIC DYSFUNCTION; ATRIAL-FIBRILLATION; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; IN-VIVO	Cardiac fibroblasts contribute to the pathogenesis of cardiac remodeling. Methylglyoxal (MG) is an endogenous carbonyl compound produced under hyperglycemic conditions, which may play a role in the development of pathophysiological conditions including diabetic cardiomyopathy. However, the mechanism by which this occurs and the molecular targets of MG are unclear. We investigated the effects of MG on Ca2+ signals, its underlying mechanism, and cell cycle progression/cell differentiation in human cardiac fibroblasts. The conventional and quantitative real-time RT-PCR, Western blot, immunocytochemical analysis, and intracellular Ca2+ concentration [Ca2+]i measurement were applied. Cell cycle progression was assessed using the fluorescence activated cell sorting. MG induced Ca2+ entry concentration dependently. Ruthenium red (RR), a general cation channel blocker, and HC030031, a selective transient receptor potential ankyrin 1 (TRPA1) antagonist, inhibited MG-induced Ca2+ entry. Treatment with aminoguanidine, a MG scavenger, also inhibited it. Allyl isothiocyanate, a selective TRPA1 agonist, increased Ca2+ entry. The use of small interfering RNA to knock down TRPA1 reduced the MG-induced Ca2+ entry as well as TRPA1 mRNA expression. The quantitative real-time RT-PCR analysis showed the prominent existence of TRPA1 mRNA. Expression of TRPA1 protein was confirmed by Western blotting and immunocytochemical analyses. MG promoted cell cycle progression from G0/G1 to S/G2/M, which was suppressed by HC030031 or RR. MG also enhanced alpha-smooth muscle actin expression. The present results suggest that methylglyoxal activates TRPA1 and promotes cell cycle progression and differentiation in human cardiac fibroblasts. MG might participate the development of pathophysiological conditions including diabetic cardiomyopathy via activation of TRPA1.	[Oguri, Gaku; Yamamoto, Yumiko; Takano, Nami; Tanaka, Tomofumi; Kikuchi, Hironobu; Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan; [Nakajima, Toshiaki; Morita, Toshihiro] Univ Tokyo, Dept Ischem Circulatory Physiol, Tokyo, Japan; [Yamasoba, Tatsuya] Univ Tokyo, Dept Otolaryngol, Tokyo 113, Japan; [Nakamura, Fumitaka] Teikyo Univ, Chiba Med Ctr, Ichihara, Chiba, Japan	Nakajima, T (reprint author), Univ Tokyo, Dept Ischem Circulatory Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.	nakajima-2im@h.u-tokyo.ac.jp					Abramochkin DV, 2014, J MOL CELL CARDIOL, V70, P27, DOI 10.1016/j.yjmcc.2013.12.020; Andersson DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077986; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; THORNALLEY PJ, 1989, DIABETES RES CLIN PR, V7, P115, DOI 10.1016/0168-8227(89)90101-0; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Suskin N, 2000, EUR HEART J, V21, P1368, DOI 10.1053/euhj.1999.2043; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Davis J, 2012, DEV CELL, V23, P705, DOI 10.1016/j.devcel.2012.08.017; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Yuen A, 2010, MATRIX BIOL, V29, P537, DOI 10.1016/j.matbio.2010.04.004; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Eberhardt MJ, 2012, J BIOL CHEM, V287, P28291, DOI 10.1074/jbc.M111.328674; Wuensch T, 2010, DIABETES, V59, P844, DOI 10.2337/db09-1100; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Dhar A, 2008, METABOLISM, V57, P1211, DOI 10.1016/j.metabol.2008.04.014; Mukhopadhyay I, 2011, J RECEPT SIG TRANSD, V31, P350, DOI 10.3109/10799893.2011.602413; Kelly DJ, 2007, AM J PHYSIOL-HEART C, V293, pH2860, DOI 10.1152/ajpheart.01167.2006; Koch SE, 2012, J MOL CELL CARDIOL, V53, P134, DOI 10.1016/j.yjmcc.2012.04.011; Che WY, 1997, J BIOL CHEM, V272, P18453, DOI 10.1074/jbc.272.29.18453; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; LO TWC, 1994, BIOCHEM PHARMACOL, V48, P1865, DOI 10.1016/0006-2952(94)90584-3; Chen K, 2004, CIRC RES, V95, P1167, DOI 10.1161/01.RES.0000150369.68826.2f; Chen JB, 2010, J CELL PHYSIOL, V223, P68, DOI 10.1002/jcp.22010; Stahrenberg R, 2010, DIABETOLOGIA, V53, P1331, DOI 10.1007/s00125-010-1718-8; Wang H, 2007, CLIN BIOCHEM, V40, P1232, DOI 10.1016/j.clinbiochem.2007.07.016; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Du JY, 2010, CIRC RES, V106, P992, DOI 10.1161/CIRCRESAHA.109.206771; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; From AM, 2010, J AM COLL CARDIOL, V55, P300, DOI 10.1016/j.jacc.2009.12.003; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Harada M, 2012, CIRCULATION, V126, P2051, DOI 10.1161/CIRCULATIONAHA.112.121830; van Heerebeek L, 2008, CIRCULATION, V117, P43, DOI 10.1161/CIRCULATIONAHA.107.728550; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Ohkawara S, 2012, J TOXICOL SCI, V37, P831; Lapolla A, 2003, CLIN CHEM LAB MED, V41, P1166, DOI 10.1515/CCLM.2003.180; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Wang XX, 2005, J HYPERTENS, V23, P1565, DOI 10.1097/01.hjh.0000173778.85233.1b; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Tang MX, 2007, MOL CELL BIOCHEM, V301, P109, DOI 10.1007/s11010-006-9401-6; Wang XX, 2007, AM J HYPERTENS, V20, P629, DOI 10.1016/j.amjhyper.2006.12.003; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Mukherjee S, 2012, AM J RESP CELL MOL, V46, P757, DOI 10.1165/rcmb.2011-0223OC; Heymes C, 1999, CIRCULATION, V99, P3009; Mukohda M, 2009, J PHARMACOL SCI, V109, P305; Graham S, 2011, AM J PHYSIOL-CELL PH, V301, pC304, DOI 10.1152/ajpcell.00014.2011; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Weber KT, 2004, J HYPERTENS, V22, P47, DOI 10.1097/01.hjh.0000098174.36890.be; Akhand AA, 2001, FREE RADICAL BIO MED, V31, P20, DOI 10.1016/S0891-5849(01)00550-0; Asbun J, 2005, AM J PHYSIOL-HEART C, V288, pH227, DOI 10.1152/ajpheart.00340.2004; Beisswenger PJ, 2001, DIABETES CARE, V24, P726, DOI 10.2337/diacare.24.4.726; Brouwers O, 2010, DIABETOLOGIA, V53, P989, DOI 10.1007/s00125-010-1677-0; Cao DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038005; Chang TJ, 2011, FASEB J, V25, P1746, DOI 10.1096/fj.10-178053; Chaplen FWR, 1998, P NATL ACAD SCI USA, V95, P5533, DOI 10.1073/pnas.95.10.5533; Cook LJ, 1998, BIOCHEM PHARMACOL, V55, P1361, DOI 10.1016/S0006-2952(97)00619-9; Cruz-Orengo L, 2008, MOL PAIN, V4; Dai B, 2013, CELL PHYSIOL BIOCHEM, V32, P960, DOI 10.1159/000354499; Desai Kaushik, 2007, Recent Pat Cardiovasc Drug Discov, V2, P89; Guinamard R, 2007, BBA-MOL BASIS DIS, V1772, P885, DOI 10.1016/j.bbadis.2007.02.007; Huang W, 2010, J HYPERTENS, V28, P367, DOI 10.1097/HJH.0b013e328333af48; Ikeda K, 2013, CELL CALCIUM, V54, P213, DOI 10.1016/j.ceca.2013.06.005; Jia XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036610; Kumaran C, 2002, AM J PHYSIOL-HEART C, V282, pH1855, DOI 10.1152/ajpheart.00747.2001; Nakajima T, 2000, BRIT J PHARMACOL, V130, P1457, DOI 10.1038/sj.bjp.0703471; Shao CH, 2011, DIABETES, V60, P947, DOI 10.2337/db10-1145; Stokes A, 2006, CELL SIGNAL, V18, P1584, DOI 10.1016/j.cellsig.2005.12.009; WAHL M, 1993, MOL BIOL CELL, V4, P293; Wang P, 2009, J ENDOCRINOL INVEST, V32, P242; Wang YJ, 2006, J MEMBRANE BIOL, V213, P175, DOI 10.1007/s00232-007-0027-8; Zhao Y, 2012, Eur J Histochem, V56, pe32, DOI 10.4081/ejh.2012.e32	75	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6135	1522-1539		AM J PHYSIOL-HEART C	Am. J. Physiol.-Heart Circul. Physiol.	NOV 1	2014	307	9					H1339	H1352		10.1152/ajpheart.01021.2013		14	Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Physiology	AT5PY	WOS:000344995700009		
J	Diez, D; Agusti, A; Wheelock, CE				Diez, Diego; Agusti, Alvar; Wheelock, Craig E.			Network Analysis in the Investigation of Chronic Respiratory Diseases	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE			English	Article						systems biology; systems medicine; protein-protein interaction network; signaling network; gene regulatory network	TRANSCRIPTIONAL REGULATORY MODULES; IDIOPATHIC PULMONARY-FIBROSIS; SYSTEMS BIOLOGY; MEDICINE; LUNG; ASTHMA; GENE; SOFTWARE; BIOINFORMATICS; HYPERTENSION	Chronic respiratory diseases are complex multifactorial disorders whose pathogenesis depends on the interplay between host and environmental factors. To fully understand them and to identify novel treatments, a holistic approach that integrates multiple types and levels of clinical and biological data is necessary. Toward this end, the application of systems biology-based strategies, in particular, network analysis, offers great potential. These systems-based approaches rely heavily on computational methods that can be challenging for the nonspecialist. Accordingly, this Pulmonary Perspective: (1) outlines the basic concepts of networks in biology and the fundamentals of network analysis, and (2) discusses recent applications of network analysis to understand respiratory diseases. The intent of this Perspective is to provide readers with increased understanding of the strengths and weaknesses of network analysis methods as well as their usefulness in addressing research questions involving chronic respiratory diseases.	[Diez, Diego] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Quantitat Immunol Res Unit, Osaka, Japan; [Agusti, Alvar] Univ Barcelona, Thorax Inst, Hosp Clin, Inst Invest Biomed August Pi & Sunyer IDIBAPS,Ctr, Madrid, Spain; [Wheelock, Craig E.] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden	Diez, D (reprint author), Osaka Univ, WPI Immunol Frontier Res Ctr IFReC, Quantitat Immunol Res Unit, 8F Integrated Life Sci Bldg,3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	diez@ifrec.osaka-u.ac.jp	Diez, Diego/A-6571-2011; Agusti Garcia-Navarro, Alvar/F-4474-2015	Diez, Diego/0000-0002-2325-4893; Agusti Garcia-Navarro, Alvar/0000-0003-3271-3788	Osaka University; JSPS KAKENHI grant [25430182]; Swedish Heart Lung Foundation; Center for Allergy Research;  [FIS 12/01117];  [SEPAR 192/2012];  [065/2013];  [RESERCAIXA 2012]	Supported by Osaka University and JSPS KAKENHI grant 25430182 (D.D.); grants FIS 12/01117, SEPAR 192/2012, and 065/2013, and RESERCAIXA 2012 (A.A.); and the Swedish Heart Lung Foundation and the Center for Allergy Research (C.E.W.).	Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Faner R, 2014, EUR RESPIR J, V44, P775, DOI 10.1183/09031936.00078714; Maher TM, 2013, CURR OPIN PULM MED, V19, P460, DOI 10.1097/MCP.0b013e328363f4b7; Hwang S, 2008, J THEOR BIOL, V252, P722, DOI 10.1016/j.jtbi.2008.02.011; Zacher B, 2012, BIOINFORMATICS, V28, P1714, DOI 10.1093/bioinformatics/bts257; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Faner R, 2012, AM J RESP CRIT CARE, V186, P306, DOI 10.1164/rccm.201202-0282PP; Studer Sean M, 2007, Proc Am Thorac Soc, V4, P85, DOI 10.1513/pats.200607-139JG; Wheelock CE, 2013, EUR RESPIR J, V42, P802, DOI 10.1183/09031936.00078812; Beisser D, 2010, BIOINFORMATICS, V26, P1129, DOI 10.1093/bioinformatics/btq089; Diez D, 2010, MOL BIOSYST, V6, P289, DOI 10.1039/b912078e; Hood L, 2012, BIOTECHNOL J, V7, P992, DOI 10.1002/biot.201100306; Diez D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt913; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538; Ahmad F, 2012, CIRCULATION, V125, P1477, DOI 10.1161/CIRCULATIONAHA.112.096396; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Mitra K, 2013, NAT REV GENET, V14, P719, DOI 10.1038/nrg3552; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Oberhardt MA, 2010, J BACTERIOL, V192, P5534, DOI 10.1128/JB.00900-10; Hutchins AP, 2013, NUCLEIC ACIDS RES, V41, P2155, DOI 10.1093/nar/gks1300; Dahlin A, 2012, PHARMACOGENOMICS, V13, P1387, DOI [10.2217/pgs.12.126, 10.2217/PGS.12.126]; Agusti A, 2011, AM J RESP CRIT CARE, V183, P1129, DOI 10.1164/rccm.201009-1414PP; Thomas Sterling, 2010, Human Genomics, V4, P353; Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269; Bousquet J, 2011, GENOME MED, V3, DOI 10.1186/gm259; Diez D, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-27; Faner R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097491; Freishtat RJ, 2009, J INVEST MED, V57, P756, DOI 10.231/JIM.0b013e3181b91a83; Gamez J, 2002, P 1 EUR WORKSH PROB, P222; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonçalves Emanuel, 2013, F1000Res, V2, P192, DOI 10.12688/f1000research.2-192.v1; Grosdidier S, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0111-4; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160; Menche J, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S2-S8; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Noverstern N, 2008, AM J RESP CELL MOL, V38, P324, DOI 10.1165/rcmb.2007-0151OC; Renkonen Jutta, 2010, J Asthma Allergy, V3, P177, DOI 10.2147/JAA.S14459; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Schich M, 2014, SCIENCE, V345, P558, DOI 10.1126/science.1240064; Shannon PT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-217; Sorokin SP, 1970, MORPHOLOGY EXPT RESP, P3; Turan N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002129; Visscher S, 2009, ARTIF INTELL MED, V46, P251, DOI 10.1016/j.artmed.2008.11.006; Wu W, 2009, WIRES SYST BIOL MED, V1, P298, DOI [10.1002/wsbm.23, 10.1002/wsbm.023]	50	9	9	AMER THORACIC SOC	NEW YORK	25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA	1073-449X	1535-4970		AM J RESP CRIT CARE	Am. J. Respir. Crit. Care Med.	NOV 1	2014	190	9					981	988		10.1164/rccm.20140-0421PP		8	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	AT8RN	WOS:000345199900008		
J	Zhang, YJ; Sekine, T; He, HL				Zhang, Youjun; Sekine, Toshimori; He, Hongliang			A new interpretation of decomposition products of serpentine under shock compression	AMERICAN MINERALOGIST			English	Article						Dense hydrous magnesium silicates; phase H; high pressure; Hugoniot; decomposition; serpentine	EQUATION-OF-STATE; PHASE-D; WAVE EQUATION; LOWER MANTLE; WATER; PRESSURE; GPA; STABILITY	Dense hydrous magnesium silicates (DHMSs) may play an important role in water transport during planetary accretion and as water reservoirs in the Earth's deep mantle. We show that the dynamic decomposition products of antigorite, Mg3Si2O5(OH)(4), can be interpreted as containing the newly discovered, dense hydrous silicate, phase H (MgSiO4H2). The Hugoniot for phase H was calculated based on the Hugoniots for its constituent oxides and equation of state data derived from first-principles calculations. The measured antigorite Hugoniot, previously suggested to decompose into high-pressure phases without generating fluid H2O, was compared with those derived from calculations involving phase H. Sound velocity data were also compared to confirm that the dynamic breakdown product of antigorite at pressures above similar to 40 GPa is most likely phase H plus MgO without formation of fluid H2O.	[Zhang, Youjun; Sekine, Toshimori] Hiroshima Univ, Dept Earth & Planetary Syst Sci, Higashihiroshima 7398526, Japan; [He, Hongliang] China Acad Engn Phys, Inst Fluid Phys, Natl Key Lab Shock Wave & Detonat Phys, Mianyang 621900, Peoples R China	Zhang, YJ (reprint author), Hiroshima Univ, Dept Earth & Planetary Syst Sci, Kagamiyama 1-3-1, Higashihiroshima 7398526, Japan.	toshimori-sekine@hiroshima-u.ac.jp					Al'tshuler L.V., 1971, PHYS SOLID EARTH, V3, P11; Zha CS, 2000, P NATL ACAD SCI USA, V97, P13494, DOI 10.1073/pnas.240466697; ULMER P, 1995, SCIENCE, V268, P858, DOI 10.1126/science.268.5212.858; Kawakatsu H, 2007, SCIENCE, V316, P1468, DOI 10.1126/science.1140855; Shieh SR, 1998, EARTH PLANET SC LETT, V159, P13, DOI 10.1016/S0012-821X(98)00062-4; Tsuchiya J, 2013, GEOPHYS RES LETT, V40, P4570, DOI 10.1002/grl.50875; Bezacier L, 2010, EARTH PLANET SC LETT, V289, P198, DOI 10.1016/j.epsl.2009.11.009; Drake MJ, 2005, METEORIT PLANET SCI, V40, P519; VASSILIOU MS, 1981, GEOPHYS RES LETT, V8, P729, DOI 10.1029/GL008i007p00729; Stalder R, 2001, CONTRIB MINERAL PETR, V140, P670; MITCHELL AC, 1982, J CHEM PHYS, V76, P6273, DOI 10.1063/1.443030; MEADE C, 1991, SCIENCE, V252, P68, DOI 10.1126/science.252.5002.68; Tsuchiya J, 2005, AM MINERAL, V90, P44, DOI 10.2138/am.2005.1628; Peacock SM, 2001, GEOLOGY, V29, P299, DOI 10.1130/0091-7613(2001)029<0299:ATLPOD>2.0.CO;2; Tsuchiya J, 2008, PHYS EARTH PLANET IN, V170, P215, DOI 10.1016/j.pepi.2008.05.015; Tomioka N, 2007, METEORIT PLANET SCI, V42, P19; DUFFY TS, 1991, J GEOPHYS RES-SOLID, V96, P14319, DOI 10.1029/91JB00987; Gong ZZ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019132; Irifune T., 2007, TREATISE GEOPHYS, V2, P33; Kalashnikov N., 1973, PHYSICS SOLID EARTH, V2, P23; Luo S.N., 2002, GEOPHYS RES LETT, V29; Marsh S. P., 1980, LASL SHOCK HUGONIOT; Nishi M., 2014, NATURE GEOSCIENCE; Nomura R, 2014, SCIENCE, V343, P522, DOI 10.1126/science.1248186; Sekine T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008439; Simakov G., 1974, PHYS SOLID EARTH, V8, P488; Stewart ST, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002305; Telegin G., 1980, PHYS SOLID EARTH, V16, P319; TYBURCZY JA, 1991, J GEOPHYS RES-SOL EA, V96, P18011, DOI 10.1029/91JB01573; TYBURCZY JA, 1990, EARTH PLANET SC LETT, V98, P245, DOI 10.1016/0012-821X(90)90063-4; Zhang Y., 2014, PHYS CHEM MINER, P1	31	3	3	MINERALOGICAL SOC AMER	CHANTILLY	3635 CONCORDE PKWY STE 500, CHANTILLY, VA 20151-1125 USA	0003-004X	1945-3027		AM MINERAL	Am. Miner.	NOV-DEC	2014	99	11-12					2374	2377		10.2138/am-2014-5021		4	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	AT6OH	WOS:000345058200025		
J	Ma, DW; Martin, N; Tribet, C; Winnik, FM				Ma, Dewang; Martin, Nicolas; Tribet, Christophe; Winnik, Francoise M.			Quantitative characterization by asymmetrical flow field-flow fractionation of IgG thermal aggregation with and without polymer protective agents	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						ImmunoglobulinG (IgG); Flow field-flow fractionation; Protein aggregation; Polymer/protein complexes; Amphiphilic polymers	IMMUNOGLOBULIN-G; PROTEINS; CHROMATOGRAPHY; NANOPARTICLES	Complexes formed between poly(acrylates) and polyclonal immunoglobulin G (IgG) in its native conformation and after heat stress were characterized using asymmetric flow field-flow fractionation (AF4) coupled with on-line UV-Vis spectroscopy and multi-angle light-scattering detection (MALS). Mixtures of IgG and poly(acrylates) of increasing structural complexity, sodium poly(acrylate) (PAA), a sodium poly(acrylate) bearing at random 3 mol % n-octadecyl groups, and a random copolymer of sodium acrylate (35 mol %), N-noctylacrylamide (25 mol %) and N-isopropylacrylamide (40 mol %), were fractionated in a sodium phosphate buffer (0.02 M, pH 6.8) in the presence, or not, of 0.1 M NaCl. The AF4 protocol developed allowed the fractionation of solutions containing free poly(acrylates), native IgG monomer and dimer, poly(acrylates)/IgG complexes made up of one IgG molecule and a few polymer chains, and/or larger poly(acrylates)/IgG aggregates. The molar mass and recovery of the soluble analytes were obtained for mixed solutions of poly(acrylates) and native IgG and for the same solutions incubated at 65 degrees C for 10min. Fromthe combined AF4 results, we concluded that in solutions of low ionic strength, the presence of PAA increased the recovery ratio of IgGafter thermal stress because of the formation of electrostatically-driven PAA/IgG complexes, but PAA had no protective effect in the presence of 0.1 M NaCl. Poly(acrylates) bearing hydrophobic groups significantly increased IgG recovery after stress, independently of NaCl concentration, because of the synergistic effect of hydrophobic and electrostatic interactions. The AF4 results corroborate conclusions drawn from a previous study combining four analytical techniques. This study demonstrates that AF4 is an efficient tool for the analysis of protein formulations subjected to stress, an important achievement given the anticipated important role of proteins in near-future human therapies.	[Ma, Dewang; Winnik, Francoise M.] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada; [Ma, Dewang; Winnik, Francoise M.] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Martin, Nicolas; Tribet, Christophe] Univ Paris 06, Univ Paris 04, Ecole Normale Super, PSL Res Univ,Dept Chim,CNRS,UMR PASTEUR 8640, F-75005 Paris, France; [Winnik, Francoise M.] Natl Inst Mat Sci, WPI Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan; [Winnik, Francoise M.] Univ Helsinki, Dept Chem, Helsinki 00014, Finland; [Winnik, Francoise M.] Univ Helsinki, Fac Pharm, FIN-00014 Helsinki, Finland	Winnik, FM (reprint author), Univ Montreal, Dept Chem, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	francoise.winnik@umontreal.ca	TRIBET, christophe/C-2868-2008		Natural Sciences and Engineering Research Council of Canada; Agence Nationale pour la Recherche [1501, ANR-11-LABX-0011-01]; World Premier International Research Center Initiative (MPI) MEXT Japan	This work was supported by the Natural Sciences and Engineering Research Council of Canada (Collaborative Strategic Program) and by the Agence Nationale pour la Recherche (program Blanc International, grant INT 1501 and program Investissement d'Avenir ANR-11-LABX-0011-01). F. M. W. also acknowledges financial support from the World Premier International Research Center Initiative (MPI) MEXT Japan.	Philo JS, 2006, AAPS J, V8, pE564, DOI 10.1208/aapsj080365; Roberts CJ, 2007, BIOTECHNOL BIOENG, V98, P927, DOI 10.1002/bit-21627; Wang W, 2010, INT J PHARMACEUT, V390, P89, DOI 10.1016/j.ijpharm.2010.02.025; Qureshi RN, 2011, ANAL BIOANAL CHEM, V399, P1401, DOI 10.1007/s00216-010-4278-3; Ma PL, 2010, ANAL CHEM, V82, P9636, DOI 10.1021/ac100711j; Hawe A, 2008, ANAL BIOCHEM, V378, P115, DOI 10.1016/j.ab.2008.03.050; Runyon JR, 2013, ANAL BIOANAL CHEM, V405, P6649, DOI 10.1007/s00216-013-7115-7; Heroult J, 2014, ANAL BIOANAL CHEM, V406, P3919, DOI 10.1007/s00216-014-7831-7; Hawe A, 2012, J PHARM SCI-US, V101, P4129, DOI 10.1002/jps.23298; Wahlund KG, 2013, J CHROMATOGR A, V1287, P97, DOI 10.1016/j.chroma.2013.02.028; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Yohannes G, 2011, J CHROMATOGR A, V1218, P4104, DOI 10.1016/j.chroma.2010.12.110; Pasch H, 2014, ANAL BIOANAL CHEM, V406, P1585, DOI 10.1007/s00216-013-7308-0; ZIMM BH, 1948, J CHEM PHYS, V16, P1093, DOI 10.1063/1.1746738; Schachermeyer S, 2012, J CHROMATOGR A, V1264, P72, DOI 10.1016/j.chroma.2012.09.050; Borrega R, 1999, MACROMOLECULES, V32, P7798, DOI 10.1021/ma981872c; Johnstone A, 1987, IMMUNOCHEMISTRY PRAC; LITZEN A, 1993, ANAL BIOCHEM, V212, P469, DOI 10.1006/abio.1993.1356; Ma DW, 2012, CHEM LETT, V41, P1380, DOI 10.1246/cl.2012.1380; Martin N, 2014, BIOMACROMOLECULES, V15, P2952, DOI 10.1021/bm5005756; Reschiglian P, 2014, ANAL BIOANAL CHEM, V406, P1619, DOI 10.1007/s00216-013-7462-4; Weiss WF, 2009, J PHARM SCI-US, V98, P1246, DOI 10.1002/jps.21521	22	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	NOV	2014	406	29					7539	7547		10.1007/s00216-014-8200-2		9	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	AT3UL	WOS:000344860300013		
J	Fuyamada, M; Shibata, M; Nawa, H; Yoshida, K; Kise, Y; Katsumata, A; Ariji, E; Goto, S				Fuyamada, Mariko; Shibata, Momoko; Nawa, Hiroyuki; Yoshida, Kazuhito; Kise, Yoshitaka; Katsumata, Akitoshi; Ariji, Eiichiro; Goto, Shigemi			Reproducibility of maxillofacial landmark identification on three-dimensional cone-beam computed tomography images of patients with mandibular prognathism Comparative study of a tentative method and traditional cephalometric analysis	ANGLE ORTHODONTIST			English	Article						CT landmarks; Mandibular prognathism; Cephalometric analysis	ANATOMIC LANDMARKS; FACIAL ASYMMETRY; 3D-CT EVALUATION; RELIABILITY; ACCURACY; CT; SCANS	Objective: To clarify the reproducibility of a tentative method for identifying maxillofacial landmarks on three-dimensional (3D) images obtained with cone-beam computed tomography (CBCT) for dental use in patients with mandibular prognathism. Also, the influence of level of experience of dentists applying the method was investigated by dividing them into two groups according to experience. Materials and Methods: Dentists with less (group A) or more (group B) than 3 years of experience of cephalometry and 3D image manipulation analyzed CBCT data from 10 patients. using two different landmark identification methods: method 1 used conventional cephalometric definitions and method 2 used detailed landmark identification definitions developed for each cross-sectional plane. The plotting of nine landmarks was performed twice, and 10 coordinate values were obtained for each landmark. To assess reproducibility, the 95% confidence ellipse method was used. Results: Comparative analysis showed that method 2 was highly reproducible. Group B subjects attained smaller ellipsoid volumes than group A subjects, regardless of the landmark identification method used. With method 1, except for condyle and coronoid process, all landmarks showed a higher level of reproducibility in group A subjects than in group B subjects. With method 2, however, five landmarks showed no differences between the methods. Conclusion: The method proposed here may be highly reproducible regardless of the evaluators' experience.	[Fuyamada, Mariko; Shibata, Momoko; Goto, Shigemi] Aichi Gakuin Univ, Sch Dent, Dept Orthodont, Nagoya, Aichi 4648651, Japan; [Nawa, Hiroyuki] Aichi Gakuin Univ, Sch Dent, Dept Pediat Dent, Nagoya, Aichi 4648651, Japan; [Yoshida, Kazuhito; Kise, Yoshitaka; Ariji, Eiichiro] Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Nagoya, Aichi 4648651, Japan; [Katsumata, Akitoshi] Asahi Univ, Sch Dent, Dept Oral Radiol, Hozumi, Japan	Fuyamada, M (reprint author), Aichi Gakuin Univ, Sch Dent, Dept Orthodont, Chikusa Ku, 2-11 Suemori Dori, Nagoya, Aichi 4648651, Japan.	fuyamada@dpc.aichi-gakuin.ac.jp		Katsumata, Akitoshi/0000-0001-5281-5234			Fuyamada M, 2011, ANGLE ORTHOD, V81, P843, DOI 10.2319/010711-5.1; Lopes PML, 2008, ORAL SURG ORAL MED O, V105, P224, DOI 10.1016/j.tripleo.2007.08.036; de Oliveira AEF, 2009, ORAL SURG ORAL MED O, V107, P256, DOI 10.1016/j.tripleo.2008.05.039; Lou L, 2007, ORAL SURG ORAL MED O, V104, P402, DOI 10.1016/j.tripleo.2006.07.015; Periago DR, 2008, ANGLE ORTHOD, V78, P387, DOI 10.2319/122106-52.1; Maeda M, 2006, ORAL SURG ORAL MED O, V102, P382, DOI 10.1016/j.tripleo.2005.10.057; Gribel BF, 2011, ANGLE ORTHOD, V81, P26, DOI 10.2319/032210-166.1; Hatano Y, 2009, J ORAL MAXIL SURG, V67, P1806, DOI 10.1016/j.joms.2009.04.018; WAITZMAN AA, 1992, CLEFT PALATE-CRAN J, V29, P112, DOI 10.1597/1545-1569(1992)029<0112:CSMBOC>2.3.CO;2; Kragskov J, 1997, CLEFT PALATE-CRAN J, V34, P111, DOI 10.1597/1545-1569(1997)034<0111:COTROC>2.3.CO;2; Ariji Y, 2000, DENTOMAXILLOFAC RAD, V29, P113, DOI 10.1038/sj.dmfr.4600515; Lascala C, 2004, DENTOMAXILLOFAC RAD, V33, P291, DOI 10.1259/dmfr/25500850; Katsumata A, 2005, ORAL SURG ORAL MED O, V99, P212, DOI 10.1016/j.tripleo.2004.06.072; Cavalcanti MGP, 2004, DENTOMAXILLOFAC RAD, V33, P170, DOI 10.1259/dmfr/13603271; Yitschaky O, 2011, ANGLE ORTHOD, V81, P11, DOI 10.2319/031710-157.1; Kawamata A, 2000, Dent Clin North Am, V44, P395; Kimura M, 2009, ORAL RADIOL, V25, P37, DOI 10.1007/s11282-009-0013-1; Maeda M, 2007, ORAL RADIOL, V23, P10, DOI 10.1007/s11282-007-0058-y; Maki K, 2003, Orthod Craniofac Res, V6 Suppl 1, P95, DOI 10.1034/j.1600-0544.2003.241.x; Muramatsu A, 2008, ANGLE ORTHOD, V78, P396, DOI 10.2319/040207-166.1; Naitoh M, 2010, J ORAL IMPLANTOL, V36, P377, DOI 10.1563/AAID-JOI-D-09-00080; Nakata K, 2009, J ENDODONT, V35, P1594, DOI 10.1016/j.joen.2009.05.029; Oded Y, 2011, ANGLE ORTHOD, V81, P11; Park SH, 2006, AM J ORTHOD DENTOFAC, V129, P600; Shibata M, 2012, ANGLE ORTHOD, V82, P776, DOI 10.2319/102511-662.1	25	1	1	E H ANGLE EDUCATION RESEARCH FOUNDATION, INC	NEWTON N	1615 BEACON ST, NEWTON N, MA 02468-1507 USA	0003-3219	1945-7103		ANGLE ORTHOD	Angle Orthod.	NOV	2014	84	6					966	973		10.2319/111313-836.1		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT6OD	WOS:000345057800005		
J	Muguruma, T; Iijima, M; Brantley, WA; Ahluwalia, KS; Kohda, N; Mizoguchi, I				Muguruma, Takeshi; Iijima, Masahiro; Brantley, William A.; Ahluwalia, Karamdeep S.; Kohda, Naohisa; Mizoguchi, Itaru			Effects of third-order torque on frictional force of self-ligating brackets	ANGLE ORTHODONTIST			English	Article						Friction; Self-ligating brackets; Archwire; SEM	INCREASE TREATMENT EFFICIENCY; IN-VITRO; ORTHODONTIC BRACKET; RESISTANCE; ALIGNMENT	Objective: To investigate the effects of third-order torque on frictional properties of self-ligating brackets (SLBs). Materials and Methods: Three SLBs (two passive and one active) and three archwires (0.016 x 0.022-inch nickel-titanium, and 0.017 x 0.025-inch and 0.019 x 0.025-inch stainless steel) were used. Static friction was measured by drawing archwires though bracket slots with four torque levels (0, 10, 20, 30), using a mechanical testing machine (n = 10). A conventional stainless-steel bracket was used for comparison. Results were subjected to Kruskal-Wallis and Mann-Whitney U-tests. Contact between the bracket and wire was studied using a scanning electron microscope. Results: In most bracket-wire combinations, increasing the torque produced a significant increase in static friction. Most SLB-wire combinations at all torques produced less friction than that from the conventional bracket. Active-type SLB-wire combinations showed higher friction than that from passive-type SLB-wire combinations in most conditions. When increasing the torque, more contact between the wall of a bracket slot and the edge of a wire was observed for all bracket types. Conclusions: Increasing torque when using SLBs causes an increase in friction, since contact between the bracket slot wall and the wire edge becomes greater; the design of brackets influences static friction.	[Muguruma, Takeshi; Iijima, Masahiro; Kohda, Naohisa; Mizoguchi, Itaru] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Growth & Dev, Div Orthodont & Dentofacial Orthoped, Ishikari, Hokkaido 0610293, Japan; [Brantley, William A.] Ohio State Univ, Coll Dent, Div Restorat Prosthet & Primary Care Dent, Columbus, OH 43210 USA; [Ahluwalia, Karamdeep S.] Jaipur Dent Coll, Dept Orthodont & Dentofacial Orthoped, Jaipur, Rajasthan, India	Iijima, M (reprint author), Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Growth & Dev, Div Orthodont & Dentofacial Orthoped, Kanazawa 1757, Ishikari, Hokkaido 0610293, Japan.	iijima@hoku-iryo-u.ac.jp					Huang TH, 2012, EUR J ORTHODONT, V34, P625, DOI 10.1093/ejo/cjr065; Rinchuse DJ, 2007, AM J ORTHOD DENTOFAC, V132, P216, DOI 10.1016/j.ajodo.2006.06.018; SAUNDERS CR, 1994, AM J ORTHOD DENTOFAC, V106, P76, DOI 10.1016/S0889-5406(94)70024-9; Wichelhaus A, 2005, DENT MATER, V21, P938, DOI 10.1016/j.dental.2004.11.011; Cacciafesta V, 2003, AM J ORTHOD DENTOFAC, V124, P395, DOI 10.1016/S0889-5406(03)00504-3; Thorstenson GA, 2002, AM J ORTHOD DENTOFAC, V122, P295, DOI 10.1067/mod.2002.126156; Bazakidou E, 1997, AM J ORTHOD DENTOFAC, V112, P138, DOI 10.1016/S0889-5406(97)70238-5; Berger JL, 2008, SEMIN ORTHOD, V14, P54, DOI 10.1053/j.sodo.2007.12.006; Burrow SJ, 2009, AM J ORTHOD DENTOFAC, V135, P442, DOI 10.1016/j.ajodo.2008.09.023; Chung M, 2009, ANGLE ORTHOD, V79, P551, DOI 10.2319/022608-114.1; Cordasco G, 2012, KOREAN J ORTHOD, V42, P218, DOI 10.4041/kjod.2012.42.4.218; Fleming PS, 2013, AM J ORTHOD DENTOFAC, V143, P11, DOI 10.1016/j.ajodo.2012.10.012; FRANK CA, 1980, AM J ORTHOD DENTOFAC, V78, P593, DOI 10.1016/0002-9416(80)90199-2; Harradine N, 2013, AM J ORTHOD DENTOFAC, V143, P10, DOI 10.1016/j.ajodo.2012.10.011; Harradine N W T, 2003, J Orthod, V30, P262, DOI 10.1093/ortho/30.3.262; KUSY RP, 1992, DENT MATER, V8, P167, DOI 10.1016/0109-5641(92)90076-O; Miles PG, 2006, ANGLE ORTHOD, V76, P480; Muguruma T, 2011, ANGLE ORTHOD, V81, P143; Pandis N, 2009, SELF LIGATION ORTHOD, P69; Redlich M, 2003, AM J ORTHOD DENTOFAC, V124, P69, DOI 10.1016/S0889-5406(03)00238-5; Stolzenberg J., 1935, INT J ORTHOD DENT CH, V21, P837, DOI 10.1016/S0097-0522(35)90368-9	21	0	0	E H ANGLE EDUCATION RESEARCH FOUNDATION, INC	NEWTON N	1615 BEACON ST, NEWTON N, MA 02468-1507 USA	0003-3219	1945-7103		ANGLE ORTHOD	Angle Orthod.	NOV	2014	84	6					1054	1061		10.2319/111913-845.1		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT6OD	WOS:000345057800017		
J	Nakano, T; Hotokezaka, H; Hashimoto, M; Sirisoontorn, I; Arita, K; Kurohama, T; Darendeliler, MA; Yoshida, N				Nakano, Takako; Hotokezaka, Hitoshi; Hashimoto, Megumi; Sirisoontorn, Inn; Arita, Kotaro; Kurohama, Takeshi; Darendeliler, M. Ali; Yoshida, Noriaki			Effects of different types of tooth movement and force magnitudes on the amount of tooth movement and root resorption in rats	ANGLE ORTHODONTIST			English	Article						Tooth movement; Root resorption; Type of tooth movement	MICROCOMPUTED TOMOGRAPHY; PHYSICAL-PROPERTIES; MODEL; ADOLESCENTS; ROTATION; EXTENT; MOLAR	Objective: To investigate differences in the amount of tooth movement and root resorption that occurred after tipping and bodily movement of the maxillary first molar in rats. Materials and Methods: Ten-week-old female Wistar rats were divided into two groups according to type of tooth movement and subdivided into four subgroups according to the magnitude of applied force. Nickel-titanium closed-coil springs exerting forces of 10, 25, 50, or 100 g were applied to the maxillary left first molars to induce mesial tooth movement. We designed a novel orthodontic appliance for bodily tooth movement. Tooth movement distance and root resorption were measured using microcomputed tomography and scanning electron and scanning laser microscopy. Results: The amount of tooth movement in the bodily tooth movement group was less than half that in the tipping tooth movement group. The greatest amount of tooth movement occurred in the 10-g tipping and 50-g bodily tooth movement subgroups, and the amount of tooth movement decreased with the application of an excessive magnitude of force. Conversely, root resorption increased when the heavier orthodontic force was applied in both groups. Root resorption in the tipping tooth movement group was approximately twice that in the bodily tooth movement group. Conclusions: Root resorption in the tipping tooth movement group was more pronounced than that in the bodily tooth movement group. Although the amount of tooth movement decreased when extremely heavy forces were applied, root resorption increased in both the tipping and bodily tooth movement groups in rats.	[Nakano, Takako; Hotokezaka, Hitoshi; Hashimoto, Megumi; Arita, Kotaro; Kurohama, Takeshi; Yoshida, Noriaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Nagasaki 8528588, Japan; [Sirisoontorn, Inn] Srinakharinwirot Univ, Panyananthaphikkhu Chonprathan Med Ctr, Dent Sect, Nonthaburi, Thailand; [Darendeliler, M. Ali] Univ Sydney, Dept Orthodont, Sydney Dent Hosp, South Western Sydney Area Hlth Serv, Sydney, NSW 2006, Australia	Hotokezaka, H (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Sakamoto 1-7-1, Nagasaki 8528588, Japan.	hotoke@nagasaki-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan	We appreciate the reviewers very much for their valuable and important comments to modify this paper. This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan.	Yoshida N, 2001, AM J ORTHOD DENTOFAC, V120, P190, DOI 10.1067/mod.2001.115036; Ren YJ, 2004, AM J ORTHOD DENTOFAC, V125, P71, DOI 10.1016/j.ajodo.2003.02.005; Gonzales C, 2008, ANGLE ORTHOD, V78, P502, DOI 10.2319/052007-240.1; Gonzales C, 2009, ANGLE ORTHOD, V79, P703, DOI 10.2319/071308-366.1; Wu ATJ, 2011, AM J ORTHOD DENTOFAC, V139, pE495, DOI 10.1016/j.ajodo.2010.01.036; King AD, 2011, AM J ORTHOD DENTOFAC, V140, pE299, DOI 10.1016/j.ajodo.2011.06.023; Ren YJ, 2004, EUR J ORTHODONT, V26, P483, DOI 10.1093/ejo/26.5.483; FROST HM, 1987, BONE MINER, V2, P73; OwmanMoll P, 1996, EUR J ORTHODONT, V18, P287; Weltman B, 2010, AM J ORTHOD DENTOFAC, V137, P462, DOI 10.1016/j.ajodo.2009.06.021; Bister D, 2013, EUR J ORTHODONT, V35, P160, DOI 10.1093/ejo/cjs007; BRUDVIK P, 1994, EUR J ORTHODONT, V16, P249; Brudvik P, 1993, Eur J Orthod, V15, P249; CHRISTIA.RL, 1969, AMER J ORTHODONTICS, V55, P353, DOI 10.1016/0002-9416(69)90143-2; Imamura N, 2002, ARCH ORAL BIOL, V47, P599, DOI 10.1016/S0003-9969(02)00041-9; Kohno T, 2002, J Orthod, V29, P129, DOI 10.1093/ortho/29.2.129; Montasser MA, 2014, EUR J ORTHODONT, V36, P31, DOI 10.1093/ejo/cjs110; Noda K, 2010, EUR J ORTHODONT, V32, P681, DOI 10.1093/ejo/cjq016; OwmanMoll P, 1996, EUR J ORTHODONT, V18, P141, DOI 10.1093/ejo/18.1.141; Proffit WR, 2006, CONT ORTHODONTICS, P343; Rhee JN, 2001, AM J ORTHOD DENTOFAC, V119, P292, DOI 10.1067/mod.2001.112452; Rudolph DJ, 2001, ANGLE ORTHOD, V71, P127; Sandstedt C., 1901, NAGRA BIDRAG TILL TA	23	1	1	E H ANGLE EDUCATION RESEARCH FOUNDATION, INC	NEWTON N	1615 BEACON ST, NEWTON N, MA 02468-1507 USA	0003-3219	1945-7103		ANGLE ORTHOD	Angle Orthod.	NOV	2014	84	6					1079	1085		10.2319/121913-929.1		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT6OD	WOS:000345057800021		
J	Inoue, H; Niimi, A; Takeda, T; Matsumoto, H; Ito, I; Matsuoka, H; Jinnai, M; Otsuka, K; Oguma, T; Nakaji, H; Tajiri, T; Iwata, T; Nagasaki, T; Kanemitsu, Y; Chin, K; Mishima, M				Inoue, Hideki; Niimi, Akio; Takeda, Tomoshi; Matsumoto, Hisako; Ito, Isao; Matsuoka, Hirofumi; Jinnai, Makiko; Otsuka, Kojiro; Oguma, Tsuyoshi; Nakaji, Hitoshi; Tajiri, Tomoko; Iwata, Toshiyuki; Nagasaki, Tadao; Kanemitsu, Yoshihiro; Chin, Kazuo; Mishima, Michiaki			Pathophysiological characteristics of asthma in the elderly: a comprehensive study	ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY			English	Article							AIRWAY WALL THICKNESS; COUGH-VARIANT ASTHMA; AGE-RELATED-CHANGES; COMPUTED-TOMOGRAPHY; INDUCED SPUTUM; INFLAMMATORY SUBTYPES; IMPULSE OSCILLOMETRY; PREDICTIVE EQUATIONS; FORCED OSCILLATION; QUANTITATIVE CT	Background: Comprehensive studies of the pathophysiologic characteristics of elderly asthma, including predominant site of disease, airway inflammation profiles, and airway hyperresponsiveness, are scarce despite their clinical importance. Objective: To clarify the pathophysiologic characteristics of elderly patients with asthma. Methods: Patients older than 65 years (elderly; n = 45) vs those no older than 65 years (nonelderly; n = 67) were retrospectively analyzed by spirometry, computed tomographic indices of large airway wall thickness and small airway involvement (air trapping), impulse oscillation measurements, exhaled nitric oxide levels, blood and induced sputum cell differentials, methacholine airway responsiveness, and total and specific serum IgE levels. Results: Elderly patients with asthma had significantly lower values for forced expiration volume in 1 second, mid-forced expiratory flow (percentage predicted), and ratio of forced expiration volume in 1 second to forced vital capacity than nonelderly patients with asthma (median 81.2% vs 88.8%, P = .02; 50.9% vs 78.6%, P = .03; 0.72 vs 0.78, P = .001, respectively). In computed tomographic measurements, elderly patients with asthma had significantly greater airway wall thickening and air trapping than nonelderly patients. Impulse oscillation measurements indicated that elderly patients with asthma showed significantly greater resistance at 5 Hz (used as an index of total airway resistance), greater decrease in resistance from 5 to 20 Hz, a higher ratio of decrease in resistance from 5 to 20 Hz to resistance at 5 Hz, higher integrated area between 5 Hz and frequency of resonance, greater frequency of resonance, and lower reactance at a frequency of 5 Hz (potential markers of small airway disease) than nonelderly patients. There were no significant differences in blood or sputum cell differentials, exhaled nitric oxide, or methacholine airway responsiveness between the 2 groups. Total serum IgE levels and positive rates of specific IgE antibodies against several allergens were significantly lower in elderly than in nonelderly patients with asthma. Conclusion: Based on spirometric, computed tomographic, and impulse oscillation analyses, elderly patients with asthma have greater involvement of small and large airways than nonelderly patients with asthma. (C) 2014 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.	[Inoue, Hideki; Takeda, Tomoshi; Matsumoto, Hisako; Ito, Isao; Matsuoka, Hirofumi; Jinnai, Makiko; Otsuka, Kojiro; Oguma, Tsuyoshi; Nakaji, Hitoshi; Tajiri, Tomoko; Iwata, Toshiyuki; Nagasaki, Tadao; Kanemitsu, Yoshihiro; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Niimi, Akio] Nagoya City Univ, Grad Sch Med, Dept Resp Med Allergy & Clin Immunol, Nagoya, Aichi 4678602, Japan; [Chin, Kazuo] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan	Niimi, A (reprint author), Nagoya City Univ, Grad Sch Med, Dept Resp Med Allergy & Clin Immunol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678602, Japan.	a.niimi@med.nagoya-cu.ac.jp					Cowan DC, 2010, THORAX, V65, P384, DOI 10.1136/thx.2009.126722; Ueda T, 2006, J ALLERGY CLIN IMMUN, V118, P1019, DOI 10.1016/j.jaci.2006.07.032; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Niimi A, 1998, EUR RESPIR J, V11, P1064, DOI 10.1183/09031936.98.11051064; Smith AD, 2004, AM J RESP CRIT CARE, V169, P473, DOI 10.1164/rccm.200310-1376OC; Chalmers GW, 2001, CHEST, V120, P1917, DOI 10.1378/chest.120.6.1917; Otsuka K, 2012, RESPIRATION, V83, P507, DOI 10.1159/000330840; Thomas RA, 2004, CHEST, V126, P1811, DOI 10.1378/chest.126.6.1811; Goldman MD, 2005, RESP PHYSIOL NEUROBI, V148, P179, DOI 10.1016/j.resp.2005.05.026; Mathur SK, 2008, CHEST, V133, P412, DOI 10.1378/chest.07-2114; Gibson PG, 2010, LANCET, V376, P803, DOI 10.1016/S0140-6736(10)61087-2; PIN I, 1992, THORAX, V47, P25, DOI 10.1136/thx.47.1.25; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Bai TR, 2000, AM J RESP CRIT CARE, V162, P663; [Anonymous], 2011, VIT STAT JAP, V1-3; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Niimi A, 2000, AM J RESP CRIT CARE, V162, P1518; [Anonymous], 1987, AM REV RESP DIS, V136, P225; Orlandi I, 2005, RADIOLOGY, V234, P604, DOI 10.1148/radiol.2342040013; Busse PJ, 2010, J ALLERGY CLIN IMMUN, V126, P690, DOI 10.1016/j.jaci.2010.08.011; Matsuoka H, 2009, CHEST, V135, P898, DOI 10.1378/chest.08-1783; Busacker A, 2009, CHEST, V135, P48, DOI 10.1378/chest.08-0049; Vignola AM, 2003, EUR RESPIR J, V22, P795, DOI 10.1183/09031936.03.00112302; Nyenhuis SM, 2010, J ALLERGY CLIN IMMUN, V125, P1163, DOI 10.1016/j.jaci.2010.02.015; Matsumoto H, 2005, THORAX, V60, P277, DOI 10.1136/thx.2004.028936; Wenzel S, 2012, CLIN EXP ALLERGY, V42, P650, DOI 10.1111/j.1365-2222.2011.03929.x; Takeda T, 2010, RESPIRATION, V80, P120, DOI 10.1159/000242113; Yamaguchi M, 2009, PULM PHARMACOL THER, V22, P326, DOI 10.1016/j.pupt.2009.01.005; Diaz-Guzman E, 2010, J ALLERGY CLIN IMMUN, V126, P702, DOI 10.1016/j.jaci.2010.08.022; Agache I, 2012, ALLERGY, V67, P835, DOI 10.1111/j.1398-9995.2012.02832.x; Australian Centre for Asthma Monitoring, ASTHM AUSTR 2008; Bellia V, 2009, EUR RESPIR MONOGR, P56; Calabresi C, 2007, EXP GERONTOL, V42, P1003, DOI 10.1016/j.exger.2007.06.016; Cassino C, 2000, AM J RESP CRIT CARE, V162, P1423; CHERNIAC.RM, 1972, AM REV RESPIR DIS, V106, P38; Cuttitta G, 2001, CHEST, V119, P1685, DOI 10.1378/chest.119.6.1685; GILLOOLY M, 1993, THORAX, V48, P39, DOI 10.1136/thx.48.1.39; Gono H, 2003, EUR RESPIR J, V22, P965, DOI 10.1183/09031936.03.00085302; Japanese Respiratory Society, 2001, REF VAL SPIR ART BLO; KALENDER WA, 1990, RADIOLOGY, V175, P265; Kang JY, 2013, CLIN INTERV AGING, V8, P1393, DOI 10.2147/CIA.S50496; Lederlin M, 2012, AM J ROENTGENOL, V199, P1226, DOI 10.2214/AJR.11.8396; Matsumoto H, 2011, RESPIRATION, V81, P311, DOI 10.1159/000319566; Matsuoka H, 2010, CHEST, V138, P1418, DOI [10.1378/chest.10-0132, 10.1378/chest.10.0132]; Matsuoka H, 2008, J ALLERGY CLIN IMMUN, V121, P774, DOI 10.1016/j.jaci.2007.11.032; Mitsunobu F, 2003, AM J RESP CRIT CARE, V167, P411, DOI 10.1164/rccm.2112070; Mitsuta K, 2001, RESPIRATION, V68, P460, DOI 10.1159/000050551; Newbury W, 2008, RESPIROLOGY, V13, P1070, DOI 10.1111/j.1440-1843.2008.01375.x; Niimi A, 2009, EUR RESPIR J, V1, pE1860; Niimi A, 2003, AM J RESP CRIT CARE, V168, P983, DOI 10.1164/rccm.200211.1268OC; Niimi A, 2004, CLIN REV ALLERG IMMU, V27, P45, DOI 10.1385/CRIAI:27:1:045; Ohara T, 2008, CHEST, V134, P1244, DOI 10.1378/chest.07-3054; S. American Thoracic and S. European Respiratory, 2005, AM J RESP CRIT CARE, V171, P912; Shi YX, 2012, J ALLERGY CLIN IMMUN, V129, P671, DOI 10.1016/j.jaci.2011.11.002; Shiota S, 2005, RESPIROLOGY, V10, P310, DOI 10.1111/j.1440-1843.2005.00703.x; Sippel JM, 2000, J ALLERGY CLIN IMMUN, V106, P645, DOI 10.1067/mai.2000.1096618; Takeda T, 2011, AM J RESP CRIT CARE, V183; Takemura M, 2004, CHEST, V125, P1352, DOI 10.1378/chest.125.4.1352; TAKISHIMA T, 1981, CHEST, V80, P600, DOI 10.1378/chest.80.5.600; TAKISHIMA T, 1991, AM REV RESPIR DIS, V143, pS49; US Census Bureau, 2014, WORLD POP INF INT DA; World Health Organization, 2012, DEF OLD ELD PERS HLT; Yamaguchi M, 2008, J INVEST ALLERG CLIN, V18, P202	63	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1081-1206	1534-4436		ANN ALLERG ASTHMA IM	Ann. Allergy Asthma Immunol.	NOV	2014	113	5					527	533		10.1016/j.anai.2014.08.002		7	Allergy; Immunology	Allergy; Immunology	AT4YM	WOS:000344949200007		
J	Yoshida, K; Adachi, Y; Sasaki, M; Furukawa, M; Itazawa, T; Hashimoto, K; Odajima, H; Akasawa, A				Yoshida, Koichi; Adachi, Yuichi; Sasaki, Mari; Furukawa, Mayumi; Itazawa, Toshiko; Hashimoto, Koji; Odajima, Hiroshi; Akasawa, Akira			Time-dependent variation in the responses to the web-based ISAAC questionnaire	ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY			English	Article							EXERCISE-INDUCED ASTHMA; SEASONAL-VARIATION; SCHOOL-CHILDREN; ATOPIC ECZEMA; PREVALENCE; POLLEN; SYMPTOMS; RHINITIS; ASSOCIATION; ALLERGIES	Background: Epidemiologic studies have shown seasonal variations in responses to the written questionnaire for rhinitis symptoms. Objective: To evaluate whether the timing of data collection affected responses to the International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire in a Web-based study. Methods: The Web-based ISAAC questionnaires were completed by parents with children 6 to 12 years old using an online research system. The authors conducted surveys of asthma symptoms every month for 1 year and surveys of rhinitis and eczema symptoms every season throughout 1 entire year. Results: There was a significant fluctuation in the positive responses to questions about wheezing in the past 12 months (P <.001) but not in the positive responses to questions about exercise-induced wheezing in the past 12 months and asthma ever (P =.75 and P = .15, respectively). The positive responses to questions about rhinitis and allergic rhinoconjunctivitis in the past 12 months and pollinosis ever exhibited significant seasonal variations (P = .002, P <.001, and P <.001, respectively). In contrast, there were no significant variations in positive responses regarding eczema in the past 12 months and eczema ever (P = .33 and P = .55, respectively). Conclusion: There were time-dependent fluctuations in responses to the Web-based questionnaire regarding allergic symptoms. Timing of data collection should be taken into account when evaluating prevalence of asthma and rhinitis in children. = 2014 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.	[Yoshida, Koichi; Sasaki, Mari; Furukawa, Mayumi; Akasawa, Akira] Tokyo Metropolitan Childrens Med Ctr, Div Allergy, Tokyo, Japan; [Adachi, Yuichi; Itazawa, Toshiko] Toyama Univ, Dept Pediat, Toyama 930, Japan; [Hashimoto, Koji] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo, Japan; [Odajima, Hiroshi] Fukuoka Natl Hosp, Dept Pediat, Fukuoka, Japan	Yoshida, K (reprint author), Tokyo Metropolitan Childrens Med Ctr, Div Allergy, 2-8-29 Musashidai, Fuchu, Tokyo 1838561, Japan.	kouichi_yoshida@tmhp.jp			Environmental Restoration and Conservation Agency, Japan	This study was supported by a grant from the Environmental Restoration and Conservation Agency, Japan.	Kroth PJ, 2009, ANN FAM MED, V7, P245, DOI 10.1370/afm.944; Darrow LA, 2012, J ALLERGY CLIN IMMUN, V130, P630, DOI 10.1016/j.jaci.2012.06.020; Yoshida K, 2013, ALLERGY, V68, P757, DOI 10.1111/all.12164; JOHNSTON SL, 1995, BRIT MED J, V310, P1225; Koh YI, 2002, RESPIRATION, V69, P38, DOI 10.1159/000049368; Silverberg JI, 2013, J INVEST DERMATOL, V133, P1752, DOI 10.1038/jid.2013.19; Weiland SK, 2004, OCCUP ENVIRON MED, V61, P609, DOI 10.1136/oem.2002.006809; Okupa AY, 2013, CHEST, V143, P993, DOI 10.1378/chest.12-1055; Kramer U, 2005, J INVEST DERMATOL, V124, P514, DOI 10.1111/j.0022-202X.2005.23625.x; Suarez-Varela MM, 2008, INT J BIOMETEOROL, V52, P833, DOI 10.1007/s00484-008-0177-0; Peters SP, 2007, J ALLERGY CLIN IMMUN, V119, P1454, DOI 10.1016/j.jaci.2007.03.022; Yamazaki S, 2009, J EPIDEMIOL, V19, P143, DOI 10.2188/jea.JE20081025; Osborne NJ, 2012, J ALLERGY CLIN IMMUN, V129, P865, DOI 10.1016/j.jaci.2012.01.037; van Gelder MMHJ, 2010, AM J EPIDEMIOL, V172, P1292, DOI 10.1093/aje/kwq291; Gleason JA, 2014, ENVIRON RES, V132, P421, DOI 10.1016/j.envres.2014.03.035; Calderon P, 2009, J EUR ACAD DERMATOL, V23, P1328, DOI 10.1111/j.1468-3083.2009.03154.x; ASHER MI, 1988, AM REV RESPIR DIS, V138, P524; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Choi IS, 2012, ALLERGY ASTHMA IMMUN, V4, P192, DOI 10.4168/aair.2012.4.4.192; Demoly P, 2009, Eur Respir Rev, V18, P105, DOI 10.1183/09059180.00001209; HENRIKSEN JM, 1986, ALLERGY, V41, P499, DOI 10.1111/j.1398-9995.1986.tb00335.x; KARJALAINEN J, 1989, CLIN EXP ALLERGY, V19, P273, DOI 10.1111/j.1365-2222.1989.tb02383.x; KHOT A, 1984, BRIT MED J, V289, P235; Okabe Y, 2011, PEDIATR INT, V53, P192, DOI 10.1111/j.1442-200X.2010.03197.x; PEAT JK, 1994, BRIT MED J, V308, P1591; Sears MR, 2007, J ALLERGY CLIN IMMUN, V120, P526, DOI 10.1016/j.jaci.2007.05.047; Stewart AW, 1997, INT J EPIDEMIOL, V26, P126, DOI 10.1093/ije/26.1.126; Yoshida K, 2014, ANN ALLERG ASTHMA IM, V112, P181, DOI 10.1016/j.anai.2013.12.008	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1081-1206	1534-4436		ANN ALLERG ASTHMA IM	Ann. Allergy Asthma Immunol.	NOV	2014	113	5					539	543		10.1016/j.anai.2014.07.027		5	Allergy; Immunology	Allergy; Immunology	AT4YM	WOS:000344949200009		
J	Tsunoda, M; Tsunoda, K				Tsunoda, Meiko; Tsunoda, Koichi			Patient-Controlled Taping for the Treatment of Ingrown Toenails	ANNALS OF FAMILY MEDICINE			English	Article						ingrown nails; self-care; adhesive surgical tape; nail bracing; taping	MANAGEMENT; NAIL	Various methods are used to treat ingrown or pincer-like toenails. We developed a novel taping method to prevent topical interruption of the circulation and resulting skin conditions and evaluated it over 14.5 years. We instructed 541 patients or their guardians in the use of the technique. Ingrown toenail symptoms and abnormal nail growth were resolved and no additional therapy was required in 276 patients. The novel taping method was significantly more effective than treatments our patients had received previously. Patient-controlled taping is the first-line treatment for every ingrown or curved toenail seen in our clinic.	[Tsunoda, Meiko] Tsunoda Clin, Dept Dermatol, Tokyo, Japan; [Tsunoda, Koichi] Natl Hosp Org, Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Dept Artificial Organs & Med Device Creat, Tokyo 1598902, Japan	Tsunoda, K (reprint author), Natl Hosp Org, Natl Tokyo Med Ctr, Dept Artificial Organs & Med Device Creat, Natl Inst Sensory Organs,Meguro Ku, 2-5-1 Higashigaoka, Tokyo 1598902, Japan.	tsunodakoichi@kankakuki.go.jp			National Hospital Organization, Japan	This research was supported in part by a grant in aid from the National Hospital Organization, Japan.	WALLACE WA, 1979, BRIT MED J, V2, P168; Schulte KW, 1998, J AM ACAD DERMATOL, V39, P629; Heidelbaugh JJ, 2009, AM FAM PHYSICIAN, V79, P303; NISHIOKA K, 1985, BRIT J DERMATOL, V113, P246; SENAPATI A, 1986, J ROY SOC MED, V79, P339; Zuber TJ, 2002, AM FAM PHYSICIAN, V65, P2547; Arai H, 2004, INT J DERMATOL, V43, P759, DOI 10.1111/j.1365-4632.2004.02342.x; Harrer J, 2005, J AM PODIAT MED ASSN, V95, P542; Karaca N, 2012, ANN FAM MED, V10, P556, DOI 10.1370/afm.1406; Strube HD, 1993, ORTHOPED TRAUMATOL, V2, P60, DOI 10.1007/BF02620537	10	0	0	ANNALS FAMILY MEDICINE	LEAWOOD	11400 TOMAHAWK CREEK PARKWAY, LEAWOOD, KS 66211-2672 USA	1544-1709	1544-1717		ANN FAM MED	Ann. Fam. Med.	NOV-DEC	2014	12	6					553	555		10.1370/afm.1712		3	Primary Health Care; Medicine, General & Internal	General & Internal Medicine	AT5DE	WOS:000344962900011		
J	Tohda, S				Tohda, Shuji			NOTCH Signaling Roles in Acute Myeloid Leukemia Cell Growth and Interaction with other Stemness-related Signals	ANTICANCER RESEARCH			English	Review						Acute myeloid leukaemia; NOTCH; JAGGED; WNT; HEDGEHOG; review	GAMMA-SECRETASE INHIBITORS; SELF-RENEWAL CAPACITY; ACUTE MYELOBLASTIC-LEUKEMIA; LYMPHOMA-CELLS; HEMATOLOGICAL MALIGNANCIES; ACTIVATING MUTATIONS; DELTA-1; LIGAND; DIFFERENTIATION; EXPRESSION	NOTCH activation plays oncogenic roles in acute T-lymphoblastic leukaemia (T-ALL). However, whether NOTCH is oncogenic or tumor-suppressive in acute myeloid leukaemia (AML) is still controversial. Herein, the roles of NOTCH in AML are reviewed. AML cells express NOTCH and NOTCH ligands; however, cell-autonomous activation is not observed. Activating NOTCH1 mutations are rare in AML, unlike in T-ALL. NOTCH ligand stimulation generally suppresses the in vitro growth of AML cells but promotes transient growth of some samples. Conversely, knockdown of NOTCH1 and NOTCH2 does not affect the growth of AML cells, whereas it suppresses the growth of T-ALL cells. These findings suggest that NOTCH is dispensable or suppressive for AML cell growth. However, the effects of NOTCH differ depending on cell conditions, and various stemness-related signals modify these effects; hence, forced NOTCH activation in vitro may not exhibit effects in bone marrow. Thus, further understanding is required for the development of AML therapies targeting NOTCH signalling.	[Tohda, Shuji] Tokyo Med & Dent Univ, Dept Lab Med, Tokyo 1138519, Japan	Tohda, S (reprint author), Tokyo Med & Dent Univ, Dept Lab Med, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138519, Japan.	tohda.mlab@tmd.ac.jp					Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Lobry C, 2013, J EXP MED, V210, P301, DOI 10.1084/jem.20121484; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Kawaguchi-Ihara N, 2008, ANTICANCER RES, V28, P2701; Takeuchi H, 2010, SEMIN CELL DEV BIOL, V21, P638, DOI 10.1016/j.semcdb.2010.03.003; Kawahara T, 2009, ANTICANCER RES, V29, P4629; Okuhashi Y, 2011, ANTICANCER RES, V31, P893; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Yonekura S, 2013, ANTICANCER RES, V33, P3099; Tohda S, 2001, LEUKEMIA LYMPHOMA, V42, P467, DOI 10.3109/10428190109064603; Murata-Ohsawa M, 2005, LEUKEMIA RES, V29, P197, DOI 10.1016/j.leukres.2004.05.020; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Andersen P, 2012, TRENDS CELL BIOL, V22, P257, DOI 10.1016/j.tcb.2012.02.003; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Espinoza I, 2013, PHARMACOL THERAPEUT, V139, P95, DOI 10.1016/j.pharmthera.2013.02.003; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Wouters BJ, 2007, BLOOD, V110, P3706, DOI 10.1182/blood-2007-02-073486; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; Chiang MY, 2013, BLOOD, V121, P905, DOI 10.1182/blood-2012-03-416503; Adamia S, 2014, BLOOD, V123, P2816, DOI 10.1182/blood-2013-02-481507; Kannan S, 2013, J EXP MED, V210, P321, DOI 10.1084/jem.20121527; Bigas A, 2012, BLOOD, V119, P3226, DOI 10.1182/blood-2011-10-355826; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; Chapuis N, 2010, LEUKEMIA, V24, P1686, DOI 10.1038/leu.2010.170; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Grieselhuber NR, 2013, LEUKEMIA, V27, P1548, DOI 10.1038/leu.2013.68; Dallas MH, 2005, J EXP MED, V201, P1361, DOI 10.1084/jem.20042450; Fu L, 2007, LEUKEMIA RES, V31, P1160, DOI 10.1016/j.leukres.2006.09.020; Fu L, 2009, ANTICANCER RES, V29, P3967; Fu L, 2006, LEUKEMIA LYMPHOMA, V47, P2400, DOI 10.1080/10428190600773339; Itoh M, 2009, ONCOL REP, V22, P631, DOI 10.3892/or_00000482; Kanamori E, 2012, EXP THER MED, V4, P397, DOI 10.3892/etm.2012.633; Kawaguchi-Ihara N, 2011, ANTICANCER RES, V31, P781; Kogoshi H, 2007, ONCOL REP, V18, P77; Murata-Ohsawa M, 2004, INT J MOL MED, V14, P223; Murata-Ohsawa M, 2004, INT J MOL MED, V14, P861; Okuhashi Y, 2010, ANTICANCER RES, V30, P495; Okuhashi Y, 2013, ANTICANCER RES, V33, P4293; Okuhashi Y, 2010, ANTICANCER RES, V30, P4071; Ono A, 2013, ANTICANCER RES, V33, P809; Palomero T, 2006, LEUKEMIA, V20, P1963, DOI 10.1038/sj.leu.2404409; Takahashi Y, 2012, ANTICANCER RES, V32, P2813; Tohda S, 2003, INT J ONCOL, V22, P1073; Tohda S, 2005, EXP HEMATOL, V33, P558, DOI 10.1016/j.exphem.2005.01.010; Tohda S, 2002, BRIT J HAEMATOL, V117, P373, DOI 10.1046/j.1365-2141.2002.03446.x	48	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2014	34	11					6259	6264				6	Oncology	Oncology	AT5CN	WOS:000344961300001		
J	Nair, N; Kasai, T; Seno, M				Nair, Neha; Kasai, Tomonari; Seno, Masaharu			Bacteria: Prospective Savior in Battle against Cancer	ANTICANCER RESEARCH			English	Review						Bacteria; attenuation; toxins; polysaccharide; vector; treatment; review	CLOSTRIDIUM-PERFRINGENS ENTEROTOXIN; INHIBIT TUMOR-GROWTH; SALMONELLA-TYPHIMURIUM; COLON-CANCER; LISTERIA-MONOCYTOGENES; DRUG-DELIVERY; GENE-THERAPY; CELLS; IMMUNOTHERAPY; VACCINE	Conventional anticancer therapies such as chemotherapy are losing their sheen in the battle against cancer. Therefore, strategies for treatment of cancer need to be constantly modified to fulfill the growing demands of alternative therapies. Several viral and non-viral vectors have been exploited for anticancer gene therapy. But over the years bacteria have been proven to be an important candidate for successful evasion of cancer. They serve as invaluable source of tumor-specific anticancer genes, toxins, polysaccharides for synthesis of nanodrugs and gene-delivery vectors. The current review assesses the role of important bacterial groups in different spheres of anti-cancer research.	[Nair, Neha; Kasai, Tomonari; Seno, Masaharu] Okayama Univ, Dept Biotechnol, Div Chem & Biotechnol, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	Seno, M (reprint author), Okayama Univ, Dept Biotechnol, Div Chem & Biotechnol, Grad Sch Nat Sci & Technol,Fac Eng,Kita Ku, Km 460,Bldg ENG 6,3,1-1 Tsushima Naka, Okayama 7008530, Japan.	mseno@cc.okayama-u.ac.jp	SENO, Masaharu /B-2092-2011	SENO, Masaharu /0000-0001-8547-6259			Al-Ramadi BK, 2008, ANN NY ACAD SCI, V1138, P351, DOI 10.1196/annals.1414.036; Yamada T, 2004, P NATL ACAD SCI USA, V101, P4770, DOI 10.1073/pnas.0400899101; Dang LH, 2001, P NATL ACAD SCI USA, V98, P15155, DOI 10.1073/pnas.251543698; Ruan ZH, 2009, J IMMUNOTHER, V32, P486, DOI 10.1097/CJI.0b013e3181a1d134; Chen YT, 2013, ONCOL LETT, V5, P1787, DOI 10.3892/ol.2013.1284; Yuk JM, 2010, AUTOPHAGY, V6, P46; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Hayashi K, 2009, J CELL BIOCHEM, V106, P992, DOI 10.1002/jcb.22078; SHINKAI M, 1995, BIOTECHNOL APPL BIOC, V21, P125; Ganai S, 2009, BRIT J CANCER, V101, P1683, DOI 10.1038/sj.bjc.6605403; Raveendran S, 2013, CARBOHYD POLYM, V91, P22, DOI 10.1016/j.carbpol.2012.07.079; ASO Y, 1992, UROL INT, V49, P125; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Richardson MA, 1999, ALTERN THER HEALTH M, V5, P42; Liu SC, 2002, GENE THER, V9, P291, DOI 10.1038/sj/gt/3301659; Chorobik P, 2013, ACTA BIOCHIM POL, V60, P285; Nemunaitis J, 2003, CANCER GENE THER, V10, P737, DOI 10.1038/sj.cgt.7700634; Robbins DH, 2000, CLIN CANCER RES, V6, P693; Nuyts S, 2001, GENE THER, V8, P1197, DOI 10.1038/sj.gt.3301499; CHAUDHARY VK, 1989, NATURE, V339, P394, DOI 10.1038/339394a0; Pawelek JM, 1997, CANCER RES, V57, P4537; Mathew M, 2009, CANCER SCI, V100, P1359, DOI 10.1111/j.1349-7006.2009.01192.x; Yang Y, 2014, CELL MOL IMMUNOL, V11, P184, DOI 10.1038/cmi.2013.64; Singh J, 1997, CARCINOGENESIS, V18, P833, DOI 10.1093/carcin/18.4.833; Kim Y, 2010, LETT APPL MICROBIOL, V51, P123, DOI 10.1111/j.1472-765X.2010.02859.x; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Zhang L, 2007, CANCER RES, V67, P5859, DOI 10.1158/0008-5472.CAN-07-0098; Ma EL, 2010, INT J CANCER, V127, P780, DOI 10.1002/ijc.25011; Maeda T, 2012, PROSTATE, V72, P351, DOI 10.1002/pros.21436; Linnebacher M, 2012, LANGENBECK ARCH SURG, V397, P557, DOI 10.1007/s00423-011-0892-6; Bunting A, 2013, UOJM, V3, P26; Daniluk J, 2012, J CLIN EXP ONCOL, V1, P2; Frankel AE, 2002, CURR CANCER DRUG TAR, V2, P19, DOI 10.2174/1568009023333944; Gao ZJ, 2011, CLIN CANCER RES, V17, P1065, DOI 10.1158/1078-0432.CCR-10-1644; Gravekamp C, 2010, CANCER BIOL THER, V9, P257, DOI 10.4161/cbt.9.4.11216; Hobohm U, 2008, CRIT REV IMMUNOL, V28, P95; Jasosz M, 2013, GENE THER, V20, P262; Karbach J, 2012, CLIN CANCER RES, V18, P5449, DOI 10.1158/1078-0432.CCR-12-1116; Kim CN, 1999, LEUKEMIA RES, V23, P527, DOI 10.1016/S0145-2126(99)00039-9; Kreitman RJ, 2009, BIODRUGS, V23, P1, DOI 10.2165/00063030-200923010-00001; Lee CH, 2005, CANCER GENE THER, V12, P175, DOI 10.1038/sj.cgt.7700777; Li X, 2003, CANCER GENE THER, V10, P105, DOI 10.1038/sj.cgt.7700530; Loeffler M, 2008, CANCER GENE THER, V15, P787, DOI 10.1038/cgt.2008.48; Loeffler M, 2009, CANCER IMMUNOL IMMUN, V58, P769, DOI 10.1007/s00262-008-0555-9; Marais R, 1996, CANCER RES, V56, P4735; Masuyama A, 2005, J PHARMACOL EXP THER, V314, P789, DOI 10.1124/jpet.105.085399; MINTON NP, 1995, FEMS MICROBIOL REV, V17, P357, DOI 10.1111/j.1574-6976.1995.tb00219.x; MOSE JR, 1964, CANCER RES, V24, P212; Nauts H C, 1980, CANC RES I MONOGRAPH, V8, P2; Park SJ, 2013, NATURE SCI REPORTS, V3, P3394; Patyar S, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-21; Paukner S, 2004, J CONTROL RELEASE, V94, P63, DOI 10.1016/j.jconrel.2003.09.010; Richard A, 1955, CANCER RES, V15, P473; Soccol CR, 2010, FOOD TECHNOL BIOTECH, V48, P413; Umer B, 2012, J TOXICOLOGY, V2012; Yu B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00436; Zhang Y, 2010, PONE, V5, P5; Zhang Y, 2012, ANTICANCER RES, V32, P501; Zhang YL, 2012, APPL ENVIRON MICROB, V78, P7603, DOI 10.1128/AEM.01390-12	59	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2014	34	11					6289	6296				8	Oncology	Oncology	AT5CN	WOS:000344961300006		
J	Batsaikhan, BE; Yoshikawa, K; Kurita, N; Iwata, T; Takasu, C; Kashihara, H; Shimada, M				Batsaikhan, Bat-Erdene; Yoshikawa, Kozo; Kurita, Nobuhiro; Iwata, Takashi; Takasu, Chie; Kashihara, Hideya; Shimada, Mitsuo			Cyclopamine Decreased the Expression of Sonic Hedgehog and its Downstream Genes in Colon Cancer Stem Cells	ANTICANCER RESEARCH			English	Article						Cancer stem-like cells; epithelial-inesenchymal transition; cancer cells; sonic hedgehog	EPITHELIAL-MESENCHYMAL TRANSITION; PANCREATIC-CANCER; SIGNALING PATHWAY; E-CADHERIN; TARGET; METASTASIS	Backround: Most solid cancers including colon cancer are believed to be initiated from and maintained by cancer stem cells (CSCs), that are responsible for treatment resistance, resulting in tumor relapse. The aim of this study was to clarify the possible role of the Sonic Hedgehog (Shh) signaling pathway in the regulation of cancer stem cells. Materials and Methods: The HCT-116 cell line was cultured with fetal bovine serum in RPM1-1640 medium and its sphere was grown in serum-free non-adherent culture. Gene expressions were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) from cells treated with and without cyclopamine. Results: HCT-116 sphere-derived cells grown in serum-free, non-adherent culture, showed significantly increased expression of stem cell markers, Shh downstream genes and epithelial-mesenchymal transition (EMT) markers compared to parental cells grown in conventional culture. The expression of sternness markers. Shh downstream genes and EMT markers were higher in cancer spheres than the parental cell line and downregulated by cyclopamine treatment in a dose-dependent manner. Conclusion: Overall, these findings show that cyclopamine treatment could down-regulate the expression of sternness markers chh downstream genes and EMT markers on HCT-116 spheres.	[Batsaikhan, Bat-Erdene; Yoshikawa, Kozo; Kurita, Nobuhiro; Iwata, Takashi; Takasu, Chie; Kashihara, Hideya; Shimada, Mitsuo] Univ Tokushima, Dept Surg, Inst Hlth Biosci, Tokushima 7708503, Japan	Yoshikawa, K (reprint author), Univ Tokushima, Dept Surg, Inst Hlth Biosci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	yoshikawa.kozo@tokushima-u.ac.jp					Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Zhang CJ, 2011, J CANCER RES CLIN, V137, P1679, DOI 10.1007/s00432-011-1038-5; Santin AD, 2005, CANCER RES, V65, P4334, DOI 10.1158/0008-5472.CAN-04-3472; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Yin X, 2012, ANN SURG ONCOL, V19, P2877, DOI 10.1245/s10434-012-2314-6; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Katoh Y, 2009, CURR MOL MED, V9, P873; Sims-Mourtada J, 2006, CLIN CANCER RES, V12, P6565, DOI 10.1158/1078-0432.CCR-06-0176; Sun XD, 2013, ONCOL REP, V29, P2401, DOI 10.3892/or.2013.2385; Rodova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046083; Seidel B, 2004, ONCOGENE, V23, P5532, DOI 10.1038/sj.onc.1207718; Shida T, 2006, CANCER BIOL THER, V5, P1530; Song Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017687; Turksen K, 2011, STEM CELL REV REP, V7, P797, DOI 10.1007/s12015-011-9267-1; Xu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043119; Yao J, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13208	23	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2014	34	11					6339	6344				6	Oncology	Oncology	AT5CN	WOS:000344961300012		
J	Koido, S; Kan, S; Yoshida, K; Yoshizaki, S; Takakura, K; Namiki, Y; Tsukinaga, S; Odahara, S; Kajihara, M; Okamoto, M; Ito, M; Yusa, SI; Gong, JL; Sugiyama, H; Ohkusa, T; Homma, S; Tajiri, H				Koido, Shigeo; Kan, Shin; Yoshida, Kosaku; Yoshizaki, Shinji; Takakura, Kazuki; Namiki, Yoshihisa; Tsukinaga, Shintaro; Odahara, Shunichi; Kajihara, Mikio; Okamoto, Masato; Ito, Masaki; Yusa, Sei-ichi; Gong, Jianlin; Sugiyama, Haruo; Ohkusa, Toshifumi; Homma, Sadamu; Tajiri, Hisao			Immunogenic Modulation of Cholangiocarcinoma Cells by Chemoimmunotherapy	ANTICANCER RESEARCH			English	Article						Gemcitabine; 5-fluorouracil; IFN-gamma; WT1; PDL1; chemoimmunotherapy; immunomodulation	PANCREATIC-CANCER; CALRETICULIN EXPOSURE; IMMUNE-SYSTEM; CHEMOTHERAPY; IMMUNOTHERAPY; GEMCITABINE; DEATH; COMBINATION; RESPONSES; VACCINE	Backgrou 1 At Chcmoiinmunolherapy has been used to treat intrahepatic cholangiocarcinoma ICC). However, little is known about the phenomena underlying the immunomodulation of ICC cells elicited by chemoimmunotherapy. Materials and Methods: Primary ICC cells from a patient with ICC who received gemcitabine followed by 5fluorouracil (5-FU), both combined with dendritic cells pulsed with Wilms' tumor 1 (WT1) peptides were cultured. ICC cells were treated with gemcitabine, 5-FU or interferon (IFN)-gamma in vitro. The phenotype of the ICC cells was examined by flow cvtometry and quantitative reverse transcription polymerase chain reaction. Results: Stimulation of the ICC cells with gemcitabine resulted in up-regulation of WTI mRNA, programmed death receptor ligand-I (PEIL]) and calreticulin. Gemcitabine, 5-FU and IFN-gamma induced upregulation of mucin-I. Moreover, human leukocyte antigen (HLA)-ABC, HLA-DR and PDLI were extremely upregulated by 1FN-gamma. Conclusion: Chemohnumnomodulating agents alter the immunogenicity of ICC cells, resulting in complex clinical efficacy results.	[Koido, Shigeo; Takakura, Kazuki; Tsukinaga, Shintaro; Odahara, Shunichi; Kajihara, Mikio; Ohkusa, Toshifumi; Tajiri, Hisao] Jikei Univ, Div Gastroenterol & Hepatol, Sch Med, Dept Internal Med, Tokyo, Japan; [Koido, Shigeo; Namiki, Yoshihisa] Jikei Univ, Inst Clin Med & Res, Sch Med, Tokyo, Japan; [Koido, Shigeo; Kan, Shin; Ito, Masaki; Homma, Sadamu] Jikei Univ, Dept Oncol, Sch Med, Tokyo, Japan; [Yoshida, Kosaku; Yoshizaki, Shinji; Yusa, Sei-ichi] Tella Inc, Res & Dev Div, Tokyo, Japan; [Okamoto, Masato] Kitasato Univ, Dept Adv Immunotherapeut, Sch Pharm, Tokyo, Japan; [Gong, Jianlin] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Sugiyama, Haruo] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Osaka, Japan	Koido, S (reprint author), Jikei Univ, Dept Gastroenterol & Hepatol, Sch Med, 163-1 Kashiwa Shita, Kashiwa, Chiba 2778567, Japan.	shigeo_koido@jikei.ac.jp			Ministry of Education, Cultures, Sports, Science and Technology of Japan; Mitsui Life Social Welfare Foundation	This work was supported, in part, by Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Cultures, Sports, Science and Technology of Japan and the Mitsui Life Social Welfare Foundation.	Algarra I, 2004, CANCER IMMUNOL IMMUN, V53, P904, DOI 10.1007/s00262-004-0517-9; Takahara A, 2011, CANCER IMMUNOL IMMUN, V60, P1289, DOI 10.1007/s00262-011-1033-3; Kimura Y, 2012, PANCREAS, V41, P195, DOI 10.1097/MPA.0b013e31822398c6; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Nishida S, 2014, J IMMUNOTHER, V37, P105, DOI 10.1097/CJI.0000000000000020; Koido S, 2014, CLIN CANCER RES, V20, P4228, DOI 10.1158/1078-0432.CCR-14-0314; Obeid M, 2007, CANCER RES, V67, P7941, DOI 10.1158/0008-5472.CAN-07-1622; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Hodge JW, 2013, INT J CANCER, V133, P624, DOI 10.1002/ijc.28070; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Zitvogel L, 2012, ONCOIMMUNOLOGY, V1, P1223, DOI 10.4161/onci.21335; Sugiyama H, 2005, EXPERT REV VACCINES, V4, P503, DOI 10.1586/14760584.4.4-503; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Furuse Junji, 2011, Cancers (Basel), V3, P2243, DOI 10.3390/cancers3022243; Kaida M, 2011, J IMMUNOTHER, V34, P92, DOI 10.1097/CJI.0b013e3181fb65b9; Koido S, 2012, IMMUNOTHERAPY-UK, V4, P5, DOI [10.2217/imt.11.150, 10.2217/IMT.11.150]; National Cancer Institute, 2011, COMM TERM CRIT ADV E; Ramírez-Merino Natalia, 2013, World J Gastrointest Oncol, V5, P171, DOI 10.4251/wjgo.v5.i7.171; Taube JM, 2012, SCI TRANSL MED, V4, P127, DOI DOI 10.1126/SCITRANSLMED.3003689	23	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2014	34	11					6353	6361				9	Oncology	Oncology	AT5CN	WOS:000344961300014		
J	Masuda, T; Nakashima, Y; Ando, K; Yoshinaga, K; Saeki, H; Oki, E; Morita, M; Oda, Y; Maehara, Y				Masuda, Takanobu; Nakashima, Yuichiro; Ando, Koji; Yoshinaga, Keiji; Saeki, Hiroshi; Oki, Eiji; Morita, Masaru; Oda, Yoshinao; Maehara, Yoshihiko			Nuclear Expression of Chemokine Receptor CXCR4 Indicates Poorer Prognosis in Gastric Cancer	ANTICANCER RESEARCH			English	Article						CXCL12; immunohistochemistry; translocation	LYMPH-NODE METASTASIS; COLORECTAL-CANCER; BREAST-CANCER; LIGAND SDF-1; TUMOR-CELLS; CARCINOMA; CXCL12; SDF-1-ALPHA; SURVIVAL; TRACT	Background: The CXCL12ICXCR4 axis plays a pivotal role in cancer progression and metastases in epithelial cancer cells. The aim of the present study was to evaluate the localization and correlation between CXCL.121CXCR4 expression and clinicopathological features in gastric cancers. Materials and Methods: This study included 111 Japanese patients with primary gastric cancers, which invade submucosa or more, all of whom underwent gastrectomy between 1992 and 1996. Immunohistochemical analysis was per/armed, Results: A significant correlation was found in the immunoreactivity of nuclear CXCR4 and poor differentiation (p== 0,0026 infiltrated pattern (p<0.0001), larger size (p<0.0001), advanced stage (p=0.0342) and reduced 5-year survival rate (30% vs. 61%, p=0.0012). Multivariate analysis revealed that high nuclear CXCR4 inummoreactivity (RR: 3.077, p=0.0329) retained its strength as an independent prognostic factor for overall survival. Conclusion: High immunoreactivitv of nuclear CXCR4 in gastric cancer suggests that CXCL12 binds to its unique receptor CXCR4 at the membrane, translocates to the nucleus and then becomes more invasive, and thus can be considered a prognostic factor.	[Masuda, Takanobu; Nakashima, Yuichiro; Ando, Koji; Yoshinaga, Keiji; Saeki, Hiroshi; Oki, Eiji; Morita, Masaru; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 812, Japan	Masuda, T (reprint author), Hiroshima Red Cross Hosp, Naka Ku, 1-9-6 Senda Machi, Hiroshima 7308619, Japan.	nbmasuda@surg2.med.kyushu-u.ac.jp					Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; Yasumoto K, 2006, CANCER RES, V66, P2181, DOI 10.1158/0008-5472.CAN-05-3393; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Signoret N, 1998, J CELL SCI, V111, P2819; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Arya M, 2003, CURR MED RES OPIN, V19, P557, DOI 10.1185/030079903125002216; Kim J, 2005, J CLIN ONCOL, V23, P2744, DOI 10.1200/JCO.2005.07.078; Wagner PL, 2009, J THORAC CARDIOV SUR, V137, P615, DOI 10.1016/j.jtcvs.2008.07.039; Iwasa S, 2009, ANTICANCER RES, V29, P4751; Woo SU, 2008, ANN SURG ONCOL, V15, P281, DOI 10.1245/s10434-007-9595-1; Ottaiano A, 2006, CLIN CANCER RES, V12, P2795, DOI 10.1158/1078-0432.CCR-05-2142; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Salvucci O, 2006, BREAST CANCER RES TR, V97, P275, DOI 10.1007/s10549-005-9121-8; Ishigami S, 2007, ANN SURG ONCOL, V14, P3154, DOI 10.1245/s10434-007-9521-6; Japanese Gastric Cancer Association, 1993, JAP CLASS GASTR CARC; Kato M, 2003, BREAST CANCER RES, V5, pR144, DOI 10.1186/bcr627; Kwak MK, 2005, TUMOR BIOL, V26, P65, DOI 10.1159/000085587; Lee HJ, 2009, INT J ONCOL, V34, P473, DOI 10.3892/ijo_00000172; Mirisola V, 2009, EUR J CANCER, V45, P2579, DOI 10.1016/j.ejca.2009.06.026; Na IK, 2008, HUM PATHOL, V39, P1751, DOI 10.1016/j.humpath.2008.04.017; Shibuta K, 1997, INT J CANCER, V73, P656, DOI 10.1002/(SICI)1097-0215(19971127)73:5<656::AID-IJC8>3.0.CO;2-W; Speetjens Frank M, 2009, Cancer Microenviron, V2, P1, DOI 10.1007/s12307-008-0016-1; Tsuboi K, 2008, ONCOL REP, V20, P1117, DOI 10.3892/or_00000118; Wang LH, 2009, ONCOL REP, V22, P1333, DOI 10.3892/or_00000572; Wang SC, 2010, INT J COLORECTAL DIS, V25, P1185, DOI 10.1007/s00384-010-0999-1; Woo IS, 2008, CANCER INVEST, V26, P256, DOI 10.1080/07357900701684057; Yoshitake N, 2008, BRIT J CANCER, V98, P1682, DOI 10.1038/sj.bjc.6604363	28	1	3	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2014	34	11					6397	6403				7	Oncology	Oncology	AT5CN	WOS:000344961300018		
J	Morii, T; Ohtsuka, K; Ohnishi, H; Mochizuki, K; Yoshiyama, A; Aoyagi, T; Hornicek, FJ; Ichimura, S				Morii, Takeshi; Ohtsuka, Kouki; Ohnishi, Hiroaki; Mochizuki, Kazuo; Yoshiyama, Akira; Aoyagi, Takayuki; Hornicek, Francis J.; Ichimura, Shoichi			BH3 Mimetics Inhibit Growth of Chondrosarcoma - A Novel Targeted-therapy for Candidate Models	ANTICANCER RESEARCH			English	Article						Chondrosarcoma; apoptosis; BH3 mimetics; Bcl2	BCL-2 FAMILY; DRUG-RESISTANCE; PERIPHERAL CHONDROSARCOMA; ABT-737; CELLS; EXPRESSION; APOPTOSIS; TUMORS; CHEMORESISTANCE; OSTEOSARCOMA	Background: Chondrosarcoma is refractory to conventional chemotherapy. BH-3 mimetics ABT-737 and ABT-263 are synthetic small-molecule inhibitors of anti-apoptotic proteins B-cell lymphoma-2 (Bcl2) and Bcl-xL, which play a critical role in survival of chondrosarcoma cells. Materials and Methods: Clumdrosarcoma cell lines SW-1353 and CS-1 were used as the disease model. We used immunoblotting to assess the expression of target molecules Bcl2 and Bel-xL, and the apoptotic inducers Bcl2-associated X (Bax) and Bcl2-antagonist/killer Bak). In vitro growth inluhition by BH-3 tnimetics was confirmed by photomicroscopic cell counting and 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymetharypheny1)-2-(4- sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay. Apoptotic induction was confirmed by Enzyme-Linked ImmunoSorbent Assay (ELLS'A). In vivo growth inhibition was assessed in a non-obese diabetic/severe combined immutodeficient (NOD/SCID) mouse model. Results: Expression of the target and effector molecules was confirmed in chondrosarcoma cell lines. BH3 mimetics significantly inhibited cell growth and induced apoptosis in vitro. Administration of ABT-263 inhibited chondrosarcotna growth and improved survival in a mouse model. Conclusion: BH3 mimetics represent a novel treatment modality for chondrosarcoma.	[Morii, Takeshi; Mochizuki, Kazuo; Yoshiyama, Akira; Aoyagi, Takayuki; Ichimura, Shoichi] Kyorin Univ, Dept Orthopaed Surg, Fac Med, Mitaka, Tokyo 1618611, Japan; [Ohtsuka, Kouki; Ohnishi, Hiroaki] Kyorin Univ, Dept Lab Med, Fac Med, Mitaka, Tokyo 1618611, Japan; [Hornicek, Francis J.] Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Boston, MA 02114 USA	Morii, T (reprint author), Kyorin Univ, Dept Orthopaed Surg, Fac Med, 6-20-2 Shinkawa, Mitaka, Tokyo 1618611, Japan.	t-morii@gh3.so-net.ne.jp			Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labor and Welfare [H26-084]; Kyorin University School of Medicine	We are grateful to Ms. Mizuho Kosuge and Ms. Miyukii Murayama for their skilful technical assistance. This study was supported in part by the Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labor and Welfare H26-084) and by a Research Encouragement Award by Kyorin University School of Medicine.	Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI [10.1016/S1470-2045(10)70261-8, 10.1016/S1470.2045(10)70261.8]; Soderstrom M, 2010, APMIS, V118, P769, DOI 10.1111/j.1600-0463.2010.02656.x; de Andrea CE, 2012, ONCOGENE, V31, P1095, DOI 10.1038/onc.2011.311; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Hann CL, 2008, CANCER RES, V68, P2321, DOI 10.1158/0008-5472.CAN-07-5031; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kuroda J, 2008, BRIT J HAEMATOL, V140, P181, DOI 10.1111/j.1365-2141.2007.06899.x; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Huang J, 2012, CANCER RES, V72, P230, DOI 10.1158/0008-5472.CAN-11-2001; Enyedy IJ, 2001, J MED CHEM, V44, P4313, DOI 10.1021/jm010016f; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; van Oosterwijk JG, 2012, ANN ONCOL, V23, P1617, DOI 10.1093/annonc/mdr512; Bovee JVMG, 2000, LAB INVEST, V80, P1925, DOI 10.1038/labinvest.3780202; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Daugaard S, 2009, APMIS, V117, P518, DOI 10.1111/j.1600-0463.2009.02461.x; Fletcher Ch, 2013, WHO CLASSIFICATION T; Hameetman L, 2005, VIRCHOWS ARCH, V446, P430, DOI 10.1007/s00428-005-1208-4; Kim DW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-28; Lu XC, 2010, J SURG ONCOL, V102, P821, DOI 10.1002/jso.21661; Morii T, 2010, ANTICANCER RES, V30, P3565; Morioka H, 2003, CLIN CANCER RES, V9, P1211; Romani AA, 2011, CANCER CHEMOTH PHARM, V67, P557, DOI 10.1007/s00280-010-1345-6; Shen ZN, 2005, BIOCHEM BIOPH RES CO, V328, P375, DOI 10.1016/j.bbrc.2004.12.186; Tan ML, 2010, BIOCHEM BIOPH RES CO, V398, P613, DOI 10.1016/j.bbrc.2010.05.098; Zall H, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-164	28	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2014	34	11					6423	6430				8	Oncology	Oncology	AT5CN	WOS:000344961300021		
J	Kida-Takaoka, S; Yamaai, T; Mizukawa, N; Murakami, J; Iida, S				Kida-Takaoka, Saori; Yamaai, Tomoichiro; Mizukawa, Nobuyoshi; Murakami, Jun; Iida, Seiji			Surrounding Cells Affect the Gene Expression Pattern of Human Beta-defensins in Squamous Cell Carcinoma In Vitro	ANTICANCER RESEARCH			English	Article						Beta-defensins; co-culture techniques real-time polymerase chain reaction; carcinoma; squamous cell	ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-2; SALIVARY-GLANDS	Background/Aim: Defensins are basic peptides involved in non-immune bio-defense mechanisms in a normal epithelhon. Human oral squamous cell carcinoma cells (OSCC) also produce human beta-defensins (HBDs), although their exact junction is not clear. This study aimed to analyze the variation in gene expression levels of hBDs in co-cultures of OSCC with murine cells. Materials and Methods: Two OSCC cell lines (HSC-3, HSC-4) were co-cultured with mouse embryonic fibroblasts, NIH/3T3 or a mouse chondrogenic cell line derived from teraiocarcinoma, ATDC5,for 1.5 days. Expression patterns of the hBD genes were investigated by real-time polymerase chain reaction (RT-PCR). Results: hBD1 expression increased when co-cultured with NIH/3T3 but decreased when co-cultured with ATDC5. Expression of hBD2 and hBD4 tended to decrease. OSCC cells formed colonies when co-cultured with NIH/3T3 but were scattered when co-cultured with ATDC5. Conclusion: hBDs expression in OSCC is dependent on the type of co-cultured cells and differences in gene expression may be responsible for the morphological differences observed. OSCC may produce HBDs for purposes other than bio-defense by surrounding cells.	[Kida-Takaoka, Saori; Iida, Seiji] Okayama Univ, Dept Oral & Maxillofacial Reconstruct Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Yamaai, Tomoichiro] Okayama Univ, Dept Oral Funct & Anat, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Mizukawa, Nobuyoshi] Okayama Univ Hosp, Dept Oral & Maxillofacial Reconstruct Surg, Okayama, Japan; [Murakami, Jun] Okayama Univ Hosp, Dept Oral Diag & Dentomaxillofacial Radiol, Okayama, Japan	Kida-Takaoka, S (reprint author), Okayama Univ, Dept Oral & Maxillofacial Reconstruct Surg, Grad Sch Med Dent & Pharmaceut Sci, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	phc61is1@s.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Sciences and Technology, Japan [22592215, 24791998]; Japan Society for the Promotion of Science	This work was supported by a Grant-in-Aid for Scientific Research (C) 22592215 (to NM), and partly supported by a Grant-in-Aid for Young Scientists (B) 24791998 (to JM) from the Ministry of Education, Culture, Sports, Sciences and Technology, Japan and Japan Society for the Promotion of Science. The authors want to acknowledge Dr. Emilio Satoshi Hara (Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences) for reading the manuscript.	Gerashchenko O. L., 2013, Experimental Oncology, V35, P76; Schroder JM, 1999, INT J BIOCHEM CELL B, V31, P645, DOI 10.1016/S1357-2725(99)00013-8; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Abiko Y, 1999, CANCER LETT, V143, P37, DOI 10.1016/S0304-3835(99)00171-8; Ganz T, 1999, SCIENCE, V286, P420, DOI 10.1126/science.286.5439.420; Mathews M, 1999, INFECT IMMUN, V67, P2740; Weinberg A, 1998, CRIT REV ORAL BIOL M, V9, P399; Sawaki K, 2002, ANTICANCER RES, V22, P2103; Schneider JJ, 2005, J MOL MED-JMM, V83, P587, DOI 10.1007/s00109-005-0657-1; Yoshimoto T, 2003, ANTICANCER RES, V23, P4629; Frederic MK, 2008, ORAL DIS, V14, P652, DOI 10.1111/j.1601-0825.2008.01451.x; JAINCHIL.JL, 1969, J VIROL, V4, P549; Joly S, 2009, ORAL MICROBIOL IMMUN, V24, P353, DOI 10.1111/j.1399-302X.2009.00512.x; Kaneda Y, 2009, EUR J ORAL SCI, V117, P506, DOI 10.1111/j.1600-0722.2009.00667.x; Sawaki K, 2003, ANTICANCER RES, V23, P79; Takeda S, 2013, J TOXICOL PATHOL, V26, P35, DOI 10.1293/tox.26.35; Wenghoefer M, 2008, INT J ORAL MAX SURG, V37, P660, DOI 10.1016/j.ijom.2008.02.003; Winter J, 2011, CANCER INVEST, V29, P196, DOI 10.3109/07357907.2010.543210; Zhuravel E., 2011, Experimental Oncology, V33, P114	20	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2014	34	11					6443	6449				7	Oncology	Oncology	AT5CN	WOS:000344961300023		
J	Yumita, N; Iwase, Y; Watanabe, T; Nishi, K; Kuwahara, H; Shigeyama, M; Sadamoto, K; Ikeda, T; Umemura, SI				Yumita, Nagahiko; Iwase, Yumiko; Watanabe, Takahiro; Nishi, Koji; Kuwahara, Hiroyuki; Shigeyama, Masato; Sadamoto, Kiyomi; Ikeda, Toshihiko; Umemura, Shin-Ichiro			Involvement of Reactive Oxygen Species in the Enhancement of Membrane Lipid Peroxidation by Sonodynamic Therapy with Functionalized Fullerenes	ANTICANCER RESEARCH			English	Article						Ultrasound; nanomedicine; fullerenes; sonodynamic therapy; membrane lipid peroxidation; sarcoma 180; reactive oxygen species	GALLIUM-PORPHYRIN COMPLEX; INDUCED CELL-DAMAGE; ASPARTYL CHLORIN E6; INDUCED APOPTOSIS; CANCER-THERAPY; ULTRASOUND; HEMATOPORPHYRIN; GENERATION; ATX-70; CYTOTOXICITY	Background/Aim: Sonodynamic cancer therapy is based on the preferential uptake and/or retention of a sonosensitizing drug (sonosensitizer) in tumor tissues and subsequent activation of the drug by ultrasound irradiation. In the present study, we investigated the participation of lipid peroxidation in the mechanism of the sonodynamically-induced antitumor effect with functionalized fullerenes, such as polyhydroxy fullerene (PHF. Materials and Methods: Ultrasonically-induced cell damage and lipid peroxidation with PHF were compared in the same in vitro insonation setup. Sarcoma 180 cells suspended in PBS were exposed to 2 MHz ultrasound in the presence and absence of PHF. Cell viability was determined by the Trypan Blue exclusion test. Lipid peroxidation in cell membranes was estimated by measuring the amount of malondialdehyde as the thiobarbituric acid-reactive-substances. Results: Significant enhancement of the rates of both ultrasonically-induced cell damage and lipid peroxidation was observed in the presence of PHF, both of which were positively correlated with PHF. The enhancement of cell damage and lipid peroxidation with PHF was suppressed by reactive oxygen scavengers such as histidine and tryptophan. Conclusion: The good correlation observed in the presence of PHF suggests that membrane lipid peroxidation is one of the important intermediary events in sonodynamically-induced cellular damage. The inhibitory effects of histidine and tryptophan also provide evidence that singlet oxygen plays an important role in PHF-mediated sonosensitization of membranes and that this moiety may be an important mediator of cell destruction in sonodynamic therapy associated with PHF and ultrasound.	[Yumita, Nagahiko; Iwase, Yumiko; Watanabe, Takahiro; Nishi, Koji; Kuwahara, Hiroyuki; Shigeyama, Masato; Sadamoto, Kiyomi; Ikeda, Toshihiko] Yokohama Coll Pharm, Yokohama, Kanagawa 2450066, Japan; [Umemura, Shin-Ichiro] Tohoku Univ, Dept Elect & Commun Engn, Aoba Ku, Sendai, Miyagi 980, Japan	Yumita, N (reprint author), Yokohama Coll Pharm, Totsuka Ku, 601 Matano Cho, Yokohama, Kanagawa 2450066, Japan.	n.yumita@hamayaku.ac.jp					AGARWAL R, 1991, CANCER LETT, V56, P125, DOI 10.1016/0304-3835(91)90086-W; KREMKAU FW, 1979, J CLIN ULTRASOUND, V7, P287, DOI 10.1002/jcu.1870070410; Yumita N, 2010, CANCER CHEMOTH PHARM, V66, P1071, DOI 10.1007/s00280-010-1264-6; Yumita N, 2011, ANTICANCER RES, V31, P501; Yumita N, 2007, CANCER CHEMOTH PHARM, V60, P891, DOI 10.1007/s00280-007-0436-5; Yumita N, 2013, ANTICANCER RES, V33, P3145; Chen ZY, 2012, THERANOSTICS, V2, P238, DOI 10.7150/thno.3509; Yumita N, 2012, THERANOSTICS, V2, P880, DOI 10.7150/thno.3899; Yumita N, 1998, CANCER LETT, V125, P209, DOI 10.1016/S0304-3835(97)00515-6; GOLDSTEIN S, 1984, INT J RADIAT BIOL, V46, P725, DOI 10.1080/09553008414551961; YUMITA N, 1989, JPN J CANCER RES, V80, P219; Serpe L, 2012, NANOTECHNOL REV, V1, P173, DOI 10.1515/ntrev-2011-0009; Krishna V, 2010, SMALL, V6, P2236, DOI 10.1002/smll.201000847; Yumita N, 2000, J CANCER RES CLIN, V126, P601, DOI 10.1007/PL00008471; Yumita N, 2010, ANTICANCER RES, V30, P2241; Constantin C, 2010, NANOMEDICINE-UK, V5, P307, DOI [10.2217/nnm.09.111, 10.2217/NNM.09.111]; Liu Z, 2012, THERANOSTICS, V2, P235, DOI 10.7150/thno.4156; Torchilin VP, 2007, AAPS J, V9, pE128, DOI 10.1208/aapsj0902015; Rosenthal I, 2004, ULTRASON SONOCHEM, V11, P349, DOI 10.1016/j.ultsonch.2004.03.004; YUMITA N, 1994, RADIAT RES, V138, P171, DOI 10.2307/3578586; Coyuco JC, 2011, INT J NANOMED, V6, P2253, DOI 10.2147/IJN.S23962; DAS M, 1985, CANCER RES, V45, P608; KESSEL D, 1994, INT J RADIAT BIOL, V66, P221, DOI 10.1080/09553009414551131; KONDO T, 1988, INT J RADIAT BIOL, V54, P955, DOI 10.1080/09553008814552351; Liao F, 2011, ONCOL RES, V19, P203, DOI 10.3727/096504011X12970940207805; Paszko E, 2011, PHOTODIAGN PHOTODYN, V8, P14, DOI 10.1016/j.pdpdt.2010.12.001; Umemura S, 1997, CANCER LETT, V121, P195, DOI 10.1016/S0304-3835(97)00354-6; Umemura S, 1990, JPN J CANCER RES, V81, P955; UMEMURA SI, 1993, JPN J CANCER RES, V84, P582; Yumita N, 2008, CANCER SCI, V99, P166, DOI 10.1111/j.1349-7006.2007.00653.x; Yumita N, 1996, JPN J CANCER RES, V87, P310; Yumita N, 1996, INT J RADIAT BIOL, V69, P397, DOI 10.1080/095530096145959; YUMITA N, 1990, JPN J CANCER RES, V81, P304; Yumita N, 2003, BBA-GEN SUBJECTS, V1620, P179, DOI 10.1016/S0304-4165(02)00530-5; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400	35	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2014	34	11					6481	6487				7	Oncology	Oncology	AT5CN	WOS:000344961300028		
J	Sakai, C; Arai, M; Tanaka, S; Onda, K; Sugiyama, K; Hirano, T				Sakai, Chizuko; Arai, Mariko; Tanaka, Sachiko; Onda, Kenji; Sugiyama, Kentaro; Hirano, Toshihiko			Effects of Arsenic Compounds on Growth, Cell-Cycle Distribution and Apoptosis of Tretinoin-resistant Human Promyelocytic Leukemia Cells	ANTICANCER RESEARCH			English	Article						Arsenic trioxide; arsenate; organic arsenicals; HL-60 cells; all-trans-retinoic and resistance; apoptosis induction	TRIOXIDE INDUCES APOPTOSIS; TRANS-RETINOIC ACID; HL-60 CELLS; PATHWAY; GLUTATHIONE; ACTIVATION; DEPLETION; THERAPY; STRESS; MOLT-4	Background/Aim: The effects of inorganic and organic arsenicals on proliferation, cell-cycle distribution, and apoptosis of all-transretinoic acid (ATRA)-resistant human promyelocytic leukemia HL-60 (HL-60-R2) cells were herein investigated. Materials and Methods: Cell proliferation was examined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Cell-cycle distribution and apoptotic cells were analyzed by flow cytometry. Results: The 50% inhibitory concentrations (IC50 values) for As2O3 against proliferation of HL-60 and HL-60-R2 cells were 12.2 and 7.2 mu M, while those for arsenate were >200 and 62.1 mu M, respectively. In contrast, organic methylarsinic acid, dimethylarsonic acid, trimethylarsine oxide, and tetramethylarsonium did not exert any inhibitory effects even at 200 mu M. As2O3 and arsenate increased the proportion of apoptotic cells dose-dependently at a concentration range of 5-200 mu M. As2O3 did not activate caspase 3/7 in HL-60 and HL-60-R2 cells. Conclusion: As2O3 and arsenate inhibit cell proliferation, affect cell-cycle distribution, and induce apoptosis of ATRA-resistant HL-60-R2 cells. The apoptosis-inducing mechanism appears not to be mediated through caspase3/7.	[Sakai, Chizuko; Tanaka, Sachiko; Onda, Kenji; Sugiyama, Kentaro; Hirano, Toshihiko] Tokyo Univ Pharm & Life Sci, Dept Clin Pharmacol, Sch Pharm, Hachioji, Tokyo 1920392, Japan; [Arai, Mariko] Kitasato Univ, Dept Pharm, East Hosp, Sagamihara, Kanagawa 228, Japan	Hirano, T (reprint author), Tokyo Univ Pharm & Life Sci, Dept Clin Pharmacol, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	hiranot@toyaku.ac.jp					Yen YP, 2012, ARCH TOXICOL, V86, P923, DOI 10.1007/s00204-012-0864-9; Li JM, 2014, INT J HEMATOL, V100, P38, DOI 10.1007/s12185-014-1603-1; You BR, 2012, ONCOL REP, V28, P749, DOI 10.3892/or.2012.1852; Nichol JN, 2014, BEST PRACT RES CL HA, V27, P19, DOI 10.1016/j.beha.2014.04.009; Han YH, 2010, INT J MOL MED, V25, P121, DOI 10.3892/ijmm_00000321; Douer D, 2002, ACTA HAEMATOL-BASEL, V107, P1, DOI 10.1159/000046623; Shen ZX, 1997, BLOOD, V89, P3354; Charoensuk V, 2009, TOXICOL APPL PHARM, V239, P64, DOI 10.1016/j.taap.2009.05.016; Hikita E, 2011, ANTICANCER RES, V31, P4169; Hiwatashi Y, 2011, J PHARM PHARMACOL, V63, P1202, DOI 10.1111/j.2042-7158.2011.01330.x; Hu XM, 2003, CANCER CHEMOTH PHARM, V51, P119, DOI 10.1007/s00280-002-0543-2; Hu XM, 2003, CANCER CHEMOTH PHARM, V52, P47, DOI 10.1007/s00280-003-0629-5; Kumar S, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-42; Lin CP, 2000, LEUKEMIA LYMPHOMA, V38, P191; Matulis SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052662; Mori J, 1999, JPN J CANCER RES, V90, P660; Ralph Stephen John, 2008, Metal-Based Drugs, P260146, DOI 10.1155/2008/260146; Sanz MA, 2014, BEST PRACT RES CL HA, V27, P33, DOI 10.1016/j.beha.2014.04.004; Shen P, 2011, CELL BIOL INT, V35, P803, DOI 10.1042/CBI20100739; Xu WB, 2014, MOL MED REP, V10, P1519, DOI 10.3892/mmr.2014.2333; Zhang XH, 2013, LEUKEMIA RES, V37, P1719, DOI 10.1016/j.leukres.2013.09.019	21	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2014	34	11					6489	6494				6	Oncology	Oncology	AT5CN	WOS:000344961300029		
J	Nagahara, Y; Nagahara, K				Nagahara, Yukitoshi; Nagahara, Katsuhiko			N-(2-Amino-5-chlorobenzoyl)benzamidoxime Derivatives Inhibit Human Leukemia Cell Growth	ANTICANCER RESEARCH			English	Article						Benzamidoxime; cancer; apoptosis; Jurkat; HL-60RG	MULTIPLE-DRUG RESISTANCE; MULTIDRUG-RESISTANCE; CANCER; 1,2,4-OXADIAZOLES; MECHANISMS; CHEMOTHERAPY; ANALOGS; AGENTS; CYCLE	Background/Aim: Amidoxime derivatives have been previously reported to have potent anti-microbial and anti-tumor activity. Little is known about the tumor cell growth-inhibition mechanism of amidoximes, especially benzamidoxime derivatives. Herein we determined the effects of N-(2-amino-5-chlorobenzoyl)benzamidoxime analogs on mammalian cancer cells. Materials and Methods: We synthesized tour chloride-substituted benzamidoxime analogs from the original benzamidoxime to investigate their anticancer cell activity using the Jurkat T-cell lymphoma cell line and the human leukemia cell line HL-60RG. Results: All amidoxime derivatives inhibited Jurkat and HL-60RG cell viability dose-dependently. Benzamidoximes tended to damage HL-60RG cells to a greater extent compared to Jurkat cells. Benzamidoximes with chloride substitutes caused a strong decrease in cell growth, and this cell growth attenuation was transient at 5 mu M (below the half-maximal inhibitory concentration, IC50) but long-lasting at 10 mu M (greater than the IC50). Conclusion: Benzamidoxime derivatives caused a transient cell-cycle delay at a low dose and cell death at a high dose.	[Nagahara, Yukitoshi] Tokyo Denki Univ, Div Life Sci & Engn, Coll Sci & Engn, Hatoyama, Saitama 3500394, Japan; [Nagahara, Katsuhiko] Kitasato Univ, Dept Pharmaceut Life Sci, Fac Pharm, Minato Ku, Tokyo, Japan	Nagahara, Y (reprint author), Tokyo Denki Univ, Div Life Sci & Engn, Coll Sci & Engn, Hatoyama, Saitama 3500394, Japan.	yuki@mail.dendai.ac.jp					Daniel C, 2013, BBA-MOL BASIS DIS, V1832, P606, DOI 10.1016/j.bbadis.2013.01.020; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Yared JA, 2012, DRUG DES DEV THER, V6, P371, DOI 10.2147/DDDT.S28997; Stavrovskaya AA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P95; Ozben T, 2006, FEBS LETT, V580, P2903, DOI 10.1016/j.febslet.2006.02.020; Lamont EB, 1999, CLIN CANCER RES, V5, P2289; Deep G, 2008, CURR OPIN INVEST DR, V9, P591; Dent P, 2011, MOL INTERV, V11, P133, DOI 10.1124/mi.11.2.11; Shiokawa Z, 2013, BIOORGAN MED CHEM, V21, P7938, DOI 10.1016/j.bmc.2013.09.067; CLEMENT B, 1988, J CANCER RES CLIN, V114, P363, DOI 10.1007/BF02128179; Hall JE, 1998, ANTIMICROB AGENTS CH, V42, P666; Kardon T, 2006, ANTICANCER RES, V26, P1023; Kumar D, 2011, EUR J MED CHEM, V46, P3085, DOI 10.1016/j.ejmech.2011.03.031; Morbt N, 2011, J PROTEOME RES, V10, P363, DOI 10.1021/pr1005718; NAGAHARA K, 1979, HETEROCYCLES, V12, P239; NAGAHARA K, 1975, CHEM PHARM BULL, V23, P3178; Sangshetti JN, 2011, EUR J MED CHEM, V46, P1040, DOI 10.1016/j.ejmech.2011.01.015	17	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2014	34	11					6521	6526				6	Oncology	Oncology	AT5CN	WOS:000344961300033		
J	Beppu, T; Emi, Y; Tokunaga, S; Oki, E; Shirabe, K; Ueno, S; Kuramoto, M; Kabashima, A; Takahashi, I; Samura, H; Eguchi, S; Akagi, Y; Natsugoe, S; Ogata, Y; Kakeji, Y; Baba, H; Maehara, Y				Beppu, Toru; Emi, Yasunori; Tokunaga, Shoji; Oki, Eiji; Shirabe, Ken; Ueno, Shinichi; Kuramoto, Masafumi; Kabashima, Akira; Takahashi, Ikuo; Samura, Hironori; Eguchi, Susumu; Akagi, Yoshito; Natsugoe, Shoji; Ogata, Yutaka; Kakeji, Yoshihiro; Baba, Hideo; Maehara, Yoshihiko		Kyushu Study Grp Clinical Canc	Liver Resectability of Advanced Liver-limited Colorectal Liver Metastases Following mFOLFOX6 with Bevacizumab (KSCC0802 Study)	ANTICANCER RESEARCH			English	Article						Colorectal liver metastases; hepatic resection; chemotherapy; oxaliplatin; fluorouracil; leucovorin; bevacizumab	SINUSOIDAL OBSTRUCTION SYNDROME; OXALIPLATIN-BASED CHEMOTHERAPY; RANDOMIZED PHASE-III; PREOPERATIVE CHEMOTHERAPY; HEPATIC RESECTION; 1ST-LINE THERAPY; CURATIVE-INTENT; CANCER; HEPATECTOMY; PROGNOSIS	Background/Aim: The Kyushu Study group of Clinical Cancer (KSCC) conducted phase II trials (KSCC0802 - UMIN000001308) concerning liver resectability after first-line treatment of advanced liver-limited colorectal metastases (CRLM) by a prospective, multi-center study. Patients and Methods: Patients received 6 cycles of mFOLFOX6 with bevacizumab followed by evaluating liver resectability. The primary end-point was liver resection rate. Results: The 40 patients enrolled from September 2008 to August 2010. The median number of administration cycles was 6 (range=1-7). The liver resectability cases were 16/40 (40.0 %) and the number of R0 cases was 10 patients (25.0%). An overall response rate was 30.0% (95% CI=15.2%-44.8%). Median progression-free and overall survival of all patients was 9.7 months and 33.0 months), respectively. Conclusion: mFOLFOX6 with bevacizumab regimen is safe and effective for advanced liver-limited CRLM and might lead to high liver resectability.	[Beppu, Toru; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol Surg, Kumamoto, Japan; [Emi, Yasunori] Saiseikai Fukuoka Gen Hosp, Dept Surg, Fukuoka, Japan; [Tokunaga, Shoji] Kyushu Univ Hosp, Med Informat Ctr, Fukuoka 812, Japan; [Oki, Eiji; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Ueno, Shinichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Clin Oncol, Kagoshima 890, Japan; [Kuramoto, Masafumi] Kumamoto Social Insurance Gen Hosp, Dept Surg, Kumamoto, Japan; [Kabashima, Akira] Mutual Aid Assoc Publ Sch Teachers, Kyushu Cent Hosp, Dept Surg, Fukuoka, Japan; [Takahashi, Ikuo] Matsuyama Red Cross Hosp, Dept Surg, Matsuyama, Ehime, Japan; [Samura, Hironori] Univ Ryukyus, Dept Surg 1, Okinawa, Japan; [Eguchi, Susumu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 852, Japan; [Akagi, Yoshito] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 830, Japan; [Natsugoe, Shoji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest Surg Breast & Thyroid Surg, Kagoshima 890, Japan; [Ogata, Yutaka] Kurume Univ, Med Ctr, Dept Surg, Kurume, Fukuoka 830, Japan; [Kakeji, Yoshihiro] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo 657, Japan	Maehara, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	maehara@surg2.med.kyushu-u.ac.jp					Cassidy J, 2011, BRIT J CANCER, V105, P58, DOI 10.1038/bjc.2011.201; Tsai MS, 2007, ANN SURG ONCOL, V14, P786, DOI 10.1245/s10434-006-9215-5; Yamaguchi T, 2008, HEPATO-GASTROENTEROL, V55, P173; Rubbia-Brandt L, 2004, ANN ONCOL, V15, P460, DOI 10.1093/annonc/mdh095; Schwarz RE, 2013, HPB, V15, P106, DOI 10.1111/j.1477-2574.2012.00558.x; Blazer DG, 2008, J CLIN ONCOL, V26, P5344, DOI 10.1200/JCO.2008.17.5299; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Poston GJ, 2005, J CLIN ONCOL, V23, P7125, DOI 10.1200/JCO.2005.08.722; Klinger M, 2009, EJSO-EUR J SURG ONC, V35, P515, DOI 10.1016/j.ejso.2008.12.013; Folprecht G, 2010, LANCET ONCOL, V11, P38, DOI 10.1016/S1470-2045(09)70330-4; Okines A, 2009, BRIT J CANCER, V101, P1033, DOI 10.1038/sj.bjc.6605259; Imai K, 2014, EJSO-EUR J SURG ONC, V40, P559, DOI 10.1016/j.ejso.2013.12.009; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Shindoh J, 2012, J CLIN ONCOL, V30, P4566, DOI 10.1200/JCO.2012.45.2854; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S01053-4296(03)00031-6; Tamandl D, 2011, ANN SURG ONCOL, V18, P421, DOI 10.1245/s10434-010-1317-4; Beppu T, 2014, ANN SURG ONCOL, V21, P405, DOI 10.1245/s10434-014-3577-x; Kishi Y, 2010, ANN SURG ONCOL, V17, P2870, DOI 10.1245/s10434-010-1166-1; Gruenberger B, 2008, J CLIN ONCOL, V26, P1830, DOI 10.1200/JCO.2007.13.7679; Beppu T, 2010, ANTICANCER RES, V30, P1015; Beppu T, 2012, J HEPATO-BIL-PAN SCI, V19, P72, DOI 10.1007/s00534-011-0460-z; Bridgewater J, 2013, EUR CANC C 2013; English Second, 2009, JAP CLASS COL CARC; Hirokawa F, 2013, ANN SURG ONCOL; Kato T, 2003, DIS COLON RECTUM, V46, pS22, DOI 10.1097/01.DCR.0000089106.71914.00; Schiffer E, 2009, J SURG ONCOL, V99, P439, DOI 10.1002/jso.21276; Wicherts DA, 2011, BRIT J SURG, V98, P399, DOI 10.1002/bjs.7368	30	2	2	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2014	34	11					6655	6662				8	Oncology	Oncology	AT5CN	WOS:000344961300050		
J	Okegawa, T; Itaya, N; Hara, H; Tambo, M; Nutahara, K				Okegawa, Takatsugu; Itaya, Naoshi; Hara, Hidehiko; Tambo, Mitsuhiro; Nutahara, Kikuo			Circulating Tumor Cells as a Biomarker Predictive of Sensitivity to Docetaxel Chemotherapy in Patients with Castration-resistant Prostate Cancer	ANTICANCER RESEARCH			English	Article						Circulating tumor cells; castration-resistant prostate cancer; biomarker; docetaxel	ABIRATERONE ACETATE; IMMUNOMAGNETIC QUANTIFICATION; ANTITUMOR-ACTIVITY; PLUS PREDNISONE; END-POINTS; SURVIVAL; DISEASE; COUNTS; BLOOD; TRIAL	Aim: We examined whether Circulating Tumor Cells (CTCs) can be used to predict survival in patients with bone-metastatic castration-resistant-prostate cancer (mCRPC) treated with docetaxel chemotherapy. Patients and Methods: All patients with mCRPC who had experienced treatment failure with androgen deprivation therapy and had received docetaxel chemotherapy were eligible for study inclusion. CTCs in whole blood were enumerated with the CellSearch in. Results: The median CTC count at baseline before starting trial treatment was 7 (range=0-227) CTCs per 7.5 ml blood. Out of the 57 patients, 24 (42.1%) had a CTC count of less than 5, while 27 patients (47.4%) had a CTC count of 550 and six patients (10.5%) had a CTC count of more than 50. A threshold of 5 or more CTCs per 7.5 ml blood was used to assess the ability to predict survival. The patient charts were examined to determine the median overall survival time, ranged from 6 to 37 months (mean=12.8 +/- 8.1 months, median=15.3 months). Thirty-three patients (57.9%) had 5 or more CTCs before docetaxel chemotherapy, with a median overall survival of 10.5 months compared to 25.0 months for 24 patients (42.1%) with fewer than 5 CTCs (p<0.001). CTC and alkaline phosphatase (ALP) were independent predictors of overall survival time (p=0.004, and p=0.023, respectively). In addition, poorer overall survival was predicted by a CTC count of 5 or more after three courses of docetaxel chemotherapy. Conclusion: The CTC count may be an independent predictor of overall survival in patients with mCRPC treated with docetaxel chemotherapy. The numbers of CTCs detected was important in assessing response to chemotherapy and predict disease outcome.	[Okegawa, Takatsugu; Itaya, Naoshi; Hara, Hidehiko; Tambo, Mitsuhiro; Nutahara, Kikuo] Kyorin Univ, Dept Urol, Mitaka, Tokyo 1818611, Japan	Okegawa, T (reprint author), Kyorin Univ, Dept Urol, Sch Med, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	toke@ks.kyorin-u.ac.jp					Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Scher HI, 2009, LANCET ONCOL, V10, P233, DOI 10.1016/S1470-2045(08)70340-1; Okegawa T, 2009, J UROLOGY, V181, P1091, DOI 10.1016/j.juro.2008.11.015; Danila DC, 2011, CLIN CANCER RES, V17, P3903, DOI 10.1158/1078-0432.CCR-10-2650; Olmos D, 2009, ANN ONCOL, V20, P27, DOI 10.1093/annonc/mdn544; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Reid AHM, 2010, J CLIN ONCOL, V28, P1489, DOI 10.1200/JCO.2009.24.6819; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Danila DC, 2007, CLIN CANCER RES, V13, P7053, DOI 10.1158/1078-0432.CCR-07-1506; Goldkorn A, 2014, J CLIN ONCOL, V32, P1136, DOI 10.1200/JCO.2013.51.7417; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Moreno JG, 2005, UROLOGY, V65, P713, DOI 10.1016/j.urology.2004.11.006; Danila DC, 2011, EUR UROL, V60, P897, DOI 10.1016/j.eururo.2011.07.011; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Danila DC, 2010, J CLIN ONCOL, V28, P1496, DOI 10.1200/JCO.2009.25.9259; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; SOLOWAY MS, 1988, CANCER, V61, P195, DOI 10.1002/1097-0142(19880101)61:1<195::AID-CNCR2820610133>3.0.CO;2-Y; Armstrong AJ, 2010, EUR J CANCER, V46, P517, DOI 10.1016/j.ejca.2009.11.007; Bono de JS1, 2008, CLIN CANC RES, V14, P6302; Chen BT, 2005, UROLOGY, V65, P616, DOI 10.1016/j.urology.2004.10.053; Okegawa T, 2008, J UROLOGY, V180, P1342, DOI 10.1016/j.juro.2008.06.021; Shulman MJ, 2004, J UROLOGY, V172, P141, DOI 10.1097/01.ju.0000129051.81608.d8	23	6	6	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2014	34	11					6705	6710				6	Oncology	Oncology	AT5CN	WOS:000344961300057		
J	Kitagawa, Y; Sawada, K; Urata, S; Izumi, K; Ueno, S; Kadono, Y; Konaka, H; Mizokami, A; Namiki, M				Kitagawa, Yasuhide; Sawada, Kiyoshi; Urata, Satoko; Izumi, Kouji; Ueno, Satoru; Kadono, Yoshifumi; Konaka, Hiroyuki; Mizokami, Atsushi; Namiki, Mikio			Impact of PSA Levels on Second-round Screening for the Development of Prostate Cancer in Men with Low Baseline PSA Levels (<= 2.0 mg/ml)	ANTICANCER RESEARCH			English	Article						Prostate cancer; PSA; PSA velocity; population-based screening; risk factor	ANTIGEN LEVELS; VELOCITY; GUIDELINES; NG/ML; MORTALITY; CARCINOMA; JAPAN	Background: To investigate the cumulative probability of developing prostate according to prostate-specific antigen (PSA) velocity (PSAV) from second-round PSA-based population screening in men with low baseline serum PSA levels. Patients and Methods: A total of 11,913 men aged between 54 and 69 years with baseline PSA levels of <= 2.0 ng/ml at the first population screening and who underwent population screening at least twice, were enrolled. The cumulative probability of developing prostate cancer according to age, baseline PSA and PSAV was investigated. The clinicopathological features of screen-detected cancer were also investigated. Results: Out of the 11,913 men, 110 (0.92%) were pathologically diagnosed with prostate cancer during the observation period. The cumulative probability of developing prostate cancer in all participants after 5 and 10 years was 0.64% and 1.79%. respectively. Univariate and multivariate analyses determined that baseline PSA levels and PSAVs were significant predictors of developing cancer and the hazard ratio increased with increasing baseline PSA levels and PSAVs. The optimal PSAV cut-off levels for prostate cancer development were 0.069, 0.106 and 0.285 for the baseline PS'A ranges of 0.0-1.0, 1.1-1.5 and 1.6-2.0 ng/ml, respectively. There were no significant differences in baseline PSA levels and PSAVs according to the clinical characteristics of the screen-detected prostate cancer patients. Conclusion: The present study demonstrated that serum PSA levels at second round screening were a strong predictor of cancer development in men with baseline PSA levels ng/ml at the first population screening.	[Kitagawa, Yasuhide; Sawada, Kiyoshi; Urata, Satoko; Izumi, Kouji; Ueno, Satoru; Kadono, Yoshifumi; Konaka, Hiroyuki; Mizokami, Atsushi; Namiki, Mikio] Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, Kanazawa, Ishikawa 9208640, Japan	Kitagawa, Y (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, Takaramachi 13-1, Kanazawa, Ishikawa 9208640, Japan.	yasukita@med.kanazawa-u.ac.jp	IZUMI, KOUJI/C-5973-2015				Vickers A, 2012, EUR UROL, V62, P204, DOI 10.1016/j.eururo.2012.04.024; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Vickers AJ, 2014, UROLOGY, V83, P592, DOI 10.1016/j.urology.2013.09.075; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Vickers AJ, 2011, J NATL CANCER I, V103, P462, DOI 10.1093/jnci/djr028; Aus G, 2005, ARCH INTERN MED, V165, P1857, DOI 10.1001/archinte.165.16.1857; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Roobol MJ, 2005, UROLOGY, V65, P343, DOI 10.1016/j.urology.2004.09.046; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Bouchardy C, 2008, INT J CANCER, V123, P421, DOI 10.1002/ijc.23520; Candas B, 2006, J UROLOGY, V175, P510, DOI 10.1016/S0022-5347(05)00165-5; Naito S, 2010, INT J UROL, V17, P830, DOI 10.1111/j.1442-2042.2010.02613.x; Ito K, 2003, UROLOGY, V62, P64, DOI 10.1016/S0090-4295(03)00135-3; Ito K, 2005, CANCER, V103, P242, DOI 10.1002/cncr.20739; Kakehi Y, 2008, JPN J CLIN ONCOL, V38, P122, DOI 10.1093/jjco/hym161; Kitagawa Y, 2011, INT J UROL, V18, P592, DOI 10.1111/j.1442-2042.2011.02796.x; Kobori Y, 2008, INT J CLIN ONCOL, V13, P229, DOI 10.1007/s10147-007-0742-2; Loeb S, 2011, UROLOGY, V77, P143, DOI 10.1016/j.urology.2010.04.068; Loeb S, 2007, J UROLOGY, V178, P2348, DOI 10.1016/j.juro.2007.08.016; Sawada K, 2014, INT J UROL, V21, P560, DOI 10.1111/iju.12380; Sobin LH, 1997, TNM CLASSIFICATION M, P170	23	2	2	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2014	34	11					6739	6746				8	Oncology	Oncology	AT5CN	WOS:000344961300063		
J	Kikuchi, M; Tanino, H; Kosaka, Y; Sengoku, N; Yamashita, K; Minatani, N; Nishimiya, H; Waraya, M; Katoh, H; Enomoto, T; Kajita, S; Woodhams, R; Watanabe, M				Kikuchi, Mariko; Tanino, Hirokazu; Kosaka, Yoshimasa; Sengoku, Norihiko; Yamashita, Keishi; Minatani, Naoko; Nishimiya, Hiroshi; Waraya, Mina; Katoh, Hiroshi; Enomoto, Takumo; Kajita, Sabine; Woodhams, Reiko; Watanabe, Masahiko			Usefulness of MRI of Microcalcification Lesions to Determine the Indication for Stereotactic Mammotome Biopsy	ANTICANCER RESEARCH			English	Article						Mammotome biopsy; microcalcification; MRI; BIRADS	VACUUM-ASSISTED BIOPSY; BREAST BIOPSY; MAMMOGRAPHY; MULTICENTER; CANCER	Background: With the recent rise in mammography (MMG) screenings there has been an increase in the identification of microcalcifications without lump. Therefore, a vacuum-assisted needle biopsy under stereotactic guidance (ST-MTB) is frequently performed for diagnosis. However, ST-MTB is a highly invasive examination. In this study, we investigated the effectiveness of utilizing contrast-enhanced magnetic resonance imaging (MRI) to differentiate between benign and malignant category 3 (C3) calcifications. Materials and Methods: One hundred and sixty-eight patients with microcalcifications underwent contrast-enhanced MRI prior to ST-MTB in our hospital. Their MRI scans were reviewed to determine whether the contrast-enhanced MRI findings were consistent. We calculated the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of contrast-enhanced MRI. Results: No malignancy was not found in the 51 of the 168 cases analyzed by MRI. The calculated sensitivity, specificity, PPV and NPV of contrast-enhanced MRI were 84%, 82%, 58% and 95%, respectively. Conclusion: Contrast-enhanced MRI for Category 3 calcified lesions would be a useful diagnostic tool for identifying ST-MTB-indicated patients.	[Kikuchi, Mariko; Tanino, Hirokazu; Kosaka, Yoshimasa; Sengoku, Norihiko; Yamashita, Keishi; Minatani, Naoko; Nishimiya, Hiroshi; Waraya, Mina; Katoh, Hiroshi; Enomoto, Takumo; Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 2520374, Japan; [Kajita, Sabine] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa 2520374, Japan; [Woodhams, Reiko] Kitasato Univ, Sch Med, Dept Diagnost Radiol, Sagamihara, Kanagawa 2520374, Japan	Tanino, H (reprint author), Kitasato Univ, Sch Med, Dept Surg, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	htanino@breastlife.com					Akita A, 2009, EUR RADIOL, V19, P2089, DOI 10.1007/s00330-009-1396-4; American College of Radiology, 2003, AM COLL RAD ACR BREA; Cilotti A, 2007, RADIOL MED, V112, P272, DOI 10.1007/s11547-007-0141-9; Esserman L, 1999, J CLIN ONCOL, V17, P110; Fischer U, 1999, RADIOLOGY, V213, P881; BOETES C, 1995, RADIOLOGY, V197, P743; [Anonymous], 2010, COMM MAMM GUID; Kettritz U, 2004, CANCER, V100, P245, DOI 10.1002/cncr.11887; OREL SG, 1995, RADIOLOGY, V196, P115; PARKER SH, 1990, RADIOLOGY, V176, P741; Uematsu T, 2007, BREAST CANCER RES TR, V103, P269, DOI 10.1007/s10549-006-9373-y; Bazzocchi M, 2006, AM J ROENTGENOL, V186, P1723, DOI 10.2214/AJR.04.1898; Liberman L, 1998, RADIOLOGY, V206, P711; Mendez A, 2004, CANCER, V100, P710, DOI 10.1002/cncr.20017; Parker SH, 1997, RADIOGRAPHICS, V17, P1233; Tozaki Mitsuhiro, 2006, Magn Reson Med Sci, V5, P7, DOI 10.2463/mrms.5.7; Verkooijen HM, 2002, SURG ONCOL, V10, P177, DOI 10.1016/S0960-7404(02)00021-X; Westerhof JP, 1998, RADIOLOGY, V207, P675	18	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2014	34	11					6749	6753				5	Oncology	Oncology	AT5CN	WOS:000344961300065		
J	Song, AH; Myojo, K; Laudenslager, J; Harada, D; Miura, T; Suzuki, K; Kuni-Kamochi, R; Soloff, R; Ohgami, K; Kanda, Y				Song, Aihua; Myojo, Kensuke; Laudenslager, John; Harada, Daisuke; Miura, Toru; Suzuki, Kazuo; Kuni-Kamochi, Reiko; Soloff, Rachel; Ohgami, Kinya; Kanda, Yutaka			Evaluation of a fully human monoclonal antibody against multiple influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates	ANTIVIRAL RESEARCH			English	Article						Influenza A; Matrix protein 2; Antibody; Virus infection; Therapeutic	M2 PROTEIN; EXTRACELLULAR DOMAIN; VIRUS HEMAGGLUTININ; OSELTAMIVIR RESISTANCE; CYNOMOLGUS MACAQUES; MATRIX PROTEIN-2; UNITED-STATES; VACCINE; H5N1; CONSTRUCTS	Influenza virus is a global health concern due to its unpredictable pandemic potential. Frequent mutations of surface molecules, hemagglutinin (HA) and neuraminidase (NA), contribute to low efficacy of the annual flu vaccine and therapeutic resistance to standard antiviral agents. The populations at high risk of influenza virus infection, such as the elderly and infants, generally mount low immune responses to vaccines, and develop severe disease after infection. Novel therapeutics with high effectiveness and mutation resistance are needed. Previously, we described the generation of a fully human influenza virus matrix protein 2 (M2) specific monoclonal antibody (mAb), Z3G1, which recognized the majority of M2 variants from natural viral isolates, including highly pathogenic avian strains. Passive immunotherapy with Z3G1 significantly protected mice from the infection when administered either prophylactically or 1-2 days post infection. In the present study, we showed that Z3G1 significantly protected mice from lethal infection when treatment was initiated 3 days post infection. In addition, therapeutic administration of Z3G1 reduced lung viral titers in mice infected with different viral strains, including amantadine and oseltamivir-resistant strains. Furthermore, prophylactic and therapeutic administration of Z3G1 sustained O-2 saturation and reduced lung pathology in monkeys infected with a pandemic H1N1 strain. Finally, de-fucosylated Z3G1 with an IgG1/IgG3 chimeric Fc region was generated (AccretaMab (R) Z3G1), and showed increased ADCC and CDC in vitro. Our data suggest that the anti-M2 mAb Z3G1 has great potential as a novel anti-flu therapeutic agent. (C) 2014 Elsevier B.V. All rights reserved.	[Song, Aihua; Laudenslager, John; Soloff, Rachel] Kyowa Hakko Kirin, Calif Inc, Div Res, La Jolla, CA 92037 USA; [Myojo, Kensuke; Harada, Daisuke; Miura, Toru; Suzuki, Kazuo; Kuni-Kamochi, Reiko; Ohgami, Kinya; Kanda, Yutaka] Kyowa Hakko Kirin Co Ltd, R&D Div, Tokyo, Japan	Song, AH (reprint author), Kyowa Hakko Kirin, Calif Inc, 9420 Athena Circle, La Jolla, CA 92037 USA.	asong@kyowa-kirin-ca.com			Kyowa Hakko Kirin Co., Ltd., Japan	The monkey studies were conducted by ViroClinics Biosciences B.V. at the central animal facilities of the Erasmus MC in Rotterdam, The Netherlands. The central animal facility of the Erasmus MC is approved for animal work under local legislation. The study protocol is approved by the animal ethics committee. We thank S. Sarawar for valuable discussions. This work was supported by Kyowa Hakko Kirin Co., Ltd., Japan.	Abed Y, 2005, ANTIMICROB AGENTS CH, V49, P556, DOI 10.1128/AAC.49.2.556-559.2005; Krammer F, 2013, CURR OPIN VIROL, V3, P521, DOI 10.1016/j.coviro.2013.07.007; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.00641]; Jegerlehner A, 2004, J IMMUNOL, V172, P5598; Liu WL, 2005, MICROBES INFECT, V7, P171, DOI 10.1016/j.micinf.2004.10.006; Hurt AC, 2009, DRUGS, V69, P2523, DOI 10.2165/11531450-000000000-00000; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Sagawa H, 1996, J GEN VIROL, V77, P1483, DOI 10.1099/0022-1317-77-7-1483; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Prawira Y, 2012, SE ASIAN J TROP MED, V43, P877; Margine I, 2013, J VIROL, V87, P10435, DOI 10.1128/JVI.01715-13; Wang RF, 2008, ANTIVIR RES, V80, P168, DOI 10.1016/j.antiviral.2008.06.002; Motoki K, 2005, CLIN CANCER RES, V11, P3126, DOI 10.1158/1078-0432.CCR-04-1867; Grandea AG, 2010, P NATL ACAD SCI USA, V107, P12658, DOI 10.1073/pnas.0911806107; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Denis J, 2008, VACCINE, V26, P3395, DOI 10.1016/j.vaccine.2008.04.052; ZEBEDEE SL, 1988, J VIROL, V62, P2762; Schneemann A, 2012, J VIROL, V86, P11686, DOI 10.1128/JVI.01694-12; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Zharikova D, 2005, J VIROL, V79, P6644, DOI 10.1128/JVI.79.11.6644-6654.2005; Neirynck S, 1999, NAT MED, V5, P1157; VIRELIZIER JL, 1975, J IMMUNOL, V115, P434; Herfst S, 2010, VET PATHOL, V47, P1040, DOI 10.1177/0300985810374836; Natsume A, 2008, CANCER RES, V68, P3863, DOI 10.1158/0008-5472.CAN-07-6297; Beerli RR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-224; Humphreys IR, 2003, J EXP MED, V198, P1237, DOI 10.1084/jem.20030351; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; PALLADINO G, 1995, J VIROL, V69, P2075; Salas CFS, 2013, J ASTHMA, V50, P1069, DOI 10.3109/02770903.2013.834505; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Stittelaar KJ, 2008, ANTIVIR RES, V80, P225, DOI 10.1016/j.antiviral.2008.06.014; Thomson CA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00087; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Uyeki TM, 2008, RESPIROLOGY, V13, pS2, DOI 10.1111/j.1440-1843.2008.01246.x	45	5	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-3542	1872-9096		ANTIVIR RES	Antiviral Res.	NOV	2014	111						60	68		10.1016/j.antiviral.2014.08.016		9	Pharmacology & Pharmacy; Virology	Pharmacology & Pharmacy; Virology	AT8LP	WOS:000345185100010		
J	Yamada, H; Nagao, C; Haredy, AM; Mori, Y; Mizuguchi, K; Yamanishi, K; Okamoto, S				Yamada, Hiroshi; Nagao, Chioko; Haredy, Ahmad M.; Mori, Yasuko; Mizuguchi, Kenji; Yamanishi, Koichi; Okamoto, Shigefumi			Dextran sulfate-resistant A/Puerto Rico/8/34 influenza virus is associated with the emergence of specific mutations in the neuraminidase glycoprotein	ANTIVIRAL RESEARCH			English	Article						Influenza; Dextran sulfate; Neuraminidase	HUMAN-IMMUNODEFICIENCY-VIRUS; AMINO-ACID-SEQUENCES; IN-VITRO; VESICULAR STOMATITIS; A VIRUSES; REPLICATION; FUSION; INFECTION; H1N1; POLYSACCHARIDES	Dextran sulfate (DS) is a negatively charged sulfated polysaccharide that suppresses the replication of influenza A viruses. The suppression was thought to be associated with inhibition of the hemagglutinin-dependent fusion activity. However, we previously showed that suppression by DS was observed not only at the initial stage of viral infection, but also later when virus is released from infected cells due to inhibition of neuraminidase (NA) activity. In the present study, we isolated DS-resistant A/Puerto Rico/8/34 (PR8) influenza viruses and analyzed the inhibition by DS. We found six mutations in NA genes of five independent resistant PR8 viruses and each resistant NA gene had two mutations. All mutations were from basic to acidic or neutral amino acids. In addition, R430L, K432E or K435E in the 430-435 region was a common mutation in all resistant NA genes. To determine which amino acid(s) are responsible for this resistance, a panel of recombinant viruses containing a PR8 and A/WSN/33(WSN) chimeric NA gene or an NA gene with different mutation(s) was generated using reverse genetics. Using recombinant viruses containing a PR8/WSN chimeric NA, we showed that one third of the C-terminal region of PR8 NA was responsible for DS-sensitivity. Recombinant viruses with a single mutation in NA replicated better than wild-type PR8 in the presence of DS, but were still DS-sensitive. However, replication of recombinant viruses with double mutations from the resistant viruses was not affected by the presence or absence of DS. In addition, resistant recombinant viruses were found to be sensitive to the NA inhibitor, oseltamivir and the oseltamivir-resistant recombinant virus was sensitive to DS. These results suggested that DS is an NA inhibitor with a different mechanism of action from the currently used NA inhibitors and that DS could be used in combination with these inhibitors to treat influenza virus infections. (C) 2014 Elsevier B.V. All rights reserved.	[Yamada, Hiroshi; Haredy, Ahmad M.; Yamanishi, Koichi; Okamoto, Shigefumi] Natl Inst Biomed Innovat, Div Biomed Res, Lab Virol & Vaccinol, Ibaraki, Osaka 5670085, Japan; [Nagao, Chioko; Mizuguchi, Kenji] Natl Inst Biomed Innovat, Ibaraki, Osaka 5670085, Japan; [Mori, Yasuko] Kobe Univ, Grad Sch Med, Div Clin Virol, Kobe, Hyogo 657, Japan	Yamada, H (reprint author), Natl Inst Biomed Innovat, Lab Virol & Vaccinol, 7-6-8 Saito Asagi, Ibaraki, Osaka 5670085, Japan.	hiyamada@nibio.go.jp	Okamoto, Shigefumi/C-3232-2015	Okamoto, Shigefumi/0000-0001-9359-380X	Japanese Ministry of Health, Welfare, and Labor; Japanese Ministry of Education, Culture, Sports, Science, and Technology	We thank Dr. Yoshihiro Kawaoka for providing the influenza reverse genetics products. This study was partly supported by grants from the Japanese Ministry of Health, Welfare, and Labor, and the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; An JH, 2009, J MED CHEM, V52, P2667, DOI 10.1021/jm800455g; Amaro RE, 2007, J AM CHEM SOC, V129, P7764, DOI 10.1021/ja0723535; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Horimoto T, 2007, VIROLOGY, V366, P23, DOI 10.1016/j.virol.2007.07.002; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.biochem.56.1.365; Barman S, 2004, J VIROL, V78, P5258, DOI 10.1128/JVI.78.10.5258-5239.2004; PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Boltz DA, 2010, DRUGS, V70, P1349, DOI 10.2165/11537960-000000000-00000; BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Arnberg N, 2002, VIROLOGY, V302, P33, DOI 10.1006/viro.2002.1503; Amaro RE, 2009, J AM CHEM SOC, V131, P4702, DOI 10.1021/ja8085643; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; COLMAN PM, 1993, J VIROL, V67, P2972; DECLERCQ E, 1986, J MED CHEM, V29, P1561, DOI 10.1021/jm00159a001; DESOMER P, 1968, J VIROL, V2, P878; Eswar N, 2006, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0506S15; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Hayden F.G, 1997, AM J MED, V102, P75; Hayden Frederick G., 1997, American Journal of Medicine, V102, P55, DOI 10.1016/S0002-9343(97)80013-7; HERRMANN A, 1992, ANTIVIR RES, V19, P295, DOI 10.1016/0166-3542(92)90011-S; HOSOYA M, 1991, ANTIMICROB AGENTS CH, V35, P2515; Klenk H D, 1988, Adv Virus Res, V34, P247, DOI 10.1016/S0065-3527(08)60520-5; LUSCHERMATTLI M, 1993, ARCH VIROL, V130, P317, DOI 10.1007/BF01309663; LUSCHERMATTLI M, 1990, ANTIVIR RES, V14, P39, DOI 10.1016/0166-3542(90)90064-E; MITSUYA H, 1988, SCIENCE, V240, P646, DOI 10.1126/science.2452480; Nistal-Villan E, 2009, NAT MED, V15, P1253, DOI 10.1038/nm1109-1253; Ramalho-Santos J, 2001, BIOSCIENCE REP, V21, P293, DOI 10.1023/A:1013282015121; Whitley RJ, 2006, J INFECT DIS, V194, pS133, DOI 10.1086/507548; Yamada H, 2012, ANTIVIR RES, V96, P344, DOI 10.1016/j.antiviral.2012.09.012	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-3542	1872-9096		ANTIVIR RES	Antiviral Res.	NOV	2014	111						69	77		10.1016/j.antiviral.2014.09.002		9	Pharmacology & Pharmacy; Virology	Pharmacology & Pharmacy; Virology	AT8LP	WOS:000345185100011		
J	Mahara, Y; Ohta, T; Morikawa, N; Nakano, T; Tokumasu, M; Hukutani, S; Tokunaga, T; Igarashi, T				Mahara, Yasunori; Ohta, Tomoko; Morikawa, Noritoshi; Nakano, Takanori; Tokumasu, Minoru; Hukutani, Satoshi; Tokunaga, Tomochika; Igarashi, Toshifumi			Effects of terrigenic He components on tritium-helium dating: A case study of shallow groundwater in the Saijo Basin	APPLIED GEOCHEMISTRY			English	Article							NOBLE-GASES; WATERS; REGION; JAPAN; LAKES	Dating using a combination of H-3 and He-3 is believed to be the most practical method for estimating the short residence time of shallow groundwater. However, this method must estimate tritiogenic He-3 alone and tends to overestimate the residence time of groundwater, if terrigenic He-3 from the mantle cannot be excluded from the total dissolved He-3. We demonstrate the exclusion of terrigenic He-3 in the Saijo Basin, where mantle He is easily released along the major active fault, Median Tectonic Line. The He-3/He-4 ratios suggest that the west bank of the Kamo River, which lies within the basin, has experienced greater emanations of mantle He than the east bank. We estimate the residence times to be 1.1-96 years by the proposed exclusion method. (C) 2014 Elsevier Ltd. All rights reserved.	[Mahara, Yasunori] Kyoto Univ, Kyoto 6068501, Japan; [Mahara, Yasunori; Ohta, Tomoko; Igarashi, Toshifumi] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan; [Morikawa, Noritoshi] Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan; [Nakano, Takanori] Res Inst Human & Nat, Kyoto 6038047, Japan; [Tokumasu, Minoru] Saijo Municipal Off, Saijo 7938601, Japan; [Hukutani, Satoshi] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan; [Tokunaga, Tomochika] Univ Tokyo, Sch Frontier Sci, Dept Environm Syst, Kashiwa, Chiba 2778563, Japan	Mahara, Y (reprint author), Kyoto Univ, Kyoto 6068501, Japan.	mahara@mta.biglobe.ne.jp					STUTE M, 1992, SCIENCE, V256, P1000, DOI 10.1126/science.256.5059.1000; Aeschbach-Hertig W, 1998, GROUND WATER, V36, P661, DOI 10.1111/j.1745-6584.1998.tb02841.x; Porcelli D, 2002, REV MINERAL GEOCHEM, V47, P1, DOI 10.2138/rmg.2002.47.1; SANO Y, 1988, GEOCHEM J, V22, P293; Aeschbach-Hertig W, 1999, WATER RESOUR RES, V35, P2779, DOI 10.1029/1999WR900130; Kipfer R, 2002, REV MINERAL GEOCHEM, V47, P615, DOI 10.2138/rmg.2002.47.14; Aeschbach-Hertig W, 2000, NATURE, V405, P1040, DOI 10.1038/35016542; Kotarba MJ, 2008, CHEM GEOL, V255, P426, DOI 10.1016/j.chemgeo.2008.07.011; Lippmann J, 2003, GEOCHIM COSMOCHIM AC, V67, P4597, DOI 10.1016/S0016-7037(03)00414-9; Dogan T, 2006, CHEM GEOL, V233, P235, DOI 10.1016/j.chemgeo.2006.03.008; Mahara Y., 2009, J PLASMA FUSION RES, V85, P434; Nagao K, 2010, GEOCHEM J, V44, P519; Osenbruck K, 1998, GEOCHIM COSMOCHIM AC, V62, P3041, DOI 10.1016/S0016-7037(98)00198-7; Ozima M., 1983, NOBLE GAS GEOCHEMIST; Sano Y., 1985, J GEOPHYS RES, V90, P8728; Solomon D.K., 1993, WATER RESOUR RES, V29, P2851; Solomon D.K., 2000, ENV TRACERS SUBSURFA, P529	17	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0883-2927			APPL GEOCHEM	Appl. Geochem.	NOV	2014	50						142	149		10.1016/j.apgeochem.2014.02.013		8	Geochemistry & Geophysics	Geochemistry & Geophysics	AT4YH	WOS:000344948100015		
J	Klawitter, A				Klawitter, Arne			Alphabet, Lexicography and Encyclopedistic. Historical Concepts and literary-artistic Process	ARCADIA			German	Book Review									[Klawitter, Arne] Waseda Univ, Sch Letters Arts & Sci, Deutsch Seminar, Tokyo 1628644, Japan	Klawitter, A (reprint author), Waseda Univ, Sch Letters Arts & Sci, Deutsch Seminar, Toyama 1-24-1, Tokyo 1628644, Japan.	klawitter@waseda.jp					Barthes Roland, 2010, UBER MICH SELBST, P173; Paul Jean, 1959, SAMTLICHE WERKE ABTE, V5, P782; SCHMITZEMANS M, 2012, ALPHABET LEXIKOGRAPH	3	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0003-7982	1613-0642		ARCADIA	Arcadia	NOV	2014	49	2					437	441		10.1515/arcadia-2014-0034		5	Literature	Literature	AT7EJ	WOS:000345099400015		
J	Watanabe, K; Shinkai, M; Shinoda, M; Ishigatsubo, Y; Kaneko, T				Watanabe, Keisuke; Shinkai, Masaharu; Shinoda, Masahiro; Ishigatsubo, Yoshiaki; Kaneko, Takeshi			Intrapulmonary Schwannoma Diagnosed With Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: Case Report	ARCHIVOS DE BRONCONEUMOLOGIA			Spanish	Article						Intrapulmonary schwannoma; Endobronchial ultrasonography; Endobronchial ultrasound-guided; transbronchial needle aspiration	POSITRON-EMISSION-TOMOGRAPHY; LESIONS	A 47-year-old woman was referred to our hospital for further examination of a lung tumor. CT of the chest revealed a round, well-defined 2.4-cm nodule in 52, adjacent to right superior lobe bronchus. Endobronchial ultrasonography showed a well-defined, hypoechoic tumor with echogenic capsule and posterior acoustic enhancement. Diagnosis of schwannoma was confirmed from the specimen obtained by endobronchial ultrasound-guided transbronchial needle aspiration. She underwent tumorectomy due to the possibility of obstructive pneumonia. Pathology diagnosis from the surgical specimen was also schwannoma. Endobronchial ultrasound-guided transbronchial needle aspiration and findings with endobronchial ultrasonography might be helpful in the diagnosis of intrapulmonary schwannoma. (C) 2013 SEPAR. Published by Elsevier Espafia, S.L.U. All rights reserved.	[Watanabe, Keisuke; Shinkai, Masaharu; Shinoda, Masahiro] Yokohama City Univ, Med Ctr, Resp Dis Ctr, Yokohama, Kanagawa 232, Japan; [Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan; [Kaneko, Takeshi] Yokohama City Univ, Grad Sch Med, Dept Pulmonol, Yokohama, Kanagawa 232, Japan	Shinkai, M (reprint author), Yokohama City Univ, Med Ctr, Resp Dis Ctr, Yokohama, Kanagawa 232, Japan.	shinkai@yokohama-cu.ac.jp					Beaulieu S, 2004, AM J ROENTGENOL, V182, P971; Nakajima T, 2008, J THORAC ONCOL, V3, P985, DOI 10.1097/JTO.0b013e31818396b9; Gould MK, 2001, JAMA-J AM MED ASSOC, V285, P914, DOI 10.1001/jama.285.7.914; Beggs I, 1999, J CLIN ULTRASOUND, V27, P363, DOI 10.1002/(SICI)1097-0096(199909)27:7<363::AID-JCU1>3.0.CO;2-7; Asano F, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-50	5	0	0	EDICIONES DOYMA S A	BARCELONA	TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN	0300-2896	1579-2129		ARCH BRONCONEUMOL	Arch. Bronconeumol.	NOV	2014	50	11					490	492		10.1016/j.arbres.2013.11.013		3	Respiratory System	Respiratory System	AT4KC	WOS:000344907200006		
J	Kehara, H; Takano, T; Ohashi, N; Terasaki, T; Amano, J				Kehara, Hiromu; Takano, Tamaki; Ohashi, Noburo; Terasaki, Takamitsu; Amano, Jun			Platelet Function During Cardiopulmonary Bypass Using Multiple Electrode Aggregometry: Comparison of Centrifugal and Roller Pumps	ARTIFICIAL ORGANS			English	Article						Centrifugal pump; Roller pump; Platelet function; Multiple electrode aggregometry; Contact with foreign materials	CORONARY-ARTERY SURGERY; WHOLE-BLOOD AGGREGOMETRY; CARDIAC-SURGERY; ACTIVATION; HEPARIN; AGGREGATION; DYSFUNCTION; SURFACES; FLOW	Blood trauma may be lower with centrifugal pumps (CPs) than with roller pumps (RPs) during cardiopulmonary bypass (CPB), because, unlike RPs, CPs do not compress the tubing, and shear stress is considered lower in CPs than in RPs. However, relative platelet function remains unclear. Using multiple electrode aggregometry (MEA), we compared platelet function with CP and RP. Ten swine underwent CPB for 3h, with five weaned off using CP and five using RP. Platelet function was measured using MEA, as were hemoglobin concentration and platelet count, before sternotomy, after heparin infusion, 30min and 3h after starting CPB, after protamine infusion, and 60min after stopping CPB. Platelet activation was initiated with adenosine diphosphate (ADP), arachidonic acid (AA), and thrombin receptor-activating protein 6 (TRAP). Fibrinogen, platelet factor 4 (PF4), and -thromboglobin (-TG) concentrations were measured before sternotomy and 60min after stopping CPB. In the CP group and using ADP, aggregation was significantly reduced 30min (P=0.019) and 3h (P=0.027) after starting CPB, recovering to baseline 60min after CPB was stopped. In the RP group, aggregation was significantly decreased 30min (P=0.007) and 3h (P=0.003) after starting CPB and after protamine administration (P=0.028). With AA, aggregation significantly decreased 30min after starting CPB in both the CP (P=0.012) and RP (P=0.016) groups, slightly increasing 3h after starting CPB and after protamine infusion, and recovering to baseline 60min after CPB cessation. With TRAP, aggregation in the CP and RP groups decreased 30min after starting the pump, although changes were not significant; aggregation gradually recovered after 3h and returned to baseline 60min after the pumps were stopped. There were no significant differences at all sampling points of MEA. In both groups, fibrinogen, PF4, and -TG concentrations were similar 60min after pump cessation and before sternotomy. Platelet function, evaluated with MEA, was lowest 30min after CPB was started but did not decrease over time in either group. As assessed by MEA, platelet function using CP and RP did not differ significantly. Platelet dysfunction was caused mainly by initial contact with foreign materials and may not be dependent on type of pump.	[Kehara, Hiromu; Takano, Tamaki; Ohashi, Noburo; Terasaki, Takamitsu; Amano, Jun] Shinshu Univ, Sch Med, Dept Cardiovasc Surg, Matsumoto, Nagano 3908621, Japan	Takano, T (reprint author), Shinshu Univ, Sch Med, Dept Cardiovasc Surg, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	ttakano-ths@umin.ac.jp					Velik-Salchner C, 2009, ANESTH ANALG, V108, P1747, DOI 10.1213/ane.0b013e3181a198ac; Rahe-Meyer N, 2009, ACTA ANAESTH SCAND, V53, P168, DOI 10.1111/j.1399-6576.2008.01845.x; KESTIN AS, 1993, BLOOD, V82, P107; Greilich PE, 2002, THROMB RES, V105, P523, DOI 10.1016/S0049-3848(02)00061-0; Lim H, 2011, CLIN HEMORHEOL MICRO, V47, P211, DOI 10.3233/CH-2010-1382; Toth O, 2006, THROMB HAEMOSTASIS, V96, P781, DOI 10.1160/TH06-05-0242; Scott DA, 2001, J CARDIOTHOR VASC AN, V15, P322, DOI 10.1053/jcan.2001.23279; Finley MJ, 2012, BIOMATERIALS, V33, P5803, DOI 10.1016/j.biomaterials.2012.04.051; Hansbro SD, 1999, PERFUSION-UK, V14, P3; Kobzar G, 2006, PLATELETS, V17, P289, DOI 10.1080/09537100600745245; Ranucci M, 2011, ANN THORAC SURG, V91, P123, DOI 10.1016/j.athoracsur.2010.09.022; Andersen KS, 2003, SCAND CARDIOVASC J, V37, P356, DOI 10.1080/14017430310015523; HARKER LA, 1980, BLOOD, V56, P824; Gertler R, 2011, J CARDIOTHOR VASC AN, V25, P981, DOI 10.1053/j.jvca.2010.11.020; ZILLA P, 1989, J THORAC CARDIOV SUR, V97, P379; Saczkowski R, 2012, ARTIF ORGANS, V36, P668, DOI 10.1111/j.1525-1594.2012.01497.x; Clancey N, 2009, VET CLIN PATH, V38, P467, DOI 10.1111/j.1939-165X.2009.00162.x; Clemetson KJ, 2004, HEMATOL J, V5, pS159, DOI 10.1038/sj.thj.6200444; Izuha Hitoshi, 2005, J Artif Organs, V8, P41, DOI 10.1007/s10047-004-0280-x; Jakob H G, 1991, ASAIO Trans, V37, pM487; Krajewski S, 2012, PLATELETS, V23, P386, DOI 10.3109/09537104.2011.624209; Laga S, 2005, ARTIF ORGANS, V29, P541, DOI 10.1111/j.1525-1594.2005.29090.x; Mengistu AM, 2008, J CARDIOTHOR VASC AN, V22, P40, DOI 10.1053/j.jvca.2007.02.015; Mengistu AM, 2011, J CARDIOTHOR VASC AN, V25, P42, DOI 10.1053/j.jvca.2010.02.008; Moen O, 1996, ANN THORAC SURG, V62, P1134, DOI 10.1016/0003-4975(96)00492-4; Morgan IS, 1998, EUR J CARDIO-THORAC, V13, P526, DOI 10.1016/S1010-7940(98)00067-0; Mulholland JW, 2005, J FLUID STRUCT, V20, P129, DOI 10.1016/j.jfluidstructs.2004.10.008; Muriithi EW, 2000, ANN THORAC SURG, V69, P1827, DOI 10.1016/S0003-4975(00)01299-6; PERKINS HA, 1975, TRANSFUSION, V15, P87; Poullis M, 2000, J THORAC CARDIOV SUR, V120, P370, DOI 10.1067/mtc.2000.108531; Rahe-Meyer N, 2008, ANESTH ANALG, V107, P1791, DOI 10.1213/ane.0b013e3181865733; Reece MJ, 2011, ANAESTHESIA, V66, P97, DOI 10.1111/j.1365-2044.2010.06608.x; Reul HM, 2000, PERFUSION-UK, V15, P295; WHEELDON D R, 1990, Perfusion (London), V5, P135, DOI 10.1177/026765919000500207; Yoshimoto Y, 2013, MICROSC RES TECHNIQ, V76, P342, DOI 10.1002/jemt.22172	35	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-564X	1525-1594		ARTIF ORGANS	Artif. Organs	NOV	2014	38	11					924	930		10.1111/aor.12299		7	Engineering, Biomedical; Transplantation	Engineering; Transplantation	AU0WQ	WOS:000345343300004		
J	Nakayama, T; Sakuraba, T; Tomita, S; Kaneko, A; Takai, E; Shiraki, K; Tashiro, K; Ishii, N; Hasegawa, Y; Yamada, Y; Kumai, R; Yamamoto, Y				Nakayama, Toru; Sakuraba, Taro; Tomita, Shunsuke; Kaneko, Akira; Takai, Eisuke; Shiraki, Kentaro; Tashiro, Kentaro; Ishii, Noriyuki; Hasegawa, Yuri; Yamada, Yoichi; Kumai, Reiji; Yamamoto, Yohei			Charge-Separated Fmoc-Peptide beta-Sheets: Sequence-Secondary Structure Relationship for Arranging Charged Side Chains on Both Sides	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						amino acids; beta-sheet; nanostructures; peptides; self-assembly	SELF-COMPLEMENTARY OLIGOPEPTIDE; SUPRAMOLECULAR HYDROGELS; ORGANIC-MOLECULES; ROOM-TEMPERATURE; FERROELECTRICITY; ASSEMBLIES; NANOSTRUCTURE; AROMATICITY; ATTACHMENT; SCAFFOLDS	beta-Sheet formation from fluorenylmethoxycarbonyl (Fmoc)-substituted polar oligopeptides was demonstrated, where acidic and basic side chains are located separately on either side of the beta-sheet surfaces. For yielding such charge-separated beta-sheets, self-assembly of 18 pentapeptides was studied, all of which contain glutamic acid (E), lysine (K), and valine (V). Fmoc-pentapeptides containing one E and one K all formed fibrillar nano-structures consisting of stacked beta-sheets. On the other hand, Fmoc-pentapeptides containing two E and two K formed beta-sheet fibrils only when V was located at the center and separated two EK pairs. Photoluminescence studies of these peptides in a glycine buffer containing thioflavin T revealed a clear relationship between the amino acid sequence and secondary structure, where the location of neutral V plays a pivotal role for the bsheet formation. The beta-sheet formation propensity was further supported by computer simulation studies with the TANGO algorithm.	[Nakayama, Toru; Sakuraba, Taro; Kaneko, Akira; Yamamoto, Yohei] Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan; [Nakayama, Toru; Sakuraba, Taro; Kaneko, Akira; Yamamoto, Yohei] Univ Tsukuba, Fac Pure & Appl Sci, TIMS, Tsukuba, Ibaraki 3058573, Japan; [Tomita, Shunsuke; Ishii, Noriyuki] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Takai, Eisuke; Shiraki, Kentaro; Hasegawa, Yuri; Yamada, Yoichi] Univ Tsukuba, Fac Pure & Appl Sci, Div Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Tashiro, Kentaro] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan; [Kumai, Reiji] High Energy Accelerator Res Org KEK, Condensed Matter Res Ctr, Tsukuba, Ibaraki 3050801, Japan	Yamamoto, Y (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	yamamoto@ims.tsukuba.ac.jp	洋平, 山本/C-8919-2011; Tomita, Shunsuke/I-1464-2015	洋平, 山本/0000-0002-2166-3730; Tomita, Shunsuke/0000-0002-0586-6976	MEXT [25107507]; Cooperative Research Program of "Network Joint Research Center for Materials and Devices"; Asahi Glass Foundation; Murata Science Foundation; Photon Factory Program Advisory Committee [2013G528]	This work was partly supported by a Grant-in-Aid for Scientific Research on Innovative Areas (no. 25107507), MEXT, the Cooperative Research Program of "Network Joint Research Center for Materials and Devices", the Asahi Glass Foundation, and the Murata Science Foundation. The synchrotron radiation experiments were performed under the approval of the Photon Factory Program Advisory Committee (proposal no. 2013G528).	Horiuchi S, 2005, NAT MATER, V4, P163, DOI 10.1038/nmat1298; Nowinski AK, 2012, J AM CHEM SOC, V134, P6000, DOI 10.1021/ja3006868; Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522; Liu C, 2012, P NATL ACAD SCI USA, V109, P20913, DOI 10.1073/pnas.1218792109; Marder SR, 1997, NATURE, V388, P845, DOI 10.1038/42190; MARDER SR, 1994, SCIENCE, V263, P511, DOI 10.1126/science.263.5146.511; Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999; Cavalli S, 2010, CHEM SOC REV, V39, P241, DOI 10.1039/b906701a; Cheng G, 2011, SOFT MATTER, V7, P1326, DOI 10.1039/c0sm00408a; Horiuchi S, 2008, NAT MATER, V7, P357, DOI 10.1038/nmat2137; Horiuchi S, 2013, J AM CHEM SOC, V135, P4492, DOI 10.1021/ja400318v; Sakai N, 2008, ACCOUNTS CHEM RES, V41, P1354, DOI 10.1021/ar700229r; Yang ZM, 2004, ADV MATER, V16, P1440, DOI 10.1002/adma.200400340; MARDER SR, 1991, SCIENCE, V252, P103, DOI 10.1126/science.252.5002.103; Loo Y, 2012, BIOTECHNOL ADV, V30, P593, DOI 10.1016/j.biotechadv.2011.10.004; Dong B, 2013, J AM CHEM SOC, V135, P1284, DOI 10.1021/ja312214a; Jayawarna V, 2009, ACTA BIOMATER, V5, P934, DOI 10.1016/j.actbio.2009.01.006; Zhang Y, 2003, J AM CHEM SOC, V125, P13680, DOI 10.1021/ja036817k; Johansson J, 2010, BIOCHEM BIOPH RES CO, V402, P515, DOI 10.1016/j.bbrc.2010.10.062; Matile S, 2011, CHEM SOC REV, V40, P2453, DOI 10.1039/c0cs00209g; Dong H, 2007, J AM CHEM SOC, V129, P12468, DOI 10.1021/ja072536r; Pagel K, 2006, J AM CHEM SOC, V128, P2196, DOI 10.1021/ja057450h; Horiuchi S, 2010, NATURE, V463, P789, DOI 10.1038/nature08731; Hirst AR, 2010, NAT CHEM, V2, P1089, DOI [10.1038/nchem.861, 10.1038/NCHEM.861]; Bakota EL, 2013, BIOMACROMOLECULES, V14, P1370, DOI 10.1021/bm4000019; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012; Debnath S, 2010, J PHYS CHEM B, V114, P4407, DOI 10.1021/jp909520w; Orbach R, 2009, BIOMACROMOLECULES, V10, P2646, DOI 10.1021/bm900584m; Castelletto V, 2011, SOFT MATTER, V7, P11405, DOI 10.1039/c1sm06550e; Xu HX, 2010, NANOSCALE, V2, P960, DOI 10.1039/b9nr00233b; Cheng G, 2010, LANGMUIR, V26, P4990, DOI 10.1021/la903678e; Bando Y, 2012, CHEM COMMUN, V48, P2301, DOI 10.1039/c2cc17282h; Bowerman CJ, 2011, BIOMACROMOLECULES, V12, P2735, DOI 10.1021/bm200510k; Bowerman C. J., 2012, PEPT SCI, V98, P169; Castelletto V, 2012, SOFT MATTER, V8, P5434, DOI 10.1039/c2sm25546d; Chen CX, 2010, BIOMACROMOLECULES, V11, P402, DOI 10.1021/bm901130u; Easterhoff D, 2011, BIOPHYS J, V100, P1325, DOI 10.1016/j.bpj.2011.01.037; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fracaroli AM, 2012, INORG CHEM, V51, P6437, DOI 10.1021/ic300744x; Kimura S, 2008, ORG BIOMOL CHEM, V6, P1143, DOI 10.1039/b717898k; Manhart S, 2003, BIOCHEMISTRY-US, V42, P3081, DOI 10.1021/bi026868e; Tsutsumi M, 2011, J CHEM INF MODEL, V51, P1457, DOI 10.1021/ci200027d; Vairaprakash P, 2011, J AM CHEM SOC, V133, P759, DOI 10.1021/ja1097644; Jentzsch AV, 2013, ACCOUNTS CHEM RES, V46, P2791, DOI 10.1021/ar400014r; Yang ZM, 2004, CHEM COMMUN, P208, DOI 10.1039/b310574a; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334	48	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	NOV	2014	3	11					1182	1188		10.1002/ajoc.201402129		7	Chemistry, Organic	Chemistry	AT6EN	WOS:000345032100008		
J	Yoshida, H; Takemoto, Y; Takaki, K				Yoshida, Hiroto; Takemoto, Yuki; Takaki, Ken			Direct Synthesis of Boron-Protected Alkenyl- and Alkylborons via Copper-Catalyzed Formal Hydroboration of Alkynes and Alkenes	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						boron-protection; copper; hydroboration; regioselectivity	SMALL-MOLECULE SYNTHESIS; VERSATILE BUILDING-BLOCK; CROSS-COUPLING MODULES; EFFICIENT SYNTHESIS; INTERNAL ALKYNES; COPPER(I)-CATALYZED REACTION; 3-COMPONENT CARBOBORATION; STEREOSELECTIVE-SYNTHESIS; DIBORON REAGENTS; GENERAL-SOLUTION	Formal hydroboration of internal alkynes proceeds regio- and stereoselectively by the use of a diboron reagent masked with 1,8-diaminonaphthalene (dan) in the presence of readily available [(Ph3P)(3)CuCl], leading to direct formation of diverse B-protected alkenylborons in high yield. The B(dan) moiety can also be efficiently installed into the C-C double bond of alkenes to afford the respective alkylborons.	[Yoshida, Hiroto; Takemoto, Yuki; Takaki, Ken] Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan; [Yoshida, Hiroto] Japan Sci & Technol Agcy JST, Adv Catalyt Transformat Program Carbon Utilizat A, Higashihiroshima 7398527, Japan	Yoshida, H (reprint author), Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan.	yhiroto@hiroshima-u.ac.jp	Yoshida, Hiroto/B-7954-2011	Yoshida, Hiroto/0000-0001-6890-4397			Gillis EP, 2007, J AM CHEM SOC, V129, P6716, DOI 10.1021/ja0716204; Iwadate N, 2010, CHEM LETT, V39, P558, DOI 10.1246/cl.2010.558; Nelson DJ, 2014, ORGANOMETALLICS, V33, P2048, DOI 10.1021/om5001919; Kubota K, 2013, J AM CHEM SOC, V135, P2635, DOI 10.1021/ja3104582; Semba K, 2013, CHEM-EUR J, V19, P7125, DOI 10.1002/chem.201300443; Matsuda N, 2013, J AM CHEM SOC, V135, P4934, DOI 10.1021/ja4007645; Yoshida H, 2012, ANGEW CHEM INT EDIT, V51, P235, DOI 10.1002/anie.201106706; Ito H, 2010, J AM CHEM SOC, V132, P5990, DOI 10.1021/ja101793a; Woerly EM, 2010, J AM CHEM SOC, V132, P6941, DOI 10.1021/ja102721p; Fujihara T, 2014, CATAL SCI TECHNOL, V4, P1699, DOI 10.1039/c4cy00070f; Yun J, 2013, ASIAN J ORG CHEM, V2, P1016, DOI 10.1002/ajoc.201300110; Struble JR, 2010, TETRAHEDRON, V66, P4710, DOI 10.1016/j.tet.2010.04.020; Gomez-Suarez A, 2011, ORGANOMETALLICS, V30, P5463, DOI 10.1021/om200705y; Yoshida H, 2013, ORG LETT, V15, P952, DOI 10.1021/ol4001526; Yuan WM, 2012, ORG BIOMOL CHEM, V10, P7266, DOI 10.1039/c2ob26147b; Woerly EM, 2013, TETRAHEDRON, V69, P7732, DOI 10.1016/j.tet.2013.05.050; Noguchi H, 2008, ORG LETT, V10, P377, DOI 10.1021/ol702420x; Iwadate N, 2009, ORG LETT, V11, P1899, DOI 10.1021/ol9003096; Gillis EP, 2008, J AM CHEM SOC, V130, P14084, DOI 10.1021/ja8063759; Uno BE, 2009, TETRAHEDRON, V65, P3130, DOI 10.1016/j.tet.2008.11.010; Noguchi H, 2007, J AM CHEM SOC, V129, P758, DOI 10.1021/ja067975p; Moure AL, 2012, J AM CHEM SOC, V134, P7219, DOI 10.1021/ja300627s; Woerly EM, 2014, NAT CHEM, V6, P484, DOI 10.1038/NCHEM.1947; Lee SJ, 2008, J AM CHEM SOC, V130, P466, DOI 10.1021/ja078129x; Knapp DM, 2009, J AM CHEM SOC, V131, P6961, DOI 10.1021/ja901416p; Takemoto Y, 2012, CHEM-EUR J, V18, P14841, DOI 10.1002/chem.201202435; Dick GR, 2012, ANGEW CHEM INT EDIT, V51, P2667, DOI 10.1002/anie.201108608; Lee SJ, 2010, ANGEW CHEM INT EDIT, V49, P8860, DOI 10.1002/anie.201004911; Sakae R, 2014, ORG LETT, V16, P1228, DOI 10.1021/ol5001507; Kim HR, 2011, CHEM COMMUN, V47, P2943, DOI 10.1039/c0cc04496b; Dick GR, 2010, ORG LETT, V12, P2314, DOI 10.1021/ol100671v; Yoshida H, 2014, ORG LETT, V16, P3512, DOI 10.1021/ol501465x; Park JK, 2012, ORG LETT, V14, P4790, DOI 10.1021/ol302086v; Iwadate N, 2010, J AM CHEM SOC, V132, P2548, DOI 10.1021/ja1000642; Berthon-Gelloz G, 2010, DALTON T, V39, P1444, DOI 10.1039/b921894g; Ito H, 2008, ANGEW CHEM INT EDIT, V47, P7424, DOI 10.1002/anie.200802342; Kaupp G, 2003, CHEM-EUR J, V9, P4156, DOI 10.1002/chem.200304793; COSTA G, 1965, J INORG NUCL CHEM, V27, P2581, DOI 10.1016/0022-1902(65)80159-2; Dick G. H., 2012, ANGEW CHEM, V124, P2721; Eliel E. L., 1994, STEREOCHEMISTRY ORGA, P695; Fujii S, 2011, ANGEW CHEM INT EDIT, V50, P7862, DOI 10.1002/anie.201102688; Fujii S., 2011, ANGEW CHEM, V123, P8008; Ito H., 2008, ANGEW CHEM, V120, P7534, DOI 10.1002/ange.200802342; Iwadate N, 2009, J ORGANOMET CHEM, V694, P1713, DOI 10.1016/j.jorganchem.2008.11.068; Jung HY, 2012, ORG LETT, V14, P2606, DOI 10.1021/ol300909k; Kageyuki I, 2014, SYNTHESIS-STUTTGART, V46, P1924, DOI 10.1055/s-0033-1341267; Lee JE, 2008, CHEM COMMUN, P733, DOI 10.1039/b716697d; Lee S. J., 2010, ANGEW CHEM, V122, P9044, DOI 10.1002/ange.201004911; Meng FK, 2013, ORG LETT, V15, P1414, DOI 10.1021/ol4004178; Semba K., 2013, ANGEW CHEM, V125, P12626; Semba K, 2012, CHEM-EUR J, V18, P4179, DOI 10.1002/chem.201103612; Semba K, 2013, ANGEW CHEM INT EDIT, V52, P12400, DOI 10.1002/anie.201306843; Woerly EM, 2011, TETRAHEDRON, V67, P4333, DOI 10.1016/j.tet.2011.04.021; Yoshida H., 2012, ANGEW CHEM, V124, P239, DOI DOI 10.1002/ANGE.201106706; Yoshida H, 2013, CHEM COMMUN, V49, P11671, DOI 10.1039/c3cc47173j; Yoshida H, 2014, CHEM COMMUN, V50, P8299, DOI 10.1039/c4cc01757a; Yuan WM, 2012, ADV SYNTH CATAL, V354, P1867, DOI 10.1002/adsc.201100929	57	6	6	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	NOV	2014	3	11					1204	1209		10.1002/ajoc.201402166		6	Chemistry, Organic	Chemistry	AT6EN	WOS:000345032100012		
J	Kuramitsu, S; Sonoda, S; Yokoi, H; Iwabuchi, M; Nishizaki, Y; Shinozaki, T; Domei, T; Hyodo, M; Inoue, K; Shirai, S; Ando, K; Nobuyoshi, M				Kuramitsu, Shoichi; Sonoda, Shinjo; Yokoi, Hiroyoshi; Iwabuchi, Masashi; Nishizaki, Yuji; Shinozaki, Tomohiro; Domei, Takenori; Hyodo, Makoto; Inoue, Katsumi; Shirai, Shinichi; Ando, Kenji; Nobuyoshi, Masakiyo			Long-term coronary arterial response to biodegradable polymer biolimus-eluting stents in comparison with durable polymer sirolimus-eluting stents and bare-metal stents: Five-year follow-up optical coherence tomography study	ATHEROSCLEROSIS			English	Article						Biolimus-eluting stent; Optical coherence tomography; In-stent neoatherosclerosis; Biodegradable polymer	NONINFERIORITY TRIAL; THROMBUS FORMATION; IMPLANTATION; COVERAGE; RISK; NEOATHEROSCLEROSIS; RESTENOSIS; PATHOLOGY	Objective: The long-term coronary arterial response of biodegradable polymer biolimus-eluting stents (BES) remains unclear. We sought to evaluate the coronary arterial response of biodegradable polymer BES at 5 years after stent implantation using optical coherence tomography (OCT) as compared with that of durable polymer sirolimus-eluting stents (SES) and bare-metal stents (BMS). Methods: Five-year follow-up OCT was performed in 30 patients with 33 stents (10 with 12 BES; 10 with 11 SES; 10 with 10 BMS). Quantitative parameters and qualitative characteristics of the neointima were evaluated. A total of 5178 struts (BES, n = 2056; SES, n = 1410; BMS, n = 1712) were analyzed. Results: Uncovered struts were found in 15 out of 2055 struts in the BES (weighted estimate 0.01%, 95% confidence intervals [CI]: 0.00-0.33%) and 54 out of 1410 struts in the SES (0.11%, 95% CI: 0.00-3.33%) (odds ratio [OR] 0.12, 95% CI: 0.01-1.95, p = 0.13). None of 1712 struts were uncovered in the BMS. Cross-sectional qualitative analysis of neointimal tissue showed that the frequency of lipid-laden neointima tended to be lower in the BES (2.26%, 95% CI: 0.38-12.3%) compared with the SES (9.90%, 95% CI: 4.37-20.9%; OR 0.21, 95% CI 0.03-1.16, p = 0.07), and was similar to the BMS (2.23%, 95% CI: 0.54-8.74%; OR 0.98, 95% CI 0.13-7.14, p = 0.98). Conclusions: Biodegradable polymer BES shows a favorable coronary arterial response compared with SES, but different response with BMS at 5 years follow-up. The observed frequency of in-stent neoatherosclerosis within BES was similar to BMS and tended to be lower than SES. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kuramitsu, Shoichi; Yokoi, Hiroyoshi; Iwabuchi, Masashi; Domei, Takenori; Hyodo, Makoto; Shirai, Shinichi; Ando, Kenji; Nobuyoshi, Masakiyo] Kokura Mem Hosp, Dept Cardiol, Kokurakita Ku, Kitakyushu, Fukuoka 8028555, Japan; [Sonoda, Shinjo] Univ Occupat & Environm Hlth, Japan Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka 807, Japan; [Nishizaki, Yuji] Juntendo Univ, Grad Sch Med, Dept Cardiol, Tokyo, Japan; [Shinozaki, Tomohiro] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan; [Inoue, Katsumi] Kokura Mem Hosp, Dept Lab Med, Kokurakita Ku, Kitakyushu, Fukuoka 8028555, Japan	Kuramitsu, S (reprint author), Kokura Mem Hosp, Dept Cardiol, Kokurakita Ku, 3-2-1 Asano, Kitakyushu, Fukuoka 8028555, Japan.	kuramitsu@circulation.jp					Kang SJ, 2011, CIRCULATION, V123, P2954, DOI 10.1161/CIRCULATIONAHA.110.988436; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Nakazawa G, 2009, JACC-CARDIOVASC IMAG, V2, P625, DOI 10.1016/j.jcmg.2009.01.011; Tada T, 2012, CIRC-CARDIOVASC INTE, V5, P649, DOI 10.1161/CIRCINTERVENTIONS.112.968487; Barlis P, 2010, EUR HEART J, V31, P165, DOI 10.1093/eurheartj/ehp480; Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092; Natsuaki M, 2013, J AM COLL CARDIOL, V62, P181, DOI 10.1016/j.jacc.2013.04.045; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Gonzalo N, 2009, AM HEART J, V158, P284, DOI 10.1016/j.ahj.2009.06.004; Lee CW, 2010, J AM COLL CARDIOL, V55, P1936, DOI 10.1016/j.jacc.2009.10.077; Kim Y, 2013, AM STAT, V67, P171, DOI 10.1080/00031305.2013.817357; Imai M, 2011, CIRCULATION, V123, P2382, DOI 10.1161/CIRCULATIONAHA.110.003459; Takano M, 2009, J AM COLL CARDIOL, V55, P26, DOI 10.1016/j.jacc.2009.08.032; Otake H, 2009, JACC-CARDIOVASC INTE, V2, P459, DOI 10.1016/j.jcin.2009.03.003; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Kimura T, 2012, CIRCULATION, V125, P584, DOI 10.1161/CIRCULATIONAHA.111.046599; Kadota K, 2012, CATHETER CARDIO INTE, V80, P789, DOI 10.1002/ccd.23280; Kang SJ, 2013, JACC-CARDIOVASC IMAG, V6, P695, DOI 10.1016/j.jcmg.2013.02.006; Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2; Gutierrez-Chico JL, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.09.005; Hagiwara H, 2012, EUROINTERVENTION, V8, P743, DOI 10.4244/EIJV8I6A114; Kim JS, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.029; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; Tanigawa Jun, 2007, EuroIntervention, V3, P128	27	3	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	NOV	2014	237	1					23	29		10.1016/j.atherosclerosis.2014.08.031		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT5WT	WOS:000345011300004		
J	Adachi, H				Adachi, Hisashi			Microalbuminuria is an independent prognostic information for cardiovascular disease	ATHEROSCLEROSIS			English	Editorial Material						Cardiovascular disease; Hypercreatininemia; Metabolic syndrome; Microalbuminuria; Epidemiology	CHRONIC KIDNEY-DISEASE; METABOLIC SYNDROME; GENERAL-POPULATION; SERUM CREATININE; RENAL-FUNCTION; MORTALITY; RISK; HYPERTENSION; ASSOCIATION; ADULTS		Kurume Univ, Sch Med, Dept Community Med, Kurume, Fukuoka 830, Japan	Adachi, H (reprint author), Kurume Univ, Sch Med, Dept Community Med, Kurume, Fukuoka 830, Japan.	hadac@med.kurume-u.ac.jp					Chen J, 2004, ANN INTERN MED, V140, P167; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Liu LJ, 2014, AM J CARDIOL, V113, P84, DOI 10.1016/j.amjcard.2013.08.042; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Cheng TYD, 2008, AM J KIDNEY DIS, V52, P1051, DOI 10.1053/j.ajkd.2008.05.030; Hao Z, 2007, INTERNAL MED, V46, P341, DOI 10.2169/internalmedicine.46.6056; Klausen KP, 2007, J INTERN MED, V262, P470, DOI 10.1111/j.1365-2796.2007.01839.x; Culleton BF, 1999, ARCH INTERN MED, V159, P1785, DOI 10.1001/archinte.159.15.1785; Crook ED, 2002, AM J MED SCI, V324, P138, DOI 10.1097/00000441-200209000-00004; Farbom P, 2008, HYPERTENSION, V52, P115, DOI 10.1161/HYPERTENSIONAHA.107.109264; Oliveras A, 2013, AM J HYPERTENS, V26, P1148, DOI 10.1093/ajh/hpt074; Sibilitz KL, 2014, ATHROSCLERO IN PRESS	12	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	NOV	2014	237	1					106	107		10.1016/j.atherosclerosis.2014.05.964		2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT5WT	WOS:000345011300017		
J	Kosaka, T; Kokubo, Y; Ono, T; Sekine, S; Kida, M; Kikui, M; Yamamoto, M; Watanabe, M; Amano, A; Maeda, Y; Miyamoto, Y				Kosaka, Takayuki; Kokubo, Yoshihiro; Ono, Takahiro; Sekine, Shinichi; Kida, Momoyo; Kikui, Miki; Yamamoto, Masaaki; Watanabe, Makoto; Amano, Atsuo; Maeda, Yoshinobu; Miyamoto, Yoshihiro			Salivary inflammatory cytokines may be novel markers of carotid atherosclerosis in a Japanese general population: The Suita study	ATHEROSCLEROSIS			English	Article						Salivary inflammatory cytokine; Carotid atherosclerosis; Intima-media thickness; Periodontal disease	INTIMA-MEDIA THICKNESS; SUBCLINICAL ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; HYPERTENSIVE PATIENTS; PERIODONTAL-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; ASSOCIATION; BIOMARKERS; INFECTION	Objective: Salivary biomarkers have been recently useful of periodontal disease, which is also risk factor of atherosclerosis. However, there are few studies of the association between salivary inflammatory cytokines and carotid atherosclerosis. We aimed to clarify the association between salivary inflammatory cytokines and periodontal disease and carotid atherosclerosis in a general urban population. Methods: We studied 608 Japanese men and women (mean age: 65.4 years) in the Suita study. Carotid atherosclerosis was evaluated by high-resolution ultrasonography with atherosclerotic indexes of intima-media thickness (IMT). Periodontal status was evaluated by the Community Periodontal Index (CPI). Salivary levels of interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha (TNF-alpha), and prostaglandin E2 (PGE2) were measured by enzyme linked immunosorbent assay. The risks of carotid atherosclerosis (>= 75th percentiles of mean-[0.88 mm] and Max-IMT [1.50 mm]) according to the quartiles of salivary inflammatory cytokines were compared using of adjusted-logistic regression models. Results and conclusion: All salivary inflammatory cytokines were positively associated with CPI. The adjusted odds ratios for carotid atherosclerosis of mean-IMT in the highest quartile of interleukin-6 and TNF-alpha were higher than those in the lowest quartiles (OR = 2.32 and 2.88; 95% confidence intervals = 1.19 -4.51 and 1.51-5.49, respectively). The adjusted odds ratio for carotid atherosclerosis of mean-IMT in the highest quartile of PGE2 was greater than those in the lowest quartile inwomen(OR = 2.78; 95% confidence intervals = 1.11-6.95). In conclusion, higher levels of salivary inflammatory cytokines were associated with both periodontal disease and carotid atherosclerosis. Selected salivary inflammatory cytokines may be useful screening markers for periodontal disease and carotid atherosclerosis. (C) 2014 Published by Elsevier Ireland Ltd.	[Kosaka, Takayuki; Ono, Takahiro; Kida, Momoyo; Kikui, Miki; Yamamoto, Masaaki; Maeda, Yoshinobu] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka 5650871, Japan; [Kokubo, Yoshihiro; Watanabe, Makoto; Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka 5658565, Japan; [Sekine, Shinichi; Amano, Atsuo] Osaka Univ, Grad Sch Dent, Dept Prevent Dent, Suita, Osaka 5650871, Japan	Ono, T (reprint author), Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kosaka@dent.osaka-u.ac.jp; ykokubo@hsp.ncvc.go.jp; ono@dent.osaka-u.ac.jp; sekines@dent.osaka-u.ac.jp; m-kida@dent.osaka-u.ac.jp; m-kikui@dent.osaka-u.ac.jp; masaakiy@dent.osaka-u.ac.jp; watanabe.makoto.hp@ncvc.go.jp; amanoa@dent.osaka-u.ac.jp; ymaeda@dent.osaka-u.ac.jp; miyamoty@hsp.ncvc.go.jp			Intramural Research Fund of the National Cerebral and Cardiovascular Center [22-4-5]; Ministry of Education Science and Culture of Japan [20390489, 23390441, 26293411]	This study was supported by the Intramural Research Fund of the National Cerebral and Cardiovascular Center (22-4-5), and Grants-in-Aid from the Ministry of Education Science and Culture of Japan (Nos. 20390489, 23390441 and 26293411).	Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Scuteri A, 2011, ATHEROSCLEROSIS, V215, P459, DOI [10.1016/j.atherosclerosis.2010.12.023, 10.1016/j.athrrosclerosis.2010.12.023]; Yoon AJ, 2012, J CLIN PERIODONTOL, V39, P434, DOI 10.1111/j.1600-051X.2012.01866.x; Higashi Y, 2008, HYPERTENSION, V51, P446, DOI 10.1161/HYPERTENSIONAHA.107.101535; Sardo MA, 2009, CLIN CHIM ACTA, V406, P89, DOI 10.1016/j.cca.2009.05.024; Yang CF, 1999, AM J TROP MED HYG, V61, P226; AINAMO J, 1982, INT DENT J, V32, P281; Kokubo Y, 2008, HYPERTENSION, V52, P652, DOI 10.1161/HYPERTENSIONAHA.108.118273; Liu ZD, 2012, ATHEROSCLEROSIS, V221, P232, DOI 10.1016/j.atherosclerosis.2011.12.026; Epstein SE, 1999, CIRCULATION, V100, pE20; Yue Y, 2013, INT J BIOL MARKER, V28, P108, DOI [10.5301/jbm.5000014, 10.5301/JBM.5000014]; Sexton WM, 2011, J CLIN PERIODONTOL, V38, P434, DOI 10.1111/j.1600-051X.2011.01706.x; Nomura Y, 2012, ARCH ORAL BIOL, V57, P413, DOI 10.1016/j.archoralbio.2011.09.011; Gokulakrishnan K, 2008, CLIN BIOCHEM, V41, P480, DOI 10.1016/j.clinbiochem.2008.01.030; Lopez-Jornet P, 2012, J PERIODONTOL, V83, P690, DOI 10.1902/jop.2011.110412; Vita JA, 2002, CIRCULATION, V106, P164, DOI 10.1161/01.CIR.0000023452.26135.34; Freitas WM, 2011, ATHEROSCLEROSIS, V216, P212, DOI 10.1016/j.atherosclerosis.2011.01.040; Ohara T, 2013, STROKE, V44, P3537, DOI 10.1161/STROKEAHA.113.002957; Pizzi C, 2010, ATHEROSCLEROSIS, V212, P292, DOI 10.1016/j.atherosclerosis.2010.04.038; Beloqui Q, 2005, EUR HEART J, V26, P153; Genco R, 2002, J AM DENT ASSOC, V133, p14S; Guarneri M, 2013, HYPERTENS RES, V36, P129, DOI 10.1038/hr.2012.136; Joldersma M, 2001, AM J PHYSIOL-ENDOC M, V280, P436; Kapellas K, 2014, HYPERTENSION; Labat C, 2013, J HYPERTENS, V31, P2251, DOI 10.1097/HJH.0b013e328363dccc; Lee A, 2013, J PERIODONTOL, V83, P79; Nakashima A, 2003, INTERNAL MED, V42, P1095, DOI 10.2169/internalmedicine.42.1095; Okazaki S, 2010, CEREBROVASC DIS, V30, P180, DOI 10.1159/000317106; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20	29	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	NOV	2014	237	1					123	128		10.1016/j.atherosclerosis.2014.08.046		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT5WT	WOS:000345011300020		
J	Chitose, T; Sugiyama, S; Sakamoto, K; Shimomura, H; Yamashita, T; Hokamaki, J; Tsunoda, R; Shiraishi, S; Yamashita, Y; Ogawa, H				Chitose, Tadasuke; Sugiyama, Seigo; Sakamoto, Kenji; Shimomura, Hideki; Yamashita, Takuro; Hokamaki, Jun; Tsunoda, Ryusuke; Shiraishi, Shinya; Yamashita, Yasuyuki; Ogawa, Hisao			Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction - A pilot study	ATHEROSCLEROSIS			English	Article						ST-elevated acute myocardial infarction; Statin; Reperfusion; Scintigraphy	ACUTE CORONARY SYNDROMES; CHRONIC HEART-FAILURE; INHIBITORS INDUCE APOPTOSIS; COA REDUCTASE INHIBITORS; COENZYME-A REDUCTASE; ATORVASTATIN PRETREATMENT; CHOLESTEROL LEVELS; SEGMENT ELEVATION; CONTROLLED TRIAL; PRIMARY PCI	Objective: Early statin therapy after acute coronary syndrome reduces atherothrombotic vascular events. This study aimed to compare the effects of hydrophilic and hydrophobic statins on myocardial salvage and left ventricular (LV) function in patients with ST-elevated myocardial infarction (STEMI). Methods: Seventy-five STEMI patients who had received emergency reperfusion therapy were enrolled and randomized into the hydrophilic statin group (rosuvastatin; 5mg/day, n = 38) and hydrophobic statin group (atorvastatin; 10 mg/day, n = 37) for 6 months. LV ejection fraction (LVEF), and B-type natriuretic peptide (BNP) and co-enzyme Q10 (CoQ10) levels were measured at baseline and the end of treatment. The myocardial salvage index was assessed by single photon emission computed tomography with I123--beta-methyl-iodophenylpentadecanoic acid (ischemic area-at-risk at onset of STEMI: AAR) and (201)-thallium scintigraphy (area-at-infarction at 6 months: AAI) [myocardial salvage index = (AAR-AAI) x 100/AAR (%)]. Results: Onset-to-balloon time and maximum creatine phosphokinase levelswere comparable between the groups. After 6 months, rosuvastatin (-37.6% +/- 17.2%) and atorvastatin (-32.4% +/- 22.4%) equally reduced low-density lipoprotein-cholesterol (LDL-C) levels (p = 0.28). However, rosuvastatin (+3.1% +/- 5.9%, p < 0.05), but not atorvastatin (+1.6% +/- 5.7%, p = 0.15), improved LVEF. Rosuvastatin reduced BNP levels compared with atorvastatin (-53.3% +/- 48.8% versus -13.8% +/- 82.9%, p < 0.05). The myocardial salvage index was significantly higher in the rosuvastatin group than the atorvastatin group (78.6% +/- 29.1% versus 52.5% +/- 38.0%, p < 0.05). CoQ10/LDL-C levels at 6 months were increased in the rosuvastatin group (+23.5%, p < 0.01) and percent changes in CoQ10/LDL-C were correlated with the myocardial salvage index (r = 0.56, p < 0.01). Conclusion: Rosuvastatin shows better beneficial effects on myocardial salvage than atorvastatin in STEMI patients, including long-term cardiac function, associated with increasing CoQ10/LDL-C. Clinical trial registration: URL http://www.umin.ac.jp/ctr/index.htm Unique Identifier: UMIN000003893. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Chitose, Tadasuke; Sugiyama, Seigo; Sakamoto, Kenji; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Fac Life Sci, Dept Cardiovasc Med,Cyuou Ku, Kumamoto 8608556, Japan; [Shimomura, Hideki] Fukuoka Tokushukai Hosp, Div Cardiol, Kasuga, Fukuoka 8160864, Japan; [Chitose, Tadasuke; Yamashita, Takuro] Social Insurance Omuta Tenryo Hosp, Omuta City, Fukuoka 8368566, Japan; [Hokamaki, Jun; Tsunoda, Ryusuke] Kumamoto Red Cross Hosp, Kumamoto 8618520, Japan; [Shiraishi, Shinya; Yamashita, Yasuyuki] Kumamoto Univ, Dept Med Diagnost Radiol, Chuo Ku, Kumamoto 8608556, Japan; [Sugiyama, Seigo] Jinnouchi Hosp, Diabet Care Ctr, Div Cardiovasc Med, Kumamoto 8620976, Japan	Sugiyama, S (reprint author), Kumamoto Univ, Grad Sch Med Sci, Fac Life Sci, Dept Cardiovasc Med,Cyuou Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	titose-t@kumamoto-u.ac.jp; ssugiyam@kumamoto-u.ac.jp; sakakenn@kumamoto-u.ac.jp; hrrmshim@bb.csf.ne.jp; ta-yamashita@omutatenryo-hp.jp; junhokamaki@awa.bbiq.jp; rtsunoda@kumamoto-med.jrc.or.jp; shiraish@kumamoto-u.ac.jp; yama@kumamoto-u.ac.jp; ogawah@kumamoto-u.ac.jp			Ministry of Education, Science, and Culture in Japan [C22590786, C25461086]	This study was supported in part by a grant-in-aid for Scientific Research (Nos. C22590786 and C25461086 for S. Sugiyama) from the Ministry of Education, Science, and Culture in Japan.	Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Frohlich GM, 2013, EUR HEART J, V34, P1714, DOI 10.1093/eurheartj/eht090; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Marcoff L, 2007, J AM COLL CARDIOL, V49, P2231, DOI 10.1016/j.jacc.2007.02.049; YEAGLE PL, 1989, FASEB J, V3, P1833; Lee E, 2005, CLIN PHARMACOL THER, V78, P330, DOI 10.1016/j.clpt.2005.06.013; Reiner Z, 2013, NAT REV CARDIOL, V10, P453, DOI 10.1038/nrcardio.2013.80; Hahn JY, 2011, AM HEART J, V162, P1026, DOI 10.1016/j.ahj.2011.08.011; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Okazaki S, 2004, CIRCULATION, V110, P1061, DOI 10.1161/01.CIR.0000140261.58966.A4; [Anonymous], 1995, LANCET, V345, P1274; Takano H, 2013, CIRC J, V77, P917, DOI 10.1253/circj.CJ-12-1062; Post S, 2012, CATHETER CARDIO INTE, V80, P756, DOI 10.1002/ccd.23449; Kaufmann P, 2006, CELL MOL LIFE SCI, V63, P2415, DOI 10.1007/s00018-006-6235-z; Yamashita S, 1997, ANAL BIOCHEM, V250, P66, DOI 10.1006/abio.1997.2187; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI 10.1093/eurheartj/ehr158; Guijarro C, 1998, CIRC RES, V83, P490; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025; Molyneux SL, 2008, J AM COLL CARDIOL, V52, P1435, DOI 10.1016/j.jacc.2008.07.044; Carnicka S, 2011, PHYSIOL RES, V60, P825; Demyanets S, 2006, BIOCHEM PHARMACOL, V71, P1324, DOI 10.1016/j.bcp.2006.01.016; Granger Christopher B, 2004, Rev Cardiovasc Med, V5 Suppl 5, pS39; Ichihara K, 2002, LANCET, V359, P2195, DOI 10.1016/S0140-6736(02)09098-0; ICHIHARA K, 1993, J CARDIOVASC PHARM, V22, P852; Katsiki N, 2010, ATHEROSCLEROSIS, V211, P9, DOI 10.1016/j.atherosclerosis.2009.12.028; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Miyauchi K, 2006, CIRC J, V70, P1624, DOI 10.1253/circj.70.1624; Perk Joep, 2012, Atherosclerosis, V223, P1, DOI 10.1016/j.atherosclerosis.2012.05.007; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sakamoto T, 2007, CIRC J, V71, P1348, DOI 10.1253/circj.71.1348; Satoh K, 2008, J PHARMACOL SCI, V106, P593, DOI 10.1254/jphs.08017FP; Satoh K, 2000, J CARDIOVASC PHARM, V35, P256, DOI 10.1097/00005344-200002000-00012; Sheiban I, 2001, J AM COLL CARDIOL, V38, P464, DOI 10.1016/S0735-1097(01)01407-3; Toyama K, 2011, ATHEROSCLEROSIS, V217, P158, DOI 10.1016/j.atherosclerosis.2011.02.050; Yoshinaga K, 2011, CIRC J, V75, P2187, DOI 10.1253/circj.CJ-10-1272	40	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	NOV	2014	237	1					251	258		10.1016/j.atherosclerosis.2014.08.053		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT5WT	WOS:000345011300039		
J	Matsumura, Y; Sugioka, K; Fujita, S; Ito, A; Iwata, S; Yoshiyama, M				Matsumura, Yoshiki; Sugioka, Kenichi; Fujita, Suwako; Ito, Asahiro; Iwata, Shinichi; Yoshiyama, Minoru			Association between chronic kidney disease and thoracic aortic atherosclerosis detected using transesophageal echocardiography	ATHEROSCLEROSIS			English	Article						Aorta; Atherosclerosis; Kidney; Echocardiography	RENAL DYSFUNCTION; ISCHEMIC-STROKE; RISK-FACTOR; CARDIOVASCULAR-DISEASE; SYSTEMIC EMBOLIZATION; ATRIAL-FIBRILLATION; ARCH; PREVALENCE; PLAQUES; PREVENTION	Objective: Accelerated atherosclerosis occurs with a high frequency in patients with chronic kidney disease (CKD). We evaluated the association between CKD and thoracic aortic plaques using transesophageal echocardiography (TEE). Methods: This study population consisted of 297 patients who underwent TEE. Aortic plaques were evaluated in the proximal thoracic aorta (PTA) (from the ascending aorta to the aortic arch) and the distal thoracic aorta (DTA) (the descending aorta) using TEE. Aortic plaques were defined as complex plaques of >= 4 mm thickness and with ulceration or mobile components. CKD was defined as the estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m(2). The association between CKD and aortic plaques was evaluated using multivariate analysis after adjusting for traditional atherosclerotic risk factors. Results: Patients with CKD (n = 144) had a higher incidence of any plaques and complex plaques compared with those without CKD (n = 153) (85% vs. 47% and 42% vs. 17%, respectively, both P < 0.001). Univariate analysis indicated that the presence of CKD was significantly associated with complex plaques both in the DTA and the PTA (both, P < 0.001); however, multivariate analysis indicated that the presence of CKD was associated with only complex plaques in the DTA (P < 0.05), but not with those in the PTA. Conclusion: The presence of CKD was associated with complex aortic plaques, with this association being stronger for complex plaques in the DTA than those in the PTA. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Matsumura, Yoshiki; Sugioka, Kenichi; Fujita, Suwako; Ito, Asahiro; Iwata, Shinichi; Yoshiyama, Minoru] Osaka City Univ, Grad Sch Med, Dept Cardiovasc Med, Abeno Ku, Osaka 5458585, Japan	Matsumura, Y (reprint author), Osaka City Univ, Grad Sch Med, Dept Cardiovasc Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	matsumura@med.osaka-cu.ac.jp					AMARENCO P, 1994, NEW ENGL J MED, V331, P1474, DOI 10.1056/NEJM199412013312202; Di Tullio MR, 2009, CIRCULATION, V119, P2376, DOI 10.1161/CIRCULATIONAHA.108.811935; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Muntner P, 2004, ANN INTERN MED, V140, P9; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; Shlipak MG, 2003, CIRCULATION, V107, P87, DOI 10.1161/01.CIR.0000042700.48769.59; FINE MJ, 1987, ANGIOLOGY, V38, P769, DOI 10.1177/000331978703801007; Weiner DE, 2004, AM J KIDNEY DIS, V44, P198, DOI 10.1053/j.ajkd.2004.04.024; [Anonymous], 1998, ANN INTERN MED, V128, P639; Kronzon I, 2006, CIRCULATION, V114, P63, DOI 10.1161/CIRCULATIONAHA.105.593418; Sugioka K, 2011, AM J CARDIOL, V108, P1002, DOI 10.1016/j.amjcard.2011.05.036; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke, 1996, N ENGL J MED, V334, P1216; Blackshear JL, 1999, STROKE, V30, P834; COY KM, 1992, AM HEART J, V123, P1684, DOI 10.1016/0002-8703(92)90823-E; DANIEL WG, 1991, CIRCULATION, V83, P817; Davila-Roman VG, 1999, J THORAC CARDIOV SUR, V117, P111, DOI 10.1016/S0022-5223(99)70475-7; Desai MY, 2008, J AM SOC ECHOCARDIOG, V21, P751, DOI 10.1016/j.echo.2007.10.028; Ferrari E, 1999, J AM COLL CARDIOL, V33, P1317, DOI 10.1016/S0735-1097(99)00003-0; Gu XY, 2011, AM J CARDIOL, V107, P175, DOI 10.1016/j.amjcard.2010.09.003; Haruki N, 2010, CIRC J, V74, P2627, DOI 10.1253/circj.CJ-10-0288; Izumi C, 2010, CIRC J, V74, P2152, DOI 10.1253/circj.CJ-10-0414; KASSIRER JP, 1969, NEW ENGL J MED, V280, P812, DOI 10.1056/NEJM196904102801506; Khoury Z, 1997, AM J CARDIOL, V79, P23; McNamara RL, 1997, ANN INTERN MED, V127, P775; Montgomery DH, 1996, J AM COLL CARDIOL, V27, P95, DOI 10.1016/0735-1097(95)00431-9; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS1, DOI DOI 10.1053/AJKD.2002.30571.PUBMED:11904577; STONE DA, 1995, AM HEART J, V130, P105, DOI 10.1016/0002-8703(95)90243-0; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; Sugioka K, 2002, STROKE, V33, P2077, DOI 10.1161/01.STR.0000021410.83049.32; TUNICK PA, 1991, ANN INTERN MED, V115, P423; TUNICK PA, 1990, AM HEART J, V120, P658, DOI 10.1016/0002-8703(90)90024-R; TUNICK PA, 1994, J AM COLL CARDIOL, V23, P1085	34	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	NOV	2014	237	1					301	306		10.1016/j.atherosclerosis.2014.09.013		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT5WT	WOS:000345011300046		
J	Nakanishi, K; Fukuda, S; Tanaka, A; Otsuka, K; Jissho, S; Taguchi, H; Yoshikawa, J; Shimada, K				Nakanishi, Koki; Fukuda, Shota; Tanaka, Atsushi; Otsuka, Kenichiro; Jissho, Satoshi; Taguchi, Haruyuki; Yoshikawa, Junichi; Shimada, Kenei			Persistent epicardial adipose tissue accumulation is associated with coronary plaque vulnerability and future acute coronary syndrome in non-obese subjects with coronary artery disease	ATHEROSCLEROSIS			English	Article						Epicardial adipose tissue; Acute coronary syndrome; Multidetector computed tomography	TYPE-2 DIABETES-MELLITUS; PERICARDIAL FAT; CT ANGIOGRAPHY; COMPUTED-TOMOGRAPHY; ATHEROSCLEROTIC PLAQUE; BARIATRIC SURGERY; WEIGHT-LOSS; OBESITY; COMMITTEE; COLLEGE	Objective. Epicardial adipose tissue (EAT) is recognized as a novel risk factor for coronary artery disease (CAD), and its contribution is thought to be stronger in non-obese patients than in obese patients. However, the prognostic impact of the progression of EAT accumulation after comprehensive management for atherosclerotic risk factors remains unclear. This study aimed to investigate whether an increase of the EAT volume during follow-up predicts future acute coronary syndrome (ACS) events in non-obese CAD patients. Methods. This study consisted of 517 non-obese CAD patients (368 men; age, 66 +/- 10 years) who underwent serial multidetector computed tomography (MDCT) examinations to evaluate coronary atherosclerosis progression. The MDCT examination was used to assess the severity of stenosis, plaque characteristics, and EAT volume. All patients received comprehensive management to reduce CAD risk factors after the first MDCT examination. The MDCT examination was repeated at 6-24 months, and patients were followed-up for more than 1 year or until the occurrence of ACS events. Results. Of 517 patients, 159 (31%) patients were classified into increase of EAT volume during follow-up, 91 (18%) into decrease of EAT volume during follow-up, and 267 (51%) patients into constant of EAT volume during follow-up. The prevalence of obstructive plaques and MDCT-derived vulnerable features of coronary plaques were significantly elevated in patients with increase of EAT volume during follow-up. In contrast, no significant changes were observed in the other 2 groups. During the follow-up period of 4.1 +/- 1.8 years (median 4.4 years) after the second MDCT examination, ACS occurred in 43 (8.3%) patients. Multivariate Cox regression analysis showed that the presence of low-attenuation plaque (hazard ratio [HR]; 1.78, p = 0.04) and napkin-ring sign (HR; 3.74, p < 0.001) at second MDCT examination, and changes of EAT volume per 10 ml (HR; 1.34, p = 0.004) were associated with future ACS events. Conclusion. Patients with increase of EAT volume during follow-up despite comprehensive management for CAD risks had an increased prevalence of obstructive plaques and plaques with high-risk features, which could be associated with unfavorable ACS outcomes in non-obese CAD patients. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Nakanishi, Koki; Otsuka, Kenichiro; Shimada, Kenei] Osaka City Univ, Grad Sch Med, Dept Internal Med & Cardiol, Osaka 558, Japan; [Fukuda, Shota; Jissho, Satoshi; Taguchi, Haruyuki] Osaka Ekisaikai Hosp, Dept Med, Osaka, Japan; [Tanaka, Atsushi] Social Insualance Kinan Hosp, Dept Cardiovasc Med, Tanabe, Japan; [Yoshikawa, Junichi] Nishinomiya Watanabe Cardiovasc Ctr, Nishinomiya, Hyogo, Japan	Nakanishi, K (reprint author), Osaka City Univ, Grad Sch Med, Dept Internal Med & Cardiol, Osaka 558, Japan.	blacktea10redtea@yahoo.co.jp					Konishi M, 2010, ATHEROSCLEROSIS, V209, P573, DOI 10.1016/j.atherosclerosis.2009.10.008; Sarin S, 2008, AM J CARDIOL, V102, P767, DOI 10.1016/j.amjcard.2008.04.058; Bettencourt N, 2012, INT J CARDIOL, V158, P26, DOI 10.1016/j.ijcard.2010.12.085; Inoue K, 2010, JACC-CARDIOVASC IMAG, V3, P691, DOI 10.1016/j.jcmg.2010.04.011; Nakanishi K, 2012, CIRC J, V76, P2748, DOI 10.1253/circj.CJ-12-0637; Otsuka K, 2013, JACC-CARDIOVASC IMAG, V6, P448, DOI [10.1016/j.jcmg.2012.09.016, 10.1016/j.jcmg.2012.12.016]; Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53; Ding JZ, 2009, AM J CLIN NUTR, V90, P499, DOI 10.3945/ajcn.2008.27358; Moscariello A, 2011, EUR RADIOL, V21, P2130, DOI 10.1007/s00330-011-2164-9; Maruyama T, 2008, J AM COLL CARDIOL, V52, P1450, DOI 10.1016/j.jacc.2008.07.048; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; [Anonymous], 2002, CIRC J, V66, P987; Korosoglou G, 2011, HEART, V97, P823, DOI 10.1136/hrt.2010.193201; Snel M, 2012, OBESITY, V20, P1572, DOI 10.1038/oby.2011.390; Bischoff B, 2009, JACC-CARDIOVASC IMAG, V2, P940, DOI 10.1016/j.jcmg.2009.02.015; Jonker JT, 2010, J CLIN ENDOCR METAB, V95, P456, DOI 10.1210/jc.2009-1441; Gorter PM, 2008, AM J CARDIOL, V102, P380, DOI 10.1016/j.amjcard.2008.04.002; Cheng VY, 2010, JACC-CARDIOVASC IMAG, V3, P352, DOI 10.1016/j.jcmg.2009.12.013; Gaborit B, 2012, J AM COLL CARDIOL, V60, P1381, DOI 10.1016/j.jacc.2012.06.016; Laufer EM, 2010, ARTERIOSCL THROM VAS, V30, P1269, DOI 10.1161/ATVBAHA.109.200394; Payne GA, 2012, BRIT J PHARMACOL, V165, P659, DOI 10.1111/j.1476-5381.2011.01370.x; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Takaoka M, 2009, CIRC RES, V105, P906, DOI 10.1161/CIRCRESAHA.109.199653; Alexopoulos N, 2013, J AM COLL CARDIOL, V61, P1956, DOI 10.1016/j.jacc.2012.12.051; Gibbons Raymond J., 2003, Journal of the American College of Cardiology, V41, P159, DOI 10.1016/S0735-1097(02)02848-6; Iacobellis G, 2008, OBESITY, V16, P1693, DOI 10.1038/oby.2008.251; Kim MK, 2009, NUTR METAB CARDIOVAS, V19, P760, DOI 10.1016/j.numecd.2009.01.010; Nakanishi K, 2012, J CARDIOL, V59, P167, DOI 10.1016/j.jjcc.2011.11.010; Tanaka A, 2008, CIRC J, V72, P1276, DOI 10.1253/circj.72.1276; Alpert JS, 2000, EUR HEART J, V21, P1502; Willens HJ, 2007, AM J CARDIOL, V99, P1242, DOI 10.1016/j.amjcard.2006.12.042	31	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	NOV	2014	237	1					353	360		10.1016/j.atherosclerosis.2014.09.015		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT5WT	WOS:000345011300052		
